data_2k6y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k6y _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.418 ' H ' ' HB ' ' A' ' 21' ' ' THR . 8.5 mt-10 . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.665 -0.495 . . . . 5.6200000000000001 109.665 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.59 176.71 29.88 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.386 0.993 . . . . 1.1499999999999999 113.768 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -161.12 161.94 31.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.528 1.531 . . . . 1.9399999999999999 112.186 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.07 126.4 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.822 -0.807 . . . . 1.73 108.822 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.01 117.84 30.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.112 1.365 . . . . 5.0700000000000003 109.013 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -74.59 -171.53 1.27 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.263 1.03 . . . . 4.0599999999999996 113.637 -170.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.11 167.64 2.73 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.311 1.845 . . . . 2.1600000000000001 109.95 160.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.04 -6.91 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.123 2.548 . . . . 1.7 113.088 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.39 169.19 21.19 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.109 1.338 . . . . 1.5900000000000001 113.109 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.41 -7.68 39.15 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 118.068 0.934 . . . . 1.9399999999999999 113.542 -0.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -128.55 167.53 16.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.182 1.393 . . . . 2.02 114.173 -170.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.85 -173.1 2.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.028 2.131 . . . . 1.3400000000000001 112.585 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.24 154.43 43.82 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.611 0.967 . . . . 1.72 113.611 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.89 146.89 33.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.769 1.228 . . . . 1.49 112.958 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -140.82 157.42 45.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.404 1.482 . . . . 3.1600000000000001 112.657 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -166.41 158.44 13.73 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.949 1.463 . . . . 2.7000000000000002 114.949 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 5' ' ' GLU . 15.7 m -84.54 133.0 34.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.773 2.029 . . . . 2.3799999999999999 107.778 159.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.73 141.32 27.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.622 1.169 . . . . 3.3199999999999998 111.175 -167.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.31 153.07 23.0 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.002 0.742 . . . . 3.0699999999999998 113.002 -160.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -120.93 112.43 33.54 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.106 1.362 . . . . 1.0600000000000001 110.972 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.17 -9.06 10.67 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.858 2.372 . . . . 1.1699999999999999 113.666 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.01 168.88 52.55 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.177 0.894 . . . . 1.1499999999999999 113.665 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.0 m-20 -94.55 -4.81 47.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.13 1.772 . . . . 2.79 112.823 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.68 160.34 38.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.046 1.738 . . . . 2.1699999999999999 109.949 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.87 156.42 30.92 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.919 2.413 . . . . 0.71999999999999997 111.902 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.94 150.41 21.96 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.556 0.742 . . . . 3.1000000000000001 109.97 166.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -133.57 109.83 9.5 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.058 1.343 . . . . 3.96 109.169 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 tp -91.17 112.8 24.86 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.706 2.402 . . . . 1.8500000000000001 108.519 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.58 -11.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.198 0.999 . . . . 1.79 112.962 -169.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.65 -160.61 28.13 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 124.202 0.906 . . . . 0.56999999999999995 112.318 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.69 -178.29 6.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.5 1.12 . . . . 1.5800000000000001 110.618 164.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -155.41 135.94 13.35 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.052 -1.462 . . . . 6.3200000000000003 107.052 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -152.55 152.8 29.54 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.936 0.895 . . . . 1.5900000000000001 110.909 -163.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.45 -11.37 10.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.521 2.814 . . . . 1.0 113.707 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.324 0.8 OUTLIER -94.0 -4.01 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 114.1 1.148 . . . . 1.98 114.1 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.29 158.74 44.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.677 1.191 . . . . 1.9099999999999999 112.04 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -98.67 -60.91 1.45 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 3.2999999999999998 109.806 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -84.39 134.44 34.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.373 1.069 . . . . 3.5 109.34 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 p -147.97 136.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.649 1.979 . . . . 2.1600000000000001 108.527 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -148.62 135.98 20.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.174 1.39 . . . . 1.99 110.458 -168.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -81.21 125.51 30.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.85 1.31 . . . . 2.0899999999999999 110.875 168.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.5 m170 -119.05 157.54 27.6 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.576 2.35 . . . . 0.75 111.461 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -99.58 173.76 6.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.908 1.683 . . . . 2.02 110.272 164.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -127.99 130.25 48.06 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.961 -1.866 . . . . 1.77 105.961 157.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -111.85 163.91 13.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.74 1.216 . . . . 3.6600000000000001 113.125 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -108.46 143.87 36.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.893 -1.048 . . . . 3.6200000000000001 108.24 146.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.1 136.34 10.89 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.331 1.053 . . . . 5.8700000000000001 109.832 -175.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.43 148.25 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.146 0.578 . . . . 4.0 110.631 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.46 -87.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.118 1.367 . . . . 3.6200000000000001 109.305 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -75.41 34.75 0.11 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.902 2.081 . . . . 3.3599999999999999 111.456 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.52 -19.79 0.65 Allowed Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.272 -1.517 . . . . 1.97 113.827 -164.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -83.03 146.53 28.69 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.892 2.077 . . . . 3.1099999999999999 109.743 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -79.52 121.1 24.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.574 0.75 . . . . 4.5599999999999996 111.412 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.1 t -112.64 148.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.653 1.981 . . . . 2.7599999999999998 108.686 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.4 mtm -134.56 142.08 46.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.21 1.004 . . . . 4.2300000000000004 111.963 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.82 -177.61 44.07 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.616 1.103 . . . . 1.8300000000000001 113.078 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -107.55 159.13 16.67 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.903 1.281 . . . . 2.98 112.643 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.92 155.42 10.84 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.44 1.496 . . . . 4.4500000000000002 111.158 171.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.9 Cg_endo -67.44 149.38 80.34 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.646 1.564 . . . . 0.95999999999999996 112.033 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -114.26 158.65 39.15 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.923 1.689 . . . . 2.3599999999999999 109.565 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.62 -19.37 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.238 1.958 . . . . 1.75 112.63 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.2 p90 177.47 171.52 0.58 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.744 2.018 . . . . 3.3399999999999999 110.924 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mt -116.57 171.68 7.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.021 1.729 . . . . 2.1200000000000001 108.969 153.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -155.21 164.92 38.15 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.06 -1.025 . . . . 1.97 111.743 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.36 128.66 9.13 Favored Pre-proline 0 N--CA 1.466 0.365 0 C-N-CA 125.02 1.328 . . . . 2.0800000000000001 108.162 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.82 164.69 32.46 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.762 1.641 . . . . 1.04 111.05 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.6 137.99 83.26 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.173 2.582 . . . . 1.1200000000000001 110.971 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 62.1 mmtt 66.31 0.93 1.86 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 2.6600000000000001 113.646 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.28 -179.06 45.5 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.746 2.117 . . . . 1.45 113.65 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -155.73 147.83 23.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.397 -1.901 . . . . 5.29 111.355 -172.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.01 167.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.359 2.264 . . . . 2.4399999999999999 109.958 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.97 129.37 38.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.81 0.814 . . . . 4.2999999999999998 111.201 168.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -75.53 71.88 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.539 1.536 . . . . 1.6399999999999999 109.291 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -68.37 140.59 92.81 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.635 1.574 . . . . 3.9300000000000002 111.697 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.7 -32.33 68.49 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.023 2.482 . . . . 1.53 112.928 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.42 51.56 4.53 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.851 0.75 . . . . 1.1899999999999999 111.311 163.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.65 -136.92 4.29 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.119 1.343 . . . . 2.6200000000000001 112.974 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -73.07 144.58 47.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.838 0.855 . . . . 3.3399999999999999 112.167 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -171.04 174.22 4.77 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.322 1.049 . . . . 0.98999999999999999 109.762 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -101.62 131.82 47.62 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.107 0.563 . . . . 3.3599999999999999 110.518 166.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -90.76 141.66 28.57 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.538 0.735 . . . . 1.73 109.969 160.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.44 141.59 51.45 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.909 1.683 . . . . 2.6499999999999999 109.66 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -147.43 144.49 28.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.992 1.317 . . . . 2.7799999999999998 111.232 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.84 0.56 Allowed Glycine 0 N--CA 1.466 0.66 0 N-CA-C 109.202 -1.559 . . . . 2.3300000000000001 109.202 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.43 101.38 4.79 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.001 0.905 . . . . 1.9099999999999999 110.265 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -79.5 -4.73 52.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.32 0.859 . . . . 2.7400000000000002 113.32 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -126.39 142.51 43.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 126.715 2.006 . . . . 6.54 108.585 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.14 151.6 72.58 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.655 1.57 . . . . 1.9399999999999999 108.624 157.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.3 mt -120.86 132.0 54.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.098 0.951 . . . . 4.0 112.122 -170.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 127.71 54.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.793 1.637 . . . . 3.8500000000000001 106.968 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 151.5 11.75 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.985 -1.072 . . . . 2.4300000000000002 113.329 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.88 39.03 94.83 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.554 -0.581 . . . . 1.8100000000000001 113.747 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -116.3 -166.52 1.16 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.617 -1.253 . . . . 2.71 107.617 154.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -126.08 159.08 33.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.79 0.805 . . . . 3.5800000000000001 111.913 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.24 116.58 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 125.702 1.601 . . . . 1.8100000000000001 107.273 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.95 134.43 47.2 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.712 -1.218 . . . . 2.9199999999999999 107.712 164.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.98 129.25 15.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.192 0.997 . . . . 2.54 111.13 -168.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.4 99.77 9.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.556 1.942 . . . . 2.04 110.353 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.8 mt -72.43 116.67 13.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.281 . . . . 2.1499999999999999 109.789 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.42 131.52 35.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.457 1.103 . . . . 1.6899999999999999 111.234 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -122.73 155.56 36.22 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.044 0.938 . . . . 3.0600000000000001 112.681 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.69 121.11 12.57 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 2.1000000000000001 112.852 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.71 -156.48 28.95 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.095 1.331 . . . . 3.1000000000000001 111.415 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.73 51.58 3.77 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.103 -0.832 . . . . 2.25 114.8 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -125.05 137.79 54.21 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.518 1.659 . . . . 5.7400000000000002 111.136 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.61 136.77 19.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.294 1.838 . . . . 1.8799999999999999 106.992 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.9 mt -119.76 115.08 23.16 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.921 0.888 . . . . 2.5899999999999999 109.506 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -79.11 133.38 36.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.239 0.615 . . . . 3.4199999999999999 111.658 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.47 170.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.843 1.657 . . . . 2.3399999999999999 110.443 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.95 132.5 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.848 -1.167 . . . . 3.0499999999999998 107.848 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 mt -143.58 144.03 25.97 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.186 1.394 . . . . 2.6899999999999999 110.011 -168.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.88 152.37 57.84 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.831 3.021 . . . . 1.1299999999999999 115.12 -172.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.4 t -83.67 107.43 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.293 2.237 . . . . 2.29 109.881 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.95 136.55 36.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.541 1.936 . . . . 4.0099999999999998 108.83 160.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -105.82 135.79 46.62 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.897 0.379 . . . . 2.4100000000000001 110.319 163.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 130.49 3.516 . . . . 7.6699999999999999 106.53 -161.678 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 113.252 0.834 . . . . 5.25 113.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.36 -173.95 34.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 126.389 1.947 . . . . 1.21 112.36 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.7 p90 -155.26 140.88 17.94 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.135 1.374 . . . . 1.96 110.509 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.08 136.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.333 1.053 . . . . 1.98 109.633 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -24.46 31.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.934 1.694 . . . . 4.8099999999999996 114.962 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.34 174.24 0.26 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.015 2.126 . . . . 4.8600000000000003 115.138 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 m -174.73 174.46 0.92 Allowed Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.209 3.404 . . . . 2.1600000000000001 107.737 151.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.17 -21.85 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.007 1.805 . . . . 2.3500000000000001 112.461 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.3 173.99 13.49 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.259 1.885 . . . . 1.77 111.92 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.79 -11.5 39.54 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 119.263 1.532 . . . . 2.2999999999999998 113.124 -5.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -122.26 168.74 11.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.479 . . . . 2.1299999999999999 112.914 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.56 -175.72 4.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.569 2.348 . . . . 1.3500000000000001 110.339 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.56 17.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.676 1.19 . . . . 1.5600000000000001 112.207 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 158.36 38.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 1.5600000000000001 113.424 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -147.23 154.16 40.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.007 1.723 . . . . 3.6000000000000001 110.75 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.3 160.75 6.3 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.918 1.822 . . . . 3.0 115.918 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.9 m -91.72 105.36 17.66 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.28 2.632 . . . . 2.1699999999999999 109.178 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.6 142.02 28.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.724 1.61 . . . . 4.3300000000000001 110.471 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -109.32 155.77 20.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.149 0.58 . . . . 4.6900000000000004 111.893 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -134.06 110.04 11.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.391 -0.822 . . . . 1.05 109.057 155.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.91 -7.03 3.33 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.212 2.608 . . . . 1.0 114.471 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 169.19 42.7 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.994 1.27 . . . . 1.1899999999999999 112.883 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -85.88 5.28 33.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.556 1.542 . . . . 3.9399999999999999 112.914 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.48 156.26 35.49 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.966 1.707 . . . . 3.9500000000000002 109.266 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.25 157.33 22.91 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.216 2.611 . . . . 0.93999999999999995 110.448 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.93 134.33 54.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.07 0.948 . . . . 3.5299999999999998 110.656 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 68' ' ' GLU . 5.9 ttm180 -126.54 111.06 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.701 1.201 . . . . 5.2699999999999996 110.347 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.06 136.78 32.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.279 1.832 . . . . 2.1099999999999999 108.862 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.42 -10.29 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.21 1.004 . . . . 1.8300000000000001 113.354 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.11 -164.57 35.22 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.447 1.022 . . . . 0.52000000000000002 111.968 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.64 -176.69 5.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.216 1.007 . . . . 1.73 109.626 164.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mtm-85 -142.61 147.27 35.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.877 1.217 . . . . 7.3600000000000003 108.934 163.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.46 ' HG1' HG13 ' A' ' 99' ' ' VAL . 1.4 t -142.9 154.52 62.2 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 125.07 1.348 . . . . 1.78 109.018 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -20.0 27.97 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.058 1.838 . . . . 1.1100000000000001 112.707 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.326 3.2 m -92.84 15.87 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.709 1.003 . . . . 1.8400000000000001 113.709 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.28 165.63 35.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.09 0.956 . . . . 1.9199999999999999 112.728 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.82 -71.83 0.75 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.557 1.543 . . . . 3.5099999999999998 108.004 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -79.2 103.77 9.37 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.991 -1.068 . . . . 4.2300000000000004 109.85 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.91 143.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.9 0.88 . . . . 3.21 110.124 160.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.39 117.0 10.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.823 1.249 . . . . 2.2999999999999998 109.408 168.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.77 120.47 25.19 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.825 -1.172 . . . . 1.8200000000000001 110.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -105.19 152.03 23.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.83999999999999997 112.567 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.37 172.14 10.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.721 1.609 . . . . 2.7999999999999998 110.451 161.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.8 m -151.63 111.85 4.11 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.021 1.328 . . . . 1.77 108.396 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -129.08 160.02 34.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.069 1.348 . . . . 3.0499999999999998 112.383 -161.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -97.48 143.9 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.653 0.781 . . . . 4.1200000000000001 110.197 160.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -155.19 145.35 21.8 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.475 0.71 . . . . 6.7199999999999998 110.932 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -64.42 148.51 50.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.904 1.682 . . . . 3.8199999999999998 111.034 167.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.6 t -138.94 -88.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.667 1.587 . . . . 3.3900000000000001 108.614 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.524 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 5.8 tt0 -77.81 44.97 0.48 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.197 2.199 . . . . 3.4500000000000002 110.319 170.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.69 -37.02 0.48 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 126.283 1.897 . . . . 2.21 113.65 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 43.1 mtmt -78.8 150.64 32.29 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.238 2.615 . . . . 3.1099999999999999 109.218 175.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -87.71 142.42 27.84 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.235 1.198 . . . . 4.0700000000000003 114.235 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.21 150.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.314 2.246 . . . . 2.7599999999999998 108.354 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.2 mmt -93.57 133.96 36.35 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.933 0.893 . . . . 3.8199999999999998 110.946 175.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.01 167.6 24.84 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 123.738 0.685 . . . . 0.94999999999999996 113.461 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.73 137.61 35.26 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.665 1.586 . . . . 3.1200000000000001 109.344 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -150.33 144.85 17.87 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.276 1.43 . . . . 4.5700000000000003 109.247 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.65 142.38 70.47 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.965 1.777 . . . . 0.78000000000000003 110.773 169.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.39 154.38 47.6 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 126.074 1.749 . . . . 1.8 110.606 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.96 -9.31 23.47 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.882 2.388 . . . . 1.0900000000000001 113.954 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -175.57 170.37 2.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.263 1.392 . . . . 3.7799999999999998 111.397 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 166.21 17.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.813 1.645 . . . . 1.6599999999999999 109.215 157.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.3 pt-20 -155.49 161.53 40.91 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.188 -0.945 . . . . 2.8900000000000001 113.034 174.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -148.3 142.67 16.62 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.726 1.21 . . . . 2.4900000000000002 109.517 -166.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.8 16.61 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.475 2.117 . . . . 1.1299999999999999 112.278 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.32 148.36 86.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.894 3.062 . . . . 1.1399999999999999 112.211 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 64.89 -0.27 1.05 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.602 1.561 . . . . 3.3100000000000001 113.843 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.53 111.2 3.67 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.901 1.715 . . . . 0.89000000000000001 111.398 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.45 123.42 44.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.68 1.192 . . . . 5.25 109.061 165.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.41 143.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.106 1.362 . . . . 3.1899999999999999 111.796 -165.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -88.91 144.31 26.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.202 1.001 . . . . 3.2400000000000002 111.765 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.24 73.77 2.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.402 1.081 . . . . 1.73 109.457 158.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 131.77 88.31 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.886 -1.054 . . . . 4.6399999999999997 111.111 173.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.43 -32.89 89.16 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.873 2.382 . . . . 1.51 112.893 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.18 51.77 4.41 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.229 0.919 . . . . 1.73 112.328 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.04 -56.6 0.08 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.82 1.2 . . . . 1.49 114.209 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -155.47 141.62 18.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.055 1.742 . . . . 3.4399999999999999 111.411 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -163.08 176.32 10.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.008 -1.057 . . . . 0.90000000000000002 111.233 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.46 131.07 55.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.825 0.45 . . . . 3.0099999999999998 110.949 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mmt -85.36 144.54 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.88 1.272 . . . . 1.9099999999999999 110.759 154.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -124.05 129.02 50.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.204 1.802 . . . . 2.77 108.682 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -133.64 136.57 44.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.094 0.958 . . . . 2.9500000000000002 111.624 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.36 76.04 0.79 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.675 -1.37 . . . . 2.8599999999999999 109.675 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.2 mt -78.15 135.25 37.62 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.176 -1.046 . . . . 1.8799999999999999 108.176 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -80.51 -0.32 36.97 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.968 -1.082 . . . . 3.6699999999999999 112.264 -169.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -174.21 160.13 2.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.601 2.36 . . . . 7.96 110.156 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.62 146.73 55.64 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.48 2.12 . . . . 3.3599999999999999 110.092 163.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -112.93 168.53 9.62 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.551 1.54 . . . . 3.6899999999999999 111.874 -172.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.39 137.48 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.658 1.183 . . . . 4.1900000000000004 111.862 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.86 129.47 41.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.785 -1.197 . . . . 2.96 110.437 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 52.11 3.66 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 112.174 -0.37 . . . . 2.3399999999999999 112.174 -165.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -129.02 165.02 21.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.955 1.702 . . . . 3.73 107.616 161.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.64 155.56 16.93 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.993 1.317 . . . . 5.5300000000000002 111.003 168.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.46 HG13 ' HG1' ' A' ' 37' ' ' THR . 11.8 t -130.06 124.06 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 126.113 1.765 . . . . 2.1200000000000001 108.567 169.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.62 125.69 29.53 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.079 -0.712 . . . . 3.9300000000000002 109.079 161.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mt -126.67 125.42 41.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.991 0.916 . . . . 2.8500000000000001 111.81 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -105.06 94.7 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.78 1.232 . . . . 2.54 110.568 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.5 mt -65.67 123.36 19.51 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 2.52 110.446 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.8 mt -97.43 131.37 44.14 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.31 1.444 . . . . 1.98 110.342 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -125.67 167.09 15.61 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.683 1.23 . . . . 3.6800000000000002 111.566 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.76 166.47 10.92 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.993 -1.003 . . . . 3.0099999999999998 111.432 168.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.4 15.44 80.3 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.802 0.681 . . . . 4.29 114.802 173.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.62 6.16 89.33 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 118.427 1.113 . . . . 1.8500000000000001 113.767 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -79.29 138.38 37.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.903 1.352 . . . . 7.3399999999999999 112.376 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.15 148.94 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.19 1.796 . . . . 2.6499999999999999 108.105 158.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.0 mt -124.15 125.28 44.2 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.573 1.549 . . . . 3.25 108.4 172.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -87.68 133.31 33.85 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.761 0.824 . . . . 3.0099999999999998 111.651 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.29 127.45 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.835 1.254 . . . . 2.6899999999999999 113.23 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.88 135.48 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.8 1.24 . . . . 2.6099999999999999 111.56 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.9 mt -143.78 160.68 49.47 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 128.041 2.536 . . . . 3.04 111.079 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -84.92 157.17 11.62 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.085 3.19 . . . . 1.0900000000000001 114.624 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -94.32 124.1 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.33 2.252 . . . . 2.04 110.576 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.34 156.09 18.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.983 1.313 . . . . 3.25 109.044 156.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.83 81.51 4.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.366 -0.976 . . . . 3.3999999999999999 108.366 161.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 115.761 -2.066 . . . . 7.1399999999999997 115.486 -158.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 121.043 0.449 . . . . 6.3200000000000003 111.292 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.55 167.45 30.9 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.608 1.099 . . . . 1.25 114.476 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -152.22 143.13 23.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.781 1.232 . . . . 1.71 111.999 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.06 118.16 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 122.963 0.505 . . . . 2.1499999999999999 109.676 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -85.72 96.45 9.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.293 1.037 . . . . 5.5 110.405 -169.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.71 154.53 3.73 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.666 2.386 . . . . 3.3900000000000001 112.884 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.83 149.08 20.26 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 118.463 -0.78 . . . . 3.3999999999999999 109.668 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 56.68 5.6 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.415 2.743 . . . . 2.1600000000000001 109.281 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.79 -164.38 46.15 Favored Glycine 0 CA--C 1.541 1.677 0 O-C-N 121.482 -0.761 . . . . 2.1600000000000001 112.582 -168.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.54 -11.73 20.11 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 117.681 0.74 . . . . 2.9399999999999999 111.331 -28.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -146.82 168.09 22.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.751 2.021 . . . . 2.1800000000000002 109.976 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 -177.34 6.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.535 1.534 . . . . 2.02 111.819 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.81 156.69 43.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 1.98 111.99 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.1 143.21 36.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.118 0.967 . . . . 1.8200000000000001 112.111 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -136.66 141.4 43.16 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.389 1.876 . . . . 3.46 109.58 -172.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -165.22 147.33 7.81 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.331 1.975 . . . . 3.21 116.331 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 m -99.54 129.77 45.73 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.569 1.548 . . . . 2.7000000000000002 108.786 169.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tp -130.69 162.95 28.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 5.2199999999999998 110.734 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.28 141.82 51.86 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.092 1.357 . . . . 3.1600000000000001 111.214 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -100.28 110.91 61.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.512 -0.921 . . . . 1.25 108.512 157.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.87 -15.37 3.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.364 2.709 . . . . 1.3 113.769 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.75 -176.27 51.37 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.045 0.838 . . . . 1.3700000000000001 113.23 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -105.33 12.97 31.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.707 1.603 . . . . 4.0700000000000003 111.437 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mt -113.8 156.37 43.83 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 126.957 2.103 . . . . 3.9399999999999999 109.132 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.72 158.33 24.8 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.991 2.461 . . . . 0.97999999999999998 109.926 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.3 130.56 42.93 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.56 1.144 . . . . 3.6699999999999999 109.73 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -117.26 115.61 25.62 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.864 1.266 . . . . 5.0899999999999999 110.422 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -94.63 117.14 29.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.537 2.335 . . . . 2.0 108.68 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.77 -10.88 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.729 1.011 . . . . 1.77 113.729 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.25 -163.17 31.66 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.664 -0.648 . . . . 0.40000000000000002 112.344 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.97 12.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.731 0.813 . . . . 1.5800000000000001 111.189 167.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -144.85 133.31 21.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.921 1.688 . . . . 8.0 108.058 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -148.9 149.74 30.96 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.421 1.489 . . . . 1.78 110.335 -166.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.1 -37.93 4.31 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.337 2.024 . . . . 1.22 112.157 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.273 2.6 m -84.79 3.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.907 1.447 . . . . 2.0299999999999998 114.907 -169.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.31 137.08 45.82 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.356 -1.465 . . . . 1.71 112.23 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -76.11 -70.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.319 -1.363 . . . . 5.2300000000000004 107.319 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -84.92 143.32 29.08 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.266 2.226 . . . . 3.8999999999999999 109.37 169.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.75 131.81 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.359 1.864 . . . . 2.1600000000000001 107.932 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -142.94 128.68 19.3 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.234 1.414 . . . . 2.2400000000000002 109.493 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.87 121.42 24.82 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.367 1.079 . . . . 1.76 110.454 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -112.36 158.38 19.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.019 2.128 . . . . 0.70999999999999996 112.035 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.86 179.39 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.912 1.685 . . . . 2.02 110.909 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 m -135.22 106.23 6.65 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.195 1.398 . . . . 2.0600000000000001 107.274 163.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -107.0 152.06 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.706 1.202 . . . . 3.3599999999999999 111.225 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -84.77 145.33 27.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.527 0.679 . . . . 4.1600000000000001 110.27 166.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -148.14 160.17 43.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.558 1.543 . . . . 6.3200000000000003 110.333 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -84.57 148.12 26.65 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.528 0.731 . . . . 6.7000000000000002 109.393 164.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.95 -87.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.55 -1.648 . . . . 3.2200000000000002 106.55 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -77.68 43.96 0.43 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.999 2.52 . . . . 3.7999999999999998 110.809 170.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.9 -29.63 0.29 Allowed Glycine 0 N--CA 1.482 1.751 0 O-C-N 119.999 -1.688 . . . . 2.5 115.117 -171.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -69.71 132.22 45.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.828 2.051 . . . . 4.5499999999999998 109.853 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -83.46 102.18 11.9 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.904 -1.147 . . . . 6.3899999999999997 107.904 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.11 155.26 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.516 1.926 . . . . 3.8999999999999999 110.823 -167.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.0 mtm -75.22 153.22 38.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.622 0.971 . . . . 5.4699999999999998 113.622 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.64 160.7 28.28 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.446 1.974 . . . . 1.1599999999999999 110.567 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -123.01 148.31 45.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.897 1.279 . . . . 2.5099999999999998 110.322 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -171.68 157.85 4.49 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 117.165 -1.398 . . . . 4.9900000000000002 111.223 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.4 Cg_endo -69.75 157.35 60.71 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.026 1.817 . . . . 0.78000000000000003 112.605 168.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.03 158.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 126.029 1.732 . . . . 1.8300000000000001 110.613 171.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.4 -11.67 24.75 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.918 2.412 . . . . 0.93999999999999995 113.577 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -179.05 162.24 1.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.307 1.843 . . . . 3.6899999999999999 110.192 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.99 172.85 6.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.471 1.909 . . . . 2.02 108.756 156.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.04 170.17 23.14 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.837 -1.164 . . . . 2.5299999999999998 113.389 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.05 135.28 11.87 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 125.288 1.435 . . . . 1.78 109.465 -167.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.05 168.32 24.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.15 1.9 . . . . 1.01 110.688 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.58 148.59 92.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.082 2.521 . . . . 1.1000000000000001 111.95 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 68.39 -3.38 1.33 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.94 2.096 . . . . 2.7000000000000002 114.48 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.29 117.93 5.18 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 126.204 1.859 . . . . 1.05 112.184 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 127.96 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.54 -0.83 . . . . 7.2000000000000002 110.264 159.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.05 165.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.568 1.547 . . . . 2.1000000000000001 110.608 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.08 114.03 8.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.885 0.874 . . . . 3.9199999999999999 112.099 -163.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.25 67.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.848 2.059 . . . . 1.8899999999999999 109.379 165.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.44 143.56 98.73 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.996 1.719 . . . . 4.21 111.83 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.1 -61.17 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.172 3.248 . . . . 1.3600000000000001 112.668 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 102.32 2.05 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.802 -1.719 . . . . 1.53 108.802 162.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.99 -69.83 0.3 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.822 1.677 . . . . 1.22 112.662 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -155.71 139.19 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.946 1.699 . . . . 3.3700000000000001 109.495 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -167.1 172.36 10.12 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.135 -0.978 . . . . 1.0900000000000001 109.598 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -103.66 141.5 35.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.415 0.552 . . . . 3.6400000000000001 110.225 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.7 mmt -89.17 139.29 30.63 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.858 0.863 . . . . 1.8999999999999999 110.077 159.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -122.0 130.33 53.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.53 1.932 . . . . 3.0800000000000001 109.24 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -136.65 159.45 41.78 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.636 0.774 . . . . 2.98 112.241 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.32 -57.08 3.28 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 126.54 2.019 . . . . 2.7999999999999998 113.672 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.1 mt 76.64 91.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 130.423 3.489 . . . . 2.1699999999999999 111.847 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -74.54 4.37 6.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.627 1.343 . . . . 3.2400000000000002 114.627 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -144.67 152.84 53.7 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 128.713 2.805 . . . . 7.4199999999999999 108.063 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.21 150.64 81.76 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.242 1.961 . . . . 2.6299999999999999 109.516 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.54 134.22 44.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.413 1.485 . . . . 3.9199999999999999 110.141 -170.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.41 101.49 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.029 0.919 . . . . 5.0 109.37 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.64 130.73 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.211 -0.931 . . . . 3.46 111.176 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.09 50.7 2.97 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.057 -0.519 . . . . 2.0800000000000001 112.923 -167.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -137.17 -167.28 2.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.077 1.351 . . . . 2.9399999999999999 109.899 159.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -130.55 153.44 48.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.4 1.08 . . . . 3.3799999999999999 108.742 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.8 115.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.606 1.162 . . . . 2.3700000000000001 108.686 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -63.69 122.99 17.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.701 -1.591 . . . . 3.5899999999999999 109.327 160.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -129.72 116.52 18.91 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.711 0.767 . . . . 2.7599999999999998 110.917 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.32 96.47 9.04 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.833 1.653 . . . . 2.27 108.77 165.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.8 126.76 31.53 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.238 -0.914 . . . . 2.5899999999999999 109.091 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.35 136.86 37.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.929 1.292 . . . . 1.9199999999999999 111.056 -168.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -132.94 148.49 52.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.296 1.046 . . . . 3.9500000000000002 113.014 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.55 163.85 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.067 -0.97 . . . . 2.96 111.971 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.08 76.44 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.791 -0.568 . . . . 4.6600000000000001 113.575 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.01 63.71 3.2 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.553 1.073 . . . . 1.97 111.069 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -144.35 166.03 26.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.872 1.32 . . . . 4.6299999999999999 112.755 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -170.78 147.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 128.234 2.614 . . . . 3.0099999999999998 108.239 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.0 mt -134.62 118.72 17.51 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.052 1.341 . . . . 3.5299999999999998 108.703 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -86.19 125.08 33.28 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.353 -0.842 . . . . 3.3900000000000001 110.673 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.16 133.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.272 1.029 . . . . 2.7799999999999998 108.691 166.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.92 136.96 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.849 -1.167 . . . . 2.9100000000000001 107.849 168.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -142.6 136.39 14.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.321 1.448 . . . . 3.1200000000000001 109.001 -170.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.09 154.05 75.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.323 3.349 . . . . 1.0800000000000001 114.034 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.4 t -79.76 125.94 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 122.797 0.439 . . . . 1.96 110.309 170.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.45 141.77 28.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.485 1.914 . . . . 3.3799999999999999 108.125 162.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.53 22.46 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.629 2.085 . . . . 2.79 116.629 -161.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.272 2.3 tmt_? . . . . . 0 N--CA 1.481 1.079 1 C-N-CA 132.063 4.145 . . . . 9.25 113.789 171.737 . . . . . . . . 2 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 109.409 -0.589 . . . . 5.2999999999999998 109.409 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.94 175.79 22.42 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 119.08 0.855 . . . . 1.26 115.127 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 p90 -155.75 162.67 40.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.962 1.705 . . . . 2.5699999999999998 111.296 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.1 t -131.16 117.73 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.758 -0.589 . . . . 1.8500000000000001 109.655 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.47 95.6 8.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.003 0.921 . . . . 6.5099999999999998 109.914 -171.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.93 145.88 55.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.867 1.667 . . . . 3.5800000000000001 112.709 -176.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.0 t -142.61 148.01 44.89 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.482 1.513 . . . . 3.9900000000000002 107.747 162.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.59 48.31 1.57 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.599 3.533 . . . . 1.74 112.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.55 -173.11 55.16 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 121.346 -0.846 . . . . 1.75 112.419 -168.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.28 -21.45 8.91 Favored 'Cis proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.139 -1.192 . . . . 1.6499999999999999 110.761 -24.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -121.84 165.72 15.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.813 2.045 . . . . 1.9199999999999999 111.81 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.33 -179.15 7.81 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.23 2.212 . . . . 1.99 110.356 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.08 155.36 48.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.726 1.148 . . . . 1.72 113.443 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.48 45.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.466 1.106 . . . . 1.73 113.19 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -156.11 157.94 36.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.013 1.325 . . . . 3.71 112.133 -158.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 178.93 149.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.15 1.537 . . . . 2.8599999999999999 115.15 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.2 m -85.0 135.08 34.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.347 1.859 . . . . 2.4399999999999999 108.838 160.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 tp -136.29 153.16 51.26 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.841 1.257 . . . . 5.0499999999999998 109.693 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.56 134.17 28.46 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.601 -0.687 . . . . 4.3099999999999996 111.047 166.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.73 114.38 47.63 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.453 1.501 . . . . 1.0 110.444 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.69 -15.35 10.91 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.778 2.318 . . . . 1.1699999999999999 113.875 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.62 166.01 54.8 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 122.509 1.061 . . . . 1.1100000000000001 113.611 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -77.72 -17.63 57.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.173 2.189 . . . . 4.7699999999999996 112.281 162.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.01 156.02 60.71 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.479 1.512 . . . . 4.0099999999999998 111.752 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.6 155.26 9.03 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.014 3.143 . . . . 1.72 110.73 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.67 145.74 50.03 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.592 1.557 . . . . 3.2599999999999998 110.432 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -142.45 108.97 5.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.619 1.167 . . . . 5.7400000000000002 111.719 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -94.37 114.73 26.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.098 2.159 . . . . 1.8700000000000001 109.629 -169.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 m -106.29 -11.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.109 1.364 . . . . 2.23 113.724 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.76 -167.61 39.52 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 121.604 -0.685 . . . . 0.71999999999999997 111.749 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.26 152.13 30.83 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.38 1.072 . . . . 1.9099999999999999 110.598 166.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.427 HH22 ' CD ' ' A' ' 100' ' ' GLU . 13.4 ttp85 -110.96 131.25 55.2 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.65 -1.611 . . . . 9.4399999999999995 106.65 -174.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.535 ' HG1' HG13 ' A' ' 99' ' ' VAL . 2.4 t -139.35 149.56 60.97 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.593 1.157 . . . . 1.4299999999999999 109.243 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.52 -21.19 19.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.988 2.459 . . . . 1.0 113.069 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.333 2.5 m -90.93 9.64 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 114.607 1.336 . . . . 1.97 114.607 -176.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.3 167.71 27.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.98 0.912 . . . . 1.8200000000000001 112.792 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -107.4 -77.15 0.6 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.654 1.582 . . . . 3.5499999999999998 109.068 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -75.53 105.24 6.45 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.799 -1.188 . . . . 4.2300000000000004 109.74 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 p -79.56 143.16 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.13 0.972 . . . . 2.9399999999999999 110.456 158.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -136.29 134.19 37.73 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.53 1.532 . . . . 2.1699999999999999 108.48 161.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -86.43 124.79 33.15 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.628 1.558 . . . . 1.95 110.882 167.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -116.15 164.72 14.07 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.842 2.057 . . . . 0.71999999999999997 112.43 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -114.63 -174.57 2.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.115 1.766 . . . . 1.96 111.606 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.1 m -138.25 114.5 10.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.161 -1.422 . . . . 2.3399999999999999 107.161 155.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -90.8 160.01 15.99 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.315 1.046 . . . . 2.9900000000000002 111.593 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.4 mtm -92.08 148.48 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.319 0.648 . . . . 2.9399999999999999 110.089 154.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -158.96 120.81 3.45 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.486 1.514 . . . . 6.6600000000000001 108.008 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.45 152.27 18.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.143 0.577 . . . . 4.8399999999999999 110.74 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.8 t -144.25 116.77 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.145 0.978 . . . . 4.04 108.637 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 61.84 17.92 9.29 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.483 1.513 . . . . 4.6600000000000001 111.785 -168.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.22 74.19 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.9 1.238 . . . . 2.8900000000000001 113.972 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -77.46 137.14 38.5 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.889 1.345 . . . . 3.8199999999999998 108.972 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.97 137.62 58.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.599 -0.715 . . . . 5.5300000000000002 111.807 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 160.21 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.966 0.506 . . . . 2.9900000000000002 110.418 164.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.1 mtm -133.81 156.31 48.25 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.528 1.531 . . . . 3.3300000000000001 110.233 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.37 163.49 33.46 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 123.376 0.512 . . . . 0.96999999999999997 112.914 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -103.59 166.97 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.753 1.221 . . . . 2.3900000000000001 111.096 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -176.51 154.17 1.27 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 126.442 1.897 . . . . 4.3600000000000003 110.34 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -70.98 153.72 63.22 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.123 1.882 . . . . 0.73999999999999999 111.685 167.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.31 156.22 53.08 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 126.208 1.803 . . . . 1.99 110.602 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.08 -20.6 37.8 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.829 2.353 . . . . 0.81000000000000005 112.461 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -176.39 169.5 2.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.914 2.085 . . . . 3.3999999999999999 110.755 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.63 170.53 8.03 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.343 1.457 . . . . 2.0499999999999998 109.598 154.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -139.21 166.81 23.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.189 0.519 . . . . 2.5299999999999998 110.86 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.59 120.62 5.19 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.15 1.38 . . . . 2.48 107.734 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.87 164.74 32.87 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.677 1.584 . . . . 1.28 110.864 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.19 138.46 72.32 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.38 2.72 . . . . 1.0 111.368 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 67.0 -0.37 1.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.563 1.545 . . . . 2.9900000000000002 113.415 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 117.37 4.5 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 127.382 2.42 . . . . 1.3100000000000001 112.071 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -79.77 133.12 36.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.75 -1.225 . . . . 6.8600000000000003 110.923 163.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.85 166.2 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.175 2.19 . . . . 3.5600000000000001 110.088 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.15 110.38 2.31 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.699 0.799 . . . . 4.3099999999999996 109.424 -168.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.09 75.64 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.131 1.372 . . . . 1.9399999999999999 108.004 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -69.34 153.23 96.06 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 127.894 2.478 . . . . 3.52 113.555 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.39 -41.92 24.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.655 2.904 . . . . 2.96 114.092 -162.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.33 128.28 9.52 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.984 -2.046 . . . . 2.2400000000000002 107.984 152.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.08 -143.42 14.85 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.072 1.32 . . . . 2.9199999999999999 111.393 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -73.21 138.7 45.78 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.848 -0.795 . . . . 3.3599999999999999 111.537 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -161.28 158.3 26.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.454 1.102 . . . . 1.02 109.433 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -87.59 135.2 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.973 -0.751 . . . . 3.5699999999999998 108.973 160.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.55 120.34 41.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.549 1.54 . . . . 2.3599999999999999 108.077 168.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.63 142.68 35.89 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.272 1.029 . . . . 4.4199999999999999 110.467 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.35 135.74 24.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.745 1.618 . . . . 3.0600000000000001 111.543 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.07 81.84 0.58 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.714 -0.954 . . . . 2.6600000000000001 110.714 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.16 100.79 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.921 0.867 . . . . 2.0299999999999998 110.459 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -86.75 10.5 15.65 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.534 1.309 . . . . 2.98 114.534 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -145.14 166.29 18.53 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 127.349 2.259 . . . . 5.8899999999999997 109.128 167.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.19 -176.73 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.851 1.7 . . . . 2.8199999999999998 110.278 151.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -176.5 59.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.797 2.439 . . . . 3.71 107.781 -163.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.91 151.25 30.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 7.1299999999999999 113.031 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.38 120.22 8.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.56 -1.2 . . . . 2.3500000000000001 108.455 156.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.23 17.46 46.57 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.107 -1.385 . . . . 1.9299999999999999 114.808 -170.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.84 167.25 10.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.733 1.766 . . . . 3.2799999999999998 107.779 151.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -116.22 147.49 41.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.823 0.849 . . . . 3.4900000000000002 109.163 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.535 HG13 ' HG1' ' A' ' 37' ' ' THR . 22.0 t -106.79 116.86 51.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.18 1.792 . . . . 1.8999999999999999 108.665 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.427 ' CD ' HH22 ' A' ' 36' ' ' ARG . 26.1 tt0 -65.36 129.37 39.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.174 -1.047 . . . . 3.1400000000000001 108.174 156.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.39 126.56 42.66 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.595 0.758 . . . . 3.1400000000000001 110.898 168.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.95 94.13 5.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.215 1.806 . . . . 2.7000000000000002 109.912 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.39 118.6 8.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.275 1.43 . . . . 2.1499999999999999 110.568 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.2 mt -92.41 127.7 38.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.322 1.449 . . . . 2.1899999999999999 110.821 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.12 133.79 50.33 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.815 1.293 . . . . 3.8500000000000001 113.76 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.06 53.59 2.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.965 1.706 . . . . 3.1699999999999999 112.383 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -151.5 26.49 0.96 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.682 2.087 . . . . 5.0700000000000003 113.557 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.98 50.59 45.64 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 124.132 0.873 . . . . 2.4199999999999999 111.368 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -149.73 160.56 43.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.035 1.734 . . . . 4.21 112.832 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -162.81 130.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 129.149 2.98 . . . . 2.3799999999999999 108.51 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.95 121.01 36.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 3.8300000000000001 109.35 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.18 134.56 34.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.901 1.074 . . . . 3.6200000000000001 113.901 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.62 163.67 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.375 1.47 . . . . 3.0299999999999998 109.42 164.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.09 134.88 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.975 -1.491 . . . . 2.8100000000000001 106.975 164.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.8 mt -135.62 148.0 63.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 126.239 1.815 . . . . 3.1600000000000001 108.594 -172.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.87 163.32 33.97 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.511 2.808 . . . . 1.47 111.904 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -102.27 118.75 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.781 0.832 . . . . 1.98 110.802 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -95.36 140.63 29.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.841 2.456 . . . . 4.96 109.189 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.56 -176.66 5.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.456 -1.403 . . . . 3.0499999999999998 111.53 164.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 126.566 1.946 . . . . 12.359999999999999 116.108 -170.767 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.479 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 13.3 tt0 . . . . . 0 CA--C 1.547 0.847 0 CA-C-O 120.999 0.428 . . . . 6.3300000000000001 111.377 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.479 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -93.97 169.92 30.01 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 125.253 1.406 . . . . 1.78 116.354 -174.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -155.05 133.91 12.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.668 1.587 . . . . 2.1000000000000001 111.264 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.97 122.94 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.784 -1.191 . . . . 2.2200000000000002 107.784 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -103.8 87.33 2.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.693 0.797 . . . . 5.3300000000000001 110.127 -161.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.58 144.05 38.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.909 2.083 . . . . 3.3700000000000001 111.389 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -138.32 153.36 72.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.513 1.125 . . . . 3.1299999999999999 109.6 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -65.71 -9.59 23.38 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.977 2.452 . . . . 1.8600000000000001 113.195 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.71 177.83 18.44 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.463 1.03 . . . . 1.6899999999999999 113.836 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 -7.77 32.89 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 117.68 0.74 . . . . 1.6000000000000001 113.105 -4.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -128.47 160.61 31.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.335 1.054 . . . . 4.4400000000000004 112.559 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.98 -174.21 4.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.775 1.63 . . . . 1.3200000000000001 111.916 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.22 154.62 49.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.888 0.875 . . . . 1.8899999999999999 112.978 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.15 146.27 50.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.083 0.953 . . . . 1.95 112.257 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -143.87 156.52 44.49 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.356 1.863 . . . . 3.5699999999999998 110.703 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -168.46 160.21 10.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.346 1.058 . . . . 2.9700000000000002 113.748 -176.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.4 m -81.9 147.8 29.1 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.048 1.339 . . . . 2.96 108.558 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -155.2 131.65 10.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.157 0.983 . . . . 3.52 111.507 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -113.32 145.16 41.53 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.654 1.981 . . . . 3.7200000000000002 112.003 173.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -95.14 97.31 2.53 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 114.372 -1.285 . . . . 1.25 109.652 155.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.46 -8.22 18.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.25 1.967 . . . . 1.1799999999999999 112.939 173.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.17 176.49 50.35 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 124.401 1.001 . . . . 1.1100000000000001 113.606 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 4.8 m-20 -100.37 -5.42 27.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.737 2.015 . . . . 2.7000000000000002 113.0 -174.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 160.33 44.02 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.84 2.056 . . . . 2.4500000000000002 109.7 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 158.73 31.05 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.859 2.372 . . . . 0.81999999999999995 112.877 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.19 146.63 28.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.72 1.208 . . . . 2.8300000000000001 110.197 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -131.82 112.38 12.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.934 1.294 . . . . 4.2800000000000002 109.844 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -97.91 115.6 28.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.017 2.527 . . . . 1.9199999999999999 108.751 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.92 -9.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.448 1.099 . . . . 1.74 113.116 -166.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.87 -168.86 41.02 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.535 1.064 . . . . 0.44 111.841 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.89 -178.62 6.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.894 1.278 . . . . 1.5900000000000001 110.848 172.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.471 HH21 ' CG ' ' A' ' 102' ' ' ASP . 7.0 ttp85 -151.34 139.97 20.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.372 -2.455 . . . . 8.9900000000000002 104.372 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.446 ' HG1' ' CG1' ' A' ' 99' ' ' VAL . 1.7 t -147.37 155.4 46.08 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.055 -1.091 . . . . 1.7 108.055 173.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.39 -29.93 24.81 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.486 2.124 . . . . 0.93000000000000005 113.19 171.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -85.36 -19.98 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.188 1.181 . . . . 2.1299999999999999 114.188 -169.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.84 159.03 22.05 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.21 1.004 . . . . 1.8300000000000001 112.909 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HA ' ' HZ1' ' A' ' 90' ' ' LYS . 11.0 tp10 -98.11 -91.96 0.26 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.183 0.993 . . . . 3.04 111.202 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -78.66 110.49 13.84 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 121.079 -1.013 . . . . 4.7800000000000002 108.736 -172.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -79.61 142.31 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 124.565 1.146 . . . . 3.29 111.253 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -142.05 128.49 20.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.211 1.004 . . . . 2.8199999999999998 109.75 164.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -80.41 116.46 20.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.299 1.047 . . . . 1.8700000000000001 110.476 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -107.96 155.13 20.66 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.509 1.524 . . . . 0.83999999999999997 111.876 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.67 -171.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.142 1.777 . . . . 2.1800000000000002 110.432 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -146.45 114.09 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.888 -1.132 . . . . 2.0699999999999998 108.206 163.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -103.33 174.1 6.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.282 1.433 . . . . 3.02 111.989 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -118.16 154.41 32.21 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.267 1.427 . . . . 3.3900000000000001 110.823 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -155.87 164.35 38.62 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.732 1.613 . . . . 7.1900000000000004 111.731 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.518 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 2.5 tp10 -85.74 142.63 28.86 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.529 0.732 . . . . 4.1600000000000001 110.513 162.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.34 -96.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.988 -0.745 . . . . 3.5499999999999998 108.988 163.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -76.68 37.41 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.972 2.109 . . . . 3.7200000000000002 111.919 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.25 0.44 4.49 Favored Glycine 0 CA--C 1.542 1.738 0 O-C-N 120.388 -1.445 . . . . 2.1400000000000001 113.463 -159.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -95.47 141.32 29.15 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.241 2.616 . . . . 3.8700000000000001 110.17 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 3.0 mmpt? -73.03 136.88 45.09 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.565 -0.743 . . . . 5.9900000000000002 109.821 -175.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -139.78 143.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.647 1.179 . . . . 2.52 109.5 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -114.56 145.66 41.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.753 1.221 . . . . 3.3599999999999999 111.28 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.36 168.87 34.26 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 123.794 0.711 . . . . 1.0700000000000001 113.547 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -103.17 161.1 14.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.93 1.292 . . . . 2.6899999999999999 112.416 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -167.14 154.45 8.39 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.289 1.835 . . . . 4.6500000000000004 110.071 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.01 150.03 72.3 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.685 2.257 . . . . 1.29 111.458 167.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.11 158.43 41.01 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.955 1.702 . . . . 2.0299999999999998 110.459 169.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.84 -16.9 41.93 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.659 2.24 . . . . 1.0600000000000001 112.937 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 177.49 163.43 0.56 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.951 2.1 . . . . 3.0899999999999999 109.756 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mt -105.22 170.82 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.312 1.445 . . . . 1.9199999999999999 109.638 155.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.15 158.06 39.82 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.189 -0.944 . . . . 2.4399999999999999 111.813 170.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.45 128.31 13.73 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.461 1.504 . . . . 2.0099999999999998 108.863 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.01 162.67 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.532 2.155 . . . . 0.92000000000000004 111.522 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.04 139.47 87.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.704 2.936 . . . . 0.91000000000000003 112.639 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 68.8 mmtt 69.13 2.83 3.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.158 2.183 . . . . 2.5800000000000001 114.301 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.42 144.13 16.97 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 126.989 2.233 . . . . 1.1899999999999999 109.645 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -117.24 150.65 38.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.978 1.311 . . . . 4.6500000000000004 112.714 166.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.65 168.26 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.324 1.85 . . . . 2.6299999999999999 110.677 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -135.07 132.88 38.71 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.199 -1.408 . . . . 4.5099999999999998 107.199 162.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.59 77.39 1.99 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.156 1.455 . . . . 1.98 111.356 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -64.25 123.78 83.55 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 117.575 -1.202 . . . . 5.4000000000000004 111.452 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -47.87 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.844 3.696 . . . . 1.71 114.606 -171.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 56.86 4.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.566 1.079 . . . . 1.3500000000000001 111.991 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.86 -53.86 0.05 OUTLIER Glycine 0 N--CA 1.466 0.635 0 C-N-CA 126.097 1.808 . . . . 1.53 112.781 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -152.93 140.45 19.76 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.925 2.09 . . . . 3.6800000000000002 111.223 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -166.58 172.35 10.8 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.857 -1.152 . . . . 0.93000000000000005 111.784 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -105.05 126.69 52.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.012 0.925 . . . . 3.0899999999999999 111.032 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.5 mmt -86.65 137.56 32.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.794 1.238 . . . . 1.8300000000000001 111.42 167.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.7 mt -115.35 88.77 2.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.791 1.636 . . . . 2.8999999999999999 109.261 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -86.92 101.6 13.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.555 1.542 . . . . 3.1800000000000002 110.599 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.5 133.03 4.83 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.347 0.975 . . . . 3.0699999999999998 110.779 -173.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.0 mt -112.98 112.55 24.08 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.374 1.087 . . . . 2.1200000000000001 109.439 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.505 ' HZ1' ' HA ' ' A' ' 41' ' ' GLU . 2.3 pttm -90.54 -9.57 46.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.198 1.184 . . . . 2.98 114.198 -172.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.7 mmt-85 -146.45 150.91 42.18 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.567 1.547 . . . . 9.7699999999999996 109.389 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.1 174.72 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.393 2.729 . . . . 2.7400000000000002 111.432 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -176.42 158.08 1.77 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.346 1.858 . . . . 3.8300000000000001 109.355 -160.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.33 178.17 7.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.025 1.73 . . . . 4.3899999999999997 112.219 174.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.4 133.99 15.53 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.925 1.29 . . . . 2.7599999999999998 112.939 165.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.93 -0.3 89.5 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.301 -1.277 . . . . 2.1600000000000001 115.268 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -77.83 167.41 21.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.863 1.331 . . . . 3.9199999999999999 111.861 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.14 152.96 20.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.306 -1.315 . . . . 3.79 110.525 162.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.446 ' CG1' ' HG1' ' A' ' 37' ' ' THR . 20.8 t -139.84 126.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 126.148 1.779 . . . . 2.2799999999999998 109.049 173.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.31 142.35 57.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.599 -0.519 . . . . 3.6000000000000001 109.599 164.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -141.05 127.37 19.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.52 1.152 . . . . 2.8999999999999999 111.987 157.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.471 ' CG ' HH21 ' A' ' 36' ' ' ARG . 1.5 m-20 -98.94 114.63 27.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.614 1.965 . . . . 2.2000000000000002 109.935 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.54 125.7 29.92 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.546 -0.721 . . . . 3.77 109.816 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt -98.1 128.66 44.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.089 0.956 . . . . 1.6699999999999999 109.879 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.28 156.78 31.77 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.015 0.926 . . . . 3.2799999999999998 112.024 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.81 143.34 57.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.953 0.501 . . . . 2.1400000000000001 111.039 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -168.27 53.53 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.0 -0.84 . . . . 2.9399999999999999 111.0 -164.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.45 40.59 2.21 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.806 -0.82 . . . . 2.5600000000000001 114.379 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -115.84 122.0 44.07 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.047 1.423 . . . . 5.6200000000000001 112.529 -173.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.45 135.49 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.424 1.49 . . . . 2.29 108.466 161.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.5 mt -129.81 128.58 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.587 1.155 . . . . 2.5099999999999998 109.204 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -88.34 134.8 33.72 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.87 0.868 . . . . 3.2999999999999998 112.656 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.32 167.37 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.801 0.84 . . . . 2.4900000000000002 110.514 153.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.74 141.51 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.853 -1.536 . . . . 3.04 106.853 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.2 mt -137.44 151.97 72.22 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.632 1.573 . . . . 3.0800000000000001 110.133 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.71 155.5 44.34 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.627 2.885 . . . . 1.1699999999999999 112.036 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.79 123.34 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.083 0.953 . . . . 1.96 110.823 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.6 149.19 22.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.828 1.651 . . . . 3.4399999999999999 109.233 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.0 23.09 11.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 113.927 1.084 . . . . 2.21 113.927 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.384 1.473 . . . . 8.1199999999999992 112.662 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 109.362 -0.607 . . . . 5.0300000000000002 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.75 157.48 27.42 Favored Glycine 0 N--CA 1.469 0.854 0 O-C-N 120.707 -1.246 . . . . 1.51 115.095 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -136.06 144.63 45.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.904 1.281 . . . . 1.96 111.966 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.8 t -102.28 136.86 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.718 -1.216 . . . . 2.04 107.718 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -104.17 106.62 17.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.156 0.982 . . . . 4.5 110.187 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.36 147.86 29.72 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.085 1.754 . . . . 3.8900000000000001 112.401 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -150.95 158.86 34.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.707 1.603 . . . . 2.4100000000000001 109.805 162.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.43 -15.33 31.11 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.161 2.574 . . . . 1.6699999999999999 113.497 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.4 170.24 14.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.529 1.062 . . . . 1.73 113.0 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.06 -5.56 15.82 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 118.215 1.008 . . . . 2.1600000000000001 113.025 -3.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -122.69 170.06 10.43 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.243 1.817 . . . . 2.2200000000000002 113.997 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.52 -177.21 5.47 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.138 2.175 . . . . 2.02 111.319 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.36 154.25 51.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.159 0.89 . . . . 1.79 112.19 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.53 157.16 43.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.029 0.918 . . . . 1.6399999999999999 112.806 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -149.62 161.85 41.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.46 1.504 . . . . 3.3599999999999999 110.356 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -162.5 159.26 24.72 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 112.854 0.687 . . . . 2.6200000000000001 112.854 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.0 m -83.5 119.65 24.95 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.403 -1.332 . . . . 2.1200000000000001 107.403 150.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.83 134.52 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 3.29 107.452 166.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -128.39 121.77 29.85 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.957 0.903 . . . . 3.6299999999999999 110.125 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -95.49 111.94 57.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.308 1.043 . . . . 1.2 109.974 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -86.44 -12.22 5.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.263 2.642 . . . . 0.98999999999999999 113.711 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.36 160.57 42.15 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.108 0.861 . . . . 1.3 112.488 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.475 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.1 m-20 -90.62 6.78 42.41 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.029 1.732 . . . . 2.9399999999999999 113.616 -174.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.75 157.97 53.16 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.01 1.724 . . . . 2.2599999999999998 110.595 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.99 160.52 30.29 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.229 2.619 . . . . 0.83999999999999997 111.935 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -124.5 124.41 42.22 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.718 1.207 . . . . 3.2799999999999998 111.547 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -118.75 112.0 19.2 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.217 1.407 . . . . 4.7400000000000002 112.791 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.3 tp -100.03 110.23 22.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.897 2.479 . . . . 2.1000000000000001 109.951 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -98.12 -11.94 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.859 1.664 . . . . 2.02 112.954 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.5 -159.82 30.79 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 119.097 0.862 . . . . 0.54000000000000004 113.556 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.45 -171.13 3.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.866 1.267 . . . . 1.8300000000000001 111.164 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -166.43 124.46 1.42 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.674 -1.232 . . . . 6.3700000000000001 107.674 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -138.35 162.08 55.5 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.989 1.316 . . . . 1.7 109.494 -167.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.2 -22.71 3.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.636 2.891 . . . . 0.95999999999999996 113.989 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 2.6 m -86.93 -0.77 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 114.393 1.257 . . . . 2.0800000000000001 114.393 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.7 168.19 27.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.089 2.156 . . . . 2.4199999999999999 109.867 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -106.28 -79.22 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.539 1.063 . . . . 3.79 110.737 171.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -75.27 105.31 6.23 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 120.917 -1.115 . . . . 4.2699999999999996 110.082 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.6 137.69 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.094 1.358 . . . . 2.3100000000000001 111.262 171.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -132.17 129.49 39.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.239 1.816 . . . . 2.0099999999999998 109.137 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.79 117.15 22.48 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.538 1.161 . . . . 1.8200000000000001 110.953 168.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -105.01 152.63 22.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.197 1.799 . . . . 0.64000000000000001 112.032 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.66 172.7 8.09 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.613 1.165 . . . . 1.9399999999999999 110.228 161.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.501 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 53.0 m -149.05 102.32 3.24 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.392 1.477 . . . . 2.0899999999999999 107.487 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -105.6 162.92 13.08 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.174 1.79 . . . . 3.7999999999999998 112.49 -164.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -102.91 151.1 22.84 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.948 -0.569 . . . . 3.46 110.777 151.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -158.97 145.06 16.69 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.754 1.622 . . . . 5.7699999999999996 109.873 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.31 146.86 23.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.258 0.551 . . . . 4.3300000000000001 111.287 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.24 135.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.384 1.874 . . . . 4.21 109.309 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 60.13 20.14 9.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.386 1.075 . . . . 4.2199999999999998 112.185 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.96 -3.81 68.89 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.894 1.235 . . . . 2.3900000000000001 113.959 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -99.44 146.24 26.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.156 1.782 . . . . 4.0700000000000003 110.407 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -77.2 131.03 38.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.834 -0.541 . . . . 4.8600000000000003 110.53 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -128.6 153.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.909 1.684 . . . . 2.8799999999999999 108.841 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.4 mtm -121.03 146.68 46.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.916 . . . . 3.5800000000000001 110.816 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.58 -177.24 31.48 Favored Glycine 0 N--CA 1.468 0.829 0 C-N-CA 124.346 0.974 . . . . 0.97999999999999998 113.081 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.11 162.0 34.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.24 1.416 . . . . 3.1499999999999999 110.655 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -171.45 151.85 3.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.147 1.379 . . . . 4.2400000000000002 111.45 172.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.54 146.69 85.46 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.494 2.129 . . . . 1.0600000000000001 111.803 166.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.49 155.79 51.77 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.922 1.689 . . . . 1.6000000000000001 110.237 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.31 -18.62 44.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.674 2.25 . . . . 0.82999999999999996 112.637 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -179.1 167.22 1.58 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 126.676 1.99 . . . . 3.6899999999999999 110.903 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.69 168.28 9.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.069 1.348 . . . . 1.9199999999999999 109.468 154.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -151.96 161.99 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.822 0.675 . . . . 2.77 112.822 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.29 134.78 24.43 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.952 1.701 . . . . 2.0299999999999998 108.564 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.71 164.05 32.82 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.062 1.841 . . . . 0.94999999999999996 111.289 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.39 147.52 93.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.094 2.529 . . . . 0.96999999999999997 111.663 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 16.2 mmmt 68.12 -0.61 2.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.325 1.85 . . . . 2.29 113.508 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.69 127.58 9.04 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 127.679 2.561 . . . . 1.0 111.646 -170.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -98.22 134.61 41.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.974 1.31 . . . . 6.9299999999999997 112.465 163.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.35 136.29 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.043 . . . . 2.2599999999999998 111.202 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.84 115.68 31.06 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.555 1.542 . . . . 3.3799999999999999 110.352 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -68.15 77.02 0.24 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.746 2.019 . . . . 1.8799999999999999 109.95 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -74.05 138.11 75.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.293 1.437 . . . . 4.3899999999999997 111.773 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.49 -43.33 59.18 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.08 3.187 . . . . 1.3 112.757 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.29 89.71 1.11 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.243 -1.543 . . . . 1.27 109.243 161.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.501 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.53 -76.2 0.26 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.909 1.719 . . . . 1.25 113.589 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -154.74 142.4 19.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.437 1.895 . . . . 3.2799999999999998 111.163 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -162.06 167.95 23.49 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.409 -0.807 . . . . 1.0800000000000001 111.692 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.37 127.95 46.55 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.665 0.786 . . . . 3.0499999999999998 110.186 168.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.8 mmt -91.44 132.8 35.98 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.15 0.98 . . . . 1.8799999999999999 110.068 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.7 147.47 35.51 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.612 1.165 . . . . 4.0 110.609 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mt -146.43 160.81 41.59 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.135 2.174 . . . . 3.1699999999999999 110.175 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.46 57.61 11.06 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-O 118.917 -0.935 . . . . 2.54 111.152 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 mt -66.98 100.13 0.71 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.382 1.091 . . . . 1.99 112.054 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -71.12 -15.08 62.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.452 0.908 . . . . 2.6299999999999999 113.452 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -128.42 147.0 62.05 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.986 2.114 . . . . 6.7599999999999998 110.95 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.01 145.15 35.17 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.246 1.964 . . . . 1.8999999999999999 108.938 149.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 163.88 35.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.424 1.89 . . . . 3.46 111.334 -168.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.01 168.16 19.57 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 118.94 2.941 . . . . 8.0399999999999991 118.94 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.37 133.94 23.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.412 1.885 . . . . 2.6800000000000002 112.406 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 2.34 88.45 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.988 -1.451 . . . . 2.2799999999999998 114.727 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.69 159.84 23.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.788 1.794 . . . . 3.0299999999999998 111.333 170.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -108.66 128.18 54.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.492 1.917 . . . . 3.6299999999999999 109.13 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.41 103.72 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.574 1.15 . . . . 2.1800000000000002 109.545 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -63.25 126.94 29.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.579 -0.897 . . . . 2.9700000000000002 108.579 157.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.9 144.92 27.19 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.248 -0.907 . . . . 2.71 110.501 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -94.03 138.64 31.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.487 2.715 . . . . 3.5899999999999999 110.156 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.8 mt -110.77 125.46 53.57 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.397 2.279 . . . . 2.1299999999999999 109.908 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.2 mt -98.59 124.15 43.2 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.883 0.873 . . . . 1.98 111.633 -170.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.76 141.82 49.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.242 1.201 . . . . 3.2400000000000002 114.242 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.65 88.68 0.71 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.879 1.272 . . . . 2.8599999999999999 111.145 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.74 67.57 0.12 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.051 1.31 . . . . 4.0199999999999996 113.165 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.3 17.41 72.26 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 116.59 1.396 . . . . 1.6399999999999999 116.59 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.04 114.22 20.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.038 1.419 . . . . 4.3099999999999996 112.005 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.37 136.59 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.835 2.454 . . . . 3.71 105.863 146.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.4 mt -144.92 119.63 9.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.198 0.999 . . . . 2.8900000000000001 109.569 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -90.27 146.6 24.1 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.007 1.114 . . . . 5.5099999999999998 114.007 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.6 m -135.17 152.18 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.352 1.861 . . . . 2.0899999999999999 110.034 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.3 p -106.56 132.36 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.132 0.973 . . . . 2.3799999999999999 109.553 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.9 mt -135.07 134.95 22.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.428 1.491 . . . . 2.6800000000000002 110.239 -171.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.62 151.28 79.55 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.984 2.456 . . . . 1.03 113.5 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.99 119.75 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.886 1.275 . . . . 1.78 110.873 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -90.32 149.37 22.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.872 2.069 . . . . 3.5499999999999998 108.892 156.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.25 4.66 4.06 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 116.222 1.934 . . . . 3.0699999999999998 116.222 -155.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.784 1.634 . . . . 8.4499999999999993 112.542 -168.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 107.559 -1.274 . . . . 5.9000000000000004 107.559 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.42 137.11 9.21 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 120.961 1.71 . . . . 1.8799999999999999 114.202 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -128.1 127.07 42.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.473 1.13 . . . . 2.23 111.957 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.74 95.21 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.81 -1.552 . . . . 2.79 106.81 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.42 105.82 9.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.575 1.178 . . . . 4.0999999999999996 110.238 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -74.03 159.81 32.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.631 1.572 . . . . 3.6499999999999999 112.55 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.416 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 75.6 m -149.71 159.25 36.45 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.29 1.836 . . . . 3.2400000000000002 110.691 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.47 -2.86 12.4 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.369 2.712 . . . . 1.98 114.879 -171.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 167.61 27.95 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.33 0.967 . . . . 1.3300000000000001 112.83 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.82 -2.65 18.35 Favored 'Cis proline' 0 CA--C 1.541 0.833 0 CA-C-N 118.579 1.19 . . . . 1.97 112.91 -4.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.39 169.84 13.81 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.047 1.739 . . . . 2.2599999999999998 113.791 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.22 171.81 18.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.377 2.271 . . . . 1.7 111.586 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.96 120.45 31.62 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.761 0.824 . . . . 1.6000000000000001 110.668 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.02 32.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.567 0.747 . . . . 1.8899999999999999 111.83 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.88 162.92 31.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.395 1.478 . . . . 3.3100000000000001 111.137 -174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.07 143.6 3.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 115.635 1.717 . . . . 2.7799999999999998 115.635 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -69.96 87.88 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.205 -1.035 . . . . 1.95 108.205 160.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 tt -75.27 143.55 42.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.928 -0.768 . . . . 3.7599999999999998 108.928 169.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -125.98 143.45 51.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.52 0.676 . . . . 3.27 112.044 170.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.67 100.9 13.54 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.99 -1.005 . . . . 1.01 109.193 161.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.96 -7.77 15.44 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.587 2.192 . . . . 1.29 112.624 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.56 179.73 51.46 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.802 1.192 . . . . 1.24 113.486 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.0 m-20 -106.98 -3.18 20.4 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.272 1.829 . . . . 3.04 113.044 -171.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.02 162.67 28.35 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.367 1.867 . . . . 2.3100000000000001 109.682 167.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.34 154.29 21.53 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.832 2.355 . . . . 1.21 112.672 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.0 mt -104.05 126.88 51.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.016 0.926 . . . . 3.02 110.832 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.57 109.02 20.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.03 -0.986 . . . . 3.9199999999999999 110.304 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.2 tp -95.14 120.58 35.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.736 2.014 . . . . 2.0600000000000001 108.598 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.01 -14.72 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.684 0.794 . . . . 1.8899999999999999 112.453 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.49 -167.95 40.13 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 121.789 0.661 . . . . 0.40000000000000002 113.139 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.52 176.9 8.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 1.5900000000000001 109.393 159.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -157.43 145.41 19.03 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 106.425 -1.694 . . . . 7.6399999999999997 106.425 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -149.13 155.27 40.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.359 1.064 . . . . 1.74 108.149 -164.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.04 -26.78 36.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.857 2.371 . . . . 1.3999999999999999 112.749 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -78.16 -12.24 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 114.415 1.265 . . . . 2.1899999999999999 114.415 -171.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.06 156.23 46.68 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.897 1.279 . . . . 1.73 111.818 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -102.54 -62.87 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.014 0.526 . . . . 3.5699999999999998 110.753 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -79.16 146.57 33.06 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.768 -0.827 . . . . 4.8899999999999997 108.768 165.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.79 133.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.748 1.619 . . . . 2.6400000000000001 108.329 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -140.89 129.27 22.45 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.711 1.604 . . . . 2.1400000000000001 109.351 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.22 123.01 29.66 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.995 1.271 . . . . 1.8999999999999999 110.648 167.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -111.33 159.96 17.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.177 1.791 . . . . 0.58999999999999997 112.256 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -116.51 179.19 4.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.188 2.195 . . . . 2.1200000000000001 111.034 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -131.22 133.14 45.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.707 1.603 . . . . 2.5499999999999998 107.713 166.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -125.7 150.92 47.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.349 1.059 . . . . 3.0299999999999998 111.94 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.2 ptp -84.74 153.7 22.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.715 1.606 . . . . 5.5099999999999998 110.433 167.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -153.79 34.54 0.44 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.061 1.504 . . . . 7.0099999999999998 115.061 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -56.74 146.78 24.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.647 1.579 . . . . 5.25 113.268 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -156.4 136.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.622 2.369 . . . . 7.2699999999999996 105.416 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 60.89 23.43 13.48 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.813 0.816 . . . . 6.9299999999999997 111.68 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.72 0.35 24.84 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 119.916 -1.74 . . . . 4.7400000000000002 114.862 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -86.42 132.88 33.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.507 1.923 . . . . 4.1600000000000001 108.836 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.74 142.86 29.76 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.401 1.26 . . . . 8.3100000000000005 114.401 -166.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -155.37 138.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.443 1.897 . . . . 3.0800000000000001 108.618 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 ptp -141.21 138.92 33.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.46 0.704 . . . . 4.0300000000000002 111.126 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.52 175.74 20.79 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 124.623 1.106 . . . . 1.1399999999999999 112.451 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.5 mtt -128.45 156.79 42.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.787 1.635 . . . . 2.8799999999999999 110.78 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -167.93 154.79 7.6 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 125.149 1.379 . . . . 4.3399999999999999 111.441 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.3 Cg_endo -70.23 151.2 66.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.011 1.807 . . . . 0.71999999999999997 112.221 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.0 156.78 54.17 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.748 2.019 . . . . 1.76 110.614 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.49 -16.0 27.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.954 2.436 . . . . 0.83999999999999997 113.113 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.4 p90 179.14 170.72 0.93 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.027 2.131 . . . . 3.98 110.321 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.0 174.69 7.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.679 2.392 . . . . 1.8999999999999999 108.933 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -152.8 164.42 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.028 -1.045 . . . . 2.27 112.535 164.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 t -138.86 128.83 14.67 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.524 1.53 . . . . 2.0499999999999998 109.58 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.58 163.41 39.07 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.506 2.137 . . . . 1.28 111.69 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.9 138.18 84.18 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.503 2.802 . . . . 1.22 112.055 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.428 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 65.0 mmtt 68.92 2.64 3.63 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.966 2.106 . . . . 2.27 113.708 -175.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.11 114.1 3.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 125.85 1.691 . . . . 1.3100000000000001 111.269 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -93.18 125.81 37.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.391 1.077 . . . . 8.9600000000000009 109.32 162.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.5 m -145.44 130.18 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.219 1.008 . . . . 2.54 111.296 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.85 132.93 34.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.197 0.999 . . . . 6.9299999999999997 111.248 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.27 60.34 3.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.018 1.866 . . . . 2.1899999999999999 111.979 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -47.94 133.91 11.56 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 128.038 2.535 . . . . 4.5099999999999998 113.27 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.2 -51.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.325 2.684 . . . . 1.78 111.99 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.65 94.98 1.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.264 -1.535 . . . . 1.5700000000000001 109.264 166.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -76.96 0.29 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.993 1.758 . . . . 1.3400000000000001 113.008 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -158.03 130.55 7.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.6 1.56 . . . . 3.4100000000000001 111.299 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -162.13 173.3 14.51 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.938 1.699 . . . . 0.89000000000000001 111.977 -166.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.95 120.5 41.6 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.742 -0.599 . . . . 3.48 112.078 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 mmt -84.75 121.49 27.76 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.233 1.013 . . . . 1.8100000000000001 109.854 164.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -106.02 131.14 53.66 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.223 1.409 . . . . 2.71 108.496 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -140.07 142.37 36.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.791 0.836 . . . . 2.8799999999999999 111.133 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 60.45 4.37 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 109.042 -1.623 . . . . 2.4199999999999999 109.042 -166.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -65.66 127.57 32.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.32 1.06 . . . . 1.9399999999999999 108.998 172.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -106.3 12.64 29.71 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 2.6099999999999999 112.89 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -162.33 153.21 14.69 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.811 1.644 . . . . 7.0300000000000002 110.919 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.94 163.45 39.17 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.921 2.414 . . . . 2.5899999999999999 109.378 159.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mp -133.93 162.77 31.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.104 0.954 . . . . 4.4900000000000002 112.139 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -119.36 120.01 35.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.888 2.075 . . . . 6.8099999999999996 110.478 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.06 118.29 4.52 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.85 -1.156 . . . . 2.8999999999999999 109.79 168.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.94 48.09 22.25 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.719 -0.489 . . . . 2.2999999999999998 112.761 -167.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.28 -168.33 1.32 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 107.53 -1.285 . . . . 2.7599999999999998 107.53 140.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -128.85 155.53 45.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 4.3899999999999997 111.639 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.08 118.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.685 1.594 . . . . 2.5099999999999998 108.938 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.42 138.9 39.54 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.524 0.729 . . . . 3.46 110.021 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.3 143.02 19.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.873 1.269 . . . . 2.9300000000000002 110.912 -168.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -89.82 110.36 21.29 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 128.995 2.918 . . . . 3.0299999999999998 110.323 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.43 113.08 21.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.426 1.012 . . . . 2.8100000000000001 109.372 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.2 mt -93.6 123.47 36.94 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.043 0.937 . . . . 1.8 110.772 -166.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -124.58 137.64 54.38 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.427 -0.796 . . . . 3.5499999999999998 112.571 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.98 130.89 30.74 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.614 1.166 . . . . 2.1499999999999999 113.164 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.5 -150.17 20.59 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.367 -1.093 . . . . 3.48 110.367 -163.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.29 28.02 9.56 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.402 1.001 . . . . 2.21 114.715 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mppt? -100.38 135.38 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.722 1.761 . . . . 5.9699999999999998 112.084 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.88 138.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.763 1.225 . . . . 2.2799999999999998 109.454 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -116.41 104.87 11.89 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.837 0.855 . . . . 2.46 109.319 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.22 114.03 17.83 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 4.7699999999999996 109.36 174.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.09 150.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.093 1.357 . . . . 4.1299999999999999 112.546 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.75 142.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.051 1.74 . . . . 2.79 111.904 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -142.5 146.1 37.4 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.086 1.755 . . . . 4.0899999999999999 110.55 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.8 152.53 69.14 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.823 3.015 . . . . 1.98 113.007 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.6 t -93.81 127.04 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.938 1.295 . . . . 2.3700000000000001 110.746 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.64 -177.7 3.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.376 1.47 . . . . 5.3600000000000003 109.186 165.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.25 154.2 31.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 119.769 -1.832 . . . . 2.5299999999999998 114.027 -164.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 125.918 1.687 . . . . 6.5 113.448 156.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 . . . . . 0 CA--C 1.545 0.769 0 CA-C-O 120.286 0.089 . . . . 4.7400000000000002 111.019 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.28 170.39 37.06 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 120.556 -1.34 . . . . 1.6299999999999999 114.183 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -157.87 147.79 20.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.292 1.037 . . . . 1.6799999999999999 111.935 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -93.45 121.62 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.146 -0.971 . . . . 2.3700000000000001 108.809 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -63.46 -29.84 71.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.749 1.62 . . . . 5.8499999999999996 113.719 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.99 -179.74 0.22 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.221 2.208 . . . . 3.4300000000000002 112.692 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m 176.25 165.84 0.44 Allowed Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 128.751 2.82 . . . . 2.2200000000000002 108.575 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.27 5.65 3.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.248 2.632 . . . . 2.1600000000000001 113.726 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.5 170.66 36.04 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.35 0.976 . . . . 2.3599999999999999 112.333 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.86 -6.48 33.06 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 CA-C-N 118.612 1.206 . . . . 3.1000000000000001 113.66 -5.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -135.42 171.84 13.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.962 2.105 . . . . 5.6600000000000001 110.804 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.62 -168.3 1.14 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.785 2.434 . . . . 2.2000000000000002 112.21 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.23 166.97 24.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.317 1.847 . . . . 2.3900000000000001 111.786 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.33 159.32 42.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.647 1.179 . . . . 2.3100000000000001 114.067 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -141.53 156.77 45.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.665 2.386 . . . . 3.3599999999999999 110.942 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -175.04 167.69 3.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.286 1.217 . . . . 3.0099999999999998 114.286 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.3 m -124.7 137.48 54.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.775 1.63 . . . . 2.4199999999999999 109.033 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.4 tp -131.14 156.4 45.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.152 1.381 . . . . 5.3300000000000001 110.849 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -130.58 129.49 42.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.3 -1.0 . . . . 3.9700000000000002 108.3 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -94.75 105.8 20.84 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.634 1.174 . . . . 1.04 109.162 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.66 -8.98 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.729 2.286 . . . . 1.1200000000000001 113.637 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.06 156.21 43.44 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 118.942 0.792 . . . . 1.28 112.693 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.3 m-20 -88.26 7.67 31.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.978 1.711 . . . . 3.21 113.209 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.02 158.84 43.13 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.999 1.72 . . . . 2.3599999999999999 110.64 166.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.31 156.9 25.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.304 2.669 . . . . 0.87 110.782 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.5 mt -107.18 151.45 25.4 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.706 -0.621 . . . . 3.1200000000000001 110.58 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -128.68 112.38 14.17 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.641 1.176 . . . . 5.5499999999999998 109.572 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.06 127.54 42.16 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.122 1.769 . . . . 1.9299999999999999 109.228 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -116.33 -14.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.444 0.905 . . . . 1.95 113.444 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.27 -165.57 35.0 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 121.626 -0.671 . . . . 0.53000000000000003 112.514 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.5 -179.4 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.249 1.02 . . . . 1.98 110.356 167.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -159.95 145.21 15.23 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.945 -1.872 . . . . 7.5899999999999999 105.945 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.75 156.06 26.18 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 119.088 0.858 . . . . 2.3300000000000001 109.97 -159.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.71 -37.17 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.341 2.027 . . . . 0.90000000000000002 112.465 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.52 -10.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 115.236 1.569 . . . . 2.0299999999999998 115.236 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 163.29 32.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.285 1.434 . . . . 1.8200000000000001 110.374 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -105.23 -77.76 0.58 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.315 1.046 . . . . 3.6699999999999999 109.881 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 44' ' ' GLU . 22.0 ttt180 -79.46 104.29 9.97 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.757 0.823 . . . . 4.4100000000000001 110.467 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -110.18 137.61 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.126 1.37 . . . . 2.3300000000000001 110.587 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 42' ' ' ARG . 43.5 mt-10 -141.23 128.46 20.97 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.499 1.52 . . . . 2.2799999999999998 111.41 -170.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.59 122.83 28.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.76 0.791 . . . . 1.95 111.691 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -104.91 151.42 23.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.686 1.594 . . . . 1.0900000000000001 114.173 172.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.11 165.87 14.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.613 1.965 . . . . 2.1299999999999999 110.937 160.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.2 m -148.76 112.96 5.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.512 1.525 . . . . 3.23 107.952 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -126.02 171.5 10.74 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.934 1.294 . . . . 3.6899999999999999 112.598 -163.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.0 mtm -124.3 118.27 26.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.851 1.26 . . . . 5.7199999999999998 110.053 161.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -153.04 159.73 42.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.058 1.343 . . . . 7.6100000000000003 110.651 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -64.34 147.89 51.56 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.322 1.449 . . . . 4.29 112.518 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.21 -18.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.497 1.295 . . . . 4.5599999999999996 114.497 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 56' ' ' LYS . 14.0 tt0 -155.93 33.13 0.35 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.938 2.095 . . . . 3.4199999999999999 108.96 -175.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.79 -25.21 0.64 Allowed Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.235 -1.541 . . . . 2.7000000000000002 113.141 -160.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 54' ' ' GLU . 67.8 mttt -80.34 139.32 36.63 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.305 2.242 . . . . 3.1600000000000001 109.2 171.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -76.45 144.63 39.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.612 0.642 . . . . 4.79 112.667 169.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.37 164.79 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 4.3099999999999996 109.798 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.7 mtm -78.46 154.2 30.79 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 4.9699999999999998 111.081 168.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.2 166.47 38.8 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 121.738 -0.601 . . . . 1.8799999999999999 113.668 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.6 149.8 46.93 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.88 1.272 . . . . 2.8100000000000001 110.831 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -158.62 152.04 19.01 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-O 117.133 -1.413 . . . . 4.1900000000000004 110.428 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.03 148.27 69.44 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.177 1.918 . . . . 0.92000000000000004 111.412 162.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.58 152.33 68.66 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 125.44 1.496 . . . . 1.8100000000000001 110.582 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.13 -6.79 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.885 2.39 . . . . 1.25 113.477 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -176.69 159.91 1.89 Allowed 'General case' 0 C--N 1.348 0.508 0 C-N-CA 125.222 1.409 . . . . 3.3500000000000001 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -111.19 175.7 5.32 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.88 1.672 . . . . 2.04 109.194 152.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.39 167.18 31.23 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.807 -1.183 . . . . 2.98 110.291 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -144.18 136.89 13.57 Favored Pre-proline 0 C--N 1.328 -0.367 0 C-N-CA 124.21 1.004 . . . . 1.8999999999999999 108.762 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 167.38 25.4 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.571 1.514 . . . . 1.1699999999999999 111.373 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.36 143.9 99.58 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.217 2.611 . . . . 1.0800000000000001 111.003 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.461 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 14.9 mmmt 66.25 4.12 3.03 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.448 1.499 . . . . 2.6400000000000001 112.797 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.92 3.74 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 127.403 2.43 . . . . 1.0800000000000001 112.857 -170.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 118.37 31.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.535 1.534 . . . . 6.3300000000000001 109.772 172.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.11 147.03 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 120.465 1.484 . . . . 2.52 114.403 -166.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 131.62 54.37 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.805 1.242 . . . . 3.48 112.826 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.94 71.64 0.54 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.464 1.505 . . . . 2.3700000000000001 109.929 157.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -78.0 144.3 67.58 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.939 1.696 . . . . 4.4500000000000002 112.688 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.1 -23.16 72.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.546 2.83 . . . . 1.6499999999999999 114.644 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.74 38.78 3.04 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.248 1.404 . . . . 1.52 113.02 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.95 -58.74 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 CA-C-N 118.581 1.19 . . . . 1.8100000000000001 114.948 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -155.12 144.2 20.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.975 1.71 . . . . 3.6400000000000001 110.395 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -164.0 173.84 12.11 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.798 -1.189 . . . . 0.93999999999999995 110.213 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -108.95 135.42 50.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.093 0.557 . . . . 3.6099999999999999 110.182 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 mmt -85.08 140.69 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.673 0.789 . . . . 2.3700000000000001 109.955 156.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.3 mt -122.8 112.28 17.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 2.7599999999999998 108.375 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -111.21 140.96 45.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.836 1.654 . . . . 4.1299999999999999 108.436 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.02 72.95 0.91 Allowed Glycine 0 N--CA 1.471 0.968 0 O-C-N 121.206 -0.934 . . . . 2.5699999999999998 111.097 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.79 104.24 4.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 122.523 1.154 . . . . 2.0499999999999998 110.13 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -82.83 13.94 3.56 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 3.52 113.008 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -147.07 159.07 43.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.694 1.998 . . . . 5.9000000000000004 110.392 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.45 163.29 39.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.584 2.189 . . . . 2.0899999999999999 109.6 152.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -141.92 162.48 35.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.754 1.222 . . . . 3.6099999999999999 110.781 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.12 109.19 2.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.105 1.762 . . . . 4.2800000000000002 109.574 -175.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.04 126.08 24.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.93 -1.106 . . . . 3.4399999999999999 110.26 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.29 7.42 40.38 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.762 -1.021 . . . . 1.8999999999999999 114.562 -165.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -107.13 -170.82 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.263 1.531 . . . . 2.8599999999999999 110.057 147.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -125.9 165.06 19.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.857 1.663 . . . . 3.3199999999999998 110.509 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.56 116.7 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.115 1.366 . . . . 2.6200000000000001 108.446 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.92 144.59 33.24 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.77 -1.105 . . . . 3.4199999999999999 111.213 167.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 tt -155.6 132.9 10.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.988 0.899 . . . . 2.4500000000000002 110.527 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -86.5 101.51 13.25 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.874 3.27 . . . . 2.6800000000000002 111.363 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.99 111.77 17.77 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.273 -1.517 . . . . 2.3500000000000001 109.575 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.28 125.71 35.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.391 1.476 . . . . 1.5900000000000001 110.1 -166.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.84 153.08 31.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.005 0.522 . . . . 3.6600000000000001 112.027 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.43 128.77 37.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.062 0.545 . . . . 2.3700000000000001 110.398 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 -153.97 30.35 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.475 0.559 . . . . 2.8900000000000001 111.878 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.15 54.32 4.85 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.932 -0.927 . . . . 2.6800000000000002 114.434 -169.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -143.78 147.12 33.71 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.293 1.546 . . . . 5.04 115.057 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.83 131.72 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 128.19 2.596 . . . . 2.1000000000000001 108.171 166.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.42 101.46 7.97 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.028 1.331 . . . . 3.8100000000000001 108.031 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.26 133.6 33.82 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.466 -0.771 . . . . 3.46 112.727 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.7 m -140.94 153.45 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.061 1.744 . . . . 2.25 110.986 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.88 128.49 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.836 1.254 . . . . 3.0299999999999998 111.188 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.9 155.33 60.71 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.272 1.829 . . . . 4.5 110.3 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.0 152.38 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.929 2.42 . . . . 1.24 111.125 168.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.58 116.41 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.569 -1.641 . . . . 2.1099999999999999 106.569 161.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 120' ' ' ARG . 39.4 tt0 -127.97 118.92 24.43 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.877 -1.527 . . . . 3.8199999999999998 106.877 172.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.62 118.36 16.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.791 -0.818 . . . . 3.3300000000000001 108.791 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 118' ' ' GLU . 82.5 mtt-85 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 117.952 -1.023 . . . . 9.7400000000000002 113.174 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.238 0.464 0 N-CA-C 107.726 -1.212 . . . . 6.0800000000000001 107.726 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.27 172.47 12.88 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.592 1.568 . . . . 2.6099999999999999 113.521 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -155.52 155.28 33.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.38 1.072 . . . . 2.6499999999999999 111.585 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.63 119.2 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.592 -0.892 . . . . 1.8799999999999999 108.592 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.28 108.74 16.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.557 0.743 . . . . 4.5700000000000003 109.687 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 136.41 48.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 3.8399999999999999 110.427 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.2 t -131.22 156.03 80.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.486 1.914 . . . . 3.6800000000000002 109.222 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.01 -10.38 28.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.872 2.381 . . . . 2.04 112.717 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.53 -174.36 15.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.624 1.583 . . . . 1.6599999999999999 112.166 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -76.71 -0.58 23.69 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 118.306 1.053 . . . . 1.8600000000000001 112.629 -8.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -149.65 178.05 9.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.848 1.659 . . . . 2.23 111.191 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.0 -166.22 1.53 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.529 1.931 . . . . 2.0499999999999998 112.42 -172.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.74 154.57 34.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.716 1.206 . . . . 2.1000000000000001 111.761 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.13 46.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.297 1.439 . . . . 1.52 111.281 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -136.13 148.54 48.27 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.484 1.914 . . . . 3.5299999999999998 109.011 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -171.6 155.92 4.22 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.803 0.841 . . . . 2.79 112.741 -171.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -97.71 136.59 37.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.486 -1.234 . . . . 2.1299999999999999 111.827 166.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -112.65 149.3 33.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.873 2.469 . . . . 3.9100000000000001 109.083 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -148.89 120.36 7.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.127 0.965 . . . . 2.7599999999999998 112.89 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -90.14 115.36 63.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.722 1.209 . . . . 1.0700000000000001 110.233 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -86.52 -8.69 7.17 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.155 2.57 . . . . 1.1000000000000001 113.441 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.72 169.29 54.65 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.006 0.812 . . . . 0.97999999999999998 113.722 -172.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.481 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.3 m-20 -95.08 -2.24 50.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.489 1.916 . . . . 2.8799999999999999 112.702 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.27 161.15 32.85 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 126.221 1.809 . . . . 2.2000000000000002 110.299 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.03 161.54 23.63 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.05 2.5 . . . . 0.73999999999999999 111.184 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.02 150.52 28.41 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.552 0.741 . . . . 3.1499999999999999 110.48 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.417 HH21 ' CD ' ' A' ' 68' ' ' GLU . 21.1 ttm180 -125.52 114.6 19.0 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.231 1.012 . . . . 5.0199999999999996 109.532 167.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -90.85 119.43 31.05 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.822 2.449 . . . . 2.2000000000000002 109.095 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.17 -8.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.54 1.136 . . . . 1.77 113.931 -171.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -162.03 32.31 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.512 -0.742 . . . . 0.46999999999999997 112.275 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.59 -172.0 3.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.488 1.115 . . . . 1.5800000000000001 111.219 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -148.22 143.88 27.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.789 2.036 . . . . 7.1299999999999999 105.506 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -149.05 153.73 38.54 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.409 1.004 . . . . 1.54 109.339 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.43 -43.46 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.514 2.809 . . . . 1.6499999999999999 111.696 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.281 1.1 m -76.46 -5.23 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.416 1.636 . . . . 2.0800000000000001 115.416 -170.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.1 -175.91 4.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.601 1.56 . . . . 2.04 110.751 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 7.1 tp10 -132.92 -60.94 0.85 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.156 0.889 . . . . 4.6799999999999997 111.721 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -65.02 129.93 41.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.395 -1.335 . . . . 3.7200000000000002 107.395 158.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.89 117.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.454 -1.684 . . . . 2.9100000000000001 106.454 171.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -138.76 115.65 10.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.635 -1.166 . . . . 2.8300000000000001 109.013 -155.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.427 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 6.1 tt -78.04 120.66 23.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.216 1.008 . . . . 1.99 110.546 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -107.47 150.0 27.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.84 1.656 . . . . 0.60999999999999999 112.222 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.74 168.55 19.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.843 -1.526 . . . . 2.4700000000000002 110.306 159.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -143.65 86.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.882 -1.525 . . . . 2.3999999999999999 106.882 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -94.14 153.41 18.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.177 1.791 . . . . 3.0699999999999998 112.373 -164.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 ttp -91.74 137.68 32.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.389 1.476 . . . . 3.5099999999999998 110.003 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -153.53 122.78 6.58 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.377 0.671 . . . . 6.1100000000000003 111.461 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -99.06 155.28 17.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.845 1.258 . . . . 5.7400000000000002 110.133 169.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.37 127.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.91 . . . . 4.7000000000000002 110.678 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 58.72 26.4 14.58 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.317 1.056 . . . . 4.96 111.053 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.43 1.19 57.03 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 119.825 -1.797 . . . . 3.3100000000000001 114.379 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -92.84 143.19 26.52 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.032 1.733 . . . . 4.3399999999999999 109.488 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -88.27 130.22 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.754 1.622 . . . . 6.8899999999999997 112.607 -164.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.421 HG11 ' H ' ' A' ' 59' ' ' MET . 0.1 OUTLIER -147.05 169.5 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 122.387 1.089 . . . . 3.2999999999999998 113.044 178.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.421 ' H ' HG11 ' A' ' 58' ' ' VAL . 14.6 tpp -137.48 160.91 37.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.913 2.885 . . . . 3.6400000000000001 107.938 173.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.07 169.31 33.12 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.562 1.074 . . . . 1.24 114.078 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.11 139.48 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.433 1.493 . . . . 2.8399999999999999 109.598 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -154.6 145.38 16.2 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 125.652 1.581 . . . . 4.2000000000000002 109.531 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.39 143.25 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.967 1.778 . . . . 1.0900000000000001 110.657 165.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.64 156.16 42.82 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.691 1.596 . . . . 1.79 110.663 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.75 -14.66 33.11 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.919 2.413 . . . . 0.82999999999999996 113.369 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -177.16 162.17 1.95 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.574 1.55 . . . . 3.0800000000000001 110.816 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mt -109.48 171.08 7.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.673 1.189 . . . . 1.75 108.682 149.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.417 ' CD ' HH21 ' A' ' 31' ' ' ARG . 7.1 pt-20 -155.57 165.09 37.63 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.03 -1.044 . . . . 2.3500000000000001 111.774 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.87 136.36 11.67 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.841 0.857 . . . . 2.4100000000000001 109.516 -161.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.83 169.58 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.715 1.61 . . . . 1.02 111.429 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.78 143.9 94.53 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.172 2.581 . . . . 0.82999999999999996 111.26 163.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 66.5 mmtt 67.31 0.57 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.524 1.53 . . . . 2.0899999999999999 114.215 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.16 113.7 3.68 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 126.01 1.767 . . . . 0.93999999999999995 112.869 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -81.04 133.2 35.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.082 -1.059 . . . . 5.46 109.746 154.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.95 134.16 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.624 1.569 . . . . 2.2999999999999998 110.597 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.1 118.02 25.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.127 -1.064 . . . . 4.6699999999999999 108.127 -160.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.54 73.11 1.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.236 1.493 . . . . 1.9099999999999999 111.87 -169.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -55.24 116.88 12.68 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.226 1.41 . . . . 5.9199999999999999 110.347 168.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.21 -30.37 88.33 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.24 2.627 . . . . 1.52 114.108 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.89 41.68 1.75 Allowed Glycine 0 CA--C 1.533 1.181 0 CA-C-N 118.858 0.754 . . . . 1.9399999999999999 112.791 167.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.33 -49.82 0.04 OUTLIER Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.954 2.216 . . . . 1.47 113.609 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -151.26 146.89 26.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.691 1.596 . . . . 3.5699999999999998 112.049 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -156.48 167.41 30.54 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.735 1.214 . . . . 1.29 110.983 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.427 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 31.7 m-85 -105.83 117.8 34.95 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.704 -0.85 . . . . 3.1000000000000001 108.704 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.87 133.08 34.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.975 0.51 . . . . 2.54 110.258 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.71 133.39 53.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.854 1.662 . . . . 2.9700000000000002 111.659 -172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -142.91 157.97 44.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.758 1.223 . . . . 2.9199999999999999 112.028 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -43.76 2.66 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 124.759 1.171 . . . . 2.27 112.129 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt 47.37 71.83 0.3 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.975 2.51 . . . . 2.2599999999999998 113.706 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.418 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 6.9 ptpp? -69.67 -1.7 9.71 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.032 1.123 . . . . 3.3900000000000001 114.032 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.46 HH21 ' CD ' ' A' ' 97' ' ' GLU . 10.3 mtp85 -125.45 142.36 41.53 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 126.308 1.843 . . . . 6.6200000000000001 109.053 172.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.22 124.12 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 107.245 -1.867 . . . . 2.0699999999999998 107.245 145.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.5 pt? -127.21 157.54 39.52 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.675 1.99 . . . . 3.98 111.164 -163.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -165.11 142.69 6.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.527 1.306 . . . . 8.9700000000000006 114.527 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 124.86 19.1 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.279 -0.888 . . . . 2.6099999999999999 109.669 164.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.24 -12.25 14.26 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.94 -1.478 . . . . 1.8600000000000001 113.363 -161.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' CD ' HH21 ' A' ' 91' ' ' ARG . 6.7 pt-20 -106.1 172.68 6.68 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.162 1.481 . . . . 3.8700000000000001 110.828 155.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.5 155.18 46.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.529 1.532 . . . . 4.75 108.959 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.66 110.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.582 1.153 . . . . 2.0699999999999998 108.975 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 35.7 mt-10 -71.35 129.41 38.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.534 -0.913 . . . . 4.3899999999999997 108.534 153.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.63 140.03 45.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.578 1.151 . . . . 2.6800000000000002 108.761 172.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.3 103.41 12.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.996 2.519 . . . . 3.3500000000000001 110.587 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.38 125.18 28.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.731 1.613 . . . . 2.2400000000000002 110.813 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.5 mt -93.18 129.86 39.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.654 1.182 . . . . 1.8500000000000001 111.565 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -127.74 119.97 26.91 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.38 0.672 . . . . 3.5299999999999998 112.295 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.51 27.9 0.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.975 2.11 . . . . 3.02 114.784 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.57 -53.38 1.57 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.741 1.638 . . . . 3.9100000000000001 113.104 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.68 3.71 63.04 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 117.036 1.574 . . . . 1.8 117.036 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 150.36 44.08 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.112 1.956 . . . . 4.5800000000000001 111.316 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.31 136.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.854 1.662 . . . . 2.0099999999999998 109.205 166.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.7 mt -146.18 132.56 19.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.501 1.521 . . . . 2.6899999999999999 109.499 -172.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.417 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 7.1 ptmt -102.1 158.56 16.08 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.951 1.834 . . . . 4.0700000000000003 115.951 -169.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.21 147.21 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.605 1.962 . . . . 3.3799999999999999 109.915 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -107.55 133.71 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.115 1.366 . . . . 4.1100000000000003 111.247 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 mt -140.44 131.38 13.92 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 127.059 2.144 . . . . 3.0499999999999998 109.365 -165.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.35 151.47 71.39 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.318 2.678 . . . . 1.78 112.146 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.42 125.85 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.53 0.681 . . . . 1.95 112.087 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.48 148.32 24.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.086 2.154 . . . . 4.96 109.838 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.33 129.62 54.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.919 -1.039 . . . . 2.71 109.395 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 131.365 3.866 . . . . 7.6500000000000004 107.677 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 119.607 -0.235 . . . . 5.8200000000000003 110.749 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.19 175.3 47.59 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 115.455 0.942 . . . . 1.55 115.455 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -156.23 123.65 5.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.034 1.334 . . . . 1.8500000000000001 113.094 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.33 153.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 120.75 -1.219 . . . . 2.0600000000000001 108.823 164.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -110.15 -19.19 13.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 116.438 2.014 . . . . 8.1799999999999997 116.438 -168.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 60.79 173.42 0.1 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.401 1.48 . . . . 3.3799999999999999 112.781 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.29 171.8 0.5 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.947 2.899 . . . . 2.1600000000000001 109.657 171.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.97 -0.41 9.0 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.301 2.667 . . . . 1.8799999999999999 113.78 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 174.23 33.69 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.93 1.252 . . . . 1.78 112.418 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.23 -5.37 34.2 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 118.596 1.198 . . . . 2.3100000000000001 112.998 -4.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -130.4 177.23 7.5 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.989 1.716 . . . . 2.1099999999999999 112.767 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -168.63 -168.8 0.94 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.789 2.436 . . . . 1.48 110.64 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.45 167.92 17.84 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.848 1.659 . . . . 1.6799999999999999 112.15 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.14 149.72 31.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.525 1.53 . . . . 1.6699999999999999 111.337 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -146.04 151.8 38.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.481 1.512 . . . . 3.71 110.135 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -173.84 161.02 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.938 1.295 . . . . 3.3199999999999998 113.05 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.9 m -84.35 150.23 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.685 1.594 . . . . 1.9199999999999999 109.037 166.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.72 176.27 9.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.365 1.066 . . . . 4.9000000000000004 110.955 152.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -154.83 162.02 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.476 -0.765 . . . . 3.71 111.424 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -114.61 101.64 54.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.876 1.67 . . . . 1.3100000000000001 109.577 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.06 -2.65 11.86 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.786 2.991 . . . . 1.6599999999999999 113.112 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.9 -172.35 48.79 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.786 1.184 . . . . 1.49 113.726 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.457 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 15.9 m-20 -119.21 2.32 11.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.818 1.647 . . . . 3.79 112.954 -169.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.1 161.35 35.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.185 1.794 . . . . 2.4900000000000002 109.374 165.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.8 154.68 15.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.096 2.531 . . . . 1.1899999999999999 111.123 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.37 158.04 17.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.962 0.905 . . . . 3.6200000000000001 111.175 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.421 HH21 ' CD ' ' A' ' 68' ' ' GLU . 24.2 ttm180 -135.35 113.42 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.855 1.262 . . . . 4.8399999999999999 110.381 173.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.44 115.35 27.51 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 127.943 2.497 . . . . 2.0 108.985 -173.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.7 -8.73 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.725 1.009 . . . . 1.8300000000000001 113.725 -165.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.69 -162.25 32.22 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.749 -0.594 . . . . 0.45000000000000001 112.81 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.93 -175.43 4.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.606 0.595 . . . . 1.7 112.606 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -156.95 144.25 18.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.924 0.889 . . . . 6.4800000000000004 109.551 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -152.74 155.13 32.23 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.961 0.904 . . . . 2.0800000000000001 110.471 -170.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.31 -21.17 23.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.809 2.339 . . . . 1.4099999999999999 113.617 169.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.53 -15.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 114.639 1.348 . . . . 2.1600000000000001 114.639 -166.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.36 40.25 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.084 0.954 . . . . 2.2799999999999998 112.347 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -93.63 -86.2 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.386 1.074 . . . . 3.7599999999999998 110.597 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -85.02 90.96 7.96 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.807 -1.183 . . . . 6.1500000000000004 108.741 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -76.03 139.16 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.51 -0.768 . . . . 2.77 111.014 165.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -138.14 120.7 16.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.204 2.202 . . . . 3.3799999999999999 111.048 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.3 118.18 22.41 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.016 0.912 . . . . 1.9299999999999999 111.809 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -103.22 153.68 20.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.782 1.633 . . . . 0.82999999999999996 113.661 172.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -95.18 178.21 5.61 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.42 1.888 . . . . 2.4700000000000002 110.021 162.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.9 m -145.7 111.93 5.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.891 -1.151 . . . . 2.3100000000000001 107.891 164.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -97.15 158.34 15.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.379 1.472 . . . . 3.8100000000000001 112.498 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -101.95 148.03 25.83 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.42 1.088 . . . . 4.71 108.92 163.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -158.92 146.64 17.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.379 1.471 . . . . 6.9800000000000004 110.147 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.524 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -95.45 145.84 24.86 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.582 0.353 . . . . 3.7599999999999998 110.917 165.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -139.78 120.48 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.019 -1.475 . . . . 3.75 107.019 165.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.459 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.6 tm-20 57.52 33.57 23.44 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.28 1.032 . . . . 5.4199999999999999 110.757 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.64 -9.92 4.37 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 119.995 -1.69 . . . . 2.23 114.547 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 33.7 mmtm -78.39 139.98 38.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 5.2000000000000002 110.367 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 28.5 mmmt -69.97 131.1 43.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.044 0.938 . . . . 3.73 110.825 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.93 146.84 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.685 1.994 . . . . 3.04 109.361 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -128.43 148.98 50.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.685 1.194 . . . . 4.46 110.893 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.71 -179.83 34.78 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.906 0.765 . . . . 1.0700000000000001 112.855 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -127.95 149.27 50.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.245 1.018 . . . . 3.2999999999999998 111.981 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -142.76 147.46 42.18 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.552 1.541 . . . . 4.1299999999999999 108.908 172.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 151.62 78.42 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.697 1.598 . . . . 0.93999999999999995 110.867 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.13 154.55 78.69 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 125.156 1.382 . . . . 2.3399999999999999 110.79 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -70.2 -11.8 30.91 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.671 2.247 . . . . 1.6799999999999999 113.063 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -177.47 163.45 1.97 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.618 1.567 . . . . 3.5099999999999998 111.885 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -113.2 174.11 6.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.329 2.251 . . . . 2.1200000000000001 109.4 155.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 31' ' ' ARG . 9.1 pt-20 -154.88 167.62 29.68 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.041 -1.037 . . . . 2.5499999999999998 112.277 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.73 135.42 11.07 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.818 0.847 . . . . 1.97 110.543 -165.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.76 167.08 27.04 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.295 1.997 . . . . 1.1000000000000001 111.893 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -65.26 144.61 81.45 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.709 2.939 . . . . 1.4199999999999999 111.655 166.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP 0.261 0.6 OUTLIER 46.69 55.29 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 123.454 1.597 . . . . 3.1000000000000001 114.757 -166.873 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.35 121.33 2.66 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 113.962 -1.472 . . . . 1.0600000000000001 114.164 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.53 146.99 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.65 0.78 . . . . 5.6799999999999997 109.978 162.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.18 137.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.544 1.138 . . . . 2.3999999999999999 109.974 171.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -111.92 140.25 46.74 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.794 0.807 . . . . 3.4500000000000002 110.957 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.24 63.78 2.53 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.323 1.535 . . . . 2.0499999999999998 109.926 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -58.37 121.39 51.9 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.954 1.302 . . . . 5.9199999999999999 110.709 170.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.88 -58.14 1.58 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.888 3.726 . . . . 1.48 114.598 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.69 2.9 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.678 1.132 . . . . 1.9399999999999999 113.405 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.75 -51.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.352 1.93 . . . . 1.48 113.339 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -156.01 139.47 15.84 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.631 1.972 . . . . 3.5299999999999998 109.654 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -166.93 173.66 9.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.353 1.061 . . . . 0.94999999999999996 111.477 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.13 134.0 52.64 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.025 0.53 . . . . 3.0 111.246 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.3 mmt -84.73 144.02 28.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.977 1.311 . . . . 1.8799999999999999 110.316 157.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.59 116.47 28.2 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.68 1.592 . . . . 2.9500000000000002 107.861 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -109.63 134.86 51.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.967 0.803 . . . . 3.4100000000000001 110.147 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.2 0.6 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.042 -1.223 . . . . 2.5800000000000001 110.042 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.53 100.52 2.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.086 0.943 . . . . 1.9199999999999999 110.068 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -76.71 -12.7 60.03 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.235 0.828 . . . . 2.7200000000000002 113.235 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.42 148.63 31.99 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.905 . . . . 6.0499999999999998 111.139 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -67.56 148.71 79.0 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.735 2.29 . . . . 2.2200000000000002 109.229 159.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.96 30.94 0.3 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.861 1.315 . . . . 4.2400000000000002 113.59 -160.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.25 149.22 0.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.183 2.193 . . . . 5.0499999999999998 113.904 -169.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.79 134.93 30.38 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.603 -1.311 . . . . 3.4199999999999999 112.107 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.42 -11.79 66.77 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.061 -1.41 . . . . 2.4100000000000001 114.354 -166.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 158.02 37.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.052 1.426 . . . . 4.2800000000000002 109.009 160.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.9 147.54 29.67 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.812 2.045 . . . . 4.2699999999999996 108.174 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.19 123.07 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.576 1.55 . . . . 1.8700000000000001 109.995 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.5 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -74.04 121.49 21.16 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.708 0.803 . . . . 4.1299999999999999 109.068 159.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.07 126.6 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.078 0.951 . . . . 2.6200000000000001 110.521 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.17 95.87 8.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.53 1.932 . . . . 2.6000000000000001 109.779 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.93 126.18 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.794 1.179 . . . . 3.6200000000000001 110.106 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.6 mt -95.1 137.97 33.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.516 1.526 . . . . 1.98 110.589 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -134.11 148.51 51.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.213 1.006 . . . . 3.6000000000000001 113.028 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.77 162.77 18.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.128 -0.942 . . . . 2.8799999999999999 111.853 169.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.75 24.9 66.11 Favored Glycine 0 N--CA 1.473 1.145 0 O-C-N 121.66 -0.65 . . . . 4.7000000000000002 113.696 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.94 60.65 4.77 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.303 0.954 . . . . 2.1099999999999999 111.116 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -143.63 165.16 28.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.984 1.313 . . . . 4.29 112.412 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -169.98 144.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 129.39 3.076 . . . . 3.2400000000000002 107.213 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.2 mt -137.4 96.93 3.35 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.393 1.477 . . . . 3.6800000000000002 107.766 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -81.45 143.24 32.24 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.956 0.724 . . . . 3.6800000000000002 112.956 178.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.33 140.55 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.414 1.086 . . . . 2.8199999999999998 109.899 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 145.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.668 0.787 . . . . 3.0299999999999998 109.61 172.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.5 153.19 12.79 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.924 1.29 . . . . 3.7000000000000002 113.17 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.09 161.66 40.49 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.039 2.493 . . . . 1.4299999999999999 112.555 -175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -93.46 130.61 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.978 . . . . 2.5299999999999998 109.786 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.01 164.44 12.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.723 1.209 . . . . 3.4500000000000002 108.931 156.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.41 115.84 26.59 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.068 -1.02 . . . . 3.1499999999999999 112.772 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.521 2.328 . . . . 6.25 113.133 167.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.022 0.439 . . . . 5.0300000000000002 112.171 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.15 164.34 21.47 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 124.822 1.201 . . . . 1.25 114.078 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -152.53 145.2 24.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 2.0 112.026 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.1 131.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.381 -0.6 . . . . 2.1800000000000002 109.381 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 116.75 22.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.207 0.603 . . . . 5.0999999999999996 109.405 -171.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.86 133.23 33.94 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.592 -1.317 . . . . 3.6299999999999999 110.914 167.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -149.48 163.24 25.85 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.567 1.947 . . . . 3.0800000000000001 109.007 165.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.91 31.14 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.062 3.175 . . . . 1.9299999999999999 114.113 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.06 -173.16 54.51 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.248 -0.908 . . . . 1.72 113.125 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.26 -4.42 18.31 Favored 'Cis proline' 0 CA--C 1.539 0.741 0 CA-C-N 118.228 1.014 . . . . 2.0899999999999999 112.8 -10.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -139.51 178.87 6.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.701 1.6 . . . . 2.6099999999999999 111.484 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.07 -173.93 3.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.004 2.122 . . . . 2.1200000000000001 108.647 163.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.42 161.15 17.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 2.25 112.161 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.1 136.58 48.51 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.039 -1.038 . . . . 2.0600000000000001 111.106 163.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -122.61 155.56 36.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.413 1.885 . . . . 3.4199999999999999 111.015 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -166.24 142.28 4.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.708 1.744 . . . . 2.4500000000000002 115.708 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.9 m -72.13 132.73 44.56 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.79 -0.819 . . . . 2.3599999999999999 108.79 156.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.1 tt -140.68 147.41 39.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.313 1.845 . . . . 3.6099999999999999 110.1 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -131.92 147.14 52.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.289 1.042 . . . . 3.3199999999999998 112.414 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -88.07 108.9 23.93 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.362 -1.29 . . . . 1.02 109.216 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.74 -11.51 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.631 2.221 . . . . 1.4299999999999999 113.287 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.04 -173.39 49.84 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.867 1.222 . . . . 0.95999999999999996 113.812 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 16.7 m-20 -114.17 -0.85 13.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.884 1.674 . . . . 2.98 112.855 -173.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.04 161.77 36.79 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.457 1.903 . . . . 2.6099999999999999 109.464 165.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 155.61 28.22 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.554 2.169 . . . . 0.85999999999999999 112.287 -169.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.43 149.82 23.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.437 1.095 . . . . 3.0 110.532 168.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -130.94 111.93 12.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.735 1.214 . . . . 3.9500000000000002 110.408 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 tp -94.21 118.33 31.41 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.564 2.345 . . . . 1.8300000000000001 108.746 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -110.15 -10.37 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.977 0.911 . . . . 1.73 113.003 -171.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.94 -167.14 38.31 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 124.242 0.925 . . . . 0.5 112.233 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.15 -179.03 6.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.165 0.986 . . . . 1.71 110.746 164.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.0 mmt-85 -149.48 139.66 22.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.26 1.424 . . . . 7.5 109.271 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.428 ' HG1' ' CG1' ' A' ' 99' ' ' VAL . 1.7 t -150.01 152.12 33.4 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.218 -0.896 . . . . 1.73 110.572 -169.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.98 -23.94 53.51 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.827 2.351 . . . . 0.96999999999999997 113.629 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.351 1.6 m -94.25 3.07 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.049 1.5 . . . . 1.8700000000000001 115.049 -171.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.86 164.1 36.28 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.418 1.636 . . . . 1.6200000000000001 115.418 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.18 -89.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.907 2.083 . . . . 3.4300000000000002 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -80.27 80.12 6.74 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.385 -1.447 . . . . 4.4900000000000002 109.62 -173.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.59 131.7 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 128.146 2.579 . . . . 2.5899999999999999 112.269 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.51 132.07 30.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.487 1.915 . . . . 2.48 110.27 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.14 121.74 26.49 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 121.278 1.854 . . . . 1.95 111.64 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -107.92 154.3 21.8 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.548 1.939 . . . . 0.56000000000000005 112.975 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -109.99 166.33 11.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 2.3900000000000001 110.699 166.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.3 m -115.21 117.83 31.6 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.563 1.945 . . . . 2.0800000000000001 107.114 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -126.26 154.44 43.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.343 1.057 . . . . 3.79 112.699 -168.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.4 mtt -92.63 153.77 18.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.657 -1.156 . . . . 3.6299999999999999 111.339 166.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -153.17 137.77 16.87 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.647 0.779 . . . . 6.96 112.706 159.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.14 151.03 16.18 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.853 1.661 . . . . 4.5899999999999999 110.269 160.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 54' ' ' GLU 0.298 11.8 p -158.03 -88.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 126.249 1.82 . . . . 4.0300000000000002 110.287 175.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.544 ' H ' HG12 ' A' ' 53' ' ' VAL . 20.6 tt0 -78.58 47.72 0.74 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.296 2.239 . . . . 3.7200000000000002 110.296 168.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.48 -43.78 0.91 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 127.595 2.522 . . . . 2.2400000000000002 113.912 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -77.83 152.9 33.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.974 2.11 . . . . 4.3099999999999996 113.178 -173.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.37 107.08 18.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.91 0.484 . . . . 5.1699999999999999 112.069 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -80.95 142.03 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.886 1.275 . . . . 2.4500000000000002 109.017 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.11 133.95 50.01 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.912 1.685 . . . . 5.5599999999999996 110.622 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 -179.2 30.23 Favored Glycine 0 N--CA 1.472 1.09 0 C-N-CA 124.226 0.917 . . . . 1.5600000000000001 113.079 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.48 160.53 19.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.802 1.241 . . . . 3.2400000000000002 112.138 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.16 149.96 2.29 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.505 1.522 . . . . 4.5300000000000002 112.652 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -71.6 141.52 38.22 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.097 2.532 . . . . 0.82999999999999996 113.275 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -110.82 156.07 41.31 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.892 1.677 . . . . 1.8700000000000001 109.798 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.2 -13.31 30.95 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.899 2.4 . . . . 0.84999999999999998 113.292 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.7 p90 178.63 168.34 0.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.005 2.122 . . . . 2.9399999999999999 110.301 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.16 169.43 9.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.189 1.795 . . . . 1.8400000000000001 109.104 157.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.5 159.0 39.41 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.141 -0.974 . . . . 2.5699999999999998 111.655 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.27 126.81 9.21 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.506 1.122 . . . . 2.04 110.133 -163.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.76 161.34 44.1 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.308 2.005 . . . . 0.81999999999999995 111.712 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.11 139.29 86.73 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.89 3.06 . . . . 0.78000000000000003 112.865 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 37.6 mmtm 67.34 -1.2 1.59 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.958 2.103 . . . . 2.3199999999999998 113.647 -173.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.79 119.64 4.93 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 126.615 2.055 . . . . 0.81999999999999995 111.279 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -84.22 142.79 30.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.316 1.046 . . . . 6.2400000000000002 110.722 156.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 m -148.48 147.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.518 1.927 . . . . 2.1899999999999999 110.218 168.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.91 123.93 46.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.315 1.055 . . . . 3.0899999999999999 112.327 170.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.46 85.88 0.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.799 1.239 . . . . 2.46 107.716 158.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -100.41 160.65 26.39 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.055 2.542 . . . . 4.04 113.279 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -58.56 -55.31 2.17 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.554 2.836 . . . . 1.46 112.664 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.92 65.53 3.73 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 110.884 -0.886 . . . . 1.6200000000000001 110.884 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.94 -108.37 0.28 Allowed Glycine 0 N--CA 1.468 0.816 0 C-N-CA 124.616 1.103 . . . . 1.5600000000000001 113.005 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -130.84 143.19 50.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.002 1.401 . . . . 3.5 111.029 -172.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -170.21 163.37 8.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 120.995 -1.066 . . . . 2.0299999999999998 109.935 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -88.23 133.31 34.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.678 -0.677 . . . . 3.9199999999999999 110.29 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.1 mmt -84.13 136.36 34.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.78 0.832 . . . . 1.99 110.196 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.42 75.67 0.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.578 1.551 . . . . 2.7599999999999998 109.164 -170.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.39 116.04 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.245 -1.02 . . . . 4.3399999999999999 108.245 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.98 96.69 0.4 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.291 -1.123 . . . . 2.8500000000000001 110.291 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.1 119.52 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.291 -1.374 . . . . 2.25 107.291 167.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.79 4.76 23.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.798 -1.189 . . . . 2.8500000000000001 112.833 -164.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -167.66 152.69 6.76 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.739 2.016 . . . . 6.3799999999999999 109.595 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.19 151.94 82.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.46 -1.4 . . . . 1.9199999999999999 108.46 161.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.63 162.43 41.0 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.627 1.971 . . . . 3.6699999999999999 108.64 -164.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -154.19 162.6 41.08 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.896 1.813 . . . . 4.8700000000000001 115.896 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.57 133.21 48.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 2.8999999999999999 107.989 157.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.57 13.81 62.54 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.956 -0.914 . . . . 2.1600000000000001 113.493 -162.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.0 169.24 9.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.689 1.245 . . . . 3.1099999999999999 107.868 151.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -136.72 150.35 48.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.523 1.929 . . . . 3.6699999999999999 107.805 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.428 ' CG1' ' HG1' ' A' ' 37' ' ' THR . 70.1 t -116.47 103.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 124.788 1.235 . . . . 1.72 108.384 -168.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -59.82 134.04 56.66 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 125.1 1.5 . . . . 4.1399999999999997 108.46 154.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.94 130.37 23.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.855 1.662 . . . . 2.5800000000000001 109.579 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 112' ' ' LYS . 5.0 m-20 -103.5 92.23 4.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.994 1.718 . . . . 2.3999999999999999 109.063 -175.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.7 mt -77.68 112.33 14.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.893 1.677 . . . . 2.4199999999999999 110.226 -172.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -86.5 128.07 34.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.805 0.842 . . . . 1.95 111.475 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.29 142.87 50.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.687 0.795 . . . . 3.27 113.003 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.59 133.05 30.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.528 1.531 . . . . 2.0099999999999998 114.292 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.11 -142.93 23.61 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.777 -1.329 . . . . 3.6099999999999999 109.777 -162.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.46 71.12 0.25 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.979 0.8 . . . . 2.1600000000000001 112.951 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -131.0 148.59 52.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.701 1.25 . . . . 5.8300000000000001 111.416 168.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.82 139.73 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.639 1.575 . . . . 1.78 109.235 170.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.71 145.71 48.79 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.424 1.09 . . . . 2.25 110.378 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 102' ' ' ASP . 17.2 mtpp -112.83 143.71 43.61 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.079 0.952 . . . . 4.0599999999999996 112.323 -169.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -158.64 125.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.326 1.45 . . . . 2.5 109.689 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.0 p -92.29 121.72 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.338 1.055 . . . . 3.0 109.142 170.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.04 143.28 48.34 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.293 1.437 . . . . 3.1600000000000001 111.634 -171.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.36 150.22 70.4 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.373 2.715 . . . . 1.1299999999999999 112.992 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.13 127.02 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.464 0.705 . . . . 2.0499999999999998 110.256 171.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.85 142.4 27.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.274 2.23 . . . . 5.0800000000000001 108.411 163.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.33 134.61 12.38 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.515 0.561 . . . . 2.71 112.515 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 116.179 -1.867 . . . . 9.9199999999999999 113.492 164.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 111.632 0.234 . . . . 5.1500000000000004 111.632 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.85 169.54 40.21 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 120.941 -1.1 . . . . 1.72 114.781 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.42 152.18 19.89 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.14 0.793 . . . . 1.97 113.14 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.78 124.2 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.452 -0.944 . . . . 2.0 108.452 163.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -83.34 109.17 17.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.177 0.991 . . . . 6.3700000000000001 108.655 167.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -179.31 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.841 1.052 . . . . 4.04 113.841 -173.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m -168.48 167.56 6.17 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.572 1.949 . . . . 2.25 109.198 162.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.15 -26.78 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.039 2.493 . . . . 2.5699999999999998 112.105 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.2 177.96 15.72 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.384 1.468 . . . . 1.6100000000000001 112.668 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.02 -15.8 19.87 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 118.69 1.245 . . . . 1.97 113.247 -1.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -129.15 164.98 22.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.631 1.572 . . . . 2.1099999999999999 112.77 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.97 163.4 30.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.391 2.276 . . . . 1.71 109.883 171.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.98 145.44 38.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.33 1.052 . . . . 2.1200000000000001 110.876 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.67 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.317 0.858 . . . . 1.53 113.317 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -145.78 158.44 43.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.998 1.719 . . . . 3.2799999999999998 110.844 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.7 152.31 13.71 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.497 1.119 . . . . 3.0600000000000001 111.395 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 m -79.57 149.74 31.3 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.594 1.558 . . . . 2.5800000000000001 108.065 155.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -155.7 134.44 11.9 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.916 1.287 . . . . 4.0099999999999998 108.902 173.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.62 119.05 27.91 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.895 1.278 . . . . 4.3200000000000003 109.693 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -77.42 117.01 62.63 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 1.46 109.939 173.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.32 -11.12 8.58 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.042 2.495 . . . . 1.5600000000000001 113.825 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.72 163.93 54.74 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 119.025 0.83 . . . . 1.5900000000000001 113.521 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.475 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.4 m-20 -91.87 -1.7 57.19 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.275 1.83 . . . . 3.54 112.634 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.28 159.74 40.32 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.311 1.844 . . . . 2.52 110.856 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.03 159.09 23.92 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.042 2.495 . . . . 1.25 111.41 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.72 156.48 17.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.857 0.837 . . . . 3.96 110.537 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -129.54 120.32 25.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.086 1.355 . . . . 6.1500000000000004 108.308 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -101.16 118.52 37.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.839 1.655 . . . . 1.96 108.541 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.77 -11.18 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.289 1.036 . . . . 1.8500000000000001 113.346 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.92 -170.78 43.7 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.601 1.096 . . . . 0.67000000000000004 111.314 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 149.99 25.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 2.04 111.809 166.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -118.3 139.76 50.85 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.848 -1.158 . . . . 6.6900000000000004 110.065 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.539 ' HG1' HG13 ' A' ' 99' ' ' VAL . 3.4 t -140.94 152.25 64.79 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.629 1.172 . . . . 2.04 110.083 -171.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.65 -26.67 83.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.239 1.959 . . . . 1.3600000000000001 113.978 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 m -88.38 -7.9 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 114.991 1.478 . . . . 2.0899999999999999 114.991 -170.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.55 168.96 21.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.9 0.88 . . . . 1.7 113.349 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.84 -73.89 0.63 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.586 0.354 . . . . 4.2199999999999998 111.036 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -68.39 139.89 55.82 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.721 -1.237 . . . . 3.3900000000000001 109.298 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.55 139.85 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 125.242 1.417 . . . . 3.27 108.336 162.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -129.95 117.34 19.95 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.465 1.106 . . . . 2.0800000000000001 108.682 164.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -77.21 120.85 22.84 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.743 0.782 . . . . 1.95 109.253 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -106.77 151.05 25.67 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.414 1.486 . . . . 0.67000000000000004 112.681 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 62' ' ' ARG . 13.2 pt-20 -95.78 160.59 14.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.782 2.033 . . . . 1.98 110.151 164.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.3 m -131.44 108.74 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.464 1.905 . . . . 2.1800000000000002 107.127 166.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -109.85 160.31 16.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 3.8900000000000001 112.232 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -113.06 139.34 48.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.083 0.953 . . . . 3.3300000000000001 110.115 157.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -151.56 150.94 30.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.107 1.363 . . . . 7.3700000000000001 111.985 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.68 144.34 52.28 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.835 0.854 . . . . 4.2199999999999998 110.74 154.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -154.58 -39.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 114.718 1.377 . . . . 4.3399999999999999 114.718 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -112.28 38.21 2.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.667 1.987 . . . . 4.21 109.205 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.67 -35.03 0.59 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.204 1.383 . . . . 3.3999999999999999 113.445 -164.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -92.7 160.22 15.08 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.722 2.409 . . . . 4.7300000000000004 111.037 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -74.27 142.28 45.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.48 0.919 . . . . 4.6699999999999999 113.48 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.59 158.03 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 127.792 2.437 . . . . 3.3500000000000001 108.09 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.2 mtm -111.08 152.82 26.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 3.8799999999999999 112.535 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.76 177.1 41.08 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 123.716 0.674 . . . . 1.1399999999999999 113.468 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -124.45 161.01 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.692 1.197 . . . . 2.6699999999999999 111.646 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 47' ' ' GLU . 86.5 mtm-85 -158.61 151.65 18.52 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 126.806 2.042 . . . . 6.4199999999999999 109.447 173.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.57 142.41 71.05 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 CA-C-N 121.375 1.527 . . . . 1.0 110.672 154.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -104.23 155.31 37.4 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.739 1.216 . . . . 1.75 110.76 168.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.19 -19.46 56.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.85999999999999999 112.641 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -177.63 165.55 2.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.243 2.217 . . . . 3.0699999999999998 110.617 175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -105.91 170.56 7.83 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.828 1.251 . . . . 2.0099999999999998 110.05 153.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -143.08 169.71 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.326 0.65 . . . . 2.5299999999999998 110.811 171.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -146.91 133.16 9.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 107.926 -1.139 . . . . 2.1099999999999999 107.926 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.01 167.57 25.67 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.127 1.218 . . . . 1.27 111.319 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.99 140.98 87.6 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.32 2.68 . . . . 1.3 110.952 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 59.3 mmtt 66.07 4.01 2.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.146 1.379 . . . . 2.5800000000000001 113.074 -173.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.88 114.05 3.96 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 127.129 2.3 . . . . 1.47 113.06 -169.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -75.86 132.16 40.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.028 -1.586 . . . . 5.5599999999999996 110.076 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.93 164.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.119 2.168 . . . . 2.8500000000000001 109.428 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.97 117.89 0.91 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.024 0.929 . . . . 3.4900000000000002 109.574 -171.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -74.96 64.3 1.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.762 2.025 . . . . 2.54 111.615 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -63.42 133.35 95.46 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.791 -1.193 . . . . 3.96 110.789 167.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.49 -20.91 66.32 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.339 2.692 . . . . 1.8500000000000001 113.76 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.21 55.98 5.05 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.081 0.848 . . . . 1.49 111.23 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.46 -64.49 0.13 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.635 1.112 . . . . 1.3500000000000001 113.998 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -153.85 145.0 22.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.64 1.576 . . . . 3.2599999999999998 111.254 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -166.06 163.73 18.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.296 1.038 . . . . 1.3100000000000001 111.169 -174.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -107.73 127.02 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.069 0.548 . . . . 3.52 111.065 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -90.69 108.41 19.8 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.265 1.426 . . . . 2.25 110.142 164.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.39 130.76 37.98 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.144 0.978 . . . . 4.3300000000000001 108.772 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.82 150.62 51.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.265 1.426 . . . . 2.75 110.781 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.35 53.31 5.19 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.979 -0.848 . . . . 2.9900000000000002 110.979 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.6 mt -68.95 114.04 6.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.883 0.842 . . . . 2.0899999999999999 109.555 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -98.96 -0.1 42.86 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.866 1.266 . . . . 2.8999999999999999 111.961 -166.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -157.04 148.84 17.3 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.526 1.93 . . . . 7.04 108.7 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.44 156.38 54.43 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.363 2.042 . . . . 2.1400000000000001 109.624 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mp -103.11 155.56 18.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.573 1.178 . . . . 4.2199999999999998 112.139 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -120.53 123.58 43.25 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.099 2.16 . . . . 5.8099999999999996 109.392 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 131.58 50.82 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.151 -0.968 . . . . 2.8700000000000001 111.586 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.08 44.06 78.71 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.16 -0.8 . . . . 1.78 112.669 -172.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.95 -178.07 3.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.741 -1.207 . . . . 3.04 107.741 151.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -127.0 161.29 28.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.472 1.109 . . . . 3.77 109.543 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.539 HG13 ' HG1' ' A' ' 37' ' ' THR . 16.8 t -126.22 120.78 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 124.615 1.166 . . . . 2.4700000000000002 109.816 -175.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -68.89 119.23 12.89 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 124.488 1.117 . . . . 2.7599999999999998 108.619 154.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.99 120.81 40.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.735 0.779 . . . . 2.8500000000000001 109.055 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.9 93.66 8.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.762 -1.563 . . . . 2.4300000000000002 107.964 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.05 119.45 11.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.685 -0.857 . . . . 2.2000000000000002 108.685 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.8 mt -90.92 120.59 32.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.665 -0.865 . . . . 1.7 108.665 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.12 131.18 57.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.069 0.938 . . . . 3.5 112.343 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.61 -18.51 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 131.014 3.726 . . . . 3.7599999999999998 116.932 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.81 -22.42 0.71 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.345 1.926 . . . . 5.7999999999999998 113.721 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.01 -6.56 0.06 OUTLIER Glycine 0 N--CA 1.474 1.204 0 N-CA-C 117.362 1.705 . . . . 3.8100000000000001 117.362 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 101.0 8.18 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 120.384 2.092 . . . . 5.9199999999999999 109.582 175.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.21 138.44 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.729 1.212 . . . . 2.5299999999999998 110.041 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.53 136.55 33.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.36 1.064 . . . . 2.9100000000000001 111.748 166.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.45 125.41 25.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.975 0.51 . . . . 3.3300000000000001 111.967 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -101.54 154.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.946 -0.761 . . . . 3.0 108.946 142.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.8 p -118.99 139.8 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.062 -1.088 . . . . 2.9100000000000001 108.062 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -162.55 155.57 16.9 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.022 1.729 . . . . 3.9399999999999999 110.127 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.93 160.12 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.389 3.393 . . . . 1.2 115.04 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.3 t -87.6 122.59 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.697 1.199 . . . . 1.9099999999999999 110.058 164.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -92.64 131.17 37.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.729 2.011 . . . . 3.8199999999999998 107.554 161.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.21 116.17 5.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.308 0.643 . . . . 3.4100000000000001 111.431 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 129.3 3.04 . . . . 8.2400000000000002 107.208 176.68 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 110.122 -0.325 . . . . 5.1600000000000001 110.122 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.94 154.82 18.24 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 120.885 -1.135 . . . . 1.4099999999999999 112.684 166.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -158.3 145.09 17.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.476 1.111 . . . . 1.5 111.675 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -97.33 137.16 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.791 -0.818 . . . . 1.8200000000000001 108.791 171.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.28 92.32 4.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.921 1.289 . . . . 4.1299999999999999 109.536 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.18 159.67 9.4 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 123.548 1.642 . . . . 3.3199999999999998 112.383 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -162.85 154.69 15.4 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 129.08 2.952 . . . . 2.8900000000000001 106.54 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 39.06 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.058 3.172 . . . . 2.1899999999999999 112.418 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.23 178.79 51.42 Favored Glycine 0 CA--C 1.541 1.668 0 O-C-N 121.206 -0.934 . . . . 2.2999999999999998 112.173 -156.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.82 -12.23 23.54 Favored 'Cis proline' 0 CA--C 1.54 0.798 0 CA-C-N 118.435 1.118 . . . . 3.1800000000000002 112.457 -11.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -155.7 168.54 26.84 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.411 1.884 . . . . 2.25 110.997 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.61 -177.15 4.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 1.5700000000000001 111.042 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.24 152.67 47.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.224 1.01 . . . . 2.0699999999999998 112.506 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.01 140.32 52.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.166 0.986 . . . . 1.8200000000000001 111.858 167.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -128.19 152.0 48.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.499 1.92 . . . . 3.3799999999999999 110.517 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pp -165.11 133.51 3.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.938 1.829 . . . . 2.73 115.938 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 m -76.81 139.02 40.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.143 -1.39 . . . . 1.8300000000000001 108.685 156.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.25 145.07 16.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 3.6000000000000001 108.257 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.43 144.94 49.18 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.518 0.599 . . . . 3.3399999999999999 111.502 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -86.9 109.58 25.68 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 108.621 -0.881 . . . . 1.3400000000000001 108.621 155.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.05 -14.07 5.24 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.965 1.777 . . . . 1.3300000000000001 114.411 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.27 -153.98 24.16 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.63 1.012 . . . . 1.46 115.63 -159.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -93.74 -32.03 14.18 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.138 2.575 . . . . 5.8200000000000003 113.932 -173.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.12 158.83 36.91 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.375 1.47 . . . . 2.5600000000000001 112.052 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.85 155.33 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.798 2.332 . . . . 1.3899999999999999 111.786 -170.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.91 132.52 56.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.142 1.377 . . . . 3.6200000000000001 109.138 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -125.98 106.54 9.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.297 1.039 . . . . 5.79 111.937 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.7 tp -92.21 112.51 24.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.463 2.305 . . . . 2.1800000000000002 109.651 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.02 -7.4 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.155 1.382 . . . . 1.9299999999999999 113.277 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.94 -167.09 38.67 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 121.458 -0.776 . . . . 0.62 112.247 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.34 175.29 10.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.107 0.563 . . . . 1.73 111.9 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -156.31 91.27 1.24 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.221 -1.77 . . . . 7.7400000000000002 106.221 -164.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.415 ' HG1' ' CG1' ' A' ' 99' ' ' VAL . 1.5 t -104.7 152.85 39.54 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.116 1.366 . . . . 1.6799999999999999 110.59 -176.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -27.55 16.28 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.394 2.729 . . . . 1.27 113.531 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.31 1.7 m -89.93 -0.11 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 114.355 1.243 . . . . 1.8799999999999999 114.355 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.96 140.66 50.88 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.876 0.871 . . . . 1.73 112.24 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -72.48 -68.89 0.44 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.173 -1.047 . . . . 5.54 108.173 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -90.09 149.25 22.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.442 2.297 . . . . 4.1299999999999999 109.653 168.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.23 139.66 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.545 1.538 . . . . 2.5699999999999998 109.548 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -142.17 140.82 32.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.906 1.682 . . . . 2.0299999999999998 110.521 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -81.79 122.5 27.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.515 1.052 . . . . 2.2599999999999998 111.346 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -111.74 156.9 21.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.561 1.544 . . . . 0.68999999999999995 112.553 174.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.95 -179.64 4.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.228 2.211 . . . . 1.8200000000000001 111.112 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.5 m -126.85 114.29 17.71 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.808 -1.553 . . . . 2.3900000000000001 106.808 151.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -89.5 152.15 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 3.8199999999999998 111.025 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.1 ptp -101.24 144.88 29.55 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.499 -0.773 . . . . 3.75 110.133 155.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.4 158.79 34.88 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.216 1.806 . . . . 8.3599999999999994 109.468 171.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.484 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -90.37 148.95 22.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.585 -0.895 . . . . 3.8799999999999999 108.585 167.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.96 -79.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.649 0.737 . . . . 3.98 110.372 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 56' ' ' LYS . 13.8 tt0 -76.19 35.18 0.14 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.445 2.298 . . . . 4.6399999999999997 111.651 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.33 -12.37 0.94 Allowed Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.289 -1.507 . . . . 2.0 113.744 -161.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 54' ' ' GLU . 34.4 mtpt -106.78 154.34 21.14 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 128.032 2.533 . . . . 5.2000000000000002 109.736 -173.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.484 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 19.7 mtpp -70.14 137.49 51.11 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.696 0.399 . . . . 4.6600000000000001 110.868 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.71 148.69 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.482 1.913 . . . . 3.0600000000000001 108.402 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 19.8 mmt -115.5 142.04 47.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.697 1.199 . . . . 5.5800000000000001 109.351 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.82 151.76 23.37 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.283 0.947 . . . . 1.24 114.19 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -93.64 159.27 15.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.147 0.979 . . . . 2.9399999999999999 111.833 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -173.41 140.21 0.86 Allowed Pre-proline 0 N--CA 1.473 0.692 0 CA-C-O 116.67 -1.633 . . . . 4.6600000000000001 110.246 -168.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -70.63 148.76 60.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.363 1.88 . . . . 1.25 111.378 170.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.86 151.9 74.47 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 125.254 1.422 . . . . 1.98 110.206 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.06 -13.65 26.12 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.938 2.425 . . . . 1.1899999999999999 113.777 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -175.03 164.71 3.4 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.8 1.24 . . . . 3.1699999999999999 111.572 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -121.64 170.25 9.9 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 127.404 2.282 . . . . 1.95 108.915 152.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.57 172.43 18.57 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.244 -0.91 . . . . 2.23 110.804 169.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.9 t -147.55 122.57 5.18 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 125.161 1.385 . . . . 2.2000000000000002 109.664 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.11 159.66 51.55 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.947 1.765 . . . . 1.47 110.656 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.3 139.11 88.45 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.872 3.048 . . . . 1.1799999999999999 111.588 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.07 -8.32 1.32 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.252 2.221 . . . . 4.25 115.088 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.08 129.03 8.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 126.525 2.012 . . . . 1.1299999999999999 110.283 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -87.65 148.16 24.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.556 -0.822 . . . . 5.6299999999999999 112.411 163.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.99 167.02 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.653 1.581 . . . . 3.7000000000000002 110.788 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -154.23 85.28 1.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.845 1.658 . . . . 3.04 107.0 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.83 68.87 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.894 1.678 . . . . 2.71 112.055 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -72.36 151.45 92.01 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.497 2.719 . . . . 4.1299999999999999 113.658 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.45 -58.91 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.752 2.968 . . . . 1.6299999999999999 112.614 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.85 83.3 1.16 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.389 -1.484 . . . . 1.5 109.389 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.6 -97.18 0.16 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 125.274 1.416 . . . . 1.3 111.492 -166.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -151.65 134.23 15.47 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.658 1.583 . . . . 3.3799999999999999 109.455 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -163.53 175.73 10.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.724 1.147 . . . . 1.21 110.647 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -108.65 125.81 52.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.128 0.571 . . . . 3.7000000000000002 110.497 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -85.57 144.46 27.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.334 1.054 . . . . 1.9099999999999999 110.273 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -124.18 138.9 54.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.418 1.887 . . . . 2.9300000000000002 109.543 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.69 157.22 46.12 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.153 0.981 . . . . 3.3100000000000001 112.106 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.26 -54.78 3.59 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 126.343 1.925 . . . . 2.8599999999999999 114.732 167.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.8 mt 76.81 95.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 130.305 3.442 . . . . 1.8899999999999999 113.037 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -78.62 -0.97 31.97 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.834 1.42 . . . . 3.23 114.834 -172.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -144.3 145.66 30.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 127.136 2.174 . . . . 6.4000000000000004 108.206 172.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.31 115.67 4.38 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.19 1.26 . . . . 2.7599999999999998 110.174 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.72 151.69 23.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 112.869 -1.969 . . . . 3.6600000000000001 109.913 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU 0.268 0.0 OUTLIER -144.82 -7.84 0.65 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 117.121 2.267 . . . . 5.8300000000000001 117.121 179.855 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.67 170.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.103 2.561 . . . . 3.25 112.972 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.51 34.51 53.97 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.253 -0.748 . . . . 1.6899999999999999 111.681 -164.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.404 ' CD ' ' HZ3' ' A' ' 94' ' ' LYS . 11.4 pt-20 -151.32 174.01 13.82 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 127.224 2.21 . . . . 3.3700000000000001 109.694 -174.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 164.18 14.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.021 2.128 . . . . 4.0 111.696 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.415 ' CG1' ' HG1' ' A' ' 37' ' ' THR . 99.2 t -133.86 108.38 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.593 1.157 . . . . 1.6399999999999999 109.455 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.478 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 53.0 mt-10 -71.34 98.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.979 -1.119 . . . . 3.6400000000000001 107.979 159.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 tt -98.74 138.61 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.697 -0.853 . . . . 3.0 108.697 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.01 138.6 31.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 3.77 112.053 168.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.38 122.74 43.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.457 2.303 . . . . 2.3300000000000001 109.075 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.6 mt -92.89 119.73 32.5 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.136 0.974 . . . . 1.96 109.935 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -115.57 150.52 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.943 0.877 . . . . 3.6000000000000001 113.254 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 162.83 28.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.996 -0.547 . . . . 2.4100000000000001 111.332 165.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 20.4 79.55 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.263 -0.743 . . . . 4.6799999999999997 114.266 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.52 61.28 2.8 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 118.61 1.205 . . . . 2.4300000000000002 112.319 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 154.76 43.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.071 2.148 . . . . 4.8499999999999996 110.115 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -168.66 140.83 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.392 2.277 . . . . 2.8599999999999999 107.407 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.8 mt -150.21 109.61 3.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.187 0.903 . . . . 2.6200000000000001 111.175 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 30.4 ttpt -81.7 111.6 18.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.284 0.634 . . . . 3.79 110.769 173.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -117.0 141.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.188 1.795 . . . . 2.3599999999999999 110.427 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.83 116.16 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.049 0.939 . . . . 2.7999999999999998 112.227 -173.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.8 150.57 46.02 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.573 1.549 . . . . 4.4699999999999998 110.018 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.11 159.91 26.75 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.074 3.183 . . . . 1.1799999999999999 111.954 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 130.59 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.086 0.955 . . . . 2.2799999999999998 111.342 169.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -97.96 139.65 33.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.832 2.453 . . . . 3.2400000000000002 107.48 159.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.05 9.31 32.49 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.345 1.98 . . . . 2.8799999999999999 116.345 -162.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.785 0 C-N-CA 126.956 2.102 . . . . 7.6100000000000003 110.133 -172.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 . . . . . 0 CA--C 1.547 0.853 0 CA-C-O 120.444 0.164 . . . . 5.3399999999999999 110.692 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.81 163.1 12.86 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.714 1.149 . . . . 1.77 115.277 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -151.37 149.46 29.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.4 1.08 . . . . 1.8700000000000001 113.228 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.49 121.55 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.405 0.682 . . . . 1.6499999999999999 110.118 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -86.69 90.43 8.27 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.027 0.931 . . . . 6.8700000000000001 110.754 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.03 149.33 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.246 1.418 . . . . 3.7999999999999998 112.054 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.0 m -155.59 162.54 27.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.774 2.029 . . . . 2.8599999999999999 109.724 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.03 -5.87 13.87 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.522 2.814 . . . . 2.0499999999999998 113.582 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 170.29 31.99 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.517 1.056 . . . . 1.8100000000000001 113.328 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.84 -2.29 21.84 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 117.951 0.875 . . . . 2.23 113.272 -4.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.73 152.85 33.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.43 1.092 . . . . 2.9900000000000002 112.595 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.89 175.1 14.38 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.377 1.871 . . . . 1.8200000000000001 111.318 166.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.61 156.23 36.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.846 0.858 . . . . 2.0299999999999998 110.73 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.5 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.747 0.784 . . . . 1.5700000000000001 111.311 162.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.52 143.28 49.82 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.947 1.699 . . . . 3.5899999999999999 108.3 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.02 144.78 23.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 120.687 -1.258 . . . . 2.5699999999999998 113.985 174.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -92.39 111.48 23.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.913 -1.494 . . . . 2.23 107.35 170.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.1 tt -120.16 147.18 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.873 2.469 . . . . 3.8500000000000001 109.126 -174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -142.71 152.43 42.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.16 0.981 . . . . 2.75 113.418 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -100.14 102.39 17.84 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 113.976 -1.465 . . . . 1.1799999999999999 109.269 171.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.88 -9.93 16.84 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.811 2.341 . . . . 1.26 113.041 174.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.84 -179.12 52.78 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 124.55 1.071 . . . . 1.1200000000000001 113.464 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.3 m-20 -107.73 -2.73 19.8 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.182 1.793 . . . . 3.1499999999999999 112.965 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.25 160.66 40.52 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.479 1.911 . . . . 2.23 109.873 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.41 156.47 32.68 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.47 2.113 . . . . 0.78000000000000003 111.884 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.13 120.02 36.5 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.991 1.316 . . . . 3.5800000000000001 110.05 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -106.89 103.72 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.936 1.294 . . . . 6.3799999999999999 111.609 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.22 114.45 26.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.858 2.063 . . . . 1.72 109.282 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 m -92.21 -23.48 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.486 0.714 . . . . 2.1899999999999999 112.554 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.77 -168.64 40.24 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 123.751 0.691 . . . . 0.54000000000000004 111.529 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.93 175.07 12.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.506 -0.759 . . . . 2.0899999999999999 111.019 169.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -154.96 157.69 38.09 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.101 1.319 . . . . 7.7599999999999998 111.96 -167.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.509 ' HG1' HG12 ' A' ' 99' ' ' VAL . 2.7 t -161.18 154.88 18.49 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 124.843 1.257 . . . . 2.21 110.226 -172.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -68.21 -17.42 45.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.995 1.797 . . . . 1.1899999999999999 113.074 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 1.5 m -86.22 11.74 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.123 1.157 . . . . 1.77 114.123 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.62 162.18 40.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.747 1.219 . . . . 2.0099999999999998 111.917 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.9 -75.68 0.62 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.482 -0.562 . . . . 3.3100000000000001 109.482 170.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -75.31 146.0 41.34 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.763 -1.199 . . . . 4.8499999999999996 107.763 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -165.12 137.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.029 1.332 . . . . 2.5699999999999998 108.58 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -142.64 136.28 28.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.733 1.213 . . . . 1.99 110.547 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -79.97 120.15 23.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.568 0.699 . . . . 1.8300000000000001 109.635 163.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -104.27 152.75 21.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.032 1.333 . . . . 0.58999999999999997 111.327 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -106.54 163.67 12.69 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.562 1.945 . . . . 2.5099999999999998 110.016 163.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.6 m -152.2 113.71 4.33 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.104 1.362 . . . . 1.96 108.403 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -131.77 151.65 51.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.689 1.196 . . . . 3.6099999999999999 112.343 -160.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.32 154.33 25.35 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.151 0.98 . . . . 4.8899999999999997 112.262 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -156.05 160.23 39.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.23 1.012 . . . . 6.5700000000000003 111.516 172.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.12 155.21 16.92 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.975 1.31 . . . . 5.21 109.658 162.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.29 113.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 124.99 1.431 . . . . 4.21 111.175 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 60.53 17.41 7.32 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.032 0.933 . . . . 4.3899999999999997 112.345 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.85 4.91 89.62 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.239 -1.538 . . . . 3.46 114.267 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.43 128.75 34.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.722 1.609 . . . . 3.8999999999999999 109.795 168.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.05 134.75 51.16 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.252 -0.905 . . . . 7.1100000000000003 109.699 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.56 165.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.881 0.872 . . . . 4.3700000000000001 110.829 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.6 ptp -130.24 148.81 52.11 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.25 1.02 . . . . 4.1200000000000001 111.649 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 164.83 15.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.005 1.288 . . . . 2.1400000000000001 111.716 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.31 157.21 46.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 3.4300000000000002 110.609 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -160.77 137.15 6.3 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 116.153 -1.879 . . . . 5.1399999999999997 108.99 -173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.34 146.36 85.6 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.971 1.74 . . . . 0.89000000000000001 110.403 151.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.98 155.96 52.54 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.853 1.261 . . . . 2.1499999999999999 110.538 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.14 -14.59 25.91 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.005 2.47 . . . . 1.5600000000000001 113.095 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -176.18 165.96 2.86 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.492 1.917 . . . . 4.1299999999999999 112.292 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -117.59 176.0 5.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.459 2.304 . . . . 2.46 109.022 154.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.83 168.92 23.57 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.883 -1.135 . . . . 2.6800000000000002 112.217 163.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.8 t -140.72 130.83 13.37 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.222 1.009 . . . . 2.0 109.446 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.61 162.67 38.19 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.473 2.115 . . . . 0.97999999999999998 111.206 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.6 143.67 99.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.162 2.575 . . . . 1.05 111.638 176.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 63.9 mmtt 66.93 1.45 2.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.614 1.966 . . . . 2.3500000000000001 113.752 -175.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.4 119.69 4.97 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 126.94 2.21 . . . . 1.03 111.164 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 135.21 36.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.77 1.228 . . . . 4.6500000000000004 111.147 160.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.96 152.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.024 1.729 . . . . 2.1099999999999999 110.77 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.55 120.56 32.32 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.85 1.66 . . . . 4.6799999999999997 109.075 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.34 69.24 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.251 1.5 . . . . 1.9099999999999999 112.973 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.49 133.6 53.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.405 1.882 . . . . 3.8700000000000001 113.368 169.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -56.34 -44.96 41.2 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.411 2.074 . . . . 2.02 111.201 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.69 2.4 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.948 1.261 . . . . 1.3999999999999999 111.65 167.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -74.24 0.2 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.756 2.122 . . . . 1.5900000000000001 112.271 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -151.87 132.74 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.35 1.46 . . . . 3.5899999999999999 111.574 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -158.89 176.76 11.92 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.679 -1.263 . . . . 1.0800000000000001 111.357 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -111.93 130.46 55.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 112.359 0.503 . . . . 3.5800000000000001 112.359 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -94.3 130.11 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.836 1.255 . . . . 1.6599999999999999 111.066 165.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.0 mt -109.83 132.74 53.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.797 1.639 . . . . 2.7999999999999998 109.001 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.02 150.49 49.23 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.32 1.057 . . . . 2.5800000000000001 112.969 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.92 -61.96 4.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.517 1.056 . . . . 2.6800000000000002 110.979 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mt 68.42 88.56 0.11 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 129.925 3.29 . . . . 2.1699999999999999 110.42 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -74.86 -3.81 34.16 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.131 -0.981 . . . . 2.73 113.281 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -145.56 144.39 22.61 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 127.809 2.444 . . . . 5.3300000000000001 107.768 168.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.71 173.2 14.49 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.649 2.233 . . . . 2.29 110.186 157.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.3 172.01 10.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.516 1.926 . . . . 5.29 108.149 166.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HZ2' ' CD ' ' A' ' 97' ' ' GLU 0.252 0.0 OUTLIER -126.79 1.9 6.71 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.828 1.788 . . . . 4.1500000000000004 115.828 174.082 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 76.38 158.43 0.2 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.785 2.834 . . . . 2.3700000000000001 110.922 -167.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 55.8 6.83 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 121.532 -0.73 . . . . 1.75 111.626 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.485 ' CD ' ' HZ2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -157.92 176.9 11.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.302 2.241 . . . . 3.5800000000000001 109.494 173.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.66 171.76 7.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.858 1.263 . . . . 4.25 109.804 166.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.509 HG12 ' HG1' ' A' ' 37' ' ' THR . 16.7 t -128.8 125.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.825 1.65 . . . . 1.6599999999999999 107.376 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 27.5 tt0 -77.68 140.95 39.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.474 0.484 . . . . 3.1699999999999999 109.81 166.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.71 126.6 12.73 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.856 1.058 . . . . 2.3999999999999999 113.856 -168.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.82 102.21 14.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.742 2.417 . . . . 2.6800000000000002 111.314 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.3 mt -78.58 111.91 15.13 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.926 -1.109 . . . . 2.98 111.166 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -90.8 122.38 33.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.884 1.274 . . . . 1.98 112.01 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.46 134.94 55.08 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.011 -1.056 . . . . 3.2200000000000002 113.597 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.03 -28.03 69.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.896 1.278 . . . . 2.48 113.605 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 31.25 1.09 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.73 1.157 . . . . 4.21 114.366 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.75 44.76 88.61 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.913 1.244 . . . . 1.8200000000000001 112.628 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 150.22 45.66 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.394 1.478 . . . . 5.0 111.283 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.83 137.28 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.048 -1.464 . . . . 2.5899999999999999 107.048 155.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.4 mt -120.2 104.94 10.49 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 107.897 -1.149 . . . . 2.8399999999999999 107.897 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.461 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 22.5 ttpt -84.15 128.49 34.6 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.881 -0.512 . . . . 4.1500000000000004 110.99 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.02 149.93 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.619 1.568 . . . . 3.6000000000000001 110.637 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.62 150.85 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.62 1.168 . . . . 4.1600000000000001 111.121 171.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -149.36 150.1 30.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.258 1.823 . . . . 3.0899999999999999 109.577 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.37 156.22 54.88 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.299 3.333 . . . . 1.6399999999999999 114.054 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 69.1 t -87.22 145.9 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.379 1.072 . . . . 2.4500000000000002 111.882 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.25 152.52 51.3 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.378 3.471 . . . . 3.8500000000000001 107.065 176.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.87 168.58 19.44 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.251 1.575 . . . . 3.1499999999999999 115.251 -152.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 C-N-CA 128.006 2.523 . . . . 10.9 110.718 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.514 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 14.4 tt0 . . . . . 0 CA--C 1.545 0.761 0 CA-C-O 121.456 0.646 . . . . 5.5199999999999996 111.067 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.514 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -124.42 146.77 16.36 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.323 1.439 . . . . 1.3799999999999999 113.244 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -137.31 141.48 41.89 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.591 0.96 . . . . 1.6399999999999999 113.591 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.8 t -95.47 107.95 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.709 0.804 . . . . 2.02 109.48 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -88.92 111.72 22.44 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.492 1.042 . . . . 4.7800000000000002 111.027 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.26 168.92 18.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.399 1.48 . . . . 3.9500000000000002 112.844 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -160.98 158.3 23.91 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.267 1.827 . . . . 2.4500000000000002 110.212 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.69 6.65 3.96 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.027 3.151 . . . . 1.51 114.022 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.07 166.98 29.16 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.363 0.982 . . . . 1.4199999999999999 112.367 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.11 -2.27 22.87 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 CA-C-N 118.359 1.079 . . . . 1.71 112.724 -5.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -136.61 169.66 17.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.29 1.436 . . . . 2.0800000000000001 113.54 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.46 171.04 21.08 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.134 1.774 . . . . 1.8300000000000001 112.372 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.55 101.88 6.37 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.199 0.999 . . . . 1.78 112.845 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.6 139.08 31.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.88 0.696 . . . . 1.8799999999999999 112.88 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.12 156.47 28.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.389 . . . . 3.4700000000000002 111.0 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.484 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -160.77 146.02 14.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.732 1.753 . . . . 2.46 115.732 166.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 m -79.66 126.9 31.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.461 -0.94 . . . . 1.8 108.461 158.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -130.22 138.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.855 1.662 . . . . 3.6400000000000001 110.215 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.09 160.22 39.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.84 0.829 . . . . 2.7400000000000002 113.07 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.19 94.28 47.14 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.507 1.523 . . . . 1.01 109.999 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.98 -5.01 15.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.938 1.759 . . . . 1.3300000000000001 112.769 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.14 156.31 37.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.33 0.967 . . . . 1.1399999999999999 113.085 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.441 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.3 m-20 -91.91 4.73 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.456 1.902 . . . . 2.98 113.668 -171.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.84 159.07 42.16 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.859 1.663 . . . . 2.2400000000000002 110.506 168.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.09 154.24 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.14 2.56 . . . . 0.72999999999999998 111.286 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.74 155.09 20.58 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.042 0.937 . . . . 3.0800000000000001 111.104 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 68' ' ' GLU . 19.5 ttm180 -133.47 112.34 11.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.042 1.337 . . . . 5.2199999999999998 109.012 168.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.6 tp -93.93 110.47 22.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.759 2.024 . . . . 1.8600000000000001 108.051 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -102.06 -13.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.277 0.843 . . . . 1.6499999999999999 113.277 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -160.72 29.53 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.117 0.865 . . . . 0.46000000000000002 112.76 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.59 174.4 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.788 1.235 . . . . 1.9199999999999999 111.229 166.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -141.99 135.89 29.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.458 1.503 . . . . 6.1799999999999997 109.279 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -145.09 147.65 35.36 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 119.594 1.088 . . . . 1.9399999999999999 110.643 -171.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.29 -0.39 10.0 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.5 2.8 . . . . 1.21 113.92 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.08 13.28 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.781 1.232 . . . . 2.1200000000000001 114.093 174.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.34 157.04 43.75 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.431 -1.418 . . . . 2.2799999999999998 111.667 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -105.35 -70.49 0.78 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.733 -0.84 . . . . 3.9500000000000002 108.733 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -79.22 146.85 32.83 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.969 -1.123 . . . . 4.4900000000000002 107.969 161.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -147.09 137.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.097 1.359 . . . . 2.3999999999999999 108.713 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -128.45 133.76 48.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.701 2.0 . . . . 2.3300000000000001 108.565 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -82.82 123.34 29.26 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.839 1.199 . . . . 2.1200000000000001 110.28 167.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 15.3 m170 -109.1 154.96 21.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.387 1.475 . . . . 0.65000000000000002 111.913 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -109.49 -179.14 3.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.594 1.958 . . . . 2.3799999999999999 110.923 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.7 m -133.63 114.34 13.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.497 1.519 . . . . 2.1899999999999999 108.013 164.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -100.72 151.96 21.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.369 1.068 . . . . 3.0099999999999998 111.712 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -83.96 149.63 26.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.814 0.846 . . . . 4.75 111.082 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -154.66 135.9 14.01 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.779 0.832 . . . . 6.6299999999999999 110.844 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.91 146.57 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.051 -0.722 . . . . 4.9000000000000004 109.051 157.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -152.6 123.61 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.329 1.452 . . . . 4.1600000000000001 108.586 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 50.11 38.33 16.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.205 1.002 . . . . 4.5700000000000003 111.806 -169.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.32 -2.69 9.33 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.895 1.712 . . . . 2.7999999999999998 115.924 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -84.67 130.36 34.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.356 1.578 . . . . 3.4500000000000002 109.514 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.08 136.79 40.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.856 1.262 . . . . 5.9100000000000001 112.609 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -151.75 151.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.225 2.21 . . . . 3.1400000000000001 108.685 -167.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -113.72 131.65 56.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.196 0.998 . . . . 3.8799999999999999 109.9 168.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.81 164.21 22.0 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 124.384 0.992 . . . . 1.29 112.857 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -106.73 160.52 15.41 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.665 1.186 . . . . 2.6899999999999999 112.58 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -168.65 155.82 7.14 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 126.334 1.854 . . . . 4.5700000000000003 110.583 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.8 Cg_endo -69.58 152.84 70.28 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.79 1.66 . . . . 0.84999999999999998 112.286 167.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.27 158.42 48.63 Favored Pre-proline 0 N--CA 1.473 0.694 0 C-N-CA 126.312 1.845 . . . . 1.98 110.148 172.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.77 -16.76 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.594 2.196 . . . . 0.92000000000000004 112.68 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -179.74 162.55 1.08 Allowed 'General case' 0 C--N 1.347 0.465 0 C-N-CA 126.236 1.815 . . . . 3.1099999999999999 110.573 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -109.63 174.23 5.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.002 2.121 . . . . 1.97 109.554 157.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.5 pt-20 -154.83 166.84 32.23 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.145 -0.972 . . . . 2.3799999999999999 112.125 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.28 135.9 11.18 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 124.024 0.93 . . . . 1.8700000000000001 109.403 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.21 168.22 22.76 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.021 1.814 . . . . 0.91000000000000003 111.435 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.66 143.18 91.99 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.365 2.71 . . . . 0.81000000000000005 111.615 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.9 mmmt 68.15 1.0 2.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.968 2.107 . . . . 2.5299999999999998 114.012 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.92 -171.61 27.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.353 1.93 . . . . 1.1399999999999999 112.289 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -158.16 160.89 37.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.276 1.213 . . . . 4.9199999999999999 114.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 m -143.9 132.14 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.365 1.466 . . . . 3.3100000000000001 111.136 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -93.4 126.55 38.59 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.283 0.633 . . . . 3.6899999999999999 109.336 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -71.03 66.6 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.834 1.302 . . . . 2.0099999999999998 109.268 161.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -73.11 141.55 81.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.533 2.333 . . . . 4.0800000000000001 111.422 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.13 -44.46 49.16 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 1.3 113.677 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.89 80.85 1.56 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.671 -1.372 . . . . 1.3899999999999999 109.671 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.17 -70.33 0.2 Allowed Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.097 -0.835 . . . . 1.3100000000000001 114.211 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -157.17 146.98 20.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.344 1.857 . . . . 3.4199999999999999 110.154 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -172.89 152.56 2.44 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.569 -1.332 . . . . 1.6000000000000001 110.444 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -88.98 123.89 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.537 0.335 . . . . 3.7400000000000002 110.961 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.6 mmt -83.54 100.9 11.08 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.881 1.272 . . . . 1.6399999999999999 109.798 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -78.79 138.6 38.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.723 1.209 . . . . 2.6499999999999999 107.811 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -144.09 148.9 35.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.443 1.116 . . . . 2.4700000000000002 112.178 -173.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.8 -53.13 4.53 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.8 1.191 . . . . 2.5699999999999998 111.42 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 61.15 95.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.667 2.787 . . . . 1.9399999999999999 110.92 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.9 -15.1 62.09 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.794 -1.191 . . . . 3.4500000000000002 112.339 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -147.14 145.66 22.87 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 128.292 2.637 . . . . 5.54 107.848 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.72 176.63 8.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.984 2.456 . . . . 2.7400000000000002 109.879 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.55 -179.0 5.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.972 0.909 . . . . 4.75 111.93 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -151.0 144.65 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.461 1.904 . . . . 5.8099999999999996 110.022 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 131.57 49.3 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.624 1.169 . . . . 3.04 112.955 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.58 -16.37 52.05 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.887 -1.507 . . . . 3.9300000000000002 115.125 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.69 172.11 8.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.541 1.67 . . . . 6.0800000000000001 111.191 -166.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.42 111.88 23.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.263 1.825 . . . . 4.4299999999999997 111.485 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.67 117.63 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.085 -1.08 . . . . 2.1699999999999999 108.085 165.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -74.19 140.91 45.44 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.38 1.086 . . . . 2.9399999999999999 110.911 157.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.78 125.97 12.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.938 1.695 . . . . 2.8799999999999999 109.843 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.57 96.29 7.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.98 2.112 . . . . 2.8399999999999999 109.439 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.0 mt -80.27 112.42 17.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.023 1.729 . . . . 2.79 110.222 -171.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.4 mt -82.85 128.61 34.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.314 1.046 . . . . 2.27 111.472 -170.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.2 126.96 47.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.649 0.78 . . . . 3.7599999999999998 112.055 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 41.28 29.34 0.09 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.59 2.356 . . . . 3.0600000000000001 116.399 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.73 -55.39 3.8 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.321 1.439 . . . . 4.3099999999999996 113.087 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.33 -3.13 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.82 1.2 . . . . 2.1200000000000001 115.374 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -130.52 161.16 32.1 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.07 1.435 . . . . 6.2199999999999998 114.025 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.48 166.44 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.874 2.07 . . . . 1.95 108.715 155.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.6 mt -137.24 126.5 24.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.713 1.605 . . . . 2.5499999999999998 109.339 159.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -83.48 131.71 34.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.133 0.424 . . . . 3.6000000000000001 111.469 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.02 156.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.592 1.157 . . . . 4.5800000000000001 109.535 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.396 1.878 . . . . 2.52 109.995 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -143.49 144.44 27.79 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.495 1.518 . . . . 3.8500000000000001 110.773 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 149.46 28.52 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.202 2.602 . . . . 1.3 113.616 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.4 t -84.23 130.56 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.006 1.322 . . . . 1.9299999999999999 112.571 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.0 144.67 29.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.106 1.762 . . . . 3.3100000000000001 109.527 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.51 86.77 2.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.643 1.177 . . . . 2.3599999999999999 109.784 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.167 1.387 . . . . 8.2400000000000002 110.733 -166.002 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 122.288 1.042 . . . . 5.6600000000000001 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.18 170.59 42.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.415 1.959 . . . . 1.6899999999999999 111.353 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.0 p90 -158.13 146.49 18.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.596 1.158 . . . . 1.6399999999999999 110.998 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -106.72 118.35 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.583 -1.266 . . . . 1.75 107.583 170.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -89.51 114.61 26.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.159 0.984 . . . . 4.4000000000000004 109.769 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.07 166.92 21.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.05 1.405 . . . . 3.6499999999999999 113.497 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t -156.32 155.26 28.71 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.602 2.361 . . . . 3.9399999999999999 108.385 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.93 -13.78 39.36 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.544 2.163 . . . . 1.8899999999999999 112.559 165.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.87 174.71 18.37 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.964 1.745 . . . . 1.72 112.737 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 -5.91 48.26 Favored 'Cis proline' 0 CA--C 1.54 0.809 0 CA-C-N 118.415 1.107 . . . . 2.0699999999999998 113.513 -1.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -126.98 161.98 27.07 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.611 1.165 . . . . 2.1000000000000001 113.23 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.01 -176.37 5.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.361 2.264 . . . . 2.1099999999999999 111.635 -175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.56 146.6 25.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.211 0.819 . . . . 1.99 113.211 -168.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.37 156.08 45.2 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.749 1.018 . . . . 1.49 113.749 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.37 149.77 28.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.381 1.872 . . . . 3.46 109.881 -169.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -171.74 160.81 5.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.281 1.032 . . . . 2.9500000000000002 113.66 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -94.54 119.9 33.94 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.16 0.984 . . . . 2.23 109.875 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.2 124.95 40.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.861 1.264 . . . . 4.3200000000000003 108.619 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -120.18 122.63 41.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.983 1.313 . . . . 3.8599999999999999 110.328 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -102.61 103.96 35.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.349 -0.611 . . . . 0.97999999999999998 109.349 164.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -86.6 -11.32 5.92 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.223 2.616 . . . . 1.1799999999999999 113.122 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.83 160.44 43.03 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 124.273 0.939 . . . . 1.1399999999999999 112.657 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.2 m-20 -90.25 5.97 44.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 2.9500000000000002 113.235 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.98 160.02 40.54 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.241 1.816 . . . . 3.2400000000000002 110.602 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.82 152.16 22.07 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.915 2.41 . . . . 0.97999999999999998 111.432 -171.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -116.63 123.76 48.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.674 1.19 . . . . 3.1600000000000001 110.385 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ttp-105 -117.77 110.45 17.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.227 1.411 . . . . 5.2199999999999998 111.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -97.73 106.15 18.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.278 2.231 . . . . 1.9199999999999999 108.936 -170.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.04 -19.36 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.056 0.942 . . . . 2.25 112.683 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.93 -162.34 30.57 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.536 0.607 . . . . 0.70999999999999996 112.674 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.0 -177.57 4.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.054 0.942 . . . . 1.9299999999999999 110.444 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -148.26 141.7 25.32 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 105.149 -2.167 . . . . 8.6799999999999997 105.149 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.544 ' HG1' ' CG1' ' A' ' 99' ' ' VAL . 1.0 OUTLIER -148.68 152.3 37.44 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.649 -1.167 . . . . 1.74 109.195 -178.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.6 -34.21 98.7 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.647 2.231 . . . . 1.54 113.029 167.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.284 2.2 m -81.94 4.04 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.484 0.92 . . . . 2.02 113.484 -165.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.08 19.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.527 1.058 . . . . 1.76 113.51 -174.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.09 -51.8 1.54 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 3.6299999999999999 110.656 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -79.51 133.54 36.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.037 -1.097 . . . . 4.1200000000000001 108.037 155.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -145.75 126.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 127.062 2.145 . . . . 2.0899999999999999 108.364 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.91 115.87 6.03 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.69 0.796 . . . . 2.5699999999999998 110.972 -157.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.39 121.42 23.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.821 1.192 . . . . 1.8999999999999999 110.377 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.3 m170 -108.1 151.67 25.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.75 1.62 . . . . 0.59999999999999998 113.259 174.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.91 172.02 8.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.746 1.618 . . . . 2.23 110.125 163.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -151.06 86.58 1.37 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.382 1.473 . . . . 2.1499999999999999 107.674 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -96.56 -173.81 2.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.802 2.041 . . . . 3.8900000000000001 111.576 -171.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.44 139.72 27.08 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.028 0.918 . . . . 4.1200000000000001 111.855 170.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.22 150.43 26.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.602 1.161 . . . . 7.29 111.959 -170.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.327 16.6 pm0 -64.99 142.17 58.53 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.227 1.811 . . . . 6.0999999999999996 113.44 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 t -130.21 -95.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.157 1.383 . . . . 3.3900000000000001 107.37 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.462 ' CD ' ' HZ3' ' A' ' 56' ' ' LYS . 4.7 pt-20 -73.08 45.48 0.15 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.908 2.083 . . . . 4.8600000000000003 111.919 164.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.98 -40.15 1.18 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.533 1.539 . . . . 2.3399999999999999 113.265 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.462 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 52.8 mttt -61.81 138.62 58.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.023 1.729 . . . . 4.6500000000000004 110.862 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -77.89 112.23 14.56 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.201 0.6 . . . . 5.5499999999999998 109.803 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.86 139.56 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.443 1.897 . . . . 2.54 108.632 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -83.86 139.65 32.51 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.725 1.21 . . . . 3.98 110.824 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.41 163.36 31.54 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.493 0.557 . . . . 0.94999999999999996 114.493 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -112.85 165.56 12.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.276 1.43 . . . . 2.4399999999999999 112.406 -176.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.252 76.0 mtt180 -169.52 141.58 1.98 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 128.738 2.815 . . . . 5.6600000000000001 106.55 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.2 Cg_endo -68.95 150.73 73.39 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 CA-C-N 122.024 1.759 . . . . 0.87 110.192 156.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.97 156.87 47.73 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.143 1.377 . . . . 1.6399999999999999 110.438 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.42 -23.48 50.86 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.356 2.037 . . . . 0.81000000000000005 112.395 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -178.78 167.38 1.7 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 126.434 1.893 . . . . 3.4100000000000001 111.585 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.091 1.356 . . . . 2.2000000000000002 110.071 150.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.251 2.8 pt-20 -153.55 160.0 42.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.888 -0.507 . . . . 2.7200000000000002 111.949 164.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 t -141.42 134.46 14.31 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 125.798 1.639 . . . . 2.3399999999999999 108.851 -166.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.52 164.61 32.19 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.409 2.073 . . . . 1.1200000000000001 111.679 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.38 145.03 99.12 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.346 2.697 . . . . 0.81999999999999995 111.825 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.477 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 16.5 mmmt 68.96 -1.62 2.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.36 1.864 . . . . 2.54 113.66 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.02 125.94 7.85 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 127.649 2.547 . . . . 0.92000000000000004 112.811 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -86.37 149.43 25.03 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.994 -1.103 . . . . 6.3099999999999996 111.79 156.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 m -152.45 131.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.64 1.576 . . . . 2.4700000000000002 109.52 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -89.84 134.43 34.2 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.287 1.035 . . . . 4.0899999999999999 111.028 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 mp -76.13 66.22 2.25 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.214 1.483 . . . . 2.2799999999999998 110.122 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -56.97 124.47 65.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 6.0300000000000002 109.838 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.32 -33.96 88.35 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.574 2.85 . . . . 1.48 113.765 -169.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.94 45.63 2.52 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.068 0.849 . . . . 1.8899999999999999 112.361 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.45 -57.87 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.567 2.032 . . . . 1.4399999999999999 113.988 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -150.26 145.54 26.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.889 1.676 . . . . 3.3799999999999999 110.877 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -166.14 179.83 5.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.344 1.058 . . . . 0.94999999999999996 110.941 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -115.7 132.48 56.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.23 1.012 . . . . 3.46 111.132 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.7 mmt -93.11 139.77 30.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 1.6699999999999999 110.772 165.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 143.18 51.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.719 1.608 . . . . 4.1399999999999997 109.736 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -146.18 160.32 42.12 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 2.8799999999999999 112.079 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.58 -82.39 1.69 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.084 1.326 . . . . 2.7799999999999998 109.895 -169.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 76.85 125.68 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.786 3.634 . . . . 2.0 110.941 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -77.74 -22.97 49.51 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.818 -1.176 . . . . 3.3900000000000001 112.881 -170.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -161.83 158.15 21.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 130.233 3.413 . . . . 7.5199999999999996 109.059 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.39 149.09 56.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.758 2.305 . . . . 4.0599999999999996 109.653 160.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 -176.57 2.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.037 1.735 . . . . 4.6399999999999997 109.82 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.35 141.63 19.55 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.214 -1.554 . . . . 4.1299999999999999 110.513 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -34.79 135.99 0.17 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.637 1.717 . . . . 2.7599999999999998 115.637 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.83 22.39 69.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.124 0.81 . . . . 1.9099999999999999 115.124 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -88.83 -179.46 5.98 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.754 1.222 . . . . 3.46 109.839 158.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -130.74 168.89 16.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.103 0.961 . . . . 3.5899999999999999 111.321 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.544 ' CG1' ' HG1' ' A' ' 37' ' ' THR . 18.9 t -136.33 117.71 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.391 1.476 . . . . 2.2799999999999998 109.967 -172.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.42 42.04 0.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.016 2.127 . . . . 4.3399999999999999 114.214 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 tt -65.39 137.09 57.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 123.4 1.571 . . . . 3.2000000000000002 112.958 -164.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.09 112.61 25.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.781 2.032 . . . . 2.4900000000000002 111.303 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -82.43 120.32 25.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.084 1.354 . . . . 2.1099999999999999 110.752 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.8 mt -96.68 123.42 40.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.614 1.166 . . . . 1.99 111.54 -168.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.45 133.65 55.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.147 1.536 . . . . 3.1299999999999999 115.147 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.17 48.28 0.85 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.821 2.048 . . . . 2.8599999999999999 112.768 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.38 19.79 2.81 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.106 2.289 . . . . 4.9299999999999997 112.307 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.98 38.07 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 118.275 1.037 . . . . 2.25 112.098 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 150.01 36.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.155 1.782 . . . . 4.29 111.197 -175.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.85 131.62 20.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 126.015 1.726 . . . . 1.9199999999999999 108.073 161.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.14 122.69 41.56 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.331 1.452 . . . . 3.52 109.277 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -79.84 132.34 36.09 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.835 -0.541 . . . . 3.4500000000000002 111.548 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -129.55 127.47 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.393 1.077 . . . . 2.5699999999999998 109.567 167.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.22 138.38 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.059 0.943 . . . . 3.9199999999999999 110.224 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.4 mt -143.55 142.62 21.37 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.252 1.421 . . . . 2.71 110.083 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.85 153.04 64.13 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.385 2.723 . . . . 1.25 112.667 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.5 t -83.4 113.95 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.113 1.365 . . . . 2.1400000000000001 108.926 165.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -100.36 145.81 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.583 1.953 . . . . 3.7999999999999998 108.015 167.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.91 55.21 0.78 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.3 1.593 . . . . 2.9100000000000001 115.3 -152.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.076 2.15 . . . . 8.7400000000000002 111.25 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 110.312 -0.255 . . . . 5.1600000000000001 110.312 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.97 169.04 26.31 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.647 -1.283 . . . . 1.1200000000000001 114.436 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -150.63 146.59 26.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.762 1.625 . . . . 1.71 111.558 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -109.44 107.66 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.682 -1.229 . . . . 1.9099999999999999 107.682 171.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -82.4 121.9 27.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.276 -0.639 . . . . 4.5999999999999996 109.276 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -160.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.447 1.099 . . . . 3.4700000000000002 112.016 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t 174.0 157.65 0.31 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 128.641 2.776 . . . . 3.5299999999999998 106.935 168.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.97 -10.78 29.74 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.572 2.182 . . . . 1.7 113.197 167.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.53 177.69 26.06 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.005 1.288 . . . . 1.49 112.007 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.51 -1.21 32.26 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 CA-C-N 118.665 1.232 . . . . 1.7 113.621 1.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -140.58 158.27 44.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.793 1.237 . . . . 2.0699999999999998 112.478 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.98 -178.74 7.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.155 2.582 . . . . 1.52 110.27 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.22 133.59 16.43 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.344 1.239 . . . . 1.96 114.344 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.55 153.02 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.847 1.259 . . . . 1.47 111.981 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.44 136.95 15.9 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.911 1.684 . . . . 3.4700000000000002 109.373 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -161.53 150.8 16.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.07 1.508 . . . . 3.52 115.07 -167.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -72.11 125.79 28.15 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.282 1.033 . . . . 2.7200000000000002 108.714 165.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 tt -107.13 155.33 19.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.939 1.696 . . . . 3.8999999999999999 110.47 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.01 161.77 37.24 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 115.536 1.68 . . . . 3.75 115.536 165.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -130.79 96.46 23.07 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 127.306 2.242 . . . . 1.1799999999999999 109.425 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.88 -8.19 13.28 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.506 2.138 . . . . 1.0 113.703 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.05 157.71 41.48 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 119.655 1.116 . . . . 1.3600000000000001 112.179 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.466 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 8.7 m-20 -82.87 9.8 9.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.126 1.771 . . . . 3.2999999999999998 112.681 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mt -110.58 165.32 12.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 129.031 2.933 . . . . 3.6400000000000001 108.507 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.34 157.58 12.79 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.958 2.439 . . . . 0.88 111.445 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.99 147.76 38.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.437 1.095 . . . . 2.9100000000000001 111.231 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 ttp-105 -135.79 112.24 9.92 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.125 1.37 . . . . 4.2199999999999998 110.768 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -88.07 120.68 29.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.957 2.103 . . . . 2.0600000000000001 108.741 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.78 -20.85 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.03 1.332 . . . . 1.9299999999999999 112.669 -177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.67 -162.2 20.31 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 122.214 0.897 . . . . 0.79000000000000004 112.061 169.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.48 177.58 9.58 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.229 1.811 . . . . 1.8799999999999999 108.64 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -161.82 152.64 17.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.04 1.291 . . . . 7.0800000000000001 109.323 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -153.72 151.42 25.05 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 125.469 1.508 . . . . 1.5900000000000001 108.932 -166.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.1 -23.03 46.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.184 1.923 . . . . 1.0 113.843 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 m -88.01 -3.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 115.36 1.615 . . . . 2.04 115.36 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.58 134.71 49.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.931 1.241 . . . . 1.8899999999999999 111.176 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -56.44 18.94 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.777 1.171 . . . . 5.71 109.277 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -124.12 151.48 43.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.53 1.932 . . . . 5.0800000000000001 110.974 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.86 135.2 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.904 2.082 . . . . 3.6400000000000001 107.934 163.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -126.77 130.1 49.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.95 0.9 . . . . 2.3799999999999999 109.666 167.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tp -85.92 117.34 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.59 1.556 . . . . 4.6100000000000003 108.843 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -126.43 151.96 47.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.084 1.354 . . . . 0.88 113.778 -170.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.65 167.7 13.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.079 1.751 . . . . 2.52 111.806 165.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.4 m -153.61 92.66 1.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.706 2.002 . . . . 3.04 107.213 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -109.61 163.48 13.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.111 1.152 . . . . 3.8700000000000001 114.111 -156.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.68 143.93 27.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.301 1.04 . . . . 4.7699999999999996 109.907 150.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -149.57 151.75 34.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.665 2.386 . . . . 8.9100000000000001 107.09 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.562 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -110.33 145.44 37.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.683 0.793 . . . . 4.9100000000000001 111.72 178.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.88 117.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.81 -1.552 . . . . 4.9000000000000004 106.81 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.3 28.58 17.96 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.3 1.04 . . . . 7.29 111.461 -172.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.33 -12.79 12.38 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 120.486 -1.384 . . . . 4.3099999999999996 114.049 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -75.52 135.09 40.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.305 1.442 . . . . 5.8700000000000001 109.75 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 29.3 mmmt -74.06 135.24 43.01 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.205 1.002 . . . . 5.46 111.878 -170.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.03 144.84 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.775 1.63 . . . . 3.3799999999999999 109.421 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.97 139.0 51.14 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.804 1.242 . . . . 3.9700000000000002 111.905 172.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -179.15 38.66 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 123.854 0.74 . . . . 1.29 113.694 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.4 177.63 4.96 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.057 1.343 . . . . 2.8900000000000001 111.823 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 175.64 143.1 0.22 Allowed Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 126.813 2.045 . . . . 9.1300000000000008 110.039 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.83 154.46 72.96 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 121.617 1.613 . . . . 0.85999999999999999 110.783 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.93 156.43 69.0 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 125.989 1.716 . . . . 2.1699999999999999 109.986 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.77 -19.92 40.52 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.028 1.819 . . . . 0.85999999999999999 112.58 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 178.84 169.96 0.88 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.728 1.611 . . . . 3.0 111.031 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.03 163.58 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.11 1.364 . . . . 1.8600000000000001 108.938 157.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.253 0.2 OUTLIER -153.57 158.39 41.13 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.504 -0.748 . . . . 2.0099999999999998 112.28 177.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -146.34 133.65 10.2 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.298 1.439 . . . . 2.0 108.863 -162.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.11 168.36 24.95 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.0 2.467 . . . . 0.89000000000000001 111.902 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.49 137.65 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.188 3.925 . . . . 1.78 114.287 165.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.466 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 18.3 mmmt 68.38 1.21 2.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.951 1.7 . . . . 2.6699999999999999 114.049 169.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 115.08 4.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.86 1.695 . . . . 1.0900000000000001 112.209 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.71 122.26 42.45 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.065 1.746 . . . . 5.8499999999999996 109.5 161.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.1 m -155.22 146.29 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.273 1.429 . . . . 2.9900000000000002 112.288 -163.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -91.27 142.79 27.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.085 0.954 . . . . 3.1499999999999999 113.021 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.4 68.85 0.23 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 2.2999999999999998 108.508 148.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -54.19 122.62 37.53 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.054 1.742 . . . . 4.9199999999999999 110.381 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.15 -42.16 66.29 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.546 2.831 . . . . 1.74 112.891 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.02 75.3 2.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.7 -0.96 . . . . 1.2 110.7 161.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.77 -61.03 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.759 1.647 . . . . 1.3 112.462 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -151.55 150.67 30.61 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.482 1.513 . . . . 4.4400000000000004 111.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -160.19 170.72 20.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.221 1.008 . . . . 1.6499999999999999 111.079 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -102.51 127.4 49.58 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.249 1.019 . . . . 3.46 110.64 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mmt -83.44 124.87 31.12 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.798 0.839 . . . . 1.79 110.574 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.28 134.35 48.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.195 1.398 . . . . 2.7999999999999998 108.707 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.3 mt -134.2 161.01 36.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.65 1.18 . . . . 3.02 112.008 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.91 35.06 39.11 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 126.144 1.83 . . . . 2.4100000000000001 114.998 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 mt -37.14 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.245 2.218 . . . . 1.8500000000000001 114.652 -156.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -77.25 14.25 0.97 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.977 1.473 . . . . 3.0699999999999998 114.977 -165.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -159.49 147.03 13.04 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 131.44 3.896 . . . . 8.5299999999999994 109.468 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.98 170.52 15.45 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.015 2.476 . . . . 2.48 109.317 166.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 157.64 43.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.302 1.049 . . . . 5.3899999999999997 112.791 -165.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HZ2' ' CD ' ' A' ' 97' ' ' GLU . 5.2 tmtt? -143.18 144.11 32.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.821 1.648 . . . . 5.0899999999999999 109.639 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.4 144.04 57.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.856 0.863 . . . . 2.8900000000000001 111.901 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.91 45.22 27.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.854 -0.97 . . . . 1.73 112.934 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.447 ' CD ' ' HZ2' ' A' ' 94' ' ' LYS . 8.9 mm-40 -109.35 177.87 4.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.534 0.734 . . . . 4.8499999999999996 109.741 148.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.57 161.62 17.64 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.216 1.806 . . . . 4.5999999999999996 110.201 152.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -125.58 133.16 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.691 1.597 . . . . 2.2799999999999998 109.721 163.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.65 144.76 28.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.901 1.68 . . . . 3.1699999999999999 110.292 172.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.8 tt -156.37 131.74 9.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.39 1.076 . . . . 2.5899999999999999 112.087 -175.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.42 115.18 27.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.537 2.335 . . . . 2.2799999999999998 111.947 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.19 118.9 22.96 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.688 1.585 . . . . 2.3999999999999999 109.547 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.7 mt -98.37 122.51 41.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.231 1.012 . . . . 1.75 110.36 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -113.82 154.41 27.48 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.036 0.934 . . . . 3.4199999999999999 112.6 -173.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.7 95.97 0.37 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.088 1.355 . . . . 2.4199999999999999 112.605 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.45 -147.78 18.61 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.056 1.312 . . . . 3.0299999999999998 111.317 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.47 36.94 2.02 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.287 0.946 . . . . 2.2999999999999998 115.379 -171.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -127.74 134.08 49.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.696 1.748 . . . . 5.9500000000000002 113.075 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.61 147.32 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.362 1.865 . . . . 1.8300000000000001 108.064 158.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -141.17 115.89 9.66 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.182 1.393 . . . . 2.46 108.164 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.11 153.06 21.81 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.705 1.002 . . . . 3.5600000000000001 113.705 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.75 166.88 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.319 2.248 . . . . 2.1800000000000002 109.768 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.23 133.99 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.21 1.004 . . . . 2.6699999999999999 108.457 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt -145.64 152.44 49.03 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.28 1.432 . . . . 2.9500000000000002 110.56 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.81 151.97 74.04 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 125.2 3.933 . . . . 0.95999999999999996 115.16 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.2 t -83.41 100.72 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.681 1.592 . . . . 2.0299999999999998 109.719 170.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -90.7 74.68 6.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.009 1.724 . . . . 3.0699999999999998 109.018 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.16 128.6 37.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.077 -1.014 . . . . 3.0499999999999998 113.544 -166.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 . . . . . 0 N--CA 1.484 1.273 1 C-N-CA 132.647 4.379 . . . . 8.3499999999999996 108.493 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 106.55 -1.648 . . . . 5.7000000000000002 106.55 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.21 156.06 22.61 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.681 -0.637 . . . . 1.3400000000000001 113.638 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -154.73 147.32 24.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.19 0.996 . . . . 1.9099999999999999 111.797 175.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.44 116.97 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.616 0.767 . . . . 2.2799999999999998 110.649 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 ttp85 -81.61 103.23 11.18 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.028 1.331 . . . . 4.7999999999999998 110.577 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.55 165.06 25.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 123.431 1.586 . . . . 3.6200000000000001 112.465 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -161.22 154.08 17.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.58 2.352 . . . . 2.5899999999999999 107.949 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.28 27.6 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.398 3.398 . . . . 1.5900000000000001 113.503 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.71 169.42 42.76 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.477 -0.764 . . . . 1.4199999999999999 113.049 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.14 -5.58 25.77 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 118.005 0.902 . . . . 1.73 112.604 -10.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.99 157.65 44.06 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.073 1.349 . . . . 4.2800000000000002 113.34 -168.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.27 -176.21 5.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.63 1.972 . . . . 1.51 111.294 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.44 129.0 15.04 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.986 0.914 . . . . 1.8300000000000001 111.814 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.27 138.41 44.59 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.787 1.235 . . . . 1.5600000000000001 111.84 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -124.83 151.32 45.39 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.138 2.175 . . . . 3.8599999999999999 109.102 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.03 150.11 16.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.173 1.175 . . . . 2.9199999999999999 114.173 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -89.49 113.63 25.03 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.501 -0.926 . . . . 2.1499999999999999 108.501 166.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.82 156.54 20.97 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.038 1.735 . . . . 3.6299999999999999 110.806 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.15 157.45 43.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.911 0.708 . . . . 3.5600000000000001 112.911 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -96.34 109.79 49.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 114.359 -1.291 . . . . 1.0900000000000001 110.19 166.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.84 -2.82 10.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.371 2.714 . . . . 1.3500000000000001 113.78 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.69 171.27 37.64 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.4 1.0 . . . . 1.04 113.133 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -95.57 0.13 52.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.525 1.53 . . . . 3.5299999999999998 113.781 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -116.84 154.61 49.55 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.674 1.589 . . . . 2.3399999999999999 110.056 167.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.91 159.05 27.55 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.501 2.801 . . . . 0.78000000000000003 112.506 -164.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -106.59 152.23 23.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.68 1.192 . . . . 2.8900000000000001 110.837 171.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 68' ' ' GLU . 26.0 ttm180 -130.78 112.25 12.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.084 1.353 . . . . 5.0199999999999996 109.619 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 tp -94.81 112.3 24.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.065 2.546 . . . . 1.6899999999999999 109.601 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.79 -11.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.922 1.082 . . . . 1.6499999999999999 113.922 -165.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.74 -167.95 40.67 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.506 -0.746 . . . . 0.63 112.583 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.54 -179.69 7.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.506 0.558 . . . . 1.8700000000000001 112.506 167.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -145.69 142.19 28.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.327 1.051 . . . . 8.5 109.044 169.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.447 ' HG1' HG12 ' A' ' 99' ' ' VAL . 1.4 t -153.9 151.09 24.09 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.544 1.138 . . . . 1.9099999999999999 110.448 -164.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.72 -17.81 37.55 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.396 2.064 . . . . 1.0800000000000001 112.652 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.32 2.0 m -96.91 11.07 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.199 1.555 . . . . 2.3300000000000001 115.199 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -154.82 144.29 21.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.91 1.448 . . . . 1.8899999999999999 114.91 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.87 -69.82 0.75 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.934 -0.765 . . . . 3.1200000000000001 108.934 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.912 -1.514 . . . . 3.3900000000000001 106.912 164.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.19 129.17 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.173 1.789 . . . . 2.3700000000000001 107.548 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.3 131.95 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.325 1.45 . . . . 1.9099999999999999 109.273 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.07 122.17 27.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.086 0.945 . . . . 1.8999999999999999 110.579 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -112.52 159.29 18.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.834 2.054 . . . . 0.55000000000000004 111.986 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.37 -177.34 3.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.742 2.017 . . . . 2.6600000000000001 110.925 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 m -137.12 116.28 12.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.339 1.456 . . . . 2.2999999999999998 107.59 163.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -96.74 162.53 13.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.863 0.865 . . . . 3.6600000000000001 110.996 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -112.32 143.14 43.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 4.4299999999999997 110.822 162.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -153.78 159.67 41.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.742 1.617 . . . . 6.3099999999999996 111.295 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 141.35 36.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.823 -0.806 . . . . 4.1399999999999997 108.823 156.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.33 -8.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 115.139 1.533 . . . . 4.1500000000000004 115.139 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -158.27 46.0 0.33 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.673 1.989 . . . . 4.0800000000000001 107.586 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.74 -24.06 0.4 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.766 1.651 . . . . 2.02 114.706 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -99.79 153.47 19.1 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.122 2.169 . . . . 4.2199999999999998 112.49 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -61.66 136.54 58.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.956 0.902 . . . . 4.5300000000000002 111.34 169.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.8 t -140.0 150.44 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.061 2.144 . . . . 2.98 108.275 168.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.3 mtm -111.57 144.48 40.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.396 1.079 . . . . 3.5299999999999998 111.347 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.47 158.03 28.16 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 123.597 0.618 . . . . 1.0900000000000001 113.012 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.67 165.56 11.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.413 1.085 . . . . 2.5699999999999998 112.551 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -171.15 155.29 4.32 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.535 1.934 . . . . 4.5599999999999996 109.848 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.6 Cg_endo -69.75 152.33 69.36 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.926 1.75 . . . . 0.93999999999999995 111.482 167.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -115.17 157.97 42.27 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 126.381 1.872 . . . . 1.9399999999999999 110.278 170.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -69.36 -21.43 35.36 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 0.92000000000000004 111.952 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -177.93 161.25 1.54 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.267 1.827 . . . . 3.29 110.82 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -108.2 174.97 5.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.741 2.016 . . . . 1.8799999999999999 109.455 157.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.9 pt-20 -152.55 165.07 36.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.048 -1.032 . . . . 2.3100000000000001 111.222 170.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -146.07 130.14 8.61 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 123.436 0.694 . . . . 1.96 109.334 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.12 164.85 34.34 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.197 1.932 . . . . 0.88 111.108 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.39 137.01 75.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.514 2.809 . . . . 0.81000000000000005 112.144 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 64.05 11.15 5.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.834 1.654 . . . . 2.7599999999999998 113.622 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.08 120.06 5.13 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 127.766 2.603 . . . . 0.91000000000000003 111.197 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -85.38 142.91 28.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.005 1.322 . . . . 7.0499999999999998 111.87 162.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.98 148.32 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.029 1.731 . . . . 2.5600000000000001 110.398 172.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -129.92 114.5 15.94 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.289 -1.004 . . . . 5.0199999999999996 108.289 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.76 67.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.64 1.976 . . . . 1.98 112.388 -171.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.57 133.92 44.88 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.854 2.461 . . . . 3.4300000000000002 113.634 166.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.6 -52.59 7.23 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.502 2.802 . . . . 1.75 112.132 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.33 89.12 1.01 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.401 -1.48 . . . . 1.53 109.401 166.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.95 -72.25 0.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.73 2.109 . . . . 1.25 112.753 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -155.43 132.25 10.62 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.474 1.51 . . . . 3.2400000000000002 112.299 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -156.88 165.93 34.81 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.023 -1.048 . . . . 0.87 111.487 -171.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.27 113.71 26.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.307 0.575 . . . . 2.98 109.699 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.26 125.13 33.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.508 1.123 . . . . 2.23 109.195 175.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -113.68 135.91 53.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.912 1.285 . . . . 2.71 110.077 -168.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -146.65 154.67 41.73 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.782 1.633 . . . . 3.02 111.02 -172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.39 -54.46 4.32 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.734 1.159 . . . . 2.4100000000000001 112.371 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt 70.02 107.51 0.06 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.875 3.27 . . . . 2.0499999999999998 111.133 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -81.18 14.33 2.41 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.76 -1.212 . . . . 2.7200000000000002 113.712 -169.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.452 HH21 ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.8 153.52 15.91 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.682 2.393 . . . . 6.3399999999999999 109.633 176.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.7 140.61 23.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.772 2.314 . . . . 2.79 109.875 166.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.3 mt -115.57 152.68 32.61 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.148 1.379 . . . . 3.9100000000000001 111.794 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -147.75 9.63 0.91 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.724 2.12 . . . . 4.1699999999999999 116.724 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 64.0 172.87 0.18 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.934 2.094 . . . . 2.8999999999999999 112.225 -169.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.58 52.48 52.82 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 121.661 -0.649 . . . . 2.3999999999999999 111.99 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.452 ' CD ' HH21 ' A' ' 91' ' ' ARG . 9.8 pt-20 -152.01 163.88 38.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.003 2.121 . . . . 3.77 111.051 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -101.51 123.1 45.0 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.279 1.831 . . . . 4.4299999999999997 109.499 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.447 HG12 ' HG1' ' A' ' 37' ' ' THR . 66.6 t -83.68 106.09 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.001 -1.111 . . . . 2.1299999999999999 108.001 171.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 143.22 42.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.631 -1.168 . . . . 3.1400000000000001 109.171 160.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -155.33 116.39 3.93 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.946 -1.096 . . . . 2.79 111.213 -167.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.86 100.58 12.65 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.297 1.439 . . . . 2.3900000000000001 110.378 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 mt -80.52 119.65 23.46 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.646 -0.659 . . . . 2.6000000000000001 109.528 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.8 mt -93.6 129.93 39.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.178 0.991 . . . . 2.2599999999999998 110.61 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -130.37 122.49 27.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.408 0.623 . . . . 3.2799999999999998 112.504 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.0 12.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.401 2.001 . . . . 3.2799999999999998 116.401 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.62 -45.73 1.6 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.967 1.27 . . . . 3.3900000000000001 112.64 -165.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.87 4.67 44.19 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.194 1.378 . . . . 2.46 116.042 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.69 152.85 33.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.53 1.932 . . . . 4.6100000000000003 112.686 176.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.9 140.64 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.647 1.979 . . . . 1.8600000000000001 107.819 161.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -139.04 124.05 18.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.755 1.222 . . . . 2.3399999999999999 108.056 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.45 150.7 20.01 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.817 1.414 . . . . 3.3300000000000001 114.817 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.91 145.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.823 1.649 . . . . 2.1800000000000002 110.91 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -106.84 129.81 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.614 1.166 . . . . 2.6299999999999999 108.623 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.3 mt -140.68 150.52 60.47 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.743 1.617 . . . . 3.0600000000000001 110.183 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.02 146.49 37.11 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.096 2.53 . . . . 0.97999999999999998 112.874 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.29 139.43 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.636 -0.711 . . . . 1.9299999999999999 110.567 156.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.57 151.34 39.54 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.428 3.491 . . . . 3.5800000000000001 108.672 170.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.72 73.27 1.46 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.194 1.554 . . . . 2.27 115.194 -157.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.377 1.071 . . . . 8.5399999999999991 112.556 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 113.543 0.942 . . . . 5.6699999999999999 113.543 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.04 165.24 17.26 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.592 1.568 . . . . 2.4500000000000002 114.525 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -148.97 134.4 18.52 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.146 1.778 . . . . 2.9399999999999999 110.552 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.4 t -91.33 140.15 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.74 1.216 . . . . 2.1200000000000001 107.879 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.431 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 0.3 OUTLIER -93.46 -24.4 18.04 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.884 1.439 . . . . 4.1699999999999999 114.884 -175.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.28 175.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.697 1.999 . . . . 3.3799999999999999 114.559 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 m 176.34 167.24 0.43 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 130.92 3.688 . . . . 2.25 107.903 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.24 -6.55 18.58 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.993 2.462 . . . . 2.1899999999999999 113.584 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 112.28 166.34 17.41 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.115 1.816 . . . . 1.8600000000000001 111.696 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.62 -7.71 45.1 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.112 1.456 . . . . 2.0699999999999998 113.633 -1.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -130.17 174.08 10.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.05 1.34 . . . . 2.2799999999999998 112.836 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.51 -174.66 3.23 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.216 2.206 . . . . 1.3999999999999999 112.037 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.19 165.49 22.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.598 1.159 . . . . 1.8300000000000001 111.352 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.66 162.35 40.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.241 1.816 . . . . 1.8200000000000001 111.355 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -155.6 165.0 37.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.727 1.611 . . . . 3.5299999999999998 111.274 -173.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.4 pt? -160.44 161.3 32.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 116.0 1.852 . . . . 2.6099999999999999 116.0 170.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -70.06 125.6 27.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 112.663 -2.062 . . . . 1.99 106.164 153.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -134.67 129.58 35.03 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.559 1.544 . . . . 3.9300000000000002 107.108 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -153.9 150.76 28.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 114.583 1.327 . . . . 2.77 114.583 -173.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -103.63 103.65 37.58 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 112.987 -1.915 . . . . 0.95999999999999996 109.099 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.8 -10.49 14.22 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.631 2.22 . . . . 1.4399999999999999 113.018 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.15 -177.19 49.9 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.848 1.214 . . . . 1.1599999999999999 113.466 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.448 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.0 m-20 -106.89 -2.62 21.13 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.075 1.75 . . . . 3.4300000000000002 113.018 -170.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.72 161.26 42.84 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.447 1.899 . . . . 2.1800000000000002 110.062 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.75 149.05 20.5 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.674 2.249 . . . . 0.73999999999999999 111.969 -169.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.14 120.89 42.07 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.624 1.17 . . . . 3.5899999999999999 110.692 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -105.81 103.87 13.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.967 1.707 . . . . 4.8700000000000001 110.65 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -91.84 116.56 29.0 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.805 1.642 . . . . 2.1800000000000002 109.024 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -95.0 -22.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.995 0.918 . . . . 1.8300000000000001 112.387 -174.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -161.52 28.21 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 121.78 -0.575 . . . . 0.63 112.581 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.43 -178.16 5.17 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.185 0.994 . . . . 1.5600000000000001 110.7 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 136.82 17.37 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.895 2.078 . . . . 6.6699999999999999 106.518 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -153.29 151.58 26.04 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 120.737 1.608 . . . . 1.9199999999999999 111.097 -166.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.09 -18.36 27.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.82 3.013 . . . . 0.94999999999999996 114.097 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.269 3.0 m -89.91 -2.07 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 114.081 1.141 . . . . 1.95 114.081 -173.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.88 39.5 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.576 0.954 . . . . 1.6699999999999999 113.576 -174.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.22 -86.86 0.34 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.284 1.833 . . . . 3.4199999999999999 108.41 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -78.49 86.36 4.52 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.67 -1.269 . . . . 3.9900000000000002 110.614 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.77 139.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.793 1.237 . . . . 1.97 110.486 158.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -136.51 126.52 26.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.489 1.915 . . . . 2.2400000000000002 109.821 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.18 121.57 26.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.209 1.368 . . . . 1.8200000000000001 111.245 167.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -107.26 151.64 25.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.596 1.558 . . . . 0.77000000000000002 112.3 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.42 173.14 8.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.721 1.209 . . . . 2.1899999999999999 110.5 158.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -148.72 96.64 2.61 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.166 1.386 . . . . 1.8 107.515 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -109.04 153.96 22.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.948 1.699 . . . . 3.6800000000000002 112.2 -166.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.7 mtm -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.081 0.952 . . . . 3.4100000000000001 110.937 170.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -155.62 167.92 28.81 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.198 1.799 . . . . 10.26 111.235 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 1.5 mp0 -79.73 157.73 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.264 0.625 . . . . 3.4700000000000002 111.115 160.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -135.11 -89.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.215 1.006 . . . . 4.0599999999999996 108.922 160.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 56' ' ' LYS . 2.8 tt0 -79.45 55.34 1.91 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.683 1.993 . . . . 3.8399999999999999 110.338 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.92 -18.52 0.35 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 125.62 1.581 . . . . 2.1400000000000001 114.906 -173.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 54' ' ' GLU . 37.2 mtmt -108.2 163.28 13.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.752 2.421 . . . . 3.9500000000000002 111.38 -174.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.482 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 23.9 mmtt -66.64 135.63 54.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.673 1.189 . . . . 4.3700000000000001 112.817 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.1 160.42 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 126.895 2.078 . . . . 3.25 109.221 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.1 mmt -79.96 165.09 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 4.5499999999999998 112.647 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.17 143.11 11.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.735 1.635 . . . . 1.5600000000000001 110.707 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.03 142.21 49.04 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.355 1.462 . . . . 3.0899999999999999 109.539 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -172.86 127.46 0.52 Allowed Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 117.116 -1.421 . . . . 5.0599999999999996 111.136 -152.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.63 146.07 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.184 1.922 . . . . 0.75 111.251 170.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.28 156.71 60.13 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.799 1.64 . . . . 1.6399999999999999 110.589 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.99 -24.37 28.69 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.258 1.972 . . . . 0.81999999999999995 112.509 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -174.06 166.25 4.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.882 1.273 . . . . 3.5600000000000001 112.273 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.52 173.04 6.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.065 2.146 . . . . 1.78 109.526 157.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.56 163.19 40.3 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.663 -0.648 . . . . 1.8899999999999999 112.236 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.38 130.74 11.68 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 124.844 1.258 . . . . 1.96 109.606 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.18 161.62 43.72 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.026 2.484 . . . . 0.93000000000000005 111.295 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.27 140.88 90.97 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.238 2.626 . . . . 1.03 112.105 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 65.8 mmtt 67.96 -3.32 1.23 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.967 2.107 . . . . 2.6099999999999999 113.921 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.74 134.82 13.52 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 127.136 2.303 . . . . 0.85999999999999999 110.052 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -109.9 146.7 34.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.514 -1.343 . . . . 7.5099999999999998 112.192 163.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.08 171.69 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.968 1.707 . . . . 2.2000000000000002 110.099 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -139.03 117.68 12.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.722 1.609 . . . . 3.8799999999999999 108.036 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.77 70.77 0.99 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.95 1.7 . . . . 2.2400000000000002 111.323 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.48 140.5 94.85 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.967 -1.083 . . . . 3.7400000000000002 111.754 171.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.98 -33.4 83.5 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.83 2.353 . . . . 1.51 112.201 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.01 53.41 4.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.058 0.837 . . . . 1.4399999999999999 112.31 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.14 -64.26 0.05 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.452 1.025 . . . . 1.3899999999999999 114.842 177.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -154.63 137.79 15.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.657 1.583 . . . . 3.4100000000000001 110.558 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -162.17 172.24 16.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.227 -0.921 . . . . 0.85999999999999999 111.963 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -105.12 131.83 52.11 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.099 0.559 . . . . 3.1000000000000001 110.405 167.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.3 mmt -88.91 143.93 26.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.279 1.032 . . . . 1.74 109.9 156.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.8 125.56 46.8 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.932 1.293 . . . . 3.8100000000000001 108.801 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mt -124.85 133.87 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.314 1.846 . . . . 2.7400000000000002 110.692 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.67 78.37 0.67 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.778 -1.329 . . . . 2.4700000000000002 109.778 -174.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.39 104.08 4.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.332 1.066 . . . . 2.1000000000000001 109.972 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.46 17.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.834 1.05 . . . . 3.0499999999999998 113.834 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -122.6 140.3 32.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.529 1.932 . . . . 6.9800000000000004 109.647 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -69.39 140.33 43.79 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 N-CA-C 108.26 -1.477 . . . . 2.3500000000000001 108.26 148.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.7 mt -120.51 155.62 33.24 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.464 1.106 . . . . 4.2699999999999996 111.433 -174.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -130.92 1.37 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.188 1.551 . . . . 4.1399999999999997 115.188 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 59.11 178.62 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.219 2.207 . . . . 3.1200000000000001 111.92 -171.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.2 56.22 25.81 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 110.445 -1.062 . . . . 1.9099999999999999 110.445 -172.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -166.72 157.12 11.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 128.572 2.749 . . . . 3.0899999999999999 109.961 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -112.46 148.41 34.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.533 1.133 . . . . 4.3499999999999996 112.054 -167.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.1 t -125.41 117.48 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.18 1.792 . . . . 2.25 108.342 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.72 133.28 33.69 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.836 -0.801 . . . . 4.04 108.836 157.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.71 141.71 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.957 1.703 . . . . 3.21 108.708 -173.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.06 123.1 31.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.891 1.677 . . . . 2.3500000000000001 109.961 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.74 120.33 27.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.103 0.961 . . . . 2.52 109.8 168.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.77 125.61 40.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.18 0.992 . . . . 1.6499999999999999 111.731 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -125.51 114.14 18.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.996 0.903 . . . . 3.4300000000000002 111.73 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.12 25.7 0.12 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 127.502 2.321 . . . . 3.2999999999999998 116.317 171.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.68 -42.03 1.04 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.52 1.533 . . . . 4.2599999999999998 113.906 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.04 0.09 87.93 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.224 1.392 . . . . 2.1499999999999999 116.102 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.25 155.24 41.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.933 2.093 . . . . 5.0800000000000001 111.748 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.72 141.0 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.429 1.892 . . . . 1.98 108.599 171.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.9 112.4 9.32 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.112 1.365 . . . . 2.5499999999999998 109.24 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -83.92 137.39 33.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.016 0.747 . . . . 4.7699999999999996 113.016 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 m -138.24 153.43 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.988 1.715 . . . . 2.3100000000000001 110.894 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 m -95.2 149.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.265 1.426 . . . . 4.21 112.416 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -147.13 141.77 16.26 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.89 2.076 . . . . 4.3200000000000003 108.382 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.09 156.75 33.97 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.979 2.452 . . . . 1.1100000000000001 111.027 163.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -84.17 109.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.074 0.949 . . . . 1.8400000000000001 109.828 164.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 120' ' ' ARG . 4.8 mm-40 -79.01 146.51 33.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.284 1.034 . . . . 3.7000000000000002 108.288 155.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.37 94.03 4.77 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.045 -1.095 . . . . 2.1600000000000001 108.045 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.455 HH21 ' CD ' ' A' ' 118' ' ' GLU . 32.0 ttm-85 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 113.57 0.952 . . . . 9.1199999999999992 113.57 -164.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 . . . . . 0 CA--C 1.546 0.822 0 CA-C-O 121.303 0.573 . . . . 4.5599999999999996 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.69 -175.91 43.49 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.956 1.741 . . . . 1.53 114.762 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -159.62 156.44 27.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.126 1.371 . . . . 1.99 113.257 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -113.92 131.07 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.543 -0.723 . . . . 1.9099999999999999 109.947 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.461 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 70.9 ttt180 -72.2 114.17 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.776 1.231 . . . . 5.4100000000000001 109.249 174.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 129.09 37.17 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.723 0.809 . . . . 3.3300000000000001 109.136 162.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.35 163.26 38.09 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.877 1.671 . . . . 2.9199999999999999 108.1 167.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.12 17.68 0.49 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.459 3.439 . . . . 1.48 115.456 -167.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.31 174.38 49.48 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.599 -0.688 . . . . 1.3 112.772 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.23 -3.0 36.91 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.364 1.082 . . . . 1.6200000000000001 113.034 -4.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -141.2 169.41 17.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.297 1.439 . . . . 2.0299999999999998 112.5 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.19 -158.5 0.34 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.985 2.514 . . . . 1.7 111.177 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.49 171.08 20.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.62 1.168 . . . . 1.6100000000000001 113.664 -169.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.93 151.0 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.343 1.057 . . . . 1.74 113.186 170.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -142.81 145.65 33.43 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.594 1.558 . . . . 3.3599999999999999 110.468 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -169.62 160.97 9.25 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.46 0.911 . . . . 2.5800000000000001 113.46 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.0 m -78.19 141.53 38.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.54 1.536 . . . . 2.1000000000000001 109.076 162.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -128.21 136.72 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.458 1.103 . . . . 3.77 108.561 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -130.69 148.98 52.54 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.97 0.908 . . . . 2.7200000000000002 110.657 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.497 HD22 ' HB2' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -119.35 70.91 12.21 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.366 0.666 . . . . 3.8300000000000001 112.309 -159.307 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 -14.65 44.46 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.231 2.621 . . . . 1.1799999999999999 115.438 -168.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.25 161.33 53.35 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.397 0.998 . . . . 1.1699999999999999 112.92 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 3.8 m-20 -91.08 -2.24 57.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.507 1.523 . . . . 3.1000000000000001 113.353 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -117.73 160.06 39.92 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.034 1.733 . . . . 2.1800000000000002 110.618 172.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.43 157.38 25.56 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.77 2.314 . . . . 0.72999999999999998 111.235 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.497 ' HB2' HD22 ' A' ' 24' ' ' ASN . 2.3 mp -124.02 127.95 48.64 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.58 1.552 . . . . 3.5299999999999998 110.727 -172.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -113.37 104.98 12.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.263 1.425 . . . . 5.5199999999999996 110.794 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.2 tp -89.64 115.68 27.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.664 2.385 . . . . 1.8799999999999999 108.78 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.8 m -110.24 -8.65 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.403 1.081 . . . . 1.8200000000000001 113.541 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.6 -159.76 32.14 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 121.636 -0.665 . . . . 0.38 113.331 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.71 178.74 8.23 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.59 0.756 . . . . 1.8799999999999999 112.221 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -152.58 145.92 24.79 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.572 -1.27 . . . . 8.2799999999999994 107.572 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -155.76 156.06 30.2 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.927 1.291 . . . . 1.8 109.279 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.35 -26.94 71.24 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.585 2.19 . . . . 1.1299999999999999 113.339 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.323 1.5 m -92.45 11.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.914 1.45 . . . . 2.1200000000000001 114.914 -170.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.9 151.01 26.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.981 1.312 . . . . 1.8999999999999999 112.409 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -97.34 -78.19 0.48 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.318 -0.993 . . . . 3.3599999999999999 108.318 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -74.6 107.42 6.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.078 -1.453 . . . . 3.9900000000000002 107.078 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.21 129.24 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 2.6099999999999999 108.22 173.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.39 127.81 18.9 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.026 1.331 . . . . 2.3100000000000001 110.138 -162.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -79.21 121.16 24.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.825 0.821 . . . . 1.97 110.588 175.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -107.4 153.49 22.71 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.393 1.877 . . . . 0.87 112.94 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.0 164.17 13.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.852 1.661 . . . . 2.29 110.89 161.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 81.5 m -129.75 105.88 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.888 1.675 . . . . 2.2799999999999998 108.334 166.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -106.2 158.1 17.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.788 1.235 . . . . 3.6299999999999999 113.261 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.0 mtp -124.52 100.82 6.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.363 1.465 . . . . 5.1500000000000004 110.36 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -122.63 145.87 47.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.415 1.486 . . . . 6.7000000000000002 110.928 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.457 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 45.2 mp0 -59.96 147.33 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.529 0.731 . . . . 3.5699999999999998 111.349 165.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -159.31 -47.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.944 1.09 . . . . 3.6600000000000001 113.944 170.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -93.28 38.28 1.04 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.485 1.914 . . . . 5.8300000000000001 110.746 171.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.54 -40.16 0.76 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.5 1.524 . . . . 2.6200000000000001 113.043 -167.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -86.93 154.52 20.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.581 2.352 . . . . 4.5800000000000001 111.122 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.457 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 33.1 mttp -68.44 122.99 19.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.875 0.87 . . . . 4.8700000000000001 111.267 170.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.84 151.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.351 1.461 . . . . 3.6499999999999999 109.935 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -83.55 141.95 31.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.61 1.564 . . . . 3.3700000000000001 111.155 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.77 170.5 33.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.967 0.794 . . . . 1.1299999999999999 112.884 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.98 145.12 41.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.76 1.224 . . . . 3.2599999999999998 111.229 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -153.32 143.36 15.34 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 125.447 1.499 . . . . 3.8999999999999999 109.964 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.78 145.56 75.52 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.755 1.637 . . . . 0.91000000000000003 110.595 163.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -118.32 154.16 51.92 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.687 1.595 . . . . 1.9299999999999999 110.084 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.09 -9.56 26.28 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.827 2.351 . . . . 1.5900000000000001 114.136 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -172.37 163.03 5.56 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.098 1.317 . . . . 3.23 111.664 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -119.19 169.69 9.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.586 1.554 . . . . 1.8799999999999999 108.482 148.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -158.16 164.24 36.77 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.045 -1.034 . . . . 2.2999999999999998 112.118 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.02 138.5 14.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 2.3799999999999999 110.593 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.07 161.6 45.37 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.676 2.25 . . . . 1.26 111.314 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.38 146.2 93.2 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.98 2.453 . . . . 0.89000000000000001 111.798 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 68.7 mmtt 69.97 -12.48 0.48 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.507 2.723 . . . . 2.2200000000000002 114.624 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.5 130.86 29.13 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 126.456 1.979 . . . . 0.96999999999999997 111.974 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -94.49 129.02 41.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.095 -1.553 . . . . 6.46 110.045 161.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.73 178.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.681 1.592 . . . . 2.0600000000000001 110.345 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -141.07 140.2 34.18 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.128 0.971 . . . . 3.2999999999999998 110.169 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.59 59.77 3.1 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.702 1.239 . . . . 1.8899999999999999 108.912 155.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -72.14 122.41 87.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.677 -1.154 . . . . 4.5300000000000002 110.116 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.95 -27.08 83.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.372 2.715 . . . . 1.55 114.792 -168.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.13 84.31 1.6 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.746 -1.742 . . . . 1.5800000000000001 108.746 157.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.01 -87.44 0.16 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.334 1.921 . . . . 1.5600000000000001 111.55 -166.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -143.42 153.77 43.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.246 1.818 . . . . 3.25 110.881 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -157.79 165.43 35.35 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.509 1.123 . . . . 0.85999999999999999 109.736 175.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -93.2 137.23 32.73 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.8 -1.185 . . . . 3.5299999999999998 107.8 159.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.7 139.5 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.744 1.218 . . . . 2.4700000000000002 109.411 168.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.5 mt -117.83 131.69 56.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.86 1.264 . . . . 3.0699999999999998 110.459 -172.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.85 159.49 42.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.721 1.608 . . . . 2.52 111.928 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -56.87 4.51 Favored Glycine 0 N--CA 1.47 0.934 0 C-N-CA 124.897 1.237 . . . . 2.3700000000000001 112.73 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.4 mt 70.76 98.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 129.715 3.206 . . . . 2.3799999999999999 113.252 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -11.01 59.83 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.17 1.174 . . . . 2.6699999999999999 114.17 -171.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -141.33 158.1 64.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 129.588 3.155 . . . . 8.8499999999999996 108.928 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.49 163.2 39.83 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.513 2.809 . . . . 2.1400000000000001 110.294 160.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.27 151.6 44.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.183 0.993 . . . . 3.3799999999999999 112.275 -167.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.476 ' HZ1' ' CD ' ' A' ' 97' ' ' GLU . 22.7 tptp -142.34 120.58 12.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.446 1.098 . . . . 4.4699999999999998 110.445 -170.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 140.27 54.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.548 0.739 . . . . 2.6299999999999999 112.783 172.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.02 -20.6 33.14 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.339 1.447 . . . . 3.0800000000000001 115.158 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.476 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -89.81 -173.72 4.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.249 1.024 . . . . 5.3399999999999999 111.084 -169.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -95.64 152.06 18.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.715 0.769 . . . . 4.25 110.727 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.26 127.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.388 2.275 . . . . 2.29 108.156 163.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -86.03 150.14 24.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.731 0.812 . . . . 3.27 109.842 170.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tt -158.68 140.04 13.27 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.248 1.019 . . . . 2.5 113.252 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.41 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 2.7 m-20 -101.99 107.08 18.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.513 2.325 . . . . 2.2000000000000002 111.443 171.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.9 119.22 21.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.154 0.982 . . . . 2.0899999999999999 110.397 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.4 mt -95.05 131.93 40.49 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.788 1.235 . . . . 1.76 111.768 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.23 139.47 53.7 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.226 1.195 . . . . 3.1899999999999999 114.226 -177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.27 72.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.895 1.278 . . . . 2.3599999999999999 114.203 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.49 33.43 1.83 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.588 1.09 . . . . 4.4199999999999999 114.176 -174.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.25 49.21 67.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.721 1.153 . . . . 1.71 112.645 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 160.75 39.28 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.865 1.666 . . . . 4.8700000000000001 112.053 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.22 145.55 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.523 1.929 . . . . 2.2000000000000002 107.707 170.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.71 121.68 25.93 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.826 1.25 . . . . 2.7400000000000002 110.717 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 3.0 tpmt? -72.07 131.19 42.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.039 0.536 . . . . 3.3700000000000001 111.331 176.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.86 150.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.232 1.413 . . . . 2.7200000000000002 109.832 166.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.82 152.15 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.958 1.703 . . . . 3.6299999999999999 109.045 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.5 mt -148.69 144.77 18.74 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.254 1.422 . . . . 3.4100000000000001 109.708 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.25 149.0 81.34 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.17 2.58 . . . . 1.3100000000000001 112.214 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.28 128.08 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.829 1.252 . . . . 2.3700000000000001 109.24 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 120' ' ' ARG . 36.8 tt0 -118.23 135.08 54.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.726 1.61 . . . . 3.3199999999999998 107.501 166.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.9 125.07 30.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.695 0.68 . . . . 2.8399999999999999 110.283 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.461 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 14.6 ttm-85 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.037 1.335 . . . . 8.2200000000000006 111.795 -175.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 105.835 -1.913 . . . . 6.4400000000000004 105.835 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.57 -151.98 28.85 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.297 0.951 . . . . 2.1000000000000001 112.586 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -166.22 138.54 3.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.771 1.228 . . . . 1.9299999999999999 112.487 177.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.73 145.27 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.377 1.071 . . . . 2.2999999999999998 108.356 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -117.03 85.95 2.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.106 0.962 . . . . 5.4800000000000004 109.758 -166.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.76 149.46 48.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.878 1.671 . . . . 3.8399999999999999 112.222 -174.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -152.43 153.44 30.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.32 2.248 . . . . 2.6099999999999999 107.743 174.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.27 -12.67 35.68 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.227 2.618 . . . . 2.4700000000000002 112.865 170.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.78 -167.84 13.96 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.395 0.998 . . . . 1.6699999999999999 114.162 170.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.34 -2.23 19.84 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 CA-C-N 118.195 0.998 . . . . 1.98 113.309 -3.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -134.63 163.26 30.14 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.248 1.819 . . . . 2.4399999999999999 112.482 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.43 179.51 9.06 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.757 2.023 . . . . 1.5 111.288 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.67 166.08 23.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.668 0.787 . . . . 1.98 112.864 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.88 135.35 32.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.309 0.644 . . . . 1.76 111.806 170.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.45 147.87 42.32 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.329 1.452 . . . . 3.8399999999999999 108.252 172.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.06 148.6 20.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.418 0.687 . . . . 3.0800000000000001 111.593 -170.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -91.17 116.07 28.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.722 0.772 . . . . 3.1099999999999999 109.452 166.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 125.44 35.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.204 -1.406 . . . . 3.6600000000000001 107.204 164.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.59 146.45 47.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.128 0.966 . . . . 3.6400000000000001 111.328 165.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -114.87 90.88 24.11 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-N 114.725 -1.125 . . . . 0.97999999999999998 109.22 171.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.04 -9.59 20.78 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.539 2.159 . . . . 1.05 112.98 176.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 -167.18 42.34 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.84 1.209 . . . . 1.1399999999999999 113.394 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.446 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.8 m-20 -121.57 5.51 10.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.376 1.47 . . . . 2.73 112.855 -166.019 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.93 163.06 41.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.61 1.964 . . . . 2.4500000000000002 109.915 173.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.82 148.09 15.5 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.406 2.071 . . . . 0.72999999999999998 112.272 -171.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -111.44 108.36 17.89 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.344 1.458 . . . . 3.1800000000000002 109.703 -177.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -102.18 102.49 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.536 1.534 . . . . 5.5899999999999999 112.355 -178.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.51 124.57 37.59 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.636 1.974 . . . . 2.1200000000000001 108.394 -173.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.92 -11.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.662 1.185 . . . . 1.7 112.723 -172.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -162.57 29.96 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 123.789 0.709 . . . . 0.60999999999999999 112.463 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.87 -179.27 7.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.421 1.089 . . . . 1.78 110.697 174.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -156.1 145.17 20.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.136 -1.431 . . . . 6.1100000000000003 107.136 173.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.41 ' HG1' ' CG1' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -151.59 149.17 23.47 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 118.95 0.795 . . . . 1.6499999999999999 109.928 -176.184 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.08 -10.74 29.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.948 2.432 . . . . 1.05 113.305 173.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 3.0 m -92.51 7.36 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 114.324 1.231 . . . . 2.2000000000000002 114.324 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.39 165.83 28.17 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.071 -1.018 . . . . 1.8999999999999999 112.801 -179.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -111.29 -62.49 1.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.966 -0.753 . . . . 3.6600000000000001 108.966 170.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -86.12 138.76 31.68 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.286 -0.884 . . . . 4.7699999999999996 109.862 168.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.12 138.75 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.432 2.293 . . . . 2.54 109.19 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -143.11 136.54 28.37 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.952 1.701 . . . . 2.8599999999999999 110.157 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.11 119.27 24.78 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.325 0.966 . . . . 2.04 110.686 167.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -110.42 167.0 10.54 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.547 1.939 . . . . 0.90000000000000002 112.111 178.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.74 -173.18 3.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.848 1.659 . . . . 3.4199999999999999 112.172 175.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.8 m -136.79 124.11 21.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.273 -1.01 . . . . 2.6099999999999999 108.273 167.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -114.02 176.96 4.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 3.6600000000000001 111.09 179.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtm -131.93 139.25 48.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.322 1.049 . . . . 3.6099999999999999 110.457 163.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtp85 -143.16 156.62 44.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.096 1.358 . . . . 6.4199999999999999 111.961 173.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 mp0 -67.25 151.63 47.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.025 1.73 . . . . 4.6900000000000004 110.948 159.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.29 -41.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 114.38 -1.282 . . . . 3.5699999999999998 114.238 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -117.68 32.4 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.769 2.028 . . . . 4.5199999999999996 110.541 167.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.4 -35.68 1.34 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.845 -1.159 . . . . 2.6000000000000001 112.785 -166.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 mttp -70.58 144.5 51.2 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.274 -1.133 . . . . 3.7799999999999998 109.095 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -99.48 140.72 33.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.439 0.903 . . . . 4.5300000000000002 113.439 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.21 150.57 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.497 1.919 . . . . 3.7000000000000002 108.819 -171.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.3 mtm -80.26 149.81 30.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.147 1.379 . . . . 3.9700000000000002 111.517 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.16 160.67 30.63 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.961 -0.462 . . . . 1.28 113.184 173.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -115.64 152.58 32.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.786 1.234 . . . . 2.6200000000000001 111.385 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -164.87 156.99 13.76 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.955 1.302 . . . . 8.3599999999999994 111.646 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.01 145.17 78.77 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.79 2.327 . . . . 0.95999999999999996 110.73 161.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 156.39 53.83 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.838 1.655 . . . . 2.1600000000000001 109.758 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.99 -11.01 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.062 2.508 . . . . 1.26 114.338 -179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -175.91 168.9 2.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.515 1.526 . . . . 3.48 110.638 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.77 168.78 13.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.091 1.757 . . . . 2.0899999999999999 108.58 154.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -155.44 164.04 39.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.058 -1.026 . . . . 2.27 111.978 163.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.79 129.08 16.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 124.034 0.934 . . . . 1.6899999999999999 110.03 -172.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.22 162.88 40.66 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.435 2.09 . . . . 0.84999999999999998 111.082 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.6 141.48 91.43 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.111 2.541 . . . . 1.01 112.083 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 60.3 mmtt 70.23 -1.33 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.77 2.428 . . . . 2.0299999999999998 113.728 -172.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.34 121.49 5.54 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 127.248 2.356 . . . . 0.81999999999999995 111.644 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -99.23 135.76 40.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.43 1.492 . . . . 7.0899999999999999 110.48 161.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.34 148.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.6 1.56 . . . . 2.2000000000000002 110.285 174.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -131.4 120.93 23.75 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.647 -0.501 . . . . 5.4800000000000004 109.647 -166.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.6 68.65 9.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.448 1.594 . . . . 2.1299999999999999 112.565 -161.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -64.54 142.31 98.42 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.52 2.328 . . . . 5.0 114.519 173.24 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -30.77 47.47 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.955 3.104 . . . . 1.7 113.397 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.73 74.21 2.43 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 108.424 -1.87 . . . . 1.45 108.424 163.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.78 -152.77 21.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.954 1.74 . . . . 2.4900000000000002 111.514 -167.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -72.47 135.91 45.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.226 1.41 . . . . 4.0499999999999998 111.839 -174.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -168.09 178.88 4.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.613 1.165 . . . . 1.1599999999999999 109.457 -174.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -114.2 139.83 49.05 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.336 0.516 . . . . 3.9900000000000002 111.823 173.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 mmt -101.72 131.1 48.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.902 1.681 . . . . 1.8100000000000001 110.101 168.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.94 138.94 53.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.631 1.573 . . . . 4.1900000000000004 110.684 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.96 157.67 45.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.902 1.681 . . . . 3.27 112.036 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.39 -47.86 3.93 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 124.854 1.216 . . . . 2.5800000000000001 112.799 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt 57.92 88.76 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.923 2.489 . . . . 1.79 112.97 169.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.43 0.49 12.15 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.168 1.544 . . . . 3.2000000000000002 115.168 -169.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.403 HH22 ' CD ' ' A' ' 97' ' ' GLU . 24.3 mtp-105 -149.04 151.36 34.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.347 2.259 . . . . 6.0300000000000002 108.837 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -88.72 -10.27 4.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.71 3.607 . . . . 3.3700000000000001 117.86 -176.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.0 mt 80.09 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 127.904 2.481 . . . . 4.46 114.357 156.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.22 -175.66 4.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 130.781 3.633 . . . . 5.5999999999999996 109.43 176.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.1 149.84 32.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.247 -1.39 . . . . 3.73 107.247 139.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.96 15.44 77.39 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 118.849 0.749 . . . . 2.71 112.819 -164.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 91' ' ' ARG . 11.6 pt-20 -115.57 140.68 48.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.095 -1.446 . . . . 3.6299999999999999 107.095 144.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.42 134.75 53.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.16 -1.836 . . . . 4.9299999999999997 109.457 -160.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.41 ' CG1' ' HG1' ' A' ' 37' ' ' THR . 78.6 t -106.42 104.74 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.299 -0.409 . . . . 2.27 111.462 -150.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.435 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 49.6 mt-10 -65.14 128.4 35.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.456 -1.247 . . . . 3.3900000000000001 110.097 160.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -138.49 137.88 37.55 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.628 1.571 . . . . 2.7200000000000002 108.755 -177.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -91.31 106.63 18.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.33 2.252 . . . . 2.5600000000000001 111.12 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.73 106.58 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.445 1.098 . . . . 3.0600000000000001 110.863 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.39 118.11 22.94 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.76 -0.459 . . . . 2.02 109.76 -174.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.28 147.78 38.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.011 0.924 . . . . 3.1499999999999999 111.726 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.61 130.5 28.26 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.22 1.008 . . . . 2.2799999999999998 112.329 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.64 -151.98 20.85 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.277 0.941 . . . . 3.79 110.756 -163.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.92 23.21 35.37 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.828 1.204 . . . . 2.5899999999999999 114.104 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.55 125.36 35.18 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.042 -1.269 . . . . 6.0599999999999996 111.428 -177.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.96 124.79 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.322 1.049 . . . . 3.0 110.928 171.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.31 122.12 41.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.542 1.537 . . . . 4.8200000000000003 109.811 -174.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 29.5 ttpt -85.76 124.09 31.88 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.903 -0.498 . . . . 3.5299999999999998 111.566 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.71 148.22 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.16 1.384 . . . . 2.6899999999999999 111.242 178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.97 131.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.881 1.272 . . . . 2.9199999999999999 111.333 -177.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -128.66 151.96 77.88 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 125.289 1.436 . . . . 3.02 112.71 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.51 145.79 26.81 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.645 3.563 . . . . 2.0800000000000001 112.147 177.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.18 139.56 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.537 1.135 . . . . 2.6899999999999999 112.057 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -131.11 148.78 52.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.527 2.731 . . . . 3.54 108.487 173.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.73 48.28 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.062 -1.024 . . . . 2.2400000000000002 110.711 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 N-CA-C 115.084 1.513 . . . . 6.8300000000000001 115.084 -175.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 110.105 -0.331 . . . . 6.5199999999999996 110.105 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.7 -169.97 42.77 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 114.967 0.747 . . . . 1.4099999999999999 114.967 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -164.99 160.7 19.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 1.79 112.949 -175.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.53 132.72 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.766 -0.584 . . . . 2.2999999999999998 110.605 177.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.3 ttp85 -96.61 97.89 9.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.85 1.26 . . . . 4.9299999999999997 110.056 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 152.51 44.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.973 1.709 . . . . 3.29 111.625 -175.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 m -155.14 149.8 20.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 119.77 -1.832 . . . . 2.46 111.209 168.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.32 25.52 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.622 3.548 . . . . 1.6599999999999999 114.19 -175.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.86 165.31 29.15 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.47 -0.769 . . . . 1.3200000000000001 113.952 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.87 -3.77 31.52 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 CA-C-N 118.097 0.949 . . . . 1.8100000000000001 113.629 -2.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -154.69 -179.53 8.09 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.591 1.556 . . . . 2.04 111.644 -175.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.67 -175.06 4.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.891 1.677 . . . . 1.52 111.924 -179.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.11 149.47 45.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.782 0.833 . . . . 1.75 112.654 -175.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.31 51.77 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.203 1.401 . . . . 1.5900000000000001 112.159 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.57 157.95 43.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.108 1.363 . . . . 3.6899999999999999 111.906 -177.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.6 159.66 12.24 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.73 1.212 . . . . 2.9100000000000001 111.92 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.3 m -79.99 146.39 32.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.617 1.567 . . . . 2.4399999999999999 108.455 154.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -143.43 136.92 28.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.483 0.713 . . . . 3.6299999999999999 109.609 169.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -116.21 143.04 46.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.053 0.941 . . . . 3.02 112.71 167.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -87.98 111.98 46.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.46 1.104 . . . . 1.1699999999999999 108.624 161.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -85.48 -12.12 6.75 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.156 2.571 . . . . 1.21 113.456 174.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.24 161.92 39.79 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.519 1.057 . . . . 1.28 112.482 -177.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.474 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.1 m-20 -92.09 4.06 53.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.217 1.807 . . . . 3.3100000000000001 113.327 -174.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.31 161.36 35.5 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.397 1.879 . . . . 2.4300000000000002 110.02 168.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.85 154.4 26.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.853 2.369 . . . . 0.76000000000000001 111.574 -171.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.58 127.6 52.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.33 1.452 . . . . 3.3300000000000001 110.169 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -118.0 114.11 22.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.66 1.184 . . . . 4.5 111.787 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.9 tp -100.51 109.9 22.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.369 2.668 . . . . 2.2799999999999998 109.806 -171.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.41 -13.76 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.413 1.085 . . . . 1.8200000000000001 113.84 -165.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.39 -160.56 31.91 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.0 0.81 . . . . 0.42999999999999999 112.41 -176.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.71 -174.08 4.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 117.73 0.765 . . . . 1.9199999999999999 112.998 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -149.77 138.17 20.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.813 2.445 . . . . 7.1200000000000001 107.541 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.44 ' HG1' HG12 ' A' ' 99' ' ' VAL . 1.7 t -150.02 153.89 36.18 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 119.855 1.207 . . . . 1.55 110.686 -170.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.45 -32.33 12.51 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.252 1.968 . . . . 1.3700000000000001 111.716 165.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.402 1.3 m -93.1 6.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 115.503 1.668 . . . . 2.1000000000000001 115.503 -169.559 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.75 174.26 13.24 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.052 1.341 . . . . 1.77 109.744 167.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -118.01 -74.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.778 0.717 . . . . 4.3099999999999996 109.618 175.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttm105 -66.25 133.98 51.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.735 -1.209 . . . . 6.0599999999999996 107.735 163.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.26 129.62 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.823 1.249 . . . . 2.7799999999999998 108.406 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -134.44 127.76 32.14 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.084 0.954 . . . . 2.3900000000000001 109.452 -160.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.81 117.6 20.07 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.496 1.141 . . . . 1.9399999999999999 109.909 171.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.6 m170 -107.1 154.02 21.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.671 1.588 . . . . 0.92000000000000004 111.326 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.74 179.46 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.261 -1.336 . . . . 1.9399999999999999 110.449 167.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.7 m -149.97 94.46 2.16 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.284 1.433 . . . . 2.1499999999999999 107.725 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -90.71 165.53 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.169 1.788 . . . . 3.2599999999999998 112.857 -169.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.7 mtm -98.52 152.45 19.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.349 -0.841 . . . . 3.04 109.891 158.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -151.67 132.0 13.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.216 1.806 . . . . 6.6799999999999997 108.895 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.75 144.14 31.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.519 0.728 . . . . 4.3899999999999997 110.899 173.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.2 122.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.154 1.382 . . . . 4.4400000000000004 107.542 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 58.76 29.69 19.02 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.325 1.059 . . . . 5.5599999999999996 110.994 -174.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.49 -6.57 16.03 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 120.089 -1.632 . . . . 2.25 114.47 -173.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -85.06 138.92 32.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.455 1.502 . . . . 5.0499999999999998 109.115 179.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -85.79 142.97 28.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.278 0.49 . . . . 5.0800000000000001 112.24 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.92 159.61 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 3.9700000000000002 110.433 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.7 mtp -102.93 166.08 10.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.04 0.936 . . . . 5.4199999999999999 111.688 169.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.48 174.74 34.94 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 123.829 0.728 . . . . 1.1799999999999999 112.006 167.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.37 159.94 38.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.803 1.241 . . . . 3.0499999999999998 110.025 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.81 151.18 0.98 Allowed Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.928 1.691 . . . . 4.0700000000000003 110.431 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.7 Cg_endo -68.9 149.74 72.62 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.613 1.542 . . . . 1.1899999999999999 111.103 166.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.28 157.84 39.95 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 1.77 109.859 172.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -66.78 -20.15 52.53 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.229 1.953 . . . . 0.84999999999999998 112.522 174.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -179.56 161.28 1.02 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 126.731 2.012 . . . . 3.7599999999999998 110.877 178.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mt -103.99 168.83 8.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.082 0.953 . . . . 1.99 109.705 150.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.47 164.58 36.45 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.843 -0.536 . . . . 2.4199999999999999 111.419 167.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.7 t -140.51 129.49 13.06 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 125.555 1.542 . . . . 1.8700000000000001 108.664 -164.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.79 161.83 44.7 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.977 1.784 . . . . 0.98999999999999999 111.161 177.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.2 140.71 96.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.182 2.588 . . . . 0.96999999999999997 111.74 177.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.474 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 14.5 mmmt 67.95 -3.27 1.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.857 2.063 . . . . 2.3900000000000001 113.368 -177.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.07 119.85 4.97 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 127.277 2.37 . . . . 1.1699999999999999 111.891 -172.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -81.76 136.95 35.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.642 1.177 . . . . 5.5099999999999998 110.459 156.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 m -150.99 145.48 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.102 1.761 . . . . 2.5 109.807 173.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -103.35 139.28 38.97 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.477 0.917 . . . . 3.5699999999999998 113.477 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.38 54.95 0.95 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.128 1.442 . . . . 2.0099999999999998 109.72 156.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -54.2 114.99 7.42 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.546 -1.216 . . . . 6.04 109.966 162.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.58 -28.18 85.05 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.211 2.607 . . . . 1.6399999999999999 114.824 -170.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.19 36.24 0.94 Allowed Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.342 0.973 . . . . 1.8700000000000001 113.367 166.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.06 -48.19 0.04 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.93 2.205 . . . . 1.3700000000000001 113.65 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -154.08 145.12 22.75 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.072 1.749 . . . . 3.2000000000000002 110.39 -174.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -165.66 171.81 12.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.969 1.308 . . . . 0.92000000000000004 110.52 -178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -103.35 135.08 45.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.108 0.563 . . . . 3.1699999999999999 110.667 165.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.1 mmt -92.74 134.74 34.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.532 1.133 . . . . 1.5600000000000001 110.467 165.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.2 mt -109.78 114.98 29.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.802 1.641 . . . . 3.1800000000000002 110.186 -176.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.77 155.48 31.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.223 1.409 . . . . 4.8799999999999999 111.039 -174.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.55 -39.69 3.1 Favored Glycine 0 N--CA 1.48 1.572 0 O-C-N 120.628 -1.295 . . . . 2.29 113.55 165.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 49.78 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 124.434 2.064 . . . . 2.46 115.822 162.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -79.72 4.63 15.67 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.245 -1.798 . . . . 4.0199999999999996 114.187 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -155.42 158.97 32.05 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.837 2.855 . . . . 5.7599999999999998 107.32 -175.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 94' ' ' LYS . 59.5 Cg_endo -75.08 -13.77 21.14 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.518 . . . . 4.3700000000000001 117.552 -173.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mp 60.82 -4.77 0.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 130.069 3.348 . . . . 4.71 113.716 -169.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -42.64 149.65 0.17 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.7 2.8 . . . . 4.0899999999999999 115.124 -171.007 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.7 126.34 21.58 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.955 1.302 . . . . 2.5499999999999998 112.125 178.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.74 30.1 45.19 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.778 -0.457 . . . . 3.5299999999999998 112.931 -165.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 -176.7 3.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.992 -1.855 . . . . 4.2800000000000002 105.992 139.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.23 155.11 50.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.634 -1.247 . . . . 4.7199999999999998 107.634 165.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.44 HG12 ' HG1' ' A' ' 37' ' ' THR . 21.3 t -115.5 93.18 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 122.428 1.109 . . . . 2.0899999999999999 110.538 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.05 123.1 16.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.856 -1.974 . . . . 3.8199999999999998 108.857 153.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.1 114.28 16.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.656 0.741 . . . . 2.8500000000000001 109.062 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.99 89.33 7.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.291 1.836 . . . . 2.4500000000000002 108.307 176.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.9 120.46 13.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.923 1.689 . . . . 2.25 109.567 -178.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.3 mt -86.1 139.04 31.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.084 1.353 . . . . 1.8100000000000001 110.391 -175.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -117.04 165.02 13.85 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.845 -0.534 . . . . 3.5899999999999999 112.421 177.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.96 70.84 1.53 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.504 1.122 . . . . 2.3300000000000001 112.681 -176.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 137.07 -154.11 22.13 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.95 1.738 . . . . 3.1200000000000001 111.638 -178.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.67 46.84 2.65 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.372 0.987 . . . . 2.2799999999999998 114.894 -173.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -136.03 143.43 44.73 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.53 1.932 . . . . 5.21 110.673 173.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -152.07 143.85 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 127.506 2.323 . . . . 1.9199999999999999 107.108 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -133.71 118.3 17.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.85 0.86 . . . . 2.8999999999999999 111.538 -171.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -74.67 117.88 16.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.843 0.457 . . . . 3.4300000000000002 111.612 173.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.46 165.28 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.767 1.227 . . . . 3.0499999999999998 110.42 160.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.21 136.15 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.457 1.103 . . . . 3.8300000000000001 109.195 171.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.9 mt -146.9 109.35 4.04 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.509 1.123 . . . . 3.02 110.693 -167.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.77 156.56 65.05 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.13 2.553 . . . . 1.21 113.165 -174.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -80.36 133.87 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 122.084 0.945 . . . . 2.3700000000000001 112.018 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -121.5 151.65 40.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 130.44 3.496 . . . . 3.7799999999999998 106.711 165.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.55 16.41 7.59 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.377 1.621 . . . . 2.7799999999999998 115.377 -154.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 113.717 1.006 . . . . 8.4100000000000001 113.717 -160.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 111.911 0.337 . . . . 6.0800000000000001 111.911 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.99 167.52 28.3 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.699 1.619 . . . . 1.6000000000000001 113.981 176.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -151.49 128.04 10.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.739 1.216 . . . . 2.3300000000000001 111.593 -170.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -100.03 112.21 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.344 -0.847 . . . . 2.2799999999999998 109.952 -170.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 1.8 tmt_? -84.03 89.71 7.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.333 1.453 . . . . 4.0999999999999996 111.649 -161.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.3 147.53 40.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.78 2.032 . . . . 3.6099999999999999 111.768 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.0 m -159.05 156.76 27.1 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 127.524 2.33 . . . . 3.1200000000000001 109.273 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.01 12.61 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.852 3.035 . . . . 2.5099999999999998 114.457 -172.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.44 171.82 36.46 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.026 0.83 . . . . 2.4300000000000002 112.455 -167.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.65 -3.69 11.03 Favored 'Cis proline' 0 C--N 1.351 0.7 0 CA-C-N 119.143 1.472 . . . . 3.6800000000000002 113.352 -4.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -146.67 175.12 10.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.73 1.612 . . . . 2.9399999999999999 110.625 175.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.16 -177.37 5.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.665 2.386 . . . . 1.3400000000000001 108.869 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.7 175.29 9.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.446 1.021 . . . . 1.77 113.401 -173.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.51 152.74 29.24 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.425 0.898 . . . . 1.99 113.425 169.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.18 162.42 38.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.599 1.56 . . . . 3.4100000000000001 110.582 174.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -174.12 150.2 1.53 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.977 1.711 . . . . 3.1699999999999999 113.646 -173.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.7 m -68.55 135.24 51.24 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.701 1.6 . . . . 2.9199999999999999 109.12 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.21 133.78 37.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.359 -0.978 . . . . 3.8700000000000001 108.359 173.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -149.56 138.09 20.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.082 0.944 . . . . 3.5 111.391 175.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -100.26 100.69 12.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.885 1.674 . . . . 1.22 108.961 -178.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.69 -8.89 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.109 1.873 . . . . 1.45 112.998 174.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.98 161.17 43.5 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.058 0.837 . . . . 1.0900000000000001 113.092 -178.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.457 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.2 m-20 -94.04 5.8 50.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.115 1.766 . . . . 3.0699999999999998 113.422 -172.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.02 159.06 42.5 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.936 1.694 . . . . 2.6400000000000001 109.949 165.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.39 159.21 25.97 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.274 2.65 . . . . 1.24 111.796 -170.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.8 mt -110.95 156.32 21.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.396 1.093 . . . . 2.8500000000000001 111.384 170.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -144.12 106.62 4.41 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.511 1.524 . . . . 4.2999999999999998 109.432 175.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.3 tp -91.66 122.37 34.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.312 2.245 . . . . 1.99 108.576 -177.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.23 -16.1 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 113.898 1.074 . . . . 1.73 113.898 -174.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -160.83 30.68 Favored Glycine 0 C--N 1.341 0.853 0 O-C-N 121.47 -0.769 . . . . 0.46999999999999997 112.27 177.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.7 178.6 8.95 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 1.78 111.081 168.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -147.03 141.22 26.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.35 1.06 . . . . 7.6399999999999997 110.39 177.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -149.19 157.23 39.85 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.296 1.438 . . . . 1.6200000000000001 111.369 -167.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.1 -25.14 8.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.343 2.029 . . . . 1.49 113.355 165.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.29 3.6 m -87.5 12.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.484 1.29 . . . . 2.02 114.484 -173.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.12 145.99 30.72 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.521 1.128 . . . . 1.72 110.741 173.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.05 -74.71 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.707 -1.59 . . . . 5.7999999999999998 106.707 170.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -80.17 142.19 34.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.305 1.842 . . . . 3.6099999999999999 109.692 169.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.22 131.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.66 1.584 . . . . 2.6000000000000001 108.811 177.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -146.65 133.82 20.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.445 1.498 . . . . 1.95 109.96 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.65 123.81 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.296 1.046 . . . . 2.1400000000000001 111.003 171.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -117.29 152.02 35.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.847 2.059 . . . . 0.80000000000000004 113.492 -178.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.49 160.18 15.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.003 1.321 . . . . 2.1299999999999999 110.493 165.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.2 m -110.53 144.14 39.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.172 1.789 . . . . 2.6699999999999999 107.7 163.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -152.19 162.42 41.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 114.679 1.363 . . . . 3.3799999999999999 114.679 -169.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.2 ptp -121.08 144.6 48.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.233 1.413 . . . . 5.04 110.332 159.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -147.76 142.31 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.113 1.365 . . . . 9.4800000000000004 110.402 171.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.18 149.07 46.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.611 1.564 . . . . 4.1299999999999999 111.718 175.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 p -146.63 -11.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.458 1.281 . . . . 4.25 114.458 173.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.21 30.56 0.49 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.175 1.79 . . . . 4.4000000000000004 110.875 178.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.35 -14.97 3.72 Favored Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.494 -1.379 . . . . 1.98 113.659 -167.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 167.76 9.57 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.185 2.194 . . . . 3.8100000000000001 110.019 158.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.56 148.68 34.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.997 1.851 . . . . 4.7999999999999998 115.997 -170.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.82 141.94 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.402 1.881 . . . . 4.0999999999999996 109.086 165.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 tpp -93.25 137.59 32.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.589 1.555 . . . . 3.8900000000000001 109.836 171.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 -177.77 29.01 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.801 0.715 . . . . 1.6399999999999999 114.584 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.4 mtt -141.48 156.64 45.74 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.159 1.784 . . . . 3.3799999999999999 110.211 176.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -164.96 156.07 12.87 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.25 1.42 . . . . 5.3499999999999996 110.84 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.93 150.45 82.98 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.933 1.755 . . . . 1.0800000000000001 112.284 169.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.96 158.69 41.75 Favored Pre-proline 0 N--CA 1.471 0.625 0 C-N-CA 126.599 1.96 . . . . 2.2200000000000002 109.829 174.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.04 -29.5 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.142 1.895 . . . . 1.5900000000000001 112.247 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 p90 175.92 160.88 0.3 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.499 1.52 . . . . 3.04 107.14 -175.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -112.13 162.55 15.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.275 1.036 . . . . 4.0099999999999998 111.033 155.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -145.27 157.66 44.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.071 -1.422 . . . . 2.52 114.174 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -145.88 133.74 10.5 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 114.553 -1.203 . . . . 2.0 108.481 -161.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.9 171.22 15.01 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.011 1.807 . . . . 1.4399999999999999 111.334 176.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.86 144.06 99.51 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.075 2.517 . . . . 1.26 111.435 165.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 14.5 mmmt 66.62 4.85 3.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.859 1.664 . . . . 2.8300000000000001 113.173 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.46 126.23 8.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 128.232 2.825 . . . . 1.1599999999999999 112.494 -170.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -98.78 141.82 31.1 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.642 1.577 . . . . 4.6100000000000003 112.601 166.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.4 122.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.321 1.848 . . . . 2.4300000000000002 108.744 168.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.417 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 18.0 mp0 -89.68 143.37 26.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.255 -0.903 . . . . 4.0499999999999998 111.163 176.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.44 148.49 43.21 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.321 -0.862 . . . . 2.6200000000000001 109.07 164.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 76' ' ' GLU . 12.3 ptpt -166.86 138.72 2.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.947 1.299 . . . . 5.0700000000000003 111.363 -165.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.91 -26.79 58.94 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.153 3.236 . . . . 1.45 114.294 -169.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.72 78.71 1.03 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.145 -1.582 . . . . 1.74 109.145 161.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.42 -76.5 0.21 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 124.247 0.927 . . . . 1.24 114.236 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -148.3 136.64 21.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.167 1.387 . . . . 3.5499999999999998 111.623 -168.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.55 167.24 29.03 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.801 -0.562 . . . . 1.0900000000000001 110.053 -172.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -96.88 133.73 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.392 -0.966 . . . . 3.8100000000000001 108.392 165.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 mmt -82.92 137.57 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.182 -0.673 . . . . 1.7 109.182 157.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.94 127.81 55.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.967 2.107 . . . . 2.8700000000000001 107.112 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -136.2 158.37 44.57 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.495 1.118 . . . . 2.7400000000000002 111.412 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.58 -61.36 3.23 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.421 1.486 . . . . 3.1400000000000001 112.551 178.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.5 mt 76.84 100.33 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 130.861 3.664 . . . . 2.25 110.837 173.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.026 -1.046 . . . . 2.9100000000000001 113.139 -169.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -150.4 153.8 35.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.488 2.715 . . . . 7.8099999999999996 108.282 169.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -67.43 158.79 55.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.857 2.372 . . . . 2.71 110.386 166.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.19 157.29 26.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.383 1.473 . . . . 3.4300000000000002 111.565 -171.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -139.28 134.43 32.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.344 1.057 . . . . 4.5199999999999996 111.142 176.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.87 38.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.202 0.601 . . . . 2.6299999999999999 111.906 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.13 -15.12 8.28 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.372 1.463 . . . . 2.21 116.038 173.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -176.04 3.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.19 1.495 . . . . 4.6399999999999997 111.243 -171.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -89.28 160.97 16.64 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.62 1.568 . . . . 4.75 112.362 171.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.37 127.59 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.054 1.742 . . . . 1.9299999999999999 108.863 167.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.32 134.11 41.1 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.326 1.45 . . . . 3.3300000000000001 110.259 164.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.67 127.37 10.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.498 1.142 . . . . 2.6200000000000001 113.59 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.71 94.5 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.534 1.534 . . . . 2.6000000000000001 110.446 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.27 115.94 11.01 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.379 1.472 . . . . 2.3700000000000001 110.524 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.0 mt -88.09 129.92 35.16 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.685 1.194 . . . . 1.8899999999999999 110.643 -172.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.66 144.9 50.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.056 0.931 . . . . 3.2999999999999998 112.463 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.91 125.55 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.856 1.262 . . . . 2.0 113.473 -169.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.2 70.23 1.25 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.643 1.115 . . . . 3.3399999999999999 112.549 177.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.49 15.76 81.27 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.557 1.383 . . . . 2.5899999999999999 116.557 163.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -105.92 148.36 27.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.967 1.883 . . . . 5.5899999999999999 110.972 171.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.11 140.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.84 1.656 . . . . 1.97 107.914 167.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -120.2 116.99 26.72 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.224 1.009 . . . . 2.3700000000000001 109.385 178.009 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -75.73 128.81 35.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.83 0.452 . . . . 3.3999999999999999 110.835 174.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -137.04 144.32 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.01 1.724 . . . . 2.8100000000000001 109.612 175.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.55 130.98 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.927 1.291 . . . . 3.2999999999999998 108.473 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 mp -140.26 153.56 69.02 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.667 1.587 . . . . 3.7400000000000002 110.013 -172.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.89 155.86 43.49 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.597 2.865 . . . . 1.54 112.937 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.46 142.75 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.776 1.23 . . . . 1.96 110.491 168.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.5 151.46 39.34 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.652 1.981 . . . . 3.2200000000000002 108.501 164.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.72 28.68 7.19 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.914 1.45 . . . . 2.4199999999999999 114.914 -161.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.456 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.86 1.264 . . . . 8.6400000000000006 111.978 -165.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 CA--C 1.551 1.016 0 N-CA-C 110.528 -0.175 . . . . 5.6100000000000003 110.528 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.91 170.95 23.54 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.168 -1.582 . . . . 1.1899999999999999 114.581 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 p90 -165.58 149.78 8.4 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.137 0.975 . . . . 1.5700000000000001 111.291 -175.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.42 147.54 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.368 -0.975 . . . . 1.72 108.368 167.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -97.08 119.72 36.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.947 0.794 . . . . 6.3899999999999997 110.043 164.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.12 134.62 38.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.864 0.84 . . . . 3.71 108.86 156.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.2 m -139.66 160.89 59.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 125.635 1.574 . . . . 2.9900000000000002 109.336 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.24 -7.26 13.41 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.485 2.79 . . . . 2.4500000000000002 115.038 178.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.91 -164.47 18.53 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.254 0.934 . . . . 2.3500000000000001 113.549 175.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.33 -7.46 12.99 Favored 'Cis proline' 0 C--N 1.351 0.672 0 CA-C-N 118.69 1.245 . . . . 2.3100000000000001 113.389 -4.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.06 136.92 34.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.345 1.458 . . . . 3.3100000000000001 110.919 176.496 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.57 -177.94 3.27 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.097 1.759 . . . . 1.4199999999999999 110.695 -177.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.63 136.66 34.56 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.243 0.929 . . . . 1.77 113.068 -169.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.49 141.42 52.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 1.75 112.294 -178.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -135.62 165.43 25.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.806 1.643 . . . . 3.79 110.658 -172.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -171.34 148.96 2.68 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 2.3700000000000001 112.783 168.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.0 m -77.28 138.07 39.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.809 -1.182 . . . . 2.2599999999999998 107.809 149.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -136.33 143.22 44.02 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.522 1.929 . . . . 3.48 107.967 -177.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' CD ' HH12 ' A' ' 74' ' ' ARG . 12.8 pt-20 -127.63 135.24 49.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.731 0.812 . . . . 3.5 111.003 -177.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -97.23 100.73 8.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.515 -0.92 . . . . 1.1499999999999999 108.515 165.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.79 -10.79 15.5 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.637 2.225 . . . . 1.28 113.146 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.44 -173.08 49.49 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.729 1.157 . . . . 1.3999999999999999 113.413 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.3 m-20 -112.21 1.34 16.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.913 1.685 . . . . 3.0 112.802 -168.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -123.03 161.0 47.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.327 1.851 . . . . 2.6200000000000001 110.392 174.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 148.63 17.29 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.509 2.14 . . . . 0.89000000000000001 111.833 -171.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.07 111.68 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.053 1.341 . . . . 3.1299999999999999 110.605 -176.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 68' ' ' GLU . 25.4 ttm180 -98.79 101.91 13.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.871 1.268 . . . . 5.3200000000000003 110.865 -179.158 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.07 114.56 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.676 1.99 . . . . 1.6499999999999999 108.629 -175.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.77 -19.51 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.29 0.848 . . . . 1.7 113.29 -171.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.37 -163.55 30.43 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.267 0.937 . . . . 0.40000000000000002 111.552 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.82 179.53 7.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 1.72 110.658 164.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -149.41 135.36 18.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.859 1.664 . . . . 7.9800000000000004 108.068 -177.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.483 ' HG1' HG11 ' A' ' 99' ' ' VAL . 1.4 t -140.0 156.96 70.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.421 1.488 . . . . 1.8200000000000001 109.997 -171.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.48 -25.19 9.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.276 1.984 . . . . 1.04 112.103 169.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.259 14.3 m -82.91 -11.52 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.469 1.285 . . . . 2.1099999999999999 114.469 -173.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.11 155.71 47.65 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.526 0.935 . . . . 1.8 113.526 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.26 -91.83 0.11 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.945 1.298 . . . . 3.3900000000000001 110.212 175.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -84.28 92.2 7.93 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.886 0.874 . . . . 3.75 108.826 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -87.15 139.26 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.288 1.035 . . . . 2.3500000000000001 110.798 172.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -137.52 138.79 40.03 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.356 1.862 . . . . 1.9299999999999999 110.751 -174.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.43 121.04 29.35 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.913 1.233 . . . . 1.8300000000000001 111.747 169.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -108.61 155.91 20.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.266 1.826 . . . . 0.68999999999999995 112.339 175.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.55 -179.76 4.04 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 2.5800000000000001 110.696 169.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -140.32 116.19 10.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.144 1.378 . . . . 2.1600000000000001 107.442 172.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -117.47 -179.49 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.509 1.524 . . . . 2.8999999999999999 110.854 -174.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 73.6 mtm -130.16 128.04 40.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.169 0.988 . . . . 3.6299999999999999 110.868 164.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -97.61 168.17 10.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.744 1.218 . . . . 8.1899999999999995 111.527 167.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -88.51 142.57 27.6 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.535 0.734 . . . . 5.9699999999999998 109.397 153.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.04 -6.92 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.141 1.163 . . . . 4.5099999999999998 114.141 175.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 56' ' ' LYS . 16.3 tt0 -175.84 31.66 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.804 2.042 . . . . 4.0099999999999998 109.425 -165.638 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.66 -19.68 0.15 Allowed Glycine 0 N--CA 1.479 1.501 0 O-C-N 119.545 -1.972 . . . . 2.29 114.769 -158.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 54' ' ' GLU . 85.0 mttt -74.2 132.36 42.11 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.115 1.766 . . . . 4.9900000000000002 109.159 175.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -76.4 126.34 30.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.101 -1.074 . . . . 5.0899999999999999 108.101 169.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -140.01 139.13 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.176 1.391 . . . . 3.5299999999999998 108.79 -175.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.8 mtp -69.9 162.25 28.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.217 1.192 . . . . 6.0999999999999996 114.217 -175.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.71 164.17 32.52 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.791 1.186 . . . . 1.01 111.597 167.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.13 157.88 30.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.994 1.317 . . . . 2.6400000000000001 110.183 172.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -169.44 151.56 4.51 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 4.5199999999999996 110.607 177.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.3 Cg_endo -69.02 153.23 72.65 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.758 1.639 . . . . 0.75 111.708 169.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.76 159.02 50.42 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 126.261 1.824 . . . . 1.9099999999999999 110.53 174.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -72.46 -21.49 22.59 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.677 2.251 . . . . 0.90000000000000002 112.58 172.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -175.75 169.96 2.92 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.739 1.616 . . . . 3.7799999999999998 110.839 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -122.11 174.33 7.01 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.905 2.482 . . . . 1.98 108.78 160.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.6 pt-20 -152.88 165.54 35.11 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.257 -0.902 . . . . 2.6600000000000001 113.217 164.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -135.04 128.29 18.54 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 125.45 1.5 . . . . 2.1800000000000002 109.058 -176.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.85 162.2 43.45 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.474 2.116 . . . . 1.2 111.03 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.21 94.45 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.975 2.45 . . . . 1.24 111.649 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 63.6 mmtt 68.1 -1.05 1.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.685 1.994 . . . . 2.21 113.671 -174.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.09 117.86 4.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 126.556 2.027 . . . . 1.1899999999999999 111.894 -177.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.454 HH12 ' CD ' ' A' ' 23' ' ' GLU . 8.7 ttt85 -91.75 129.61 37.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.235 1.014 . . . . 7.2300000000000004 110.035 157.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.07 171.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.861 1.664 . . . . 2.3399999999999999 110.226 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -139.65 146.03 39.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.7 1.238 . . . . 4.6500000000000004 114.117 176.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -85.34 71.64 10.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.939 1.696 . . . . 1.97 109.391 178.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -61.4 141.56 94.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 114.133 -1.394 . . . . 4.9299999999999997 112.262 177.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.48 -18.04 51.58 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.653 2.236 . . . . 1.3 113.149 165.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.59 26.09 23.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.252 1.406 . . . . 1.26 114.107 172.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.52 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.476 1.36 0 CA-C-N 119.414 1.607 . . . . 1.51 115.735 175.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -159.97 140.4 11.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.632 1.573 . . . . 3.25 109.413 -176.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -171.0 168.68 6.89 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.491 1.951 . . . . 1.54 111.173 -175.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.31 125.75 46.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.507 0.723 . . . . 2.9199999999999999 111.46 -178.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mmt -91.99 142.57 27.4 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.449 1.099 . . . . 2.1200000000000001 110.014 170.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 mt -119.89 85.79 2.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.618 1.567 . . . . 2.7999999999999998 109.053 -171.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.68 107.71 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.242 1.017 . . . . 4.4199999999999999 108.632 -176.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.03 130.37 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.118 0.866 . . . . 2.77 111.801 -172.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.3 mt -112.6 118.49 35.22 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.771 0.828 . . . . 2.0299999999999998 108.999 178.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.2 9.79 19.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.069 0.766 . . . . 3.4199999999999999 113.069 -166.19 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -172.55 159.2 3.93 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 128.016 2.527 . . . . 6.21 108.919 -171.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.24 160.61 48.96 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.374 1.383 . . . . 2.1299999999999999 110.018 162.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mp -115.48 -164.72 0.97 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.453 1.901 . . . . 3.4900000000000002 108.728 -171.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.15 136.95 13.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.399 1.48 . . . . 5.9299999999999997 110.976 168.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.04 126.97 29.88 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.055 -1.091 . . . . 2.4900000000000002 108.055 151.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.38 78.53 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.137 -1.924 . . . . 1.8899999999999999 115.614 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -93.7 177.96 5.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.514 2.157 . . . . 3.5600000000000001 110.051 153.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -103.58 149.13 25.18 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.589 0.756 . . . . 4.8499999999999996 109.783 167.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.483 HG11 ' HG1' ' A' ' 37' ' ' THR . 8.4 t -105.52 123.13 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.651 1.18 . . . . 2.48 108.215 168.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.64 124.06 21.81 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 113.949 -1.478 . . . . 4.71 107.5 162.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.17 109.42 10.8 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.932 0.873 . . . . 2.8799999999999999 111.074 174.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.79 86.11 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.702 2.401 . . . . 2.6299999999999999 109.673 173.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.18 117.22 8.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.829 1.252 . . . . 2.21 109.623 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.4 126.2 35.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.853 1.261 . . . . 2.1000000000000001 110.735 -175.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.42 117.77 25.18 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.535 -0.728 . . . . 3.2000000000000002 111.58 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.96 22.04 0.18 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.196 2.199 . . . . 3.2400000000000002 115.985 171.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.9 -41.72 1.07 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.786 1.66 . . . . 3.9399999999999999 113.847 -171.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.06 -1.82 90.15 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.987 -1.452 . . . . 1.73 116.071 -174.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.45 159.32 42.46 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.712 2.005 . . . . 4.7599999999999998 111.727 168.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.14 145.99 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 126.42 1.888 . . . . 2.1400000000000001 108.179 168.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -134.76 108.42 7.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.265 1.026 . . . . 2.6299999999999999 109.858 -177.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.87 96.83 6.46 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.604 0.361 . . . . 3.7400000000000002 110.817 176.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.86 151.39 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.631 0.772 . . . . 2.6499999999999999 110.837 176.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.23 131.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.813 1.645 . . . . 2.96 108.734 168.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.7 mt -139.93 130.63 14.19 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 2.6800000000000002 109.499 176.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.93 151.6 56.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.489 2.793 . . . . 1.24 111.692 176.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.3 t -97.84 117.14 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.924 0.89 . . . . 2.2200000000000002 111.787 178.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -75.57 155.36 36.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.553 2.741 . . . . 3.98 109.072 159.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.3 131.19 45.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.833 -1.167 . . . . 2.6600000000000001 112.631 171.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.0 mtt180 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 127.577 2.351 . . . . 8.0600000000000005 108.153 169.699 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 118.745 -0.645 . . . . 5.46 109.697 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 170.97 24.26 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 120.877 1.671 . . . . 1.2 114.232 177.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -155.31 164.98 38.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.285 1.041 . . . . 2.29 113.681 174.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.58 119.13 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.169 -0.923 . . . . 1.77 108.549 174.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.83 113.46 19.04 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.435 0.636 . . . . 4.9500000000000002 110.383 175.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.5 134.64 53.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.021 0.915 . . . . 3.96 108.98 162.319 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.03 164.62 20.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.691 1.996 . . . . 3.4500000000000002 107.298 170.312 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.62 -10.65 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.755 2.304 . . . . 1.6299999999999999 114.283 -174.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.17 -159.74 27.78 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.95 0.786 . . . . 1.49 111.743 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.37 -6.57 12.46 Favored 'Cis proline' 0 CA--C 1.538 0.704 0 CA-C-N 119.141 1.471 . . . . 1.96 113.7 3.076 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -136.9 158.83 43.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.821 1.248 . . . . 2.21 112.021 170.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.78 -162.57 1.11 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.004 2.122 . . . . 2.2799999999999998 111.226 -176.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.23 163.07 40.01 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.537 1.31 . . . . 1.9099999999999999 114.537 -170.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.27 150.37 36.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.688 1.595 . . . . 1.54 112.256 172.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.38 134.36 20.28 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.271 1.828 . . . . 3.79 108.778 -172.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.56 137.81 8.11 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 115.055 1.502 . . . . 3.29 115.055 -160.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -66.97 136.08 54.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.609 -0.723 . . . . 3.1200000000000001 110.637 167.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.31 153.59 40.04 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.971 2.108 . . . . 3.6099999999999999 109.926 163.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.64 149.49 48.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.772 0.796 . . . . 3.4100000000000001 110.582 164.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -106.2 95.24 10.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.141 -0.936 . . . . 1.25 110.004 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.15 -5.09 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.875 2.384 . . . . 1.79 113.0 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.84 162.19 52.77 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 124.972 1.273 . . . . 1.5 113.39 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -74.56 -32.03 62.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.265 2.226 . . . . 5.8200000000000003 112.788 174.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.28 164.09 17.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.358 1.863 . . . . 2.6699999999999999 112.102 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.55 152.54 17.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.864 2.376 . . . . 0.73999999999999999 111.497 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.28 115.98 30.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.852 1.261 . . . . 3.5600000000000001 110.226 -176.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.422 HH11 ' HB2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -99.58 107.27 19.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.528 1.131 . . . . 5.0800000000000001 110.538 177.065 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -95.55 119.24 33.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.093 1.357 . . . . 1.8899999999999999 109.318 -174.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.21 -12.93 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.476 1.11 . . . . 1.8500000000000001 113.927 -171.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.5 -162.73 30.19 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.426 1.012 . . . . 0.56999999999999995 111.971 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.09 -167.96 2.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 2.1000000000000001 111.442 165.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -159.13 161.04 36.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.252 0.933 . . . . 6.6699999999999999 108.824 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.24 156.96 30.93 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 125.842 1.657 . . . . 1.6699999999999999 111.088 -178.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.5 -17.97 15.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.612 2.875 . . . . 1.25 114.462 170.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -98.35 -18.17 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 115.013 1.486 . . . . 2.3399999999999999 115.013 -174.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -108.55 152.8 24.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.75 1.159 . . . . 1.76 112.073 176.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.95 -90.9 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.747 0.819 . . . . 3.5499999999999998 109.497 173.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -79.53 141.81 36.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.114 -1.069 . . . . 4.2999999999999998 108.114 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.08 131.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.715 1.206 . . . . 2.6600000000000001 110.462 173.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.04 132.21 20.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.277 1.031 . . . . 2.1699999999999999 111.847 -163.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tt -79.13 124.22 28.11 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 121.474 0.654 . . . . 1.8600000000000001 111.034 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -112.62 157.07 21.66 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.196 1.798 . . . . 1.01 112.147 172.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.44 -170.85 1.84 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.548 1.139 . . . . 2.71 112.319 165.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.6 m -147.42 88.09 1.69 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.32 1.848 . . . . 2.0299999999999998 107.447 170.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -78.46 157.24 29.0 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 3.6400000000000001 112.009 -177.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.9 mtm -107.69 130.72 54.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.401 1.08 . . . . 3.6200000000000001 110.012 166.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 -146.89 149.39 33.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.308 1.043 . . . . 5.7699999999999996 111.542 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 145.54 55.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.544 0.738 . . . . 3.9900000000000002 109.843 155.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.74 -90.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.727 1.611 . . . . 4.0800000000000001 108.693 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 56' ' ' LYS . 6.2 tt0 -77.43 41.29 0.31 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.392 2.277 . . . . 3.5499999999999998 111.613 175.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.97 -10.27 1.26 Allowed Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.544 -1.348 . . . . 2.02 114.327 -166.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 54' ' ' GLU . 60.0 mttt -102.45 155.79 18.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 128.625 2.77 . . . . 3.3799999999999999 109.374 175.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -90.59 145.62 24.71 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.303 1.223 . . . . 4.1200000000000001 114.303 178.003 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.9 t -141.27 148.16 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.306 1.843 . . . . 2.9700000000000002 109.421 -178.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -89.87 123.45 33.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.577 1.551 . . . . 4.2800000000000002 110.11 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.87 138.31 10.51 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 119.041 0.837 . . . . 1.3100000000000001 113.678 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -90.04 156.62 18.27 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.828 0.851 . . . . 2.7000000000000002 111.676 170.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -167.42 153.7 7.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.135 1.774 . . . . 5.29 110.088 168.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -68.46 156.95 63.85 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.342 1.361 . . . . 0.85999999999999999 110.698 170.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.99 156.14 78.63 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.237 1.415 . . . . 1.76 110.751 -178.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.87 -20.07 30.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.969 2.446 . . . . 0.82999999999999996 113.112 178.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.6 166.91 3.86 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.444 1.098 . . . . 3.0099999999999998 112.455 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -115.92 178.0 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.471 2.308 . . . . 1.73 109.296 153.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.12 159.63 44.36 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.122 -0.986 . . . . 2.0800000000000001 111.57 164.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.41 126.53 20.29 Favored Pre-proline 0 N--CA 1.468 0.425 0 C-N-CA 126.021 1.728 . . . . 2.1400000000000001 108.202 -178.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.64 162.39 42.3 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.509 2.14 . . . . 0.93999999999999995 110.998 178.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.51 131.76 32.99 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.29 2.66 . . . . 1.02 110.622 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.9 1.52 3.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.869 2.467 . . . . 3.8100000000000001 114.226 -170.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.84 118.81 9.24 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 125.811 1.672 . . . . 1.0 109.055 172.024 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -117.79 114.58 23.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.833 2.053 . . . . 5.2699999999999996 109.171 172.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -149.96 154.02 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.459 1.103 . . . . 3.0099999999999998 112.174 -165.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -102.96 134.49 46.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.302 0.572 . . . . 3.0499999999999998 111.751 176.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.13 137.0 57.36 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.241 -1.392 . . . . 2.0800000000000001 107.241 141.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -150.17 143.75 16.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.489 2.316 . . . . 4.29 109.938 -161.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.05 -43.68 28.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.807 3.005 . . . . 1.55 113.151 -167.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 118.34 5.86 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.371 -1.892 . . . . 2.1099999999999999 108.371 157.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -77.29 0.38 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.683 1.135 . . . . 1.23 112.937 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -154.5 131.9 11.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.41 1.105 . . . . 3.3199999999999998 110.448 -175.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -163.66 172.17 14.64 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.764 -1.21 . . . . 0.96999999999999997 111.714 -167.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.13 122.08 45.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.162 0.585 . . . . 3.1200000000000001 109.776 173.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 mmt -80.39 134.23 36.0 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.171 -0.678 . . . . 1.9199999999999999 109.171 165.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.52 118.52 36.77 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.198 1.399 . . . . 3.2599999999999998 107.711 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.78 104.71 9.78 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.373 1.469 . . . . 2.9700000000000002 109.192 -171.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.06 141.39 1.05 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.302 -0.719 . . . . 3.1499999999999999 111.302 -159.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.9 mt -117.67 120.47 38.11 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.489 -0.93 . . . . 2.29 108.489 171.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.79 -4.38 54.41 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.946 1.091 . . . . 3.02 113.946 -170.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -150.41 159.21 35.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.134 2.173 . . . . 7.6600000000000001 110.076 178.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -66.76 159.11 52.88 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.354 2.036 . . . . 2.2400000000000002 109.226 153.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.54 160.4 31.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.689 1.596 . . . . 3.79 109.75 -162.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.69 129.53 10.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.412 1.101 . . . . 5.75 112.902 -158.22 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.31 121.19 13.72 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.479 -0.763 . . . . 3.0899999999999999 110.213 174.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.43 7.69 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.423 -1.209 . . . . 2.29 114.804 -166.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.9 174.2 7.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.652 1.726 . . . . 3.6200000000000001 108.958 144.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -89.7 148.28 23.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.045 0.938 . . . . 3.9700000000000002 110.617 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 t -93.63 127.48 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.254 -1.017 . . . . 2.0099999999999998 108.254 161.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.543 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 51.5 mt-10 -65.45 111.87 3.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.281 -0.872 . . . . 3.1899999999999999 108.678 153.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.95 123.29 44.91 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.594 -1.262 . . . . 3.7200000000000002 107.594 163.113 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -102.68 85.64 2.61 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.835 2.054 . . . . 2.2799999999999998 109.145 177.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.28 121.47 16.31 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.444 1.898 . . . . 4.2400000000000002 110.5 -175.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.5 mt -92.98 133.54 36.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.42 1.088 . . . . 1.96 111.279 -176.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.77 153.31 38.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.159 0.984 . . . . 3.0600000000000001 111.454 178.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.9 132.35 53.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.346 0.658 . . . . 2.3999999999999999 111.303 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.83 -142.92 16.27 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.662 -0.975 . . . . 3.7999999999999998 110.662 -167.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -100.62 12.25 59.6 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.676 1.131 . . . . 2.5699999999999998 115.359 -176.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -87.36 137.36 32.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.589 1.694 . . . . 6.5700000000000003 113.306 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.38 138.52 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.749 1.62 . . . . 2.2200000000000002 109.787 165.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.07 113.4 25.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.472 1.509 . . . . 3.79 109.898 177.416 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.543 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 23.0 ttmm -78.69 116.91 19.37 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.126 -0.694 . . . . 3.5699999999999998 109.126 168.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.83 149.46 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.408 1.083 . . . . 2.7599999999999998 109.89 173.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -95.8 138.07 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.663 1.185 . . . . 4.1399999999999997 109.62 170.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.3 mt -144.91 140.61 16.43 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.678 1.591 . . . . 3.0600000000000001 109.807 178.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.04 144.37 63.53 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.079 3.186 . . . . 1.3999999999999999 114.005 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.16 126.22 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.45 1.1 . . . . 2.46 110.831 172.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -97.31 168.79 10.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.038 2.935 . . . . 3.1699999999999999 109.222 169.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.57 30.89 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.622 1.556 . . . . 2.4300000000000002 110.386 161.494 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.2 ttm-85 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.862 1.665 . . . . 7.7599999999999998 113.075 -171.704 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 121.353 0.597 . . . . 5.8499999999999996 110.692 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.06 172.34 30.69 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.371 -0.83 . . . . 1.1399999999999999 114.824 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -159.63 129.8 5.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 2.54 112.66 -173.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.01 103.09 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.79 -1.189 . . . . 2.0 107.79 175.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.5 ttp85 -85.46 114.37 22.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.576 0.703 . . . . 5.0800000000000001 110.695 -174.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.24 163.21 18.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.138 1.775 . . . . 3.9500000000000002 112.903 -167.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -168.89 142.31 2.36 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.17 1.788 . . . . 3.5800000000000001 109.95 156.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.61 -8.38 18.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.069 3.179 . . . . 2.2400000000000002 114.425 -169.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.94 161.93 10.62 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.929 0.776 . . . . 2.6899999999999999 113.302 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.87 -1.44 8.12 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 118.612 1.206 . . . . 3.6000000000000001 112.659 -11.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -153.51 173.09 16.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 3.29 113.322 -179.003 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.02 171.57 14.24 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.139 2.576 . . . . 1.96 110.373 168.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.69 104.42 4.91 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.885 0.874 . . . . 2.2799999999999998 111.307 -171.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 149.99 21.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.508 0.929 . . . . 1.52 113.508 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.12 162.97 32.82 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.625 1.57 . . . . 3.71 111.167 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.93 152.62 6.59 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.46 1.104 . . . . 2.4500000000000002 112.075 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 m -84.24 142.37 30.32 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.251 -1.018 . . . . 2.2599999999999998 108.251 154.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.82 146.33 39.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.447 1.899 . . . . 3.8599999999999999 106.951 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -116.97 142.51 46.86 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.484 0.714 . . . . 3.5600000000000001 111.548 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -101.58 105.14 38.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.121 0.969 . . . . 1.3 109.685 166.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.14 -8.43 11.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.641 2.227 . . . . 1.02 113.672 178.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.26 166.92 48.6 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 119.707 1.139 . . . . 1.22 112.93 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.83 2.37 51.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.195 2.198 . . . . 3.27 111.877 173.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -109.67 159.53 31.26 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 128.333 2.653 . . . . 4.0 108.888 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.76 152.03 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.094 2.53 . . . . 1.2 111.287 177.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.99 106.51 17.06 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.013 0.925 . . . . 3.4300000000000002 110.495 173.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.1 114.16 21.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.581 -1.645 . . . . 4.1500000000000004 109.112 170.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -105.14 128.77 53.53 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.535 1.934 . . . . 4.0899999999999999 108.693 -177.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.79 -7.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.169 0.988 . . . . 1.8500000000000001 113.259 -175.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.9 -159.18 32.19 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 119.588 -1.291 . . . . 0.54000000000000004 114.303 178.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.4 173.15 14.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.674 0.79 . . . . 2.0 112.351 -179.143 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.139 -1.43 . . . . 7.1799999999999997 107.139 164.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -147.2 142.96 17.49 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 117.886 -1.054 . . . . 1.8899999999999999 109.066 -175.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.29 -21.72 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.005 1.803 . . . . 1.21 111.517 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.367 1.0 OUTLIER -77.86 11.73 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 118.739 0.7 . . . . 2.2799999999999998 112.453 174.894 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.43 145.71 39.2 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 114.584 1.327 . . . . 2.1699999999999999 114.584 176.456 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -87.17 -83.19 0.2 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.742 -1.207 . . . . 4.1200000000000001 107.742 170.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -77.99 147.59 34.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.1 0.96 . . . . 4.1699999999999999 108.84 162.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.28 143.54 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.231 1.412 . . . . 2.4100000000000001 109.279 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -139.87 137.44 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.424 1.49 . . . . 2.27 109.773 -174.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.0 tt -86.56 121.97 29.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.962 1.255 . . . . 2.02 110.511 164.624 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -109.92 153.66 24.19 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.038 1.335 . . . . 1.0 112.329 174.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.82 169.69 10.73 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.053 1.741 . . . . 2.21 110.618 163.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -152.11 128.27 10.47 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.898 1.279 . . . . 2.5299999999999998 108.992 175.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.65 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.136 0.974 . . . . 3.1099999999999999 112.674 -161.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 ptt? -105.48 148.92 26.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.239 0.616 . . . . 3.9300000000000002 110.474 155.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -162.11 164.55 27.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.572 1.949 . . . . 6.0999999999999996 109.98 174.04 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -99.0 149.68 22.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.922 0.889 . . . . 4.3799999999999999 110.959 -174.885 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -128.36 -96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 124.329 1.018 . . . . 3.79 109.244 -178.111 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -76.72 42.02 0.28 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.909 2.084 . . . . 4.4199999999999999 110.963 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.61 -9.12 3.69 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 119.827 -1.796 . . . . 2.9100000000000001 114.04 -168.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.17 148.02 24.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.702 1.601 . . . . 4.6500000000000004 110.285 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.494 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 28.5 mmmt -65.58 134.41 53.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.472 0.709 . . . . 4.3499999999999996 110.203 167.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -137.5 153.75 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.377 1.471 . . . . 2.8399999999999999 109.126 176.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 ptp -108.02 142.44 38.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.371 1.068 . . . . 5.6200000000000001 111.866 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.22 32.63 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 123.741 0.686 . . . . 1.3500000000000001 113.342 -176.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.18 167.18 23.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 3.21 110.329 -173.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -173.69 154.35 2.36 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.763 1.625 . . . . 4.4800000000000004 111.215 170.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.67 143.82 69.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.397 2.065 . . . . 1.3400000000000001 112.01 166.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.27 156.86 59.91 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.005 2.122 . . . . 1.9399999999999999 110.521 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.97 -21.46 18.35 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.522 2.148 . . . . 0.84999999999999998 113.186 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -172.7 174.8 3.58 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.841 1.201 . . . . 3.8399999999999999 111.905 -177.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.1 176.34 8.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.455 2.702 . . . . 2.0 108.513 165.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.87 168.45 27.17 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 120.728 -1.232 . . . . 2.4700000000000002 112.649 166.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.37 129.9 18.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.516 1.527 . . . . 2.6899999999999999 108.969 179.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.52 162.97 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.15 2.566 . . . . 1.6200000000000001 112.219 -177.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.01 136.04 70.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.885 3.056 . . . . 1.3400000000000001 112.005 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt 67.02 5.57 4.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.08 1.752 . . . . 2.04 113.665 -178.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.39 123.43 7.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 126.809 2.147 . . . . 1.3300000000000001 110.238 -178.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.35 129.96 48.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.156 0.982 . . . . 5.3399999999999999 110.915 159.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.8 m -153.01 158.8 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.171 1.388 . . . . 3.3599999999999999 110.693 -174.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.63 142.47 46.85 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.15 1.38 . . . . 3.6000000000000001 114.278 -177.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.58 73.22 0.53 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.863 1.665 . . . . 1.8799999999999999 108.954 165.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -62.6 140.88 96.94 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.251 1.42 . . . . 4.0 112.272 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.06 -37.63 91.77 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.281 2.654 . . . . 1.3600000000000001 112.822 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.22 71.08 2.99 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.943 -1.263 . . . . 1.3200000000000001 109.943 164.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.77 -58.65 0.2 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.553 1.073 . . . . 1.4099999999999999 115.09 176.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -157.63 149.46 22.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.4 1.88 . . . . 4.1900000000000004 111.898 -172.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -161.18 165.08 29.99 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.117 -0.989 . . . . 1.4299999999999999 111.166 177.247 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CE1' HD12 ' A' ' 45' ' ' LEU . 53.9 m-85 -100.14 109.87 22.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.796 -0.816 . . . . 2.98 108.796 168.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 119.73 22.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 2.6699999999999999 108.335 172.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.03 121.29 41.14 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.054 1.342 . . . . 2.6299999999999999 107.877 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.36 144.6 43.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.956 1.302 . . . . 4.8899999999999997 109.667 -173.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.33 -61.36 4.72 Favored Glycine 0 N--CA 1.475 1.249 0 O-C-N 121.15 -0.969 . . . . 2.7400000000000002 113.477 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt 78.23 119.15 0.05 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.62 3.168 . . . . 2.4100000000000001 111.996 171.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.52 -2.45 20.37 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.719 1.007 . . . . 3.2599999999999998 113.719 -174.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.52 159.67 40.9 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.887 1.275 . . . . 7.4900000000000002 108.597 169.022 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.24 158.68 54.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.905 2.403 . . . . 2.8700000000000001 110.602 173.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.24 13.61 8.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.684 1.194 . . . . 4.3899999999999997 112.423 -160.525 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 160.76 5.31 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.174 1.176 . . . . 4.1100000000000003 114.174 -167.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.45 121.53 9.21 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.233 -0.917 . . . . 2.3900000000000001 110.26 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.12 20.37 55.38 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.264 -0.742 . . . . 2.5 114.209 -169.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.25 161.34 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.647 1.724 . . . . 3.3900000000000001 108.655 135.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.41 131.21 56.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.513 -2.032 . . . . 3.98 105.513 155.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.4 102.51 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.901 0.858 . . . . 2.3500000000000001 110.555 -174.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -65.3 146.79 54.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.976 -1.011 . . . . 4.75 111.248 164.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.2 tt -152.85 128.41 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.657 0.783 . . . . 2.5 110.835 178.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -84.73 106.62 16.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.192 1.797 . . . . 2.4700000000000002 111.235 173.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.6 mt -78.14 120.71 23.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.02 0.827 . . . . 2.0699999999999998 109.097 176.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.0 mt -100.85 112.66 25.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.145 0.978 . . . . 2.0699999999999998 110.486 -168.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.53 149.51 31.28 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.243 1.02 . . . . 3.3900000000000001 112.263 -174.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.72 118.95 6.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.326 1.05 . . . . 2.3500000000000001 112.106 -170.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.02 71.71 1.14 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.645 1.117 . . . . 3.6200000000000001 113.011 178.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.72 -3.72 68.01 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 117.239 1.655 . . . . 2.1899999999999999 117.239 162.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.87 130.86 34.76 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.225 2.012 . . . . 5.3600000000000003 110.081 173.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.6 136.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.306 1.042 . . . . 1.8999999999999999 109.89 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.58 115.15 13.54 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.615 1.166 . . . . 2.75 109.965 -174.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -77.05 119.37 20.67 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.662 -0.649 . . . . 4.1299999999999999 111.971 172.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.93 167.79 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.344 1.457 . . . . 2.25 110.205 163.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.67 149.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.354 1.862 . . . . 4.0899999999999999 109.195 163.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.8 mt -146.49 127.33 7.17 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.126 1.37 . . . . 2.75 109.235 -172.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 162.82 41.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.896 2.397 . . . . 0.96999999999999997 111.507 174.242 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -87.62 134.91 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.621 1.169 . . . . 2.79 111.614 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.0 164.38 13.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.092 1.757 . . . . 3.1600000000000001 107.8 157.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.02 -166.85 1.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.021 1.489 . . . . 4.3399999999999999 115.021 -171.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 115.729 1.751 . . . . 11.699999999999999 115.729 -158.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 121.144 0.497 . . . . 6.0499999999999998 111.427 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.45 167.1 32.93 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.388 1.47 . . . . 1.21 113.727 -176.234 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -162.16 167.16 24.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.75 1.22 . . . . 1.9399999999999999 113.377 -173.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -113.12 136.42 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.76 1.224 . . . . 2.25 108.868 171.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HB2' ' HH ' ' A' ' 19' ' ' TYR . 39.8 mtp180 -92.93 100.63 13.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.289 0.566 . . . . 5.0 109.493 162.28 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.4 122.55 19.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.363 -0.977 . . . . 3.9900000000000002 108.363 160.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.6 167.63 19.7 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 125.732 1.613 . . . . 3.8799999999999999 108.452 172.017 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.07 5.08 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.794 2.996 . . . . 3.04 116.637 -162.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.01 -177.17 44.46 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.207 0.912 . . . . 2.3300000000000001 113.408 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.12 -2.8 13.64 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 118.347 1.073 . . . . 2.0499999999999998 112.923 -4.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -121.7 165.66 15.45 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.617 1.567 . . . . 2.4100000000000001 112.752 173.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.06 -171.49 3.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.383 2.673 . . . . 1.8600000000000001 109.443 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.38 160.12 39.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.772 1.397 . . . . 2.3300000000000001 114.772 -173.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.4 145.77 51.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.865 1.266 . . . . 1.8899999999999999 112.328 170.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.412 ' HH ' ' HB2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -146.0 139.72 26.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.877 1.671 . . . . 3.4700000000000002 110.308 -171.928 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.06 150.38 9.51 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.983 1.846 . . . . 2.8500000000000001 115.983 -173.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.9 m -86.67 129.87 34.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.531 2.333 . . . . 2.6400000000000001 109.179 165.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.55 171.67 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.644 1.178 . . . . 5.6799999999999997 110.911 171.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -147.05 138.71 24.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.227 1.011 . . . . 2.9399999999999999 111.374 -173.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -96.36 108.43 41.89 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.767 1.227 . . . . 1.0800000000000001 109.236 168.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.58 -9.18 14.8 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.441 2.094 . . . . 1.1000000000000001 113.196 174.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.34 169.64 52.83 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.362 0.982 . . . . 1.03 114.062 -176.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.47 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 4.8 m-20 -96.46 -6.19 37.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.506 1.923 . . . . 3.0600000000000001 113.358 -175.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.52 160.9 27.69 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.682 . . . . 2.1099999999999999 110.157 168.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.57 161.5 19.36 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.192 2.595 . . . . 0.90000000000000002 112.094 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.8 mt -104.94 147.92 27.26 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.237 1.015 . . . . 3.3100000000000001 111.426 167.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -117.92 115.52 25.09 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.699 1.599 . . . . 6.5099999999999998 108.823 164.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.6 tp -95.53 115.26 27.18 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.704 1.602 . . . . 2.04 108.303 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.91 -8.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.558 0.948 . . . . 2.1000000000000001 113.558 -167.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.12 -174.03 46.2 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.992 0.806 . . . . 0.55000000000000004 111.805 175.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.07 174.84 10.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.161 -0.923 . . . . 1.97 110.188 166.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.97 148.84 19.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.867 1.212 . . . . 6.6399999999999997 110.54 169.271 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.35 160.56 54.09 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 1.6499999999999999 109.107 -159.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.75 -31.14 40.24 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.307 2.004 . . . . 1.26 113.607 167.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 2.1 m -88.11 -5.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.501 1.667 . . . . 2.21 115.501 -163.575 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.17 159.34 42.82 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.099 1.148 . . . . 1.95 114.099 -171.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.4 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 12.3 tp10 -99.18 -78.82 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.295 1.038 . . . . 3.4100000000000001 111.477 -175.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -74.37 127.62 33.47 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.97 -1.122 . . . . 3.7599999999999998 107.97 169.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.95 131.77 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.306 1.842 . . . . 2.2200000000000002 109.291 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -150.15 135.79 18.31 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.416 1.086 . . . . 2.3799999999999999 111.236 -167.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -80.11 125.04 29.31 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.653 1.115 . . . . 1.8999999999999999 110.817 169.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.6 m170 -114.96 153.9 29.74 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.171 1.788 . . . . 0.81000000000000005 112.811 178.275 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -86.66 168.68 13.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.135 2.174 . . . . 2.46 111.164 164.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.4 m -150.62 131.73 14.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.882 1.273 . . . . 2.1899999999999999 108.633 171.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -148.67 162.99 38.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.024 1.12 . . . . 3.3599999999999999 114.024 -158.445 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 mtp -114.72 119.22 35.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.427 1.891 . . . . 5.9299999999999997 108.863 162.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -148.66 156.65 42.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.538 1.135 . . . . 9.6899999999999995 111.977 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.0 145.19 42.74 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.233 1.413 . . . . 4.0499999999999998 111.903 165.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -148.75 -63.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.482 1.513 . . . . 4.8799999999999999 109.41 176.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 56' ' ' LYS . 1.2 tt0 -78.77 30.21 0.2 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.562 2.745 . . . . 5.4500000000000002 111.719 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.0 -21.21 0.29 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.167 1.365 . . . . 4.5 113.629 -162.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 54' ' ' GLU . 6.6 mtmt -113.09 168.88 9.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 128.891 2.876 . . . . 3.77 110.332 170.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -89.42 146.78 24.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.634 2.087 . . . . 4.21 116.634 -172.213 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.1 p -145.36 175.08 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 127.788 2.435 . . . . 4.5999999999999996 108.894 174.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 19.7 mtm -107.1 146.37 31.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.049 1.339 . . . . 5.0300000000000002 112.466 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.8 176.86 33.18 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 114.731 0.652 . . . . 1.3400000000000001 114.731 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 mtt -139.22 146.17 40.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.125 2.17 . . . . 3.21 109.796 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -158.34 148.49 15.54 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 125.746 1.619 . . . . 6.9199999999999999 110.237 -177.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.2 Cg_endo -69.18 154.17 70.43 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.914 1.743 . . . . 0.80000000000000004 112.359 170.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.32 158.16 65.03 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.923 1.689 . . . . 1.8 110.624 176.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.93 -19.02 35.87 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.447 2.098 . . . . 1.0800000000000001 113.129 175.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -178.79 172.18 1.38 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.676 1.591 . . . . 3.8300000000000001 111.579 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -117.28 173.38 6.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.378 1.871 . . . . 1.8600000000000001 109.634 154.144 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.49 168.76 18.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.208 0.603 . . . . 3.77 110.596 169.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -145.58 129.54 8.64 Favored Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 125.691 1.596 . . . . 1.8600000000000001 107.461 177.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.78 167.63 25.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.777 1.652 . . . . 1.1000000000000001 111.414 178.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.83 139.71 86.66 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.949 2.433 . . . . 0.93000000000000005 110.785 168.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.47 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 62.4 mmtt 65.97 1.88 2.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.78 1.632 . . . . 2.2200000000000002 113.694 -175.165 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.25 115.23 4.06 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.143 1.83 . . . . 0.84999999999999998 111.149 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.93 135.18 33.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.206 1.002 . . . . 5.9699999999999998 109.61 157.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 m -153.17 151.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.929 1.292 . . . . 2.4700000000000002 110.678 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 133.23 55.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.661 1.22 . . . . 3.7000000000000002 113.173 172.119 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.04 78.99 0.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.803 1.641 . . . . 2.0699999999999998 107.641 161.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -70.61 138.41 85.97 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.363 1.465 . . . . 3.9100000000000001 111.748 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.09 -24.27 76.21 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.153 2.569 . . . . 1.3 113.229 178.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.83 59.27 0.77 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.125 1.345 . . . . 1.23 111.668 166.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.64 -55.47 0.13 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 115.57 0.988 . . . . 1.3899999999999999 115.57 173.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -155.1 140.42 17.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.241 1.416 . . . . 3.3900000000000001 110.34 -176.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -164.31 178.35 7.58 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.094 -1.003 . . . . 0.95999999999999996 111.034 -173.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -110.21 126.39 54.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.497 0.719 . . . . 3.02 110.455 170.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 mmt -82.7 139.68 33.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.301 1.04 . . . . 2.1200000000000001 110.938 168.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.1 mt -116.91 128.93 55.71 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.091 1.756 . . . . 2.9300000000000002 108.162 175.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.05 116.42 11.2 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.884 1.274 . . . . 3.0099999999999998 110.943 -173.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.95 130.53 0.55 Allowed Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.616 -1.393 . . . . 2.7599999999999998 109.616 -167.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.0 mt -127.76 108.63 10.9 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 122.21 1.005 . . . . 2.1899999999999999 110.391 -171.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 4.0 pttm -88.38 0.31 56.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.924 1.29 . . . . 2.8700000000000001 114.378 -173.653 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -149.85 157.22 38.28 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.781 2.433 . . . . 7.1100000000000003 108.552 175.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.29 145.83 79.12 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.653 1.568 . . . . 2.6499999999999999 108.584 162.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -100.77 17.95 20.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.606 1.562 . . . . 4.3700000000000001 111.161 -175.404 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.567 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -40.84 138.1 1.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.325 2.25 . . . . 4.8600000000000003 115.048 -161.495 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 116.86 6.0 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.593 -1.317 . . . . 2.25 109.845 170.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.82 17.22 33.54 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.749 -1.029 . . . . 2.7599999999999998 113.792 -163.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.567 ' CD ' ' HZ3' ' A' ' 94' ' ' LYS . 15.6 mm-40 -81.97 175.06 10.68 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.01 1.405 . . . . 3.2599999999999998 108.366 133.257 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -125.19 131.01 53.26 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.901 -1.888 . . . . 5.0300000000000002 105.901 155.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -94.73 94.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.64 -0.874 . . . . 1.95 108.64 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.34 113.85 3.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.345 -0.942 . . . . 3.9300000000000002 108.981 153.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.75 142.44 50.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.727 1.211 . . . . 2.6800000000000002 109.542 170.221 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.64 126.83 34.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.585 2.354 . . . . 2.71 111.634 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.35 125.23 37.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.393 1.077 . . . . 2.27 110.712 167.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.58 123.45 43.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.729 1.212 . . . . 1.8899999999999999 109.721 -174.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -119.49 126.75 52.04 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.236 -0.915 . . . . 3.46 112.948 -174.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.36 -22.64 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 130.474 3.509 . . . . 3.29 117.538 173.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.53 10.18 3.03 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.035 1.779 . . . . 4.04 115.432 -173.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -165.5 -28.44 0.02 OUTLIER Glycine 0 N--CA 1.477 1.419 0 CA-C-N 119.645 1.723 . . . . 2.8300000000000001 117.225 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.02 133.98 35.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.537 1.668 . . . . 6.7699999999999996 109.331 173.331 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.07 145.93 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.831 0.852 . . . . 1.8700000000000001 109.812 168.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.77 128.35 18.09 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.937 1.695 . . . . 3.02 108.083 172.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -99.08 151.76 20.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.655 0.983 . . . . 3.8900000000000001 113.655 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.56 146.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.87 1.668 . . . . 2.3700000000000001 110.823 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.21 144.04 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.377 1.471 . . . . 4.3200000000000003 110.771 168.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.3 mt -149.87 95.54 3.66 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 3.0099999999999998 108.761 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.26 152.8 74.2 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.49 2.793 . . . . 1.27 112.809 -172.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.2 t -92.63 119.33 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.086 0.954 . . . . 2.0099999999999998 111.741 -171.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.31 132.98 35.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.033 0.933 . . . . 3.79 108.638 152.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -93.34 99.81 12.26 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.65 -1.241 . . . . 2.4900000000000002 107.65 159.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 117.933 -1.032 . . . . 8.8399999999999999 112.55 -159.862 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.557 -0.905 . . . . 4.6600000000000001 108.557 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.34 179.38 37.75 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 115.213 0.845 . . . . 1.6499999999999999 115.213 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -161.02 151.37 17.83 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.829 1.252 . . . . 1.98 113.548 176.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.8 t -110.09 145.66 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.995 0.918 . . . . 1.79 108.828 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.39 122.64 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.91 1.284 . . . . 5.6799999999999997 109.639 -175.319 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.21 174.25 10.95 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.764 1.765 . . . . 3.6200000000000001 115.764 -171.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.7 t -171.5 158.28 4.75 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 128.118 2.567 . . . . 3.8999999999999999 108.083 170.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.68 -21.16 19.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.596 2.197 . . . . 2.9700000000000002 112.07 164.491 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.62 175.72 14.12 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.754 1.645 . . . . 2.1600000000000001 113.155 178.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.91 -4.53 56.48 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 118.3 1.05 . . . . 2.8399999999999999 112.965 -9.712 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.01 150.03 40.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.863 1.265 . . . . 3.8999999999999999 112.181 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.22 -173.51 3.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.854 1.662 . . . . 1.6000000000000001 112.007 174.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.6 151.12 46.99 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.798 0.839 . . . . 2.0299999999999998 113.065 -173.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.61 150.06 39.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.478 1.111 . . . . 1.6399999999999999 112.726 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.25 153.79 41.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.062 1.745 . . . . 3.46 109.495 -175.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -177.62 157.51 1.25 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.124 1.77 . . . . 3.0099999999999998 109.957 -170.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' GLU 0.26 14.1 t -85.44 140.91 30.33 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.363 1.078 . . . . 4.9100000000000001 111.406 166.072 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.67 131.9 37.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.132 -1.803 . . . . 4.2999999999999998 106.132 162.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.55 102.15 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.542 0.737 . . . . 5.0099999999999998 110.406 -173.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.57 112.02 56.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.758 1.223 . . . . 1.0 111.347 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.7 -9.01 8.03 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.232 2.621 . . . . 1.0800000000000001 113.924 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.26 54.73 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 119.216 0.916 . . . . 1.0700000000000001 114.139 -172.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 6.5 m-20 -103.2 -0.24 30.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.204 1.802 . . . . 2.8900000000000001 112.708 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.68 161.56 29.75 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.128 1.771 . . . . 2.52 109.877 165.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.08 159.67 20.64 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.149 2.566 . . . . 0.89000000000000001 111.617 -172.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.78 145.57 33.37 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.463 1.105 . . . . 3.0800000000000001 111.012 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -129.6 109.18 10.8 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.129 1.372 . . . . 3.96 109.955 173.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.33 120.14 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.007 2.523 . . . . 1.98 108.837 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.9 -8.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.665 0.987 . . . . 1.8700000000000001 113.665 -171.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -164.59 35.12 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 118.931 0.787 . . . . 0.55000000000000004 111.967 176.192 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.72 -176.09 4.92 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.049 -0.976 . . . . 1.99 111.301 172.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -160.1 156.17 26.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.81 1.244 . . . . 7.9500000000000002 108.162 166.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.406 ' HG1' HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -157.93 155.84 27.18 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.155 1.382 . . . . 1.8700000000000001 109.152 -171.449 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.29 -39.51 9.92 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.72 1.614 . . . . 1.3200000000000001 112.316 173.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -82.0 -20.65 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.204 1.366 . . . . 2.23 114.44 -169.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.55 169.05 9.57 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.787 0.835 . . . . 1.99 111.221 169.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -91.92 -82.91 0.3 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.443 -1.688 . . . . 3.8799999999999999 106.443 161.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -74.81 163.07 28.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.756 2.022 . . . . 7.6299999999999999 112.234 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -168.71 107.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.65 1.58 . . . . 3.4700000000000002 109.306 176.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.17 130.72 55.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.042 -1.89 . . . . 5.0 110.053 -167.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.13 126.08 31.62 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.018 0.913 . . . . 1.77 112.248 -171.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.4 m170 -113.52 158.79 20.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.996 2.118 . . . . 0.73999999999999999 113.025 176.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -108.57 -178.87 3.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.525 1.93 . . . . 1.79 111.616 172.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.4 m -132.4 119.04 20.14 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.337 -1.357 . . . . 2.5299999999999998 107.337 155.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -102.83 162.64 12.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.188 1.395 . . . . 3.1299999999999999 111.727 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.2 mtt -103.74 150.22 24.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.357 1.063 . . . . 3.2999999999999998 110.502 158.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -160.15 144.81 14.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 7.0300000000000002 112.486 167.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.84 145.88 15.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.258 1.423 . . . . 4.8200000000000003 110.34 156.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.24 -80.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.339 1.455 . . . . 3.3399999999999999 107.985 172.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 56' ' ' LYS . 23.7 mt-10 -77.02 26.73 0.14 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.835 2.054 . . . . 3.8500000000000001 111.837 171.154 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.34 -33.71 0.67 Allowed Glycine 0 CA--C 1.537 1.461 0 O-C-N 120.373 -1.455 . . . . 2.6099999999999999 112.839 -158.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 54' ' ' GLU . 27.2 mtmt -63.67 145.2 56.18 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.7 1.6 . . . . 3.1099999999999999 109.673 166.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -88.87 135.31 33.6 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.844 0.313 . . . . 5.1900000000000004 111.844 -179.295 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.88 147.81 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.036 2.135 . . . . 2.8999999999999999 108.894 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.52 129.29 55.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.001 1.32 . . . . 5.4699999999999998 110.127 175.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.72 162.35 28.28 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 123.973 0.797 . . . . 1.1299999999999999 113.3 -174.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.4 mtt -106.77 158.84 16.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.903 1.281 . . . . 3.0699999999999998 111.724 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -169.95 155.43 5.55 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.553 1.541 . . . . 5.4100000000000001 110.406 173.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.9 Cg_endo -69.69 153.51 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.768 1.645 . . . . 1.1000000000000001 111.297 168.391 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.51 157.73 64.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 125.576 1.55 . . . . 1.8899999999999999 110.88 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.4 -17.23 39.32 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.772 2.315 . . . . 1.1399999999999999 112.828 179.316 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.2 p90 178.03 169.56 0.73 Allowed 'General case' 0 C--N 1.345 0.396 0 C-N-CA 126.882 2.073 . . . . 3.6099999999999999 110.266 179.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.02 165.69 13.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.085 1.354 . . . . 2.0600000000000001 109.262 156.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.98 161.85 42.04 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.304 -0.873 . . . . 2.2400000000000002 112.44 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -149.96 136.78 11.04 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.016 1.326 . . . . 2.4500000000000002 109.694 -163.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.58 170.16 17.01 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.044 2.496 . . . . 0.94999999999999996 112.597 177.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.32 142.99 99.87 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.638 2.892 . . . . 0.88 112.039 166.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 35.7 mmtm 66.52 1.32 2.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.075 1.75 . . . . 2.8399999999999999 113.948 -178.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.13 124.75 7.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 127.064 2.269 . . . . 1.02 111.579 -173.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 140.79 36.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.934 0.894 . . . . 5.4100000000000001 111.255 159.486 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.2 m -147.31 125.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.23 1.412 . . . . 2.7799999999999998 110.082 173.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.0 mp0 -83.08 131.99 35.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.03 0.932 . . . . 3.5899999999999999 112.132 -177.281 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.2 159.82 33.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.114 0.959 . . . . 2.29 109.834 162.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -167.07 145.4 4.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.714 1.206 . . . . 3.6200000000000001 112.436 -161.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 -25.54 30.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.728 2.952 . . . . 2.02 114.148 -176.332 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.23 95.08 1.19 Allowed Glycine 0 N--CA 1.467 0.765 0 N-CA-C 108.694 -1.762 . . . . 1.45 108.694 161.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.82 -148.39 18.4 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.889 1.233 . . . . 2.6000000000000001 111.748 -168.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.15 136.99 37.28 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.213 -0.581 . . . . 3.6800000000000002 111.634 -171.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.62 167.45 21.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.373 0.669 . . . . 0.84999999999999998 110.257 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.46 122.81 48.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.743 0.817 . . . . 3.1099999999999999 110.526 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -86.35 111.81 20.84 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.854 0.862 . . . . 1.78 109.557 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.7 mt -80.73 138.87 36.34 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.213 1.405 . . . . 3.1099999999999999 109.749 176.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -133.18 154.03 51.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.901 1.334 . . . . 3.0299999999999998 113.732 -176.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 -60.33 3.78 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 127.101 2.286 . . . . 2.4300000000000002 112.959 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mt 60.36 93.12 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.278 3.031 . . . . 2.3399999999999999 111.452 -166.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.99 -10.94 60.63 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.011 -1.055 . . . . 4.2300000000000004 112.81 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 -153.78 140.22 12.73 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 129.266 3.026 . . . . 9.2400000000000002 107.148 171.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.2 154.18 41.36 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.331 2.687 . . . . 3.04 110.373 175.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.03 142.99 28.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.381 1.073 . . . . 4.7999999999999998 111.556 -173.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -19.11 26.17 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.627 1.343 . . . . 4.7000000000000002 114.627 -177.558 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 83.3 136.64 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 1 C-N-CA 132.213 4.205 . . . . 3.29 109.822 -171.093 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.73 52.98 8.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.149 -0.781 . . . . 1.96 111.149 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 176.31 5.21 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.108 0.963 . . . . 3.3799999999999999 108.489 155.007 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -100.09 163.08 12.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.905 -0.776 . . . . 3.96 108.905 152.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.406 HG12 ' HG1' ' A' ' 37' ' ' THR . 53.6 t -132.5 120.15 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.236 1.414 . . . . 1.6899999999999999 109.021 175.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 147.04 32.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 3.5699999999999998 109.224 167.141 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.39 123.76 7.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.322 1.049 . . . . 4.0700000000000003 111.073 -174.64 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.81 114.06 21.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.925 2.09 . . . . 2.5600000000000001 111.231 177.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.4 mt -80.71 114.07 19.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.956 -1.09 . . . . 2.3599999999999999 109.006 176.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.23 125.58 35.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.245 0.618 . . . . 1.9399999999999999 110.116 -173.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.39 164.19 12.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.792 0.664 . . . . 3.6200000000000001 112.792 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.96 62.08 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.082 1.753 . . . . 2.5800000000000001 113.753 -173.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 141.45 -149.98 21.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.545 1.545 . . . . 3.1000000000000001 111.506 -178.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.77 37.83 1.06 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.692 1.139 . . . . 2.1000000000000001 115.696 -172.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -127.64 133.71 49.66 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.311 1.556 . . . . 5.3300000000000001 110.75 170.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.78 140.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.179 1.792 . . . . 2.1699999999999999 107.24 163.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -142.83 116.09 8.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.758 1.223 . . . . 2.29 109.742 -172.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -88.66 142.39 27.72 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.875 1.435 . . . . 3.46 114.875 -177.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.2 164.02 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.753 2.021 . . . . 2.7200000000000002 111.278 175.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.91 134.63 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.593 1.157 . . . . 3.3999999999999999 110.67 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.6 mt -141.58 145.14 36.17 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.402 1.881 . . . . 2.79 109.602 -165.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.33 159.93 15.04 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.932 3.088 . . . . 1.49 112.623 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.81 112.78 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.502 1.121 . . . . 2.0099999999999998 113.006 174.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.39 147.39 28.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.732 2.813 . . . . 3.6600000000000001 109.774 160.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.23 -171.07 3.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.588 1.329 . . . . 2.1200000000000001 114.588 -162.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.512 ' HE ' ' C ' ' A' ' 120' ' ' ARG 0.307 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 130.875 3.67 . . . . 10.16 113.901 174.787 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 122.484 1.135 . . . . 6.8600000000000003 109.522 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.95 171.95 43.6 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.177 0.894 . . . . 1.4199999999999999 113.868 174.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -160.11 156.68 27.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.121 1.368 . . . . 2.1499999999999999 112.358 -176.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.62 129.02 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.988 . . . . 2.04 110.118 175.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -82.73 112.79 19.9 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.894 -1.15 . . . . 4.8600000000000003 107.894 166.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -60.95 -45.19 95.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.768 1.766 . . . . 3.6499999999999999 115.768 -164.923 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 6.0 t 58.86 155.57 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 128.35 2.66 . . . . 3.29 113.941 -159.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.91 0.5 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.997 2.464 . . . . 1.8300000000000001 113.219 160.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.98 177.38 36.41 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.15 0.881 . . . . 1.3400000000000001 113.11 -177.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -80.36 -2.55 41.66 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 118.99 1.395 . . . . 1.8400000000000001 113.507 -3.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -138.45 165.6 26.41 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.676 1.991 . . . . 1.9299999999999999 111.648 178.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.96 -175.51 5.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.507 1.523 . . . . 1.5900000000000001 113.588 -169.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.2 149.41 33.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.818 0.847 . . . . 1.8600000000000001 112.678 -172.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.46 152.52 40.75 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.428 0.899 . . . . 2.0800000000000001 113.428 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 150.53 32.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.04 1.336 . . . . 3.7799999999999998 110.462 -170.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.38 159.32 4.6 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.707 1.603 . . . . 3.23 110.541 -175.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 m -78.24 152.73 32.41 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.399 -0.963 . . . . 2.75 108.399 155.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 134.63 38.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.793 2.037 . . . . 4.75 107.751 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.25 139.0 42.41 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.793 1.237 . . . . 5.2599999999999998 113.543 -177.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -104.44 107.83 58.83 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.796 -0.638 . . . . 1.51 109.676 149.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -92.04 -7.74 3.06 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.601 2.867 . . . . 1.51 114.04 175.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.75 178.72 41.12 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.467 1.03 . . . . 1.3500000000000001 113.322 -176.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -95.62 -0.79 51.41 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.587 . . . . 3.6099999999999999 113.376 176.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.59 160.07 31.86 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.463 1.505 . . . . 2.73 110.516 171.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.43 153.97 24.15 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.758 2.306 . . . . 0.76000000000000001 111.413 -171.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -116.26 119.31 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.746 1.218 . . . . 3.3399999999999999 110.053 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -115.13 102.55 10.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.266 1.426 . . . . 5.4400000000000004 111.342 -177.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 tp -92.08 119.91 32.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.975 2.51 . . . . 1.8400000000000001 109.196 -172.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.04 -8.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.513 1.125 . . . . 1.8300000000000001 113.459 -169.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.08 -158.93 31.76 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 124.627 1.108 . . . . 0.39000000000000001 111.391 173.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.07 -177.04 5.52 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 122.467 -0.431 . . . . 1.77 111.745 169.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -146.33 129.5 16.59 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.322 1.049 . . . . 7.4400000000000004 109.732 170.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.5 t -141.16 156.78 67.75 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 126.704 2.002 . . . . 1.4399999999999999 109.526 -173.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.51 -32.97 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.151 1.901 . . . . 1.24 113.203 170.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.289 1.4 m -75.42 -9.53 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 120.27 1.396 . . . . 1.8200000000000001 114.21 -164.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.61 147.11 52.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.165 1.786 . . . . 1.9099999999999999 109.894 175.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -50.02 -59.64 3.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.039 1.29 . . . . 5.6200000000000001 108.693 168.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -130.4 153.36 48.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.872 2.069 . . . . 4.5999999999999996 109.951 -168.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.15 127.57 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.858 1.663 . . . . 3.0600000000000001 107.091 173.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -121.38 128.02 51.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.353 1.861 . . . . 1.9399999999999999 107.41 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.05 122.3 26.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.98 0.895 . . . . 2.1499999999999999 109.806 170.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -111.45 158.49 19.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.019 1.728 . . . . 0.62 110.993 179.451 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.85 -178.59 3.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.663 1.985 . . . . 2.2400000000000002 111.656 177.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 m -140.51 113.26 8.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.911 -1.144 . . . . 2.7000000000000002 107.911 150.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -96.2 -171.34 2.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.446 1.498 . . . . 3.4900000000000002 109.811 173.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -141.55 149.14 40.42 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.568 0.747 . . . . 4.3399999999999999 110.982 163.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -134.65 141.89 46.7 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.35 1.06 . . . . 7.7599999999999998 110.309 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -75.85 116.38 16.5 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.187 0.995 . . . . 5.7999999999999998 109.552 162.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 t -88.01 -119.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 106.455 -1.683 . . . . 3.9700000000000002 106.455 169.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.552 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.03 75.68 8.01 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.541 1.064 . . . . 4.9100000000000001 108.33 163.478 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.44 -20.72 0.1 OUTLIER Glycine 0 N--CA 1.475 1.287 0 C-N-CA 129.522 3.439 . . . . 2.1800000000000002 117.004 178.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.552 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 7.2 ptpp? -68.34 122.92 19.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.595 -1.532 . . . . 5.3300000000000001 110.468 169.066 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -99.42 69.16 1.65 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.078 1.751 . . . . 6.2800000000000002 109.121 -170.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -87.26 139.59 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.924 1.69 . . . . 2.5899999999999999 110.67 -163.367 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -78.52 134.02 37.32 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.6 1.56 . . . . 4.7699999999999996 111.576 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.49 150.79 19.95 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.354 0.978 . . . . 1.4399999999999999 112.925 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -112.67 152.71 28.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.845 1.258 . . . . 2.5099999999999998 111.397 -179.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 mtp-105 -164.42 153.86 11.96 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 127.081 2.152 . . . . 4.4400000000000004 108.151 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -69.0 151.83 73.32 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.971 1.382 . . . . 0.97999999999999998 111.001 157.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.7 152.66 56.1 Favored Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.944 1.298 . . . . 1.8100000000000001 110.253 173.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.94 -9.48 25.77 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.692 2.261 . . . . 0.94999999999999996 113.355 178.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -177.91 165.5 1.99 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.643 1.577 . . . . 3.2400000000000002 110.526 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -117.27 166.17 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.664 1.586 . . . . 1.9399999999999999 109.053 151.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.97 162.34 39.6 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.498 -0.751 . . . . 2.0 112.621 167.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -143.18 129.87 10.56 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-N 114.669 -1.151 . . . . 2.79 110.187 -168.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.32 162.02 42.24 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.665 2.244 . . . . 1.3 111.374 176.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.82 145.48 96.37 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.038 3.159 . . . . 1.04 113.637 -178.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp 67.21 -5.68 0.69 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.213 2.205 . . . . 2.9100000000000001 115.196 178.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.21 123.78 7.02 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 126.613 2.054 . . . . 1.28 111.095 176.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -86.42 147.95 25.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.052 0.541 . . . . 5.5199999999999996 110.677 154.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -146.15 155.83 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.05 1.34 . . . . 2.9199999999999999 110.242 175.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.502 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -98.43 142.53 29.93 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.673 0.749 . . . . 4.5999999999999996 112.988 -178.116 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.99 65.69 1.47 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.983 1.373 . . . . 2.1499999999999999 108.422 152.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.502 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -58.36 113.92 7.63 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.522 1.529 . . . . 4.1600000000000001 109.787 169.125 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.99 -45.38 41.47 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.392 2.728 . . . . 1.3799999999999999 114.634 -161.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.94 90.88 1.56 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.79 -1.724 . . . . 1.46 108.79 161.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.35 -64.82 0.39 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.819 1.676 . . . . 1.52 111.197 -174.001 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -150.42 145.8 26.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.761 1.625 . . . . 3.6299999999999999 111.194 170.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -158.77 157.4 31.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.292 1.437 . . . . 1.0900000000000001 109.779 178.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.93 131.7 34.5 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.298 -0.631 . . . . 3.3100000000000001 109.298 164.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.3 125.58 51.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.559 1.544 . . . . 2.2400000000000002 109.027 173.191 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.58 139.12 46.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.324 1.45 . . . . 3.54 110.545 -170.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -133.79 158.25 43.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.032 0.933 . . . . 2.7200000000000002 112.842 -171.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.69 60.86 7.37 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.553 1.549 . . . . 2.1200000000000001 113.29 169.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.52 101.08 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.872 1.32 . . . . 1.9399999999999999 112.743 -164.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -83.54 -3.99 58.14 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.547 -0.751 . . . . 3.0099999999999998 113.006 -166.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -131.04 153.77 81.85 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 129.474 3.109 . . . . 8.3900000000000006 108.568 168.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.74 167.43 27.11 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.089 2.526 . . . . 1.9299999999999999 109.31 157.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.5 164.85 29.38 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.199 1.4 . . . . 3.8999999999999999 112.037 -165.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 140.22 2.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.621 1.568 . . . . 6.7400000000000002 113.185 -163.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.91 134.24 37.49 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.358 -1.464 . . . . 2.8999999999999999 112.868 173.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.93 56.31 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.734 -1.592 . . . . 1.9399999999999999 115.063 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.76 -177.94 3.48 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.339 1.57 . . . . 3.23 108.585 156.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.89 138.93 52.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.444 1.116 . . . . 3.6400000000000001 112.054 -172.086 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.3 t -90.19 107.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.366 1.466 . . . . 2.5299999999999998 108.753 -172.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.61 130.46 45.32 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 124.525 1.141 . . . . 4.0499999999999998 108.856 158.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mt -154.74 132.09 11.15 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.914 1.686 . . . . 2.6699999999999999 112.283 -177.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.11 114.45 27.97 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.71 1.604 . . . . 2.8500000000000001 110.836 169.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.83 118.2 19.2 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.029 1.331 . . . . 2.1400000000000001 109.986 175.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.78 133.65 34.59 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.861 0.864 . . . . 1.8999999999999999 110.54 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -125.19 164.36 20.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.961 0.886 . . . . 3.5299999999999998 112.41 176.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.01 156.01 9.97 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.686 -0.688 . . . . 2.5499999999999998 111.478 164.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.78 10.97 85.8 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.247 -0.751 . . . . 3.6400000000000001 114.885 -178.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.98 1.85 85.8 Favored Glycine 0 N--CA 1.473 1.163 0 CA-C-N 118.57 1.185 . . . . 2.4300000000000002 113.977 -178.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.99 130.98 44.91 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.093 -1.239 . . . . 6.8700000000000001 110.266 179.132 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.89 149.97 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.978 0.911 . . . . 2.02 110.239 170.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -146.44 129.26 16.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.681 1.192 . . . . 3.0 112.453 -174.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -63.48 134.47 55.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.669 1.188 . . . . 3.2799999999999998 112.393 172.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.2 m -138.98 146.1 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.14 1.776 . . . . 2.3199999999999998 109.568 163.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.2 123.06 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.981 0.912 . . . . 2.8300000000000001 110.509 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -139.07 146.33 48.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.992 1.317 . . . . 2.7599999999999998 110.176 -169.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.3 146.2 68.46 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.033 2.489 . . . . 1.1499999999999999 113.202 -175.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.2 t -79.37 134.78 27.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 124.524 1.13 . . . . 2.4399999999999999 108.385 161.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.58 141.91 51.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.224 1.81 . . . . 5.1799999999999997 109.21 169.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.56 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -128.34 71.7 1.4 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 122.275 1.036 . . . . 3.3599999999999999 113.788 -167.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.195 0 C-N-CA 126.544 1.938 . . . . 9.3399999999999999 109.196 169.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 110.836 -0.061 . . . . 4.6799999999999997 110.836 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.14 179.62 48.86 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.167 0.889 . . . . 1.4099999999999999 113.256 -174.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -155.09 153.42 30.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.275 1.43 . . . . 1.52 112.902 -177.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.69 122.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.463 1.105 . . . . 2.0899999999999999 110.548 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -57.36 -39.93 77.0 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.649 1.979 . . . . 6.6200000000000001 114.126 -168.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.34 151.79 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.655 1.982 . . . . 3.8900000000000001 113.528 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.28 165.99 2.01 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 119.748 -1.845 . . . . 2.2999999999999998 109.889 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.79 23.15 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.034 3.156 . . . . 2.0099999999999998 112.819 175.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.69 -176.06 54.73 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 121.312 -0.867 . . . . 1.53 111.837 -159.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.72 -11.41 18.03 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 CA-C-N 118.499 1.15 . . . . 2.2999999999999998 112.233 -12.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -134.73 154.22 51.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.372 1.069 . . . . 2.7999999999999998 112.294 168.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.58 -177.67 3.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.291 1.836 . . . . 1.45 108.31 156.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.64 173.35 11.77 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.169 0.988 . . . . 2.21 110.537 173.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.46 151.03 41.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.223 1.009 . . . . 2.0499999999999998 112.396 167.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.09 142.39 38.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.842 2.457 . . . . 3.6099999999999999 109.235 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -169.66 159.49 8.27 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.598 1.333 . . . . 3.2799999999999998 114.598 -175.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -97.96 119.57 36.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.02 1.728 . . . . 2.4700000000000002 108.379 173.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.31 142.72 41.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.018 1.327 . . . . 3.4900000000000002 109.931 176.094 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -142.35 150.0 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.196 1.398 . . . . 2.9500000000000002 110.941 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -118.48 108.22 41.88 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.831 0.852 . . . . 1.23 110.962 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -86.41 -5.39 8.32 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.77 2.313 . . . . 1.1200000000000001 114.325 175.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 -157.31 16.09 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 120.129 1.331 . . . . 2.0899999999999999 115.365 -167.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -95.12 -41.03 9.31 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.57 2.348 . . . . 6.0300000000000002 112.384 178.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.03 166.13 13.12 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.136 1.774 . . . . 2.7000000000000002 111.729 -173.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.07 167.13 25.53 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.505 2.137 . . . . 1.2 113.691 -166.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.56 148.11 26.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.773 1.229 . . . . 3.8199999999999998 109.747 165.148 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -141.81 103.53 4.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.638 1.575 . . . . 5.2000000000000002 108.141 171.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.15 104.4 16.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.867 2.467 . . . . 1.8999999999999999 108.941 -166.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.62 -12.44 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.872 1.269 . . . . 1.9099999999999999 112.924 -172.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.92 -163.6 33.25 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 123.733 0.682 . . . . 0.42999999999999999 112.349 178.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.18 178.4 9.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.005 1.322 . . . . 1.54 110.401 173.028 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.18 145.54 32.9 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.993 -1.114 . . . . 8.9800000000000004 107.993 174.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.483 ' HG1' HG13 ' A' ' 99' ' ' VAL . 3.7 t -151.37 151.6 29.36 Favored Pre-proline 0 N--CA 1.47 0.534 0 CA-C-O 118.374 -0.822 . . . . 2.0099999999999998 110.949 172.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.43 -23.41 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.725 2.95 . . . . 2.2400000000000002 114.891 160.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.28 1.3 m -95.17 5.65 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.96 1.467 . . . . 2.0 114.96 -168.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.38 163.43 32.81 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.884 1.274 . . . . 1.8700000000000001 111.946 -178.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.453 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 8.8 tp10 -100.72 -89.87 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.912 -0.773 . . . . 3.4700000000000002 108.912 164.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -76.55 114.89 15.77 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.032 -1.042 . . . . 3.8599999999999999 109.013 -179.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.76 140.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.698 1.599 . . . . 3.3100000000000001 111.161 163.467 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -144.02 122.5 12.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.274 1.43 . . . . 2.6000000000000001 109.623 166.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -80.08 119.07 22.39 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.746 1.157 . . . . 1.77 110.88 169.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -107.36 152.83 23.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.941 1.696 . . . . 0.70999999999999996 112.395 175.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.93 -178.06 3.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.41 1.484 . . . . 2.1800000000000002 110.603 167.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -146.57 130.25 17.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.887 1.275 . . . . 2.1899999999999999 107.777 174.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.78 165.4 27.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.527 1.131 . . . . 3.0800000000000001 112.655 -165.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.9 mtm -98.23 144.69 27.4 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.798 1.239 . . . . 3.04 111.56 174.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -156.59 178.93 9.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.139 1.376 . . . . 11.699999999999999 112.523 -175.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.67 158.16 17.07 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.198 1.799 . . . . 9.0 110.3 167.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.03 121.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 125.893 1.677 . . . . 5.4299999999999997 109.232 140.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 55.54 54.14 8.82 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.907 1.283 . . . . 4.75 109.78 -174.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.49 -26.23 0.17 Allowed Glycine 0 N--CA 1.476 1.322 0 C-N-CA 128.964 3.174 . . . . 3.54 116.129 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -78.18 140.38 38.96 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.793 -1.416 . . . . 5.1699999999999999 111.778 -171.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.54 122.94 17.04 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 5.3799999999999999 111.094 174.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.9 t -142.71 161.63 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.118 1.767 . . . . 3.4500000000000002 108.154 173.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.18 158.54 15.79 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.024 -1.047 . . . . 3.73 112.6 -178.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.75 159.01 24.41 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 124.944 1.259 . . . . 1.1499999999999999 112.038 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -125.88 155.87 40.55 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.9 1.68 . . . . 2.23 108.307 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -169.06 150.26 4.32 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.004 1.322 . . . . 5.6600000000000001 110.3 177.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.36 153.14 77.79 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.314 2.009 . . . . 1.23 111.264 169.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -125.14 155.96 70.29 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.454 1.502 . . . . 1.8899999999999999 110.172 171.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.05 -14.5 41.11 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.782 2.321 . . . . 1.03 112.92 176.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -179.48 162.24 1.12 Allowed 'General case' 0 C--N 1.348 0.51 0 C-N-CA 126.092 1.757 . . . . 3.6600000000000001 110.362 178.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -104.43 176.63 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.313 1.445 . . . . 1.79 109.732 153.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.29 168.95 25.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.049 -1.032 . . . . 1.96 113.76 171.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.81 136.18 10.35 Favored Pre-proline 0 N--CA 1.467 0.406 0 C-N-CA 125.395 1.478 . . . . 1.9099999999999999 108.246 -176.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.78 171.41 11.02 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 121.812 1.675 . . . . 1.28 111.251 170.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.04 142.62 75.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.741 2.294 . . . . 1.3200000000000001 110.341 163.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt 73.83 -4.96 2.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.73 2.412 . . . . 2.4900000000000002 113.261 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.07 -170.99 44.29 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 126.369 1.938 . . . . 1.4099999999999999 112.389 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -167.25 154.89 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.194 1.798 . . . . 7.3300000000000001 112.178 -178.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.62 159.3 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.202 1.801 . . . . 3.2799999999999998 110.42 177.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.49 116.7 23.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.773 -1.195 . . . . 4.4800000000000004 107.773 177.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.5 67.86 2.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.784 1.233 . . . . 1.9299999999999999 108.823 170.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -75.67 149.12 83.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.344 1.058 . . . . 4.4699999999999998 111.428 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.97 -30.31 92.95 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.741 2.294 . . . . 1.4299999999999999 113.336 176.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.33 48.68 2.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.565 1.079 . . . . 1.3500000000000001 112.453 168.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.84 -64.92 0.05 OUTLIER Glycine 0 N--CA 1.473 1.163 0 N-CA-C 115.837 1.095 . . . . 1.3600000000000001 115.837 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -156.55 146.3 20.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.353 1.861 . . . . 3.7200000000000002 109.541 -173.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -165.55 170.92 13.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.739 -1.225 . . . . 0.84999999999999998 110.438 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.04 136.3 42.11 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.916 -0.772 . . . . 3.0600000000000001 108.916 168.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -83.1 128.79 34.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.104 0.961 . . . . 1.7 110.047 156.027 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 mt -113.87 104.3 12.04 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.421 1.489 . . . . 2.6699999999999999 107.85 177.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.99 155.77 17.52 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.443 0.639 . . . . 2.7999999999999998 112.349 -176.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.79 -53.39 4.84 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.248 1.404 . . . . 2.6899999999999999 113.757 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 62.98 85.15 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.782 2.433 . . . . 2.2000000000000002 112.806 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HE3' ' OE1' ' A' ' 41' ' ' GLU . 4.3 ptpp? -73.84 -0.48 16.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.759 1.392 . . . . 2.9100000000000001 114.759 -168.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -149.44 159.37 36.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 128.766 2.827 . . . . 6.25 108.837 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.29 162.33 36.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.12 1.88 . . . . 2.2200000000000002 109.583 154.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.11 43.8 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 123.065 1.412 . . . . 4.0999999999999996 111.929 -158.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -74.42 143.82 44.57 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.101 1.76 . . . . 6.2400000000000002 113.631 -168.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.03 118.59 2.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.754 1.222 . . . . 2.8799999999999999 113.153 177.274 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.1 16.82 26.81 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 117.991 -1.45 . . . . 1.78 114.817 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.22 166.02 11.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.279 1.539 . . . . 3.8900000000000001 108.797 136.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -111.83 134.26 53.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.972 1.709 . . . . 5.4100000000000001 108.753 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.483 HG13 ' HG1' ' A' ' 37' ' ' THR . 59.2 t -84.44 113.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.639 0.776 . . . . 1.9299999999999999 110.352 -178.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -68.8 129.16 39.14 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.148 -0.933 . . . . 3.52 109.091 161.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.91 147.92 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.624 0.77 . . . . 2.71 111.269 -173.669 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -114.53 132.15 56.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.469 -1.241 . . . . 2.4700000000000002 110.342 162.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.4 mt -98.33 121.13 39.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.737 1.215 . . . . 2.25 109.021 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.2 mt -96.76 129.88 44.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.084 0.954 . . . . 2.3100000000000001 111.333 -170.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -122.34 145.76 47.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.939 0.896 . . . . 3.4300000000000002 112.179 -176.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.88 131.02 45.96 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.116 0.966 . . . . 2.48 111.826 176.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.69 -159.6 23.12 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.495 1.045 . . . . 2.9199999999999999 110.705 -164.374 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.51 26.46 6.41 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.264 0.935 . . . . 2.7599999999999998 113.783 178.518 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -99.43 129.55 45.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.015 1.408 . . . . 6.4199999999999999 111.632 -173.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.83 138.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.449 1.499 . . . . 2.3100000000000001 108.866 167.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.53 121.34 39.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.267 1.027 . . . . 3.0099999999999998 109.645 177.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -79.96 139.82 36.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.972 0.509 . . . . 3.1200000000000001 110.937 175.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m -145.1 171.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.719 2.007 . . . . 2.1699999999999999 109.893 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.87 131.14 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.376 1.071 . . . . 2.6800000000000002 109.124 176.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mp -145.75 152.64 49.09 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.917 1.287 . . . . 2.9399999999999999 111.063 -168.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.2 155.37 67.97 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.422 2.748 . . . . 1.47 114.279 -177.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.31 125.42 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.168 -0.923 . . . . 2.3199999999999998 108.681 157.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.64 138.23 35.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.415 1.486 . . . . 3.7799999999999998 109.068 170.329 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.03 134.79 55.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.941 2.2 . . . . 3.0099999999999998 116.941 -128.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.078 1 C-N-CA 132.372 4.269 . . . . 7.6399999999999997 111.243 160.688 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 111.913 0.338 . . . . 4.4400000000000004 111.913 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.1 151.64 21.88 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 121.304 -0.872 . . . . 1.3600000000000001 114.323 169.39 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -155.01 152.7 29.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.999 1.719 . . . . 1.8 111.596 -179.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.32 122.55 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.029 -1.1 . . . . 1.8799999999999999 108.029 178.793 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 89.47 8.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.825 1.25 . . . . 4.2400000000000002 108.477 171.334 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -67.09 139.25 57.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.363 1.065 . . . . 3.3900000000000001 109.027 168.092 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.6 m -138.39 158.31 70.88 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.49 . . . . 3.2200000000000002 108.026 168.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.88 27.91 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.616 3.544 . . . . 2.2799999999999998 115.113 -171.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.49 170.18 44.51 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.141 -0.974 . . . . 1.6499999999999999 113.957 178.878 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.36 -7.94 35.4 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 117.811 0.806 . . . . 1.8200000000000001 113.373 -7.038 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -130.69 161.98 30.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.216 1.806 . . . . 3.6600000000000001 111.216 -175.528 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.91 -173.88 4.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.541 1.936 . . . . 1.4099999999999999 112.038 -177.2 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.61 40.5 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.315 0.858 . . . . 1.8500000000000001 113.315 -172.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.07 146.4 27.71 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 2.1400000000000001 112.148 173.341 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.25 151.04 51.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.595 1.958 . . . . 3.7400000000000002 109.644 -173.23 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -169.4 145.35 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.336 1.236 . . . . 2.8100000000000001 114.336 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.9 m -75.68 139.97 42.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.081 1.752 . . . . 2.5600000000000001 108.977 163.19 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.0 133.51 21.96 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.139 1.376 . . . . 3.5699999999999998 108.944 174.195 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.46 156.76 46.15 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 114.225 1.195 . . . . 3.1400000000000001 114.225 -175.666 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -116.85 100.06 53.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.249 -1.342 . . . . 1.6100000000000001 110.47 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -85.02 -3.16 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.222 2.615 . . . . 1.3300000000000001 114.091 176.237 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.19 -119.78 0.81 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.797 1.189 . . . . 2.9500000000000002 114.626 -168.618 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -154.15 -41.98 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.371 1.868 . . . . 5.3899999999999997 112.021 -161.786 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -96.12 165.06 17.1 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.833 2.053 . . . . 2.4700000000000002 111.335 171.419 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.44 157.5 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.227 2.618 . . . . 0.92000000000000004 112.282 -174.277 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.37 156.71 17.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.308 1.043 . . . . 3.0600000000000001 111.33 171.195 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -146.54 101.06 3.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.104 1.361 . . . . 4.7699999999999996 112.811 177.529 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.3 tp -85.07 108.25 17.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.15 2.18 . . . . 2.0800000000000001 109.115 -176.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -99.17 -16.13 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.677 1.191 . . . . 1.8400000000000001 112.987 -173.458 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.32 42.72 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.773 0.701 . . . . 0.47999999999999998 111.717 -177.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.03 -178.95 5.5 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.308 1.043 . . . . 1.6200000000000001 110.434 169.196 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -154.31 128.56 9.05 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 106.363 -1.718 . . . . 7.4100000000000001 106.363 175.736 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -146.34 151.31 43.58 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.578 1.151 . . . . 1.97 109.295 -168.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.32 -23.11 21.07 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.412 2.074 . . . . 1.27 113.5 175.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.98 -13.16 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 115.569 1.692 . . . . 2.4900000000000002 115.569 -165.251 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.4 152.35 50.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.319 1.048 . . . . 2.0499999999999998 112.711 -165.675 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -56.45 22.01 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.59 1.087 . . . . 6.6299999999999999 109.185 171.771 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.419 ' HG2' ' H ' ' A' ' 43' ' ' VAL . 16.1 ttm180 -128.85 176.07 8.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.006 2.522 . . . . 4.8899999999999997 109.926 179.177 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.419 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 2.3 p -155.43 137.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.287 2.235 . . . . 2.0299999999999998 107.455 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -142.32 137.53 30.63 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.585 1.554 . . . . 1.8999999999999999 108.851 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.37 126.97 32.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.676 1.125 . . . . 1.9399999999999999 110.165 166.673 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.3 m170 -119.35 155.38 32.0 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.795 2.038 . . . . 0.68000000000000005 112.017 176.478 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -92.57 166.07 12.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.761 1.624 . . . . 2.4700000000000002 110.46 164.679 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.3 m -123.63 127.72 48.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 106.357 -1.719 . . . . 2.46 106.357 154.117 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -122.4 170.96 9.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.442 1.275 . . . . 3.75 114.442 -166.392 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.9 mtm -125.82 127.15 45.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.097 1.359 . . . . 3.8199999999999998 109.389 161.794 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -153.52 165.81 34.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.099 1.76 . . . . 10.359999999999999 110.416 174.303 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.466 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 3.5 mp0 -71.51 152.46 43.0 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.684 1.194 . . . . 3.4500000000000002 111.285 168.606 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.32 -86.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.599 1.16 . . . . 4.1100000000000003 109.241 176.256 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 56' ' ' LYS . 3.0 tt0 -78.44 51.31 1.03 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.681 1.992 . . . . 4.29 110.562 176.166 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -20.69 0.3 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.951 1.738 . . . . 3.02 114.683 -170.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 54' ' ' GLU . 37.3 mtmt -107.78 159.24 16.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.474 2.71 . . . . 3.7400000000000002 110.276 -176.466 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 7.9 ttmm -72.5 138.35 46.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.095 1.358 . . . . 4.1100000000000003 112.977 179.017 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -137.7 154.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.61 1.964 . . . . 2.6000000000000001 108.773 177.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 ptp -125.35 135.63 52.63 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.694 1.198 . . . . 3.5299999999999998 112.99 176.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.7 -179.74 40.59 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.609 1.099 . . . . 1.8600000000000001 113.171 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.31 166.42 11.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.812 1.245 . . . . 3.3100000000000001 113.438 -177.47 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -171.44 155.6 4.17 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 7.1799999999999997 110.576 164.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.7 Cg_exo -64.98 157.01 59.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.88 1.72 . . . . 1.03 112.146 171.583 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.81 159.12 72.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 126.013 1.725 . . . . 2.0299999999999998 110.151 176.716 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.92 -24.8 23.97 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.23 1.953 . . . . 1.4199999999999999 112.853 175.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -179.59 171.26 1.24 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.659 1.584 . . . . 3.3700000000000001 112.63 -178.37 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mt -118.89 167.61 11.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.925 2.09 . . . . 2.3300000000000001 109.573 152.266 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -154.82 156.47 36.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.563 -0.711 . . . . 2.6099999999999999 111.823 178.621 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -137.49 126.94 15.22 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 2.29 108.965 -166.576 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.9 160.43 43.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.0 1.8 . . . . 1.1899999999999999 111.402 175.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.15 140.0 86.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.617 2.878 . . . . 1.3100000000000001 111.304 176.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 71.37 -1.56 2.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.309 2.244 . . . . 3.0800000000000001 113.051 -178.218 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.04 -177.74 31.88 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 126.599 2.047 . . . . 1.75 111.414 178.811 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -161.93 156.41 22.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 6.7300000000000004 113.759 -179.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.92 161.01 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.286 1.434 . . . . 3.0699999999999998 109.413 174.538 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -123.6 135.91 54.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.444 -0.947 . . . . 5.0099999999999998 108.444 158.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.33 55.73 1.01 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.041 1.336 . . . . 1.8999999999999999 109.216 168.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -50.17 132.29 23.84 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.645 1.578 . . . . 5.2199999999999998 111.349 179.249 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.2 -36.86 97.42 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.946 3.097 . . . . 2.5499999999999998 114.983 -166.537 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.97 52.34 4.68 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-N 119.327 0.967 . . . . 1.8400000000000001 111.527 169.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.55 -145.5 5.66 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.524 2.011 . . . . 2.8399999999999999 112.024 -166.726 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -67.79 141.86 56.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.625 0.713 . . . . 3.5499999999999998 110.376 178.037 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -160.3 165.79 30.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.952 0.797 . . . . 1.0 111.003 -172.445 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -95.64 123.99 39.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.22 -0.659 . . . . 3.5800000000000001 109.22 163.406 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.52 126.06 45.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.612 1.165 . . . . 2.27 108.959 174.437 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.36 139.79 49.19 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.602 1.561 . . . . 4.0800000000000001 110.009 -172.557 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mp -132.51 166.08 22.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.606 0.762 . . . . 3.4900000000000002 112.789 -172.043 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 50.22 41.33 38.91 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 126.81 2.148 . . . . 2.1299999999999999 114.753 168.445 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.9 mt -53.17 117.51 3.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.566 1.321 . . . . 2.4100000000000001 114.566 -147.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -86.54 -3.18 58.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.547 0.943 . . . . 4.04 113.547 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -111.41 150.38 42.01 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.712 1.205 . . . . 5.5599999999999996 107.898 155.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 -10.94 23.17 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.567 2.845 . . . . 4.1299999999999999 115.15 166.394 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 10' ' ' PHE . 3.0 mp 72.39 -173.24 0.15 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.768 3.627 . . . . 3.3399999999999999 111.293 173.711 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -170.03 119.02 0.6 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.197 1.399 . . . . 4.46 110.094 -167.372 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.39 124.57 21.27 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.322 -0.861 . . . . 2.8100000000000001 109.495 166.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.21 54.79 27.67 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.699 -0.56 . . . . 2.02 111.699 -166.744 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -112.46 163.14 14.81 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 122.455 1.121 . . . . 4.1299999999999999 110.092 138.643 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -110.26 105.6 14.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.074 1.749 . . . . 4.5899999999999999 107.742 -172.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.86 112.62 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.134 0.973 . . . . 2.4500000000000002 109.412 -173.537 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.532 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 36.7 mt-10 -70.96 137.83 49.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.887 -0.597 . . . . 3.1899999999999999 110.342 159.322 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 tt -149.37 135.46 18.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.902 1.281 . . . . 2.7599999999999998 109.852 179.484 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.31 110.99 22.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.679 2.792 . . . . 2.1000000000000001 110.842 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.0 117.95 20.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.989 0.916 . . . . 2.5099999999999998 109.228 176.344 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.63 121.42 34.04 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 1.71 110.522 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -118.1 121.84 41.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 3.4300000000000002 113.053 -179.613 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.08 23.55 0.3 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.267 2.227 . . . . 2.73 116.975 168.608 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.7 10.97 80.53 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 115.947 1.139 . . . . 4.5800000000000001 115.947 174.693 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.69 -31.18 0.03 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 119.076 1.438 . . . . 2.6699999999999999 116.478 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -89.11 139.48 30.43 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.741 -1.446 . . . . 5.3399999999999999 109.398 169.541 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -141.2 140.56 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.644 1.178 . . . . 2.1099999999999999 108.203 165.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.12 122.98 15.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.101 1.36 . . . . 2.8999999999999999 108.852 -178.269 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.532 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 23.2 ptmt -83.1 140.38 32.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.323 0.86 . . . . 3.8300000000000001 113.323 -179.544 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.85 165.71 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.565 1.946 . . . . 2.2599999999999998 109.782 167.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.07 139.41 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.757 1.223 . . . . 2.8500000000000001 109.957 173.677 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 mt -138.32 130.07 15.84 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.612 1.965 . . . . 2.96 109.782 -167.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.37 144.74 37.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.601 2.2 . . . . 1.1599999999999999 111.051 176.661 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.4 t -79.95 118.59 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.862 0.839 . . . . 1.96 111.956 169.442 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 145.51 28.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.977 3.311 . . . . 3.4199999999999999 107.46 166.574 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.2 101.74 5.92 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.974 -1.079 . . . . 2.52 112.003 -161.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.262 1.025 . . . . 7.6500000000000004 112.705 -166.83 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.06 0 CA-C-O 119.581 -0.566 . . . . 10.449999999999999 113.104 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 m -169.38 -43.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.382 2.273 . . . . 8.7899999999999991 109.716 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -137.63 -165.05 1.71 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.846 2.458 . . . . 9.4900000000000002 109.485 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.6 p -73.43 95.97 2.3 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.161 -0.962 . . . . 7.5999999999999996 110.616 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.418 ' H ' ' HB ' ' A' ' 21' ' ' THR . 8.5 mt-10 -122.75 119.93 32.12 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.56 1.944 . . . . 5.6200000000000001 109.665 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.59 176.71 29.88 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.386 0.993 . . . . 1.1499999999999999 113.768 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -161.12 161.94 31.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.528 1.531 . . . . 1.9399999999999999 112.186 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.07 126.4 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.822 -0.807 . . . . 1.73 108.822 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.01 117.84 30.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.112 1.365 . . . . 5.0700000000000003 109.013 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -74.59 -171.53 1.27 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.263 1.03 . . . . 4.0599999999999996 113.637 -170.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.11 167.64 2.73 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.311 1.845 . . . . 2.1600000000000001 109.95 160.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.04 -6.91 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.123 2.548 . . . . 1.7 113.088 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.39 169.19 21.19 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.109 1.338 . . . . 1.5900000000000001 113.109 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.41 -7.68 39.15 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 118.068 0.934 . . . . 1.9399999999999999 113.542 -0.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -128.55 167.53 16.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.182 1.393 . . . . 2.02 114.173 -170.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.85 -173.1 2.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.028 2.131 . . . . 1.3400000000000001 112.585 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.24 154.43 43.82 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.611 0.967 . . . . 1.72 113.611 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.89 146.89 33.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.769 1.228 . . . . 1.49 112.958 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -140.82 157.42 45.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.404 1.482 . . . . 3.1600000000000001 112.657 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -166.41 158.44 13.73 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.949 1.463 . . . . 2.7000000000000002 114.949 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 5' ' ' GLU . 15.7 m -84.54 133.0 34.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.773 2.029 . . . . 2.3799999999999999 107.778 159.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.73 141.32 27.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.622 1.169 . . . . 3.3199999999999998 111.175 -167.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.31 153.07 23.0 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.002 0.742 . . . . 3.0699999999999998 113.002 -160.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -120.93 112.43 33.54 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.106 1.362 . . . . 1.0600000000000001 110.972 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.17 -9.06 10.67 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.858 2.372 . . . . 1.1699999999999999 113.666 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.01 168.88 52.55 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.177 0.894 . . . . 1.1499999999999999 113.665 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.0 m-20 -94.55 -4.81 47.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.13 1.772 . . . . 2.79 112.823 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.68 160.34 38.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.046 1.738 . . . . 2.1699999999999999 109.949 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.87 156.42 30.92 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.919 2.413 . . . . 0.71999999999999997 111.902 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.94 150.41 21.96 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.556 0.742 . . . . 3.1000000000000001 109.97 166.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -133.57 109.83 9.5 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.058 1.343 . . . . 3.96 109.169 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 tp -91.17 112.8 24.86 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.706 2.402 . . . . 1.8500000000000001 108.519 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.58 -11.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.198 0.999 . . . . 1.79 112.962 -169.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.65 -160.61 28.13 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 124.202 0.906 . . . . 0.56999999999999995 112.318 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.69 -178.29 6.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.5 1.12 . . . . 1.5800000000000001 110.618 164.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -155.41 135.94 13.35 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.052 -1.462 . . . . 6.3200000000000003 107.052 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -152.55 152.8 29.54 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.936 0.895 . . . . 1.5900000000000001 110.909 -163.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.45 -11.37 10.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.521 2.814 . . . . 1.0 113.707 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.324 0.8 OUTLIER -94.0 -4.01 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 114.1 1.148 . . . . 1.98 114.1 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.29 158.74 44.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.677 1.191 . . . . 1.9099999999999999 112.04 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -98.67 -60.91 1.45 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 3.2999999999999998 109.806 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -84.39 134.44 34.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.373 1.069 . . . . 3.5 109.34 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 p -147.97 136.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.649 1.979 . . . . 2.1600000000000001 108.527 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -148.62 135.98 20.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.174 1.39 . . . . 1.99 110.458 -168.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -81.21 125.51 30.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.85 1.31 . . . . 2.0899999999999999 110.875 168.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.5 m170 -119.05 157.54 27.6 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.576 2.35 . . . . 0.75 111.461 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -99.58 173.76 6.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.908 1.683 . . . . 2.02 110.272 164.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -127.99 130.25 48.06 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.961 -1.866 . . . . 1.77 105.961 157.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -111.85 163.91 13.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.74 1.216 . . . . 3.6600000000000001 113.125 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -108.46 143.87 36.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.893 -1.048 . . . . 3.6200000000000001 108.24 146.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.1 136.34 10.89 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.331 1.053 . . . . 5.8700000000000001 109.832 -175.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.43 148.25 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.146 0.578 . . . . 4.0 110.631 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.46 -87.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.118 1.367 . . . . 3.6200000000000001 109.305 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -75.41 34.75 0.11 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.902 2.081 . . . . 3.3599999999999999 111.456 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.52 -19.79 0.65 Allowed Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.272 -1.517 . . . . 1.97 113.827 -164.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -83.03 146.53 28.69 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.892 2.077 . . . . 3.1099999999999999 109.743 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -79.52 121.1 24.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.574 0.75 . . . . 4.5599999999999996 111.412 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.1 t -112.64 148.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.653 1.981 . . . . 2.7599999999999998 108.686 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.4 mtm -134.56 142.08 46.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.21 1.004 . . . . 4.2300000000000004 111.963 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.82 -177.61 44.07 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.616 1.103 . . . . 1.8300000000000001 113.078 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -107.55 159.13 16.67 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.903 1.281 . . . . 2.98 112.643 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.92 155.42 10.84 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.44 1.496 . . . . 4.4500000000000002 111.158 171.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.9 Cg_endo -67.44 149.38 80.34 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.646 1.564 . . . . 0.95999999999999996 112.033 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -114.26 158.65 39.15 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.923 1.689 . . . . 2.3599999999999999 109.565 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.62 -19.37 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.238 1.958 . . . . 1.75 112.63 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.2 p90 177.47 171.52 0.58 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.744 2.018 . . . . 3.3399999999999999 110.924 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mt -116.57 171.68 7.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.021 1.729 . . . . 2.1200000000000001 108.969 153.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -155.21 164.92 38.15 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.06 -1.025 . . . . 1.97 111.743 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.36 128.66 9.13 Favored Pre-proline 0 N--CA 1.466 0.365 0 C-N-CA 125.02 1.328 . . . . 2.0800000000000001 108.162 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.82 164.69 32.46 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.762 1.641 . . . . 1.04 111.05 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.6 137.99 83.26 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.173 2.582 . . . . 1.1200000000000001 110.971 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 62.1 mmtt 66.31 0.93 1.86 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 2.6600000000000001 113.646 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.28 -179.06 45.5 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.746 2.117 . . . . 1.45 113.65 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -155.73 147.83 23.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.397 -1.901 . . . . 5.29 111.355 -172.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.01 167.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.359 2.264 . . . . 2.4399999999999999 109.958 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.97 129.37 38.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.81 0.814 . . . . 4.2999999999999998 111.201 168.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -75.53 71.88 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.539 1.536 . . . . 1.6399999999999999 109.291 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -68.37 140.59 92.81 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.635 1.574 . . . . 3.9300000000000002 111.697 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.7 -32.33 68.49 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.023 2.482 . . . . 1.53 112.928 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.42 51.56 4.53 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.851 0.75 . . . . 1.1899999999999999 111.311 163.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.65 -136.92 4.29 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.119 1.343 . . . . 2.6200000000000001 112.974 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -73.07 144.58 47.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.838 0.855 . . . . 3.3399999999999999 112.167 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -171.04 174.22 4.77 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.322 1.049 . . . . 0.98999999999999999 109.762 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -101.62 131.82 47.62 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.107 0.563 . . . . 3.3599999999999999 110.518 166.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -90.76 141.66 28.57 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.538 0.735 . . . . 1.73 109.969 160.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.44 141.59 51.45 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.909 1.683 . . . . 2.6499999999999999 109.66 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -147.43 144.49 28.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.992 1.317 . . . . 2.7799999999999998 111.232 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.84 0.56 Allowed Glycine 0 N--CA 1.466 0.66 0 N-CA-C 109.202 -1.559 . . . . 2.3300000000000001 109.202 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.43 101.38 4.79 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.001 0.905 . . . . 1.9099999999999999 110.265 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -79.5 -4.73 52.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.32 0.859 . . . . 2.7400000000000002 113.32 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -126.39 142.51 43.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 126.715 2.006 . . . . 6.54 108.585 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.14 151.6 72.58 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.655 1.57 . . . . 1.9399999999999999 108.624 157.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.3 mt -120.86 132.0 54.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.098 0.951 . . . . 4.0 112.122 -170.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 127.71 54.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.793 1.637 . . . . 3.8500000000000001 106.968 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 151.5 11.75 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.985 -1.072 . . . . 2.4300000000000002 113.329 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.88 39.03 94.83 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.554 -0.581 . . . . 1.8100000000000001 113.747 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -116.3 -166.52 1.16 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.617 -1.253 . . . . 2.71 107.617 154.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -126.08 159.08 33.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.79 0.805 . . . . 3.5800000000000001 111.913 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.24 116.58 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 125.702 1.601 . . . . 1.8100000000000001 107.273 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.95 134.43 47.2 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.712 -1.218 . . . . 2.9199999999999999 107.712 164.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.98 129.25 15.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.192 0.997 . . . . 2.54 111.13 -168.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.4 99.77 9.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.556 1.942 . . . . 2.04 110.353 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.8 mt -72.43 116.67 13.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.281 . . . . 2.1499999999999999 109.789 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.42 131.52 35.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.457 1.103 . . . . 1.6899999999999999 111.234 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -122.73 155.56 36.22 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.044 0.938 . . . . 3.0600000000000001 112.681 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.69 121.11 12.57 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 2.1000000000000001 112.852 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.71 -156.48 28.95 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.095 1.331 . . . . 3.1000000000000001 111.415 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.73 51.58 3.77 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.103 -0.832 . . . . 2.25 114.8 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -125.05 137.79 54.21 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.518 1.659 . . . . 5.7400000000000002 111.136 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.61 136.77 19.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.294 1.838 . . . . 1.8799999999999999 106.992 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.9 mt -119.76 115.08 23.16 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.921 0.888 . . . . 2.5899999999999999 109.506 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -79.11 133.38 36.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.239 0.615 . . . . 3.4199999999999999 111.658 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.47 170.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.843 1.657 . . . . 2.3399999999999999 110.443 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.95 132.5 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.848 -1.167 . . . . 3.0499999999999998 107.848 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 mt -143.58 144.03 25.97 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.186 1.394 . . . . 2.6899999999999999 110.011 -168.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.88 152.37 57.84 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.831 3.021 . . . . 1.1299999999999999 115.12 -172.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.4 t -83.67 107.43 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.293 2.237 . . . . 2.29 109.881 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.95 136.55 36.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.541 1.936 . . . . 4.0099999999999998 108.83 160.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -105.82 135.79 46.62 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.897 0.379 . . . . 2.4100000000000001 110.319 163.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 130.49 3.516 . . . . 7.6699999999999999 106.53 -161.678 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.478 ' H1 ' ' CD ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 109.893 -1.283 . . . . 13.41 109.893 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -90.13 26.46 1.87 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.203 1.801 . . . . 14.01 113.079 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 78.59 5.91 2.44 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.012 2.125 . . . . 10.9 111.022 -146.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.5 p -87.15 85.83 7.24 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.059 2.144 . . . . 8.2100000000000009 109.876 163.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.478 ' CD ' ' H1 ' ' A' ' 1' ' ' GLY . 42.0 mm-40 -113.93 142.62 45.91 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.425 1.09 . . . . 5.25 113.252 -163.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.36 -173.95 34.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 126.389 1.947 . . . . 1.21 112.36 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.7 p90 -155.26 140.88 17.94 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.135 1.374 . . . . 1.96 110.509 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.08 136.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.333 1.053 . . . . 1.98 109.633 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -24.46 31.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.934 1.694 . . . . 4.8099999999999996 114.962 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.34 174.24 0.26 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.015 2.126 . . . . 4.8600000000000003 115.138 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 m -174.73 174.46 0.92 Allowed Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.209 3.404 . . . . 2.1600000000000001 107.737 151.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.17 -21.85 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.007 1.805 . . . . 2.3500000000000001 112.461 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.3 173.99 13.49 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.259 1.885 . . . . 1.77 111.92 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.79 -11.5 39.54 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 119.263 1.532 . . . . 2.2999999999999998 113.124 -5.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -122.26 168.74 11.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.479 . . . . 2.1299999999999999 112.914 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.56 -175.72 4.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.569 2.348 . . . . 1.3500000000000001 110.339 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.56 17.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.676 1.19 . . . . 1.5600000000000001 112.207 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 158.36 38.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 1.5600000000000001 113.424 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -147.23 154.16 40.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.007 1.723 . . . . 3.6000000000000001 110.75 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.3 160.75 6.3 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.918 1.822 . . . . 3.0 115.918 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.9 m -91.72 105.36 17.66 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.28 2.632 . . . . 2.1699999999999999 109.178 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.6 142.02 28.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.724 1.61 . . . . 4.3300000000000001 110.471 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -109.32 155.77 20.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.149 0.58 . . . . 4.6900000000000004 111.893 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -134.06 110.04 11.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.391 -0.822 . . . . 1.05 109.057 155.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.91 -7.03 3.33 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.212 2.608 . . . . 1.0 114.471 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 169.19 42.7 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.994 1.27 . . . . 1.1899999999999999 112.883 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -85.88 5.28 33.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.556 1.542 . . . . 3.9399999999999999 112.914 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.48 156.26 35.49 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.966 1.707 . . . . 3.9500000000000002 109.266 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.25 157.33 22.91 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.216 2.611 . . . . 0.93999999999999995 110.448 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.93 134.33 54.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.07 0.948 . . . . 3.5299999999999998 110.656 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 68' ' ' GLU . 5.9 ttm180 -126.54 111.06 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.701 1.201 . . . . 5.2699999999999996 110.347 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.06 136.78 32.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.279 1.832 . . . . 2.1099999999999999 108.862 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.42 -10.29 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.21 1.004 . . . . 1.8300000000000001 113.354 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.11 -164.57 35.22 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.447 1.022 . . . . 0.52000000000000002 111.968 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.64 -176.69 5.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.216 1.007 . . . . 1.73 109.626 164.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mtm-85 -142.61 147.27 35.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.877 1.217 . . . . 7.3600000000000003 108.934 163.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.46 ' HG1' HG13 ' A' ' 99' ' ' VAL . 1.4 t -142.9 154.52 62.2 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 125.07 1.348 . . . . 1.78 109.018 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -20.0 27.97 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.058 1.838 . . . . 1.1100000000000001 112.707 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.326 3.2 m -92.84 15.87 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.709 1.003 . . . . 1.8400000000000001 113.709 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.28 165.63 35.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.09 0.956 . . . . 1.9199999999999999 112.728 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.82 -71.83 0.75 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.557 1.543 . . . . 3.5099999999999998 108.004 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -79.2 103.77 9.37 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.991 -1.068 . . . . 4.2300000000000004 109.85 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.91 143.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.9 0.88 . . . . 3.21 110.124 160.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.39 117.0 10.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.823 1.249 . . . . 2.2999999999999998 109.408 168.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.77 120.47 25.19 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.825 -1.172 . . . . 1.8200000000000001 110.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -105.19 152.03 23.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.83999999999999997 112.567 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.37 172.14 10.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.721 1.609 . . . . 2.7999999999999998 110.451 161.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.8 m -151.63 111.85 4.11 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.021 1.328 . . . . 1.77 108.396 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -129.08 160.02 34.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.069 1.348 . . . . 3.0499999999999998 112.383 -161.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -97.48 143.9 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.653 0.781 . . . . 4.1200000000000001 110.197 160.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -155.19 145.35 21.8 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.475 0.71 . . . . 6.7199999999999998 110.932 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -64.42 148.51 50.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.904 1.682 . . . . 3.8199999999999998 111.034 167.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.6 t -138.94 -88.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.667 1.587 . . . . 3.3900000000000001 108.614 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.524 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 5.8 tt0 -77.81 44.97 0.48 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.197 2.199 . . . . 3.4500000000000002 110.319 170.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.69 -37.02 0.48 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 126.283 1.897 . . . . 2.21 113.65 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 43.1 mtmt -78.8 150.64 32.29 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.238 2.615 . . . . 3.1099999999999999 109.218 175.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -87.71 142.42 27.84 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.235 1.198 . . . . 4.0700000000000003 114.235 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.21 150.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.314 2.246 . . . . 2.7599999999999998 108.354 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.2 mmt -93.57 133.96 36.35 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.933 0.893 . . . . 3.8199999999999998 110.946 175.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.01 167.6 24.84 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 123.738 0.685 . . . . 0.94999999999999996 113.461 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.73 137.61 35.26 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.665 1.586 . . . . 3.1200000000000001 109.344 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -150.33 144.85 17.87 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.276 1.43 . . . . 4.5700000000000003 109.247 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.65 142.38 70.47 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.965 1.777 . . . . 0.78000000000000003 110.773 169.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.39 154.38 47.6 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 126.074 1.749 . . . . 1.8 110.606 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.96 -9.31 23.47 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.882 2.388 . . . . 1.0900000000000001 113.954 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -175.57 170.37 2.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.263 1.392 . . . . 3.7799999999999998 111.397 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 166.21 17.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.813 1.645 . . . . 1.6599999999999999 109.215 157.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.3 pt-20 -155.49 161.53 40.91 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.188 -0.945 . . . . 2.8900000000000001 113.034 174.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -148.3 142.67 16.62 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.726 1.21 . . . . 2.4900000000000002 109.517 -166.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.8 16.61 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.475 2.117 . . . . 1.1299999999999999 112.278 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.32 148.36 86.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.894 3.062 . . . . 1.1399999999999999 112.211 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 64.89 -0.27 1.05 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.602 1.561 . . . . 3.3100000000000001 113.843 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.53 111.2 3.67 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.901 1.715 . . . . 0.89000000000000001 111.398 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.45 123.42 44.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.68 1.192 . . . . 5.25 109.061 165.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.41 143.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.106 1.362 . . . . 3.1899999999999999 111.796 -165.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -88.91 144.31 26.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.202 1.001 . . . . 3.2400000000000002 111.765 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.24 73.77 2.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.402 1.081 . . . . 1.73 109.457 158.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 131.77 88.31 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.886 -1.054 . . . . 4.6399999999999997 111.111 173.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.43 -32.89 89.16 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.873 2.382 . . . . 1.51 112.893 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.18 51.77 4.41 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.229 0.919 . . . . 1.73 112.328 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.04 -56.6 0.08 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.82 1.2 . . . . 1.49 114.209 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -155.47 141.62 18.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.055 1.742 . . . . 3.4399999999999999 111.411 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -163.08 176.32 10.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.008 -1.057 . . . . 0.90000000000000002 111.233 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.46 131.07 55.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.825 0.45 . . . . 3.0099999999999998 110.949 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mmt -85.36 144.54 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.88 1.272 . . . . 1.9099999999999999 110.759 154.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -124.05 129.02 50.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.204 1.802 . . . . 2.77 108.682 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -133.64 136.57 44.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.094 0.958 . . . . 2.9500000000000002 111.624 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.36 76.04 0.79 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.675 -1.37 . . . . 2.8599999999999999 109.675 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.2 mt -78.15 135.25 37.62 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.176 -1.046 . . . . 1.8799999999999999 108.176 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -80.51 -0.32 36.97 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.968 -1.082 . . . . 3.6699999999999999 112.264 -169.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -174.21 160.13 2.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.601 2.36 . . . . 7.96 110.156 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.62 146.73 55.64 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.48 2.12 . . . . 3.3599999999999999 110.092 163.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -112.93 168.53 9.62 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.551 1.54 . . . . 3.6899999999999999 111.874 -172.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.39 137.48 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.658 1.183 . . . . 4.1900000000000004 111.862 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.86 129.47 41.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.785 -1.197 . . . . 2.96 110.437 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 52.11 3.66 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 112.174 -0.37 . . . . 2.3399999999999999 112.174 -165.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -129.02 165.02 21.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.955 1.702 . . . . 3.73 107.616 161.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.64 155.56 16.93 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.993 1.317 . . . . 5.5300000000000002 111.003 168.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.46 HG13 ' HG1' ' A' ' 37' ' ' THR . 11.8 t -130.06 124.06 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 126.113 1.765 . . . . 2.1200000000000001 108.567 169.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.62 125.69 29.53 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.079 -0.712 . . . . 3.9300000000000002 109.079 161.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mt -126.67 125.42 41.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.991 0.916 . . . . 2.8500000000000001 111.81 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -105.06 94.7 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.78 1.232 . . . . 2.54 110.568 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.5 mt -65.67 123.36 19.51 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 2.52 110.446 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.8 mt -97.43 131.37 44.14 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.31 1.444 . . . . 1.98 110.342 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -125.67 167.09 15.61 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.683 1.23 . . . . 3.6800000000000002 111.566 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.76 166.47 10.92 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.993 -1.003 . . . . 3.0099999999999998 111.432 168.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.4 15.44 80.3 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.802 0.681 . . . . 4.29 114.802 173.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.62 6.16 89.33 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 118.427 1.113 . . . . 1.8500000000000001 113.767 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -79.29 138.38 37.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.903 1.352 . . . . 7.3399999999999999 112.376 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.15 148.94 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.19 1.796 . . . . 2.6499999999999999 108.105 158.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.0 mt -124.15 125.28 44.2 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.573 1.549 . . . . 3.25 108.4 172.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -87.68 133.31 33.85 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.761 0.824 . . . . 3.0099999999999998 111.651 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.29 127.45 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.835 1.254 . . . . 2.6899999999999999 113.23 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.88 135.48 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.8 1.24 . . . . 2.6099999999999999 111.56 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.9 mt -143.78 160.68 49.47 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 128.041 2.536 . . . . 3.04 111.079 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -84.92 157.17 11.62 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.085 3.19 . . . . 1.0900000000000001 114.624 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -94.32 124.1 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.33 2.252 . . . . 2.04 110.576 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.34 156.09 18.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.983 1.313 . . . . 3.25 109.044 156.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.83 81.51 4.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.366 -0.976 . . . . 3.3999999999999999 108.366 161.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 115.761 -2.066 . . . . 7.1399999999999997 115.486 -158.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.029 0 N-CA-C 107.154 -2.378 . . . . 13.029999999999999 107.154 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 t -84.7 -134.77 0.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 117.609 -1.636 . . . . 10.93 107.461 128.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 76.74 -3.36 2.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.939 1.295 . . . . 10.92 114.226 155.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.5 p -74.3 85.15 1.93 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.582 1.553 . . . . 7.4000000000000004 110.028 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -93.98 108.4 20.21 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.929 1.692 . . . . 6.3200000000000003 111.292 -163.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.55 167.45 30.9 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.608 1.099 . . . . 1.25 114.476 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -152.22 143.13 23.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.781 1.232 . . . . 1.71 111.999 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.06 118.16 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 122.963 0.505 . . . . 2.1499999999999999 109.676 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -85.72 96.45 9.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.293 1.037 . . . . 5.5 110.405 -169.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.71 154.53 3.73 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.666 2.386 . . . . 3.3900000000000001 112.884 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.83 149.08 20.26 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 118.463 -0.78 . . . . 3.3999999999999999 109.668 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 56.68 5.6 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.415 2.743 . . . . 2.1600000000000001 109.281 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.79 -164.38 46.15 Favored Glycine 0 CA--C 1.541 1.677 0 O-C-N 121.482 -0.761 . . . . 2.1600000000000001 112.582 -168.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.54 -11.73 20.11 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 117.681 0.74 . . . . 2.9399999999999999 111.331 -28.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -146.82 168.09 22.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.751 2.021 . . . . 2.1800000000000002 109.976 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 -177.34 6.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.535 1.534 . . . . 2.02 111.819 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.81 156.69 43.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 1.98 111.99 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.1 143.21 36.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.118 0.967 . . . . 1.8200000000000001 112.111 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -136.66 141.4 43.16 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.389 1.876 . . . . 3.46 109.58 -172.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -165.22 147.33 7.81 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.331 1.975 . . . . 3.21 116.331 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 m -99.54 129.77 45.73 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.569 1.548 . . . . 2.7000000000000002 108.786 169.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tp -130.69 162.95 28.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 5.2199999999999998 110.734 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.28 141.82 51.86 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.092 1.357 . . . . 3.1600000000000001 111.214 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -100.28 110.91 61.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.512 -0.921 . . . . 1.25 108.512 157.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.87 -15.37 3.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.364 2.709 . . . . 1.3 113.769 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.75 -176.27 51.37 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.045 0.838 . . . . 1.3700000000000001 113.23 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -105.33 12.97 31.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.707 1.603 . . . . 4.0700000000000003 111.437 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mt -113.8 156.37 43.83 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 126.957 2.103 . . . . 3.9399999999999999 109.132 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.72 158.33 24.8 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.991 2.461 . . . . 0.97999999999999998 109.926 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.3 130.56 42.93 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.56 1.144 . . . . 3.6699999999999999 109.73 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -117.26 115.61 25.62 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.864 1.266 . . . . 5.0899999999999999 110.422 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -94.63 117.14 29.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.537 2.335 . . . . 2.0 108.68 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.77 -10.88 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.729 1.011 . . . . 1.77 113.729 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.25 -163.17 31.66 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.664 -0.648 . . . . 0.40000000000000002 112.344 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.97 12.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.731 0.813 . . . . 1.5800000000000001 111.189 167.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -144.85 133.31 21.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.921 1.688 . . . . 8.0 108.058 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -148.9 149.74 30.96 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.421 1.489 . . . . 1.78 110.335 -166.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.1 -37.93 4.31 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.337 2.024 . . . . 1.22 112.157 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.273 2.6 m -84.79 3.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.907 1.447 . . . . 2.0299999999999998 114.907 -169.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.31 137.08 45.82 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.356 -1.465 . . . . 1.71 112.23 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -76.11 -70.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.319 -1.363 . . . . 5.2300000000000004 107.319 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -84.92 143.32 29.08 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.266 2.226 . . . . 3.8999999999999999 109.37 169.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.75 131.81 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.359 1.864 . . . . 2.1600000000000001 107.932 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -142.94 128.68 19.3 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.234 1.414 . . . . 2.2400000000000002 109.493 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.87 121.42 24.82 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.367 1.079 . . . . 1.76 110.454 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -112.36 158.38 19.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.019 2.128 . . . . 0.70999999999999996 112.035 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.86 179.39 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.912 1.685 . . . . 2.02 110.909 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 m -135.22 106.23 6.65 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.195 1.398 . . . . 2.0600000000000001 107.274 163.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -107.0 152.06 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.706 1.202 . . . . 3.3599999999999999 111.225 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -84.77 145.33 27.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.527 0.679 . . . . 4.1600000000000001 110.27 166.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -148.14 160.17 43.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.558 1.543 . . . . 6.3200000000000003 110.333 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -84.57 148.12 26.65 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.528 0.731 . . . . 6.7000000000000002 109.393 164.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.95 -87.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.55 -1.648 . . . . 3.2200000000000002 106.55 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -77.68 43.96 0.43 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.999 2.52 . . . . 3.7999999999999998 110.809 170.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.9 -29.63 0.29 Allowed Glycine 0 N--CA 1.482 1.751 0 O-C-N 119.999 -1.688 . . . . 2.5 115.117 -171.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -69.71 132.22 45.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.828 2.051 . . . . 4.5499999999999998 109.853 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -83.46 102.18 11.9 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.904 -1.147 . . . . 6.3899999999999997 107.904 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.11 155.26 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.516 1.926 . . . . 3.8999999999999999 110.823 -167.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.0 mtm -75.22 153.22 38.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.622 0.971 . . . . 5.4699999999999998 113.622 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.64 160.7 28.28 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.446 1.974 . . . . 1.1599999999999999 110.567 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -123.01 148.31 45.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.897 1.279 . . . . 2.5099999999999998 110.322 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -171.68 157.85 4.49 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 117.165 -1.398 . . . . 4.9900000000000002 111.223 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.4 Cg_endo -69.75 157.35 60.71 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.026 1.817 . . . . 0.78000000000000003 112.605 168.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.03 158.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 126.029 1.732 . . . . 1.8300000000000001 110.613 171.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.4 -11.67 24.75 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.918 2.412 . . . . 0.93999999999999995 113.577 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -179.05 162.24 1.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.307 1.843 . . . . 3.6899999999999999 110.192 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.99 172.85 6.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.471 1.909 . . . . 2.02 108.756 156.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.04 170.17 23.14 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.837 -1.164 . . . . 2.5299999999999998 113.389 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.05 135.28 11.87 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 125.288 1.435 . . . . 1.78 109.465 -167.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.05 168.32 24.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.15 1.9 . . . . 1.01 110.688 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.58 148.59 92.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.082 2.521 . . . . 1.1000000000000001 111.95 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 68.39 -3.38 1.33 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.94 2.096 . . . . 2.7000000000000002 114.48 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.29 117.93 5.18 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 126.204 1.859 . . . . 1.05 112.184 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 127.96 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.54 -0.83 . . . . 7.2000000000000002 110.264 159.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.05 165.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.568 1.547 . . . . 2.1000000000000001 110.608 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.08 114.03 8.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.885 0.874 . . . . 3.9199999999999999 112.099 -163.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.25 67.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.848 2.059 . . . . 1.8899999999999999 109.379 165.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.44 143.56 98.73 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.996 1.719 . . . . 4.21 111.83 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.1 -61.17 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.172 3.248 . . . . 1.3600000000000001 112.668 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 102.32 2.05 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.802 -1.719 . . . . 1.53 108.802 162.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.99 -69.83 0.3 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.822 1.677 . . . . 1.22 112.662 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -155.71 139.19 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.946 1.699 . . . . 3.3700000000000001 109.495 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -167.1 172.36 10.12 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.135 -0.978 . . . . 1.0900000000000001 109.598 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -103.66 141.5 35.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.415 0.552 . . . . 3.6400000000000001 110.225 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.7 mmt -89.17 139.29 30.63 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.858 0.863 . . . . 1.8999999999999999 110.077 159.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -122.0 130.33 53.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.53 1.932 . . . . 3.0800000000000001 109.24 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -136.65 159.45 41.78 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.636 0.774 . . . . 2.98 112.241 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.32 -57.08 3.28 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 126.54 2.019 . . . . 2.7999999999999998 113.672 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.1 mt 76.64 91.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 130.423 3.489 . . . . 2.1699999999999999 111.847 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -74.54 4.37 6.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.627 1.343 . . . . 3.2400000000000002 114.627 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -144.67 152.84 53.7 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 128.713 2.805 . . . . 7.4199999999999999 108.063 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.21 150.64 81.76 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.242 1.961 . . . . 2.6299999999999999 109.516 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.54 134.22 44.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.413 1.485 . . . . 3.9199999999999999 110.141 -170.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.41 101.49 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.029 0.919 . . . . 5.0 109.37 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.64 130.73 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.211 -0.931 . . . . 3.46 111.176 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.09 50.7 2.97 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.057 -0.519 . . . . 2.0800000000000001 112.923 -167.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -137.17 -167.28 2.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.077 1.351 . . . . 2.9399999999999999 109.899 159.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -130.55 153.44 48.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.4 1.08 . . . . 3.3799999999999999 108.742 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.8 115.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.606 1.162 . . . . 2.3700000000000001 108.686 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -63.69 122.99 17.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.701 -1.591 . . . . 3.5899999999999999 109.327 160.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -129.72 116.52 18.91 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.711 0.767 . . . . 2.7599999999999998 110.917 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.32 96.47 9.04 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.833 1.653 . . . . 2.27 108.77 165.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.8 126.76 31.53 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.238 -0.914 . . . . 2.5899999999999999 109.091 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.35 136.86 37.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.929 1.292 . . . . 1.9199999999999999 111.056 -168.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -132.94 148.49 52.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.296 1.046 . . . . 3.9500000000000002 113.014 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.55 163.85 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.067 -0.97 . . . . 2.96 111.971 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.08 76.44 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.791 -0.568 . . . . 4.6600000000000001 113.575 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.01 63.71 3.2 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.553 1.073 . . . . 1.97 111.069 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -144.35 166.03 26.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.872 1.32 . . . . 4.6299999999999999 112.755 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -170.78 147.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 128.234 2.614 . . . . 3.0099999999999998 108.239 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.0 mt -134.62 118.72 17.51 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.052 1.341 . . . . 3.5299999999999998 108.703 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -86.19 125.08 33.28 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.353 -0.842 . . . . 3.3900000000000001 110.673 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.16 133.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.272 1.029 . . . . 2.7799999999999998 108.691 166.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.92 136.96 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.849 -1.167 . . . . 2.9100000000000001 107.849 168.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -142.6 136.39 14.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.321 1.448 . . . . 3.1200000000000001 109.001 -170.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.09 154.05 75.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.323 3.349 . . . . 1.0800000000000001 114.034 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.4 t -79.76 125.94 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 122.797 0.439 . . . . 1.96 110.309 170.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.45 141.77 28.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.485 1.914 . . . . 3.3799999999999999 108.125 162.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.53 22.46 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.629 2.085 . . . . 2.79 116.629 -161.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.272 2.3 tmt_? . . . . . 0 N--CA 1.481 1.079 1 C-N-CA 132.063 4.145 . . . . 9.25 113.789 171.737 . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 109.159 -1.577 . . . . 12.9 109.159 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 173.67 -160.9 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 130.4 3.48 . . . . 9.3900000000000006 106.576 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -95.85 -171.18 2.28 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.803 1.183 . . . . 10.66 109.934 162.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.6 p -92.77 86.55 5.56 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.784 -1.197 . . . . 7.5099999999999998 110.042 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.66 103.11 8.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.758 -1.11 . . . . 5.2999999999999998 109.409 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.94 175.79 22.42 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 119.08 0.855 . . . . 1.26 115.127 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 p90 -155.75 162.67 40.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.962 1.705 . . . . 2.5699999999999998 111.296 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.1 t -131.16 117.73 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.758 -0.589 . . . . 1.8500000000000001 109.655 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.47 95.6 8.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.003 0.921 . . . . 6.5099999999999998 109.914 -171.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.93 145.88 55.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.867 1.667 . . . . 3.5800000000000001 112.709 -176.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.0 t -142.61 148.01 44.89 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.482 1.513 . . . . 3.9900000000000002 107.747 162.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.59 48.31 1.57 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.599 3.533 . . . . 1.74 112.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.55 -173.11 55.16 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 121.346 -0.846 . . . . 1.75 112.419 -168.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.28 -21.45 8.91 Favored 'Cis proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.139 -1.192 . . . . 1.6499999999999999 110.761 -24.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -121.84 165.72 15.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.813 2.045 . . . . 1.9199999999999999 111.81 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.33 -179.15 7.81 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.23 2.212 . . . . 1.99 110.356 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.08 155.36 48.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.726 1.148 . . . . 1.72 113.443 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.48 45.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.466 1.106 . . . . 1.73 113.19 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -156.11 157.94 36.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.013 1.325 . . . . 3.71 112.133 -158.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 178.93 149.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.15 1.537 . . . . 2.8599999999999999 115.15 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.2 m -85.0 135.08 34.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.347 1.859 . . . . 2.4399999999999999 108.838 160.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 tp -136.29 153.16 51.26 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.841 1.257 . . . . 5.0499999999999998 109.693 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.56 134.17 28.46 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.601 -0.687 . . . . 4.3099999999999996 111.047 166.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.73 114.38 47.63 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.453 1.501 . . . . 1.0 110.444 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.69 -15.35 10.91 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.778 2.318 . . . . 1.1699999999999999 113.875 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.62 166.01 54.8 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 122.509 1.061 . . . . 1.1100000000000001 113.611 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -77.72 -17.63 57.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.173 2.189 . . . . 4.7699999999999996 112.281 162.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.01 156.02 60.71 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.479 1.512 . . . . 4.0099999999999998 111.752 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.6 155.26 9.03 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.014 3.143 . . . . 1.72 110.73 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.67 145.74 50.03 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.592 1.557 . . . . 3.2599999999999998 110.432 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -142.45 108.97 5.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.619 1.167 . . . . 5.7400000000000002 111.719 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -94.37 114.73 26.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.098 2.159 . . . . 1.8700000000000001 109.629 -169.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 m -106.29 -11.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.109 1.364 . . . . 2.23 113.724 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.76 -167.61 39.52 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 121.604 -0.685 . . . . 0.71999999999999997 111.749 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.26 152.13 30.83 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.38 1.072 . . . . 1.9099999999999999 110.598 166.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.427 HH22 ' CD ' ' A' ' 100' ' ' GLU . 13.4 ttp85 -110.96 131.25 55.2 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.65 -1.611 . . . . 9.4399999999999995 106.65 -174.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.535 ' HG1' HG13 ' A' ' 99' ' ' VAL . 2.4 t -139.35 149.56 60.97 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.593 1.157 . . . . 1.4299999999999999 109.243 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.52 -21.19 19.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.988 2.459 . . . . 1.0 113.069 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.333 2.5 m -90.93 9.64 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 114.607 1.336 . . . . 1.97 114.607 -176.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.3 167.71 27.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.98 0.912 . . . . 1.8200000000000001 112.792 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -107.4 -77.15 0.6 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.654 1.582 . . . . 3.5499999999999998 109.068 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -75.53 105.24 6.45 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.799 -1.188 . . . . 4.2300000000000004 109.74 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 p -79.56 143.16 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.13 0.972 . . . . 2.9399999999999999 110.456 158.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -136.29 134.19 37.73 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.53 1.532 . . . . 2.1699999999999999 108.48 161.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -86.43 124.79 33.15 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.628 1.558 . . . . 1.95 110.882 167.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -116.15 164.72 14.07 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.842 2.057 . . . . 0.71999999999999997 112.43 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -114.63 -174.57 2.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.115 1.766 . . . . 1.96 111.606 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.1 m -138.25 114.5 10.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.161 -1.422 . . . . 2.3399999999999999 107.161 155.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -90.8 160.01 15.99 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.315 1.046 . . . . 2.9900000000000002 111.593 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.4 mtm -92.08 148.48 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.319 0.648 . . . . 2.9399999999999999 110.089 154.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -158.96 120.81 3.45 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.486 1.514 . . . . 6.6600000000000001 108.008 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.45 152.27 18.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.143 0.577 . . . . 4.8399999999999999 110.74 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.8 t -144.25 116.77 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.145 0.978 . . . . 4.04 108.637 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 61.84 17.92 9.29 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.483 1.513 . . . . 4.6600000000000001 111.785 -168.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.22 74.19 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.9 1.238 . . . . 2.8900000000000001 113.972 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -77.46 137.14 38.5 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.889 1.345 . . . . 3.8199999999999998 108.972 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.97 137.62 58.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.599 -0.715 . . . . 5.5300000000000002 111.807 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 160.21 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.966 0.506 . . . . 2.9900000000000002 110.418 164.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.1 mtm -133.81 156.31 48.25 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.528 1.531 . . . . 3.3300000000000001 110.233 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.37 163.49 33.46 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 123.376 0.512 . . . . 0.96999999999999997 112.914 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -103.59 166.97 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.753 1.221 . . . . 2.3900000000000001 111.096 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -176.51 154.17 1.27 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 126.442 1.897 . . . . 4.3600000000000003 110.34 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -70.98 153.72 63.22 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.123 1.882 . . . . 0.73999999999999999 111.685 167.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.31 156.22 53.08 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 126.208 1.803 . . . . 1.99 110.602 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.08 -20.6 37.8 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.829 2.353 . . . . 0.81000000000000005 112.461 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -176.39 169.5 2.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.914 2.085 . . . . 3.3999999999999999 110.755 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.63 170.53 8.03 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.343 1.457 . . . . 2.0499999999999998 109.598 154.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -139.21 166.81 23.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.189 0.519 . . . . 2.5299999999999998 110.86 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.59 120.62 5.19 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.15 1.38 . . . . 2.48 107.734 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.87 164.74 32.87 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.677 1.584 . . . . 1.28 110.864 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.19 138.46 72.32 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.38 2.72 . . . . 1.0 111.368 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 67.0 -0.37 1.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.563 1.545 . . . . 2.9900000000000002 113.415 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 117.37 4.5 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 127.382 2.42 . . . . 1.3100000000000001 112.071 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -79.77 133.12 36.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.75 -1.225 . . . . 6.8600000000000003 110.923 163.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.85 166.2 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.175 2.19 . . . . 3.5600000000000001 110.088 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.15 110.38 2.31 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.699 0.799 . . . . 4.3099999999999996 109.424 -168.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.09 75.64 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.131 1.372 . . . . 1.9399999999999999 108.004 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -69.34 153.23 96.06 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 127.894 2.478 . . . . 3.52 113.555 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.39 -41.92 24.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.655 2.904 . . . . 2.96 114.092 -162.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.33 128.28 9.52 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.984 -2.046 . . . . 2.2400000000000002 107.984 152.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.08 -143.42 14.85 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.072 1.32 . . . . 2.9199999999999999 111.393 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -73.21 138.7 45.78 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.848 -0.795 . . . . 3.3599999999999999 111.537 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -161.28 158.3 26.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.454 1.102 . . . . 1.02 109.433 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -87.59 135.2 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.973 -0.751 . . . . 3.5699999999999998 108.973 160.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.55 120.34 41.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.549 1.54 . . . . 2.3599999999999999 108.077 168.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.63 142.68 35.89 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.272 1.029 . . . . 4.4199999999999999 110.467 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.35 135.74 24.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.745 1.618 . . . . 3.0600000000000001 111.543 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.07 81.84 0.58 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.714 -0.954 . . . . 2.6600000000000001 110.714 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.16 100.79 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.921 0.867 . . . . 2.0299999999999998 110.459 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -86.75 10.5 15.65 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.534 1.309 . . . . 2.98 114.534 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -145.14 166.29 18.53 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 127.349 2.259 . . . . 5.8899999999999997 109.128 167.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.19 -176.73 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.851 1.7 . . . . 2.8199999999999998 110.278 151.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -176.5 59.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.797 2.439 . . . . 3.71 107.781 -163.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.91 151.25 30.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 7.1299999999999999 113.031 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.38 120.22 8.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.56 -1.2 . . . . 2.3500000000000001 108.455 156.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.23 17.46 46.57 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.107 -1.385 . . . . 1.9299999999999999 114.808 -170.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.84 167.25 10.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.733 1.766 . . . . 3.2799999999999998 107.779 151.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -116.22 147.49 41.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.823 0.849 . . . . 3.4900000000000002 109.163 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.535 HG13 ' HG1' ' A' ' 37' ' ' THR . 22.0 t -106.79 116.86 51.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.18 1.792 . . . . 1.8999999999999999 108.665 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.427 ' CD ' HH22 ' A' ' 36' ' ' ARG . 26.1 tt0 -65.36 129.37 39.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.174 -1.047 . . . . 3.1400000000000001 108.174 156.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.39 126.56 42.66 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.595 0.758 . . . . 3.1400000000000001 110.898 168.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.95 94.13 5.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.215 1.806 . . . . 2.7000000000000002 109.912 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.39 118.6 8.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.275 1.43 . . . . 2.1499999999999999 110.568 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.2 mt -92.41 127.7 38.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.322 1.449 . . . . 2.1899999999999999 110.821 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.12 133.79 50.33 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.815 1.293 . . . . 3.8500000000000001 113.76 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.06 53.59 2.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.965 1.706 . . . . 3.1699999999999999 112.383 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -151.5 26.49 0.96 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.682 2.087 . . . . 5.0700000000000003 113.557 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.98 50.59 45.64 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 124.132 0.873 . . . . 2.4199999999999999 111.368 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -149.73 160.56 43.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.035 1.734 . . . . 4.21 112.832 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -162.81 130.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 129.149 2.98 . . . . 2.3799999999999999 108.51 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.95 121.01 36.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 3.8300000000000001 109.35 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.18 134.56 34.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.901 1.074 . . . . 3.6200000000000001 113.901 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.62 163.67 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.375 1.47 . . . . 3.0299999999999998 109.42 164.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.09 134.88 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.975 -1.491 . . . . 2.8100000000000001 106.975 164.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.8 mt -135.62 148.0 63.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 126.239 1.815 . . . . 3.1600000000000001 108.594 -172.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.87 163.32 33.97 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.511 2.808 . . . . 1.47 111.904 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -102.27 118.75 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.781 0.832 . . . . 1.98 110.802 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -95.36 140.63 29.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.841 2.456 . . . . 4.96 109.189 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.56 -176.66 5.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.456 -1.403 . . . . 3.0499999999999998 111.53 164.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 126.566 1.946 . . . . 12.359999999999999 116.108 -170.767 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.434 0 N-CA-C 109.234 -1.547 . . . . 12.210000000000001 109.234 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 p -68.96 -171.22 0.29 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.465 1.132 . . . . 11.42 109.694 139.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -69.14 -28.4 66.41 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.634 -1.291 . . . . 14.65 113.622 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.6 p -166.03 -60.47 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.417 2.287 . . . . 8.0299999999999994 111.451 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.479 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 13.3 tt0 -132.01 -167.49 1.89 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.894 1.678 . . . . 6.3300000000000001 111.377 -152.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.479 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -93.97 169.92 30.01 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 125.253 1.406 . . . . 1.78 116.354 -174.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -155.05 133.91 12.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.668 1.587 . . . . 2.1000000000000001 111.264 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.97 122.94 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.784 -1.191 . . . . 2.2200000000000002 107.784 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -103.8 87.33 2.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.693 0.797 . . . . 5.3300000000000001 110.127 -161.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.58 144.05 38.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.909 2.083 . . . . 3.3700000000000001 111.389 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -138.32 153.36 72.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.513 1.125 . . . . 3.1299999999999999 109.6 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -65.71 -9.59 23.38 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.977 2.452 . . . . 1.8600000000000001 113.195 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.71 177.83 18.44 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.463 1.03 . . . . 1.6899999999999999 113.836 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 -7.77 32.89 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 117.68 0.74 . . . . 1.6000000000000001 113.105 -4.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -128.47 160.61 31.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.335 1.054 . . . . 4.4400000000000004 112.559 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.98 -174.21 4.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.775 1.63 . . . . 1.3200000000000001 111.916 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.22 154.62 49.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.888 0.875 . . . . 1.8899999999999999 112.978 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.15 146.27 50.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.083 0.953 . . . . 1.95 112.257 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -143.87 156.52 44.49 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.356 1.863 . . . . 3.5699999999999998 110.703 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -168.46 160.21 10.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.346 1.058 . . . . 2.9700000000000002 113.748 -176.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.4 m -81.9 147.8 29.1 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.048 1.339 . . . . 2.96 108.558 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -155.2 131.65 10.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.157 0.983 . . . . 3.52 111.507 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -113.32 145.16 41.53 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.654 1.981 . . . . 3.7200000000000002 112.003 173.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -95.14 97.31 2.53 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 114.372 -1.285 . . . . 1.25 109.652 155.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.46 -8.22 18.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.25 1.967 . . . . 1.1799999999999999 112.939 173.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.17 176.49 50.35 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 124.401 1.001 . . . . 1.1100000000000001 113.606 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 4.8 m-20 -100.37 -5.42 27.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.737 2.015 . . . . 2.7000000000000002 113.0 -174.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 160.33 44.02 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.84 2.056 . . . . 2.4500000000000002 109.7 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 158.73 31.05 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.859 2.372 . . . . 0.81999999999999995 112.877 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.19 146.63 28.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.72 1.208 . . . . 2.8300000000000001 110.197 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -131.82 112.38 12.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.934 1.294 . . . . 4.2800000000000002 109.844 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -97.91 115.6 28.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.017 2.527 . . . . 1.9199999999999999 108.751 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.92 -9.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.448 1.099 . . . . 1.74 113.116 -166.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.87 -168.86 41.02 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.535 1.064 . . . . 0.44 111.841 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.89 -178.62 6.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.894 1.278 . . . . 1.5900000000000001 110.848 172.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.471 HH21 ' CG ' ' A' ' 102' ' ' ASP . 7.0 ttp85 -151.34 139.97 20.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.372 -2.455 . . . . 8.9900000000000002 104.372 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.446 ' HG1' ' CG1' ' A' ' 99' ' ' VAL . 1.7 t -147.37 155.4 46.08 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.055 -1.091 . . . . 1.7 108.055 173.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.39 -29.93 24.81 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.486 2.124 . . . . 0.93000000000000005 113.19 171.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -85.36 -19.98 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.188 1.181 . . . . 2.1299999999999999 114.188 -169.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.84 159.03 22.05 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.21 1.004 . . . . 1.8300000000000001 112.909 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HA ' ' HZ1' ' A' ' 90' ' ' LYS . 11.0 tp10 -98.11 -91.96 0.26 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.183 0.993 . . . . 3.04 111.202 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -78.66 110.49 13.84 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 121.079 -1.013 . . . . 4.7800000000000002 108.736 -172.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -79.61 142.31 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 124.565 1.146 . . . . 3.29 111.253 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -142.05 128.49 20.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.211 1.004 . . . . 2.8199999999999998 109.75 164.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -80.41 116.46 20.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.299 1.047 . . . . 1.8700000000000001 110.476 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -107.96 155.13 20.66 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.509 1.524 . . . . 0.83999999999999997 111.876 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.67 -171.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.142 1.777 . . . . 2.1800000000000002 110.432 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -146.45 114.09 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.888 -1.132 . . . . 2.0699999999999998 108.206 163.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -103.33 174.1 6.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.282 1.433 . . . . 3.02 111.989 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -118.16 154.41 32.21 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.267 1.427 . . . . 3.3900000000000001 110.823 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -155.87 164.35 38.62 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.732 1.613 . . . . 7.1900000000000004 111.731 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.518 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 2.5 tp10 -85.74 142.63 28.86 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.529 0.732 . . . . 4.1600000000000001 110.513 162.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.34 -96.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.988 -0.745 . . . . 3.5499999999999998 108.988 163.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -76.68 37.41 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.972 2.109 . . . . 3.7200000000000002 111.919 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.25 0.44 4.49 Favored Glycine 0 CA--C 1.542 1.738 0 O-C-N 120.388 -1.445 . . . . 2.1400000000000001 113.463 -159.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -95.47 141.32 29.15 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.241 2.616 . . . . 3.8700000000000001 110.17 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 3.0 mmpt? -73.03 136.88 45.09 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.565 -0.743 . . . . 5.9900000000000002 109.821 -175.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -139.78 143.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.647 1.179 . . . . 2.52 109.5 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -114.56 145.66 41.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.753 1.221 . . . . 3.3599999999999999 111.28 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.36 168.87 34.26 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 123.794 0.711 . . . . 1.0700000000000001 113.547 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -103.17 161.1 14.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.93 1.292 . . . . 2.6899999999999999 112.416 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -167.14 154.45 8.39 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.289 1.835 . . . . 4.6500000000000004 110.071 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.01 150.03 72.3 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.685 2.257 . . . . 1.29 111.458 167.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.11 158.43 41.01 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.955 1.702 . . . . 2.0299999999999998 110.459 169.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.84 -16.9 41.93 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.659 2.24 . . . . 1.0600000000000001 112.937 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 177.49 163.43 0.56 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.951 2.1 . . . . 3.0899999999999999 109.756 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mt -105.22 170.82 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.312 1.445 . . . . 1.9199999999999999 109.638 155.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.15 158.06 39.82 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.189 -0.944 . . . . 2.4399999999999999 111.813 170.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.45 128.31 13.73 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.461 1.504 . . . . 2.0099999999999998 108.863 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.01 162.67 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.532 2.155 . . . . 0.92000000000000004 111.522 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.04 139.47 87.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.704 2.936 . . . . 0.91000000000000003 112.639 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 68.8 mmtt 69.13 2.83 3.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.158 2.183 . . . . 2.5800000000000001 114.301 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.42 144.13 16.97 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 126.989 2.233 . . . . 1.1899999999999999 109.645 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -117.24 150.65 38.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.978 1.311 . . . . 4.6500000000000004 112.714 166.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.65 168.26 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.324 1.85 . . . . 2.6299999999999999 110.677 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -135.07 132.88 38.71 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.199 -1.408 . . . . 4.5099999999999998 107.199 162.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.59 77.39 1.99 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.156 1.455 . . . . 1.98 111.356 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -64.25 123.78 83.55 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 117.575 -1.202 . . . . 5.4000000000000004 111.452 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -47.87 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.844 3.696 . . . . 1.71 114.606 -171.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 56.86 4.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.566 1.079 . . . . 1.3500000000000001 111.991 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.86 -53.86 0.05 OUTLIER Glycine 0 N--CA 1.466 0.635 0 C-N-CA 126.097 1.808 . . . . 1.53 112.781 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -152.93 140.45 19.76 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.925 2.09 . . . . 3.6800000000000002 111.223 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -166.58 172.35 10.8 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.857 -1.152 . . . . 0.93000000000000005 111.784 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -105.05 126.69 52.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.012 0.925 . . . . 3.0899999999999999 111.032 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.5 mmt -86.65 137.56 32.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.794 1.238 . . . . 1.8300000000000001 111.42 167.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.7 mt -115.35 88.77 2.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.791 1.636 . . . . 2.8999999999999999 109.261 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -86.92 101.6 13.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.555 1.542 . . . . 3.1800000000000002 110.599 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.5 133.03 4.83 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.347 0.975 . . . . 3.0699999999999998 110.779 -173.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.0 mt -112.98 112.55 24.08 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.374 1.087 . . . . 2.1200000000000001 109.439 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.505 ' HZ1' ' HA ' ' A' ' 41' ' ' GLU . 2.3 pttm -90.54 -9.57 46.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.198 1.184 . . . . 2.98 114.198 -172.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.7 mmt-85 -146.45 150.91 42.18 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.567 1.547 . . . . 9.7699999999999996 109.389 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.1 174.72 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.393 2.729 . . . . 2.7400000000000002 111.432 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -176.42 158.08 1.77 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.346 1.858 . . . . 3.8300000000000001 109.355 -160.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.33 178.17 7.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.025 1.73 . . . . 4.3899999999999997 112.219 174.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.4 133.99 15.53 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.925 1.29 . . . . 2.7599999999999998 112.939 165.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.93 -0.3 89.5 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.301 -1.277 . . . . 2.1600000000000001 115.268 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -77.83 167.41 21.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.863 1.331 . . . . 3.9199999999999999 111.861 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.14 152.96 20.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.306 -1.315 . . . . 3.79 110.525 162.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.446 ' CG1' ' HG1' ' A' ' 37' ' ' THR . 20.8 t -139.84 126.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 126.148 1.779 . . . . 2.2799999999999998 109.049 173.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.31 142.35 57.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.599 -0.519 . . . . 3.6000000000000001 109.599 164.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -141.05 127.37 19.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.52 1.152 . . . . 2.8999999999999999 111.987 157.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' CG ' HH21 ' A' ' 36' ' ' ARG . 1.5 m-20 -98.94 114.63 27.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.614 1.965 . . . . 2.2000000000000002 109.935 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.54 125.7 29.92 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.546 -0.721 . . . . 3.77 109.816 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt -98.1 128.66 44.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.089 0.956 . . . . 1.6699999999999999 109.879 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.28 156.78 31.77 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.015 0.926 . . . . 3.2799999999999998 112.024 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.81 143.34 57.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.953 0.501 . . . . 2.1400000000000001 111.039 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -168.27 53.53 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.0 -0.84 . . . . 2.9399999999999999 111.0 -164.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.45 40.59 2.21 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.806 -0.82 . . . . 2.5600000000000001 114.379 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -115.84 122.0 44.07 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.047 1.423 . . . . 5.6200000000000001 112.529 -173.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.45 135.49 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.424 1.49 . . . . 2.29 108.466 161.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.5 mt -129.81 128.58 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.587 1.155 . . . . 2.5099999999999998 109.204 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -88.34 134.8 33.72 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.87 0.868 . . . . 3.2999999999999998 112.656 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.32 167.37 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.801 0.84 . . . . 2.4900000000000002 110.514 153.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.74 141.51 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.853 -1.536 . . . . 3.04 106.853 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.2 mt -137.44 151.97 72.22 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.632 1.573 . . . . 3.0800000000000001 110.133 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.71 155.5 44.34 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.627 2.885 . . . . 1.1699999999999999 112.036 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.79 123.34 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.083 0.953 . . . . 1.96 110.823 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.6 149.19 22.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.828 1.651 . . . . 3.4399999999999999 109.233 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.0 23.09 11.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 113.927 1.084 . . . . 2.21 113.927 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.384 1.473 . . . . 8.1199999999999992 112.662 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 CA-C-O 117.686 -1.619 . . . . 10.77 109.518 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m 62.87 60.56 1.24 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.524 1.162 . . . . 11.4 111.275 -164.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.301 9.1 m-85 67.08 169.37 0.25 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.939 1.696 . . . . 11.35 112.05 -154.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.61 159.42 1.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.443 -0.799 . . . . 7.4199999999999999 111.251 -136.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -170.56 -167.26 0.58 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.168 2.587 . . . . 5.0300000000000002 109.362 -170.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.75 157.48 27.42 Favored Glycine 0 N--CA 1.469 0.854 0 O-C-N 120.707 -1.246 . . . . 1.51 115.095 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -136.06 144.63 45.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.904 1.281 . . . . 1.96 111.966 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.8 t -102.28 136.86 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.718 -1.216 . . . . 2.04 107.718 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -104.17 106.62 17.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.156 0.982 . . . . 4.5 110.187 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.36 147.86 29.72 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.085 1.754 . . . . 3.8900000000000001 112.401 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -150.95 158.86 34.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.707 1.603 . . . . 2.4100000000000001 109.805 162.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.43 -15.33 31.11 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.161 2.574 . . . . 1.6699999999999999 113.497 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.4 170.24 14.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.529 1.062 . . . . 1.73 113.0 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.06 -5.56 15.82 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 118.215 1.008 . . . . 2.1600000000000001 113.025 -3.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -122.69 170.06 10.43 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.243 1.817 . . . . 2.2200000000000002 113.997 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.52 -177.21 5.47 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.138 2.175 . . . . 2.02 111.319 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.36 154.25 51.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.159 0.89 . . . . 1.79 112.19 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.53 157.16 43.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.029 0.918 . . . . 1.6399999999999999 112.806 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -149.62 161.85 41.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.46 1.504 . . . . 3.3599999999999999 110.356 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -162.5 159.26 24.72 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 112.854 0.687 . . . . 2.6200000000000001 112.854 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.0 m -83.5 119.65 24.95 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.403 -1.332 . . . . 2.1200000000000001 107.403 150.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.83 134.52 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 3.29 107.452 166.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -128.39 121.77 29.85 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.957 0.903 . . . . 3.6299999999999999 110.125 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -95.49 111.94 57.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.308 1.043 . . . . 1.2 109.974 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -86.44 -12.22 5.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.263 2.642 . . . . 0.98999999999999999 113.711 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.36 160.57 42.15 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.108 0.861 . . . . 1.3 112.488 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.475 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.1 m-20 -90.62 6.78 42.41 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.029 1.732 . . . . 2.9399999999999999 113.616 -174.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.75 157.97 53.16 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.01 1.724 . . . . 2.2599999999999998 110.595 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.99 160.52 30.29 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.229 2.619 . . . . 0.83999999999999997 111.935 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -124.5 124.41 42.22 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.718 1.207 . . . . 3.2799999999999998 111.547 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -118.75 112.0 19.2 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.217 1.407 . . . . 4.7400000000000002 112.791 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.3 tp -100.03 110.23 22.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.897 2.479 . . . . 2.1000000000000001 109.951 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -98.12 -11.94 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.859 1.664 . . . . 2.02 112.954 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.5 -159.82 30.79 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 119.097 0.862 . . . . 0.54000000000000004 113.556 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.45 -171.13 3.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.866 1.267 . . . . 1.8300000000000001 111.164 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -166.43 124.46 1.42 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.674 -1.232 . . . . 6.3700000000000001 107.674 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -138.35 162.08 55.5 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.989 1.316 . . . . 1.7 109.494 -167.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.2 -22.71 3.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.636 2.891 . . . . 0.95999999999999996 113.989 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 2.6 m -86.93 -0.77 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 114.393 1.257 . . . . 2.0800000000000001 114.393 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.7 168.19 27.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.089 2.156 . . . . 2.4199999999999999 109.867 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -106.28 -79.22 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.539 1.063 . . . . 3.79 110.737 171.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -75.27 105.31 6.23 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 120.917 -1.115 . . . . 4.2699999999999996 110.082 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.6 137.69 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.094 1.358 . . . . 2.3100000000000001 111.262 171.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -132.17 129.49 39.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.239 1.816 . . . . 2.0099999999999998 109.137 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.79 117.15 22.48 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.538 1.161 . . . . 1.8200000000000001 110.953 168.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -105.01 152.63 22.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.197 1.799 . . . . 0.64000000000000001 112.032 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.66 172.7 8.09 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.613 1.165 . . . . 1.9399999999999999 110.228 161.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.501 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 53.0 m -149.05 102.32 3.24 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.392 1.477 . . . . 2.0899999999999999 107.487 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -105.6 162.92 13.08 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.174 1.79 . . . . 3.7999999999999998 112.49 -164.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -102.91 151.1 22.84 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.948 -0.569 . . . . 3.46 110.777 151.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -158.97 145.06 16.69 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.754 1.622 . . . . 5.7699999999999996 109.873 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.31 146.86 23.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.258 0.551 . . . . 4.3300000000000001 111.287 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.24 135.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.384 1.874 . . . . 4.21 109.309 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 60.13 20.14 9.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.386 1.075 . . . . 4.2199999999999998 112.185 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.96 -3.81 68.89 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.894 1.235 . . . . 2.3900000000000001 113.959 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -99.44 146.24 26.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.156 1.782 . . . . 4.0700000000000003 110.407 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -77.2 131.03 38.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.834 -0.541 . . . . 4.8600000000000003 110.53 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -128.6 153.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.909 1.684 . . . . 2.8799999999999999 108.841 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.4 mtm -121.03 146.68 46.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.916 . . . . 3.5800000000000001 110.816 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.58 -177.24 31.48 Favored Glycine 0 N--CA 1.468 0.829 0 C-N-CA 124.346 0.974 . . . . 0.97999999999999998 113.081 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.11 162.0 34.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.24 1.416 . . . . 3.1499999999999999 110.655 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -171.45 151.85 3.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.147 1.379 . . . . 4.2400000000000002 111.45 172.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.54 146.69 85.46 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.494 2.129 . . . . 1.0600000000000001 111.803 166.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.49 155.79 51.77 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.922 1.689 . . . . 1.6000000000000001 110.237 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.31 -18.62 44.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.674 2.25 . . . . 0.82999999999999996 112.637 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -179.1 167.22 1.58 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 126.676 1.99 . . . . 3.6899999999999999 110.903 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.69 168.28 9.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.069 1.348 . . . . 1.9199999999999999 109.468 154.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -151.96 161.99 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.822 0.675 . . . . 2.77 112.822 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.29 134.78 24.43 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.952 1.701 . . . . 2.0299999999999998 108.564 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.71 164.05 32.82 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.062 1.841 . . . . 0.94999999999999996 111.289 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.39 147.52 93.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.094 2.529 . . . . 0.96999999999999997 111.663 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 16.2 mmmt 68.12 -0.61 2.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.325 1.85 . . . . 2.29 113.508 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.69 127.58 9.04 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 127.679 2.561 . . . . 1.0 111.646 -170.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -98.22 134.61 41.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.974 1.31 . . . . 6.9299999999999997 112.465 163.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.35 136.29 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.043 . . . . 2.2599999999999998 111.202 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.84 115.68 31.06 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.555 1.542 . . . . 3.3799999999999999 110.352 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -68.15 77.02 0.24 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.746 2.019 . . . . 1.8799999999999999 109.95 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -74.05 138.11 75.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.293 1.437 . . . . 4.3899999999999997 111.773 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.49 -43.33 59.18 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.08 3.187 . . . . 1.3 112.757 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.29 89.71 1.11 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.243 -1.543 . . . . 1.27 109.243 161.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.501 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.53 -76.2 0.26 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.909 1.719 . . . . 1.25 113.589 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -154.74 142.4 19.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.437 1.895 . . . . 3.2799999999999998 111.163 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -162.06 167.95 23.49 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.409 -0.807 . . . . 1.0800000000000001 111.692 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.37 127.95 46.55 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.665 0.786 . . . . 3.0499999999999998 110.186 168.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.8 mmt -91.44 132.8 35.98 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.15 0.98 . . . . 1.8799999999999999 110.068 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.7 147.47 35.51 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.612 1.165 . . . . 4.0 110.609 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mt -146.43 160.81 41.59 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.135 2.174 . . . . 3.1699999999999999 110.175 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.46 57.61 11.06 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-O 118.917 -0.935 . . . . 2.54 111.152 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 mt -66.98 100.13 0.71 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.382 1.091 . . . . 1.99 112.054 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -71.12 -15.08 62.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.452 0.908 . . . . 2.6299999999999999 113.452 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -128.42 147.0 62.05 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.986 2.114 . . . . 6.7599999999999998 110.95 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.01 145.15 35.17 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.246 1.964 . . . . 1.8999999999999999 108.938 149.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 163.88 35.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.424 1.89 . . . . 3.46 111.334 -168.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.01 168.16 19.57 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 118.94 2.941 . . . . 8.0399999999999991 118.94 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.37 133.94 23.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.412 1.885 . . . . 2.6800000000000002 112.406 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 2.34 88.45 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.988 -1.451 . . . . 2.2799999999999998 114.727 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.69 159.84 23.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.788 1.794 . . . . 3.0299999999999998 111.333 170.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -108.66 128.18 54.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.492 1.917 . . . . 3.6299999999999999 109.13 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.41 103.72 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.574 1.15 . . . . 2.1800000000000002 109.545 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -63.25 126.94 29.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.579 -0.897 . . . . 2.9700000000000002 108.579 157.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.9 144.92 27.19 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.248 -0.907 . . . . 2.71 110.501 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -94.03 138.64 31.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.487 2.715 . . . . 3.5899999999999999 110.156 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.8 mt -110.77 125.46 53.57 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.397 2.279 . . . . 2.1299999999999999 109.908 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.2 mt -98.59 124.15 43.2 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.883 0.873 . . . . 1.98 111.633 -170.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.76 141.82 49.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.242 1.201 . . . . 3.2400000000000002 114.242 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.65 88.68 0.71 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.879 1.272 . . . . 2.8599999999999999 111.145 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.74 67.57 0.12 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.051 1.31 . . . . 4.0199999999999996 113.165 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.3 17.41 72.26 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 116.59 1.396 . . . . 1.6399999999999999 116.59 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.04 114.22 20.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.038 1.419 . . . . 4.3099999999999996 112.005 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.37 136.59 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.835 2.454 . . . . 3.71 105.863 146.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.4 mt -144.92 119.63 9.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.198 0.999 . . . . 2.8900000000000001 109.569 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -90.27 146.6 24.1 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.007 1.114 . . . . 5.5099999999999998 114.007 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.6 m -135.17 152.18 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.352 1.861 . . . . 2.0899999999999999 110.034 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.3 p -106.56 132.36 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.132 0.973 . . . . 2.3799999999999999 109.553 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.9 mt -135.07 134.95 22.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.428 1.491 . . . . 2.6800000000000002 110.239 -171.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.62 151.28 79.55 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.984 2.456 . . . . 1.03 113.5 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.99 119.75 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.886 1.275 . . . . 1.78 110.873 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -90.32 149.37 22.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.872 2.069 . . . . 3.5499999999999998 108.892 156.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.25 4.66 4.06 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 116.222 1.934 . . . . 3.0699999999999998 116.222 -155.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.784 1.634 . . . . 8.4499999999999993 112.542 -168.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.27 0 N-CA-C 107.77 -2.132 . . . . 16.399999999999999 107.77 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 m -155.72 166.99 31.84 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.68 1.24 . . . . 12.81 110.182 -164.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -174.41 144.0 0.88 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.106 2.162 . . . . 13.279999999999999 108.64 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.9 m -94.53 -45.58 7.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.536 0.734 . . . . 8.5700000000000003 111.437 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -170.84 -137.27 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.251 2.22 . . . . 5.9000000000000004 107.559 -162.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.42 137.11 9.21 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 120.961 1.71 . . . . 1.8799999999999999 114.202 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -128.1 127.07 42.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.473 1.13 . . . . 2.23 111.957 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.74 95.21 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.81 -1.552 . . . . 2.79 106.81 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.42 105.82 9.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.575 1.178 . . . . 4.0999999999999996 110.238 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -74.03 159.81 32.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.631 1.572 . . . . 3.6499999999999999 112.55 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.416 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 75.6 m -149.71 159.25 36.45 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.29 1.836 . . . . 3.2400000000000002 110.691 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.47 -2.86 12.4 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.369 2.712 . . . . 1.98 114.879 -171.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 167.61 27.95 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.33 0.967 . . . . 1.3300000000000001 112.83 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.82 -2.65 18.35 Favored 'Cis proline' 0 CA--C 1.541 0.833 0 CA-C-N 118.579 1.19 . . . . 1.97 112.91 -4.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.39 169.84 13.81 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.047 1.739 . . . . 2.2599999999999998 113.791 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.22 171.81 18.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.377 2.271 . . . . 1.7 111.586 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.96 120.45 31.62 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.761 0.824 . . . . 1.6000000000000001 110.668 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.02 32.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.567 0.747 . . . . 1.8899999999999999 111.83 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.88 162.92 31.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.395 1.478 . . . . 3.3100000000000001 111.137 -174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.07 143.6 3.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 115.635 1.717 . . . . 2.7799999999999998 115.635 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -69.96 87.88 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.205 -1.035 . . . . 1.95 108.205 160.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 tt -75.27 143.55 42.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.928 -0.768 . . . . 3.7599999999999998 108.928 169.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -125.98 143.45 51.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.52 0.676 . . . . 3.27 112.044 170.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.67 100.9 13.54 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.99 -1.005 . . . . 1.01 109.193 161.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.96 -7.77 15.44 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.587 2.192 . . . . 1.29 112.624 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.56 179.73 51.46 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.802 1.192 . . . . 1.24 113.486 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.428 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.0 m-20 -106.98 -3.18 20.4 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.272 1.829 . . . . 3.04 113.044 -171.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.02 162.67 28.35 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.367 1.867 . . . . 2.3100000000000001 109.682 167.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.34 154.29 21.53 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.832 2.355 . . . . 1.21 112.672 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.0 mt -104.05 126.88 51.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.016 0.926 . . . . 3.02 110.832 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.57 109.02 20.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.03 -0.986 . . . . 3.9199999999999999 110.304 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.2 tp -95.14 120.58 35.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.736 2.014 . . . . 2.0600000000000001 108.598 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.01 -14.72 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.684 0.794 . . . . 1.8899999999999999 112.453 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.49 -167.95 40.13 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 121.789 0.661 . . . . 0.40000000000000002 113.139 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.52 176.9 8.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 1.5900000000000001 109.393 159.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -157.43 145.41 19.03 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 106.425 -1.694 . . . . 7.6399999999999997 106.425 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -149.13 155.27 40.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.359 1.064 . . . . 1.74 108.149 -164.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.04 -26.78 36.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.857 2.371 . . . . 1.3999999999999999 112.749 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -78.16 -12.24 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 114.415 1.265 . . . . 2.1899999999999999 114.415 -171.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.06 156.23 46.68 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.897 1.279 . . . . 1.73 111.818 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -102.54 -62.87 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.014 0.526 . . . . 3.5699999999999998 110.753 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -79.16 146.57 33.06 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.768 -0.827 . . . . 4.8899999999999997 108.768 165.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.79 133.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.748 1.619 . . . . 2.6400000000000001 108.329 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -140.89 129.27 22.45 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.711 1.604 . . . . 2.1400000000000001 109.351 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.22 123.01 29.66 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.995 1.271 . . . . 1.8999999999999999 110.648 167.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -111.33 159.96 17.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.177 1.791 . . . . 0.58999999999999997 112.256 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -116.51 179.19 4.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.188 2.195 . . . . 2.1200000000000001 111.034 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -131.22 133.14 45.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.707 1.603 . . . . 2.5499999999999998 107.713 166.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -125.7 150.92 47.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.349 1.059 . . . . 3.0299999999999998 111.94 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.2 ptp -84.74 153.7 22.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.715 1.606 . . . . 5.5099999999999998 110.433 167.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -153.79 34.54 0.44 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.061 1.504 . . . . 7.0099999999999998 115.061 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -56.74 146.78 24.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.647 1.579 . . . . 5.25 113.268 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -156.4 136.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.622 2.369 . . . . 7.2699999999999996 105.416 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 60.89 23.43 13.48 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.813 0.816 . . . . 6.9299999999999997 111.68 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.72 0.35 24.84 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 119.916 -1.74 . . . . 4.7400000000000002 114.862 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -86.42 132.88 33.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.507 1.923 . . . . 4.1600000000000001 108.836 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.74 142.86 29.76 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.401 1.26 . . . . 8.3100000000000005 114.401 -166.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -155.37 138.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.443 1.897 . . . . 3.0800000000000001 108.618 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 ptp -141.21 138.92 33.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.46 0.704 . . . . 4.0300000000000002 111.126 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.52 175.74 20.79 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 124.623 1.106 . . . . 1.1399999999999999 112.451 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.5 mtt -128.45 156.79 42.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.787 1.635 . . . . 2.8799999999999999 110.78 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -167.93 154.79 7.6 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 125.149 1.379 . . . . 4.3399999999999999 111.441 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.3 Cg_endo -70.23 151.2 66.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.011 1.807 . . . . 0.71999999999999997 112.221 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.0 156.78 54.17 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.748 2.019 . . . . 1.76 110.614 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.49 -16.0 27.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.954 2.436 . . . . 0.83999999999999997 113.113 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.4 p90 179.14 170.72 0.93 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.027 2.131 . . . . 3.98 110.321 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.0 174.69 7.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.679 2.392 . . . . 1.8999999999999999 108.933 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -152.8 164.42 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.028 -1.045 . . . . 2.27 112.535 164.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 t -138.86 128.83 14.67 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.524 1.53 . . . . 2.0499999999999998 109.58 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.58 163.41 39.07 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.506 2.137 . . . . 1.28 111.69 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.9 138.18 84.18 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.503 2.802 . . . . 1.22 112.055 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.428 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 65.0 mmtt 68.92 2.64 3.63 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.966 2.106 . . . . 2.27 113.708 -175.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.11 114.1 3.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 125.85 1.691 . . . . 1.3100000000000001 111.269 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -93.18 125.81 37.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.391 1.077 . . . . 8.9600000000000009 109.32 162.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.5 m -145.44 130.18 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.219 1.008 . . . . 2.54 111.296 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.85 132.93 34.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.197 0.999 . . . . 6.9299999999999997 111.248 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.27 60.34 3.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.018 1.866 . . . . 2.1899999999999999 111.979 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -47.94 133.91 11.56 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 128.038 2.535 . . . . 4.5099999999999998 113.27 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.2 -51.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.325 2.684 . . . . 1.78 111.99 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.65 94.98 1.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.264 -1.535 . . . . 1.5700000000000001 109.264 166.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -76.96 0.29 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.993 1.758 . . . . 1.3400000000000001 113.008 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -158.03 130.55 7.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.6 1.56 . . . . 3.4100000000000001 111.299 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -162.13 173.3 14.51 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.938 1.699 . . . . 0.89000000000000001 111.977 -166.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.95 120.5 41.6 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.742 -0.599 . . . . 3.48 112.078 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 mmt -84.75 121.49 27.76 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.233 1.013 . . . . 1.8100000000000001 109.854 164.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -106.02 131.14 53.66 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.223 1.409 . . . . 2.71 108.496 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -140.07 142.37 36.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.791 0.836 . . . . 2.8799999999999999 111.133 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 60.45 4.37 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 109.042 -1.623 . . . . 2.4199999999999999 109.042 -166.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -65.66 127.57 32.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.32 1.06 . . . . 1.9399999999999999 108.998 172.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -106.3 12.64 29.71 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 2.6099999999999999 112.89 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -162.33 153.21 14.69 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.811 1.644 . . . . 7.0300000000000002 110.919 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.94 163.45 39.17 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.921 2.414 . . . . 2.5899999999999999 109.378 159.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mp -133.93 162.77 31.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.104 0.954 . . . . 4.4900000000000002 112.139 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -119.36 120.01 35.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.888 2.075 . . . . 6.8099999999999996 110.478 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.06 118.29 4.52 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.85 -1.156 . . . . 2.8999999999999999 109.79 168.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.94 48.09 22.25 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.719 -0.489 . . . . 2.2999999999999998 112.761 -167.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.28 -168.33 1.32 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 107.53 -1.285 . . . . 2.7599999999999998 107.53 140.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -128.85 155.53 45.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 4.3899999999999997 111.639 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.08 118.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.685 1.594 . . . . 2.5099999999999998 108.938 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.42 138.9 39.54 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.524 0.729 . . . . 3.46 110.021 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.3 143.02 19.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.873 1.269 . . . . 2.9300000000000002 110.912 -168.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -89.82 110.36 21.29 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 128.995 2.918 . . . . 3.0299999999999998 110.323 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.43 113.08 21.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.426 1.012 . . . . 2.8100000000000001 109.372 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.2 mt -93.6 123.47 36.94 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.043 0.937 . . . . 1.8 110.772 -166.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -124.58 137.64 54.38 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.427 -0.796 . . . . 3.5499999999999998 112.571 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.98 130.89 30.74 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.614 1.166 . . . . 2.1499999999999999 113.164 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.5 -150.17 20.59 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.367 -1.093 . . . . 3.48 110.367 -163.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.29 28.02 9.56 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.402 1.001 . . . . 2.21 114.715 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mppt? -100.38 135.38 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.722 1.761 . . . . 5.9699999999999998 112.084 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.88 138.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.763 1.225 . . . . 2.2799999999999998 109.454 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -116.41 104.87 11.89 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.837 0.855 . . . . 2.46 109.319 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.22 114.03 17.83 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 4.7699999999999996 109.36 174.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.09 150.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.093 1.357 . . . . 4.1299999999999999 112.546 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.75 142.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.051 1.74 . . . . 2.79 111.904 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -142.5 146.1 37.4 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.086 1.755 . . . . 4.0899999999999999 110.55 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.8 152.53 69.14 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.823 3.015 . . . . 1.98 113.007 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.6 t -93.81 127.04 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.938 1.295 . . . . 2.3700000000000001 110.746 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.64 -177.7 3.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.376 1.47 . . . . 5.3600000000000003 109.186 165.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.25 154.2 31.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 119.769 -1.832 . . . . 2.5299999999999998 114.027 -164.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 125.918 1.687 . . . . 6.5 113.448 156.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 107.346 -2.302 . . . . 14.09 107.346 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 p 170.05 173.51 0.06 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.425 1.112 . . . . 10.32 110.164 -150.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -56.04 168.61 0.47 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.635 1.174 . . . . 8.9900000000000002 111.991 167.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.3 m -153.26 162.91 40.78 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.693 1.597 . . . . 8.5399999999999991 107.913 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -115.4 -147.57 0.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.648 1.179 . . . . 4.7400000000000002 111.019 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.28 170.39 37.06 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 120.556 -1.34 . . . . 1.6299999999999999 114.183 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -157.87 147.79 20.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.292 1.037 . . . . 1.6799999999999999 111.935 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -93.45 121.62 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.146 -0.971 . . . . 2.3700000000000001 108.809 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -63.46 -29.84 71.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.749 1.62 . . . . 5.8499999999999996 113.719 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.99 -179.74 0.22 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.221 2.208 . . . . 3.4300000000000002 112.692 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m 176.25 165.84 0.44 Allowed Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 128.751 2.82 . . . . 2.2200000000000002 108.575 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.27 5.65 3.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.248 2.632 . . . . 2.1600000000000001 113.726 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.5 170.66 36.04 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.35 0.976 . . . . 2.3599999999999999 112.333 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.86 -6.48 33.06 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 CA-C-N 118.612 1.206 . . . . 3.1000000000000001 113.66 -5.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -135.42 171.84 13.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.962 2.105 . . . . 5.6600000000000001 110.804 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.62 -168.3 1.14 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.785 2.434 . . . . 2.2000000000000002 112.21 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.23 166.97 24.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.317 1.847 . . . . 2.3900000000000001 111.786 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.33 159.32 42.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.647 1.179 . . . . 2.3100000000000001 114.067 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -141.53 156.77 45.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.665 2.386 . . . . 3.3599999999999999 110.942 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -175.04 167.69 3.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.286 1.217 . . . . 3.0099999999999998 114.286 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.3 m -124.7 137.48 54.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.775 1.63 . . . . 2.4199999999999999 109.033 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.4 tp -131.14 156.4 45.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.152 1.381 . . . . 5.3300000000000001 110.849 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -130.58 129.49 42.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.3 -1.0 . . . . 3.9700000000000002 108.3 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -94.75 105.8 20.84 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.634 1.174 . . . . 1.04 109.162 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.66 -8.98 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.729 2.286 . . . . 1.1200000000000001 113.637 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.06 156.21 43.44 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 118.942 0.792 . . . . 1.28 112.693 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.3 m-20 -88.26 7.67 31.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.978 1.711 . . . . 3.21 113.209 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.02 158.84 43.13 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.999 1.72 . . . . 2.3599999999999999 110.64 166.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.31 156.9 25.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.304 2.669 . . . . 0.87 110.782 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.5 mt -107.18 151.45 25.4 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.706 -0.621 . . . . 3.1200000000000001 110.58 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -128.68 112.38 14.17 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.641 1.176 . . . . 5.5499999999999998 109.572 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.06 127.54 42.16 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.122 1.769 . . . . 1.9299999999999999 109.228 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -116.33 -14.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.444 0.905 . . . . 1.95 113.444 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.27 -165.57 35.0 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 121.626 -0.671 . . . . 0.53000000000000003 112.514 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.5 -179.4 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.249 1.02 . . . . 1.98 110.356 167.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -159.95 145.21 15.23 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.945 -1.872 . . . . 7.5899999999999999 105.945 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.75 156.06 26.18 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 119.088 0.858 . . . . 2.3300000000000001 109.97 -159.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.71 -37.17 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.341 2.027 . . . . 0.90000000000000002 112.465 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.52 -10.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 115.236 1.569 . . . . 2.0299999999999998 115.236 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 163.29 32.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.285 1.434 . . . . 1.8200000000000001 110.374 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -105.23 -77.76 0.58 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.315 1.046 . . . . 3.6699999999999999 109.881 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 44' ' ' GLU . 22.0 ttt180 -79.46 104.29 9.97 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.757 0.823 . . . . 4.4100000000000001 110.467 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -110.18 137.61 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.126 1.37 . . . . 2.3300000000000001 110.587 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 42' ' ' ARG . 43.5 mt-10 -141.23 128.46 20.97 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.499 1.52 . . . . 2.2799999999999998 111.41 -170.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.59 122.83 28.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.76 0.791 . . . . 1.95 111.691 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -104.91 151.42 23.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.686 1.594 . . . . 1.0900000000000001 114.173 172.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.11 165.87 14.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.613 1.965 . . . . 2.1299999999999999 110.937 160.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.2 m -148.76 112.96 5.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.512 1.525 . . . . 3.23 107.952 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -126.02 171.5 10.74 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.934 1.294 . . . . 3.6899999999999999 112.598 -163.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.0 mtm -124.3 118.27 26.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.851 1.26 . . . . 5.7199999999999998 110.053 161.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -153.04 159.73 42.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.058 1.343 . . . . 7.6100000000000003 110.651 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -64.34 147.89 51.56 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.322 1.449 . . . . 4.29 112.518 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.21 -18.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.497 1.295 . . . . 4.5599999999999996 114.497 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 56' ' ' LYS . 14.0 tt0 -155.93 33.13 0.35 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.938 2.095 . . . . 3.4199999999999999 108.96 -175.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.79 -25.21 0.64 Allowed Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.235 -1.541 . . . . 2.7000000000000002 113.141 -160.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 54' ' ' GLU . 67.8 mttt -80.34 139.32 36.63 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.305 2.242 . . . . 3.1600000000000001 109.2 171.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -76.45 144.63 39.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.612 0.642 . . . . 4.79 112.667 169.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.37 164.79 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 4.3099999999999996 109.798 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.7 mtm -78.46 154.2 30.79 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 4.9699999999999998 111.081 168.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.2 166.47 38.8 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 121.738 -0.601 . . . . 1.8799999999999999 113.668 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.6 149.8 46.93 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.88 1.272 . . . . 2.8100000000000001 110.831 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -158.62 152.04 19.01 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-O 117.133 -1.413 . . . . 4.1900000000000004 110.428 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.03 148.27 69.44 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.177 1.918 . . . . 0.92000000000000004 111.412 162.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.58 152.33 68.66 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 125.44 1.496 . . . . 1.8100000000000001 110.582 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.13 -6.79 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.885 2.39 . . . . 1.25 113.477 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -176.69 159.91 1.89 Allowed 'General case' 0 C--N 1.348 0.508 0 C-N-CA 125.222 1.409 . . . . 3.3500000000000001 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -111.19 175.7 5.32 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.88 1.672 . . . . 2.04 109.194 152.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.39 167.18 31.23 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.807 -1.183 . . . . 2.98 110.291 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -144.18 136.89 13.57 Favored Pre-proline 0 C--N 1.328 -0.367 0 C-N-CA 124.21 1.004 . . . . 1.8999999999999999 108.762 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 167.38 25.4 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.571 1.514 . . . . 1.1699999999999999 111.373 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.36 143.9 99.58 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.217 2.611 . . . . 1.0800000000000001 111.003 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.461 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 14.9 mmmt 66.25 4.12 3.03 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.448 1.499 . . . . 2.6400000000000001 112.797 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.92 3.74 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 127.403 2.43 . . . . 1.0800000000000001 112.857 -170.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 118.37 31.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.535 1.534 . . . . 6.3300000000000001 109.772 172.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.11 147.03 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 120.465 1.484 . . . . 2.52 114.403 -166.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 131.62 54.37 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.805 1.242 . . . . 3.48 112.826 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.94 71.64 0.54 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.464 1.505 . . . . 2.3700000000000001 109.929 157.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -78.0 144.3 67.58 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.939 1.696 . . . . 4.4500000000000002 112.688 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.1 -23.16 72.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.546 2.83 . . . . 1.6499999999999999 114.644 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.74 38.78 3.04 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.248 1.404 . . . . 1.52 113.02 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.95 -58.74 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 CA-C-N 118.581 1.19 . . . . 1.8100000000000001 114.948 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -155.12 144.2 20.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.975 1.71 . . . . 3.6400000000000001 110.395 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -164.0 173.84 12.11 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.798 -1.189 . . . . 0.93999999999999995 110.213 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -108.95 135.42 50.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.093 0.557 . . . . 3.6099999999999999 110.182 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 mmt -85.08 140.69 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.673 0.789 . . . . 2.3700000000000001 109.955 156.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.3 mt -122.8 112.28 17.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 2.7599999999999998 108.375 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -111.21 140.96 45.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.836 1.654 . . . . 4.1299999999999999 108.436 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.02 72.95 0.91 Allowed Glycine 0 N--CA 1.471 0.968 0 O-C-N 121.206 -0.934 . . . . 2.5699999999999998 111.097 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.79 104.24 4.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 122.523 1.154 . . . . 2.0499999999999998 110.13 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -82.83 13.94 3.56 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 3.52 113.008 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -147.07 159.07 43.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.694 1.998 . . . . 5.9000000000000004 110.392 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.45 163.29 39.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.584 2.189 . . . . 2.0899999999999999 109.6 152.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -141.92 162.48 35.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.754 1.222 . . . . 3.6099999999999999 110.781 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.12 109.19 2.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.105 1.762 . . . . 4.2800000000000002 109.574 -175.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.04 126.08 24.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.93 -1.106 . . . . 3.4399999999999999 110.26 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.29 7.42 40.38 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.762 -1.021 . . . . 1.8999999999999999 114.562 -165.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -107.13 -170.82 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.263 1.531 . . . . 2.8599999999999999 110.057 147.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -125.9 165.06 19.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.857 1.663 . . . . 3.3199999999999998 110.509 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.56 116.7 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.115 1.366 . . . . 2.6200000000000001 108.446 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.92 144.59 33.24 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.77 -1.105 . . . . 3.4199999999999999 111.213 167.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 tt -155.6 132.9 10.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.988 0.899 . . . . 2.4500000000000002 110.527 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -86.5 101.51 13.25 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.874 3.27 . . . . 2.6800000000000002 111.363 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.99 111.77 17.77 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.273 -1.517 . . . . 2.3500000000000001 109.575 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.28 125.71 35.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.391 1.476 . . . . 1.5900000000000001 110.1 -166.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.84 153.08 31.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.005 0.522 . . . . 3.6600000000000001 112.027 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.43 128.77 37.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.062 0.545 . . . . 2.3700000000000001 110.398 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 -153.97 30.35 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.475 0.559 . . . . 2.8900000000000001 111.878 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.15 54.32 4.85 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.932 -0.927 . . . . 2.6800000000000002 114.434 -169.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -143.78 147.12 33.71 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.293 1.546 . . . . 5.04 115.057 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.83 131.72 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 128.19 2.596 . . . . 2.1000000000000001 108.171 166.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.42 101.46 7.97 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.028 1.331 . . . . 3.8100000000000001 108.031 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.26 133.6 33.82 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.466 -0.771 . . . . 3.46 112.727 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.7 m -140.94 153.45 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.061 1.744 . . . . 2.25 110.986 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.88 128.49 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.836 1.254 . . . . 3.0299999999999998 111.188 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.9 155.33 60.71 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.272 1.829 . . . . 4.5 110.3 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.0 152.38 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.929 2.42 . . . . 1.24 111.125 168.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.58 116.41 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.569 -1.641 . . . . 2.1099999999999999 106.569 161.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 120' ' ' ARG . 39.4 tt0 -127.97 118.92 24.43 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.877 -1.527 . . . . 3.8199999999999998 106.877 172.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.62 118.36 16.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.791 -0.818 . . . . 3.3300000000000001 108.791 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 118' ' ' GLU . 82.5 mtt-85 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 117.952 -1.023 . . . . 9.7400000000000002 113.174 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.057 0 N-CA-C 107.801 -2.12 . . . . 14.59 107.801 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 t -169.58 -142.98 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.505 1.522 . . . . 10.83 107.283 -171.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -62.02 105.9 0.64 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.441 1.018 . . . . 10.300000000000001 110.464 166.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.9 m -63.34 148.33 48.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.987 1.315 . . . . 7.7300000000000004 108.785 166.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -141.49 144.47 34.39 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.012 1.325 . . . . 6.0800000000000001 107.726 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.27 172.47 12.88 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.592 1.568 . . . . 2.6099999999999999 113.521 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -155.52 155.28 33.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.38 1.072 . . . . 2.6499999999999999 111.585 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.63 119.2 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.592 -0.892 . . . . 1.8799999999999999 108.592 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.28 108.74 16.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.557 0.743 . . . . 4.5700000000000003 109.687 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 136.41 48.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 3.8399999999999999 110.427 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.2 t -131.22 156.03 80.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.486 1.914 . . . . 3.6800000000000002 109.222 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.01 -10.38 28.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.872 2.381 . . . . 2.04 112.717 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.53 -174.36 15.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.624 1.583 . . . . 1.6599999999999999 112.166 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -76.71 -0.58 23.69 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 118.306 1.053 . . . . 1.8600000000000001 112.629 -8.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -149.65 178.05 9.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.848 1.659 . . . . 2.23 111.191 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.0 -166.22 1.53 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.529 1.931 . . . . 2.0499999999999998 112.42 -172.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.74 154.57 34.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.716 1.206 . . . . 2.1000000000000001 111.761 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.13 46.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.297 1.439 . . . . 1.52 111.281 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -136.13 148.54 48.27 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.484 1.914 . . . . 3.5299999999999998 109.011 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -171.6 155.92 4.22 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.803 0.841 . . . . 2.79 112.741 -171.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -97.71 136.59 37.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.486 -1.234 . . . . 2.1299999999999999 111.827 166.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -112.65 149.3 33.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.873 2.469 . . . . 3.9100000000000001 109.083 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -148.89 120.36 7.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.127 0.965 . . . . 2.7599999999999998 112.89 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -90.14 115.36 63.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.722 1.209 . . . . 1.0700000000000001 110.233 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -86.52 -8.69 7.17 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.155 2.57 . . . . 1.1000000000000001 113.441 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.72 169.29 54.65 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.006 0.812 . . . . 0.97999999999999998 113.722 -172.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.481 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.3 m-20 -95.08 -2.24 50.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.489 1.916 . . . . 2.8799999999999999 112.702 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.27 161.15 32.85 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 126.221 1.809 . . . . 2.2000000000000002 110.299 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.03 161.54 23.63 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.05 2.5 . . . . 0.73999999999999999 111.184 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.02 150.52 28.41 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.552 0.741 . . . . 3.1499999999999999 110.48 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.417 HH21 ' CD ' ' A' ' 68' ' ' GLU . 21.1 ttm180 -125.52 114.6 19.0 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.231 1.012 . . . . 5.0199999999999996 109.532 167.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -90.85 119.43 31.05 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.822 2.449 . . . . 2.2000000000000002 109.095 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.17 -8.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.54 1.136 . . . . 1.77 113.931 -171.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -162.03 32.31 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.512 -0.742 . . . . 0.46999999999999997 112.275 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.59 -172.0 3.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.488 1.115 . . . . 1.5800000000000001 111.219 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -148.22 143.88 27.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.789 2.036 . . . . 7.1299999999999999 105.506 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -149.05 153.73 38.54 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.409 1.004 . . . . 1.54 109.339 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.43 -43.46 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.514 2.809 . . . . 1.6499999999999999 111.696 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.281 1.1 m -76.46 -5.23 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.416 1.636 . . . . 2.0800000000000001 115.416 -170.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.1 -175.91 4.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.601 1.56 . . . . 2.04 110.751 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 7.1 tp10 -132.92 -60.94 0.85 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.156 0.889 . . . . 4.6799999999999997 111.721 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -65.02 129.93 41.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.395 -1.335 . . . . 3.7200000000000002 107.395 158.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.89 117.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.454 -1.684 . . . . 2.9100000000000001 106.454 171.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -138.76 115.65 10.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.635 -1.166 . . . . 2.8300000000000001 109.013 -155.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.427 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 6.1 tt -78.04 120.66 23.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.216 1.008 . . . . 1.99 110.546 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -107.47 150.0 27.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.84 1.656 . . . . 0.60999999999999999 112.222 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.74 168.55 19.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.843 -1.526 . . . . 2.4700000000000002 110.306 159.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -143.65 86.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.882 -1.525 . . . . 2.3999999999999999 106.882 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -94.14 153.41 18.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.177 1.791 . . . . 3.0699999999999998 112.373 -164.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 ttp -91.74 137.68 32.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.389 1.476 . . . . 3.5099999999999998 110.003 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -153.53 122.78 6.58 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.377 0.671 . . . . 6.1100000000000003 111.461 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -99.06 155.28 17.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.845 1.258 . . . . 5.7400000000000002 110.133 169.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.37 127.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.91 . . . . 4.7000000000000002 110.678 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 58.72 26.4 14.58 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.317 1.056 . . . . 4.96 111.053 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.43 1.19 57.03 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 119.825 -1.797 . . . . 3.3100000000000001 114.379 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -92.84 143.19 26.52 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.032 1.733 . . . . 4.3399999999999999 109.488 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -88.27 130.22 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.754 1.622 . . . . 6.8899999999999997 112.607 -164.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.421 HG11 ' H ' ' A' ' 59' ' ' MET . 0.1 OUTLIER -147.05 169.5 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 122.387 1.089 . . . . 3.2999999999999998 113.044 178.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.421 ' H ' HG11 ' A' ' 58' ' ' VAL . 14.6 tpp -137.48 160.91 37.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.913 2.885 . . . . 3.6400000000000001 107.938 173.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.07 169.31 33.12 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.562 1.074 . . . . 1.24 114.078 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.11 139.48 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.433 1.493 . . . . 2.8399999999999999 109.598 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -154.6 145.38 16.2 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 125.652 1.581 . . . . 4.2000000000000002 109.531 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.39 143.25 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.967 1.778 . . . . 1.0900000000000001 110.657 165.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.64 156.16 42.82 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.691 1.596 . . . . 1.79 110.663 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.75 -14.66 33.11 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.919 2.413 . . . . 0.82999999999999996 113.369 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -177.16 162.17 1.95 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.574 1.55 . . . . 3.0800000000000001 110.816 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mt -109.48 171.08 7.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.673 1.189 . . . . 1.75 108.682 149.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.417 ' CD ' HH21 ' A' ' 31' ' ' ARG . 7.1 pt-20 -155.57 165.09 37.63 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.03 -1.044 . . . . 2.3500000000000001 111.774 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.87 136.36 11.67 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.841 0.857 . . . . 2.4100000000000001 109.516 -161.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.83 169.58 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.715 1.61 . . . . 1.02 111.429 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.78 143.9 94.53 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.172 2.581 . . . . 0.82999999999999996 111.26 163.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 66.5 mmtt 67.31 0.57 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.524 1.53 . . . . 2.0899999999999999 114.215 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.16 113.7 3.68 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 126.01 1.767 . . . . 0.93999999999999995 112.869 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -81.04 133.2 35.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.082 -1.059 . . . . 5.46 109.746 154.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.95 134.16 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.624 1.569 . . . . 2.2999999999999998 110.597 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.1 118.02 25.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.127 -1.064 . . . . 4.6699999999999999 108.127 -160.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.54 73.11 1.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.236 1.493 . . . . 1.9099999999999999 111.87 -169.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -55.24 116.88 12.68 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.226 1.41 . . . . 5.9199999999999999 110.347 168.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.21 -30.37 88.33 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.24 2.627 . . . . 1.52 114.108 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.89 41.68 1.75 Allowed Glycine 0 CA--C 1.533 1.181 0 CA-C-N 118.858 0.754 . . . . 1.9399999999999999 112.791 167.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.33 -49.82 0.04 OUTLIER Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.954 2.216 . . . . 1.47 113.609 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -151.26 146.89 26.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.691 1.596 . . . . 3.5699999999999998 112.049 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -156.48 167.41 30.54 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.735 1.214 . . . . 1.29 110.983 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.427 ' CZ ' HD11 ' A' ' 45' ' ' LEU . 31.7 m-85 -105.83 117.8 34.95 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.704 -0.85 . . . . 3.1000000000000001 108.704 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.87 133.08 34.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.975 0.51 . . . . 2.54 110.258 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.71 133.39 53.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.854 1.662 . . . . 2.9700000000000002 111.659 -172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -142.91 157.97 44.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.758 1.223 . . . . 2.9199999999999999 112.028 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -43.76 2.66 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 124.759 1.171 . . . . 2.27 112.129 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt 47.37 71.83 0.3 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.975 2.51 . . . . 2.2599999999999998 113.706 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.418 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 6.9 ptpp? -69.67 -1.7 9.71 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.032 1.123 . . . . 3.3900000000000001 114.032 -176.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.46 HH21 ' CD ' ' A' ' 97' ' ' GLU . 10.3 mtp85 -125.45 142.36 41.53 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 126.308 1.843 . . . . 6.6200000000000001 109.053 172.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.22 124.12 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 107.245 -1.867 . . . . 2.0699999999999998 107.245 145.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.5 pt? -127.21 157.54 39.52 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.675 1.99 . . . . 3.98 111.164 -163.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -165.11 142.69 6.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.527 1.306 . . . . 8.9700000000000006 114.527 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 124.86 19.1 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.279 -0.888 . . . . 2.6099999999999999 109.669 164.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.24 -12.25 14.26 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.94 -1.478 . . . . 1.8600000000000001 113.363 -161.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' CD ' HH21 ' A' ' 91' ' ' ARG . 6.7 pt-20 -106.1 172.68 6.68 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.162 1.481 . . . . 3.8700000000000001 110.828 155.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.5 155.18 46.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.529 1.532 . . . . 4.75 108.959 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.66 110.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.582 1.153 . . . . 2.0699999999999998 108.975 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 35.7 mt-10 -71.35 129.41 38.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.534 -0.913 . . . . 4.3899999999999997 108.534 153.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.63 140.03 45.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.578 1.151 . . . . 2.6800000000000002 108.761 172.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.3 103.41 12.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.996 2.519 . . . . 3.3500000000000001 110.587 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.38 125.18 28.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.731 1.613 . . . . 2.2400000000000002 110.813 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.5 mt -93.18 129.86 39.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.654 1.182 . . . . 1.8500000000000001 111.565 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -127.74 119.97 26.91 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.38 0.672 . . . . 3.5299999999999998 112.295 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.51 27.9 0.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.975 2.11 . . . . 3.02 114.784 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.57 -53.38 1.57 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.741 1.638 . . . . 3.9100000000000001 113.104 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.68 3.71 63.04 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 117.036 1.574 . . . . 1.8 117.036 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 150.36 44.08 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.112 1.956 . . . . 4.5800000000000001 111.316 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.31 136.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.854 1.662 . . . . 2.0099999999999998 109.205 166.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.7 mt -146.18 132.56 19.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.501 1.521 . . . . 2.6899999999999999 109.499 -172.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.417 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 7.1 ptmt -102.1 158.56 16.08 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.951 1.834 . . . . 4.0700000000000003 115.951 -169.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.21 147.21 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.605 1.962 . . . . 3.3799999999999999 109.915 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -107.55 133.71 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.115 1.366 . . . . 4.1100000000000003 111.247 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 mt -140.44 131.38 13.92 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 127.059 2.144 . . . . 3.0499999999999998 109.365 -165.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.35 151.47 71.39 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.318 2.678 . . . . 1.78 112.146 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.42 125.85 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.53 0.681 . . . . 1.95 112.087 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.48 148.32 24.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.086 2.154 . . . . 4.96 109.838 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.33 129.62 54.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.919 -1.039 . . . . 2.71 109.395 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 131.365 3.866 . . . . 7.6500000000000004 107.677 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 109.119 -1.592 . . . . 17.66 109.119 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -142.63 152.74 42.79 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.246 1.018 . . . . 13.949999999999999 109.212 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -161.88 -4.88 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.752 1.39 . . . . 14.48 114.752 -167.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.9 p -89.95 103.29 15.96 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.114 0.965 . . . . 8.3499999999999996 109.916 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -85.13 128.27 34.59 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.578 0.751 . . . . 5.8200000000000003 110.749 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.19 175.3 47.59 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 115.455 0.942 . . . . 1.55 115.455 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -156.23 123.65 5.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.034 1.334 . . . . 1.8500000000000001 113.094 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.33 153.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 120.75 -1.219 . . . . 2.0600000000000001 108.823 164.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -110.15 -19.19 13.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 116.438 2.014 . . . . 8.1799999999999997 116.438 -168.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 60.79 173.42 0.1 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.401 1.48 . . . . 3.3799999999999999 112.781 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.29 171.8 0.5 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.947 2.899 . . . . 2.1600000000000001 109.657 171.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.97 -0.41 9.0 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.301 2.667 . . . . 1.8799999999999999 113.78 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 174.23 33.69 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.93 1.252 . . . . 1.78 112.418 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.23 -5.37 34.2 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 118.596 1.198 . . . . 2.3100000000000001 112.998 -4.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -130.4 177.23 7.5 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.989 1.716 . . . . 2.1099999999999999 112.767 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -168.63 -168.8 0.94 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.789 2.436 . . . . 1.48 110.64 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.45 167.92 17.84 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.848 1.659 . . . . 1.6799999999999999 112.15 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.14 149.72 31.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.525 1.53 . . . . 1.6699999999999999 111.337 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -146.04 151.8 38.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.481 1.512 . . . . 3.71 110.135 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -173.84 161.02 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.938 1.295 . . . . 3.3199999999999998 113.05 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.9 m -84.35 150.23 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.685 1.594 . . . . 1.9199999999999999 109.037 166.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.72 176.27 9.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.365 1.066 . . . . 4.9000000000000004 110.955 152.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -154.83 162.02 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.476 -0.765 . . . . 3.71 111.424 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -114.61 101.64 54.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.876 1.67 . . . . 1.3100000000000001 109.577 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.06 -2.65 11.86 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.786 2.991 . . . . 1.6599999999999999 113.112 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.9 -172.35 48.79 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.786 1.184 . . . . 1.49 113.726 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.457 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 15.9 m-20 -119.21 2.32 11.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.818 1.647 . . . . 3.79 112.954 -169.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.1 161.35 35.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.185 1.794 . . . . 2.4900000000000002 109.374 165.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.8 154.68 15.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.096 2.531 . . . . 1.1899999999999999 111.123 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.37 158.04 17.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.962 0.905 . . . . 3.6200000000000001 111.175 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.421 HH21 ' CD ' ' A' ' 68' ' ' GLU . 24.2 ttm180 -135.35 113.42 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.855 1.262 . . . . 4.8399999999999999 110.381 173.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.44 115.35 27.51 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 127.943 2.497 . . . . 2.0 108.985 -173.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.7 -8.73 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.725 1.009 . . . . 1.8300000000000001 113.725 -165.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.69 -162.25 32.22 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.749 -0.594 . . . . 0.45000000000000001 112.81 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.93 -175.43 4.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.606 0.595 . . . . 1.7 112.606 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -156.95 144.25 18.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.924 0.889 . . . . 6.4800000000000004 109.551 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -152.74 155.13 32.23 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.961 0.904 . . . . 2.0800000000000001 110.471 -170.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.31 -21.17 23.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.809 2.339 . . . . 1.4099999999999999 113.617 169.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.53 -15.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 114.639 1.348 . . . . 2.1600000000000001 114.639 -166.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.36 40.25 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.084 0.954 . . . . 2.2799999999999998 112.347 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -93.63 -86.2 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.386 1.074 . . . . 3.7599999999999998 110.597 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -85.02 90.96 7.96 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.807 -1.183 . . . . 6.1500000000000004 108.741 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -76.03 139.16 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.51 -0.768 . . . . 2.77 111.014 165.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -138.14 120.7 16.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.204 2.202 . . . . 3.3799999999999999 111.048 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.3 118.18 22.41 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.016 0.912 . . . . 1.9299999999999999 111.809 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -103.22 153.68 20.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.782 1.633 . . . . 0.82999999999999996 113.661 172.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -95.18 178.21 5.61 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.42 1.888 . . . . 2.4700000000000002 110.021 162.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.9 m -145.7 111.93 5.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.891 -1.151 . . . . 2.3100000000000001 107.891 164.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -97.15 158.34 15.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.379 1.472 . . . . 3.8100000000000001 112.498 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -101.95 148.03 25.83 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.42 1.088 . . . . 4.71 108.92 163.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -158.92 146.64 17.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.379 1.471 . . . . 6.9800000000000004 110.147 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.524 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -95.45 145.84 24.86 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.582 0.353 . . . . 3.7599999999999998 110.917 165.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -139.78 120.48 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.019 -1.475 . . . . 3.75 107.019 165.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.6 tm-20 57.52 33.57 23.44 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.28 1.032 . . . . 5.4199999999999999 110.757 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.64 -9.92 4.37 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 119.995 -1.69 . . . . 2.23 114.547 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 33.7 mmtm -78.39 139.98 38.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 5.2000000000000002 110.367 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 28.5 mmmt -69.97 131.1 43.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.044 0.938 . . . . 3.73 110.825 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.93 146.84 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.685 1.994 . . . . 3.04 109.361 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -128.43 148.98 50.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.685 1.194 . . . . 4.46 110.893 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.71 -179.83 34.78 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.906 0.765 . . . . 1.0700000000000001 112.855 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -127.95 149.27 50.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.245 1.018 . . . . 3.2999999999999998 111.981 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -142.76 147.46 42.18 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.552 1.541 . . . . 4.1299999999999999 108.908 172.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 151.62 78.42 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.697 1.598 . . . . 0.93999999999999995 110.867 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.13 154.55 78.69 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 125.156 1.382 . . . . 2.3399999999999999 110.79 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -70.2 -11.8 30.91 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.671 2.247 . . . . 1.6799999999999999 113.063 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -177.47 163.45 1.97 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.618 1.567 . . . . 3.5099999999999998 111.885 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -113.2 174.11 6.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.329 2.251 . . . . 2.1200000000000001 109.4 155.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 31' ' ' ARG . 9.1 pt-20 -154.88 167.62 29.68 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.041 -1.037 . . . . 2.5499999999999998 112.277 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.73 135.42 11.07 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.818 0.847 . . . . 1.97 110.543 -165.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.76 167.08 27.04 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.295 1.997 . . . . 1.1000000000000001 111.893 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -65.26 144.61 81.45 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.709 2.939 . . . . 1.4199999999999999 111.655 166.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP 0.261 0.6 OUTLIER 46.69 55.29 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 123.454 1.597 . . . . 3.1000000000000001 114.757 -166.873 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.35 121.33 2.66 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 113.962 -1.472 . . . . 1.0600000000000001 114.164 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.53 146.99 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.65 0.78 . . . . 5.6799999999999997 109.978 162.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.18 137.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.544 1.138 . . . . 2.3999999999999999 109.974 171.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -111.92 140.25 46.74 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.794 0.807 . . . . 3.4500000000000002 110.957 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.24 63.78 2.53 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.323 1.535 . . . . 2.0499999999999998 109.926 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -58.37 121.39 51.9 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.954 1.302 . . . . 5.9199999999999999 110.709 170.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.88 -58.14 1.58 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.888 3.726 . . . . 1.48 114.598 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.69 2.9 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.678 1.132 . . . . 1.9399999999999999 113.405 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.75 -51.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.352 1.93 . . . . 1.48 113.339 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -156.01 139.47 15.84 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.631 1.972 . . . . 3.5299999999999998 109.654 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -166.93 173.66 9.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.353 1.061 . . . . 0.94999999999999996 111.477 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.13 134.0 52.64 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.025 0.53 . . . . 3.0 111.246 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.3 mmt -84.73 144.02 28.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.977 1.311 . . . . 1.8799999999999999 110.316 157.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.59 116.47 28.2 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.68 1.592 . . . . 2.9500000000000002 107.861 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -109.63 134.86 51.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.967 0.803 . . . . 3.4100000000000001 110.147 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.2 0.6 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.042 -1.223 . . . . 2.5800000000000001 110.042 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.53 100.52 2.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.086 0.943 . . . . 1.9199999999999999 110.068 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -76.71 -12.7 60.03 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.235 0.828 . . . . 2.7200000000000002 113.235 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.42 148.63 31.99 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.905 . . . . 6.0499999999999998 111.139 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -67.56 148.71 79.0 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.735 2.29 . . . . 2.2200000000000002 109.229 159.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.96 30.94 0.3 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.861 1.315 . . . . 4.2400000000000002 113.59 -160.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.25 149.22 0.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.183 2.193 . . . . 5.0499999999999998 113.904 -169.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.79 134.93 30.38 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.603 -1.311 . . . . 3.4199999999999999 112.107 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.42 -11.79 66.77 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.061 -1.41 . . . . 2.4100000000000001 114.354 -166.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 158.02 37.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.052 1.426 . . . . 4.2800000000000002 109.009 160.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.9 147.54 29.67 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.812 2.045 . . . . 4.2699999999999996 108.174 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.19 123.07 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.576 1.55 . . . . 1.8700000000000001 109.995 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.5 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -74.04 121.49 21.16 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.708 0.803 . . . . 4.1299999999999999 109.068 159.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.07 126.6 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.078 0.951 . . . . 2.6200000000000001 110.521 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.17 95.87 8.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.53 1.932 . . . . 2.6000000000000001 109.779 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.93 126.18 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.794 1.179 . . . . 3.6200000000000001 110.106 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.6 mt -95.1 137.97 33.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.516 1.526 . . . . 1.98 110.589 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -134.11 148.51 51.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.213 1.006 . . . . 3.6000000000000001 113.028 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.77 162.77 18.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.128 -0.942 . . . . 2.8799999999999999 111.853 169.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.75 24.9 66.11 Favored Glycine 0 N--CA 1.473 1.145 0 O-C-N 121.66 -0.65 . . . . 4.7000000000000002 113.696 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.94 60.65 4.77 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.303 0.954 . . . . 2.1099999999999999 111.116 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -143.63 165.16 28.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.984 1.313 . . . . 4.29 112.412 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -169.98 144.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 129.39 3.076 . . . . 3.2400000000000002 107.213 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.2 mt -137.4 96.93 3.35 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.393 1.477 . . . . 3.6800000000000002 107.766 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -81.45 143.24 32.24 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.956 0.724 . . . . 3.6800000000000002 112.956 178.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.33 140.55 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.414 1.086 . . . . 2.8199999999999998 109.899 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 145.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.668 0.787 . . . . 3.0299999999999998 109.61 172.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.5 153.19 12.79 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.924 1.29 . . . . 3.7000000000000002 113.17 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.09 161.66 40.49 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.039 2.493 . . . . 1.4299999999999999 112.555 -175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -93.46 130.61 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.978 . . . . 2.5299999999999998 109.786 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.01 164.44 12.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.723 1.209 . . . . 3.4500000000000002 108.931 156.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.41 115.84 26.59 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.068 -1.02 . . . . 3.1499999999999999 112.772 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.521 2.328 . . . . 6.25 113.133 167.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.207 0 N-CA-C 105.751 -2.94 . . . . 13.32 105.751 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -55.37 170.28 0.24 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.284 0.564 . . . . 10.74 111.722 134.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -148.45 31.93 0.81 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.34 1.856 . . . . 10.390000000000001 110.481 -174.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -155.48 -10.12 0.12 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 128.034 2.534 . . . . 7.54 113.115 -149.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -146.52 156.74 43.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.549 1.94 . . . . 5.0300000000000002 112.171 -150.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.15 164.34 21.47 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 124.822 1.201 . . . . 1.25 114.078 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -152.53 145.2 24.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 2.0 112.026 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.1 131.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.381 -0.6 . . . . 2.1800000000000002 109.381 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 116.75 22.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.207 0.603 . . . . 5.0999999999999996 109.405 -171.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.86 133.23 33.94 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.592 -1.317 . . . . 3.6299999999999999 110.914 167.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -149.48 163.24 25.85 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.567 1.947 . . . . 3.0800000000000001 109.007 165.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.91 31.14 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.062 3.175 . . . . 1.9299999999999999 114.113 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.06 -173.16 54.51 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.248 -0.908 . . . . 1.72 113.125 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.26 -4.42 18.31 Favored 'Cis proline' 0 CA--C 1.539 0.741 0 CA-C-N 118.228 1.014 . . . . 2.0899999999999999 112.8 -10.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -139.51 178.87 6.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.701 1.6 . . . . 2.6099999999999999 111.484 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.07 -173.93 3.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.004 2.122 . . . . 2.1200000000000001 108.647 163.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.42 161.15 17.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 2.25 112.161 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.1 136.58 48.51 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.039 -1.038 . . . . 2.0600000000000001 111.106 163.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -122.61 155.56 36.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.413 1.885 . . . . 3.4199999999999999 111.015 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -166.24 142.28 4.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.708 1.744 . . . . 2.4500000000000002 115.708 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.9 m -72.13 132.73 44.56 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.79 -0.819 . . . . 2.3599999999999999 108.79 156.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.1 tt -140.68 147.41 39.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.313 1.845 . . . . 3.6099999999999999 110.1 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -131.92 147.14 52.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.289 1.042 . . . . 3.3199999999999998 112.414 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -88.07 108.9 23.93 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.362 -1.29 . . . . 1.02 109.216 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.74 -11.51 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.631 2.221 . . . . 1.4299999999999999 113.287 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.04 -173.39 49.84 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.867 1.222 . . . . 0.95999999999999996 113.812 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 16.7 m-20 -114.17 -0.85 13.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.884 1.674 . . . . 2.98 112.855 -173.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.04 161.77 36.79 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.457 1.903 . . . . 2.6099999999999999 109.464 165.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 155.61 28.22 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.554 2.169 . . . . 0.85999999999999999 112.287 -169.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.43 149.82 23.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.437 1.095 . . . . 3.0 110.532 168.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -130.94 111.93 12.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.735 1.214 . . . . 3.9500000000000002 110.408 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 tp -94.21 118.33 31.41 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.564 2.345 . . . . 1.8300000000000001 108.746 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -110.15 -10.37 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.977 0.911 . . . . 1.73 113.003 -171.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.94 -167.14 38.31 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 124.242 0.925 . . . . 0.5 112.233 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.15 -179.03 6.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.165 0.986 . . . . 1.71 110.746 164.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.0 mmt-85 -149.48 139.66 22.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.26 1.424 . . . . 7.5 109.271 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.428 ' HG1' ' CG1' ' A' ' 99' ' ' VAL . 1.7 t -150.01 152.12 33.4 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.218 -0.896 . . . . 1.73 110.572 -169.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.98 -23.94 53.51 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.827 2.351 . . . . 0.96999999999999997 113.629 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.351 1.6 m -94.25 3.07 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.049 1.5 . . . . 1.8700000000000001 115.049 -171.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.86 164.1 36.28 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.418 1.636 . . . . 1.6200000000000001 115.418 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.18 -89.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.907 2.083 . . . . 3.4300000000000002 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -80.27 80.12 6.74 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.385 -1.447 . . . . 4.4900000000000002 109.62 -173.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.59 131.7 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 128.146 2.579 . . . . 2.5899999999999999 112.269 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.51 132.07 30.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.487 1.915 . . . . 2.48 110.27 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.14 121.74 26.49 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 121.278 1.854 . . . . 1.95 111.64 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -107.92 154.3 21.8 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.548 1.939 . . . . 0.56000000000000005 112.975 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -109.99 166.33 11.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 2.3900000000000001 110.699 166.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.3 m -115.21 117.83 31.6 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.563 1.945 . . . . 2.0800000000000001 107.114 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -126.26 154.44 43.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.343 1.057 . . . . 3.79 112.699 -168.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.4 mtt -92.63 153.77 18.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.657 -1.156 . . . . 3.6299999999999999 111.339 166.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -153.17 137.77 16.87 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.647 0.779 . . . . 6.96 112.706 159.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.14 151.03 16.18 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.853 1.661 . . . . 4.5899999999999999 110.269 160.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 54' ' ' GLU 0.298 11.8 p -158.03 -88.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 126.249 1.82 . . . . 4.0300000000000002 110.287 175.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.544 ' H ' HG12 ' A' ' 53' ' ' VAL . 20.6 tt0 -78.58 47.72 0.74 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.296 2.239 . . . . 3.7200000000000002 110.296 168.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.48 -43.78 0.91 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 127.595 2.522 . . . . 2.2400000000000002 113.912 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -77.83 152.9 33.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.974 2.11 . . . . 4.3099999999999996 113.178 -173.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.37 107.08 18.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.91 0.484 . . . . 5.1699999999999999 112.069 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -80.95 142.03 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.886 1.275 . . . . 2.4500000000000002 109.017 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.11 133.95 50.01 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.912 1.685 . . . . 5.5599999999999996 110.622 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 -179.2 30.23 Favored Glycine 0 N--CA 1.472 1.09 0 C-N-CA 124.226 0.917 . . . . 1.5600000000000001 113.079 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.48 160.53 19.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.802 1.241 . . . . 3.2400000000000002 112.138 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.16 149.96 2.29 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.505 1.522 . . . . 4.5300000000000002 112.652 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -71.6 141.52 38.22 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.097 2.532 . . . . 0.82999999999999996 113.275 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -110.82 156.07 41.31 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.892 1.677 . . . . 1.8700000000000001 109.798 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.2 -13.31 30.95 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.899 2.4 . . . . 0.84999999999999998 113.292 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.7 p90 178.63 168.34 0.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.005 2.122 . . . . 2.9399999999999999 110.301 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.16 169.43 9.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.189 1.795 . . . . 1.8400000000000001 109.104 157.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.5 159.0 39.41 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.141 -0.974 . . . . 2.5699999999999998 111.655 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.27 126.81 9.21 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.506 1.122 . . . . 2.04 110.133 -163.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.76 161.34 44.1 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.308 2.005 . . . . 0.81999999999999995 111.712 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.11 139.29 86.73 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.89 3.06 . . . . 0.78000000000000003 112.865 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 37.6 mmtm 67.34 -1.2 1.59 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.958 2.103 . . . . 2.3199999999999998 113.647 -173.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.79 119.64 4.93 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 126.615 2.055 . . . . 0.81999999999999995 111.279 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -84.22 142.79 30.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.316 1.046 . . . . 6.2400000000000002 110.722 156.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 m -148.48 147.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.518 1.927 . . . . 2.1899999999999999 110.218 168.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.91 123.93 46.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.315 1.055 . . . . 3.0899999999999999 112.327 170.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.46 85.88 0.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.799 1.239 . . . . 2.46 107.716 158.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -100.41 160.65 26.39 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.055 2.542 . . . . 4.04 113.279 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -58.56 -55.31 2.17 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.554 2.836 . . . . 1.46 112.664 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.92 65.53 3.73 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 110.884 -0.886 . . . . 1.6200000000000001 110.884 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.94 -108.37 0.28 Allowed Glycine 0 N--CA 1.468 0.816 0 C-N-CA 124.616 1.103 . . . . 1.5600000000000001 113.005 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -130.84 143.19 50.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.002 1.401 . . . . 3.5 111.029 -172.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -170.21 163.37 8.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 120.995 -1.066 . . . . 2.0299999999999998 109.935 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -88.23 133.31 34.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.678 -0.677 . . . . 3.9199999999999999 110.29 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.1 mmt -84.13 136.36 34.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.78 0.832 . . . . 1.99 110.196 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.42 75.67 0.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.578 1.551 . . . . 2.7599999999999998 109.164 -170.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.39 116.04 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.245 -1.02 . . . . 4.3399999999999999 108.245 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.98 96.69 0.4 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.291 -1.123 . . . . 2.8500000000000001 110.291 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.1 119.52 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.291 -1.374 . . . . 2.25 107.291 167.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.79 4.76 23.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.798 -1.189 . . . . 2.8500000000000001 112.833 -164.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -167.66 152.69 6.76 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.739 2.016 . . . . 6.3799999999999999 109.595 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.19 151.94 82.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.46 -1.4 . . . . 1.9199999999999999 108.46 161.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.63 162.43 41.0 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.627 1.971 . . . . 3.6699999999999999 108.64 -164.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -154.19 162.6 41.08 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.896 1.813 . . . . 4.8700000000000001 115.896 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.57 133.21 48.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 2.8999999999999999 107.989 157.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.57 13.81 62.54 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.956 -0.914 . . . . 2.1600000000000001 113.493 -162.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.0 169.24 9.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.689 1.245 . . . . 3.1099999999999999 107.868 151.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -136.72 150.35 48.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.523 1.929 . . . . 3.6699999999999999 107.805 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.428 ' CG1' ' HG1' ' A' ' 37' ' ' THR . 70.1 t -116.47 103.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 124.788 1.235 . . . . 1.72 108.384 -168.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -59.82 134.04 56.66 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 125.1 1.5 . . . . 4.1399999999999997 108.46 154.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.94 130.37 23.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.855 1.662 . . . . 2.5800000000000001 109.579 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 112' ' ' LYS . 5.0 m-20 -103.5 92.23 4.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.994 1.718 . . . . 2.3999999999999999 109.063 -175.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.7 mt -77.68 112.33 14.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.893 1.677 . . . . 2.4199999999999999 110.226 -172.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -86.5 128.07 34.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.805 0.842 . . . . 1.95 111.475 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.29 142.87 50.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.687 0.795 . . . . 3.27 113.003 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.59 133.05 30.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.528 1.531 . . . . 2.0099999999999998 114.292 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.11 -142.93 23.61 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.777 -1.329 . . . . 3.6099999999999999 109.777 -162.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.46 71.12 0.25 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.979 0.8 . . . . 2.1600000000000001 112.951 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -131.0 148.59 52.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.701 1.25 . . . . 5.8300000000000001 111.416 168.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.82 139.73 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.639 1.575 . . . . 1.78 109.235 170.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.71 145.71 48.79 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.424 1.09 . . . . 2.25 110.378 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 102' ' ' ASP . 17.2 mtpp -112.83 143.71 43.61 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.079 0.952 . . . . 4.0599999999999996 112.323 -169.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -158.64 125.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.326 1.45 . . . . 2.5 109.689 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.0 p -92.29 121.72 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.338 1.055 . . . . 3.0 109.142 170.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.04 143.28 48.34 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.293 1.437 . . . . 3.1600000000000001 111.634 -171.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.36 150.22 70.4 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.373 2.715 . . . . 1.1299999999999999 112.992 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.13 127.02 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.464 0.705 . . . . 2.0499999999999998 110.256 171.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.85 142.4 27.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.274 2.23 . . . . 5.0800000000000001 108.411 163.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.33 134.61 12.38 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.515 0.561 . . . . 2.71 112.515 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 116.179 -1.867 . . . . 9.9199999999999999 113.492 164.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.386 0 N-CA-C 108.925 -1.67 . . . . 17.77 108.925 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 m -135.98 163.37 30.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.57 1.148 . . . . 13.130000000000001 110.266 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -116.21 155.86 27.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.762 1.225 . . . . 13.449999999999999 108.199 159.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.7 t -157.02 169.17 25.43 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.487 1.115 . . . . 6.2400000000000002 109.81 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -108.78 117.19 33.55 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.977 0.911 . . . . 5.1500000000000004 111.632 -162.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.85 169.54 40.21 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 120.941 -1.1 . . . . 1.72 114.781 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.42 152.18 19.89 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.14 0.793 . . . . 1.97 113.14 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.78 124.2 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.452 -0.944 . . . . 2.0 108.452 163.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -83.34 109.17 17.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.177 0.991 . . . . 6.3700000000000001 108.655 167.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -179.31 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.841 1.052 . . . . 4.04 113.841 -173.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m -168.48 167.56 6.17 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.572 1.949 . . . . 2.25 109.198 162.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.15 -26.78 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.039 2.493 . . . . 2.5699999999999998 112.105 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.2 177.96 15.72 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.384 1.468 . . . . 1.6100000000000001 112.668 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.02 -15.8 19.87 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 118.69 1.245 . . . . 1.97 113.247 -1.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -129.15 164.98 22.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.631 1.572 . . . . 2.1099999999999999 112.77 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.97 163.4 30.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.391 2.276 . . . . 1.71 109.883 171.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.98 145.44 38.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.33 1.052 . . . . 2.1200000000000001 110.876 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.67 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.317 0.858 . . . . 1.53 113.317 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -145.78 158.44 43.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.998 1.719 . . . . 3.2799999999999998 110.844 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.7 152.31 13.71 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.497 1.119 . . . . 3.0600000000000001 111.395 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 m -79.57 149.74 31.3 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.594 1.558 . . . . 2.5800000000000001 108.065 155.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -155.7 134.44 11.9 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.916 1.287 . . . . 4.0099999999999998 108.902 173.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.62 119.05 27.91 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.895 1.278 . . . . 4.3200000000000003 109.693 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -77.42 117.01 62.63 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 1.46 109.939 173.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.32 -11.12 8.58 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.042 2.495 . . . . 1.5600000000000001 113.825 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.72 163.93 54.74 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 119.025 0.83 . . . . 1.5900000000000001 113.521 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.475 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.4 m-20 -91.87 -1.7 57.19 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.275 1.83 . . . . 3.54 112.634 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.28 159.74 40.32 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.311 1.844 . . . . 2.52 110.856 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.03 159.09 23.92 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.042 2.495 . . . . 1.25 111.41 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.72 156.48 17.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.857 0.837 . . . . 3.96 110.537 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -129.54 120.32 25.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.086 1.355 . . . . 6.1500000000000004 108.308 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -101.16 118.52 37.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.839 1.655 . . . . 1.96 108.541 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.77 -11.18 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.289 1.036 . . . . 1.8500000000000001 113.346 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.92 -170.78 43.7 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.601 1.096 . . . . 0.67000000000000004 111.314 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 149.99 25.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 2.04 111.809 166.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -118.3 139.76 50.85 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.848 -1.158 . . . . 6.6900000000000004 110.065 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.539 ' HG1' HG13 ' A' ' 99' ' ' VAL . 3.4 t -140.94 152.25 64.79 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.629 1.172 . . . . 2.04 110.083 -171.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.65 -26.67 83.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.239 1.959 . . . . 1.3600000000000001 113.978 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 m -88.38 -7.9 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 114.991 1.478 . . . . 2.0899999999999999 114.991 -170.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.55 168.96 21.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.9 0.88 . . . . 1.7 113.349 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.84 -73.89 0.63 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.586 0.354 . . . . 4.2199999999999998 111.036 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -68.39 139.89 55.82 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.721 -1.237 . . . . 3.3900000000000001 109.298 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.55 139.85 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 125.242 1.417 . . . . 3.27 108.336 162.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -129.95 117.34 19.95 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.465 1.106 . . . . 2.0800000000000001 108.682 164.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -77.21 120.85 22.84 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.743 0.782 . . . . 1.95 109.253 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -106.77 151.05 25.67 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.414 1.486 . . . . 0.67000000000000004 112.681 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 62' ' ' ARG . 13.2 pt-20 -95.78 160.59 14.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.782 2.033 . . . . 1.98 110.151 164.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.3 m -131.44 108.74 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.464 1.905 . . . . 2.1800000000000002 107.127 166.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -109.85 160.31 16.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 3.8900000000000001 112.232 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -113.06 139.34 48.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.083 0.953 . . . . 3.3300000000000001 110.115 157.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -151.56 150.94 30.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.107 1.363 . . . . 7.3700000000000001 111.985 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.68 144.34 52.28 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.835 0.854 . . . . 4.2199999999999998 110.74 154.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -154.58 -39.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 114.718 1.377 . . . . 4.3399999999999999 114.718 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -112.28 38.21 2.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.667 1.987 . . . . 4.21 109.205 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.67 -35.03 0.59 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.204 1.383 . . . . 3.3999999999999999 113.445 -164.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -92.7 160.22 15.08 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.722 2.409 . . . . 4.7300000000000004 111.037 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -74.27 142.28 45.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.48 0.919 . . . . 4.6699999999999999 113.48 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.59 158.03 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 127.792 2.437 . . . . 3.3500000000000001 108.09 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.2 mtm -111.08 152.82 26.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 3.8799999999999999 112.535 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.76 177.1 41.08 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 123.716 0.674 . . . . 1.1399999999999999 113.468 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -124.45 161.01 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.692 1.197 . . . . 2.6699999999999999 111.646 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 47' ' ' GLU . 86.5 mtm-85 -158.61 151.65 18.52 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 126.806 2.042 . . . . 6.4199999999999999 109.447 173.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.57 142.41 71.05 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 CA-C-N 121.375 1.527 . . . . 1.0 110.672 154.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -104.23 155.31 37.4 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.739 1.216 . . . . 1.75 110.76 168.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.19 -19.46 56.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.85999999999999999 112.641 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -177.63 165.55 2.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.243 2.217 . . . . 3.0699999999999998 110.617 175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -105.91 170.56 7.83 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.828 1.251 . . . . 2.0099999999999998 110.05 153.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -143.08 169.71 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.326 0.65 . . . . 2.5299999999999998 110.811 171.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -146.91 133.16 9.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 107.926 -1.139 . . . . 2.1099999999999999 107.926 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.01 167.57 25.67 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.127 1.218 . . . . 1.27 111.319 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.99 140.98 87.6 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.32 2.68 . . . . 1.3 110.952 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 59.3 mmtt 66.07 4.01 2.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.146 1.379 . . . . 2.5800000000000001 113.074 -173.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.88 114.05 3.96 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 127.129 2.3 . . . . 1.47 113.06 -169.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -75.86 132.16 40.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.028 -1.586 . . . . 5.5599999999999996 110.076 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.93 164.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.119 2.168 . . . . 2.8500000000000001 109.428 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.97 117.89 0.91 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.024 0.929 . . . . 3.4900000000000002 109.574 -171.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -74.96 64.3 1.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.762 2.025 . . . . 2.54 111.615 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -63.42 133.35 95.46 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.791 -1.193 . . . . 3.96 110.789 167.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.49 -20.91 66.32 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.339 2.692 . . . . 1.8500000000000001 113.76 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.21 55.98 5.05 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.081 0.848 . . . . 1.49 111.23 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.46 -64.49 0.13 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.635 1.112 . . . . 1.3500000000000001 113.998 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -153.85 145.0 22.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.64 1.576 . . . . 3.2599999999999998 111.254 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -166.06 163.73 18.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.296 1.038 . . . . 1.3100000000000001 111.169 -174.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -107.73 127.02 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.069 0.548 . . . . 3.52 111.065 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -90.69 108.41 19.8 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.265 1.426 . . . . 2.25 110.142 164.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.39 130.76 37.98 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.144 0.978 . . . . 4.3300000000000001 108.772 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.82 150.62 51.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.265 1.426 . . . . 2.75 110.781 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.35 53.31 5.19 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.979 -0.848 . . . . 2.9900000000000002 110.979 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.6 mt -68.95 114.04 6.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.883 0.842 . . . . 2.0899999999999999 109.555 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -98.96 -0.1 42.86 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.866 1.266 . . . . 2.8999999999999999 111.961 -166.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -157.04 148.84 17.3 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.526 1.93 . . . . 7.04 108.7 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.44 156.38 54.43 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.363 2.042 . . . . 2.1400000000000001 109.624 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mp -103.11 155.56 18.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.573 1.178 . . . . 4.2199999999999998 112.139 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -120.53 123.58 43.25 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.099 2.16 . . . . 5.8099999999999996 109.392 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 131.58 50.82 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.151 -0.968 . . . . 2.8700000000000001 111.586 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.08 44.06 78.71 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.16 -0.8 . . . . 1.78 112.669 -172.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.95 -178.07 3.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.741 -1.207 . . . . 3.04 107.741 151.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -127.0 161.29 28.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.472 1.109 . . . . 3.77 109.543 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.539 HG13 ' HG1' ' A' ' 37' ' ' THR . 16.8 t -126.22 120.78 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 124.615 1.166 . . . . 2.4700000000000002 109.816 -175.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -68.89 119.23 12.89 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 124.488 1.117 . . . . 2.7599999999999998 108.619 154.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.99 120.81 40.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.735 0.779 . . . . 2.8500000000000001 109.055 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.9 93.66 8.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.762 -1.563 . . . . 2.4300000000000002 107.964 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.05 119.45 11.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.685 -0.857 . . . . 2.2000000000000002 108.685 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.8 mt -90.92 120.59 32.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.665 -0.865 . . . . 1.7 108.665 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.12 131.18 57.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.069 0.938 . . . . 3.5 112.343 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.61 -18.51 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 131.014 3.726 . . . . 3.7599999999999998 116.932 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.81 -22.42 0.71 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.345 1.926 . . . . 5.7999999999999998 113.721 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.01 -6.56 0.06 OUTLIER Glycine 0 N--CA 1.474 1.204 0 N-CA-C 117.362 1.705 . . . . 3.8100000000000001 117.362 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 101.0 8.18 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 120.384 2.092 . . . . 5.9199999999999999 109.582 175.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.21 138.44 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.729 1.212 . . . . 2.5299999999999998 110.041 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.53 136.55 33.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.36 1.064 . . . . 2.9100000000000001 111.748 166.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.45 125.41 25.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.975 0.51 . . . . 3.3300000000000001 111.967 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -101.54 154.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.946 -0.761 . . . . 3.0 108.946 142.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.8 p -118.99 139.8 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.062 -1.088 . . . . 2.9100000000000001 108.062 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -162.55 155.57 16.9 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.022 1.729 . . . . 3.9399999999999999 110.127 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.93 160.12 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.389 3.393 . . . . 1.2 115.04 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.3 t -87.6 122.59 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.697 1.199 . . . . 1.9099999999999999 110.058 164.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -92.64 131.17 37.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.729 2.011 . . . . 3.8199999999999998 107.554 161.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.21 116.17 5.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.308 0.643 . . . . 3.4100000000000001 111.431 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 129.3 3.04 . . . . 8.2400000000000002 107.208 176.68 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 N-CA-C 109.448 -1.461 . . . . 16.379999999999999 109.448 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 t -165.43 178.73 6.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.204 1.002 . . . . 12.59 109.458 -174.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.76 -11.28 14.41 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.291 1.219 . . . . 15.98 114.291 -167.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.5 m -137.01 3.27 2.65 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.76 1.624 . . . . 9.2300000000000004 112.371 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -98.61 -176.37 3.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.934 1.294 . . . . 5.1600000000000001 110.122 171.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.94 154.82 18.24 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 120.885 -1.135 . . . . 1.4099999999999999 112.684 166.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -158.3 145.09 17.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.476 1.111 . . . . 1.5 111.675 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -97.33 137.16 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.791 -0.818 . . . . 1.8200000000000001 108.791 171.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.28 92.32 4.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.921 1.289 . . . . 4.1299999999999999 109.536 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.18 159.67 9.4 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 123.548 1.642 . . . . 3.3199999999999998 112.383 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -162.85 154.69 15.4 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 129.08 2.952 . . . . 2.8900000000000001 106.54 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 39.06 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.058 3.172 . . . . 2.1899999999999999 112.418 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.23 178.79 51.42 Favored Glycine 0 CA--C 1.541 1.668 0 O-C-N 121.206 -0.934 . . . . 2.2999999999999998 112.173 -156.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.82 -12.23 23.54 Favored 'Cis proline' 0 CA--C 1.54 0.798 0 CA-C-N 118.435 1.118 . . . . 3.1800000000000002 112.457 -11.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -155.7 168.54 26.84 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.411 1.884 . . . . 2.25 110.997 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.61 -177.15 4.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 1.5700000000000001 111.042 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.24 152.67 47.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.224 1.01 . . . . 2.0699999999999998 112.506 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.01 140.32 52.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.166 0.986 . . . . 1.8200000000000001 111.858 167.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -128.19 152.0 48.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.499 1.92 . . . . 3.3799999999999999 110.517 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pp -165.11 133.51 3.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.938 1.829 . . . . 2.73 115.938 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 m -76.81 139.02 40.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.143 -1.39 . . . . 1.8300000000000001 108.685 156.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.25 145.07 16.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 3.6000000000000001 108.257 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.43 144.94 49.18 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.518 0.599 . . . . 3.3399999999999999 111.502 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -86.9 109.58 25.68 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 108.621 -0.881 . . . . 1.3400000000000001 108.621 155.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.05 -14.07 5.24 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.965 1.777 . . . . 1.3300000000000001 114.411 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.27 -153.98 24.16 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.63 1.012 . . . . 1.46 115.63 -159.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -93.74 -32.03 14.18 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.138 2.575 . . . . 5.8200000000000003 113.932 -173.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.12 158.83 36.91 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.375 1.47 . . . . 2.5600000000000001 112.052 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.85 155.33 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.798 2.332 . . . . 1.3899999999999999 111.786 -170.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.91 132.52 56.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.142 1.377 . . . . 3.6200000000000001 109.138 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -125.98 106.54 9.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.297 1.039 . . . . 5.79 111.937 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.7 tp -92.21 112.51 24.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.463 2.305 . . . . 2.1800000000000002 109.651 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.02 -7.4 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.155 1.382 . . . . 1.9299999999999999 113.277 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.94 -167.09 38.67 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 121.458 -0.776 . . . . 0.62 112.247 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.34 175.29 10.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.107 0.563 . . . . 1.73 111.9 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -156.31 91.27 1.24 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.221 -1.77 . . . . 7.7400000000000002 106.221 -164.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.415 ' HG1' ' CG1' ' A' ' 99' ' ' VAL . 1.5 t -104.7 152.85 39.54 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.116 1.366 . . . . 1.6799999999999999 110.59 -176.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -27.55 16.28 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.394 2.729 . . . . 1.27 113.531 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.31 1.7 m -89.93 -0.11 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 114.355 1.243 . . . . 1.8799999999999999 114.355 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.96 140.66 50.88 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.876 0.871 . . . . 1.73 112.24 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -72.48 -68.89 0.44 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.173 -1.047 . . . . 5.54 108.173 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -90.09 149.25 22.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.442 2.297 . . . . 4.1299999999999999 109.653 168.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.23 139.66 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.545 1.538 . . . . 2.5699999999999998 109.548 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -142.17 140.82 32.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.906 1.682 . . . . 2.0299999999999998 110.521 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -81.79 122.5 27.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.515 1.052 . . . . 2.2599999999999998 111.346 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -111.74 156.9 21.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.561 1.544 . . . . 0.68999999999999995 112.553 174.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.95 -179.64 4.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.228 2.211 . . . . 1.8200000000000001 111.112 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.5 m -126.85 114.29 17.71 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.808 -1.553 . . . . 2.3900000000000001 106.808 151.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -89.5 152.15 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 3.8199999999999998 111.025 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.1 ptp -101.24 144.88 29.55 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.499 -0.773 . . . . 3.75 110.133 155.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.4 158.79 34.88 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.216 1.806 . . . . 8.3599999999999994 109.468 171.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.484 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -90.37 148.95 22.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.585 -0.895 . . . . 3.8799999999999999 108.585 167.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.96 -79.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.649 0.737 . . . . 3.98 110.372 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 56' ' ' LYS . 13.8 tt0 -76.19 35.18 0.14 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.445 2.298 . . . . 4.6399999999999997 111.651 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.33 -12.37 0.94 Allowed Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.289 -1.507 . . . . 2.0 113.744 -161.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 54' ' ' GLU . 34.4 mtpt -106.78 154.34 21.14 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 128.032 2.533 . . . . 5.2000000000000002 109.736 -173.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.484 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 19.7 mtpp -70.14 137.49 51.11 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.696 0.399 . . . . 4.6600000000000001 110.868 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.71 148.69 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.482 1.913 . . . . 3.0600000000000001 108.402 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 19.8 mmt -115.5 142.04 47.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.697 1.199 . . . . 5.5800000000000001 109.351 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.82 151.76 23.37 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.283 0.947 . . . . 1.24 114.19 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -93.64 159.27 15.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.147 0.979 . . . . 2.9399999999999999 111.833 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -173.41 140.21 0.86 Allowed Pre-proline 0 N--CA 1.473 0.692 0 CA-C-O 116.67 -1.633 . . . . 4.6600000000000001 110.246 -168.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -70.63 148.76 60.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.363 1.88 . . . . 1.25 111.378 170.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.86 151.9 74.47 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 125.254 1.422 . . . . 1.98 110.206 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.06 -13.65 26.12 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.938 2.425 . . . . 1.1899999999999999 113.777 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -175.03 164.71 3.4 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.8 1.24 . . . . 3.1699999999999999 111.572 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -121.64 170.25 9.9 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 127.404 2.282 . . . . 1.95 108.915 152.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.57 172.43 18.57 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.244 -0.91 . . . . 2.23 110.804 169.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.9 t -147.55 122.57 5.18 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 125.161 1.385 . . . . 2.2000000000000002 109.664 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.11 159.66 51.55 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.947 1.765 . . . . 1.47 110.656 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.3 139.11 88.45 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.872 3.048 . . . . 1.1799999999999999 111.588 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.07 -8.32 1.32 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.252 2.221 . . . . 4.25 115.088 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.08 129.03 8.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 126.525 2.012 . . . . 1.1299999999999999 110.283 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -87.65 148.16 24.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.556 -0.822 . . . . 5.6299999999999999 112.411 163.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.99 167.02 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.653 1.581 . . . . 3.7000000000000002 110.788 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -154.23 85.28 1.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.845 1.658 . . . . 3.04 107.0 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.83 68.87 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.894 1.678 . . . . 2.71 112.055 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -72.36 151.45 92.01 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.497 2.719 . . . . 4.1299999999999999 113.658 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.45 -58.91 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.752 2.968 . . . . 1.6299999999999999 112.614 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.85 83.3 1.16 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.389 -1.484 . . . . 1.5 109.389 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.6 -97.18 0.16 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 125.274 1.416 . . . . 1.3 111.492 -166.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -151.65 134.23 15.47 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.658 1.583 . . . . 3.3799999999999999 109.455 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -163.53 175.73 10.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.724 1.147 . . . . 1.21 110.647 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -108.65 125.81 52.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.128 0.571 . . . . 3.7000000000000002 110.497 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -85.57 144.46 27.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.334 1.054 . . . . 1.9099999999999999 110.273 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -124.18 138.9 54.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.418 1.887 . . . . 2.9300000000000002 109.543 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.69 157.22 46.12 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.153 0.981 . . . . 3.3100000000000001 112.106 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.26 -54.78 3.59 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 126.343 1.925 . . . . 2.8599999999999999 114.732 167.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.8 mt 76.81 95.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 130.305 3.442 . . . . 1.8899999999999999 113.037 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -78.62 -0.97 31.97 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.834 1.42 . . . . 3.23 114.834 -172.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -144.3 145.66 30.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 127.136 2.174 . . . . 6.4000000000000004 108.206 172.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.31 115.67 4.38 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.19 1.26 . . . . 2.7599999999999998 110.174 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.72 151.69 23.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 112.869 -1.969 . . . . 3.6600000000000001 109.913 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU 0.268 0.0 OUTLIER -144.82 -7.84 0.65 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 117.121 2.267 . . . . 5.8300000000000001 117.121 179.855 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.67 170.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.103 2.561 . . . . 3.25 112.972 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.51 34.51 53.97 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.253 -0.748 . . . . 1.6899999999999999 111.681 -164.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.404 ' CD ' ' HZ3' ' A' ' 94' ' ' LYS . 11.4 pt-20 -151.32 174.01 13.82 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 127.224 2.21 . . . . 3.3700000000000001 109.694 -174.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 164.18 14.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.021 2.128 . . . . 4.0 111.696 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.415 ' CG1' ' HG1' ' A' ' 37' ' ' THR . 99.2 t -133.86 108.38 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.593 1.157 . . . . 1.6399999999999999 109.455 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.478 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 53.0 mt-10 -71.34 98.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.979 -1.119 . . . . 3.6400000000000001 107.979 159.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 tt -98.74 138.61 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.697 -0.853 . . . . 3.0 108.697 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.01 138.6 31.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 3.77 112.053 168.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.38 122.74 43.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.457 2.303 . . . . 2.3300000000000001 109.075 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.6 mt -92.89 119.73 32.5 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.136 0.974 . . . . 1.96 109.935 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -115.57 150.52 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.943 0.877 . . . . 3.6000000000000001 113.254 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 162.83 28.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.996 -0.547 . . . . 2.4100000000000001 111.332 165.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 20.4 79.55 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.263 -0.743 . . . . 4.6799999999999997 114.266 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.52 61.28 2.8 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 118.61 1.205 . . . . 2.4300000000000002 112.319 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 154.76 43.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.071 2.148 . . . . 4.8499999999999996 110.115 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -168.66 140.83 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.392 2.277 . . . . 2.8599999999999999 107.407 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.8 mt -150.21 109.61 3.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.187 0.903 . . . . 2.6200000000000001 111.175 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 30.4 ttpt -81.7 111.6 18.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.284 0.634 . . . . 3.79 110.769 173.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -117.0 141.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.188 1.795 . . . . 2.3599999999999999 110.427 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.83 116.16 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.049 0.939 . . . . 2.7999999999999998 112.227 -173.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.8 150.57 46.02 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.573 1.549 . . . . 4.4699999999999998 110.018 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.11 159.91 26.75 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.074 3.183 . . . . 1.1799999999999999 111.954 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 130.59 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.086 0.955 . . . . 2.2799999999999998 111.342 169.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -97.96 139.65 33.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.832 2.453 . . . . 3.2400000000000002 107.48 159.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.05 9.31 32.49 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.345 1.98 . . . . 2.8799999999999999 116.345 -162.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.785 0 C-N-CA 126.956 2.102 . . . . 7.6100000000000003 110.133 -172.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.416 0 N-CA-C 108.921 -1.671 . . . . 13.529999999999999 108.921 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 p -179.18 165.25 1.46 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.811 1.244 . . . . 10.08 109.893 -166.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -76.53 54.64 0.96 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.807 1.243 . . . . 15.109999999999999 112.134 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.6 m -91.32 -28.61 17.63 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.536 1.934 . . . . 7.3300000000000001 110.643 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -130.87 179.95 5.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.839 2.456 . . . . 5.3399999999999999 110.692 -161.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.81 163.1 12.86 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.714 1.149 . . . . 1.77 115.277 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -151.37 149.46 29.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.4 1.08 . . . . 1.8700000000000001 113.228 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.49 121.55 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.405 0.682 . . . . 1.6499999999999999 110.118 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -86.69 90.43 8.27 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.027 0.931 . . . . 6.8700000000000001 110.754 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.03 149.33 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.246 1.418 . . . . 3.7999999999999998 112.054 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.0 m -155.59 162.54 27.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.774 2.029 . . . . 2.8599999999999999 109.724 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.03 -5.87 13.87 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.522 2.814 . . . . 2.0499999999999998 113.582 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 170.29 31.99 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.517 1.056 . . . . 1.8100000000000001 113.328 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.84 -2.29 21.84 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 117.951 0.875 . . . . 2.23 113.272 -4.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.73 152.85 33.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.43 1.092 . . . . 2.9900000000000002 112.595 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.89 175.1 14.38 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.377 1.871 . . . . 1.8200000000000001 111.318 166.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.61 156.23 36.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.846 0.858 . . . . 2.0299999999999998 110.73 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.5 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.747 0.784 . . . . 1.5700000000000001 111.311 162.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.52 143.28 49.82 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.947 1.699 . . . . 3.5899999999999999 108.3 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.02 144.78 23.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 120.687 -1.258 . . . . 2.5699999999999998 113.985 174.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -92.39 111.48 23.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.913 -1.494 . . . . 2.23 107.35 170.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.1 tt -120.16 147.18 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.873 2.469 . . . . 3.8500000000000001 109.126 -174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -142.71 152.43 42.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.16 0.981 . . . . 2.75 113.418 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -100.14 102.39 17.84 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 113.976 -1.465 . . . . 1.1799999999999999 109.269 171.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.88 -9.93 16.84 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.811 2.341 . . . . 1.26 113.041 174.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.84 -179.12 52.78 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 124.55 1.071 . . . . 1.1200000000000001 113.464 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.3 m-20 -107.73 -2.73 19.8 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.182 1.793 . . . . 3.1499999999999999 112.965 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.25 160.66 40.52 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.479 1.911 . . . . 2.23 109.873 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.41 156.47 32.68 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.47 2.113 . . . . 0.78000000000000003 111.884 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.13 120.02 36.5 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.991 1.316 . . . . 3.5800000000000001 110.05 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -106.89 103.72 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.936 1.294 . . . . 6.3799999999999999 111.609 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.22 114.45 26.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.858 2.063 . . . . 1.72 109.282 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 m -92.21 -23.48 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.486 0.714 . . . . 2.1899999999999999 112.554 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.77 -168.64 40.24 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 123.751 0.691 . . . . 0.54000000000000004 111.529 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.93 175.07 12.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.506 -0.759 . . . . 2.0899999999999999 111.019 169.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -154.96 157.69 38.09 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.101 1.319 . . . . 7.7599999999999998 111.96 -167.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.509 ' HG1' HG12 ' A' ' 99' ' ' VAL . 2.7 t -161.18 154.88 18.49 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 124.843 1.257 . . . . 2.21 110.226 -172.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -68.21 -17.42 45.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.995 1.797 . . . . 1.1899999999999999 113.074 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 1.5 m -86.22 11.74 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.123 1.157 . . . . 1.77 114.123 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.62 162.18 40.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.747 1.219 . . . . 2.0099999999999998 111.917 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.9 -75.68 0.62 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.482 -0.562 . . . . 3.3100000000000001 109.482 170.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -75.31 146.0 41.34 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.763 -1.199 . . . . 4.8499999999999996 107.763 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -165.12 137.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.029 1.332 . . . . 2.5699999999999998 108.58 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -142.64 136.28 28.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.733 1.213 . . . . 1.99 110.547 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -79.97 120.15 23.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.568 0.699 . . . . 1.8300000000000001 109.635 163.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -104.27 152.75 21.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.032 1.333 . . . . 0.58999999999999997 111.327 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -106.54 163.67 12.69 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.562 1.945 . . . . 2.5099999999999998 110.016 163.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.6 m -152.2 113.71 4.33 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.104 1.362 . . . . 1.96 108.403 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -131.77 151.65 51.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.689 1.196 . . . . 3.6099999999999999 112.343 -160.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.32 154.33 25.35 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.151 0.98 . . . . 4.8899999999999997 112.262 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -156.05 160.23 39.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.23 1.012 . . . . 6.5700000000000003 111.516 172.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.12 155.21 16.92 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.975 1.31 . . . . 5.21 109.658 162.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.29 113.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 124.99 1.431 . . . . 4.21 111.175 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 60.53 17.41 7.32 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.032 0.933 . . . . 4.3899999999999997 112.345 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.85 4.91 89.62 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.239 -1.538 . . . . 3.46 114.267 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.43 128.75 34.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.722 1.609 . . . . 3.8999999999999999 109.795 168.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.05 134.75 51.16 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.252 -0.905 . . . . 7.1100000000000003 109.699 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.56 165.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.881 0.872 . . . . 4.3700000000000001 110.829 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.6 ptp -130.24 148.81 52.11 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.25 1.02 . . . . 4.1200000000000001 111.649 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 164.83 15.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.005 1.288 . . . . 2.1400000000000001 111.716 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.31 157.21 46.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 3.4300000000000002 110.609 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -160.77 137.15 6.3 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 116.153 -1.879 . . . . 5.1399999999999997 108.99 -173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.34 146.36 85.6 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.971 1.74 . . . . 0.89000000000000001 110.403 151.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.98 155.96 52.54 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.853 1.261 . . . . 2.1499999999999999 110.538 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.14 -14.59 25.91 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.005 2.47 . . . . 1.5600000000000001 113.095 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -176.18 165.96 2.86 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.492 1.917 . . . . 4.1299999999999999 112.292 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -117.59 176.0 5.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.459 2.304 . . . . 2.46 109.022 154.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.83 168.92 23.57 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.883 -1.135 . . . . 2.6800000000000002 112.217 163.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.8 t -140.72 130.83 13.37 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.222 1.009 . . . . 2.0 109.446 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.61 162.67 38.19 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.473 2.115 . . . . 0.97999999999999998 111.206 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.6 143.67 99.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.162 2.575 . . . . 1.05 111.638 176.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 63.9 mmtt 66.93 1.45 2.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.614 1.966 . . . . 2.3500000000000001 113.752 -175.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.4 119.69 4.97 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 126.94 2.21 . . . . 1.03 111.164 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 135.21 36.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.77 1.228 . . . . 4.6500000000000004 111.147 160.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.96 152.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.024 1.729 . . . . 2.1099999999999999 110.77 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.55 120.56 32.32 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.85 1.66 . . . . 4.6799999999999997 109.075 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.34 69.24 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.251 1.5 . . . . 1.9099999999999999 112.973 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.49 133.6 53.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.405 1.882 . . . . 3.8700000000000001 113.368 169.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -56.34 -44.96 41.2 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.411 2.074 . . . . 2.02 111.201 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.69 2.4 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.948 1.261 . . . . 1.3999999999999999 111.65 167.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -74.24 0.2 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.756 2.122 . . . . 1.5900000000000001 112.271 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -151.87 132.74 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.35 1.46 . . . . 3.5899999999999999 111.574 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -158.89 176.76 11.92 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.679 -1.263 . . . . 1.0800000000000001 111.357 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -111.93 130.46 55.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 112.359 0.503 . . . . 3.5800000000000001 112.359 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -94.3 130.11 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.836 1.255 . . . . 1.6599999999999999 111.066 165.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.0 mt -109.83 132.74 53.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.797 1.639 . . . . 2.7999999999999998 109.001 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.02 150.49 49.23 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.32 1.057 . . . . 2.5800000000000001 112.969 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.92 -61.96 4.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.517 1.056 . . . . 2.6800000000000002 110.979 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mt 68.42 88.56 0.11 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 129.925 3.29 . . . . 2.1699999999999999 110.42 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -74.86 -3.81 34.16 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.131 -0.981 . . . . 2.73 113.281 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -145.56 144.39 22.61 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 127.809 2.444 . . . . 5.3300000000000001 107.768 168.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.71 173.2 14.49 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.649 2.233 . . . . 2.29 110.186 157.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.3 172.01 10.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.516 1.926 . . . . 5.29 108.149 166.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HZ2' ' CD ' ' A' ' 97' ' ' GLU 0.252 0.0 OUTLIER -126.79 1.9 6.71 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.828 1.788 . . . . 4.1500000000000004 115.828 174.082 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 76.38 158.43 0.2 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.785 2.834 . . . . 2.3700000000000001 110.922 -167.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 55.8 6.83 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 121.532 -0.73 . . . . 1.75 111.626 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.485 ' CD ' ' HZ2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -157.92 176.9 11.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.302 2.241 . . . . 3.5800000000000001 109.494 173.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.66 171.76 7.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.858 1.263 . . . . 4.25 109.804 166.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.509 HG12 ' HG1' ' A' ' 37' ' ' THR . 16.7 t -128.8 125.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.825 1.65 . . . . 1.6599999999999999 107.376 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 27.5 tt0 -77.68 140.95 39.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.474 0.484 . . . . 3.1699999999999999 109.81 166.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.71 126.6 12.73 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.856 1.058 . . . . 2.3999999999999999 113.856 -168.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.82 102.21 14.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.742 2.417 . . . . 2.6800000000000002 111.314 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.3 mt -78.58 111.91 15.13 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.926 -1.109 . . . . 2.98 111.166 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -90.8 122.38 33.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.884 1.274 . . . . 1.98 112.01 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.46 134.94 55.08 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.011 -1.056 . . . . 3.2200000000000002 113.597 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.03 -28.03 69.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.896 1.278 . . . . 2.48 113.605 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 31.25 1.09 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.73 1.157 . . . . 4.21 114.366 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.75 44.76 88.61 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.913 1.244 . . . . 1.8200000000000001 112.628 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 150.22 45.66 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.394 1.478 . . . . 5.0 111.283 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.83 137.28 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.048 -1.464 . . . . 2.5899999999999999 107.048 155.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.4 mt -120.2 104.94 10.49 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 107.897 -1.149 . . . . 2.8399999999999999 107.897 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.461 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 22.5 ttpt -84.15 128.49 34.6 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.881 -0.512 . . . . 4.1500000000000004 110.99 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.02 149.93 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.619 1.568 . . . . 3.6000000000000001 110.637 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.62 150.85 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.62 1.168 . . . . 4.1600000000000001 111.121 171.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -149.36 150.1 30.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.258 1.823 . . . . 3.0899999999999999 109.577 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.37 156.22 54.88 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.299 3.333 . . . . 1.6399999999999999 114.054 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 69.1 t -87.22 145.9 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.379 1.072 . . . . 2.4500000000000002 111.882 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.25 152.52 51.3 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.378 3.471 . . . . 3.8500000000000001 107.065 176.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.87 168.58 19.44 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.251 1.575 . . . . 3.1499999999999999 115.251 -152.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 C-N-CA 128.006 2.523 . . . . 10.9 110.718 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.234 0 N-CA-C 106.265 -2.734 . . . . 14.18 106.265 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -53.83 154.32 4.02 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 119.392 -0.923 . . . . 12.58 109.946 134.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.1 144.99 41.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.021 0.928 . . . . 15.49 111.039 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.7 m -147.16 -27.5 0.38 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.493 1.917 . . . . 7.7699999999999996 111.193 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.514 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 14.4 tt0 -89.36 173.52 8.33 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.24 1.416 . . . . 5.5199999999999996 111.067 164.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.514 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -124.42 146.77 16.36 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.323 1.439 . . . . 1.3799999999999999 113.244 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -137.31 141.48 41.89 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.591 0.96 . . . . 1.6399999999999999 113.591 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.8 t -95.47 107.95 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.709 0.804 . . . . 2.02 109.48 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -88.92 111.72 22.44 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.492 1.042 . . . . 4.7800000000000002 111.027 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.26 168.92 18.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.399 1.48 . . . . 3.9500000000000002 112.844 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -160.98 158.3 23.91 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.267 1.827 . . . . 2.4500000000000002 110.212 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.69 6.65 3.96 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.027 3.151 . . . . 1.51 114.022 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.07 166.98 29.16 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.363 0.982 . . . . 1.4199999999999999 112.367 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.11 -2.27 22.87 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 CA-C-N 118.359 1.079 . . . . 1.71 112.724 -5.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -136.61 169.66 17.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.29 1.436 . . . . 2.0800000000000001 113.54 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.46 171.04 21.08 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.134 1.774 . . . . 1.8300000000000001 112.372 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.55 101.88 6.37 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.199 0.999 . . . . 1.78 112.845 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.6 139.08 31.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.88 0.696 . . . . 1.8799999999999999 112.88 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.12 156.47 28.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.389 . . . . 3.4700000000000002 111.0 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.484 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -160.77 146.02 14.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.732 1.753 . . . . 2.46 115.732 166.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 m -79.66 126.9 31.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.461 -0.94 . . . . 1.8 108.461 158.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -130.22 138.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.855 1.662 . . . . 3.6400000000000001 110.215 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.09 160.22 39.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.84 0.829 . . . . 2.7400000000000002 113.07 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.19 94.28 47.14 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.507 1.523 . . . . 1.01 109.999 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.98 -5.01 15.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.938 1.759 . . . . 1.3300000000000001 112.769 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.14 156.31 37.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.33 0.967 . . . . 1.1399999999999999 113.085 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.3 m-20 -91.91 4.73 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.456 1.902 . . . . 2.98 113.668 -171.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.84 159.07 42.16 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.859 1.663 . . . . 2.2400000000000002 110.506 168.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.09 154.24 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.14 2.56 . . . . 0.72999999999999998 111.286 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.74 155.09 20.58 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.042 0.937 . . . . 3.0800000000000001 111.104 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 68' ' ' GLU . 19.5 ttm180 -133.47 112.34 11.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.042 1.337 . . . . 5.2199999999999998 109.012 168.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.6 tp -93.93 110.47 22.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.759 2.024 . . . . 1.8600000000000001 108.051 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -102.06 -13.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.277 0.843 . . . . 1.6499999999999999 113.277 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -160.72 29.53 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.117 0.865 . . . . 0.46000000000000002 112.76 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.59 174.4 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.788 1.235 . . . . 1.9199999999999999 111.229 166.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -141.99 135.89 29.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.458 1.503 . . . . 6.1799999999999997 109.279 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -145.09 147.65 35.36 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 119.594 1.088 . . . . 1.9399999999999999 110.643 -171.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.29 -0.39 10.0 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.5 2.8 . . . . 1.21 113.92 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.08 13.28 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.781 1.232 . . . . 2.1200000000000001 114.093 174.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.34 157.04 43.75 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.431 -1.418 . . . . 2.2799999999999998 111.667 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -105.35 -70.49 0.78 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.733 -0.84 . . . . 3.9500000000000002 108.733 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -79.22 146.85 32.83 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.969 -1.123 . . . . 4.4900000000000002 107.969 161.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -147.09 137.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.097 1.359 . . . . 2.3999999999999999 108.713 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -128.45 133.76 48.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.701 2.0 . . . . 2.3300000000000001 108.565 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -82.82 123.34 29.26 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.839 1.199 . . . . 2.1200000000000001 110.28 167.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 15.3 m170 -109.1 154.96 21.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.387 1.475 . . . . 0.65000000000000002 111.913 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -109.49 -179.14 3.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.594 1.958 . . . . 2.3799999999999999 110.923 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.7 m -133.63 114.34 13.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.497 1.519 . . . . 2.1899999999999999 108.013 164.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -100.72 151.96 21.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.369 1.068 . . . . 3.0099999999999998 111.712 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -83.96 149.63 26.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.814 0.846 . . . . 4.75 111.082 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -154.66 135.9 14.01 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.779 0.832 . . . . 6.6299999999999999 110.844 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.91 146.57 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.051 -0.722 . . . . 4.9000000000000004 109.051 157.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -152.6 123.61 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.329 1.452 . . . . 4.1600000000000001 108.586 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 50.11 38.33 16.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.205 1.002 . . . . 4.5700000000000003 111.806 -169.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.32 -2.69 9.33 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.895 1.712 . . . . 2.7999999999999998 115.924 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -84.67 130.36 34.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.356 1.578 . . . . 3.4500000000000002 109.514 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.08 136.79 40.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.856 1.262 . . . . 5.9100000000000001 112.609 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -151.75 151.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.225 2.21 . . . . 3.1400000000000001 108.685 -167.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -113.72 131.65 56.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.196 0.998 . . . . 3.8799999999999999 109.9 168.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.81 164.21 22.0 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 124.384 0.992 . . . . 1.29 112.857 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -106.73 160.52 15.41 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.665 1.186 . . . . 2.6899999999999999 112.58 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -168.65 155.82 7.14 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 126.334 1.854 . . . . 4.5700000000000003 110.583 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.8 Cg_endo -69.58 152.84 70.28 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.79 1.66 . . . . 0.84999999999999998 112.286 167.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.27 158.42 48.63 Favored Pre-proline 0 N--CA 1.473 0.694 0 C-N-CA 126.312 1.845 . . . . 1.98 110.148 172.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.77 -16.76 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.594 2.196 . . . . 0.92000000000000004 112.68 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -179.74 162.55 1.08 Allowed 'General case' 0 C--N 1.347 0.465 0 C-N-CA 126.236 1.815 . . . . 3.1099999999999999 110.573 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -109.63 174.23 5.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.002 2.121 . . . . 1.97 109.554 157.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.5 pt-20 -154.83 166.84 32.23 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.145 -0.972 . . . . 2.3799999999999999 112.125 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.28 135.9 11.18 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 124.024 0.93 . . . . 1.8700000000000001 109.403 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.21 168.22 22.76 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.021 1.814 . . . . 0.91000000000000003 111.435 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.66 143.18 91.99 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.365 2.71 . . . . 0.81000000000000005 111.615 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.9 mmmt 68.15 1.0 2.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.968 2.107 . . . . 2.5299999999999998 114.012 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.92 -171.61 27.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.353 1.93 . . . . 1.1399999999999999 112.289 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -158.16 160.89 37.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.276 1.213 . . . . 4.9199999999999999 114.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 m -143.9 132.14 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.365 1.466 . . . . 3.3100000000000001 111.136 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -93.4 126.55 38.59 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.283 0.633 . . . . 3.6899999999999999 109.336 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -71.03 66.6 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.834 1.302 . . . . 2.0099999999999998 109.268 161.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -73.11 141.55 81.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.533 2.333 . . . . 4.0800000000000001 111.422 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.13 -44.46 49.16 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 1.3 113.677 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.89 80.85 1.56 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.671 -1.372 . . . . 1.3899999999999999 109.671 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.17 -70.33 0.2 Allowed Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.097 -0.835 . . . . 1.3100000000000001 114.211 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -157.17 146.98 20.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.344 1.857 . . . . 3.4199999999999999 110.154 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -172.89 152.56 2.44 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.569 -1.332 . . . . 1.6000000000000001 110.444 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -88.98 123.89 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.537 0.335 . . . . 3.7400000000000002 110.961 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.6 mmt -83.54 100.9 11.08 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.881 1.272 . . . . 1.6399999999999999 109.798 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -78.79 138.6 38.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.723 1.209 . . . . 2.6499999999999999 107.811 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -144.09 148.9 35.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.443 1.116 . . . . 2.4700000000000002 112.178 -173.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.8 -53.13 4.53 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.8 1.191 . . . . 2.5699999999999998 111.42 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 61.15 95.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.667 2.787 . . . . 1.9399999999999999 110.92 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.9 -15.1 62.09 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.794 -1.191 . . . . 3.4500000000000002 112.339 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -147.14 145.66 22.87 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 128.292 2.637 . . . . 5.54 107.848 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.72 176.63 8.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.984 2.456 . . . . 2.7400000000000002 109.879 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.55 -179.0 5.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.972 0.909 . . . . 4.75 111.93 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -151.0 144.65 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.461 1.904 . . . . 5.8099999999999996 110.022 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 131.57 49.3 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.624 1.169 . . . . 3.04 112.955 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.58 -16.37 52.05 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.887 -1.507 . . . . 3.9300000000000002 115.125 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.69 172.11 8.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.541 1.67 . . . . 6.0800000000000001 111.191 -166.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.42 111.88 23.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.263 1.825 . . . . 4.4299999999999997 111.485 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.67 117.63 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.085 -1.08 . . . . 2.1699999999999999 108.085 165.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -74.19 140.91 45.44 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.38 1.086 . . . . 2.9399999999999999 110.911 157.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.78 125.97 12.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.938 1.695 . . . . 2.8799999999999999 109.843 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.57 96.29 7.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.98 2.112 . . . . 2.8399999999999999 109.439 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.0 mt -80.27 112.42 17.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.023 1.729 . . . . 2.79 110.222 -171.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.4 mt -82.85 128.61 34.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.314 1.046 . . . . 2.27 111.472 -170.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.2 126.96 47.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.649 0.78 . . . . 3.7599999999999998 112.055 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 41.28 29.34 0.09 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.59 2.356 . . . . 3.0600000000000001 116.399 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.73 -55.39 3.8 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.321 1.439 . . . . 4.3099999999999996 113.087 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.33 -3.13 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.82 1.2 . . . . 2.1200000000000001 115.374 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -130.52 161.16 32.1 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.07 1.435 . . . . 6.2199999999999998 114.025 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.48 166.44 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.874 2.07 . . . . 1.95 108.715 155.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.6 mt -137.24 126.5 24.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.713 1.605 . . . . 2.5499999999999998 109.339 159.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -83.48 131.71 34.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.133 0.424 . . . . 3.6000000000000001 111.469 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.02 156.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.592 1.157 . . . . 4.5800000000000001 109.535 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.396 1.878 . . . . 2.52 109.995 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -143.49 144.44 27.79 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.495 1.518 . . . . 3.8500000000000001 110.773 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 149.46 28.52 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.202 2.602 . . . . 1.3 113.616 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.4 t -84.23 130.56 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.006 1.322 . . . . 1.9299999999999999 112.571 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.0 144.67 29.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.106 1.762 . . . . 3.3100000000000001 109.527 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.51 86.77 2.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.643 1.177 . . . . 2.3599999999999999 109.784 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.167 1.387 . . . . 8.2400000000000002 110.733 -166.002 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 N-CA-C 108.05 -2.02 . . . . 13.279999999999999 108.05 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m 62.1 -15.04 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 121.296 3.813 . . . . 11.68 121.296 125.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 63.56 113.78 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.521 1.055 . . . . 10.99 109.66 -129.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -137.17 127.94 27.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.062 1.345 . . . . 6.6600000000000001 108.512 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -119.02 128.53 54.46 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.715 1.259 . . . . 5.6600000000000001 110.942 -161.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.18 170.59 42.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.415 1.959 . . . . 1.6899999999999999 111.353 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.0 p90 -158.13 146.49 18.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.596 1.158 . . . . 1.6399999999999999 110.998 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -106.72 118.35 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.583 -1.266 . . . . 1.75 107.583 170.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -89.51 114.61 26.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.159 0.984 . . . . 4.4000000000000004 109.769 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.07 166.92 21.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.05 1.405 . . . . 3.6499999999999999 113.497 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t -156.32 155.26 28.71 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.602 2.361 . . . . 3.9399999999999999 108.385 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.93 -13.78 39.36 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.544 2.163 . . . . 1.8899999999999999 112.559 165.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.87 174.71 18.37 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.964 1.745 . . . . 1.72 112.737 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 -5.91 48.26 Favored 'Cis proline' 0 CA--C 1.54 0.809 0 CA-C-N 118.415 1.107 . . . . 2.0699999999999998 113.513 -1.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -126.98 161.98 27.07 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.611 1.165 . . . . 2.1000000000000001 113.23 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.01 -176.37 5.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.361 2.264 . . . . 2.1099999999999999 111.635 -175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.56 146.6 25.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.211 0.819 . . . . 1.99 113.211 -168.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.37 156.08 45.2 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.749 1.018 . . . . 1.49 113.749 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.37 149.77 28.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.381 1.872 . . . . 3.46 109.881 -169.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -171.74 160.81 5.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.281 1.032 . . . . 2.9500000000000002 113.66 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -94.54 119.9 33.94 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.16 0.984 . . . . 2.23 109.875 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.2 124.95 40.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.861 1.264 . . . . 4.3200000000000003 108.619 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -120.18 122.63 41.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.983 1.313 . . . . 3.8599999999999999 110.328 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -102.61 103.96 35.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.349 -0.611 . . . . 0.97999999999999998 109.349 164.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -86.6 -11.32 5.92 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.223 2.616 . . . . 1.1799999999999999 113.122 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.83 160.44 43.03 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 124.273 0.939 . . . . 1.1399999999999999 112.657 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.2 m-20 -90.25 5.97 44.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 2.9500000000000002 113.235 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.98 160.02 40.54 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.241 1.816 . . . . 3.2400000000000002 110.602 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.82 152.16 22.07 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.915 2.41 . . . . 0.97999999999999998 111.432 -171.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -116.63 123.76 48.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.674 1.19 . . . . 3.1600000000000001 110.385 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ttp-105 -117.77 110.45 17.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.227 1.411 . . . . 5.2199999999999998 111.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -97.73 106.15 18.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.278 2.231 . . . . 1.9199999999999999 108.936 -170.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.04 -19.36 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.056 0.942 . . . . 2.25 112.683 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.93 -162.34 30.57 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.536 0.607 . . . . 0.70999999999999996 112.674 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.0 -177.57 4.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.054 0.942 . . . . 1.9299999999999999 110.444 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -148.26 141.7 25.32 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 105.149 -2.167 . . . . 8.6799999999999997 105.149 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.544 ' HG1' ' CG1' ' A' ' 99' ' ' VAL . 1.0 OUTLIER -148.68 152.3 37.44 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.649 -1.167 . . . . 1.74 109.195 -178.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.6 -34.21 98.7 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.647 2.231 . . . . 1.54 113.029 167.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.284 2.2 m -81.94 4.04 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.484 0.92 . . . . 2.02 113.484 -165.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.08 19.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.527 1.058 . . . . 1.76 113.51 -174.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.09 -51.8 1.54 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 3.6299999999999999 110.656 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -79.51 133.54 36.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.037 -1.097 . . . . 4.1200000000000001 108.037 155.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -145.75 126.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 127.062 2.145 . . . . 2.0899999999999999 108.364 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.91 115.87 6.03 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.69 0.796 . . . . 2.5699999999999998 110.972 -157.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.39 121.42 23.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.821 1.192 . . . . 1.8999999999999999 110.377 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.3 m170 -108.1 151.67 25.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.75 1.62 . . . . 0.59999999999999998 113.259 174.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.91 172.02 8.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.746 1.618 . . . . 2.23 110.125 163.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -151.06 86.58 1.37 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.382 1.473 . . . . 2.1499999999999999 107.674 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -96.56 -173.81 2.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.802 2.041 . . . . 3.8900000000000001 111.576 -171.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.44 139.72 27.08 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.028 0.918 . . . . 4.1200000000000001 111.855 170.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.22 150.43 26.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.602 1.161 . . . . 7.29 111.959 -170.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.327 16.6 pm0 -64.99 142.17 58.53 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.227 1.811 . . . . 6.0999999999999996 113.44 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 t -130.21 -95.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.157 1.383 . . . . 3.3900000000000001 107.37 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.462 ' CD ' ' HZ3' ' A' ' 56' ' ' LYS . 4.7 pt-20 -73.08 45.48 0.15 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.908 2.083 . . . . 4.8600000000000003 111.919 164.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.98 -40.15 1.18 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.533 1.539 . . . . 2.3399999999999999 113.265 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.462 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 52.8 mttt -61.81 138.62 58.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.023 1.729 . . . . 4.6500000000000004 110.862 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -77.89 112.23 14.56 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.201 0.6 . . . . 5.5499999999999998 109.803 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.86 139.56 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.443 1.897 . . . . 2.54 108.632 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -83.86 139.65 32.51 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.725 1.21 . . . . 3.98 110.824 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.41 163.36 31.54 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.493 0.557 . . . . 0.94999999999999996 114.493 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -112.85 165.56 12.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.276 1.43 . . . . 2.4399999999999999 112.406 -176.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.252 76.0 mtt180 -169.52 141.58 1.98 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 128.738 2.815 . . . . 5.6600000000000001 106.55 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.2 Cg_endo -68.95 150.73 73.39 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 CA-C-N 122.024 1.759 . . . . 0.87 110.192 156.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.97 156.87 47.73 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.143 1.377 . . . . 1.6399999999999999 110.438 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.42 -23.48 50.86 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.356 2.037 . . . . 0.81000000000000005 112.395 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -178.78 167.38 1.7 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 126.434 1.893 . . . . 3.4100000000000001 111.585 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.091 1.356 . . . . 2.2000000000000002 110.071 150.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.251 2.8 pt-20 -153.55 160.0 42.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.888 -0.507 . . . . 2.7200000000000002 111.949 164.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 t -141.42 134.46 14.31 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 125.798 1.639 . . . . 2.3399999999999999 108.851 -166.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.52 164.61 32.19 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.409 2.073 . . . . 1.1200000000000001 111.679 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.38 145.03 99.12 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.346 2.697 . . . . 0.81999999999999995 111.825 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.477 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 16.5 mmmt 68.96 -1.62 2.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.36 1.864 . . . . 2.54 113.66 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.02 125.94 7.85 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 127.649 2.547 . . . . 0.92000000000000004 112.811 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -86.37 149.43 25.03 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.994 -1.103 . . . . 6.3099999999999996 111.79 156.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 m -152.45 131.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.64 1.576 . . . . 2.4700000000000002 109.52 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -89.84 134.43 34.2 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.287 1.035 . . . . 4.0899999999999999 111.028 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 mp -76.13 66.22 2.25 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.214 1.483 . . . . 2.2799999999999998 110.122 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -56.97 124.47 65.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 6.0300000000000002 109.838 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.32 -33.96 88.35 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.574 2.85 . . . . 1.48 113.765 -169.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.94 45.63 2.52 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.068 0.849 . . . . 1.8899999999999999 112.361 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.45 -57.87 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.567 2.032 . . . . 1.4399999999999999 113.988 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -150.26 145.54 26.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.889 1.676 . . . . 3.3799999999999999 110.877 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -166.14 179.83 5.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.344 1.058 . . . . 0.94999999999999996 110.941 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -115.7 132.48 56.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.23 1.012 . . . . 3.46 111.132 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.7 mmt -93.11 139.77 30.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 1.6699999999999999 110.772 165.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 143.18 51.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.719 1.608 . . . . 4.1399999999999997 109.736 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -146.18 160.32 42.12 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 2.8799999999999999 112.079 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.58 -82.39 1.69 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.084 1.326 . . . . 2.7799999999999998 109.895 -169.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 76.85 125.68 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.786 3.634 . . . . 2.0 110.941 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -77.74 -22.97 49.51 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.818 -1.176 . . . . 3.3900000000000001 112.881 -170.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -161.83 158.15 21.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 130.233 3.413 . . . . 7.5199999999999996 109.059 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.39 149.09 56.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.758 2.305 . . . . 4.0599999999999996 109.653 160.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 -176.57 2.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.037 1.735 . . . . 4.6399999999999997 109.82 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.35 141.63 19.55 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.214 -1.554 . . . . 4.1299999999999999 110.513 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -34.79 135.99 0.17 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.637 1.717 . . . . 2.7599999999999998 115.637 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.83 22.39 69.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.124 0.81 . . . . 1.9099999999999999 115.124 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -88.83 -179.46 5.98 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.754 1.222 . . . . 3.46 109.839 158.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -130.74 168.89 16.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.103 0.961 . . . . 3.5899999999999999 111.321 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.544 ' CG1' ' HG1' ' A' ' 37' ' ' THR . 18.9 t -136.33 117.71 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.391 1.476 . . . . 2.2799999999999998 109.967 -172.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.42 42.04 0.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.016 2.127 . . . . 4.3399999999999999 114.214 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 tt -65.39 137.09 57.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 123.4 1.571 . . . . 3.2000000000000002 112.958 -164.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.09 112.61 25.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.781 2.032 . . . . 2.4900000000000002 111.303 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -82.43 120.32 25.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.084 1.354 . . . . 2.1099999999999999 110.752 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.8 mt -96.68 123.42 40.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.614 1.166 . . . . 1.99 111.54 -168.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.45 133.65 55.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.147 1.536 . . . . 3.1299999999999999 115.147 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.17 48.28 0.85 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.821 2.048 . . . . 2.8599999999999999 112.768 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.38 19.79 2.81 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.106 2.289 . . . . 4.9299999999999997 112.307 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.98 38.07 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 118.275 1.037 . . . . 2.25 112.098 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 150.01 36.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.155 1.782 . . . . 4.29 111.197 -175.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.85 131.62 20.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 126.015 1.726 . . . . 1.9199999999999999 108.073 161.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.14 122.69 41.56 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.331 1.452 . . . . 3.52 109.277 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -79.84 132.34 36.09 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.835 -0.541 . . . . 3.4500000000000002 111.548 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -129.55 127.47 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.393 1.077 . . . . 2.5699999999999998 109.567 167.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.22 138.38 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.059 0.943 . . . . 3.9199999999999999 110.224 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.4 mt -143.55 142.62 21.37 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.252 1.421 . . . . 2.71 110.083 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.85 153.04 64.13 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.385 2.723 . . . . 1.25 112.667 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.5 t -83.4 113.95 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.113 1.365 . . . . 2.1400000000000001 108.926 165.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -100.36 145.81 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.583 1.953 . . . . 3.7999999999999998 108.015 167.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.91 55.21 0.78 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.3 1.593 . . . . 2.9100000000000001 115.3 -152.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.076 2.15 . . . . 8.7400000000000002 111.25 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.197 0 N-CA-C 106.968 -2.453 . . . . 11.56 106.968 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 t 64.53 -147.55 0.27 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.043 -1.466 . . . . 11.17 107.043 -121.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -58.52 157.87 8.4 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.793 1.179 . . . . 10.720000000000001 112.494 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.83 151.71 27.5 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.014 2.126 . . . . 8.8300000000000001 108.279 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -129.06 -142.09 0.25 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.333 1.453 . . . . 5.1600000000000001 110.312 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.97 169.04 26.31 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.647 -1.283 . . . . 1.1200000000000001 114.436 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -150.63 146.59 26.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.762 1.625 . . . . 1.71 111.558 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -109.44 107.66 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.682 -1.229 . . . . 1.9099999999999999 107.682 171.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -82.4 121.9 27.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.276 -0.639 . . . . 4.5999999999999996 109.276 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -160.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.447 1.099 . . . . 3.4700000000000002 112.016 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t 174.0 157.65 0.31 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 128.641 2.776 . . . . 3.5299999999999998 106.935 168.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.97 -10.78 29.74 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.572 2.182 . . . . 1.7 113.197 167.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.53 177.69 26.06 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.005 1.288 . . . . 1.49 112.007 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.51 -1.21 32.26 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 CA-C-N 118.665 1.232 . . . . 1.7 113.621 1.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -140.58 158.27 44.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.793 1.237 . . . . 2.0699999999999998 112.478 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.98 -178.74 7.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.155 2.582 . . . . 1.52 110.27 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.22 133.59 16.43 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.344 1.239 . . . . 1.96 114.344 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.55 153.02 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.847 1.259 . . . . 1.47 111.981 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.44 136.95 15.9 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.911 1.684 . . . . 3.4700000000000002 109.373 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -161.53 150.8 16.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.07 1.508 . . . . 3.52 115.07 -167.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -72.11 125.79 28.15 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.282 1.033 . . . . 2.7200000000000002 108.714 165.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 tt -107.13 155.33 19.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.939 1.696 . . . . 3.8999999999999999 110.47 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.01 161.77 37.24 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 115.536 1.68 . . . . 3.75 115.536 165.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -130.79 96.46 23.07 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 127.306 2.242 . . . . 1.1799999999999999 109.425 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.88 -8.19 13.28 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.506 2.138 . . . . 1.0 113.703 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.05 157.71 41.48 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 119.655 1.116 . . . . 1.3600000000000001 112.179 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 8.7 m-20 -82.87 9.8 9.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.126 1.771 . . . . 3.2999999999999998 112.681 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mt -110.58 165.32 12.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 129.031 2.933 . . . . 3.6400000000000001 108.507 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.34 157.58 12.79 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.958 2.439 . . . . 0.88 111.445 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.99 147.76 38.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.437 1.095 . . . . 2.9100000000000001 111.231 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 ttp-105 -135.79 112.24 9.92 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.125 1.37 . . . . 4.2199999999999998 110.768 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -88.07 120.68 29.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.957 2.103 . . . . 2.0600000000000001 108.741 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.78 -20.85 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.03 1.332 . . . . 1.9299999999999999 112.669 -177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.67 -162.2 20.31 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 122.214 0.897 . . . . 0.79000000000000004 112.061 169.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.48 177.58 9.58 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.229 1.811 . . . . 1.8799999999999999 108.64 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -161.82 152.64 17.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.04 1.291 . . . . 7.0800000000000001 109.323 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -153.72 151.42 25.05 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 125.469 1.508 . . . . 1.5900000000000001 108.932 -166.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.1 -23.03 46.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.184 1.923 . . . . 1.0 113.843 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 m -88.01 -3.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 115.36 1.615 . . . . 2.04 115.36 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.58 134.71 49.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.931 1.241 . . . . 1.8899999999999999 111.176 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -56.44 18.94 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.777 1.171 . . . . 5.71 109.277 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -124.12 151.48 43.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.53 1.932 . . . . 5.0800000000000001 110.974 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.86 135.2 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.904 2.082 . . . . 3.6400000000000001 107.934 163.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -126.77 130.1 49.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.95 0.9 . . . . 2.3799999999999999 109.666 167.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tp -85.92 117.34 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.59 1.556 . . . . 4.6100000000000003 108.843 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -126.43 151.96 47.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.084 1.354 . . . . 0.88 113.778 -170.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.65 167.7 13.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.079 1.751 . . . . 2.52 111.806 165.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.4 m -153.61 92.66 1.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.706 2.002 . . . . 3.04 107.213 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -109.61 163.48 13.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.111 1.152 . . . . 3.8700000000000001 114.111 -156.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.68 143.93 27.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.301 1.04 . . . . 4.7699999999999996 109.907 150.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -149.57 151.75 34.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.665 2.386 . . . . 8.9100000000000001 107.09 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.562 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -110.33 145.44 37.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.683 0.793 . . . . 4.9100000000000001 111.72 178.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.88 117.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.81 -1.552 . . . . 4.9000000000000004 106.81 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.3 28.58 17.96 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.3 1.04 . . . . 7.29 111.461 -172.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.33 -12.79 12.38 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 120.486 -1.384 . . . . 4.3099999999999996 114.049 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -75.52 135.09 40.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.305 1.442 . . . . 5.8700000000000001 109.75 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 29.3 mmmt -74.06 135.24 43.01 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.205 1.002 . . . . 5.46 111.878 -170.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.03 144.84 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.775 1.63 . . . . 3.3799999999999999 109.421 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.97 139.0 51.14 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.804 1.242 . . . . 3.9700000000000002 111.905 172.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -179.15 38.66 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 123.854 0.74 . . . . 1.29 113.694 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.4 177.63 4.96 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.057 1.343 . . . . 2.8900000000000001 111.823 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 175.64 143.1 0.22 Allowed Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 126.813 2.045 . . . . 9.1300000000000008 110.039 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.83 154.46 72.96 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 121.617 1.613 . . . . 0.85999999999999999 110.783 161.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.93 156.43 69.0 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 125.989 1.716 . . . . 2.1699999999999999 109.986 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.77 -19.92 40.52 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.028 1.819 . . . . 0.85999999999999999 112.58 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 178.84 169.96 0.88 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.728 1.611 . . . . 3.0 111.031 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.03 163.58 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.11 1.364 . . . . 1.8600000000000001 108.938 157.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.253 0.2 OUTLIER -153.57 158.39 41.13 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.504 -0.748 . . . . 2.0099999999999998 112.28 177.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -146.34 133.65 10.2 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.298 1.439 . . . . 2.0 108.863 -162.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.11 168.36 24.95 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.0 2.467 . . . . 0.89000000000000001 111.902 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.49 137.65 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.188 3.925 . . . . 1.78 114.287 165.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.466 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 18.3 mmmt 68.38 1.21 2.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.951 1.7 . . . . 2.6699999999999999 114.049 169.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 115.08 4.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.86 1.695 . . . . 1.0900000000000001 112.209 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.71 122.26 42.45 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.065 1.746 . . . . 5.8499999999999996 109.5 161.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.1 m -155.22 146.29 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.273 1.429 . . . . 2.9900000000000002 112.288 -163.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -91.27 142.79 27.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.085 0.954 . . . . 3.1499999999999999 113.021 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.4 68.85 0.23 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 2.2999999999999998 108.508 148.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -54.19 122.62 37.53 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.054 1.742 . . . . 4.9199999999999999 110.381 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.15 -42.16 66.29 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.546 2.831 . . . . 1.74 112.891 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.02 75.3 2.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.7 -0.96 . . . . 1.2 110.7 161.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.77 -61.03 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.759 1.647 . . . . 1.3 112.462 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -151.55 150.67 30.61 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.482 1.513 . . . . 4.4400000000000004 111.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -160.19 170.72 20.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.221 1.008 . . . . 1.6499999999999999 111.079 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -102.51 127.4 49.58 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.249 1.019 . . . . 3.46 110.64 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mmt -83.44 124.87 31.12 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.798 0.839 . . . . 1.79 110.574 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.28 134.35 48.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.195 1.398 . . . . 2.7999999999999998 108.707 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.3 mt -134.2 161.01 36.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.65 1.18 . . . . 3.02 112.008 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.91 35.06 39.11 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 126.144 1.83 . . . . 2.4100000000000001 114.998 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 mt -37.14 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.245 2.218 . . . . 1.8500000000000001 114.652 -156.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -77.25 14.25 0.97 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.977 1.473 . . . . 3.0699999999999998 114.977 -165.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -159.49 147.03 13.04 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 131.44 3.896 . . . . 8.5299999999999994 109.468 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.98 170.52 15.45 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.015 2.476 . . . . 2.48 109.317 166.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 157.64 43.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.302 1.049 . . . . 5.3899999999999997 112.791 -165.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HZ2' ' CD ' ' A' ' 97' ' ' GLU . 5.2 tmtt? -143.18 144.11 32.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.821 1.648 . . . . 5.0899999999999999 109.639 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.4 144.04 57.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.856 0.863 . . . . 2.8900000000000001 111.901 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.91 45.22 27.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.854 -0.97 . . . . 1.73 112.934 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.447 ' CD ' ' HZ2' ' A' ' 94' ' ' LYS . 8.9 mm-40 -109.35 177.87 4.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.534 0.734 . . . . 4.8499999999999996 109.741 148.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.57 161.62 17.64 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.216 1.806 . . . . 4.5999999999999996 110.201 152.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -125.58 133.16 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.691 1.597 . . . . 2.2799999999999998 109.721 163.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.65 144.76 28.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.901 1.68 . . . . 3.1699999999999999 110.292 172.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.8 tt -156.37 131.74 9.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.39 1.076 . . . . 2.5899999999999999 112.087 -175.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.42 115.18 27.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.537 2.335 . . . . 2.2799999999999998 111.947 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.19 118.9 22.96 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.688 1.585 . . . . 2.3999999999999999 109.547 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.7 mt -98.37 122.51 41.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.231 1.012 . . . . 1.75 110.36 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -113.82 154.41 27.48 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.036 0.934 . . . . 3.4199999999999999 112.6 -173.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.7 95.97 0.37 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.088 1.355 . . . . 2.4199999999999999 112.605 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.45 -147.78 18.61 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.056 1.312 . . . . 3.0299999999999998 111.317 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.47 36.94 2.02 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.287 0.946 . . . . 2.2999999999999998 115.379 -171.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -127.74 134.08 49.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.696 1.748 . . . . 5.9500000000000002 113.075 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.61 147.32 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.362 1.865 . . . . 1.8300000000000001 108.064 158.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -141.17 115.89 9.66 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.182 1.393 . . . . 2.46 108.164 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.11 153.06 21.81 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.705 1.002 . . . . 3.5600000000000001 113.705 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.75 166.88 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.319 2.248 . . . . 2.1800000000000002 109.768 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.23 133.99 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.21 1.004 . . . . 2.6699999999999999 108.457 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt -145.64 152.44 49.03 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.28 1.432 . . . . 2.9500000000000002 110.56 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.81 151.97 74.04 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 125.2 3.933 . . . . 0.95999999999999996 115.16 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.2 t -83.41 100.72 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.681 1.592 . . . . 2.0299999999999998 109.719 170.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -90.7 74.68 6.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.009 1.724 . . . . 3.0699999999999998 109.018 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.16 128.6 37.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.077 -1.014 . . . . 3.0499999999999998 113.544 -166.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 . . . . . 0 N--CA 1.484 1.273 1 C-N-CA 132.647 4.379 . . . . 8.3499999999999996 108.493 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 109.371 -1.492 . . . . 11.1 109.371 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 p -60.7 -32.98 72.2 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.469 1.635 . . . . 10.449999999999999 110.742 150.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -152.81 176.24 12.02 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 131.634 3.974 . . . . 9.4800000000000004 105.982 156.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -139.48 -135.9 0.12 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 104.988 -2.227 . . . . 8.8699999999999992 104.988 168.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -155.25 163.38 40.23 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 127.573 2.349 . . . . 5.7000000000000002 106.55 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.21 156.06 22.61 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.681 -0.637 . . . . 1.3400000000000001 113.638 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -154.73 147.32 24.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.19 0.996 . . . . 1.9099999999999999 111.797 175.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.44 116.97 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.616 0.767 . . . . 2.2799999999999998 110.649 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 ttp85 -81.61 103.23 11.18 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.028 1.331 . . . . 4.7999999999999998 110.577 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.55 165.06 25.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 123.431 1.586 . . . . 3.6200000000000001 112.465 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -161.22 154.08 17.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.58 2.352 . . . . 2.5899999999999999 107.949 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.28 27.6 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.398 3.398 . . . . 1.5900000000000001 113.503 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.71 169.42 42.76 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.477 -0.764 . . . . 1.4199999999999999 113.049 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.14 -5.58 25.77 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 118.005 0.902 . . . . 1.73 112.604 -10.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.99 157.65 44.06 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.073 1.349 . . . . 4.2800000000000002 113.34 -168.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.27 -176.21 5.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.63 1.972 . . . . 1.51 111.294 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.44 129.0 15.04 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.986 0.914 . . . . 1.8300000000000001 111.814 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.27 138.41 44.59 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.787 1.235 . . . . 1.5600000000000001 111.84 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -124.83 151.32 45.39 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.138 2.175 . . . . 3.8599999999999999 109.102 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.03 150.11 16.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.173 1.175 . . . . 2.9199999999999999 114.173 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -89.49 113.63 25.03 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.501 -0.926 . . . . 2.1499999999999999 108.501 166.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.82 156.54 20.97 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.038 1.735 . . . . 3.6299999999999999 110.806 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.15 157.45 43.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.911 0.708 . . . . 3.5600000000000001 112.911 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -96.34 109.79 49.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 114.359 -1.291 . . . . 1.0900000000000001 110.19 166.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.84 -2.82 10.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.371 2.714 . . . . 1.3500000000000001 113.78 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.69 171.27 37.64 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.4 1.0 . . . . 1.04 113.133 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -95.57 0.13 52.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.525 1.53 . . . . 3.5299999999999998 113.781 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -116.84 154.61 49.55 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.674 1.589 . . . . 2.3399999999999999 110.056 167.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.91 159.05 27.55 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.501 2.801 . . . . 0.78000000000000003 112.506 -164.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -106.59 152.23 23.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.68 1.192 . . . . 2.8900000000000001 110.837 171.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 68' ' ' GLU . 26.0 ttm180 -130.78 112.25 12.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.084 1.353 . . . . 5.0199999999999996 109.619 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 tp -94.81 112.3 24.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.065 2.546 . . . . 1.6899999999999999 109.601 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.79 -11.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.922 1.082 . . . . 1.6499999999999999 113.922 -165.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.74 -167.95 40.67 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.506 -0.746 . . . . 0.63 112.583 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.54 -179.69 7.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.506 0.558 . . . . 1.8700000000000001 112.506 167.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -145.69 142.19 28.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.327 1.051 . . . . 8.5 109.044 169.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.447 ' HG1' HG12 ' A' ' 99' ' ' VAL . 1.4 t -153.9 151.09 24.09 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.544 1.138 . . . . 1.9099999999999999 110.448 -164.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.72 -17.81 37.55 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.396 2.064 . . . . 1.0800000000000001 112.652 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.32 2.0 m -96.91 11.07 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.199 1.555 . . . . 2.3300000000000001 115.199 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -154.82 144.29 21.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.91 1.448 . . . . 1.8899999999999999 114.91 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.87 -69.82 0.75 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.934 -0.765 . . . . 3.1200000000000001 108.934 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.912 -1.514 . . . . 3.3900000000000001 106.912 164.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.19 129.17 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.173 1.789 . . . . 2.3700000000000001 107.548 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.3 131.95 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.325 1.45 . . . . 1.9099999999999999 109.273 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.07 122.17 27.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.086 0.945 . . . . 1.8999999999999999 110.579 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -112.52 159.29 18.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.834 2.054 . . . . 0.55000000000000004 111.986 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.37 -177.34 3.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.742 2.017 . . . . 2.6600000000000001 110.925 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 m -137.12 116.28 12.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.339 1.456 . . . . 2.2999999999999998 107.59 163.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -96.74 162.53 13.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.863 0.865 . . . . 3.6600000000000001 110.996 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -112.32 143.14 43.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 4.4299999999999997 110.822 162.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -153.78 159.67 41.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.742 1.617 . . . . 6.3099999999999996 111.295 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 141.35 36.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.823 -0.806 . . . . 4.1399999999999997 108.823 156.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.33 -8.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 115.139 1.533 . . . . 4.1500000000000004 115.139 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -158.27 46.0 0.33 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.673 1.989 . . . . 4.0800000000000001 107.586 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.74 -24.06 0.4 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.766 1.651 . . . . 2.02 114.706 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -99.79 153.47 19.1 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.122 2.169 . . . . 4.2199999999999998 112.49 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -61.66 136.54 58.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.956 0.902 . . . . 4.5300000000000002 111.34 169.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.8 t -140.0 150.44 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.061 2.144 . . . . 2.98 108.275 168.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.3 mtm -111.57 144.48 40.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.396 1.079 . . . . 3.5299999999999998 111.347 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.47 158.03 28.16 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 123.597 0.618 . . . . 1.0900000000000001 113.012 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.67 165.56 11.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.413 1.085 . . . . 2.5699999999999998 112.551 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -171.15 155.29 4.32 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.535 1.934 . . . . 4.5599999999999996 109.848 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.6 Cg_endo -69.75 152.33 69.36 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.926 1.75 . . . . 0.93999999999999995 111.482 167.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -115.17 157.97 42.27 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 126.381 1.872 . . . . 1.9399999999999999 110.278 170.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -69.36 -21.43 35.36 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 0.92000000000000004 111.952 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -177.93 161.25 1.54 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.267 1.827 . . . . 3.29 110.82 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -108.2 174.97 5.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.741 2.016 . . . . 1.8799999999999999 109.455 157.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.9 pt-20 -152.55 165.07 36.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.048 -1.032 . . . . 2.3100000000000001 111.222 170.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -146.07 130.14 8.61 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 123.436 0.694 . . . . 1.96 109.334 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.12 164.85 34.34 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.197 1.932 . . . . 0.88 111.108 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.39 137.01 75.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.514 2.809 . . . . 0.81000000000000005 112.144 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 64.05 11.15 5.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.834 1.654 . . . . 2.7599999999999998 113.622 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.08 120.06 5.13 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 127.766 2.603 . . . . 0.91000000000000003 111.197 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -85.38 142.91 28.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.005 1.322 . . . . 7.0499999999999998 111.87 162.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.98 148.32 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.029 1.731 . . . . 2.5600000000000001 110.398 172.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -129.92 114.5 15.94 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.289 -1.004 . . . . 5.0199999999999996 108.289 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.76 67.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.64 1.976 . . . . 1.98 112.388 -171.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.57 133.92 44.88 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.854 2.461 . . . . 3.4300000000000002 113.634 166.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.6 -52.59 7.23 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.502 2.802 . . . . 1.75 112.132 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.33 89.12 1.01 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.401 -1.48 . . . . 1.53 109.401 166.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.95 -72.25 0.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.73 2.109 . . . . 1.25 112.753 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -155.43 132.25 10.62 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.474 1.51 . . . . 3.2400000000000002 112.299 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -156.88 165.93 34.81 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.023 -1.048 . . . . 0.87 111.487 -171.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.27 113.71 26.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.307 0.575 . . . . 2.98 109.699 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.26 125.13 33.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.508 1.123 . . . . 2.23 109.195 175.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -113.68 135.91 53.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.912 1.285 . . . . 2.71 110.077 -168.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -146.65 154.67 41.73 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.782 1.633 . . . . 3.02 111.02 -172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.39 -54.46 4.32 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.734 1.159 . . . . 2.4100000000000001 112.371 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt 70.02 107.51 0.06 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.875 3.27 . . . . 2.0499999999999998 111.133 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -81.18 14.33 2.41 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.76 -1.212 . . . . 2.7200000000000002 113.712 -169.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.452 HH21 ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.8 153.52 15.91 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.682 2.393 . . . . 6.3399999999999999 109.633 176.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.7 140.61 23.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.772 2.314 . . . . 2.79 109.875 166.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.3 mt -115.57 152.68 32.61 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.148 1.379 . . . . 3.9100000000000001 111.794 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -147.75 9.63 0.91 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.724 2.12 . . . . 4.1699999999999999 116.724 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 64.0 172.87 0.18 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.934 2.094 . . . . 2.8999999999999999 112.225 -169.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.58 52.48 52.82 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 121.661 -0.649 . . . . 2.3999999999999999 111.99 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.452 ' CD ' HH21 ' A' ' 91' ' ' ARG . 9.8 pt-20 -152.01 163.88 38.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.003 2.121 . . . . 3.77 111.051 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -101.51 123.1 45.0 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.279 1.831 . . . . 4.4299999999999997 109.499 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.447 HG12 ' HG1' ' A' ' 37' ' ' THR . 66.6 t -83.68 106.09 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.001 -1.111 . . . . 2.1299999999999999 108.001 171.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 143.22 42.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.631 -1.168 . . . . 3.1400000000000001 109.171 160.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -155.33 116.39 3.93 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.946 -1.096 . . . . 2.79 111.213 -167.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.86 100.58 12.65 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.297 1.439 . . . . 2.3900000000000001 110.378 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 mt -80.52 119.65 23.46 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.646 -0.659 . . . . 2.6000000000000001 109.528 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.8 mt -93.6 129.93 39.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.178 0.991 . . . . 2.2599999999999998 110.61 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -130.37 122.49 27.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.408 0.623 . . . . 3.2799999999999998 112.504 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.0 12.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.401 2.001 . . . . 3.2799999999999998 116.401 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.62 -45.73 1.6 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.967 1.27 . . . . 3.3900000000000001 112.64 -165.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.87 4.67 44.19 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.194 1.378 . . . . 2.46 116.042 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.69 152.85 33.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.53 1.932 . . . . 4.6100000000000003 112.686 176.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.9 140.64 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.647 1.979 . . . . 1.8600000000000001 107.819 161.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -139.04 124.05 18.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.755 1.222 . . . . 2.3399999999999999 108.056 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.45 150.7 20.01 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.817 1.414 . . . . 3.3300000000000001 114.817 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.91 145.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.823 1.649 . . . . 2.1800000000000002 110.91 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -106.84 129.81 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.614 1.166 . . . . 2.6299999999999999 108.623 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.3 mt -140.68 150.52 60.47 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.743 1.617 . . . . 3.0600000000000001 110.183 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.02 146.49 37.11 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.096 2.53 . . . . 0.97999999999999998 112.874 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.29 139.43 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.636 -0.711 . . . . 1.9299999999999999 110.567 156.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.57 151.34 39.54 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.428 3.491 . . . . 3.5800000000000001 108.672 170.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.72 73.27 1.46 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.194 1.554 . . . . 2.27 115.194 -157.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.377 1.071 . . . . 8.5399999999999991 112.556 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 107.006 -2.438 . . . . 12.59 107.006 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 m 64.72 136.41 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 O-C-N 124.752 0.913 . . . . 10.779999999999999 109.025 -126.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -169.53 145.34 3.16 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.292 -0.88 . . . . 12.99 111.859 -160.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -154.99 -52.19 0.09 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.134 2.174 . . . . 6.9500000000000002 109.867 -173.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -134.52 -173.1 3.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.57 1.148 . . . . 5.6699999999999999 113.543 -159.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.04 165.24 17.26 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.592 1.568 . . . . 2.4500000000000002 114.525 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -148.97 134.4 18.52 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.146 1.778 . . . . 2.9399999999999999 110.552 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.4 t -91.33 140.15 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.74 1.216 . . . . 2.1200000000000001 107.879 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.431 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 0.3 OUTLIER -93.46 -24.4 18.04 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.884 1.439 . . . . 4.1699999999999999 114.884 -175.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.28 175.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.697 1.999 . . . . 3.3799999999999999 114.559 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 m 176.34 167.24 0.43 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 130.92 3.688 . . . . 2.25 107.903 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.24 -6.55 18.58 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.993 2.462 . . . . 2.1899999999999999 113.584 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 112.28 166.34 17.41 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.115 1.816 . . . . 1.8600000000000001 111.696 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.62 -7.71 45.1 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.112 1.456 . . . . 2.0699999999999998 113.633 -1.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -130.17 174.08 10.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.05 1.34 . . . . 2.2799999999999998 112.836 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.51 -174.66 3.23 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.216 2.206 . . . . 1.3999999999999999 112.037 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.19 165.49 22.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.598 1.159 . . . . 1.8300000000000001 111.352 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.66 162.35 40.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.241 1.816 . . . . 1.8200000000000001 111.355 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -155.6 165.0 37.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.727 1.611 . . . . 3.5299999999999998 111.274 -173.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.4 pt? -160.44 161.3 32.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 116.0 1.852 . . . . 2.6099999999999999 116.0 170.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -70.06 125.6 27.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 112.663 -2.062 . . . . 1.99 106.164 153.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -134.67 129.58 35.03 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.559 1.544 . . . . 3.9300000000000002 107.108 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -153.9 150.76 28.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 114.583 1.327 . . . . 2.77 114.583 -173.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -103.63 103.65 37.58 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 112.987 -1.915 . . . . 0.95999999999999996 109.099 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.8 -10.49 14.22 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.631 2.22 . . . . 1.4399999999999999 113.018 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.15 -177.19 49.9 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.848 1.214 . . . . 1.1599999999999999 113.466 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.448 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.0 m-20 -106.89 -2.62 21.13 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.075 1.75 . . . . 3.4300000000000002 113.018 -170.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.72 161.26 42.84 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.447 1.899 . . . . 2.1800000000000002 110.062 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.75 149.05 20.5 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.674 2.249 . . . . 0.73999999999999999 111.969 -169.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.14 120.89 42.07 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.624 1.17 . . . . 3.5899999999999999 110.692 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -105.81 103.87 13.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.967 1.707 . . . . 4.8700000000000001 110.65 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -91.84 116.56 29.0 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.805 1.642 . . . . 2.1800000000000002 109.024 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -95.0 -22.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.995 0.918 . . . . 1.8300000000000001 112.387 -174.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -161.52 28.21 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 121.78 -0.575 . . . . 0.63 112.581 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.43 -178.16 5.17 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.185 0.994 . . . . 1.5600000000000001 110.7 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 136.82 17.37 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.895 2.078 . . . . 6.6699999999999999 106.518 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -153.29 151.58 26.04 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 120.737 1.608 . . . . 1.9199999999999999 111.097 -166.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.09 -18.36 27.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.82 3.013 . . . . 0.94999999999999996 114.097 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.269 3.0 m -89.91 -2.07 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 114.081 1.141 . . . . 1.95 114.081 -173.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.88 39.5 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.576 0.954 . . . . 1.6699999999999999 113.576 -174.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.22 -86.86 0.34 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.284 1.833 . . . . 3.4199999999999999 108.41 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -78.49 86.36 4.52 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.67 -1.269 . . . . 3.9900000000000002 110.614 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.77 139.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.793 1.237 . . . . 1.97 110.486 158.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -136.51 126.52 26.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.489 1.915 . . . . 2.2400000000000002 109.821 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.18 121.57 26.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.209 1.368 . . . . 1.8200000000000001 111.245 167.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -107.26 151.64 25.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.596 1.558 . . . . 0.77000000000000002 112.3 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.42 173.14 8.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.721 1.209 . . . . 2.1899999999999999 110.5 158.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -148.72 96.64 2.61 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.166 1.386 . . . . 1.8 107.515 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -109.04 153.96 22.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.948 1.699 . . . . 3.6800000000000002 112.2 -166.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.7 mtm -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.081 0.952 . . . . 3.4100000000000001 110.937 170.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -155.62 167.92 28.81 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.198 1.799 . . . . 10.26 111.235 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 1.5 mp0 -79.73 157.73 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.264 0.625 . . . . 3.4700000000000002 111.115 160.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -135.11 -89.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.215 1.006 . . . . 4.0599999999999996 108.922 160.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 56' ' ' LYS . 2.8 tt0 -79.45 55.34 1.91 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.683 1.993 . . . . 3.8399999999999999 110.338 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.92 -18.52 0.35 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 125.62 1.581 . . . . 2.1400000000000001 114.906 -173.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 54' ' ' GLU . 37.2 mtmt -108.2 163.28 13.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.752 2.421 . . . . 3.9500000000000002 111.38 -174.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.482 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 23.9 mmtt -66.64 135.63 54.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.673 1.189 . . . . 4.3700000000000001 112.817 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.1 160.42 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 126.895 2.078 . . . . 3.25 109.221 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.1 mmt -79.96 165.09 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 4.5499999999999998 112.647 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.17 143.11 11.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.735 1.635 . . . . 1.5600000000000001 110.707 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.03 142.21 49.04 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.355 1.462 . . . . 3.0899999999999999 109.539 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -172.86 127.46 0.52 Allowed Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 117.116 -1.421 . . . . 5.0599999999999996 111.136 -152.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.63 146.07 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.184 1.922 . . . . 0.75 111.251 170.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.28 156.71 60.13 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.799 1.64 . . . . 1.6399999999999999 110.589 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.99 -24.37 28.69 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.258 1.972 . . . . 0.81999999999999995 112.509 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -174.06 166.25 4.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.882 1.273 . . . . 3.5600000000000001 112.273 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.52 173.04 6.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.065 2.146 . . . . 1.78 109.526 157.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.56 163.19 40.3 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.663 -0.648 . . . . 1.8899999999999999 112.236 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.38 130.74 11.68 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 124.844 1.258 . . . . 1.96 109.606 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.18 161.62 43.72 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.026 2.484 . . . . 0.93000000000000005 111.295 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.27 140.88 90.97 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.238 2.626 . . . . 1.03 112.105 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 65.8 mmtt 67.96 -3.32 1.23 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.967 2.107 . . . . 2.6099999999999999 113.921 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.74 134.82 13.52 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 127.136 2.303 . . . . 0.85999999999999999 110.052 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -109.9 146.7 34.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.514 -1.343 . . . . 7.5099999999999998 112.192 163.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.08 171.69 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.968 1.707 . . . . 2.2000000000000002 110.099 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -139.03 117.68 12.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.722 1.609 . . . . 3.8799999999999999 108.036 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.77 70.77 0.99 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.95 1.7 . . . . 2.2400000000000002 111.323 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.48 140.5 94.85 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.967 -1.083 . . . . 3.7400000000000002 111.754 171.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.98 -33.4 83.5 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.83 2.353 . . . . 1.51 112.201 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.01 53.41 4.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.058 0.837 . . . . 1.4399999999999999 112.31 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.14 -64.26 0.05 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.452 1.025 . . . . 1.3899999999999999 114.842 177.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -154.63 137.79 15.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.657 1.583 . . . . 3.4100000000000001 110.558 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -162.17 172.24 16.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.227 -0.921 . . . . 0.85999999999999999 111.963 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -105.12 131.83 52.11 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.099 0.559 . . . . 3.1000000000000001 110.405 167.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.3 mmt -88.91 143.93 26.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.279 1.032 . . . . 1.74 109.9 156.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.8 125.56 46.8 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.932 1.293 . . . . 3.8100000000000001 108.801 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mt -124.85 133.87 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.314 1.846 . . . . 2.7400000000000002 110.692 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.67 78.37 0.67 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.778 -1.329 . . . . 2.4700000000000002 109.778 -174.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.39 104.08 4.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.332 1.066 . . . . 2.1000000000000001 109.972 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.46 17.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.834 1.05 . . . . 3.0499999999999998 113.834 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -122.6 140.3 32.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.529 1.932 . . . . 6.9800000000000004 109.647 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -69.39 140.33 43.79 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 N-CA-C 108.26 -1.477 . . . . 2.3500000000000001 108.26 148.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.7 mt -120.51 155.62 33.24 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.464 1.106 . . . . 4.2699999999999996 111.433 -174.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -130.92 1.37 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.188 1.551 . . . . 4.1399999999999997 115.188 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 59.11 178.62 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.219 2.207 . . . . 3.1200000000000001 111.92 -171.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.2 56.22 25.81 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 110.445 -1.062 . . . . 1.9099999999999999 110.445 -172.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -166.72 157.12 11.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 128.572 2.749 . . . . 3.0899999999999999 109.961 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -112.46 148.41 34.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.533 1.133 . . . . 4.3499999999999996 112.054 -167.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.1 t -125.41 117.48 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.18 1.792 . . . . 2.25 108.342 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.72 133.28 33.69 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.836 -0.801 . . . . 4.04 108.836 157.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.71 141.71 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.957 1.703 . . . . 3.21 108.708 -173.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.06 123.1 31.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.891 1.677 . . . . 2.3500000000000001 109.961 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.74 120.33 27.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.103 0.961 . . . . 2.52 109.8 168.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.77 125.61 40.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.18 0.992 . . . . 1.6499999999999999 111.731 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -125.51 114.14 18.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.996 0.903 . . . . 3.4300000000000002 111.73 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.12 25.7 0.12 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 127.502 2.321 . . . . 3.2999999999999998 116.317 171.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.68 -42.03 1.04 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.52 1.533 . . . . 4.2599999999999998 113.906 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.04 0.09 87.93 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.224 1.392 . . . . 2.1499999999999999 116.102 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.25 155.24 41.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.933 2.093 . . . . 5.0800000000000001 111.748 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.72 141.0 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.429 1.892 . . . . 1.98 108.599 171.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.9 112.4 9.32 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.112 1.365 . . . . 2.5499999999999998 109.24 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -83.92 137.39 33.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.016 0.747 . . . . 4.7699999999999996 113.016 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 m -138.24 153.43 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.988 1.715 . . . . 2.3100000000000001 110.894 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 m -95.2 149.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.265 1.426 . . . . 4.21 112.416 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -147.13 141.77 16.26 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.89 2.076 . . . . 4.3200000000000003 108.382 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.09 156.75 33.97 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.979 2.452 . . . . 1.1100000000000001 111.027 163.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -84.17 109.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.074 0.949 . . . . 1.8400000000000001 109.828 164.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 120' ' ' ARG . 4.8 mm-40 -79.01 146.51 33.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.284 1.034 . . . . 3.7000000000000002 108.288 155.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.37 94.03 4.77 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.045 -1.095 . . . . 2.1600000000000001 108.045 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.455 HH21 ' CD ' ' A' ' 118' ' ' GLU . 32.0 ttm-85 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 113.57 0.952 . . . . 9.1199999999999992 113.57 -164.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.987 0 N-CA-C 107.383 -2.287 . . . . 11.77 107.383 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -153.62 -141.22 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.734 0.813 . . . . 9.5700000000000003 108.826 -161.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -76.44 -170.93 1.64 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.056 0.843 . . . . 12.199999999999999 108.814 149.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -80.23 98.39 7.35 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.569 -1.332 . . . . 8.7100000000000009 108.198 161.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -79.32 84.64 5.22 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.522 0.729 . . . . 4.5599999999999996 110.588 -172.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.69 -175.91 43.49 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.956 1.741 . . . . 1.53 114.762 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -159.62 156.44 27.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.126 1.371 . . . . 1.99 113.257 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -113.92 131.07 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.543 -0.723 . . . . 1.9099999999999999 109.947 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.461 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 70.9 ttt180 -72.2 114.17 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.776 1.231 . . . . 5.4100000000000001 109.249 174.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 129.09 37.17 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.723 0.809 . . . . 3.3300000000000001 109.136 162.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.35 163.26 38.09 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.877 1.671 . . . . 2.9199999999999999 108.1 167.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.12 17.68 0.49 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.459 3.439 . . . . 1.48 115.456 -167.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.31 174.38 49.48 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.599 -0.688 . . . . 1.3 112.772 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.23 -3.0 36.91 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.364 1.082 . . . . 1.6200000000000001 113.034 -4.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -141.2 169.41 17.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.297 1.439 . . . . 2.0299999999999998 112.5 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.19 -158.5 0.34 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.985 2.514 . . . . 1.7 111.177 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.49 171.08 20.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.62 1.168 . . . . 1.6100000000000001 113.664 -169.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.93 151.0 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.343 1.057 . . . . 1.74 113.186 170.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -142.81 145.65 33.43 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.594 1.558 . . . . 3.3599999999999999 110.468 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -169.62 160.97 9.25 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.46 0.911 . . . . 2.5800000000000001 113.46 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.0 m -78.19 141.53 38.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.54 1.536 . . . . 2.1000000000000001 109.076 162.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -128.21 136.72 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.458 1.103 . . . . 3.77 108.561 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -130.69 148.98 52.54 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.97 0.908 . . . . 2.7200000000000002 110.657 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.497 HD22 ' HB2' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -119.35 70.91 12.21 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.366 0.666 . . . . 3.8300000000000001 112.309 -159.307 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 -14.65 44.46 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.231 2.621 . . . . 1.1799999999999999 115.438 -168.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.25 161.33 53.35 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.397 0.998 . . . . 1.1699999999999999 112.92 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 3.8 m-20 -91.08 -2.24 57.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.507 1.523 . . . . 3.1000000000000001 113.353 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -117.73 160.06 39.92 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.034 1.733 . . . . 2.1800000000000002 110.618 172.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.43 157.38 25.56 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.77 2.314 . . . . 0.72999999999999998 111.235 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.497 ' HB2' HD22 ' A' ' 24' ' ' ASN . 2.3 mp -124.02 127.95 48.64 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.58 1.552 . . . . 3.5299999999999998 110.727 -172.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -113.37 104.98 12.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.263 1.425 . . . . 5.5199999999999996 110.794 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.2 tp -89.64 115.68 27.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.664 2.385 . . . . 1.8799999999999999 108.78 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.8 m -110.24 -8.65 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.403 1.081 . . . . 1.8200000000000001 113.541 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.6 -159.76 32.14 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 121.636 -0.665 . . . . 0.38 113.331 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.71 178.74 8.23 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.59 0.756 . . . . 1.8799999999999999 112.221 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -152.58 145.92 24.79 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.572 -1.27 . . . . 8.2799999999999994 107.572 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -155.76 156.06 30.2 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.927 1.291 . . . . 1.8 109.279 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.35 -26.94 71.24 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.585 2.19 . . . . 1.1299999999999999 113.339 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.323 1.5 m -92.45 11.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.914 1.45 . . . . 2.1200000000000001 114.914 -170.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.9 151.01 26.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.981 1.312 . . . . 1.8999999999999999 112.409 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -97.34 -78.19 0.48 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.318 -0.993 . . . . 3.3599999999999999 108.318 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -74.6 107.42 6.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.078 -1.453 . . . . 3.9900000000000002 107.078 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.21 129.24 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 2.6099999999999999 108.22 173.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.39 127.81 18.9 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.026 1.331 . . . . 2.3100000000000001 110.138 -162.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -79.21 121.16 24.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.825 0.821 . . . . 1.97 110.588 175.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -107.4 153.49 22.71 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.393 1.877 . . . . 0.87 112.94 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.0 164.17 13.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.852 1.661 . . . . 2.29 110.89 161.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 81.5 m -129.75 105.88 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.888 1.675 . . . . 2.2799999999999998 108.334 166.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -106.2 158.1 17.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.788 1.235 . . . . 3.6299999999999999 113.261 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.0 mtp -124.52 100.82 6.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.363 1.465 . . . . 5.1500000000000004 110.36 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -122.63 145.87 47.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.415 1.486 . . . . 6.7000000000000002 110.928 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.457 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 45.2 mp0 -59.96 147.33 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.529 0.731 . . . . 3.5699999999999998 111.349 165.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -159.31 -47.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.944 1.09 . . . . 3.6600000000000001 113.944 170.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -93.28 38.28 1.04 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.485 1.914 . . . . 5.8300000000000001 110.746 171.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.54 -40.16 0.76 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.5 1.524 . . . . 2.6200000000000001 113.043 -167.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -86.93 154.52 20.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.581 2.352 . . . . 4.5800000000000001 111.122 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.457 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 33.1 mttp -68.44 122.99 19.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.875 0.87 . . . . 4.8700000000000001 111.267 170.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.84 151.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.351 1.461 . . . . 3.6499999999999999 109.935 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -83.55 141.95 31.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.61 1.564 . . . . 3.3700000000000001 111.155 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.77 170.5 33.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.967 0.794 . . . . 1.1299999999999999 112.884 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.98 145.12 41.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.76 1.224 . . . . 3.2599999999999998 111.229 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -153.32 143.36 15.34 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 125.447 1.499 . . . . 3.8999999999999999 109.964 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.78 145.56 75.52 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.755 1.637 . . . . 0.91000000000000003 110.595 163.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -118.32 154.16 51.92 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.687 1.595 . . . . 1.9299999999999999 110.084 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.09 -9.56 26.28 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.827 2.351 . . . . 1.5900000000000001 114.136 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -172.37 163.03 5.56 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.098 1.317 . . . . 3.23 111.664 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -119.19 169.69 9.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.586 1.554 . . . . 1.8799999999999999 108.482 148.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -158.16 164.24 36.77 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.045 -1.034 . . . . 2.2999999999999998 112.118 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.02 138.5 14.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 2.3799999999999999 110.593 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.07 161.6 45.37 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.676 2.25 . . . . 1.26 111.314 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.38 146.2 93.2 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.98 2.453 . . . . 0.89000000000000001 111.798 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 68.7 mmtt 69.97 -12.48 0.48 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.507 2.723 . . . . 2.2200000000000002 114.624 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.5 130.86 29.13 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 126.456 1.979 . . . . 0.96999999999999997 111.974 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -94.49 129.02 41.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.095 -1.553 . . . . 6.46 110.045 161.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.73 178.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.681 1.592 . . . . 2.0600000000000001 110.345 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -141.07 140.2 34.18 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.128 0.971 . . . . 3.2999999999999998 110.169 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.59 59.77 3.1 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.702 1.239 . . . . 1.8899999999999999 108.912 155.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -72.14 122.41 87.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.677 -1.154 . . . . 4.5300000000000002 110.116 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.95 -27.08 83.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.372 2.715 . . . . 1.55 114.792 -168.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.13 84.31 1.6 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.746 -1.742 . . . . 1.5800000000000001 108.746 157.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.01 -87.44 0.16 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.334 1.921 . . . . 1.5600000000000001 111.55 -166.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -143.42 153.77 43.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.246 1.818 . . . . 3.25 110.881 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -157.79 165.43 35.35 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.509 1.123 . . . . 0.85999999999999999 109.736 175.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -93.2 137.23 32.73 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.8 -1.185 . . . . 3.5299999999999998 107.8 159.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.7 139.5 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.744 1.218 . . . . 2.4700000000000002 109.411 168.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.5 mt -117.83 131.69 56.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.86 1.264 . . . . 3.0699999999999998 110.459 -172.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.85 159.49 42.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.721 1.608 . . . . 2.52 111.928 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -56.87 4.51 Favored Glycine 0 N--CA 1.47 0.934 0 C-N-CA 124.897 1.237 . . . . 2.3700000000000001 112.73 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.4 mt 70.76 98.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 129.715 3.206 . . . . 2.3799999999999999 113.252 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -11.01 59.83 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.17 1.174 . . . . 2.6699999999999999 114.17 -171.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -141.33 158.1 64.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 129.588 3.155 . . . . 8.8499999999999996 108.928 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.49 163.2 39.83 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.513 2.809 . . . . 2.1400000000000001 110.294 160.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.27 151.6 44.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.183 0.993 . . . . 3.3799999999999999 112.275 -167.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.476 ' HZ1' ' CD ' ' A' ' 97' ' ' GLU . 22.7 tptp -142.34 120.58 12.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.446 1.098 . . . . 4.4699999999999998 110.445 -170.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 140.27 54.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.548 0.739 . . . . 2.6299999999999999 112.783 172.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.02 -20.6 33.14 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.339 1.447 . . . . 3.0800000000000001 115.158 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.476 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -89.81 -173.72 4.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.249 1.024 . . . . 5.3399999999999999 111.084 -169.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -95.64 152.06 18.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.715 0.769 . . . . 4.25 110.727 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.26 127.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.388 2.275 . . . . 2.29 108.156 163.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -86.03 150.14 24.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.731 0.812 . . . . 3.27 109.842 170.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tt -158.68 140.04 13.27 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.248 1.019 . . . . 2.5 113.252 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.41 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 2.7 m-20 -101.99 107.08 18.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.513 2.325 . . . . 2.2000000000000002 111.443 171.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.9 119.22 21.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.154 0.982 . . . . 2.0899999999999999 110.397 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.4 mt -95.05 131.93 40.49 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.788 1.235 . . . . 1.76 111.768 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.23 139.47 53.7 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.226 1.195 . . . . 3.1899999999999999 114.226 -177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.27 72.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.895 1.278 . . . . 2.3599999999999999 114.203 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.49 33.43 1.83 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.588 1.09 . . . . 4.4199999999999999 114.176 -174.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.25 49.21 67.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.721 1.153 . . . . 1.71 112.645 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 160.75 39.28 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.865 1.666 . . . . 4.8700000000000001 112.053 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.22 145.55 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.523 1.929 . . . . 2.2000000000000002 107.707 170.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.71 121.68 25.93 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.826 1.25 . . . . 2.7400000000000002 110.717 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 3.0 tpmt? -72.07 131.19 42.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.039 0.536 . . . . 3.3700000000000001 111.331 176.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.86 150.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.232 1.413 . . . . 2.7200000000000002 109.832 166.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.82 152.15 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.958 1.703 . . . . 3.6299999999999999 109.045 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.5 mt -148.69 144.77 18.74 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.254 1.422 . . . . 3.4100000000000001 109.708 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.25 149.0 81.34 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.17 2.58 . . . . 1.3100000000000001 112.214 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.28 128.08 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.829 1.252 . . . . 2.3700000000000001 109.24 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 120' ' ' ARG . 36.8 tt0 -118.23 135.08 54.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.726 1.61 . . . . 3.3199999999999998 107.501 166.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.9 125.07 30.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.695 0.68 . . . . 2.8399999999999999 110.283 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 14.6 ttm-85 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.037 1.335 . . . . 8.2200000000000006 111.795 -175.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.445 ' HA2' ' CE2' ' A' ' 7' ' ' TRP . . . . . . . . 0 N--CA 1.467 0.754 0 N-CA-C 110.314 -1.115 . . . . 16.420000000000002 110.314 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 m -147.61 -140.12 0.1 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.2 1.0 . . . . 12.220000000000001 112.012 -164.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.2 p90 177.95 159.58 0.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 129.888 3.275 . . . . 11.67 108.442 -172.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m 90.87 -44.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 128.841 2.856 . . . . 7.2300000000000004 110.612 -176.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.62 163.77 20.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.291 2.637 . . . . 6.4400000000000004 105.835 156.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.57 -151.98 28.85 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.297 0.951 . . . . 2.1000000000000001 112.586 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.445 ' CE2' ' HA2' ' A' ' 1' ' ' GLY . 9.2 p90 -166.22 138.54 3.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.771 1.228 . . . . 1.9299999999999999 112.487 177.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.73 145.27 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.377 1.071 . . . . 2.2999999999999998 108.356 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -117.03 85.95 2.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.106 0.962 . . . . 5.4800000000000004 109.758 -166.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.76 149.46 48.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.878 1.671 . . . . 3.8399999999999999 112.222 -174.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -152.43 153.44 30.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.32 2.248 . . . . 2.6099999999999999 107.743 174.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.27 -12.67 35.68 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.227 2.618 . . . . 2.4700000000000002 112.865 170.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.78 -167.84 13.96 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.395 0.998 . . . . 1.6699999999999999 114.162 170.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.34 -2.23 19.84 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 CA-C-N 118.195 0.998 . . . . 1.98 113.309 -3.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -134.63 163.26 30.14 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.248 1.819 . . . . 2.4399999999999999 112.482 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.43 179.51 9.06 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.757 2.023 . . . . 1.5 111.288 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.67 166.08 23.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.668 0.787 . . . . 1.98 112.864 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.88 135.35 32.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.309 0.644 . . . . 1.76 111.806 170.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.45 147.87 42.32 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.329 1.452 . . . . 3.8399999999999999 108.252 172.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.06 148.6 20.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.418 0.687 . . . . 3.0800000000000001 111.593 -170.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -91.17 116.07 28.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.722 0.772 . . . . 3.1099999999999999 109.452 166.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 125.44 35.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.204 -1.406 . . . . 3.6600000000000001 107.204 164.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.59 146.45 47.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.128 0.966 . . . . 3.6400000000000001 111.328 165.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -114.87 90.88 24.11 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-N 114.725 -1.125 . . . . 0.97999999999999998 109.22 171.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.04 -9.59 20.78 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.539 2.159 . . . . 1.05 112.98 176.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 -167.18 42.34 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.84 1.209 . . . . 1.1399999999999999 113.394 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.446 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.8 m-20 -121.57 5.51 10.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.376 1.47 . . . . 2.73 112.855 -166.019 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.93 163.06 41.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.61 1.964 . . . . 2.4500000000000002 109.915 173.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.82 148.09 15.5 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.406 2.071 . . . . 0.72999999999999998 112.272 -171.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -111.44 108.36 17.89 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.344 1.458 . . . . 3.1800000000000002 109.703 -177.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -102.18 102.49 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.536 1.534 . . . . 5.5899999999999999 112.355 -178.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.51 124.57 37.59 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.636 1.974 . . . . 2.1200000000000001 108.394 -173.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.92 -11.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.662 1.185 . . . . 1.7 112.723 -172.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -162.57 29.96 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 123.789 0.709 . . . . 0.60999999999999999 112.463 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.87 -179.27 7.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.421 1.089 . . . . 1.78 110.697 174.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -156.1 145.17 20.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.136 -1.431 . . . . 6.1100000000000003 107.136 173.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.41 ' HG1' ' CG1' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -151.59 149.17 23.47 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 118.95 0.795 . . . . 1.6499999999999999 109.928 -176.184 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.08 -10.74 29.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.948 2.432 . . . . 1.05 113.305 173.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 3.0 m -92.51 7.36 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 114.324 1.231 . . . . 2.2000000000000002 114.324 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.39 165.83 28.17 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.071 -1.018 . . . . 1.8999999999999999 112.801 -179.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -111.29 -62.49 1.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.966 -0.753 . . . . 3.6600000000000001 108.966 170.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -86.12 138.76 31.68 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.286 -0.884 . . . . 4.7699999999999996 109.862 168.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.12 138.75 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.432 2.293 . . . . 2.54 109.19 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -143.11 136.54 28.37 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.952 1.701 . . . . 2.8599999999999999 110.157 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.11 119.27 24.78 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.325 0.966 . . . . 2.04 110.686 167.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -110.42 167.0 10.54 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.547 1.939 . . . . 0.90000000000000002 112.111 178.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.74 -173.18 3.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.848 1.659 . . . . 3.4199999999999999 112.172 175.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.8 m -136.79 124.11 21.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.273 -1.01 . . . . 2.6099999999999999 108.273 167.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -114.02 176.96 4.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 3.6600000000000001 111.09 179.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtm -131.93 139.25 48.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.322 1.049 . . . . 3.6099999999999999 110.457 163.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtp85 -143.16 156.62 44.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.096 1.358 . . . . 6.4199999999999999 111.961 173.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 mp0 -67.25 151.63 47.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.025 1.73 . . . . 4.6900000000000004 110.948 159.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.29 -41.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 114.38 -1.282 . . . . 3.5699999999999998 114.238 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -117.68 32.4 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.769 2.028 . . . . 4.5199999999999996 110.541 167.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.4 -35.68 1.34 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.845 -1.159 . . . . 2.6000000000000001 112.785 -166.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 mttp -70.58 144.5 51.2 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.274 -1.133 . . . . 3.7799999999999998 109.095 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -99.48 140.72 33.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.439 0.903 . . . . 4.5300000000000002 113.439 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.21 150.57 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.497 1.919 . . . . 3.7000000000000002 108.819 -171.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.3 mtm -80.26 149.81 30.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.147 1.379 . . . . 3.9700000000000002 111.517 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.16 160.67 30.63 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.961 -0.462 . . . . 1.28 113.184 173.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -115.64 152.58 32.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.786 1.234 . . . . 2.6200000000000001 111.385 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -164.87 156.99 13.76 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.955 1.302 . . . . 8.3599999999999994 111.646 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.01 145.17 78.77 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.79 2.327 . . . . 0.95999999999999996 110.73 161.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 156.39 53.83 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.838 1.655 . . . . 2.1600000000000001 109.758 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.99 -11.01 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.062 2.508 . . . . 1.26 114.338 -179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -175.91 168.9 2.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.515 1.526 . . . . 3.48 110.638 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.77 168.78 13.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.091 1.757 . . . . 2.0899999999999999 108.58 154.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -155.44 164.04 39.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.058 -1.026 . . . . 2.27 111.978 163.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.79 129.08 16.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 124.034 0.934 . . . . 1.6899999999999999 110.03 -172.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.22 162.88 40.66 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.435 2.09 . . . . 0.84999999999999998 111.082 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.6 141.48 91.43 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.111 2.541 . . . . 1.01 112.083 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 60.3 mmtt 70.23 -1.33 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.77 2.428 . . . . 2.0299999999999998 113.728 -172.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.34 121.49 5.54 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 127.248 2.356 . . . . 0.81999999999999995 111.644 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -99.23 135.76 40.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.43 1.492 . . . . 7.0899999999999999 110.48 161.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.34 148.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.6 1.56 . . . . 2.2000000000000002 110.285 174.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -131.4 120.93 23.75 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.647 -0.501 . . . . 5.4800000000000004 109.647 -166.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.6 68.65 9.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.448 1.594 . . . . 2.1299999999999999 112.565 -161.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -64.54 142.31 98.42 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.52 2.328 . . . . 5.0 114.519 173.24 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -30.77 47.47 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.955 3.104 . . . . 1.7 113.397 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.73 74.21 2.43 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 108.424 -1.87 . . . . 1.45 108.424 163.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.78 -152.77 21.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.954 1.74 . . . . 2.4900000000000002 111.514 -167.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -72.47 135.91 45.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.226 1.41 . . . . 4.0499999999999998 111.839 -174.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -168.09 178.88 4.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.613 1.165 . . . . 1.1599999999999999 109.457 -174.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -114.2 139.83 49.05 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.336 0.516 . . . . 3.9900000000000002 111.823 173.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 mmt -101.72 131.1 48.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.902 1.681 . . . . 1.8100000000000001 110.101 168.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.94 138.94 53.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.631 1.573 . . . . 4.1900000000000004 110.684 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.96 157.67 45.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.902 1.681 . . . . 3.27 112.036 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.39 -47.86 3.93 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 124.854 1.216 . . . . 2.5800000000000001 112.799 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt 57.92 88.76 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.923 2.489 . . . . 1.79 112.97 169.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.43 0.49 12.15 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.168 1.544 . . . . 3.2000000000000002 115.168 -169.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.403 HH22 ' CD ' ' A' ' 97' ' ' GLU . 24.3 mtp-105 -149.04 151.36 34.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.347 2.259 . . . . 6.0300000000000002 108.837 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -88.72 -10.27 4.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.71 3.607 . . . . 3.3700000000000001 117.86 -176.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.0 mt 80.09 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 127.904 2.481 . . . . 4.46 114.357 156.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.22 -175.66 4.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 130.781 3.633 . . . . 5.5999999999999996 109.43 176.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.1 149.84 32.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.247 -1.39 . . . . 3.73 107.247 139.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.96 15.44 77.39 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 118.849 0.749 . . . . 2.71 112.819 -164.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 91' ' ' ARG . 11.6 pt-20 -115.57 140.68 48.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.095 -1.446 . . . . 3.6299999999999999 107.095 144.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.42 134.75 53.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.16 -1.836 . . . . 4.9299999999999997 109.457 -160.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.41 ' CG1' ' HG1' ' A' ' 37' ' ' THR . 78.6 t -106.42 104.74 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.299 -0.409 . . . . 2.27 111.462 -150.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.435 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 49.6 mt-10 -65.14 128.4 35.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.456 -1.247 . . . . 3.3900000000000001 110.097 160.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -138.49 137.88 37.55 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.628 1.571 . . . . 2.7200000000000002 108.755 -177.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -91.31 106.63 18.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.33 2.252 . . . . 2.5600000000000001 111.12 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.73 106.58 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.445 1.098 . . . . 3.0600000000000001 110.863 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.39 118.11 22.94 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.76 -0.459 . . . . 2.02 109.76 -174.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.28 147.78 38.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.011 0.924 . . . . 3.1499999999999999 111.726 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.61 130.5 28.26 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.22 1.008 . . . . 2.2799999999999998 112.329 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.64 -151.98 20.85 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.277 0.941 . . . . 3.79 110.756 -163.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.92 23.21 35.37 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.828 1.204 . . . . 2.5899999999999999 114.104 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.55 125.36 35.18 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.042 -1.269 . . . . 6.0599999999999996 111.428 -177.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.96 124.79 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.322 1.049 . . . . 3.0 110.928 171.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.31 122.12 41.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.542 1.537 . . . . 4.8200000000000003 109.811 -174.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 29.5 ttpt -85.76 124.09 31.88 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.903 -0.498 . . . . 3.5299999999999998 111.566 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.71 148.22 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.16 1.384 . . . . 2.6899999999999999 111.242 178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.97 131.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.881 1.272 . . . . 2.9199999999999999 111.333 -177.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -128.66 151.96 77.88 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 125.289 1.436 . . . . 3.02 112.71 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.51 145.79 26.81 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.645 3.563 . . . . 2.0800000000000001 112.147 177.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.18 139.56 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.537 1.135 . . . . 2.6899999999999999 112.057 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -131.11 148.78 52.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.527 2.731 . . . . 3.54 108.487 173.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.73 48.28 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.062 -1.024 . . . . 2.2400000000000002 110.711 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 N-CA-C 115.084 1.513 . . . . 6.8300000000000001 115.084 -175.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.03 0 N-CA-C 109.785 -1.326 . . . . 12.83 109.785 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -52.97 -31.31 39.95 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 118.455 1.127 . . . . 12.92 113.171 171.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -112.24 142.26 44.94 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.707 -1.59 . . . . 13.41 106.707 153.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.8 p -94.0 115.39 27.72 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.374 0.67 . . . . 8.9499999999999993 109.209 -178.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.77 104.41 17.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.141 2.176 . . . . 6.5199999999999996 110.105 -165.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.7 -169.97 42.77 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 114.967 0.747 . . . . 1.4099999999999999 114.967 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -164.99 160.7 19.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 1.79 112.949 -175.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.53 132.72 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.766 -0.584 . . . . 2.2999999999999998 110.605 177.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.3 ttp85 -96.61 97.89 9.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.85 1.26 . . . . 4.9299999999999997 110.056 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 152.51 44.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.973 1.709 . . . . 3.29 111.625 -175.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 m -155.14 149.8 20.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 119.77 -1.832 . . . . 2.46 111.209 168.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.32 25.52 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.622 3.548 . . . . 1.6599999999999999 114.19 -175.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.86 165.31 29.15 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.47 -0.769 . . . . 1.3200000000000001 113.952 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.87 -3.77 31.52 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 CA-C-N 118.097 0.949 . . . . 1.8100000000000001 113.629 -2.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -154.69 -179.53 8.09 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.591 1.556 . . . . 2.04 111.644 -175.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.67 -175.06 4.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.891 1.677 . . . . 1.52 111.924 -179.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.11 149.47 45.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.782 0.833 . . . . 1.75 112.654 -175.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.31 51.77 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.203 1.401 . . . . 1.5900000000000001 112.159 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.57 157.95 43.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.108 1.363 . . . . 3.6899999999999999 111.906 -177.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.6 159.66 12.24 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.73 1.212 . . . . 2.9100000000000001 111.92 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.3 m -79.99 146.39 32.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.617 1.567 . . . . 2.4399999999999999 108.455 154.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -143.43 136.92 28.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.483 0.713 . . . . 3.6299999999999999 109.609 169.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -116.21 143.04 46.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.053 0.941 . . . . 3.02 112.71 167.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -87.98 111.98 46.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.46 1.104 . . . . 1.1699999999999999 108.624 161.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -85.48 -12.12 6.75 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.156 2.571 . . . . 1.21 113.456 174.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.24 161.92 39.79 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.519 1.057 . . . . 1.28 112.482 -177.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.474 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.1 m-20 -92.09 4.06 53.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.217 1.807 . . . . 3.3100000000000001 113.327 -174.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.31 161.36 35.5 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.397 1.879 . . . . 2.4300000000000002 110.02 168.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.85 154.4 26.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.853 2.369 . . . . 0.76000000000000001 111.574 -171.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.58 127.6 52.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.33 1.452 . . . . 3.3300000000000001 110.169 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -118.0 114.11 22.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.66 1.184 . . . . 4.5 111.787 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.9 tp -100.51 109.9 22.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.369 2.668 . . . . 2.2799999999999998 109.806 -171.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.41 -13.76 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.413 1.085 . . . . 1.8200000000000001 113.84 -165.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.39 -160.56 31.91 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.0 0.81 . . . . 0.42999999999999999 112.41 -176.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.71 -174.08 4.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 117.73 0.765 . . . . 1.9199999999999999 112.998 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -149.77 138.17 20.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.813 2.445 . . . . 7.1200000000000001 107.541 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.44 ' HG1' HG12 ' A' ' 99' ' ' VAL . 1.7 t -150.02 153.89 36.18 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 119.855 1.207 . . . . 1.55 110.686 -170.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.45 -32.33 12.51 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.252 1.968 . . . . 1.3700000000000001 111.716 165.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.402 1.3 m -93.1 6.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 115.503 1.668 . . . . 2.1000000000000001 115.503 -169.559 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.75 174.26 13.24 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.052 1.341 . . . . 1.77 109.744 167.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -118.01 -74.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.778 0.717 . . . . 4.3099999999999996 109.618 175.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttm105 -66.25 133.98 51.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.735 -1.209 . . . . 6.0599999999999996 107.735 163.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.26 129.62 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.823 1.249 . . . . 2.7799999999999998 108.406 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -134.44 127.76 32.14 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.084 0.954 . . . . 2.3900000000000001 109.452 -160.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.81 117.6 20.07 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.496 1.141 . . . . 1.9399999999999999 109.909 171.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.6 m170 -107.1 154.02 21.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.671 1.588 . . . . 0.92000000000000004 111.326 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.74 179.46 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.261 -1.336 . . . . 1.9399999999999999 110.449 167.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.7 m -149.97 94.46 2.16 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.284 1.433 . . . . 2.1499999999999999 107.725 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -90.71 165.53 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.169 1.788 . . . . 3.2599999999999998 112.857 -169.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.7 mtm -98.52 152.45 19.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.349 -0.841 . . . . 3.04 109.891 158.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -151.67 132.0 13.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.216 1.806 . . . . 6.6799999999999997 108.895 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.75 144.14 31.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.519 0.728 . . . . 4.3899999999999997 110.899 173.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.2 122.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.154 1.382 . . . . 4.4400000000000004 107.542 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 58.76 29.69 19.02 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.325 1.059 . . . . 5.5599999999999996 110.994 -174.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.49 -6.57 16.03 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 120.089 -1.632 . . . . 2.25 114.47 -173.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -85.06 138.92 32.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.455 1.502 . . . . 5.0499999999999998 109.115 179.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -85.79 142.97 28.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.278 0.49 . . . . 5.0800000000000001 112.24 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.92 159.61 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 3.9700000000000002 110.433 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.7 mtp -102.93 166.08 10.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.04 0.936 . . . . 5.4199999999999999 111.688 169.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.48 174.74 34.94 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 123.829 0.728 . . . . 1.1799999999999999 112.006 167.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.37 159.94 38.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.803 1.241 . . . . 3.0499999999999998 110.025 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.81 151.18 0.98 Allowed Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.928 1.691 . . . . 4.0700000000000003 110.431 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.7 Cg_endo -68.9 149.74 72.62 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.613 1.542 . . . . 1.1899999999999999 111.103 166.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.28 157.84 39.95 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 1.77 109.859 172.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -66.78 -20.15 52.53 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.229 1.953 . . . . 0.84999999999999998 112.522 174.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -179.56 161.28 1.02 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 126.731 2.012 . . . . 3.7599999999999998 110.877 178.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mt -103.99 168.83 8.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.082 0.953 . . . . 1.99 109.705 150.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.47 164.58 36.45 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.843 -0.536 . . . . 2.4199999999999999 111.419 167.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.7 t -140.51 129.49 13.06 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 125.555 1.542 . . . . 1.8700000000000001 108.664 -164.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.79 161.83 44.7 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.977 1.784 . . . . 0.98999999999999999 111.161 177.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.2 140.71 96.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.182 2.588 . . . . 0.96999999999999997 111.74 177.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.474 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 14.5 mmmt 67.95 -3.27 1.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.857 2.063 . . . . 2.3900000000000001 113.368 -177.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.07 119.85 4.97 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 127.277 2.37 . . . . 1.1699999999999999 111.891 -172.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -81.76 136.95 35.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.642 1.177 . . . . 5.5099999999999998 110.459 156.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 m -150.99 145.48 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.102 1.761 . . . . 2.5 109.807 173.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -103.35 139.28 38.97 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.477 0.917 . . . . 3.5699999999999998 113.477 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.38 54.95 0.95 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.128 1.442 . . . . 2.0099999999999998 109.72 156.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -54.2 114.99 7.42 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.546 -1.216 . . . . 6.04 109.966 162.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.58 -28.18 85.05 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.211 2.607 . . . . 1.6399999999999999 114.824 -170.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.19 36.24 0.94 Allowed Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.342 0.973 . . . . 1.8700000000000001 113.367 166.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.06 -48.19 0.04 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.93 2.205 . . . . 1.3700000000000001 113.65 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -154.08 145.12 22.75 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.072 1.749 . . . . 3.2000000000000002 110.39 -174.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -165.66 171.81 12.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.969 1.308 . . . . 0.92000000000000004 110.52 -178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -103.35 135.08 45.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.108 0.563 . . . . 3.1699999999999999 110.667 165.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.1 mmt -92.74 134.74 34.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.532 1.133 . . . . 1.5600000000000001 110.467 165.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.2 mt -109.78 114.98 29.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.802 1.641 . . . . 3.1800000000000002 110.186 -176.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.77 155.48 31.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.223 1.409 . . . . 4.8799999999999999 111.039 -174.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.55 -39.69 3.1 Favored Glycine 0 N--CA 1.48 1.572 0 O-C-N 120.628 -1.295 . . . . 2.29 113.55 165.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 49.78 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 124.434 2.064 . . . . 2.46 115.822 162.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -79.72 4.63 15.67 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.245 -1.798 . . . . 4.0199999999999996 114.187 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -155.42 158.97 32.05 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.837 2.855 . . . . 5.7599999999999998 107.32 -175.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 94' ' ' LYS . 59.5 Cg_endo -75.08 -13.77 21.14 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.518 . . . . 4.3700000000000001 117.552 -173.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mp 60.82 -4.77 0.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 130.069 3.348 . . . . 4.71 113.716 -169.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -42.64 149.65 0.17 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.7 2.8 . . . . 4.0899999999999999 115.124 -171.007 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.7 126.34 21.58 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.955 1.302 . . . . 2.5499999999999998 112.125 178.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.74 30.1 45.19 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.778 -0.457 . . . . 3.5299999999999998 112.931 -165.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 -176.7 3.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.992 -1.855 . . . . 4.2800000000000002 105.992 139.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.23 155.11 50.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.634 -1.247 . . . . 4.7199999999999998 107.634 165.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.44 HG12 ' HG1' ' A' ' 37' ' ' THR . 21.3 t -115.5 93.18 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 122.428 1.109 . . . . 2.0899999999999999 110.538 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.05 123.1 16.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.856 -1.974 . . . . 3.8199999999999998 108.857 153.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.1 114.28 16.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.656 0.741 . . . . 2.8500000000000001 109.062 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.99 89.33 7.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.291 1.836 . . . . 2.4500000000000002 108.307 176.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.9 120.46 13.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.923 1.689 . . . . 2.25 109.567 -178.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.3 mt -86.1 139.04 31.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.084 1.353 . . . . 1.8100000000000001 110.391 -175.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -117.04 165.02 13.85 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.845 -0.534 . . . . 3.5899999999999999 112.421 177.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.96 70.84 1.53 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.504 1.122 . . . . 2.3300000000000001 112.681 -176.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 137.07 -154.11 22.13 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.95 1.738 . . . . 3.1200000000000001 111.638 -178.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.67 46.84 2.65 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.372 0.987 . . . . 2.2799999999999998 114.894 -173.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -136.03 143.43 44.73 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.53 1.932 . . . . 5.21 110.673 173.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -152.07 143.85 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 127.506 2.323 . . . . 1.9199999999999999 107.108 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -133.71 118.3 17.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.85 0.86 . . . . 2.8999999999999999 111.538 -171.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -74.67 117.88 16.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.843 0.457 . . . . 3.4300000000000002 111.612 173.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.46 165.28 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.767 1.227 . . . . 3.0499999999999998 110.42 160.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.21 136.15 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.457 1.103 . . . . 3.8300000000000001 109.195 171.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.9 mt -146.9 109.35 4.04 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.509 1.123 . . . . 3.02 110.693 -167.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.77 156.56 65.05 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.13 2.553 . . . . 1.21 113.165 -174.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -80.36 133.87 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 122.084 0.945 . . . . 2.3700000000000001 112.018 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -121.5 151.65 40.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 130.44 3.496 . . . . 3.7799999999999998 106.711 165.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.55 16.41 7.59 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.377 1.621 . . . . 2.7799999999999998 115.377 -154.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 113.717 1.006 . . . . 8.4100000000000001 113.717 -160.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 0 N-CA-C 109.287 -1.525 . . . . 13.16 109.287 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m -83.12 160.04 21.96 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.032 0.916 . . . . 11.720000000000001 112.253 172.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 76.61 155.94 0.17 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.365 2.266 . . . . 14.27 113.631 170.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p 177.23 -44.95 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.125 2.57 . . . . 7.25 109.116 -158.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -124.77 -165.44 1.39 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.54 1.536 . . . . 6.0800000000000001 111.911 -166.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.99 167.52 28.3 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.699 1.619 . . . . 1.6000000000000001 113.981 176.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -151.49 128.04 10.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.739 1.216 . . . . 2.3300000000000001 111.593 -170.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -100.03 112.21 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.344 -0.847 . . . . 2.2799999999999998 109.952 -170.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 1.8 tmt_? -84.03 89.71 7.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.333 1.453 . . . . 4.0999999999999996 111.649 -161.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.3 147.53 40.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.78 2.032 . . . . 3.6099999999999999 111.768 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.0 m -159.05 156.76 27.1 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 127.524 2.33 . . . . 3.1200000000000001 109.273 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.01 12.61 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.852 3.035 . . . . 2.5099999999999998 114.457 -172.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.44 171.82 36.46 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.026 0.83 . . . . 2.4300000000000002 112.455 -167.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.65 -3.69 11.03 Favored 'Cis proline' 0 C--N 1.351 0.7 0 CA-C-N 119.143 1.472 . . . . 3.6800000000000002 113.352 -4.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -146.67 175.12 10.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.73 1.612 . . . . 2.9399999999999999 110.625 175.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.16 -177.37 5.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.665 2.386 . . . . 1.3400000000000001 108.869 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.7 175.29 9.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.446 1.021 . . . . 1.77 113.401 -173.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.51 152.74 29.24 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.425 0.898 . . . . 1.99 113.425 169.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.18 162.42 38.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.599 1.56 . . . . 3.4100000000000001 110.582 174.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -174.12 150.2 1.53 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.977 1.711 . . . . 3.1699999999999999 113.646 -173.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.7 m -68.55 135.24 51.24 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.701 1.6 . . . . 2.9199999999999999 109.12 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.21 133.78 37.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.359 -0.978 . . . . 3.8700000000000001 108.359 173.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -149.56 138.09 20.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.082 0.944 . . . . 3.5 111.391 175.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -100.26 100.69 12.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.885 1.674 . . . . 1.22 108.961 -178.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.69 -8.89 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.109 1.873 . . . . 1.45 112.998 174.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.98 161.17 43.5 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.058 0.837 . . . . 1.0900000000000001 113.092 -178.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.457 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.2 m-20 -94.04 5.8 50.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.115 1.766 . . . . 3.0699999999999998 113.422 -172.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.02 159.06 42.5 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.936 1.694 . . . . 2.6400000000000001 109.949 165.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.39 159.21 25.97 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.274 2.65 . . . . 1.24 111.796 -170.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.8 mt -110.95 156.32 21.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.396 1.093 . . . . 2.8500000000000001 111.384 170.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -144.12 106.62 4.41 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.511 1.524 . . . . 4.2999999999999998 109.432 175.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.3 tp -91.66 122.37 34.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.312 2.245 . . . . 1.99 108.576 -177.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.23 -16.1 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 113.898 1.074 . . . . 1.73 113.898 -174.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -160.83 30.68 Favored Glycine 0 C--N 1.341 0.853 0 O-C-N 121.47 -0.769 . . . . 0.46999999999999997 112.27 177.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.7 178.6 8.95 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 1.78 111.081 168.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -147.03 141.22 26.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.35 1.06 . . . . 7.6399999999999997 110.39 177.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -149.19 157.23 39.85 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.296 1.438 . . . . 1.6200000000000001 111.369 -167.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.1 -25.14 8.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.343 2.029 . . . . 1.49 113.355 165.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.29 3.6 m -87.5 12.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.484 1.29 . . . . 2.02 114.484 -173.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.12 145.99 30.72 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.521 1.128 . . . . 1.72 110.741 173.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.05 -74.71 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.707 -1.59 . . . . 5.7999999999999998 106.707 170.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -80.17 142.19 34.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.305 1.842 . . . . 3.6099999999999999 109.692 169.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.22 131.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.66 1.584 . . . . 2.6000000000000001 108.811 177.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -146.65 133.82 20.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.445 1.498 . . . . 1.95 109.96 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.65 123.81 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.296 1.046 . . . . 2.1400000000000001 111.003 171.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -117.29 152.02 35.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.847 2.059 . . . . 0.80000000000000004 113.492 -178.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.49 160.18 15.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.003 1.321 . . . . 2.1299999999999999 110.493 165.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.2 m -110.53 144.14 39.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.172 1.789 . . . . 2.6699999999999999 107.7 163.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -152.19 162.42 41.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 114.679 1.363 . . . . 3.3799999999999999 114.679 -169.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.2 ptp -121.08 144.6 48.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.233 1.413 . . . . 5.04 110.332 159.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -147.76 142.31 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.113 1.365 . . . . 9.4800000000000004 110.402 171.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.18 149.07 46.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.611 1.564 . . . . 4.1299999999999999 111.718 175.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 p -146.63 -11.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.458 1.281 . . . . 4.25 114.458 173.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.21 30.56 0.49 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.175 1.79 . . . . 4.4000000000000004 110.875 178.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.35 -14.97 3.72 Favored Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.494 -1.379 . . . . 1.98 113.659 -167.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 167.76 9.57 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.185 2.194 . . . . 3.8100000000000001 110.019 158.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.56 148.68 34.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.997 1.851 . . . . 4.7999999999999998 115.997 -170.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.82 141.94 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.402 1.881 . . . . 4.0999999999999996 109.086 165.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 tpp -93.25 137.59 32.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.589 1.555 . . . . 3.8900000000000001 109.836 171.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 -177.77 29.01 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.801 0.715 . . . . 1.6399999999999999 114.584 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.4 mtt -141.48 156.64 45.74 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.159 1.784 . . . . 3.3799999999999999 110.211 176.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -164.96 156.07 12.87 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.25 1.42 . . . . 5.3499999999999996 110.84 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.93 150.45 82.98 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.933 1.755 . . . . 1.0800000000000001 112.284 169.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.96 158.69 41.75 Favored Pre-proline 0 N--CA 1.471 0.625 0 C-N-CA 126.599 1.96 . . . . 2.2200000000000002 109.829 174.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.04 -29.5 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.142 1.895 . . . . 1.5900000000000001 112.247 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 p90 175.92 160.88 0.3 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.499 1.52 . . . . 3.04 107.14 -175.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -112.13 162.55 15.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.275 1.036 . . . . 4.0099999999999998 111.033 155.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -145.27 157.66 44.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.071 -1.422 . . . . 2.52 114.174 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -145.88 133.74 10.5 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 114.553 -1.203 . . . . 2.0 108.481 -161.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.9 171.22 15.01 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.011 1.807 . . . . 1.4399999999999999 111.334 176.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.86 144.06 99.51 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.075 2.517 . . . . 1.26 111.435 165.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 14.5 mmmt 66.62 4.85 3.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.859 1.664 . . . . 2.8300000000000001 113.173 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.46 126.23 8.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 128.232 2.825 . . . . 1.1599999999999999 112.494 -170.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -98.78 141.82 31.1 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.642 1.577 . . . . 4.6100000000000003 112.601 166.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.4 122.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.321 1.848 . . . . 2.4300000000000002 108.744 168.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 18.0 mp0 -89.68 143.37 26.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.255 -0.903 . . . . 4.0499999999999998 111.163 176.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.44 148.49 43.21 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.321 -0.862 . . . . 2.6200000000000001 109.07 164.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 76' ' ' GLU . 12.3 ptpt -166.86 138.72 2.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.947 1.299 . . . . 5.0700000000000003 111.363 -165.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.91 -26.79 58.94 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.153 3.236 . . . . 1.45 114.294 -169.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.72 78.71 1.03 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.145 -1.582 . . . . 1.74 109.145 161.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.42 -76.5 0.21 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 124.247 0.927 . . . . 1.24 114.236 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -148.3 136.64 21.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.167 1.387 . . . . 3.5499999999999998 111.623 -168.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.55 167.24 29.03 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.801 -0.562 . . . . 1.0900000000000001 110.053 -172.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -96.88 133.73 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.392 -0.966 . . . . 3.8100000000000001 108.392 165.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 mmt -82.92 137.57 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.182 -0.673 . . . . 1.7 109.182 157.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.94 127.81 55.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.967 2.107 . . . . 2.8700000000000001 107.112 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -136.2 158.37 44.57 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.495 1.118 . . . . 2.7400000000000002 111.412 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.58 -61.36 3.23 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.421 1.486 . . . . 3.1400000000000001 112.551 178.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.5 mt 76.84 100.33 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 130.861 3.664 . . . . 2.25 110.837 173.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.026 -1.046 . . . . 2.9100000000000001 113.139 -169.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -150.4 153.8 35.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.488 2.715 . . . . 7.8099999999999996 108.282 169.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -67.43 158.79 55.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.857 2.372 . . . . 2.71 110.386 166.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.19 157.29 26.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.383 1.473 . . . . 3.4300000000000002 111.565 -171.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -139.28 134.43 32.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.344 1.057 . . . . 4.5199999999999996 111.142 176.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.87 38.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.202 0.601 . . . . 2.6299999999999999 111.906 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.13 -15.12 8.28 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.372 1.463 . . . . 2.21 116.038 173.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -176.04 3.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.19 1.495 . . . . 4.6399999999999997 111.243 -171.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -89.28 160.97 16.64 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.62 1.568 . . . . 4.75 112.362 171.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.37 127.59 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.054 1.742 . . . . 1.9299999999999999 108.863 167.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.32 134.11 41.1 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.326 1.45 . . . . 3.3300000000000001 110.259 164.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.67 127.37 10.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.498 1.142 . . . . 2.6200000000000001 113.59 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.71 94.5 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.534 1.534 . . . . 2.6000000000000001 110.446 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.27 115.94 11.01 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.379 1.472 . . . . 2.3700000000000001 110.524 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.0 mt -88.09 129.92 35.16 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.685 1.194 . . . . 1.8899999999999999 110.643 -172.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.66 144.9 50.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.056 0.931 . . . . 3.2999999999999998 112.463 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.91 125.55 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.856 1.262 . . . . 2.0 113.473 -169.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.2 70.23 1.25 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.643 1.115 . . . . 3.3399999999999999 112.549 177.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.49 15.76 81.27 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.557 1.383 . . . . 2.5899999999999999 116.557 163.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -105.92 148.36 27.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.967 1.883 . . . . 5.5899999999999999 110.972 171.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.11 140.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.84 1.656 . . . . 1.97 107.914 167.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -120.2 116.99 26.72 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.224 1.009 . . . . 2.3700000000000001 109.385 178.009 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -75.73 128.81 35.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.83 0.452 . . . . 3.3999999999999999 110.835 174.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -137.04 144.32 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.01 1.724 . . . . 2.8100000000000001 109.612 175.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.55 130.98 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.927 1.291 . . . . 3.2999999999999998 108.473 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 mp -140.26 153.56 69.02 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.667 1.587 . . . . 3.7400000000000002 110.013 -172.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.89 155.86 43.49 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.597 2.865 . . . . 1.54 112.937 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.46 142.75 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.776 1.23 . . . . 1.96 110.491 168.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.5 151.46 39.34 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.652 1.981 . . . . 3.2200000000000002 108.501 164.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.72 28.68 7.19 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.914 1.45 . . . . 2.4199999999999999 114.914 -161.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.456 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.86 1.264 . . . . 8.6400000000000006 111.978 -165.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 109.755 -1.338 . . . . 15.44 109.755 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -165.29 171.1 13.95 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.801 1.641 . . . . 11.27 108.974 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.93 100.86 5.61 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.277 1.031 . . . . 13.06 109.598 178.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.4 p -145.49 168.23 21.08 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.931 1.292 . . . . 9.1199999999999992 112.137 -163.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -114.71 -157.8 0.64 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.822 2.449 . . . . 5.6100000000000003 110.528 -178.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.91 170.95 23.54 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.168 -1.582 . . . . 1.1899999999999999 114.581 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 p90 -165.58 149.78 8.4 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.137 0.975 . . . . 1.5700000000000001 111.291 -175.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.42 147.54 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.368 -0.975 . . . . 1.72 108.368 167.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -97.08 119.72 36.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.947 0.794 . . . . 6.3899999999999997 110.043 164.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.12 134.62 38.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.864 0.84 . . . . 3.71 108.86 156.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.2 m -139.66 160.89 59.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 125.635 1.574 . . . . 2.9900000000000002 109.336 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.24 -7.26 13.41 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.485 2.79 . . . . 2.4500000000000002 115.038 178.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.91 -164.47 18.53 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.254 0.934 . . . . 2.3500000000000001 113.549 175.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.33 -7.46 12.99 Favored 'Cis proline' 0 C--N 1.351 0.672 0 CA-C-N 118.69 1.245 . . . . 2.3100000000000001 113.389 -4.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.06 136.92 34.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.345 1.458 . . . . 3.3100000000000001 110.919 176.496 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.57 -177.94 3.27 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.097 1.759 . . . . 1.4199999999999999 110.695 -177.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.63 136.66 34.56 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.243 0.929 . . . . 1.77 113.068 -169.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.49 141.42 52.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 1.75 112.294 -178.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -135.62 165.43 25.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.806 1.643 . . . . 3.79 110.658 -172.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -171.34 148.96 2.68 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 2.3700000000000001 112.783 168.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.0 m -77.28 138.07 39.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.809 -1.182 . . . . 2.2599999999999998 107.809 149.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -136.33 143.22 44.02 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.522 1.929 . . . . 3.48 107.967 -177.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' CD ' HH12 ' A' ' 74' ' ' ARG . 12.8 pt-20 -127.63 135.24 49.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.731 0.812 . . . . 3.5 111.003 -177.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -97.23 100.73 8.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.515 -0.92 . . . . 1.1499999999999999 108.515 165.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.79 -10.79 15.5 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.637 2.225 . . . . 1.28 113.146 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.44 -173.08 49.49 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.729 1.157 . . . . 1.3999999999999999 113.413 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.3 m-20 -112.21 1.34 16.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.913 1.685 . . . . 3.0 112.802 -168.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -123.03 161.0 47.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.327 1.851 . . . . 2.6200000000000001 110.392 174.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 148.63 17.29 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.509 2.14 . . . . 0.89000000000000001 111.833 -171.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.07 111.68 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.053 1.341 . . . . 3.1299999999999999 110.605 -176.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 68' ' ' GLU . 25.4 ttm180 -98.79 101.91 13.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.871 1.268 . . . . 5.3200000000000003 110.865 -179.158 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.07 114.56 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.676 1.99 . . . . 1.6499999999999999 108.629 -175.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.77 -19.51 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.29 0.848 . . . . 1.7 113.29 -171.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.37 -163.55 30.43 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.267 0.937 . . . . 0.40000000000000002 111.552 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.82 179.53 7.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 1.72 110.658 164.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -149.41 135.36 18.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.859 1.664 . . . . 7.9800000000000004 108.068 -177.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.483 ' HG1' HG11 ' A' ' 99' ' ' VAL . 1.4 t -140.0 156.96 70.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.421 1.488 . . . . 1.8200000000000001 109.997 -171.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.48 -25.19 9.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.276 1.984 . . . . 1.04 112.103 169.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.259 14.3 m -82.91 -11.52 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.469 1.285 . . . . 2.1099999999999999 114.469 -173.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.11 155.71 47.65 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.526 0.935 . . . . 1.8 113.526 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.26 -91.83 0.11 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.945 1.298 . . . . 3.3900000000000001 110.212 175.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -84.28 92.2 7.93 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.886 0.874 . . . . 3.75 108.826 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -87.15 139.26 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.288 1.035 . . . . 2.3500000000000001 110.798 172.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -137.52 138.79 40.03 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.356 1.862 . . . . 1.9299999999999999 110.751 -174.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.43 121.04 29.35 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.913 1.233 . . . . 1.8300000000000001 111.747 169.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -108.61 155.91 20.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.266 1.826 . . . . 0.68999999999999995 112.339 175.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.55 -179.76 4.04 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 2.5800000000000001 110.696 169.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -140.32 116.19 10.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.144 1.378 . . . . 2.1600000000000001 107.442 172.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -117.47 -179.49 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.509 1.524 . . . . 2.8999999999999999 110.854 -174.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 73.6 mtm -130.16 128.04 40.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.169 0.988 . . . . 3.6299999999999999 110.868 164.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -97.61 168.17 10.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.744 1.218 . . . . 8.1899999999999995 111.527 167.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -88.51 142.57 27.6 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.535 0.734 . . . . 5.9699999999999998 109.397 153.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.04 -6.92 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.141 1.163 . . . . 4.5099999999999998 114.141 175.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 56' ' ' LYS . 16.3 tt0 -175.84 31.66 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.804 2.042 . . . . 4.0099999999999998 109.425 -165.638 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.66 -19.68 0.15 Allowed Glycine 0 N--CA 1.479 1.501 0 O-C-N 119.545 -1.972 . . . . 2.29 114.769 -158.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 54' ' ' GLU . 85.0 mttt -74.2 132.36 42.11 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.115 1.766 . . . . 4.9900000000000002 109.159 175.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -76.4 126.34 30.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.101 -1.074 . . . . 5.0899999999999999 108.101 169.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -140.01 139.13 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.176 1.391 . . . . 3.5299999999999998 108.79 -175.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.8 mtp -69.9 162.25 28.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.217 1.192 . . . . 6.0999999999999996 114.217 -175.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.71 164.17 32.52 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.791 1.186 . . . . 1.01 111.597 167.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.13 157.88 30.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.994 1.317 . . . . 2.6400000000000001 110.183 172.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -169.44 151.56 4.51 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 4.5199999999999996 110.607 177.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.3 Cg_endo -69.02 153.23 72.65 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.758 1.639 . . . . 0.75 111.708 169.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.76 159.02 50.42 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 126.261 1.824 . . . . 1.9099999999999999 110.53 174.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -72.46 -21.49 22.59 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.677 2.251 . . . . 0.90000000000000002 112.58 172.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -175.75 169.96 2.92 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.739 1.616 . . . . 3.7799999999999998 110.839 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -122.11 174.33 7.01 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.905 2.482 . . . . 1.98 108.78 160.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.6 pt-20 -152.88 165.54 35.11 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.257 -0.902 . . . . 2.6600000000000001 113.217 164.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -135.04 128.29 18.54 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 125.45 1.5 . . . . 2.1800000000000002 109.058 -176.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.85 162.2 43.45 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.474 2.116 . . . . 1.2 111.03 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.21 94.45 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.975 2.45 . . . . 1.24 111.649 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 63.6 mmtt 68.1 -1.05 1.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.685 1.994 . . . . 2.21 113.671 -174.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.09 117.86 4.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 126.556 2.027 . . . . 1.1899999999999999 111.894 -177.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.454 HH12 ' CD ' ' A' ' 23' ' ' GLU . 8.7 ttt85 -91.75 129.61 37.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.235 1.014 . . . . 7.2300000000000004 110.035 157.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.07 171.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.861 1.664 . . . . 2.3399999999999999 110.226 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -139.65 146.03 39.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.7 1.238 . . . . 4.6500000000000004 114.117 176.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -85.34 71.64 10.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.939 1.696 . . . . 1.97 109.391 178.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -61.4 141.56 94.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 114.133 -1.394 . . . . 4.9299999999999997 112.262 177.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.48 -18.04 51.58 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.653 2.236 . . . . 1.3 113.149 165.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.59 26.09 23.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.252 1.406 . . . . 1.26 114.107 172.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.52 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.476 1.36 0 CA-C-N 119.414 1.607 . . . . 1.51 115.735 175.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -159.97 140.4 11.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.632 1.573 . . . . 3.25 109.413 -176.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -171.0 168.68 6.89 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.491 1.951 . . . . 1.54 111.173 -175.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.31 125.75 46.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.507 0.723 . . . . 2.9199999999999999 111.46 -178.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mmt -91.99 142.57 27.4 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.449 1.099 . . . . 2.1200000000000001 110.014 170.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 mt -119.89 85.79 2.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.618 1.567 . . . . 2.7999999999999998 109.053 -171.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.68 107.71 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.242 1.017 . . . . 4.4199999999999999 108.632 -176.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.03 130.37 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.118 0.866 . . . . 2.77 111.801 -172.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.3 mt -112.6 118.49 35.22 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.771 0.828 . . . . 2.0299999999999998 108.999 178.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.2 9.79 19.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.069 0.766 . . . . 3.4199999999999999 113.069 -166.19 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -172.55 159.2 3.93 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 128.016 2.527 . . . . 6.21 108.919 -171.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.24 160.61 48.96 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.374 1.383 . . . . 2.1299999999999999 110.018 162.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mp -115.48 -164.72 0.97 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.453 1.901 . . . . 3.4900000000000002 108.728 -171.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.15 136.95 13.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.399 1.48 . . . . 5.9299999999999997 110.976 168.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.04 126.97 29.88 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.055 -1.091 . . . . 2.4900000000000002 108.055 151.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.38 78.53 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.137 -1.924 . . . . 1.8899999999999999 115.614 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -93.7 177.96 5.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.514 2.157 . . . . 3.5600000000000001 110.051 153.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -103.58 149.13 25.18 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.589 0.756 . . . . 4.8499999999999996 109.783 167.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.483 HG11 ' HG1' ' A' ' 37' ' ' THR . 8.4 t -105.52 123.13 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.651 1.18 . . . . 2.48 108.215 168.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.64 124.06 21.81 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 113.949 -1.478 . . . . 4.71 107.5 162.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.17 109.42 10.8 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.932 0.873 . . . . 2.8799999999999999 111.074 174.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.79 86.11 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.702 2.401 . . . . 2.6299999999999999 109.673 173.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.18 117.22 8.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.829 1.252 . . . . 2.21 109.623 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.4 126.2 35.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.853 1.261 . . . . 2.1000000000000001 110.735 -175.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.42 117.77 25.18 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.535 -0.728 . . . . 3.2000000000000002 111.58 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.96 22.04 0.18 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.196 2.199 . . . . 3.2400000000000002 115.985 171.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.9 -41.72 1.07 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.786 1.66 . . . . 3.9399999999999999 113.847 -171.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.06 -1.82 90.15 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.987 -1.452 . . . . 1.73 116.071 -174.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.45 159.32 42.46 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.712 2.005 . . . . 4.7599999999999998 111.727 168.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.14 145.99 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 126.42 1.888 . . . . 2.1400000000000001 108.179 168.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -134.76 108.42 7.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.265 1.026 . . . . 2.6299999999999999 109.858 -177.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.87 96.83 6.46 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.604 0.361 . . . . 3.7400000000000002 110.817 176.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.86 151.39 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.631 0.772 . . . . 2.6499999999999999 110.837 176.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.23 131.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.813 1.645 . . . . 2.96 108.734 168.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.7 mt -139.93 130.63 14.19 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 2.6800000000000002 109.499 176.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.93 151.6 56.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.489 2.793 . . . . 1.24 111.692 176.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.3 t -97.84 117.14 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.924 0.89 . . . . 2.2200000000000002 111.787 178.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -75.57 155.36 36.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.553 2.741 . . . . 3.98 109.072 159.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.3 131.19 45.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.833 -1.167 . . . . 2.6600000000000001 112.631 171.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.0 mtt180 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 127.577 2.351 . . . . 8.0600000000000005 108.153 169.699 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.45 0 N-CA-C 108.908 -1.677 . . . . 14.23 108.908 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -71.23 -23.27 61.97 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.469 1.655 . . . . 14.68 115.469 -173.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -171.73 162.49 6.28 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.556 1.942 . . . . 15.56 109.839 -175.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.5 p -136.16 -29.95 0.97 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.9 1.28 . . . . 8.6099999999999994 114.068 -176.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -113.05 -133.62 0.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.289 2.236 . . . . 5.46 109.697 -173.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 170.97 24.26 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 120.877 1.671 . . . . 1.2 114.232 177.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -155.31 164.98 38.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.285 1.041 . . . . 2.29 113.681 174.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.58 119.13 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.169 -0.923 . . . . 1.77 108.549 174.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.83 113.46 19.04 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.435 0.636 . . . . 4.9500000000000002 110.383 175.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.5 134.64 53.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.021 0.915 . . . . 3.96 108.98 162.319 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.03 164.62 20.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.691 1.996 . . . . 3.4500000000000002 107.298 170.312 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.62 -10.65 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.755 2.304 . . . . 1.6299999999999999 114.283 -174.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.17 -159.74 27.78 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.95 0.786 . . . . 1.49 111.743 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.37 -6.57 12.46 Favored 'Cis proline' 0 CA--C 1.538 0.704 0 CA-C-N 119.141 1.471 . . . . 1.96 113.7 3.076 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -136.9 158.83 43.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.821 1.248 . . . . 2.21 112.021 170.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.78 -162.57 1.11 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.004 2.122 . . . . 2.2799999999999998 111.226 -176.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.23 163.07 40.01 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.537 1.31 . . . . 1.9099999999999999 114.537 -170.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.27 150.37 36.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.688 1.595 . . . . 1.54 112.256 172.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.38 134.36 20.28 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.271 1.828 . . . . 3.79 108.778 -172.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.56 137.81 8.11 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 115.055 1.502 . . . . 3.29 115.055 -160.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -66.97 136.08 54.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.609 -0.723 . . . . 3.1200000000000001 110.637 167.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.31 153.59 40.04 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.971 2.108 . . . . 3.6099999999999999 109.926 163.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.64 149.49 48.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.772 0.796 . . . . 3.4100000000000001 110.582 164.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -106.2 95.24 10.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.141 -0.936 . . . . 1.25 110.004 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.15 -5.09 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.875 2.384 . . . . 1.79 113.0 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.84 162.19 52.77 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 124.972 1.273 . . . . 1.5 113.39 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -74.56 -32.03 62.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.265 2.226 . . . . 5.8200000000000003 112.788 174.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.28 164.09 17.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.358 1.863 . . . . 2.6699999999999999 112.102 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.55 152.54 17.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.864 2.376 . . . . 0.73999999999999999 111.497 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.28 115.98 30.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.852 1.261 . . . . 3.5600000000000001 110.226 -176.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.422 HH11 ' HB2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -99.58 107.27 19.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.528 1.131 . . . . 5.0800000000000001 110.538 177.065 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -95.55 119.24 33.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.093 1.357 . . . . 1.8899999999999999 109.318 -174.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.21 -12.93 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.476 1.11 . . . . 1.8500000000000001 113.927 -171.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.5 -162.73 30.19 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.426 1.012 . . . . 0.56999999999999995 111.971 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.09 -167.96 2.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 2.1000000000000001 111.442 165.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -159.13 161.04 36.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.252 0.933 . . . . 6.6699999999999999 108.824 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.24 156.96 30.93 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 125.842 1.657 . . . . 1.6699999999999999 111.088 -178.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.5 -17.97 15.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.612 2.875 . . . . 1.25 114.462 170.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -98.35 -18.17 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 115.013 1.486 . . . . 2.3399999999999999 115.013 -174.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -108.55 152.8 24.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.75 1.159 . . . . 1.76 112.073 176.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.95 -90.9 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.747 0.819 . . . . 3.5499999999999998 109.497 173.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -79.53 141.81 36.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.114 -1.069 . . . . 4.2999999999999998 108.114 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.08 131.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.715 1.206 . . . . 2.6600000000000001 110.462 173.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.04 132.21 20.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.277 1.031 . . . . 2.1699999999999999 111.847 -163.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tt -79.13 124.22 28.11 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 121.474 0.654 . . . . 1.8600000000000001 111.034 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -112.62 157.07 21.66 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.196 1.798 . . . . 1.01 112.147 172.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.44 -170.85 1.84 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.548 1.139 . . . . 2.71 112.319 165.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.6 m -147.42 88.09 1.69 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.32 1.848 . . . . 2.0299999999999998 107.447 170.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -78.46 157.24 29.0 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 3.6400000000000001 112.009 -177.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.9 mtm -107.69 130.72 54.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.401 1.08 . . . . 3.6200000000000001 110.012 166.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 -146.89 149.39 33.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.308 1.043 . . . . 5.7699999999999996 111.542 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 145.54 55.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.544 0.738 . . . . 3.9900000000000002 109.843 155.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.74 -90.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.727 1.611 . . . . 4.0800000000000001 108.693 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 56' ' ' LYS . 6.2 tt0 -77.43 41.29 0.31 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.392 2.277 . . . . 3.5499999999999998 111.613 175.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.97 -10.27 1.26 Allowed Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.544 -1.348 . . . . 2.02 114.327 -166.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 54' ' ' GLU . 60.0 mttt -102.45 155.79 18.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 128.625 2.77 . . . . 3.3799999999999999 109.374 175.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -90.59 145.62 24.71 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.303 1.223 . . . . 4.1200000000000001 114.303 178.003 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.9 t -141.27 148.16 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.306 1.843 . . . . 2.9700000000000002 109.421 -178.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -89.87 123.45 33.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.577 1.551 . . . . 4.2800000000000002 110.11 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.87 138.31 10.51 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 119.041 0.837 . . . . 1.3100000000000001 113.678 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -90.04 156.62 18.27 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.828 0.851 . . . . 2.7000000000000002 111.676 170.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -167.42 153.7 7.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.135 1.774 . . . . 5.29 110.088 168.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -68.46 156.95 63.85 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.342 1.361 . . . . 0.85999999999999999 110.698 170.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.99 156.14 78.63 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.237 1.415 . . . . 1.76 110.751 -178.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.87 -20.07 30.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.969 2.446 . . . . 0.82999999999999996 113.112 178.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.6 166.91 3.86 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.444 1.098 . . . . 3.0099999999999998 112.455 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -115.92 178.0 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.471 2.308 . . . . 1.73 109.296 153.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.12 159.63 44.36 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.122 -0.986 . . . . 2.0800000000000001 111.57 164.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.41 126.53 20.29 Favored Pre-proline 0 N--CA 1.468 0.425 0 C-N-CA 126.021 1.728 . . . . 2.1400000000000001 108.202 -178.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.64 162.39 42.3 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.509 2.14 . . . . 0.93999999999999995 110.998 178.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.51 131.76 32.99 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.29 2.66 . . . . 1.02 110.622 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.9 1.52 3.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.869 2.467 . . . . 3.8100000000000001 114.226 -170.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.84 118.81 9.24 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 125.811 1.672 . . . . 1.0 109.055 172.024 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -117.79 114.58 23.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.833 2.053 . . . . 5.2699999999999996 109.171 172.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -149.96 154.02 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.459 1.103 . . . . 3.0099999999999998 112.174 -165.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -102.96 134.49 46.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.302 0.572 . . . . 3.0499999999999998 111.751 176.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.13 137.0 57.36 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.241 -1.392 . . . . 2.0800000000000001 107.241 141.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -150.17 143.75 16.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.489 2.316 . . . . 4.29 109.938 -161.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.05 -43.68 28.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.807 3.005 . . . . 1.55 113.151 -167.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 118.34 5.86 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.371 -1.892 . . . . 2.1099999999999999 108.371 157.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -77.29 0.38 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.683 1.135 . . . . 1.23 112.937 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -154.5 131.9 11.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.41 1.105 . . . . 3.3199999999999998 110.448 -175.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -163.66 172.17 14.64 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.764 -1.21 . . . . 0.96999999999999997 111.714 -167.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.13 122.08 45.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.162 0.585 . . . . 3.1200000000000001 109.776 173.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 mmt -80.39 134.23 36.0 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.171 -0.678 . . . . 1.9199999999999999 109.171 165.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.52 118.52 36.77 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.198 1.399 . . . . 3.2599999999999998 107.711 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.78 104.71 9.78 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.373 1.469 . . . . 2.9700000000000002 109.192 -171.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.06 141.39 1.05 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.302 -0.719 . . . . 3.1499999999999999 111.302 -159.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.9 mt -117.67 120.47 38.11 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.489 -0.93 . . . . 2.29 108.489 171.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.79 -4.38 54.41 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.946 1.091 . . . . 3.02 113.946 -170.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -150.41 159.21 35.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.134 2.173 . . . . 7.6600000000000001 110.076 178.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -66.76 159.11 52.88 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.354 2.036 . . . . 2.2400000000000002 109.226 153.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.54 160.4 31.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.689 1.596 . . . . 3.79 109.75 -162.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.69 129.53 10.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.412 1.101 . . . . 5.75 112.902 -158.22 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.31 121.19 13.72 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.479 -0.763 . . . . 3.0899999999999999 110.213 174.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.43 7.69 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.423 -1.209 . . . . 2.29 114.804 -166.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.9 174.2 7.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.652 1.726 . . . . 3.6200000000000001 108.958 144.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -89.7 148.28 23.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.045 0.938 . . . . 3.9700000000000002 110.617 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 t -93.63 127.48 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.254 -1.017 . . . . 2.0099999999999998 108.254 161.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.543 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 51.5 mt-10 -65.45 111.87 3.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.281 -0.872 . . . . 3.1899999999999999 108.678 153.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.95 123.29 44.91 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.594 -1.262 . . . . 3.7200000000000002 107.594 163.113 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -102.68 85.64 2.61 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.835 2.054 . . . . 2.2799999999999998 109.145 177.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.28 121.47 16.31 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.444 1.898 . . . . 4.2400000000000002 110.5 -175.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.5 mt -92.98 133.54 36.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.42 1.088 . . . . 1.96 111.279 -176.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.77 153.31 38.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.159 0.984 . . . . 3.0600000000000001 111.454 178.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.9 132.35 53.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.346 0.658 . . . . 2.3999999999999999 111.303 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.83 -142.92 16.27 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.662 -0.975 . . . . 3.7999999999999998 110.662 -167.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -100.62 12.25 59.6 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.676 1.131 . . . . 2.5699999999999998 115.359 -176.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -87.36 137.36 32.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.589 1.694 . . . . 6.5700000000000003 113.306 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.38 138.52 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.749 1.62 . . . . 2.2200000000000002 109.787 165.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.07 113.4 25.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.472 1.509 . . . . 3.79 109.898 177.416 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.543 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 23.0 ttmm -78.69 116.91 19.37 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.126 -0.694 . . . . 3.5699999999999998 109.126 168.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.83 149.46 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.408 1.083 . . . . 2.7599999999999998 109.89 173.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -95.8 138.07 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.663 1.185 . . . . 4.1399999999999997 109.62 170.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.3 mt -144.91 140.61 16.43 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.678 1.591 . . . . 3.0600000000000001 109.807 178.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.04 144.37 63.53 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.079 3.186 . . . . 1.3999999999999999 114.005 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.16 126.22 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.45 1.1 . . . . 2.46 110.831 172.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -97.31 168.79 10.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.038 2.935 . . . . 3.1699999999999999 109.222 169.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.57 30.89 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.622 1.556 . . . . 2.4300000000000002 110.386 161.494 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.2 ttm-85 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.862 1.665 . . . . 7.7599999999999998 113.075 -171.704 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.235 0 N-CA-C 105.166 -3.174 . . . . 16.309999999999999 105.166 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.3 m -157.28 146.38 19.99 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 118.963 -1.095 . . . . 13.050000000000001 111.823 -123.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -153.98 121.17 5.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.301 1.44 . . . . 11.0 110.042 -173.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.5 p -141.05 97.56 3.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.474 1.11 . . . . 7.3899999999999997 110.55 -178.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.28 122.54 45.61 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.159 1.784 . . . . 5.8499999999999996 110.692 -173.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.06 172.34 30.69 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.371 -0.83 . . . . 1.1399999999999999 114.824 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -159.63 129.8 5.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 2.54 112.66 -173.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.01 103.09 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.79 -1.189 . . . . 2.0 107.79 175.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.5 ttp85 -85.46 114.37 22.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.576 0.703 . . . . 5.0800000000000001 110.695 -174.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.24 163.21 18.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.138 1.775 . . . . 3.9500000000000002 112.903 -167.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -168.89 142.31 2.36 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.17 1.788 . . . . 3.5800000000000001 109.95 156.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.61 -8.38 18.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.069 3.179 . . . . 2.2400000000000002 114.425 -169.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.94 161.93 10.62 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.929 0.776 . . . . 2.6899999999999999 113.302 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.87 -1.44 8.12 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 118.612 1.206 . . . . 3.6000000000000001 112.659 -11.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -153.51 173.09 16.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 3.29 113.322 -179.003 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.02 171.57 14.24 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.139 2.576 . . . . 1.96 110.373 168.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.69 104.42 4.91 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.885 0.874 . . . . 2.2799999999999998 111.307 -171.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 149.99 21.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.508 0.929 . . . . 1.52 113.508 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.12 162.97 32.82 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.625 1.57 . . . . 3.71 111.167 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.93 152.62 6.59 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.46 1.104 . . . . 2.4500000000000002 112.075 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 m -84.24 142.37 30.32 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.251 -1.018 . . . . 2.2599999999999998 108.251 154.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.82 146.33 39.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.447 1.899 . . . . 3.8599999999999999 106.951 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -116.97 142.51 46.86 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.484 0.714 . . . . 3.5600000000000001 111.548 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -101.58 105.14 38.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.121 0.969 . . . . 1.3 109.685 166.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.14 -8.43 11.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.641 2.227 . . . . 1.02 113.672 178.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.26 166.92 48.6 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 119.707 1.139 . . . . 1.22 112.93 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.83 2.37 51.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.195 2.198 . . . . 3.27 111.877 173.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -109.67 159.53 31.26 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 128.333 2.653 . . . . 4.0 108.888 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.76 152.03 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.094 2.53 . . . . 1.2 111.287 177.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.99 106.51 17.06 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.013 0.925 . . . . 3.4300000000000002 110.495 173.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.1 114.16 21.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.581 -1.645 . . . . 4.1500000000000004 109.112 170.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -105.14 128.77 53.53 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.535 1.934 . . . . 4.0899999999999999 108.693 -177.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.79 -7.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.169 0.988 . . . . 1.8500000000000001 113.259 -175.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.9 -159.18 32.19 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 119.588 -1.291 . . . . 0.54000000000000004 114.303 178.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.4 173.15 14.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.674 0.79 . . . . 2.0 112.351 -179.143 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.139 -1.43 . . . . 7.1799999999999997 107.139 164.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -147.2 142.96 17.49 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 117.886 -1.054 . . . . 1.8899999999999999 109.066 -175.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.29 -21.72 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.005 1.803 . . . . 1.21 111.517 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.367 1.0 OUTLIER -77.86 11.73 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 118.739 0.7 . . . . 2.2799999999999998 112.453 174.894 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.43 145.71 39.2 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 114.584 1.327 . . . . 2.1699999999999999 114.584 176.456 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -87.17 -83.19 0.2 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.742 -1.207 . . . . 4.1200000000000001 107.742 170.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -77.99 147.59 34.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.1 0.96 . . . . 4.1699999999999999 108.84 162.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.28 143.54 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.231 1.412 . . . . 2.4100000000000001 109.279 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -139.87 137.44 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.424 1.49 . . . . 2.27 109.773 -174.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.0 tt -86.56 121.97 29.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.962 1.255 . . . . 2.02 110.511 164.624 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -109.92 153.66 24.19 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.038 1.335 . . . . 1.0 112.329 174.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.82 169.69 10.73 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.053 1.741 . . . . 2.21 110.618 163.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -152.11 128.27 10.47 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.898 1.279 . . . . 2.5299999999999998 108.992 175.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.65 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.136 0.974 . . . . 3.1099999999999999 112.674 -161.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 ptt? -105.48 148.92 26.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.239 0.616 . . . . 3.9300000000000002 110.474 155.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -162.11 164.55 27.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.572 1.949 . . . . 6.0999999999999996 109.98 174.04 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -99.0 149.68 22.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.922 0.889 . . . . 4.3799999999999999 110.959 -174.885 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -128.36 -96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 124.329 1.018 . . . . 3.79 109.244 -178.111 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -76.72 42.02 0.28 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.909 2.084 . . . . 4.4199999999999999 110.963 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.61 -9.12 3.69 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 119.827 -1.796 . . . . 2.9100000000000001 114.04 -168.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.17 148.02 24.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.702 1.601 . . . . 4.6500000000000004 110.285 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.494 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 28.5 mmmt -65.58 134.41 53.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.472 0.709 . . . . 4.3499999999999996 110.203 167.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -137.5 153.75 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.377 1.471 . . . . 2.8399999999999999 109.126 176.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 ptp -108.02 142.44 38.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.371 1.068 . . . . 5.6200000000000001 111.866 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.22 32.63 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 123.741 0.686 . . . . 1.3500000000000001 113.342 -176.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.18 167.18 23.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 3.21 110.329 -173.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -173.69 154.35 2.36 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.763 1.625 . . . . 4.4800000000000004 111.215 170.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.67 143.82 69.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.397 2.065 . . . . 1.3400000000000001 112.01 166.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.27 156.86 59.91 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.005 2.122 . . . . 1.9399999999999999 110.521 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.97 -21.46 18.35 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.522 2.148 . . . . 0.84999999999999998 113.186 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -172.7 174.8 3.58 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.841 1.201 . . . . 3.8399999999999999 111.905 -177.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.1 176.34 8.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.455 2.702 . . . . 2.0 108.513 165.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.87 168.45 27.17 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 120.728 -1.232 . . . . 2.4700000000000002 112.649 166.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.37 129.9 18.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.516 1.527 . . . . 2.6899999999999999 108.969 179.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.52 162.97 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.15 2.566 . . . . 1.6200000000000001 112.219 -177.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.01 136.04 70.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.885 3.056 . . . . 1.3400000000000001 112.005 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt 67.02 5.57 4.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.08 1.752 . . . . 2.04 113.665 -178.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.39 123.43 7.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 126.809 2.147 . . . . 1.3300000000000001 110.238 -178.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.35 129.96 48.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.156 0.982 . . . . 5.3399999999999999 110.915 159.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.8 m -153.01 158.8 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.171 1.388 . . . . 3.3599999999999999 110.693 -174.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.63 142.47 46.85 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.15 1.38 . . . . 3.6000000000000001 114.278 -177.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.58 73.22 0.53 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.863 1.665 . . . . 1.8799999999999999 108.954 165.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -62.6 140.88 96.94 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.251 1.42 . . . . 4.0 112.272 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.06 -37.63 91.77 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.281 2.654 . . . . 1.3600000000000001 112.822 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.22 71.08 2.99 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.943 -1.263 . . . . 1.3200000000000001 109.943 164.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.77 -58.65 0.2 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.553 1.073 . . . . 1.4099999999999999 115.09 176.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -157.63 149.46 22.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.4 1.88 . . . . 4.1900000000000004 111.898 -172.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -161.18 165.08 29.99 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.117 -0.989 . . . . 1.4299999999999999 111.166 177.247 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CE1' HD12 ' A' ' 45' ' ' LEU . 53.9 m-85 -100.14 109.87 22.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.796 -0.816 . . . . 2.98 108.796 168.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 119.73 22.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 2.6699999999999999 108.335 172.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.03 121.29 41.14 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.054 1.342 . . . . 2.6299999999999999 107.877 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.36 144.6 43.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.956 1.302 . . . . 4.8899999999999997 109.667 -173.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.33 -61.36 4.72 Favored Glycine 0 N--CA 1.475 1.249 0 O-C-N 121.15 -0.969 . . . . 2.7400000000000002 113.477 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt 78.23 119.15 0.05 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.62 3.168 . . . . 2.4100000000000001 111.996 171.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.52 -2.45 20.37 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.719 1.007 . . . . 3.2599999999999998 113.719 -174.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.52 159.67 40.9 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.887 1.275 . . . . 7.4900000000000002 108.597 169.022 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.24 158.68 54.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.905 2.403 . . . . 2.8700000000000001 110.602 173.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.24 13.61 8.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.684 1.194 . . . . 4.3899999999999997 112.423 -160.525 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 160.76 5.31 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.174 1.176 . . . . 4.1100000000000003 114.174 -167.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.45 121.53 9.21 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.233 -0.917 . . . . 2.3900000000000001 110.26 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.12 20.37 55.38 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.264 -0.742 . . . . 2.5 114.209 -169.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.25 161.34 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.647 1.724 . . . . 3.3900000000000001 108.655 135.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.41 131.21 56.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.513 -2.032 . . . . 3.98 105.513 155.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.4 102.51 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.901 0.858 . . . . 2.3500000000000001 110.555 -174.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -65.3 146.79 54.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.976 -1.011 . . . . 4.75 111.248 164.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.2 tt -152.85 128.41 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.657 0.783 . . . . 2.5 110.835 178.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -84.73 106.62 16.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.192 1.797 . . . . 2.4700000000000002 111.235 173.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.6 mt -78.14 120.71 23.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.02 0.827 . . . . 2.0699999999999998 109.097 176.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.0 mt -100.85 112.66 25.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.145 0.978 . . . . 2.0699999999999998 110.486 -168.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.53 149.51 31.28 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.243 1.02 . . . . 3.3900000000000001 112.263 -174.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.72 118.95 6.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.326 1.05 . . . . 2.3500000000000001 112.106 -170.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.02 71.71 1.14 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.645 1.117 . . . . 3.6200000000000001 113.011 178.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.72 -3.72 68.01 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 117.239 1.655 . . . . 2.1899999999999999 117.239 162.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.87 130.86 34.76 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.225 2.012 . . . . 5.3600000000000003 110.081 173.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.6 136.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.306 1.042 . . . . 1.8999999999999999 109.89 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.58 115.15 13.54 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.615 1.166 . . . . 2.75 109.965 -174.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -77.05 119.37 20.67 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.662 -0.649 . . . . 4.1299999999999999 111.971 172.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.93 167.79 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.344 1.457 . . . . 2.25 110.205 163.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.67 149.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.354 1.862 . . . . 4.0899999999999999 109.195 163.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.8 mt -146.49 127.33 7.17 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.126 1.37 . . . . 2.75 109.235 -172.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 162.82 41.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.896 2.397 . . . . 0.96999999999999997 111.507 174.242 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -87.62 134.91 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.621 1.169 . . . . 2.79 111.614 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.0 164.38 13.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.092 1.757 . . . . 3.1600000000000001 107.8 157.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.02 -166.85 1.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.021 1.489 . . . . 4.3399999999999999 115.021 -171.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 115.729 1.751 . . . . 11.699999999999999 115.729 -158.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -1.025 0 N-CA-C 108.652 -1.779 . . . . 13.43 108.652 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.4 t 151.79 56.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 131.216 3.806 . . . . 11.460000000000001 104.074 -164.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 43.21 -119.51 0.57 Allowed 'General case' 0 CA--C 1.551 1.009 0 O-C-N 120.618 -1.301 . . . . 10.0 109.171 -132.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.312 30.2 p 106.6 77.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 1 C-N-CA 133.763 4.825 . . . . 7.1699999999999999 109.23 173.418 . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -79.65 106.98 12.07 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.305 1.842 . . . . 6.0499999999999998 111.427 -160.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.45 167.1 32.93 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.388 1.47 . . . . 1.21 113.727 -176.234 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -162.16 167.16 24.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.75 1.22 . . . . 1.9399999999999999 113.377 -173.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -113.12 136.42 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.76 1.224 . . . . 2.25 108.868 171.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HB2' ' HH ' ' A' ' 19' ' ' TYR . 39.8 mtp180 -92.93 100.63 13.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.289 0.566 . . . . 5.0 109.493 162.28 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.4 122.55 19.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.363 -0.977 . . . . 3.9900000000000002 108.363 160.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.6 167.63 19.7 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 125.732 1.613 . . . . 3.8799999999999999 108.452 172.017 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.07 5.08 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.794 2.996 . . . . 3.04 116.637 -162.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.01 -177.17 44.46 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.207 0.912 . . . . 2.3300000000000001 113.408 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.12 -2.8 13.64 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 118.347 1.073 . . . . 2.0499999999999998 112.923 -4.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -121.7 165.66 15.45 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.617 1.567 . . . . 2.4100000000000001 112.752 173.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.06 -171.49 3.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.383 2.673 . . . . 1.8600000000000001 109.443 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.38 160.12 39.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.772 1.397 . . . . 2.3300000000000001 114.772 -173.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.4 145.77 51.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.865 1.266 . . . . 1.8899999999999999 112.328 170.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.412 ' HH ' ' HB2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -146.0 139.72 26.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.877 1.671 . . . . 3.4700000000000002 110.308 -171.928 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.06 150.38 9.51 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.983 1.846 . . . . 2.8500000000000001 115.983 -173.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.9 m -86.67 129.87 34.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.531 2.333 . . . . 2.6400000000000001 109.179 165.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.55 171.67 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.644 1.178 . . . . 5.6799999999999997 110.911 171.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -147.05 138.71 24.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.227 1.011 . . . . 2.9399999999999999 111.374 -173.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -96.36 108.43 41.89 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.767 1.227 . . . . 1.0800000000000001 109.236 168.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.58 -9.18 14.8 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.441 2.094 . . . . 1.1000000000000001 113.196 174.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.34 169.64 52.83 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.362 0.982 . . . . 1.03 114.062 -176.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.47 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 4.8 m-20 -96.46 -6.19 37.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.506 1.923 . . . . 3.0600000000000001 113.358 -175.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.52 160.9 27.69 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.682 . . . . 2.1099999999999999 110.157 168.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.57 161.5 19.36 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.192 2.595 . . . . 0.90000000000000002 112.094 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.8 mt -104.94 147.92 27.26 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.237 1.015 . . . . 3.3100000000000001 111.426 167.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -117.92 115.52 25.09 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.699 1.599 . . . . 6.5099999999999998 108.823 164.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.6 tp -95.53 115.26 27.18 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.704 1.602 . . . . 2.04 108.303 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.91 -8.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.558 0.948 . . . . 2.1000000000000001 113.558 -167.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.12 -174.03 46.2 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.992 0.806 . . . . 0.55000000000000004 111.805 175.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.07 174.84 10.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.161 -0.923 . . . . 1.97 110.188 166.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.97 148.84 19.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.867 1.212 . . . . 6.6399999999999997 110.54 169.271 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.35 160.56 54.09 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 1.6499999999999999 109.107 -159.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.75 -31.14 40.24 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.307 2.004 . . . . 1.26 113.607 167.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 2.1 m -88.11 -5.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.501 1.667 . . . . 2.21 115.501 -163.575 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.17 159.34 42.82 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.099 1.148 . . . . 1.95 114.099 -171.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.4 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 12.3 tp10 -99.18 -78.82 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.295 1.038 . . . . 3.4100000000000001 111.477 -175.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -74.37 127.62 33.47 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.97 -1.122 . . . . 3.7599999999999998 107.97 169.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.95 131.77 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.306 1.842 . . . . 2.2200000000000002 109.291 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -150.15 135.79 18.31 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.416 1.086 . . . . 2.3799999999999999 111.236 -167.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -80.11 125.04 29.31 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.653 1.115 . . . . 1.8999999999999999 110.817 169.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.6 m170 -114.96 153.9 29.74 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.171 1.788 . . . . 0.81000000000000005 112.811 178.275 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -86.66 168.68 13.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.135 2.174 . . . . 2.46 111.164 164.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.4 m -150.62 131.73 14.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.882 1.273 . . . . 2.1899999999999999 108.633 171.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -148.67 162.99 38.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.024 1.12 . . . . 3.3599999999999999 114.024 -158.445 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 mtp -114.72 119.22 35.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.427 1.891 . . . . 5.9299999999999997 108.863 162.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -148.66 156.65 42.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.538 1.135 . . . . 9.6899999999999995 111.977 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.0 145.19 42.74 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.233 1.413 . . . . 4.0499999999999998 111.903 165.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -148.75 -63.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.482 1.513 . . . . 4.8799999999999999 109.41 176.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 56' ' ' LYS . 1.2 tt0 -78.77 30.21 0.2 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.562 2.745 . . . . 5.4500000000000002 111.719 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.0 -21.21 0.29 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.167 1.365 . . . . 4.5 113.629 -162.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 54' ' ' GLU . 6.6 mtmt -113.09 168.88 9.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 128.891 2.876 . . . . 3.77 110.332 170.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -89.42 146.78 24.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.634 2.087 . . . . 4.21 116.634 -172.213 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.1 p -145.36 175.08 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 127.788 2.435 . . . . 4.5999999999999996 108.894 174.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 19.7 mtm -107.1 146.37 31.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.049 1.339 . . . . 5.0300000000000002 112.466 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.8 176.86 33.18 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 114.731 0.652 . . . . 1.3400000000000001 114.731 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 mtt -139.22 146.17 40.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.125 2.17 . . . . 3.21 109.796 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -158.34 148.49 15.54 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 125.746 1.619 . . . . 6.9199999999999999 110.237 -177.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.2 Cg_endo -69.18 154.17 70.43 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.914 1.743 . . . . 0.80000000000000004 112.359 170.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.32 158.16 65.03 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.923 1.689 . . . . 1.8 110.624 176.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.93 -19.02 35.87 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.447 2.098 . . . . 1.0800000000000001 113.129 175.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -178.79 172.18 1.38 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.676 1.591 . . . . 3.8300000000000001 111.579 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -117.28 173.38 6.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.378 1.871 . . . . 1.8600000000000001 109.634 154.144 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.49 168.76 18.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.208 0.603 . . . . 3.77 110.596 169.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -145.58 129.54 8.64 Favored Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 125.691 1.596 . . . . 1.8600000000000001 107.461 177.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.78 167.63 25.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.777 1.652 . . . . 1.1000000000000001 111.414 178.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.83 139.71 86.66 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.949 2.433 . . . . 0.93000000000000005 110.785 168.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.47 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 62.4 mmtt 65.97 1.88 2.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.78 1.632 . . . . 2.2200000000000002 113.694 -175.165 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.25 115.23 4.06 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.143 1.83 . . . . 0.84999999999999998 111.149 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.93 135.18 33.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.206 1.002 . . . . 5.9699999999999998 109.61 157.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 m -153.17 151.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.929 1.292 . . . . 2.4700000000000002 110.678 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 133.23 55.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.661 1.22 . . . . 3.7000000000000002 113.173 172.119 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.04 78.99 0.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.803 1.641 . . . . 2.0699999999999998 107.641 161.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -70.61 138.41 85.97 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.363 1.465 . . . . 3.9100000000000001 111.748 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.09 -24.27 76.21 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.153 2.569 . . . . 1.3 113.229 178.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.83 59.27 0.77 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.125 1.345 . . . . 1.23 111.668 166.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.64 -55.47 0.13 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 115.57 0.988 . . . . 1.3899999999999999 115.57 173.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -155.1 140.42 17.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.241 1.416 . . . . 3.3900000000000001 110.34 -176.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -164.31 178.35 7.58 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.094 -1.003 . . . . 0.95999999999999996 111.034 -173.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -110.21 126.39 54.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.497 0.719 . . . . 3.02 110.455 170.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 mmt -82.7 139.68 33.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.301 1.04 . . . . 2.1200000000000001 110.938 168.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.1 mt -116.91 128.93 55.71 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.091 1.756 . . . . 2.9300000000000002 108.162 175.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.05 116.42 11.2 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.884 1.274 . . . . 3.0099999999999998 110.943 -173.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.95 130.53 0.55 Allowed Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.616 -1.393 . . . . 2.7599999999999998 109.616 -167.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.0 mt -127.76 108.63 10.9 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 122.21 1.005 . . . . 2.1899999999999999 110.391 -171.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 4.0 pttm -88.38 0.31 56.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.924 1.29 . . . . 2.8700000000000001 114.378 -173.653 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -149.85 157.22 38.28 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.781 2.433 . . . . 7.1100000000000003 108.552 175.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.29 145.83 79.12 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.653 1.568 . . . . 2.6499999999999999 108.584 162.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -100.77 17.95 20.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.606 1.562 . . . . 4.3700000000000001 111.161 -175.404 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.567 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -40.84 138.1 1.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.325 2.25 . . . . 4.8600000000000003 115.048 -161.495 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 116.86 6.0 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.593 -1.317 . . . . 2.25 109.845 170.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.82 17.22 33.54 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.749 -1.029 . . . . 2.7599999999999998 113.792 -163.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.567 ' CD ' ' HZ3' ' A' ' 94' ' ' LYS . 15.6 mm-40 -81.97 175.06 10.68 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.01 1.405 . . . . 3.2599999999999998 108.366 133.257 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -125.19 131.01 53.26 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.901 -1.888 . . . . 5.0300000000000002 105.901 155.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -94.73 94.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.64 -0.874 . . . . 1.95 108.64 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.34 113.85 3.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.345 -0.942 . . . . 3.9300000000000002 108.981 153.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.75 142.44 50.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.727 1.211 . . . . 2.6800000000000002 109.542 170.221 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.64 126.83 34.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.585 2.354 . . . . 2.71 111.634 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.35 125.23 37.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.393 1.077 . . . . 2.27 110.712 167.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.58 123.45 43.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.729 1.212 . . . . 1.8899999999999999 109.721 -174.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -119.49 126.75 52.04 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.236 -0.915 . . . . 3.46 112.948 -174.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.36 -22.64 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 130.474 3.509 . . . . 3.29 117.538 173.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.53 10.18 3.03 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.035 1.779 . . . . 4.04 115.432 -173.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -165.5 -28.44 0.02 OUTLIER Glycine 0 N--CA 1.477 1.419 0 CA-C-N 119.645 1.723 . . . . 2.8300000000000001 117.225 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.02 133.98 35.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.537 1.668 . . . . 6.7699999999999996 109.331 173.331 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.07 145.93 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.831 0.852 . . . . 1.8700000000000001 109.812 168.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.77 128.35 18.09 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.937 1.695 . . . . 3.02 108.083 172.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -99.08 151.76 20.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.655 0.983 . . . . 3.8900000000000001 113.655 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.56 146.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.87 1.668 . . . . 2.3700000000000001 110.823 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.21 144.04 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.377 1.471 . . . . 4.3200000000000003 110.771 168.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.3 mt -149.87 95.54 3.66 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 3.0099999999999998 108.761 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.26 152.8 74.2 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.49 2.793 . . . . 1.27 112.809 -172.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.2 t -92.63 119.33 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.086 0.954 . . . . 2.0099999999999998 111.741 -171.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.31 132.98 35.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.033 0.933 . . . . 3.79 108.638 152.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -93.34 99.81 12.26 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.65 -1.241 . . . . 2.4900000000000002 107.65 159.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 117.933 -1.032 . . . . 8.8399999999999999 112.55 -159.862 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 N-CA-C 110.578 -1.009 . . . . 10.81 110.578 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m 170.93 -70.91 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 129.277 3.031 . . . . 10.359999999999999 109.577 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -99.76 61.71 1.15 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.572 1.149 . . . . 14.26 108.261 175.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t 106.97 176.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 1 C-N-CA 131.798 4.039 . . . . 7.79 111.483 -168.381 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -145.63 133.16 20.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.752 2.421 . . . . 4.6600000000000001 108.557 173.122 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.34 179.38 37.75 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 115.213 0.845 . . . . 1.6499999999999999 115.213 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -161.02 151.37 17.83 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.829 1.252 . . . . 1.98 113.548 176.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.8 t -110.09 145.66 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.995 0.918 . . . . 1.79 108.828 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.39 122.64 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.91 1.284 . . . . 5.6799999999999997 109.639 -175.319 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.21 174.25 10.95 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.764 1.765 . . . . 3.6200000000000001 115.764 -171.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.7 t -171.5 158.28 4.75 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 128.118 2.567 . . . . 3.8999999999999999 108.083 170.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.68 -21.16 19.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.596 2.197 . . . . 2.9700000000000002 112.07 164.491 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.62 175.72 14.12 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.754 1.645 . . . . 2.1600000000000001 113.155 178.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.91 -4.53 56.48 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 118.3 1.05 . . . . 2.8399999999999999 112.965 -9.712 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.01 150.03 40.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.863 1.265 . . . . 3.8999999999999999 112.181 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.22 -173.51 3.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.854 1.662 . . . . 1.6000000000000001 112.007 174.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.6 151.12 46.99 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.798 0.839 . . . . 2.0299999999999998 113.065 -173.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.61 150.06 39.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.478 1.111 . . . . 1.6399999999999999 112.726 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.25 153.79 41.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.062 1.745 . . . . 3.46 109.495 -175.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -177.62 157.51 1.25 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.124 1.77 . . . . 3.0099999999999998 109.957 -170.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' GLU 0.26 14.1 t -85.44 140.91 30.33 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.363 1.078 . . . . 4.9100000000000001 111.406 166.072 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.67 131.9 37.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.132 -1.803 . . . . 4.2999999999999998 106.132 162.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.55 102.15 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.542 0.737 . . . . 5.0099999999999998 110.406 -173.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.57 112.02 56.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.758 1.223 . . . . 1.0 111.347 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.7 -9.01 8.03 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.232 2.621 . . . . 1.0800000000000001 113.924 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.26 54.73 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 119.216 0.916 . . . . 1.0700000000000001 114.139 -172.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 6.5 m-20 -103.2 -0.24 30.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.204 1.802 . . . . 2.8900000000000001 112.708 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.68 161.56 29.75 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.128 1.771 . . . . 2.52 109.877 165.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.08 159.67 20.64 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.149 2.566 . . . . 0.89000000000000001 111.617 -172.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.78 145.57 33.37 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.463 1.105 . . . . 3.0800000000000001 111.012 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -129.6 109.18 10.8 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.129 1.372 . . . . 3.96 109.955 173.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.33 120.14 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.007 2.523 . . . . 1.98 108.837 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.9 -8.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.665 0.987 . . . . 1.8700000000000001 113.665 -171.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -164.59 35.12 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 118.931 0.787 . . . . 0.55000000000000004 111.967 176.192 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.72 -176.09 4.92 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.049 -0.976 . . . . 1.99 111.301 172.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -160.1 156.17 26.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.81 1.244 . . . . 7.9500000000000002 108.162 166.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.406 ' HG1' HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -157.93 155.84 27.18 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.155 1.382 . . . . 1.8700000000000001 109.152 -171.449 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.29 -39.51 9.92 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.72 1.614 . . . . 1.3200000000000001 112.316 173.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -82.0 -20.65 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.204 1.366 . . . . 2.23 114.44 -169.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.55 169.05 9.57 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.787 0.835 . . . . 1.99 111.221 169.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -91.92 -82.91 0.3 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.443 -1.688 . . . . 3.8799999999999999 106.443 161.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -74.81 163.07 28.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.756 2.022 . . . . 7.6299999999999999 112.234 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -168.71 107.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.65 1.58 . . . . 3.4700000000000002 109.306 176.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.17 130.72 55.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.042 -1.89 . . . . 5.0 110.053 -167.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.13 126.08 31.62 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.018 0.913 . . . . 1.77 112.248 -171.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.4 m170 -113.52 158.79 20.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.996 2.118 . . . . 0.73999999999999999 113.025 176.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -108.57 -178.87 3.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.525 1.93 . . . . 1.79 111.616 172.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.4 m -132.4 119.04 20.14 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.337 -1.357 . . . . 2.5299999999999998 107.337 155.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -102.83 162.64 12.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.188 1.395 . . . . 3.1299999999999999 111.727 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.2 mtt -103.74 150.22 24.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.357 1.063 . . . . 3.2999999999999998 110.502 158.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -160.15 144.81 14.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 7.0300000000000002 112.486 167.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.84 145.88 15.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.258 1.423 . . . . 4.8200000000000003 110.34 156.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.24 -80.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.339 1.455 . . . . 3.3399999999999999 107.985 172.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 56' ' ' LYS . 23.7 mt-10 -77.02 26.73 0.14 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.835 2.054 . . . . 3.8500000000000001 111.837 171.154 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.34 -33.71 0.67 Allowed Glycine 0 CA--C 1.537 1.461 0 O-C-N 120.373 -1.455 . . . . 2.6099999999999999 112.839 -158.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 54' ' ' GLU . 27.2 mtmt -63.67 145.2 56.18 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.7 1.6 . . . . 3.1099999999999999 109.673 166.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -88.87 135.31 33.6 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.844 0.313 . . . . 5.1900000000000004 111.844 -179.295 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.88 147.81 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.036 2.135 . . . . 2.8999999999999999 108.894 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.52 129.29 55.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.001 1.32 . . . . 5.4699999999999998 110.127 175.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.72 162.35 28.28 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 123.973 0.797 . . . . 1.1299999999999999 113.3 -174.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.4 mtt -106.77 158.84 16.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.903 1.281 . . . . 3.0699999999999998 111.724 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -169.95 155.43 5.55 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.553 1.541 . . . . 5.4100000000000001 110.406 173.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.9 Cg_endo -69.69 153.51 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.768 1.645 . . . . 1.1000000000000001 111.297 168.391 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.51 157.73 64.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 125.576 1.55 . . . . 1.8899999999999999 110.88 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.4 -17.23 39.32 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.772 2.315 . . . . 1.1399999999999999 112.828 179.316 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.2 p90 178.03 169.56 0.73 Allowed 'General case' 0 C--N 1.345 0.396 0 C-N-CA 126.882 2.073 . . . . 3.6099999999999999 110.266 179.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.02 165.69 13.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.085 1.354 . . . . 2.0600000000000001 109.262 156.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.98 161.85 42.04 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.304 -0.873 . . . . 2.2400000000000002 112.44 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -149.96 136.78 11.04 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.016 1.326 . . . . 2.4500000000000002 109.694 -163.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.58 170.16 17.01 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.044 2.496 . . . . 0.94999999999999996 112.597 177.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.32 142.99 99.87 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.638 2.892 . . . . 0.88 112.039 166.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 35.7 mmtm 66.52 1.32 2.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.075 1.75 . . . . 2.8399999999999999 113.948 -178.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.13 124.75 7.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 127.064 2.269 . . . . 1.02 111.579 -173.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 140.79 36.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.934 0.894 . . . . 5.4100000000000001 111.255 159.486 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.2 m -147.31 125.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.23 1.412 . . . . 2.7799999999999998 110.082 173.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.0 mp0 -83.08 131.99 35.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.03 0.932 . . . . 3.5899999999999999 112.132 -177.281 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.2 159.82 33.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.114 0.959 . . . . 2.29 109.834 162.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -167.07 145.4 4.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.714 1.206 . . . . 3.6200000000000001 112.436 -161.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 -25.54 30.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.728 2.952 . . . . 2.02 114.148 -176.332 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.23 95.08 1.19 Allowed Glycine 0 N--CA 1.467 0.765 0 N-CA-C 108.694 -1.762 . . . . 1.45 108.694 161.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.82 -148.39 18.4 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.889 1.233 . . . . 2.6000000000000001 111.748 -168.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.15 136.99 37.28 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.213 -0.581 . . . . 3.6800000000000002 111.634 -171.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.62 167.45 21.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.373 0.669 . . . . 0.84999999999999998 110.257 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.46 122.81 48.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.743 0.817 . . . . 3.1099999999999999 110.526 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -86.35 111.81 20.84 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.854 0.862 . . . . 1.78 109.557 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.7 mt -80.73 138.87 36.34 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.213 1.405 . . . . 3.1099999999999999 109.749 176.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -133.18 154.03 51.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.901 1.334 . . . . 3.0299999999999998 113.732 -176.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 -60.33 3.78 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 127.101 2.286 . . . . 2.4300000000000002 112.959 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mt 60.36 93.12 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.278 3.031 . . . . 2.3399999999999999 111.452 -166.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.99 -10.94 60.63 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.011 -1.055 . . . . 4.2300000000000004 112.81 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 -153.78 140.22 12.73 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 129.266 3.026 . . . . 9.2400000000000002 107.148 171.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.2 154.18 41.36 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.331 2.687 . . . . 3.04 110.373 175.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.03 142.99 28.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.381 1.073 . . . . 4.7999999999999998 111.556 -173.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -19.11 26.17 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.627 1.343 . . . . 4.7000000000000002 114.627 -177.558 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 83.3 136.64 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 1 C-N-CA 132.213 4.205 . . . . 3.29 109.822 -171.093 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.73 52.98 8.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.149 -0.781 . . . . 1.96 111.149 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 176.31 5.21 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.108 0.963 . . . . 3.3799999999999999 108.489 155.007 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -100.09 163.08 12.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.905 -0.776 . . . . 3.96 108.905 152.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.406 HG12 ' HG1' ' A' ' 37' ' ' THR . 53.6 t -132.5 120.15 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.236 1.414 . . . . 1.6899999999999999 109.021 175.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 147.04 32.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 3.5699999999999998 109.224 167.141 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.39 123.76 7.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.322 1.049 . . . . 4.0700000000000003 111.073 -174.64 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.81 114.06 21.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.925 2.09 . . . . 2.5600000000000001 111.231 177.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.4 mt -80.71 114.07 19.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.956 -1.09 . . . . 2.3599999999999999 109.006 176.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.23 125.58 35.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.245 0.618 . . . . 1.9399999999999999 110.116 -173.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.39 164.19 12.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.792 0.664 . . . . 3.6200000000000001 112.792 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.96 62.08 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.082 1.753 . . . . 2.5800000000000001 113.753 -173.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 141.45 -149.98 21.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.545 1.545 . . . . 3.1000000000000001 111.506 -178.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.77 37.83 1.06 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.692 1.139 . . . . 2.1000000000000001 115.696 -172.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -127.64 133.71 49.66 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.311 1.556 . . . . 5.3300000000000001 110.75 170.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.78 140.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.179 1.792 . . . . 2.1699999999999999 107.24 163.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -142.83 116.09 8.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.758 1.223 . . . . 2.29 109.742 -172.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -88.66 142.39 27.72 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.875 1.435 . . . . 3.46 114.875 -177.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.2 164.02 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.753 2.021 . . . . 2.7200000000000002 111.278 175.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.91 134.63 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.593 1.157 . . . . 3.3999999999999999 110.67 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.6 mt -141.58 145.14 36.17 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.402 1.881 . . . . 2.79 109.602 -165.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.33 159.93 15.04 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.932 3.088 . . . . 1.49 112.623 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.81 112.78 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.502 1.121 . . . . 2.0099999999999998 113.006 174.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.39 147.39 28.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.732 2.813 . . . . 3.6600000000000001 109.774 160.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.23 -171.07 3.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.588 1.329 . . . . 2.1200000000000001 114.588 -162.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.512 ' HE ' ' C ' ' A' ' 120' ' ' ARG 0.307 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 130.875 3.67 . . . . 10.16 113.901 174.787 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.319 0 N-CA-C 108.189 -1.964 . . . . 16.649999999999999 108.189 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.8 m -149.25 153.28 37.34 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.347 1.073 . . . . 12.9 109.25 -168.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -130.96 125.16 32.66 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.351 -0.981 . . . . 11.59 108.351 -178.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -77.05 97.33 4.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 122.204 1.002 . . . . 8.6999999999999993 110.152 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.46 74.4 5.0 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.54 1.536 . . . . 6.8600000000000003 109.522 173.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.95 171.95 43.6 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.177 0.894 . . . . 1.4199999999999999 113.868 174.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -160.11 156.68 27.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.121 1.368 . . . . 2.1499999999999999 112.358 -176.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.62 129.02 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.988 . . . . 2.04 110.118 175.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -82.73 112.79 19.9 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.894 -1.15 . . . . 4.8600000000000003 107.894 166.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -60.95 -45.19 95.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.768 1.766 . . . . 3.6499999999999999 115.768 -164.923 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 6.0 t 58.86 155.57 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 128.35 2.66 . . . . 3.29 113.941 -159.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.91 0.5 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.997 2.464 . . . . 1.8300000000000001 113.219 160.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.98 177.38 36.41 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.15 0.881 . . . . 1.3400000000000001 113.11 -177.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -80.36 -2.55 41.66 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 118.99 1.395 . . . . 1.8400000000000001 113.507 -3.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -138.45 165.6 26.41 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.676 1.991 . . . . 1.9299999999999999 111.648 178.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.96 -175.51 5.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.507 1.523 . . . . 1.5900000000000001 113.588 -169.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.2 149.41 33.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.818 0.847 . . . . 1.8600000000000001 112.678 -172.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.46 152.52 40.75 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.428 0.899 . . . . 2.0800000000000001 113.428 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 150.53 32.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.04 1.336 . . . . 3.7799999999999998 110.462 -170.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.38 159.32 4.6 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.707 1.603 . . . . 3.23 110.541 -175.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 m -78.24 152.73 32.41 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.399 -0.963 . . . . 2.75 108.399 155.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 134.63 38.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.793 2.037 . . . . 4.75 107.751 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.25 139.0 42.41 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.793 1.237 . . . . 5.2599999999999998 113.543 -177.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -104.44 107.83 58.83 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.796 -0.638 . . . . 1.51 109.676 149.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -92.04 -7.74 3.06 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.601 2.867 . . . . 1.51 114.04 175.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.75 178.72 41.12 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.467 1.03 . . . . 1.3500000000000001 113.322 -176.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -95.62 -0.79 51.41 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.587 . . . . 3.6099999999999999 113.376 176.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.59 160.07 31.86 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.463 1.505 . . . . 2.73 110.516 171.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.43 153.97 24.15 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.758 2.306 . . . . 0.76000000000000001 111.413 -171.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -116.26 119.31 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.746 1.218 . . . . 3.3399999999999999 110.053 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -115.13 102.55 10.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.266 1.426 . . . . 5.4400000000000004 111.342 -177.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 tp -92.08 119.91 32.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.975 2.51 . . . . 1.8400000000000001 109.196 -172.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.04 -8.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.513 1.125 . . . . 1.8300000000000001 113.459 -169.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.08 -158.93 31.76 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 124.627 1.108 . . . . 0.39000000000000001 111.391 173.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.07 -177.04 5.52 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 122.467 -0.431 . . . . 1.77 111.745 169.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -146.33 129.5 16.59 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.322 1.049 . . . . 7.4400000000000004 109.732 170.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.5 t -141.16 156.78 67.75 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 126.704 2.002 . . . . 1.4399999999999999 109.526 -173.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.51 -32.97 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.151 1.901 . . . . 1.24 113.203 170.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.289 1.4 m -75.42 -9.53 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 120.27 1.396 . . . . 1.8200000000000001 114.21 -164.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.61 147.11 52.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.165 1.786 . . . . 1.9099999999999999 109.894 175.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -50.02 -59.64 3.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.039 1.29 . . . . 5.6200000000000001 108.693 168.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -130.4 153.36 48.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.872 2.069 . . . . 4.5999999999999996 109.951 -168.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.15 127.57 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.858 1.663 . . . . 3.0600000000000001 107.091 173.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -121.38 128.02 51.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.353 1.861 . . . . 1.9399999999999999 107.41 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.05 122.3 26.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.98 0.895 . . . . 2.1499999999999999 109.806 170.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -111.45 158.49 19.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.019 1.728 . . . . 0.62 110.993 179.451 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.85 -178.59 3.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.663 1.985 . . . . 2.2400000000000002 111.656 177.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 m -140.51 113.26 8.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.911 -1.144 . . . . 2.7000000000000002 107.911 150.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -96.2 -171.34 2.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.446 1.498 . . . . 3.4900000000000002 109.811 173.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -141.55 149.14 40.42 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.568 0.747 . . . . 4.3399999999999999 110.982 163.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -134.65 141.89 46.7 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.35 1.06 . . . . 7.7599999999999998 110.309 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -75.85 116.38 16.5 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.187 0.995 . . . . 5.7999999999999998 109.552 162.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 t -88.01 -119.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 106.455 -1.683 . . . . 3.9700000000000002 106.455 169.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.552 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -81.03 75.68 8.01 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.541 1.064 . . . . 4.9100000000000001 108.33 163.478 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.44 -20.72 0.1 OUTLIER Glycine 0 N--CA 1.475 1.287 0 C-N-CA 129.522 3.439 . . . . 2.1800000000000002 117.004 178.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.552 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 7.2 ptpp? -68.34 122.92 19.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.595 -1.532 . . . . 5.3300000000000001 110.468 169.066 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -99.42 69.16 1.65 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.078 1.751 . . . . 6.2800000000000002 109.121 -170.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -87.26 139.59 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.924 1.69 . . . . 2.5899999999999999 110.67 -163.367 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -78.52 134.02 37.32 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.6 1.56 . . . . 4.7699999999999996 111.576 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.49 150.79 19.95 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.354 0.978 . . . . 1.4399999999999999 112.925 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -112.67 152.71 28.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.845 1.258 . . . . 2.5099999999999998 111.397 -179.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 mtp-105 -164.42 153.86 11.96 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 127.081 2.152 . . . . 4.4400000000000004 108.151 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -69.0 151.83 73.32 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.971 1.382 . . . . 0.97999999999999998 111.001 157.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.7 152.66 56.1 Favored Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.944 1.298 . . . . 1.8100000000000001 110.253 173.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.94 -9.48 25.77 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.692 2.261 . . . . 0.94999999999999996 113.355 178.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -177.91 165.5 1.99 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.643 1.577 . . . . 3.2400000000000002 110.526 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -117.27 166.17 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.664 1.586 . . . . 1.9399999999999999 109.053 151.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.97 162.34 39.6 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.498 -0.751 . . . . 2.0 112.621 167.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -143.18 129.87 10.56 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-N 114.669 -1.151 . . . . 2.79 110.187 -168.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.32 162.02 42.24 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.665 2.244 . . . . 1.3 111.374 176.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.82 145.48 96.37 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.038 3.159 . . . . 1.04 113.637 -178.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp 67.21 -5.68 0.69 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.213 2.205 . . . . 2.9100000000000001 115.196 178.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.21 123.78 7.02 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 126.613 2.054 . . . . 1.28 111.095 176.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -86.42 147.95 25.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.052 0.541 . . . . 5.5199999999999996 110.677 154.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -146.15 155.83 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.05 1.34 . . . . 2.9199999999999999 110.242 175.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.502 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -98.43 142.53 29.93 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.673 0.749 . . . . 4.5999999999999996 112.988 -178.116 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.99 65.69 1.47 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.983 1.373 . . . . 2.1499999999999999 108.422 152.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.502 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -58.36 113.92 7.63 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.522 1.529 . . . . 4.1600000000000001 109.787 169.125 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.99 -45.38 41.47 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.392 2.728 . . . . 1.3799999999999999 114.634 -161.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.94 90.88 1.56 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.79 -1.724 . . . . 1.46 108.79 161.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.35 -64.82 0.39 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.819 1.676 . . . . 1.52 111.197 -174.001 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -150.42 145.8 26.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.761 1.625 . . . . 3.6299999999999999 111.194 170.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -158.77 157.4 31.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.292 1.437 . . . . 1.0900000000000001 109.779 178.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.93 131.7 34.5 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.298 -0.631 . . . . 3.3100000000000001 109.298 164.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.3 125.58 51.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.559 1.544 . . . . 2.2400000000000002 109.027 173.191 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.58 139.12 46.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.324 1.45 . . . . 3.54 110.545 -170.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -133.79 158.25 43.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.032 0.933 . . . . 2.7200000000000002 112.842 -171.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.69 60.86 7.37 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.553 1.549 . . . . 2.1200000000000001 113.29 169.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.52 101.08 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.872 1.32 . . . . 1.9399999999999999 112.743 -164.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -83.54 -3.99 58.14 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.547 -0.751 . . . . 3.0099999999999998 113.006 -166.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -131.04 153.77 81.85 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 129.474 3.109 . . . . 8.3900000000000006 108.568 168.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.74 167.43 27.11 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.089 2.526 . . . . 1.9299999999999999 109.31 157.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.5 164.85 29.38 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.199 1.4 . . . . 3.8999999999999999 112.037 -165.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 140.22 2.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.621 1.568 . . . . 6.7400000000000002 113.185 -163.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.91 134.24 37.49 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.358 -1.464 . . . . 2.8999999999999999 112.868 173.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.93 56.31 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.734 -1.592 . . . . 1.9399999999999999 115.063 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.76 -177.94 3.48 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.339 1.57 . . . . 3.23 108.585 156.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.89 138.93 52.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.444 1.116 . . . . 3.6400000000000001 112.054 -172.086 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 95.3 t -90.19 107.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.366 1.466 . . . . 2.5299999999999998 108.753 -172.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.61 130.46 45.32 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 124.525 1.141 . . . . 4.0499999999999998 108.856 158.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mt -154.74 132.09 11.15 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.914 1.686 . . . . 2.6699999999999999 112.283 -177.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.11 114.45 27.97 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.71 1.604 . . . . 2.8500000000000001 110.836 169.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.83 118.2 19.2 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.029 1.331 . . . . 2.1400000000000001 109.986 175.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.78 133.65 34.59 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.861 0.864 . . . . 1.8999999999999999 110.54 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -125.19 164.36 20.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.961 0.886 . . . . 3.5299999999999998 112.41 176.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.01 156.01 9.97 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.686 -0.688 . . . . 2.5499999999999998 111.478 164.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.78 10.97 85.8 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.247 -0.751 . . . . 3.6400000000000001 114.885 -178.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.98 1.85 85.8 Favored Glycine 0 N--CA 1.473 1.163 0 CA-C-N 118.57 1.185 . . . . 2.4300000000000002 113.977 -178.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.99 130.98 44.91 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.093 -1.239 . . . . 6.8700000000000001 110.266 179.132 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.89 149.97 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.978 0.911 . . . . 2.02 110.239 170.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -146.44 129.26 16.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.681 1.192 . . . . 3.0 112.453 -174.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -63.48 134.47 55.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.669 1.188 . . . . 3.2799999999999998 112.393 172.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.2 m -138.98 146.1 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.14 1.776 . . . . 2.3199999999999998 109.568 163.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.2 123.06 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.981 0.912 . . . . 2.8300000000000001 110.509 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -139.07 146.33 48.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.992 1.317 . . . . 2.7599999999999998 110.176 -169.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.3 146.2 68.46 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.033 2.489 . . . . 1.1499999999999999 113.202 -175.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.2 t -79.37 134.78 27.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 124.524 1.13 . . . . 2.4399999999999999 108.385 161.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.58 141.91 51.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.224 1.81 . . . . 5.1799999999999997 109.21 169.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.56 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -128.34 71.7 1.4 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 122.275 1.036 . . . . 3.3599999999999999 113.788 -167.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.195 0 C-N-CA 126.544 1.938 . . . . 9.3399999999999999 109.196 169.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 N-CA-C 108.609 -1.796 . . . . 12.08 108.609 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 t 168.25 -164.63 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 129.761 3.225 . . . . 10.300000000000001 106.241 -166.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -66.92 -26.76 67.02 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.746 1.612 . . . . 13.279999999999999 114.092 -178.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 m 105.6 112.27 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 1 C-N-CA 133.493 4.717 . . . . 7.9900000000000002 106.989 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -96.52 109.46 22.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.782 -1.099 . . . . 4.6799999999999997 110.836 -154.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.14 179.62 48.86 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.167 0.889 . . . . 1.4099999999999999 113.256 -174.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -155.09 153.42 30.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.275 1.43 . . . . 1.52 112.902 -177.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.69 122.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.463 1.105 . . . . 2.0899999999999999 110.548 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -57.36 -39.93 77.0 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.649 1.979 . . . . 6.6200000000000001 114.126 -168.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.34 151.79 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.655 1.982 . . . . 3.8900000000000001 113.528 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.28 165.99 2.01 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 119.748 -1.845 . . . . 2.2999999999999998 109.889 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.79 23.15 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.034 3.156 . . . . 2.0099999999999998 112.819 175.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.69 -176.06 54.73 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 121.312 -0.867 . . . . 1.53 111.837 -159.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.72 -11.41 18.03 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 CA-C-N 118.499 1.15 . . . . 2.2999999999999998 112.233 -12.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -134.73 154.22 51.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.372 1.069 . . . . 2.7999999999999998 112.294 168.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.58 -177.67 3.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.291 1.836 . . . . 1.45 108.31 156.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.64 173.35 11.77 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.169 0.988 . . . . 2.21 110.537 173.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.46 151.03 41.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.223 1.009 . . . . 2.0499999999999998 112.396 167.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.09 142.39 38.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.842 2.457 . . . . 3.6099999999999999 109.235 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -169.66 159.49 8.27 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.598 1.333 . . . . 3.2799999999999998 114.598 -175.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -97.96 119.57 36.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.02 1.728 . . . . 2.4700000000000002 108.379 173.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.31 142.72 41.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.018 1.327 . . . . 3.4900000000000002 109.931 176.094 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -142.35 150.0 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.196 1.398 . . . . 2.9500000000000002 110.941 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -118.48 108.22 41.88 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.831 0.852 . . . . 1.23 110.962 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -86.41 -5.39 8.32 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.77 2.313 . . . . 1.1200000000000001 114.325 175.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 -157.31 16.09 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 120.129 1.331 . . . . 2.0899999999999999 115.365 -167.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -95.12 -41.03 9.31 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.57 2.348 . . . . 6.0300000000000002 112.384 178.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.03 166.13 13.12 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.136 1.774 . . . . 2.7000000000000002 111.729 -173.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.07 167.13 25.53 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.505 2.137 . . . . 1.2 113.691 -166.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.56 148.11 26.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.773 1.229 . . . . 3.8199999999999998 109.747 165.148 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -141.81 103.53 4.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.638 1.575 . . . . 5.2000000000000002 108.141 171.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.15 104.4 16.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.867 2.467 . . . . 1.8999999999999999 108.941 -166.146 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.62 -12.44 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.872 1.269 . . . . 1.9099999999999999 112.924 -172.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.92 -163.6 33.25 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 123.733 0.682 . . . . 0.42999999999999999 112.349 178.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.18 178.4 9.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.005 1.322 . . . . 1.54 110.401 173.028 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.18 145.54 32.9 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.993 -1.114 . . . . 8.9800000000000004 107.993 174.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.483 ' HG1' HG13 ' A' ' 99' ' ' VAL . 3.7 t -151.37 151.6 29.36 Favored Pre-proline 0 N--CA 1.47 0.534 0 CA-C-O 118.374 -0.822 . . . . 2.0099999999999998 110.949 172.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.43 -23.41 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.725 2.95 . . . . 2.2400000000000002 114.891 160.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.28 1.3 m -95.17 5.65 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.96 1.467 . . . . 2.0 114.96 -168.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.38 163.43 32.81 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.884 1.274 . . . . 1.8700000000000001 111.946 -178.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.453 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 8.8 tp10 -100.72 -89.87 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.912 -0.773 . . . . 3.4700000000000002 108.912 164.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -76.55 114.89 15.77 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.032 -1.042 . . . . 3.8599999999999999 109.013 -179.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.76 140.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.698 1.599 . . . . 3.3100000000000001 111.161 163.467 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -144.02 122.5 12.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.274 1.43 . . . . 2.6000000000000001 109.623 166.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -80.08 119.07 22.39 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.746 1.157 . . . . 1.77 110.88 169.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -107.36 152.83 23.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.941 1.696 . . . . 0.70999999999999996 112.395 175.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.93 -178.06 3.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.41 1.484 . . . . 2.1800000000000002 110.603 167.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -146.57 130.25 17.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.887 1.275 . . . . 2.1899999999999999 107.777 174.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.78 165.4 27.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.527 1.131 . . . . 3.0800000000000001 112.655 -165.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.9 mtm -98.23 144.69 27.4 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.798 1.239 . . . . 3.04 111.56 174.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -156.59 178.93 9.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.139 1.376 . . . . 11.699999999999999 112.523 -175.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.67 158.16 17.07 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.198 1.799 . . . . 9.0 110.3 167.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.03 121.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 125.893 1.677 . . . . 5.4299999999999997 109.232 140.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 55.54 54.14 8.82 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.907 1.283 . . . . 4.75 109.78 -174.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.49 -26.23 0.17 Allowed Glycine 0 N--CA 1.476 1.322 0 C-N-CA 128.964 3.174 . . . . 3.54 116.129 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -78.18 140.38 38.96 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.793 -1.416 . . . . 5.1699999999999999 111.778 -171.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.54 122.94 17.04 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 5.3799999999999999 111.094 174.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.9 t -142.71 161.63 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.118 1.767 . . . . 3.4500000000000002 108.154 173.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.18 158.54 15.79 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.024 -1.047 . . . . 3.73 112.6 -178.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.75 159.01 24.41 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 124.944 1.259 . . . . 1.1499999999999999 112.038 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -125.88 155.87 40.55 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.9 1.68 . . . . 2.23 108.307 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -169.06 150.26 4.32 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.004 1.322 . . . . 5.6600000000000001 110.3 177.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.36 153.14 77.79 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.314 2.009 . . . . 1.23 111.264 169.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -125.14 155.96 70.29 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.454 1.502 . . . . 1.8899999999999999 110.172 171.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.05 -14.5 41.11 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.782 2.321 . . . . 1.03 112.92 176.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -179.48 162.24 1.12 Allowed 'General case' 0 C--N 1.348 0.51 0 C-N-CA 126.092 1.757 . . . . 3.6600000000000001 110.362 178.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -104.43 176.63 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.313 1.445 . . . . 1.79 109.732 153.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.29 168.95 25.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.049 -1.032 . . . . 1.96 113.76 171.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.81 136.18 10.35 Favored Pre-proline 0 N--CA 1.467 0.406 0 C-N-CA 125.395 1.478 . . . . 1.9099999999999999 108.246 -176.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.78 171.41 11.02 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 121.812 1.675 . . . . 1.28 111.251 170.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.04 142.62 75.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.741 2.294 . . . . 1.3200000000000001 110.341 163.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt 73.83 -4.96 2.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.73 2.412 . . . . 2.4900000000000002 113.261 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.07 -170.99 44.29 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 126.369 1.938 . . . . 1.4099999999999999 112.389 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -167.25 154.89 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.194 1.798 . . . . 7.3300000000000001 112.178 -178.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.62 159.3 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.202 1.801 . . . . 3.2799999999999998 110.42 177.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.49 116.7 23.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.773 -1.195 . . . . 4.4800000000000004 107.773 177.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.5 67.86 2.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.784 1.233 . . . . 1.9299999999999999 108.823 170.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -75.67 149.12 83.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.344 1.058 . . . . 4.4699999999999998 111.428 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.97 -30.31 92.95 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.741 2.294 . . . . 1.4299999999999999 113.336 176.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.33 48.68 2.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.565 1.079 . . . . 1.3500000000000001 112.453 168.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.84 -64.92 0.05 OUTLIER Glycine 0 N--CA 1.473 1.163 0 N-CA-C 115.837 1.095 . . . . 1.3600000000000001 115.837 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -156.55 146.3 20.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.353 1.861 . . . . 3.7200000000000002 109.541 -173.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -165.55 170.92 13.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.739 -1.225 . . . . 0.84999999999999998 110.438 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.04 136.3 42.11 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.916 -0.772 . . . . 3.0600000000000001 108.916 168.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -83.1 128.79 34.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.104 0.961 . . . . 1.7 110.047 156.027 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 mt -113.87 104.3 12.04 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.421 1.489 . . . . 2.6699999999999999 107.85 177.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.99 155.77 17.52 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.443 0.639 . . . . 2.7999999999999998 112.349 -176.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.79 -53.39 4.84 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.248 1.404 . . . . 2.6899999999999999 113.757 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 62.98 85.15 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.782 2.433 . . . . 2.2000000000000002 112.806 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HE3' ' OE1' ' A' ' 41' ' ' GLU . 4.3 ptpp? -73.84 -0.48 16.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.759 1.392 . . . . 2.9100000000000001 114.759 -168.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -149.44 159.37 36.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 128.766 2.827 . . . . 6.25 108.837 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.29 162.33 36.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.12 1.88 . . . . 2.2200000000000002 109.583 154.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.11 43.8 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 123.065 1.412 . . . . 4.0999999999999996 111.929 -158.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -74.42 143.82 44.57 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.101 1.76 . . . . 6.2400000000000002 113.631 -168.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.03 118.59 2.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.754 1.222 . . . . 2.8799999999999999 113.153 177.274 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.1 16.82 26.81 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 117.991 -1.45 . . . . 1.78 114.817 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.22 166.02 11.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.279 1.539 . . . . 3.8900000000000001 108.797 136.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -111.83 134.26 53.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.972 1.709 . . . . 5.4100000000000001 108.753 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.483 HG13 ' HG1' ' A' ' 37' ' ' THR . 59.2 t -84.44 113.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.639 0.776 . . . . 1.9299999999999999 110.352 -178.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -68.8 129.16 39.14 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.148 -0.933 . . . . 3.52 109.091 161.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.91 147.92 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.624 0.77 . . . . 2.71 111.269 -173.669 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -114.53 132.15 56.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.469 -1.241 . . . . 2.4700000000000002 110.342 162.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.4 mt -98.33 121.13 39.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.737 1.215 . . . . 2.25 109.021 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.2 mt -96.76 129.88 44.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.084 0.954 . . . . 2.3100000000000001 111.333 -170.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -122.34 145.76 47.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.939 0.896 . . . . 3.4300000000000002 112.179 -176.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.88 131.02 45.96 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.116 0.966 . . . . 2.48 111.826 176.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.69 -159.6 23.12 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.495 1.045 . . . . 2.9199999999999999 110.705 -164.374 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.51 26.46 6.41 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.264 0.935 . . . . 2.7599999999999998 113.783 178.518 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -99.43 129.55 45.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.015 1.408 . . . . 6.4199999999999999 111.632 -173.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.83 138.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.449 1.499 . . . . 2.3100000000000001 108.866 167.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.53 121.34 39.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.267 1.027 . . . . 3.0099999999999998 109.645 177.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -79.96 139.82 36.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.972 0.509 . . . . 3.1200000000000001 110.937 175.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m -145.1 171.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.719 2.007 . . . . 2.1699999999999999 109.893 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.87 131.14 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.376 1.071 . . . . 2.6800000000000002 109.124 176.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mp -145.75 152.64 49.09 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.917 1.287 . . . . 2.9399999999999999 111.063 -168.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.2 155.37 67.97 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.422 2.748 . . . . 1.47 114.279 -177.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.31 125.42 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.168 -0.923 . . . . 2.3199999999999998 108.681 157.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.64 138.23 35.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.415 1.486 . . . . 3.7799999999999998 109.068 170.329 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.03 134.79 55.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.941 2.2 . . . . 3.0099999999999998 116.941 -128.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.078 1 C-N-CA 132.372 4.269 . . . . 7.6399999999999997 111.243 160.688 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.175 0 N-CA-C 110.245 -1.142 . . . . 12.08 110.245 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m -129.85 -30.94 1.99 Allowed 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.049 0.759 . . . . 11.32 113.049 178.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -174.86 84.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 130.883 3.673 . . . . 13.460000000000001 104.253 179.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -170.31 -32.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.889 1.44 . . . . 7.8099999999999996 114.889 -144.596 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -148.29 -172.43 4.07 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.19 0.996 . . . . 4.4400000000000004 111.913 -151.103 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.1 151.64 21.88 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 121.304 -0.872 . . . . 1.3600000000000001 114.323 169.39 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -155.01 152.7 29.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.999 1.719 . . . . 1.8 111.596 -179.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.32 122.55 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.029 -1.1 . . . . 1.8799999999999999 108.029 178.793 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 89.47 8.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.825 1.25 . . . . 4.2400000000000002 108.477 171.334 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -67.09 139.25 57.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.363 1.065 . . . . 3.3900000000000001 109.027 168.092 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.6 m -138.39 158.31 70.88 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.49 . . . . 3.2200000000000002 108.026 168.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.88 27.91 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.616 3.544 . . . . 2.2799999999999998 115.113 -171.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.49 170.18 44.51 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.141 -0.974 . . . . 1.6499999999999999 113.957 178.878 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.36 -7.94 35.4 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 117.811 0.806 . . . . 1.8200000000000001 113.373 -7.038 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -130.69 161.98 30.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.216 1.806 . . . . 3.6600000000000001 111.216 -175.528 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.91 -173.88 4.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.541 1.936 . . . . 1.4099999999999999 112.038 -177.2 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.61 40.5 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.315 0.858 . . . . 1.8500000000000001 113.315 -172.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.07 146.4 27.71 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 2.1400000000000001 112.148 173.341 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.25 151.04 51.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.595 1.958 . . . . 3.7400000000000002 109.644 -173.23 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -169.4 145.35 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.336 1.236 . . . . 2.8100000000000001 114.336 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.9 m -75.68 139.97 42.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.081 1.752 . . . . 2.5600000000000001 108.977 163.19 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.0 133.51 21.96 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.139 1.376 . . . . 3.5699999999999998 108.944 174.195 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.46 156.76 46.15 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 114.225 1.195 . . . . 3.1400000000000001 114.225 -175.666 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -116.85 100.06 53.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.249 -1.342 . . . . 1.6100000000000001 110.47 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -85.02 -3.16 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.222 2.615 . . . . 1.3300000000000001 114.091 176.237 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.19 -119.78 0.81 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.797 1.189 . . . . 2.9500000000000002 114.626 -168.618 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -154.15 -41.98 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.371 1.868 . . . . 5.3899999999999997 112.021 -161.786 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -96.12 165.06 17.1 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.833 2.053 . . . . 2.4700000000000002 111.335 171.419 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.44 157.5 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.227 2.618 . . . . 0.92000000000000004 112.282 -174.277 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.37 156.71 17.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.308 1.043 . . . . 3.0600000000000001 111.33 171.195 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -146.54 101.06 3.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.104 1.361 . . . . 4.7699999999999996 112.811 177.529 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.3 tp -85.07 108.25 17.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.15 2.18 . . . . 2.0800000000000001 109.115 -176.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -99.17 -16.13 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.677 1.191 . . . . 1.8400000000000001 112.987 -173.458 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.32 42.72 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.773 0.701 . . . . 0.47999999999999998 111.717 -177.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.03 -178.95 5.5 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.308 1.043 . . . . 1.6200000000000001 110.434 169.196 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -154.31 128.56 9.05 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 106.363 -1.718 . . . . 7.4100000000000001 106.363 175.736 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -146.34 151.31 43.58 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.578 1.151 . . . . 1.97 109.295 -168.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.32 -23.11 21.07 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.412 2.074 . . . . 1.27 113.5 175.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.98 -13.16 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 115.569 1.692 . . . . 2.4900000000000002 115.569 -165.251 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.4 152.35 50.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.319 1.048 . . . . 2.0499999999999998 112.711 -165.675 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -56.45 22.01 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.59 1.087 . . . . 6.6299999999999999 109.185 171.771 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.419 ' HG2' ' H ' ' A' ' 43' ' ' VAL . 16.1 ttm180 -128.85 176.07 8.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.006 2.522 . . . . 4.8899999999999997 109.926 179.177 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.419 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 2.3 p -155.43 137.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.287 2.235 . . . . 2.0299999999999998 107.455 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -142.32 137.53 30.63 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.585 1.554 . . . . 1.8999999999999999 108.851 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.37 126.97 32.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.676 1.125 . . . . 1.9399999999999999 110.165 166.673 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.3 m170 -119.35 155.38 32.0 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.795 2.038 . . . . 0.68000000000000005 112.017 176.478 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -92.57 166.07 12.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.761 1.624 . . . . 2.4700000000000002 110.46 164.679 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.3 m -123.63 127.72 48.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 106.357 -1.719 . . . . 2.46 106.357 154.117 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -122.4 170.96 9.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.442 1.275 . . . . 3.75 114.442 -166.392 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.9 mtm -125.82 127.15 45.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.097 1.359 . . . . 3.8199999999999998 109.389 161.794 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -153.52 165.81 34.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.099 1.76 . . . . 10.359999999999999 110.416 174.303 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.466 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 3.5 mp0 -71.51 152.46 43.0 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.684 1.194 . . . . 3.4500000000000002 111.285 168.606 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.32 -86.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.599 1.16 . . . . 4.1100000000000003 109.241 176.256 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 56' ' ' LYS . 3.0 tt0 -78.44 51.31 1.03 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.681 1.992 . . . . 4.29 110.562 176.166 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -20.69 0.3 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.951 1.738 . . . . 3.02 114.683 -170.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 54' ' ' GLU . 37.3 mtmt -107.78 159.24 16.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.474 2.71 . . . . 3.7400000000000002 110.276 -176.466 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 7.9 ttmm -72.5 138.35 46.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.095 1.358 . . . . 4.1100000000000003 112.977 179.017 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -137.7 154.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.61 1.964 . . . . 2.6000000000000001 108.773 177.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 ptp -125.35 135.63 52.63 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.694 1.198 . . . . 3.5299999999999998 112.99 176.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.7 -179.74 40.59 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.609 1.099 . . . . 1.8600000000000001 113.171 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.31 166.42 11.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.812 1.245 . . . . 3.3100000000000001 113.438 -177.47 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -171.44 155.6 4.17 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 7.1799999999999997 110.576 164.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.7 Cg_exo -64.98 157.01 59.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.88 1.72 . . . . 1.03 112.146 171.583 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.81 159.12 72.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 126.013 1.725 . . . . 2.0299999999999998 110.151 176.716 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.92 -24.8 23.97 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.23 1.953 . . . . 1.4199999999999999 112.853 175.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -179.59 171.26 1.24 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.659 1.584 . . . . 3.3700000000000001 112.63 -178.37 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mt -118.89 167.61 11.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.925 2.09 . . . . 2.3300000000000001 109.573 152.266 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -154.82 156.47 36.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.563 -0.711 . . . . 2.6099999999999999 111.823 178.621 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -137.49 126.94 15.22 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 2.29 108.965 -166.576 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.9 160.43 43.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.0 1.8 . . . . 1.1899999999999999 111.402 175.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.15 140.0 86.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.617 2.878 . . . . 1.3100000000000001 111.304 176.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 71.37 -1.56 2.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.309 2.244 . . . . 3.0800000000000001 113.051 -178.218 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.04 -177.74 31.88 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 126.599 2.047 . . . . 1.75 111.414 178.811 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -161.93 156.41 22.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 6.7300000000000004 113.759 -179.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.92 161.01 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.286 1.434 . . . . 3.0699999999999998 109.413 174.538 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -123.6 135.91 54.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.444 -0.947 . . . . 5.0099999999999998 108.444 158.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.33 55.73 1.01 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.041 1.336 . . . . 1.8999999999999999 109.216 168.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -50.17 132.29 23.84 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.645 1.578 . . . . 5.2199999999999998 111.349 179.249 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.2 -36.86 97.42 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.946 3.097 . . . . 2.5499999999999998 114.983 -166.537 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.97 52.34 4.68 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-N 119.327 0.967 . . . . 1.8400000000000001 111.527 169.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.55 -145.5 5.66 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.524 2.011 . . . . 2.8399999999999999 112.024 -166.726 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -67.79 141.86 56.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.625 0.713 . . . . 3.5499999999999998 110.376 178.037 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -160.3 165.79 30.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.952 0.797 . . . . 1.0 111.003 -172.445 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -95.64 123.99 39.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.22 -0.659 . . . . 3.5800000000000001 109.22 163.406 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.52 126.06 45.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.612 1.165 . . . . 2.27 108.959 174.437 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.36 139.79 49.19 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.602 1.561 . . . . 4.0800000000000001 110.009 -172.557 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mp -132.51 166.08 22.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.606 0.762 . . . . 3.4900000000000002 112.789 -172.043 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 50.22 41.33 38.91 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 126.81 2.148 . . . . 2.1299999999999999 114.753 168.445 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.9 mt -53.17 117.51 3.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.566 1.321 . . . . 2.4100000000000001 114.566 -147.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -86.54 -3.18 58.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.547 0.943 . . . . 4.04 113.547 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -111.41 150.38 42.01 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.712 1.205 . . . . 5.5599999999999996 107.898 155.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 -10.94 23.17 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.567 2.845 . . . . 4.1299999999999999 115.15 166.394 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 10' ' ' PHE . 3.0 mp 72.39 -173.24 0.15 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.768 3.627 . . . . 3.3399999999999999 111.293 173.711 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -170.03 119.02 0.6 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.197 1.399 . . . . 4.46 110.094 -167.372 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.39 124.57 21.27 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.322 -0.861 . . . . 2.8100000000000001 109.495 166.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.21 54.79 27.67 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.699 -0.56 . . . . 2.02 111.699 -166.744 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -112.46 163.14 14.81 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 122.455 1.121 . . . . 4.1299999999999999 110.092 138.643 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -110.26 105.6 14.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.074 1.749 . . . . 4.5899999999999999 107.742 -172.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.86 112.62 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.134 0.973 . . . . 2.4500000000000002 109.412 -173.537 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.532 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 36.7 mt-10 -70.96 137.83 49.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.887 -0.597 . . . . 3.1899999999999999 110.342 159.322 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 tt -149.37 135.46 18.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.902 1.281 . . . . 2.7599999999999998 109.852 179.484 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.31 110.99 22.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.679 2.792 . . . . 2.1000000000000001 110.842 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.0 117.95 20.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.989 0.916 . . . . 2.5099999999999998 109.228 176.344 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.63 121.42 34.04 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 1.71 110.522 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -118.1 121.84 41.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 3.4300000000000002 113.053 -179.613 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.08 23.55 0.3 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.267 2.227 . . . . 2.73 116.975 168.608 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.7 10.97 80.53 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 115.947 1.139 . . . . 4.5800000000000001 115.947 174.693 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.69 -31.18 0.03 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 119.076 1.438 . . . . 2.6699999999999999 116.478 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -89.11 139.48 30.43 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.741 -1.446 . . . . 5.3399999999999999 109.398 169.541 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -141.2 140.56 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.644 1.178 . . . . 2.1099999999999999 108.203 165.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.12 122.98 15.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.101 1.36 . . . . 2.8999999999999999 108.852 -178.269 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.532 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 23.2 ptmt -83.1 140.38 32.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.323 0.86 . . . . 3.8300000000000001 113.323 -179.544 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.85 165.71 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.565 1.946 . . . . 2.2599999999999998 109.782 167.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.07 139.41 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.757 1.223 . . . . 2.8500000000000001 109.957 173.677 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 mt -138.32 130.07 15.84 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.612 1.965 . . . . 2.96 109.782 -167.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.37 144.74 37.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.601 2.2 . . . . 1.1599999999999999 111.051 176.661 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.4 t -79.95 118.59 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.862 0.839 . . . . 1.96 111.956 169.442 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 145.51 28.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.977 3.311 . . . . 3.4199999999999999 107.46 166.574 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.2 101.74 5.92 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.974 -1.079 . . . . 2.52 112.003 -161.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.262 1.025 . . . . 7.6500000000000004 112.705 -166.83 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.665 -0.495 . . . . 5.6200000000000001 109.665 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.59 176.71 29.88 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.386 0.993 . . . . 0.88 113.768 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -161.12 161.94 31.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.528 1.531 . . . . 1.6799999999999999 112.186 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.07 126.4 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.822 -0.807 . . . . 0.79000000000000004 108.822 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.01 117.84 30.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.112 1.365 . . . . 4.2199999999999998 109.013 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -74.59 -171.53 1.27 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.263 1.03 . . . . 2.8100000000000001 113.637 -170.218 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.11 167.64 2.73 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.311 1.845 . . . . 1.74 109.95 160.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.04 -6.91 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.123 2.548 . . . . 1.5800000000000001 113.088 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.39 169.19 21.19 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.109 1.338 . . . . 1.5900000000000001 113.109 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.41 -7.68 39.15 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 118.068 0.934 . . . . 1.6699999999999999 113.542 -0.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -128.55 167.53 16.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.182 1.393 . . . . 2.02 114.173 -170.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.85 -173.1 2.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.028 2.131 . . . . 0.56999999999999995 112.585 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.24 154.43 43.82 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.611 0.967 . . . . 0.82999999999999996 113.611 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.89 146.89 33.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.769 1.228 . . . . 0.72999999999999998 112.958 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -140.82 157.42 45.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.404 1.482 . . . . 1.8899999999999999 112.657 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -166.41 158.44 13.73 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.949 1.463 . . . . 1.6200000000000001 114.949 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.7 m -84.54 133.0 34.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.773 2.029 . . . . 1.4299999999999999 107.778 159.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.73 141.32 27.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.622 1.169 . . . . 2.5499999999999998 111.175 -167.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.31 153.07 23.0 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.002 0.742 . . . . 3.0699999999999998 113.002 -160.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -120.93 112.43 33.54 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.106 1.362 . . . . 1.0600000000000001 110.972 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.17 -9.06 10.67 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.858 2.372 . . . . 1.1699999999999999 113.666 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.01 168.88 52.55 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.177 0.894 . . . . 1.1499999999999999 113.665 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.55 -4.81 47.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.13 1.772 . . . . 2.79 112.823 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.68 160.34 38.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.046 1.738 . . . . 1.4199999999999999 109.949 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.87 156.42 30.92 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.919 2.413 . . . . 0.64000000000000001 111.902 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.94 150.41 21.96 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.556 0.742 . . . . 1.98 109.97 166.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -133.57 109.83 9.5 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.058 1.343 . . . . 3.3199999999999998 109.169 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 tp -91.17 112.8 24.86 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.706 2.402 . . . . 0.96999999999999997 108.519 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.58 -11.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.198 0.999 . . . . 0.77000000000000002 112.962 -169.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.65 -160.61 28.13 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 124.202 0.906 . . . . 0.56999999999999995 112.318 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.69 -178.29 6.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.5 1.12 . . . . 0.68999999999999995 110.618 164.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -155.41 135.94 13.35 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.052 -1.462 . . . . 5.3300000000000001 107.052 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -152.55 152.8 29.54 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.936 0.895 . . . . 0.76000000000000001 110.909 -163.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.45 -11.37 10.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.521 2.814 . . . . 0.87 113.707 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.324 0.8 OUTLIER -94.0 -4.01 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 114.1 1.148 . . . . 0.92000000000000004 114.1 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.29 158.74 44.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.677 1.191 . . . . 0.76000000000000001 112.04 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -98.67 -60.91 1.45 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 3.2999999999999998 109.806 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -84.39 134.44 34.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.373 1.069 . . . . 2.8399999999999999 109.34 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 p -147.97 136.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.649 1.979 . . . . 1.29 108.527 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -148.62 135.98 20.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.174 1.39 . . . . 1.99 110.458 -168.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -81.21 125.51 30.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.85 1.31 . . . . 0.96999999999999997 110.875 168.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.5 m170 -119.05 157.54 27.6 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.576 2.35 . . . . 0.68000000000000005 111.461 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -99.58 173.76 6.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.908 1.683 . . . . 2.02 110.272 164.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -127.99 130.25 48.06 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.961 -1.866 . . . . 1.1899999999999999 105.961 157.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -111.85 163.91 13.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.74 1.216 . . . . 2.6400000000000001 113.125 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -108.46 143.87 36.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.893 -1.048 . . . . 2.7799999999999998 108.24 146.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.1 136.34 10.89 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.331 1.053 . . . . 5.25 109.832 -175.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.43 148.25 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.146 0.578 . . . . 4.0 110.631 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.46 -87.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.118 1.367 . . . . 2.8700000000000001 109.305 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -75.41 34.75 0.11 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.902 2.081 . . . . 3.3599999999999999 111.456 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.52 -19.79 0.65 Allowed Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.272 -1.517 . . . . 1.97 113.827 -164.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -83.03 146.53 28.69 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.892 2.077 . . . . 2.6099999999999999 109.743 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -79.52 121.1 24.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.574 0.75 . . . . 3.75 111.412 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.1 t -112.64 148.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.653 1.981 . . . . 1.96 108.686 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.4 mtm -134.56 142.08 46.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.21 1.004 . . . . 3.5299999999999998 111.963 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.82 -177.61 44.07 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.616 1.103 . . . . 1.8300000000000001 113.078 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -107.55 159.13 16.67 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.903 1.281 . . . . 2.1699999999999999 112.643 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.92 155.42 10.84 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.44 1.496 . . . . 3.7200000000000002 111.158 171.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.9 Cg_endo -67.44 149.38 80.34 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.646 1.564 . . . . 0.92000000000000004 112.033 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -114.26 158.65 39.15 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.923 1.689 . . . . 1.21 109.565 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.62 -19.37 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.238 1.958 . . . . 1.51 112.63 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.2 p90 177.47 171.52 0.58 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.744 2.018 . . . . 2.2000000000000002 110.924 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mt -116.57 171.68 7.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.021 1.729 . . . . 1.0700000000000001 108.969 153.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -155.21 164.92 38.15 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.06 -1.025 . . . . 1.97 111.743 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.36 128.66 9.13 Favored Pre-proline 0 N--CA 1.466 0.365 0 C-N-CA 125.02 1.328 . . . . 1.0600000000000001 108.162 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.82 164.69 32.46 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.762 1.641 . . . . 0.97999999999999998 111.05 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.6 137.99 83.26 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.173 2.582 . . . . 1.1200000000000001 110.971 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt 66.31 0.93 1.86 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 1.8400000000000001 113.646 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.28 -179.06 45.5 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.746 2.117 . . . . 1.45 113.65 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -155.73 147.83 23.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.397 -1.901 . . . . 4.5099999999999998 111.355 -172.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.01 167.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.359 2.264 . . . . 1.6799999999999999 109.958 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.97 129.37 38.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.81 0.814 . . . . 4.2999999999999998 111.201 168.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -75.53 71.88 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.539 1.536 . . . . 1.0600000000000001 109.291 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -68.37 140.59 92.81 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.635 1.574 . . . . 3.02 111.697 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.7 -32.33 68.49 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.023 2.482 . . . . 1.51 112.928 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.42 51.56 4.53 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.851 0.75 . . . . 1.1899999999999999 111.311 163.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.65 -136.92 4.29 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.119 1.343 . . . . 2.6200000000000001 112.974 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -73.07 144.58 47.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.838 0.855 . . . . 2.02 112.167 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -171.04 174.22 4.77 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.322 1.049 . . . . 0.83999999999999997 109.762 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -101.62 131.82 47.62 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.107 0.563 . . . . 2.1099999999999999 110.518 166.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -90.76 141.66 28.57 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.538 0.735 . . . . 0.88 109.969 160.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.44 141.59 51.45 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.909 1.683 . . . . 1.6699999999999999 109.66 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -147.43 144.49 28.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.992 1.317 . . . . 2.0699999999999998 111.232 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.84 0.56 Allowed Glycine 0 N--CA 1.466 0.66 0 N-CA-C 109.202 -1.559 . . . . 2.3300000000000001 109.202 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.43 101.38 4.79 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.001 0.905 . . . . 0.93999999999999995 110.265 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -79.5 -4.73 52.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.32 0.859 . . . . 1.8500000000000001 113.32 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -126.39 142.51 43.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 126.715 2.006 . . . . 5.3200000000000003 108.585 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.14 151.6 72.58 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.655 1.57 . . . . 1.75 108.624 157.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.3 mt -120.86 132.0 54.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.098 0.951 . . . . 2.9300000000000002 112.122 -170.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 127.71 54.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.793 1.637 . . . . 3.3599999999999999 106.968 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 151.5 11.75 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.985 -1.072 . . . . 1.6399999999999999 113.329 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.88 39.03 94.83 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.554 -0.581 . . . . 1.8100000000000001 113.747 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -116.3 -166.52 1.16 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.617 -1.253 . . . . 2.71 107.617 154.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -126.08 159.08 33.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.79 0.805 . . . . 3.5800000000000001 111.913 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.24 116.58 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 125.702 1.601 . . . . 0.94999999999999996 107.273 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.95 134.43 47.2 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.712 -1.218 . . . . 2.9199999999999999 107.712 164.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.98 129.25 15.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.192 0.997 . . . . 1.54 111.13 -168.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.4 99.77 9.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.556 1.942 . . . . 2.04 110.353 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.8 mt -72.43 116.67 13.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.281 . . . . 1.1799999999999999 109.789 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.42 131.52 35.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.457 1.103 . . . . 0.59999999999999998 111.234 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -122.73 155.56 36.22 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.044 0.938 . . . . 1.8200000000000001 112.681 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.69 121.11 12.57 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 2.0600000000000001 112.852 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.71 -156.48 28.95 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.095 1.331 . . . . 3.1000000000000001 111.415 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.73 51.58 3.77 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.103 -0.832 . . . . 1.6399999999999999 114.8 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -125.05 137.79 54.21 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.518 1.659 . . . . 4.7400000000000002 111.136 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.61 136.77 19.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.294 1.838 . . . . 0.97999999999999998 106.992 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.9 mt -119.76 115.08 23.16 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.921 0.888 . . . . 1.6200000000000001 109.506 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -79.11 133.38 36.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.239 0.615 . . . . 2.4500000000000002 111.658 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.47 170.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.843 1.657 . . . . 1.3400000000000001 110.443 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.95 132.5 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.848 -1.167 . . . . 2.0899999999999999 107.848 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 mt -143.58 144.03 25.97 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.186 1.394 . . . . 1.6899999999999999 110.011 -168.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.88 152.37 57.84 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.831 3.021 . . . . 1.03 115.12 -172.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.4 t -83.67 107.43 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.293 2.237 . . . . 1.4099999999999999 109.881 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.95 136.55 36.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.541 1.936 . . . . 4.0099999999999998 108.83 160.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -105.82 135.79 46.62 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.897 0.379 . . . . 1.8999999999999999 110.319 163.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 130.49 3.516 . . . . 7.0 106.53 -161.678 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 113.252 0.834 . . . . 5.25 113.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.36 -173.95 34.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 126.389 1.947 . . . . 0.89000000000000001 112.36 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.7 p90 -155.26 140.88 17.94 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.135 1.374 . . . . 1.6499999999999999 110.509 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.08 136.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.333 1.053 . . . . 1.0600000000000001 109.633 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -24.46 31.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.934 1.694 . . . . 4.0999999999999996 114.962 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.34 174.24 0.26 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.015 2.126 . . . . 3.4199999999999999 115.138 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 m -174.73 174.46 0.92 Allowed Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.209 3.404 . . . . 1.75 107.737 151.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.17 -21.85 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.007 1.805 . . . . 2.3500000000000001 112.461 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.3 173.99 13.49 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.259 1.885 . . . . 1.77 111.92 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.79 -11.5 39.54 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 119.263 1.532 . . . . 2.0299999999999998 113.124 -5.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -122.26 168.74 11.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.479 . . . . 1.96 112.914 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.56 -175.72 4.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.569 2.348 . . . . 0.62 110.339 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.56 17.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.676 1.19 . . . . 0.85999999999999999 112.207 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 158.36 38.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 0.76000000000000001 113.424 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -147.23 154.16 40.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.007 1.723 . . . . 2.27 110.75 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.3 160.75 6.3 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.918 1.822 . . . . 1.71 115.918 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.9 m -91.72 105.36 17.66 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.28 2.632 . . . . 1.1200000000000001 109.178 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.6 142.02 28.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.724 1.61 . . . . 3.3199999999999998 110.471 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -109.32 155.77 20.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.149 0.58 . . . . 4.6900000000000004 111.893 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -134.06 110.04 11.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.391 -0.822 . . . . 1.05 109.057 155.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.91 -7.03 3.33 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.212 2.608 . . . . 0.92000000000000004 114.471 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 169.19 42.7 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.994 1.27 . . . . 1.1899999999999999 112.883 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -85.88 5.28 33.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.556 1.542 . . . . 3.9399999999999999 112.914 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.48 156.26 35.49 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.966 1.707 . . . . 2.6400000000000001 109.266 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.25 157.33 22.91 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.216 2.611 . . . . 0.83999999999999997 110.448 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.93 134.33 54.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.07 0.948 . . . . 2.23 110.656 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -126.54 111.06 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.701 1.201 . . . . 4.4100000000000001 110.347 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.06 136.78 32.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.279 1.832 . . . . 0.85999999999999999 108.862 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.42 -10.29 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.21 1.004 . . . . 0.53000000000000003 113.354 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.11 -164.57 35.22 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.447 1.022 . . . . 0.52000000000000002 111.968 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.64 -176.69 5.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.216 1.007 . . . . 0.81000000000000005 109.626 164.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mtm-85 -142.61 147.27 35.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.877 1.217 . . . . 6.04 108.934 163.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -142.9 154.52 62.2 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 125.07 1.348 . . . . 0.69999999999999996 109.018 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -20.0 27.97 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.058 1.838 . . . . 0.89000000000000001 112.707 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.326 3.2 m -92.84 15.87 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.709 1.003 . . . . 1.2 113.709 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.28 165.63 35.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.09 0.956 . . . . 0.82999999999999996 112.728 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.82 -71.83 0.75 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.557 1.543 . . . . 3.5099999999999998 108.004 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -79.2 103.77 9.37 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.991 -1.068 . . . . 3.4399999999999999 109.85 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.91 143.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.9 0.88 . . . . 2.1699999999999999 110.124 160.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.39 117.0 10.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.823 1.249 . . . . 2.2999999999999998 109.408 168.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.77 120.47 25.19 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.825 -1.172 . . . . 0.76000000000000001 110.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.1 m170 -105.19 152.03 23.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.75 112.567 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.37 172.14 10.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.721 1.609 . . . . 2.7999999999999998 110.451 161.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.8 m -151.63 111.85 4.11 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.021 1.328 . . . . 0.98999999999999999 108.396 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -129.08 160.02 34.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.069 1.348 . . . . 1.9199999999999999 112.383 -161.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -97.48 143.9 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.653 0.781 . . . . 3.3500000000000001 110.197 160.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -155.19 145.35 21.8 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.475 0.71 . . . . 5.5300000000000002 110.932 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -64.42 148.51 50.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.904 1.682 . . . . 3.8199999999999998 111.034 167.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.6 t -138.94 -88.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.667 1.587 . . . . 2.6600000000000001 108.614 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -77.81 44.97 0.48 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.197 2.199 . . . . 3.3999999999999999 110.319 170.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.69 -37.02 0.48 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 126.283 1.897 . . . . 2.1699999999999999 113.65 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -78.8 150.64 32.29 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.238 2.615 . . . . 2.5699999999999998 109.218 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -87.71 142.42 27.84 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.235 1.198 . . . . 3.3100000000000001 114.235 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.21 150.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.314 2.246 . . . . 1.8700000000000001 108.354 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.2 mmt -93.57 133.96 36.35 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.933 0.893 . . . . 2.8199999999999998 110.946 175.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.01 167.6 24.84 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 123.738 0.685 . . . . 0.94999999999999996 113.461 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.73 137.61 35.26 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.665 1.586 . . . . 2.1800000000000002 109.344 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -150.33 144.85 17.87 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.276 1.43 . . . . 3.7999999999999998 109.247 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 37.7 Cg_endo -65.65 142.38 70.47 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.965 1.777 . . . . 0.66000000000000003 110.773 169.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.39 154.38 47.6 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 126.074 1.749 . . . . 0.65000000000000002 110.606 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.96 -9.31 23.47 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.882 2.388 . . . . 0.90000000000000002 113.954 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -175.57 170.37 2.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.263 1.392 . . . . 2.3900000000000001 111.397 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 166.21 17.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.813 1.645 . . . . 0.68000000000000005 109.215 157.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.49 161.53 40.91 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.188 -0.945 . . . . 2.8900000000000001 113.034 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -148.3 142.67 16.62 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.726 1.21 . . . . 1.25 109.517 -166.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.8 16.61 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.475 2.117 . . . . 1.01 112.278 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.32 148.36 86.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.894 3.062 . . . . 1.05 112.211 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 64.89 -0.27 1.05 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.602 1.561 . . . . 2.3100000000000001 113.843 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.53 111.2 3.67 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.901 1.715 . . . . 0.89000000000000001 111.398 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.45 123.42 44.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.68 1.192 . . . . 4.1900000000000004 109.061 165.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.41 143.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.106 1.362 . . . . 2.0 111.796 -165.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -88.91 144.31 26.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.202 1.001 . . . . 3.2400000000000002 111.765 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.24 73.77 2.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.402 1.081 . . . . 1.3300000000000001 109.457 158.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -59.53 131.77 88.31 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.886 -1.054 . . . . 4.0099999999999998 111.111 173.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.43 -32.89 89.16 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.873 2.382 . . . . 1.4399999999999999 112.893 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.18 51.77 4.41 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.229 0.919 . . . . 1.73 112.328 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.04 -56.6 0.08 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.82 1.2 . . . . 1.49 114.209 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -155.47 141.62 18.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.055 1.742 . . . . 2.0899999999999999 111.411 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -163.08 176.32 10.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.008 -1.057 . . . . 0.78000000000000003 111.233 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.46 131.07 55.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.825 0.45 . . . . 1.79 110.949 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mmt -85.36 144.54 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.88 1.272 . . . . 1.02 110.759 154.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -124.05 129.02 50.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.204 1.802 . . . . 1.77 108.682 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -133.64 136.57 44.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.094 0.958 . . . . 2.0600000000000001 111.624 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.36 76.04 0.79 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.675 -1.37 . . . . 2.8599999999999999 109.675 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.2 mt -78.15 135.25 37.62 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.176 -1.046 . . . . 0.90000000000000002 108.176 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -80.51 -0.32 36.97 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.968 -1.082 . . . . 2.2200000000000002 112.264 -169.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -174.21 160.13 2.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.601 2.36 . . . . 6.79 110.156 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.62 146.73 55.64 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.48 2.12 . . . . 3.0 110.092 163.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -112.93 168.53 9.62 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.551 1.54 . . . . 2.8199999999999998 111.874 -172.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.39 137.48 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.658 1.183 . . . . 3.5099999999999998 111.862 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.86 129.47 41.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.785 -1.197 . . . . 2.3199999999999998 110.437 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 52.11 3.66 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 112.174 -0.37 . . . . 2.3399999999999999 112.174 -165.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -129.02 165.02 21.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.955 1.702 . . . . 3.6299999999999999 107.616 161.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.64 155.56 16.93 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.993 1.317 . . . . 5.5300000000000002 111.003 168.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.06 124.06 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 126.113 1.765 . . . . 0.85999999999999999 108.567 169.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.62 125.69 29.53 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.079 -0.712 . . . . 3.9300000000000002 109.079 161.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mt -126.67 125.42 41.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.991 0.916 . . . . 1.6599999999999999 111.81 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -105.06 94.7 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.78 1.232 . . . . 2.54 110.568 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.5 mt -65.67 123.36 19.51 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 1.53 110.446 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.8 mt -97.43 131.37 44.14 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.31 1.444 . . . . 0.79000000000000004 110.342 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -125.67 167.09 15.61 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.683 1.23 . . . . 2.29 111.566 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.76 166.47 10.92 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.993 -1.003 . . . . 3.0099999999999998 111.432 168.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.4 15.44 80.3 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.802 0.681 . . . . 4.29 114.802 173.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.62 6.16 89.33 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 118.427 1.113 . . . . 1.8500000000000001 113.767 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -79.29 138.38 37.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.903 1.352 . . . . 6.46 112.376 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.15 148.94 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.19 1.796 . . . . 1.4399999999999999 108.105 158.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.0 mt -124.15 125.28 44.2 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.573 1.549 . . . . 2.2999999999999998 108.4 172.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -87.68 133.31 33.85 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.761 0.824 . . . . 2.2599999999999998 111.651 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.29 127.45 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.835 1.254 . . . . 1.5600000000000001 113.23 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.88 135.48 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.8 1.24 . . . . 1.8100000000000001 111.56 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.9 mt -143.78 160.68 49.47 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 128.041 2.536 . . . . 2.1099999999999999 111.079 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -84.92 157.17 11.62 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.085 3.19 . . . . 0.96999999999999997 114.624 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -94.32 124.1 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.33 2.252 . . . . 1.0700000000000001 110.576 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.34 156.09 18.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.983 1.313 . . . . 3.25 109.044 156.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.83 81.51 4.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.366 -0.976 . . . . 2.25 108.366 161.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 115.761 -2.066 . . . . 6.5 115.486 -158.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 121.043 0.449 . . . . 6.3200000000000003 111.292 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.55 167.45 30.9 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.608 1.099 . . . . 1.05 114.476 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -152.22 143.13 23.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.781 1.232 . . . . 1.54 111.999 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.06 118.16 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 122.963 0.505 . . . . 1.0 109.676 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -85.72 96.45 9.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.293 1.037 . . . . 4.6600000000000001 110.405 -169.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.71 154.53 3.73 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.666 2.386 . . . . 2.1800000000000002 112.884 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.83 149.08 20.26 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 118.463 -0.78 . . . . 2.1499999999999999 109.668 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 56.68 5.6 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.415 2.743 . . . . 2.1600000000000001 109.281 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.79 -164.38 46.15 Favored Glycine 0 CA--C 1.541 1.677 0 O-C-N 121.482 -0.761 . . . . 2.0299999999999998 112.582 -168.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.54 -11.73 20.11 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 117.681 0.74 . . . . 2.46 111.331 -28.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -146.82 168.09 22.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.751 2.021 . . . . 2.1800000000000002 109.976 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 -177.34 6.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.535 1.534 . . . . 0.64000000000000001 111.819 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.81 156.69 43.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 0.76000000000000001 111.99 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.1 143.21 36.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.118 0.967 . . . . 0.72999999999999998 112.111 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -136.66 141.4 43.16 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.389 1.876 . . . . 2.1499999999999999 109.58 -172.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -165.22 147.33 7.81 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.331 1.975 . . . . 1.9399999999999999 116.331 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 m -99.54 129.77 45.73 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.569 1.548 . . . . 1.6599999999999999 108.786 169.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tp -130.69 162.95 28.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 4.1399999999999997 110.734 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.28 141.82 51.86 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.092 1.357 . . . . 3.1600000000000001 111.214 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -100.28 110.91 61.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.512 -0.921 . . . . 1.25 108.512 157.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.87 -15.37 3.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.364 2.709 . . . . 1.3 113.769 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.75 -176.27 51.37 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.045 0.838 . . . . 1.3700000000000001 113.23 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -105.33 12.97 31.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.707 1.603 . . . . 4.0700000000000003 111.437 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mt -113.8 156.37 43.83 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 126.957 2.103 . . . . 2.7200000000000002 109.132 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.72 158.33 24.8 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.991 2.461 . . . . 0.83999999999999997 109.926 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.3 130.56 42.93 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.56 1.144 . . . . 2.3799999999999999 109.73 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -117.26 115.61 25.62 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.864 1.266 . . . . 4.1500000000000004 110.422 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -94.63 117.14 29.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.537 2.335 . . . . 0.83999999999999997 108.68 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.77 -10.88 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.729 1.011 . . . . 0.57999999999999996 113.729 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.25 -163.17 31.66 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.664 -0.648 . . . . 0.40000000000000002 112.344 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.97 12.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.731 0.813 . . . . 0.65000000000000002 111.189 167.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -144.85 133.31 21.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.921 1.688 . . . . 7.0099999999999998 108.058 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -148.9 149.74 30.96 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.421 1.489 . . . . 0.72999999999999998 110.335 -166.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.1 -37.93 4.31 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.337 2.024 . . . . 1.03 112.157 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.273 2.6 m -84.79 3.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.907 1.447 . . . . 0.91000000000000003 114.907 -169.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -133.31 137.08 45.82 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.356 -1.465 . . . . 0.80000000000000004 112.23 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -76.11 -70.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.319 -1.363 . . . . 5.2300000000000004 107.319 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -84.92 143.32 29.08 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.266 2.226 . . . . 3.2200000000000002 109.37 169.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.75 131.81 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.359 1.864 . . . . 1.3300000000000001 107.932 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -142.94 128.68 19.3 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.234 1.414 . . . . 2.2400000000000002 109.493 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.87 121.42 24.82 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.367 1.079 . . . . 0.78000000000000003 110.454 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -112.36 158.38 19.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.019 2.128 . . . . 0.63 112.035 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.86 179.39 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.912 1.685 . . . . 2.02 110.909 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 m -135.22 106.23 6.65 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.195 1.398 . . . . 1.1499999999999999 107.274 163.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -107.0 152.06 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.706 1.202 . . . . 2.29 111.225 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -84.77 145.33 27.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.527 0.679 . . . . 3.96 110.27 166.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -148.14 160.17 43.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.558 1.543 . . . . 5.6600000000000001 110.333 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -84.57 148.12 26.65 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.528 0.731 . . . . 6.7000000000000002 109.393 164.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.95 -87.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.55 -1.648 . . . . 2.5099999999999998 106.55 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -77.68 43.96 0.43 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.999 2.52 . . . . 3.7999999999999998 110.809 170.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.9 -29.63 0.29 Allowed Glycine 0 N--CA 1.482 1.751 0 O-C-N 119.999 -1.688 . . . . 2.5 115.117 -171.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -69.71 132.22 45.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.828 2.051 . . . . 3.6499999999999999 109.853 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -83.46 102.18 11.9 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.904 -1.147 . . . . 5.46 107.904 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.11 155.26 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.516 1.926 . . . . 2.8399999999999999 110.823 -167.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.0 mtm -75.22 153.22 38.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.622 0.971 . . . . 4.4100000000000001 113.622 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.64 160.7 28.28 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.446 1.974 . . . . 1.1599999999999999 110.567 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -123.01 148.31 45.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.897 1.279 . . . . 1.8300000000000001 110.322 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -171.68 157.85 4.49 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 117.165 -1.398 . . . . 3.9900000000000002 111.223 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.4 Cg_endo -69.75 157.35 60.71 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.026 1.817 . . . . 0.58999999999999997 112.605 168.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.03 158.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 126.029 1.732 . . . . 0.67000000000000004 110.613 171.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.4 -11.67 24.75 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.918 2.412 . . . . 0.81000000000000005 113.577 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -179.05 162.24 1.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.307 1.843 . . . . 2.2400000000000002 110.192 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.99 172.85 6.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.471 1.909 . . . . 0.80000000000000004 108.756 156.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.04 170.17 23.14 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.837 -1.164 . . . . 2.5299999999999998 113.389 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.05 135.28 11.87 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 125.288 1.435 . . . . 0.93000000000000005 109.465 -167.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.05 168.32 24.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.15 1.9 . . . . 0.92000000000000004 110.688 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.58 148.59 92.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.082 2.521 . . . . 1.1000000000000001 111.95 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 68.39 -3.38 1.33 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.94 2.096 . . . . 1.78 114.48 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.29 117.93 5.18 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 126.204 1.859 . . . . 1.05 112.184 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 127.96 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.54 -0.83 . . . . 6.2300000000000004 110.264 159.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.05 165.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.568 1.547 . . . . 1.29 110.608 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.08 114.03 8.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.885 0.874 . . . . 3.6699999999999999 112.099 -163.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.25 67.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.848 2.059 . . . . 1.0700000000000001 109.379 165.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.44 143.56 98.73 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.996 1.719 . . . . 3.46 111.83 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.1 -61.17 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.172 3.248 . . . . 1.3600000000000001 112.668 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 102.32 2.05 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.802 -1.719 . . . . 1.53 108.802 162.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.99 -69.83 0.3 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.822 1.677 . . . . 1.22 112.662 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -155.71 139.19 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.946 1.699 . . . . 2.02 109.495 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -167.1 172.36 10.12 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.135 -0.978 . . . . 0.85999999999999999 109.598 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -103.66 141.5 35.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.415 0.552 . . . . 2.1800000000000002 110.225 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.7 mmt -89.17 139.29 30.63 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.858 0.863 . . . . 1.01 110.077 159.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -122.0 130.33 53.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.53 1.932 . . . . 1.9399999999999999 109.24 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -136.65 159.45 41.78 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.636 0.774 . . . . 2.2799999999999998 112.241 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.32 -57.08 3.28 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 126.54 2.019 . . . . 2.7999999999999998 113.672 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.1 mt 76.64 91.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 130.423 3.489 . . . . 1.1399999999999999 111.847 172.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -74.54 4.37 6.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.627 1.343 . . . . 2.4900000000000002 114.627 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -144.67 152.84 53.7 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 128.713 2.805 . . . . 6.3399999999999999 108.063 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.21 150.64 81.76 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.242 1.961 . . . . 2.2799999999999998 109.516 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.54 134.22 44.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.413 1.485 . . . . 2.9300000000000002 110.141 -170.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.41 101.49 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.029 0.919 . . . . 4.2800000000000002 109.37 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.64 130.73 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.211 -0.931 . . . . 2.5699999999999998 111.176 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.09 50.7 2.97 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.057 -0.519 . . . . 2.0800000000000001 112.923 -167.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -137.17 -167.28 2.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.077 1.351 . . . . 2.9399999999999999 109.899 159.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -130.55 153.44 48.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.4 1.08 . . . . 3.3799999999999999 108.742 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.8 115.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.606 1.162 . . . . 1.21 108.686 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -63.69 122.99 17.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.701 -1.591 . . . . 3.5899999999999999 109.327 160.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -129.72 116.52 18.91 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.711 0.767 . . . . 1.6699999999999999 110.917 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.32 96.47 9.04 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.833 1.653 . . . . 2.27 108.77 165.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.8 126.76 31.53 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.238 -0.914 . . . . 1.6899999999999999 109.091 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.35 136.86 37.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.929 1.292 . . . . 0.70999999999999996 111.056 -168.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -132.94 148.49 52.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.296 1.046 . . . . 2.5099999999999998 113.014 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.55 163.85 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.067 -0.97 . . . . 2.96 111.971 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.08 76.44 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.791 -0.568 . . . . 4.6600000000000001 113.575 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.01 63.71 3.2 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.553 1.073 . . . . 1.97 111.069 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -144.35 166.03 26.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.872 1.32 . . . . 3.73 112.755 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -170.78 147.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 128.234 2.614 . . . . 1.95 108.239 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.0 mt -134.62 118.72 17.51 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.052 1.341 . . . . 2.5899999999999999 108.703 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -86.19 125.08 33.28 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.353 -0.842 . . . . 2.1499999999999999 110.673 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.16 133.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.272 1.029 . . . . 1.74 108.691 166.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.92 136.96 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.849 -1.167 . . . . 1.9399999999999999 107.849 168.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -142.6 136.39 14.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.321 1.448 . . . . 2.0299999999999998 109.001 -170.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.09 154.05 75.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.323 3.349 . . . . 1.0 114.034 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.4 t -79.76 125.94 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 122.797 0.439 . . . . 1.1000000000000001 110.309 170.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.45 141.77 28.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.485 1.914 . . . . 3.3799999999999999 108.125 162.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.53 22.46 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.629 2.085 . . . . 2.79 116.629 -161.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.272 2.3 tmt_? . . . . . 0 N--CA 1.481 1.079 1 C-N-CA 132.063 4.145 . . . . 8.4900000000000002 113.789 171.737 . . . . . . . . 2 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 109.409 -0.589 . . . . 5.2999999999999998 109.409 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.94 175.79 22.42 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 119.08 0.855 . . . . 1.26 115.127 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 p90 -155.75 162.67 40.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.962 1.705 . . . . 2.1099999999999999 111.296 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.1 t -131.16 117.73 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.758 -0.589 . . . . 1.04 109.655 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.47 95.6 8.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.003 0.921 . . . . 6.1399999999999997 109.914 -171.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.93 145.88 55.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.867 1.667 . . . . 2.3700000000000001 112.709 -176.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.0 t -142.61 148.01 44.89 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.482 1.513 . . . . 2.71 107.747 162.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.59 48.31 1.57 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.599 3.533 . . . . 1.74 112.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.55 -173.11 55.16 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 121.346 -0.846 . . . . 1.51 112.419 -168.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.28 -21.45 8.91 Favored 'Cis proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.139 -1.192 . . . . 1.45 110.761 -24.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -121.84 165.72 15.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.813 2.045 . . . . 1.9099999999999999 111.81 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.33 -179.15 7.81 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.23 2.212 . . . . 0.70999999999999996 110.356 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.08 155.36 48.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.726 1.148 . . . . 0.80000000000000004 113.443 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.48 45.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.466 1.106 . . . . 0.70999999999999996 113.19 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -156.11 157.94 36.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.013 1.325 . . . . 2.3799999999999999 112.133 -158.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 178.93 149.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.15 1.537 . . . . 1.6100000000000001 115.15 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.2 m -85.0 135.08 34.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.347 1.859 . . . . 1.49 108.838 160.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 tp -136.29 153.16 51.26 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.841 1.257 . . . . 3.9100000000000001 109.693 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.56 134.17 28.46 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.601 -0.687 . . . . 4.3099999999999996 111.047 166.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.73 114.38 47.63 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.453 1.501 . . . . 1.0 110.444 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.69 -15.35 10.91 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.778 2.318 . . . . 1.1699999999999999 113.875 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.62 166.01 54.8 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 122.509 1.061 . . . . 1.1100000000000001 113.611 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -77.72 -17.63 57.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.173 2.189 . . . . 4.7699999999999996 112.281 162.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.01 156.02 60.71 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.479 1.512 . . . . 2.8199999999999998 111.752 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.6 155.26 9.03 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.014 3.143 . . . . 1.4299999999999999 110.73 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.67 145.74 50.03 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.592 1.557 . . . . 2.0499999999999998 110.432 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -142.45 108.97 5.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.619 1.167 . . . . 5.0099999999999998 111.719 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -94.37 114.73 26.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.098 2.159 . . . . 0.77000000000000002 109.629 -169.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 m -106.29 -11.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.109 1.364 . . . . 1.05 113.724 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.76 -167.61 39.52 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 121.604 -0.685 . . . . 0.71999999999999997 111.749 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.26 152.13 30.83 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.38 1.072 . . . . 1.47 110.598 166.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 -110.96 131.25 55.2 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.65 -1.611 . . . . 8.1999999999999993 106.65 -174.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -139.35 149.56 60.97 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.593 1.157 . . . . 0.58999999999999997 109.243 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.52 -21.19 19.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.988 2.459 . . . . 0.79000000000000004 113.069 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.333 2.5 m -90.93 9.64 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 114.607 1.336 . . . . 0.85999999999999999 114.607 -176.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.3 167.71 27.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.98 0.912 . . . . 0.90000000000000002 112.792 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -107.4 -77.15 0.6 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.654 1.582 . . . . 3.5499999999999998 109.068 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -75.53 105.24 6.45 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.799 -1.188 . . . . 3.52 109.74 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 p -79.56 143.16 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.13 0.972 . . . . 1.8600000000000001 110.456 158.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -136.29 134.19 37.73 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.53 1.532 . . . . 2.1699999999999999 108.48 161.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -86.43 124.79 33.15 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.628 1.558 . . . . 0.79000000000000004 110.882 167.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -116.15 164.72 14.07 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.842 2.057 . . . . 0.64000000000000001 112.43 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -114.63 -174.57 2.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.115 1.766 . . . . 1.96 111.606 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.1 m -138.25 114.5 10.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.161 -1.422 . . . . 1.24 107.161 155.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -90.8 160.01 15.99 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.315 1.046 . . . . 1.8899999999999999 111.593 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.4 mtm -92.08 148.48 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.319 0.648 . . . . 2.48 110.089 154.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -158.96 120.81 3.45 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.486 1.514 . . . . 6.0199999999999996 108.008 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.45 152.27 18.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.143 0.577 . . . . 4.8399999999999999 110.74 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.8 t -144.25 116.77 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.145 0.978 . . . . 3.75 108.637 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 61.84 17.92 9.29 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.483 1.513 . . . . 3.71 111.785 -168.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.22 74.19 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.9 1.238 . . . . 2.8900000000000001 113.972 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -77.46 137.14 38.5 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.889 1.345 . . . . 3.1200000000000001 108.972 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.97 137.62 58.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.599 -0.715 . . . . 4.4800000000000004 111.807 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 160.21 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.966 0.506 . . . . 2.0 110.418 164.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.1 mtm -133.81 156.31 48.25 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.528 1.531 . . . . 2.6499999999999999 110.233 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.37 163.49 33.46 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 123.376 0.512 . . . . 0.96999999999999997 112.914 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -103.59 166.97 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.753 1.221 . . . . 1.55 111.096 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -176.51 154.17 1.27 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 126.442 1.897 . . . . 3.71 110.34 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -70.98 153.72 63.22 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.123 1.882 . . . . 0.60999999999999999 111.685 167.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.31 156.22 53.08 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 126.208 1.803 . . . . 0.69999999999999996 110.602 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.08 -20.6 37.8 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.829 2.353 . . . . 0.72999999999999998 112.461 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -176.39 169.5 2.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.914 2.085 . . . . 2.2599999999999998 110.755 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.63 170.53 8.03 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.343 1.457 . . . . 0.81000000000000005 109.598 154.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -139.21 166.81 23.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.189 0.519 . . . . 2.5299999999999998 110.86 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.59 120.62 5.19 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.15 1.38 . . . . 1.1599999999999999 107.734 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.87 164.74 32.87 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.677 1.584 . . . . 1.0900000000000001 110.864 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.19 138.46 72.32 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.38 2.72 . . . . 1.0 111.368 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 67.0 -0.37 1.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.563 1.545 . . . . 1.8600000000000001 113.415 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 117.37 4.5 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 127.382 2.42 . . . . 1.3100000000000001 112.071 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -79.77 133.12 36.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.75 -1.225 . . . . 5.6100000000000003 110.923 163.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.85 166.2 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.175 2.19 . . . . 2.0800000000000001 110.088 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.15 110.38 2.31 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.699 0.799 . . . . 4.3099999999999996 109.424 -168.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.09 75.64 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.131 1.372 . . . . 1.1599999999999999 108.004 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' A' ' 78' ' ' LYS . 15.8 ptpt -69.34 153.23 96.06 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 127.894 2.478 . . . . 2.77 113.555 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.39 -41.92 24.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.655 2.904 . . . . 2.8700000000000001 114.092 -162.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.33 128.28 9.52 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.984 -2.046 . . . . 2.2400000000000002 107.984 152.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.08 -143.42 14.85 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.072 1.32 . . . . 2.9199999999999999 111.393 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -73.21 138.7 45.78 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.848 -0.795 . . . . 2.0699999999999998 111.537 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -161.28 158.3 26.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.454 1.102 . . . . 0.93000000000000005 109.433 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -87.59 135.2 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.973 -0.751 . . . . 2.1000000000000001 108.973 160.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.55 120.34 41.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.549 1.54 . . . . 1.1799999999999999 108.077 168.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.63 142.68 35.89 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.272 1.029 . . . . 3.3300000000000001 110.467 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.35 135.74 24.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.745 1.618 . . . . 2.1200000000000001 111.543 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.07 81.84 0.58 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.714 -0.954 . . . . 2.6600000000000001 110.714 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.16 100.79 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.921 0.867 . . . . 1.04 110.459 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -86.75 10.5 15.65 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.534 1.309 . . . . 2.0099999999999998 114.534 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -145.14 166.29 18.53 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 127.349 2.259 . . . . 4.9299999999999997 109.128 167.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.19 -176.73 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.851 1.7 . . . . 2.3500000000000001 110.278 151.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -176.5 59.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.797 2.439 . . . . 3.1000000000000001 107.781 -163.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.91 151.25 30.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 5.8700000000000001 113.031 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.38 120.22 8.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.56 -1.2 . . . . 1.5900000000000001 108.455 156.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.23 17.46 46.57 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.107 -1.385 . . . . 1.9299999999999999 114.808 -170.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.84 167.25 10.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.733 1.766 . . . . 3.2799999999999998 107.779 151.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -116.22 147.49 41.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.823 0.849 . . . . 3.4900000000000002 109.163 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.79 116.86 51.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.18 1.792 . . . . 0.93000000000000005 108.665 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.36 129.37 39.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.174 -1.047 . . . . 3.1400000000000001 108.174 156.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.39 126.56 42.66 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.595 0.758 . . . . 1.8100000000000001 110.898 168.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.95 94.13 5.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.215 1.806 . . . . 2.7000000000000002 109.912 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.39 118.6 8.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.275 1.43 . . . . 1.1399999999999999 110.568 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.2 mt -92.41 127.7 38.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.322 1.449 . . . . 0.81999999999999995 110.821 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.12 133.79 50.33 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.815 1.293 . . . . 2.3799999999999999 113.76 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.06 53.59 2.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.965 1.706 . . . . 2.2400000000000002 112.383 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -151.5 26.49 0.96 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.682 2.087 . . . . 5.0700000000000003 113.557 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.98 50.59 45.64 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 124.132 0.873 . . . . 2.4199999999999999 111.368 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -149.73 160.56 43.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.035 1.734 . . . . 3.5800000000000001 112.832 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -162.81 130.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 129.149 2.98 . . . . 1.4199999999999999 108.51 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.95 121.01 36.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 2.5699999999999998 109.35 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.18 134.56 34.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.901 1.074 . . . . 2.7000000000000002 113.901 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.62 163.67 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.375 1.47 . . . . 1.8899999999999999 109.42 164.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.09 134.88 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.975 -1.491 . . . . 1.9299999999999999 106.975 164.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.8 mt -135.62 148.0 63.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 126.239 1.815 . . . . 1.98 108.594 -172.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.87 163.32 33.97 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.511 2.808 . . . . 1.3200000000000001 111.904 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -102.27 118.75 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.781 0.832 . . . . 1.5600000000000001 110.802 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -95.36 140.63 29.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.841 2.456 . . . . 4.96 109.189 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.56 -176.66 5.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.456 -1.403 . . . . 2.7200000000000002 111.53 164.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 126.566 1.946 . . . . 11.390000000000001 116.108 -170.767 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 13.3 tt0 . . . . . 0 CA--C 1.547 0.847 0 CA-C-O 120.999 0.428 . . . . 6.3300000000000001 111.377 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -93.97 169.92 30.01 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 125.253 1.406 . . . . 1.26 116.354 -174.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -155.05 133.91 12.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.668 1.587 . . . . 1.8200000000000001 111.264 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.97 122.94 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.784 -1.191 . . . . 1.1499999999999999 107.784 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -103.8 87.33 2.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.693 0.797 . . . . 4.4699999999999998 110.127 -161.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.58 144.05 38.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.909 2.083 . . . . 2.1400000000000001 111.389 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -138.32 153.36 72.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.513 1.125 . . . . 2.1800000000000002 109.6 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -65.71 -9.59 23.38 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.977 2.452 . . . . 1.72 113.195 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.71 177.83 18.44 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.463 1.03 . . . . 1.55 113.836 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 -7.77 32.89 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 117.68 0.74 . . . . 1.3999999999999999 113.105 -4.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -128.47 160.61 31.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.335 1.054 . . . . 3.2799999999999998 112.559 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.98 -174.21 4.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.775 1.63 . . . . 0.56999999999999995 111.916 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.22 154.62 49.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.888 0.875 . . . . 0.90000000000000002 112.978 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.15 146.27 50.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.083 0.953 . . . . 0.95999999999999996 112.257 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -143.87 156.52 44.49 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.356 1.863 . . . . 2.2799999999999998 110.703 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -168.46 160.21 10.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.346 1.058 . . . . 2.1299999999999999 113.748 -176.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.4 m -81.9 147.8 29.1 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.048 1.339 . . . . 2.02 108.558 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -155.2 131.65 10.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.157 0.983 . . . . 2.6699999999999999 111.507 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -113.32 145.16 41.53 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.654 1.981 . . . . 3.7200000000000002 112.003 173.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -95.14 97.31 2.53 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 114.372 -1.285 . . . . 1.25 109.652 155.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.46 -8.22 18.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.25 1.967 . . . . 1.1200000000000001 112.939 173.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.17 176.49 50.35 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 124.401 1.001 . . . . 1.1100000000000001 113.606 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.37 -5.42 27.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.737 2.015 . . . . 2.7000000000000002 113.0 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 160.33 44.02 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.84 2.056 . . . . 1.48 109.7 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 158.73 31.05 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.859 2.372 . . . . 0.77000000000000002 112.877 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.19 146.63 28.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.72 1.208 . . . . 1.8500000000000001 110.197 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -131.82 112.38 12.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.934 1.294 . . . . 3.5899999999999999 109.844 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -97.91 115.6 28.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.017 2.527 . . . . 0.77000000000000002 108.751 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.92 -9.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.448 1.099 . . . . 0.55000000000000004 113.116 -166.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.87 -168.86 41.02 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.535 1.064 . . . . 0.44 111.841 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.824 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -146.89 -178.62 6.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.894 1.278 . . . . 0.69999999999999996 110.848 172.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 7.0 ttp85 -151.34 139.97 20.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.372 -2.455 . . . . 7.7699999999999996 104.372 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -147.37 155.4 46.08 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.055 -1.091 . . . . 0.63 108.055 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.39 -29.93 24.81 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.486 2.124 . . . . 0.79000000000000004 113.19 171.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -85.36 -19.98 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.188 1.181 . . . . 1.1200000000000001 114.188 -169.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.84 159.03 22.05 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.21 1.004 . . . . 0.75 112.909 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.441 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 11.0 tp10 -98.11 -91.96 0.26 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.183 0.993 . . . . 3.04 111.202 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -78.66 110.49 13.84 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 121.079 -1.013 . . . . 3.8900000000000001 108.736 -172.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -79.61 142.31 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 124.565 1.146 . . . . 2.2200000000000002 111.253 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -142.05 128.49 20.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.211 1.004 . . . . 2.8199999999999998 109.75 164.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -80.41 116.46 20.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.299 1.047 . . . . 0.75 110.476 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 15.5 m170 -107.96 155.13 20.66 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.509 1.524 . . . . 0.71999999999999997 111.876 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.67 -171.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.142 1.777 . . . . 2.1800000000000002 110.432 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -146.45 114.09 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.888 -1.132 . . . . 1.0600000000000001 108.206 163.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -103.33 174.1 6.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.282 1.433 . . . . 1.8999999999999999 111.989 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -118.16 154.41 32.21 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.267 1.427 . . . . 2.9700000000000002 110.823 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -155.87 164.35 38.62 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.732 1.613 . . . . 6.46 111.731 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -85.74 142.63 28.86 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.529 0.732 . . . . 4.1600000000000001 110.513 162.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.34 -96.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.988 -0.745 . . . . 2.6600000000000001 108.988 163.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -76.68 37.41 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.972 2.109 . . . . 3.7200000000000002 111.919 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.25 0.44 4.49 Favored Glycine 0 CA--C 1.542 1.738 0 O-C-N 120.388 -1.445 . . . . 2.1400000000000001 113.463 -159.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -95.47 141.32 29.15 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.241 2.616 . . . . 3.1400000000000001 110.17 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -73.03 136.88 45.09 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.565 -0.743 . . . . 5.0899999999999999 109.821 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -139.78 143.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.647 1.179 . . . . 1.6799999999999999 109.5 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -114.56 145.66 41.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.753 1.221 . . . . 2.8199999999999998 111.28 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.36 168.87 34.26 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 123.794 0.711 . . . . 1.0700000000000001 113.547 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -103.17 161.1 14.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.93 1.292 . . . . 1.8 112.416 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -167.14 154.45 8.39 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.289 1.835 . . . . 3.4900000000000002 110.071 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 41.0 Cg_endo -69.01 150.03 72.3 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.685 2.257 . . . . 1.05 111.458 167.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.11 158.43 41.01 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.955 1.702 . . . . 0.81000000000000005 110.459 169.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.84 -16.9 41.93 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.659 2.24 . . . . 0.91000000000000003 112.937 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 177.49 163.43 0.56 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.951 2.1 . . . . 1.9399999999999999 109.756 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mt -105.22 170.82 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.312 1.445 . . . . 0.78000000000000003 109.638 155.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.15 158.06 39.82 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.189 -0.944 . . . . 2.4399999999999999 111.813 170.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.45 128.31 13.73 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.461 1.504 . . . . 0.81000000000000005 108.863 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.01 162.67 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.532 2.155 . . . . 0.83999999999999997 111.522 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.04 139.47 87.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.704 2.936 . . . . 0.91000000000000003 112.639 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt 69.13 2.83 3.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.158 2.183 . . . . 1.8300000000000001 114.301 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.42 144.13 16.97 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 126.989 2.233 . . . . 1.1899999999999999 109.645 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -117.24 150.65 38.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.978 1.311 . . . . 3.8700000000000001 112.714 166.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.65 168.26 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.324 1.85 . . . . 1.5800000000000001 110.677 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -135.07 132.88 38.71 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.199 -1.408 . . . . 4.5099999999999998 107.199 162.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.59 77.39 1.99 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.156 1.455 . . . . 1.0600000000000001 111.356 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -64.25 123.78 83.55 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 117.575 -1.202 . . . . 4.3600000000000003 111.452 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -47.87 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.844 3.696 . . . . 1.71 114.606 -171.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 56.86 4.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.566 1.079 . . . . 1.3500000000000001 111.991 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.86 -53.86 0.05 OUTLIER Glycine 0 N--CA 1.466 0.635 0 C-N-CA 126.097 1.808 . . . . 1.53 112.781 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -152.93 140.45 19.76 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.925 2.09 . . . . 2.3500000000000001 111.223 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -166.58 172.35 10.8 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.857 -1.152 . . . . 0.81000000000000005 111.784 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 61.1 m-85 -105.05 126.69 52.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.012 0.925 . . . . 1.8899999999999999 111.032 168.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.5 mmt -86.65 137.56 32.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.794 1.238 . . . . 0.83999999999999997 111.42 167.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.7 mt -115.35 88.77 2.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.791 1.636 . . . . 1.78 109.261 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -86.92 101.6 13.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.555 1.542 . . . . 2.2000000000000002 110.599 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.5 133.03 4.83 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.347 0.975 . . . . 3.0699999999999998 110.779 -173.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.0 mt -112.98 112.55 24.08 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.374 1.087 . . . . 1.04 109.439 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.441 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 2.3 pttm -90.54 -9.57 46.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.198 1.184 . . . . 1.9199999999999999 114.198 -172.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.7 mmt-85 -146.45 150.91 42.18 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.567 1.547 . . . . 8.3499999999999996 109.389 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.1 174.72 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.393 2.729 . . . . 2.4700000000000002 111.432 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -176.42 158.08 1.77 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.346 1.858 . . . . 2.6699999999999999 109.355 -160.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.33 178.17 7.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.025 1.73 . . . . 3.8500000000000001 112.219 174.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.4 133.99 15.53 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.925 1.29 . . . . 1.8899999999999999 112.939 165.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.93 -0.3 89.5 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.301 -1.277 . . . . 2.1600000000000001 115.268 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -77.83 167.41 21.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.863 1.331 . . . . 3.9199999999999999 111.861 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.14 152.96 20.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.306 -1.315 . . . . 3.79 110.525 162.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.8 t -139.84 126.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 126.148 1.779 . . . . 1.51 109.049 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.31 142.35 57.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.599 -0.519 . . . . 3.6000000000000001 109.599 164.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.824 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.3 tt -141.05 127.37 19.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.52 1.152 . . . . 1.6499999999999999 111.987 157.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.428 ' N ' HD23 ' A' ' 101' ' ' LEU . 1.5 m-20 -98.94 114.63 27.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.614 1.965 . . . . 2.2000000000000002 109.935 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.54 125.7 29.92 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.546 -0.721 . . . . 2.3900000000000001 109.816 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt -98.1 128.66 44.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.089 0.956 . . . . 0.62 109.879 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.28 156.78 31.77 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.015 0.926 . . . . 2.0 112.024 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.81 143.34 57.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.953 0.501 . . . . 2.1400000000000001 111.039 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -168.27 53.53 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.0 -0.84 . . . . 2.9399999999999999 111.0 -164.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.45 40.59 2.21 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.806 -0.82 . . . . 1.74 114.379 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -115.84 122.0 44.07 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.047 1.423 . . . . 4.4299999999999997 112.529 -173.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.45 135.49 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.424 1.49 . . . . 1.0700000000000001 108.466 161.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.5 mt -129.81 128.58 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.587 1.155 . . . . 1.5700000000000001 109.204 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -88.34 134.8 33.72 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.87 0.868 . . . . 2.3100000000000001 112.656 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.32 167.37 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.801 0.84 . . . . 1.53 110.514 153.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.74 141.51 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.853 -1.536 . . . . 2.2000000000000002 106.853 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.2 mt -137.44 151.97 72.22 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.632 1.573 . . . . 1.78 110.133 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.71 155.5 44.34 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.627 2.885 . . . . 1.1499999999999999 112.036 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.79 123.34 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.083 0.953 . . . . 1.01 110.823 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.6 149.19 22.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.828 1.651 . . . . 3.4399999999999999 109.233 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.0 23.09 11.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 113.927 1.084 . . . . 2.21 113.927 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.384 1.473 . . . . 7.1500000000000004 112.662 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 109.362 -0.607 . . . . 5.0300000000000002 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.75 157.48 27.42 Favored Glycine 0 N--CA 1.469 0.854 0 O-C-N 120.707 -1.246 . . . . 1.51 115.095 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -136.06 144.63 45.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.904 1.281 . . . . 1.72 111.966 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.8 t -102.28 136.86 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.718 -1.216 . . . . 0.88 107.718 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -104.17 106.62 17.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.156 0.982 . . . . 3.7000000000000002 110.187 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.36 147.86 29.72 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.085 1.754 . . . . 2.54 112.401 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -150.95 158.86 34.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.707 1.603 . . . . 1.79 109.805 162.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.43 -15.33 31.11 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.161 2.574 . . . . 1.6699999999999999 113.497 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.4 170.24 14.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.529 1.062 . . . . 1.73 113.0 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.06 -5.56 15.82 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 118.215 1.008 . . . . 1.8899999999999999 113.025 -3.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -122.69 170.06 10.43 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.243 1.817 . . . . 2.2200000000000002 113.997 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.52 -177.21 5.47 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.138 2.175 . . . . 0.79000000000000004 111.319 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.36 154.25 51.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.159 0.89 . . . . 0.89000000000000001 112.19 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.53 157.16 43.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.029 0.918 . . . . 0.71999999999999997 112.806 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -149.62 161.85 41.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.46 1.504 . . . . 2.02 110.356 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -162.5 159.26 24.72 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 112.854 0.687 . . . . 1.49 112.854 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.0 m -83.5 119.65 24.95 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.403 -1.332 . . . . 1.21 107.403 150.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.83 134.52 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 2.5099999999999998 107.452 166.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 6.4 mt-10 -128.39 121.77 29.85 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.957 0.903 . . . . 3.52 110.125 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -95.49 111.94 57.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.308 1.043 . . . . 1.2 109.974 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -86.44 -12.22 5.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.263 2.642 . . . . 0.91000000000000003 113.711 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.36 160.57 42.15 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.108 0.861 . . . . 1.3 112.488 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -90.62 6.78 42.41 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.029 1.732 . . . . 2.9399999999999999 113.616 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.75 157.97 53.16 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.01 1.724 . . . . 1.3400000000000001 110.595 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.99 160.52 30.29 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.229 2.619 . . . . 0.77000000000000002 111.935 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -124.5 124.41 42.22 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.718 1.207 . . . . 2.1000000000000001 111.547 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -118.75 112.0 19.2 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.217 1.407 . . . . 4.0099999999999998 112.791 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.3 tp -100.03 110.23 22.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.897 2.479 . . . . 0.85999999999999999 109.951 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -98.12 -11.94 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.859 1.664 . . . . 0.97999999999999998 112.954 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.5 -159.82 30.79 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 119.097 0.862 . . . . 0.54000000000000004 113.556 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.45 -171.13 3.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.866 1.267 . . . . 1.0 111.164 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -166.43 124.46 1.42 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.674 -1.232 . . . . 5.3600000000000003 107.674 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -138.35 162.08 55.5 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.989 1.316 . . . . 0.89000000000000001 109.494 -167.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.2 -22.71 3.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.636 2.891 . . . . 0.81999999999999995 113.989 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 2.6 m -86.93 -0.77 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 114.393 1.257 . . . . 1.1699999999999999 114.393 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.7 168.19 27.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.089 2.156 . . . . 1.0800000000000001 109.867 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -106.28 -79.22 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.539 1.063 . . . . 3.79 110.737 171.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -75.27 105.31 6.23 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 120.917 -1.115 . . . . 3.25 110.082 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.6 137.69 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.094 1.358 . . . . 1.27 111.262 171.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -132.17 129.49 39.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.239 1.816 . . . . 2.0099999999999998 109.137 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.79 117.15 22.48 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.538 1.161 . . . . 0.75 110.953 168.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 20.2 m170 -105.01 152.63 22.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.197 1.799 . . . . 0.56999999999999995 112.032 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.66 172.7 8.09 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.613 1.165 . . . . 1.9399999999999999 110.228 161.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.565 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 53.0 m -149.05 102.32 3.24 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.392 1.477 . . . . 1.3100000000000001 107.487 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -105.6 162.92 13.08 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.174 1.79 . . . . 2.3900000000000001 112.49 -164.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -102.91 151.1 22.84 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.948 -0.569 . . . . 2.7599999999999998 110.777 151.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -158.97 145.06 16.69 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.754 1.622 . . . . 5.0899999999999999 109.873 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.31 146.86 23.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.258 0.551 . . . . 4.3300000000000001 111.287 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.24 135.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.384 1.874 . . . . 3.2400000000000002 109.309 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 60.13 20.14 9.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.386 1.075 . . . . 4.2199999999999998 112.185 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.96 -3.81 68.89 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.894 1.235 . . . . 2.3100000000000001 113.959 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -99.44 146.24 26.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.156 1.782 . . . . 3.3700000000000001 110.407 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -77.2 131.03 38.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.834 -0.541 . . . . 4.0099999999999998 110.53 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -128.6 153.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.909 1.684 . . . . 1.95 108.841 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.4 mtm -121.03 146.68 46.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.916 . . . . 2.96 110.816 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.58 -177.24 31.48 Favored Glycine 0 N--CA 1.468 0.829 0 C-N-CA 124.346 0.974 . . . . 0.97999999999999998 113.081 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.11 162.0 34.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.24 1.416 . . . . 2.2999999999999998 110.655 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -171.45 151.85 3.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.147 1.379 . . . . 3.6099999999999999 111.45 172.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 35.6 Cg_endo -65.54 146.69 85.46 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.494 2.129 . . . . 0.73999999999999999 111.803 166.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.49 155.79 51.77 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.922 1.689 . . . . 0.56999999999999995 110.237 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.31 -18.62 44.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.674 2.25 . . . . 0.69999999999999996 112.637 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -179.1 167.22 1.58 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 126.676 1.99 . . . . 2.25 110.903 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.69 168.28 9.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.069 1.348 . . . . 0.73999999999999999 109.468 154.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -151.96 161.99 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.822 0.675 . . . . 2.77 112.822 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.29 134.78 24.43 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.952 1.701 . . . . 0.88 108.564 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.71 164.05 32.82 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.062 1.841 . . . . 0.89000000000000001 111.289 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.39 147.52 93.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.094 2.529 . . . . 0.96999999999999997 111.663 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt 68.12 -0.61 2.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.325 1.85 . . . . 1.3100000000000001 113.508 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.69 127.58 9.04 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 127.679 2.561 . . . . 1.0 111.646 -170.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 9.2 ptp180 -98.22 134.61 41.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.974 1.31 . . . . 6.0199999999999996 112.465 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.35 136.29 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.043 . . . . 1.3100000000000001 111.202 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.84 115.68 31.06 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.555 1.542 . . . . 3.3799999999999999 110.352 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -68.15 77.02 0.24 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.746 2.019 . . . . 1.0900000000000001 109.95 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -74.05 138.11 75.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.293 1.437 . . . . 3.3999999999999999 111.773 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.49 -43.33 59.18 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.08 3.187 . . . . 1.1799999999999999 112.757 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.29 89.71 1.11 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.243 -1.543 . . . . 1.27 109.243 161.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.53 -76.2 0.26 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.909 1.719 . . . . 1.25 113.589 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -154.74 142.4 19.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.437 1.895 . . . . 1.98 111.163 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -162.06 167.95 23.49 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.409 -0.807 . . . . 0.93000000000000005 111.692 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.37 127.95 46.55 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.665 0.786 . . . . 1.8500000000000001 110.186 168.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.8 mmt -91.44 132.8 35.98 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.15 0.98 . . . . 0.97999999999999998 110.068 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.7 147.47 35.51 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.612 1.165 . . . . 2.9399999999999999 110.609 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mt -146.43 160.81 41.59 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.135 2.174 . . . . 2.3199999999999998 110.175 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.46 57.61 11.06 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-O 118.917 -0.935 . . . . 2.54 111.152 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 mt -66.98 100.13 0.71 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.382 1.091 . . . . 0.96999999999999997 112.054 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -71.12 -15.08 62.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.452 0.908 . . . . 1.72 113.452 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -128.42 147.0 62.05 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.986 2.114 . . . . 5.7599999999999998 110.95 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.01 145.15 35.17 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.246 1.964 . . . . 1.8999999999999999 108.938 149.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 163.88 35.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.424 1.89 . . . . 2.4300000000000002 111.334 -168.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.01 168.16 19.57 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 118.94 2.941 . . . . 6.9900000000000002 118.94 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.37 133.94 23.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.412 1.885 . . . . 1.72 112.406 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 2.34 88.45 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.988 -1.451 . . . . 2.2799999999999998 114.727 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.69 159.84 23.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.788 1.794 . . . . 2.8900000000000001 111.333 170.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -108.66 128.18 54.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.492 1.917 . . . . 3.6299999999999999 109.13 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.41 103.72 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.574 1.15 . . . . 0.90000000000000002 109.545 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -63.25 126.94 29.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.579 -0.897 . . . . 2.9700000000000002 108.579 157.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.9 144.92 27.19 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.248 -0.907 . . . . 1.8700000000000001 110.501 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -94.03 138.64 31.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.487 2.715 . . . . 3.5899999999999999 110.156 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.8 mt -110.77 125.46 53.57 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.397 2.279 . . . . 1.28 109.908 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.2 mt -98.59 124.15 43.2 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.883 0.873 . . . . 0.73999999999999999 111.633 -170.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.76 141.82 49.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.242 1.201 . . . . 1.99 114.242 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.65 88.68 0.71 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.879 1.272 . . . . 2.4199999999999999 111.145 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.74 67.57 0.12 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.051 1.31 . . . . 4.0199999999999996 113.165 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.3 17.41 72.26 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 116.59 1.396 . . . . 1.55 116.59 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.04 114.22 20.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.038 1.419 . . . . 3.6600000000000001 112.005 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.37 136.59 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.835 2.454 . . . . 2.46 105.863 146.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.4 mt -144.92 119.63 9.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.198 0.999 . . . . 2.0099999999999998 109.569 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -90.27 146.6 24.1 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.007 1.114 . . . . 4.1500000000000004 114.007 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.6 m -135.17 152.18 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.352 1.861 . . . . 1.29 110.034 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.3 p -106.56 132.36 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.132 0.973 . . . . 1.55 109.553 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.9 mt -135.07 134.95 22.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.428 1.491 . . . . 1.8200000000000001 110.239 -171.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.62 151.28 79.55 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.984 2.456 . . . . 0.94999999999999996 113.5 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.99 119.75 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.886 1.275 . . . . 0.93999999999999995 110.873 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -90.32 149.37 22.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.872 2.069 . . . . 3.5499999999999998 108.892 156.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.25 4.66 4.06 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 116.222 1.934 . . . . 3.0699999999999998 116.222 -155.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.784 1.634 . . . . 7.5300000000000002 112.542 -168.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 107.559 -1.274 . . . . 5.9000000000000004 107.559 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.42 137.11 9.21 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 120.961 1.71 . . . . 1.8799999999999999 114.202 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -128.1 127.07 42.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.473 1.13 . . . . 2.02 111.957 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.74 95.21 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.81 -1.552 . . . . 1.52 106.81 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.42 105.82 9.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.575 1.178 . . . . 3.3100000000000001 110.238 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -74.03 159.81 32.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.631 1.572 . . . . 2.46 112.55 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.416 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 75.6 m -149.71 159.25 36.45 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.29 1.836 . . . . 2.7999999999999998 110.691 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.47 -2.86 12.4 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.369 2.712 . . . . 1.75 114.879 -171.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 167.61 27.95 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.33 0.967 . . . . 1.3300000000000001 112.83 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.82 -2.65 18.35 Favored 'Cis proline' 0 CA--C 1.541 0.833 0 CA-C-N 118.579 1.19 . . . . 1.74 112.91 -4.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.39 169.84 13.81 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.047 1.739 . . . . 2.23 113.791 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.22 171.81 18.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.377 2.271 . . . . 0.90000000000000002 111.586 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.96 120.45 31.62 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.761 0.824 . . . . 1.1399999999999999 110.668 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.02 32.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.567 0.747 . . . . 0.79000000000000004 111.83 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.88 162.92 31.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.395 1.478 . . . . 2.04 111.137 -174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.07 143.6 3.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 115.635 1.717 . . . . 1.6299999999999999 115.635 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -69.96 87.88 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.205 -1.035 . . . . 1.27 108.205 160.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 tt -75.27 143.55 42.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.928 -0.768 . . . . 2.9300000000000002 108.928 169.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -125.98 143.45 51.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.52 0.676 . . . . 3.27 112.044 170.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.67 100.9 13.54 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.99 -1.005 . . . . 0.97999999999999998 109.193 161.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.96 -7.77 15.44 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.587 2.192 . . . . 1.1699999999999999 112.624 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.56 179.73 51.46 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.802 1.192 . . . . 1.24 113.486 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.98 -3.18 20.4 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.272 1.829 . . . . 3.04 113.044 -171.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.02 162.67 28.35 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.367 1.867 . . . . 1.3300000000000001 109.682 167.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.34 154.29 21.53 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.832 2.355 . . . . 1.04 112.672 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.0 mt -104.05 126.88 51.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.016 0.926 . . . . 2.0 110.832 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.57 109.02 20.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.03 -0.986 . . . . 3.2999999999999998 110.304 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.2 tp -95.14 120.58 35.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.736 2.014 . . . . 0.81000000000000005 108.598 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.01 -14.72 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.684 0.794 . . . . 0.59999999999999998 112.453 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.49 -167.95 40.13 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 121.789 0.661 . . . . 0.40000000000000002 113.139 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.52 176.9 8.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 0.80000000000000004 109.393 159.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -157.43 145.41 19.03 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 106.425 -1.694 . . . . 6.4900000000000002 106.425 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -149.13 155.27 40.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.359 1.064 . . . . 0.84999999999999998 108.149 -164.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.04 -26.78 36.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.857 2.371 . . . . 1.27 112.749 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -78.16 -12.24 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 114.415 1.265 . . . . 1.25 114.415 -171.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.06 156.23 46.68 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.897 1.279 . . . . 0.83999999999999997 111.818 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -102.54 -62.87 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.014 0.526 . . . . 3.5699999999999998 110.753 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -79.16 146.57 33.06 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.768 -0.827 . . . . 4.0899999999999999 108.768 165.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.79 133.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.748 1.619 . . . . 1.5800000000000001 108.329 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -140.89 129.27 22.45 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.711 1.604 . . . . 2.1400000000000001 109.351 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.22 123.01 29.66 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.995 1.271 . . . . 0.77000000000000002 110.648 167.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -111.33 159.96 17.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.177 1.791 . . . . 0.53000000000000003 112.256 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -116.51 179.19 4.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.188 2.195 . . . . 2.1200000000000001 111.034 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -131.22 133.14 45.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.707 1.603 . . . . 1.6200000000000001 107.713 166.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -125.7 150.92 47.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.349 1.059 . . . . 1.95 111.94 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.2 ptp -84.74 153.7 22.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.715 1.606 . . . . 4.3700000000000001 110.433 167.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -153.79 34.54 0.44 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.061 1.504 . . . . 6.0999999999999996 115.061 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -56.74 146.78 24.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.647 1.579 . . . . 5.25 113.268 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -156.4 136.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.622 2.369 . . . . 6.2000000000000002 105.416 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 60.89 23.43 13.48 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.813 0.816 . . . . 5.8600000000000003 111.68 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.72 0.35 24.84 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 119.916 -1.74 . . . . 4.4500000000000002 114.862 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -86.42 132.88 33.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.507 1.923 . . . . 3.5 108.836 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.74 142.86 29.76 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.401 1.26 . . . . 7.1600000000000001 114.401 -166.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -155.37 138.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.443 1.897 . . . . 2.0899999999999999 108.618 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 ptp -141.21 138.92 33.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.46 0.704 . . . . 3.1499999999999999 111.126 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.52 175.74 20.79 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 124.623 1.106 . . . . 0.97999999999999998 112.451 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.5 mtt -128.45 156.79 42.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.787 1.635 . . . . 2.3799999999999999 110.78 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -167.93 154.79 7.6 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 125.149 1.379 . . . . 3.6899999999999999 111.441 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.3 Cg_endo -70.23 151.2 66.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.011 1.807 . . . . 0.56000000000000005 112.221 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.0 156.78 54.17 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.748 2.019 . . . . 0.65000000000000002 110.614 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.49 -16.0 27.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.954 2.436 . . . . 0.75 113.113 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.4 p90 179.14 170.72 0.93 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.027 2.131 . . . . 2.52 110.321 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.0 174.69 7.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.679 2.392 . . . . 0.75 108.933 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -152.8 164.42 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.028 -1.045 . . . . 2.27 112.535 164.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 t -138.86 128.83 14.67 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.524 1.53 . . . . 1.04 109.58 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.58 163.41 39.07 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.506 2.137 . . . . 1.1899999999999999 111.69 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.9 138.18 84.18 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.503 2.802 . . . . 1.22 112.055 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt 68.92 2.64 3.63 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.966 2.106 . . . . 1.52 113.708 -175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.11 114.1 3.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 125.85 1.691 . . . . 1.3100000000000001 111.269 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -93.18 125.81 37.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.391 1.077 . . . . 8.0600000000000005 109.32 162.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.5 m -145.44 130.18 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.219 1.008 . . . . 1.5600000000000001 111.296 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.85 132.93 34.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.197 0.999 . . . . 6.9299999999999997 111.248 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.27 60.34 3.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.018 1.866 . . . . 1.8 111.979 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -47.94 133.91 11.56 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 128.038 2.535 . . . . 3.6800000000000002 113.27 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.2 -51.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.325 2.684 . . . . 1.6200000000000001 111.99 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.65 94.98 1.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.264 -1.535 . . . . 1.5700000000000001 109.264 166.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -76.96 0.29 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.993 1.758 . . . . 1.3400000000000001 113.008 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -158.03 130.55 7.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.6 1.56 . . . . 2.1099999999999999 111.299 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -162.13 173.3 14.51 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.938 1.699 . . . . 0.75 111.977 -166.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.95 120.5 41.6 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.742 -0.599 . . . . 2.0499999999999998 112.078 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 mmt -84.75 121.49 27.76 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.233 1.013 . . . . 0.95999999999999996 109.854 164.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -106.02 131.14 53.66 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.223 1.409 . . . . 1.72 108.496 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -140.07 142.37 36.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.791 0.836 . . . . 2.1099999999999999 111.133 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 60.45 4.37 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 109.042 -1.623 . . . . 2.4199999999999999 109.042 -166.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -65.66 127.57 32.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.32 1.06 . . . . 1.02 108.998 172.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -106.3 12.64 29.71 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 1.73 112.89 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -162.33 153.21 14.69 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.811 1.644 . . . . 5.96 110.919 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.94 163.45 39.17 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.921 2.414 . . . . 2.27 109.378 159.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mp -133.93 162.77 31.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.104 0.954 . . . . 3.3500000000000001 112.139 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -119.36 120.01 35.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.888 2.075 . . . . 5.7400000000000002 110.478 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.06 118.29 4.52 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.85 -1.156 . . . . 2.5800000000000001 109.79 168.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.94 48.09 22.25 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.719 -0.489 . . . . 2.2999999999999998 112.761 -167.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.28 -168.33 1.32 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 107.53 -1.285 . . . . 2.7599999999999998 107.53 140.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -128.85 155.53 45.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 4.3899999999999997 111.639 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.08 118.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.685 1.594 . . . . 1.6200000000000001 108.938 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.42 138.9 39.54 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.524 0.729 . . . . 3.46 110.021 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.413 HD23 ' C ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -155.3 143.02 19.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.873 1.269 . . . . 1.99 110.912 -168.747 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -89.82 110.36 21.29 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 128.995 2.918 . . . . 3.0299999999999998 110.323 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.43 113.08 21.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.426 1.012 . . . . 1.5600000000000001 109.372 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.2 mt -93.6 123.47 36.94 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.043 0.937 . . . . 0.57999999999999996 110.772 -166.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -124.58 137.64 54.38 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.427 -0.796 . . . . 2.2599999999999998 112.571 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.98 130.89 30.74 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.614 1.166 . . . . 1.8500000000000001 113.164 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.5 -150.17 20.59 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.367 -1.093 . . . . 3.48 110.367 -163.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.29 28.02 9.56 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.402 1.001 . . . . 2.0800000000000001 114.715 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mppt? -100.38 135.38 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.722 1.761 . . . . 5.25 112.084 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.88 138.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.763 1.225 . . . . 1.29 109.454 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -116.41 104.87 11.89 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.837 0.855 . . . . 1.6200000000000001 109.319 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.22 114.03 17.83 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 3.46 109.36 174.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.09 150.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.093 1.357 . . . . 3.2400000000000002 112.546 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.75 142.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.051 1.74 . . . . 2.1299999999999999 111.904 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -142.5 146.1 37.4 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.086 1.755 . . . . 3.0899999999999999 110.55 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.8 152.53 69.14 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.823 3.015 . . . . 1.8600000000000001 113.007 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.6 t -93.81 127.04 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.938 1.295 . . . . 1.5600000000000001 110.746 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.64 -177.7 3.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.376 1.47 . . . . 5.3600000000000003 109.186 165.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.25 154.2 31.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 119.769 -1.832 . . . . 2.5299999999999998 114.027 -164.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 125.918 1.687 . . . . 5.8799999999999999 113.448 156.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 . . . . . 0 CA--C 1.545 0.769 0 CA-C-O 120.286 0.089 . . . . 4.7400000000000002 111.019 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -161.28 170.39 37.06 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 120.556 -1.34 . . . . 1.29 114.183 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -157.87 147.79 20.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.292 1.037 . . . . 1.54 111.935 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -93.45 121.62 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.146 -0.971 . . . . 1.1100000000000001 108.809 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -63.46 -29.84 71.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.749 1.62 . . . . 4.8499999999999996 113.719 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.99 -179.74 0.22 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.221 2.208 . . . . 2.2999999999999998 112.692 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m 176.25 165.84 0.44 Allowed Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 128.751 2.82 . . . . 1.8899999999999999 108.575 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.27 5.65 3.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.248 2.632 . . . . 2.1600000000000001 113.726 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.5 170.66 36.04 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.35 0.976 . . . . 2.3599999999999999 112.333 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.86 -6.48 33.06 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 CA-C-N 118.612 1.206 . . . . 2.8100000000000001 113.66 -5.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -135.42 171.84 13.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.962 2.105 . . . . 5.6600000000000001 110.804 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.62 -168.3 1.14 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.785 2.434 . . . . 1.3 112.21 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.23 166.97 24.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.317 1.847 . . . . 1.3799999999999999 111.786 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.33 159.32 42.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.647 1.179 . . . . 0.92000000000000004 114.067 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -141.53 156.77 45.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.665 2.386 . . . . 2.0 110.942 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.415 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.2 pp -175.04 167.69 3.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.286 1.217 . . . . 2.1299999999999999 114.286 -174.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.3 m -124.7 137.48 54.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.775 1.63 . . . . 1.54 109.033 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.4 tp -131.14 156.4 45.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.152 1.381 . . . . 4.4699999999999998 110.849 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -130.58 129.49 42.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.3 -1.0 . . . . 3.9700000000000002 108.3 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -94.75 105.8 20.84 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.634 1.174 . . . . 1.04 109.162 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.66 -8.98 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.729 2.286 . . . . 0.98999999999999999 113.637 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.06 156.21 43.44 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 118.942 0.792 . . . . 1.28 112.693 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.3 m-20 -88.26 7.67 31.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.978 1.711 . . . . 3.21 113.209 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.02 158.84 43.13 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.999 1.72 . . . . 1.3899999999999999 110.64 166.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.31 156.9 25.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.304 2.669 . . . . 0.80000000000000004 110.782 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.5 mt -107.18 151.45 25.4 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.706 -0.621 . . . . 1.8500000000000001 110.58 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -128.68 112.38 14.17 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.641 1.176 . . . . 4.7999999999999998 109.572 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.06 127.54 42.16 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.122 1.769 . . . . 0.91000000000000003 109.228 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -116.33 -14.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.444 0.905 . . . . 0.65000000000000002 113.444 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.27 -165.57 35.0 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 121.626 -0.671 . . . . 0.53000000000000003 112.514 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -137.5 -179.4 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.249 1.02 . . . . 0.84999999999999998 110.356 167.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -159.95 145.21 15.23 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.945 -1.872 . . . . 6.4199999999999999 105.945 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.75 156.06 26.18 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 119.088 0.858 . . . . 1.0600000000000001 109.97 -159.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.71 -37.17 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.341 2.027 . . . . 0.90000000000000002 112.465 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.52 -10.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 115.236 1.569 . . . . 1.3500000000000001 115.236 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 163.29 32.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.285 1.434 . . . . 0.79000000000000004 110.374 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -105.23 -77.76 0.58 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.315 1.046 . . . . 3.6699999999999999 109.881 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -79.46 104.29 9.97 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.757 0.823 . . . . 3.4199999999999999 110.467 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -110.18 137.61 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.126 1.37 . . . . 1.28 110.587 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -141.23 128.46 20.97 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.499 1.52 . . . . 2.2799999999999998 111.41 -170.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.59 122.83 28.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.76 0.791 . . . . 0.75 111.691 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.5 OUTLIER -104.91 151.42 23.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.686 1.594 . . . . 0.93999999999999995 114.173 172.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.11 165.87 14.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.613 1.965 . . . . 2.1299999999999999 110.937 160.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.2 m -148.76 112.96 5.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.512 1.525 . . . . 1.8400000000000001 107.952 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -126.02 171.5 10.74 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.934 1.294 . . . . 2.7000000000000002 112.598 -163.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.0 mtm -124.3 118.27 26.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.851 1.26 . . . . 4.8600000000000003 110.053 161.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -153.04 159.73 42.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.058 1.343 . . . . 6.71 110.651 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -64.34 147.89 51.56 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.322 1.449 . . . . 4.29 112.518 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.21 -18.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.497 1.295 . . . . 3.6000000000000001 114.497 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -155.93 33.13 0.35 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.938 2.095 . . . . 3.3900000000000001 108.96 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.79 -25.21 0.64 Allowed Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.235 -1.541 . . . . 2.6200000000000001 113.141 -160.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -80.34 139.32 36.63 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.305 2.242 . . . . 2.4100000000000001 109.2 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -76.45 144.63 39.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.612 0.642 . . . . 4.2800000000000002 112.667 169.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.37 164.79 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 3.1899999999999999 109.798 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.7 mtm -78.46 154.2 30.79 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 4.0599999999999996 111.081 168.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.2 166.47 38.8 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 121.738 -0.601 . . . . 1.5900000000000001 113.668 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.6 149.8 46.93 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.88 1.272 . . . . 1.8500000000000001 110.831 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -158.62 152.04 19.01 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-O 117.133 -1.413 . . . . 3.4500000000000002 110.428 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 47.5 Cg_endo -69.03 148.27 69.44 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.177 1.918 . . . . 0.79000000000000004 111.412 162.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.58 152.33 68.66 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 125.44 1.496 . . . . 0.65000000000000002 110.582 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.13 -6.79 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.885 2.39 . . . . 1.05 113.477 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -176.69 159.91 1.89 Allowed 'General case' 0 C--N 1.348 0.508 0 C-N-CA 125.222 1.409 . . . . 2.2999999999999998 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -111.19 175.7 5.32 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.88 1.672 . . . . 0.85999999999999999 109.194 152.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.39 167.18 31.23 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.807 -1.183 . . . . 2.98 110.291 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -144.18 136.89 13.57 Favored Pre-proline 0 C--N 1.328 -0.367 0 C-N-CA 124.21 1.004 . . . . 0.98999999999999999 108.762 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 167.38 25.4 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.571 1.514 . . . . 1.0 111.373 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.36 143.9 99.58 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.217 2.611 . . . . 0.98999999999999999 111.003 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 14.9 mmmt 66.25 4.12 3.03 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.448 1.499 . . . . 1.51 112.797 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.92 3.74 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 127.403 2.43 . . . . 1.0800000000000001 112.857 -170.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 118.37 31.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.535 1.534 . . . . 5.0 109.772 172.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.11 147.03 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 120.465 1.484 . . . . 1.51 114.403 -166.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 131.62 54.37 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.805 1.242 . . . . 3.48 112.826 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.94 71.64 0.54 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.464 1.505 . . . . 1.3899999999999999 109.929 157.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -78.0 144.3 67.58 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.939 1.696 . . . . 3.6400000000000001 112.688 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.1 -23.16 72.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.546 2.83 . . . . 1.6499999999999999 114.644 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.74 38.78 3.04 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.248 1.404 . . . . 1.45 113.02 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.95 -58.74 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 CA-C-N 118.581 1.19 . . . . 1.3899999999999999 114.948 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -155.12 144.2 20.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.975 1.71 . . . . 2.2999999999999998 110.395 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -164.0 173.84 12.11 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.798 -1.189 . . . . 0.87 110.213 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 54.0 m-85 -108.95 135.42 50.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.093 0.557 . . . . 2.2000000000000002 110.182 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 mmt -85.08 140.69 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.673 0.789 . . . . 1.3200000000000001 109.955 156.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.3 mt -122.8 112.28 17.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 1.71 108.375 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -111.21 140.96 45.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.836 1.654 . . . . 2.8599999999999999 108.436 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.02 72.95 0.91 Allowed Glycine 0 N--CA 1.471 0.968 0 O-C-N 121.206 -0.934 . . . . 2.5699999999999998 111.097 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.79 104.24 4.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 122.523 1.154 . . . . 1.0 110.13 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -82.83 13.94 3.56 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 2.4300000000000002 113.008 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -147.07 159.07 43.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.694 1.998 . . . . 4.7000000000000002 110.392 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.45 163.29 39.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.584 2.189 . . . . 1.76 109.6 152.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -141.92 162.48 35.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.754 1.222 . . . . 2.5099999999999998 110.781 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.12 109.19 2.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.105 1.762 . . . . 3.3100000000000001 109.574 -175.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.04 126.08 24.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.93 -1.106 . . . . 2.29 110.26 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.29 7.42 40.38 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.762 -1.021 . . . . 1.8999999999999999 114.562 -165.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -107.13 -170.82 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.263 1.531 . . . . 2.8599999999999999 110.057 147.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -125.9 165.06 19.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.857 1.663 . . . . 3.3199999999999998 110.509 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.56 116.7 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.115 1.366 . . . . 1.3300000000000001 108.446 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.92 144.59 33.24 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.77 -1.105 . . . . 3.4199999999999999 111.213 167.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.643 HD21 ' HB1' ' A' ' 35' ' ' ALA . 3.0 tt -155.6 132.9 10.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.988 0.899 . . . . 1.48 110.527 -167.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -86.5 101.51 13.25 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.874 3.27 . . . . 2.6800000000000002 111.363 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.99 111.77 17.77 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.273 -1.517 . . . . 1.3100000000000001 109.575 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.28 125.71 35.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.391 1.476 . . . . 0.56999999999999995 110.1 -166.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.84 153.08 31.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.005 0.522 . . . . 2.2599999999999998 112.027 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.43 128.77 37.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.062 0.545 . . . . 1.95 110.398 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 -153.97 30.35 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.475 0.559 . . . . 2.8900000000000001 111.878 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.15 54.32 4.85 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.932 -0.927 . . . . 2.25 114.434 -169.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -143.78 147.12 33.71 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.293 1.546 . . . . 4.0899999999999999 115.057 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.83 131.72 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 128.19 2.596 . . . . 1.0700000000000001 108.171 166.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.42 101.46 7.97 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.028 1.331 . . . . 2.5099999999999998 108.031 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.26 133.6 33.82 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.466 -0.771 . . . . 2.5899999999999999 112.727 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.7 m -140.94 153.45 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.061 1.744 . . . . 1.28 110.986 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.88 128.49 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.836 1.254 . . . . 2.04 111.188 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.9 155.33 60.71 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.272 1.829 . . . . 3.1600000000000001 110.3 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.0 152.38 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.929 2.42 . . . . 1.1000000000000001 111.125 168.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.58 116.41 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.569 -1.641 . . . . 1.1699999999999999 106.569 161.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -127.97 118.92 24.43 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.877 -1.527 . . . . 3.8199999999999998 106.877 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.62 118.36 16.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.791 -0.818 . . . . 2.6200000000000001 108.791 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 117.952 -1.023 . . . . 9.25 113.174 176.737 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.238 0.464 0 N-CA-C 107.726 -1.212 . . . . 6.0800000000000001 107.726 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . 140.27 172.47 12.88 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.592 1.568 . . . . 1.6000000000000001 113.521 174.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -155.52 155.28 33.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.38 1.072 . . . . 2.3300000000000001 111.585 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.63 119.2 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.592 -0.892 . . . . 1.1499999999999999 108.592 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.28 108.74 16.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.557 0.743 . . . . 4.0300000000000002 109.687 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 136.41 48.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 2.5600000000000001 110.427 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.2 t -131.22 156.03 80.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.486 1.914 . . . . 2.6299999999999999 109.222 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.01 -10.38 28.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.872 2.381 . . . . 1.9099999999999999 112.717 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.53 -174.36 15.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.624 1.583 . . . . 1.6399999999999999 112.166 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -76.71 -0.58 23.69 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 118.306 1.053 . . . . 1.6100000000000001 112.629 -8.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -149.65 178.05 9.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.848 1.659 . . . . 1.8600000000000001 111.191 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.0 -166.22 1.53 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.529 1.931 . . . . 0.76000000000000001 112.42 -172.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.74 154.57 34.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.716 1.206 . . . . 0.85999999999999999 111.761 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.13 46.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.297 1.439 . . . . 0.67000000000000004 111.281 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -136.13 148.54 48.27 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.484 1.914 . . . . 2.1899999999999999 109.011 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.8 pp -171.6 155.92 4.22 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.803 0.841 . . . . 1.6699999999999999 112.741 -171.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.424 HG21 ' CZ ' ' A' ' 74' ' ' ARG . 25.0 m -97.71 136.59 37.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.486 -1.234 . . . . 1.3200000000000001 111.827 166.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 23' ' ' GLU . 6.7 tt -112.65 149.3 33.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.873 2.469 . . . . 2.79 109.083 173.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 22' ' ' LEU . 8.0 pt-20 -148.89 120.36 7.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.127 0.965 . . . . 2.7599999999999998 112.89 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -90.14 115.36 63.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.722 1.209 . . . . 1.0700000000000001 110.233 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -86.52 -8.69 7.17 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.155 2.57 . . . . 0.95999999999999996 113.441 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.72 169.29 54.65 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.006 0.812 . . . . 0.97999999999999998 113.722 -172.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.08 -2.24 50.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.489 1.916 . . . . 2.8799999999999999 112.702 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.27 161.15 32.85 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 126.221 1.809 . . . . 1.1899999999999999 110.299 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.03 161.54 23.63 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.05 2.5 . . . . 0.68000000000000005 111.184 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.02 150.52 28.41 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.552 0.741 . . . . 1.8600000000000001 110.48 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -125.52 114.6 19.0 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.231 1.012 . . . . 4.0499999999999998 109.532 167.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -90.85 119.43 31.05 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.822 2.449 . . . . 0.93000000000000005 109.095 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.17 -8.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.54 1.136 . . . . 0.63 113.931 -171.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -162.03 32.31 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.512 -0.742 . . . . 0.46999999999999997 112.275 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.59 -172.0 3.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.488 1.115 . . . . 1.02 111.219 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -148.22 143.88 27.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.789 2.036 . . . . 5.8899999999999997 105.506 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -149.05 153.73 38.54 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.409 1.004 . . . . 0.88 109.339 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.43 -43.46 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.514 2.809 . . . . 1.3700000000000001 111.696 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.281 1.1 m -76.46 -5.23 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.416 1.636 . . . . 1.02 115.416 -170.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.1 -175.91 4.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.601 1.56 . . . . 1.1699999999999999 110.751 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -132.92 -60.94 0.85 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.156 0.889 . . . . 4.6799999999999997 111.721 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -65.02 129.93 41.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.395 -1.335 . . . . 3.0499999999999998 107.395 158.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.89 117.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.454 -1.684 . . . . 1.8200000000000001 106.454 171.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -138.76 115.65 10.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.635 -1.166 . . . . 2.8300000000000001 109.013 -155.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.446 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 6.1 tt -78.04 120.66 23.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.216 1.008 . . . . 0.78000000000000003 110.546 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -107.47 150.0 27.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.84 1.656 . . . . 0.52000000000000002 112.222 177.131 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.74 168.55 19.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.843 -1.526 . . . . 2.4700000000000002 110.306 159.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -143.65 86.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.882 -1.525 . . . . 1.29 106.882 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -94.14 153.41 18.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.177 1.791 . . . . 1.98 112.373 -164.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 ttp -91.74 137.68 32.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.389 1.476 . . . . 2.7799999999999998 110.003 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -153.53 122.78 6.58 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.377 0.671 . . . . 5.4800000000000004 111.461 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.06 155.28 17.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.845 1.258 . . . . 5.7400000000000002 110.133 169.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.37 127.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.91 . . . . 3.71 110.678 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 58.72 26.4 14.58 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.317 1.056 . . . . 4.96 111.053 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.43 1.19 57.03 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 119.825 -1.797 . . . . 3.3100000000000001 114.379 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -92.84 143.19 26.52 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.032 1.733 . . . . 3.5299999999999998 109.488 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.27 130.22 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.754 1.622 . . . . 6.1799999999999997 112.607 -164.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.05 169.5 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 122.387 1.089 . . . . 2.0499999999999998 113.044 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 14.6 tpp -137.48 160.91 37.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.913 2.885 . . . . 2.9399999999999999 107.938 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.07 169.31 33.12 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.562 1.074 . . . . 1.24 114.078 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.11 139.48 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.433 1.493 . . . . 1.8899999999999999 109.598 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -154.6 145.38 16.2 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 125.652 1.581 . . . . 3.5499999999999998 109.531 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 40.3 Cg_endo -65.39 143.25 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.967 1.778 . . . . 0.80000000000000004 110.657 165.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.64 156.16 42.82 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.691 1.596 . . . . 0.57999999999999996 110.663 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.75 -14.66 33.11 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.919 2.413 . . . . 0.72999999999999998 113.369 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -177.16 162.17 1.95 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.574 1.55 . . . . 1.9399999999999999 110.816 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mt -109.48 171.08 7.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.673 1.189 . . . . 0.68000000000000005 108.682 149.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -155.57 165.09 37.63 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.03 -1.044 . . . . 2.3500000000000001 111.774 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.87 136.36 11.67 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.841 0.857 . . . . 0.98999999999999999 109.516 -161.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.83 169.58 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.715 1.61 . . . . 0.85999999999999999 111.429 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.78 143.9 94.53 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.172 2.581 . . . . 0.75 111.26 163.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt 67.31 0.57 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.524 1.53 . . . . 1.29 114.215 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.16 113.7 3.68 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 126.01 1.767 . . . . 0.93999999999999995 112.869 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.424 ' CZ ' HG21 ' A' ' 21' ' ' THR . 23.1 ttt85 -81.04 133.2 35.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.082 -1.059 . . . . 4.6100000000000003 109.746 154.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.95 134.16 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.624 1.569 . . . . 1.3700000000000001 110.597 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.1 118.02 25.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.127 -1.064 . . . . 4.6699999999999999 108.127 -160.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.54 73.11 1.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.236 1.493 . . . . 1.4299999999999999 111.87 -169.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -55.24 116.88 12.68 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.226 1.41 . . . . 4.9800000000000004 110.347 168.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.21 -30.37 88.33 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.24 2.627 . . . . 1.3500000000000001 114.108 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.89 41.68 1.75 Allowed Glycine 0 CA--C 1.533 1.181 0 CA-C-N 118.858 0.754 . . . . 1.9399999999999999 112.791 167.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.33 -49.82 0.04 OUTLIER Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.954 2.216 . . . . 1.47 113.609 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -151.26 146.89 26.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.691 1.596 . . . . 2.1899999999999999 112.049 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -156.48 167.41 30.54 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.735 1.214 . . . . 1.1200000000000001 110.983 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.446 ' CZ ' HD12 ' A' ' 45' ' ' LEU . 31.7 m-85 -105.83 117.8 34.95 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.704 -0.85 . . . . 1.9099999999999999 108.704 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.87 133.08 34.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.975 0.51 . . . . 1.22 110.258 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.71 133.39 53.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.854 1.662 . . . . 1.9099999999999999 111.659 -172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -142.91 157.97 44.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.758 1.223 . . . . 2.02 112.028 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -43.76 2.66 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 124.759 1.171 . . . . 2.27 112.129 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt 47.37 71.83 0.3 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.975 2.51 . . . . 1.28 113.706 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -69.67 -1.7 9.71 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.032 1.123 . . . . 2.3300000000000001 114.032 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 97' ' ' GLU . 10.3 mtp85 -125.45 142.36 41.53 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 126.308 1.843 . . . . 5.8399999999999999 109.053 172.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.22 124.12 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 107.245 -1.867 . . . . 1.95 107.245 145.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.578 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.5 pt? -127.21 157.54 39.52 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.675 1.99 . . . . 2.96 111.164 -163.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -165.11 142.69 6.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.527 1.306 . . . . 8.0999999999999996 114.527 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 124.86 19.1 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.279 -0.888 . . . . 1.8799999999999999 109.669 164.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.24 -12.25 14.26 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.94 -1.478 . . . . 1.8600000000000001 113.363 -161.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 91' ' ' ARG . 6.7 pt-20 -106.1 172.68 6.68 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.162 1.481 . . . . 3.8700000000000001 110.828 155.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.5 155.18 46.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.529 1.532 . . . . 4.75 108.959 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.66 110.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.582 1.153 . . . . 1.3300000000000001 108.975 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.35 129.41 38.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.534 -0.913 . . . . 4.3899999999999997 108.534 153.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -134.63 140.03 45.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.578 1.151 . . . . 1.8600000000000001 108.761 172.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.3 103.41 12.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.996 2.519 . . . . 3.3500000000000001 110.587 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.38 125.18 28.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.731 1.613 . . . . 1.29 110.813 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.5 mt -93.18 129.86 39.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.654 1.182 . . . . 0.75 111.565 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -127.74 119.97 26.91 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.38 0.672 . . . . 2.1499999999999999 112.295 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.51 27.9 0.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.975 2.11 . . . . 2.5099999999999998 114.784 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.57 -53.38 1.57 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.741 1.638 . . . . 3.9100000000000001 113.104 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.68 3.71 63.04 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 117.036 1.574 . . . . 1.8 117.036 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 150.36 44.08 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.112 1.956 . . . . 3.9100000000000001 111.316 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.31 136.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.854 1.662 . . . . 1.0800000000000001 109.205 166.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.7 mt -146.18 132.56 19.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.501 1.521 . . . . 1.54 109.499 -172.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.1 ptmt -102.1 158.56 16.08 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.951 1.834 . . . . 2.8799999999999999 115.951 -169.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.21 147.21 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.605 1.962 . . . . 2.4199999999999999 109.915 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -107.55 133.71 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.115 1.366 . . . . 2.9399999999999999 111.247 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 mt -140.44 131.38 13.92 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 127.059 2.144 . . . . 2.1499999999999999 109.365 -165.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.35 151.47 71.39 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.318 2.678 . . . . 1.6200000000000001 112.146 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.42 125.85 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.53 0.681 . . . . 1.46 112.087 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.48 148.32 24.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.086 2.154 . . . . 4.96 109.838 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.33 129.62 54.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.919 -1.039 . . . . 2.0299999999999998 109.395 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 131.365 3.866 . . . . 6.8200000000000003 107.677 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 119.607 -0.235 . . . . 5.8200000000000003 110.749 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.19 175.3 47.59 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 115.455 0.942 . . . . 1.29 115.455 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -156.23 123.65 5.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.034 1.334 . . . . 1.6100000000000001 113.094 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.33 153.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 120.75 -1.219 . . . . 1.1599999999999999 108.823 164.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -110.15 -19.19 13.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 116.438 2.014 . . . . 6.6399999999999997 116.438 -168.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 60.79 173.42 0.1 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.401 1.48 . . . . 2.1200000000000001 112.781 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.29 171.8 0.5 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.947 2.899 . . . . 1.79 109.657 171.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.97 -0.41 9.0 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.301 2.667 . . . . 1.71 113.78 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 174.23 33.69 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.93 1.252 . . . . 1.78 112.418 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.23 -5.37 34.2 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 118.596 1.198 . . . . 2.0600000000000001 112.998 -4.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -130.4 177.23 7.5 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.989 1.716 . . . . 1.8899999999999999 112.767 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -168.63 -168.8 0.94 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.789 2.436 . . . . 0.79000000000000004 110.64 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.45 167.92 17.84 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.848 1.659 . . . . 1.1699999999999999 112.15 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.14 149.72 31.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.525 1.53 . . . . 0.78000000000000003 111.337 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -146.04 151.8 38.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.481 1.512 . . . . 2.3900000000000001 110.135 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -173.84 161.02 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.938 1.295 . . . . 2.0699999999999998 113.05 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.9 m -84.35 150.23 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.685 1.594 . . . . 1.3400000000000001 109.037 166.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.72 176.27 9.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.365 1.066 . . . . 3.8999999999999999 110.955 152.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -154.83 162.02 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.476 -0.765 . . . . 3.71 111.424 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -114.61 101.64 54.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.876 1.67 . . . . 1.3100000000000001 109.577 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.06 -2.65 11.86 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.786 2.991 . . . . 1.5600000000000001 113.112 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.9 -172.35 48.79 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.786 1.184 . . . . 1.49 113.726 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -119.21 2.32 11.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.818 1.647 . . . . 3.79 112.954 -169.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.1 161.35 35.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.185 1.794 . . . . 1.5900000000000001 109.374 165.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.8 154.68 15.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.096 2.531 . . . . 1.1200000000000001 111.123 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.37 158.04 17.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.962 0.905 . . . . 2.25 111.175 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -135.35 113.42 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.855 1.262 . . . . 3.71 110.381 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.44 115.35 27.51 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 127.943 2.497 . . . . 0.92000000000000004 108.985 -173.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.7 -8.73 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.725 1.009 . . . . 0.70999999999999996 113.725 -165.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.69 -162.25 32.22 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.749 -0.594 . . . . 0.45000000000000001 112.81 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.93 -175.43 4.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.606 0.595 . . . . 0.82999999999999996 112.606 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -156.95 144.25 18.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.924 0.889 . . . . 5.4400000000000004 109.551 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -152.74 155.13 32.23 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.961 0.904 . . . . 0.92000000000000004 110.471 -170.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.31 -21.17 23.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.809 2.339 . . . . 1.1699999999999999 113.617 169.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.785 HG21 HD13 ' A' ' 93' ' ' LEU . 1.4 m -90.53 -15.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 114.639 1.348 . . . . 1.1599999999999999 114.639 -166.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.36 40.25 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.084 0.954 . . . . 1.1000000000000001 112.347 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -93.63 -86.2 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.386 1.074 . . . . 3.7599999999999998 110.597 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -85.02 90.96 7.96 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.807 -1.183 . . . . 5.3200000000000003 108.741 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -76.03 139.16 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.51 -0.768 . . . . 1.55 111.014 165.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -138.14 120.7 16.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.204 2.202 . . . . 3.3799999999999999 111.048 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.3 118.18 22.41 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.016 0.912 . . . . 0.82999999999999996 111.809 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -103.22 153.68 20.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.782 1.633 . . . . 0.72999999999999998 113.661 172.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -95.18 178.21 5.61 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.42 1.888 . . . . 2.4700000000000002 110.021 162.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.9 m -145.7 111.93 5.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.891 -1.151 . . . . 1.1899999999999999 107.891 164.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -97.15 158.34 15.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.379 1.472 . . . . 2.4300000000000002 112.498 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -101.95 148.03 25.83 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.42 1.088 . . . . 3.7599999999999998 108.92 163.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -158.92 146.64 17.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.379 1.471 . . . . 6.25 110.147 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.45 145.84 24.86 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.582 0.353 . . . . 3.7599999999999998 110.917 165.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -139.78 120.48 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.019 -1.475 . . . . 3.1299999999999999 107.019 165.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.6 tm-20 57.52 33.57 23.44 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.28 1.032 . . . . 5.4199999999999999 110.757 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.64 -9.92 4.37 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 119.995 -1.69 . . . . 2.1800000000000002 114.547 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.463 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 33.7 mmtm -78.39 139.98 38.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 4.0800000000000001 110.367 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -69.97 131.1 43.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.044 0.938 . . . . 3.3199999999999998 110.825 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.93 146.84 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.685 1.994 . . . . 2.1299999999999999 109.361 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -128.43 148.98 50.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.685 1.194 . . . . 3.6299999999999999 110.893 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.71 -179.83 34.78 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.906 0.765 . . . . 1.0700000000000001 112.855 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -127.95 149.27 50.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.245 1.018 . . . . 2.3199999999999998 111.981 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -142.76 147.46 42.18 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.552 1.541 . . . . 3.52 108.908 172.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 151.62 78.42 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.697 1.598 . . . . 0.77000000000000002 110.867 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.13 154.55 78.69 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 125.156 1.382 . . . . 1.1299999999999999 110.79 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -70.2 -11.8 30.91 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.671 2.247 . . . . 1.45 113.063 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -177.47 163.45 1.97 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.618 1.567 . . . . 2.3300000000000001 111.885 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -113.2 174.11 6.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.329 2.251 . . . . 0.82999999999999996 109.4 155.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -154.88 167.62 29.68 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.041 -1.037 . . . . 2.5499999999999998 112.277 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.73 135.42 11.07 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.818 0.847 . . . . 1.1100000000000001 110.543 -165.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.76 167.08 27.04 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.295 1.997 . . . . 1.03 111.893 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -65.26 144.61 81.45 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.709 2.939 . . . . 1.4199999999999999 111.655 166.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.261 0.6 OUTLIER 46.69 55.29 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 123.454 1.597 . . . . 2.7599999999999998 114.757 -166.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.35 121.33 2.66 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 113.962 -1.472 . . . . 1.0600000000000001 114.164 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.53 146.99 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.65 0.78 . . . . 4.96 109.978 162.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.18 137.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.544 1.138 . . . . 1.6299999999999999 109.974 171.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -111.92 140.25 46.74 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.794 0.807 . . . . 3.4500000000000002 110.957 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.24 63.78 2.53 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.323 1.535 . . . . 1.3200000000000001 109.926 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -58.37 121.39 51.9 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.954 1.302 . . . . 4.8899999999999997 110.709 170.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.88 -58.14 1.58 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.888 3.726 . . . . 1.48 114.598 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.69 2.9 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.678 1.132 . . . . 1.9399999999999999 113.405 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.75 -51.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.352 1.93 . . . . 1.48 113.339 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -156.01 139.47 15.84 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.631 1.972 . . . . 2.1899999999999999 109.654 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -166.93 173.66 9.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.353 1.061 . . . . 0.83999999999999997 111.477 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.13 134.0 52.64 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.025 0.53 . . . . 1.8100000000000001 111.246 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.3 mmt -84.73 144.02 28.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.977 1.311 . . . . 1.0900000000000001 110.316 157.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.59 116.47 28.2 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.68 1.592 . . . . 1.9199999999999999 107.861 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -109.63 134.86 51.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.967 0.803 . . . . 2.2799999999999998 110.147 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.2 0.6 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.042 -1.223 . . . . 2.5800000000000001 110.042 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.53 100.52 2.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.086 0.943 . . . . 1.0600000000000001 110.068 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -76.71 -12.7 60.03 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.235 0.828 . . . . 1.77 113.235 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.42 148.63 31.99 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.905 . . . . 5.2199999999999998 111.139 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -67.56 148.71 79.0 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.735 2.29 . . . . 2.0899999999999999 109.229 159.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.785 HD13 HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -156.96 30.94 0.3 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.861 1.315 . . . . 4.2400000000000002 113.59 -160.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.25 149.22 0.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.183 2.193 . . . . 4.3399999999999999 113.904 -169.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.79 134.93 30.38 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.603 -1.311 . . . . 2.4900000000000002 112.107 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.42 -11.79 66.77 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.061 -1.41 . . . . 2.4100000000000001 114.354 -166.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 158.02 37.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.052 1.426 . . . . 4.2800000000000002 109.009 160.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.9 147.54 29.67 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.812 2.045 . . . . 4.2699999999999996 108.174 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.19 123.07 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.576 1.55 . . . . 1.0800000000000001 109.995 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 121.49 21.16 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.708 0.803 . . . . 4.1299999999999999 109.068 159.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.07 126.6 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.078 0.951 . . . . 1.5900000000000001 110.521 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.17 95.87 8.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.53 1.932 . . . . 2.6000000000000001 109.779 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.93 126.18 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.794 1.179 . . . . 2.6000000000000001 110.106 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.6 mt -95.1 137.97 33.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.516 1.526 . . . . 0.84999999999999998 110.589 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -134.11 148.51 51.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.213 1.006 . . . . 2.3100000000000001 113.028 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.77 162.77 18.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.128 -0.942 . . . . 2.8799999999999999 111.853 169.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.75 24.9 66.11 Favored Glycine 0 N--CA 1.473 1.145 0 O-C-N 121.66 -0.65 . . . . 4.7000000000000002 113.696 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.94 60.65 4.77 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.303 0.954 . . . . 2.1099999999999999 111.116 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -143.63 165.16 28.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.984 1.313 . . . . 3.6800000000000002 112.412 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -169.98 144.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 129.39 3.076 . . . . 2.1899999999999999 107.213 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.2 mt -137.4 96.93 3.35 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.393 1.477 . . . . 2.6899999999999999 107.766 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.45 143.24 32.24 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.956 0.724 . . . . 2.6600000000000001 112.956 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.33 140.55 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.414 1.086 . . . . 1.8799999999999999 109.899 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 145.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.668 0.787 . . . . 2.0299999999999998 109.61 172.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.5 153.19 12.79 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.924 1.29 . . . . 2.8399999999999999 113.17 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.09 161.66 40.49 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.039 2.493 . . . . 1.24 112.555 -175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -93.46 130.61 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.978 . . . . 1.4299999999999999 109.786 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.01 164.44 12.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.723 1.209 . . . . 3.4500000000000002 108.931 156.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.41 115.84 26.59 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.068 -1.02 . . . . 2.46 112.772 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.521 2.328 . . . . 5.6799999999999997 113.133 167.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.022 0.439 . . . . 5.0300000000000002 112.171 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.15 164.34 21.47 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 124.822 1.201 . . . . 0.97999999999999998 114.078 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -152.53 145.2 24.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 1.74 112.026 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.1 131.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.381 -0.6 . . . . 1.1200000000000001 109.381 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 116.75 22.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.207 0.603 . . . . 4.0800000000000001 109.405 -171.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.86 133.23 33.94 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.592 -1.317 . . . . 2.3399999999999999 110.914 167.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -149.48 163.24 25.85 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.567 1.947 . . . . 2.4500000000000002 109.007 165.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.91 31.14 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.062 3.175 . . . . 1.9299999999999999 114.113 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.06 -173.16 54.51 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.248 -0.908 . . . . 1.72 113.125 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.26 -4.42 18.31 Favored 'Cis proline' 0 CA--C 1.539 0.741 0 CA-C-N 118.228 1.014 . . . . 1.8300000000000001 112.8 -10.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -139.51 178.87 6.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.701 1.6 . . . . 2.6099999999999999 111.484 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.07 -173.93 3.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.004 2.122 . . . . 1.1100000000000001 108.647 163.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.42 161.15 17.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 1.0600000000000001 112.161 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.1 136.58 48.51 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.039 -1.038 . . . . 1.1200000000000001 111.106 163.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -122.61 155.56 36.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.413 1.885 . . . . 2.0699999999999998 111.015 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -166.24 142.28 4.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.708 1.744 . . . . 1.5700000000000001 115.708 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.9 m -72.13 132.73 44.56 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.79 -0.819 . . . . 1.1799999999999999 108.79 156.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.1 tt -140.68 147.41 39.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.313 1.845 . . . . 2.52 110.1 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -131.92 147.14 52.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.289 1.042 . . . . 3.3199999999999998 112.414 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -88.07 108.9 23.93 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.362 -1.29 . . . . 1.02 109.216 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.74 -11.51 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.631 2.221 . . . . 1.23 113.287 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.04 -173.39 49.84 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.867 1.222 . . . . 0.95999999999999996 113.812 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -114.17 -0.85 13.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.884 1.674 . . . . 2.98 112.855 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.04 161.77 36.79 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.457 1.903 . . . . 1.4299999999999999 109.464 165.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 155.61 28.22 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.554 2.169 . . . . 0.73999999999999999 112.287 -169.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.43 149.82 23.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.437 1.095 . . . . 1.8 110.532 168.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -130.94 111.93 12.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.735 1.214 . . . . 3.27 110.408 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 tp -94.21 118.33 31.41 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.564 2.345 . . . . 0.75 108.746 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -110.15 -10.37 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.977 0.911 . . . . 0.57999999999999996 113.003 -171.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.94 -167.14 38.31 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 124.242 0.925 . . . . 0.5 112.233 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.15 -179.03 6.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.165 0.986 . . . . 0.66000000000000003 110.746 164.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 102' ' ' ASP . 22.0 mmt-85 -149.48 139.66 22.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.26 1.424 . . . . 6.2999999999999998 109.271 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -150.01 152.12 33.4 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.218 -0.896 . . . . 0.55000000000000004 110.572 -169.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.98 -23.94 53.51 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.827 2.351 . . . . 0.77000000000000002 113.629 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.546 HG12 HH11 ' A' ' 91' ' ' ARG 0.351 1.6 m -94.25 3.07 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.049 1.5 . . . . 0.91000000000000003 115.049 -171.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.86 164.1 36.28 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.418 1.636 . . . . 0.71999999999999997 115.418 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.18 -89.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.907 2.083 . . . . 3.4300000000000002 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -80.27 80.12 6.74 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.385 -1.447 . . . . 3.5499999999999998 109.62 -173.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.59 131.7 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 128.146 2.579 . . . . 1.5 112.269 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.51 132.07 30.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.487 1.915 . . . . 2.48 110.27 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.14 121.74 26.49 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 121.278 1.854 . . . . 0.71999999999999997 111.64 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.2 m170 -107.92 154.3 21.8 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.548 1.939 . . . . 0.48999999999999999 112.975 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -109.99 166.33 11.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 2.3900000000000001 110.699 166.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.3 m -115.21 117.83 31.6 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.563 1.945 . . . . 1.3999999999999999 107.114 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -126.26 154.44 43.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.343 1.057 . . . . 2.3700000000000001 112.699 -168.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.4 mtt -92.63 153.77 18.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.657 -1.156 . . . . 2.6699999999999999 111.339 166.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -153.17 137.77 16.87 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.647 0.779 . . . . 6.0 112.706 159.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.14 151.03 16.18 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.853 1.661 . . . . 4.5899999999999999 110.269 160.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.818 HG13 ' H ' ' A' ' 54' ' ' GLU 0.298 11.8 p -158.03 -88.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 126.249 1.82 . . . . 2.8999999999999999 110.287 175.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.818 ' H ' HG13 ' A' ' 53' ' ' VAL . 20.6 tt0 -78.58 47.72 0.74 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.296 2.239 . . . . 3.7200000000000002 110.296 168.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.48 -43.78 0.91 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 127.595 2.522 . . . . 2.2400000000000002 113.912 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -77.83 152.9 33.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.974 2.11 . . . . 3.3999999999999999 113.178 -173.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.37 107.08 18.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.91 0.484 . . . . 4.5499999999999998 112.069 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -80.95 142.03 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.886 1.275 . . . . 1.6100000000000001 109.017 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.11 133.95 50.01 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.912 1.685 . . . . 4.5800000000000001 110.622 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 -179.2 30.23 Favored Glycine 0 N--CA 1.472 1.09 0 C-N-CA 124.226 0.917 . . . . 1.5600000000000001 113.079 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.48 160.53 19.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.802 1.241 . . . . 2.4500000000000002 112.138 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.16 149.96 2.29 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.505 1.522 . . . . 3.6899999999999999 112.652 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 28.2 Cg_endo -71.6 141.52 38.22 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.097 2.532 . . . . 0.63 113.275 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -110.82 156.07 41.31 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.892 1.677 . . . . 0.66000000000000003 109.798 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.2 -13.31 30.95 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.899 2.4 . . . . 0.71999999999999997 113.292 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.7 p90 178.63 168.34 0.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.005 2.122 . . . . 1.79 110.301 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.16 169.43 9.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.189 1.795 . . . . 0.72999999999999998 109.104 157.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.5 159.0 39.41 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.141 -0.974 . . . . 2.5699999999999998 111.655 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.27 126.81 9.21 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.506 1.122 . . . . 0.81000000000000005 110.133 -163.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.76 161.34 44.1 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.308 2.005 . . . . 0.73999999999999999 111.712 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.11 139.29 86.73 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.89 3.06 . . . . 0.78000000000000003 112.865 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm 67.34 -1.2 1.59 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.958 2.103 . . . . 1.3799999999999999 113.647 -173.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.79 119.64 4.93 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 126.615 2.055 . . . . 0.81999999999999995 111.279 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -84.22 142.79 30.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.316 1.046 . . . . 5.4100000000000001 110.722 156.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 m -148.48 147.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.518 1.927 . . . . 1.22 110.218 168.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.91 123.93 46.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.315 1.055 . . . . 3.0899999999999999 112.327 170.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.46 85.88 0.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.799 1.239 . . . . 1.8999999999999999 107.716 158.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -100.41 160.65 26.39 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.055 2.542 . . . . 3.1800000000000002 113.279 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -58.56 -55.31 2.17 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.554 2.836 . . . . 1.3999999999999999 112.664 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.92 65.53 3.73 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 110.884 -0.886 . . . . 1.6200000000000001 110.884 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.94 -108.37 0.28 Allowed Glycine 0 N--CA 1.468 0.816 0 C-N-CA 124.616 1.103 . . . . 1.5600000000000001 113.005 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -130.84 143.19 50.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.002 1.401 . . . . 2.1600000000000001 111.029 -172.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -170.21 163.37 8.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 120.995 -1.066 . . . . 1.5900000000000001 109.935 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -88.23 133.31 34.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.678 -0.677 . . . . 2.46 110.29 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.1 mmt -84.13 136.36 34.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.78 0.832 . . . . 0.84999999999999998 110.196 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.42 75.67 0.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.578 1.551 . . . . 1.73 109.164 -170.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.39 116.04 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.245 -1.02 . . . . 3.27 108.245 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.98 96.69 0.4 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.291 -1.123 . . . . 2.8500000000000001 110.291 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.1 119.52 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.291 -1.374 . . . . 1.3300000000000001 107.291 167.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.79 4.76 23.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.798 -1.189 . . . . 1.79 112.833 -164.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.546 HH11 HG12 ' A' ' 39' ' ' VAL . 9.4 ptm180 -167.66 152.69 6.76 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.739 2.016 . . . . 5.21 109.595 -172.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.19 151.94 82.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.46 -1.4 . . . . 1.77 108.46 161.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.63 162.43 41.0 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.627 1.971 . . . . 2.6299999999999999 108.64 -164.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -154.19 162.6 41.08 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.896 1.813 . . . . 4.2000000000000002 115.896 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.57 133.21 48.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 1.8899999999999999 107.989 157.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.57 13.81 62.54 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.956 -0.914 . . . . 2.1600000000000001 113.493 -162.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.0 169.24 9.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.689 1.245 . . . . 3.1099999999999999 107.868 151.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -136.72 150.35 48.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.523 1.929 . . . . 3.6699999999999999 107.805 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.47 103.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 124.788 1.235 . . . . 0.89000000000000001 108.384 -168.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -59.82 134.04 56.66 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 125.1 1.5 . . . . 4.1399999999999997 108.46 154.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.94 130.37 23.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.855 1.662 . . . . 1.45 109.579 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' CG ' ' HZ3' ' A' ' 112' ' ' LYS . 5.0 m-20 -103.5 92.23 4.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.994 1.718 . . . . 2.3999999999999999 109.063 -175.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.7 mt -77.68 112.33 14.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.893 1.677 . . . . 1.3100000000000001 110.226 -172.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -86.5 128.07 34.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.805 0.842 . . . . 0.68999999999999995 111.475 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.29 142.87 50.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.687 0.795 . . . . 2.0099999999999998 113.003 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.59 133.05 30.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.528 1.531 . . . . 1.8700000000000001 114.292 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.11 -142.93 23.61 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.777 -1.329 . . . . 3.6099999999999999 109.777 -162.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.46 71.12 0.25 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.979 0.8 . . . . 1.73 112.951 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -131.0 148.59 52.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.701 1.25 . . . . 5.0300000000000002 111.416 168.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.82 139.73 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.639 1.575 . . . . 0.93000000000000005 109.235 170.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.71 145.71 48.79 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.424 1.09 . . . . 1.3799999999999999 110.378 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HZ3' ' CG ' ' A' ' 102' ' ' ASP . 17.2 mtpp -112.83 143.71 43.61 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.079 0.952 . . . . 2.6000000000000001 112.323 -169.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -158.64 125.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.326 1.45 . . . . 1.4199999999999999 109.689 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.0 p -92.29 121.72 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.338 1.055 . . . . 1.9099999999999999 109.142 170.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.04 143.28 48.34 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.293 1.437 . . . . 2.2200000000000002 111.634 -171.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.36 150.22 70.4 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.373 2.715 . . . . 1.04 112.992 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.13 127.02 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.464 0.705 . . . . 1.24 110.256 171.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.85 142.4 27.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.274 2.23 . . . . 5.0800000000000001 108.411 163.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.33 134.61 12.38 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.515 0.561 . . . . 2.3799999999999999 112.515 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 116.179 -1.867 . . . . 9.0299999999999994 113.492 164.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 111.632 0.234 . . . . 5.1500000000000004 111.632 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.85 169.54 40.21 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 120.941 -1.1 . . . . 1.28 114.781 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.42 152.18 19.89 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.14 0.793 . . . . 1.71 113.14 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.78 124.2 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.452 -0.944 . . . . 0.89000000000000001 108.452 163.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -83.34 109.17 17.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.177 0.991 . . . . 5.4299999999999997 108.655 167.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.48 ' HB2' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.1 -179.31 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.841 1.052 . . . . 2.6299999999999999 113.841 -173.332 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m -168.48 167.56 6.17 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.572 1.949 . . . . 1.8500000000000001 109.198 162.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.15 -26.78 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.039 2.493 . . . . 2.5699999999999998 112.105 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.2 177.96 15.72 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.384 1.468 . . . . 1.6100000000000001 112.668 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.02 -15.8 19.87 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 118.69 1.245 . . . . 1.75 113.247 -1.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -129.15 164.98 22.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.631 1.572 . . . . 2.1099999999999999 112.77 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.97 163.4 30.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.391 2.276 . . . . 0.98999999999999999 109.883 171.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.98 145.44 38.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.33 1.052 . . . . 0.89000000000000001 110.876 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.67 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.317 0.858 . . . . 0.81000000000000005 113.317 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -145.78 158.44 43.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.998 1.719 . . . . 1.98 110.844 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.7 152.31 13.71 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.497 1.119 . . . . 1.78 111.395 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 m -79.57 149.74 31.3 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.594 1.558 . . . . 1.6699999999999999 108.065 155.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -155.7 134.44 11.9 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.916 1.287 . . . . 2.8999999999999999 108.902 173.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.62 119.05 27.91 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.895 1.278 . . . . 4.3200000000000003 109.693 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -77.42 117.01 62.63 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 1.4399999999999999 109.939 173.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.32 -11.12 8.58 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.042 2.495 . . . . 1.5600000000000001 113.825 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.72 163.93 54.74 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 119.025 0.83 . . . . 1.5900000000000001 113.521 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.439 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.4 m-20 -91.87 -1.7 57.19 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.275 1.83 . . . . 3.54 112.634 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.28 159.74 40.32 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.311 1.844 . . . . 1.6699999999999999 110.856 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.03 159.09 23.92 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.042 2.495 . . . . 1.1399999999999999 111.41 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.72 156.48 17.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.857 0.837 . . . . 2.6899999999999999 110.537 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -129.54 120.32 25.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.086 1.355 . . . . 5.29 108.308 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -101.16 118.52 37.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.839 1.655 . . . . 1.1000000000000001 108.541 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.77 -11.18 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.289 1.036 . . . . 0.70999999999999996 113.346 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.92 -170.78 43.7 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.601 1.096 . . . . 0.65000000000000002 111.314 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 149.99 25.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 1.73 111.809 166.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -118.3 139.76 50.85 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.848 -1.158 . . . . 5.5099999999999998 110.065 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -140.94 152.25 64.79 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.629 1.172 . . . . 0.87 110.083 -171.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.65 -26.67 83.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.239 1.959 . . . . 1.1100000000000001 113.978 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.566 HG21 HD21 ' A' ' 93' ' ' LEU . 1.9 m -88.38 -7.9 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 114.991 1.478 . . . . 1.3999999999999999 114.991 -170.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.55 168.96 21.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.9 0.88 . . . . 1.0700000000000001 113.349 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.84 -73.89 0.63 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.586 0.354 . . . . 4.2199999999999998 111.036 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -68.39 139.89 55.82 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.721 -1.237 . . . . 2.7799999999999998 109.298 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.55 139.85 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 125.242 1.417 . . . . 2.1899999999999999 108.336 162.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -129.95 117.34 19.95 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.465 1.106 . . . . 2.0800000000000001 108.682 164.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -77.21 120.85 22.84 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.743 0.782 . . . . 0.91000000000000003 109.253 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -106.77 151.05 25.67 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.414 1.486 . . . . 0.67000000000000004 112.681 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -95.78 160.59 14.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.782 2.033 . . . . 1.98 110.151 164.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.3 m -131.44 108.74 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.464 1.905 . . . . 1.1299999999999999 107.127 166.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -109.85 160.31 16.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 2.4500000000000002 112.232 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -113.06 139.34 48.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.083 0.953 . . . . 2.5899999999999999 110.115 157.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -151.56 150.94 30.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.107 1.363 . . . . 6.29 111.985 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.68 144.34 52.28 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.835 0.854 . . . . 4.2199999999999998 110.74 154.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -154.58 -39.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 114.718 1.377 . . . . 3.8700000000000001 114.718 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 3.7 tm-20 -112.28 38.21 2.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.667 1.987 . . . . 4.21 109.205 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.67 -35.03 0.59 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.204 1.383 . . . . 3.3999999999999999 113.445 -164.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 16.0 mtmt -92.7 160.22 15.08 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.722 2.409 . . . . 4.0999999999999996 111.037 175.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -74.27 142.28 45.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.48 0.919 . . . . 3.8599999999999999 113.48 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.59 158.03 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 127.792 2.437 . . . . 2.4700000000000002 108.09 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.2 mtm -111.08 152.82 26.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 3.21 112.535 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.76 177.1 41.08 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 123.716 0.674 . . . . 1.1399999999999999 113.468 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -124.45 161.01 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.692 1.197 . . . . 1.8500000000000001 111.646 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -158.61 151.65 18.52 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 126.806 2.042 . . . . 5.0800000000000001 109.447 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.57 142.41 71.05 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 CA-C-N 121.375 1.527 . . . . 0.67000000000000004 110.672 154.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -104.23 155.31 37.4 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.739 1.216 . . . . 0.62 110.76 168.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.19 -19.46 56.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.76000000000000001 112.641 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -177.63 165.55 2.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.243 2.217 . . . . 1.8999999999999999 110.617 175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -105.91 170.56 7.83 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.828 1.251 . . . . 0.90000000000000002 110.05 153.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -143.08 169.71 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.326 0.65 . . . . 2.5299999999999998 110.811 171.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -146.91 133.16 9.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 107.926 -1.139 . . . . 1.03 107.926 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.01 167.57 25.67 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.127 1.218 . . . . 1.1899999999999999 111.319 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.99 140.98 87.6 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.32 2.68 . . . . 1.3 110.952 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 59.3 mmtt 66.07 4.01 2.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.146 1.379 . . . . 1.79 113.074 -173.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.88 114.05 3.96 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 127.129 2.3 . . . . 1.47 113.06 -169.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -75.86 132.16 40.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.028 -1.586 . . . . 4.7699999999999996 110.076 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.93 164.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.119 2.168 . . . . 1.5800000000000001 109.428 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.97 117.89 0.91 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.024 0.929 . . . . 3.4399999999999999 109.574 -171.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -74.96 64.3 1.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.762 2.025 . . . . 1.6499999999999999 111.615 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -63.42 133.35 95.46 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.791 -1.193 . . . . 3.2000000000000002 110.789 167.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.49 -20.91 66.32 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.339 2.692 . . . . 1.78 113.76 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.21 55.98 5.05 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.081 0.848 . . . . 1.49 111.23 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.46 -64.49 0.13 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.635 1.112 . . . . 1.3500000000000001 113.998 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -153.85 145.0 22.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.64 1.576 . . . . 1.99 111.254 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -166.06 163.73 18.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.296 1.038 . . . . 1.1200000000000001 111.169 -174.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -107.73 127.02 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.069 0.548 . . . . 2.1099999999999999 111.065 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -90.69 108.41 19.8 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.265 1.426 . . . . 1.1899999999999999 110.142 164.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.39 130.76 37.98 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.144 0.978 . . . . 3.3999999999999999 108.772 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.82 150.62 51.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.265 1.426 . . . . 1.8799999999999999 110.781 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.35 53.31 5.19 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.979 -0.848 . . . . 2.9900000000000002 110.979 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.6 mt -68.95 114.04 6.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.883 0.842 . . . . 0.96999999999999997 109.555 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -98.96 -0.1 42.86 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.866 1.266 . . . . 2.02 111.961 -166.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -157.04 148.84 17.3 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.526 1.93 . . . . 6.0499999999999998 108.7 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.44 156.38 54.43 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.363 2.042 . . . . 1.8400000000000001 109.624 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 39' ' ' VAL . 4.2 mp -103.11 155.56 18.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.573 1.178 . . . . 3.1600000000000001 112.139 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -120.53 123.58 43.25 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.099 2.16 . . . . 4.7999999999999998 109.392 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 131.58 50.82 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.151 -0.968 . . . . 1.8999999999999999 111.586 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.08 44.06 78.71 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.16 -0.8 . . . . 1.78 112.669 -172.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.95 -178.07 3.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.741 -1.207 . . . . 3.04 107.741 151.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -127.0 161.29 28.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.472 1.109 . . . . 3.77 109.543 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.8 t -126.22 120.78 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 124.615 1.166 . . . . 1.0700000000000001 109.816 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -68.89 119.23 12.89 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 124.488 1.117 . . . . 2.7599999999999998 108.619 154.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.99 120.81 40.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.735 0.779 . . . . 1.72 109.055 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.9 93.66 8.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.762 -1.563 . . . . 2.4300000000000002 107.964 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.05 119.45 11.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.685 -0.857 . . . . 1.2 108.685 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.8 mt -90.92 120.59 32.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.665 -0.865 . . . . 0.64000000000000001 108.665 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 88.6 m-85 -116.12 131.18 57.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.069 0.938 . . . . 2.1400000000000001 112.343 -176.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.61 -18.51 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 131.014 3.726 . . . . 3.7599999999999998 116.932 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.81 -22.42 0.71 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.345 1.926 . . . . 5.7999999999999998 113.721 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.01 -6.56 0.06 OUTLIER Glycine 0 N--CA 1.474 1.204 0 N-CA-C 117.362 1.705 . . . . 3.8100000000000001 117.362 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -79.74 101.0 8.18 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 120.384 2.092 . . . . 4.8700000000000001 109.582 175.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.21 138.44 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.729 1.212 . . . . 1.6100000000000001 110.041 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.53 136.55 33.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.36 1.064 . . . . 1.8700000000000001 111.748 166.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.45 125.41 25.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.975 0.51 . . . . 2.1200000000000001 111.967 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -101.54 154.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.946 -0.761 . . . . 1.8200000000000001 108.946 142.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.8 p -118.99 139.8 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.062 -1.088 . . . . 2.1099999999999999 108.062 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -162.55 155.57 16.9 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.022 1.729 . . . . 2.6400000000000001 110.127 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.93 160.12 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.389 3.393 . . . . 1.01 115.04 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.3 t -87.6 122.59 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.697 1.199 . . . . 0.93999999999999995 110.058 164.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -92.64 131.17 37.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.729 2.011 . . . . 3.8199999999999998 107.554 161.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.21 116.17 5.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.308 0.643 . . . . 3.4100000000000001 111.431 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 129.3 3.04 . . . . 7.4100000000000001 107.208 176.68 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 110.122 -0.325 . . . . 5.1600000000000001 110.122 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.94 154.82 18.24 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 120.885 -1.135 . . . . 1.0600000000000001 112.684 166.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -158.3 145.09 17.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.476 1.111 . . . . 1.3300000000000001 111.675 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -97.33 137.16 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.791 -0.818 . . . . 1.1499999999999999 108.791 171.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.28 92.32 4.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.921 1.289 . . . . 3.46 109.536 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.18 159.67 9.4 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 123.548 1.642 . . . . 2.0800000000000001 112.383 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -162.85 154.69 15.4 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 129.08 2.952 . . . . 2.23 106.54 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 39.06 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.058 3.172 . . . . 1.97 112.418 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.23 178.79 51.42 Favored Glycine 0 CA--C 1.541 1.668 0 O-C-N 121.206 -0.934 . . . . 2.2999999999999998 112.173 -156.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.82 -12.23 23.54 Favored 'Cis proline' 0 CA--C 1.54 0.798 0 CA-C-N 118.435 1.118 . . . . 2.73 112.457 -11.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -155.7 168.54 26.84 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.411 1.884 . . . . 2.25 110.997 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.61 -177.15 4.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 0.85999999999999999 111.042 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.24 152.67 47.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.224 1.01 . . . . 0.98999999999999999 112.506 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.01 140.32 52.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.166 0.986 . . . . 0.96999999999999997 111.858 167.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -128.19 152.0 48.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.499 1.92 . . . . 2.0800000000000001 110.517 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pp -165.11 133.51 3.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.938 1.829 . . . . 1.75 115.938 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 m -76.81 139.02 40.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.143 -1.39 . . . . 1.1100000000000001 108.685 156.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.25 145.07 16.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 2.7599999999999998 108.257 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.43 144.94 49.18 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.518 0.599 . . . . 3.3399999999999999 111.502 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -86.9 109.58 25.68 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 108.621 -0.881 . . . . 1.25 108.621 155.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.05 -14.07 5.24 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.965 1.777 . . . . 1.1599999999999999 114.411 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.27 -153.98 24.16 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.63 1.012 . . . . 1.46 115.63 -159.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -93.74 -32.03 14.18 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.138 2.575 . . . . 5.8200000000000003 113.932 -173.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.12 158.83 36.91 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.375 1.47 . . . . 1.6599999999999999 112.052 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.85 155.33 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.798 2.332 . . . . 1.28 111.786 -170.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.91 132.52 56.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.142 1.377 . . . . 2.46 109.138 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -125.98 106.54 9.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.297 1.039 . . . . 4.8899999999999997 111.937 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.7 tp -92.21 112.51 24.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.463 2.305 . . . . 0.90000000000000002 109.651 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.02 -7.4 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.155 1.382 . . . . 0.76000000000000001 113.277 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.94 -167.09 38.67 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 121.458 -0.776 . . . . 0.62 112.247 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.34 175.29 10.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.107 0.563 . . . . 0.80000000000000004 111.9 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -156.31 91.27 1.24 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.221 -1.77 . . . . 6.6500000000000004 106.221 -164.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -104.7 152.85 39.54 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.116 1.366 . . . . 0.85999999999999999 110.59 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -27.55 16.28 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.394 2.729 . . . . 1.0800000000000001 113.531 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.31 1.7 m -89.93 -0.11 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 114.355 1.243 . . . . 0.91000000000000003 114.355 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.96 140.66 50.88 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.876 0.871 . . . . 0.81000000000000005 112.24 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -72.48 -68.89 0.44 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.173 -1.047 . . . . 5.54 108.173 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -90.09 149.25 22.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.442 2.297 . . . . 3.02 109.653 168.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.23 139.66 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.545 1.538 . . . . 1.5 109.548 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -142.17 140.82 32.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.906 1.682 . . . . 2.0299999999999998 110.521 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -81.79 122.5 27.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.515 1.052 . . . . 0.92000000000000004 111.346 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.9 m170 -111.74 156.9 21.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.561 1.544 . . . . 0.59999999999999998 112.553 174.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.95 -179.64 4.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.228 2.211 . . . . 1.8200000000000001 111.112 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.5 m -126.85 114.29 17.71 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.808 -1.553 . . . . 1.4199999999999999 106.808 151.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -89.5 152.15 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 2.3500000000000001 111.025 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.1 ptp -101.24 144.88 29.55 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.499 -0.773 . . . . 3.54 110.133 155.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.4 158.79 34.88 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.216 1.806 . . . . 7.25 109.468 171.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.37 148.95 22.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.585 -0.895 . . . . 3.8799999999999999 108.585 167.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.96 -79.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.649 0.737 . . . . 2.9100000000000001 110.372 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -76.19 35.18 0.14 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.445 2.298 . . . . 4.6399999999999997 111.651 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.33 -12.37 0.94 Allowed Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.289 -1.507 . . . . 2.0 113.744 -161.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -106.78 154.34 21.14 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 128.032 2.533 . . . . 4.0899999999999999 109.736 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -70.14 137.49 51.11 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.696 0.399 . . . . 3.8399999999999999 110.868 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.71 148.69 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.482 1.913 . . . . 2.0 108.402 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 19.8 mmt -115.5 142.04 47.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.697 1.199 . . . . 4.2699999999999996 109.351 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.82 151.76 23.37 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.283 0.947 . . . . 1.24 114.19 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -93.64 159.27 15.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.147 0.979 . . . . 2.1899999999999999 111.833 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -173.41 140.21 0.86 Allowed Pre-proline 0 N--CA 1.473 0.692 0 CA-C-O 116.67 -1.633 . . . . 3.5800000000000001 110.246 -168.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.0 OUTLIER -70.63 148.76 60.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.363 1.88 . . . . 0.93000000000000005 111.378 170.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.86 151.9 74.47 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 125.254 1.422 . . . . 0.68999999999999995 110.206 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.06 -13.65 26.12 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.938 2.425 . . . . 1.0 113.777 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -175.03 164.71 3.4 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.8 1.24 . . . . 2.0800000000000001 111.572 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -121.64 170.25 9.9 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 127.404 2.282 . . . . 0.76000000000000001 108.915 152.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.57 172.43 18.57 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.244 -0.91 . . . . 2.23 110.804 169.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.9 t -147.55 122.57 5.18 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 125.161 1.385 . . . . 1.05 109.664 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.11 159.66 51.55 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.947 1.765 . . . . 1.3 110.656 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.3 139.11 88.45 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.872 3.048 . . . . 1.1499999999999999 111.588 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.07 -8.32 1.32 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.252 2.221 . . . . 3.2400000000000002 115.088 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.08 129.03 8.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 126.525 2.012 . . . . 1.1299999999999999 110.283 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -87.65 148.16 24.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.556 -0.822 . . . . 4.7999999999999998 112.411 163.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.99 167.02 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.653 1.581 . . . . 2.2999999999999998 110.788 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -154.23 85.28 1.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.845 1.658 . . . . 3.04 107.0 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.83 68.87 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.894 1.678 . . . . 1.6100000000000001 112.055 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -72.36 151.45 92.01 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.497 2.719 . . . . 3.29 113.658 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.45 -58.91 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.752 2.968 . . . . 1.6299999999999999 112.614 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.85 83.3 1.16 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.389 -1.484 . . . . 1.5 109.389 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.6 -97.18 0.16 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 125.274 1.416 . . . . 1.3 111.492 -166.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -151.65 134.23 15.47 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.658 1.583 . . . . 2.0299999999999998 109.455 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -163.53 175.73 10.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.724 1.147 . . . . 1.04 110.647 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -108.65 125.81 52.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.128 0.571 . . . . 2.2599999999999998 110.497 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -85.57 144.46 27.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.334 1.054 . . . . 1.02 110.273 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -124.18 138.9 54.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.418 1.887 . . . . 1.9199999999999999 109.543 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.69 157.22 46.12 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.153 0.981 . . . . 2.25 112.106 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.26 -54.78 3.59 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 126.343 1.925 . . . . 2.8599999999999999 114.732 167.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.8 mt 76.81 95.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 130.305 3.442 . . . . 1.2 113.037 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -78.62 -0.97 31.97 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.834 1.42 . . . . 2.4700000000000002 114.834 -172.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -144.3 145.66 30.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 127.136 2.174 . . . . 5.3399999999999999 108.206 172.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.31 115.67 4.38 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.19 1.26 . . . . 2.4700000000000002 110.174 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.72 151.69 23.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 112.869 -1.969 . . . . 2.6800000000000002 109.913 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -144.82 -7.84 0.65 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 117.121 2.267 . . . . 5.1600000000000001 117.121 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.67 170.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.103 2.561 . . . . 2.2000000000000002 112.972 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.51 34.51 53.97 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.253 -0.748 . . . . 1.6899999999999999 111.681 -164.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.32 174.01 13.82 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 127.224 2.21 . . . . 3.3700000000000001 109.694 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 164.18 14.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.021 2.128 . . . . 4.0 111.696 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.2 t -133.86 108.38 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.593 1.157 . . . . 0.94999999999999996 109.455 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -71.34 98.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.979 -1.119 . . . . 3.6400000000000001 107.979 159.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 tt -98.74 138.61 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.697 -0.853 . . . . 1.9099999999999999 108.697 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.01 138.6 31.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 3.77 112.053 168.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.38 122.74 43.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.457 2.303 . . . . 1.3100000000000001 109.075 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.6 mt -92.89 119.73 32.5 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.136 0.974 . . . . 0.90000000000000002 109.935 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -115.57 150.52 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.943 0.877 . . . . 2.21 113.254 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 162.83 28.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.996 -0.547 . . . . 2.1899999999999999 111.332 165.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 20.4 79.55 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.263 -0.743 . . . . 4.6799999999999997 114.266 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.52 61.28 2.8 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 118.61 1.205 . . . . 2.4300000000000002 112.319 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 154.76 43.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.071 2.148 . . . . 4.0599999999999996 110.115 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -168.66 140.83 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.392 2.277 . . . . 1.5700000000000001 107.407 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.8 mt -150.21 109.61 3.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.187 0.903 . . . . 1.45 111.175 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -81.7 111.6 18.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.284 0.634 . . . . 2.8500000000000001 110.769 173.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -117.0 141.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.188 1.795 . . . . 1.6100000000000001 110.427 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.83 116.16 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.049 0.939 . . . . 1.79 112.227 -173.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.8 150.57 46.02 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.573 1.549 . . . . 3.2400000000000002 110.018 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.11 159.91 26.75 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.074 3.183 . . . . 1.05 111.954 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 130.59 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.086 0.955 . . . . 1.3600000000000001 111.342 169.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -97.96 139.65 33.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.832 2.453 . . . . 3.2400000000000002 107.48 159.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.05 9.31 32.49 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.345 1.98 . . . . 2.2599999999999998 116.345 -162.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.785 0 C-N-CA 126.956 2.102 . . . . 6.6799999999999997 110.133 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 . . . . . 0 CA--C 1.547 0.853 0 CA-C-O 120.444 0.164 . . . . 5.3399999999999999 110.692 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.81 163.1 12.86 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.714 1.149 . . . . 1.3300000000000001 115.277 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -151.37 149.46 29.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.4 1.08 . . . . 1.6699999999999999 113.228 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.49 121.55 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.405 0.682 . . . . 0.90000000000000002 110.118 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -86.69 90.43 8.27 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.027 0.931 . . . . 5.5999999999999996 110.754 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.03 149.33 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.246 1.418 . . . . 2.6000000000000001 112.054 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.0 m -155.59 162.54 27.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.774 2.029 . . . . 2.1699999999999999 109.724 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.03 -5.87 13.87 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.522 2.814 . . . . 2.0499999999999998 113.582 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 170.29 31.99 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.517 1.056 . . . . 1.8100000000000001 113.328 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.84 -2.29 21.84 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 117.951 0.875 . . . . 1.8700000000000001 113.272 -4.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.73 152.85 33.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.43 1.092 . . . . 2.9900000000000002 112.595 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.89 175.1 14.38 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.377 1.871 . . . . 0.71999999999999997 111.318 166.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.61 156.23 36.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.846 0.858 . . . . 0.81000000000000005 110.73 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.5 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.747 0.784 . . . . 0.60999999999999999 111.311 162.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.52 143.28 49.82 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.947 1.699 . . . . 2.27 108.3 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.02 144.78 23.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 120.687 -1.258 . . . . 1.6799999999999999 113.985 174.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -92.39 111.48 23.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.913 -1.494 . . . . 1.27 107.35 170.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.1 tt -120.16 147.18 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.873 2.469 . . . . 3.02 109.126 -174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -142.71 152.43 42.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.16 0.981 . . . . 2.75 113.418 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -100.14 102.39 17.84 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 113.976 -1.465 . . . . 1.1299999999999999 109.269 171.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.88 -9.93 16.84 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.811 2.341 . . . . 1.1799999999999999 113.041 174.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.84 -179.12 52.78 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 124.55 1.071 . . . . 1.1200000000000001 113.464 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.73 -2.73 19.8 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.182 1.793 . . . . 3.1499999999999999 112.965 -172.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.25 160.66 40.52 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.479 1.911 . . . . 1.3999999999999999 109.873 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.41 156.47 32.68 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.47 2.113 . . . . 0.75 111.884 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.13 120.02 36.5 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.991 1.316 . . . . 2.4700000000000002 110.05 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -106.89 103.72 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.936 1.294 . . . . 5.0700000000000003 111.609 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.22 114.45 26.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.858 2.063 . . . . 0.81999999999999995 109.282 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 m -92.21 -23.48 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.486 0.714 . . . . 0.89000000000000001 112.554 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.77 -168.64 40.24 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 123.751 0.691 . . . . 0.54000000000000004 111.529 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' CD2' ' A' ' 101' ' ' LEU . . . -150.93 175.07 12.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.506 -0.759 . . . . 1.3799999999999999 111.019 169.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 2.4 mmt85 -154.96 157.69 38.09 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.101 1.319 . . . . 6.9900000000000002 111.96 -167.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 t -161.18 154.88 18.49 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 124.843 1.257 . . . . 0.82999999999999996 110.226 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -68.21 -17.42 45.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.995 1.797 . . . . 1.0 113.074 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 1.5 m -86.22 11.74 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.123 1.157 . . . . 1.04 114.123 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.62 162.18 40.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.747 1.219 . . . . 0.77000000000000002 111.917 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.9 -75.68 0.62 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.482 -0.562 . . . . 3.3100000000000001 109.482 170.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -75.31 146.0 41.34 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.763 -1.199 . . . . 4.04 107.763 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -165.12 137.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.029 1.332 . . . . 1.4099999999999999 108.58 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -142.64 136.28 28.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.733 1.213 . . . . 1.99 110.547 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -79.97 120.15 23.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.568 0.699 . . . . 0.79000000000000004 109.635 163.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -104.27 152.75 21.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.032 1.333 . . . . 0.56999999999999995 111.327 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -106.54 163.67 12.69 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.562 1.945 . . . . 2.5099999999999998 110.016 163.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.6 m -152.2 113.71 4.33 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.104 1.362 . . . . 1.6699999999999999 108.403 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -131.77 151.65 51.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.689 1.196 . . . . 2.6099999999999999 112.343 -160.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.32 154.33 25.35 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.151 0.98 . . . . 4.1200000000000001 112.262 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -156.05 160.23 39.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.23 1.012 . . . . 5.9400000000000004 111.516 172.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.12 155.21 16.92 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.975 1.31 . . . . 5.21 109.658 162.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.29 113.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 124.99 1.431 . . . . 3.3700000000000001 111.175 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 60.53 17.41 7.32 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.032 0.933 . . . . 4.3899999999999997 112.345 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.85 4.91 89.62 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.239 -1.538 . . . . 3.46 114.267 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.43 128.75 34.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.722 1.609 . . . . 2.9700000000000002 109.795 168.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.05 134.75 51.16 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.252 -0.905 . . . . 6.1399999999999997 109.699 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.56 165.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.881 0.872 . . . . 3.1499999999999999 110.829 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.6 ptp -130.24 148.81 52.11 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.25 1.02 . . . . 3.6800000000000002 111.649 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 164.83 15.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.005 1.288 . . . . 2.1400000000000001 111.716 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.31 157.21 46.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 2.71 110.609 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -160.77 137.15 6.3 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 116.153 -1.879 . . . . 4.4000000000000004 108.99 -173.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.34 146.36 85.6 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.971 1.74 . . . . 0.87 110.403 151.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.98 155.96 52.54 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.853 1.261 . . . . 0.98999999999999999 110.538 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.14 -14.59 25.91 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.005 2.47 . . . . 1.3700000000000001 113.095 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -176.18 165.96 2.86 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.492 1.917 . . . . 2.6899999999999999 112.292 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -117.59 176.0 5.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.459 2.304 . . . . 1.1000000000000001 109.022 154.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.83 168.92 23.57 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.883 -1.135 . . . . 2.6800000000000002 112.217 163.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.8 t -140.72 130.83 13.37 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.222 1.009 . . . . 0.82999999999999996 109.446 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.61 162.67 38.19 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.473 2.115 . . . . 0.89000000000000001 111.206 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.6 143.67 99.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.162 2.575 . . . . 1.01 111.638 176.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 66.93 1.45 2.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.614 1.966 . . . . 1.5600000000000001 113.752 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.4 119.69 4.97 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 126.94 2.21 . . . . 1.03 111.164 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 135.21 36.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.77 1.228 . . . . 3.9100000000000001 111.147 160.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.96 152.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.024 1.729 . . . . 1.3799999999999999 110.77 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.55 120.56 32.32 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.85 1.66 . . . . 4.6799999999999997 109.075 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.34 69.24 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.251 1.5 . . . . 1.3600000000000001 112.973 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.49 133.6 53.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.405 1.882 . . . . 3.0299999999999998 113.368 169.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -56.34 -44.96 41.2 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.411 2.074 . . . . 1.8999999999999999 111.201 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.69 2.4 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.948 1.261 . . . . 1.3999999999999999 111.65 167.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -74.24 0.2 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.756 2.122 . . . . 1.5900000000000001 112.271 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -151.87 132.74 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.35 1.46 . . . . 2.3300000000000001 111.574 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -158.89 176.76 11.92 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.679 -1.263 . . . . 0.88 111.357 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -111.93 130.46 55.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 112.359 0.503 . . . . 2.1699999999999999 112.359 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -94.3 130.11 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.836 1.255 . . . . 0.93999999999999995 111.066 165.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.0 mt -109.83 132.74 53.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.797 1.639 . . . . 1.8500000000000001 109.001 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.02 150.49 49.23 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.32 1.057 . . . . 1.6499999999999999 112.969 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.92 -61.96 4.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.517 1.056 . . . . 2.6800000000000002 110.979 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mt 68.42 88.56 0.11 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 129.925 3.29 . . . . 0.89000000000000001 110.42 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -74.86 -3.81 34.16 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.131 -0.981 . . . . 1.97 113.281 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -145.56 144.39 22.61 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 127.809 2.444 . . . . 4.5499999999999998 107.768 168.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.71 173.2 14.49 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.649 2.233 . . . . 1.97 110.186 157.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.3 172.01 10.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.516 1.926 . . . . 4.25 108.149 166.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -126.79 1.9 6.71 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.828 1.788 . . . . 3.8799999999999999 115.828 174.082 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 76.38 158.43 0.2 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.785 2.834 . . . . 1.5600000000000001 110.922 -167.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 55.8 6.83 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 121.532 -0.73 . . . . 1.75 111.626 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.92 176.9 11.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.302 2.241 . . . . 3.5800000000000001 109.494 173.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.66 171.76 7.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.858 1.263 . . . . 4.25 109.804 166.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.7 t -128.8 125.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.825 1.65 . . . . 0.87 107.376 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -77.68 140.95 39.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.474 0.484 . . . . 3.1699999999999999 109.81 166.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.536 ' CD2' ' HB1' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -147.71 126.6 12.73 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.856 1.058 . . . . 1.29 113.856 -168.715 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.82 102.21 14.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.742 2.417 . . . . 2.6800000000000002 111.314 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.3 mt -78.58 111.91 15.13 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.926 -1.109 . . . . 1.6399999999999999 111.166 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -90.8 122.38 33.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.884 1.274 . . . . 0.78000000000000003 112.01 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.46 134.94 55.08 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.011 -1.056 . . . . 1.97 113.597 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.03 -28.03 69.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.896 1.278 . . . . 2.4399999999999999 113.605 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 31.25 1.09 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.73 1.157 . . . . 4.21 114.366 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.75 44.76 88.61 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.913 1.244 . . . . 1.78 112.628 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 150.22 45.66 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.394 1.478 . . . . 4.3700000000000001 111.283 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.83 137.28 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.048 -1.464 . . . . 1.49 107.048 155.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.4 mt -120.2 104.94 10.49 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 107.897 -1.149 . . . . 1.78 107.897 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -84.15 128.49 34.6 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.881 -0.512 . . . . 3.02 110.99 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.02 149.93 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.619 1.568 . . . . 2.3900000000000001 110.637 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.62 150.85 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.62 1.168 . . . . 3.1000000000000001 111.121 171.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -149.36 150.1 30.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.258 1.823 . . . . 2.0299999999999998 109.577 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.37 156.22 54.88 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.299 3.333 . . . . 1.51 114.054 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 69.1 t -87.22 145.9 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.379 1.072 . . . . 1.8700000000000001 111.882 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.25 152.52 51.3 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.378 3.471 . . . . 3.8500000000000001 107.065 176.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.87 168.58 19.44 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.251 1.575 . . . . 2.3100000000000001 115.251 -152.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 C-N-CA 128.006 2.523 . . . . 10.02 110.718 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 CA--C 1.545 0.761 0 CA-C-O 121.456 0.646 . . . . 5.5199999999999996 111.067 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -124.42 146.77 16.36 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.323 1.439 . . . . 1.3799999999999999 113.244 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -137.31 141.48 41.89 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.591 0.96 . . . . 1.3 113.591 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.8 t -95.47 107.95 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.709 0.804 . . . . 0.93999999999999995 109.48 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -88.92 111.72 22.44 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.492 1.042 . . . . 3.8900000000000001 111.027 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.26 168.92 18.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.399 1.48 . . . . 2.6400000000000001 112.844 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -160.98 158.3 23.91 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.267 1.827 . . . . 1.8799999999999999 110.212 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.69 6.65 3.96 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.027 3.151 . . . . 1.51 114.022 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.07 166.98 29.16 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.363 0.982 . . . . 1.4199999999999999 112.367 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.11 -2.27 22.87 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 CA-C-N 118.359 1.079 . . . . 1.52 112.724 -5.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -136.61 169.66 17.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.29 1.436 . . . . 2.0800000000000001 113.54 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.46 171.04 21.08 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.134 1.774 . . . . 0.78000000000000003 112.372 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.55 101.88 6.37 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.199 0.999 . . . . 1.3700000000000001 112.845 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.6 139.08 31.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.88 0.696 . . . . 0.80000000000000004 112.88 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.12 156.47 28.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.389 . . . . 2.1800000000000002 111.0 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.503 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -160.77 146.02 14.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.732 1.753 . . . . 1.53 115.732 166.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 m -79.66 126.9 31.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.461 -0.94 . . . . 1.1499999999999999 108.461 158.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -130.22 138.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.855 1.662 . . . . 2.8199999999999998 110.215 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.09 160.22 39.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.84 0.829 . . . . 2.7400000000000002 113.07 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.19 94.28 47.14 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.507 1.523 . . . . 1.01 109.999 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.98 -5.01 15.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.938 1.759 . . . . 1.1299999999999999 112.769 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.14 156.31 37.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.33 0.967 . . . . 1.1399999999999999 113.085 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.3 m-20 -91.91 4.73 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.456 1.902 . . . . 2.98 113.668 -171.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.84 159.07 42.16 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.859 1.663 . . . . 1.3 110.506 168.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.09 154.24 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.14 2.56 . . . . 0.65000000000000002 111.286 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.74 155.09 20.58 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.042 0.937 . . . . 1.8600000000000001 111.104 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.402 HH21 ' CD ' ' A' ' 68' ' ' GLU . 19.5 ttm180 -133.47 112.34 11.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.042 1.337 . . . . 4.0800000000000001 109.012 168.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.6 tp -93.93 110.47 22.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.759 2.024 . . . . 0.76000000000000001 108.051 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -102.06 -13.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.277 0.843 . . . . 0.56000000000000005 113.277 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -160.72 29.53 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.117 0.865 . . . . 0.46000000000000002 112.76 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.59 174.4 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.788 1.235 . . . . 0.80000000000000004 111.229 166.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -141.99 135.89 29.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.458 1.503 . . . . 5.46 109.279 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -145.09 147.65 35.36 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 119.594 1.088 . . . . 0.69999999999999996 110.643 -171.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.29 -0.39 10.0 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.5 2.8 . . . . 1.0700000000000001 113.92 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 93' ' ' LEU . 1.7 m -107.08 13.28 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.781 1.232 . . . . 1.0 114.093 174.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.34 157.04 43.75 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.431 -1.418 . . . . 1.03 111.667 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -105.35 -70.49 0.78 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.733 -0.84 . . . . 3.9500000000000002 108.733 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -79.22 146.85 32.83 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.969 -1.123 . . . . 3.75 107.969 161.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -147.09 137.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.097 1.359 . . . . 1.3 108.713 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -128.45 133.76 48.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.701 2.0 . . . . 2.3300000000000001 108.565 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -82.82 123.34 29.26 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.839 1.199 . . . . 0.83999999999999997 110.28 167.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 15.3 m170 -109.1 154.96 21.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.387 1.475 . . . . 0.65000000000000002 111.913 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -109.49 -179.14 3.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.594 1.958 . . . . 2.3799999999999999 110.923 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.7 m -133.63 114.34 13.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.497 1.519 . . . . 1.24 108.013 164.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -100.72 151.96 21.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.369 1.068 . . . . 1.8999999999999999 111.712 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -83.96 149.63 26.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.814 0.846 . . . . 4.3600000000000003 111.082 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -154.66 135.9 14.01 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.779 0.832 . . . . 5.4800000000000004 110.844 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.91 146.57 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.051 -0.722 . . . . 4.9000000000000004 109.051 157.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -152.6 123.61 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.329 1.452 . . . . 3.23 108.586 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 50.11 38.33 16.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.205 1.002 . . . . 4.4400000000000004 111.806 -169.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.32 -2.69 9.33 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.895 1.712 . . . . 2.6000000000000001 115.924 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -84.67 130.36 34.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.356 1.578 . . . . 2.7999999999999998 109.514 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.08 136.79 40.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.856 1.262 . . . . 5.1200000000000001 112.609 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -151.75 151.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.225 2.21 . . . . 2.3199999999999998 108.685 -167.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -113.72 131.65 56.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.196 0.998 . . . . 3.6800000000000002 109.9 168.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.81 164.21 22.0 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 124.384 0.992 . . . . 1.29 112.857 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -106.73 160.52 15.41 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.665 1.186 . . . . 1.8799999999999999 112.58 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -168.65 155.82 7.14 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 126.334 1.854 . . . . 3.8700000000000001 110.583 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.8 Cg_endo -69.58 152.84 70.28 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.79 1.66 . . . . 0.59999999999999998 112.286 167.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.27 158.42 48.63 Favored Pre-proline 0 N--CA 1.473 0.694 0 C-N-CA 126.312 1.845 . . . . 0.79000000000000004 110.148 172.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.77 -16.76 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.594 2.196 . . . . 0.83999999999999997 112.68 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -179.74 162.55 1.08 Allowed 'General case' 0 C--N 1.347 0.465 0 C-N-CA 126.236 1.815 . . . . 1.96 110.573 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -109.63 174.23 5.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.002 2.121 . . . . 1.03 109.554 157.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.5 pt-20 -154.83 166.84 32.23 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.145 -0.972 . . . . 2.3799999999999999 112.125 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.28 135.9 11.18 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 124.024 0.93 . . . . 0.82999999999999996 109.403 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.21 168.22 22.76 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.021 1.814 . . . . 0.79000000000000004 111.435 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.66 143.18 91.99 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.365 2.71 . . . . 0.76000000000000001 111.615 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.9 mmmt 68.15 1.0 2.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.968 2.107 . . . . 1.3600000000000001 114.012 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.92 -171.61 27.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.353 1.93 . . . . 1.1399999999999999 112.289 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -158.16 160.89 37.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.276 1.213 . . . . 3.96 114.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 m -143.9 132.14 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.365 1.466 . . . . 2.0099999999999998 111.136 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -93.4 126.55 38.59 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.283 0.633 . . . . 3.6899999999999999 109.336 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -71.03 66.6 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.834 1.302 . . . . 1.45 109.268 161.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -73.11 141.55 81.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.533 2.333 . . . . 3.1400000000000001 111.422 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.13 -44.46 49.16 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 1.2 113.677 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.89 80.85 1.56 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.671 -1.372 . . . . 1.3899999999999999 109.671 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.17 -70.33 0.2 Allowed Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.097 -0.835 . . . . 1.3100000000000001 114.211 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -157.17 146.98 20.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.344 1.857 . . . . 2.1499999999999999 110.154 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -172.89 152.56 2.44 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.569 -1.332 . . . . 1.25 110.444 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -88.98 123.89 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.537 0.335 . . . . 2.3399999999999999 110.961 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.6 mmt -83.54 100.9 11.08 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.881 1.272 . . . . 0.96999999999999997 109.798 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -78.79 138.6 38.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.723 1.209 . . . . 1.8500000000000001 107.811 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -144.09 148.9 35.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.443 1.116 . . . . 1.71 112.178 -173.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.8 -53.13 4.53 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.8 1.191 . . . . 2.5699999999999998 111.42 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 61.15 95.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.667 2.787 . . . . 0.84999999999999998 110.92 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.9 -15.1 62.09 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.794 -1.191 . . . . 2.3799999999999999 112.339 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -147.14 145.66 22.87 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 128.292 2.637 . . . . 4.75 107.848 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.72 176.63 8.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.984 2.456 . . . . 2.3599999999999999 109.879 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 39' ' ' VAL . 1.5 mp -130.55 -179.0 5.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.972 0.909 . . . . 3.79 111.93 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -151.0 144.65 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.461 1.904 . . . . 5.0099999999999998 110.022 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 131.57 49.3 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.624 1.169 . . . . 2.2799999999999998 112.955 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.58 -16.37 52.05 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.887 -1.507 . . . . 3.9300000000000002 115.125 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.69 172.11 8.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.541 1.67 . . . . 6.0800000000000001 111.191 -166.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.42 111.88 23.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.263 1.825 . . . . 4.4299999999999997 111.485 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.67 117.63 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.085 -1.08 . . . . 1.0 108.085 165.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -74.19 140.91 45.44 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.38 1.086 . . . . 2.9399999999999999 110.911 157.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.78 125.97 12.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.938 1.695 . . . . 1.76 109.843 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.57 96.29 7.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.98 2.112 . . . . 2.8399999999999999 109.439 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.0 mt -80.27 112.42 17.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.023 1.729 . . . . 1.6899999999999999 110.222 -171.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.4 mt -82.85 128.61 34.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.314 1.046 . . . . 1.0 111.472 -170.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 89.0 m-85 -124.2 126.96 47.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.649 0.78 . . . . 2.3599999999999999 112.055 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 41.28 29.34 0.09 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.59 2.356 . . . . 2.5299999999999998 116.399 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.73 -55.39 3.8 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.321 1.439 . . . . 4.3099999999999996 113.087 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.33 -3.13 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.82 1.2 . . . . 2.0899999999999999 115.374 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 6.2 mtpp -130.52 161.16 32.1 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.07 1.435 . . . . 5.21 114.025 175.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.48 166.44 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.874 2.07 . . . . 1.22 108.715 155.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.6 mt -137.24 126.5 24.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.713 1.605 . . . . 1.6399999999999999 109.339 159.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -83.48 131.71 34.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.133 0.424 . . . . 2.5600000000000001 111.469 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.02 156.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.592 1.157 . . . . 3.1200000000000001 109.535 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.396 1.878 . . . . 1.71 109.995 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -143.49 144.44 27.79 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.495 1.518 . . . . 2.6299999999999999 110.773 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 149.46 28.52 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.202 2.602 . . . . 1.1599999999999999 113.616 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.4 t -84.23 130.56 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.006 1.322 . . . . 1.0600000000000001 112.571 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.0 144.67 29.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.106 1.762 . . . . 3.3100000000000001 109.527 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.51 86.77 2.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.643 1.177 . . . . 2.1499999999999999 109.784 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.167 1.387 . . . . 7.5499999999999998 110.733 -166.002 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 122.288 1.042 . . . . 5.6600000000000001 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.18 170.59 42.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.415 1.959 . . . . 1.22 111.353 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.0 p90 -158.13 146.49 18.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.596 1.158 . . . . 1.3999999999999999 110.998 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -106.72 118.35 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.583 -1.266 . . . . 0.93999999999999995 107.583 170.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -89.51 114.61 26.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.159 0.984 . . . . 3.75 109.769 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.07 166.92 21.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.05 1.405 . . . . 2.3999999999999999 113.497 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t -156.32 155.26 28.71 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.602 2.361 . . . . 3.1200000000000001 108.385 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.93 -13.78 39.36 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.544 2.163 . . . . 1.8899999999999999 112.559 165.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.87 174.71 18.37 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.964 1.745 . . . . 1.72 112.737 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 -5.91 48.26 Favored 'Cis proline' 0 CA--C 1.54 0.809 0 CA-C-N 118.415 1.107 . . . . 1.79 113.513 -1.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -126.98 161.98 27.07 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.611 1.165 . . . . 1.97 113.23 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.01 -176.37 5.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.361 2.264 . . . . 0.70999999999999996 111.635 -175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.56 146.6 25.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.211 0.819 . . . . 0.80000000000000004 113.211 -168.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.37 156.08 45.2 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.749 1.018 . . . . 0.72999999999999998 113.749 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.37 149.77 28.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.381 1.872 . . . . 2.1400000000000001 109.881 -169.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -171.74 160.81 5.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.281 1.032 . . . . 1.78 113.66 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -94.54 119.9 33.94 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.16 0.984 . . . . 1.23 109.875 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.2 124.95 40.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.861 1.264 . . . . 3.1000000000000001 108.619 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -120.18 122.63 41.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.983 1.313 . . . . 3.8599999999999999 110.328 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -102.61 103.96 35.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.349 -0.611 . . . . 0.97999999999999998 109.349 164.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -86.6 -11.32 5.92 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.223 2.616 . . . . 1.05 113.122 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.83 160.44 43.03 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 124.273 0.939 . . . . 1.1399999999999999 112.657 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.45 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.2 m-20 -90.25 5.97 44.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 2.9500000000000002 113.235 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.98 160.02 40.54 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.241 1.816 . . . . 1.8400000000000001 110.602 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.82 152.16 22.07 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.915 2.41 . . . . 0.82999999999999996 111.432 -171.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -116.63 123.76 48.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.674 1.19 . . . . 2.0699999999999998 110.385 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ttp-105 -117.77 110.45 17.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.227 1.411 . . . . 4.4900000000000002 111.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -97.73 106.15 18.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.278 2.231 . . . . 0.84999999999999998 108.936 -170.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.04 -19.36 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.056 0.942 . . . . 0.82999999999999996 112.683 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.93 -162.34 30.57 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.536 0.607 . . . . 0.70999999999999996 112.674 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -138.0 -177.57 4.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.054 0.942 . . . . 0.81999999999999995 110.444 170.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -148.26 141.7 25.32 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 105.149 -2.167 . . . . 7.4299999999999997 105.149 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.68 152.3 37.44 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.649 -1.167 . . . . 0.71999999999999997 109.195 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.6 -34.21 98.7 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.647 2.231 . . . . 0.97999999999999998 113.029 167.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.284 2.2 m -81.94 4.04 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.484 0.92 . . . . 0.94999999999999996 113.484 -165.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.08 19.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.527 1.058 . . . . 0.71999999999999997 113.51 -174.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.09 -51.8 1.54 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 3.6299999999999999 110.656 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -79.51 133.54 36.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.037 -1.097 . . . . 3.2000000000000002 108.037 155.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -145.75 126.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 127.062 2.145 . . . . 1.29 108.364 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.91 115.87 6.03 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.69 0.796 . . . . 2.5699999999999998 110.972 -157.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.39 121.42 23.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.821 1.192 . . . . 0.80000000000000004 110.377 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.3 m170 -108.1 151.67 25.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.75 1.62 . . . . 0.52000000000000002 113.259 174.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.91 172.02 8.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.746 1.618 . . . . 2.23 110.125 163.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -151.06 86.58 1.37 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.382 1.473 . . . . 1.0700000000000001 107.674 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -96.56 -173.81 2.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.802 2.041 . . . . 2.48 111.576 -171.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.44 139.72 27.08 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.028 0.918 . . . . 3.21 111.855 170.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.22 150.43 26.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.602 1.161 . . . . 6.4199999999999999 111.959 -170.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.327 16.6 pm0 -64.99 142.17 58.53 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.227 1.811 . . . . 6.0999999999999996 113.44 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 t -130.21 -95.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.157 1.383 . . . . 2.7599999999999998 107.37 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -73.08 45.48 0.15 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.908 2.083 . . . . 4.8600000000000003 111.919 164.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.98 -40.15 1.18 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.533 1.539 . . . . 2.25 113.265 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -61.81 138.62 58.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.023 1.729 . . . . 3.79 110.862 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -77.89 112.23 14.56 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.201 0.6 . . . . 4.9400000000000004 109.803 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.86 139.56 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.443 1.897 . . . . 1.6599999999999999 108.632 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -83.86 139.65 32.51 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.725 1.21 . . . . 3.0800000000000001 110.824 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.41 163.36 31.54 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.493 0.557 . . . . 0.94999999999999996 114.493 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -112.85 165.56 12.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.276 1.43 . . . . 1.71 112.406 -176.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.252 76.0 mtt180 -169.52 141.58 1.98 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 128.738 2.815 . . . . 4.8200000000000003 106.55 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.2 Cg_endo -68.95 150.73 73.39 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 CA-C-N 122.024 1.759 . . . . 0.66000000000000003 110.192 156.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.97 156.87 47.73 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.143 1.377 . . . . 0.55000000000000004 110.438 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.42 -23.48 50.86 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.356 2.037 . . . . 0.69999999999999996 112.395 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -178.78 167.38 1.7 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 126.434 1.893 . . . . 2.23 111.585 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.091 1.356 . . . . 0.93999999999999995 110.071 150.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.251 2.8 pt-20 -153.55 160.0 42.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.888 -0.507 . . . . 2.7200000000000002 111.949 164.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 t -141.42 134.46 14.31 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 125.798 1.639 . . . . 1.1000000000000001 108.851 -166.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.52 164.61 32.19 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.409 2.073 . . . . 0.98999999999999999 111.679 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.38 145.03 99.12 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.346 2.697 . . . . 0.79000000000000004 111.825 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 16.5 mmmt 68.96 -1.62 2.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.36 1.864 . . . . 1.4099999999999999 113.66 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.02 125.94 7.85 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 127.649 2.547 . . . . 0.92000000000000004 112.811 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -86.37 149.43 25.03 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.994 -1.103 . . . . 5.3700000000000001 111.79 156.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 m -152.45 131.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.64 1.576 . . . . 1.6599999999999999 109.52 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -89.84 134.43 34.2 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.287 1.035 . . . . 4.0899999999999999 111.028 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 mp -76.13 66.22 2.25 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.214 1.483 . . . . 1.53 110.122 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -56.97 124.47 65.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 4.8499999999999996 109.838 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.32 -33.96 88.35 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.574 2.85 . . . . 1.3799999999999999 113.765 -169.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.94 45.63 2.52 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.068 0.849 . . . . 1.8899999999999999 112.361 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.45 -57.87 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.567 2.032 . . . . 1.4399999999999999 113.988 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -150.26 145.54 26.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.889 1.676 . . . . 2.0299999999999998 110.877 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -166.14 179.83 5.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.344 1.058 . . . . 0.79000000000000004 110.941 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -115.7 132.48 56.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.23 1.012 . . . . 2.2400000000000002 111.132 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.7 mmt -93.11 139.77 30.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 0.85999999999999999 110.772 165.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 143.18 51.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.719 1.608 . . . . 2.98 109.736 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -146.18 160.32 42.12 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 2.2000000000000002 112.079 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.58 -82.39 1.69 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.084 1.326 . . . . 2.7799999999999998 109.895 -169.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 76.85 125.68 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.786 3.634 . . . . 0.92000000000000004 110.941 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -77.74 -22.97 49.51 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.818 -1.176 . . . . 2.02 112.881 -170.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -161.83 158.15 21.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 130.233 3.413 . . . . 6.8499999999999996 109.059 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.39 149.09 56.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.758 2.305 . . . . 3.4500000000000002 109.653 160.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 -176.57 2.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.037 1.735 . . . . 3.4199999999999999 109.82 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.35 141.63 19.55 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.214 -1.554 . . . . 3.5 110.513 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -34.79 135.99 0.17 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.637 1.717 . . . . 1.8100000000000001 115.637 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.83 22.39 69.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.124 0.81 . . . . 1.9099999999999999 115.124 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -88.83 -179.46 5.98 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.754 1.222 . . . . 3.3100000000000001 109.839 158.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -130.74 168.89 16.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.103 0.961 . . . . 3.5899999999999999 111.321 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.9 t -136.33 117.71 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.391 1.476 . . . . 0.93000000000000005 109.967 -172.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.42 42.04 0.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.016 2.127 . . . . 4.3399999999999999 114.214 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.5 tt -65.39 137.09 57.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 123.4 1.571 . . . . 1.8600000000000001 112.958 -164.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.09 112.61 25.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.781 2.032 . . . . 2.4900000000000002 111.303 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -82.43 120.32 25.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.084 1.354 . . . . 1.1899999999999999 110.752 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.8 mt -96.68 123.42 40.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.614 1.166 . . . . 0.83999999999999997 111.54 -168.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.45 133.65 55.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.147 1.536 . . . . 1.8700000000000001 115.147 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.17 48.28 0.85 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.821 2.048 . . . . 2.6800000000000002 112.768 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.38 19.79 2.81 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.106 2.289 . . . . 4.9299999999999997 112.307 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.98 38.07 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 118.275 1.037 . . . . 2.25 112.098 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 150.01 36.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.155 1.782 . . . . 3.6699999999999999 111.197 -175.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.85 131.62 20.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 126.015 1.726 . . . . 1.1100000000000001 108.073 161.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.14 122.69 41.56 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.331 1.452 . . . . 2.2000000000000002 109.277 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -79.84 132.34 36.09 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.835 -0.541 . . . . 2.4500000000000002 111.548 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -129.55 127.47 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.393 1.077 . . . . 1.49 109.567 167.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.22 138.38 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.059 0.943 . . . . 2.8300000000000001 110.224 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.4 mt -143.55 142.62 21.37 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.252 1.421 . . . . 1.8300000000000001 110.083 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.85 153.04 64.13 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.385 2.723 . . . . 1.1100000000000001 112.667 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.5 t -83.4 113.95 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.113 1.365 . . . . 1.1499999999999999 108.926 165.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -100.36 145.81 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.583 1.953 . . . . 3.7999999999999998 108.015 167.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.91 55.21 0.78 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.3 1.593 . . . . 2.9100000000000001 115.3 -152.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.076 2.15 . . . . 7.8399999999999999 111.25 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 110.312 -0.255 . . . . 5.1600000000000001 110.312 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.97 169.04 26.31 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.647 -1.283 . . . . 0.87 114.436 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -150.63 146.59 26.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.762 1.625 . . . . 1.48 111.558 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -109.44 107.66 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.682 -1.229 . . . . 1.0700000000000001 107.682 171.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -82.4 121.9 27.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.276 -0.639 . . . . 3.77 109.276 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -160.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.447 1.099 . . . . 2.23 112.016 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 8.6 t 174.0 157.65 0.31 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 128.641 2.776 . . . . 2.77 106.935 168.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.97 -10.78 29.74 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.572 2.182 . . . . 1.7 113.197 167.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.53 177.69 26.06 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.005 1.288 . . . . 1.49 112.007 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.51 -1.21 32.26 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 CA-C-N 118.665 1.232 . . . . 1.49 113.621 1.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -140.58 158.27 44.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.793 1.237 . . . . 2.0699999999999998 112.478 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 11' ' ' SER . . . -152.98 -178.74 7.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.155 2.582 . . . . 0.63 110.27 -177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.22 133.59 16.43 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.344 1.239 . . . . 0.98999999999999999 114.344 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.55 153.02 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.847 1.259 . . . . 0.71999999999999997 111.981 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.44 136.95 15.9 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.911 1.684 . . . . 2.21 109.373 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -161.53 150.8 16.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.07 1.508 . . . . 2.1800000000000002 115.07 -167.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -72.11 125.79 28.15 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.282 1.033 . . . . 1.45 108.714 165.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 tt -107.13 155.33 19.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.939 1.696 . . . . 3.04 110.47 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.01 161.77 37.24 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 115.536 1.68 . . . . 3.75 115.536 165.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -130.79 96.46 23.07 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 127.306 2.242 . . . . 1.1799999999999999 109.425 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.88 -8.19 13.28 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.506 2.138 . . . . 1.0 113.703 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.05 157.71 41.48 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 119.655 1.116 . . . . 1.3600000000000001 112.179 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -82.87 9.8 9.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.126 1.771 . . . . 3.2999999999999998 112.681 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mt -110.58 165.32 12.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 129.031 2.933 . . . . 2.46 108.507 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.34 157.58 12.79 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.958 2.439 . . . . 0.77000000000000002 111.445 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.99 147.76 38.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.437 1.095 . . . . 1.8999999999999999 111.231 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 ttp-105 -135.79 112.24 9.92 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.125 1.37 . . . . 3.4700000000000002 110.768 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -88.07 120.68 29.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.957 2.103 . . . . 1.1599999999999999 108.741 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.78 -20.85 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.03 1.332 . . . . 0.65000000000000002 112.669 -177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.67 -162.2 20.31 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 122.214 0.897 . . . . 0.65000000000000002 112.061 169.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.889 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -149.48 177.58 9.58 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.229 1.811 . . . . 0.65000000000000002 108.64 171.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -161.82 152.64 17.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.04 1.291 . . . . 6.1100000000000003 109.323 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -153.72 151.42 25.05 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 125.469 1.508 . . . . 0.60999999999999999 108.932 -166.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.1 -23.03 46.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.184 1.923 . . . . 0.88 113.843 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 m -88.01 -3.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 115.36 1.615 . . . . 1.0600000000000001 115.36 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.58 134.71 49.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.931 1.241 . . . . 0.85999999999999999 111.176 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -56.44 18.94 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.777 1.171 . . . . 5.71 109.277 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -124.12 151.48 43.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.53 1.932 . . . . 4.2300000000000004 110.974 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.86 135.2 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.904 2.082 . . . . 2.4500000000000002 107.934 163.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -126.77 130.1 49.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.95 0.9 . . . . 2.3799999999999999 109.666 167.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tp -85.92 117.34 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.59 1.556 . . . . 3.4399999999999999 108.843 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.3 m170 -126.43 151.96 47.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.084 1.354 . . . . 0.83999999999999997 113.778 -170.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.65 167.7 13.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.079 1.751 . . . . 2.52 111.806 165.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.4 m -153.61 92.66 1.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.706 2.002 . . . . 2.0800000000000001 107.213 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -109.61 163.48 13.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.111 1.152 . . . . 2.48 114.111 -156.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.68 143.93 27.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.301 1.04 . . . . 4.0 109.907 150.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -149.57 151.75 34.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.665 2.386 . . . . 7.8200000000000003 107.09 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.33 145.44 37.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.683 0.793 . . . . 4.9100000000000001 111.72 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.88 117.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.81 -1.552 . . . . 3.9500000000000002 106.81 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.3 28.58 17.96 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.3 1.04 . . . . 7.29 111.461 -172.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.33 -12.79 12.38 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 120.486 -1.384 . . . . 4.3099999999999996 114.049 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -75.52 135.09 40.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.305 1.442 . . . . 5.04 109.75 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -74.06 135.24 43.01 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.205 1.002 . . . . 4.5199999999999996 111.878 -170.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.03 144.84 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.775 1.63 . . . . 2.54 109.421 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.97 139.0 51.14 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.804 1.242 . . . . 3.0899999999999999 111.905 172.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -179.15 38.66 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 123.854 0.74 . . . . 1.29 113.694 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.4 177.63 4.96 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.057 1.343 . . . . 2.04 111.823 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 175.64 143.1 0.22 Allowed Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 126.813 2.045 . . . . 7.4500000000000002 110.039 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.3 Cg_endo -67.83 154.46 72.96 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 121.617 1.613 . . . . 0.76000000000000001 110.783 161.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.93 156.43 69.0 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 125.989 1.716 . . . . 0.84999999999999998 109.986 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.77 -19.92 40.52 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.028 1.819 . . . . 0.73999999999999999 112.58 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 178.84 169.96 0.88 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.728 1.611 . . . . 1.8500000000000001 111.031 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.03 163.58 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.11 1.364 . . . . 0.69999999999999996 108.938 157.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.253 0.2 OUTLIER -153.57 158.39 41.13 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.504 -0.748 . . . . 2.0099999999999998 112.28 177.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -146.34 133.65 10.2 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.298 1.439 . . . . 0.98999999999999999 108.863 -162.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.11 168.36 24.95 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.0 2.467 . . . . 0.81999999999999995 111.902 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.49 137.65 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.188 3.925 . . . . 1.28 114.287 165.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt 68.38 1.21 2.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.951 1.7 . . . . 1.5800000000000001 114.049 169.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 115.08 4.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.86 1.695 . . . . 1.0900000000000001 112.209 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.71 122.26 42.45 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.065 1.746 . . . . 4.8300000000000001 109.5 161.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.1 m -155.22 146.29 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.273 1.429 . . . . 2.0099999999999998 112.288 -163.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -91.27 142.79 27.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.085 0.954 . . . . 3.1499999999999999 113.021 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.4 68.85 0.23 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 1.22 108.508 148.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -54.19 122.62 37.53 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.054 1.742 . . . . 4.0499999999999998 110.381 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.15 -42.16 66.29 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.546 2.831 . . . . 1.52 112.891 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.02 75.3 2.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.7 -0.96 . . . . 1.2 110.7 161.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.77 -61.03 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.759 1.647 . . . . 1.3 112.462 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -151.55 150.67 30.61 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.482 1.513 . . . . 3.0699999999999998 111.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -160.19 170.72 20.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.221 1.008 . . . . 1.3999999999999999 111.079 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -102.51 127.4 49.58 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.249 1.019 . . . . 2.2000000000000002 110.64 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mmt -83.44 124.87 31.12 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.798 0.839 . . . . 1.29 110.574 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.28 134.35 48.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.195 1.398 . . . . 1.8700000000000001 108.707 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.3 mt -134.2 161.01 36.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.65 1.18 . . . . 1.7 112.008 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.91 35.06 39.11 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 126.144 1.83 . . . . 2.4100000000000001 114.998 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 mt -37.14 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.245 2.218 . . . . 0.96999999999999997 114.652 -156.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -77.25 14.25 0.97 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.977 1.473 . . . . 1.8899999999999999 114.977 -165.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -159.49 147.03 13.04 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 131.44 3.896 . . . . 7.2000000000000002 109.468 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.98 170.52 15.45 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.015 2.476 . . . . 2.1899999999999999 109.317 166.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 157.64 43.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.302 1.049 . . . . 4.4400000000000004 112.791 -165.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -143.18 144.11 32.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.821 1.648 . . . . 4.29 109.639 176.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.4 144.04 57.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.856 0.863 . . . . 1.8 111.901 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.91 45.22 27.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.854 -0.97 . . . . 1.73 112.934 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -109.35 177.87 4.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.534 0.734 . . . . 4.8499999999999996 109.741 148.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.57 161.62 17.64 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.216 1.806 . . . . 4.5999999999999996 110.201 152.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -125.58 133.16 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.691 1.597 . . . . 1.1799999999999999 109.721 163.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.65 144.76 28.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.901 1.68 . . . . 3.1699999999999999 110.292 172.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.889 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.8 tt -156.37 131.74 9.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.39 1.076 . . . . 1.6799999999999999 112.087 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.42 115.18 27.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.537 2.335 . . . . 2.2799999999999998 111.947 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.19 118.9 22.96 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.688 1.585 . . . . 1.26 109.547 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.7 mt -98.37 122.51 41.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.231 1.012 . . . . 0.70999999999999996 110.36 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -113.82 154.41 27.48 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.036 0.934 . . . . 2.02 112.6 -173.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.7 95.97 0.37 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.088 1.355 . . . . 1.96 112.605 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.45 -147.78 18.61 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.056 1.312 . . . . 3.0299999999999998 111.317 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.47 36.94 2.02 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.287 0.946 . . . . 1.71 115.379 -171.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -127.74 134.08 49.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.696 1.748 . . . . 4.7300000000000004 113.075 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.61 147.32 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.362 1.865 . . . . 1.0900000000000001 108.064 158.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -141.17 115.89 9.66 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.182 1.393 . . . . 1.5800000000000001 108.164 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.11 153.06 21.81 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.705 1.002 . . . . 2.5499999999999998 113.705 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.75 166.88 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.319 2.248 . . . . 1.26 109.768 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.23 133.99 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.21 1.004 . . . . 1.72 108.457 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt -145.64 152.44 49.03 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.28 1.432 . . . . 2.0499999999999998 110.56 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.81 151.97 74.04 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 125.2 3.933 . . . . 0.85999999999999999 115.16 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.2 t -83.41 100.72 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.681 1.592 . . . . 1.05 109.719 170.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -90.7 74.68 6.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.009 1.724 . . . . 3.0699999999999998 109.018 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.16 128.6 37.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.077 -1.014 . . . . 2.1099999999999999 113.544 -166.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 . . . . . 0 N--CA 1.484 1.273 1 C-N-CA 132.647 4.379 . . . . 7.3300000000000001 108.493 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 106.55 -1.648 . . . . 5.7000000000000002 106.55 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.21 156.06 22.61 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.681 -0.637 . . . . 0.95999999999999996 113.638 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -154.73 147.32 24.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.19 0.996 . . . . 1.6599999999999999 111.797 175.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.44 116.97 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.616 0.767 . . . . 0.91000000000000003 110.649 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 ttp85 -81.61 103.23 11.18 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.028 1.331 . . . . 4.04 110.577 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.55 165.06 25.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 123.431 1.586 . . . . 2.2999999999999998 112.465 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -161.22 154.08 17.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.58 2.352 . . . . 1.9399999999999999 107.949 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.28 27.6 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.398 3.398 . . . . 1.5600000000000001 113.503 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.71 169.42 42.76 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.477 -0.764 . . . . 1.4199999999999999 113.049 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.14 -5.58 25.77 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 118.005 0.902 . . . . 1.53 112.604 -10.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.99 157.65 44.06 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.073 1.349 . . . . 3.0 113.34 -168.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.27 -176.21 5.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.63 1.972 . . . . 0.67000000000000004 111.294 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.44 129.0 15.04 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.986 0.914 . . . . 1.01 111.814 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.27 138.41 44.59 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.787 1.235 . . . . 0.71999999999999997 111.84 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -124.83 151.32 45.39 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.138 2.175 . . . . 2.5 109.102 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.03 150.11 16.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.173 1.175 . . . . 1.74 114.173 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -89.49 113.63 25.03 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.501 -0.926 . . . . 1.4299999999999999 108.501 166.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.82 156.54 20.97 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.038 1.735 . . . . 2.7000000000000002 110.806 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.15 157.45 43.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.911 0.708 . . . . 3.5600000000000001 112.911 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -96.34 109.79 49.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 114.359 -1.291 . . . . 1.0900000000000001 110.19 166.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.84 -2.82 10.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.371 2.714 . . . . 1.21 113.78 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.69 171.27 37.64 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.4 1.0 . . . . 1.04 113.133 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -95.57 0.13 52.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.525 1.53 . . . . 3.5299999999999998 113.781 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -116.84 154.61 49.55 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.674 1.589 . . . . 1.3500000000000001 110.056 167.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.91 159.05 27.55 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.501 2.801 . . . . 0.68999999999999995 112.506 -164.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -106.59 152.23 23.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.68 1.192 . . . . 1.8200000000000001 110.837 171.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -130.78 112.25 12.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.084 1.353 . . . . 3.8900000000000001 109.619 171.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 tp -94.81 112.3 24.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.065 2.546 . . . . 0.72999999999999998 109.601 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.79 -11.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.922 1.082 . . . . 0.58999999999999997 113.922 -165.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.74 -167.95 40.67 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.506 -0.746 . . . . 0.63 112.583 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.54 -179.69 7.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.506 0.558 . . . . 0.85999999999999999 112.506 167.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -145.69 142.19 28.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.327 1.051 . . . . 7.21 109.044 169.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -153.9 151.09 24.09 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.544 1.138 . . . . 0.65000000000000002 110.448 -164.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.72 -17.81 37.55 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.396 2.064 . . . . 1.04 112.652 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.32 2.0 m -96.91 11.07 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.199 1.555 . . . . 1.6399999999999999 115.199 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . . . -154.82 144.29 21.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.91 1.448 . . . . 0.97999999999999998 114.91 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.87 -69.82 0.75 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.934 -0.765 . . . . 3.1200000000000001 108.934 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.912 -1.514 . . . . 2.7599999999999998 106.912 164.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.19 129.17 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.173 1.789 . . . . 1.28 107.548 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.3 131.95 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.325 1.45 . . . . 1.9099999999999999 109.273 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.07 122.17 27.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.086 0.945 . . . . 0.78000000000000003 110.579 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -112.52 159.29 18.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.834 2.054 . . . . 0.5 111.986 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.37 -177.34 3.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.742 2.017 . . . . 2.6600000000000001 110.925 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 m -137.12 116.28 12.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.339 1.456 . . . . 1.3300000000000001 107.59 163.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -96.74 162.53 13.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.863 0.865 . . . . 2.25 110.996 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -112.32 143.14 43.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 3.5800000000000001 110.822 162.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -153.78 159.67 41.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.742 1.617 . . . . 5.6399999999999997 111.295 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 141.35 36.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.823 -0.806 . . . . 4.1399999999999997 108.823 156.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.33 -8.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 115.139 1.533 . . . . 3.1400000000000001 115.139 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -158.27 46.0 0.33 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.673 1.989 . . . . 4.0800000000000001 107.586 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.74 -24.06 0.4 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.766 1.651 . . . . 2.0 114.706 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -99.79 153.47 19.1 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.122 2.169 . . . . 3.1200000000000001 112.49 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -61.66 136.54 58.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.956 0.902 . . . . 3.8900000000000001 111.34 169.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.8 t -140.0 150.44 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.061 2.144 . . . . 1.9299999999999999 108.275 168.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.3 mtm -111.57 144.48 40.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.396 1.079 . . . . 3.1800000000000002 111.347 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.47 158.03 28.16 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 123.597 0.618 . . . . 1.0900000000000001 113.012 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.67 165.56 11.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.413 1.085 . . . . 1.74 112.551 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -171.15 155.29 4.32 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.535 1.934 . . . . 3.8700000000000001 109.848 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.6 Cg_endo -69.75 152.33 69.36 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.926 1.75 . . . . 0.59999999999999998 111.482 167.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -115.17 157.97 42.27 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 126.381 1.872 . . . . 0.78000000000000003 110.278 170.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -69.36 -21.43 35.36 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 0.81999999999999995 111.952 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -177.93 161.25 1.54 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.267 1.827 . . . . 2.1200000000000001 110.82 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -108.2 174.97 5.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.741 2.016 . . . . 0.76000000000000001 109.455 157.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.55 165.07 36.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.048 -1.032 . . . . 2.3100000000000001 111.222 170.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -146.07 130.14 8.61 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 123.436 0.694 . . . . 0.79000000000000004 109.334 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.12 164.85 34.34 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.197 1.932 . . . . 0.80000000000000004 111.108 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.39 137.01 75.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.514 2.809 . . . . 0.81000000000000005 112.144 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 64.05 11.15 5.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.834 1.654 . . . . 1.5800000000000001 113.622 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.08 120.06 5.13 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 127.766 2.603 . . . . 0.91000000000000003 111.197 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -85.38 142.91 28.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.005 1.322 . . . . 5.71 111.87 162.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.98 148.32 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.029 1.731 . . . . 1.73 110.398 172.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -129.92 114.5 15.94 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.289 -1.004 . . . . 5.0199999999999996 108.289 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.76 67.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.64 1.976 . . . . 1.3500000000000001 112.388 -171.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.57 133.92 44.88 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.854 2.461 . . . . 2.6800000000000002 113.634 166.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.6 -52.59 7.23 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.502 2.802 . . . . 1.5600000000000001 112.132 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.33 89.12 1.01 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.401 -1.48 . . . . 1.53 109.401 166.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.95 -72.25 0.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.73 2.109 . . . . 1.25 112.753 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -155.43 132.25 10.62 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.474 1.51 . . . . 1.9399999999999999 112.299 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -156.88 165.93 34.81 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.023 -1.048 . . . . 0.75 111.487 -171.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.27 113.71 26.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.307 0.575 . . . . 1.78 109.699 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.26 125.13 33.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.508 1.123 . . . . 1.4299999999999999 109.195 175.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 24.0 mt -113.68 135.91 53.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.912 1.285 . . . . 1.76 110.077 -168.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -146.65 154.67 41.73 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.782 1.633 . . . . 2.0600000000000001 111.02 -172.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.39 -54.46 4.32 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.734 1.159 . . . . 2.4100000000000001 112.371 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt 70.02 107.51 0.06 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.875 3.27 . . . . 1.3899999999999999 111.133 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.18 14.33 2.41 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.76 -1.212 . . . . 1.99 113.712 -169.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.452 HH21 ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.8 153.52 15.91 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.682 2.393 . . . . 5.5700000000000003 109.633 176.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.7 140.61 23.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.772 2.314 . . . . 2.4300000000000002 109.875 166.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.3 mt -115.57 152.68 32.61 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.148 1.379 . . . . 3.1499999999999999 111.794 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -147.75 9.63 0.91 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.724 2.12 . . . . 3.9399999999999999 116.724 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 64.0 172.87 0.18 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.934 2.094 . . . . 2.7200000000000002 112.225 -169.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.58 52.48 52.82 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 121.661 -0.649 . . . . 2.3999999999999999 111.99 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.452 ' CD ' HH21 ' A' ' 91' ' ' ARG . 9.8 pt-20 -152.01 163.88 38.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.003 2.121 . . . . 3.77 111.051 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -101.51 123.1 45.0 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.279 1.831 . . . . 4.4299999999999997 109.499 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.68 106.09 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.001 -1.111 . . . . 1.21 108.001 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 143.22 42.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.631 -1.168 . . . . 3.1400000000000001 109.171 160.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -155.33 116.39 3.93 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.946 -1.096 . . . . 1.5900000000000001 111.213 -167.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.86 100.58 12.65 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.297 1.439 . . . . 2.3900000000000001 110.378 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 mt -80.52 119.65 23.46 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.646 -0.659 . . . . 1.5800000000000001 109.528 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.8 mt -93.6 129.93 39.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.178 0.991 . . . . 0.83999999999999997 110.61 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -130.37 122.49 27.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.408 0.623 . . . . 2.0 112.504 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.0 12.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.401 2.001 . . . . 2.4300000000000002 116.401 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.62 -45.73 1.6 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.967 1.27 . . . . 3.3900000000000001 112.64 -165.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.87 4.67 44.19 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.194 1.378 . . . . 2.46 116.042 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.69 152.85 33.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.53 1.932 . . . . 3.8599999999999999 112.686 176.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.9 140.64 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.647 1.979 . . . . 1.03 107.819 161.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -139.04 124.05 18.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.755 1.222 . . . . 1.5900000000000001 108.056 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.45 150.7 20.01 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.817 1.414 . . . . 2.3700000000000001 114.817 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.91 145.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.823 1.649 . . . . 1.26 110.91 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -106.84 129.81 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.614 1.166 . . . . 1.8 108.623 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.3 mt -140.68 150.52 60.47 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.743 1.617 . . . . 1.8200000000000001 110.183 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.02 146.49 37.11 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.096 2.53 . . . . 0.89000000000000001 112.874 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.29 139.43 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.636 -0.711 . . . . 1.0700000000000001 110.567 156.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.57 151.34 39.54 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.428 3.491 . . . . 3.5800000000000001 108.672 170.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.72 73.27 1.46 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.194 1.554 . . . . 2.27 115.194 -157.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.377 1.071 . . . . 7.4199999999999999 112.556 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 113.543 0.942 . . . . 5.6699999999999999 113.543 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.04 165.24 17.26 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.592 1.568 . . . . 1.97 114.525 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -148.97 134.4 18.52 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.146 1.778 . . . . 2.5899999999999999 110.552 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.4 t -91.33 140.15 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.74 1.216 . . . . 1.0600000000000001 107.879 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.46 -24.4 18.04 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.884 1.439 . . . . 3.4100000000000001 114.884 -175.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.28 175.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.697 1.999 . . . . 2.23 114.559 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 m 176.34 167.24 0.43 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 130.92 3.688 . . . . 1.6899999999999999 107.903 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.24 -6.55 18.58 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.993 2.462 . . . . 2.1899999999999999 113.584 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 112.28 166.34 17.41 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.115 1.816 . . . . 1.8600000000000001 111.696 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.62 -7.71 45.1 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.112 1.456 . . . . 1.8500000000000001 113.633 -1.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -130.17 174.08 10.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.05 1.34 . . . . 2.1800000000000002 112.836 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.51 -174.66 3.23 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.216 2.206 . . . . 0.59999999999999998 112.037 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.19 165.49 22.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.598 1.159 . . . . 0.88 111.352 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.66 162.35 40.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.241 1.816 . . . . 0.70999999999999996 111.355 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -155.6 165.0 37.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.727 1.611 . . . . 2.23 111.274 -173.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.467 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.4 pt? -160.44 161.3 32.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 116.0 1.852 . . . . 1.54 116.0 170.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -70.06 125.6 27.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 112.663 -2.062 . . . . 1.5 106.164 153.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -134.67 129.58 35.03 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.559 1.544 . . . . 2.75 107.108 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -153.9 150.76 28.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 114.583 1.327 . . . . 2.77 114.583 -173.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -103.63 103.65 37.58 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 112.987 -1.915 . . . . 0.95999999999999996 109.099 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.8 -10.49 14.22 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.631 2.22 . . . . 1.3200000000000001 113.018 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.15 -177.19 49.9 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.848 1.214 . . . . 1.1599999999999999 113.466 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.89 -2.62 21.13 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.075 1.75 . . . . 3.4300000000000002 113.018 -170.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.72 161.26 42.84 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.447 1.899 . . . . 1.3500000000000001 110.062 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.75 149.05 20.5 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.674 2.249 . . . . 0.65000000000000002 111.969 -169.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.14 120.89 42.07 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.624 1.17 . . . . 2.46 110.692 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -105.81 103.87 13.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.967 1.707 . . . . 3.77 110.65 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -91.84 116.56 29.0 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.805 1.642 . . . . 1.0700000000000001 109.024 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -95.0 -22.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.995 0.918 . . . . 0.93999999999999995 112.387 -174.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -161.52 28.21 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 121.78 -0.575 . . . . 0.63 112.581 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.43 -178.16 5.17 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.185 0.994 . . . . 0.70999999999999996 110.7 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 136.82 17.37 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.895 2.078 . . . . 5.6399999999999997 106.518 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -153.29 151.58 26.04 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 120.737 1.608 . . . . 0.62 111.097 -166.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.09 -18.36 27.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.82 3.013 . . . . 0.78000000000000003 114.097 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.269 3.0 m -89.91 -2.07 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 114.081 1.141 . . . . 0.82999999999999996 114.081 -173.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.88 39.5 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.576 0.954 . . . . 0.75 113.576 -174.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.22 -86.86 0.34 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.284 1.833 . . . . 3.4199999999999999 108.41 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -78.49 86.36 4.52 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.67 -1.269 . . . . 3.1800000000000002 110.614 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.77 139.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.793 1.237 . . . . 1.1599999999999999 110.486 158.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -136.51 126.52 26.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.489 1.915 . . . . 2.2400000000000002 109.821 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.18 121.57 26.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.209 1.368 . . . . 0.73999999999999999 111.245 167.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.6 m170 -107.26 151.64 25.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.596 1.558 . . . . 0.68000000000000005 112.3 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.42 173.14 8.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.721 1.209 . . . . 2.1899999999999999 110.5 158.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -148.72 96.64 2.61 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.166 1.386 . . . . 1.02 107.515 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -109.04 153.96 22.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.948 1.699 . . . . 2.6200000000000001 112.2 -166.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.7 mtm -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.081 0.952 . . . . 2.9100000000000001 110.937 170.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -155.62 167.92 28.81 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.198 1.799 . . . . 9.0999999999999996 111.235 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.73 157.73 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.264 0.625 . . . . 3.4700000000000002 111.115 160.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -135.11 -89.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.215 1.006 . . . . 3.1200000000000001 108.922 160.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.45 55.34 1.91 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.683 1.993 . . . . 3.8399999999999999 110.338 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.92 -18.52 0.35 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 125.62 1.581 . . . . 2.04 114.906 -173.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -108.2 163.28 13.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.752 2.421 . . . . 3.0600000000000001 111.38 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -66.64 135.63 54.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.673 1.189 . . . . 3.7000000000000002 112.817 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.1 160.42 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 126.895 2.078 . . . . 1.99 109.221 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.1 mmt -79.96 165.09 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 3.6200000000000001 112.647 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.17 143.11 11.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.735 1.635 . . . . 1.5600000000000001 110.707 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.03 142.21 49.04 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.355 1.462 . . . . 2.0600000000000001 109.539 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -172.86 127.46 0.52 Allowed Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 117.116 -1.421 . . . . 4.0700000000000003 111.136 -152.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 38.2 Cg_endo -66.63 146.07 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.184 1.922 . . . . 0.55000000000000004 111.251 170.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.28 156.71 60.13 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.799 1.64 . . . . 0.54000000000000004 110.589 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.99 -24.37 28.69 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.258 1.972 . . . . 0.70999999999999996 112.509 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -174.06 166.25 4.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.882 1.273 . . . . 2.1299999999999999 112.273 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.52 173.04 6.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.065 2.146 . . . . 0.69999999999999996 109.526 157.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.56 163.19 40.3 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.663 -0.648 . . . . 1.8899999999999999 112.236 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.38 130.74 11.68 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 124.844 1.258 . . . . 0.95999999999999996 109.606 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.18 161.62 43.72 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.026 2.484 . . . . 0.83999999999999997 111.295 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.27 140.88 90.97 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.238 2.626 . . . . 1.02 112.105 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt 67.96 -3.32 1.23 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.967 2.107 . . . . 1.8300000000000001 113.921 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.74 134.82 13.52 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 127.136 2.303 . . . . 0.85999999999999999 110.052 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -109.9 146.7 34.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.514 -1.343 . . . . 6.4500000000000002 112.192 163.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.08 171.69 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.968 1.707 . . . . 1.3200000000000001 110.099 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -139.03 117.68 12.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.722 1.609 . . . . 3.8799999999999999 108.036 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.77 70.77 0.99 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.95 1.7 . . . . 1.3 111.323 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.48 140.5 94.85 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.967 -1.083 . . . . 2.98 111.754 171.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.98 -33.4 83.5 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.83 2.353 . . . . 1.3500000000000001 112.201 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.01 53.41 4.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.058 0.837 . . . . 1.4399999999999999 112.31 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.14 -64.26 0.05 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.452 1.025 . . . . 1.3899999999999999 114.842 177.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -154.63 137.79 15.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.657 1.583 . . . . 2.1200000000000001 110.558 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -162.17 172.24 16.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.227 -0.921 . . . . 0.75 111.963 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -105.12 131.83 52.11 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.099 0.559 . . . . 1.9099999999999999 110.405 167.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.3 mmt -88.91 143.93 26.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.279 1.032 . . . . 0.95999999999999996 109.9 156.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.8 125.56 46.8 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.932 1.293 . . . . 2.7000000000000002 108.801 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mt -124.85 133.87 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.314 1.846 . . . . 2.02 110.692 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.67 78.37 0.67 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.778 -1.329 . . . . 2.4700000000000002 109.778 -174.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.39 104.08 4.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.332 1.066 . . . . 0.93000000000000005 109.972 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.46 17.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.834 1.05 . . . . 2.1200000000000001 113.834 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -122.6 140.3 32.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.529 1.932 . . . . 6.2199999999999998 109.647 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -69.39 140.33 43.79 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 N-CA-C 108.26 -1.477 . . . . 2.02 108.26 148.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.7 mt -120.51 155.62 33.24 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.464 1.106 . . . . 3.1200000000000001 111.433 -174.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -130.92 1.37 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.188 1.551 . . . . 3.71 115.188 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 59.11 178.62 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.219 2.207 . . . . 2.0800000000000001 111.92 -171.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.2 56.22 25.81 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 110.445 -1.062 . . . . 1.9099999999999999 110.445 -172.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -166.72 157.12 11.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 128.572 2.749 . . . . 3.0899999999999999 109.961 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -112.46 148.41 34.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.533 1.133 . . . . 4.3499999999999996 112.054 -167.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.1 t -125.41 117.48 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.18 1.792 . . . . 1.1599999999999999 108.342 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.72 133.28 33.69 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.836 -0.801 . . . . 4.04 108.836 157.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -138.71 141.71 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.957 1.703 . . . . 1.95 108.708 -173.686 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.06 123.1 31.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.891 1.677 . . . . 2.3500000000000001 109.961 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.74 120.33 27.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.103 0.961 . . . . 1.3600000000000001 109.8 168.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.77 125.61 40.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.18 0.992 . . . . 0.56999999999999995 111.731 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -125.51 114.14 18.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.996 0.903 . . . . 2.0600000000000001 111.73 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.12 25.7 0.12 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 127.502 2.321 . . . . 3.2999999999999998 116.317 171.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.68 -42.03 1.04 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.52 1.533 . . . . 4.2599999999999998 113.906 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.04 0.09 87.93 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.224 1.392 . . . . 2.1299999999999999 116.102 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.25 155.24 41.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.933 2.093 . . . . 4.4400000000000004 111.748 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.72 141.0 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.429 1.892 . . . . 1.1000000000000001 108.599 171.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.9 112.4 9.32 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.112 1.365 . . . . 1.6299999999999999 109.24 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -83.92 137.39 33.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.016 0.747 . . . . 3.71 113.016 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 m -138.24 153.43 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.988 1.715 . . . . 1.5900000000000001 110.894 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 m -95.2 149.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.265 1.426 . . . . 3.04 112.416 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -147.13 141.77 16.26 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.89 2.076 . . . . 3.0 108.382 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.09 156.75 33.97 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.979 2.452 . . . . 1.05 111.027 163.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -84.17 109.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.074 0.949 . . . . 1.0900000000000001 109.828 164.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 120' ' ' ARG . 4.8 mm-40 -79.01 146.51 33.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.284 1.034 . . . . 3.7000000000000002 108.288 155.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.37 94.03 4.77 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.045 -1.095 . . . . 2.1600000000000001 108.045 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 118' ' ' GLU . 32.0 ttm-85 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 113.57 0.952 . . . . 8.5700000000000003 113.57 -164.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 . . . . . 0 CA--C 1.546 0.822 0 CA-C-O 121.303 0.573 . . . . 4.5599999999999996 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.69 -175.91 43.49 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.956 1.741 . . . . 1.3200000000000001 114.762 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -159.62 156.44 27.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.126 1.371 . . . . 1.76 113.257 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -113.92 131.07 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.543 -0.723 . . . . 0.88 109.947 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -72.2 114.17 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.776 1.231 . . . . 4.6799999999999997 109.249 174.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 129.09 37.17 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.723 0.809 . . . . 2.1299999999999999 109.136 162.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.35 163.26 38.09 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.877 1.671 . . . . 2.3300000000000001 108.1 167.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.12 17.68 0.49 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.459 3.439 . . . . 1.48 115.456 -167.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.31 174.38 49.48 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.599 -0.688 . . . . 1.3 112.772 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.23 -3.0 36.91 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.364 1.082 . . . . 1.4199999999999999 113.034 -4.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -141.2 169.41 17.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.297 1.439 . . . . 2.0299999999999998 112.5 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.19 -158.5 0.34 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.985 2.514 . . . . 0.84999999999999998 111.177 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.49 171.08 20.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.62 1.168 . . . . 0.80000000000000004 113.664 -169.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.93 151.0 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.343 1.057 . . . . 0.87 113.186 170.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -142.81 145.65 33.43 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.594 1.558 . . . . 2.0699999999999998 110.468 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -169.62 160.97 9.25 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.46 0.911 . . . . 1.5800000000000001 113.46 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.0 m -78.19 141.53 38.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.54 1.536 . . . . 1.29 109.076 162.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -128.21 136.72 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.458 1.103 . . . . 2.8599999999999999 108.561 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -130.69 148.98 52.54 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.97 0.908 . . . . 2.7200000000000002 110.657 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.453 HD21 HD13 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -119.35 70.91 12.21 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.366 0.666 . . . . 3.8300000000000001 112.309 -159.307 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 -14.65 44.46 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.231 2.621 . . . . 1.05 115.438 -168.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.25 161.33 53.35 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.397 0.998 . . . . 1.1699999999999999 112.92 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 3.8 m-20 -91.08 -2.24 57.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.507 1.523 . . . . 3.1000000000000001 113.353 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -117.73 160.06 39.92 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.034 1.733 . . . . 1.3 110.618 172.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.43 157.38 25.56 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.77 2.314 . . . . 0.66000000000000003 111.235 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.453 HD13 HD21 ' A' ' 24' ' ' ASN . 2.3 mp -124.02 127.95 48.64 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.58 1.552 . . . . 2.3700000000000001 110.727 -172.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -113.37 104.98 12.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.263 1.425 . . . . 4.6699999999999999 110.794 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.2 tp -89.64 115.68 27.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.664 2.385 . . . . 0.83999999999999997 108.78 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.8 m -110.24 -8.65 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.403 1.081 . . . . 0.55000000000000004 113.541 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.6 -159.76 32.14 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 121.636 -0.665 . . . . 0.38 113.331 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.813 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -147.71 178.74 8.23 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.59 0.756 . . . . 0.68000000000000005 112.221 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -152.58 145.92 24.79 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.572 -1.27 . . . . 6.9699999999999998 107.572 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -155.76 156.06 30.2 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.927 1.291 . . . . 0.63 109.279 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.35 -26.94 71.24 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.585 2.19 . . . . 0.96999999999999997 113.339 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.323 1.5 m -92.45 11.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.914 1.45 . . . . 1.5 114.914 -170.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -155.9 151.01 26.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.981 1.312 . . . . 0.90000000000000002 112.409 177.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -97.34 -78.19 0.48 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.318 -0.993 . . . . 3.3599999999999999 108.318 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -74.6 107.42 6.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.078 -1.453 . . . . 3.3599999999999999 107.078 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.21 129.24 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 1.47 108.22 173.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.39 127.81 18.9 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.026 1.331 . . . . 2.3100000000000001 110.138 -162.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -79.21 121.16 24.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.825 0.821 . . . . 0.76000000000000001 110.588 175.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.4 153.49 22.71 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.393 1.877 . . . . 0.72999999999999998 112.94 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.0 164.17 13.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.852 1.661 . . . . 2.29 110.89 161.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 81.5 m -129.75 105.88 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.888 1.675 . . . . 1.03 108.334 166.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -106.2 158.1 17.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.788 1.235 . . . . 2.25 113.261 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.0 mtp -124.52 100.82 6.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.363 1.465 . . . . 4.0199999999999996 110.36 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -122.63 145.87 47.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.415 1.486 . . . . 5.5199999999999996 110.928 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.2 mp0 -59.96 147.33 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.529 0.731 . . . . 3.5699999999999998 111.349 165.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -159.31 -47.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.944 1.09 . . . . 2.96 113.944 170.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -93.28 38.28 1.04 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.485 1.914 . . . . 5.8300000000000001 110.746 171.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.54 -40.16 0.76 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.5 1.524 . . . . 2.5600000000000001 113.043 -167.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -86.93 154.52 20.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.581 2.352 . . . . 3.71 111.122 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -68.44 122.99 19.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.875 0.87 . . . . 4.1299999999999999 111.267 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.84 151.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.351 1.461 . . . . 2.7200000000000002 109.935 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -83.55 141.95 31.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.61 1.564 . . . . 2.9100000000000001 111.155 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.77 170.5 33.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.967 0.794 . . . . 1.1299999999999999 112.884 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.98 145.12 41.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.76 1.224 . . . . 2.1000000000000001 111.229 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -153.32 143.36 15.34 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 125.447 1.499 . . . . 3.29 109.964 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.78 145.56 75.52 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.755 1.637 . . . . 0.75 110.595 163.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -118.32 154.16 51.92 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.687 1.595 . . . . 0.76000000000000001 110.084 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.09 -9.56 26.28 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.827 2.351 . . . . 1.23 114.136 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -172.37 163.03 5.56 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.098 1.317 . . . . 2.1200000000000001 111.664 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -119.19 169.69 9.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.586 1.554 . . . . 0.68999999999999995 108.482 148.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -158.16 164.24 36.77 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.045 -1.034 . . . . 2.2999999999999998 112.118 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.02 138.5 14.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 1.1200000000000001 110.593 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.07 161.6 45.37 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.676 2.25 . . . . 1.1000000000000001 111.314 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.38 146.2 93.2 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.98 2.453 . . . . 0.82999999999999996 111.798 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 68.7 mmtt 69.97 -12.48 0.48 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.507 2.723 . . . . 1.3600000000000001 114.624 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.5 130.86 29.13 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 126.456 1.979 . . . . 0.94999999999999996 111.974 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -94.49 129.02 41.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.095 -1.553 . . . . 5.5700000000000003 110.045 161.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.73 178.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.681 1.592 . . . . 1.3999999999999999 110.345 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -141.07 140.2 34.18 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.128 0.971 . . . . 3.2999999999999998 110.169 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.59 59.77 3.1 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.702 1.239 . . . . 1.1499999999999999 108.912 155.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -72.14 122.41 87.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.677 -1.154 . . . . 3.52 110.116 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.95 -27.08 83.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.372 2.715 . . . . 1.55 114.792 -168.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.13 84.31 1.6 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.746 -1.742 . . . . 1.5800000000000001 108.746 157.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.443 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.01 -87.44 0.16 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.334 1.921 . . . . 1.3600000000000001 111.55 -166.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -143.42 153.77 43.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.246 1.818 . . . . 1.9099999999999999 110.881 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -157.79 165.43 35.35 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.509 1.123 . . . . 0.73999999999999999 109.736 175.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -93.2 137.23 32.73 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.8 -1.185 . . . . 2.0899999999999999 107.8 159.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.7 139.5 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.744 1.218 . . . . 1.46 109.411 168.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.5 mt -117.83 131.69 56.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.86 1.264 . . . . 1.96 110.459 -172.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.85 159.49 42.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.721 1.608 . . . . 1.79 111.928 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -56.87 4.51 Favored Glycine 0 N--CA 1.47 0.934 0 C-N-CA 124.897 1.237 . . . . 2.3700000000000001 112.73 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.4 mt 70.76 98.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 129.715 3.206 . . . . 1.3999999999999999 113.252 171.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -11.01 59.83 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.17 1.174 . . . . 1.78 114.17 -171.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -141.33 158.1 64.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 129.588 3.155 . . . . 7.6900000000000004 108.928 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.49 163.2 39.83 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.513 2.809 . . . . 1.8899999999999999 110.294 160.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.27 151.6 44.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.183 0.993 . . . . 2.52 112.275 -167.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -142.34 120.58 12.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.446 1.098 . . . . 3.8100000000000001 110.445 -170.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 140.27 54.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.548 0.739 . . . . 1.76 112.783 172.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.02 -20.6 33.14 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.339 1.447 . . . . 3.0800000000000001 115.158 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -173.72 4.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.249 1.024 . . . . 5.3399999999999999 111.084 -169.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -95.64 152.06 18.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.715 0.769 . . . . 4.25 110.727 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.26 127.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.388 2.275 . . . . 1.3700000000000001 108.156 163.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.03 150.14 24.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.731 0.812 . . . . 3.27 109.842 170.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.813 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.2 tt -158.68 140.04 13.27 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.248 1.019 . . . . 1.6699999999999999 113.252 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.472 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.7 m-20 -101.99 107.08 18.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.513 2.325 . . . . 2.2000000000000002 111.443 171.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.9 119.22 21.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.154 0.982 . . . . 1.1100000000000001 110.397 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.4 mt -95.05 131.93 40.49 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.788 1.235 . . . . 0.58999999999999997 111.768 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.23 139.47 53.7 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.226 1.195 . . . . 1.9099999999999999 114.226 -177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.27 72.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.895 1.278 . . . . 2.3599999999999999 114.203 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.49 33.43 1.83 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.588 1.09 . . . . 4.4199999999999999 114.176 -174.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.25 49.21 67.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.721 1.153 . . . . 1.6799999999999999 112.645 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 160.75 39.28 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.865 1.666 . . . . 4.1500000000000004 112.053 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.22 145.55 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.523 1.929 . . . . 1.0800000000000001 107.707 170.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.71 121.68 25.93 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.826 1.25 . . . . 1.6799999999999999 110.717 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 3.0 tpmt? -72.07 131.19 42.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.039 0.536 . . . . 2.4199999999999999 111.331 176.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.86 150.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.232 1.413 . . . . 1.5800000000000001 109.832 166.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.82 152.15 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.958 1.703 . . . . 2.5699999999999998 109.045 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.5 mt -148.69 144.77 18.74 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.254 1.422 . . . . 2.2400000000000002 109.708 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.25 149.0 81.34 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.17 2.58 . . . . 1.1899999999999999 112.214 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.28 128.08 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.829 1.252 . . . . 1.1200000000000001 109.24 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -118.23 135.08 54.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.726 1.61 . . . . 3.3199999999999998 107.501 166.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.9 125.07 30.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.695 0.68 . . . . 2.0600000000000001 110.283 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.037 1.335 . . . . 7.4900000000000002 111.795 -175.487 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 105.835 -1.913 . . . . 6.4400000000000004 105.835 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.57 -151.98 28.85 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.297 0.951 . . . . 1.5900000000000001 112.586 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -166.22 138.54 3.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.771 1.228 . . . . 1.6399999999999999 112.487 177.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.73 145.27 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.377 1.071 . . . . 1.46 108.356 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.437 ' HE ' ' HB3' ' A' ' 17' ' ' ALA . 5.3 tmm_? -117.03 85.95 2.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.106 0.962 . . . . 4.6600000000000001 109.758 -166.08 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.76 149.46 48.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.878 1.671 . . . . 2.7799999999999998 112.222 -174.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -152.43 153.44 30.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.32 2.248 . . . . 2.0800000000000001 107.743 174.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.27 -12.67 35.68 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.227 2.618 . . . . 2.2200000000000002 112.865 170.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.78 -167.84 13.96 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.395 0.998 . . . . 1.6699999999999999 114.162 170.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.34 -2.23 19.84 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 CA-C-N 118.195 0.998 . . . . 1.78 113.309 -3.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -134.63 163.26 30.14 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.248 1.819 . . . . 2.4100000000000001 112.482 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.43 179.51 9.06 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.757 2.023 . . . . 0.73999999999999999 111.288 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB3' ' HE ' ' A' ' 9' ' ' ARG . . . -134.67 166.08 23.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.668 0.787 . . . . 1.0700000000000001 112.864 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.88 135.35 32.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.309 0.644 . . . . 0.78000000000000003 111.806 170.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.45 147.87 42.32 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.329 1.452 . . . . 2.4900000000000002 108.252 172.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.06 148.6 20.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.418 0.687 . . . . 2.0 111.593 -170.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -91.17 116.07 28.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.722 0.772 . . . . 1.78 109.452 166.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 125.44 35.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.204 -1.406 . . . . 2.79 107.204 164.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.59 146.45 47.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.128 0.966 . . . . 3.6400000000000001 111.328 165.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -114.87 90.88 24.11 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-N 114.725 -1.125 . . . . 0.97999999999999998 109.22 171.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.04 -9.59 20.78 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.539 2.159 . . . . 0.94999999999999996 112.98 176.573 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 -167.18 42.34 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.84 1.209 . . . . 1.1399999999999999 113.394 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -121.57 5.51 10.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.376 1.47 . . . . 2.73 112.855 -166.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.93 163.06 41.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.61 1.964 . . . . 1.4399999999999999 109.915 173.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.82 148.09 15.5 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.406 2.071 . . . . 0.66000000000000003 112.272 -171.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -111.44 108.36 17.89 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.344 1.458 . . . . 2.0899999999999999 109.703 -177.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -102.18 102.49 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.536 1.534 . . . . 4.6299999999999999 112.355 -178.051 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.51 124.57 37.59 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.636 1.974 . . . . 0.93999999999999995 108.394 -173.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.92 -11.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.662 1.185 . . . . 0.72999999999999998 112.723 -172.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -162.57 29.96 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 123.789 0.709 . . . . 0.60999999999999999 112.463 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.564 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -152.87 -179.27 7.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.421 1.089 . . . . 0.81999999999999995 110.697 174.492 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -156.1 145.17 20.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.136 -1.431 . . . . 5.1699999999999999 107.136 173.036 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.59 149.17 23.47 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 118.95 0.795 . . . . 0.68000000000000005 109.928 -176.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.08 -10.74 29.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.948 2.432 . . . . 0.84999999999999998 113.305 173.1 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 3.0 m -92.51 7.36 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 114.324 1.231 . . . . 1.1000000000000001 114.324 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.39 165.83 28.17 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.071 -1.018 . . . . 0.82999999999999996 112.801 -179.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -111.29 -62.49 1.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.966 -0.753 . . . . 3.6600000000000001 108.966 170.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -86.12 138.76 31.68 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.286 -0.884 . . . . 3.5899999999999999 109.862 168.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.12 138.75 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.432 2.293 . . . . 1.48 109.19 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -143.11 136.54 28.37 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.952 1.701 . . . . 2.8599999999999999 110.157 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.445 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 6.4 tt -84.11 119.27 24.78 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.325 0.966 . . . . 0.72999999999999998 110.686 167.171 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.3 m170 -110.42 167.0 10.54 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.547 1.939 . . . . 0.83999999999999997 112.111 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 6.0 pt-20 -136.74 -173.18 3.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.848 1.659 . . . . 3.4199999999999999 112.172 175.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.8 m -136.79 124.11 21.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.273 -1.01 . . . . 1.54 108.273 167.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -114.02 176.96 4.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 2.25 111.09 179.3 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtm -131.93 139.25 48.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.322 1.049 . . . . 2.8700000000000001 110.457 163.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtp85 -143.16 156.62 44.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.096 1.358 . . . . 5.4500000000000002 111.961 173.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 mp0 -67.25 151.63 47.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.025 1.73 . . . . 4.6900000000000004 110.948 159.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.29 -41.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 114.38 -1.282 . . . . 2.9399999999999999 114.238 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -117.68 32.4 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.769 2.028 . . . . 3.9399999999999999 110.541 167.503 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.4 -35.68 1.34 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.845 -1.159 . . . . 2.6000000000000001 112.785 -166.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 mttp -70.58 144.5 51.2 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.274 -1.133 . . . . 2.9500000000000002 109.095 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -99.48 140.72 33.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.439 0.903 . . . . 4.0199999999999996 113.439 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.21 150.57 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.497 1.919 . . . . 2.3100000000000001 108.819 -171.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.3 mtm -80.26 149.81 30.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.147 1.379 . . . . 3.23 111.517 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.16 160.67 30.63 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.961 -0.462 . . . . 1.28 113.184 173.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -115.64 152.58 32.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.786 1.234 . . . . 2.0299999999999998 111.385 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -164.87 156.99 13.76 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.955 1.302 . . . . 6.7699999999999996 111.646 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 43.4 Cg_endo -66.01 145.17 78.77 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.79 2.327 . . . . 0.94999999999999996 110.73 161.122 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 156.39 53.83 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.838 1.655 . . . . 1.02 109.758 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.99 -11.01 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.062 2.508 . . . . 1.1100000000000001 114.338 -179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -175.91 168.9 2.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.515 1.526 . . . . 2.3900000000000001 110.638 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.77 168.78 13.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.091 1.757 . . . . 0.84999999999999998 108.58 154.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -155.44 164.04 39.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.058 -1.026 . . . . 2.27 111.978 163.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.79 129.08 16.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 124.034 0.934 . . . . 0.82999999999999996 110.03 -172.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.22 162.88 40.66 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.435 2.09 . . . . 0.75 111.082 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.6 141.48 91.43 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.111 2.541 . . . . 0.93000000000000005 112.083 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt 70.23 -1.33 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.77 2.428 . . . . 1.1899999999999999 113.728 -172.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.34 121.49 5.54 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 127.248 2.356 . . . . 0.81999999999999995 111.644 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -99.23 135.76 40.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.43 1.492 . . . . 5.9400000000000004 110.48 161.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.34 148.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.6 1.56 . . . . 1.26 110.285 174.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -131.4 120.93 23.75 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.647 -0.501 . . . . 5.4800000000000004 109.647 -166.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.6 68.65 9.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.448 1.594 . . . . 1.3400000000000001 112.565 -161.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -64.54 142.31 98.42 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.52 2.328 . . . . 4.0999999999999996 114.519 173.24 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -30.77 47.47 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.955 3.104 . . . . 1.46 113.397 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.73 74.21 2.43 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 108.424 -1.87 . . . . 1.45 108.424 163.607 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.78 -152.77 21.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.954 1.74 . . . . 2.4900000000000002 111.514 -167.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 6.0 m-85 -72.47 135.91 45.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.226 1.41 . . . . 2.6299999999999999 111.839 -174.54 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -168.09 178.88 4.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.613 1.165 . . . . 1.1399999999999999 109.457 -174.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.445 ' CZ ' HD12 ' A' ' 45' ' ' LEU . 57.7 m-85 -114.2 139.83 49.05 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.336 0.516 . . . . 2.52 111.823 173.244 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 mmt -101.72 131.1 48.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.902 1.681 . . . . 1.0700000000000001 110.101 168.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.94 138.94 53.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.631 1.573 . . . . 3.1200000000000001 110.684 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.96 157.67 45.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.902 1.681 . . . . 2.3900000000000001 112.036 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.39 -47.86 3.93 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 124.854 1.216 . . . . 2.5800000000000001 112.799 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt 57.92 88.76 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.923 2.489 . . . . 0.93999999999999995 112.97 169.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.43 0.49 12.15 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.168 1.544 . . . . 2.23 115.168 -169.146 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.3 mtp-105 -149.04 151.36 34.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.347 2.259 . . . . 4.96 108.837 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -88.72 -10.27 4.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.71 3.607 . . . . 3.3700000000000001 117.86 -176.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.0 mt 80.09 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 127.904 2.481 . . . . 3.5899999999999999 114.357 156.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.22 -175.66 4.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 130.781 3.633 . . . . 4.7300000000000004 109.43 176.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.1 149.84 32.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.247 -1.39 . . . . 2.54 107.247 139.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.96 15.44 77.39 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 118.849 0.749 . . . . 2.71 112.819 -164.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -115.57 140.68 48.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.095 -1.446 . . . . 3.6299999999999999 107.095 144.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.42 134.75 53.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.16 -1.836 . . . . 4.9299999999999997 109.457 -160.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.6 t -106.42 104.74 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.299 -0.409 . . . . 1.24 111.462 -150.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.14 128.4 35.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.456 -1.247 . . . . 3.3900000000000001 110.097 160.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.564 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.3 tt -138.49 137.88 37.55 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.628 1.571 . . . . 2.0299999999999998 108.755 -177.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -91.31 106.63 18.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.33 2.252 . . . . 2.5600000000000001 111.12 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.73 106.58 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.445 1.098 . . . . 1.75 110.863 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.39 118.11 22.94 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.76 -0.459 . . . . 0.88 109.76 -174.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.28 147.78 38.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.011 0.924 . . . . 1.9299999999999999 111.726 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.61 130.5 28.26 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.22 1.008 . . . . 1.79 112.329 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.64 -151.98 20.85 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.277 0.941 . . . . 3.79 110.756 -163.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.92 23.21 35.37 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.828 1.204 . . . . 2.5899999999999999 114.104 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.55 125.36 35.18 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.042 -1.269 . . . . 5.3899999999999997 111.428 -177.356 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.96 124.79 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.322 1.049 . . . . 1.8100000000000001 110.928 171.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.31 122.12 41.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.542 1.537 . . . . 3.4199999999999999 109.811 -174.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -85.76 124.09 31.88 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.903 -0.498 . . . . 2.6899999999999999 111.566 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.71 148.22 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.16 1.384 . . . . 1.8999999999999999 111.242 178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.97 131.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.881 1.272 . . . . 1.6899999999999999 111.333 -177.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -128.66 151.96 77.88 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 125.289 1.436 . . . . 2.0800000000000001 112.71 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.51 145.79 26.81 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.645 3.563 . . . . 1.8600000000000001 112.147 177.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.18 139.56 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.537 1.135 . . . . 1.7 112.057 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -131.11 148.78 52.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.527 2.731 . . . . 3.54 108.487 173.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.73 48.28 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.062 -1.024 . . . . 2.2400000000000002 110.711 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 N-CA-C 115.084 1.513 . . . . 5.9800000000000004 115.084 -175.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 110.105 -0.331 . . . . 6.5199999999999996 110.105 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.7 -169.97 42.77 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 114.967 0.747 . . . . 1.25 114.967 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -164.99 160.7 19.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 1.5900000000000001 112.949 -175.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.53 132.72 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.766 -0.584 . . . . 1.27 110.605 177.261 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.3 ttp85 -96.61 97.89 9.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.85 1.26 . . . . 4.1900000000000004 110.056 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 152.51 44.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.973 1.709 . . . . 2.04 111.625 -175.324 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 m -155.14 149.8 20.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 119.77 -1.832 . . . . 1.8600000000000001 111.209 168.26 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.32 25.52 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.622 3.548 . . . . 1.6599999999999999 114.19 -175.077 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.86 165.31 29.15 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.47 -0.769 . . . . 1.3200000000000001 113.952 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.87 -3.77 31.52 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 CA-C-N 118.097 0.949 . . . . 1.53 113.629 -2.586 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -154.69 -179.53 8.09 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.591 1.556 . . . . 1.8700000000000001 111.644 -175.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.67 -175.06 4.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.891 1.677 . . . . 0.62 111.924 -179.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.11 149.47 45.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.782 0.833 . . . . 0.93000000000000005 112.654 -175.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.31 51.77 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.203 1.401 . . . . 0.75 112.159 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.57 157.95 43.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.108 1.363 . . . . 2.2999999999999998 111.906 -177.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.6 159.66 12.24 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.73 1.212 . . . . 1.6399999999999999 111.92 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.3 m -79.99 146.39 32.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.617 1.567 . . . . 1.6599999999999999 108.455 154.379 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -143.43 136.92 28.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.483 0.713 . . . . 2.6200000000000001 109.609 169.129 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -116.21 143.04 46.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.053 0.941 . . . . 2.9300000000000002 112.71 167.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -87.98 111.98 46.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.46 1.104 . . . . 1.1200000000000001 108.624 161.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -85.48 -12.12 6.75 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.156 2.571 . . . . 1.1599999999999999 113.456 174.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.24 161.92 39.79 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.519 1.057 . . . . 1.28 112.482 -177.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.09 4.06 53.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.217 1.807 . . . . 3.3100000000000001 113.327 -174.032 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.31 161.36 35.5 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.397 1.879 . . . . 1.3200000000000001 110.02 168.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.85 154.4 26.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.853 2.369 . . . . 0.68000000000000005 111.574 -171.258 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.58 127.6 52.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.33 1.452 . . . . 2.1499999999999999 110.169 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -118.0 114.11 22.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.66 1.184 . . . . 3.7999999999999998 111.787 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.9 tp -100.51 109.9 22.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.369 2.668 . . . . 1.0600000000000001 109.806 -171.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.41 -13.76 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.413 1.085 . . . . 0.68000000000000005 113.84 -165.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.39 -160.56 31.91 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.0 0.81 . . . . 0.42999999999999999 112.41 -176.46 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.71 -174.08 4.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 117.73 0.765 . . . . 0.94999999999999996 112.998 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 102' ' ' ASP . 2.1 mmp_? -149.77 138.17 20.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.813 2.445 . . . . 6.0899999999999999 107.541 176.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -150.02 153.89 36.18 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 119.855 1.207 . . . . 0.88 110.686 -170.143 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.45 -32.33 12.51 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.252 1.968 . . . . 1.21 111.716 165.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.402 1.3 m -93.1 6.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 115.503 1.668 . . . . 1.22 115.503 -169.559 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.75 174.26 13.24 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.052 1.341 . . . . 1.1699999999999999 109.744 167.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -118.01 -74.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.778 0.717 . . . . 4.3099999999999996 109.618 175.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttm105 -66.25 133.98 51.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.735 -1.209 . . . . 4.6900000000000004 107.735 163.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.26 129.62 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.823 1.249 . . . . 1.54 108.406 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -134.44 127.76 32.14 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.084 0.954 . . . . 2.3900000000000001 109.452 -160.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.81 117.6 20.07 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.496 1.141 . . . . 0.81000000000000005 109.909 171.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.6 m170 -107.1 154.02 21.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.671 1.588 . . . . 0.80000000000000004 111.326 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.74 179.46 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.261 -1.336 . . . . 1.9399999999999999 110.449 167.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.7 m -149.97 94.46 2.16 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.284 1.433 . . . . 1.1599999999999999 107.725 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -90.71 165.53 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.169 1.788 . . . . 2.1499999999999999 112.857 -169.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.7 mtm -98.52 152.45 19.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.349 -0.841 . . . . 2.52 109.891 158.207 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -151.67 132.0 13.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.216 1.806 . . . . 6.0700000000000003 108.895 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.75 144.14 31.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.519 0.728 . . . . 4.3899999999999997 110.899 173.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.2 122.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.154 1.382 . . . . 3.3999999999999999 107.542 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.6 tm-20 58.76 29.69 19.02 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.325 1.059 . . . . 5.5599999999999996 110.994 -174.221 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.49 -6.57 16.03 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 120.089 -1.632 . . . . 2.1699999999999999 114.47 -173.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 34.7 mmtm -85.06 138.92 32.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.455 1.502 . . . . 4.0899999999999999 109.115 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -85.79 142.97 28.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.278 0.49 . . . . 4.1299999999999999 112.24 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.92 159.61 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 2.7000000000000002 110.433 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.7 mtp -102.93 166.08 10.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.04 0.936 . . . . 4.6200000000000001 111.688 169.079 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.48 174.74 34.94 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 123.829 0.728 . . . . 1.1799999999999999 112.006 167.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.37 159.94 38.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.803 1.241 . . . . 1.8899999999999999 110.025 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.81 151.18 0.98 Allowed Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.928 1.691 . . . . 3.46 110.431 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.7 Cg_endo -68.9 149.74 72.62 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.613 1.542 . . . . 1.0 111.103 166.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.28 157.84 39.95 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 0.57999999999999996 109.859 172.251 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -66.78 -20.15 52.53 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.229 1.953 . . . . 0.73999999999999999 112.522 174.488 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -179.56 161.28 1.02 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 126.731 2.012 . . . . 2.2999999999999998 110.877 178.283 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mt -103.99 168.83 8.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.082 0.953 . . . . 0.81000000000000005 109.705 150.365 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.47 164.58 36.45 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.843 -0.536 . . . . 2.4199999999999999 111.419 167.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.7 t -140.51 129.49 13.06 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 125.555 1.542 . . . . 0.77000000000000002 108.664 -164.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.79 161.83 44.7 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.977 1.784 . . . . 0.91000000000000003 111.161 177.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.2 140.71 96.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.182 2.588 . . . . 0.93000000000000005 111.74 177.09 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 67.95 -3.27 1.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.857 2.063 . . . . 1.3700000000000001 113.368 -177.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.07 119.85 4.97 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 127.277 2.37 . . . . 1.1699999999999999 111.891 -172.014 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -81.76 136.95 35.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.642 1.177 . . . . 4.8499999999999996 110.459 156.319 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 m -150.99 145.48 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.102 1.761 . . . . 1.6799999999999999 109.807 173.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -103.35 139.28 38.97 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.477 0.917 . . . . 3.5699999999999998 113.477 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.38 54.95 0.95 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.128 1.442 . . . . 1.29 109.72 156.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -54.2 114.99 7.42 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.546 -1.216 . . . . 4.8200000000000003 109.966 162.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.58 -28.18 85.05 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.211 2.607 . . . . 1.3500000000000001 114.824 -170.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.19 36.24 0.94 Allowed Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.342 0.973 . . . . 1.8700000000000001 113.367 166.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.06 -48.19 0.04 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.93 2.205 . . . . 1.3700000000000001 113.65 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -154.08 145.12 22.75 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.072 1.749 . . . . 1.8999999999999999 110.39 -174.72 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -165.66 171.81 12.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.969 1.308 . . . . 0.77000000000000002 110.52 -178.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -103.35 135.08 45.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.108 0.563 . . . . 1.95 110.667 165.053 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.1 mmt -92.74 134.74 34.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.532 1.133 . . . . 0.85999999999999999 110.467 165.026 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.2 mt -109.78 114.98 29.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.802 1.641 . . . . 2.23 110.186 -176.386 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.77 155.48 31.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.223 1.409 . . . . 3.5499999999999998 111.039 -174.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.55 -39.69 3.1 Favored Glycine 0 N--CA 1.48 1.572 0 O-C-N 120.628 -1.295 . . . . 2.29 113.55 165.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 49.78 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 124.434 2.064 . . . . 1.3899999999999999 115.822 162.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -79.72 4.63 15.67 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.245 -1.798 . . . . 2.8500000000000001 114.187 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -155.42 158.97 32.05 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.837 2.855 . . . . 4.8600000000000003 107.32 -175.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.08 -13.77 21.14 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.518 . . . . 4.3700000000000001 117.552 -173.605 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mp 60.82 -4.77 0.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 130.069 3.348 . . . . 4.2800000000000002 113.716 -169.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -42.64 149.65 0.17 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.7 2.8 . . . . 3.3599999999999999 115.124 -171.007 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.7 126.34 21.58 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.955 1.302 . . . . 1.8799999999999999 112.125 178.371 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.74 30.1 45.19 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.778 -0.457 . . . . 3.5299999999999998 112.931 -165.663 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 -176.7 3.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.992 -1.855 . . . . 4.2800000000000002 105.992 139.557 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.23 155.11 50.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.634 -1.247 . . . . 4.7199999999999998 107.634 165.06 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.5 93.18 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 122.428 1.109 . . . . 1.27 110.538 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.05 123.1 16.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.856 -1.974 . . . . 3.8199999999999998 108.857 153.048 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.1 114.28 16.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.656 0.741 . . . . 1.76 109.062 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 9.7 m-20 -89.99 89.33 7.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.291 1.836 . . . . 2.4500000000000002 108.307 176.298 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.9 120.46 13.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.923 1.689 . . . . 1.3100000000000001 109.567 -178.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.3 mt -86.1 139.04 31.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.084 1.353 . . . . 0.56999999999999995 110.391 -175.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -117.04 165.02 13.85 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.845 -0.534 . . . . 2.1600000000000001 112.421 177.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.96 70.84 1.53 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.504 1.122 . . . . 1.9399999999999999 112.681 -176.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 137.07 -154.11 22.13 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.95 1.738 . . . . 3.1200000000000001 111.638 -178.083 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.67 46.84 2.65 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.372 0.987 . . . . 1.9199999999999999 114.894 -173.046 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -136.03 143.43 44.73 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.53 1.932 . . . . 4.4299999999999997 110.673 173.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -152.07 143.85 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 127.506 2.323 . . . . 1.1200000000000001 107.108 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -133.71 118.3 17.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.85 0.86 . . . . 1.78 111.538 -171.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -74.67 117.88 16.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.843 0.457 . . . . 2.4500000000000002 111.612 173.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.46 165.28 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.767 1.227 . . . . 2.0499999999999998 110.42 160.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.21 136.15 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.457 1.103 . . . . 2.6299999999999999 109.195 171.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.9 mt -146.9 109.35 4.04 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.509 1.123 . . . . 2.02 110.693 -167.534 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.77 156.56 65.05 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.13 2.553 . . . . 1.21 113.165 -174.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -80.36 133.87 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 122.084 0.945 . . . . 1.3 112.018 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -121.5 151.65 40.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 130.44 3.496 . . . . 3.7799999999999998 106.711 165.625 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.55 16.41 7.59 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.377 1.621 . . . . 2.7799999999999998 115.377 -154.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 113.717 1.006 . . . . 7.3099999999999996 113.717 -160.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 111.911 0.337 . . . . 6.0800000000000001 111.911 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.99 167.52 28.3 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.699 1.619 . . . . 1.3200000000000001 113.981 176.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -151.49 128.04 10.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.739 1.216 . . . . 2.04 111.593 -170.323 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -100.03 112.21 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.344 -0.847 . . . . 1.27 109.952 -170.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 1.8 tmt_? -84.03 89.71 7.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.333 1.453 . . . . 3.4100000000000001 111.649 -161.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.3 147.53 40.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.78 2.032 . . . . 2.2799999999999998 111.768 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.0 m -159.05 156.76 27.1 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 127.524 2.33 . . . . 2.75 109.273 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.01 12.61 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.852 3.035 . . . . 2.5099999999999998 114.457 -172.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.44 171.82 36.46 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.026 0.83 . . . . 2.4300000000000002 112.455 -167.306 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.65 -3.69 11.03 Favored 'Cis proline' 0 C--N 1.351 0.7 0 CA-C-N 119.143 1.472 . . . . 3.23 113.352 -4.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -146.67 175.12 10.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.73 1.612 . . . . 2.5099999999999998 110.625 175.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.16 -177.37 5.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.665 2.386 . . . . 0.68999999999999995 108.869 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.7 175.29 9.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.446 1.021 . . . . 1.04 113.401 -173.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.51 152.74 29.24 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.425 0.898 . . . . 0.68999999999999995 113.425 169.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.18 162.42 38.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.599 1.56 . . . . 2.1099999999999999 110.582 174.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -174.12 150.2 1.53 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.977 1.711 . . . . 1.95 113.646 -173.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.7 m -68.55 135.24 51.24 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.701 1.6 . . . . 1.8100000000000001 109.12 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.21 133.78 37.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.359 -0.978 . . . . 2.9399999999999999 108.359 173.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -149.56 138.09 20.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.082 0.944 . . . . 3.5 111.391 175.167 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -100.26 100.69 12.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.885 1.674 . . . . 1.22 108.961 -178.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.69 -8.89 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.109 1.873 . . . . 1.28 112.998 174.005 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.98 161.17 43.5 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.058 0.837 . . . . 1.0900000000000001 113.092 -178.105 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.04 5.8 50.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.115 1.766 . . . . 3.0699999999999998 113.422 -172.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.02 159.06 42.5 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.936 1.694 . . . . 1.73 109.949 165.039 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.39 159.21 25.97 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.274 2.65 . . . . 1.1599999999999999 111.796 -170.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.8 mt -110.95 156.32 21.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.396 1.093 . . . . 1.8400000000000001 111.384 170.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -144.12 106.62 4.41 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.511 1.524 . . . . 3.6000000000000001 109.432 175.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.3 tp -91.66 122.37 34.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.312 2.245 . . . . 0.93000000000000005 108.576 -177.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.23 -16.1 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 113.898 1.074 . . . . 0.65000000000000002 113.898 -174.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -160.83 30.68 Favored Glycine 0 C--N 1.341 0.853 0 O-C-N 121.47 -0.769 . . . . 0.46999999999999997 112.27 177.635 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.7 178.6 8.95 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 0.65000000000000002 111.081 168.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -147.03 141.22 26.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.35 1.06 . . . . 6.9000000000000004 110.39 177.225 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -149.19 157.23 39.85 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.296 1.438 . . . . 0.92000000000000004 111.369 -167.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.1 -25.14 8.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.343 2.029 . . . . 1.3 113.355 165.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.29 3.6 m -87.5 12.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.484 1.29 . . . . 1.22 114.484 -173.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.12 145.99 30.72 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.521 1.128 . . . . 0.96999999999999997 110.741 173.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.05 -74.71 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.707 -1.59 . . . . 5.7999999999999998 106.707 170.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -80.17 142.19 34.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.305 1.842 . . . . 2.9300000000000002 109.692 169.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.22 131.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.66 1.584 . . . . 1.47 108.811 177.284 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -146.65 133.82 20.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.445 1.498 . . . . 1.95 109.96 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.65 123.81 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.296 1.046 . . . . 0.91000000000000003 111.003 171.146 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 14.9 m170 -117.29 152.02 35.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.847 2.059 . . . . 0.71999999999999997 113.492 -178.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.49 160.18 15.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.003 1.321 . . . . 2.1299999999999999 110.493 165.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.2 m -110.53 144.14 39.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.172 1.789 . . . . 1.46 107.7 163.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -152.19 162.42 41.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 114.679 1.363 . . . . 2.3900000000000001 114.679 -169.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.2 ptp -121.08 144.6 48.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.233 1.413 . . . . 3.8100000000000001 110.332 159.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -147.76 142.31 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.113 1.365 . . . . 8.3100000000000005 110.402 171.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.18 149.07 46.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.611 1.564 . . . . 4.1299999999999999 111.718 175.599 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 p -146.63 -11.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.458 1.281 . . . . 3.2400000000000002 114.458 173.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.21 30.56 0.49 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.175 1.79 . . . . 4.0999999999999996 110.875 178.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.35 -14.97 3.72 Favored Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.494 -1.379 . . . . 1.98 113.659 -167.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 167.76 9.57 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.185 2.194 . . . . 2.6200000000000001 110.019 158.551 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.56 148.68 34.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.997 1.851 . . . . 3.6699999999999999 115.997 -170.419 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.82 141.94 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.402 1.881 . . . . 3.1600000000000001 109.086 165.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 tpp -93.25 137.59 32.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.589 1.555 . . . . 2.8100000000000001 109.836 171.221 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 -177.77 29.01 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.801 0.715 . . . . 1.6399999999999999 114.584 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.4 mtt -141.48 156.64 45.74 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.159 1.784 . . . . 3.1699999999999999 110.211 176.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -164.96 156.07 12.87 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.25 1.42 . . . . 4.3700000000000001 110.84 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 33.0 Cg_endo -66.93 150.45 82.98 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.933 1.755 . . . . 0.81000000000000005 112.284 169.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.96 158.69 41.75 Favored Pre-proline 0 N--CA 1.471 0.625 0 C-N-CA 126.599 1.96 . . . . 0.95999999999999996 109.829 174.141 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.04 -29.5 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.142 1.895 . . . . 1.3600000000000001 112.247 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 p90 175.92 160.88 0.3 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.499 1.52 . . . . 1.8999999999999999 107.14 -175.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -112.13 162.55 15.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.275 1.036 . . . . 2.6200000000000001 111.033 155.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -145.27 157.66 44.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.071 -1.422 . . . . 2.52 114.174 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -145.88 133.74 10.5 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 114.553 -1.203 . . . . 1.0700000000000001 108.481 -161.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.9 171.22 15.01 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.011 1.807 . . . . 1.3300000000000001 111.334 176.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.86 144.06 99.51 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.075 2.517 . . . . 1.24 111.435 165.432 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 66.62 4.85 3.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.859 1.664 . . . . 1.5800000000000001 113.173 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.46 126.23 8.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 128.232 2.825 . . . . 1.1599999999999999 112.494 -170.302 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -98.78 141.82 31.1 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.642 1.577 . . . . 3.9199999999999999 112.601 166.27 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.4 122.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.321 1.848 . . . . 1.4199999999999999 108.744 168.146 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.443 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 18.0 mp0 -89.68 143.37 26.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.255 -0.903 . . . . 4.0499999999999998 111.163 176.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.44 148.49 43.21 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.321 -0.862 . . . . 2.6200000000000001 109.07 164.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' A' ' 76' ' ' GLU . 12.3 ptpt -166.86 138.72 2.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.947 1.299 . . . . 4.1399999999999997 111.363 -165.426 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.91 -26.79 58.94 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.153 3.236 . . . . 1.45 114.294 -169.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.72 78.71 1.03 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.145 -1.582 . . . . 1.74 109.145 161.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.42 -76.5 0.21 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 124.247 0.927 . . . . 1.24 114.236 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -148.3 136.64 21.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.167 1.387 . . . . 2.2599999999999998 111.623 -168.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.55 167.24 29.03 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.801 -0.562 . . . . 0.88 110.053 -172.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -96.88 133.73 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.392 -0.966 . . . . 2.3399999999999999 108.392 165.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 mmt -82.92 137.57 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.182 -0.673 . . . . 0.89000000000000001 109.182 157.265 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.94 127.81 55.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.967 2.107 . . . . 1.8799999999999999 107.112 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -136.2 158.37 44.57 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.495 1.118 . . . . 1.8799999999999999 111.412 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.58 -61.36 3.23 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.421 1.486 . . . . 3.1400000000000001 112.551 178.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.5 mt 76.84 100.33 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 130.861 3.664 . . . . 1.23 110.837 173.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.026 -1.046 . . . . 1.9299999999999999 113.139 -169.045 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -150.4 153.8 35.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.488 2.715 . . . . 6.6699999999999999 108.282 169.347 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -67.43 158.79 55.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.857 2.372 . . . . 2.4199999999999999 110.386 166.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.19 157.29 26.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.383 1.473 . . . . 2.5299999999999998 111.565 -171.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -139.28 134.43 32.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.344 1.057 . . . . 3.6899999999999999 111.142 176.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.87 38.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.202 0.601 . . . . 1.6599999999999999 111.906 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.13 -15.12 8.28 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.372 1.463 . . . . 2.21 116.038 173.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -176.04 3.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.19 1.495 . . . . 4.6399999999999997 111.243 -171.397 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -89.28 160.97 16.64 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.62 1.568 . . . . 4.75 112.362 171.251 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.37 127.59 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.054 1.742 . . . . 1.3400000000000001 108.863 167.263 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.32 134.11 41.1 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.326 1.45 . . . . 2.6899999999999999 110.259 164.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.67 127.37 10.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.498 1.142 . . . . 1.7 113.59 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.71 94.5 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.534 1.534 . . . . 2.6000000000000001 110.446 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.27 115.94 11.01 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.379 1.472 . . . . 1.21 110.524 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.0 mt -88.09 129.92 35.16 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.685 1.194 . . . . 0.81999999999999995 110.643 -172.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.66 144.9 50.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.056 0.931 . . . . 2.04 112.463 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.91 125.55 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.856 1.262 . . . . 1.96 113.473 -169.197 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.2 70.23 1.25 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.643 1.115 . . . . 3.3399999999999999 112.549 177.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.49 15.76 81.27 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.557 1.383 . . . . 1.95 116.557 163.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -105.92 148.36 27.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.967 1.883 . . . . 4.8899999999999997 110.972 171.174 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.11 140.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.84 1.656 . . . . 1.1200000000000001 107.914 167.541 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -120.2 116.99 26.72 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.224 1.009 . . . . 1.4299999999999999 109.385 178.009 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -75.73 128.81 35.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.83 0.452 . . . . 2.5699999999999998 110.835 174.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -137.04 144.32 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.01 1.724 . . . . 1.73 109.612 175.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.55 130.98 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.927 1.291 . . . . 2.4399999999999999 108.473 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 mp -140.26 153.56 69.02 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.667 1.587 . . . . 2.5800000000000001 110.013 -172.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.89 155.86 43.49 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.597 2.865 . . . . 1.4099999999999999 112.937 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.46 142.75 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.776 1.23 . . . . 1.4099999999999999 110.491 168.096 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.5 151.46 39.34 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.652 1.981 . . . . 2.8100000000000001 108.501 164.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.72 28.68 7.19 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.914 1.45 . . . . 1.96 114.914 -161.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.412 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.86 1.264 . . . . 7.8899999999999997 111.978 -165.191 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 CA--C 1.551 1.016 0 N-CA-C 110.528 -0.175 . . . . 5.6100000000000003 110.528 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.91 170.95 23.54 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.168 -1.582 . . . . 0.93999999999999995 114.581 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 p90 -165.58 149.78 8.4 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.137 0.975 . . . . 1.3799999999999999 111.291 -175.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.42 147.54 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.368 -0.975 . . . . 0.96999999999999997 108.368 167.3 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -97.08 119.72 36.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.947 0.794 . . . . 5.2000000000000002 110.043 164.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.12 134.62 38.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.864 0.84 . . . . 2.5600000000000001 108.86 156.505 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.2 m -139.66 160.89 59.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 125.635 1.574 . . . . 2.6200000000000001 109.336 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.24 -7.26 13.41 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.485 2.79 . . . . 2.3100000000000001 115.038 178.23 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.91 -164.47 18.53 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.254 0.934 . . . . 2.3500000000000001 113.549 175.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.33 -7.46 12.99 Favored 'Cis proline' 0 C--N 1.351 0.672 0 CA-C-N 118.69 1.245 . . . . 2.04 113.389 -4.116 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.06 136.92 34.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.345 1.458 . . . . 3.3100000000000001 110.919 176.496 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.57 -177.94 3.27 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.097 1.759 . . . . 0.58999999999999997 110.695 -177.17 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.63 136.66 34.56 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.243 0.929 . . . . 0.72999999999999998 113.068 -169.368 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.49 141.42 52.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 0.85999999999999999 112.294 -178.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -135.62 165.43 25.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.806 1.643 . . . . 2.4300000000000002 110.658 -172.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -171.34 148.96 2.68 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 1.5 112.783 168.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.0 m -77.28 138.07 39.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.809 -1.182 . . . . 1.22 107.809 149.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -136.33 143.22 44.02 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.522 1.929 . . . . 2.46 107.967 -177.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.63 135.24 49.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.731 0.812 . . . . 3.5 111.003 -177.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -97.23 100.73 8.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.515 -0.92 . . . . 1.1499999999999999 108.515 165.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.79 -10.79 15.5 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.637 2.225 . . . . 1.28 113.146 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.44 -173.08 49.49 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.729 1.157 . . . . 1.3999999999999999 113.413 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.21 1.34 16.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.913 1.685 . . . . 3.0 112.802 -168.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -123.03 161.0 47.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.327 1.851 . . . . 1.5800000000000001 110.392 174.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 148.63 17.29 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.509 2.14 . . . . 0.80000000000000004 111.833 -171.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.07 111.68 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.053 1.341 . . . . 2.0800000000000001 110.605 -176.45 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -98.79 101.91 13.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.871 1.268 . . . . 4.2800000000000002 110.865 -179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.07 114.56 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.676 1.99 . . . . 0.73999999999999999 108.629 -175.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.77 -19.51 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.29 0.848 . . . . 0.62 113.29 -171.081 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.37 -163.55 30.43 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.267 0.937 . . . . 0.39000000000000001 111.552 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.82 179.53 7.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 0.71999999999999997 110.658 164.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -149.41 135.36 18.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.859 1.664 . . . . 6.6299999999999999 108.068 -177.193 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -140.0 156.96 70.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.421 1.488 . . . . 0.79000000000000004 109.997 -171.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.48 -25.19 9.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.276 1.984 . . . . 0.93999999999999995 112.103 169.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.259 14.3 m -82.91 -11.52 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.469 1.285 . . . . 1.01 114.469 -173.456 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.11 155.71 47.65 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.526 0.935 . . . . 0.80000000000000004 113.526 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.26 -91.83 0.11 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.945 1.298 . . . . 3.3900000000000001 110.212 175.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -84.28 92.2 7.93 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.886 0.874 . . . . 3.1000000000000001 108.826 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -87.15 139.26 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.288 1.035 . . . . 1.4199999999999999 110.798 172.36 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -137.52 138.79 40.03 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.356 1.862 . . . . 1.9299999999999999 110.751 -174.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.43 121.04 29.35 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.913 1.233 . . . . 0.75 111.747 169.171 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -108.61 155.91 20.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.266 1.826 . . . . 0.58999999999999997 112.339 175.172 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.55 -179.76 4.04 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 2.5800000000000001 110.696 169.013 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -140.32 116.19 10.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.144 1.378 . . . . 1.1100000000000001 107.442 172.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -117.47 -179.49 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.509 1.524 . . . . 1.8100000000000001 110.854 -174.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 73.6 mtm -130.16 128.04 40.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.169 0.988 . . . . 3.3599999999999999 110.868 164.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -97.61 168.17 10.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.744 1.218 . . . . 7.3300000000000001 111.527 167.141 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -88.51 142.57 27.6 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.535 0.734 . . . . 5.9699999999999998 109.397 153.298 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.04 -6.92 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.141 1.163 . . . . 3.7400000000000002 114.141 175.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -175.84 31.66 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.804 2.042 . . . . 4.0099999999999998 109.425 -165.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.66 -19.68 0.15 Allowed Glycine 0 N--CA 1.479 1.501 0 O-C-N 119.545 -1.972 . . . . 2.29 114.769 -158.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -74.2 132.36 42.11 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.115 1.766 . . . . 3.96 109.159 175.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -76.4 126.34 30.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.101 -1.074 . . . . 4.2000000000000002 108.101 169.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -140.01 139.13 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.176 1.391 . . . . 2.5099999999999998 108.79 -175.045 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.8 mtp -69.9 162.25 28.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.217 1.192 . . . . 5.0999999999999996 114.217 -175.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.71 164.17 32.52 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.791 1.186 . . . . 0.96999999999999997 111.597 167.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.13 157.88 30.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.994 1.317 . . . . 1.79 110.183 172.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -169.44 151.56 4.51 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 3.8199999999999998 110.607 177.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.3 Cg_endo -69.02 153.23 72.65 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.758 1.639 . . . . 0.56000000000000005 111.708 169.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.76 159.02 50.42 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 126.261 1.824 . . . . 0.71999999999999997 110.53 174.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -72.46 -21.49 22.59 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.677 2.251 . . . . 0.78000000000000003 112.58 172.375 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -175.75 169.96 2.92 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.739 1.616 . . . . 2.3300000000000001 110.839 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -122.11 174.33 7.01 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.905 2.482 . . . . 0.77000000000000002 108.78 160.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -152.88 165.54 35.11 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.257 -0.902 . . . . 2.6600000000000001 113.217 164.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -135.04 128.29 18.54 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 125.45 1.5 . . . . 1.22 109.058 -176.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.85 162.2 43.45 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.474 2.116 . . . . 1.1599999999999999 111.03 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.21 94.45 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.975 2.45 . . . . 1.23 111.649 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt 68.1 -1.05 1.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.685 1.994 . . . . 1.53 113.671 -174.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.09 117.86 4.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 126.556 2.027 . . . . 1.1899999999999999 111.894 -177.314 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -91.75 129.61 37.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.235 1.014 . . . . 6.1699999999999999 110.035 157.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.07 171.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.861 1.664 . . . . 1.51 110.226 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -139.65 146.03 39.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.7 1.238 . . . . 4.6500000000000004 114.117 176.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -85.34 71.64 10.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.939 1.696 . . . . 1.27 109.391 178.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -61.4 141.56 94.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 114.133 -1.394 . . . . 3.7200000000000002 112.262 177.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.48 -18.04 51.58 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.653 2.236 . . . . 1.3 113.149 165.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.59 26.09 23.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.252 1.406 . . . . 1.26 114.107 172.151 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.52 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.476 1.36 0 CA-C-N 119.414 1.607 . . . . 1.3500000000000001 115.735 175.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -159.97 140.4 11.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.632 1.573 . . . . 1.95 109.413 -176.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -171.0 168.68 6.89 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.491 1.951 . . . . 1.3 111.173 -175.255 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.31 125.75 46.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.507 0.723 . . . . 1.73 111.46 -178.485 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mmt -91.99 142.57 27.4 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.449 1.099 . . . . 1.1200000000000001 110.014 170.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 mt -119.89 85.79 2.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.618 1.567 . . . . 1.78 109.053 -171.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.68 107.71 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.242 1.017 . . . . 3.3199999999999998 108.632 -176.179 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.03 130.37 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.118 0.866 . . . . 2.77 111.801 -172.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.475 HD13 HD11 ' A' ' 93' ' ' LEU . 64.3 mt -112.6 118.49 35.22 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.771 0.828 . . . . 0.88 108.999 178.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.2 9.79 19.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.069 0.766 . . . . 2.4900000000000002 113.069 -166.19 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -172.55 159.2 3.93 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 128.016 2.527 . . . . 5.2999999999999998 108.919 -171.627 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.24 160.61 48.96 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.374 1.383 . . . . 2.1299999999999999 110.018 162.196 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.475 HD11 HD13 ' A' ' 89' ' ' LEU . 3.6 mp -115.48 -164.72 0.97 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.453 1.901 . . . . 3.1899999999999999 108.728 -171.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.15 136.95 13.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.399 1.48 . . . . 5.0899999999999999 110.976 168.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.04 126.97 29.88 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.055 -1.091 . . . . 1.4299999999999999 108.055 151.657 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.38 78.53 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.137 -1.924 . . . . 1.8899999999999999 115.614 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -93.7 177.96 5.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.514 2.157 . . . . 3.5600000000000001 110.051 153.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -103.58 149.13 25.18 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.589 0.756 . . . . 4.8499999999999996 109.783 167.474 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.433 HG23 ' CG2' ' A' ' 117' ' ' VAL . 8.4 t -105.52 123.13 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.651 1.18 . . . . 1.1499999999999999 108.215 168.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.64 124.06 21.81 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 113.949 -1.478 . . . . 4.71 107.5 162.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.17 109.42 10.8 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.932 0.873 . . . . 1.8200000000000001 111.074 174.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.79 86.11 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.702 2.401 . . . . 2.6299999999999999 109.673 173.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.18 117.22 8.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.829 1.252 . . . . 1.1299999999999999 109.623 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.4 126.2 35.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.853 1.261 . . . . 0.81000000000000005 110.735 -175.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.42 117.77 25.18 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.535 -0.728 . . . . 1.95 111.58 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.96 22.04 0.18 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.196 2.199 . . . . 2.6899999999999999 115.985 171.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.9 -41.72 1.07 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.786 1.66 . . . . 3.9399999999999999 113.847 -171.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.06 -1.82 90.15 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.987 -1.452 . . . . 1.73 116.071 -174.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.45 159.32 42.46 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.712 2.005 . . . . 4.0300000000000002 111.727 168.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.14 145.99 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 126.42 1.888 . . . . 1.03 108.179 168.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -134.76 108.42 7.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.265 1.026 . . . . 1.6299999999999999 109.858 -177.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.87 96.83 6.46 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.604 0.361 . . . . 2.9399999999999999 110.817 176.661 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.86 151.39 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.631 0.772 . . . . 1.46 110.837 176.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.23 131.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.813 1.645 . . . . 1.9299999999999999 108.734 168.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.7 mt -139.93 130.63 14.19 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 1.78 109.499 176.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.93 151.6 56.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.489 2.793 . . . . 1.1000000000000001 111.692 176.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 99' ' ' VAL . 53.3 t -97.84 117.14 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.924 0.89 . . . . 1.23 111.787 178.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -75.57 155.36 36.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.553 2.741 . . . . 3.98 109.072 159.047 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.3 131.19 45.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.833 -1.167 . . . . 1.8400000000000001 112.631 171.766 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.0 mtt180 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 127.577 2.351 . . . . 7.21 108.153 169.699 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 118.745 -0.645 . . . . 5.46 109.697 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 170.97 24.26 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 120.877 1.671 . . . . 0.94999999999999996 114.232 177.445 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -155.31 164.98 38.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.285 1.041 . . . . 1.8799999999999999 113.681 174.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.58 119.13 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.169 -0.923 . . . . 1.26 108.549 174.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.531 ' HE ' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -80.83 113.46 19.04 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.435 0.636 . . . . 4.0700000000000003 110.383 175.095 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.5 134.64 53.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.021 0.915 . . . . 2.8999999999999999 108.98 162.319 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.03 164.62 20.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.691 1.996 . . . . 2.9300000000000002 107.298 170.312 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.62 -10.65 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.755 2.304 . . . . 1.6299999999999999 114.283 -174.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.17 -159.74 27.78 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.95 0.786 . . . . 1.49 111.743 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.37 -6.57 12.46 Favored 'Cis proline' 0 CA--C 1.538 0.704 0 CA-C-N 119.141 1.471 . . . . 1.71 113.7 3.076 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -136.9 158.83 43.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.821 1.248 . . . . 2.21 112.021 170.394 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.78 -162.57 1.11 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.004 2.122 . . . . 1.0600000000000001 111.226 -176.316 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB3' ' HE ' ' A' ' 9' ' ' ARG . . . -156.23 163.07 40.01 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.537 1.31 . . . . 0.72999999999999998 114.537 -170.041 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.27 150.37 36.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.688 1.595 . . . . 0.62 112.256 172.686 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.38 134.36 20.28 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.271 1.828 . . . . 2.3399999999999999 108.778 -172.669 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.56 137.81 8.11 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 115.055 1.502 . . . . 2.0499999999999998 115.055 -160.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -66.97 136.08 54.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.609 -0.723 . . . . 1.75 110.637 167.443 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.31 153.59 40.04 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.971 2.108 . . . . 2.6800000000000002 109.926 163.229 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.64 149.49 48.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.772 0.796 . . . . 3.4100000000000001 110.582 164.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -106.2 95.24 10.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.141 -0.936 . . . . 1.25 110.004 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.15 -5.09 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.875 2.384 . . . . 1.79 113.0 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.84 162.19 52.77 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 124.972 1.273 . . . . 1.5 113.39 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -74.56 -32.03 62.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.265 2.226 . . . . 5.8200000000000003 112.788 174.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.28 164.09 17.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.358 1.863 . . . . 1.73 112.102 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.55 152.54 17.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.864 2.376 . . . . 0.70999999999999996 111.497 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.28 115.98 30.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.852 1.261 . . . . 2.3199999999999998 110.226 -176.262 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.447 HH11 ' HB2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -99.58 107.27 19.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.528 1.131 . . . . 4.2400000000000002 110.538 177.065 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -95.55 119.24 33.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.093 1.357 . . . . 0.87 109.318 -174.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.21 -12.93 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.476 1.11 . . . . 0.67000000000000004 113.927 -171.095 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.5 -162.73 30.19 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.426 1.012 . . . . 0.56999999999999995 111.971 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB1' ' CD1' ' A' ' 101' ' ' LEU . . . -156.09 -167.96 2.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 0.72999999999999998 111.442 165.365 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -159.13 161.04 36.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.252 0.933 . . . . 5.6900000000000004 108.824 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.24 156.96 30.93 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 125.842 1.657 . . . . 0.73999999999999999 111.088 -178.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.5 -17.97 15.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.612 2.875 . . . . 1.0900000000000001 114.462 170.135 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -98.35 -18.17 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 115.013 1.486 . . . . 1.27 115.013 -174.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.432 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -108.55 152.8 24.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.75 1.159 . . . . 0.76000000000000001 112.073 176.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.95 -90.9 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.747 0.819 . . . . 3.5499999999999998 109.497 173.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -79.53 141.81 36.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.114 -1.069 . . . . 3.6299999999999999 108.114 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.08 131.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.715 1.206 . . . . 1.55 110.462 173.361 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.04 132.21 20.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.277 1.031 . . . . 2.1699999999999999 111.847 -163.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tt -79.13 124.22 28.11 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 121.474 0.654 . . . . 0.76000000000000001 111.034 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -112.62 157.07 21.66 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.196 1.798 . . . . 0.81000000000000005 112.147 172.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.44 -170.85 1.84 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.548 1.139 . . . . 2.71 112.319 165.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.6 m -147.42 88.09 1.69 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.32 1.848 . . . . 1.1200000000000001 107.447 170.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -78.46 157.24 29.0 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 2.2400000000000002 112.009 -177.311 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.9 mtm -107.69 130.72 54.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.401 1.08 . . . . 2.8300000000000001 110.012 166.41 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 -146.89 149.39 33.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.308 1.043 . . . . 5.0300000000000002 111.542 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 145.54 55.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.544 0.738 . . . . 3.9900000000000002 109.843 155.497 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.74 -90.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.727 1.611 . . . . 3.1000000000000001 108.693 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -77.43 41.29 0.31 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.392 2.277 . . . . 3.5499999999999998 111.613 175.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.97 -10.27 1.26 Allowed Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.544 -1.348 . . . . 2.02 114.327 -166.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -102.45 155.79 18.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 128.625 2.77 . . . . 2.6099999999999999 109.374 175.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -90.59 145.62 24.71 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.303 1.223 . . . . 3.4199999999999999 114.303 178.003 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.9 t -141.27 148.16 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.306 1.843 . . . . 1.8700000000000001 109.421 -178.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -89.87 123.45 33.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.577 1.551 . . . . 3.5299999999999998 110.11 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.87 138.31 10.51 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 119.041 0.837 . . . . 1.3 113.678 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -90.04 156.62 18.27 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.828 0.851 . . . . 1.76 111.676 170.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -167.42 153.7 7.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.135 1.774 . . . . 4.3799999999999999 110.088 168.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -68.46 156.95 63.85 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.342 1.361 . . . . 0.57999999999999996 110.698 170.118 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.99 156.14 78.63 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.237 1.415 . . . . 0.66000000000000003 110.751 -178.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.87 -20.07 30.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.969 2.446 . . . . 0.71999999999999997 113.112 178.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.6 166.91 3.86 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.444 1.098 . . . . 1.8700000000000001 112.455 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -115.92 178.0 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.471 2.308 . . . . 0.67000000000000004 109.296 153.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.12 159.63 44.36 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.122 -0.986 . . . . 2.0800000000000001 111.57 164.077 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.41 126.53 20.29 Favored Pre-proline 0 N--CA 1.468 0.425 0 C-N-CA 126.021 1.728 . . . . 1.0 108.202 -178.247 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.64 162.39 42.3 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.509 2.14 . . . . 0.88 110.998 178.184 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.51 131.76 32.99 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.29 2.66 . . . . 1.02 110.622 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.9 1.52 3.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.869 2.467 . . . . 2.5899999999999999 114.226 -170.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.84 118.81 9.24 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 125.811 1.672 . . . . 1.0 109.055 172.024 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -117.79 114.58 23.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.833 2.053 . . . . 4.46 109.171 172.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -149.96 154.02 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.459 1.103 . . . . 1.99 112.174 -165.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -102.96 134.49 46.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.302 0.572 . . . . 3.0499999999999998 111.751 176.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.13 137.0 57.36 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.241 -1.392 . . . . 2.0800000000000001 107.241 141.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -150.17 143.75 16.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.489 2.316 . . . . 3.2599999999999998 109.938 -161.101 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.05 -43.68 28.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.807 3.005 . . . . 1.54 113.151 -167.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 118.34 5.86 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.371 -1.892 . . . . 2.1099999999999999 108.371 157.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -77.29 0.38 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.683 1.135 . . . . 1.23 112.937 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -154.5 131.9 11.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.41 1.105 . . . . 2.02 110.448 -175.361 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -163.66 172.17 14.64 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.764 -1.21 . . . . 0.82999999999999996 111.714 -167.299 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.13 122.08 45.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.162 0.585 . . . . 1.8999999999999999 109.776 173.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 mmt -80.39 134.23 36.0 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.171 -0.678 . . . . 1.24 109.171 165.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.52 118.52 36.77 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.198 1.399 . . . . 2.1000000000000001 107.711 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.78 104.71 9.78 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.373 1.469 . . . . 1.96 109.192 -171.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.06 141.39 1.05 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.302 -0.719 . . . . 3.1499999999999999 111.302 -159.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.9 mt -117.67 120.47 38.11 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.489 -0.93 . . . . 1.23 108.489 171.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.79 -4.38 54.41 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.946 1.091 . . . . 2.2000000000000002 113.946 -170.851 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -150.41 159.21 35.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.134 2.173 . . . . 6.6100000000000003 110.076 178.147 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -66.76 159.11 52.88 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.354 2.036 . . . . 2.2400000000000002 109.226 153.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.54 160.4 31.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.689 1.596 . . . . 2.6499999999999999 109.75 -162.562 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.69 129.53 10.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.412 1.101 . . . . 4.6699999999999999 112.902 -158.22 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.31 121.19 13.72 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.479 -0.763 . . . . 2.0499999999999998 110.213 174.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.43 7.69 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.423 -1.209 . . . . 2.29 114.804 -166.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.9 174.2 7.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.652 1.726 . . . . 3.6200000000000001 108.958 144.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -89.7 148.28 23.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.045 0.938 . . . . 3.9399999999999999 110.617 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.4 HG23 ' CG2' ' A' ' 117' ' ' VAL . 3.1 t -93.63 127.48 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.254 -1.017 . . . . 1.1399999999999999 108.254 161.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.526 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 51.5 mt-10 -65.45 111.87 3.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.281 -0.872 . . . . 3.1899999999999999 108.678 153.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.404 ' CD1' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -100.95 123.29 44.91 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.594 -1.262 . . . . 2.5299999999999998 107.594 163.113 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -102.68 85.64 2.61 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.835 2.054 . . . . 2.2799999999999998 109.145 177.096 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.28 121.47 16.31 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.444 1.898 . . . . 3.0099999999999998 110.5 -175.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.5 mt -92.98 133.54 36.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.42 1.088 . . . . 0.97999999999999998 111.279 -176.688 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.77 153.31 38.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.159 0.984 . . . . 1.8500000000000001 111.454 178.783 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.9 132.35 53.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.346 0.658 . . . . 1.78 111.303 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.83 -142.92 16.27 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.662 -0.975 . . . . 3.7999999999999998 110.662 -167.321 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -100.62 12.25 59.6 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.676 1.131 . . . . 2.5699999999999998 115.359 -176.02 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -87.36 137.36 32.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.589 1.694 . . . . 5.79 113.306 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.38 138.52 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.749 1.62 . . . . 1.3799999999999999 109.787 165.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.07 113.4 25.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.472 1.509 . . . . 2.4100000000000001 109.898 177.416 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.526 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 23.0 ttmm -78.69 116.91 19.37 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.126 -0.694 . . . . 2.6499999999999999 109.126 168.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.83 149.46 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.408 1.083 . . . . 1.76 109.89 173.203 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -95.8 138.07 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.663 1.185 . . . . 2.8399999999999999 109.62 170.221 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.3 mt -144.91 140.61 16.43 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.678 1.591 . . . . 1.8799999999999999 109.807 178.01 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.04 144.37 63.53 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.079 3.186 . . . . 1.3 114.005 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 99' ' ' VAL . 60.4 t -88.16 126.22 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.45 1.1 . . . . 1.5900000000000001 110.831 172.177 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -97.31 168.79 10.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.038 2.935 . . . . 3.1699999999999999 109.222 169.109 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.57 30.89 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.622 1.556 . . . . 2.0299999999999998 110.386 161.494 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.2 ttm-85 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.862 1.665 . . . . 7.1600000000000001 113.075 -171.704 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 121.353 0.597 . . . . 5.8499999999999996 110.692 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.06 172.34 30.69 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.371 -0.83 . . . . 0.87 114.824 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -159.63 129.8 5.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 2.1499999999999999 112.66 -173.136 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.01 103.09 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.79 -1.189 . . . . 1.0 107.79 175.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.5 ttp85 -85.46 114.37 22.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.576 0.703 . . . . 4.1699999999999999 110.695 -174.121 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.24 163.21 18.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.138 1.775 . . . . 2.8700000000000001 112.903 -167.828 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -168.89 142.31 2.36 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.17 1.788 . . . . 2.6000000000000001 109.95 156.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.61 -8.38 18.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.069 3.179 . . . . 2.2000000000000002 114.425 -169.633 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.94 161.93 10.62 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.929 0.776 . . . . 2.6899999999999999 113.302 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.87 -1.44 8.12 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 118.612 1.206 . . . . 3.1600000000000001 112.659 -11.803 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -153.51 173.09 16.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 2.77 113.322 -179.003 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.02 171.57 14.24 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.139 2.576 . . . . 0.79000000000000004 110.373 168.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.69 104.42 4.91 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.885 0.874 . . . . 2.2599999999999998 111.307 -171.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 149.99 21.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.508 0.929 . . . . 0.63 113.508 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.12 162.97 32.82 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.625 1.57 . . . . 2.3799999999999999 111.167 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.93 152.62 6.59 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.46 1.104 . . . . 1.4399999999999999 112.075 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 m -84.24 142.37 30.32 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.251 -1.018 . . . . 1.3100000000000001 108.251 154.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.82 146.33 39.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.447 1.899 . . . . 2.7599999999999998 106.951 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 7.7 pt-20 -116.97 142.51 46.86 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.484 0.714 . . . . 3.5600000000000001 111.548 173.107 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -101.58 105.14 38.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.121 0.969 . . . . 1.1100000000000001 109.685 166.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.14 -8.43 11.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.641 2.227 . . . . 0.95999999999999996 113.672 178.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.26 166.92 48.6 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 119.707 1.139 . . . . 1.22 112.93 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.83 2.37 51.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.195 2.198 . . . . 3.27 111.877 173.168 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -109.67 159.53 31.26 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 128.333 2.653 . . . . 2.75 108.888 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.76 152.03 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.094 2.53 . . . . 1.1100000000000001 111.287 177.137 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.99 106.51 17.06 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.013 0.925 . . . . 2.3199999999999998 110.495 173.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.1 114.16 21.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.581 -1.645 . . . . 3.5499999999999998 109.112 170.338 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 104' ' ' LEU . 2.3 tm? -105.14 128.77 53.53 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.535 1.934 . . . . 2.9700000000000002 108.693 -177.561 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.79 -7.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.169 0.988 . . . . 0.63 113.259 -175.049 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.9 -159.18 32.19 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 119.588 -1.291 . . . . 0.52000000000000002 114.303 178.592 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.4 173.15 14.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.674 0.79 . . . . 0.72999999999999998 112.351 -179.143 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 45.4 mtm180 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.139 -1.43 . . . . 6.1399999999999997 107.139 164.041 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -147.2 142.96 17.49 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 117.886 -1.054 . . . . 1.25 109.066 -175.043 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.29 -21.72 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.005 1.803 . . . . 1.21 111.517 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.367 1.0 OUTLIER -77.86 11.73 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 118.739 0.7 . . . . 1.5 112.453 174.894 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.43 145.71 39.2 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 114.584 1.327 . . . . 0.96999999999999997 114.584 176.456 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -87.17 -83.19 0.2 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.742 -1.207 . . . . 4.1200000000000001 107.742 170.154 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -77.99 147.59 34.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.1 0.96 . . . . 3.2599999999999998 108.84 162.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.28 143.54 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.231 1.412 . . . . 1.3600000000000001 109.279 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -139.87 137.44 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.424 1.49 . . . . 2.27 109.773 -174.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.453 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.0 tt -86.56 121.97 29.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.962 1.255 . . . . 0.90000000000000002 110.511 164.624 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -109.92 153.66 24.19 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.038 1.335 . . . . 0.92000000000000004 112.329 174.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.82 169.69 10.73 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.053 1.741 . . . . 2.21 110.618 163.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -152.11 128.27 10.47 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.898 1.279 . . . . 1.72 108.992 175.601 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.65 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.136 0.974 . . . . 1.98 112.674 -161.46 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 ptt? -105.48 148.92 26.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.239 0.616 . . . . 3.0699999999999998 110.474 155.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -162.11 164.55 27.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.572 1.949 . . . . 5.2000000000000002 109.98 174.04 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.0 149.68 22.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.922 0.889 . . . . 4.3799999999999999 110.959 -174.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -128.36 -96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 124.329 1.018 . . . . 3.0600000000000001 109.244 -178.111 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -76.72 42.02 0.28 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.909 2.084 . . . . 3.7200000000000002 110.963 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.61 -9.12 3.69 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 119.827 -1.796 . . . . 2.9100000000000001 114.04 -168.105 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.17 148.02 24.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.702 1.601 . . . . 3.4199999999999999 110.285 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -65.58 134.41 53.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.472 0.709 . . . . 3.7200000000000002 110.203 167.033 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -137.5 153.75 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.377 1.471 . . . . 2.1200000000000001 109.126 176.536 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 ptp -108.02 142.44 38.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.371 1.068 . . . . 5.3600000000000003 111.866 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.22 32.63 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 123.741 0.686 . . . . 1.3500000000000001 113.342 -176.043 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.18 167.18 23.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 2.3300000000000001 110.329 -173.701 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -173.69 154.35 2.36 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.763 1.625 . . . . 3.9199999999999999 111.215 170.896 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.67 143.82 69.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.397 2.065 . . . . 0.95999999999999996 112.01 166.388 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.27 156.86 59.91 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.005 2.122 . . . . 0.75 110.521 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.97 -21.46 18.35 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.522 2.148 . . . . 0.73999999999999999 113.186 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -172.7 174.8 3.58 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.841 1.201 . . . . 2.3599999999999999 111.905 -177.507 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.1 176.34 8.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.455 2.702 . . . . 0.87 108.513 165.774 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.87 168.45 27.17 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 120.728 -1.232 . . . . 2.4700000000000002 112.649 166.129 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.37 129.9 18.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.516 1.527 . . . . 1.5 108.969 179.049 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.52 162.97 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.15 2.566 . . . . 1.52 112.219 -177.601 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.01 136.04 70.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.885 3.056 . . . . 1.3200000000000001 112.005 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt 67.02 5.57 4.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.08 1.752 . . . . 1.3500000000000001 113.665 -178.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.39 123.43 7.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 126.809 2.147 . . . . 1.3300000000000001 110.238 -178.771 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -102.35 129.96 48.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.156 0.982 . . . . 4.5599999999999996 110.915 159.565 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.8 m -153.01 158.8 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.171 1.388 . . . . 2.29 110.693 -174.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.63 142.47 46.85 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.15 1.38 . . . . 3.6000000000000001 114.278 -177.569 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.58 73.22 0.53 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.863 1.665 . . . . 1.22 108.954 165.592 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -62.6 140.88 96.94 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.251 1.42 . . . . 3.27 112.272 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.06 -37.63 91.77 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.281 2.654 . . . . 1.1899999999999999 112.822 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.22 71.08 2.99 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.943 -1.263 . . . . 1.3200000000000001 109.943 164.161 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.77 -58.65 0.2 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.553 1.073 . . . . 1.4099999999999999 115.09 176.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -157.63 149.46 22.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.4 1.88 . . . . 2.8199999999999998 111.898 -172.074 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -161.18 165.08 29.99 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.117 -0.989 . . . . 1.3300000000000001 111.166 177.247 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.453 ' CE1' HD12 ' A' ' 45' ' ' LEU . 53.9 m-85 -100.14 109.87 22.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.796 -0.816 . . . . 1.77 108.796 168.568 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 119.73 22.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 1.53 108.335 172.66 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.03 121.29 41.14 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.054 1.342 . . . . 1.6799999999999999 107.877 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.36 144.6 43.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.956 1.302 . . . . 3.6899999999999999 109.667 -173.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.33 -61.36 4.72 Favored Glycine 0 N--CA 1.475 1.249 0 O-C-N 121.15 -0.969 . . . . 2.7400000000000002 113.477 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt 78.23 119.15 0.05 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.62 3.168 . . . . 1.27 111.996 171.154 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.52 -2.45 20.37 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.719 1.007 . . . . 2.3300000000000001 113.719 -174.619 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.52 159.67 40.9 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.887 1.275 . . . . 6.2999999999999998 108.597 169.022 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.24 158.68 54.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.905 2.403 . . . . 2.6099999999999999 110.602 173.811 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.24 13.61 8.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.684 1.194 . . . . 4.3899999999999997 112.423 -160.525 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 160.76 5.31 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.174 1.176 . . . . 3.4100000000000001 114.174 -167.332 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.45 121.53 9.21 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.233 -0.917 . . . . 1.73 110.26 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.12 20.37 55.38 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.264 -0.742 . . . . 2.5 114.209 -169.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.25 161.34 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.647 1.724 . . . . 3.23 108.655 135.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.41 131.21 56.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.513 -2.032 . . . . 3.98 105.513 155.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.4 102.51 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.901 0.858 . . . . 1.1599999999999999 110.555 -174.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -65.3 146.79 54.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.976 -1.011 . . . . 4.75 111.248 164.02 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.2 tt -152.85 128.41 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.657 0.783 . . . . 1.6699999999999999 110.835 178.038 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 28.9 m-20 -84.73 106.62 16.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.192 1.797 . . . . 2.4700000000000002 111.235 173.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.6 mt -78.14 120.71 23.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.02 0.827 . . . . 1.22 109.097 176.293 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.488 ' O ' HD22 ' A' ' 32' ' ' LEU . 37.0 mt -100.85 112.66 25.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.145 0.978 . . . . 0.77000000000000002 110.486 -168.187 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.53 149.51 31.28 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.243 1.02 . . . . 2.1400000000000001 112.263 -174.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.72 118.95 6.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.326 1.05 . . . . 2.3500000000000001 112.106 -170.318 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.02 71.71 1.14 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.645 1.117 . . . . 3.6200000000000001 113.011 178.02 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.72 -3.72 68.01 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 117.239 1.655 . . . . 1.9299999999999999 117.239 162.152 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.87 130.86 34.76 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.225 2.012 . . . . 4.4199999999999999 110.081 173.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.6 136.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.306 1.042 . . . . 1.1899999999999999 109.89 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.58 115.15 13.54 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.615 1.166 . . . . 1.8400000000000001 109.965 -174.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -77.05 119.37 20.67 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.662 -0.649 . . . . 2.96 111.971 172.205 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.93 167.79 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.344 1.457 . . . . 1.3 110.205 163.361 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.67 149.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.354 1.862 . . . . 2.77 109.195 163.653 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.8 mt -146.49 127.33 7.17 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.126 1.37 . . . . 1.9099999999999999 109.235 -172.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 162.82 41.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.896 2.397 . . . . 0.96999999999999997 111.507 174.242 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -87.62 134.91 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.621 1.169 . . . . 1.8600000000000001 111.614 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.0 164.38 13.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.092 1.757 . . . . 3.1400000000000001 107.8 157.267 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.02 -166.85 1.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.021 1.489 . . . . 4.3399999999999999 115.021 -171.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 115.729 1.751 . . . . 10.890000000000001 115.729 -158.22 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 121.144 0.497 . . . . 6.0499999999999998 111.427 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.45 167.1 32.93 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.388 1.47 . . . . 0.95999999999999996 113.727 -176.234 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -162.16 167.16 24.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.75 1.22 . . . . 1.6599999999999999 113.377 -173.25 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -113.12 136.42 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.76 1.224 . . . . 1.3 108.868 171.312 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -92.93 100.63 13.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.289 0.566 . . . . 4.2400000000000002 109.493 162.28 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -69.4 122.55 19.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.363 -0.977 . . . . 2.5800000000000001 108.363 160.932 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.6 167.63 19.7 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 125.732 1.613 . . . . 3.3100000000000001 108.452 172.017 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.07 5.08 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.794 2.996 . . . . 2.9199999999999999 116.637 -162.397 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.01 -177.17 44.46 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.207 0.912 . . . . 2.3300000000000001 113.408 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.12 -2.8 13.64 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 118.347 1.073 . . . . 1.9099999999999999 112.923 -4.059 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -121.7 165.66 15.45 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.617 1.567 . . . . 2.4100000000000001 112.752 173.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.06 -171.49 3.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.383 2.673 . . . . 0.93999999999999995 109.443 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.38 160.12 39.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.772 1.397 . . . . 0.98999999999999999 114.772 -173.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.4 145.77 51.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.865 1.266 . . . . 0.76000000000000001 112.328 170.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.0 139.72 26.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.877 1.671 . . . . 2.0499999999999998 110.308 -171.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.06 150.38 9.51 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.983 1.846 . . . . 1.6200000000000001 115.983 -173.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.9 m -86.67 129.87 34.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.531 2.333 . . . . 1.55 109.179 165.283 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.55 171.67 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.644 1.178 . . . . 4.6699999999999999 110.911 171.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -147.05 138.71 24.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.227 1.011 . . . . 2.9399999999999999 111.374 -173.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -96.36 108.43 41.89 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.767 1.227 . . . . 1.0700000000000001 109.236 168.491 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.58 -9.18 14.8 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.441 2.094 . . . . 1.01 113.196 174.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.34 169.64 52.83 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.362 0.982 . . . . 1.03 114.062 -176.044 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.46 -6.19 37.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.506 1.923 . . . . 3.0600000000000001 113.358 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.52 160.9 27.69 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.682 . . . . 1.24 110.157 168.259 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.57 161.5 19.36 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.192 2.595 . . . . 0.83999999999999997 112.094 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.8 mt -104.94 147.92 27.26 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.237 1.015 . . . . 2.0899999999999999 111.426 167.761 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -117.92 115.52 25.09 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.699 1.599 . . . . 5.5300000000000002 108.823 164.507 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.6 tp -95.53 115.26 27.18 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.704 1.602 . . . . 0.95999999999999996 108.303 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.91 -8.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.558 0.948 . . . . 0.87 113.558 -167.6 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.12 -174.03 46.2 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.992 0.806 . . . . 0.53000000000000003 111.805 175.26 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.07 174.84 10.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.161 -0.923 . . . . 0.93000000000000005 110.188 166.191 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.97 148.84 19.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.867 1.212 . . . . 5.4400000000000004 110.54 169.271 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.35 160.56 54.09 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 0.76000000000000001 109.107 -159.819 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.75 -31.14 40.24 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.307 2.004 . . . . 1.04 113.607 167.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 2.1 m -88.11 -5.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.501 1.667 . . . . 0.98999999999999999 115.501 -163.575 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.17 159.34 42.82 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.099 1.148 . . . . 0.96999999999999997 114.099 -171.708 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 12.3 tp10 -99.18 -78.82 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.295 1.038 . . . . 3.4100000000000001 111.477 -175.324 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -74.37 127.62 33.47 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.97 -1.122 . . . . 2.9700000000000002 107.97 169.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.95 131.77 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.306 1.842 . . . . 1.3100000000000001 109.291 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -150.15 135.79 18.31 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.416 1.086 . . . . 2.3799999999999999 111.236 -167.302 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -80.11 125.04 29.31 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.653 1.115 . . . . 0.88 110.817 169.432 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.6 m170 -114.96 153.9 29.74 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.171 1.788 . . . . 0.71999999999999997 112.811 178.275 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -86.66 168.68 13.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.135 2.174 . . . . 2.46 111.164 164.253 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.4 m -150.62 131.73 14.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.882 1.273 . . . . 1.3 108.633 171.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -148.67 162.99 38.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.024 1.12 . . . . 2.25 114.024 -158.445 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 mtp -114.72 119.22 35.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.427 1.891 . . . . 4.8200000000000003 108.863 162.168 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -148.66 156.65 42.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.538 1.135 . . . . 8.5600000000000005 111.977 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.0 145.19 42.74 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.233 1.413 . . . . 4.0499999999999998 111.903 165.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -148.75 -63.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.482 1.513 . . . . 4.2800000000000002 109.41 176.635 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 56' ' ' LYS . 1.2 tt0 -78.77 30.21 0.2 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.562 2.745 . . . . 4.6200000000000001 111.719 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.0 -21.21 0.29 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.167 1.365 . . . . 4.5 113.629 -162.64 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 54' ' ' GLU . 6.6 mtmt -113.09 168.88 9.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 128.891 2.876 . . . . 3.1200000000000001 110.332 170.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -89.42 146.78 24.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.634 2.087 . . . . 3.52 116.634 -172.213 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 59' ' ' MET . 8.1 p -145.36 175.08 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 127.788 2.435 . . . . 3.5 108.894 174.703 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.456 ' H ' HG22 ' A' ' 58' ' ' VAL . 19.7 mtm -107.1 146.37 31.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.049 1.339 . . . . 4.1799999999999997 112.466 -178.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.8 176.86 33.18 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 114.731 0.652 . . . . 1.3100000000000001 114.731 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 mtt -139.22 146.17 40.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.125 2.17 . . . . 2.9300000000000002 109.796 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -158.34 148.49 15.54 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 125.746 1.619 . . . . 5.4900000000000002 110.237 -177.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.2 Cg_endo -69.18 154.17 70.43 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.914 1.743 . . . . 0.62 112.359 170.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.32 158.16 65.03 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.923 1.689 . . . . 0.64000000000000001 110.624 176.235 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.93 -19.02 35.87 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.447 2.098 . . . . 0.96999999999999997 113.129 175.791 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -178.79 172.18 1.38 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.676 1.591 . . . . 2.4100000000000001 111.579 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -117.28 173.38 6.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.378 1.871 . . . . 0.79000000000000004 109.634 154.144 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.49 168.76 18.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.208 0.603 . . . . 3.77 110.596 169.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -145.58 129.54 8.64 Favored Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 125.691 1.596 . . . . 0.90000000000000002 107.461 177.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.78 167.63 25.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.777 1.652 . . . . 1.0 111.414 178.187 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.83 139.71 86.66 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.949 2.433 . . . . 0.87 110.785 168.679 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt 65.97 1.88 2.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.78 1.632 . . . . 1.26 113.694 -175.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.25 115.23 4.06 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.143 1.83 . . . . 0.84999999999999998 111.149 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.93 135.18 33.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.206 1.002 . . . . 5.1200000000000001 109.61 157.668 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 m -153.17 151.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.929 1.292 . . . . 1.5700000000000001 110.678 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 133.23 55.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.661 1.22 . . . . 3.7000000000000002 113.173 172.119 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.04 78.99 0.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.803 1.641 . . . . 1.1799999999999999 107.641 161.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -70.61 138.41 85.97 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.363 1.465 . . . . 3.1600000000000001 111.748 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.09 -24.27 76.21 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.153 2.569 . . . . 1.21 113.229 178.075 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.83 59.27 0.77 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.125 1.345 . . . . 1.23 111.668 166.246 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.64 -55.47 0.13 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 115.57 0.988 . . . . 1.3899999999999999 115.57 173.526 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -155.1 140.42 17.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.241 1.416 . . . . 2.04 110.34 -176.449 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -164.31 178.35 7.58 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.094 -1.003 . . . . 0.81999999999999995 111.034 -173.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -110.21 126.39 54.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.497 0.719 . . . . 1.8300000000000001 110.455 170.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 mmt -82.7 139.68 33.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.301 1.04 . . . . 0.88 110.938 168.495 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.1 mt -116.91 128.93 55.71 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.091 1.756 . . . . 1.79 108.162 175.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.05 116.42 11.2 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.884 1.274 . . . . 2.02 110.943 -173.139 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.95 130.53 0.55 Allowed Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.616 -1.393 . . . . 2.7599999999999998 109.616 -167.104 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.654 HD13 HD11 ' A' ' 93' ' ' LEU . 86.0 mt -127.76 108.63 10.9 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 122.21 1.005 . . . . 1.03 110.391 -171.706 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 4.0 pttm -88.38 0.31 56.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.924 1.29 . . . . 1.95 114.378 -173.653 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -149.85 157.22 38.28 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.781 2.433 . . . . 5.8700000000000001 108.552 175.172 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.29 145.83 79.12 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.653 1.568 . . . . 2.2799999999999998 108.584 162.45 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.654 HD11 HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -100.77 17.95 20.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.606 1.562 . . . . 4.1299999999999999 111.161 -175.404 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.84 138.1 1.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.325 2.25 . . . . 4.0700000000000003 115.048 -161.495 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 116.86 6.0 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.593 -1.317 . . . . 1.5 109.845 170.045 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.82 17.22 33.54 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.749 -1.029 . . . . 2.7599999999999998 113.792 -163.481 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -81.97 175.06 10.68 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.01 1.405 . . . . 3.2599999999999998 108.366 133.257 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -125.19 131.01 53.26 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.901 -1.888 . . . . 5.0300000000000002 105.901 155.005 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -94.73 94.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.64 -0.874 . . . . 0.87 108.64 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.34 113.85 3.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.345 -0.942 . . . . 3.9300000000000002 108.981 153.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -121.75 142.44 50.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.727 1.211 . . . . 1.6899999999999999 109.542 170.221 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.64 126.83 34.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.585 2.354 . . . . 2.71 111.634 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.35 125.23 37.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.393 1.077 . . . . 1.22 110.712 167.147 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.58 123.45 43.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.729 1.212 . . . . 0.79000000000000004 109.721 -174.303 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -119.49 126.75 52.04 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.236 -0.915 . . . . 2.1899999999999999 112.948 -174.21 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.36 -22.64 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 130.474 3.509 . . . . 2.9900000000000002 117.538 173.412 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.53 10.18 3.03 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.035 1.779 . . . . 4.04 115.432 -173.043 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -165.5 -28.44 0.02 OUTLIER Glycine 0 N--CA 1.477 1.419 0 CA-C-N 119.645 1.723 . . . . 2.3900000000000001 117.225 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.02 133.98 35.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.537 1.668 . . . . 5.8099999999999996 109.331 173.331 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.07 145.93 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.831 0.852 . . . . 0.97999999999999998 109.812 168.004 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.77 128.35 18.09 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.937 1.695 . . . . 2.21 108.083 172.193 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -99.08 151.76 20.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.655 0.983 . . . . 3.0600000000000001 113.655 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.56 146.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.87 1.668 . . . . 1.54 110.823 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.21 144.04 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.377 1.471 . . . . 3.1299999999999999 110.771 168.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.3 mt -149.87 95.54 3.66 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 2.2000000000000002 108.761 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.26 152.8 74.2 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.49 2.793 . . . . 1.27 112.809 -172.082 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.2 t -92.63 119.33 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.086 0.954 . . . . 1.3200000000000001 111.741 -171.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.31 132.98 35.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.033 0.933 . . . . 3.79 108.638 152.259 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -93.34 99.81 12.26 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.65 -1.241 . . . . 2.02 107.65 159.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 117.933 -1.032 . . . . 7.8099999999999996 112.55 -159.862 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.557 -0.905 . . . . 4.6600000000000001 108.557 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.34 179.38 37.75 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 115.213 0.845 . . . . 1.22 115.213 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -161.02 151.37 17.83 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.829 1.252 . . . . 1.6899999999999999 113.548 176.778 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.8 t -110.09 145.66 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.995 0.918 . . . . 1.0700000000000001 108.828 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.39 122.64 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.91 1.284 . . . . 4.8799999999999999 109.639 -175.319 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.21 174.25 10.95 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.764 1.765 . . . . 2.4500000000000002 115.764 -171.401 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.7 t -171.5 158.28 4.75 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 128.118 2.567 . . . . 3.3500000000000001 108.083 170.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.68 -21.16 19.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.596 2.197 . . . . 2.9700000000000002 112.07 164.491 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.62 175.72 14.12 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.754 1.645 . . . . 2.1600000000000001 113.155 178.384 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.91 -4.53 56.48 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 118.3 1.05 . . . . 2.4199999999999999 112.965 -9.712 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.01 150.03 40.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.863 1.265 . . . . 3.21 112.181 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.22 -173.51 3.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.854 1.662 . . . . 0.53000000000000003 112.007 174.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.6 151.12 46.99 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.798 0.839 . . . . 0.79000000000000004 113.065 -173.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.61 150.06 39.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.478 1.111 . . . . 0.67000000000000004 112.726 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.25 153.79 41.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.062 1.745 . . . . 2.0899999999999999 109.495 -175.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -177.62 157.51 1.25 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.124 1.77 . . . . 1.8300000000000001 109.957 -170.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 76' ' ' GLU 0.26 14.1 t -85.44 140.91 30.33 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.363 1.078 . . . . 3.6099999999999999 111.406 166.072 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -92.67 131.9 37.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.132 -1.803 . . . . 3.3999999999999999 106.132 162.668 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.55 102.15 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.542 0.737 . . . . 5.0099999999999998 110.406 -173.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.57 112.02 56.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.758 1.223 . . . . 1.0 111.347 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.7 -9.01 8.03 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.232 2.621 . . . . 1.01 113.924 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.26 54.73 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 119.216 0.916 . . . . 1.0700000000000001 114.139 -172.004 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.2 -0.24 30.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.204 1.802 . . . . 2.8900000000000001 112.708 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.68 161.56 29.75 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.128 1.771 . . . . 1.46 109.877 165.093 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.08 159.67 20.64 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.149 2.566 . . . . 0.81999999999999995 111.617 -172.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.78 145.57 33.37 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.463 1.105 . . . . 1.8899999999999999 111.012 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -129.6 109.18 10.8 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.129 1.372 . . . . 3.2599999999999998 109.955 173.264 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.33 120.14 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.007 2.523 . . . . 0.95999999999999996 108.837 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.9 -8.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.665 0.987 . . . . 0.59999999999999998 113.665 -171.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -164.59 35.12 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 118.931 0.787 . . . . 0.55000000000000004 111.967 176.192 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -144.72 -176.09 4.92 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.049 -0.976 . . . . 0.79000000000000004 111.301 172.535 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 17.9 mmt180 -160.1 156.17 26.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.81 1.244 . . . . 6.8799999999999999 108.162 166.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -157.93 155.84 27.18 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.155 1.382 . . . . 0.89000000000000001 109.152 -171.449 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.29 -39.51 9.92 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.72 1.614 . . . . 1.1699999999999999 112.316 173.45 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -82.0 -20.65 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.204 1.366 . . . . 1.3700000000000001 114.44 -169.191 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB3' HG23 ' A' ' 37' ' ' THR . . . -99.55 169.05 9.57 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.787 0.835 . . . . 1.4099999999999999 111.221 169.322 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -91.92 -82.91 0.3 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.443 -1.688 . . . . 3.8799999999999999 106.443 161.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -74.81 163.07 28.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.756 2.022 . . . . 6.2199999999999998 112.234 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -168.71 107.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.65 1.58 . . . . 2.1800000000000002 109.306 176.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.17 130.72 55.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.042 -1.89 . . . . 5.0 110.053 -167.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.13 126.08 31.62 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.018 0.913 . . . . 0.84999999999999998 112.248 -171.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.4 m170 -113.52 158.79 20.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.996 2.118 . . . . 0.64000000000000001 113.025 176.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -108.57 -178.87 3.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.525 1.93 . . . . 1.79 111.616 172.238 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.4 m -132.4 119.04 20.14 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.337 -1.357 . . . . 1.6000000000000001 107.337 155.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -102.83 162.64 12.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.188 1.395 . . . . 2.0299999999999998 111.727 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.2 mtt -103.74 150.22 24.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.357 1.063 . . . . 2.5 110.502 158.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -160.15 144.81 14.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 6.1399999999999997 112.486 167.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.84 145.88 15.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.258 1.423 . . . . 4.8200000000000003 110.34 156.819 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.24 -80.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.339 1.455 . . . . 3.02 107.985 172.313 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -77.02 26.73 0.14 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.835 2.054 . . . . 3.75 111.837 171.154 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.34 -33.71 0.67 Allowed Glycine 0 CA--C 1.537 1.461 0 O-C-N 120.373 -1.455 . . . . 2.6099999999999999 112.839 -158.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -63.67 145.2 56.18 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.7 1.6 . . . . 2.3999999999999999 109.673 166.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -88.87 135.31 33.6 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.844 0.313 . . . . 4.7000000000000002 111.844 -179.295 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.88 147.81 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.036 2.135 . . . . 1.9399999999999999 108.894 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.52 129.29 55.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.001 1.32 . . . . 4.5599999999999996 110.127 175.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.72 162.35 28.28 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 123.973 0.797 . . . . 1.0800000000000001 113.3 -174.051 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.4 mtt -106.77 158.84 16.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.903 1.281 . . . . 2.2599999999999998 111.724 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -169.95 155.43 5.55 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.553 1.541 . . . . 4.0 110.406 173.59 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.9 Cg_endo -69.69 153.51 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.768 1.645 . . . . 0.78000000000000003 111.297 168.391 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.51 157.73 64.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 125.576 1.55 . . . . 0.77000000000000002 110.88 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.4 -17.23 39.32 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.772 2.315 . . . . 1.01 112.828 179.316 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.2 p90 178.03 169.56 0.73 Allowed 'General case' 0 C--N 1.345 0.396 0 C-N-CA 126.882 2.073 . . . . 2.1699999999999999 110.266 179.311 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.02 165.69 13.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.085 1.354 . . . . 0.91000000000000003 109.262 156.172 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.98 161.85 42.04 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.304 -0.873 . . . . 2.2400000000000002 112.44 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 22' ' ' LEU . 21.9 t -149.96 136.78 11.04 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.016 1.326 . . . . 1.1799999999999999 109.694 -163.247 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.58 170.16 17.01 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.044 2.496 . . . . 0.84999999999999998 112.597 177.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.32 142.99 99.87 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.638 2.892 . . . . 0.85999999999999999 112.039 166.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm 66.52 1.32 2.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.075 1.75 . . . . 1.5800000000000001 113.948 -178.544 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.13 124.75 7.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 127.064 2.269 . . . . 1.02 111.579 -173.055 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 140.79 36.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.934 0.894 . . . . 4.7800000000000002 111.255 159.486 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.2 m -147.31 125.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.23 1.412 . . . . 1.73 110.082 173.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.0 mp0 -83.08 131.99 35.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.03 0.932 . . . . 3.5899999999999999 112.132 -177.281 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.2 159.82 33.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.114 0.959 . . . . 2.29 109.834 162.753 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -167.07 145.4 4.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.714 1.206 . . . . 2.7999999999999998 112.436 -161.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 -25.54 30.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.728 2.952 . . . . 2.02 114.148 -176.332 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.23 95.08 1.19 Allowed Glycine 0 N--CA 1.467 0.765 0 N-CA-C 108.694 -1.762 . . . . 1.45 108.694 161.165 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.82 -148.39 18.4 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.889 1.233 . . . . 2.6000000000000001 111.748 -168.288 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.15 136.99 37.28 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.213 -0.581 . . . . 2.3100000000000001 111.634 -171.233 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.62 167.45 21.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.373 0.669 . . . . 0.72999999999999998 110.257 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.46 122.81 48.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.743 0.817 . . . . 1.8999999999999999 110.526 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -86.35 111.81 20.84 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.854 0.862 . . . . 0.83999999999999997 109.557 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.7 mt -80.73 138.87 36.34 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.213 1.405 . . . . 2.1699999999999999 109.749 176.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -133.18 154.03 51.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.901 1.334 . . . . 1.9299999999999999 113.732 -176.643 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 -60.33 3.78 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 127.101 2.286 . . . . 2.4300000000000002 112.959 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mt 60.36 93.12 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.278 3.031 . . . . 1.0600000000000001 111.452 -166.253 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.99 -10.94 60.63 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.011 -1.055 . . . . 3.23 112.81 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 -153.78 140.22 12.73 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 129.266 3.026 . . . . 7.9400000000000004 107.148 171.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.2 154.18 41.36 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.331 2.687 . . . . 2.5 110.373 175.32 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.03 142.99 28.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.381 1.073 . . . . 3.6699999999999999 111.556 -173.299 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -19.11 26.17 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.627 1.343 . . . . 4.7000000000000002 114.627 -177.558 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 83.3 136.64 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 1 C-N-CA 132.213 4.205 . . . . 2.4399999999999999 109.822 -171.093 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.73 52.98 8.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.149 -0.781 . . . . 1.96 111.149 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 176.31 5.21 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.108 0.963 . . . . 3.3799999999999999 108.489 155.007 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -100.09 163.08 12.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.905 -0.776 . . . . 3.96 108.905 152.053 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.5 120.15 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.236 1.414 . . . . 1.1899999999999999 109.021 175.684 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 147.04 32.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 3.5699999999999998 109.224 167.141 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.486 HD11 ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -152.39 123.76 7.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.322 1.049 . . . . 2.9199999999999999 111.073 -174.64 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.81 114.06 21.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.925 2.09 . . . . 2.5600000000000001 111.231 177.306 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.4 mt -80.71 114.07 19.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.956 -1.09 . . . . 1.3300000000000001 109.006 176.028 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.23 125.58 35.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.245 0.618 . . . . 0.70999999999999996 110.116 -173.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.39 164.19 12.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.792 0.664 . . . . 2.21 112.792 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.96 62.08 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.082 1.753 . . . . 2.23 113.753 -173.574 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 141.45 -149.98 21.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.545 1.545 . . . . 3.1000000000000001 111.506 -178.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.77 37.83 1.06 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.692 1.139 . . . . 1.9299999999999999 115.696 -172.7 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -127.64 133.71 49.66 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.311 1.556 . . . . 4.29 110.75 170.632 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.78 140.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.179 1.792 . . . . 1.02 107.24 163.341 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -142.83 116.09 8.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.758 1.223 . . . . 1.52 109.742 -172.806 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -88.66 142.39 27.72 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.875 1.435 . . . . 2.5800000000000001 114.875 -177.65 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.2 164.02 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.753 2.021 . . . . 1.76 111.278 175.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.91 134.63 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.593 1.157 . . . . 2.46 110.67 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.6 mt -141.58 145.14 36.17 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.402 1.881 . . . . 1.8500000000000001 109.602 -165.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.33 159.93 15.04 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.932 3.088 . . . . 1.3200000000000001 112.623 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.81 112.78 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.502 1.121 . . . . 1.29 113.006 174.171 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.39 147.39 28.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.732 2.813 . . . . 3.6600000000000001 109.774 160.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.23 -171.07 3.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.588 1.329 . . . . 1.8700000000000001 114.588 -162.536 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.307 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 130.875 3.67 . . . . 9.0199999999999996 113.901 174.787 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 122.484 1.135 . . . . 6.8600000000000003 109.522 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.95 171.95 43.6 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.177 0.894 . . . . 1.1299999999999999 113.868 174.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -160.11 156.68 27.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.121 1.368 . . . . 1.8899999999999999 112.358 -176.305 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 99' ' ' VAL . 93.8 t -109.62 129.02 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.988 . . . . 1.1699999999999999 110.118 175.14 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -82.73 112.79 19.9 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.894 -1.15 . . . . 3.98 107.894 166.837 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -60.95 -45.19 95.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.768 1.766 . . . . 3.5 115.768 -164.923 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 6.0 t 58.86 155.57 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 128.35 2.66 . . . . 2.2000000000000002 113.941 -159.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.91 0.5 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.997 2.464 . . . . 1.6799999999999999 113.219 160.124 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.98 177.38 36.41 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.15 0.881 . . . . 1.3100000000000001 113.11 -177.009 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -80.36 -2.55 41.66 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 118.99 1.395 . . . . 1.5800000000000001 113.507 -3.016 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -138.45 165.6 26.41 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.676 1.991 . . . . 1.8600000000000001 111.648 178.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.96 -175.51 5.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.507 1.523 . . . . 0.70999999999999996 113.588 -169.22 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.2 149.41 33.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.818 0.847 . . . . 1.23 112.678 -172.053 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.46 152.52 40.75 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.428 0.899 . . . . 1.25 113.428 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 150.53 32.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.04 1.336 . . . . 2.4100000000000001 110.462 -170.47 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.38 159.32 4.6 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.707 1.603 . . . . 1.9299999999999999 110.541 -175.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 m -78.24 152.73 32.41 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.399 -0.963 . . . . 1.73 108.399 155.796 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 134.63 38.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.793 2.037 . . . . 3.4700000000000002 107.751 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.25 139.0 42.41 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.793 1.237 . . . . 5.2599999999999998 113.543 -177.628 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -104.44 107.83 58.83 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.796 -0.638 . . . . 1.51 109.676 149.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -92.04 -7.74 3.06 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.601 2.867 . . . . 1.4099999999999999 114.04 175.421 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.75 178.72 41.12 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.467 1.03 . . . . 1.3500000000000001 113.322 -176.427 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -95.62 -0.79 51.41 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.587 . . . . 3.6099999999999999 113.376 176.305 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.59 160.07 31.86 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.463 1.505 . . . . 1.54 110.516 171.751 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.43 153.97 24.15 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.758 2.306 . . . . 0.75 111.413 -171.764 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -116.26 119.31 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.746 1.218 . . . . 2.2999999999999998 110.053 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -115.13 102.55 10.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.266 1.426 . . . . 4.5199999999999996 111.342 -177.428 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 tp -92.08 119.91 32.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.975 2.51 . . . . 0.79000000000000004 109.196 -172.464 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.04 -8.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.513 1.125 . . . . 0.63 113.459 -169.294 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.08 -158.93 31.76 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 124.627 1.108 . . . . 0.39000000000000001 111.391 173.537 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.07 -177.04 5.52 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 122.467 -0.431 . . . . 0.80000000000000004 111.745 169.069 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -146.33 129.5 16.59 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.322 1.049 . . . . 6.6699999999999999 109.732 170.818 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.5 t -141.16 156.78 67.75 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 126.704 2.002 . . . . 0.69999999999999996 109.526 -173.41 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.51 -32.97 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.151 1.901 . . . . 1.0700000000000001 113.203 170.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.289 1.4 m -75.42 -9.53 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 120.27 1.396 . . . . 0.98999999999999999 114.21 -164.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.61 147.11 52.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.165 1.786 . . . . 0.80000000000000004 109.894 175.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -50.02 -59.64 3.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.039 1.29 . . . . 5.6200000000000001 108.693 168.15 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -130.4 153.36 48.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.872 2.069 . . . . 3.8399999999999999 109.951 -168.158 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.15 127.57 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.858 1.663 . . . . 1.9399999999999999 107.091 173.139 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -121.38 128.02 51.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.353 1.861 . . . . 1.9399999999999999 107.41 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.05 122.3 26.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.98 0.895 . . . . 0.94999999999999996 109.806 170.226 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.7 m170 -111.45 158.49 19.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.019 1.728 . . . . 0.53000000000000003 110.993 179.451 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.85 -178.59 3.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.663 1.985 . . . . 2.2400000000000002 111.656 177.277 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 m -140.51 113.26 8.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.911 -1.144 . . . . 1.8500000000000001 107.911 150.466 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -96.2 -171.34 2.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.446 1.498 . . . . 2.46 109.811 173.049 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -141.55 149.14 40.42 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.568 0.747 . . . . 3.3300000000000001 110.982 163.786 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -134.65 141.89 46.7 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.35 1.06 . . . . 7.0300000000000002 110.309 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -75.85 116.38 16.5 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.187 0.995 . . . . 5.7999999999999998 109.552 162.443 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 t -88.01 -119.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 106.455 -1.683 . . . . 3.2000000000000002 106.455 169.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.03 75.68 8.01 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.541 1.064 . . . . 4.71 108.33 163.478 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.44 -20.72 0.1 OUTLIER Glycine 0 N--CA 1.475 1.287 0 C-N-CA 129.522 3.439 . . . . 2.0 117.004 178.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -68.34 122.92 19.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.595 -1.532 . . . . 4.5300000000000002 110.468 169.066 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -99.42 69.16 1.65 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.078 1.751 . . . . 5.5700000000000003 109.121 -170.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -87.26 139.59 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.924 1.69 . . . . 1.77 110.67 -163.367 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -78.52 134.02 37.32 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.6 1.56 . . . . 3.7400000000000002 111.576 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.49 150.79 19.95 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.354 0.978 . . . . 1.4299999999999999 112.925 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -112.67 152.71 28.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.845 1.258 . . . . 1.8600000000000001 111.397 -179.551 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 mtp-105 -164.42 153.86 11.96 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 127.081 2.152 . . . . 3.77 108.151 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.8 Cg_endo -69.0 151.83 73.32 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.971 1.382 . . . . 0.70999999999999996 111.001 157.547 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.7 152.66 56.1 Favored Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.944 1.298 . . . . 0.63 110.253 173.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.94 -9.48 25.77 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.692 2.261 . . . . 0.78000000000000003 113.355 178.405 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -177.91 165.5 1.99 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.643 1.577 . . . . 2.1299999999999999 110.526 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -117.27 166.17 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.664 1.586 . . . . 0.76000000000000001 109.053 151.171 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.97 162.34 39.6 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.498 -0.751 . . . . 2.0 112.621 167.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -143.18 129.87 10.56 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-N 114.669 -1.151 . . . . 1.49 110.187 -168.286 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.32 162.02 42.24 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.665 2.244 . . . . 1.2 111.374 176.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.82 145.48 96.37 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.038 3.159 . . . . 1.04 113.637 -178.139 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp 67.21 -5.68 0.69 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.213 2.205 . . . . 1.9299999999999999 115.196 178.334 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.21 123.78 7.02 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 126.613 2.054 . . . . 1.28 111.095 176.12 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -86.42 147.95 25.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.052 0.541 . . . . 4.8300000000000001 110.677 154.534 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -146.15 155.83 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.05 1.34 . . . . 1.78 110.242 175.589 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.43 142.53 29.93 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.673 0.749 . . . . 4.5999999999999996 112.988 -178.116 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.99 65.69 1.47 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.983 1.373 . . . . 1.53 108.422 152.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.36 113.92 7.63 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.522 1.529 . . . . 3.3799999999999999 109.787 169.125 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.99 -45.38 41.47 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.392 2.728 . . . . 1.3300000000000001 114.634 -161.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.94 90.88 1.56 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.79 -1.724 . . . . 1.46 108.79 161.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.35 -64.82 0.39 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.819 1.676 . . . . 1.5 111.197 -174.001 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -150.42 145.8 26.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.761 1.625 . . . . 2.2400000000000002 111.194 170.08 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -158.77 157.4 31.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.292 1.437 . . . . 0.93999999999999995 109.779 178.549 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.93 131.7 34.5 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.298 -0.631 . . . . 2.0800000000000001 109.298 164.655 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.3 125.58 51.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.559 1.544 . . . . 1.46 109.027 173.191 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.58 139.12 46.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.324 1.45 . . . . 2.29 110.545 -170.562 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -133.79 158.25 43.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.032 0.933 . . . . 1.6399999999999999 112.842 -171.216 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.69 60.86 7.37 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.553 1.549 . . . . 2.1200000000000001 113.29 169.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.52 101.08 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.872 1.32 . . . . 0.98999999999999999 112.743 -164.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -83.54 -3.99 58.14 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.547 -0.751 . . . . 2.0600000000000001 113.006 -166.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -131.04 153.77 81.85 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 129.474 3.109 . . . . 7.2999999999999998 108.568 168.376 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.74 167.43 27.11 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.089 2.526 . . . . 1.77 109.31 157.316 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.5 164.85 29.38 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.199 1.4 . . . . 2.8199999999999998 112.037 -165.406 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 140.22 2.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.621 1.568 . . . . 5.6299999999999999 113.185 -163.836 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.91 134.24 37.49 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.358 -1.464 . . . . 1.74 112.868 173.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.93 56.31 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.734 -1.592 . . . . 1.9399999999999999 115.063 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.76 -177.94 3.48 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.339 1.57 . . . . 3.23 108.585 156.582 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.89 138.93 52.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.444 1.116 . . . . 3.6400000000000001 112.054 -172.086 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 8' ' ' VAL . 95.3 t -90.19 107.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.366 1.466 . . . . 1.3100000000000001 108.753 -172.546 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.61 130.46 45.32 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 124.525 1.141 . . . . 2.8700000000000001 108.856 158.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mt -154.74 132.09 11.15 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.914 1.686 . . . . 1.52 112.283 -177.538 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.11 114.45 27.97 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.71 1.604 . . . . 2.8500000000000001 110.836 169.34 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.83 118.2 19.2 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.029 1.331 . . . . 1.1699999999999999 109.986 175.541 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.78 133.65 34.59 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.861 0.864 . . . . 0.67000000000000004 110.54 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -125.19 164.36 20.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.961 0.886 . . . . 2.1099999999999999 112.41 176.115 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.01 156.01 9.97 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.686 -0.688 . . . . 2.5499999999999998 111.478 164.603 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.78 10.97 85.8 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.247 -0.751 . . . . 3.6400000000000001 114.885 -178.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.98 1.85 85.8 Favored Glycine 0 N--CA 1.473 1.163 0 CA-C-N 118.57 1.185 . . . . 2.4300000000000002 113.977 -178.235 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.99 130.98 44.91 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.093 -1.239 . . . . 5.8300000000000001 110.266 179.132 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.89 149.97 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.978 0.911 . . . . 1.01 110.239 170.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -146.44 129.26 16.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.681 1.192 . . . . 1.8600000000000001 112.453 -174.189 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -63.48 134.47 55.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.669 1.188 . . . . 2.29 112.393 172.693 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.2 m -138.98 146.1 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.14 1.776 . . . . 1.48 109.568 163.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.2 123.06 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.981 0.912 . . . . 1.6499999999999999 110.509 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -139.07 146.33 48.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.992 1.317 . . . . 1.75 110.176 -169.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.3 146.2 68.46 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.033 2.489 . . . . 1.02 113.202 -175.024 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.2 t -79.37 134.78 27.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 124.524 1.13 . . . . 1.3100000000000001 108.385 161.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.58 141.91 51.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.224 1.81 . . . . 5.1799999999999997 109.21 169.736 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -128.34 71.7 1.4 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 122.275 1.036 . . . . 3.3599999999999999 113.788 -167.704 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.195 0 C-N-CA 126.544 1.938 . . . . 8.5899999999999999 109.196 169.426 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 110.836 -0.061 . . . . 4.6799999999999997 110.836 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.14 179.62 48.86 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.167 0.889 . . . . 1.1399999999999999 113.256 -174.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -155.09 153.42 30.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.275 1.43 . . . . 1.3600000000000001 112.902 -177.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.69 122.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.463 1.105 . . . . 1.25 110.548 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -57.36 -39.93 77.0 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.649 1.979 . . . . 5.5800000000000001 114.126 -168.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.34 151.79 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.655 1.982 . . . . 2.6000000000000001 113.528 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.28 165.99 2.01 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 119.748 -1.845 . . . . 1.8200000000000001 109.889 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.79 23.15 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.034 3.156 . . . . 2.0099999999999998 112.819 175.222 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.69 -176.06 54.73 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 121.312 -0.867 . . . . 1.53 111.837 -159.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.72 -11.41 18.03 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 CA-C-N 118.499 1.15 . . . . 2.04 112.233 -12.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -134.73 154.22 51.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.372 1.069 . . . . 2.7999999999999998 112.294 168.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.58 -177.67 3.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.291 1.836 . . . . 0.63 108.31 156.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.64 173.35 11.77 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.169 0.988 . . . . 0.88 110.537 173.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.46 151.03 41.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.223 1.009 . . . . 0.73999999999999999 112.396 167.278 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.09 142.39 38.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.842 2.457 . . . . 2.29 109.235 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -169.66 159.49 8.27 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.598 1.333 . . . . 1.9399999999999999 114.598 -175.114 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -97.96 119.57 36.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.02 1.728 . . . . 1.3999999999999999 108.379 173.56 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -110.31 142.72 41.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.018 1.327 . . . . 2.6499999999999999 109.931 176.094 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.456 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.9 pt-20 -142.35 150.0 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.196 1.398 . . . . 2.9500000000000002 110.941 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -118.48 108.22 41.88 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.831 0.852 . . . . 1.23 110.962 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -86.41 -5.39 8.32 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.77 2.313 . . . . 1.1000000000000001 114.325 175.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 -157.31 16.09 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 120.129 1.331 . . . . 2.0899999999999999 115.365 -167.067 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -95.12 -41.03 9.31 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.57 2.348 . . . . 6.0300000000000002 112.384 178.579 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.03 166.13 13.12 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.136 1.774 . . . . 1.75 111.729 -173.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.07 167.13 25.53 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.505 2.137 . . . . 1.2 113.691 -166.062 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.56 148.11 26.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.773 1.229 . . . . 2.73 109.747 165.148 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -141.81 103.53 4.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.638 1.575 . . . . 4.0599999999999996 108.141 171.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.15 104.4 16.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.867 2.467 . . . . 0.93999999999999995 108.941 -166.146 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.62 -12.44 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.872 1.269 . . . . 0.59999999999999998 112.924 -172.135 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.92 -163.6 33.25 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 123.733 0.682 . . . . 0.42999999999999999 112.349 178.282 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.18 178.4 9.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.005 1.322 . . . . 0.73999999999999999 110.401 173.028 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -143.18 145.54 32.9 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.993 -1.114 . . . . 7.6600000000000001 107.993 174.955 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 t -151.37 151.6 29.36 Favored Pre-proline 0 N--CA 1.47 0.534 0 CA-C-O 118.374 -0.822 . . . . 0.66000000000000003 110.949 172.893 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.43 -23.41 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.725 2.95 . . . . 1.3200000000000001 114.891 160.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.28 1.3 m -95.17 5.65 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.96 1.467 . . . . 1.0700000000000001 114.96 -168.594 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.38 163.43 32.81 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.884 1.274 . . . . 0.80000000000000004 111.946 -178.571 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.444 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 8.8 tp10 -100.72 -89.87 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.912 -0.773 . . . . 3.4700000000000002 108.912 164.843 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -76.55 114.89 15.77 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.032 -1.042 . . . . 3.0800000000000001 109.013 -179.026 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.76 140.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.698 1.599 . . . . 2.1800000000000002 111.161 163.467 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -144.02 122.5 12.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.274 1.43 . . . . 2.6000000000000001 109.623 166.624 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -80.08 119.07 22.39 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.746 1.157 . . . . 0.73999999999999999 110.88 169.03 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.5 m170 -107.36 152.83 23.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.941 1.696 . . . . 0.66000000000000003 112.395 175.45 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.93 -178.06 3.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.41 1.484 . . . . 2.1800000000000002 110.603 167.877 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -146.57 130.25 17.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.887 1.275 . . . . 1.01 107.777 174.266 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.78 165.4 27.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.527 1.131 . . . . 2.0 112.655 -165.241 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.9 mtm -98.23 144.69 27.4 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.798 1.239 . . . . 2.6800000000000002 111.56 174.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -156.59 178.93 9.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.139 1.376 . . . . 10.460000000000001 112.523 -175.045 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.67 158.16 17.07 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.198 1.799 . . . . 9.0 110.3 167.217 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.03 121.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 125.893 1.677 . . . . 4.71 109.232 140.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 55.54 54.14 8.82 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.907 1.283 . . . . 4.75 109.78 -174.907 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.49 -26.23 0.17 Allowed Glycine 0 N--CA 1.476 1.322 0 C-N-CA 128.964 3.174 . . . . 3.4700000000000002 116.129 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -78.18 140.38 38.96 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.793 -1.416 . . . . 4.0700000000000003 111.778 -171.89 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.54 122.94 17.04 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 4.3700000000000001 111.094 174.483 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.9 t -142.71 161.63 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.118 1.767 . . . . 2.4500000000000002 108.154 173.913 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.18 158.54 15.79 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.024 -1.047 . . . . 2.9300000000000002 112.6 -178.773 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.75 159.01 24.41 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 124.944 1.259 . . . . 1.1499999999999999 112.038 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -125.88 155.87 40.55 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.9 1.68 . . . . 1.6000000000000001 108.307 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -169.06 150.26 4.32 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.004 1.322 . . . . 4.6699999999999999 110.3 177.237 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 40.8 Cg_endo -67.36 153.14 77.79 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.314 2.009 . . . . 0.95999999999999996 111.264 169.366 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -125.14 155.96 70.29 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.454 1.502 . . . . 0.76000000000000001 110.172 171.369 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.05 -14.5 41.11 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.782 2.321 . . . . 0.90000000000000002 112.92 176.16 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -179.48 162.24 1.12 Allowed 'General case' 0 C--N 1.348 0.51 0 C-N-CA 126.092 1.757 . . . . 2.2200000000000002 110.362 178.722 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -104.43 176.63 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.313 1.445 . . . . 0.72999999999999998 109.732 153.059 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.29 168.95 25.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.049 -1.032 . . . . 1.96 113.76 171.082 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.81 136.18 10.35 Favored Pre-proline 0 N--CA 1.467 0.406 0 C-N-CA 125.395 1.478 . . . . 0.85999999999999999 108.246 -176.558 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.78 171.41 11.02 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 121.812 1.675 . . . . 1.1000000000000001 111.251 170.269 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.04 142.62 75.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.741 2.294 . . . . 1.25 110.341 163.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt 73.83 -4.96 2.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.73 2.412 . . . . 1.3600000000000001 113.261 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.07 -170.99 44.29 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 126.369 1.938 . . . . 1.4099999999999999 112.389 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -167.25 154.89 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.194 1.798 . . . . 6.2800000000000002 112.178 -178.272 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.62 159.3 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.202 1.801 . . . . 1.9199999999999999 110.42 177.046 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.49 116.7 23.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.773 -1.195 . . . . 4.4800000000000004 107.773 177.178 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.5 67.86 2.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.784 1.233 . . . . 1.0800000000000001 108.823 170.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -75.67 149.12 83.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.344 1.058 . . . . 3.7200000000000002 111.428 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.97 -30.31 92.95 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.741 2.294 . . . . 1.4199999999999999 113.336 176.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.33 48.68 2.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.565 1.079 . . . . 1.3500000000000001 112.453 168.761 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.84 -64.92 0.05 OUTLIER Glycine 0 N--CA 1.473 1.163 0 N-CA-C 115.837 1.095 . . . . 1.3600000000000001 115.837 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -156.55 146.3 20.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.353 1.861 . . . . 2.3399999999999999 109.541 -173.67 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -165.55 170.92 13.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.739 -1.225 . . . . 0.72999999999999998 110.438 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.04 136.3 42.11 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.916 -0.772 . . . . 1.8200000000000001 108.916 168.257 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -83.1 128.79 34.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.104 0.961 . . . . 1.1100000000000001 110.047 156.027 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 mt -113.87 104.3 12.04 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.421 1.489 . . . . 1.74 107.85 177.419 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.99 155.77 17.52 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.443 0.639 . . . . 1.73 112.349 -176.446 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.79 -53.39 4.84 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.248 1.404 . . . . 2.6899999999999999 113.757 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 62.98 85.15 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.782 2.433 . . . . 1.0700000000000001 112.806 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HE3' ' OE1' ' A' ' 41' ' ' GLU . 4.3 ptpp? -73.84 -0.48 16.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.759 1.392 . . . . 1.6299999999999999 114.759 -168.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -149.44 159.37 36.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 128.766 2.827 . . . . 5.1200000000000001 108.837 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.29 162.33 36.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.12 1.88 . . . . 2.0099999999999998 109.583 154.628 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.11 43.8 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 123.065 1.412 . . . . 4.0999999999999996 111.929 -158.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -74.42 143.82 44.57 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.101 1.76 . . . . 5.21 113.631 -168.738 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.03 118.59 2.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.754 1.222 . . . . 1.95 113.153 177.274 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.1 16.82 26.81 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 117.991 -1.45 . . . . 1.78 114.817 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.22 166.02 11.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.279 1.539 . . . . 3.8900000000000001 108.797 136.745 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -111.83 134.26 53.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.972 1.709 . . . . 5.4100000000000001 108.753 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.44 113.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.639 0.776 . . . . 1.0800000000000001 110.352 -178.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -68.8 129.16 39.14 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.148 -0.933 . . . . 3.52 109.091 161.913 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -139.91 147.92 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.624 0.77 . . . . 1.52 111.269 -173.669 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -114.53 132.15 56.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.469 -1.241 . . . . 2.4700000000000002 110.342 162.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.4 mt -98.33 121.13 39.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.737 1.215 . . . . 1.3100000000000001 109.021 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.2 mt -96.76 129.88 44.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.084 0.954 . . . . 0.96999999999999997 111.333 -170.869 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -122.34 145.76 47.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.939 0.896 . . . . 2.0499999999999998 112.179 -176.963 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.88 131.02 45.96 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.116 0.966 . . . . 2.48 111.826 176.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.69 -159.6 23.12 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.495 1.045 . . . . 2.9199999999999999 110.705 -164.374 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.51 26.46 6.41 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.264 0.935 . . . . 1.9099999999999999 113.783 178.518 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -99.43 129.55 45.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.015 1.408 . . . . 5.3099999999999996 111.632 -173.314 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.83 138.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.449 1.499 . . . . 1.29 108.866 167.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.53 121.34 39.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.267 1.027 . . . . 1.95 109.645 177.57 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -79.96 139.82 36.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.972 0.509 . . . . 2.2799999999999998 110.937 175.185 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m -145.1 171.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.719 2.007 . . . . 1.29 109.893 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.87 131.14 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.376 1.071 . . . . 1.79 109.124 176.71 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mp -145.75 152.64 49.09 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.917 1.287 . . . . 1.8999999999999999 111.063 -168.727 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.2 155.37 67.97 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.422 2.748 . . . . 1.3200000000000001 114.279 -177.498 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.31 125.42 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.168 -0.923 . . . . 1.3799999999999999 108.681 157.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.64 138.23 35.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.415 1.486 . . . . 3.7799999999999998 109.068 170.329 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.03 134.79 55.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.941 2.2 . . . . 3.0099999999999998 116.941 -128.243 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.078 1 C-N-CA 132.372 4.269 . . . . 7.1299999999999999 111.243 160.688 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.537 ' N ' ' HG1' ' A' ' 21' ' ' THR . 36.9 mt-10 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 111.913 0.338 . . . . 4.4400000000000004 111.913 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.1 151.64 21.88 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 121.304 -0.872 . . . . 1.3600000000000001 114.323 169.39 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -155.01 152.7 29.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.999 1.719 . . . . 1.6100000000000001 111.596 -179.519 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.32 122.55 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.029 -1.1 . . . . 0.84999999999999998 108.029 178.793 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 89.47 8.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.825 1.25 . . . . 3.3300000000000001 108.477 171.334 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.427 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -67.09 139.25 57.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.363 1.065 . . . . 2.23 109.027 168.092 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.6 m -138.39 158.31 70.88 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.49 . . . . 2.6600000000000001 108.026 168.987 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.88 27.91 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.616 3.544 . . . . 2.2799999999999998 115.113 -171.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.49 170.18 44.51 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.141 -0.974 . . . . 1.6499999999999999 113.957 178.878 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.36 -7.94 35.4 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 117.811 0.806 . . . . 1.6299999999999999 113.373 -7.038 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -130.69 161.98 30.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.216 1.806 . . . . 3.6600000000000001 111.216 -175.528 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.91 -173.88 4.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.541 1.936 . . . . 0.67000000000000004 112.038 -177.2 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.61 40.5 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.315 0.858 . . . . 0.95999999999999996 113.315 -172.991 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.07 146.4 27.71 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 0.81000000000000005 112.148 173.341 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.25 151.04 51.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.595 1.958 . . . . 2.3700000000000001 109.644 -173.23 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -169.4 145.35 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.336 1.236 . . . . 1.6100000000000001 114.336 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.537 ' HG1' ' N ' ' A' ' 5' ' ' GLU . 52.9 m -75.68 139.97 42.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.081 1.752 . . . . 1.4299999999999999 108.977 163.19 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.0 133.51 21.96 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.139 1.376 . . . . 2.7999999999999998 108.944 174.195 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.46 156.76 46.15 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 114.225 1.195 . . . . 3.1400000000000001 114.225 -175.666 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -116.85 100.06 53.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.249 -1.342 . . . . 1.6100000000000001 110.47 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -85.02 -3.16 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.222 2.615 . . . . 1.3300000000000001 114.091 176.237 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.19 -119.78 0.81 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.797 1.189 . . . . 2.9500000000000002 114.626 -168.618 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -154.15 -41.98 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.371 1.868 . . . . 5.3899999999999997 112.021 -161.786 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -96.12 165.06 17.1 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.833 2.053 . . . . 1.5700000000000001 111.335 171.419 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.44 157.5 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.227 2.618 . . . . 0.82999999999999996 112.282 -174.277 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.37 156.71 17.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.308 1.043 . . . . 1.9099999999999999 111.33 171.195 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -146.54 101.06 3.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.104 1.361 . . . . 4.0800000000000001 112.811 177.529 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.3 tp -85.07 108.25 17.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.15 2.18 . . . . 0.93000000000000005 109.115 -176.496 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -99.17 -16.13 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.677 1.191 . . . . 0.77000000000000002 112.987 -173.458 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.32 42.72 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.773 0.701 . . . . 0.47999999999999998 111.717 -177.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -138.03 -178.95 5.5 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.308 1.043 . . . . 0.81000000000000005 110.434 169.196 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -154.31 128.56 9.05 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 106.363 -1.718 . . . . 6.3399999999999999 106.363 175.736 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -146.34 151.31 43.58 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.578 1.151 . . . . 0.90000000000000002 109.295 -168.474 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.32 -23.11 21.07 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.412 2.074 . . . . 1.1499999999999999 113.5 175.779 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.98 -13.16 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 115.569 1.692 . . . . 1.21 115.569 -165.251 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -131.4 152.35 50.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.319 1.048 . . . . 1.49 112.711 -165.675 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -56.45 22.01 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.59 1.087 . . . . 6.6299999999999999 109.185 171.771 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 43' ' ' VAL . 16.1 ttm180 -128.85 176.07 8.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.006 2.522 . . . . 3.8799999999999999 109.926 179.177 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.404 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 2.3 p -155.43 137.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.287 2.235 . . . . 1.2 107.455 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -142.32 137.53 30.63 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.585 1.554 . . . . 1.8999999999999999 108.851 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.37 126.97 32.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.676 1.125 . . . . 0.84999999999999998 110.165 166.673 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.3 m170 -119.35 155.38 32.0 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.795 2.038 . . . . 0.63 112.017 176.478 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -92.57 166.07 12.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.761 1.624 . . . . 2.4700000000000002 110.46 164.679 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.3 m -123.63 127.72 48.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 106.357 -1.719 . . . . 1.28 106.357 154.117 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -122.4 170.96 9.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.442 1.275 . . . . 2.3799999999999999 114.442 -166.392 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.9 mtm -125.82 127.15 45.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.097 1.359 . . . . 3.1600000000000001 109.389 161.794 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -153.52 165.81 34.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.099 1.76 . . . . 9.2899999999999991 110.416 174.303 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.51 152.46 43.0 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.684 1.194 . . . . 3.4500000000000002 111.285 168.606 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.32 -86.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.599 1.16 . . . . 3.2200000000000002 109.241 176.256 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -78.44 51.31 1.03 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.681 1.992 . . . . 4.2000000000000002 110.562 176.166 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -20.69 0.3 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.951 1.738 . . . . 3.0 114.683 -170.954 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -107.78 159.24 16.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.474 2.71 . . . . 2.9399999999999999 110.276 -176.466 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -72.5 138.35 46.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.095 1.358 . . . . 3.2999999999999998 112.977 179.017 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -137.7 154.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.61 1.964 . . . . 1.6499999999999999 108.773 177.06 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 ptp -125.35 135.63 52.63 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.694 1.198 . . . . 2.8399999999999999 112.99 176.694 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.7 -179.74 40.59 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.609 1.099 . . . . 1.8600000000000001 113.171 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.31 166.42 11.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.812 1.245 . . . . 2.2599999999999998 113.438 -177.47 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -171.44 155.6 4.17 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 6.1399999999999997 110.576 164.928 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.7 Cg_exo -64.98 157.01 59.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.88 1.72 . . . . 0.94999999999999996 112.146 171.583 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.81 159.12 72.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 126.013 1.725 . . . . 0.91000000000000003 110.151 176.716 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.92 -24.8 23.97 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.23 1.953 . . . . 1.25 112.853 175.922 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -179.59 171.26 1.24 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.659 1.584 . . . . 2.2200000000000002 112.63 -178.37 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mt -118.89 167.61 11.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.925 2.09 . . . . 1.1200000000000001 109.573 152.266 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -154.82 156.47 36.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.563 -0.711 . . . . 2.6099999999999999 111.823 178.621 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -137.49 126.94 15.22 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 1.0900000000000001 108.965 -166.576 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.9 160.43 43.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.0 1.8 . . . . 1.1000000000000001 111.402 175.971 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.15 140.0 86.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.617 2.878 . . . . 1.3100000000000001 111.304 176.807 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 71.37 -1.56 2.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.309 2.244 . . . . 1.77 113.051 -178.218 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.04 -177.74 31.88 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 126.599 2.047 . . . . 1.75 111.414 178.811 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -161.93 156.41 22.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 5.7199999999999998 113.759 -179.127 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.92 161.01 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.286 1.434 . . . . 1.8300000000000001 109.413 174.538 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -123.6 135.91 54.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.444 -0.947 . . . . 5.0099999999999998 108.444 158.523 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.33 55.73 1.01 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.041 1.336 . . . . 1.1100000000000001 109.216 168.504 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -50.17 132.29 23.84 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.645 1.578 . . . . 4.1900000000000004 111.349 179.249 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.2 -36.86 97.42 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.946 3.097 . . . . 2.3500000000000001 114.983 -166.537 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.97 52.34 4.68 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-N 119.327 0.967 . . . . 1.8400000000000001 111.527 169.984 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.55 -145.5 5.66 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.524 2.011 . . . . 2.8399999999999999 112.024 -166.726 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -67.79 141.86 56.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.625 0.713 . . . . 2.1800000000000002 110.376 178.037 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -160.3 165.79 30.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.952 0.797 . . . . 0.88 111.003 -172.445 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -95.64 123.99 39.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.22 -0.659 . . . . 2.1600000000000001 109.22 163.406 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.52 126.06 45.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.612 1.165 . . . . 1.5 108.959 174.437 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.36 139.79 49.19 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.602 1.561 . . . . 2.9199999999999999 110.009 -172.557 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mp -132.51 166.08 22.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.606 0.762 . . . . 2.3900000000000001 112.789 -172.043 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 50.22 41.33 38.91 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 126.81 2.148 . . . . 2.1299999999999999 114.753 168.445 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 93' ' ' LEU . 57.9 mt -53.17 117.51 3.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.566 1.321 . . . . 1.6000000000000001 114.566 -147.701 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -86.54 -3.18 58.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.547 0.943 . . . . 2.6099999999999999 113.547 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -111.41 150.38 42.01 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.712 1.205 . . . . 4.8300000000000001 107.898 155.297 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 -10.94 23.17 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.567 2.845 . . . . 4.1299999999999999 115.15 166.394 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.493 HD11 HD13 ' A' ' 89' ' ' LEU . 3.0 mp 72.39 -173.24 0.15 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.768 3.627 . . . . 2.8399999999999999 111.293 173.711 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -170.03 119.02 0.6 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.197 1.399 . . . . 3.7200000000000002 110.094 -167.372 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.39 124.57 21.27 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.322 -0.861 . . . . 1.6799999999999999 109.495 166.779 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.21 54.79 27.67 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.699 -0.56 . . . . 2.02 111.699 -166.744 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -112.46 163.14 14.81 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 122.455 1.121 . . . . 4.1299999999999999 110.092 138.643 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -110.26 105.6 14.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.074 1.749 . . . . 4.5899999999999999 107.742 -172.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.86 112.62 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.134 0.973 . . . . 1.1000000000000001 109.412 -173.537 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -70.96 137.83 49.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.887 -0.597 . . . . 3.1899999999999999 110.342 159.322 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.8 tt -149.37 135.46 18.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.902 1.281 . . . . 1.7 109.852 179.484 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.31 110.99 22.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.679 2.792 . . . . 2.1000000000000001 110.842 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.0 117.95 20.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.989 0.916 . . . . 1.26 109.228 176.344 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.63 121.42 34.04 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 0.57999999999999996 110.522 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -118.1 121.84 41.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 2.1200000000000001 113.053 -179.613 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.08 23.55 0.3 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.267 2.227 . . . . 2.73 116.975 168.608 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.7 10.97 80.53 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 115.947 1.139 . . . . 4.5800000000000001 115.947 174.693 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.69 -31.18 0.03 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 119.076 1.438 . . . . 2.3999999999999999 116.478 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -89.11 139.48 30.43 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.741 -1.446 . . . . 4.4400000000000004 109.398 169.541 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -141.2 140.56 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.644 1.178 . . . . 1.3 108.203 165.22 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.12 122.98 15.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.101 1.36 . . . . 2.0800000000000001 108.852 -178.269 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 ptmt -83.1 140.38 32.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.323 0.86 . . . . 2.6800000000000002 113.323 -179.544 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.85 165.71 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.565 1.946 . . . . 1.29 109.782 167.986 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.07 139.41 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.757 1.223 . . . . 1.6899999999999999 109.957 173.677 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 mt -138.32 130.07 15.84 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.612 1.965 . . . . 2.1600000000000001 109.782 -167.999 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.37 144.74 37.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.601 2.2 . . . . 1.0600000000000001 111.051 176.661 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 10' ' ' PHE . 90.4 t -79.95 118.59 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.862 0.839 . . . . 1.22 111.956 169.442 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 145.51 28.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.977 3.311 . . . . 3.4199999999999999 107.46 166.574 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.2 101.74 5.92 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.974 -1.079 . . . . 1.8799999999999999 112.003 -161.546 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.262 1.025 . . . . 6.7300000000000004 112.705 -166.83 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.06 0 CA-C-O 119.581 -0.566 . . . . 9.9299999999999997 113.104 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 m -169.38 -43.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.382 2.273 . . . . 8.5500000000000007 109.716 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -137.63 -165.05 1.71 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.846 2.458 . . . . 8.6600000000000001 109.485 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.6 p -73.43 95.97 2.3 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.161 -0.962 . . . . 6.7400000000000002 110.616 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' H ' ' HB ' ' A' ' 21' ' ' THR . 8.5 mt-10 -122.75 119.93 32.12 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.56 1.944 . . . . 5.6200000000000001 109.665 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.59 176.71 29.88 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.386 0.993 . . . . 0.88 113.768 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -161.12 161.94 31.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.528 1.531 . . . . 1.6799999999999999 112.186 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.07 126.4 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.822 -0.807 . . . . 0.79000000000000004 108.822 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.01 117.84 30.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.112 1.365 . . . . 4.2199999999999998 109.013 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -74.59 -171.53 1.27 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.263 1.03 . . . . 2.8100000000000001 113.637 -170.218 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.11 167.64 2.73 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.311 1.845 . . . . 1.74 109.95 160.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.04 -6.91 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.123 2.548 . . . . 1.5800000000000001 113.088 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.39 169.19 21.19 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.109 1.338 . . . . 1.5900000000000001 113.109 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.41 -7.68 39.15 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 118.068 0.934 . . . . 1.6699999999999999 113.542 -0.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -128.55 167.53 16.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.182 1.393 . . . . 2.02 114.173 -170.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.85 -173.1 2.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.028 2.131 . . . . 0.56999999999999995 112.585 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.24 154.43 43.82 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.611 0.967 . . . . 0.82999999999999996 113.611 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.89 146.89 33.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.769 1.228 . . . . 0.72999999999999998 112.958 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -140.82 157.42 45.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.404 1.482 . . . . 1.8899999999999999 112.657 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -166.41 158.44 13.73 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.949 1.463 . . . . 1.6200000000000001 114.949 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 5' ' ' GLU . 15.7 m -84.54 133.0 34.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.773 2.029 . . . . 1.4299999999999999 107.778 159.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.73 141.32 27.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.622 1.169 . . . . 2.5499999999999998 111.175 -167.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.31 153.07 23.0 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.002 0.742 . . . . 3.0699999999999998 113.002 -160.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -120.93 112.43 33.54 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.106 1.362 . . . . 1.0600000000000001 110.972 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.17 -9.06 10.67 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.858 2.372 . . . . 1.1699999999999999 113.666 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.01 168.88 52.55 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.177 0.894 . . . . 1.1499999999999999 113.665 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.55 -4.81 47.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.13 1.772 . . . . 2.79 112.823 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.68 160.34 38.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.046 1.738 . . . . 1.4199999999999999 109.949 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.87 156.42 30.92 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.919 2.413 . . . . 0.64000000000000001 111.902 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.94 150.41 21.96 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.556 0.742 . . . . 1.98 109.97 166.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -133.57 109.83 9.5 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.058 1.343 . . . . 3.3199999999999998 109.169 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 tp -91.17 112.8 24.86 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.706 2.402 . . . . 0.96999999999999997 108.519 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.58 -11.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.198 0.999 . . . . 0.77000000000000002 112.962 -169.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.65 -160.61 28.13 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 124.202 0.906 . . . . 0.56999999999999995 112.318 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.69 -178.29 6.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.5 1.12 . . . . 0.68999999999999995 110.618 164.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -155.41 135.94 13.35 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.052 -1.462 . . . . 5.3300000000000001 107.052 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -152.55 152.8 29.54 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.936 0.895 . . . . 0.76000000000000001 110.909 -163.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.45 -11.37 10.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.521 2.814 . . . . 0.87 113.707 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.324 0.8 OUTLIER -94.0 -4.01 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 114.1 1.148 . . . . 0.92000000000000004 114.1 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.29 158.74 44.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.677 1.191 . . . . 0.76000000000000001 112.04 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -98.67 -60.91 1.45 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 3.2999999999999998 109.806 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -84.39 134.44 34.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.373 1.069 . . . . 2.8399999999999999 109.34 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 p -147.97 136.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.649 1.979 . . . . 1.29 108.527 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -148.62 135.98 20.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.174 1.39 . . . . 1.99 110.458 -168.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -81.21 125.51 30.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.85 1.31 . . . . 0.96999999999999997 110.875 168.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.5 m170 -119.05 157.54 27.6 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.576 2.35 . . . . 0.68000000000000005 111.461 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -99.58 173.76 6.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.908 1.683 . . . . 2.02 110.272 164.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -127.99 130.25 48.06 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.961 -1.866 . . . . 1.1899999999999999 105.961 157.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -111.85 163.91 13.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.74 1.216 . . . . 2.6400000000000001 113.125 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -108.46 143.87 36.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.893 -1.048 . . . . 2.7799999999999998 108.24 146.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.1 136.34 10.89 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.331 1.053 . . . . 5.25 109.832 -175.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.43 148.25 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.146 0.578 . . . . 4.0 110.631 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.46 -87.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.118 1.367 . . . . 2.8700000000000001 109.305 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -75.41 34.75 0.11 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.902 2.081 . . . . 3.3599999999999999 111.456 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.52 -19.79 0.65 Allowed Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.272 -1.517 . . . . 1.97 113.827 -164.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -83.03 146.53 28.69 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.892 2.077 . . . . 2.6099999999999999 109.743 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -79.52 121.1 24.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.574 0.75 . . . . 3.75 111.412 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.1 t -112.64 148.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.653 1.981 . . . . 1.96 108.686 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.4 mtm -134.56 142.08 46.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.21 1.004 . . . . 3.5299999999999998 111.963 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.82 -177.61 44.07 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.616 1.103 . . . . 1.8300000000000001 113.078 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -107.55 159.13 16.67 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.903 1.281 . . . . 2.1699999999999999 112.643 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.92 155.42 10.84 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.44 1.496 . . . . 3.7200000000000002 111.158 171.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.9 Cg_endo -67.44 149.38 80.34 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.646 1.564 . . . . 0.92000000000000004 112.033 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -114.26 158.65 39.15 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.923 1.689 . . . . 1.21 109.565 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.62 -19.37 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.238 1.958 . . . . 1.51 112.63 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.2 p90 177.47 171.52 0.58 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.744 2.018 . . . . 2.2000000000000002 110.924 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mt -116.57 171.68 7.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.021 1.729 . . . . 1.0700000000000001 108.969 153.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -155.21 164.92 38.15 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.06 -1.025 . . . . 1.97 111.743 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.36 128.66 9.13 Favored Pre-proline 0 N--CA 1.466 0.365 0 C-N-CA 125.02 1.328 . . . . 1.0600000000000001 108.162 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.82 164.69 32.46 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.762 1.641 . . . . 0.97999999999999998 111.05 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.6 137.99 83.26 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.173 2.582 . . . . 1.1200000000000001 110.971 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt 66.31 0.93 1.86 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 1.8400000000000001 113.646 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.28 -179.06 45.5 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.746 2.117 . . . . 1.45 113.65 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -155.73 147.83 23.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.397 -1.901 . . . . 4.5099999999999998 111.355 -172.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.01 167.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.359 2.264 . . . . 1.6799999999999999 109.958 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.97 129.37 38.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.81 0.814 . . . . 4.2999999999999998 111.201 168.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -75.53 71.88 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.539 1.536 . . . . 1.0600000000000001 109.291 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -68.37 140.59 92.81 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.635 1.574 . . . . 3.02 111.697 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.7 -32.33 68.49 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.023 2.482 . . . . 1.51 112.928 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.42 51.56 4.53 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.851 0.75 . . . . 1.1899999999999999 111.311 163.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.65 -136.92 4.29 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.119 1.343 . . . . 2.6200000000000001 112.974 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -73.07 144.58 47.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.838 0.855 . . . . 2.02 112.167 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -171.04 174.22 4.77 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.322 1.049 . . . . 0.83999999999999997 109.762 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -101.62 131.82 47.62 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.107 0.563 . . . . 2.1099999999999999 110.518 166.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -90.76 141.66 28.57 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.538 0.735 . . . . 0.88 109.969 160.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.44 141.59 51.45 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.909 1.683 . . . . 1.6699999999999999 109.66 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -147.43 144.49 28.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.992 1.317 . . . . 2.0699999999999998 111.232 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.84 0.56 Allowed Glycine 0 N--CA 1.466 0.66 0 N-CA-C 109.202 -1.559 . . . . 2.3300000000000001 109.202 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.43 101.38 4.79 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.001 0.905 . . . . 0.93999999999999995 110.265 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -79.5 -4.73 52.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.32 0.859 . . . . 1.8500000000000001 113.32 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -126.39 142.51 43.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 126.715 2.006 . . . . 5.3200000000000003 108.585 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.14 151.6 72.58 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.655 1.57 . . . . 1.75 108.624 157.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.3 mt -120.86 132.0 54.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.098 0.951 . . . . 2.9300000000000002 112.122 -170.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 127.71 54.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.793 1.637 . . . . 3.3599999999999999 106.968 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 151.5 11.75 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.985 -1.072 . . . . 1.6399999999999999 113.329 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.88 39.03 94.83 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.554 -0.581 . . . . 1.8100000000000001 113.747 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -116.3 -166.52 1.16 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.617 -1.253 . . . . 2.71 107.617 154.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -126.08 159.08 33.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.79 0.805 . . . . 3.5800000000000001 111.913 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.24 116.58 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 125.702 1.601 . . . . 0.94999999999999996 107.273 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.95 134.43 47.2 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.712 -1.218 . . . . 2.9199999999999999 107.712 164.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.98 129.25 15.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.192 0.997 . . . . 1.54 111.13 -168.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.4 99.77 9.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.556 1.942 . . . . 2.04 110.353 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.8 mt -72.43 116.67 13.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.281 . . . . 1.1799999999999999 109.789 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.42 131.52 35.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.457 1.103 . . . . 0.59999999999999998 111.234 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -122.73 155.56 36.22 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.044 0.938 . . . . 1.8200000000000001 112.681 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.69 121.11 12.57 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 2.0600000000000001 112.852 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.71 -156.48 28.95 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.095 1.331 . . . . 3.1000000000000001 111.415 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.73 51.58 3.77 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.103 -0.832 . . . . 1.6399999999999999 114.8 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -125.05 137.79 54.21 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.518 1.659 . . . . 4.7400000000000002 111.136 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.61 136.77 19.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.294 1.838 . . . . 0.97999999999999998 106.992 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.9 mt -119.76 115.08 23.16 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.921 0.888 . . . . 1.6200000000000001 109.506 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -79.11 133.38 36.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.239 0.615 . . . . 2.4500000000000002 111.658 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.47 170.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.843 1.657 . . . . 1.3400000000000001 110.443 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.95 132.5 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.848 -1.167 . . . . 2.0899999999999999 107.848 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 mt -143.58 144.03 25.97 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.186 1.394 . . . . 1.6899999999999999 110.011 -168.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.88 152.37 57.84 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.831 3.021 . . . . 1.03 115.12 -172.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.4 t -83.67 107.43 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.293 2.237 . . . . 1.4099999999999999 109.881 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.95 136.55 36.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.541 1.936 . . . . 4.0099999999999998 108.83 160.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -105.82 135.79 46.62 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.897 0.379 . . . . 1.8999999999999999 110.319 163.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 130.49 3.516 . . . . 7.0 106.53 -161.678 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 109.893 -1.283 . . . . 12.84 109.893 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -90.13 26.46 1.87 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.203 1.801 . . . . 13.52 113.079 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 78.59 5.91 2.44 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.012 2.125 . . . . 10.01 111.022 -146.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.5 p -87.15 85.83 7.24 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.059 2.144 . . . . 7.5700000000000003 109.876 163.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.487 ' H ' ' HB ' ' A' ' 21' ' ' THR . 42.0 mm-40 -113.93 142.62 45.91 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.425 1.09 . . . . 5.25 113.252 -163.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.36 -173.95 34.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 126.389 1.947 . . . . 0.89000000000000001 112.36 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.7 p90 -155.26 140.88 17.94 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.135 1.374 . . . . 1.6499999999999999 110.509 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.08 136.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.333 1.053 . . . . 1.0600000000000001 109.633 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -24.46 31.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.934 1.694 . . . . 4.0999999999999996 114.962 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.34 174.24 0.26 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.015 2.126 . . . . 3.4199999999999999 115.138 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 m -174.73 174.46 0.92 Allowed Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.209 3.404 . . . . 1.75 107.737 151.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.17 -21.85 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.007 1.805 . . . . 2.3500000000000001 112.461 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.3 173.99 13.49 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.259 1.885 . . . . 1.77 111.92 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.79 -11.5 39.54 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 119.263 1.532 . . . . 2.0299999999999998 113.124 -5.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -122.26 168.74 11.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.479 . . . . 1.96 112.914 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.56 -175.72 4.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.569 2.348 . . . . 0.62 110.339 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.56 17.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.676 1.19 . . . . 0.85999999999999999 112.207 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 158.36 38.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 0.76000000000000001 113.424 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -147.23 154.16 40.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.007 1.723 . . . . 2.27 110.75 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.3 160.75 6.3 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.918 1.822 . . . . 1.71 115.918 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.487 ' HB ' ' H ' ' A' ' 5' ' ' GLU . 87.9 m -91.72 105.36 17.66 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.28 2.632 . . . . 1.1200000000000001 109.178 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.6 142.02 28.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.724 1.61 . . . . 3.3199999999999998 110.471 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -109.32 155.77 20.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.149 0.58 . . . . 4.6900000000000004 111.893 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -134.06 110.04 11.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.391 -0.822 . . . . 1.05 109.057 155.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.91 -7.03 3.33 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.212 2.608 . . . . 0.92000000000000004 114.471 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 169.19 42.7 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.994 1.27 . . . . 1.1899999999999999 112.883 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -85.88 5.28 33.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.556 1.542 . . . . 3.9399999999999999 112.914 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.48 156.26 35.49 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.966 1.707 . . . . 2.6400000000000001 109.266 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.25 157.33 22.91 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.216 2.611 . . . . 0.83999999999999997 110.448 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.93 134.33 54.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.07 0.948 . . . . 2.23 110.656 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -126.54 111.06 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.701 1.201 . . . . 4.4100000000000001 110.347 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.06 136.78 32.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.279 1.832 . . . . 0.85999999999999999 108.862 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.42 -10.29 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.21 1.004 . . . . 0.53000000000000003 113.354 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.11 -164.57 35.22 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.447 1.022 . . . . 0.52000000000000002 111.968 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.64 -176.69 5.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.216 1.007 . . . . 0.81000000000000005 109.626 164.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mtm-85 -142.61 147.27 35.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.877 1.217 . . . . 6.04 108.934 163.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -142.9 154.52 62.2 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 125.07 1.348 . . . . 0.69999999999999996 109.018 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -20.0 27.97 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.058 1.838 . . . . 0.89000000000000001 112.707 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.326 3.2 m -92.84 15.87 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.709 1.003 . . . . 1.2 113.709 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.28 165.63 35.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.09 0.956 . . . . 0.82999999999999996 112.728 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.82 -71.83 0.75 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.557 1.543 . . . . 3.5099999999999998 108.004 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -79.2 103.77 9.37 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.991 -1.068 . . . . 3.4399999999999999 109.85 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.91 143.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.9 0.88 . . . . 2.1699999999999999 110.124 160.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.39 117.0 10.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.823 1.249 . . . . 2.2999999999999998 109.408 168.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.77 120.47 25.19 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.825 -1.172 . . . . 0.76000000000000001 110.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.1 m170 -105.19 152.03 23.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.75 112.567 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.37 172.14 10.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.721 1.609 . . . . 2.7999999999999998 110.451 161.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.8 m -151.63 111.85 4.11 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.021 1.328 . . . . 0.98999999999999999 108.396 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -129.08 160.02 34.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.069 1.348 . . . . 1.9199999999999999 112.383 -161.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -97.48 143.9 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.653 0.781 . . . . 3.3500000000000001 110.197 160.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -155.19 145.35 21.8 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.475 0.71 . . . . 5.5300000000000002 110.932 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -64.42 148.51 50.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.904 1.682 . . . . 3.8199999999999998 111.034 167.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.6 t -138.94 -88.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.667 1.587 . . . . 2.6600000000000001 108.614 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -77.81 44.97 0.48 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.197 2.199 . . . . 3.3999999999999999 110.319 170.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.69 -37.02 0.48 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 126.283 1.897 . . . . 2.1699999999999999 113.65 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -78.8 150.64 32.29 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.238 2.615 . . . . 2.5699999999999998 109.218 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -87.71 142.42 27.84 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.235 1.198 . . . . 3.3100000000000001 114.235 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.21 150.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.314 2.246 . . . . 1.8700000000000001 108.354 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.2 mmt -93.57 133.96 36.35 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.933 0.893 . . . . 2.8199999999999998 110.946 175.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.01 167.6 24.84 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 123.738 0.685 . . . . 0.94999999999999996 113.461 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.73 137.61 35.26 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.665 1.586 . . . . 2.1800000000000002 109.344 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -150.33 144.85 17.87 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.276 1.43 . . . . 3.7999999999999998 109.247 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 37.7 Cg_endo -65.65 142.38 70.47 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.965 1.777 . . . . 0.66000000000000003 110.773 169.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.39 154.38 47.6 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 126.074 1.749 . . . . 0.65000000000000002 110.606 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.96 -9.31 23.47 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.882 2.388 . . . . 0.90000000000000002 113.954 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -175.57 170.37 2.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.263 1.392 . . . . 2.3900000000000001 111.397 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 166.21 17.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.813 1.645 . . . . 0.68000000000000005 109.215 157.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.49 161.53 40.91 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.188 -0.945 . . . . 2.8900000000000001 113.034 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -148.3 142.67 16.62 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.726 1.21 . . . . 1.25 109.517 -166.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.8 16.61 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.475 2.117 . . . . 1.01 112.278 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.32 148.36 86.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.894 3.062 . . . . 1.05 112.211 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 64.89 -0.27 1.05 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.602 1.561 . . . . 2.3100000000000001 113.843 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.53 111.2 3.67 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.901 1.715 . . . . 0.89000000000000001 111.398 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.45 123.42 44.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.68 1.192 . . . . 4.1900000000000004 109.061 165.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.41 143.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.106 1.362 . . . . 2.0 111.796 -165.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -88.91 144.31 26.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.202 1.001 . . . . 3.2400000000000002 111.765 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.24 73.77 2.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.402 1.081 . . . . 1.3300000000000001 109.457 158.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -59.53 131.77 88.31 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.886 -1.054 . . . . 4.0099999999999998 111.111 173.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.43 -32.89 89.16 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.873 2.382 . . . . 1.4399999999999999 112.893 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.18 51.77 4.41 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.229 0.919 . . . . 1.73 112.328 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.04 -56.6 0.08 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.82 1.2 . . . . 1.49 114.209 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -155.47 141.62 18.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.055 1.742 . . . . 2.0899999999999999 111.411 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -163.08 176.32 10.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.008 -1.057 . . . . 0.78000000000000003 111.233 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.46 131.07 55.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.825 0.45 . . . . 1.79 110.949 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mmt -85.36 144.54 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.88 1.272 . . . . 1.02 110.759 154.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -124.05 129.02 50.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.204 1.802 . . . . 1.77 108.682 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -133.64 136.57 44.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.094 0.958 . . . . 2.0600000000000001 111.624 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.36 76.04 0.79 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.675 -1.37 . . . . 2.8599999999999999 109.675 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.2 mt -78.15 135.25 37.62 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.176 -1.046 . . . . 0.90000000000000002 108.176 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -80.51 -0.32 36.97 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.968 -1.082 . . . . 2.2200000000000002 112.264 -169.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -174.21 160.13 2.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.601 2.36 . . . . 6.79 110.156 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.62 146.73 55.64 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.48 2.12 . . . . 3.0 110.092 163.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -112.93 168.53 9.62 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.551 1.54 . . . . 2.8199999999999998 111.874 -172.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.39 137.48 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.658 1.183 . . . . 3.5099999999999998 111.862 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.86 129.47 41.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.785 -1.197 . . . . 2.3199999999999998 110.437 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 52.11 3.66 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 112.174 -0.37 . . . . 2.3399999999999999 112.174 -165.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -129.02 165.02 21.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.955 1.702 . . . . 3.6299999999999999 107.616 161.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.64 155.56 16.93 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.993 1.317 . . . . 5.5300000000000002 111.003 168.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.06 124.06 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 126.113 1.765 . . . . 0.85999999999999999 108.567 169.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.62 125.69 29.53 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.079 -0.712 . . . . 3.9300000000000002 109.079 161.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mt -126.67 125.42 41.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.991 0.916 . . . . 1.6599999999999999 111.81 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -105.06 94.7 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.78 1.232 . . . . 2.54 110.568 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.5 mt -65.67 123.36 19.51 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 1.53 110.446 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.8 mt -97.43 131.37 44.14 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.31 1.444 . . . . 0.79000000000000004 110.342 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -125.67 167.09 15.61 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.683 1.23 . . . . 2.29 111.566 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.76 166.47 10.92 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.993 -1.003 . . . . 3.0099999999999998 111.432 168.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.4 15.44 80.3 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.802 0.681 . . . . 4.29 114.802 173.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.62 6.16 89.33 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 118.427 1.113 . . . . 1.8500000000000001 113.767 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -79.29 138.38 37.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.903 1.352 . . . . 6.46 112.376 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.15 148.94 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.19 1.796 . . . . 1.4399999999999999 108.105 158.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.0 mt -124.15 125.28 44.2 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.573 1.549 . . . . 2.2999999999999998 108.4 172.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -87.68 133.31 33.85 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.761 0.824 . . . . 2.2599999999999998 111.651 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.29 127.45 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.835 1.254 . . . . 1.5600000000000001 113.23 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.88 135.48 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.8 1.24 . . . . 1.8100000000000001 111.56 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.9 mt -143.78 160.68 49.47 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 128.041 2.536 . . . . 2.1099999999999999 111.079 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -84.92 157.17 11.62 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.085 3.19 . . . . 0.96999999999999997 114.624 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -94.32 124.1 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.33 2.252 . . . . 1.0700000000000001 110.576 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.34 156.09 18.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.983 1.313 . . . . 3.25 109.044 156.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.83 81.51 4.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.366 -0.976 . . . . 2.25 108.366 161.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 115.761 -2.066 . . . . 6.5 115.486 -158.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.029 0 N-CA-C 107.154 -2.378 . . . . 12.91 107.154 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 t -84.7 -134.77 0.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 117.609 -1.636 . . . . 10.869999999999999 107.461 128.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 76.74 -3.36 2.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.939 1.295 . . . . 9.9299999999999997 114.226 155.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.5 p -74.3 85.15 1.93 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.582 1.553 . . . . 6.5599999999999996 110.028 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.453 ' H ' ' HB ' ' A' ' 21' ' ' THR . 37.0 tt0 -93.98 108.4 20.21 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.929 1.692 . . . . 6.3200000000000003 111.292 -163.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.55 167.45 30.9 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.608 1.099 . . . . 1.05 114.476 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -152.22 143.13 23.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.781 1.232 . . . . 1.54 111.999 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.06 118.16 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 122.963 0.505 . . . . 1.0 109.676 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -85.72 96.45 9.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.293 1.037 . . . . 4.6600000000000001 110.405 -169.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.71 154.53 3.73 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.666 2.386 . . . . 2.1800000000000002 112.884 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.83 149.08 20.26 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 118.463 -0.78 . . . . 2.1499999999999999 109.668 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 56.68 5.6 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.415 2.743 . . . . 2.1600000000000001 109.281 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.79 -164.38 46.15 Favored Glycine 0 CA--C 1.541 1.677 0 O-C-N 121.482 -0.761 . . . . 2.0299999999999998 112.582 -168.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.54 -11.73 20.11 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 117.681 0.74 . . . . 2.46 111.331 -28.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -146.82 168.09 22.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.751 2.021 . . . . 2.1800000000000002 109.976 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 -177.34 6.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.535 1.534 . . . . 0.64000000000000001 111.819 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.81 156.69 43.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 0.76000000000000001 111.99 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.1 143.21 36.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.118 0.967 . . . . 0.72999999999999998 112.111 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -136.66 141.4 43.16 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.389 1.876 . . . . 2.1499999999999999 109.58 -172.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -165.22 147.33 7.81 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.331 1.975 . . . . 1.9399999999999999 116.331 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.453 ' HB ' ' H ' ' A' ' 5' ' ' GLU . 16.2 m -99.54 129.77 45.73 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.569 1.548 . . . . 1.6599999999999999 108.786 169.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tp -130.69 162.95 28.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 4.1399999999999997 110.734 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.28 141.82 51.86 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.092 1.357 . . . . 3.1600000000000001 111.214 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -100.28 110.91 61.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.512 -0.921 . . . . 1.25 108.512 157.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.87 -15.37 3.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.364 2.709 . . . . 1.3 113.769 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.75 -176.27 51.37 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.045 0.838 . . . . 1.3700000000000001 113.23 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -105.33 12.97 31.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.707 1.603 . . . . 4.0700000000000003 111.437 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mt -113.8 156.37 43.83 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 126.957 2.103 . . . . 2.7200000000000002 109.132 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.72 158.33 24.8 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.991 2.461 . . . . 0.83999999999999997 109.926 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.3 130.56 42.93 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.56 1.144 . . . . 2.3799999999999999 109.73 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -117.26 115.61 25.62 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.864 1.266 . . . . 4.1500000000000004 110.422 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -94.63 117.14 29.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.537 2.335 . . . . 0.83999999999999997 108.68 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.77 -10.88 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.729 1.011 . . . . 0.57999999999999996 113.729 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.25 -163.17 31.66 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.664 -0.648 . . . . 0.40000000000000002 112.344 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.97 12.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.731 0.813 . . . . 0.65000000000000002 111.189 167.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -144.85 133.31 21.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.921 1.688 . . . . 7.0099999999999998 108.058 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -148.9 149.74 30.96 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.421 1.489 . . . . 0.72999999999999998 110.335 -166.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.1 -37.93 4.31 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.337 2.024 . . . . 1.03 112.157 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.273 2.6 m -84.79 3.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.907 1.447 . . . . 0.91000000000000003 114.907 -169.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -133.31 137.08 45.82 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.356 -1.465 . . . . 0.80000000000000004 112.23 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -76.11 -70.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.319 -1.363 . . . . 5.2300000000000004 107.319 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -84.92 143.32 29.08 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.266 2.226 . . . . 3.2200000000000002 109.37 169.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.75 131.81 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.359 1.864 . . . . 1.3300000000000001 107.932 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -142.94 128.68 19.3 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.234 1.414 . . . . 2.2400000000000002 109.493 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.87 121.42 24.82 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.367 1.079 . . . . 0.78000000000000003 110.454 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -112.36 158.38 19.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.019 2.128 . . . . 0.63 112.035 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.86 179.39 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.912 1.685 . . . . 2.02 110.909 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 m -135.22 106.23 6.65 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.195 1.398 . . . . 1.1499999999999999 107.274 163.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -107.0 152.06 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.706 1.202 . . . . 2.29 111.225 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -84.77 145.33 27.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.527 0.679 . . . . 3.96 110.27 166.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -148.14 160.17 43.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.558 1.543 . . . . 5.6600000000000001 110.333 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -84.57 148.12 26.65 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.528 0.731 . . . . 6.7000000000000002 109.393 164.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.95 -87.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.55 -1.648 . . . . 2.5099999999999998 106.55 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -77.68 43.96 0.43 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.999 2.52 . . . . 3.7999999999999998 110.809 170.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.9 -29.63 0.29 Allowed Glycine 0 N--CA 1.482 1.751 0 O-C-N 119.999 -1.688 . . . . 2.5 115.117 -171.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -69.71 132.22 45.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.828 2.051 . . . . 3.6499999999999999 109.853 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -83.46 102.18 11.9 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.904 -1.147 . . . . 5.46 107.904 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.11 155.26 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.516 1.926 . . . . 2.8399999999999999 110.823 -167.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.0 mtm -75.22 153.22 38.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.622 0.971 . . . . 4.4100000000000001 113.622 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.64 160.7 28.28 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.446 1.974 . . . . 1.1599999999999999 110.567 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -123.01 148.31 45.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.897 1.279 . . . . 1.8300000000000001 110.322 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -171.68 157.85 4.49 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 117.165 -1.398 . . . . 3.9900000000000002 111.223 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.4 Cg_endo -69.75 157.35 60.71 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.026 1.817 . . . . 0.58999999999999997 112.605 168.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.03 158.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 126.029 1.732 . . . . 0.67000000000000004 110.613 171.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.4 -11.67 24.75 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.918 2.412 . . . . 0.81000000000000005 113.577 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -179.05 162.24 1.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.307 1.843 . . . . 2.2400000000000002 110.192 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.99 172.85 6.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.471 1.909 . . . . 0.80000000000000004 108.756 156.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.04 170.17 23.14 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.837 -1.164 . . . . 2.5299999999999998 113.389 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.05 135.28 11.87 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 125.288 1.435 . . . . 0.93000000000000005 109.465 -167.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.05 168.32 24.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.15 1.9 . . . . 0.92000000000000004 110.688 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.58 148.59 92.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.082 2.521 . . . . 1.1000000000000001 111.95 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 68.39 -3.38 1.33 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.94 2.096 . . . . 1.78 114.48 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.29 117.93 5.18 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 126.204 1.859 . . . . 1.05 112.184 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 127.96 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.54 -0.83 . . . . 6.2300000000000004 110.264 159.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.05 165.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.568 1.547 . . . . 1.29 110.608 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.08 114.03 8.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.885 0.874 . . . . 3.6699999999999999 112.099 -163.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.25 67.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.848 2.059 . . . . 1.0700000000000001 109.379 165.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.44 143.56 98.73 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.996 1.719 . . . . 3.46 111.83 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.1 -61.17 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.172 3.248 . . . . 1.3600000000000001 112.668 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 102.32 2.05 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.802 -1.719 . . . . 1.53 108.802 162.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.99 -69.83 0.3 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.822 1.677 . . . . 1.22 112.662 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -155.71 139.19 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.946 1.699 . . . . 2.02 109.495 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -167.1 172.36 10.12 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.135 -0.978 . . . . 0.85999999999999999 109.598 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -103.66 141.5 35.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.415 0.552 . . . . 2.1800000000000002 110.225 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.7 mmt -89.17 139.29 30.63 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.858 0.863 . . . . 1.01 110.077 159.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -122.0 130.33 53.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.53 1.932 . . . . 1.9399999999999999 109.24 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -136.65 159.45 41.78 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.636 0.774 . . . . 2.2799999999999998 112.241 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.32 -57.08 3.28 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 126.54 2.019 . . . . 2.7999999999999998 113.672 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.1 mt 76.64 91.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 130.423 3.489 . . . . 1.1399999999999999 111.847 172.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -74.54 4.37 6.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.627 1.343 . . . . 2.4900000000000002 114.627 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -144.67 152.84 53.7 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 128.713 2.805 . . . . 6.3399999999999999 108.063 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.21 150.64 81.76 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.242 1.961 . . . . 2.2799999999999998 109.516 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.54 134.22 44.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.413 1.485 . . . . 2.9300000000000002 110.141 -170.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.41 101.49 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.029 0.919 . . . . 4.2800000000000002 109.37 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.64 130.73 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.211 -0.931 . . . . 2.5699999999999998 111.176 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.09 50.7 2.97 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.057 -0.519 . . . . 2.0800000000000001 112.923 -167.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -137.17 -167.28 2.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.077 1.351 . . . . 2.9399999999999999 109.899 159.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -130.55 153.44 48.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.4 1.08 . . . . 3.3799999999999999 108.742 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.8 115.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.606 1.162 . . . . 1.21 108.686 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -63.69 122.99 17.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.701 -1.591 . . . . 3.5899999999999999 109.327 160.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -129.72 116.52 18.91 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.711 0.767 . . . . 1.6699999999999999 110.917 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.32 96.47 9.04 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.833 1.653 . . . . 2.27 108.77 165.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.8 126.76 31.53 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.238 -0.914 . . . . 1.6899999999999999 109.091 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.35 136.86 37.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.929 1.292 . . . . 0.70999999999999996 111.056 -168.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -132.94 148.49 52.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.296 1.046 . . . . 2.5099999999999998 113.014 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.55 163.85 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.067 -0.97 . . . . 2.96 111.971 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.08 76.44 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.791 -0.568 . . . . 4.6600000000000001 113.575 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.01 63.71 3.2 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.553 1.073 . . . . 1.97 111.069 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -144.35 166.03 26.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.872 1.32 . . . . 3.73 112.755 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -170.78 147.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 128.234 2.614 . . . . 1.95 108.239 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.0 mt -134.62 118.72 17.51 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.052 1.341 . . . . 2.5899999999999999 108.703 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -86.19 125.08 33.28 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.353 -0.842 . . . . 2.1499999999999999 110.673 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.16 133.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.272 1.029 . . . . 1.74 108.691 166.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.92 136.96 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.849 -1.167 . . . . 1.9399999999999999 107.849 168.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -142.6 136.39 14.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.321 1.448 . . . . 2.0299999999999998 109.001 -170.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.09 154.05 75.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.323 3.349 . . . . 1.0 114.034 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.4 t -79.76 125.94 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 122.797 0.439 . . . . 1.1000000000000001 110.309 170.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.45 141.77 28.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.485 1.914 . . . . 3.3799999999999999 108.125 162.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.53 22.46 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.629 2.085 . . . . 2.79 116.629 -161.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.272 2.3 tmt_? . . . . . 0 N--CA 1.481 1.079 1 C-N-CA 132.063 4.145 . . . . 8.4900000000000002 113.789 171.737 . . . . . . . . 2 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 109.159 -1.577 . . . . 11.93 109.159 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 173.67 -160.9 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 130.4 3.48 . . . . 9.0800000000000001 106.576 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -95.85 -171.18 2.28 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.803 1.183 . . . . 9.5 109.934 162.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.6 p -92.77 86.55 5.56 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.784 -1.197 . . . . 6.6500000000000004 110.042 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.66 103.11 8.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.758 -1.11 . . . . 5.2999999999999998 109.409 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.94 175.79 22.42 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 119.08 0.855 . . . . 1.26 115.127 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 p90 -155.75 162.67 40.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.962 1.705 . . . . 2.1099999999999999 111.296 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.1 t -131.16 117.73 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.758 -0.589 . . . . 1.04 109.655 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.47 95.6 8.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.003 0.921 . . . . 6.1399999999999997 109.914 -171.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.93 145.88 55.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.867 1.667 . . . . 2.3700000000000001 112.709 -176.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.0 t -142.61 148.01 44.89 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.482 1.513 . . . . 2.71 107.747 162.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.59 48.31 1.57 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.599 3.533 . . . . 1.74 112.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.55 -173.11 55.16 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 121.346 -0.846 . . . . 1.51 112.419 -168.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.28 -21.45 8.91 Favored 'Cis proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.139 -1.192 . . . . 1.45 110.761 -24.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -121.84 165.72 15.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.813 2.045 . . . . 1.9099999999999999 111.81 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.33 -179.15 7.81 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.23 2.212 . . . . 0.70999999999999996 110.356 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.08 155.36 48.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.726 1.148 . . . . 0.80000000000000004 113.443 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.48 45.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.466 1.106 . . . . 0.70999999999999996 113.19 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -156.11 157.94 36.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.013 1.325 . . . . 2.3799999999999999 112.133 -158.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 178.93 149.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.15 1.537 . . . . 1.6100000000000001 115.15 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.2 m -85.0 135.08 34.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.347 1.859 . . . . 1.49 108.838 160.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 tp -136.29 153.16 51.26 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.841 1.257 . . . . 3.9100000000000001 109.693 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.56 134.17 28.46 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.601 -0.687 . . . . 4.3099999999999996 111.047 166.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.73 114.38 47.63 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.453 1.501 . . . . 1.0 110.444 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.69 -15.35 10.91 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.778 2.318 . . . . 1.1699999999999999 113.875 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.62 166.01 54.8 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 122.509 1.061 . . . . 1.1100000000000001 113.611 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -77.72 -17.63 57.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.173 2.189 . . . . 4.7699999999999996 112.281 162.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.01 156.02 60.71 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.479 1.512 . . . . 2.8199999999999998 111.752 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.6 155.26 9.03 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.014 3.143 . . . . 1.4299999999999999 110.73 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.67 145.74 50.03 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.592 1.557 . . . . 2.0499999999999998 110.432 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -142.45 108.97 5.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.619 1.167 . . . . 5.0099999999999998 111.719 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -94.37 114.73 26.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.098 2.159 . . . . 0.77000000000000002 109.629 -169.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 m -106.29 -11.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.109 1.364 . . . . 1.05 113.724 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.76 -167.61 39.52 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 121.604 -0.685 . . . . 0.71999999999999997 111.749 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.26 152.13 30.83 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.38 1.072 . . . . 1.47 110.598 166.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 -110.96 131.25 55.2 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.65 -1.611 . . . . 8.1999999999999993 106.65 -174.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -139.35 149.56 60.97 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.593 1.157 . . . . 0.58999999999999997 109.243 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.52 -21.19 19.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.988 2.459 . . . . 0.79000000000000004 113.069 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.333 2.5 m -90.93 9.64 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 114.607 1.336 . . . . 0.85999999999999999 114.607 -176.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.3 167.71 27.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.98 0.912 . . . . 0.90000000000000002 112.792 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -107.4 -77.15 0.6 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.654 1.582 . . . . 3.5499999999999998 109.068 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -75.53 105.24 6.45 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.799 -1.188 . . . . 3.52 109.74 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 p -79.56 143.16 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.13 0.972 . . . . 1.8600000000000001 110.456 158.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -136.29 134.19 37.73 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.53 1.532 . . . . 2.1699999999999999 108.48 161.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -86.43 124.79 33.15 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.628 1.558 . . . . 0.79000000000000004 110.882 167.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -116.15 164.72 14.07 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.842 2.057 . . . . 0.64000000000000001 112.43 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -114.63 -174.57 2.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.115 1.766 . . . . 1.96 111.606 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.1 m -138.25 114.5 10.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.161 -1.422 . . . . 1.24 107.161 155.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -90.8 160.01 15.99 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.315 1.046 . . . . 1.8899999999999999 111.593 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.4 mtm -92.08 148.48 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.319 0.648 . . . . 2.48 110.089 154.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -158.96 120.81 3.45 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.486 1.514 . . . . 6.0199999999999996 108.008 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.45 152.27 18.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.143 0.577 . . . . 4.8399999999999999 110.74 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.8 t -144.25 116.77 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.145 0.978 . . . . 3.75 108.637 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 61.84 17.92 9.29 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.483 1.513 . . . . 3.71 111.785 -168.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.22 74.19 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.9 1.238 . . . . 2.8900000000000001 113.972 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -77.46 137.14 38.5 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.889 1.345 . . . . 3.1200000000000001 108.972 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.97 137.62 58.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.599 -0.715 . . . . 4.4800000000000004 111.807 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 160.21 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.966 0.506 . . . . 2.0 110.418 164.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.1 mtm -133.81 156.31 48.25 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.528 1.531 . . . . 2.6499999999999999 110.233 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.37 163.49 33.46 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 123.376 0.512 . . . . 0.96999999999999997 112.914 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -103.59 166.97 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.753 1.221 . . . . 1.55 111.096 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -176.51 154.17 1.27 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 126.442 1.897 . . . . 3.71 110.34 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -70.98 153.72 63.22 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.123 1.882 . . . . 0.60999999999999999 111.685 167.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.31 156.22 53.08 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 126.208 1.803 . . . . 0.69999999999999996 110.602 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.08 -20.6 37.8 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.829 2.353 . . . . 0.72999999999999998 112.461 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -176.39 169.5 2.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.914 2.085 . . . . 2.2599999999999998 110.755 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.63 170.53 8.03 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.343 1.457 . . . . 0.81000000000000005 109.598 154.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -139.21 166.81 23.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.189 0.519 . . . . 2.5299999999999998 110.86 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.59 120.62 5.19 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.15 1.38 . . . . 1.1599999999999999 107.734 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.87 164.74 32.87 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.677 1.584 . . . . 1.0900000000000001 110.864 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.19 138.46 72.32 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.38 2.72 . . . . 1.0 111.368 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 67.0 -0.37 1.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.563 1.545 . . . . 1.8600000000000001 113.415 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 117.37 4.5 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 127.382 2.42 . . . . 1.3100000000000001 112.071 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -79.77 133.12 36.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.75 -1.225 . . . . 5.6100000000000003 110.923 163.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.85 166.2 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.175 2.19 . . . . 2.0800000000000001 110.088 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.15 110.38 2.31 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.699 0.799 . . . . 4.3099999999999996 109.424 -168.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.09 75.64 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.131 1.372 . . . . 1.1599999999999999 108.004 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' A' ' 78' ' ' LYS . 15.8 ptpt -69.34 153.23 96.06 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 127.894 2.478 . . . . 2.77 113.555 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.39 -41.92 24.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.655 2.904 . . . . 2.8700000000000001 114.092 -162.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.33 128.28 9.52 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.984 -2.046 . . . . 2.2400000000000002 107.984 152.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.08 -143.42 14.85 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.072 1.32 . . . . 2.9199999999999999 111.393 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -73.21 138.7 45.78 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.848 -0.795 . . . . 2.0699999999999998 111.537 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -161.28 158.3 26.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.454 1.102 . . . . 0.93000000000000005 109.433 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -87.59 135.2 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.973 -0.751 . . . . 2.1000000000000001 108.973 160.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.55 120.34 41.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.549 1.54 . . . . 1.1799999999999999 108.077 168.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.63 142.68 35.89 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.272 1.029 . . . . 3.3300000000000001 110.467 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.35 135.74 24.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.745 1.618 . . . . 2.1200000000000001 111.543 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.07 81.84 0.58 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.714 -0.954 . . . . 2.6600000000000001 110.714 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.16 100.79 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.921 0.867 . . . . 1.04 110.459 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -86.75 10.5 15.65 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.534 1.309 . . . . 2.0099999999999998 114.534 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -145.14 166.29 18.53 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 127.349 2.259 . . . . 4.9299999999999997 109.128 167.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.19 -176.73 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.851 1.7 . . . . 2.3500000000000001 110.278 151.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -176.5 59.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.797 2.439 . . . . 3.1000000000000001 107.781 -163.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.91 151.25 30.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 5.8700000000000001 113.031 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.38 120.22 8.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.56 -1.2 . . . . 1.5900000000000001 108.455 156.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.23 17.46 46.57 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.107 -1.385 . . . . 1.9299999999999999 114.808 -170.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.84 167.25 10.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.733 1.766 . . . . 3.2799999999999998 107.779 151.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -116.22 147.49 41.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.823 0.849 . . . . 3.4900000000000002 109.163 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.79 116.86 51.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.18 1.792 . . . . 0.93000000000000005 108.665 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.36 129.37 39.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.174 -1.047 . . . . 3.1400000000000001 108.174 156.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.39 126.56 42.66 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.595 0.758 . . . . 1.8100000000000001 110.898 168.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.95 94.13 5.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.215 1.806 . . . . 2.7000000000000002 109.912 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.39 118.6 8.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.275 1.43 . . . . 1.1399999999999999 110.568 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.2 mt -92.41 127.7 38.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.322 1.449 . . . . 0.81999999999999995 110.821 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.12 133.79 50.33 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.815 1.293 . . . . 2.3799999999999999 113.76 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.06 53.59 2.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.965 1.706 . . . . 2.2400000000000002 112.383 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -151.5 26.49 0.96 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.682 2.087 . . . . 5.0700000000000003 113.557 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.98 50.59 45.64 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 124.132 0.873 . . . . 2.4199999999999999 111.368 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -149.73 160.56 43.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.035 1.734 . . . . 3.5800000000000001 112.832 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -162.81 130.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 129.149 2.98 . . . . 1.4199999999999999 108.51 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.95 121.01 36.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 2.5699999999999998 109.35 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.18 134.56 34.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.901 1.074 . . . . 2.7000000000000002 113.901 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.62 163.67 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.375 1.47 . . . . 1.8899999999999999 109.42 164.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.09 134.88 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.975 -1.491 . . . . 1.9299999999999999 106.975 164.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.8 mt -135.62 148.0 63.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 126.239 1.815 . . . . 1.98 108.594 -172.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.87 163.32 33.97 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.511 2.808 . . . . 1.3200000000000001 111.904 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -102.27 118.75 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.781 0.832 . . . . 1.5600000000000001 110.802 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -95.36 140.63 29.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.841 2.456 . . . . 4.96 109.189 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.56 -176.66 5.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.456 -1.403 . . . . 2.7200000000000002 111.53 164.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 126.566 1.946 . . . . 11.390000000000001 116.108 -170.767 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' H3 ' ' CD ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.478 1.434 0 N-CA-C 109.234 -1.547 . . . . 12.210000000000001 109.234 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 p -68.96 -171.22 0.29 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.465 1.132 . . . . 10.619999999999999 109.694 139.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -69.14 -28.4 66.41 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.634 -1.291 . . . . 13.27 113.622 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.6 p -166.03 -60.47 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.417 2.287 . . . . 7.1299999999999999 111.451 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 13.3 tt0 -132.01 -167.49 1.89 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.894 1.678 . . . . 6.3300000000000001 111.377 -152.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -93.97 169.92 30.01 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 125.253 1.406 . . . . 1.26 116.354 -174.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -155.05 133.91 12.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.668 1.587 . . . . 1.8200000000000001 111.264 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.97 122.94 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.784 -1.191 . . . . 1.1499999999999999 107.784 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -103.8 87.33 2.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.693 0.797 . . . . 4.4699999999999998 110.127 -161.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.58 144.05 38.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.909 2.083 . . . . 2.1400000000000001 111.389 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -138.32 153.36 72.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.513 1.125 . . . . 2.1800000000000002 109.6 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -65.71 -9.59 23.38 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.977 2.452 . . . . 1.72 113.195 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.71 177.83 18.44 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.463 1.03 . . . . 1.55 113.836 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 -7.77 32.89 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 117.68 0.74 . . . . 1.3999999999999999 113.105 -4.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -128.47 160.61 31.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.335 1.054 . . . . 3.2799999999999998 112.559 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.98 -174.21 4.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.775 1.63 . . . . 0.56999999999999995 111.916 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.22 154.62 49.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.888 0.875 . . . . 0.90000000000000002 112.978 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.15 146.27 50.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.083 0.953 . . . . 0.95999999999999996 112.257 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -143.87 156.52 44.49 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.356 1.863 . . . . 2.2799999999999998 110.703 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -168.46 160.21 10.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.346 1.058 . . . . 2.1299999999999999 113.748 -176.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.4 m -81.9 147.8 29.1 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.048 1.339 . . . . 2.02 108.558 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -155.2 131.65 10.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.157 0.983 . . . . 2.6699999999999999 111.507 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -113.32 145.16 41.53 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.654 1.981 . . . . 3.7200000000000002 112.003 173.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -95.14 97.31 2.53 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 114.372 -1.285 . . . . 1.25 109.652 155.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.46 -8.22 18.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.25 1.967 . . . . 1.1200000000000001 112.939 173.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.17 176.49 50.35 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 124.401 1.001 . . . . 1.1100000000000001 113.606 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.37 -5.42 27.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.737 2.015 . . . . 2.7000000000000002 113.0 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 160.33 44.02 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.84 2.056 . . . . 1.48 109.7 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 158.73 31.05 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.859 2.372 . . . . 0.77000000000000002 112.877 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.19 146.63 28.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.72 1.208 . . . . 1.8500000000000001 110.197 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -131.82 112.38 12.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.934 1.294 . . . . 3.5899999999999999 109.844 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -97.91 115.6 28.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.017 2.527 . . . . 0.77000000000000002 108.751 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.92 -9.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.448 1.099 . . . . 0.55000000000000004 113.116 -166.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.87 -168.86 41.02 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.535 1.064 . . . . 0.44 111.841 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.824 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -146.89 -178.62 6.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.894 1.278 . . . . 0.69999999999999996 110.848 172.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 7.0 ttp85 -151.34 139.97 20.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.372 -2.455 . . . . 7.7699999999999996 104.372 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -147.37 155.4 46.08 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.055 -1.091 . . . . 0.63 108.055 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.39 -29.93 24.81 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.486 2.124 . . . . 0.79000000000000004 113.19 171.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -85.36 -19.98 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.188 1.181 . . . . 1.1200000000000001 114.188 -169.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.84 159.03 22.05 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.21 1.004 . . . . 0.75 112.909 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.441 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 11.0 tp10 -98.11 -91.96 0.26 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.183 0.993 . . . . 3.04 111.202 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -78.66 110.49 13.84 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 121.079 -1.013 . . . . 3.8900000000000001 108.736 -172.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -79.61 142.31 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 124.565 1.146 . . . . 2.2200000000000002 111.253 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -142.05 128.49 20.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.211 1.004 . . . . 2.8199999999999998 109.75 164.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -80.41 116.46 20.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.299 1.047 . . . . 0.75 110.476 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 15.5 m170 -107.96 155.13 20.66 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.509 1.524 . . . . 0.71999999999999997 111.876 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.67 -171.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.142 1.777 . . . . 2.1800000000000002 110.432 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -146.45 114.09 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.888 -1.132 . . . . 1.0600000000000001 108.206 163.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -103.33 174.1 6.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.282 1.433 . . . . 1.8999999999999999 111.989 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -118.16 154.41 32.21 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.267 1.427 . . . . 2.9700000000000002 110.823 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -155.87 164.35 38.62 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.732 1.613 . . . . 6.46 111.731 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -85.74 142.63 28.86 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.529 0.732 . . . . 4.1600000000000001 110.513 162.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.34 -96.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.988 -0.745 . . . . 2.6600000000000001 108.988 163.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -76.68 37.41 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.972 2.109 . . . . 3.7200000000000002 111.919 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.25 0.44 4.49 Favored Glycine 0 CA--C 1.542 1.738 0 O-C-N 120.388 -1.445 . . . . 2.1400000000000001 113.463 -159.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -95.47 141.32 29.15 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.241 2.616 . . . . 3.1400000000000001 110.17 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -73.03 136.88 45.09 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.565 -0.743 . . . . 5.0899999999999999 109.821 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -139.78 143.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.647 1.179 . . . . 1.6799999999999999 109.5 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -114.56 145.66 41.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.753 1.221 . . . . 2.8199999999999998 111.28 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.36 168.87 34.26 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 123.794 0.711 . . . . 1.0700000000000001 113.547 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -103.17 161.1 14.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.93 1.292 . . . . 1.8 112.416 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -167.14 154.45 8.39 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.289 1.835 . . . . 3.4900000000000002 110.071 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 41.0 Cg_endo -69.01 150.03 72.3 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.685 2.257 . . . . 1.05 111.458 167.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.11 158.43 41.01 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.955 1.702 . . . . 0.81000000000000005 110.459 169.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.84 -16.9 41.93 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.659 2.24 . . . . 0.91000000000000003 112.937 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 177.49 163.43 0.56 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.951 2.1 . . . . 1.9399999999999999 109.756 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mt -105.22 170.82 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.312 1.445 . . . . 0.78000000000000003 109.638 155.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.15 158.06 39.82 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.189 -0.944 . . . . 2.4399999999999999 111.813 170.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.45 128.31 13.73 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.461 1.504 . . . . 0.81000000000000005 108.863 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.01 162.67 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.532 2.155 . . . . 0.83999999999999997 111.522 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.04 139.47 87.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.704 2.936 . . . . 0.91000000000000003 112.639 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt 69.13 2.83 3.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.158 2.183 . . . . 1.8300000000000001 114.301 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.42 144.13 16.97 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 126.989 2.233 . . . . 1.1899999999999999 109.645 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -117.24 150.65 38.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.978 1.311 . . . . 3.8700000000000001 112.714 166.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.65 168.26 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.324 1.85 . . . . 1.5800000000000001 110.677 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.406 ' CD ' ' H3 ' ' A' ' 1' ' ' GLY . 47.3 mt-10 -135.07 132.88 38.71 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.199 -1.408 . . . . 4.5099999999999998 107.199 162.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.59 77.39 1.99 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.156 1.455 . . . . 1.0600000000000001 111.356 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -64.25 123.78 83.55 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 117.575 -1.202 . . . . 4.3600000000000003 111.452 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -47.87 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.844 3.696 . . . . 1.71 114.606 -171.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 56.86 4.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.566 1.079 . . . . 1.3500000000000001 111.991 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.86 -53.86 0.05 OUTLIER Glycine 0 N--CA 1.466 0.635 0 C-N-CA 126.097 1.808 . . . . 1.53 112.781 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -152.93 140.45 19.76 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.925 2.09 . . . . 2.3500000000000001 111.223 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -166.58 172.35 10.8 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.857 -1.152 . . . . 0.81000000000000005 111.784 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 61.1 m-85 -105.05 126.69 52.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.012 0.925 . . . . 1.8899999999999999 111.032 168.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.5 mmt -86.65 137.56 32.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.794 1.238 . . . . 0.83999999999999997 111.42 167.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.7 mt -115.35 88.77 2.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.791 1.636 . . . . 1.78 109.261 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -86.92 101.6 13.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.555 1.542 . . . . 2.2000000000000002 110.599 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.5 133.03 4.83 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.347 0.975 . . . . 3.0699999999999998 110.779 -173.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.0 mt -112.98 112.55 24.08 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.374 1.087 . . . . 1.04 109.439 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.441 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 2.3 pttm -90.54 -9.57 46.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.198 1.184 . . . . 1.9199999999999999 114.198 -172.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.7 mmt-85 -146.45 150.91 42.18 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.567 1.547 . . . . 8.3499999999999996 109.389 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.1 174.72 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.393 2.729 . . . . 2.4700000000000002 111.432 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -176.42 158.08 1.77 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.346 1.858 . . . . 2.6699999999999999 109.355 -160.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.33 178.17 7.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.025 1.73 . . . . 3.8500000000000001 112.219 174.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.4 133.99 15.53 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.925 1.29 . . . . 1.8899999999999999 112.939 165.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.93 -0.3 89.5 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.301 -1.277 . . . . 2.1600000000000001 115.268 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -77.83 167.41 21.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.863 1.331 . . . . 3.9199999999999999 111.861 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.14 152.96 20.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.306 -1.315 . . . . 3.79 110.525 162.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.8 t -139.84 126.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 126.148 1.779 . . . . 1.51 109.049 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.31 142.35 57.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.599 -0.519 . . . . 3.6000000000000001 109.599 164.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.824 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.3 tt -141.05 127.37 19.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.52 1.152 . . . . 1.6499999999999999 111.987 157.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.428 ' N ' HD23 ' A' ' 101' ' ' LEU . 1.5 m-20 -98.94 114.63 27.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.614 1.965 . . . . 2.2000000000000002 109.935 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.54 125.7 29.92 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.546 -0.721 . . . . 2.3900000000000001 109.816 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt -98.1 128.66 44.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.089 0.956 . . . . 0.62 109.879 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.28 156.78 31.77 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.015 0.926 . . . . 2.0 112.024 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.81 143.34 57.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.953 0.501 . . . . 2.1400000000000001 111.039 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -168.27 53.53 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.0 -0.84 . . . . 2.9399999999999999 111.0 -164.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.45 40.59 2.21 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.806 -0.82 . . . . 1.74 114.379 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -115.84 122.0 44.07 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.047 1.423 . . . . 4.4299999999999997 112.529 -173.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.45 135.49 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.424 1.49 . . . . 1.0700000000000001 108.466 161.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.5 mt -129.81 128.58 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.587 1.155 . . . . 1.5700000000000001 109.204 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -88.34 134.8 33.72 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.87 0.868 . . . . 2.3100000000000001 112.656 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.32 167.37 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.801 0.84 . . . . 1.53 110.514 153.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.74 141.51 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.853 -1.536 . . . . 2.2000000000000002 106.853 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.2 mt -137.44 151.97 72.22 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.632 1.573 . . . . 1.78 110.133 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.71 155.5 44.34 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.627 2.885 . . . . 1.1499999999999999 112.036 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.79 123.34 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.083 0.953 . . . . 1.01 110.823 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.6 149.19 22.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.828 1.651 . . . . 3.4399999999999999 109.233 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.0 23.09 11.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 113.927 1.084 . . . . 2.21 113.927 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.384 1.473 . . . . 7.1500000000000004 112.662 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 CA-C-O 117.686 -1.619 . . . . 10.460000000000001 109.518 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m 62.87 60.56 1.24 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.524 1.162 . . . . 10.800000000000001 111.275 -164.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.301 9.1 m-85 67.08 169.37 0.25 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.939 1.696 . . . . 10.1 112.05 -154.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.61 159.42 1.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.443 -0.799 . . . . 6.6100000000000003 111.251 -136.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -170.56 -167.26 0.58 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.168 2.587 . . . . 5.0300000000000002 109.362 -170.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.75 157.48 27.42 Favored Glycine 0 N--CA 1.469 0.854 0 O-C-N 120.707 -1.246 . . . . 1.51 115.095 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -136.06 144.63 45.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.904 1.281 . . . . 1.72 111.966 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.8 t -102.28 136.86 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.718 -1.216 . . . . 0.88 107.718 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -104.17 106.62 17.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.156 0.982 . . . . 3.7000000000000002 110.187 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.36 147.86 29.72 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.085 1.754 . . . . 2.54 112.401 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -150.95 158.86 34.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.707 1.603 . . . . 1.79 109.805 162.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.43 -15.33 31.11 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.161 2.574 . . . . 1.6699999999999999 113.497 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.4 170.24 14.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.529 1.062 . . . . 1.73 113.0 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.06 -5.56 15.82 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 118.215 1.008 . . . . 1.8899999999999999 113.025 -3.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -122.69 170.06 10.43 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.243 1.817 . . . . 2.2200000000000002 113.997 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.52 -177.21 5.47 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.138 2.175 . . . . 0.79000000000000004 111.319 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.36 154.25 51.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.159 0.89 . . . . 0.89000000000000001 112.19 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.53 157.16 43.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.029 0.918 . . . . 0.71999999999999997 112.806 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -149.62 161.85 41.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.46 1.504 . . . . 2.02 110.356 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -162.5 159.26 24.72 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 112.854 0.687 . . . . 1.49 112.854 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.0 m -83.5 119.65 24.95 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.403 -1.332 . . . . 1.21 107.403 150.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.83 134.52 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 2.5099999999999998 107.452 166.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 6.4 mt-10 -128.39 121.77 29.85 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.957 0.903 . . . . 3.52 110.125 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -95.49 111.94 57.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.308 1.043 . . . . 1.2 109.974 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -86.44 -12.22 5.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.263 2.642 . . . . 0.91000000000000003 113.711 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.36 160.57 42.15 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.108 0.861 . . . . 1.3 112.488 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -90.62 6.78 42.41 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.029 1.732 . . . . 2.9399999999999999 113.616 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.75 157.97 53.16 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.01 1.724 . . . . 1.3400000000000001 110.595 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.99 160.52 30.29 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.229 2.619 . . . . 0.77000000000000002 111.935 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -124.5 124.41 42.22 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.718 1.207 . . . . 2.1000000000000001 111.547 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -118.75 112.0 19.2 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.217 1.407 . . . . 4.0099999999999998 112.791 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.3 tp -100.03 110.23 22.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.897 2.479 . . . . 0.85999999999999999 109.951 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -98.12 -11.94 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.859 1.664 . . . . 0.97999999999999998 112.954 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.5 -159.82 30.79 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 119.097 0.862 . . . . 0.54000000000000004 113.556 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.45 -171.13 3.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.866 1.267 . . . . 1.0 111.164 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -166.43 124.46 1.42 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.674 -1.232 . . . . 5.3600000000000003 107.674 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -138.35 162.08 55.5 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.989 1.316 . . . . 0.89000000000000001 109.494 -167.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.2 -22.71 3.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.636 2.891 . . . . 0.81999999999999995 113.989 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 2.6 m -86.93 -0.77 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 114.393 1.257 . . . . 1.1699999999999999 114.393 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.7 168.19 27.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.089 2.156 . . . . 1.0800000000000001 109.867 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -106.28 -79.22 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.539 1.063 . . . . 3.79 110.737 171.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -75.27 105.31 6.23 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 120.917 -1.115 . . . . 3.25 110.082 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.6 137.69 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.094 1.358 . . . . 1.27 111.262 171.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -132.17 129.49 39.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.239 1.816 . . . . 2.0099999999999998 109.137 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.79 117.15 22.48 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.538 1.161 . . . . 0.75 110.953 168.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 20.2 m170 -105.01 152.63 22.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.197 1.799 . . . . 0.56999999999999995 112.032 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.66 172.7 8.09 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.613 1.165 . . . . 1.9399999999999999 110.228 161.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.565 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 53.0 m -149.05 102.32 3.24 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.392 1.477 . . . . 1.3100000000000001 107.487 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -105.6 162.92 13.08 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.174 1.79 . . . . 2.3900000000000001 112.49 -164.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -102.91 151.1 22.84 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.948 -0.569 . . . . 2.7599999999999998 110.777 151.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -158.97 145.06 16.69 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.754 1.622 . . . . 5.0899999999999999 109.873 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.31 146.86 23.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.258 0.551 . . . . 4.3300000000000001 111.287 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.24 135.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.384 1.874 . . . . 3.2400000000000002 109.309 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 60.13 20.14 9.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.386 1.075 . . . . 4.2199999999999998 112.185 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.96 -3.81 68.89 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.894 1.235 . . . . 2.3100000000000001 113.959 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -99.44 146.24 26.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.156 1.782 . . . . 3.3700000000000001 110.407 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -77.2 131.03 38.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.834 -0.541 . . . . 4.0099999999999998 110.53 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -128.6 153.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.909 1.684 . . . . 1.95 108.841 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.4 mtm -121.03 146.68 46.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.916 . . . . 2.96 110.816 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.58 -177.24 31.48 Favored Glycine 0 N--CA 1.468 0.829 0 C-N-CA 124.346 0.974 . . . . 0.97999999999999998 113.081 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.11 162.0 34.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.24 1.416 . . . . 2.2999999999999998 110.655 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -171.45 151.85 3.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.147 1.379 . . . . 3.6099999999999999 111.45 172.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 35.6 Cg_endo -65.54 146.69 85.46 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.494 2.129 . . . . 0.73999999999999999 111.803 166.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.49 155.79 51.77 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.922 1.689 . . . . 0.56999999999999995 110.237 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.31 -18.62 44.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.674 2.25 . . . . 0.69999999999999996 112.637 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -179.1 167.22 1.58 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 126.676 1.99 . . . . 2.25 110.903 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.69 168.28 9.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.069 1.348 . . . . 0.73999999999999999 109.468 154.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -151.96 161.99 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.822 0.675 . . . . 2.77 112.822 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.29 134.78 24.43 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.952 1.701 . . . . 0.88 108.564 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.71 164.05 32.82 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.062 1.841 . . . . 0.89000000000000001 111.289 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.39 147.52 93.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.094 2.529 . . . . 0.96999999999999997 111.663 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt 68.12 -0.61 2.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.325 1.85 . . . . 1.3100000000000001 113.508 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.69 127.58 9.04 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 127.679 2.561 . . . . 1.0 111.646 -170.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 9.2 ptp180 -98.22 134.61 41.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.974 1.31 . . . . 6.0199999999999996 112.465 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.35 136.29 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.043 . . . . 1.3100000000000001 111.202 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.84 115.68 31.06 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.555 1.542 . . . . 3.3799999999999999 110.352 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -68.15 77.02 0.24 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.746 2.019 . . . . 1.0900000000000001 109.95 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -74.05 138.11 75.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.293 1.437 . . . . 3.3999999999999999 111.773 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.49 -43.33 59.18 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.08 3.187 . . . . 1.1799999999999999 112.757 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.29 89.71 1.11 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.243 -1.543 . . . . 1.27 109.243 161.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.53 -76.2 0.26 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.909 1.719 . . . . 1.25 113.589 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -154.74 142.4 19.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.437 1.895 . . . . 1.98 111.163 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -162.06 167.95 23.49 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.409 -0.807 . . . . 0.93000000000000005 111.692 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.37 127.95 46.55 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.665 0.786 . . . . 1.8500000000000001 110.186 168.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.8 mmt -91.44 132.8 35.98 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.15 0.98 . . . . 0.97999999999999998 110.068 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.7 147.47 35.51 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.612 1.165 . . . . 2.9399999999999999 110.609 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mt -146.43 160.81 41.59 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.135 2.174 . . . . 2.3199999999999998 110.175 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.46 57.61 11.06 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-O 118.917 -0.935 . . . . 2.54 111.152 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 mt -66.98 100.13 0.71 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.382 1.091 . . . . 0.96999999999999997 112.054 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -71.12 -15.08 62.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.452 0.908 . . . . 1.72 113.452 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -128.42 147.0 62.05 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.986 2.114 . . . . 5.7599999999999998 110.95 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.01 145.15 35.17 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.246 1.964 . . . . 1.8999999999999999 108.938 149.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 163.88 35.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.424 1.89 . . . . 2.4300000000000002 111.334 -168.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.01 168.16 19.57 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 118.94 2.941 . . . . 6.9900000000000002 118.94 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.37 133.94 23.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.412 1.885 . . . . 1.72 112.406 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 2.34 88.45 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.988 -1.451 . . . . 2.2799999999999998 114.727 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.69 159.84 23.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.788 1.794 . . . . 2.8900000000000001 111.333 170.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -108.66 128.18 54.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.492 1.917 . . . . 3.6299999999999999 109.13 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.41 103.72 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.574 1.15 . . . . 0.90000000000000002 109.545 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -63.25 126.94 29.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.579 -0.897 . . . . 2.9700000000000002 108.579 157.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.9 144.92 27.19 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.248 -0.907 . . . . 1.8700000000000001 110.501 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -94.03 138.64 31.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.487 2.715 . . . . 3.5899999999999999 110.156 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.8 mt -110.77 125.46 53.57 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.397 2.279 . . . . 1.28 109.908 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.2 mt -98.59 124.15 43.2 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.883 0.873 . . . . 0.73999999999999999 111.633 -170.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.76 141.82 49.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.242 1.201 . . . . 1.99 114.242 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.65 88.68 0.71 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.879 1.272 . . . . 2.4199999999999999 111.145 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.74 67.57 0.12 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.051 1.31 . . . . 4.0199999999999996 113.165 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.3 17.41 72.26 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 116.59 1.396 . . . . 1.55 116.59 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.04 114.22 20.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.038 1.419 . . . . 3.6600000000000001 112.005 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.37 136.59 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.835 2.454 . . . . 2.46 105.863 146.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.4 mt -144.92 119.63 9.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.198 0.999 . . . . 2.0099999999999998 109.569 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -90.27 146.6 24.1 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.007 1.114 . . . . 4.1500000000000004 114.007 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.6 m -135.17 152.18 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.352 1.861 . . . . 1.29 110.034 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.3 p -106.56 132.36 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.132 0.973 . . . . 1.55 109.553 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.9 mt -135.07 134.95 22.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.428 1.491 . . . . 1.8200000000000001 110.239 -171.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.62 151.28 79.55 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.984 2.456 . . . . 0.94999999999999996 113.5 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.99 119.75 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.886 1.275 . . . . 0.93999999999999995 110.873 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -90.32 149.37 22.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.872 2.069 . . . . 3.5499999999999998 108.892 156.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.25 4.66 4.06 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 116.222 1.934 . . . . 3.0699999999999998 116.222 -155.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.784 1.634 . . . . 7.5300000000000002 112.542 -168.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.27 0 N-CA-C 107.77 -2.132 . . . . 15.529999999999999 107.77 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 m -155.72 166.99 31.84 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.68 1.24 . . . . 12.390000000000001 110.182 -164.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -174.41 144.0 0.88 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.106 2.162 . . . . 12.01 108.64 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.9 m -94.53 -45.58 7.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.536 0.734 . . . . 7.9500000000000002 111.437 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -170.84 -137.27 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.251 2.22 . . . . 5.9000000000000004 107.559 -162.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.42 137.11 9.21 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 120.961 1.71 . . . . 1.8799999999999999 114.202 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -128.1 127.07 42.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.473 1.13 . . . . 2.02 111.957 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.74 95.21 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.81 -1.552 . . . . 1.52 106.81 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.42 105.82 9.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.575 1.178 . . . . 3.3100000000000001 110.238 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -74.03 159.81 32.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.631 1.572 . . . . 2.46 112.55 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.416 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 75.6 m -149.71 159.25 36.45 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.29 1.836 . . . . 2.7999999999999998 110.691 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.47 -2.86 12.4 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.369 2.712 . . . . 1.75 114.879 -171.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 167.61 27.95 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.33 0.967 . . . . 1.3300000000000001 112.83 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.82 -2.65 18.35 Favored 'Cis proline' 0 CA--C 1.541 0.833 0 CA-C-N 118.579 1.19 . . . . 1.74 112.91 -4.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.39 169.84 13.81 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.047 1.739 . . . . 2.23 113.791 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.22 171.81 18.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.377 2.271 . . . . 0.90000000000000002 111.586 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.96 120.45 31.62 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.761 0.824 . . . . 1.1399999999999999 110.668 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.02 32.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.567 0.747 . . . . 0.79000000000000004 111.83 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.88 162.92 31.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.395 1.478 . . . . 2.04 111.137 -174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.07 143.6 3.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 115.635 1.717 . . . . 1.6299999999999999 115.635 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -69.96 87.88 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.205 -1.035 . . . . 1.27 108.205 160.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 tt -75.27 143.55 42.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.928 -0.768 . . . . 2.9300000000000002 108.928 169.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -125.98 143.45 51.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.52 0.676 . . . . 3.27 112.044 170.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.67 100.9 13.54 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.99 -1.005 . . . . 0.97999999999999998 109.193 161.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.96 -7.77 15.44 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.587 2.192 . . . . 1.1699999999999999 112.624 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.56 179.73 51.46 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.802 1.192 . . . . 1.24 113.486 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.98 -3.18 20.4 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.272 1.829 . . . . 3.04 113.044 -171.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.02 162.67 28.35 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.367 1.867 . . . . 1.3300000000000001 109.682 167.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.34 154.29 21.53 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.832 2.355 . . . . 1.04 112.672 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.0 mt -104.05 126.88 51.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.016 0.926 . . . . 2.0 110.832 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.57 109.02 20.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.03 -0.986 . . . . 3.2999999999999998 110.304 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.2 tp -95.14 120.58 35.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.736 2.014 . . . . 0.81000000000000005 108.598 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.01 -14.72 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.684 0.794 . . . . 0.59999999999999998 112.453 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.49 -167.95 40.13 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 121.789 0.661 . . . . 0.40000000000000002 113.139 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.52 176.9 8.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 0.80000000000000004 109.393 159.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -157.43 145.41 19.03 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 106.425 -1.694 . . . . 6.4900000000000002 106.425 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -149.13 155.27 40.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.359 1.064 . . . . 0.84999999999999998 108.149 -164.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.04 -26.78 36.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.857 2.371 . . . . 1.27 112.749 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -78.16 -12.24 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 114.415 1.265 . . . . 1.25 114.415 -171.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.06 156.23 46.68 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.897 1.279 . . . . 0.83999999999999997 111.818 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -102.54 -62.87 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.014 0.526 . . . . 3.5699999999999998 110.753 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -79.16 146.57 33.06 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.768 -0.827 . . . . 4.0899999999999999 108.768 165.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.79 133.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.748 1.619 . . . . 1.5800000000000001 108.329 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -140.89 129.27 22.45 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.711 1.604 . . . . 2.1400000000000001 109.351 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.22 123.01 29.66 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.995 1.271 . . . . 0.77000000000000002 110.648 167.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -111.33 159.96 17.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.177 1.791 . . . . 0.53000000000000003 112.256 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -116.51 179.19 4.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.188 2.195 . . . . 2.1200000000000001 111.034 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -131.22 133.14 45.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.707 1.603 . . . . 1.6200000000000001 107.713 166.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -125.7 150.92 47.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.349 1.059 . . . . 1.95 111.94 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.2 ptp -84.74 153.7 22.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.715 1.606 . . . . 4.3700000000000001 110.433 167.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -153.79 34.54 0.44 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.061 1.504 . . . . 6.0999999999999996 115.061 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -56.74 146.78 24.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.647 1.579 . . . . 5.25 113.268 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -156.4 136.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.622 2.369 . . . . 6.2000000000000002 105.416 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 60.89 23.43 13.48 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.813 0.816 . . . . 5.8600000000000003 111.68 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.72 0.35 24.84 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 119.916 -1.74 . . . . 4.4500000000000002 114.862 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -86.42 132.88 33.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.507 1.923 . . . . 3.5 108.836 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.74 142.86 29.76 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.401 1.26 . . . . 7.1600000000000001 114.401 -166.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -155.37 138.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.443 1.897 . . . . 2.0899999999999999 108.618 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 ptp -141.21 138.92 33.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.46 0.704 . . . . 3.1499999999999999 111.126 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.52 175.74 20.79 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 124.623 1.106 . . . . 0.97999999999999998 112.451 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.5 mtt -128.45 156.79 42.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.787 1.635 . . . . 2.3799999999999999 110.78 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -167.93 154.79 7.6 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 125.149 1.379 . . . . 3.6899999999999999 111.441 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.3 Cg_endo -70.23 151.2 66.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.011 1.807 . . . . 0.56000000000000005 112.221 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.0 156.78 54.17 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.748 2.019 . . . . 0.65000000000000002 110.614 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.49 -16.0 27.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.954 2.436 . . . . 0.75 113.113 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.4 p90 179.14 170.72 0.93 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.027 2.131 . . . . 2.52 110.321 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.0 174.69 7.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.679 2.392 . . . . 0.75 108.933 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -152.8 164.42 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.028 -1.045 . . . . 2.27 112.535 164.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 t -138.86 128.83 14.67 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.524 1.53 . . . . 1.04 109.58 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.58 163.41 39.07 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.506 2.137 . . . . 1.1899999999999999 111.69 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.9 138.18 84.18 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.503 2.802 . . . . 1.22 112.055 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt 68.92 2.64 3.63 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.966 2.106 . . . . 1.52 113.708 -175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.11 114.1 3.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 125.85 1.691 . . . . 1.3100000000000001 111.269 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -93.18 125.81 37.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.391 1.077 . . . . 8.0600000000000005 109.32 162.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.5 m -145.44 130.18 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.219 1.008 . . . . 1.5600000000000001 111.296 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.85 132.93 34.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.197 0.999 . . . . 6.9299999999999997 111.248 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.27 60.34 3.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.018 1.866 . . . . 1.8 111.979 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -47.94 133.91 11.56 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 128.038 2.535 . . . . 3.6800000000000002 113.27 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.2 -51.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.325 2.684 . . . . 1.6200000000000001 111.99 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.65 94.98 1.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.264 -1.535 . . . . 1.5700000000000001 109.264 166.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -76.96 0.29 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.993 1.758 . . . . 1.3400000000000001 113.008 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -158.03 130.55 7.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.6 1.56 . . . . 2.1099999999999999 111.299 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -162.13 173.3 14.51 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.938 1.699 . . . . 0.75 111.977 -166.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.95 120.5 41.6 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.742 -0.599 . . . . 2.0499999999999998 112.078 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 mmt -84.75 121.49 27.76 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.233 1.013 . . . . 0.95999999999999996 109.854 164.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -106.02 131.14 53.66 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.223 1.409 . . . . 1.72 108.496 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -140.07 142.37 36.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.791 0.836 . . . . 2.1099999999999999 111.133 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 60.45 4.37 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 109.042 -1.623 . . . . 2.4199999999999999 109.042 -166.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -65.66 127.57 32.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.32 1.06 . . . . 1.02 108.998 172.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -106.3 12.64 29.71 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 1.73 112.89 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -162.33 153.21 14.69 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.811 1.644 . . . . 5.96 110.919 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.94 163.45 39.17 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.921 2.414 . . . . 2.27 109.378 159.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mp -133.93 162.77 31.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.104 0.954 . . . . 3.3500000000000001 112.139 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -119.36 120.01 35.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.888 2.075 . . . . 5.7400000000000002 110.478 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.06 118.29 4.52 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.85 -1.156 . . . . 2.5800000000000001 109.79 168.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.94 48.09 22.25 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.719 -0.489 . . . . 2.2999999999999998 112.761 -167.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.28 -168.33 1.32 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 107.53 -1.285 . . . . 2.7599999999999998 107.53 140.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -128.85 155.53 45.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 4.3899999999999997 111.639 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.08 118.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.685 1.594 . . . . 1.6200000000000001 108.938 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.42 138.9 39.54 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.524 0.729 . . . . 3.46 110.021 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.413 HD23 ' C ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -155.3 143.02 19.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.873 1.269 . . . . 1.99 110.912 -168.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -89.82 110.36 21.29 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 128.995 2.918 . . . . 3.0299999999999998 110.323 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.43 113.08 21.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.426 1.012 . . . . 1.5600000000000001 109.372 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.2 mt -93.6 123.47 36.94 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.043 0.937 . . . . 0.57999999999999996 110.772 -166.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -124.58 137.64 54.38 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.427 -0.796 . . . . 2.2599999999999998 112.571 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.98 130.89 30.74 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.614 1.166 . . . . 1.8500000000000001 113.164 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.5 -150.17 20.59 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.367 -1.093 . . . . 3.48 110.367 -163.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.29 28.02 9.56 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.402 1.001 . . . . 2.0800000000000001 114.715 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mppt? -100.38 135.38 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.722 1.761 . . . . 5.25 112.084 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.88 138.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.763 1.225 . . . . 1.29 109.454 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -116.41 104.87 11.89 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.837 0.855 . . . . 1.6200000000000001 109.319 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.22 114.03 17.83 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 3.46 109.36 174.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.09 150.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.093 1.357 . . . . 3.2400000000000002 112.546 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.75 142.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.051 1.74 . . . . 2.1299999999999999 111.904 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -142.5 146.1 37.4 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.086 1.755 . . . . 3.0899999999999999 110.55 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.8 152.53 69.14 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.823 3.015 . . . . 1.8600000000000001 113.007 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.6 t -93.81 127.04 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.938 1.295 . . . . 1.5600000000000001 110.746 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.64 -177.7 3.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.376 1.47 . . . . 5.3600000000000003 109.186 165.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.25 154.2 31.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 119.769 -1.832 . . . . 2.5299999999999998 114.027 -164.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 125.918 1.687 . . . . 5.8799999999999999 113.448 156.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 107.346 -2.302 . . . . 13.23 107.346 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 p 170.05 173.51 0.06 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.425 1.112 . . . . 10.289999999999999 110.164 -150.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -56.04 168.61 0.47 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.635 1.174 . . . . 8.1400000000000006 111.991 167.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.3 m -153.26 162.91 40.78 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.693 1.597 . . . . 7.5899999999999999 107.913 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -115.4 -147.57 0.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.648 1.179 . . . . 4.7400000000000002 111.019 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -161.28 170.39 37.06 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 120.556 -1.34 . . . . 1.29 114.183 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -157.87 147.79 20.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.292 1.037 . . . . 1.54 111.935 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -93.45 121.62 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.146 -0.971 . . . . 1.1100000000000001 108.809 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -63.46 -29.84 71.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.749 1.62 . . . . 4.8499999999999996 113.719 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.99 -179.74 0.22 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.221 2.208 . . . . 2.2999999999999998 112.692 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m 176.25 165.84 0.44 Allowed Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 128.751 2.82 . . . . 1.8899999999999999 108.575 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.27 5.65 3.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.248 2.632 . . . . 2.1600000000000001 113.726 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.5 170.66 36.04 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.35 0.976 . . . . 2.3599999999999999 112.333 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.86 -6.48 33.06 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 CA-C-N 118.612 1.206 . . . . 2.8100000000000001 113.66 -5.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -135.42 171.84 13.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.962 2.105 . . . . 5.6600000000000001 110.804 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.62 -168.3 1.14 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.785 2.434 . . . . 1.3 112.21 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.23 166.97 24.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.317 1.847 . . . . 1.3799999999999999 111.786 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.33 159.32 42.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.647 1.179 . . . . 0.92000000000000004 114.067 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -141.53 156.77 45.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.665 2.386 . . . . 2.0 110.942 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.415 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.2 pp -175.04 167.69 3.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.286 1.217 . . . . 2.1299999999999999 114.286 -174.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.3 m -124.7 137.48 54.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.775 1.63 . . . . 1.54 109.033 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.4 tp -131.14 156.4 45.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.152 1.381 . . . . 4.4699999999999998 110.849 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -130.58 129.49 42.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.3 -1.0 . . . . 3.9700000000000002 108.3 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -94.75 105.8 20.84 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.634 1.174 . . . . 1.04 109.162 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.66 -8.98 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.729 2.286 . . . . 0.98999999999999999 113.637 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.06 156.21 43.44 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 118.942 0.792 . . . . 1.28 112.693 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.3 m-20 -88.26 7.67 31.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.978 1.711 . . . . 3.21 113.209 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.02 158.84 43.13 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.999 1.72 . . . . 1.3899999999999999 110.64 166.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.31 156.9 25.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.304 2.669 . . . . 0.80000000000000004 110.782 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.5 mt -107.18 151.45 25.4 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.706 -0.621 . . . . 1.8500000000000001 110.58 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -128.68 112.38 14.17 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.641 1.176 . . . . 4.7999999999999998 109.572 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.06 127.54 42.16 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.122 1.769 . . . . 0.91000000000000003 109.228 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -116.33 -14.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.444 0.905 . . . . 0.65000000000000002 113.444 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.27 -165.57 35.0 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 121.626 -0.671 . . . . 0.53000000000000003 112.514 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -137.5 -179.4 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.249 1.02 . . . . 0.84999999999999998 110.356 167.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -159.95 145.21 15.23 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.945 -1.872 . . . . 6.4199999999999999 105.945 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.75 156.06 26.18 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 119.088 0.858 . . . . 1.0600000000000001 109.97 -159.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.71 -37.17 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.341 2.027 . . . . 0.90000000000000002 112.465 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.52 -10.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 115.236 1.569 . . . . 1.3500000000000001 115.236 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 163.29 32.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.285 1.434 . . . . 0.79000000000000004 110.374 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -105.23 -77.76 0.58 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.315 1.046 . . . . 3.6699999999999999 109.881 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -79.46 104.29 9.97 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.757 0.823 . . . . 3.4199999999999999 110.467 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -110.18 137.61 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.126 1.37 . . . . 1.28 110.587 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -141.23 128.46 20.97 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.499 1.52 . . . . 2.2799999999999998 111.41 -170.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.59 122.83 28.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.76 0.791 . . . . 0.75 111.691 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.5 OUTLIER -104.91 151.42 23.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.686 1.594 . . . . 0.93999999999999995 114.173 172.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.11 165.87 14.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.613 1.965 . . . . 2.1299999999999999 110.937 160.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.2 m -148.76 112.96 5.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.512 1.525 . . . . 1.8400000000000001 107.952 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -126.02 171.5 10.74 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.934 1.294 . . . . 2.7000000000000002 112.598 -163.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.0 mtm -124.3 118.27 26.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.851 1.26 . . . . 4.8600000000000003 110.053 161.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -153.04 159.73 42.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.058 1.343 . . . . 6.71 110.651 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -64.34 147.89 51.56 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.322 1.449 . . . . 4.29 112.518 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.21 -18.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.497 1.295 . . . . 3.6000000000000001 114.497 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -155.93 33.13 0.35 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.938 2.095 . . . . 3.3900000000000001 108.96 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.79 -25.21 0.64 Allowed Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.235 -1.541 . . . . 2.6200000000000001 113.141 -160.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -80.34 139.32 36.63 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.305 2.242 . . . . 2.4100000000000001 109.2 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -76.45 144.63 39.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.612 0.642 . . . . 4.2800000000000002 112.667 169.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.37 164.79 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 3.1899999999999999 109.798 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.7 mtm -78.46 154.2 30.79 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 4.0599999999999996 111.081 168.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.2 166.47 38.8 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 121.738 -0.601 . . . . 1.5900000000000001 113.668 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.6 149.8 46.93 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.88 1.272 . . . . 1.8500000000000001 110.831 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -158.62 152.04 19.01 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-O 117.133 -1.413 . . . . 3.4500000000000002 110.428 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 47.5 Cg_endo -69.03 148.27 69.44 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.177 1.918 . . . . 0.79000000000000004 111.412 162.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.58 152.33 68.66 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 125.44 1.496 . . . . 0.65000000000000002 110.582 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.13 -6.79 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.885 2.39 . . . . 1.05 113.477 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -176.69 159.91 1.89 Allowed 'General case' 0 C--N 1.348 0.508 0 C-N-CA 125.222 1.409 . . . . 2.2999999999999998 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -111.19 175.7 5.32 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.88 1.672 . . . . 0.85999999999999999 109.194 152.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.39 167.18 31.23 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.807 -1.183 . . . . 2.98 110.291 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -144.18 136.89 13.57 Favored Pre-proline 0 C--N 1.328 -0.367 0 C-N-CA 124.21 1.004 . . . . 0.98999999999999999 108.762 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 167.38 25.4 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.571 1.514 . . . . 1.0 111.373 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.36 143.9 99.58 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.217 2.611 . . . . 0.98999999999999999 111.003 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 14.9 mmmt 66.25 4.12 3.03 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.448 1.499 . . . . 1.51 112.797 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.92 3.74 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 127.403 2.43 . . . . 1.0800000000000001 112.857 -170.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 118.37 31.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.535 1.534 . . . . 5.0 109.772 172.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.11 147.03 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 120.465 1.484 . . . . 1.51 114.403 -166.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 131.62 54.37 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.805 1.242 . . . . 3.48 112.826 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.94 71.64 0.54 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.464 1.505 . . . . 1.3899999999999999 109.929 157.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -78.0 144.3 67.58 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.939 1.696 . . . . 3.6400000000000001 112.688 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.1 -23.16 72.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.546 2.83 . . . . 1.6499999999999999 114.644 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.74 38.78 3.04 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.248 1.404 . . . . 1.45 113.02 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.95 -58.74 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 CA-C-N 118.581 1.19 . . . . 1.3899999999999999 114.948 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -155.12 144.2 20.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.975 1.71 . . . . 2.2999999999999998 110.395 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -164.0 173.84 12.11 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.798 -1.189 . . . . 0.87 110.213 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 54.0 m-85 -108.95 135.42 50.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.093 0.557 . . . . 2.2000000000000002 110.182 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 mmt -85.08 140.69 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.673 0.789 . . . . 1.3200000000000001 109.955 156.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.3 mt -122.8 112.28 17.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 1.71 108.375 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -111.21 140.96 45.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.836 1.654 . . . . 2.8599999999999999 108.436 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.02 72.95 0.91 Allowed Glycine 0 N--CA 1.471 0.968 0 O-C-N 121.206 -0.934 . . . . 2.5699999999999998 111.097 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.79 104.24 4.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 122.523 1.154 . . . . 1.0 110.13 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -82.83 13.94 3.56 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 2.4300000000000002 113.008 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -147.07 159.07 43.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.694 1.998 . . . . 4.7000000000000002 110.392 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.45 163.29 39.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.584 2.189 . . . . 1.76 109.6 152.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -141.92 162.48 35.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.754 1.222 . . . . 2.5099999999999998 110.781 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.12 109.19 2.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.105 1.762 . . . . 3.3100000000000001 109.574 -175.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.04 126.08 24.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.93 -1.106 . . . . 2.29 110.26 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.29 7.42 40.38 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.762 -1.021 . . . . 1.8999999999999999 114.562 -165.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -107.13 -170.82 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.263 1.531 . . . . 2.8599999999999999 110.057 147.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -125.9 165.06 19.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.857 1.663 . . . . 3.3199999999999998 110.509 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.56 116.7 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.115 1.366 . . . . 1.3300000000000001 108.446 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.92 144.59 33.24 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.77 -1.105 . . . . 3.4199999999999999 111.213 167.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.643 HD21 ' HB1' ' A' ' 35' ' ' ALA . 3.0 tt -155.6 132.9 10.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.988 0.899 . . . . 1.48 110.527 -167.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -86.5 101.51 13.25 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.874 3.27 . . . . 2.6800000000000002 111.363 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.99 111.77 17.77 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.273 -1.517 . . . . 1.3100000000000001 109.575 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.28 125.71 35.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.391 1.476 . . . . 0.56999999999999995 110.1 -166.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.84 153.08 31.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.005 0.522 . . . . 2.2599999999999998 112.027 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.43 128.77 37.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.062 0.545 . . . . 1.95 110.398 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 -153.97 30.35 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.475 0.559 . . . . 2.8900000000000001 111.878 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.15 54.32 4.85 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.932 -0.927 . . . . 2.25 114.434 -169.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -143.78 147.12 33.71 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.293 1.546 . . . . 4.0899999999999999 115.057 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.83 131.72 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 128.19 2.596 . . . . 1.0700000000000001 108.171 166.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.42 101.46 7.97 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.028 1.331 . . . . 2.5099999999999998 108.031 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.26 133.6 33.82 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.466 -0.771 . . . . 2.5899999999999999 112.727 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.7 m -140.94 153.45 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.061 1.744 . . . . 1.28 110.986 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.88 128.49 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.836 1.254 . . . . 2.04 111.188 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.9 155.33 60.71 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.272 1.829 . . . . 3.1600000000000001 110.3 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.0 152.38 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.929 2.42 . . . . 1.1000000000000001 111.125 168.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.58 116.41 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.569 -1.641 . . . . 1.1699999999999999 106.569 161.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -127.97 118.92 24.43 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.877 -1.527 . . . . 3.8199999999999998 106.877 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.62 118.36 16.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.791 -0.818 . . . . 2.6200000000000001 108.791 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 117.952 -1.023 . . . . 9.25 113.174 176.737 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.057 0 N-CA-C 107.801 -2.12 . . . . 13.84 107.801 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 t -169.58 -142.98 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.505 1.522 . . . . 10.83 107.283 -171.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -62.02 105.9 0.64 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.441 1.018 . . . . 9.3699999999999992 110.464 166.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.9 m -63.34 148.33 48.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.987 1.315 . . . . 6.79 108.785 166.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -141.49 144.47 34.39 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.012 1.325 . . . . 6.0800000000000001 107.726 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . 140.27 172.47 12.88 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.592 1.568 . . . . 1.6000000000000001 113.521 174.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -155.52 155.28 33.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.38 1.072 . . . . 2.3300000000000001 111.585 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.63 119.2 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.592 -0.892 . . . . 1.1499999999999999 108.592 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.28 108.74 16.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.557 0.743 . . . . 4.0300000000000002 109.687 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 136.41 48.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 2.5600000000000001 110.427 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.2 t -131.22 156.03 80.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.486 1.914 . . . . 2.6299999999999999 109.222 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.01 -10.38 28.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.872 2.381 . . . . 1.9099999999999999 112.717 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.53 -174.36 15.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.624 1.583 . . . . 1.6399999999999999 112.166 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -76.71 -0.58 23.69 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 118.306 1.053 . . . . 1.6100000000000001 112.629 -8.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -149.65 178.05 9.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.848 1.659 . . . . 1.8600000000000001 111.191 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.0 -166.22 1.53 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.529 1.931 . . . . 0.76000000000000001 112.42 -172.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.74 154.57 34.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.716 1.206 . . . . 0.85999999999999999 111.761 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.13 46.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.297 1.439 . . . . 0.67000000000000004 111.281 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -136.13 148.54 48.27 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.484 1.914 . . . . 2.1899999999999999 109.011 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.8 pp -171.6 155.92 4.22 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.803 0.841 . . . . 1.6699999999999999 112.741 -171.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.424 HG21 ' CZ ' ' A' ' 74' ' ' ARG . 25.0 m -97.71 136.59 37.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.486 -1.234 . . . . 1.3200000000000001 111.827 166.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 23' ' ' GLU . 6.7 tt -112.65 149.3 33.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.873 2.469 . . . . 2.79 109.083 173.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 22' ' ' LEU . 8.0 pt-20 -148.89 120.36 7.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.127 0.965 . . . . 2.7599999999999998 112.89 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -90.14 115.36 63.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.722 1.209 . . . . 1.0700000000000001 110.233 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -86.52 -8.69 7.17 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.155 2.57 . . . . 0.95999999999999996 113.441 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.72 169.29 54.65 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.006 0.812 . . . . 0.97999999999999998 113.722 -172.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.08 -2.24 50.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.489 1.916 . . . . 2.8799999999999999 112.702 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.27 161.15 32.85 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 126.221 1.809 . . . . 1.1899999999999999 110.299 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.03 161.54 23.63 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.05 2.5 . . . . 0.68000000000000005 111.184 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.02 150.52 28.41 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.552 0.741 . . . . 1.8600000000000001 110.48 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -125.52 114.6 19.0 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.231 1.012 . . . . 4.0499999999999998 109.532 167.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -90.85 119.43 31.05 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.822 2.449 . . . . 0.93000000000000005 109.095 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.17 -8.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.54 1.136 . . . . 0.63 113.931 -171.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -162.03 32.31 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.512 -0.742 . . . . 0.46999999999999997 112.275 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.59 -172.0 3.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.488 1.115 . . . . 1.02 111.219 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -148.22 143.88 27.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.789 2.036 . . . . 5.8899999999999997 105.506 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -149.05 153.73 38.54 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.409 1.004 . . . . 0.88 109.339 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.43 -43.46 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.514 2.809 . . . . 1.3700000000000001 111.696 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.281 1.1 m -76.46 -5.23 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.416 1.636 . . . . 1.02 115.416 -170.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.1 -175.91 4.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.601 1.56 . . . . 1.1699999999999999 110.751 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -132.92 -60.94 0.85 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.156 0.889 . . . . 4.6799999999999997 111.721 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -65.02 129.93 41.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.395 -1.335 . . . . 3.0499999999999998 107.395 158.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.89 117.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.454 -1.684 . . . . 1.8200000000000001 106.454 171.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -138.76 115.65 10.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.635 -1.166 . . . . 2.8300000000000001 109.013 -155.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.446 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 6.1 tt -78.04 120.66 23.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.216 1.008 . . . . 0.78000000000000003 110.546 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -107.47 150.0 27.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.84 1.656 . . . . 0.52000000000000002 112.222 177.131 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.74 168.55 19.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.843 -1.526 . . . . 2.4700000000000002 110.306 159.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -143.65 86.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.882 -1.525 . . . . 1.29 106.882 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -94.14 153.41 18.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.177 1.791 . . . . 1.98 112.373 -164.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 ttp -91.74 137.68 32.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.389 1.476 . . . . 2.7799999999999998 110.003 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -153.53 122.78 6.58 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.377 0.671 . . . . 5.4800000000000004 111.461 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.06 155.28 17.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.845 1.258 . . . . 5.7400000000000002 110.133 169.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.37 127.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.91 . . . . 3.71 110.678 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 58.72 26.4 14.58 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.317 1.056 . . . . 4.96 111.053 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.43 1.19 57.03 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 119.825 -1.797 . . . . 3.3100000000000001 114.379 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -92.84 143.19 26.52 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.032 1.733 . . . . 3.5299999999999998 109.488 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.27 130.22 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.754 1.622 . . . . 6.1799999999999997 112.607 -164.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.05 169.5 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 122.387 1.089 . . . . 2.0499999999999998 113.044 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 14.6 tpp -137.48 160.91 37.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.913 2.885 . . . . 2.9399999999999999 107.938 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.07 169.31 33.12 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.562 1.074 . . . . 1.24 114.078 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.11 139.48 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.433 1.493 . . . . 1.8899999999999999 109.598 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -154.6 145.38 16.2 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 125.652 1.581 . . . . 3.5499999999999998 109.531 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 40.3 Cg_endo -65.39 143.25 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.967 1.778 . . . . 0.80000000000000004 110.657 165.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.64 156.16 42.82 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.691 1.596 . . . . 0.57999999999999996 110.663 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.75 -14.66 33.11 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.919 2.413 . . . . 0.72999999999999998 113.369 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -177.16 162.17 1.95 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.574 1.55 . . . . 1.9399999999999999 110.816 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mt -109.48 171.08 7.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.673 1.189 . . . . 0.68000000000000005 108.682 149.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -155.57 165.09 37.63 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.03 -1.044 . . . . 2.3500000000000001 111.774 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.87 136.36 11.67 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.841 0.857 . . . . 0.98999999999999999 109.516 -161.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.83 169.58 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.715 1.61 . . . . 0.85999999999999999 111.429 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.78 143.9 94.53 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.172 2.581 . . . . 0.75 111.26 163.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt 67.31 0.57 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.524 1.53 . . . . 1.29 114.215 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.16 113.7 3.68 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 126.01 1.767 . . . . 0.93999999999999995 112.869 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' CZ ' HG21 ' A' ' 21' ' ' THR . 23.1 ttt85 -81.04 133.2 35.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.082 -1.059 . . . . 4.6100000000000003 109.746 154.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.95 134.16 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.624 1.569 . . . . 1.3700000000000001 110.597 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.1 118.02 25.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.127 -1.064 . . . . 4.6699999999999999 108.127 -160.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.54 73.11 1.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.236 1.493 . . . . 1.4299999999999999 111.87 -169.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -55.24 116.88 12.68 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.226 1.41 . . . . 4.9800000000000004 110.347 168.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.21 -30.37 88.33 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.24 2.627 . . . . 1.3500000000000001 114.108 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.89 41.68 1.75 Allowed Glycine 0 CA--C 1.533 1.181 0 CA-C-N 118.858 0.754 . . . . 1.9399999999999999 112.791 167.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.33 -49.82 0.04 OUTLIER Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.954 2.216 . . . . 1.47 113.609 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -151.26 146.89 26.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.691 1.596 . . . . 2.1899999999999999 112.049 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -156.48 167.41 30.54 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.735 1.214 . . . . 1.1200000000000001 110.983 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.446 ' CZ ' HD12 ' A' ' 45' ' ' LEU . 31.7 m-85 -105.83 117.8 34.95 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.704 -0.85 . . . . 1.9099999999999999 108.704 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.87 133.08 34.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.975 0.51 . . . . 1.22 110.258 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.71 133.39 53.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.854 1.662 . . . . 1.9099999999999999 111.659 -172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -142.91 157.97 44.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.758 1.223 . . . . 2.02 112.028 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -43.76 2.66 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 124.759 1.171 . . . . 2.27 112.129 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt 47.37 71.83 0.3 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.975 2.51 . . . . 1.28 113.706 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -69.67 -1.7 9.71 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.032 1.123 . . . . 2.3300000000000001 114.032 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 97' ' ' GLU . 10.3 mtp85 -125.45 142.36 41.53 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 126.308 1.843 . . . . 5.8399999999999999 109.053 172.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.22 124.12 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 107.245 -1.867 . . . . 1.95 107.245 145.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.578 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.5 pt? -127.21 157.54 39.52 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.675 1.99 . . . . 2.96 111.164 -163.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -165.11 142.69 6.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.527 1.306 . . . . 8.0999999999999996 114.527 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 124.86 19.1 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.279 -0.888 . . . . 1.8799999999999999 109.669 164.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.24 -12.25 14.26 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.94 -1.478 . . . . 1.8600000000000001 113.363 -161.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 91' ' ' ARG . 6.7 pt-20 -106.1 172.68 6.68 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.162 1.481 . . . . 3.8700000000000001 110.828 155.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.5 155.18 46.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.529 1.532 . . . . 4.75 108.959 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.66 110.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.582 1.153 . . . . 1.3300000000000001 108.975 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.35 129.41 38.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.534 -0.913 . . . . 4.3899999999999997 108.534 153.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -134.63 140.03 45.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.578 1.151 . . . . 1.8600000000000001 108.761 172.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.3 103.41 12.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.996 2.519 . . . . 3.3500000000000001 110.587 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.38 125.18 28.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.731 1.613 . . . . 1.29 110.813 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.5 mt -93.18 129.86 39.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.654 1.182 . . . . 0.75 111.565 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -127.74 119.97 26.91 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.38 0.672 . . . . 2.1499999999999999 112.295 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.51 27.9 0.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.975 2.11 . . . . 2.5099999999999998 114.784 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.57 -53.38 1.57 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.741 1.638 . . . . 3.9100000000000001 113.104 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.68 3.71 63.04 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 117.036 1.574 . . . . 1.8 117.036 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 150.36 44.08 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.112 1.956 . . . . 3.9100000000000001 111.316 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.31 136.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.854 1.662 . . . . 1.0800000000000001 109.205 166.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.7 mt -146.18 132.56 19.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.501 1.521 . . . . 1.54 109.499 -172.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.1 ptmt -102.1 158.56 16.08 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.951 1.834 . . . . 2.8799999999999999 115.951 -169.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.21 147.21 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.605 1.962 . . . . 2.4199999999999999 109.915 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -107.55 133.71 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.115 1.366 . . . . 2.9399999999999999 111.247 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 mt -140.44 131.38 13.92 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 127.059 2.144 . . . . 2.1499999999999999 109.365 -165.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.35 151.47 71.39 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.318 2.678 . . . . 1.6200000000000001 112.146 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.42 125.85 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.53 0.681 . . . . 1.46 112.087 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.48 148.32 24.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.086 2.154 . . . . 4.96 109.838 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.33 129.62 54.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.919 -1.039 . . . . 2.0299999999999998 109.395 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 131.365 3.866 . . . . 6.8200000000000003 107.677 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 109.119 -1.592 . . . . 16.890000000000001 109.119 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -142.63 152.74 42.79 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.246 1.018 . . . . 13.539999999999999 109.212 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -161.88 -4.88 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.752 1.39 . . . . 12.970000000000001 114.752 -167.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.9 p -89.95 103.29 15.96 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.114 0.965 . . . . 7.4900000000000002 109.916 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -85.13 128.27 34.59 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.578 0.751 . . . . 5.8200000000000003 110.749 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.19 175.3 47.59 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 115.455 0.942 . . . . 1.29 115.455 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -156.23 123.65 5.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.034 1.334 . . . . 1.6100000000000001 113.094 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.33 153.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 120.75 -1.219 . . . . 1.1599999999999999 108.823 164.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -110.15 -19.19 13.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 116.438 2.014 . . . . 6.6399999999999997 116.438 -168.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 60.79 173.42 0.1 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.401 1.48 . . . . 2.1200000000000001 112.781 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.29 171.8 0.5 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.947 2.899 . . . . 1.79 109.657 171.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.97 -0.41 9.0 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.301 2.667 . . . . 1.71 113.78 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 174.23 33.69 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.93 1.252 . . . . 1.78 112.418 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.23 -5.37 34.2 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 118.596 1.198 . . . . 2.0600000000000001 112.998 -4.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -130.4 177.23 7.5 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.989 1.716 . . . . 1.8899999999999999 112.767 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -168.63 -168.8 0.94 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.789 2.436 . . . . 0.79000000000000004 110.64 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.45 167.92 17.84 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.848 1.659 . . . . 1.1699999999999999 112.15 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.14 149.72 31.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.525 1.53 . . . . 0.78000000000000003 111.337 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -146.04 151.8 38.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.481 1.512 . . . . 2.3900000000000001 110.135 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -173.84 161.02 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.938 1.295 . . . . 2.0699999999999998 113.05 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.9 m -84.35 150.23 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.685 1.594 . . . . 1.3400000000000001 109.037 166.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.72 176.27 9.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.365 1.066 . . . . 3.8999999999999999 110.955 152.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -154.83 162.02 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.476 -0.765 . . . . 3.71 111.424 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -114.61 101.64 54.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.876 1.67 . . . . 1.3100000000000001 109.577 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.06 -2.65 11.86 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.786 2.991 . . . . 1.5600000000000001 113.112 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.9 -172.35 48.79 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.786 1.184 . . . . 1.49 113.726 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -119.21 2.32 11.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.818 1.647 . . . . 3.79 112.954 -169.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.1 161.35 35.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.185 1.794 . . . . 1.5900000000000001 109.374 165.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.8 154.68 15.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.096 2.531 . . . . 1.1200000000000001 111.123 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.37 158.04 17.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.962 0.905 . . . . 2.25 111.175 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -135.35 113.42 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.855 1.262 . . . . 3.71 110.381 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.44 115.35 27.51 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 127.943 2.497 . . . . 0.92000000000000004 108.985 -173.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.7 -8.73 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.725 1.009 . . . . 0.70999999999999996 113.725 -165.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.69 -162.25 32.22 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.749 -0.594 . . . . 0.45000000000000001 112.81 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.93 -175.43 4.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.606 0.595 . . . . 0.82999999999999996 112.606 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -156.95 144.25 18.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.924 0.889 . . . . 5.4400000000000004 109.551 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -152.74 155.13 32.23 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.961 0.904 . . . . 0.92000000000000004 110.471 -170.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.31 -21.17 23.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.809 2.339 . . . . 1.1699999999999999 113.617 169.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.785 HG21 HD13 ' A' ' 93' ' ' LEU . 1.4 m -90.53 -15.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 114.639 1.348 . . . . 1.1599999999999999 114.639 -166.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.36 40.25 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.084 0.954 . . . . 1.1000000000000001 112.347 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -93.63 -86.2 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.386 1.074 . . . . 3.7599999999999998 110.597 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -85.02 90.96 7.96 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.807 -1.183 . . . . 5.3200000000000003 108.741 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -76.03 139.16 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.51 -0.768 . . . . 1.55 111.014 165.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -138.14 120.7 16.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.204 2.202 . . . . 3.3799999999999999 111.048 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.3 118.18 22.41 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.016 0.912 . . . . 0.82999999999999996 111.809 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -103.22 153.68 20.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.782 1.633 . . . . 0.72999999999999998 113.661 172.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -95.18 178.21 5.61 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.42 1.888 . . . . 2.4700000000000002 110.021 162.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.9 m -145.7 111.93 5.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.891 -1.151 . . . . 1.1899999999999999 107.891 164.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -97.15 158.34 15.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.379 1.472 . . . . 2.4300000000000002 112.498 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -101.95 148.03 25.83 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.42 1.088 . . . . 3.7599999999999998 108.92 163.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -158.92 146.64 17.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.379 1.471 . . . . 6.25 110.147 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.45 145.84 24.86 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.582 0.353 . . . . 3.7599999999999998 110.917 165.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -139.78 120.48 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.019 -1.475 . . . . 3.1299999999999999 107.019 165.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.6 tm-20 57.52 33.57 23.44 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.28 1.032 . . . . 5.4199999999999999 110.757 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.64 -9.92 4.37 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 119.995 -1.69 . . . . 2.1800000000000002 114.547 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.463 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 33.7 mmtm -78.39 139.98 38.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 4.0800000000000001 110.367 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -69.97 131.1 43.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.044 0.938 . . . . 3.3199999999999998 110.825 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.93 146.84 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.685 1.994 . . . . 2.1299999999999999 109.361 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -128.43 148.98 50.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.685 1.194 . . . . 3.6299999999999999 110.893 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.71 -179.83 34.78 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.906 0.765 . . . . 1.0700000000000001 112.855 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -127.95 149.27 50.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.245 1.018 . . . . 2.3199999999999998 111.981 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -142.76 147.46 42.18 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.552 1.541 . . . . 3.52 108.908 172.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 151.62 78.42 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.697 1.598 . . . . 0.77000000000000002 110.867 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.13 154.55 78.69 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 125.156 1.382 . . . . 1.1299999999999999 110.79 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -70.2 -11.8 30.91 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.671 2.247 . . . . 1.45 113.063 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -177.47 163.45 1.97 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.618 1.567 . . . . 2.3300000000000001 111.885 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -113.2 174.11 6.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.329 2.251 . . . . 0.82999999999999996 109.4 155.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -154.88 167.62 29.68 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.041 -1.037 . . . . 2.5499999999999998 112.277 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.73 135.42 11.07 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.818 0.847 . . . . 1.1100000000000001 110.543 -165.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.76 167.08 27.04 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.295 1.997 . . . . 1.03 111.893 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -65.26 144.61 81.45 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.709 2.939 . . . . 1.4199999999999999 111.655 166.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.261 0.6 OUTLIER 46.69 55.29 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 123.454 1.597 . . . . 2.7599999999999998 114.757 -166.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.35 121.33 2.66 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 113.962 -1.472 . . . . 1.0600000000000001 114.164 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.53 146.99 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.65 0.78 . . . . 4.96 109.978 162.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.18 137.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.544 1.138 . . . . 1.6299999999999999 109.974 171.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -111.92 140.25 46.74 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.794 0.807 . . . . 3.4500000000000002 110.957 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.24 63.78 2.53 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.323 1.535 . . . . 1.3200000000000001 109.926 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -58.37 121.39 51.9 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.954 1.302 . . . . 4.8899999999999997 110.709 170.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.88 -58.14 1.58 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.888 3.726 . . . . 1.48 114.598 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.69 2.9 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.678 1.132 . . . . 1.9399999999999999 113.405 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.75 -51.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.352 1.93 . . . . 1.48 113.339 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -156.01 139.47 15.84 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.631 1.972 . . . . 2.1899999999999999 109.654 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -166.93 173.66 9.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.353 1.061 . . . . 0.83999999999999997 111.477 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.13 134.0 52.64 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.025 0.53 . . . . 1.8100000000000001 111.246 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.3 mmt -84.73 144.02 28.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.977 1.311 . . . . 1.0900000000000001 110.316 157.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.59 116.47 28.2 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.68 1.592 . . . . 1.9199999999999999 107.861 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -109.63 134.86 51.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.967 0.803 . . . . 2.2799999999999998 110.147 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.2 0.6 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.042 -1.223 . . . . 2.5800000000000001 110.042 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.53 100.52 2.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.086 0.943 . . . . 1.0600000000000001 110.068 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -76.71 -12.7 60.03 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.235 0.828 . . . . 1.77 113.235 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.42 148.63 31.99 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.905 . . . . 5.2199999999999998 111.139 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -67.56 148.71 79.0 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.735 2.29 . . . . 2.0899999999999999 109.229 159.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.785 HD13 HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -156.96 30.94 0.3 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.861 1.315 . . . . 4.2400000000000002 113.59 -160.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.25 149.22 0.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.183 2.193 . . . . 4.3399999999999999 113.904 -169.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.79 134.93 30.38 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.603 -1.311 . . . . 2.4900000000000002 112.107 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.42 -11.79 66.77 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.061 -1.41 . . . . 2.4100000000000001 114.354 -166.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 158.02 37.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.052 1.426 . . . . 4.2800000000000002 109.009 160.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.9 147.54 29.67 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.812 2.045 . . . . 4.2699999999999996 108.174 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.19 123.07 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.576 1.55 . . . . 1.0800000000000001 109.995 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 121.49 21.16 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.708 0.803 . . . . 4.1299999999999999 109.068 159.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.07 126.6 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.078 0.951 . . . . 1.5900000000000001 110.521 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.17 95.87 8.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.53 1.932 . . . . 2.6000000000000001 109.779 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.93 126.18 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.794 1.179 . . . . 2.6000000000000001 110.106 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.6 mt -95.1 137.97 33.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.516 1.526 . . . . 0.84999999999999998 110.589 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -134.11 148.51 51.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.213 1.006 . . . . 2.3100000000000001 113.028 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.77 162.77 18.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.128 -0.942 . . . . 2.8799999999999999 111.853 169.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.75 24.9 66.11 Favored Glycine 0 N--CA 1.473 1.145 0 O-C-N 121.66 -0.65 . . . . 4.7000000000000002 113.696 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.94 60.65 4.77 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.303 0.954 . . . . 2.1099999999999999 111.116 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -143.63 165.16 28.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.984 1.313 . . . . 3.6800000000000002 112.412 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -169.98 144.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 129.39 3.076 . . . . 2.1899999999999999 107.213 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.2 mt -137.4 96.93 3.35 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.393 1.477 . . . . 2.6899999999999999 107.766 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.45 143.24 32.24 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.956 0.724 . . . . 2.6600000000000001 112.956 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.33 140.55 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.414 1.086 . . . . 1.8799999999999999 109.899 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 145.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.668 0.787 . . . . 2.0299999999999998 109.61 172.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.5 153.19 12.79 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.924 1.29 . . . . 2.8399999999999999 113.17 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.09 161.66 40.49 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.039 2.493 . . . . 1.24 112.555 -175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -93.46 130.61 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.978 . . . . 1.4299999999999999 109.786 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.01 164.44 12.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.723 1.209 . . . . 3.4500000000000002 108.931 156.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.41 115.84 26.59 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.068 -1.02 . . . . 2.46 112.772 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.521 2.328 . . . . 5.6799999999999997 113.133 167.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.207 0 N-CA-C 105.751 -2.94 . . . . 12.59 105.751 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -55.37 170.28 0.24 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.284 0.564 . . . . 10.369999999999999 111.722 134.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -148.45 31.93 0.81 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.34 1.856 . . . . 9.6699999999999999 110.481 -174.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -155.48 -10.12 0.12 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 128.034 2.534 . . . . 6.7000000000000002 113.115 -149.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -146.52 156.74 43.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.549 1.94 . . . . 5.0300000000000002 112.171 -150.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.15 164.34 21.47 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 124.822 1.201 . . . . 0.97999999999999998 114.078 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -152.53 145.2 24.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 1.74 112.026 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.1 131.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.381 -0.6 . . . . 1.1200000000000001 109.381 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 116.75 22.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.207 0.603 . . . . 4.0800000000000001 109.405 -171.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.86 133.23 33.94 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.592 -1.317 . . . . 2.3399999999999999 110.914 167.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -149.48 163.24 25.85 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.567 1.947 . . . . 2.4500000000000002 109.007 165.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.91 31.14 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.062 3.175 . . . . 1.9299999999999999 114.113 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.06 -173.16 54.51 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.248 -0.908 . . . . 1.72 113.125 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.26 -4.42 18.31 Favored 'Cis proline' 0 CA--C 1.539 0.741 0 CA-C-N 118.228 1.014 . . . . 1.8300000000000001 112.8 -10.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -139.51 178.87 6.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.701 1.6 . . . . 2.6099999999999999 111.484 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.07 -173.93 3.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.004 2.122 . . . . 1.1100000000000001 108.647 163.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.42 161.15 17.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 1.0600000000000001 112.161 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.1 136.58 48.51 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.039 -1.038 . . . . 1.1200000000000001 111.106 163.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -122.61 155.56 36.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.413 1.885 . . . . 2.0699999999999998 111.015 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -166.24 142.28 4.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.708 1.744 . . . . 1.5700000000000001 115.708 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.9 m -72.13 132.73 44.56 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.79 -0.819 . . . . 1.1799999999999999 108.79 156.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.1 tt -140.68 147.41 39.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.313 1.845 . . . . 2.52 110.1 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -131.92 147.14 52.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.289 1.042 . . . . 3.3199999999999998 112.414 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -88.07 108.9 23.93 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.362 -1.29 . . . . 1.02 109.216 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.74 -11.51 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.631 2.221 . . . . 1.23 113.287 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.04 -173.39 49.84 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.867 1.222 . . . . 0.95999999999999996 113.812 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -114.17 -0.85 13.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.884 1.674 . . . . 2.98 112.855 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.04 161.77 36.79 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.457 1.903 . . . . 1.4299999999999999 109.464 165.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 155.61 28.22 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.554 2.169 . . . . 0.73999999999999999 112.287 -169.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.43 149.82 23.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.437 1.095 . . . . 1.8 110.532 168.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -130.94 111.93 12.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.735 1.214 . . . . 3.27 110.408 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 tp -94.21 118.33 31.41 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.564 2.345 . . . . 0.75 108.746 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -110.15 -10.37 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.977 0.911 . . . . 0.57999999999999996 113.003 -171.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.94 -167.14 38.31 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 124.242 0.925 . . . . 0.5 112.233 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.15 -179.03 6.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.165 0.986 . . . . 0.66000000000000003 110.746 164.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 102' ' ' ASP . 22.0 mmt-85 -149.48 139.66 22.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.26 1.424 . . . . 6.2999999999999998 109.271 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -150.01 152.12 33.4 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.218 -0.896 . . . . 0.55000000000000004 110.572 -169.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.98 -23.94 53.51 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.827 2.351 . . . . 0.77000000000000002 113.629 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.546 HG12 HH11 ' A' ' 91' ' ' ARG 0.351 1.6 m -94.25 3.07 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.049 1.5 . . . . 0.91000000000000003 115.049 -171.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.86 164.1 36.28 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.418 1.636 . . . . 0.71999999999999997 115.418 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.18 -89.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.907 2.083 . . . . 3.4300000000000002 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -80.27 80.12 6.74 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.385 -1.447 . . . . 3.5499999999999998 109.62 -173.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.59 131.7 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 128.146 2.579 . . . . 1.5 112.269 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.51 132.07 30.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.487 1.915 . . . . 2.48 110.27 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.14 121.74 26.49 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 121.278 1.854 . . . . 0.71999999999999997 111.64 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.2 m170 -107.92 154.3 21.8 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.548 1.939 . . . . 0.48999999999999999 112.975 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -109.99 166.33 11.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 2.3900000000000001 110.699 166.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.3 m -115.21 117.83 31.6 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.563 1.945 . . . . 1.3999999999999999 107.114 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -126.26 154.44 43.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.343 1.057 . . . . 2.3700000000000001 112.699 -168.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.4 mtt -92.63 153.77 18.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.657 -1.156 . . . . 2.6699999999999999 111.339 166.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -153.17 137.77 16.87 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.647 0.779 . . . . 6.0 112.706 159.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.14 151.03 16.18 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.853 1.661 . . . . 4.5899999999999999 110.269 160.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.818 HG13 ' H ' ' A' ' 54' ' ' GLU 0.298 11.8 p -158.03 -88.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 126.249 1.82 . . . . 2.8999999999999999 110.287 175.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.818 ' H ' HG13 ' A' ' 53' ' ' VAL . 20.6 tt0 -78.58 47.72 0.74 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.296 2.239 . . . . 3.7200000000000002 110.296 168.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.48 -43.78 0.91 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 127.595 2.522 . . . . 2.2400000000000002 113.912 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -77.83 152.9 33.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.974 2.11 . . . . 3.3999999999999999 113.178 -173.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.37 107.08 18.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.91 0.484 . . . . 4.5499999999999998 112.069 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -80.95 142.03 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.886 1.275 . . . . 1.6100000000000001 109.017 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.11 133.95 50.01 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.912 1.685 . . . . 4.5800000000000001 110.622 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 -179.2 30.23 Favored Glycine 0 N--CA 1.472 1.09 0 C-N-CA 124.226 0.917 . . . . 1.5600000000000001 113.079 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.48 160.53 19.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.802 1.241 . . . . 2.4500000000000002 112.138 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.16 149.96 2.29 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.505 1.522 . . . . 3.6899999999999999 112.652 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 28.2 Cg_endo -71.6 141.52 38.22 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.097 2.532 . . . . 0.63 113.275 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -110.82 156.07 41.31 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.892 1.677 . . . . 0.66000000000000003 109.798 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.2 -13.31 30.95 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.899 2.4 . . . . 0.71999999999999997 113.292 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.7 p90 178.63 168.34 0.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.005 2.122 . . . . 1.79 110.301 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.16 169.43 9.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.189 1.795 . . . . 0.72999999999999998 109.104 157.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.5 159.0 39.41 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.141 -0.974 . . . . 2.5699999999999998 111.655 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.27 126.81 9.21 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.506 1.122 . . . . 0.81000000000000005 110.133 -163.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.76 161.34 44.1 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.308 2.005 . . . . 0.73999999999999999 111.712 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.11 139.29 86.73 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.89 3.06 . . . . 0.78000000000000003 112.865 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm 67.34 -1.2 1.59 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.958 2.103 . . . . 1.3799999999999999 113.647 -173.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.79 119.64 4.93 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 126.615 2.055 . . . . 0.81999999999999995 111.279 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -84.22 142.79 30.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.316 1.046 . . . . 5.4100000000000001 110.722 156.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 m -148.48 147.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.518 1.927 . . . . 1.22 110.218 168.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.91 123.93 46.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.315 1.055 . . . . 3.0899999999999999 112.327 170.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.46 85.88 0.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.799 1.239 . . . . 1.8999999999999999 107.716 158.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -100.41 160.65 26.39 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.055 2.542 . . . . 3.1800000000000002 113.279 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -58.56 -55.31 2.17 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.554 2.836 . . . . 1.3999999999999999 112.664 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.92 65.53 3.73 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 110.884 -0.886 . . . . 1.6200000000000001 110.884 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.94 -108.37 0.28 Allowed Glycine 0 N--CA 1.468 0.816 0 C-N-CA 124.616 1.103 . . . . 1.5600000000000001 113.005 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -130.84 143.19 50.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.002 1.401 . . . . 2.1600000000000001 111.029 -172.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -170.21 163.37 8.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 120.995 -1.066 . . . . 1.5900000000000001 109.935 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -88.23 133.31 34.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.678 -0.677 . . . . 2.46 110.29 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.1 mmt -84.13 136.36 34.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.78 0.832 . . . . 0.84999999999999998 110.196 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.42 75.67 0.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.578 1.551 . . . . 1.73 109.164 -170.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.39 116.04 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.245 -1.02 . . . . 3.27 108.245 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.98 96.69 0.4 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.291 -1.123 . . . . 2.8500000000000001 110.291 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.1 119.52 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.291 -1.374 . . . . 1.3300000000000001 107.291 167.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.79 4.76 23.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.798 -1.189 . . . . 1.79 112.833 -164.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.546 HH11 HG12 ' A' ' 39' ' ' VAL . 9.4 ptm180 -167.66 152.69 6.76 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.739 2.016 . . . . 5.21 109.595 -172.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.19 151.94 82.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.46 -1.4 . . . . 1.77 108.46 161.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.63 162.43 41.0 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.627 1.971 . . . . 2.6299999999999999 108.64 -164.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -154.19 162.6 41.08 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.896 1.813 . . . . 4.2000000000000002 115.896 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.57 133.21 48.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 1.8899999999999999 107.989 157.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.57 13.81 62.54 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.956 -0.914 . . . . 2.1600000000000001 113.493 -162.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.0 169.24 9.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.689 1.245 . . . . 3.1099999999999999 107.868 151.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -136.72 150.35 48.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.523 1.929 . . . . 3.6699999999999999 107.805 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.47 103.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 124.788 1.235 . . . . 0.89000000000000001 108.384 -168.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -59.82 134.04 56.66 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 125.1 1.5 . . . . 4.1399999999999997 108.46 154.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.94 130.37 23.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.855 1.662 . . . . 1.45 109.579 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' CG ' ' HZ3' ' A' ' 112' ' ' LYS . 5.0 m-20 -103.5 92.23 4.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.994 1.718 . . . . 2.3999999999999999 109.063 -175.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.7 mt -77.68 112.33 14.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.893 1.677 . . . . 1.3100000000000001 110.226 -172.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -86.5 128.07 34.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.805 0.842 . . . . 0.68999999999999995 111.475 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.29 142.87 50.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.687 0.795 . . . . 2.0099999999999998 113.003 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.59 133.05 30.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.528 1.531 . . . . 1.8700000000000001 114.292 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.11 -142.93 23.61 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.777 -1.329 . . . . 3.6099999999999999 109.777 -162.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.46 71.12 0.25 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.979 0.8 . . . . 1.73 112.951 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -131.0 148.59 52.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.701 1.25 . . . . 5.0300000000000002 111.416 168.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.82 139.73 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.639 1.575 . . . . 0.93000000000000005 109.235 170.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.71 145.71 48.79 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.424 1.09 . . . . 1.3799999999999999 110.378 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HZ3' ' CG ' ' A' ' 102' ' ' ASP . 17.2 mtpp -112.83 143.71 43.61 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.079 0.952 . . . . 2.6000000000000001 112.323 -169.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -158.64 125.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.326 1.45 . . . . 1.4199999999999999 109.689 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.0 p -92.29 121.72 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.338 1.055 . . . . 1.9099999999999999 109.142 170.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.04 143.28 48.34 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.293 1.437 . . . . 2.2200000000000002 111.634 -171.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.36 150.22 70.4 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.373 2.715 . . . . 1.04 112.992 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.13 127.02 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.464 0.705 . . . . 1.24 110.256 171.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.85 142.4 27.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.274 2.23 . . . . 5.0800000000000001 108.411 163.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.33 134.61 12.38 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.515 0.561 . . . . 2.3799999999999999 112.515 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 116.179 -1.867 . . . . 9.0299999999999994 113.492 164.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.386 0 N-CA-C 108.925 -1.67 . . . . 16.800000000000001 108.925 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 m -135.98 163.37 30.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.57 1.148 . . . . 12.949999999999999 110.266 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -116.21 155.86 27.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.762 1.225 . . . . 12.279999999999999 108.199 159.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.7 t -157.02 169.17 25.43 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.487 1.115 . . . . 5.6399999999999997 109.81 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -108.78 117.19 33.55 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.977 0.911 . . . . 5.1500000000000004 111.632 -162.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.85 169.54 40.21 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 120.941 -1.1 . . . . 1.28 114.781 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.42 152.18 19.89 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.14 0.793 . . . . 1.71 113.14 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.78 124.2 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.452 -0.944 . . . . 0.89000000000000001 108.452 163.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -83.34 109.17 17.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.177 0.991 . . . . 5.4299999999999997 108.655 167.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.48 ' HB2' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.1 -179.31 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.841 1.052 . . . . 2.6299999999999999 113.841 -173.332 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m -168.48 167.56 6.17 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.572 1.949 . . . . 1.8500000000000001 109.198 162.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.15 -26.78 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.039 2.493 . . . . 2.5699999999999998 112.105 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.2 177.96 15.72 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.384 1.468 . . . . 1.6100000000000001 112.668 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.02 -15.8 19.87 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 118.69 1.245 . . . . 1.75 113.247 -1.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -129.15 164.98 22.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.631 1.572 . . . . 2.1099999999999999 112.77 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.97 163.4 30.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.391 2.276 . . . . 0.98999999999999999 109.883 171.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.98 145.44 38.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.33 1.052 . . . . 0.89000000000000001 110.876 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.67 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.317 0.858 . . . . 0.81000000000000005 113.317 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -145.78 158.44 43.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.998 1.719 . . . . 1.98 110.844 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.7 152.31 13.71 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.497 1.119 . . . . 1.78 111.395 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 m -79.57 149.74 31.3 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.594 1.558 . . . . 1.6699999999999999 108.065 155.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -155.7 134.44 11.9 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.916 1.287 . . . . 2.8999999999999999 108.902 173.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.62 119.05 27.91 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.895 1.278 . . . . 4.3200000000000003 109.693 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -77.42 117.01 62.63 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 1.4399999999999999 109.939 173.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.32 -11.12 8.58 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.042 2.495 . . . . 1.5600000000000001 113.825 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.72 163.93 54.74 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 119.025 0.83 . . . . 1.5900000000000001 113.521 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.439 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.4 m-20 -91.87 -1.7 57.19 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.275 1.83 . . . . 3.54 112.634 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.28 159.74 40.32 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.311 1.844 . . . . 1.6699999999999999 110.856 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.03 159.09 23.92 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.042 2.495 . . . . 1.1399999999999999 111.41 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.72 156.48 17.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.857 0.837 . . . . 2.6899999999999999 110.537 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -129.54 120.32 25.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.086 1.355 . . . . 5.29 108.308 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -101.16 118.52 37.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.839 1.655 . . . . 1.1000000000000001 108.541 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.77 -11.18 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.289 1.036 . . . . 0.70999999999999996 113.346 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.92 -170.78 43.7 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.601 1.096 . . . . 0.65000000000000002 111.314 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 149.99 25.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 1.73 111.809 166.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -118.3 139.76 50.85 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.848 -1.158 . . . . 5.5099999999999998 110.065 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -140.94 152.25 64.79 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.629 1.172 . . . . 0.87 110.083 -171.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.65 -26.67 83.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.239 1.959 . . . . 1.1100000000000001 113.978 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.566 HG21 HD21 ' A' ' 93' ' ' LEU . 1.9 m -88.38 -7.9 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 114.991 1.478 . . . . 1.3999999999999999 114.991 -170.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.55 168.96 21.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.9 0.88 . . . . 1.0700000000000001 113.349 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.84 -73.89 0.63 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.586 0.354 . . . . 4.2199999999999998 111.036 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -68.39 139.89 55.82 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.721 -1.237 . . . . 2.7799999999999998 109.298 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.55 139.85 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 125.242 1.417 . . . . 2.1899999999999999 108.336 162.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -129.95 117.34 19.95 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.465 1.106 . . . . 2.0800000000000001 108.682 164.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -77.21 120.85 22.84 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.743 0.782 . . . . 0.91000000000000003 109.253 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -106.77 151.05 25.67 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.414 1.486 . . . . 0.67000000000000004 112.681 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -95.78 160.59 14.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.782 2.033 . . . . 1.98 110.151 164.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.3 m -131.44 108.74 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.464 1.905 . . . . 1.1299999999999999 107.127 166.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -109.85 160.31 16.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 2.4500000000000002 112.232 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -113.06 139.34 48.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.083 0.953 . . . . 2.5899999999999999 110.115 157.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -151.56 150.94 30.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.107 1.363 . . . . 6.29 111.985 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.68 144.34 52.28 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.835 0.854 . . . . 4.2199999999999998 110.74 154.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -154.58 -39.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 114.718 1.377 . . . . 3.8700000000000001 114.718 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 3.7 tm-20 -112.28 38.21 2.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.667 1.987 . . . . 4.21 109.205 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.67 -35.03 0.59 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.204 1.383 . . . . 3.3999999999999999 113.445 -164.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 16.0 mtmt -92.7 160.22 15.08 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.722 2.409 . . . . 4.0999999999999996 111.037 175.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -74.27 142.28 45.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.48 0.919 . . . . 3.8599999999999999 113.48 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.59 158.03 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 127.792 2.437 . . . . 2.4700000000000002 108.09 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.2 mtm -111.08 152.82 26.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 3.21 112.535 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.76 177.1 41.08 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 123.716 0.674 . . . . 1.1399999999999999 113.468 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -124.45 161.01 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.692 1.197 . . . . 1.8500000000000001 111.646 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -158.61 151.65 18.52 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 126.806 2.042 . . . . 5.0800000000000001 109.447 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.57 142.41 71.05 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 CA-C-N 121.375 1.527 . . . . 0.67000000000000004 110.672 154.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -104.23 155.31 37.4 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.739 1.216 . . . . 0.62 110.76 168.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.19 -19.46 56.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.76000000000000001 112.641 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -177.63 165.55 2.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.243 2.217 . . . . 1.8999999999999999 110.617 175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -105.91 170.56 7.83 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.828 1.251 . . . . 0.90000000000000002 110.05 153.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -143.08 169.71 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.326 0.65 . . . . 2.5299999999999998 110.811 171.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -146.91 133.16 9.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 107.926 -1.139 . . . . 1.03 107.926 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.01 167.57 25.67 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.127 1.218 . . . . 1.1899999999999999 111.319 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.99 140.98 87.6 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.32 2.68 . . . . 1.3 110.952 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 59.3 mmtt 66.07 4.01 2.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.146 1.379 . . . . 1.79 113.074 -173.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.88 114.05 3.96 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 127.129 2.3 . . . . 1.47 113.06 -169.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -75.86 132.16 40.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.028 -1.586 . . . . 4.7699999999999996 110.076 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.93 164.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.119 2.168 . . . . 1.5800000000000001 109.428 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.97 117.89 0.91 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.024 0.929 . . . . 3.4399999999999999 109.574 -171.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -74.96 64.3 1.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.762 2.025 . . . . 1.6499999999999999 111.615 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -63.42 133.35 95.46 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.791 -1.193 . . . . 3.2000000000000002 110.789 167.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.49 -20.91 66.32 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.339 2.692 . . . . 1.78 113.76 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.21 55.98 5.05 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.081 0.848 . . . . 1.49 111.23 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.46 -64.49 0.13 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.635 1.112 . . . . 1.3500000000000001 113.998 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -153.85 145.0 22.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.64 1.576 . . . . 1.99 111.254 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -166.06 163.73 18.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.296 1.038 . . . . 1.1200000000000001 111.169 -174.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -107.73 127.02 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.069 0.548 . . . . 2.1099999999999999 111.065 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -90.69 108.41 19.8 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.265 1.426 . . . . 1.1899999999999999 110.142 164.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.39 130.76 37.98 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.144 0.978 . . . . 3.3999999999999999 108.772 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.82 150.62 51.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.265 1.426 . . . . 1.8799999999999999 110.781 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.35 53.31 5.19 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.979 -0.848 . . . . 2.9900000000000002 110.979 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.6 mt -68.95 114.04 6.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.883 0.842 . . . . 0.96999999999999997 109.555 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -98.96 -0.1 42.86 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.866 1.266 . . . . 2.02 111.961 -166.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -157.04 148.84 17.3 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.526 1.93 . . . . 6.0499999999999998 108.7 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.44 156.38 54.43 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.363 2.042 . . . . 1.8400000000000001 109.624 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 39' ' ' VAL . 4.2 mp -103.11 155.56 18.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.573 1.178 . . . . 3.1600000000000001 112.139 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -120.53 123.58 43.25 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.099 2.16 . . . . 4.7999999999999998 109.392 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 131.58 50.82 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.151 -0.968 . . . . 1.8999999999999999 111.586 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.08 44.06 78.71 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.16 -0.8 . . . . 1.78 112.669 -172.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.95 -178.07 3.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.741 -1.207 . . . . 3.04 107.741 151.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -127.0 161.29 28.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.472 1.109 . . . . 3.77 109.543 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.8 t -126.22 120.78 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 124.615 1.166 . . . . 1.0700000000000001 109.816 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -68.89 119.23 12.89 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 124.488 1.117 . . . . 2.7599999999999998 108.619 154.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.99 120.81 40.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.735 0.779 . . . . 1.72 109.055 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.9 93.66 8.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.762 -1.563 . . . . 2.4300000000000002 107.964 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.05 119.45 11.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.685 -0.857 . . . . 1.2 108.685 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.8 mt -90.92 120.59 32.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.665 -0.865 . . . . 0.64000000000000001 108.665 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 88.6 m-85 -116.12 131.18 57.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.069 0.938 . . . . 2.1400000000000001 112.343 -176.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.61 -18.51 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 131.014 3.726 . . . . 3.7599999999999998 116.932 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.81 -22.42 0.71 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.345 1.926 . . . . 5.7999999999999998 113.721 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.01 -6.56 0.06 OUTLIER Glycine 0 N--CA 1.474 1.204 0 N-CA-C 117.362 1.705 . . . . 3.8100000000000001 117.362 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -79.74 101.0 8.18 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 120.384 2.092 . . . . 4.8700000000000001 109.582 175.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.21 138.44 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.729 1.212 . . . . 1.6100000000000001 110.041 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.53 136.55 33.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.36 1.064 . . . . 1.8700000000000001 111.748 166.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.45 125.41 25.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.975 0.51 . . . . 2.1200000000000001 111.967 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -101.54 154.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.946 -0.761 . . . . 1.8200000000000001 108.946 142.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.8 p -118.99 139.8 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.062 -1.088 . . . . 2.1099999999999999 108.062 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -162.55 155.57 16.9 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.022 1.729 . . . . 2.6400000000000001 110.127 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.93 160.12 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.389 3.393 . . . . 1.01 115.04 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.3 t -87.6 122.59 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.697 1.199 . . . . 0.93999999999999995 110.058 164.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -92.64 131.17 37.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.729 2.011 . . . . 3.8199999999999998 107.554 161.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.21 116.17 5.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.308 0.643 . . . . 3.4100000000000001 111.431 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 129.3 3.04 . . . . 7.4100000000000001 107.208 176.68 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 N-CA-C 109.448 -1.461 . . . . 15.56 109.448 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 t -165.43 178.73 6.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.204 1.002 . . . . 12.449999999999999 109.458 -174.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.76 -11.28 14.41 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.291 1.219 . . . . 14.75 114.291 -167.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.5 m -137.01 3.27 2.65 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.76 1.624 . . . . 8.8900000000000006 112.371 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -98.61 -176.37 3.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.934 1.294 . . . . 5.1600000000000001 110.122 171.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.94 154.82 18.24 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 120.885 -1.135 . . . . 1.0600000000000001 112.684 166.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -158.3 145.09 17.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.476 1.111 . . . . 1.3300000000000001 111.675 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -97.33 137.16 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.791 -0.818 . . . . 1.1499999999999999 108.791 171.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.28 92.32 4.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.921 1.289 . . . . 3.46 109.536 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.18 159.67 9.4 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 123.548 1.642 . . . . 2.0800000000000001 112.383 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -162.85 154.69 15.4 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 129.08 2.952 . . . . 2.23 106.54 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 39.06 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.058 3.172 . . . . 1.97 112.418 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.23 178.79 51.42 Favored Glycine 0 CA--C 1.541 1.668 0 O-C-N 121.206 -0.934 . . . . 2.2999999999999998 112.173 -156.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.82 -12.23 23.54 Favored 'Cis proline' 0 CA--C 1.54 0.798 0 CA-C-N 118.435 1.118 . . . . 2.73 112.457 -11.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -155.7 168.54 26.84 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.411 1.884 . . . . 2.25 110.997 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.61 -177.15 4.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 0.85999999999999999 111.042 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.24 152.67 47.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.224 1.01 . . . . 0.98999999999999999 112.506 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.01 140.32 52.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.166 0.986 . . . . 0.96999999999999997 111.858 167.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -128.19 152.0 48.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.499 1.92 . . . . 2.0800000000000001 110.517 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pp -165.11 133.51 3.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.938 1.829 . . . . 1.75 115.938 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 m -76.81 139.02 40.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.143 -1.39 . . . . 1.1100000000000001 108.685 156.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.25 145.07 16.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 2.7599999999999998 108.257 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.43 144.94 49.18 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.518 0.599 . . . . 3.3399999999999999 111.502 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -86.9 109.58 25.68 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 108.621 -0.881 . . . . 1.25 108.621 155.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.05 -14.07 5.24 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.965 1.777 . . . . 1.1599999999999999 114.411 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.27 -153.98 24.16 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.63 1.012 . . . . 1.46 115.63 -159.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -93.74 -32.03 14.18 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.138 2.575 . . . . 5.8200000000000003 113.932 -173.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.12 158.83 36.91 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.375 1.47 . . . . 1.6599999999999999 112.052 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.85 155.33 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.798 2.332 . . . . 1.28 111.786 -170.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.91 132.52 56.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.142 1.377 . . . . 2.46 109.138 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -125.98 106.54 9.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.297 1.039 . . . . 4.8899999999999997 111.937 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.7 tp -92.21 112.51 24.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.463 2.305 . . . . 0.90000000000000002 109.651 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.02 -7.4 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.155 1.382 . . . . 0.76000000000000001 113.277 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.94 -167.09 38.67 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 121.458 -0.776 . . . . 0.62 112.247 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.34 175.29 10.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.107 0.563 . . . . 0.80000000000000004 111.9 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -156.31 91.27 1.24 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.221 -1.77 . . . . 6.6500000000000004 106.221 -164.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -104.7 152.85 39.54 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.116 1.366 . . . . 0.85999999999999999 110.59 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -27.55 16.28 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.394 2.729 . . . . 1.0800000000000001 113.531 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.31 1.7 m -89.93 -0.11 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 114.355 1.243 . . . . 0.91000000000000003 114.355 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.96 140.66 50.88 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.876 0.871 . . . . 0.81000000000000005 112.24 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -72.48 -68.89 0.44 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.173 -1.047 . . . . 5.54 108.173 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -90.09 149.25 22.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.442 2.297 . . . . 3.02 109.653 168.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.23 139.66 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.545 1.538 . . . . 1.5 109.548 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -142.17 140.82 32.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.906 1.682 . . . . 2.0299999999999998 110.521 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -81.79 122.5 27.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.515 1.052 . . . . 0.92000000000000004 111.346 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.9 m170 -111.74 156.9 21.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.561 1.544 . . . . 0.59999999999999998 112.553 174.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.95 -179.64 4.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.228 2.211 . . . . 1.8200000000000001 111.112 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.5 m -126.85 114.29 17.71 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.808 -1.553 . . . . 1.4199999999999999 106.808 151.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -89.5 152.15 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 2.3500000000000001 111.025 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.1 ptp -101.24 144.88 29.55 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.499 -0.773 . . . . 3.54 110.133 155.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.4 158.79 34.88 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.216 1.806 . . . . 7.25 109.468 171.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.37 148.95 22.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.585 -0.895 . . . . 3.8799999999999999 108.585 167.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.96 -79.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.649 0.737 . . . . 2.9100000000000001 110.372 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -76.19 35.18 0.14 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.445 2.298 . . . . 4.6399999999999997 111.651 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.33 -12.37 0.94 Allowed Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.289 -1.507 . . . . 2.0 113.744 -161.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -106.78 154.34 21.14 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 128.032 2.533 . . . . 4.0899999999999999 109.736 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -70.14 137.49 51.11 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.696 0.399 . . . . 3.8399999999999999 110.868 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.71 148.69 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.482 1.913 . . . . 2.0 108.402 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 19.8 mmt -115.5 142.04 47.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.697 1.199 . . . . 4.2699999999999996 109.351 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.82 151.76 23.37 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.283 0.947 . . . . 1.24 114.19 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -93.64 159.27 15.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.147 0.979 . . . . 2.1899999999999999 111.833 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -173.41 140.21 0.86 Allowed Pre-proline 0 N--CA 1.473 0.692 0 CA-C-O 116.67 -1.633 . . . . 3.5800000000000001 110.246 -168.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.0 OUTLIER -70.63 148.76 60.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.363 1.88 . . . . 0.93000000000000005 111.378 170.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.86 151.9 74.47 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 125.254 1.422 . . . . 0.68999999999999995 110.206 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.06 -13.65 26.12 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.938 2.425 . . . . 1.0 113.777 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -175.03 164.71 3.4 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.8 1.24 . . . . 2.0800000000000001 111.572 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -121.64 170.25 9.9 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 127.404 2.282 . . . . 0.76000000000000001 108.915 152.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.57 172.43 18.57 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.244 -0.91 . . . . 2.23 110.804 169.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.9 t -147.55 122.57 5.18 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 125.161 1.385 . . . . 1.05 109.664 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.11 159.66 51.55 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.947 1.765 . . . . 1.3 110.656 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.3 139.11 88.45 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.872 3.048 . . . . 1.1499999999999999 111.588 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.07 -8.32 1.32 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.252 2.221 . . . . 3.2400000000000002 115.088 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.08 129.03 8.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 126.525 2.012 . . . . 1.1299999999999999 110.283 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -87.65 148.16 24.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.556 -0.822 . . . . 4.7999999999999998 112.411 163.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.99 167.02 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.653 1.581 . . . . 2.2999999999999998 110.788 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -154.23 85.28 1.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.845 1.658 . . . . 3.04 107.0 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.83 68.87 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.894 1.678 . . . . 1.6100000000000001 112.055 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -72.36 151.45 92.01 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.497 2.719 . . . . 3.29 113.658 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.45 -58.91 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.752 2.968 . . . . 1.6299999999999999 112.614 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.85 83.3 1.16 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.389 -1.484 . . . . 1.5 109.389 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.6 -97.18 0.16 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 125.274 1.416 . . . . 1.3 111.492 -166.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -151.65 134.23 15.47 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.658 1.583 . . . . 2.0299999999999998 109.455 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -163.53 175.73 10.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.724 1.147 . . . . 1.04 110.647 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -108.65 125.81 52.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.128 0.571 . . . . 2.2599999999999998 110.497 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -85.57 144.46 27.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.334 1.054 . . . . 1.02 110.273 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -124.18 138.9 54.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.418 1.887 . . . . 1.9199999999999999 109.543 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.69 157.22 46.12 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.153 0.981 . . . . 2.25 112.106 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.26 -54.78 3.59 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 126.343 1.925 . . . . 2.8599999999999999 114.732 167.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.8 mt 76.81 95.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 130.305 3.442 . . . . 1.2 113.037 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -78.62 -0.97 31.97 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.834 1.42 . . . . 2.4700000000000002 114.834 -172.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -144.3 145.66 30.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 127.136 2.174 . . . . 5.3399999999999999 108.206 172.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.31 115.67 4.38 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.19 1.26 . . . . 2.4700000000000002 110.174 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.72 151.69 23.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 112.869 -1.969 . . . . 2.6800000000000002 109.913 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -144.82 -7.84 0.65 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 117.121 2.267 . . . . 5.1600000000000001 117.121 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.67 170.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.103 2.561 . . . . 2.2000000000000002 112.972 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.51 34.51 53.97 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.253 -0.748 . . . . 1.6899999999999999 111.681 -164.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.32 174.01 13.82 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 127.224 2.21 . . . . 3.3700000000000001 109.694 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 164.18 14.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.021 2.128 . . . . 4.0 111.696 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.2 t -133.86 108.38 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.593 1.157 . . . . 0.94999999999999996 109.455 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -71.34 98.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.979 -1.119 . . . . 3.6400000000000001 107.979 159.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 tt -98.74 138.61 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.697 -0.853 . . . . 1.9099999999999999 108.697 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.01 138.6 31.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 3.77 112.053 168.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.38 122.74 43.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.457 2.303 . . . . 1.3100000000000001 109.075 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.6 mt -92.89 119.73 32.5 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.136 0.974 . . . . 0.90000000000000002 109.935 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -115.57 150.52 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.943 0.877 . . . . 2.21 113.254 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 162.83 28.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.996 -0.547 . . . . 2.1899999999999999 111.332 165.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 20.4 79.55 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.263 -0.743 . . . . 4.6799999999999997 114.266 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.52 61.28 2.8 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 118.61 1.205 . . . . 2.4300000000000002 112.319 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 154.76 43.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.071 2.148 . . . . 4.0599999999999996 110.115 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -168.66 140.83 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.392 2.277 . . . . 1.5700000000000001 107.407 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.8 mt -150.21 109.61 3.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.187 0.903 . . . . 1.45 111.175 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -81.7 111.6 18.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.284 0.634 . . . . 2.8500000000000001 110.769 173.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -117.0 141.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.188 1.795 . . . . 1.6100000000000001 110.427 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.83 116.16 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.049 0.939 . . . . 1.79 112.227 -173.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.8 150.57 46.02 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.573 1.549 . . . . 3.2400000000000002 110.018 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.11 159.91 26.75 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.074 3.183 . . . . 1.05 111.954 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 130.59 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.086 0.955 . . . . 1.3600000000000001 111.342 169.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -97.96 139.65 33.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.832 2.453 . . . . 3.2400000000000002 107.48 159.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.05 9.31 32.49 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.345 1.98 . . . . 2.2599999999999998 116.345 -162.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.785 0 C-N-CA 126.956 2.102 . . . . 6.6799999999999997 110.133 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.416 0 N-CA-C 108.921 -1.671 . . . . 12.83 108.921 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 p -179.18 165.25 1.46 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.811 1.244 . . . . 9.8900000000000006 109.893 -166.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -76.53 54.64 0.96 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.807 1.243 . . . . 13.69 112.134 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.6 m -91.32 -28.61 17.63 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.536 1.934 . . . . 6.8200000000000003 110.643 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -130.87 179.95 5.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.839 2.456 . . . . 5.3399999999999999 110.692 -161.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.81 163.1 12.86 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.714 1.149 . . . . 1.3300000000000001 115.277 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -151.37 149.46 29.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.4 1.08 . . . . 1.6699999999999999 113.228 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.49 121.55 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.405 0.682 . . . . 0.90000000000000002 110.118 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -86.69 90.43 8.27 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.027 0.931 . . . . 5.5999999999999996 110.754 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.03 149.33 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.246 1.418 . . . . 2.6000000000000001 112.054 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.0 m -155.59 162.54 27.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.774 2.029 . . . . 2.1699999999999999 109.724 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.03 -5.87 13.87 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.522 2.814 . . . . 2.0499999999999998 113.582 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 170.29 31.99 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.517 1.056 . . . . 1.8100000000000001 113.328 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.84 -2.29 21.84 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 117.951 0.875 . . . . 1.8700000000000001 113.272 -4.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.73 152.85 33.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.43 1.092 . . . . 2.9900000000000002 112.595 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.89 175.1 14.38 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.377 1.871 . . . . 0.71999999999999997 111.318 166.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.61 156.23 36.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.846 0.858 . . . . 0.81000000000000005 110.73 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.5 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.747 0.784 . . . . 0.60999999999999999 111.311 162.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.52 143.28 49.82 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.947 1.699 . . . . 2.27 108.3 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.02 144.78 23.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 120.687 -1.258 . . . . 1.6799999999999999 113.985 174.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -92.39 111.48 23.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.913 -1.494 . . . . 1.27 107.35 170.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.1 tt -120.16 147.18 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.873 2.469 . . . . 3.02 109.126 -174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -142.71 152.43 42.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.16 0.981 . . . . 2.75 113.418 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -100.14 102.39 17.84 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 113.976 -1.465 . . . . 1.1299999999999999 109.269 171.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.88 -9.93 16.84 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.811 2.341 . . . . 1.1799999999999999 113.041 174.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.84 -179.12 52.78 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 124.55 1.071 . . . . 1.1200000000000001 113.464 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.73 -2.73 19.8 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.182 1.793 . . . . 3.1499999999999999 112.965 -172.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.25 160.66 40.52 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.479 1.911 . . . . 1.3999999999999999 109.873 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.41 156.47 32.68 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.47 2.113 . . . . 0.75 111.884 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.13 120.02 36.5 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.991 1.316 . . . . 2.4700000000000002 110.05 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -106.89 103.72 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.936 1.294 . . . . 5.0700000000000003 111.609 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.22 114.45 26.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.858 2.063 . . . . 0.81999999999999995 109.282 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 m -92.21 -23.48 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.486 0.714 . . . . 0.89000000000000001 112.554 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.77 -168.64 40.24 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 123.751 0.691 . . . . 0.54000000000000004 111.529 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' CD2' ' A' ' 101' ' ' LEU . . . -150.93 175.07 12.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.506 -0.759 . . . . 1.3799999999999999 111.019 169.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 2.4 mmt85 -154.96 157.69 38.09 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.101 1.319 . . . . 6.9900000000000002 111.96 -167.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 t -161.18 154.88 18.49 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 124.843 1.257 . . . . 0.82999999999999996 110.226 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -68.21 -17.42 45.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.995 1.797 . . . . 1.0 113.074 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 1.5 m -86.22 11.74 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.123 1.157 . . . . 1.04 114.123 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.62 162.18 40.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.747 1.219 . . . . 0.77000000000000002 111.917 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.9 -75.68 0.62 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.482 -0.562 . . . . 3.3100000000000001 109.482 170.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -75.31 146.0 41.34 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.763 -1.199 . . . . 4.04 107.763 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -165.12 137.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.029 1.332 . . . . 1.4099999999999999 108.58 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -142.64 136.28 28.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.733 1.213 . . . . 1.99 110.547 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -79.97 120.15 23.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.568 0.699 . . . . 0.79000000000000004 109.635 163.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -104.27 152.75 21.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.032 1.333 . . . . 0.56999999999999995 111.327 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -106.54 163.67 12.69 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.562 1.945 . . . . 2.5099999999999998 110.016 163.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.6 m -152.2 113.71 4.33 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.104 1.362 . . . . 1.6699999999999999 108.403 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -131.77 151.65 51.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.689 1.196 . . . . 2.6099999999999999 112.343 -160.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.32 154.33 25.35 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.151 0.98 . . . . 4.1200000000000001 112.262 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -156.05 160.23 39.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.23 1.012 . . . . 5.9400000000000004 111.516 172.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.12 155.21 16.92 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.975 1.31 . . . . 5.21 109.658 162.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.29 113.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 124.99 1.431 . . . . 3.3700000000000001 111.175 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 60.53 17.41 7.32 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.032 0.933 . . . . 4.3899999999999997 112.345 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.85 4.91 89.62 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.239 -1.538 . . . . 3.46 114.267 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.43 128.75 34.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.722 1.609 . . . . 2.9700000000000002 109.795 168.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.05 134.75 51.16 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.252 -0.905 . . . . 6.1399999999999997 109.699 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.56 165.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.881 0.872 . . . . 3.1499999999999999 110.829 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.6 ptp -130.24 148.81 52.11 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.25 1.02 . . . . 3.6800000000000002 111.649 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 164.83 15.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.005 1.288 . . . . 2.1400000000000001 111.716 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.31 157.21 46.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 2.71 110.609 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -160.77 137.15 6.3 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 116.153 -1.879 . . . . 4.4000000000000004 108.99 -173.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.34 146.36 85.6 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.971 1.74 . . . . 0.87 110.403 151.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.98 155.96 52.54 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.853 1.261 . . . . 0.98999999999999999 110.538 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.14 -14.59 25.91 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.005 2.47 . . . . 1.3700000000000001 113.095 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -176.18 165.96 2.86 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.492 1.917 . . . . 2.6899999999999999 112.292 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -117.59 176.0 5.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.459 2.304 . . . . 1.1000000000000001 109.022 154.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.83 168.92 23.57 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.883 -1.135 . . . . 2.6800000000000002 112.217 163.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.8 t -140.72 130.83 13.37 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.222 1.009 . . . . 0.82999999999999996 109.446 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.61 162.67 38.19 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.473 2.115 . . . . 0.89000000000000001 111.206 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.6 143.67 99.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.162 2.575 . . . . 1.01 111.638 176.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 66.93 1.45 2.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.614 1.966 . . . . 1.5600000000000001 113.752 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.4 119.69 4.97 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 126.94 2.21 . . . . 1.03 111.164 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 135.21 36.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.77 1.228 . . . . 3.9100000000000001 111.147 160.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.96 152.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.024 1.729 . . . . 1.3799999999999999 110.77 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.55 120.56 32.32 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.85 1.66 . . . . 4.6799999999999997 109.075 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.34 69.24 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.251 1.5 . . . . 1.3600000000000001 112.973 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.49 133.6 53.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.405 1.882 . . . . 3.0299999999999998 113.368 169.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -56.34 -44.96 41.2 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.411 2.074 . . . . 1.8999999999999999 111.201 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.69 2.4 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.948 1.261 . . . . 1.3999999999999999 111.65 167.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -74.24 0.2 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.756 2.122 . . . . 1.5900000000000001 112.271 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -151.87 132.74 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.35 1.46 . . . . 2.3300000000000001 111.574 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -158.89 176.76 11.92 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.679 -1.263 . . . . 0.88 111.357 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -111.93 130.46 55.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 112.359 0.503 . . . . 2.1699999999999999 112.359 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -94.3 130.11 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.836 1.255 . . . . 0.93999999999999995 111.066 165.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.0 mt -109.83 132.74 53.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.797 1.639 . . . . 1.8500000000000001 109.001 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.02 150.49 49.23 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.32 1.057 . . . . 1.6499999999999999 112.969 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.92 -61.96 4.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.517 1.056 . . . . 2.6800000000000002 110.979 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mt 68.42 88.56 0.11 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 129.925 3.29 . . . . 0.89000000000000001 110.42 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -74.86 -3.81 34.16 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.131 -0.981 . . . . 1.97 113.281 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -145.56 144.39 22.61 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 127.809 2.444 . . . . 4.5499999999999998 107.768 168.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.71 173.2 14.49 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.649 2.233 . . . . 1.97 110.186 157.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.3 172.01 10.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.516 1.926 . . . . 4.25 108.149 166.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -126.79 1.9 6.71 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.828 1.788 . . . . 3.8799999999999999 115.828 174.082 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 76.38 158.43 0.2 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.785 2.834 . . . . 1.5600000000000001 110.922 -167.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 55.8 6.83 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 121.532 -0.73 . . . . 1.75 111.626 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.92 176.9 11.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.302 2.241 . . . . 3.5800000000000001 109.494 173.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.66 171.76 7.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.858 1.263 . . . . 4.25 109.804 166.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.7 t -128.8 125.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.825 1.65 . . . . 0.87 107.376 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -77.68 140.95 39.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.474 0.484 . . . . 3.1699999999999999 109.81 166.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.536 ' CD2' ' HB1' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -147.71 126.6 12.73 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.856 1.058 . . . . 1.29 113.856 -168.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.82 102.21 14.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.742 2.417 . . . . 2.6800000000000002 111.314 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.3 mt -78.58 111.91 15.13 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.926 -1.109 . . . . 1.6399999999999999 111.166 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -90.8 122.38 33.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.884 1.274 . . . . 0.78000000000000003 112.01 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.46 134.94 55.08 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.011 -1.056 . . . . 1.97 113.597 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.03 -28.03 69.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.896 1.278 . . . . 2.4399999999999999 113.605 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 31.25 1.09 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.73 1.157 . . . . 4.21 114.366 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.75 44.76 88.61 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.913 1.244 . . . . 1.78 112.628 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 150.22 45.66 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.394 1.478 . . . . 4.3700000000000001 111.283 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.83 137.28 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.048 -1.464 . . . . 1.49 107.048 155.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.4 mt -120.2 104.94 10.49 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 107.897 -1.149 . . . . 1.78 107.897 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -84.15 128.49 34.6 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.881 -0.512 . . . . 3.02 110.99 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.02 149.93 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.619 1.568 . . . . 2.3900000000000001 110.637 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.62 150.85 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.62 1.168 . . . . 3.1000000000000001 111.121 171.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -149.36 150.1 30.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.258 1.823 . . . . 2.0299999999999998 109.577 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.37 156.22 54.88 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.299 3.333 . . . . 1.51 114.054 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 69.1 t -87.22 145.9 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.379 1.072 . . . . 1.8700000000000001 111.882 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.25 152.52 51.3 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.378 3.471 . . . . 3.8500000000000001 107.065 176.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.87 168.58 19.44 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.251 1.575 . . . . 2.3100000000000001 115.251 -152.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 C-N-CA 128.006 2.523 . . . . 10.02 110.718 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.234 0 N-CA-C 106.265 -2.734 . . . . 13.93 106.265 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -53.83 154.32 4.02 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 119.392 -0.923 . . . . 12.24 109.946 134.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.1 144.99 41.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.021 0.928 . . . . 14.02 111.039 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.7 m -147.16 -27.5 0.38 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.493 1.917 . . . . 7.1500000000000004 111.193 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -89.36 173.52 8.33 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.24 1.416 . . . . 5.5199999999999996 111.067 164.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -124.42 146.77 16.36 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.323 1.439 . . . . 1.3799999999999999 113.244 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -137.31 141.48 41.89 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.591 0.96 . . . . 1.3 113.591 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.8 t -95.47 107.95 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.709 0.804 . . . . 0.93999999999999995 109.48 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -88.92 111.72 22.44 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.492 1.042 . . . . 3.8900000000000001 111.027 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.26 168.92 18.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.399 1.48 . . . . 2.6400000000000001 112.844 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -160.98 158.3 23.91 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.267 1.827 . . . . 1.8799999999999999 110.212 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.69 6.65 3.96 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.027 3.151 . . . . 1.51 114.022 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.07 166.98 29.16 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.363 0.982 . . . . 1.4199999999999999 112.367 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.11 -2.27 22.87 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 CA-C-N 118.359 1.079 . . . . 1.52 112.724 -5.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -136.61 169.66 17.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.29 1.436 . . . . 2.0800000000000001 113.54 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.46 171.04 21.08 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.134 1.774 . . . . 0.78000000000000003 112.372 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.55 101.88 6.37 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.199 0.999 . . . . 1.3700000000000001 112.845 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.6 139.08 31.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.88 0.696 . . . . 0.80000000000000004 112.88 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.12 156.47 28.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.389 . . . . 2.1800000000000002 111.0 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.503 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -160.77 146.02 14.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.732 1.753 . . . . 1.53 115.732 166.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 m -79.66 126.9 31.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.461 -0.94 . . . . 1.1499999999999999 108.461 158.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -130.22 138.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.855 1.662 . . . . 2.8199999999999998 110.215 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.09 160.22 39.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.84 0.829 . . . . 2.7400000000000002 113.07 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.19 94.28 47.14 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.507 1.523 . . . . 1.01 109.999 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.98 -5.01 15.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.938 1.759 . . . . 1.1299999999999999 112.769 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.14 156.31 37.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.33 0.967 . . . . 1.1399999999999999 113.085 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.3 m-20 -91.91 4.73 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.456 1.902 . . . . 2.98 113.668 -171.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.84 159.07 42.16 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.859 1.663 . . . . 1.3 110.506 168.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.09 154.24 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.14 2.56 . . . . 0.65000000000000002 111.286 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.74 155.09 20.58 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.042 0.937 . . . . 1.8600000000000001 111.104 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.402 HH21 ' CD ' ' A' ' 68' ' ' GLU . 19.5 ttm180 -133.47 112.34 11.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.042 1.337 . . . . 4.0800000000000001 109.012 168.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.6 tp -93.93 110.47 22.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.759 2.024 . . . . 0.76000000000000001 108.051 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -102.06 -13.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.277 0.843 . . . . 0.56000000000000005 113.277 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -160.72 29.53 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.117 0.865 . . . . 0.46000000000000002 112.76 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.59 174.4 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.788 1.235 . . . . 0.80000000000000004 111.229 166.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -141.99 135.89 29.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.458 1.503 . . . . 5.46 109.279 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -145.09 147.65 35.36 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 119.594 1.088 . . . . 0.69999999999999996 110.643 -171.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.29 -0.39 10.0 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.5 2.8 . . . . 1.0700000000000001 113.92 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 93' ' ' LEU . 1.7 m -107.08 13.28 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.781 1.232 . . . . 1.0 114.093 174.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.34 157.04 43.75 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.431 -1.418 . . . . 1.03 111.667 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -105.35 -70.49 0.78 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.733 -0.84 . . . . 3.9500000000000002 108.733 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -79.22 146.85 32.83 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.969 -1.123 . . . . 3.75 107.969 161.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -147.09 137.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.097 1.359 . . . . 1.3 108.713 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -128.45 133.76 48.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.701 2.0 . . . . 2.3300000000000001 108.565 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -82.82 123.34 29.26 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.839 1.199 . . . . 0.83999999999999997 110.28 167.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 15.3 m170 -109.1 154.96 21.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.387 1.475 . . . . 0.65000000000000002 111.913 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -109.49 -179.14 3.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.594 1.958 . . . . 2.3799999999999999 110.923 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.7 m -133.63 114.34 13.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.497 1.519 . . . . 1.24 108.013 164.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -100.72 151.96 21.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.369 1.068 . . . . 1.8999999999999999 111.712 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -83.96 149.63 26.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.814 0.846 . . . . 4.3600000000000003 111.082 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -154.66 135.9 14.01 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.779 0.832 . . . . 5.4800000000000004 110.844 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.91 146.57 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.051 -0.722 . . . . 4.9000000000000004 109.051 157.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -152.6 123.61 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.329 1.452 . . . . 3.23 108.586 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 50.11 38.33 16.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.205 1.002 . . . . 4.4400000000000004 111.806 -169.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.32 -2.69 9.33 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.895 1.712 . . . . 2.6000000000000001 115.924 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -84.67 130.36 34.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.356 1.578 . . . . 2.7999999999999998 109.514 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.08 136.79 40.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.856 1.262 . . . . 5.1200000000000001 112.609 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -151.75 151.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.225 2.21 . . . . 2.3199999999999998 108.685 -167.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -113.72 131.65 56.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.196 0.998 . . . . 3.6800000000000002 109.9 168.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.81 164.21 22.0 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 124.384 0.992 . . . . 1.29 112.857 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -106.73 160.52 15.41 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.665 1.186 . . . . 1.8799999999999999 112.58 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -168.65 155.82 7.14 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 126.334 1.854 . . . . 3.8700000000000001 110.583 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.8 Cg_endo -69.58 152.84 70.28 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.79 1.66 . . . . 0.59999999999999998 112.286 167.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.27 158.42 48.63 Favored Pre-proline 0 N--CA 1.473 0.694 0 C-N-CA 126.312 1.845 . . . . 0.79000000000000004 110.148 172.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.77 -16.76 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.594 2.196 . . . . 0.83999999999999997 112.68 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -179.74 162.55 1.08 Allowed 'General case' 0 C--N 1.347 0.465 0 C-N-CA 126.236 1.815 . . . . 1.96 110.573 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -109.63 174.23 5.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.002 2.121 . . . . 1.03 109.554 157.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.5 pt-20 -154.83 166.84 32.23 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.145 -0.972 . . . . 2.3799999999999999 112.125 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.28 135.9 11.18 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 124.024 0.93 . . . . 0.82999999999999996 109.403 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.21 168.22 22.76 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.021 1.814 . . . . 0.79000000000000004 111.435 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.66 143.18 91.99 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.365 2.71 . . . . 0.76000000000000001 111.615 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.9 mmmt 68.15 1.0 2.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.968 2.107 . . . . 1.3600000000000001 114.012 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.92 -171.61 27.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.353 1.93 . . . . 1.1399999999999999 112.289 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -158.16 160.89 37.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.276 1.213 . . . . 3.96 114.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 m -143.9 132.14 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.365 1.466 . . . . 2.0099999999999998 111.136 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -93.4 126.55 38.59 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.283 0.633 . . . . 3.6899999999999999 109.336 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -71.03 66.6 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.834 1.302 . . . . 1.45 109.268 161.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -73.11 141.55 81.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.533 2.333 . . . . 3.1400000000000001 111.422 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.13 -44.46 49.16 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 1.2 113.677 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.89 80.85 1.56 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.671 -1.372 . . . . 1.3899999999999999 109.671 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.17 -70.33 0.2 Allowed Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.097 -0.835 . . . . 1.3100000000000001 114.211 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -157.17 146.98 20.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.344 1.857 . . . . 2.1499999999999999 110.154 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -172.89 152.56 2.44 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.569 -1.332 . . . . 1.25 110.444 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -88.98 123.89 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.537 0.335 . . . . 2.3399999999999999 110.961 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.6 mmt -83.54 100.9 11.08 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.881 1.272 . . . . 0.96999999999999997 109.798 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -78.79 138.6 38.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.723 1.209 . . . . 1.8500000000000001 107.811 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -144.09 148.9 35.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.443 1.116 . . . . 1.71 112.178 -173.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.8 -53.13 4.53 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.8 1.191 . . . . 2.5699999999999998 111.42 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 61.15 95.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.667 2.787 . . . . 0.84999999999999998 110.92 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.9 -15.1 62.09 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.794 -1.191 . . . . 2.3799999999999999 112.339 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -147.14 145.66 22.87 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 128.292 2.637 . . . . 4.75 107.848 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.72 176.63 8.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.984 2.456 . . . . 2.3599999999999999 109.879 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 39' ' ' VAL . 1.5 mp -130.55 -179.0 5.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.972 0.909 . . . . 3.79 111.93 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -151.0 144.65 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.461 1.904 . . . . 5.0099999999999998 110.022 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 131.57 49.3 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.624 1.169 . . . . 2.2799999999999998 112.955 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.58 -16.37 52.05 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.887 -1.507 . . . . 3.9300000000000002 115.125 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.69 172.11 8.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.541 1.67 . . . . 6.0800000000000001 111.191 -166.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.42 111.88 23.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.263 1.825 . . . . 4.4299999999999997 111.485 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.67 117.63 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.085 -1.08 . . . . 1.0 108.085 165.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -74.19 140.91 45.44 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.38 1.086 . . . . 2.9399999999999999 110.911 157.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.78 125.97 12.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.938 1.695 . . . . 1.76 109.843 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.57 96.29 7.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.98 2.112 . . . . 2.8399999999999999 109.439 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.0 mt -80.27 112.42 17.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.023 1.729 . . . . 1.6899999999999999 110.222 -171.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.4 mt -82.85 128.61 34.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.314 1.046 . . . . 1.0 111.472 -170.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 89.0 m-85 -124.2 126.96 47.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.649 0.78 . . . . 2.3599999999999999 112.055 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 41.28 29.34 0.09 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.59 2.356 . . . . 2.5299999999999998 116.399 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.73 -55.39 3.8 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.321 1.439 . . . . 4.3099999999999996 113.087 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.33 -3.13 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.82 1.2 . . . . 2.0899999999999999 115.374 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 6.2 mtpp -130.52 161.16 32.1 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.07 1.435 . . . . 5.21 114.025 175.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.48 166.44 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.874 2.07 . . . . 1.22 108.715 155.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.6 mt -137.24 126.5 24.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.713 1.605 . . . . 1.6399999999999999 109.339 159.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -83.48 131.71 34.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.133 0.424 . . . . 2.5600000000000001 111.469 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.02 156.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.592 1.157 . . . . 3.1200000000000001 109.535 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.396 1.878 . . . . 1.71 109.995 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -143.49 144.44 27.79 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.495 1.518 . . . . 2.6299999999999999 110.773 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 149.46 28.52 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.202 2.602 . . . . 1.1599999999999999 113.616 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.4 t -84.23 130.56 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.006 1.322 . . . . 1.0600000000000001 112.571 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.0 144.67 29.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.106 1.762 . . . . 3.3100000000000001 109.527 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.51 86.77 2.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.643 1.177 . . . . 2.1499999999999999 109.784 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.167 1.387 . . . . 7.5499999999999998 110.733 -166.002 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 N-CA-C 108.05 -2.02 . . . . 12.699999999999999 108.05 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m 62.1 -15.04 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 121.296 3.813 . . . . 11.16 121.296 125.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 63.56 113.78 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.521 1.055 . . . . 10.0 109.66 -129.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -137.17 127.94 27.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.062 1.345 . . . . 6.3899999999999997 108.512 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -119.02 128.53 54.46 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.715 1.259 . . . . 5.6600000000000001 110.942 -161.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.18 170.59 42.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.415 1.959 . . . . 1.22 111.353 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.0 p90 -158.13 146.49 18.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.596 1.158 . . . . 1.3999999999999999 110.998 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -106.72 118.35 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.583 -1.266 . . . . 0.93999999999999995 107.583 170.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -89.51 114.61 26.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.159 0.984 . . . . 3.75 109.769 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.07 166.92 21.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.05 1.405 . . . . 2.3999999999999999 113.497 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t -156.32 155.26 28.71 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.602 2.361 . . . . 3.1200000000000001 108.385 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.93 -13.78 39.36 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.544 2.163 . . . . 1.8899999999999999 112.559 165.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.87 174.71 18.37 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.964 1.745 . . . . 1.72 112.737 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 -5.91 48.26 Favored 'Cis proline' 0 CA--C 1.54 0.809 0 CA-C-N 118.415 1.107 . . . . 1.79 113.513 -1.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -126.98 161.98 27.07 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.611 1.165 . . . . 1.97 113.23 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.01 -176.37 5.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.361 2.264 . . . . 0.70999999999999996 111.635 -175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.56 146.6 25.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.211 0.819 . . . . 0.80000000000000004 113.211 -168.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.37 156.08 45.2 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.749 1.018 . . . . 0.72999999999999998 113.749 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.37 149.77 28.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.381 1.872 . . . . 2.1400000000000001 109.881 -169.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -171.74 160.81 5.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.281 1.032 . . . . 1.78 113.66 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -94.54 119.9 33.94 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.16 0.984 . . . . 1.23 109.875 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.2 124.95 40.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.861 1.264 . . . . 3.1000000000000001 108.619 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -120.18 122.63 41.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.983 1.313 . . . . 3.8599999999999999 110.328 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -102.61 103.96 35.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.349 -0.611 . . . . 0.97999999999999998 109.349 164.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -86.6 -11.32 5.92 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.223 2.616 . . . . 1.05 113.122 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.83 160.44 43.03 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 124.273 0.939 . . . . 1.1399999999999999 112.657 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.45 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.2 m-20 -90.25 5.97 44.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 2.9500000000000002 113.235 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.98 160.02 40.54 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.241 1.816 . . . . 1.8400000000000001 110.602 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.82 152.16 22.07 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.915 2.41 . . . . 0.82999999999999996 111.432 -171.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -116.63 123.76 48.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.674 1.19 . . . . 2.0699999999999998 110.385 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ttp-105 -117.77 110.45 17.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.227 1.411 . . . . 4.4900000000000002 111.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -97.73 106.15 18.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.278 2.231 . . . . 0.84999999999999998 108.936 -170.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.04 -19.36 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.056 0.942 . . . . 0.82999999999999996 112.683 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.93 -162.34 30.57 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.536 0.607 . . . . 0.70999999999999996 112.674 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -138.0 -177.57 4.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.054 0.942 . . . . 0.81999999999999995 110.444 170.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -148.26 141.7 25.32 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 105.149 -2.167 . . . . 7.4299999999999997 105.149 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.68 152.3 37.44 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.649 -1.167 . . . . 0.71999999999999997 109.195 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.6 -34.21 98.7 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.647 2.231 . . . . 0.97999999999999998 113.029 167.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.284 2.2 m -81.94 4.04 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.484 0.92 . . . . 0.94999999999999996 113.484 -165.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.08 19.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.527 1.058 . . . . 0.71999999999999997 113.51 -174.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.09 -51.8 1.54 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 3.6299999999999999 110.656 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -79.51 133.54 36.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.037 -1.097 . . . . 3.2000000000000002 108.037 155.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -145.75 126.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 127.062 2.145 . . . . 1.29 108.364 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.91 115.87 6.03 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.69 0.796 . . . . 2.5699999999999998 110.972 -157.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.39 121.42 23.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.821 1.192 . . . . 0.80000000000000004 110.377 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.3 m170 -108.1 151.67 25.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.75 1.62 . . . . 0.52000000000000002 113.259 174.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.91 172.02 8.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.746 1.618 . . . . 2.23 110.125 163.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -151.06 86.58 1.37 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.382 1.473 . . . . 1.0700000000000001 107.674 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -96.56 -173.81 2.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.802 2.041 . . . . 2.48 111.576 -171.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.44 139.72 27.08 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.028 0.918 . . . . 3.21 111.855 170.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.22 150.43 26.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.602 1.161 . . . . 6.4199999999999999 111.959 -170.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.327 16.6 pm0 -64.99 142.17 58.53 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.227 1.811 . . . . 6.0999999999999996 113.44 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 t -130.21 -95.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.157 1.383 . . . . 2.7599999999999998 107.37 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -73.08 45.48 0.15 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.908 2.083 . . . . 4.8600000000000003 111.919 164.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.98 -40.15 1.18 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.533 1.539 . . . . 2.25 113.265 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -61.81 138.62 58.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.023 1.729 . . . . 3.79 110.862 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -77.89 112.23 14.56 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.201 0.6 . . . . 4.9400000000000004 109.803 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.86 139.56 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.443 1.897 . . . . 1.6599999999999999 108.632 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -83.86 139.65 32.51 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.725 1.21 . . . . 3.0800000000000001 110.824 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.41 163.36 31.54 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.493 0.557 . . . . 0.94999999999999996 114.493 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -112.85 165.56 12.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.276 1.43 . . . . 1.71 112.406 -176.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.252 76.0 mtt180 -169.52 141.58 1.98 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 128.738 2.815 . . . . 4.8200000000000003 106.55 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.2 Cg_endo -68.95 150.73 73.39 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 CA-C-N 122.024 1.759 . . . . 0.66000000000000003 110.192 156.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.97 156.87 47.73 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.143 1.377 . . . . 0.55000000000000004 110.438 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.42 -23.48 50.86 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.356 2.037 . . . . 0.69999999999999996 112.395 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -178.78 167.38 1.7 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 126.434 1.893 . . . . 2.23 111.585 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.091 1.356 . . . . 0.93999999999999995 110.071 150.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.251 2.8 pt-20 -153.55 160.0 42.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.888 -0.507 . . . . 2.7200000000000002 111.949 164.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 t -141.42 134.46 14.31 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 125.798 1.639 . . . . 1.1000000000000001 108.851 -166.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.52 164.61 32.19 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.409 2.073 . . . . 0.98999999999999999 111.679 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.38 145.03 99.12 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.346 2.697 . . . . 0.79000000000000004 111.825 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 16.5 mmmt 68.96 -1.62 2.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.36 1.864 . . . . 1.4099999999999999 113.66 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.02 125.94 7.85 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 127.649 2.547 . . . . 0.92000000000000004 112.811 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -86.37 149.43 25.03 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.994 -1.103 . . . . 5.3700000000000001 111.79 156.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 m -152.45 131.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.64 1.576 . . . . 1.6599999999999999 109.52 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -89.84 134.43 34.2 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.287 1.035 . . . . 4.0899999999999999 111.028 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 mp -76.13 66.22 2.25 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.214 1.483 . . . . 1.53 110.122 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -56.97 124.47 65.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 4.8499999999999996 109.838 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.32 -33.96 88.35 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.574 2.85 . . . . 1.3799999999999999 113.765 -169.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.94 45.63 2.52 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.068 0.849 . . . . 1.8899999999999999 112.361 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.45 -57.87 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.567 2.032 . . . . 1.4399999999999999 113.988 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -150.26 145.54 26.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.889 1.676 . . . . 2.0299999999999998 110.877 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -166.14 179.83 5.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.344 1.058 . . . . 0.79000000000000004 110.941 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -115.7 132.48 56.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.23 1.012 . . . . 2.2400000000000002 111.132 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.7 mmt -93.11 139.77 30.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 0.85999999999999999 110.772 165.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 143.18 51.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.719 1.608 . . . . 2.98 109.736 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -146.18 160.32 42.12 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 2.2000000000000002 112.079 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.58 -82.39 1.69 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.084 1.326 . . . . 2.7799999999999998 109.895 -169.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 76.85 125.68 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.786 3.634 . . . . 0.92000000000000004 110.941 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -77.74 -22.97 49.51 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.818 -1.176 . . . . 2.02 112.881 -170.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -161.83 158.15 21.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 130.233 3.413 . . . . 6.8499999999999996 109.059 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.39 149.09 56.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.758 2.305 . . . . 3.4500000000000002 109.653 160.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 -176.57 2.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.037 1.735 . . . . 3.4199999999999999 109.82 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.35 141.63 19.55 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.214 -1.554 . . . . 3.5 110.513 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -34.79 135.99 0.17 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.637 1.717 . . . . 1.8100000000000001 115.637 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.83 22.39 69.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.124 0.81 . . . . 1.9099999999999999 115.124 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -88.83 -179.46 5.98 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.754 1.222 . . . . 3.3100000000000001 109.839 158.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -130.74 168.89 16.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.103 0.961 . . . . 3.5899999999999999 111.321 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.9 t -136.33 117.71 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.391 1.476 . . . . 0.93000000000000005 109.967 -172.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.42 42.04 0.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.016 2.127 . . . . 4.3399999999999999 114.214 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.5 tt -65.39 137.09 57.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 123.4 1.571 . . . . 1.8600000000000001 112.958 -164.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.09 112.61 25.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.781 2.032 . . . . 2.4900000000000002 111.303 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -82.43 120.32 25.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.084 1.354 . . . . 1.1899999999999999 110.752 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.8 mt -96.68 123.42 40.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.614 1.166 . . . . 0.83999999999999997 111.54 -168.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.45 133.65 55.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.147 1.536 . . . . 1.8700000000000001 115.147 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.17 48.28 0.85 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.821 2.048 . . . . 2.6800000000000002 112.768 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.38 19.79 2.81 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.106 2.289 . . . . 4.9299999999999997 112.307 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.98 38.07 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 118.275 1.037 . . . . 2.25 112.098 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 150.01 36.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.155 1.782 . . . . 3.6699999999999999 111.197 -175.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.85 131.62 20.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 126.015 1.726 . . . . 1.1100000000000001 108.073 161.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.14 122.69 41.56 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.331 1.452 . . . . 2.2000000000000002 109.277 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -79.84 132.34 36.09 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.835 -0.541 . . . . 2.4500000000000002 111.548 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -129.55 127.47 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.393 1.077 . . . . 1.49 109.567 167.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.22 138.38 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.059 0.943 . . . . 2.8300000000000001 110.224 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.4 mt -143.55 142.62 21.37 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.252 1.421 . . . . 1.8300000000000001 110.083 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.85 153.04 64.13 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.385 2.723 . . . . 1.1100000000000001 112.667 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.5 t -83.4 113.95 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.113 1.365 . . . . 1.1499999999999999 108.926 165.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -100.36 145.81 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.583 1.953 . . . . 3.7999999999999998 108.015 167.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.91 55.21 0.78 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.3 1.593 . . . . 2.9100000000000001 115.3 -152.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.076 2.15 . . . . 7.8399999999999999 111.25 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.197 0 N-CA-C 106.968 -2.453 . . . . 11.56 106.968 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 t 64.53 -147.55 0.27 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.043 -1.466 . . . . 10.779999999999999 107.043 -121.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -58.52 157.87 8.4 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.793 1.179 . . . . 9.6400000000000006 112.494 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.83 151.71 27.5 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.014 2.126 . . . . 7.9900000000000002 108.279 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -129.06 -142.09 0.25 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.333 1.453 . . . . 5.1600000000000001 110.312 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.97 169.04 26.31 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.647 -1.283 . . . . 0.87 114.436 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -150.63 146.59 26.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.762 1.625 . . . . 1.48 111.558 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -109.44 107.66 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.682 -1.229 . . . . 1.0700000000000001 107.682 171.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -82.4 121.9 27.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.276 -0.639 . . . . 3.77 109.276 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -160.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.447 1.099 . . . . 2.23 112.016 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 8.6 t 174.0 157.65 0.31 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 128.641 2.776 . . . . 2.77 106.935 168.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.97 -10.78 29.74 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.572 2.182 . . . . 1.7 113.197 167.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.53 177.69 26.06 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.005 1.288 . . . . 1.49 112.007 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.51 -1.21 32.26 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 CA-C-N 118.665 1.232 . . . . 1.49 113.621 1.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -140.58 158.27 44.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.793 1.237 . . . . 2.0699999999999998 112.478 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 11' ' ' SER . . . -152.98 -178.74 7.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.155 2.582 . . . . 0.63 110.27 -177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.22 133.59 16.43 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.344 1.239 . . . . 0.98999999999999999 114.344 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.55 153.02 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.847 1.259 . . . . 0.71999999999999997 111.981 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.44 136.95 15.9 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.911 1.684 . . . . 2.21 109.373 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -161.53 150.8 16.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.07 1.508 . . . . 2.1800000000000002 115.07 -167.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -72.11 125.79 28.15 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.282 1.033 . . . . 1.45 108.714 165.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 tt -107.13 155.33 19.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.939 1.696 . . . . 3.04 110.47 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.01 161.77 37.24 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 115.536 1.68 . . . . 3.75 115.536 165.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -130.79 96.46 23.07 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 127.306 2.242 . . . . 1.1799999999999999 109.425 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.88 -8.19 13.28 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.506 2.138 . . . . 1.0 113.703 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.05 157.71 41.48 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 119.655 1.116 . . . . 1.3600000000000001 112.179 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -82.87 9.8 9.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.126 1.771 . . . . 3.2999999999999998 112.681 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mt -110.58 165.32 12.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 129.031 2.933 . . . . 2.46 108.507 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.34 157.58 12.79 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.958 2.439 . . . . 0.77000000000000002 111.445 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.99 147.76 38.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.437 1.095 . . . . 1.8999999999999999 111.231 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 ttp-105 -135.79 112.24 9.92 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.125 1.37 . . . . 3.4700000000000002 110.768 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -88.07 120.68 29.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.957 2.103 . . . . 1.1599999999999999 108.741 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.78 -20.85 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.03 1.332 . . . . 0.65000000000000002 112.669 -177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.67 -162.2 20.31 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 122.214 0.897 . . . . 0.65000000000000002 112.061 169.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.889 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -149.48 177.58 9.58 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.229 1.811 . . . . 0.65000000000000002 108.64 171.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -161.82 152.64 17.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.04 1.291 . . . . 6.1100000000000003 109.323 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -153.72 151.42 25.05 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 125.469 1.508 . . . . 0.60999999999999999 108.932 -166.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.1 -23.03 46.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.184 1.923 . . . . 0.88 113.843 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 m -88.01 -3.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 115.36 1.615 . . . . 1.0600000000000001 115.36 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.58 134.71 49.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.931 1.241 . . . . 0.85999999999999999 111.176 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -56.44 18.94 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.777 1.171 . . . . 5.71 109.277 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -124.12 151.48 43.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.53 1.932 . . . . 4.2300000000000004 110.974 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.86 135.2 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.904 2.082 . . . . 2.4500000000000002 107.934 163.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -126.77 130.1 49.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.95 0.9 . . . . 2.3799999999999999 109.666 167.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tp -85.92 117.34 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.59 1.556 . . . . 3.4399999999999999 108.843 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.3 m170 -126.43 151.96 47.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.084 1.354 . . . . 0.83999999999999997 113.778 -170.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.65 167.7 13.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.079 1.751 . . . . 2.52 111.806 165.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.4 m -153.61 92.66 1.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.706 2.002 . . . . 2.0800000000000001 107.213 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -109.61 163.48 13.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.111 1.152 . . . . 2.48 114.111 -156.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.68 143.93 27.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.301 1.04 . . . . 4.0 109.907 150.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -149.57 151.75 34.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.665 2.386 . . . . 7.8200000000000003 107.09 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.33 145.44 37.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.683 0.793 . . . . 4.9100000000000001 111.72 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.88 117.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.81 -1.552 . . . . 3.9500000000000002 106.81 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.3 28.58 17.96 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.3 1.04 . . . . 7.29 111.461 -172.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.33 -12.79 12.38 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 120.486 -1.384 . . . . 4.3099999999999996 114.049 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -75.52 135.09 40.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.305 1.442 . . . . 5.04 109.75 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -74.06 135.24 43.01 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.205 1.002 . . . . 4.5199999999999996 111.878 -170.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.03 144.84 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.775 1.63 . . . . 2.54 109.421 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.97 139.0 51.14 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.804 1.242 . . . . 3.0899999999999999 111.905 172.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -179.15 38.66 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 123.854 0.74 . . . . 1.29 113.694 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.4 177.63 4.96 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.057 1.343 . . . . 2.04 111.823 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 175.64 143.1 0.22 Allowed Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 126.813 2.045 . . . . 7.4500000000000002 110.039 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.3 Cg_endo -67.83 154.46 72.96 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 121.617 1.613 . . . . 0.76000000000000001 110.783 161.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.93 156.43 69.0 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 125.989 1.716 . . . . 0.84999999999999998 109.986 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.77 -19.92 40.52 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.028 1.819 . . . . 0.73999999999999999 112.58 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 178.84 169.96 0.88 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.728 1.611 . . . . 1.8500000000000001 111.031 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.03 163.58 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.11 1.364 . . . . 0.69999999999999996 108.938 157.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.253 0.2 OUTLIER -153.57 158.39 41.13 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.504 -0.748 . . . . 2.0099999999999998 112.28 177.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -146.34 133.65 10.2 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.298 1.439 . . . . 0.98999999999999999 108.863 -162.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.11 168.36 24.95 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.0 2.467 . . . . 0.81999999999999995 111.902 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.49 137.65 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.188 3.925 . . . . 1.28 114.287 165.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt 68.38 1.21 2.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.951 1.7 . . . . 1.5800000000000001 114.049 169.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 115.08 4.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.86 1.695 . . . . 1.0900000000000001 112.209 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.71 122.26 42.45 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.065 1.746 . . . . 4.8300000000000001 109.5 161.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.1 m -155.22 146.29 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.273 1.429 . . . . 2.0099999999999998 112.288 -163.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -91.27 142.79 27.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.085 0.954 . . . . 3.1499999999999999 113.021 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.4 68.85 0.23 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 1.22 108.508 148.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -54.19 122.62 37.53 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.054 1.742 . . . . 4.0499999999999998 110.381 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.15 -42.16 66.29 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.546 2.831 . . . . 1.52 112.891 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.02 75.3 2.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.7 -0.96 . . . . 1.2 110.7 161.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.77 -61.03 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.759 1.647 . . . . 1.3 112.462 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -151.55 150.67 30.61 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.482 1.513 . . . . 3.0699999999999998 111.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -160.19 170.72 20.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.221 1.008 . . . . 1.3999999999999999 111.079 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -102.51 127.4 49.58 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.249 1.019 . . . . 2.2000000000000002 110.64 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mmt -83.44 124.87 31.12 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.798 0.839 . . . . 1.29 110.574 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.28 134.35 48.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.195 1.398 . . . . 1.8700000000000001 108.707 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.3 mt -134.2 161.01 36.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.65 1.18 . . . . 1.7 112.008 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.91 35.06 39.11 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 126.144 1.83 . . . . 2.4100000000000001 114.998 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 mt -37.14 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.245 2.218 . . . . 0.96999999999999997 114.652 -156.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -77.25 14.25 0.97 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.977 1.473 . . . . 1.8899999999999999 114.977 -165.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -159.49 147.03 13.04 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 131.44 3.896 . . . . 7.2000000000000002 109.468 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.98 170.52 15.45 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.015 2.476 . . . . 2.1899999999999999 109.317 166.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 157.64 43.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.302 1.049 . . . . 4.4400000000000004 112.791 -165.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -143.18 144.11 32.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.821 1.648 . . . . 4.29 109.639 176.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.4 144.04 57.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.856 0.863 . . . . 1.8 111.901 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.91 45.22 27.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.854 -0.97 . . . . 1.73 112.934 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -109.35 177.87 4.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.534 0.734 . . . . 4.8499999999999996 109.741 148.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.57 161.62 17.64 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.216 1.806 . . . . 4.5999999999999996 110.201 152.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -125.58 133.16 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.691 1.597 . . . . 1.1799999999999999 109.721 163.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.65 144.76 28.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.901 1.68 . . . . 3.1699999999999999 110.292 172.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.889 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.8 tt -156.37 131.74 9.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.39 1.076 . . . . 1.6799999999999999 112.087 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.42 115.18 27.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.537 2.335 . . . . 2.2799999999999998 111.947 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.19 118.9 22.96 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.688 1.585 . . . . 1.26 109.547 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.7 mt -98.37 122.51 41.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.231 1.012 . . . . 0.70999999999999996 110.36 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -113.82 154.41 27.48 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.036 0.934 . . . . 2.02 112.6 -173.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.7 95.97 0.37 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.088 1.355 . . . . 1.96 112.605 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.45 -147.78 18.61 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.056 1.312 . . . . 3.0299999999999998 111.317 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.47 36.94 2.02 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.287 0.946 . . . . 1.71 115.379 -171.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -127.74 134.08 49.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.696 1.748 . . . . 4.7300000000000004 113.075 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.61 147.32 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.362 1.865 . . . . 1.0900000000000001 108.064 158.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -141.17 115.89 9.66 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.182 1.393 . . . . 1.5800000000000001 108.164 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.11 153.06 21.81 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.705 1.002 . . . . 2.5499999999999998 113.705 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.75 166.88 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.319 2.248 . . . . 1.26 109.768 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.23 133.99 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.21 1.004 . . . . 1.72 108.457 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt -145.64 152.44 49.03 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.28 1.432 . . . . 2.0499999999999998 110.56 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.81 151.97 74.04 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 125.2 3.933 . . . . 0.85999999999999999 115.16 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.2 t -83.41 100.72 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.681 1.592 . . . . 1.05 109.719 170.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -90.7 74.68 6.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.009 1.724 . . . . 3.0699999999999998 109.018 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.16 128.6 37.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.077 -1.014 . . . . 2.1099999999999999 113.544 -166.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 . . . . . 0 N--CA 1.484 1.273 1 C-N-CA 132.647 4.379 . . . . 7.3300000000000001 108.493 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 109.371 -1.492 . . . . 10.77 109.371 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 p -60.7 -32.98 72.2 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.469 1.635 . . . . 9.8100000000000005 110.742 150.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -152.81 176.24 12.02 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 131.634 3.974 . . . . 8.6500000000000004 105.982 156.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -139.48 -135.9 0.12 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 104.988 -2.227 . . . . 7.8799999999999999 104.988 168.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -155.25 163.38 40.23 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 127.573 2.349 . . . . 5.7000000000000002 106.55 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.21 156.06 22.61 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.681 -0.637 . . . . 0.95999999999999996 113.638 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -154.73 147.32 24.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.19 0.996 . . . . 1.6599999999999999 111.797 175.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.44 116.97 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.616 0.767 . . . . 0.91000000000000003 110.649 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 ttp85 -81.61 103.23 11.18 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.028 1.331 . . . . 4.04 110.577 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.55 165.06 25.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 123.431 1.586 . . . . 2.2999999999999998 112.465 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -161.22 154.08 17.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.58 2.352 . . . . 1.9399999999999999 107.949 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.28 27.6 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.398 3.398 . . . . 1.5600000000000001 113.503 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.71 169.42 42.76 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.477 -0.764 . . . . 1.4199999999999999 113.049 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.14 -5.58 25.77 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 118.005 0.902 . . . . 1.53 112.604 -10.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.99 157.65 44.06 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.073 1.349 . . . . 3.0 113.34 -168.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.27 -176.21 5.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.63 1.972 . . . . 0.67000000000000004 111.294 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.44 129.0 15.04 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.986 0.914 . . . . 1.01 111.814 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.27 138.41 44.59 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.787 1.235 . . . . 0.71999999999999997 111.84 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -124.83 151.32 45.39 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.138 2.175 . . . . 2.5 109.102 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.03 150.11 16.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.173 1.175 . . . . 1.74 114.173 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -89.49 113.63 25.03 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.501 -0.926 . . . . 1.4299999999999999 108.501 166.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.82 156.54 20.97 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.038 1.735 . . . . 2.7000000000000002 110.806 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.15 157.45 43.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.911 0.708 . . . . 3.5600000000000001 112.911 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -96.34 109.79 49.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 114.359 -1.291 . . . . 1.0900000000000001 110.19 166.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.84 -2.82 10.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.371 2.714 . . . . 1.21 113.78 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.69 171.27 37.64 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.4 1.0 . . . . 1.04 113.133 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -95.57 0.13 52.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.525 1.53 . . . . 3.5299999999999998 113.781 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -116.84 154.61 49.55 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.674 1.589 . . . . 1.3500000000000001 110.056 167.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.91 159.05 27.55 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.501 2.801 . . . . 0.68999999999999995 112.506 -164.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -106.59 152.23 23.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.68 1.192 . . . . 1.8200000000000001 110.837 171.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -130.78 112.25 12.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.084 1.353 . . . . 3.8900000000000001 109.619 171.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 tp -94.81 112.3 24.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.065 2.546 . . . . 0.72999999999999998 109.601 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.79 -11.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.922 1.082 . . . . 0.58999999999999997 113.922 -165.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.74 -167.95 40.67 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.506 -0.746 . . . . 0.63 112.583 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.54 -179.69 7.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.506 0.558 . . . . 0.85999999999999999 112.506 167.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -145.69 142.19 28.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.327 1.051 . . . . 7.21 109.044 169.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -153.9 151.09 24.09 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.544 1.138 . . . . 0.65000000000000002 110.448 -164.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.72 -17.81 37.55 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.396 2.064 . . . . 1.04 112.652 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.32 2.0 m -96.91 11.07 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.199 1.555 . . . . 1.6399999999999999 115.199 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . . . -154.82 144.29 21.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.91 1.448 . . . . 0.97999999999999998 114.91 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.87 -69.82 0.75 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.934 -0.765 . . . . 3.1200000000000001 108.934 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.912 -1.514 . . . . 2.7599999999999998 106.912 164.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.19 129.17 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.173 1.789 . . . . 1.28 107.548 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.3 131.95 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.325 1.45 . . . . 1.9099999999999999 109.273 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.07 122.17 27.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.086 0.945 . . . . 0.78000000000000003 110.579 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -112.52 159.29 18.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.834 2.054 . . . . 0.5 111.986 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.37 -177.34 3.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.742 2.017 . . . . 2.6600000000000001 110.925 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 m -137.12 116.28 12.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.339 1.456 . . . . 1.3300000000000001 107.59 163.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -96.74 162.53 13.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.863 0.865 . . . . 2.25 110.996 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -112.32 143.14 43.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 3.5800000000000001 110.822 162.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -153.78 159.67 41.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.742 1.617 . . . . 5.6399999999999997 111.295 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 141.35 36.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.823 -0.806 . . . . 4.1399999999999997 108.823 156.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.33 -8.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 115.139 1.533 . . . . 3.1400000000000001 115.139 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -158.27 46.0 0.33 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.673 1.989 . . . . 4.0800000000000001 107.586 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.74 -24.06 0.4 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.766 1.651 . . . . 2.0 114.706 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -99.79 153.47 19.1 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.122 2.169 . . . . 3.1200000000000001 112.49 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -61.66 136.54 58.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.956 0.902 . . . . 3.8900000000000001 111.34 169.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.8 t -140.0 150.44 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.061 2.144 . . . . 1.9299999999999999 108.275 168.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.3 mtm -111.57 144.48 40.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.396 1.079 . . . . 3.1800000000000002 111.347 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.47 158.03 28.16 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 123.597 0.618 . . . . 1.0900000000000001 113.012 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.67 165.56 11.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.413 1.085 . . . . 1.74 112.551 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -171.15 155.29 4.32 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.535 1.934 . . . . 3.8700000000000001 109.848 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.6 Cg_endo -69.75 152.33 69.36 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.926 1.75 . . . . 0.59999999999999998 111.482 167.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -115.17 157.97 42.27 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 126.381 1.872 . . . . 0.78000000000000003 110.278 170.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -69.36 -21.43 35.36 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 0.81999999999999995 111.952 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -177.93 161.25 1.54 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.267 1.827 . . . . 2.1200000000000001 110.82 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -108.2 174.97 5.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.741 2.016 . . . . 0.76000000000000001 109.455 157.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.55 165.07 36.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.048 -1.032 . . . . 2.3100000000000001 111.222 170.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -146.07 130.14 8.61 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 123.436 0.694 . . . . 0.79000000000000004 109.334 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.12 164.85 34.34 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.197 1.932 . . . . 0.80000000000000004 111.108 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.39 137.01 75.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.514 2.809 . . . . 0.81000000000000005 112.144 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 64.05 11.15 5.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.834 1.654 . . . . 1.5800000000000001 113.622 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.08 120.06 5.13 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 127.766 2.603 . . . . 0.91000000000000003 111.197 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -85.38 142.91 28.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.005 1.322 . . . . 5.71 111.87 162.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.98 148.32 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.029 1.731 . . . . 1.73 110.398 172.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -129.92 114.5 15.94 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.289 -1.004 . . . . 5.0199999999999996 108.289 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.76 67.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.64 1.976 . . . . 1.3500000000000001 112.388 -171.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.57 133.92 44.88 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.854 2.461 . . . . 2.6800000000000002 113.634 166.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.6 -52.59 7.23 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.502 2.802 . . . . 1.5600000000000001 112.132 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.33 89.12 1.01 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.401 -1.48 . . . . 1.53 109.401 166.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.95 -72.25 0.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.73 2.109 . . . . 1.25 112.753 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -155.43 132.25 10.62 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.474 1.51 . . . . 1.9399999999999999 112.299 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -156.88 165.93 34.81 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.023 -1.048 . . . . 0.75 111.487 -171.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.27 113.71 26.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.307 0.575 . . . . 1.78 109.699 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.26 125.13 33.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.508 1.123 . . . . 1.4299999999999999 109.195 175.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 24.0 mt -113.68 135.91 53.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.912 1.285 . . . . 1.76 110.077 -168.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -146.65 154.67 41.73 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.782 1.633 . . . . 2.0600000000000001 111.02 -172.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.39 -54.46 4.32 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.734 1.159 . . . . 2.4100000000000001 112.371 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt 70.02 107.51 0.06 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.875 3.27 . . . . 1.3899999999999999 111.133 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.18 14.33 2.41 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.76 -1.212 . . . . 1.99 113.712 -169.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.452 HH21 ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.8 153.52 15.91 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.682 2.393 . . . . 5.5700000000000003 109.633 176.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.7 140.61 23.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.772 2.314 . . . . 2.4300000000000002 109.875 166.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.3 mt -115.57 152.68 32.61 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.148 1.379 . . . . 3.1499999999999999 111.794 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -147.75 9.63 0.91 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.724 2.12 . . . . 3.9399999999999999 116.724 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 64.0 172.87 0.18 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.934 2.094 . . . . 2.7200000000000002 112.225 -169.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.58 52.48 52.82 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 121.661 -0.649 . . . . 2.3999999999999999 111.99 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.452 ' CD ' HH21 ' A' ' 91' ' ' ARG . 9.8 pt-20 -152.01 163.88 38.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.003 2.121 . . . . 3.77 111.051 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -101.51 123.1 45.0 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.279 1.831 . . . . 4.4299999999999997 109.499 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.68 106.09 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.001 -1.111 . . . . 1.21 108.001 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 143.22 42.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.631 -1.168 . . . . 3.1400000000000001 109.171 160.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -155.33 116.39 3.93 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.946 -1.096 . . . . 1.5900000000000001 111.213 -167.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.86 100.58 12.65 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.297 1.439 . . . . 2.3900000000000001 110.378 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 mt -80.52 119.65 23.46 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.646 -0.659 . . . . 1.5800000000000001 109.528 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.8 mt -93.6 129.93 39.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.178 0.991 . . . . 0.83999999999999997 110.61 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -130.37 122.49 27.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.408 0.623 . . . . 2.0 112.504 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.0 12.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.401 2.001 . . . . 2.4300000000000002 116.401 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.62 -45.73 1.6 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.967 1.27 . . . . 3.3900000000000001 112.64 -165.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.87 4.67 44.19 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.194 1.378 . . . . 2.46 116.042 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.69 152.85 33.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.53 1.932 . . . . 3.8599999999999999 112.686 176.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.9 140.64 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.647 1.979 . . . . 1.03 107.819 161.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -139.04 124.05 18.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.755 1.222 . . . . 1.5900000000000001 108.056 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.45 150.7 20.01 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.817 1.414 . . . . 2.3700000000000001 114.817 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.91 145.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.823 1.649 . . . . 1.26 110.91 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -106.84 129.81 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.614 1.166 . . . . 1.8 108.623 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.3 mt -140.68 150.52 60.47 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.743 1.617 . . . . 1.8200000000000001 110.183 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.02 146.49 37.11 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.096 2.53 . . . . 0.89000000000000001 112.874 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.29 139.43 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.636 -0.711 . . . . 1.0700000000000001 110.567 156.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.57 151.34 39.54 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.428 3.491 . . . . 3.5800000000000001 108.672 170.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.72 73.27 1.46 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.194 1.554 . . . . 2.27 115.194 -157.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.377 1.071 . . . . 7.4199999999999999 112.556 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 107.006 -2.438 . . . . 12.25 107.006 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 m 64.72 136.41 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 O-C-N 124.752 0.913 . . . . 10.52 109.025 -126.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -169.53 145.34 3.16 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.292 -0.88 . . . . 11.67 111.859 -160.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -154.99 -52.19 0.09 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.134 2.174 . . . . 6.2199999999999998 109.867 -173.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -134.52 -173.1 3.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.57 1.148 . . . . 5.6699999999999999 113.543 -159.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.04 165.24 17.26 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.592 1.568 . . . . 1.97 114.525 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -148.97 134.4 18.52 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.146 1.778 . . . . 2.5899999999999999 110.552 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.4 t -91.33 140.15 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.74 1.216 . . . . 1.0600000000000001 107.879 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.46 -24.4 18.04 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.884 1.439 . . . . 3.4100000000000001 114.884 -175.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.28 175.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.697 1.999 . . . . 2.23 114.559 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 m 176.34 167.24 0.43 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 130.92 3.688 . . . . 1.6899999999999999 107.903 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.24 -6.55 18.58 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.993 2.462 . . . . 2.1899999999999999 113.584 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 112.28 166.34 17.41 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.115 1.816 . . . . 1.8600000000000001 111.696 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.62 -7.71 45.1 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.112 1.456 . . . . 1.8500000000000001 113.633 -1.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -130.17 174.08 10.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.05 1.34 . . . . 2.1800000000000002 112.836 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.51 -174.66 3.23 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.216 2.206 . . . . 0.59999999999999998 112.037 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.19 165.49 22.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.598 1.159 . . . . 0.88 111.352 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.66 162.35 40.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.241 1.816 . . . . 0.70999999999999996 111.355 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -155.6 165.0 37.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.727 1.611 . . . . 2.23 111.274 -173.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.467 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.4 pt? -160.44 161.3 32.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 116.0 1.852 . . . . 1.54 116.0 170.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -70.06 125.6 27.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 112.663 -2.062 . . . . 1.5 106.164 153.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -134.67 129.58 35.03 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.559 1.544 . . . . 2.75 107.108 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -153.9 150.76 28.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 114.583 1.327 . . . . 2.77 114.583 -173.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -103.63 103.65 37.58 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 112.987 -1.915 . . . . 0.95999999999999996 109.099 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.8 -10.49 14.22 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.631 2.22 . . . . 1.3200000000000001 113.018 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.15 -177.19 49.9 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.848 1.214 . . . . 1.1599999999999999 113.466 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.89 -2.62 21.13 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.075 1.75 . . . . 3.4300000000000002 113.018 -170.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.72 161.26 42.84 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.447 1.899 . . . . 1.3500000000000001 110.062 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.75 149.05 20.5 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.674 2.249 . . . . 0.65000000000000002 111.969 -169.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.14 120.89 42.07 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.624 1.17 . . . . 2.46 110.692 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -105.81 103.87 13.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.967 1.707 . . . . 3.77 110.65 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -91.84 116.56 29.0 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.805 1.642 . . . . 1.0700000000000001 109.024 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -95.0 -22.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.995 0.918 . . . . 0.93999999999999995 112.387 -174.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -161.52 28.21 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 121.78 -0.575 . . . . 0.63 112.581 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.43 -178.16 5.17 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.185 0.994 . . . . 0.70999999999999996 110.7 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 136.82 17.37 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.895 2.078 . . . . 5.6399999999999997 106.518 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -153.29 151.58 26.04 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 120.737 1.608 . . . . 0.62 111.097 -166.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.09 -18.36 27.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.82 3.013 . . . . 0.78000000000000003 114.097 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.269 3.0 m -89.91 -2.07 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 114.081 1.141 . . . . 0.82999999999999996 114.081 -173.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.88 39.5 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.576 0.954 . . . . 0.75 113.576 -174.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.22 -86.86 0.34 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.284 1.833 . . . . 3.4199999999999999 108.41 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -78.49 86.36 4.52 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.67 -1.269 . . . . 3.1800000000000002 110.614 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.77 139.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.793 1.237 . . . . 1.1599999999999999 110.486 158.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -136.51 126.52 26.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.489 1.915 . . . . 2.2400000000000002 109.821 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.18 121.57 26.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.209 1.368 . . . . 0.73999999999999999 111.245 167.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.6 m170 -107.26 151.64 25.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.596 1.558 . . . . 0.68000000000000005 112.3 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.42 173.14 8.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.721 1.209 . . . . 2.1899999999999999 110.5 158.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -148.72 96.64 2.61 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.166 1.386 . . . . 1.02 107.515 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -109.04 153.96 22.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.948 1.699 . . . . 2.6200000000000001 112.2 -166.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.7 mtm -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.081 0.952 . . . . 2.9100000000000001 110.937 170.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -155.62 167.92 28.81 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.198 1.799 . . . . 9.0999999999999996 111.235 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.73 157.73 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.264 0.625 . . . . 3.4700000000000002 111.115 160.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -135.11 -89.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.215 1.006 . . . . 3.1200000000000001 108.922 160.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.45 55.34 1.91 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.683 1.993 . . . . 3.8399999999999999 110.338 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.92 -18.52 0.35 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 125.62 1.581 . . . . 2.04 114.906 -173.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -108.2 163.28 13.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.752 2.421 . . . . 3.0600000000000001 111.38 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -66.64 135.63 54.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.673 1.189 . . . . 3.7000000000000002 112.817 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.1 160.42 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 126.895 2.078 . . . . 1.99 109.221 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.1 mmt -79.96 165.09 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 3.6200000000000001 112.647 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.17 143.11 11.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.735 1.635 . . . . 1.5600000000000001 110.707 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.03 142.21 49.04 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.355 1.462 . . . . 2.0600000000000001 109.539 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -172.86 127.46 0.52 Allowed Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 117.116 -1.421 . . . . 4.0700000000000003 111.136 -152.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 38.2 Cg_endo -66.63 146.07 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.184 1.922 . . . . 0.55000000000000004 111.251 170.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.28 156.71 60.13 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.799 1.64 . . . . 0.54000000000000004 110.589 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.99 -24.37 28.69 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.258 1.972 . . . . 0.70999999999999996 112.509 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -174.06 166.25 4.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.882 1.273 . . . . 2.1299999999999999 112.273 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.52 173.04 6.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.065 2.146 . . . . 0.69999999999999996 109.526 157.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.56 163.19 40.3 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.663 -0.648 . . . . 1.8899999999999999 112.236 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.38 130.74 11.68 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 124.844 1.258 . . . . 0.95999999999999996 109.606 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.18 161.62 43.72 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.026 2.484 . . . . 0.83999999999999997 111.295 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.27 140.88 90.97 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.238 2.626 . . . . 1.02 112.105 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt 67.96 -3.32 1.23 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.967 2.107 . . . . 1.8300000000000001 113.921 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.74 134.82 13.52 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 127.136 2.303 . . . . 0.85999999999999999 110.052 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -109.9 146.7 34.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.514 -1.343 . . . . 6.4500000000000002 112.192 163.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.08 171.69 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.968 1.707 . . . . 1.3200000000000001 110.099 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -139.03 117.68 12.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.722 1.609 . . . . 3.8799999999999999 108.036 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.77 70.77 0.99 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.95 1.7 . . . . 1.3 111.323 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.48 140.5 94.85 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.967 -1.083 . . . . 2.98 111.754 171.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.98 -33.4 83.5 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.83 2.353 . . . . 1.3500000000000001 112.201 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.01 53.41 4.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.058 0.837 . . . . 1.4399999999999999 112.31 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.14 -64.26 0.05 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.452 1.025 . . . . 1.3899999999999999 114.842 177.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -154.63 137.79 15.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.657 1.583 . . . . 2.1200000000000001 110.558 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -162.17 172.24 16.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.227 -0.921 . . . . 0.75 111.963 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -105.12 131.83 52.11 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.099 0.559 . . . . 1.9099999999999999 110.405 167.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.3 mmt -88.91 143.93 26.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.279 1.032 . . . . 0.95999999999999996 109.9 156.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.8 125.56 46.8 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.932 1.293 . . . . 2.7000000000000002 108.801 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mt -124.85 133.87 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.314 1.846 . . . . 2.02 110.692 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.67 78.37 0.67 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.778 -1.329 . . . . 2.4700000000000002 109.778 -174.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.39 104.08 4.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.332 1.066 . . . . 0.93000000000000005 109.972 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.46 17.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.834 1.05 . . . . 2.1200000000000001 113.834 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -122.6 140.3 32.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.529 1.932 . . . . 6.2199999999999998 109.647 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -69.39 140.33 43.79 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 N-CA-C 108.26 -1.477 . . . . 2.02 108.26 148.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.7 mt -120.51 155.62 33.24 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.464 1.106 . . . . 3.1200000000000001 111.433 -174.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -130.92 1.37 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.188 1.551 . . . . 3.71 115.188 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 59.11 178.62 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.219 2.207 . . . . 2.0800000000000001 111.92 -171.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.2 56.22 25.81 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 110.445 -1.062 . . . . 1.9099999999999999 110.445 -172.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -166.72 157.12 11.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 128.572 2.749 . . . . 3.0899999999999999 109.961 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -112.46 148.41 34.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.533 1.133 . . . . 4.3499999999999996 112.054 -167.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.1 t -125.41 117.48 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.18 1.792 . . . . 1.1599999999999999 108.342 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.72 133.28 33.69 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.836 -0.801 . . . . 4.04 108.836 157.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -138.71 141.71 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.957 1.703 . . . . 1.95 108.708 -173.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.06 123.1 31.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.891 1.677 . . . . 2.3500000000000001 109.961 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.74 120.33 27.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.103 0.961 . . . . 1.3600000000000001 109.8 168.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.77 125.61 40.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.18 0.992 . . . . 0.56999999999999995 111.731 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -125.51 114.14 18.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.996 0.903 . . . . 2.0600000000000001 111.73 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.12 25.7 0.12 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 127.502 2.321 . . . . 3.2999999999999998 116.317 171.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.68 -42.03 1.04 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.52 1.533 . . . . 4.2599999999999998 113.906 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.04 0.09 87.93 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.224 1.392 . . . . 2.1299999999999999 116.102 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.25 155.24 41.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.933 2.093 . . . . 4.4400000000000004 111.748 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.72 141.0 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.429 1.892 . . . . 1.1000000000000001 108.599 171.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.9 112.4 9.32 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.112 1.365 . . . . 1.6299999999999999 109.24 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -83.92 137.39 33.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.016 0.747 . . . . 3.71 113.016 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 m -138.24 153.43 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.988 1.715 . . . . 1.5900000000000001 110.894 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 m -95.2 149.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.265 1.426 . . . . 3.04 112.416 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -147.13 141.77 16.26 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.89 2.076 . . . . 3.0 108.382 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.09 156.75 33.97 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.979 2.452 . . . . 1.05 111.027 163.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -84.17 109.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.074 0.949 . . . . 1.0900000000000001 109.828 164.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 120' ' ' ARG . 4.8 mm-40 -79.01 146.51 33.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.284 1.034 . . . . 3.7000000000000002 108.288 155.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.37 94.03 4.77 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.045 -1.095 . . . . 2.1600000000000001 108.045 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 118' ' ' GLU . 32.0 ttm-85 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 113.57 0.952 . . . . 8.5700000000000003 113.57 -164.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' H1 ' ' CD ' ' A' ' 23' ' ' GLU . . . . . . . . 0 CA--C 1.498 -0.987 0 N-CA-C 107.383 -2.287 . . . . 11.199999999999999 107.383 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -153.62 -141.22 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.734 0.813 . . . . 9.4199999999999999 108.826 -161.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -76.44 -170.93 1.64 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.056 0.843 . . . . 11.109999999999999 108.814 149.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -80.23 98.39 7.35 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.569 -1.332 . . . . 7.75 108.198 161.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -79.32 84.64 5.22 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.522 0.729 . . . . 4.5599999999999996 110.588 -172.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.69 -175.91 43.49 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.956 1.741 . . . . 1.3200000000000001 114.762 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -159.62 156.44 27.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.126 1.371 . . . . 1.76 113.257 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -113.92 131.07 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.543 -0.723 . . . . 0.88 109.947 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -72.2 114.17 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.776 1.231 . . . . 4.6799999999999997 109.249 174.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 129.09 37.17 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.723 0.809 . . . . 2.1299999999999999 109.136 162.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.35 163.26 38.09 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.877 1.671 . . . . 2.3300000000000001 108.1 167.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.12 17.68 0.49 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.459 3.439 . . . . 1.48 115.456 -167.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.31 174.38 49.48 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.599 -0.688 . . . . 1.3 112.772 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.23 -3.0 36.91 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.364 1.082 . . . . 1.4199999999999999 113.034 -4.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -141.2 169.41 17.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.297 1.439 . . . . 2.0299999999999998 112.5 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.19 -158.5 0.34 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.985 2.514 . . . . 0.84999999999999998 111.177 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.49 171.08 20.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.62 1.168 . . . . 0.80000000000000004 113.664 -169.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.93 151.0 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.343 1.057 . . . . 0.87 113.186 170.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -142.81 145.65 33.43 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.594 1.558 . . . . 2.0699999999999998 110.468 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -169.62 160.97 9.25 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.46 0.911 . . . . 1.5800000000000001 113.46 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.0 m -78.19 141.53 38.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.54 1.536 . . . . 1.29 109.076 162.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -128.21 136.72 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.458 1.103 . . . . 2.8599999999999999 108.561 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' CD ' ' H1 ' ' A' ' 1' ' ' GLY . 20.8 pt-20 -130.69 148.98 52.54 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.97 0.908 . . . . 2.7200000000000002 110.657 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.453 HD21 HD13 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -119.35 70.91 12.21 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.366 0.666 . . . . 3.8300000000000001 112.309 -159.307 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 -14.65 44.46 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.231 2.621 . . . . 1.05 115.438 -168.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.25 161.33 53.35 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.397 0.998 . . . . 1.1699999999999999 112.92 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 3.8 m-20 -91.08 -2.24 57.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.507 1.523 . . . . 3.1000000000000001 113.353 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -117.73 160.06 39.92 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.034 1.733 . . . . 1.3 110.618 172.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.43 157.38 25.56 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.77 2.314 . . . . 0.66000000000000003 111.235 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.453 HD13 HD21 ' A' ' 24' ' ' ASN . 2.3 mp -124.02 127.95 48.64 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.58 1.552 . . . . 2.3700000000000001 110.727 -172.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -113.37 104.98 12.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.263 1.425 . . . . 4.6699999999999999 110.794 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.2 tp -89.64 115.68 27.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.664 2.385 . . . . 0.83999999999999997 108.78 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.8 m -110.24 -8.65 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.403 1.081 . . . . 0.55000000000000004 113.541 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.6 -159.76 32.14 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 121.636 -0.665 . . . . 0.38 113.331 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.813 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -147.71 178.74 8.23 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.59 0.756 . . . . 0.68000000000000005 112.221 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -152.58 145.92 24.79 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.572 -1.27 . . . . 6.9699999999999998 107.572 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -155.76 156.06 30.2 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.927 1.291 . . . . 0.63 109.279 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.35 -26.94 71.24 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.585 2.19 . . . . 0.96999999999999997 113.339 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.323 1.5 m -92.45 11.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.914 1.45 . . . . 1.5 114.914 -170.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -155.9 151.01 26.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.981 1.312 . . . . 0.90000000000000002 112.409 177.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -97.34 -78.19 0.48 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.318 -0.993 . . . . 3.3599999999999999 108.318 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -74.6 107.42 6.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.078 -1.453 . . . . 3.3599999999999999 107.078 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.21 129.24 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 1.47 108.22 173.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.39 127.81 18.9 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.026 1.331 . . . . 2.3100000000000001 110.138 -162.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -79.21 121.16 24.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.825 0.821 . . . . 0.76000000000000001 110.588 175.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.4 153.49 22.71 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.393 1.877 . . . . 0.72999999999999998 112.94 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.0 164.17 13.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.852 1.661 . . . . 2.29 110.89 161.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 81.5 m -129.75 105.88 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.888 1.675 . . . . 1.03 108.334 166.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -106.2 158.1 17.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.788 1.235 . . . . 2.25 113.261 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.0 mtp -124.52 100.82 6.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.363 1.465 . . . . 4.0199999999999996 110.36 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -122.63 145.87 47.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.415 1.486 . . . . 5.5199999999999996 110.928 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.2 mp0 -59.96 147.33 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.529 0.731 . . . . 3.5699999999999998 111.349 165.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -159.31 -47.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.944 1.09 . . . . 2.96 113.944 170.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -93.28 38.28 1.04 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.485 1.914 . . . . 5.8300000000000001 110.746 171.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.54 -40.16 0.76 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.5 1.524 . . . . 2.5600000000000001 113.043 -167.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -86.93 154.52 20.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.581 2.352 . . . . 3.71 111.122 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -68.44 122.99 19.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.875 0.87 . . . . 4.1299999999999999 111.267 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.84 151.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.351 1.461 . . . . 2.7200000000000002 109.935 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -83.55 141.95 31.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.61 1.564 . . . . 2.9100000000000001 111.155 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.77 170.5 33.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.967 0.794 . . . . 1.1299999999999999 112.884 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.98 145.12 41.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.76 1.224 . . . . 2.1000000000000001 111.229 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -153.32 143.36 15.34 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 125.447 1.499 . . . . 3.29 109.964 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.78 145.56 75.52 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.755 1.637 . . . . 0.75 110.595 163.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -118.32 154.16 51.92 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.687 1.595 . . . . 0.76000000000000001 110.084 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.09 -9.56 26.28 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.827 2.351 . . . . 1.23 114.136 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -172.37 163.03 5.56 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.098 1.317 . . . . 2.1200000000000001 111.664 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -119.19 169.69 9.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.586 1.554 . . . . 0.68999999999999995 108.482 148.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -158.16 164.24 36.77 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.045 -1.034 . . . . 2.2999999999999998 112.118 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.02 138.5 14.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 1.1200000000000001 110.593 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.07 161.6 45.37 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.676 2.25 . . . . 1.1000000000000001 111.314 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.38 146.2 93.2 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.98 2.453 . . . . 0.82999999999999996 111.798 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 68.7 mmtt 69.97 -12.48 0.48 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.507 2.723 . . . . 1.3600000000000001 114.624 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.5 130.86 29.13 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 126.456 1.979 . . . . 0.94999999999999996 111.974 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -94.49 129.02 41.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.095 -1.553 . . . . 5.5700000000000003 110.045 161.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.73 178.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.681 1.592 . . . . 1.3999999999999999 110.345 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -141.07 140.2 34.18 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.128 0.971 . . . . 3.2999999999999998 110.169 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.59 59.77 3.1 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.702 1.239 . . . . 1.1499999999999999 108.912 155.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -72.14 122.41 87.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.677 -1.154 . . . . 3.52 110.116 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.95 -27.08 83.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.372 2.715 . . . . 1.55 114.792 -168.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.13 84.31 1.6 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.746 -1.742 . . . . 1.5800000000000001 108.746 157.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.01 -87.44 0.16 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.334 1.921 . . . . 1.3600000000000001 111.55 -166.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -143.42 153.77 43.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.246 1.818 . . . . 1.9099999999999999 110.881 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -157.79 165.43 35.35 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.509 1.123 . . . . 0.73999999999999999 109.736 175.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -93.2 137.23 32.73 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.8 -1.185 . . . . 2.0899999999999999 107.8 159.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.7 139.5 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.744 1.218 . . . . 1.46 109.411 168.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.5 mt -117.83 131.69 56.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.86 1.264 . . . . 1.96 110.459 -172.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.85 159.49 42.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.721 1.608 . . . . 1.79 111.928 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -56.87 4.51 Favored Glycine 0 N--CA 1.47 0.934 0 C-N-CA 124.897 1.237 . . . . 2.3700000000000001 112.73 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.4 mt 70.76 98.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 129.715 3.206 . . . . 1.3999999999999999 113.252 171.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -11.01 59.83 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.17 1.174 . . . . 1.78 114.17 -171.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -141.33 158.1 64.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 129.588 3.155 . . . . 7.6900000000000004 108.928 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.49 163.2 39.83 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.513 2.809 . . . . 1.8899999999999999 110.294 160.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.27 151.6 44.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.183 0.993 . . . . 2.52 112.275 -167.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -142.34 120.58 12.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.446 1.098 . . . . 3.8100000000000001 110.445 -170.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 140.27 54.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.548 0.739 . . . . 1.76 112.783 172.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.02 -20.6 33.14 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.339 1.447 . . . . 3.0800000000000001 115.158 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -173.72 4.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.249 1.024 . . . . 5.3399999999999999 111.084 -169.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -95.64 152.06 18.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.715 0.769 . . . . 4.25 110.727 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.26 127.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.388 2.275 . . . . 1.3700000000000001 108.156 163.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.03 150.14 24.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.731 0.812 . . . . 3.27 109.842 170.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.813 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.2 tt -158.68 140.04 13.27 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.248 1.019 . . . . 1.6699999999999999 113.252 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.472 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.7 m-20 -101.99 107.08 18.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.513 2.325 . . . . 2.2000000000000002 111.443 171.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.9 119.22 21.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.154 0.982 . . . . 1.1100000000000001 110.397 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.4 mt -95.05 131.93 40.49 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.788 1.235 . . . . 0.58999999999999997 111.768 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.23 139.47 53.7 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.226 1.195 . . . . 1.9099999999999999 114.226 -177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.27 72.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.895 1.278 . . . . 2.3599999999999999 114.203 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.49 33.43 1.83 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.588 1.09 . . . . 4.4199999999999999 114.176 -174.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.25 49.21 67.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.721 1.153 . . . . 1.6799999999999999 112.645 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 160.75 39.28 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.865 1.666 . . . . 4.1500000000000004 112.053 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.22 145.55 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.523 1.929 . . . . 1.0800000000000001 107.707 170.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.71 121.68 25.93 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.826 1.25 . . . . 1.6799999999999999 110.717 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 3.0 tpmt? -72.07 131.19 42.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.039 0.536 . . . . 2.4199999999999999 111.331 176.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.86 150.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.232 1.413 . . . . 1.5800000000000001 109.832 166.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.82 152.15 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.958 1.703 . . . . 2.5699999999999998 109.045 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.5 mt -148.69 144.77 18.74 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.254 1.422 . . . . 2.2400000000000002 109.708 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.25 149.0 81.34 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.17 2.58 . . . . 1.1899999999999999 112.214 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.28 128.08 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.829 1.252 . . . . 1.1200000000000001 109.24 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -118.23 135.08 54.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.726 1.61 . . . . 3.3199999999999998 107.501 166.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.9 125.07 30.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.695 0.68 . . . . 2.0600000000000001 110.283 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.037 1.335 . . . . 7.4900000000000002 111.795 -175.487 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' HA2' ' CE2' ' A' ' 7' ' ' TRP . . . . . . . . 0 N--CA 1.467 0.754 0 N-CA-C 110.314 -1.115 . . . . 15.609999999999999 110.314 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 m -147.61 -140.12 0.1 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.2 1.0 . . . . 12.199999999999999 112.012 -164.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.2 p90 177.95 159.58 0.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 129.888 3.275 . . . . 10.76 108.442 -172.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m 90.87 -44.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 128.841 2.856 . . . . 7.0199999999999996 110.612 -176.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.62 163.77 20.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.291 2.637 . . . . 6.4400000000000004 105.835 156.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.57 -151.98 28.85 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.297 0.951 . . . . 1.5900000000000001 112.586 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.465 ' CE2' ' HA2' ' A' ' 1' ' ' GLY . 9.2 p90 -166.22 138.54 3.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.771 1.228 . . . . 1.6399999999999999 112.487 177.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.73 145.27 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.377 1.071 . . . . 1.46 108.356 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.437 ' HE ' ' HB3' ' A' ' 17' ' ' ALA . 5.3 tmm_? -117.03 85.95 2.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.106 0.962 . . . . 4.6600000000000001 109.758 -166.08 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.76 149.46 48.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.878 1.671 . . . . 2.7799999999999998 112.222 -174.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -152.43 153.44 30.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.32 2.248 . . . . 2.0800000000000001 107.743 174.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.27 -12.67 35.68 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.227 2.618 . . . . 2.2200000000000002 112.865 170.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.78 -167.84 13.96 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.395 0.998 . . . . 1.6699999999999999 114.162 170.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.34 -2.23 19.84 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 CA-C-N 118.195 0.998 . . . . 1.78 113.309 -3.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -134.63 163.26 30.14 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.248 1.819 . . . . 2.4100000000000001 112.482 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.43 179.51 9.06 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.757 2.023 . . . . 0.73999999999999999 111.288 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB3' ' HE ' ' A' ' 9' ' ' ARG . . . -134.67 166.08 23.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.668 0.787 . . . . 1.0700000000000001 112.864 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.88 135.35 32.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.309 0.644 . . . . 0.78000000000000003 111.806 170.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.45 147.87 42.32 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.329 1.452 . . . . 2.4900000000000002 108.252 172.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.06 148.6 20.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.418 0.687 . . . . 2.0 111.593 -170.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -91.17 116.07 28.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.722 0.772 . . . . 1.78 109.452 166.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 125.44 35.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.204 -1.406 . . . . 2.79 107.204 164.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.59 146.45 47.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.128 0.966 . . . . 3.6400000000000001 111.328 165.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -114.87 90.88 24.11 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-N 114.725 -1.125 . . . . 0.97999999999999998 109.22 171.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.04 -9.59 20.78 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.539 2.159 . . . . 0.94999999999999996 112.98 176.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 -167.18 42.34 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.84 1.209 . . . . 1.1399999999999999 113.394 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -121.57 5.51 10.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.376 1.47 . . . . 2.73 112.855 -166.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.93 163.06 41.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.61 1.964 . . . . 1.4399999999999999 109.915 173.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.82 148.09 15.5 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.406 2.071 . . . . 0.66000000000000003 112.272 -171.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -111.44 108.36 17.89 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.344 1.458 . . . . 2.0899999999999999 109.703 -177.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -102.18 102.49 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.536 1.534 . . . . 4.6299999999999999 112.355 -178.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.51 124.57 37.59 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.636 1.974 . . . . 0.93999999999999995 108.394 -173.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.92 -11.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.662 1.185 . . . . 0.72999999999999998 112.723 -172.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -162.57 29.96 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 123.789 0.709 . . . . 0.60999999999999999 112.463 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.564 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -152.87 -179.27 7.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.421 1.089 . . . . 0.81999999999999995 110.697 174.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -156.1 145.17 20.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.136 -1.431 . . . . 5.1699999999999999 107.136 173.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.59 149.17 23.47 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 118.95 0.795 . . . . 0.68000000000000005 109.928 -176.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.08 -10.74 29.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.948 2.432 . . . . 0.84999999999999998 113.305 173.1 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 3.0 m -92.51 7.36 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 114.324 1.231 . . . . 1.1000000000000001 114.324 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.39 165.83 28.17 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.071 -1.018 . . . . 0.82999999999999996 112.801 -179.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -111.29 -62.49 1.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.966 -0.753 . . . . 3.6600000000000001 108.966 170.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -86.12 138.76 31.68 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.286 -0.884 . . . . 3.5899999999999999 109.862 168.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.12 138.75 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.432 2.293 . . . . 1.48 109.19 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -143.11 136.54 28.37 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.952 1.701 . . . . 2.8599999999999999 110.157 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.445 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 6.4 tt -84.11 119.27 24.78 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.325 0.966 . . . . 0.72999999999999998 110.686 167.171 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.3 m170 -110.42 167.0 10.54 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.547 1.939 . . . . 0.83999999999999997 112.111 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 6.0 pt-20 -136.74 -173.18 3.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.848 1.659 . . . . 3.4199999999999999 112.172 175.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.8 m -136.79 124.11 21.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.273 -1.01 . . . . 1.54 108.273 167.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -114.02 176.96 4.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 2.25 111.09 179.3 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtm -131.93 139.25 48.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.322 1.049 . . . . 2.8700000000000001 110.457 163.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtp85 -143.16 156.62 44.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.096 1.358 . . . . 5.4500000000000002 111.961 173.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 mp0 -67.25 151.63 47.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.025 1.73 . . . . 4.6900000000000004 110.948 159.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.29 -41.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 114.38 -1.282 . . . . 2.9399999999999999 114.238 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -117.68 32.4 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.769 2.028 . . . . 3.9399999999999999 110.541 167.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.4 -35.68 1.34 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.845 -1.159 . . . . 2.6000000000000001 112.785 -166.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 mttp -70.58 144.5 51.2 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.274 -1.133 . . . . 2.9500000000000002 109.095 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -99.48 140.72 33.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.439 0.903 . . . . 4.0199999999999996 113.439 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.21 150.57 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.497 1.919 . . . . 2.3100000000000001 108.819 -171.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.3 mtm -80.26 149.81 30.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.147 1.379 . . . . 3.23 111.517 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.16 160.67 30.63 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.961 -0.462 . . . . 1.28 113.184 173.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -115.64 152.58 32.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.786 1.234 . . . . 2.0299999999999998 111.385 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -164.87 156.99 13.76 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.955 1.302 . . . . 6.7699999999999996 111.646 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 43.4 Cg_endo -66.01 145.17 78.77 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.79 2.327 . . . . 0.94999999999999996 110.73 161.122 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 156.39 53.83 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.838 1.655 . . . . 1.02 109.758 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.99 -11.01 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.062 2.508 . . . . 1.1100000000000001 114.338 -179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -175.91 168.9 2.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.515 1.526 . . . . 2.3900000000000001 110.638 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.77 168.78 13.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.091 1.757 . . . . 0.84999999999999998 108.58 154.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -155.44 164.04 39.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.058 -1.026 . . . . 2.27 111.978 163.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.79 129.08 16.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 124.034 0.934 . . . . 0.82999999999999996 110.03 -172.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.22 162.88 40.66 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.435 2.09 . . . . 0.75 111.082 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.6 141.48 91.43 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.111 2.541 . . . . 0.93000000000000005 112.083 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt 70.23 -1.33 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.77 2.428 . . . . 1.1899999999999999 113.728 -172.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.34 121.49 5.54 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 127.248 2.356 . . . . 0.81999999999999995 111.644 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -99.23 135.76 40.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.43 1.492 . . . . 5.9400000000000004 110.48 161.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.34 148.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.6 1.56 . . . . 1.26 110.285 174.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -131.4 120.93 23.75 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.647 -0.501 . . . . 5.4800000000000004 109.647 -166.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.6 68.65 9.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.448 1.594 . . . . 1.3400000000000001 112.565 -161.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -64.54 142.31 98.42 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.52 2.328 . . . . 4.0999999999999996 114.519 173.24 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -30.77 47.47 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.955 3.104 . . . . 1.46 113.397 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.73 74.21 2.43 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 108.424 -1.87 . . . . 1.45 108.424 163.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.78 -152.77 21.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.954 1.74 . . . . 2.4900000000000002 111.514 -167.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 6.0 m-85 -72.47 135.91 45.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.226 1.41 . . . . 2.6299999999999999 111.839 -174.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -168.09 178.88 4.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.613 1.165 . . . . 1.1399999999999999 109.457 -174.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.445 ' CZ ' HD12 ' A' ' 45' ' ' LEU . 57.7 m-85 -114.2 139.83 49.05 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.336 0.516 . . . . 2.52 111.823 173.244 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 mmt -101.72 131.1 48.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.902 1.681 . . . . 1.0700000000000001 110.101 168.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.94 138.94 53.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.631 1.573 . . . . 3.1200000000000001 110.684 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.96 157.67 45.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.902 1.681 . . . . 2.3900000000000001 112.036 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.39 -47.86 3.93 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 124.854 1.216 . . . . 2.5800000000000001 112.799 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt 57.92 88.76 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.923 2.489 . . . . 0.93999999999999995 112.97 169.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.43 0.49 12.15 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.168 1.544 . . . . 2.23 115.168 -169.146 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.3 mtp-105 -149.04 151.36 34.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.347 2.259 . . . . 4.96 108.837 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -88.72 -10.27 4.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.71 3.607 . . . . 3.3700000000000001 117.86 -176.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.0 mt 80.09 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 127.904 2.481 . . . . 3.5899999999999999 114.357 156.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.22 -175.66 4.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 130.781 3.633 . . . . 4.7300000000000004 109.43 176.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.1 149.84 32.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.247 -1.39 . . . . 2.54 107.247 139.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.96 15.44 77.39 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 118.849 0.749 . . . . 2.71 112.819 -164.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -115.57 140.68 48.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.095 -1.446 . . . . 3.6299999999999999 107.095 144.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.42 134.75 53.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.16 -1.836 . . . . 4.9299999999999997 109.457 -160.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.6 t -106.42 104.74 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.299 -0.409 . . . . 1.24 111.462 -150.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.14 128.4 35.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.456 -1.247 . . . . 3.3900000000000001 110.097 160.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.564 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.3 tt -138.49 137.88 37.55 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.628 1.571 . . . . 2.0299999999999998 108.755 -177.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -91.31 106.63 18.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.33 2.252 . . . . 2.5600000000000001 111.12 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.73 106.58 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.445 1.098 . . . . 1.75 110.863 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.39 118.11 22.94 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.76 -0.459 . . . . 0.88 109.76 -174.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.28 147.78 38.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.011 0.924 . . . . 1.9299999999999999 111.726 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.61 130.5 28.26 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.22 1.008 . . . . 1.79 112.329 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.64 -151.98 20.85 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.277 0.941 . . . . 3.79 110.756 -163.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.92 23.21 35.37 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.828 1.204 . . . . 2.5899999999999999 114.104 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.55 125.36 35.18 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.042 -1.269 . . . . 5.3899999999999997 111.428 -177.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.96 124.79 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.322 1.049 . . . . 1.8100000000000001 110.928 171.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.31 122.12 41.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.542 1.537 . . . . 3.4199999999999999 109.811 -174.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -85.76 124.09 31.88 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.903 -0.498 . . . . 2.6899999999999999 111.566 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.71 148.22 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.16 1.384 . . . . 1.8999999999999999 111.242 178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.97 131.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.881 1.272 . . . . 1.6899999999999999 111.333 -177.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -128.66 151.96 77.88 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 125.289 1.436 . . . . 2.0800000000000001 112.71 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.51 145.79 26.81 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.645 3.563 . . . . 1.8600000000000001 112.147 177.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.18 139.56 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.537 1.135 . . . . 1.7 112.057 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -131.11 148.78 52.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.527 2.731 . . . . 3.54 108.487 173.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.73 48.28 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.062 -1.024 . . . . 2.2400000000000002 110.711 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 N-CA-C 115.084 1.513 . . . . 5.9800000000000004 115.084 -175.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.03 0 N-CA-C 109.785 -1.326 . . . . 12.41 109.785 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -52.97 -31.31 39.95 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 118.455 1.127 . . . . 12.359999999999999 113.171 171.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -112.24 142.26 44.94 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.707 -1.59 . . . . 12.31 106.707 153.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.8 p -94.0 115.39 27.72 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.374 0.67 . . . . 8.0 109.209 -178.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.77 104.41 17.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.141 2.176 . . . . 6.5199999999999996 110.105 -165.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.7 -169.97 42.77 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 114.967 0.747 . . . . 1.25 114.967 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -164.99 160.7 19.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 1.5900000000000001 112.949 -175.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.53 132.72 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.766 -0.584 . . . . 1.27 110.605 177.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.3 ttp85 -96.61 97.89 9.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.85 1.26 . . . . 4.1900000000000004 110.056 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 152.51 44.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.973 1.709 . . . . 2.04 111.625 -175.324 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 m -155.14 149.8 20.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 119.77 -1.832 . . . . 1.8600000000000001 111.209 168.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.32 25.52 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.622 3.548 . . . . 1.6599999999999999 114.19 -175.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.86 165.31 29.15 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.47 -0.769 . . . . 1.3200000000000001 113.952 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.87 -3.77 31.52 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 CA-C-N 118.097 0.949 . . . . 1.53 113.629 -2.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -154.69 -179.53 8.09 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.591 1.556 . . . . 1.8700000000000001 111.644 -175.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.67 -175.06 4.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.891 1.677 . . . . 0.62 111.924 -179.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.11 149.47 45.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.782 0.833 . . . . 0.93000000000000005 112.654 -175.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.31 51.77 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.203 1.401 . . . . 0.75 112.159 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.57 157.95 43.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.108 1.363 . . . . 2.2999999999999998 111.906 -177.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.6 159.66 12.24 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.73 1.212 . . . . 1.6399999999999999 111.92 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.3 m -79.99 146.39 32.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.617 1.567 . . . . 1.6599999999999999 108.455 154.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -143.43 136.92 28.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.483 0.713 . . . . 2.6200000000000001 109.609 169.129 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -116.21 143.04 46.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.053 0.941 . . . . 2.9300000000000002 112.71 167.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -87.98 111.98 46.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.46 1.104 . . . . 1.1200000000000001 108.624 161.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -85.48 -12.12 6.75 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.156 2.571 . . . . 1.1599999999999999 113.456 174.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.24 161.92 39.79 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.519 1.057 . . . . 1.28 112.482 -177.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.09 4.06 53.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.217 1.807 . . . . 3.3100000000000001 113.327 -174.032 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.31 161.36 35.5 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.397 1.879 . . . . 1.3200000000000001 110.02 168.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.85 154.4 26.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.853 2.369 . . . . 0.68000000000000005 111.574 -171.258 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.58 127.6 52.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.33 1.452 . . . . 2.1499999999999999 110.169 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -118.0 114.11 22.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.66 1.184 . . . . 3.7999999999999998 111.787 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.9 tp -100.51 109.9 22.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.369 2.668 . . . . 1.0600000000000001 109.806 -171.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.41 -13.76 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.413 1.085 . . . . 0.68000000000000005 113.84 -165.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.39 -160.56 31.91 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.0 0.81 . . . . 0.42999999999999999 112.41 -176.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.71 -174.08 4.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 117.73 0.765 . . . . 0.94999999999999996 112.998 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 102' ' ' ASP . 2.1 mmp_? -149.77 138.17 20.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.813 2.445 . . . . 6.0899999999999999 107.541 176.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -150.02 153.89 36.18 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 119.855 1.207 . . . . 0.88 110.686 -170.143 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.45 -32.33 12.51 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.252 1.968 . . . . 1.21 111.716 165.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.402 1.3 m -93.1 6.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 115.503 1.668 . . . . 1.22 115.503 -169.559 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.75 174.26 13.24 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.052 1.341 . . . . 1.1699999999999999 109.744 167.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -118.01 -74.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.778 0.717 . . . . 4.3099999999999996 109.618 175.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttm105 -66.25 133.98 51.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.735 -1.209 . . . . 4.6900000000000004 107.735 163.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.26 129.62 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.823 1.249 . . . . 1.54 108.406 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -134.44 127.76 32.14 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.084 0.954 . . . . 2.3900000000000001 109.452 -160.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.81 117.6 20.07 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.496 1.141 . . . . 0.81000000000000005 109.909 171.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.6 m170 -107.1 154.02 21.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.671 1.588 . . . . 0.80000000000000004 111.326 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.74 179.46 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.261 -1.336 . . . . 1.9399999999999999 110.449 167.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.7 m -149.97 94.46 2.16 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.284 1.433 . . . . 1.1599999999999999 107.725 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -90.71 165.53 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.169 1.788 . . . . 2.1499999999999999 112.857 -169.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.7 mtm -98.52 152.45 19.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.349 -0.841 . . . . 2.52 109.891 158.207 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -151.67 132.0 13.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.216 1.806 . . . . 6.0700000000000003 108.895 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.75 144.14 31.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.519 0.728 . . . . 4.3899999999999997 110.899 173.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.2 122.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.154 1.382 . . . . 3.3999999999999999 107.542 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.6 tm-20 58.76 29.69 19.02 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.325 1.059 . . . . 5.5599999999999996 110.994 -174.221 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.49 -6.57 16.03 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 120.089 -1.632 . . . . 2.1699999999999999 114.47 -173.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 34.7 mmtm -85.06 138.92 32.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.455 1.502 . . . . 4.0899999999999999 109.115 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -85.79 142.97 28.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.278 0.49 . . . . 4.1299999999999999 112.24 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.92 159.61 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 2.7000000000000002 110.433 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.7 mtp -102.93 166.08 10.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.04 0.936 . . . . 4.6200000000000001 111.688 169.079 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.48 174.74 34.94 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 123.829 0.728 . . . . 1.1799999999999999 112.006 167.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.37 159.94 38.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.803 1.241 . . . . 1.8899999999999999 110.025 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.81 151.18 0.98 Allowed Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.928 1.691 . . . . 3.46 110.431 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.7 Cg_endo -68.9 149.74 72.62 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.613 1.542 . . . . 1.0 111.103 166.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.28 157.84 39.95 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 0.57999999999999996 109.859 172.251 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -66.78 -20.15 52.53 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.229 1.953 . . . . 0.73999999999999999 112.522 174.488 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -179.56 161.28 1.02 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 126.731 2.012 . . . . 2.2999999999999998 110.877 178.283 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mt -103.99 168.83 8.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.082 0.953 . . . . 0.81000000000000005 109.705 150.365 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.47 164.58 36.45 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.843 -0.536 . . . . 2.4199999999999999 111.419 167.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.7 t -140.51 129.49 13.06 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 125.555 1.542 . . . . 0.77000000000000002 108.664 -164.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.79 161.83 44.7 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.977 1.784 . . . . 0.91000000000000003 111.161 177.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.2 140.71 96.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.182 2.588 . . . . 0.93000000000000005 111.74 177.09 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 67.95 -3.27 1.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.857 2.063 . . . . 1.3700000000000001 113.368 -177.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.07 119.85 4.97 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 127.277 2.37 . . . . 1.1699999999999999 111.891 -172.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -81.76 136.95 35.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.642 1.177 . . . . 4.8499999999999996 110.459 156.319 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 m -150.99 145.48 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.102 1.761 . . . . 1.6799999999999999 109.807 173.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -103.35 139.28 38.97 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.477 0.917 . . . . 3.5699999999999998 113.477 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.38 54.95 0.95 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.128 1.442 . . . . 1.29 109.72 156.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -54.2 114.99 7.42 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.546 -1.216 . . . . 4.8200000000000003 109.966 162.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.58 -28.18 85.05 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.211 2.607 . . . . 1.3500000000000001 114.824 -170.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.19 36.24 0.94 Allowed Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.342 0.973 . . . . 1.8700000000000001 113.367 166.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.06 -48.19 0.04 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.93 2.205 . . . . 1.3700000000000001 113.65 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -154.08 145.12 22.75 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.072 1.749 . . . . 1.8999999999999999 110.39 -174.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -165.66 171.81 12.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.969 1.308 . . . . 0.77000000000000002 110.52 -178.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -103.35 135.08 45.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.108 0.563 . . . . 1.95 110.667 165.053 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.1 mmt -92.74 134.74 34.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.532 1.133 . . . . 0.85999999999999999 110.467 165.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.2 mt -109.78 114.98 29.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.802 1.641 . . . . 2.23 110.186 -176.386 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.77 155.48 31.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.223 1.409 . . . . 3.5499999999999998 111.039 -174.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.55 -39.69 3.1 Favored Glycine 0 N--CA 1.48 1.572 0 O-C-N 120.628 -1.295 . . . . 2.29 113.55 165.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 49.78 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 124.434 2.064 . . . . 1.3899999999999999 115.822 162.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -79.72 4.63 15.67 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.245 -1.798 . . . . 2.8500000000000001 114.187 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -155.42 158.97 32.05 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.837 2.855 . . . . 4.8600000000000003 107.32 -175.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.08 -13.77 21.14 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.518 . . . . 4.3700000000000001 117.552 -173.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mp 60.82 -4.77 0.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 130.069 3.348 . . . . 4.2800000000000002 113.716 -169.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -42.64 149.65 0.17 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.7 2.8 . . . . 3.3599999999999999 115.124 -171.007 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.7 126.34 21.58 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.955 1.302 . . . . 1.8799999999999999 112.125 178.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.74 30.1 45.19 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.778 -0.457 . . . . 3.5299999999999998 112.931 -165.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 -176.7 3.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.992 -1.855 . . . . 4.2800000000000002 105.992 139.557 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.23 155.11 50.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.634 -1.247 . . . . 4.7199999999999998 107.634 165.06 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.5 93.18 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 122.428 1.109 . . . . 1.27 110.538 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.05 123.1 16.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.856 -1.974 . . . . 3.8199999999999998 108.857 153.048 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.1 114.28 16.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.656 0.741 . . . . 1.76 109.062 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 9.7 m-20 -89.99 89.33 7.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.291 1.836 . . . . 2.4500000000000002 108.307 176.298 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.9 120.46 13.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.923 1.689 . . . . 1.3100000000000001 109.567 -178.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.3 mt -86.1 139.04 31.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.084 1.353 . . . . 0.56999999999999995 110.391 -175.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -117.04 165.02 13.85 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.845 -0.534 . . . . 2.1600000000000001 112.421 177.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.96 70.84 1.53 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.504 1.122 . . . . 1.9399999999999999 112.681 -176.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 137.07 -154.11 22.13 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.95 1.738 . . . . 3.1200000000000001 111.638 -178.083 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.67 46.84 2.65 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.372 0.987 . . . . 1.9199999999999999 114.894 -173.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -136.03 143.43 44.73 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.53 1.932 . . . . 4.4299999999999997 110.673 173.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -152.07 143.85 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 127.506 2.323 . . . . 1.1200000000000001 107.108 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -133.71 118.3 17.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.85 0.86 . . . . 1.78 111.538 -171.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -74.67 117.88 16.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.843 0.457 . . . . 2.4500000000000002 111.612 173.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.46 165.28 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.767 1.227 . . . . 2.0499999999999998 110.42 160.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.21 136.15 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.457 1.103 . . . . 2.6299999999999999 109.195 171.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.9 mt -146.9 109.35 4.04 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.509 1.123 . . . . 2.02 110.693 -167.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.77 156.56 65.05 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.13 2.553 . . . . 1.21 113.165 -174.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -80.36 133.87 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 122.084 0.945 . . . . 1.3 112.018 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -121.5 151.65 40.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 130.44 3.496 . . . . 3.7799999999999998 106.711 165.625 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.55 16.41 7.59 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.377 1.621 . . . . 2.7799999999999998 115.377 -154.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 113.717 1.006 . . . . 7.3099999999999996 113.717 -160.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 0 N-CA-C 109.287 -1.525 . . . . 12.27 109.287 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m -83.12 160.04 21.96 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.032 0.916 . . . . 11.17 112.253 172.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 76.61 155.94 0.17 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.365 2.266 . . . . 12.720000000000001 113.631 170.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p 177.23 -44.95 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.125 2.57 . . . . 6.5499999999999998 109.116 -158.412 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -124.77 -165.44 1.39 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.54 1.536 . . . . 6.0800000000000001 111.911 -166.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.99 167.52 28.3 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.699 1.619 . . . . 1.3200000000000001 113.981 176.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -151.49 128.04 10.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.739 1.216 . . . . 2.04 111.593 -170.323 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -100.03 112.21 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.344 -0.847 . . . . 1.27 109.952 -170.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 1.8 tmt_? -84.03 89.71 7.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.333 1.453 . . . . 3.4100000000000001 111.649 -161.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.3 147.53 40.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.78 2.032 . . . . 2.2799999999999998 111.768 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.0 m -159.05 156.76 27.1 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 127.524 2.33 . . . . 2.75 109.273 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.01 12.61 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.852 3.035 . . . . 2.5099999999999998 114.457 -172.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.44 171.82 36.46 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.026 0.83 . . . . 2.4300000000000002 112.455 -167.306 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.65 -3.69 11.03 Favored 'Cis proline' 0 C--N 1.351 0.7 0 CA-C-N 119.143 1.472 . . . . 3.23 113.352 -4.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -146.67 175.12 10.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.73 1.612 . . . . 2.5099999999999998 110.625 175.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.16 -177.37 5.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.665 2.386 . . . . 0.68999999999999995 108.869 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.7 175.29 9.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.446 1.021 . . . . 1.04 113.401 -173.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.51 152.74 29.24 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.425 0.898 . . . . 0.68999999999999995 113.425 169.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.18 162.42 38.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.599 1.56 . . . . 2.1099999999999999 110.582 174.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -174.12 150.2 1.53 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.977 1.711 . . . . 1.95 113.646 -173.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.7 m -68.55 135.24 51.24 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.701 1.6 . . . . 1.8100000000000001 109.12 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.21 133.78 37.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.359 -0.978 . . . . 2.9399999999999999 108.359 173.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -149.56 138.09 20.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.082 0.944 . . . . 3.5 111.391 175.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -100.26 100.69 12.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.885 1.674 . . . . 1.22 108.961 -178.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.69 -8.89 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.109 1.873 . . . . 1.28 112.998 174.005 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.98 161.17 43.5 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.058 0.837 . . . . 1.0900000000000001 113.092 -178.105 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.04 5.8 50.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.115 1.766 . . . . 3.0699999999999998 113.422 -172.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.02 159.06 42.5 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.936 1.694 . . . . 1.73 109.949 165.039 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.39 159.21 25.97 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.274 2.65 . . . . 1.1599999999999999 111.796 -170.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.8 mt -110.95 156.32 21.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.396 1.093 . . . . 1.8400000000000001 111.384 170.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -144.12 106.62 4.41 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.511 1.524 . . . . 3.6000000000000001 109.432 175.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.3 tp -91.66 122.37 34.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.312 2.245 . . . . 0.93000000000000005 108.576 -177.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.23 -16.1 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 113.898 1.074 . . . . 0.65000000000000002 113.898 -174.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -160.83 30.68 Favored Glycine 0 C--N 1.341 0.853 0 O-C-N 121.47 -0.769 . . . . 0.46999999999999997 112.27 177.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.7 178.6 8.95 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 0.65000000000000002 111.081 168.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -147.03 141.22 26.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.35 1.06 . . . . 6.9000000000000004 110.39 177.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -149.19 157.23 39.85 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.296 1.438 . . . . 0.92000000000000004 111.369 -167.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.1 -25.14 8.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.343 2.029 . . . . 1.3 113.355 165.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.29 3.6 m -87.5 12.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.484 1.29 . . . . 1.22 114.484 -173.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.12 145.99 30.72 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.521 1.128 . . . . 0.96999999999999997 110.741 173.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.05 -74.71 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.707 -1.59 . . . . 5.7999999999999998 106.707 170.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -80.17 142.19 34.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.305 1.842 . . . . 2.9300000000000002 109.692 169.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.22 131.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.66 1.584 . . . . 1.47 108.811 177.284 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -146.65 133.82 20.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.445 1.498 . . . . 1.95 109.96 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.65 123.81 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.296 1.046 . . . . 0.91000000000000003 111.003 171.146 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 14.9 m170 -117.29 152.02 35.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.847 2.059 . . . . 0.71999999999999997 113.492 -178.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.49 160.18 15.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.003 1.321 . . . . 2.1299999999999999 110.493 165.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.2 m -110.53 144.14 39.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.172 1.789 . . . . 1.46 107.7 163.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -152.19 162.42 41.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 114.679 1.363 . . . . 2.3900000000000001 114.679 -169.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.2 ptp -121.08 144.6 48.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.233 1.413 . . . . 3.8100000000000001 110.332 159.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -147.76 142.31 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.113 1.365 . . . . 8.3100000000000005 110.402 171.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.18 149.07 46.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.611 1.564 . . . . 4.1299999999999999 111.718 175.599 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 p -146.63 -11.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.458 1.281 . . . . 3.2400000000000002 114.458 173.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.21 30.56 0.49 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.175 1.79 . . . . 4.0999999999999996 110.875 178.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.35 -14.97 3.72 Favored Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.494 -1.379 . . . . 1.98 113.659 -167.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 167.76 9.57 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.185 2.194 . . . . 2.6200000000000001 110.019 158.551 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.56 148.68 34.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.997 1.851 . . . . 3.6699999999999999 115.997 -170.419 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.82 141.94 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.402 1.881 . . . . 3.1600000000000001 109.086 165.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 tpp -93.25 137.59 32.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.589 1.555 . . . . 2.8100000000000001 109.836 171.221 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 -177.77 29.01 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.801 0.715 . . . . 1.6399999999999999 114.584 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.4 mtt -141.48 156.64 45.74 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.159 1.784 . . . . 3.1699999999999999 110.211 176.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -164.96 156.07 12.87 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.25 1.42 . . . . 4.3700000000000001 110.84 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 33.0 Cg_endo -66.93 150.45 82.98 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.933 1.755 . . . . 0.81000000000000005 112.284 169.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.96 158.69 41.75 Favored Pre-proline 0 N--CA 1.471 0.625 0 C-N-CA 126.599 1.96 . . . . 0.95999999999999996 109.829 174.141 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.04 -29.5 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.142 1.895 . . . . 1.3600000000000001 112.247 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 p90 175.92 160.88 0.3 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.499 1.52 . . . . 1.8999999999999999 107.14 -175.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -112.13 162.55 15.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.275 1.036 . . . . 2.6200000000000001 111.033 155.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -145.27 157.66 44.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.071 -1.422 . . . . 2.52 114.174 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -145.88 133.74 10.5 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 114.553 -1.203 . . . . 1.0700000000000001 108.481 -161.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.9 171.22 15.01 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.011 1.807 . . . . 1.3300000000000001 111.334 176.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.86 144.06 99.51 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.075 2.517 . . . . 1.24 111.435 165.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 66.62 4.85 3.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.859 1.664 . . . . 1.5800000000000001 113.173 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.46 126.23 8.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 128.232 2.825 . . . . 1.1599999999999999 112.494 -170.302 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -98.78 141.82 31.1 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.642 1.577 . . . . 3.9199999999999999 112.601 166.27 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.4 122.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.321 1.848 . . . . 1.4199999999999999 108.744 168.146 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.443 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 18.0 mp0 -89.68 143.37 26.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.255 -0.903 . . . . 4.0499999999999998 111.163 176.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.44 148.49 43.21 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.321 -0.862 . . . . 2.6200000000000001 109.07 164.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' A' ' 76' ' ' GLU . 12.3 ptpt -166.86 138.72 2.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.947 1.299 . . . . 4.1399999999999997 111.363 -165.426 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.91 -26.79 58.94 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.153 3.236 . . . . 1.45 114.294 -169.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.72 78.71 1.03 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.145 -1.582 . . . . 1.74 109.145 161.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.42 -76.5 0.21 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 124.247 0.927 . . . . 1.24 114.236 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -148.3 136.64 21.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.167 1.387 . . . . 2.2599999999999998 111.623 -168.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.55 167.24 29.03 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.801 -0.562 . . . . 0.88 110.053 -172.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -96.88 133.73 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.392 -0.966 . . . . 2.3399999999999999 108.392 165.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 mmt -82.92 137.57 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.182 -0.673 . . . . 0.89000000000000001 109.182 157.265 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.94 127.81 55.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.967 2.107 . . . . 1.8799999999999999 107.112 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -136.2 158.37 44.57 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.495 1.118 . . . . 1.8799999999999999 111.412 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.58 -61.36 3.23 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.421 1.486 . . . . 3.1400000000000001 112.551 178.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.5 mt 76.84 100.33 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 130.861 3.664 . . . . 1.23 110.837 173.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.026 -1.046 . . . . 1.9299999999999999 113.139 -169.045 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -150.4 153.8 35.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.488 2.715 . . . . 6.6699999999999999 108.282 169.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -67.43 158.79 55.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.857 2.372 . . . . 2.4199999999999999 110.386 166.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.19 157.29 26.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.383 1.473 . . . . 2.5299999999999998 111.565 -171.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -139.28 134.43 32.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.344 1.057 . . . . 3.6899999999999999 111.142 176.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.87 38.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.202 0.601 . . . . 1.6599999999999999 111.906 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.13 -15.12 8.28 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.372 1.463 . . . . 2.21 116.038 173.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -176.04 3.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.19 1.495 . . . . 4.6399999999999997 111.243 -171.397 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -89.28 160.97 16.64 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.62 1.568 . . . . 4.75 112.362 171.251 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.37 127.59 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.054 1.742 . . . . 1.3400000000000001 108.863 167.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.32 134.11 41.1 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.326 1.45 . . . . 2.6899999999999999 110.259 164.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.67 127.37 10.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.498 1.142 . . . . 1.7 113.59 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.71 94.5 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.534 1.534 . . . . 2.6000000000000001 110.446 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.27 115.94 11.01 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.379 1.472 . . . . 1.21 110.524 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.0 mt -88.09 129.92 35.16 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.685 1.194 . . . . 0.81999999999999995 110.643 -172.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.66 144.9 50.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.056 0.931 . . . . 2.04 112.463 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.91 125.55 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.856 1.262 . . . . 1.96 113.473 -169.197 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.2 70.23 1.25 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.643 1.115 . . . . 3.3399999999999999 112.549 177.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.49 15.76 81.27 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.557 1.383 . . . . 1.95 116.557 163.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -105.92 148.36 27.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.967 1.883 . . . . 4.8899999999999997 110.972 171.174 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.11 140.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.84 1.656 . . . . 1.1200000000000001 107.914 167.541 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -120.2 116.99 26.72 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.224 1.009 . . . . 1.4299999999999999 109.385 178.009 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -75.73 128.81 35.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.83 0.452 . . . . 2.5699999999999998 110.835 174.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -137.04 144.32 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.01 1.724 . . . . 1.73 109.612 175.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.55 130.98 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.927 1.291 . . . . 2.4399999999999999 108.473 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 mp -140.26 153.56 69.02 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.667 1.587 . . . . 2.5800000000000001 110.013 -172.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.89 155.86 43.49 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.597 2.865 . . . . 1.4099999999999999 112.937 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.46 142.75 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.776 1.23 . . . . 1.4099999999999999 110.491 168.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.5 151.46 39.34 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.652 1.981 . . . . 2.8100000000000001 108.501 164.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.72 28.68 7.19 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.914 1.45 . . . . 1.96 114.914 -161.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.412 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.86 1.264 . . . . 7.8899999999999997 111.978 -165.191 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 109.755 -1.338 . . . . 14.890000000000001 109.755 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -165.29 171.1 13.95 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.801 1.641 . . . . 11.27 108.974 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.93 100.86 5.61 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.277 1.031 . . . . 11.77 109.598 178.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.4 p -145.49 168.23 21.08 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.931 1.292 . . . . 8.1999999999999993 112.137 -163.106 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -114.71 -157.8 0.64 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.822 2.449 . . . . 5.6100000000000003 110.528 -178.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.91 170.95 23.54 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.168 -1.582 . . . . 0.93999999999999995 114.581 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 p90 -165.58 149.78 8.4 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.137 0.975 . . . . 1.3799999999999999 111.291 -175.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.42 147.54 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.368 -0.975 . . . . 0.96999999999999997 108.368 167.3 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -97.08 119.72 36.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.947 0.794 . . . . 5.2000000000000002 110.043 164.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.12 134.62 38.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.864 0.84 . . . . 2.5600000000000001 108.86 156.505 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.2 m -139.66 160.89 59.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 125.635 1.574 . . . . 2.6200000000000001 109.336 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.24 -7.26 13.41 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.485 2.79 . . . . 2.3100000000000001 115.038 178.23 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.91 -164.47 18.53 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.254 0.934 . . . . 2.3500000000000001 113.549 175.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.33 -7.46 12.99 Favored 'Cis proline' 0 C--N 1.351 0.672 0 CA-C-N 118.69 1.245 . . . . 2.04 113.389 -4.116 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.06 136.92 34.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.345 1.458 . . . . 3.3100000000000001 110.919 176.496 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.57 -177.94 3.27 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.097 1.759 . . . . 0.58999999999999997 110.695 -177.17 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.63 136.66 34.56 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.243 0.929 . . . . 0.72999999999999998 113.068 -169.368 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.49 141.42 52.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 0.85999999999999999 112.294 -178.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -135.62 165.43 25.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.806 1.643 . . . . 2.4300000000000002 110.658 -172.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -171.34 148.96 2.68 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 1.5 112.783 168.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.0 m -77.28 138.07 39.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.809 -1.182 . . . . 1.22 107.809 149.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -136.33 143.22 44.02 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.522 1.929 . . . . 2.46 107.967 -177.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.63 135.24 49.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.731 0.812 . . . . 3.5 111.003 -177.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -97.23 100.73 8.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.515 -0.92 . . . . 1.1499999999999999 108.515 165.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.79 -10.79 15.5 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.637 2.225 . . . . 1.28 113.146 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.44 -173.08 49.49 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.729 1.157 . . . . 1.3999999999999999 113.413 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.21 1.34 16.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.913 1.685 . . . . 3.0 112.802 -168.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -123.03 161.0 47.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.327 1.851 . . . . 1.5800000000000001 110.392 174.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 148.63 17.29 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.509 2.14 . . . . 0.80000000000000004 111.833 -171.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.07 111.68 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.053 1.341 . . . . 2.0800000000000001 110.605 -176.45 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -98.79 101.91 13.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.871 1.268 . . . . 4.2800000000000002 110.865 -179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.07 114.56 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.676 1.99 . . . . 0.73999999999999999 108.629 -175.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.77 -19.51 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.29 0.848 . . . . 0.62 113.29 -171.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.37 -163.55 30.43 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.267 0.937 . . . . 0.39000000000000001 111.552 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.82 179.53 7.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 0.71999999999999997 110.658 164.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -149.41 135.36 18.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.859 1.664 . . . . 6.6299999999999999 108.068 -177.193 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -140.0 156.96 70.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.421 1.488 . . . . 0.79000000000000004 109.997 -171.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.48 -25.19 9.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.276 1.984 . . . . 0.93999999999999995 112.103 169.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.259 14.3 m -82.91 -11.52 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.469 1.285 . . . . 1.01 114.469 -173.456 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.11 155.71 47.65 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.526 0.935 . . . . 0.80000000000000004 113.526 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.26 -91.83 0.11 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.945 1.298 . . . . 3.3900000000000001 110.212 175.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -84.28 92.2 7.93 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.886 0.874 . . . . 3.1000000000000001 108.826 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -87.15 139.26 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.288 1.035 . . . . 1.4199999999999999 110.798 172.36 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -137.52 138.79 40.03 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.356 1.862 . . . . 1.9299999999999999 110.751 -174.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.43 121.04 29.35 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.913 1.233 . . . . 0.75 111.747 169.171 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -108.61 155.91 20.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.266 1.826 . . . . 0.58999999999999997 112.339 175.172 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.55 -179.76 4.04 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 2.5800000000000001 110.696 169.013 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -140.32 116.19 10.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.144 1.378 . . . . 1.1100000000000001 107.442 172.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -117.47 -179.49 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.509 1.524 . . . . 1.8100000000000001 110.854 -174.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 73.6 mtm -130.16 128.04 40.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.169 0.988 . . . . 3.3599999999999999 110.868 164.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -97.61 168.17 10.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.744 1.218 . . . . 7.3300000000000001 111.527 167.141 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -88.51 142.57 27.6 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.535 0.734 . . . . 5.9699999999999998 109.397 153.298 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.04 -6.92 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.141 1.163 . . . . 3.7400000000000002 114.141 175.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -175.84 31.66 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.804 2.042 . . . . 4.0099999999999998 109.425 -165.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.66 -19.68 0.15 Allowed Glycine 0 N--CA 1.479 1.501 0 O-C-N 119.545 -1.972 . . . . 2.29 114.769 -158.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -74.2 132.36 42.11 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.115 1.766 . . . . 3.96 109.159 175.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -76.4 126.34 30.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.101 -1.074 . . . . 4.2000000000000002 108.101 169.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -140.01 139.13 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.176 1.391 . . . . 2.5099999999999998 108.79 -175.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.8 mtp -69.9 162.25 28.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.217 1.192 . . . . 5.0999999999999996 114.217 -175.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.71 164.17 32.52 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.791 1.186 . . . . 0.96999999999999997 111.597 167.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.13 157.88 30.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.994 1.317 . . . . 1.79 110.183 172.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -169.44 151.56 4.51 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 3.8199999999999998 110.607 177.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.3 Cg_endo -69.02 153.23 72.65 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.758 1.639 . . . . 0.56000000000000005 111.708 169.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.76 159.02 50.42 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 126.261 1.824 . . . . 0.71999999999999997 110.53 174.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -72.46 -21.49 22.59 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.677 2.251 . . . . 0.78000000000000003 112.58 172.375 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -175.75 169.96 2.92 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.739 1.616 . . . . 2.3300000000000001 110.839 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -122.11 174.33 7.01 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.905 2.482 . . . . 0.77000000000000002 108.78 160.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -152.88 165.54 35.11 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.257 -0.902 . . . . 2.6600000000000001 113.217 164.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -135.04 128.29 18.54 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 125.45 1.5 . . . . 1.22 109.058 -176.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.85 162.2 43.45 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.474 2.116 . . . . 1.1599999999999999 111.03 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.21 94.45 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.975 2.45 . . . . 1.23 111.649 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt 68.1 -1.05 1.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.685 1.994 . . . . 1.53 113.671 -174.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.09 117.86 4.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 126.556 2.027 . . . . 1.1899999999999999 111.894 -177.314 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -91.75 129.61 37.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.235 1.014 . . . . 6.1699999999999999 110.035 157.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.07 171.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.861 1.664 . . . . 1.51 110.226 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -139.65 146.03 39.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.7 1.238 . . . . 4.6500000000000004 114.117 176.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -85.34 71.64 10.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.939 1.696 . . . . 1.27 109.391 178.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -61.4 141.56 94.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 114.133 -1.394 . . . . 3.7200000000000002 112.262 177.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.48 -18.04 51.58 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.653 2.236 . . . . 1.3 113.149 165.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.59 26.09 23.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.252 1.406 . . . . 1.26 114.107 172.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.52 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.476 1.36 0 CA-C-N 119.414 1.607 . . . . 1.3500000000000001 115.735 175.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -159.97 140.4 11.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.632 1.573 . . . . 1.95 109.413 -176.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -171.0 168.68 6.89 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.491 1.951 . . . . 1.3 111.173 -175.255 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.31 125.75 46.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.507 0.723 . . . . 1.73 111.46 -178.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mmt -91.99 142.57 27.4 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.449 1.099 . . . . 1.1200000000000001 110.014 170.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 mt -119.89 85.79 2.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.618 1.567 . . . . 1.78 109.053 -171.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.68 107.71 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.242 1.017 . . . . 3.3199999999999998 108.632 -176.179 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.03 130.37 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.118 0.866 . . . . 2.77 111.801 -172.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.475 HD13 HD11 ' A' ' 93' ' ' LEU . 64.3 mt -112.6 118.49 35.22 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.771 0.828 . . . . 0.88 108.999 178.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.2 9.79 19.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.069 0.766 . . . . 2.4900000000000002 113.069 -166.19 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -172.55 159.2 3.93 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 128.016 2.527 . . . . 5.2999999999999998 108.919 -171.627 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.24 160.61 48.96 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.374 1.383 . . . . 2.1299999999999999 110.018 162.196 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.475 HD11 HD13 ' A' ' 89' ' ' LEU . 3.6 mp -115.48 -164.72 0.97 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.453 1.901 . . . . 3.1899999999999999 108.728 -171.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.15 136.95 13.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.399 1.48 . . . . 5.0899999999999999 110.976 168.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.04 126.97 29.88 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.055 -1.091 . . . . 1.4299999999999999 108.055 151.657 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.38 78.53 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.137 -1.924 . . . . 1.8899999999999999 115.614 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -93.7 177.96 5.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.514 2.157 . . . . 3.5600000000000001 110.051 153.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -103.58 149.13 25.18 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.589 0.756 . . . . 4.8499999999999996 109.783 167.474 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.433 HG23 ' CG2' ' A' ' 117' ' ' VAL . 8.4 t -105.52 123.13 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.651 1.18 . . . . 1.1499999999999999 108.215 168.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.64 124.06 21.81 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 113.949 -1.478 . . . . 4.71 107.5 162.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.17 109.42 10.8 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.932 0.873 . . . . 1.8200000000000001 111.074 174.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.79 86.11 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.702 2.401 . . . . 2.6299999999999999 109.673 173.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.18 117.22 8.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.829 1.252 . . . . 1.1299999999999999 109.623 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.4 126.2 35.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.853 1.261 . . . . 0.81000000000000005 110.735 -175.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.42 117.77 25.18 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.535 -0.728 . . . . 1.95 111.58 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.96 22.04 0.18 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.196 2.199 . . . . 2.6899999999999999 115.985 171.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.9 -41.72 1.07 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.786 1.66 . . . . 3.9399999999999999 113.847 -171.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.06 -1.82 90.15 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.987 -1.452 . . . . 1.73 116.071 -174.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.45 159.32 42.46 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.712 2.005 . . . . 4.0300000000000002 111.727 168.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.14 145.99 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 126.42 1.888 . . . . 1.03 108.179 168.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -134.76 108.42 7.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.265 1.026 . . . . 1.6299999999999999 109.858 -177.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.87 96.83 6.46 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.604 0.361 . . . . 2.9399999999999999 110.817 176.661 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.86 151.39 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.631 0.772 . . . . 1.46 110.837 176.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.23 131.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.813 1.645 . . . . 1.9299999999999999 108.734 168.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.7 mt -139.93 130.63 14.19 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 1.78 109.499 176.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.93 151.6 56.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.489 2.793 . . . . 1.1000000000000001 111.692 176.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 99' ' ' VAL . 53.3 t -97.84 117.14 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.924 0.89 . . . . 1.23 111.787 178.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -75.57 155.36 36.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.553 2.741 . . . . 3.98 109.072 159.047 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.3 131.19 45.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.833 -1.167 . . . . 1.8400000000000001 112.631 171.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.0 mtt180 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 127.577 2.351 . . . . 7.21 108.153 169.699 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.45 0 N-CA-C 108.908 -1.677 . . . . 13.32 108.908 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -71.23 -23.27 61.97 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.469 1.655 . . . . 14.039999999999999 115.469 -173.014 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -171.73 162.49 6.28 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.556 1.942 . . . . 14.02 109.839 -175.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.5 p -136.16 -29.95 0.97 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.9 1.28 . . . . 7.75 114.068 -176.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -113.05 -133.62 0.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.289 2.236 . . . . 5.46 109.697 -173.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 170.97 24.26 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 120.877 1.671 . . . . 0.94999999999999996 114.232 177.445 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -155.31 164.98 38.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.285 1.041 . . . . 1.8799999999999999 113.681 174.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.58 119.13 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.169 -0.923 . . . . 1.26 108.549 174.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.531 ' HE ' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -80.83 113.46 19.04 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.435 0.636 . . . . 4.0700000000000003 110.383 175.095 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.5 134.64 53.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.021 0.915 . . . . 2.8999999999999999 108.98 162.319 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.03 164.62 20.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.691 1.996 . . . . 2.9300000000000002 107.298 170.312 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.62 -10.65 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.755 2.304 . . . . 1.6299999999999999 114.283 -174.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.17 -159.74 27.78 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.95 0.786 . . . . 1.49 111.743 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.37 -6.57 12.46 Favored 'Cis proline' 0 CA--C 1.538 0.704 0 CA-C-N 119.141 1.471 . . . . 1.71 113.7 3.076 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -136.9 158.83 43.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.821 1.248 . . . . 2.21 112.021 170.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.78 -162.57 1.11 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.004 2.122 . . . . 1.0600000000000001 111.226 -176.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB3' ' HE ' ' A' ' 9' ' ' ARG . . . -156.23 163.07 40.01 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.537 1.31 . . . . 0.72999999999999998 114.537 -170.041 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.27 150.37 36.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.688 1.595 . . . . 0.62 112.256 172.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.38 134.36 20.28 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.271 1.828 . . . . 2.3399999999999999 108.778 -172.669 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.56 137.81 8.11 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 115.055 1.502 . . . . 2.0499999999999998 115.055 -160.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -66.97 136.08 54.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.609 -0.723 . . . . 1.75 110.637 167.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.31 153.59 40.04 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.971 2.108 . . . . 2.6800000000000002 109.926 163.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.64 149.49 48.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.772 0.796 . . . . 3.4100000000000001 110.582 164.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -106.2 95.24 10.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.141 -0.936 . . . . 1.25 110.004 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.15 -5.09 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.875 2.384 . . . . 1.79 113.0 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.84 162.19 52.77 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 124.972 1.273 . . . . 1.5 113.39 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -74.56 -32.03 62.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.265 2.226 . . . . 5.8200000000000003 112.788 174.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.28 164.09 17.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.358 1.863 . . . . 1.73 112.102 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.55 152.54 17.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.864 2.376 . . . . 0.70999999999999996 111.497 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.28 115.98 30.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.852 1.261 . . . . 2.3199999999999998 110.226 -176.262 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.447 HH11 ' HB2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -99.58 107.27 19.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.528 1.131 . . . . 4.2400000000000002 110.538 177.065 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -95.55 119.24 33.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.093 1.357 . . . . 0.87 109.318 -174.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.21 -12.93 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.476 1.11 . . . . 0.67000000000000004 113.927 -171.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.5 -162.73 30.19 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.426 1.012 . . . . 0.56999999999999995 111.971 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB1' ' CD1' ' A' ' 101' ' ' LEU . . . -156.09 -167.96 2.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 0.72999999999999998 111.442 165.365 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -159.13 161.04 36.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.252 0.933 . . . . 5.6900000000000004 108.824 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.24 156.96 30.93 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 125.842 1.657 . . . . 0.73999999999999999 111.088 -178.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.5 -17.97 15.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.612 2.875 . . . . 1.0900000000000001 114.462 170.135 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -98.35 -18.17 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 115.013 1.486 . . . . 1.27 115.013 -174.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.432 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -108.55 152.8 24.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.75 1.159 . . . . 0.76000000000000001 112.073 176.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.95 -90.9 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.747 0.819 . . . . 3.5499999999999998 109.497 173.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -79.53 141.81 36.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.114 -1.069 . . . . 3.6299999999999999 108.114 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.08 131.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.715 1.206 . . . . 1.55 110.462 173.361 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.04 132.21 20.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.277 1.031 . . . . 2.1699999999999999 111.847 -163.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tt -79.13 124.22 28.11 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 121.474 0.654 . . . . 0.76000000000000001 111.034 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -112.62 157.07 21.66 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.196 1.798 . . . . 0.81000000000000005 112.147 172.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.44 -170.85 1.84 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.548 1.139 . . . . 2.71 112.319 165.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.6 m -147.42 88.09 1.69 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.32 1.848 . . . . 1.1200000000000001 107.447 170.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -78.46 157.24 29.0 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 2.2400000000000002 112.009 -177.311 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.9 mtm -107.69 130.72 54.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.401 1.08 . . . . 2.8300000000000001 110.012 166.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 -146.89 149.39 33.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.308 1.043 . . . . 5.0300000000000002 111.542 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 145.54 55.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.544 0.738 . . . . 3.9900000000000002 109.843 155.497 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.74 -90.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.727 1.611 . . . . 3.1000000000000001 108.693 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -77.43 41.29 0.31 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.392 2.277 . . . . 3.5499999999999998 111.613 175.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.97 -10.27 1.26 Allowed Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.544 -1.348 . . . . 2.02 114.327 -166.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -102.45 155.79 18.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 128.625 2.77 . . . . 2.6099999999999999 109.374 175.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -90.59 145.62 24.71 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.303 1.223 . . . . 3.4199999999999999 114.303 178.003 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.9 t -141.27 148.16 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.306 1.843 . . . . 1.8700000000000001 109.421 -178.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -89.87 123.45 33.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.577 1.551 . . . . 3.5299999999999998 110.11 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.87 138.31 10.51 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 119.041 0.837 . . . . 1.3 113.678 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -90.04 156.62 18.27 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.828 0.851 . . . . 1.76 111.676 170.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -167.42 153.7 7.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.135 1.774 . . . . 4.3799999999999999 110.088 168.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -68.46 156.95 63.85 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.342 1.361 . . . . 0.57999999999999996 110.698 170.118 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.99 156.14 78.63 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.237 1.415 . . . . 0.66000000000000003 110.751 -178.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.87 -20.07 30.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.969 2.446 . . . . 0.71999999999999997 113.112 178.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.6 166.91 3.86 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.444 1.098 . . . . 1.8700000000000001 112.455 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -115.92 178.0 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.471 2.308 . . . . 0.67000000000000004 109.296 153.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.12 159.63 44.36 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.122 -0.986 . . . . 2.0800000000000001 111.57 164.077 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.41 126.53 20.29 Favored Pre-proline 0 N--CA 1.468 0.425 0 C-N-CA 126.021 1.728 . . . . 1.0 108.202 -178.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.64 162.39 42.3 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.509 2.14 . . . . 0.88 110.998 178.184 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.51 131.76 32.99 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.29 2.66 . . . . 1.02 110.622 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.9 1.52 3.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.869 2.467 . . . . 2.5899999999999999 114.226 -170.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.84 118.81 9.24 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 125.811 1.672 . . . . 1.0 109.055 172.024 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -117.79 114.58 23.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.833 2.053 . . . . 4.46 109.171 172.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -149.96 154.02 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.459 1.103 . . . . 1.99 112.174 -165.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -102.96 134.49 46.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.302 0.572 . . . . 3.0499999999999998 111.751 176.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.13 137.0 57.36 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.241 -1.392 . . . . 2.0800000000000001 107.241 141.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -150.17 143.75 16.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.489 2.316 . . . . 3.2599999999999998 109.938 -161.101 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.05 -43.68 28.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.807 3.005 . . . . 1.54 113.151 -167.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 118.34 5.86 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.371 -1.892 . . . . 2.1099999999999999 108.371 157.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -77.29 0.38 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.683 1.135 . . . . 1.23 112.937 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -154.5 131.9 11.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.41 1.105 . . . . 2.02 110.448 -175.361 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -163.66 172.17 14.64 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.764 -1.21 . . . . 0.82999999999999996 111.714 -167.299 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.13 122.08 45.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.162 0.585 . . . . 1.8999999999999999 109.776 173.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 mmt -80.39 134.23 36.0 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.171 -0.678 . . . . 1.24 109.171 165.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.52 118.52 36.77 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.198 1.399 . . . . 2.1000000000000001 107.711 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.78 104.71 9.78 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.373 1.469 . . . . 1.96 109.192 -171.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.06 141.39 1.05 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.302 -0.719 . . . . 3.1499999999999999 111.302 -159.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.9 mt -117.67 120.47 38.11 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.489 -0.93 . . . . 1.23 108.489 171.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.79 -4.38 54.41 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.946 1.091 . . . . 2.2000000000000002 113.946 -170.851 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -150.41 159.21 35.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.134 2.173 . . . . 6.6100000000000003 110.076 178.147 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -66.76 159.11 52.88 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.354 2.036 . . . . 2.2400000000000002 109.226 153.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.54 160.4 31.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.689 1.596 . . . . 2.6499999999999999 109.75 -162.562 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.69 129.53 10.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.412 1.101 . . . . 4.6699999999999999 112.902 -158.22 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.31 121.19 13.72 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.479 -0.763 . . . . 2.0499999999999998 110.213 174.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.43 7.69 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.423 -1.209 . . . . 2.29 114.804 -166.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.9 174.2 7.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.652 1.726 . . . . 3.6200000000000001 108.958 144.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -89.7 148.28 23.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.045 0.938 . . . . 3.9399999999999999 110.617 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.4 HG23 ' CG2' ' A' ' 117' ' ' VAL . 3.1 t -93.63 127.48 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.254 -1.017 . . . . 1.1399999999999999 108.254 161.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.526 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 51.5 mt-10 -65.45 111.87 3.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.281 -0.872 . . . . 3.1899999999999999 108.678 153.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.404 ' CD1' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -100.95 123.29 44.91 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.594 -1.262 . . . . 2.5299999999999998 107.594 163.113 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -102.68 85.64 2.61 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.835 2.054 . . . . 2.2799999999999998 109.145 177.096 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.28 121.47 16.31 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.444 1.898 . . . . 3.0099999999999998 110.5 -175.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.5 mt -92.98 133.54 36.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.42 1.088 . . . . 0.97999999999999998 111.279 -176.688 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.77 153.31 38.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.159 0.984 . . . . 1.8500000000000001 111.454 178.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.9 132.35 53.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.346 0.658 . . . . 1.78 111.303 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.83 -142.92 16.27 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.662 -0.975 . . . . 3.7999999999999998 110.662 -167.321 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -100.62 12.25 59.6 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.676 1.131 . . . . 2.5699999999999998 115.359 -176.02 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -87.36 137.36 32.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.589 1.694 . . . . 5.79 113.306 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.38 138.52 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.749 1.62 . . . . 1.3799999999999999 109.787 165.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.07 113.4 25.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.472 1.509 . . . . 2.4100000000000001 109.898 177.416 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.526 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 23.0 ttmm -78.69 116.91 19.37 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.126 -0.694 . . . . 2.6499999999999999 109.126 168.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.83 149.46 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.408 1.083 . . . . 1.76 109.89 173.203 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -95.8 138.07 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.663 1.185 . . . . 2.8399999999999999 109.62 170.221 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.3 mt -144.91 140.61 16.43 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.678 1.591 . . . . 1.8799999999999999 109.807 178.01 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.04 144.37 63.53 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.079 3.186 . . . . 1.3 114.005 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 99' ' ' VAL . 60.4 t -88.16 126.22 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.45 1.1 . . . . 1.5900000000000001 110.831 172.177 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -97.31 168.79 10.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.038 2.935 . . . . 3.1699999999999999 109.222 169.109 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.57 30.89 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.622 1.556 . . . . 2.0299999999999998 110.386 161.494 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.2 ttm-85 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.862 1.665 . . . . 7.1600000000000001 113.075 -171.704 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.235 0 N-CA-C 105.166 -3.174 . . . . 15.25 105.166 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.3 m -157.28 146.38 19.99 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 118.963 -1.095 . . . . 12.91 111.823 -123.379 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -153.98 121.17 5.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.301 1.44 . . . . 9.8599999999999994 110.042 -173.719 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.5 p -141.05 97.56 3.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.474 1.11 . . . . 6.6299999999999999 110.55 -178.041 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.28 122.54 45.61 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.159 1.784 . . . . 5.8499999999999996 110.692 -173.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.06 172.34 30.69 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.371 -0.83 . . . . 0.87 114.824 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -159.63 129.8 5.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 2.1499999999999999 112.66 -173.136 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.01 103.09 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.79 -1.189 . . . . 1.0 107.79 175.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.5 ttp85 -85.46 114.37 22.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.576 0.703 . . . . 4.1699999999999999 110.695 -174.121 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.24 163.21 18.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.138 1.775 . . . . 2.8700000000000001 112.903 -167.828 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -168.89 142.31 2.36 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.17 1.788 . . . . 2.6000000000000001 109.95 156.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.61 -8.38 18.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.069 3.179 . . . . 2.2000000000000002 114.425 -169.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.94 161.93 10.62 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.929 0.776 . . . . 2.6899999999999999 113.302 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.87 -1.44 8.12 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 118.612 1.206 . . . . 3.1600000000000001 112.659 -11.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -153.51 173.09 16.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 2.77 113.322 -179.003 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.02 171.57 14.24 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.139 2.576 . . . . 0.79000000000000004 110.373 168.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.69 104.42 4.91 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.885 0.874 . . . . 2.2599999999999998 111.307 -171.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 149.99 21.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.508 0.929 . . . . 0.63 113.508 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.12 162.97 32.82 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.625 1.57 . . . . 2.3799999999999999 111.167 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.93 152.62 6.59 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.46 1.104 . . . . 1.4399999999999999 112.075 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 m -84.24 142.37 30.32 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.251 -1.018 . . . . 1.3100000000000001 108.251 154.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.82 146.33 39.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.447 1.899 . . . . 2.7599999999999998 106.951 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 7.7 pt-20 -116.97 142.51 46.86 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.484 0.714 . . . . 3.5600000000000001 111.548 173.107 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -101.58 105.14 38.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.121 0.969 . . . . 1.1100000000000001 109.685 166.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.14 -8.43 11.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.641 2.227 . . . . 0.95999999999999996 113.672 178.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.26 166.92 48.6 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 119.707 1.139 . . . . 1.22 112.93 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.83 2.37 51.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.195 2.198 . . . . 3.27 111.877 173.168 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -109.67 159.53 31.26 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 128.333 2.653 . . . . 2.75 108.888 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.76 152.03 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.094 2.53 . . . . 1.1100000000000001 111.287 177.137 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.99 106.51 17.06 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.013 0.925 . . . . 2.3199999999999998 110.495 173.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.1 114.16 21.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.581 -1.645 . . . . 3.5499999999999998 109.112 170.338 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 104' ' ' LEU . 2.3 tm? -105.14 128.77 53.53 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.535 1.934 . . . . 2.9700000000000002 108.693 -177.561 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.79 -7.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.169 0.988 . . . . 0.63 113.259 -175.049 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.9 -159.18 32.19 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 119.588 -1.291 . . . . 0.52000000000000002 114.303 178.592 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.4 173.15 14.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.674 0.79 . . . . 0.72999999999999998 112.351 -179.143 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 45.4 mtm180 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.139 -1.43 . . . . 6.1399999999999997 107.139 164.041 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -147.2 142.96 17.49 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 117.886 -1.054 . . . . 1.25 109.066 -175.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.29 -21.72 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.005 1.803 . . . . 1.21 111.517 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.367 1.0 OUTLIER -77.86 11.73 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 118.739 0.7 . . . . 1.5 112.453 174.894 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.43 145.71 39.2 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 114.584 1.327 . . . . 0.96999999999999997 114.584 176.456 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -87.17 -83.19 0.2 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.742 -1.207 . . . . 4.1200000000000001 107.742 170.154 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -77.99 147.59 34.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.1 0.96 . . . . 3.2599999999999998 108.84 162.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.28 143.54 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.231 1.412 . . . . 1.3600000000000001 109.279 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -139.87 137.44 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.424 1.49 . . . . 2.27 109.773 -174.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.453 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.0 tt -86.56 121.97 29.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.962 1.255 . . . . 0.90000000000000002 110.511 164.624 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -109.92 153.66 24.19 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.038 1.335 . . . . 0.92000000000000004 112.329 174.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.82 169.69 10.73 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.053 1.741 . . . . 2.21 110.618 163.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -152.11 128.27 10.47 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.898 1.279 . . . . 1.72 108.992 175.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.65 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.136 0.974 . . . . 1.98 112.674 -161.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 ptt? -105.48 148.92 26.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.239 0.616 . . . . 3.0699999999999998 110.474 155.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -162.11 164.55 27.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.572 1.949 . . . . 5.2000000000000002 109.98 174.04 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.0 149.68 22.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.922 0.889 . . . . 4.3799999999999999 110.959 -174.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -128.36 -96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 124.329 1.018 . . . . 3.0600000000000001 109.244 -178.111 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -76.72 42.02 0.28 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.909 2.084 . . . . 3.7200000000000002 110.963 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.61 -9.12 3.69 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 119.827 -1.796 . . . . 2.9100000000000001 114.04 -168.105 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.17 148.02 24.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.702 1.601 . . . . 3.4199999999999999 110.285 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -65.58 134.41 53.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.472 0.709 . . . . 3.7200000000000002 110.203 167.033 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -137.5 153.75 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.377 1.471 . . . . 2.1200000000000001 109.126 176.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 ptp -108.02 142.44 38.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.371 1.068 . . . . 5.3600000000000003 111.866 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.22 32.63 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 123.741 0.686 . . . . 1.3500000000000001 113.342 -176.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.18 167.18 23.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 2.3300000000000001 110.329 -173.701 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -173.69 154.35 2.36 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.763 1.625 . . . . 3.9199999999999999 111.215 170.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.67 143.82 69.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.397 2.065 . . . . 0.95999999999999996 112.01 166.388 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.27 156.86 59.91 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.005 2.122 . . . . 0.75 110.521 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.97 -21.46 18.35 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.522 2.148 . . . . 0.73999999999999999 113.186 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -172.7 174.8 3.58 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.841 1.201 . . . . 2.3599999999999999 111.905 -177.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.1 176.34 8.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.455 2.702 . . . . 0.87 108.513 165.774 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.87 168.45 27.17 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 120.728 -1.232 . . . . 2.4700000000000002 112.649 166.129 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.37 129.9 18.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.516 1.527 . . . . 1.5 108.969 179.049 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.52 162.97 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.15 2.566 . . . . 1.52 112.219 -177.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.01 136.04 70.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.885 3.056 . . . . 1.3200000000000001 112.005 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt 67.02 5.57 4.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.08 1.752 . . . . 1.3500000000000001 113.665 -178.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.39 123.43 7.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 126.809 2.147 . . . . 1.3300000000000001 110.238 -178.771 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -102.35 129.96 48.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.156 0.982 . . . . 4.5599999999999996 110.915 159.565 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.8 m -153.01 158.8 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.171 1.388 . . . . 2.29 110.693 -174.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.63 142.47 46.85 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.15 1.38 . . . . 3.6000000000000001 114.278 -177.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.58 73.22 0.53 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.863 1.665 . . . . 1.22 108.954 165.592 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -62.6 140.88 96.94 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.251 1.42 . . . . 3.27 112.272 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.06 -37.63 91.77 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.281 2.654 . . . . 1.1899999999999999 112.822 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.22 71.08 2.99 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.943 -1.263 . . . . 1.3200000000000001 109.943 164.161 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.77 -58.65 0.2 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.553 1.073 . . . . 1.4099999999999999 115.09 176.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -157.63 149.46 22.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.4 1.88 . . . . 2.8199999999999998 111.898 -172.074 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -161.18 165.08 29.99 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.117 -0.989 . . . . 1.3300000000000001 111.166 177.247 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.453 ' CE1' HD12 ' A' ' 45' ' ' LEU . 53.9 m-85 -100.14 109.87 22.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.796 -0.816 . . . . 1.77 108.796 168.568 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 119.73 22.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 1.53 108.335 172.66 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.03 121.29 41.14 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.054 1.342 . . . . 1.6799999999999999 107.877 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.36 144.6 43.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.956 1.302 . . . . 3.6899999999999999 109.667 -173.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.33 -61.36 4.72 Favored Glycine 0 N--CA 1.475 1.249 0 O-C-N 121.15 -0.969 . . . . 2.7400000000000002 113.477 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt 78.23 119.15 0.05 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.62 3.168 . . . . 1.27 111.996 171.154 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.52 -2.45 20.37 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.719 1.007 . . . . 2.3300000000000001 113.719 -174.619 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.52 159.67 40.9 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.887 1.275 . . . . 6.2999999999999998 108.597 169.022 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.24 158.68 54.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.905 2.403 . . . . 2.6099999999999999 110.602 173.811 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.24 13.61 8.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.684 1.194 . . . . 4.3899999999999997 112.423 -160.525 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 160.76 5.31 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.174 1.176 . . . . 3.4100000000000001 114.174 -167.332 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.45 121.53 9.21 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.233 -0.917 . . . . 1.73 110.26 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.12 20.37 55.38 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.264 -0.742 . . . . 2.5 114.209 -169.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.25 161.34 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.647 1.724 . . . . 3.23 108.655 135.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.41 131.21 56.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.513 -2.032 . . . . 3.98 105.513 155.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.4 102.51 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.901 0.858 . . . . 1.1599999999999999 110.555 -174.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -65.3 146.79 54.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.976 -1.011 . . . . 4.75 111.248 164.02 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.2 tt -152.85 128.41 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.657 0.783 . . . . 1.6699999999999999 110.835 178.038 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 28.9 m-20 -84.73 106.62 16.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.192 1.797 . . . . 2.4700000000000002 111.235 173.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.6 mt -78.14 120.71 23.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.02 0.827 . . . . 1.22 109.097 176.293 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.488 ' O ' HD22 ' A' ' 32' ' ' LEU . 37.0 mt -100.85 112.66 25.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.145 0.978 . . . . 0.77000000000000002 110.486 -168.187 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.53 149.51 31.28 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.243 1.02 . . . . 2.1400000000000001 112.263 -174.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.72 118.95 6.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.326 1.05 . . . . 2.3500000000000001 112.106 -170.318 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.02 71.71 1.14 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.645 1.117 . . . . 3.6200000000000001 113.011 178.02 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.72 -3.72 68.01 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 117.239 1.655 . . . . 1.9299999999999999 117.239 162.152 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.87 130.86 34.76 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.225 2.012 . . . . 4.4199999999999999 110.081 173.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.6 136.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.306 1.042 . . . . 1.1899999999999999 109.89 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.58 115.15 13.54 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.615 1.166 . . . . 1.8400000000000001 109.965 -174.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -77.05 119.37 20.67 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.662 -0.649 . . . . 2.96 111.971 172.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.93 167.79 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.344 1.457 . . . . 1.3 110.205 163.361 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.67 149.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.354 1.862 . . . . 2.77 109.195 163.653 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.8 mt -146.49 127.33 7.17 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.126 1.37 . . . . 1.9099999999999999 109.235 -172.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 162.82 41.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.896 2.397 . . . . 0.96999999999999997 111.507 174.242 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -87.62 134.91 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.621 1.169 . . . . 1.8600000000000001 111.614 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.0 164.38 13.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.092 1.757 . . . . 3.1400000000000001 107.8 157.267 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.02 -166.85 1.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.021 1.489 . . . . 4.3399999999999999 115.021 -171.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 115.729 1.751 . . . . 10.890000000000001 115.729 -158.22 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -1.025 0 N-CA-C 108.652 -1.779 . . . . 13.4 108.652 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.4 t 151.79 56.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 131.216 3.806 . . . . 11.279999999999999 104.074 -164.211 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 43.21 -119.51 0.57 Allowed 'General case' 0 CA--C 1.551 1.009 0 O-C-N 120.618 -1.301 . . . . 9.1199999999999992 109.171 -132.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.312 30.2 p 106.6 77.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 1 C-N-CA 133.763 4.825 . . . . 6.46 109.23 173.418 . . . . . . . . 3 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -79.65 106.98 12.07 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.305 1.842 . . . . 6.0499999999999998 111.427 -160.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.45 167.1 32.93 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.388 1.47 . . . . 0.95999999999999996 113.727 -176.234 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -162.16 167.16 24.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.75 1.22 . . . . 1.6599999999999999 113.377 -173.25 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -113.12 136.42 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.76 1.224 . . . . 1.3 108.868 171.312 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -92.93 100.63 13.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.289 0.566 . . . . 4.2400000000000002 109.493 162.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -69.4 122.55 19.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.363 -0.977 . . . . 2.5800000000000001 108.363 160.932 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.6 167.63 19.7 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 125.732 1.613 . . . . 3.3100000000000001 108.452 172.017 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.07 5.08 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.794 2.996 . . . . 2.9199999999999999 116.637 -162.397 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.01 -177.17 44.46 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.207 0.912 . . . . 2.3300000000000001 113.408 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.12 -2.8 13.64 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 118.347 1.073 . . . . 1.9099999999999999 112.923 -4.059 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -121.7 165.66 15.45 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.617 1.567 . . . . 2.4100000000000001 112.752 173.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.06 -171.49 3.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.383 2.673 . . . . 0.93999999999999995 109.443 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.38 160.12 39.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.772 1.397 . . . . 0.98999999999999999 114.772 -173.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.4 145.77 51.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.865 1.266 . . . . 0.76000000000000001 112.328 170.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.0 139.72 26.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.877 1.671 . . . . 2.0499999999999998 110.308 -171.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.06 150.38 9.51 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.983 1.846 . . . . 1.6200000000000001 115.983 -173.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.9 m -86.67 129.87 34.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.531 2.333 . . . . 1.55 109.179 165.283 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.55 171.67 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.644 1.178 . . . . 4.6699999999999999 110.911 171.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -147.05 138.71 24.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.227 1.011 . . . . 2.9399999999999999 111.374 -173.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -96.36 108.43 41.89 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.767 1.227 . . . . 1.0700000000000001 109.236 168.491 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.58 -9.18 14.8 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.441 2.094 . . . . 1.01 113.196 174.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.34 169.64 52.83 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.362 0.982 . . . . 1.03 114.062 -176.044 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.46 -6.19 37.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.506 1.923 . . . . 3.0600000000000001 113.358 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.52 160.9 27.69 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.682 . . . . 1.24 110.157 168.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.57 161.5 19.36 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.192 2.595 . . . . 0.83999999999999997 112.094 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.8 mt -104.94 147.92 27.26 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.237 1.015 . . . . 2.0899999999999999 111.426 167.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -117.92 115.52 25.09 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.699 1.599 . . . . 5.5300000000000002 108.823 164.507 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.6 tp -95.53 115.26 27.18 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.704 1.602 . . . . 0.95999999999999996 108.303 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.91 -8.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.558 0.948 . . . . 0.87 113.558 -167.6 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.12 -174.03 46.2 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.992 0.806 . . . . 0.53000000000000003 111.805 175.26 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.07 174.84 10.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.161 -0.923 . . . . 0.93000000000000005 110.188 166.191 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.97 148.84 19.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.867 1.212 . . . . 5.4400000000000004 110.54 169.271 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.35 160.56 54.09 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 0.76000000000000001 109.107 -159.819 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.75 -31.14 40.24 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.307 2.004 . . . . 1.04 113.607 167.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 2.1 m -88.11 -5.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.501 1.667 . . . . 0.98999999999999999 115.501 -163.575 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.17 159.34 42.82 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.099 1.148 . . . . 0.96999999999999997 114.099 -171.708 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 12.3 tp10 -99.18 -78.82 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.295 1.038 . . . . 3.4100000000000001 111.477 -175.324 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -74.37 127.62 33.47 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.97 -1.122 . . . . 2.9700000000000002 107.97 169.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.95 131.77 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.306 1.842 . . . . 1.3100000000000001 109.291 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -150.15 135.79 18.31 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.416 1.086 . . . . 2.3799999999999999 111.236 -167.302 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -80.11 125.04 29.31 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.653 1.115 . . . . 0.88 110.817 169.432 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.6 m170 -114.96 153.9 29.74 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.171 1.788 . . . . 0.71999999999999997 112.811 178.275 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -86.66 168.68 13.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.135 2.174 . . . . 2.46 111.164 164.253 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.4 m -150.62 131.73 14.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.882 1.273 . . . . 1.3 108.633 171.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -148.67 162.99 38.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.024 1.12 . . . . 2.25 114.024 -158.445 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 mtp -114.72 119.22 35.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.427 1.891 . . . . 4.8200000000000003 108.863 162.168 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -148.66 156.65 42.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.538 1.135 . . . . 8.5600000000000005 111.977 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.0 145.19 42.74 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.233 1.413 . . . . 4.0499999999999998 111.903 165.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -148.75 -63.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.482 1.513 . . . . 4.2800000000000002 109.41 176.635 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 56' ' ' LYS . 1.2 tt0 -78.77 30.21 0.2 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.562 2.745 . . . . 4.6200000000000001 111.719 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.0 -21.21 0.29 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.167 1.365 . . . . 4.5 113.629 -162.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 54' ' ' GLU . 6.6 mtmt -113.09 168.88 9.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 128.891 2.876 . . . . 3.1200000000000001 110.332 170.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -89.42 146.78 24.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.634 2.087 . . . . 3.52 116.634 -172.213 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 59' ' ' MET . 8.1 p -145.36 175.08 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 127.788 2.435 . . . . 3.5 108.894 174.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.456 ' H ' HG22 ' A' ' 58' ' ' VAL . 19.7 mtm -107.1 146.37 31.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.049 1.339 . . . . 4.1799999999999997 112.466 -178.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.8 176.86 33.18 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 114.731 0.652 . . . . 1.3100000000000001 114.731 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 mtt -139.22 146.17 40.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.125 2.17 . . . . 2.9300000000000002 109.796 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -158.34 148.49 15.54 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 125.746 1.619 . . . . 5.4900000000000002 110.237 -177.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.2 Cg_endo -69.18 154.17 70.43 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.914 1.743 . . . . 0.62 112.359 170.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.32 158.16 65.03 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.923 1.689 . . . . 0.64000000000000001 110.624 176.235 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.93 -19.02 35.87 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.447 2.098 . . . . 0.96999999999999997 113.129 175.791 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -178.79 172.18 1.38 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.676 1.591 . . . . 2.4100000000000001 111.579 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -117.28 173.38 6.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.378 1.871 . . . . 0.79000000000000004 109.634 154.144 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.49 168.76 18.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.208 0.603 . . . . 3.77 110.596 169.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -145.58 129.54 8.64 Favored Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 125.691 1.596 . . . . 0.90000000000000002 107.461 177.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.78 167.63 25.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.777 1.652 . . . . 1.0 111.414 178.187 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.83 139.71 86.66 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.949 2.433 . . . . 0.87 110.785 168.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt 65.97 1.88 2.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.78 1.632 . . . . 1.26 113.694 -175.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.25 115.23 4.06 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.143 1.83 . . . . 0.84999999999999998 111.149 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.93 135.18 33.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.206 1.002 . . . . 5.1200000000000001 109.61 157.668 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 m -153.17 151.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.929 1.292 . . . . 1.5700000000000001 110.678 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 133.23 55.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.661 1.22 . . . . 3.7000000000000002 113.173 172.119 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.04 78.99 0.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.803 1.641 . . . . 1.1799999999999999 107.641 161.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -70.61 138.41 85.97 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.363 1.465 . . . . 3.1600000000000001 111.748 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.09 -24.27 76.21 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.153 2.569 . . . . 1.21 113.229 178.075 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.83 59.27 0.77 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.125 1.345 . . . . 1.23 111.668 166.246 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.64 -55.47 0.13 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 115.57 0.988 . . . . 1.3899999999999999 115.57 173.526 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -155.1 140.42 17.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.241 1.416 . . . . 2.04 110.34 -176.449 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -164.31 178.35 7.58 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.094 -1.003 . . . . 0.81999999999999995 111.034 -173.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -110.21 126.39 54.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.497 0.719 . . . . 1.8300000000000001 110.455 170.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 mmt -82.7 139.68 33.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.301 1.04 . . . . 0.88 110.938 168.495 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.1 mt -116.91 128.93 55.71 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.091 1.756 . . . . 1.79 108.162 175.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.05 116.42 11.2 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.884 1.274 . . . . 2.02 110.943 -173.139 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.95 130.53 0.55 Allowed Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.616 -1.393 . . . . 2.7599999999999998 109.616 -167.104 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.654 HD13 HD11 ' A' ' 93' ' ' LEU . 86.0 mt -127.76 108.63 10.9 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 122.21 1.005 . . . . 1.03 110.391 -171.706 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 4.0 pttm -88.38 0.31 56.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.924 1.29 . . . . 1.95 114.378 -173.653 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -149.85 157.22 38.28 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.781 2.433 . . . . 5.8700000000000001 108.552 175.172 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.29 145.83 79.12 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.653 1.568 . . . . 2.2799999999999998 108.584 162.45 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.654 HD11 HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -100.77 17.95 20.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.606 1.562 . . . . 4.1299999999999999 111.161 -175.404 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.84 138.1 1.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.325 2.25 . . . . 4.0700000000000003 115.048 -161.495 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 116.86 6.0 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.593 -1.317 . . . . 1.5 109.845 170.045 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.82 17.22 33.54 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.749 -1.029 . . . . 2.7599999999999998 113.792 -163.481 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -81.97 175.06 10.68 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.01 1.405 . . . . 3.2599999999999998 108.366 133.257 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -125.19 131.01 53.26 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.901 -1.888 . . . . 5.0300000000000002 105.901 155.005 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -94.73 94.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.64 -0.874 . . . . 0.87 108.64 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.34 113.85 3.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.345 -0.942 . . . . 3.9300000000000002 108.981 153.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -121.75 142.44 50.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.727 1.211 . . . . 1.6899999999999999 109.542 170.221 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.64 126.83 34.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.585 2.354 . . . . 2.71 111.634 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.35 125.23 37.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.393 1.077 . . . . 1.22 110.712 167.147 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.58 123.45 43.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.729 1.212 . . . . 0.79000000000000004 109.721 -174.303 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -119.49 126.75 52.04 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.236 -0.915 . . . . 2.1899999999999999 112.948 -174.21 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.36 -22.64 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 130.474 3.509 . . . . 2.9900000000000002 117.538 173.412 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.53 10.18 3.03 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.035 1.779 . . . . 4.04 115.432 -173.043 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -165.5 -28.44 0.02 OUTLIER Glycine 0 N--CA 1.477 1.419 0 CA-C-N 119.645 1.723 . . . . 2.3900000000000001 117.225 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.02 133.98 35.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.537 1.668 . . . . 5.8099999999999996 109.331 173.331 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.07 145.93 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.831 0.852 . . . . 0.97999999999999998 109.812 168.004 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.77 128.35 18.09 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.937 1.695 . . . . 2.21 108.083 172.193 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -99.08 151.76 20.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.655 0.983 . . . . 3.0600000000000001 113.655 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.56 146.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.87 1.668 . . . . 1.54 110.823 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.21 144.04 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.377 1.471 . . . . 3.1299999999999999 110.771 168.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.3 mt -149.87 95.54 3.66 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 2.2000000000000002 108.761 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.26 152.8 74.2 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.49 2.793 . . . . 1.27 112.809 -172.082 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.2 t -92.63 119.33 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.086 0.954 . . . . 1.3200000000000001 111.741 -171.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.31 132.98 35.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.033 0.933 . . . . 3.79 108.638 152.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -93.34 99.81 12.26 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.65 -1.241 . . . . 2.02 107.65 159.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 117.933 -1.032 . . . . 7.8099999999999996 112.55 -159.862 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 N-CA-C 110.578 -1.009 . . . . 10.44 110.578 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m 170.93 -70.91 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 129.277 3.031 . . . . 10.19 109.577 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -99.76 61.71 1.15 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.572 1.149 . . . . 13.369999999999999 108.261 175.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t 106.97 176.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 1 C-N-CA 131.798 4.039 . . . . 6.79 111.483 -168.381 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -145.63 133.16 20.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.752 2.421 . . . . 4.6600000000000001 108.557 173.122 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.34 179.38 37.75 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 115.213 0.845 . . . . 1.22 115.213 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -161.02 151.37 17.83 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.829 1.252 . . . . 1.6899999999999999 113.548 176.778 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.8 t -110.09 145.66 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.995 0.918 . . . . 1.0700000000000001 108.828 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.39 122.64 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.91 1.284 . . . . 4.8799999999999999 109.639 -175.319 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.21 174.25 10.95 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.764 1.765 . . . . 2.4500000000000002 115.764 -171.401 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.7 t -171.5 158.28 4.75 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 128.118 2.567 . . . . 3.3500000000000001 108.083 170.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.68 -21.16 19.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.596 2.197 . . . . 2.9700000000000002 112.07 164.491 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.62 175.72 14.12 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.754 1.645 . . . . 2.1600000000000001 113.155 178.384 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.91 -4.53 56.48 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 118.3 1.05 . . . . 2.4199999999999999 112.965 -9.712 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.01 150.03 40.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.863 1.265 . . . . 3.21 112.181 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.22 -173.51 3.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.854 1.662 . . . . 0.53000000000000003 112.007 174.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.6 151.12 46.99 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.798 0.839 . . . . 0.79000000000000004 113.065 -173.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.61 150.06 39.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.478 1.111 . . . . 0.67000000000000004 112.726 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.25 153.79 41.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.062 1.745 . . . . 2.0899999999999999 109.495 -175.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -177.62 157.51 1.25 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.124 1.77 . . . . 1.8300000000000001 109.957 -170.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 76' ' ' GLU 0.26 14.1 t -85.44 140.91 30.33 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.363 1.078 . . . . 3.6099999999999999 111.406 166.072 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -92.67 131.9 37.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.132 -1.803 . . . . 3.3999999999999999 106.132 162.668 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.55 102.15 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.542 0.737 . . . . 5.0099999999999998 110.406 -173.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.57 112.02 56.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.758 1.223 . . . . 1.0 111.347 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.7 -9.01 8.03 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.232 2.621 . . . . 1.01 113.924 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.26 54.73 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 119.216 0.916 . . . . 1.0700000000000001 114.139 -172.004 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.2 -0.24 30.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.204 1.802 . . . . 2.8900000000000001 112.708 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.68 161.56 29.75 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.128 1.771 . . . . 1.46 109.877 165.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.08 159.67 20.64 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.149 2.566 . . . . 0.81999999999999995 111.617 -172.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.78 145.57 33.37 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.463 1.105 . . . . 1.8899999999999999 111.012 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -129.6 109.18 10.8 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.129 1.372 . . . . 3.2599999999999998 109.955 173.264 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.33 120.14 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.007 2.523 . . . . 0.95999999999999996 108.837 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.9 -8.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.665 0.987 . . . . 0.59999999999999998 113.665 -171.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -164.59 35.12 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 118.931 0.787 . . . . 0.55000000000000004 111.967 176.192 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -144.72 -176.09 4.92 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.049 -0.976 . . . . 0.79000000000000004 111.301 172.535 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 17.9 mmt180 -160.1 156.17 26.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.81 1.244 . . . . 6.8799999999999999 108.162 166.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -157.93 155.84 27.18 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.155 1.382 . . . . 0.89000000000000001 109.152 -171.449 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.29 -39.51 9.92 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.72 1.614 . . . . 1.1699999999999999 112.316 173.45 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -82.0 -20.65 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.204 1.366 . . . . 1.3700000000000001 114.44 -169.191 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB3' HG23 ' A' ' 37' ' ' THR . . . -99.55 169.05 9.57 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.787 0.835 . . . . 1.4099999999999999 111.221 169.322 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -91.92 -82.91 0.3 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.443 -1.688 . . . . 3.8799999999999999 106.443 161.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -74.81 163.07 28.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.756 2.022 . . . . 6.2199999999999998 112.234 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -168.71 107.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.65 1.58 . . . . 2.1800000000000002 109.306 176.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.17 130.72 55.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.042 -1.89 . . . . 5.0 110.053 -167.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.13 126.08 31.62 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.018 0.913 . . . . 0.84999999999999998 112.248 -171.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.4 m170 -113.52 158.79 20.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.996 2.118 . . . . 0.64000000000000001 113.025 176.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -108.57 -178.87 3.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.525 1.93 . . . . 1.79 111.616 172.238 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.4 m -132.4 119.04 20.14 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.337 -1.357 . . . . 1.6000000000000001 107.337 155.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -102.83 162.64 12.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.188 1.395 . . . . 2.0299999999999998 111.727 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.2 mtt -103.74 150.22 24.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.357 1.063 . . . . 2.5 110.502 158.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -160.15 144.81 14.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 6.1399999999999997 112.486 167.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.84 145.88 15.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.258 1.423 . . . . 4.8200000000000003 110.34 156.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.24 -80.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.339 1.455 . . . . 3.02 107.985 172.313 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -77.02 26.73 0.14 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.835 2.054 . . . . 3.75 111.837 171.154 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.34 -33.71 0.67 Allowed Glycine 0 CA--C 1.537 1.461 0 O-C-N 120.373 -1.455 . . . . 2.6099999999999999 112.839 -158.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -63.67 145.2 56.18 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.7 1.6 . . . . 2.3999999999999999 109.673 166.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -88.87 135.31 33.6 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.844 0.313 . . . . 4.7000000000000002 111.844 -179.295 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.88 147.81 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.036 2.135 . . . . 1.9399999999999999 108.894 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.52 129.29 55.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.001 1.32 . . . . 4.5599999999999996 110.127 175.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.72 162.35 28.28 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 123.973 0.797 . . . . 1.0800000000000001 113.3 -174.051 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.4 mtt -106.77 158.84 16.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.903 1.281 . . . . 2.2599999999999998 111.724 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -169.95 155.43 5.55 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.553 1.541 . . . . 4.0 110.406 173.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.9 Cg_endo -69.69 153.51 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.768 1.645 . . . . 0.78000000000000003 111.297 168.391 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.51 157.73 64.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 125.576 1.55 . . . . 0.77000000000000002 110.88 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.4 -17.23 39.32 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.772 2.315 . . . . 1.01 112.828 179.316 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.2 p90 178.03 169.56 0.73 Allowed 'General case' 0 C--N 1.345 0.396 0 C-N-CA 126.882 2.073 . . . . 2.1699999999999999 110.266 179.311 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.02 165.69 13.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.085 1.354 . . . . 0.91000000000000003 109.262 156.172 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.98 161.85 42.04 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.304 -0.873 . . . . 2.2400000000000002 112.44 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 22' ' ' LEU . 21.9 t -149.96 136.78 11.04 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.016 1.326 . . . . 1.1799999999999999 109.694 -163.247 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.58 170.16 17.01 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.044 2.496 . . . . 0.84999999999999998 112.597 177.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.32 142.99 99.87 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.638 2.892 . . . . 0.85999999999999999 112.039 166.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm 66.52 1.32 2.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.075 1.75 . . . . 1.5800000000000001 113.948 -178.544 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.13 124.75 7.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 127.064 2.269 . . . . 1.02 111.579 -173.055 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 140.79 36.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.934 0.894 . . . . 4.7800000000000002 111.255 159.486 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.2 m -147.31 125.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.23 1.412 . . . . 1.73 110.082 173.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.0 mp0 -83.08 131.99 35.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.03 0.932 . . . . 3.5899999999999999 112.132 -177.281 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.2 159.82 33.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.114 0.959 . . . . 2.29 109.834 162.753 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -167.07 145.4 4.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.714 1.206 . . . . 2.7999999999999998 112.436 -161.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 -25.54 30.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.728 2.952 . . . . 2.02 114.148 -176.332 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.23 95.08 1.19 Allowed Glycine 0 N--CA 1.467 0.765 0 N-CA-C 108.694 -1.762 . . . . 1.45 108.694 161.165 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.82 -148.39 18.4 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.889 1.233 . . . . 2.6000000000000001 111.748 -168.288 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.15 136.99 37.28 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.213 -0.581 . . . . 2.3100000000000001 111.634 -171.233 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.62 167.45 21.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.373 0.669 . . . . 0.72999999999999998 110.257 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.46 122.81 48.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.743 0.817 . . . . 1.8999999999999999 110.526 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -86.35 111.81 20.84 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.854 0.862 . . . . 0.83999999999999997 109.557 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.7 mt -80.73 138.87 36.34 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.213 1.405 . . . . 2.1699999999999999 109.749 176.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -133.18 154.03 51.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.901 1.334 . . . . 1.9299999999999999 113.732 -176.643 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 -60.33 3.78 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 127.101 2.286 . . . . 2.4300000000000002 112.959 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mt 60.36 93.12 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.278 3.031 . . . . 1.0600000000000001 111.452 -166.253 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.99 -10.94 60.63 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.011 -1.055 . . . . 3.23 112.81 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 -153.78 140.22 12.73 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 129.266 3.026 . . . . 7.9400000000000004 107.148 171.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.2 154.18 41.36 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.331 2.687 . . . . 2.5 110.373 175.32 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.03 142.99 28.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.381 1.073 . . . . 3.6699999999999999 111.556 -173.299 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -19.11 26.17 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.627 1.343 . . . . 4.7000000000000002 114.627 -177.558 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 83.3 136.64 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 1 C-N-CA 132.213 4.205 . . . . 2.4399999999999999 109.822 -171.093 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.73 52.98 8.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.149 -0.781 . . . . 1.96 111.149 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 176.31 5.21 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.108 0.963 . . . . 3.3799999999999999 108.489 155.007 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -100.09 163.08 12.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.905 -0.776 . . . . 3.96 108.905 152.053 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.5 120.15 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.236 1.414 . . . . 1.1899999999999999 109.021 175.684 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 147.04 32.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 3.5699999999999998 109.224 167.141 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.486 HD11 ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -152.39 123.76 7.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.322 1.049 . . . . 2.9199999999999999 111.073 -174.64 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.81 114.06 21.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.925 2.09 . . . . 2.5600000000000001 111.231 177.306 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.4 mt -80.71 114.07 19.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.956 -1.09 . . . . 1.3300000000000001 109.006 176.028 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.23 125.58 35.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.245 0.618 . . . . 0.70999999999999996 110.116 -173.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.39 164.19 12.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.792 0.664 . . . . 2.21 112.792 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.96 62.08 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.082 1.753 . . . . 2.23 113.753 -173.574 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 141.45 -149.98 21.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.545 1.545 . . . . 3.1000000000000001 111.506 -178.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.77 37.83 1.06 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.692 1.139 . . . . 1.9299999999999999 115.696 -172.7 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -127.64 133.71 49.66 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.311 1.556 . . . . 4.29 110.75 170.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.78 140.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.179 1.792 . . . . 1.02 107.24 163.341 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -142.83 116.09 8.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.758 1.223 . . . . 1.52 109.742 -172.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -88.66 142.39 27.72 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.875 1.435 . . . . 2.5800000000000001 114.875 -177.65 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.2 164.02 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.753 2.021 . . . . 1.76 111.278 175.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.91 134.63 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.593 1.157 . . . . 2.46 110.67 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.6 mt -141.58 145.14 36.17 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.402 1.881 . . . . 1.8500000000000001 109.602 -165.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.33 159.93 15.04 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.932 3.088 . . . . 1.3200000000000001 112.623 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.81 112.78 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.502 1.121 . . . . 1.29 113.006 174.171 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.39 147.39 28.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.732 2.813 . . . . 3.6600000000000001 109.774 160.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.23 -171.07 3.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.588 1.329 . . . . 1.8700000000000001 114.588 -162.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.307 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 130.875 3.67 . . . . 9.0199999999999996 113.901 174.787 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.319 0 N-CA-C 108.189 -1.964 . . . . 15.66 108.189 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.8 m -149.25 153.28 37.34 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.347 1.073 . . . . 12.6 109.25 -168.396 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -130.96 125.16 32.66 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.351 -0.981 . . . . 10.640000000000001 108.351 -178.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -77.05 97.33 4.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 122.204 1.002 . . . . 7.7599999999999998 110.152 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.46 74.4 5.0 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.54 1.536 . . . . 6.8600000000000003 109.522 173.338 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.95 171.95 43.6 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.177 0.894 . . . . 1.1299999999999999 113.868 174.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -160.11 156.68 27.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.121 1.368 . . . . 1.8899999999999999 112.358 -176.305 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 99' ' ' VAL . 93.8 t -109.62 129.02 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.988 . . . . 1.1699999999999999 110.118 175.14 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -82.73 112.79 19.9 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.894 -1.15 . . . . 3.98 107.894 166.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -60.95 -45.19 95.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.768 1.766 . . . . 3.5 115.768 -164.923 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 6.0 t 58.86 155.57 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 128.35 2.66 . . . . 2.2000000000000002 113.941 -159.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.91 0.5 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.997 2.464 . . . . 1.6799999999999999 113.219 160.124 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.98 177.38 36.41 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.15 0.881 . . . . 1.3100000000000001 113.11 -177.009 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -80.36 -2.55 41.66 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 118.99 1.395 . . . . 1.5800000000000001 113.507 -3.016 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -138.45 165.6 26.41 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.676 1.991 . . . . 1.8600000000000001 111.648 178.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.96 -175.51 5.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.507 1.523 . . . . 0.70999999999999996 113.588 -169.22 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.2 149.41 33.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.818 0.847 . . . . 1.23 112.678 -172.053 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.46 152.52 40.75 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.428 0.899 . . . . 1.25 113.428 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 150.53 32.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.04 1.336 . . . . 2.4100000000000001 110.462 -170.47 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.38 159.32 4.6 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.707 1.603 . . . . 1.9299999999999999 110.541 -175.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 m -78.24 152.73 32.41 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.399 -0.963 . . . . 1.73 108.399 155.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 134.63 38.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.793 2.037 . . . . 3.4700000000000002 107.751 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.25 139.0 42.41 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.793 1.237 . . . . 5.2599999999999998 113.543 -177.628 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -104.44 107.83 58.83 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.796 -0.638 . . . . 1.51 109.676 149.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -92.04 -7.74 3.06 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.601 2.867 . . . . 1.4099999999999999 114.04 175.421 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.75 178.72 41.12 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.467 1.03 . . . . 1.3500000000000001 113.322 -176.427 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -95.62 -0.79 51.41 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.587 . . . . 3.6099999999999999 113.376 176.305 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.59 160.07 31.86 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.463 1.505 . . . . 1.54 110.516 171.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.43 153.97 24.15 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.758 2.306 . . . . 0.75 111.413 -171.764 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -116.26 119.31 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.746 1.218 . . . . 2.2999999999999998 110.053 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -115.13 102.55 10.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.266 1.426 . . . . 4.5199999999999996 111.342 -177.428 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 tp -92.08 119.91 32.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.975 2.51 . . . . 0.79000000000000004 109.196 -172.464 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.04 -8.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.513 1.125 . . . . 0.63 113.459 -169.294 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.08 -158.93 31.76 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 124.627 1.108 . . . . 0.39000000000000001 111.391 173.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.07 -177.04 5.52 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 122.467 -0.431 . . . . 0.80000000000000004 111.745 169.069 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -146.33 129.5 16.59 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.322 1.049 . . . . 6.6699999999999999 109.732 170.818 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.5 t -141.16 156.78 67.75 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 126.704 2.002 . . . . 0.69999999999999996 109.526 -173.41 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.51 -32.97 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.151 1.901 . . . . 1.0700000000000001 113.203 170.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.289 1.4 m -75.42 -9.53 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 120.27 1.396 . . . . 0.98999999999999999 114.21 -164.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.61 147.11 52.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.165 1.786 . . . . 0.80000000000000004 109.894 175.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -50.02 -59.64 3.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.039 1.29 . . . . 5.6200000000000001 108.693 168.15 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -130.4 153.36 48.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.872 2.069 . . . . 3.8399999999999999 109.951 -168.158 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.15 127.57 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.858 1.663 . . . . 1.9399999999999999 107.091 173.139 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -121.38 128.02 51.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.353 1.861 . . . . 1.9399999999999999 107.41 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.05 122.3 26.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.98 0.895 . . . . 0.94999999999999996 109.806 170.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.7 m170 -111.45 158.49 19.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.019 1.728 . . . . 0.53000000000000003 110.993 179.451 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.85 -178.59 3.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.663 1.985 . . . . 2.2400000000000002 111.656 177.277 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 m -140.51 113.26 8.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.911 -1.144 . . . . 1.8500000000000001 107.911 150.466 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -96.2 -171.34 2.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.446 1.498 . . . . 2.46 109.811 173.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -141.55 149.14 40.42 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.568 0.747 . . . . 3.3300000000000001 110.982 163.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -134.65 141.89 46.7 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.35 1.06 . . . . 7.0300000000000002 110.309 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -75.85 116.38 16.5 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.187 0.995 . . . . 5.7999999999999998 109.552 162.443 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 t -88.01 -119.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 106.455 -1.683 . . . . 3.2000000000000002 106.455 169.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.03 75.68 8.01 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.541 1.064 . . . . 4.71 108.33 163.478 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.44 -20.72 0.1 OUTLIER Glycine 0 N--CA 1.475 1.287 0 C-N-CA 129.522 3.439 . . . . 2.0 117.004 178.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -68.34 122.92 19.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.595 -1.532 . . . . 4.5300000000000002 110.468 169.066 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -99.42 69.16 1.65 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.078 1.751 . . . . 5.5700000000000003 109.121 -170.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -87.26 139.59 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.924 1.69 . . . . 1.77 110.67 -163.367 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -78.52 134.02 37.32 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.6 1.56 . . . . 3.7400000000000002 111.576 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.49 150.79 19.95 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.354 0.978 . . . . 1.4299999999999999 112.925 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -112.67 152.71 28.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.845 1.258 . . . . 1.8600000000000001 111.397 -179.551 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 mtp-105 -164.42 153.86 11.96 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 127.081 2.152 . . . . 3.77 108.151 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.8 Cg_endo -69.0 151.83 73.32 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.971 1.382 . . . . 0.70999999999999996 111.001 157.547 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.7 152.66 56.1 Favored Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.944 1.298 . . . . 0.63 110.253 173.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.94 -9.48 25.77 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.692 2.261 . . . . 0.78000000000000003 113.355 178.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -177.91 165.5 1.99 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.643 1.577 . . . . 2.1299999999999999 110.526 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -117.27 166.17 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.664 1.586 . . . . 0.76000000000000001 109.053 151.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.97 162.34 39.6 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.498 -0.751 . . . . 2.0 112.621 167.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -143.18 129.87 10.56 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-N 114.669 -1.151 . . . . 1.49 110.187 -168.286 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.32 162.02 42.24 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.665 2.244 . . . . 1.2 111.374 176.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.82 145.48 96.37 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.038 3.159 . . . . 1.04 113.637 -178.139 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp 67.21 -5.68 0.69 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.213 2.205 . . . . 1.9299999999999999 115.196 178.334 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.21 123.78 7.02 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 126.613 2.054 . . . . 1.28 111.095 176.12 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -86.42 147.95 25.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.052 0.541 . . . . 4.8300000000000001 110.677 154.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -146.15 155.83 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.05 1.34 . . . . 1.78 110.242 175.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.43 142.53 29.93 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.673 0.749 . . . . 4.5999999999999996 112.988 -178.116 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.99 65.69 1.47 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.983 1.373 . . . . 1.53 108.422 152.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.36 113.92 7.63 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.522 1.529 . . . . 3.3799999999999999 109.787 169.125 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.99 -45.38 41.47 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.392 2.728 . . . . 1.3300000000000001 114.634 -161.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.94 90.88 1.56 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.79 -1.724 . . . . 1.46 108.79 161.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.35 -64.82 0.39 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.819 1.676 . . . . 1.5 111.197 -174.001 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -150.42 145.8 26.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.761 1.625 . . . . 2.2400000000000002 111.194 170.08 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -158.77 157.4 31.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.292 1.437 . . . . 0.93999999999999995 109.779 178.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.93 131.7 34.5 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.298 -0.631 . . . . 2.0800000000000001 109.298 164.655 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.3 125.58 51.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.559 1.544 . . . . 1.46 109.027 173.191 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.58 139.12 46.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.324 1.45 . . . . 2.29 110.545 -170.562 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -133.79 158.25 43.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.032 0.933 . . . . 1.6399999999999999 112.842 -171.216 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.69 60.86 7.37 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.553 1.549 . . . . 2.1200000000000001 113.29 169.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.52 101.08 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.872 1.32 . . . . 0.98999999999999999 112.743 -164.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -83.54 -3.99 58.14 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.547 -0.751 . . . . 2.0600000000000001 113.006 -166.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -131.04 153.77 81.85 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 129.474 3.109 . . . . 7.2999999999999998 108.568 168.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.74 167.43 27.11 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.089 2.526 . . . . 1.77 109.31 157.316 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.5 164.85 29.38 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.199 1.4 . . . . 2.8199999999999998 112.037 -165.406 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 140.22 2.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.621 1.568 . . . . 5.6299999999999999 113.185 -163.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.91 134.24 37.49 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.358 -1.464 . . . . 1.74 112.868 173.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.93 56.31 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.734 -1.592 . . . . 1.9399999999999999 115.063 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.76 -177.94 3.48 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.339 1.57 . . . . 3.23 108.585 156.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.89 138.93 52.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.444 1.116 . . . . 3.6400000000000001 112.054 -172.086 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 8' ' ' VAL . 95.3 t -90.19 107.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.366 1.466 . . . . 1.3100000000000001 108.753 -172.546 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.61 130.46 45.32 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 124.525 1.141 . . . . 2.8700000000000001 108.856 158.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mt -154.74 132.09 11.15 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.914 1.686 . . . . 1.52 112.283 -177.538 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.11 114.45 27.97 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.71 1.604 . . . . 2.8500000000000001 110.836 169.34 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.83 118.2 19.2 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.029 1.331 . . . . 1.1699999999999999 109.986 175.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.78 133.65 34.59 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.861 0.864 . . . . 0.67000000000000004 110.54 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -125.19 164.36 20.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.961 0.886 . . . . 2.1099999999999999 112.41 176.115 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.01 156.01 9.97 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.686 -0.688 . . . . 2.5499999999999998 111.478 164.603 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.78 10.97 85.8 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.247 -0.751 . . . . 3.6400000000000001 114.885 -178.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.98 1.85 85.8 Favored Glycine 0 N--CA 1.473 1.163 0 CA-C-N 118.57 1.185 . . . . 2.4300000000000002 113.977 -178.235 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.99 130.98 44.91 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.093 -1.239 . . . . 5.8300000000000001 110.266 179.132 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.89 149.97 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.978 0.911 . . . . 1.01 110.239 170.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -146.44 129.26 16.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.681 1.192 . . . . 1.8600000000000001 112.453 -174.189 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -63.48 134.47 55.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.669 1.188 . . . . 2.29 112.393 172.693 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.2 m -138.98 146.1 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.14 1.776 . . . . 1.48 109.568 163.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.2 123.06 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.981 0.912 . . . . 1.6499999999999999 110.509 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -139.07 146.33 48.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.992 1.317 . . . . 1.75 110.176 -169.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.3 146.2 68.46 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.033 2.489 . . . . 1.02 113.202 -175.024 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.2 t -79.37 134.78 27.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 124.524 1.13 . . . . 1.3100000000000001 108.385 161.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.58 141.91 51.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.224 1.81 . . . . 5.1799999999999997 109.21 169.736 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -128.34 71.7 1.4 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 122.275 1.036 . . . . 3.3599999999999999 113.788 -167.704 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.195 0 C-N-CA 126.544 1.938 . . . . 8.5899999999999999 109.196 169.426 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 N-CA-C 108.609 -1.796 . . . . 11.4 108.609 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 t 168.25 -164.63 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 129.761 3.225 . . . . 9.9399999999999995 106.241 -166.103 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -66.92 -26.76 67.02 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.746 1.612 . . . . 12.050000000000001 114.092 -178.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 m 105.6 112.27 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 1 C-N-CA 133.493 4.717 . . . . 7.5899999999999999 106.989 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -96.52 109.46 22.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.782 -1.099 . . . . 4.6799999999999997 110.836 -154.282 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.14 179.62 48.86 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.167 0.889 . . . . 1.1399999999999999 113.256 -174.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -155.09 153.42 30.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.275 1.43 . . . . 1.3600000000000001 112.902 -177.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.69 122.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.463 1.105 . . . . 1.25 110.548 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -57.36 -39.93 77.0 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.649 1.979 . . . . 5.5800000000000001 114.126 -168.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.34 151.79 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.655 1.982 . . . . 2.6000000000000001 113.528 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.28 165.99 2.01 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 119.748 -1.845 . . . . 1.8200000000000001 109.889 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.79 23.15 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.034 3.156 . . . . 2.0099999999999998 112.819 175.222 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.69 -176.06 54.73 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 121.312 -0.867 . . . . 1.53 111.837 -159.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.72 -11.41 18.03 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 CA-C-N 118.499 1.15 . . . . 2.04 112.233 -12.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -134.73 154.22 51.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.372 1.069 . . . . 2.7999999999999998 112.294 168.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.58 -177.67 3.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.291 1.836 . . . . 0.63 108.31 156.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.64 173.35 11.77 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.169 0.988 . . . . 0.88 110.537 173.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.46 151.03 41.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.223 1.009 . . . . 0.73999999999999999 112.396 167.278 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.09 142.39 38.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.842 2.457 . . . . 2.29 109.235 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -169.66 159.49 8.27 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.598 1.333 . . . . 1.9399999999999999 114.598 -175.114 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -97.96 119.57 36.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.02 1.728 . . . . 1.3999999999999999 108.379 173.56 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -110.31 142.72 41.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.018 1.327 . . . . 2.6499999999999999 109.931 176.094 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.9 pt-20 -142.35 150.0 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.196 1.398 . . . . 2.9500000000000002 110.941 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -118.48 108.22 41.88 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.831 0.852 . . . . 1.23 110.962 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -86.41 -5.39 8.32 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.77 2.313 . . . . 1.1000000000000001 114.325 175.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 -157.31 16.09 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 120.129 1.331 . . . . 2.0899999999999999 115.365 -167.067 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -95.12 -41.03 9.31 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.57 2.348 . . . . 6.0300000000000002 112.384 178.579 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.03 166.13 13.12 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.136 1.774 . . . . 1.75 111.729 -173.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.07 167.13 25.53 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.505 2.137 . . . . 1.2 113.691 -166.062 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.56 148.11 26.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.773 1.229 . . . . 2.73 109.747 165.148 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -141.81 103.53 4.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.638 1.575 . . . . 4.0599999999999996 108.141 171.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.15 104.4 16.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.867 2.467 . . . . 0.93999999999999995 108.941 -166.146 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.62 -12.44 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.872 1.269 . . . . 0.59999999999999998 112.924 -172.135 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.92 -163.6 33.25 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 123.733 0.682 . . . . 0.42999999999999999 112.349 178.282 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.18 178.4 9.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.005 1.322 . . . . 0.73999999999999999 110.401 173.028 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -143.18 145.54 32.9 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.993 -1.114 . . . . 7.6600000000000001 107.993 174.955 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 t -151.37 151.6 29.36 Favored Pre-proline 0 N--CA 1.47 0.534 0 CA-C-O 118.374 -0.822 . . . . 0.66000000000000003 110.949 172.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.43 -23.41 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.725 2.95 . . . . 1.3200000000000001 114.891 160.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.28 1.3 m -95.17 5.65 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.96 1.467 . . . . 1.0700000000000001 114.96 -168.594 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.38 163.43 32.81 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.884 1.274 . . . . 0.80000000000000004 111.946 -178.571 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.444 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 8.8 tp10 -100.72 -89.87 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.912 -0.773 . . . . 3.4700000000000002 108.912 164.843 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -76.55 114.89 15.77 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.032 -1.042 . . . . 3.0800000000000001 109.013 -179.026 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.76 140.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.698 1.599 . . . . 2.1800000000000002 111.161 163.467 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -144.02 122.5 12.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.274 1.43 . . . . 2.6000000000000001 109.623 166.624 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -80.08 119.07 22.39 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.746 1.157 . . . . 0.73999999999999999 110.88 169.03 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.5 m170 -107.36 152.83 23.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.941 1.696 . . . . 0.66000000000000003 112.395 175.45 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.93 -178.06 3.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.41 1.484 . . . . 2.1800000000000002 110.603 167.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -146.57 130.25 17.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.887 1.275 . . . . 1.01 107.777 174.266 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.78 165.4 27.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.527 1.131 . . . . 2.0 112.655 -165.241 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.9 mtm -98.23 144.69 27.4 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.798 1.239 . . . . 2.6800000000000002 111.56 174.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -156.59 178.93 9.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.139 1.376 . . . . 10.460000000000001 112.523 -175.045 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.67 158.16 17.07 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.198 1.799 . . . . 9.0 110.3 167.217 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.03 121.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 125.893 1.677 . . . . 4.71 109.232 140.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 55.54 54.14 8.82 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.907 1.283 . . . . 4.75 109.78 -174.907 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.49 -26.23 0.17 Allowed Glycine 0 N--CA 1.476 1.322 0 C-N-CA 128.964 3.174 . . . . 3.4700000000000002 116.129 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -78.18 140.38 38.96 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.793 -1.416 . . . . 4.0700000000000003 111.778 -171.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.54 122.94 17.04 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 4.3700000000000001 111.094 174.483 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.9 t -142.71 161.63 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.118 1.767 . . . . 2.4500000000000002 108.154 173.913 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.18 158.54 15.79 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.024 -1.047 . . . . 2.9300000000000002 112.6 -178.773 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.75 159.01 24.41 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 124.944 1.259 . . . . 1.1499999999999999 112.038 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -125.88 155.87 40.55 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.9 1.68 . . . . 1.6000000000000001 108.307 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -169.06 150.26 4.32 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.004 1.322 . . . . 4.6699999999999999 110.3 177.237 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 40.8 Cg_endo -67.36 153.14 77.79 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.314 2.009 . . . . 0.95999999999999996 111.264 169.366 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -125.14 155.96 70.29 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.454 1.502 . . . . 0.76000000000000001 110.172 171.369 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.05 -14.5 41.11 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.782 2.321 . . . . 0.90000000000000002 112.92 176.16 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -179.48 162.24 1.12 Allowed 'General case' 0 C--N 1.348 0.51 0 C-N-CA 126.092 1.757 . . . . 2.2200000000000002 110.362 178.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -104.43 176.63 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.313 1.445 . . . . 0.72999999999999998 109.732 153.059 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.29 168.95 25.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.049 -1.032 . . . . 1.96 113.76 171.082 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.81 136.18 10.35 Favored Pre-proline 0 N--CA 1.467 0.406 0 C-N-CA 125.395 1.478 . . . . 0.85999999999999999 108.246 -176.558 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.78 171.41 11.02 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 121.812 1.675 . . . . 1.1000000000000001 111.251 170.269 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.04 142.62 75.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.741 2.294 . . . . 1.25 110.341 163.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt 73.83 -4.96 2.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.73 2.412 . . . . 1.3600000000000001 113.261 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.07 -170.99 44.29 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 126.369 1.938 . . . . 1.4099999999999999 112.389 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -167.25 154.89 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.194 1.798 . . . . 6.2800000000000002 112.178 -178.272 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.62 159.3 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.202 1.801 . . . . 1.9199999999999999 110.42 177.046 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.49 116.7 23.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.773 -1.195 . . . . 4.4800000000000004 107.773 177.178 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.5 67.86 2.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.784 1.233 . . . . 1.0800000000000001 108.823 170.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -75.67 149.12 83.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.344 1.058 . . . . 3.7200000000000002 111.428 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.97 -30.31 92.95 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.741 2.294 . . . . 1.4199999999999999 113.336 176.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.33 48.68 2.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.565 1.079 . . . . 1.3500000000000001 112.453 168.761 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.84 -64.92 0.05 OUTLIER Glycine 0 N--CA 1.473 1.163 0 N-CA-C 115.837 1.095 . . . . 1.3600000000000001 115.837 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -156.55 146.3 20.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.353 1.861 . . . . 2.3399999999999999 109.541 -173.67 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -165.55 170.92 13.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.739 -1.225 . . . . 0.72999999999999998 110.438 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.04 136.3 42.11 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.916 -0.772 . . . . 1.8200000000000001 108.916 168.257 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -83.1 128.79 34.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.104 0.961 . . . . 1.1100000000000001 110.047 156.027 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 mt -113.87 104.3 12.04 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.421 1.489 . . . . 1.74 107.85 177.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.99 155.77 17.52 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.443 0.639 . . . . 1.73 112.349 -176.446 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.79 -53.39 4.84 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.248 1.404 . . . . 2.6899999999999999 113.757 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 62.98 85.15 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.782 2.433 . . . . 1.0700000000000001 112.806 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HE3' ' OE1' ' A' ' 41' ' ' GLU . 4.3 ptpp? -73.84 -0.48 16.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.759 1.392 . . . . 1.6299999999999999 114.759 -168.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -149.44 159.37 36.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 128.766 2.827 . . . . 5.1200000000000001 108.837 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.29 162.33 36.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.12 1.88 . . . . 2.0099999999999998 109.583 154.628 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.11 43.8 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 123.065 1.412 . . . . 4.0999999999999996 111.929 -158.73 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -74.42 143.82 44.57 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.101 1.76 . . . . 5.21 113.631 -168.738 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.03 118.59 2.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.754 1.222 . . . . 1.95 113.153 177.274 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.1 16.82 26.81 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 117.991 -1.45 . . . . 1.78 114.817 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.22 166.02 11.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.279 1.539 . . . . 3.8900000000000001 108.797 136.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -111.83 134.26 53.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.972 1.709 . . . . 5.4100000000000001 108.753 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.44 113.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.639 0.776 . . . . 1.0800000000000001 110.352 -178.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -68.8 129.16 39.14 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.148 -0.933 . . . . 3.52 109.091 161.913 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -139.91 147.92 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.624 0.77 . . . . 1.52 111.269 -173.669 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -114.53 132.15 56.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.469 -1.241 . . . . 2.4700000000000002 110.342 162.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.4 mt -98.33 121.13 39.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.737 1.215 . . . . 1.3100000000000001 109.021 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.2 mt -96.76 129.88 44.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.084 0.954 . . . . 0.96999999999999997 111.333 -170.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -122.34 145.76 47.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.939 0.896 . . . . 2.0499999999999998 112.179 -176.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.88 131.02 45.96 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.116 0.966 . . . . 2.48 111.826 176.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.69 -159.6 23.12 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.495 1.045 . . . . 2.9199999999999999 110.705 -164.374 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.51 26.46 6.41 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.264 0.935 . . . . 1.9099999999999999 113.783 178.518 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -99.43 129.55 45.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.015 1.408 . . . . 5.3099999999999996 111.632 -173.314 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.83 138.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.449 1.499 . . . . 1.29 108.866 167.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.53 121.34 39.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.267 1.027 . . . . 1.95 109.645 177.57 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -79.96 139.82 36.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.972 0.509 . . . . 2.2799999999999998 110.937 175.185 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m -145.1 171.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.719 2.007 . . . . 1.29 109.893 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.87 131.14 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.376 1.071 . . . . 1.79 109.124 176.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mp -145.75 152.64 49.09 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.917 1.287 . . . . 1.8999999999999999 111.063 -168.727 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.2 155.37 67.97 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.422 2.748 . . . . 1.3200000000000001 114.279 -177.498 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.31 125.42 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.168 -0.923 . . . . 1.3799999999999999 108.681 157.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.64 138.23 35.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.415 1.486 . . . . 3.7799999999999998 109.068 170.329 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.03 134.79 55.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.941 2.2 . . . . 3.0099999999999998 116.941 -128.243 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.078 1 C-N-CA 132.372 4.269 . . . . 7.1299999999999999 111.243 160.688 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.175 0 N-CA-C 110.245 -1.142 . . . . 11.26 110.245 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m -129.85 -30.94 1.99 Allowed 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.049 0.759 . . . . 10.880000000000001 113.049 178.42 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -174.86 84.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 130.883 3.673 . . . . 12.51 104.253 179.081 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -170.31 -32.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.889 1.44 . . . . 7.3399999999999999 114.889 -144.596 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -148.29 -172.43 4.07 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.19 0.996 . . . . 4.4400000000000004 111.913 -151.103 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.1 151.64 21.88 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 121.304 -0.872 . . . . 1.3600000000000001 114.323 169.39 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -155.01 152.7 29.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.999 1.719 . . . . 1.6100000000000001 111.596 -179.519 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.32 122.55 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.029 -1.1 . . . . 0.84999999999999998 108.029 178.793 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 89.47 8.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.825 1.25 . . . . 3.3300000000000001 108.477 171.334 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.427 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -67.09 139.25 57.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.363 1.065 . . . . 2.23 109.027 168.092 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.6 m -138.39 158.31 70.88 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.49 . . . . 2.6600000000000001 108.026 168.987 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.88 27.91 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.616 3.544 . . . . 2.2799999999999998 115.113 -171.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.49 170.18 44.51 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.141 -0.974 . . . . 1.6499999999999999 113.957 178.878 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.36 -7.94 35.4 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 117.811 0.806 . . . . 1.6299999999999999 113.373 -7.038 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -130.69 161.98 30.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.216 1.806 . . . . 3.6600000000000001 111.216 -175.528 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.91 -173.88 4.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.541 1.936 . . . . 0.67000000000000004 112.038 -177.2 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.61 40.5 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.315 0.858 . . . . 0.95999999999999996 113.315 -172.991 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.07 146.4 27.71 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 0.81000000000000005 112.148 173.341 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.25 151.04 51.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.595 1.958 . . . . 2.3700000000000001 109.644 -173.23 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -169.4 145.35 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.336 1.236 . . . . 1.6100000000000001 114.336 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.9 m -75.68 139.97 42.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.081 1.752 . . . . 1.4299999999999999 108.977 163.19 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.0 133.51 21.96 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.139 1.376 . . . . 2.7999999999999998 108.944 174.195 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.46 156.76 46.15 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 114.225 1.195 . . . . 3.1400000000000001 114.225 -175.666 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -116.85 100.06 53.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.249 -1.342 . . . . 1.6100000000000001 110.47 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -85.02 -3.16 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.222 2.615 . . . . 1.3300000000000001 114.091 176.237 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.19 -119.78 0.81 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.797 1.189 . . . . 2.9500000000000002 114.626 -168.618 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -154.15 -41.98 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.371 1.868 . . . . 5.3899999999999997 112.021 -161.786 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -96.12 165.06 17.1 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.833 2.053 . . . . 1.5700000000000001 111.335 171.419 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.44 157.5 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.227 2.618 . . . . 0.82999999999999996 112.282 -174.277 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.37 156.71 17.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.308 1.043 . . . . 1.9099999999999999 111.33 171.195 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -146.54 101.06 3.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.104 1.361 . . . . 4.0800000000000001 112.811 177.529 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.3 tp -85.07 108.25 17.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.15 2.18 . . . . 0.93000000000000005 109.115 -176.496 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -99.17 -16.13 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.677 1.191 . . . . 0.77000000000000002 112.987 -173.458 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.32 42.72 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.773 0.701 . . . . 0.47999999999999998 111.717 -177.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -138.03 -178.95 5.5 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.308 1.043 . . . . 0.81000000000000005 110.434 169.196 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -154.31 128.56 9.05 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 106.363 -1.718 . . . . 6.3399999999999999 106.363 175.736 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -146.34 151.31 43.58 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.578 1.151 . . . . 0.90000000000000002 109.295 -168.474 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.32 -23.11 21.07 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.412 2.074 . . . . 1.1499999999999999 113.5 175.779 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.98 -13.16 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 115.569 1.692 . . . . 1.21 115.569 -165.251 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -131.4 152.35 50.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.319 1.048 . . . . 1.49 112.711 -165.675 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -56.45 22.01 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.59 1.087 . . . . 6.6299999999999999 109.185 171.771 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 43' ' ' VAL . 16.1 ttm180 -128.85 176.07 8.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.006 2.522 . . . . 3.8799999999999999 109.926 179.177 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 2.3 p -155.43 137.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.287 2.235 . . . . 1.2 107.455 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -142.32 137.53 30.63 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.585 1.554 . . . . 1.8999999999999999 108.851 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.37 126.97 32.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.676 1.125 . . . . 0.84999999999999998 110.165 166.673 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.3 m170 -119.35 155.38 32.0 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.795 2.038 . . . . 0.63 112.017 176.478 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -92.57 166.07 12.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.761 1.624 . . . . 2.4700000000000002 110.46 164.679 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.3 m -123.63 127.72 48.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 106.357 -1.719 . . . . 1.28 106.357 154.117 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -122.4 170.96 9.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.442 1.275 . . . . 2.3799999999999999 114.442 -166.392 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.9 mtm -125.82 127.15 45.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.097 1.359 . . . . 3.1600000000000001 109.389 161.794 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -153.52 165.81 34.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.099 1.76 . . . . 9.2899999999999991 110.416 174.303 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.51 152.46 43.0 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.684 1.194 . . . . 3.4500000000000002 111.285 168.606 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.32 -86.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.599 1.16 . . . . 3.2200000000000002 109.241 176.256 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -78.44 51.31 1.03 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.681 1.992 . . . . 4.2000000000000002 110.562 176.166 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -20.69 0.3 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.951 1.738 . . . . 3.0 114.683 -170.954 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -107.78 159.24 16.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.474 2.71 . . . . 2.9399999999999999 110.276 -176.466 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -72.5 138.35 46.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.095 1.358 . . . . 3.2999999999999998 112.977 179.017 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -137.7 154.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.61 1.964 . . . . 1.6499999999999999 108.773 177.06 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 ptp -125.35 135.63 52.63 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.694 1.198 . . . . 2.8399999999999999 112.99 176.694 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.7 -179.74 40.59 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.609 1.099 . . . . 1.8600000000000001 113.171 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.31 166.42 11.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.812 1.245 . . . . 2.2599999999999998 113.438 -177.47 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -171.44 155.6 4.17 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 6.1399999999999997 110.576 164.928 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.7 Cg_exo -64.98 157.01 59.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.88 1.72 . . . . 0.94999999999999996 112.146 171.583 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.81 159.12 72.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 126.013 1.725 . . . . 0.91000000000000003 110.151 176.716 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.92 -24.8 23.97 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.23 1.953 . . . . 1.25 112.853 175.922 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -179.59 171.26 1.24 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.659 1.584 . . . . 2.2200000000000002 112.63 -178.37 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mt -118.89 167.61 11.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.925 2.09 . . . . 1.1200000000000001 109.573 152.266 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -154.82 156.47 36.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.563 -0.711 . . . . 2.6099999999999999 111.823 178.621 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -137.49 126.94 15.22 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 1.0900000000000001 108.965 -166.576 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.9 160.43 43.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.0 1.8 . . . . 1.1000000000000001 111.402 175.971 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.15 140.0 86.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.617 2.878 . . . . 1.3100000000000001 111.304 176.807 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 71.37 -1.56 2.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.309 2.244 . . . . 1.77 113.051 -178.218 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.04 -177.74 31.88 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 126.599 2.047 . . . . 1.75 111.414 178.811 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -161.93 156.41 22.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 5.7199999999999998 113.759 -179.127 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.92 161.01 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.286 1.434 . . . . 1.8300000000000001 109.413 174.538 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -123.6 135.91 54.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.444 -0.947 . . . . 5.0099999999999998 108.444 158.523 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.33 55.73 1.01 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.041 1.336 . . . . 1.1100000000000001 109.216 168.504 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -50.17 132.29 23.84 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.645 1.578 . . . . 4.1900000000000004 111.349 179.249 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.2 -36.86 97.42 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.946 3.097 . . . . 2.3500000000000001 114.983 -166.537 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.97 52.34 4.68 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-N 119.327 0.967 . . . . 1.8400000000000001 111.527 169.984 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.55 -145.5 5.66 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.524 2.011 . . . . 2.8399999999999999 112.024 -166.726 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -67.79 141.86 56.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.625 0.713 . . . . 2.1800000000000002 110.376 178.037 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -160.3 165.79 30.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.952 0.797 . . . . 0.88 111.003 -172.445 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -95.64 123.99 39.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.22 -0.659 . . . . 2.1600000000000001 109.22 163.406 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.52 126.06 45.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.612 1.165 . . . . 1.5 108.959 174.437 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.36 139.79 49.19 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.602 1.561 . . . . 2.9199999999999999 110.009 -172.557 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mp -132.51 166.08 22.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.606 0.762 . . . . 2.3900000000000001 112.789 -172.043 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 50.22 41.33 38.91 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 126.81 2.148 . . . . 2.1299999999999999 114.753 168.445 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 93' ' ' LEU . 57.9 mt -53.17 117.51 3.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.566 1.321 . . . . 1.6000000000000001 114.566 -147.701 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -86.54 -3.18 58.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.547 0.943 . . . . 2.6099999999999999 113.547 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -111.41 150.38 42.01 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.712 1.205 . . . . 4.8300000000000001 107.898 155.297 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 -10.94 23.17 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.567 2.845 . . . . 4.1299999999999999 115.15 166.394 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.493 HD11 HD13 ' A' ' 89' ' ' LEU . 3.0 mp 72.39 -173.24 0.15 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.768 3.627 . . . . 2.8399999999999999 111.293 173.711 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -170.03 119.02 0.6 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.197 1.399 . . . . 3.7200000000000002 110.094 -167.372 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.39 124.57 21.27 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.322 -0.861 . . . . 1.6799999999999999 109.495 166.779 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.21 54.79 27.67 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.699 -0.56 . . . . 2.02 111.699 -166.744 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -112.46 163.14 14.81 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 122.455 1.121 . . . . 4.1299999999999999 110.092 138.643 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -110.26 105.6 14.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.074 1.749 . . . . 4.5899999999999999 107.742 -172.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.86 112.62 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.134 0.973 . . . . 1.1000000000000001 109.412 -173.537 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -70.96 137.83 49.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.887 -0.597 . . . . 3.1899999999999999 110.342 159.322 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.8 tt -149.37 135.46 18.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.902 1.281 . . . . 1.7 109.852 179.484 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.31 110.99 22.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.679 2.792 . . . . 2.1000000000000001 110.842 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.0 117.95 20.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.989 0.916 . . . . 1.26 109.228 176.344 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.63 121.42 34.04 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 0.57999999999999996 110.522 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -118.1 121.84 41.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 2.1200000000000001 113.053 -179.613 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.08 23.55 0.3 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.267 2.227 . . . . 2.73 116.975 168.608 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.7 10.97 80.53 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 115.947 1.139 . . . . 4.5800000000000001 115.947 174.693 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.69 -31.18 0.03 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 119.076 1.438 . . . . 2.3999999999999999 116.478 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -89.11 139.48 30.43 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.741 -1.446 . . . . 4.4400000000000004 109.398 169.541 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -141.2 140.56 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.644 1.178 . . . . 1.3 108.203 165.22 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.12 122.98 15.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.101 1.36 . . . . 2.0800000000000001 108.852 -178.269 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 ptmt -83.1 140.38 32.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.323 0.86 . . . . 2.6800000000000002 113.323 -179.544 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.85 165.71 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.565 1.946 . . . . 1.29 109.782 167.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.07 139.41 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.757 1.223 . . . . 1.6899999999999999 109.957 173.677 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 mt -138.32 130.07 15.84 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.612 1.965 . . . . 2.1600000000000001 109.782 -167.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.37 144.74 37.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.601 2.2 . . . . 1.0600000000000001 111.051 176.661 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 10' ' ' PHE . 90.4 t -79.95 118.59 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.862 0.839 . . . . 1.22 111.956 169.442 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 145.51 28.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.977 3.311 . . . . 3.4199999999999999 107.46 166.574 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.2 101.74 5.92 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.974 -1.079 . . . . 1.8799999999999999 112.003 -161.546 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.262 1.025 . . . . 6.7300000000000004 112.705 -166.83 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.665 -0.495 . . . . 5.62 109.665 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.59 176.71 29.88 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.386 0.993 . . . . 0.88 113.768 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -161.12 161.94 31.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.528 1.531 . . . . 1.68 112.186 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.07 126.4 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.822 -0.807 . . . . 0.79 108.822 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.01 117.84 30.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.112 1.365 . . . . 4.22 109.013 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -74.59 -171.53 1.27 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.263 1.03 . . . . 2.81 113.637 -170.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.11 167.64 2.73 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.311 1.845 . . . . 1.74 109.95 160.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.04 -6.91 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.123 2.548 . . . . 1.58 113.088 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.39 169.19 21.19 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.109 1.338 . . . . 1.59 113.109 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.41 -7.68 39.15 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 118.068 0.934 . . . . 1.67 113.542 -0.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -128.55 167.53 16.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.182 1.393 . . . . 2.02 114.173 -170.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.85 -173.1 2.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.028 2.131 . . . . 0.57 112.585 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.24 154.43 43.82 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.611 0.967 . . . . 0.83 113.611 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.89 146.89 33.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.769 1.228 . . . . 0.73 112.958 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -140.82 157.42 45.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.404 1.482 . . . . 1.89 112.657 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -166.41 158.44 13.73 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.949 1.463 . . . . 1.62 114.949 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.7 m -84.54 133.0 34.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.773 2.029 . . . . 1.43 107.778 159.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.73 141.32 27.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.622 1.169 . . . . 2.55 111.175 -167.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.31 153.07 23.0 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.002 0.742 . . . . 3.07 113.002 -160.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -120.93 112.43 33.54 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.106 1.362 . . . . 1.06 110.972 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.17 -9.06 10.67 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.858 2.372 . . . . 1.17 113.666 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.01 168.88 52.55 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.177 0.894 . . . . 1.15 113.665 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.55 -4.81 47.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.13 1.772 . . . . 2.79 112.823 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.68 160.34 38.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.046 1.738 . . . . 1.42 109.949 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.87 156.42 30.92 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.919 2.413 . . . . 0.64 111.902 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.94 150.41 21.96 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.556 0.742 . . . . 1.98 109.97 166.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -133.57 109.83 9.5 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.058 1.343 . . . . 3.32 109.169 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 tp -91.17 112.8 24.86 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.706 2.402 . . . . 0.97 108.519 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.58 -11.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.198 0.999 . . . . 0.77 112.962 -169.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.65 -160.61 28.13 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 124.202 0.906 . . . . 0.57 112.318 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.69 -178.29 6.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.5 1.12 . . . . 0.69 110.618 164.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -155.41 135.94 13.35 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.052 -1.462 . . . . 5.33 107.052 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -152.55 152.8 29.54 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.936 0.895 . . . . 0.76 110.909 -163.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.45 -11.37 10.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.521 2.814 . . . . 0.87 113.707 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.324 0.8 OUTLIER -94.0 -4.01 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 114.1 1.148 . . . . 0.92 114.1 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.29 158.74 44.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.677 1.191 . . . . 0.76 112.04 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -98.67 -60.91 1.45 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 3.3 109.806 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -84.39 134.44 34.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.373 1.069 . . . . 2.84 109.34 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 p -147.97 136.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.649 1.979 . . . . 1.29 108.527 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -148.62 135.98 20.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.174 1.39 . . . . 1.99 110.458 -168.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -81.21 125.51 30.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.85 1.31 . . . . 0.97 110.875 168.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.5 m170 -119.05 157.54 27.6 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.576 2.35 . . . . 0.68 111.461 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -99.58 173.76 6.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.908 1.683 . . . . 2.02 110.272 164.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -127.99 130.25 48.06 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.961 -1.866 . . . . 1.19 105.961 157.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -111.85 163.91 13.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.74 1.216 . . . . 2.64 113.125 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -108.46 143.87 36.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.893 -1.048 . . . . 2.78 108.24 146.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.1 136.34 10.89 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.331 1.053 . . . . 5.25 109.832 -175.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.43 148.25 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.146 0.578 . . . . 4.0 110.631 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.46 -87.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.118 1.367 . . . . 2.87 109.305 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -75.41 34.75 0.11 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.902 2.081 . . . . 3.36 111.456 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.52 -19.79 0.65 Allowed Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.272 -1.517 . . . . 1.97 113.827 -164.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -83.03 146.53 28.69 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.892 2.077 . . . . 2.61 109.743 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -79.52 121.1 24.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.574 0.75 . . . . 3.75 111.412 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.1 t -112.64 148.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.653 1.981 . . . . 1.96 108.686 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.4 mtm -134.56 142.08 46.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.21 1.004 . . . . 3.53 111.963 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.82 -177.61 44.07 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.616 1.103 . . . . 1.83 113.078 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -107.55 159.13 16.67 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.903 1.281 . . . . 2.17 112.643 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.92 155.42 10.84 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.44 1.496 . . . . 3.72 111.158 171.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.9 Cg_endo -67.44 149.38 80.34 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.646 1.564 . . . . 0.92 112.033 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -114.26 158.65 39.15 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.923 1.689 . . . . 1.21 109.565 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.62 -19.37 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.238 1.958 . . . . 1.51 112.63 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.2 p90 177.47 171.52 0.58 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.744 2.018 . . . . 2.2 110.924 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mt -116.57 171.68 7.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.021 1.729 . . . . 1.07 108.969 153.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -155.21 164.92 38.15 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.06 -1.025 . . . . 1.97 111.743 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.36 128.66 9.13 Favored Pre-proline 0 N--CA 1.466 0.365 0 C-N-CA 125.02 1.328 . . . . 1.06 108.162 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.82 164.69 32.46 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.762 1.641 . . . . 0.98 111.05 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.6 137.99 83.26 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.173 2.582 . . . . 1.12 110.971 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt 66.31 0.93 1.86 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 1.84 113.646 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.28 -179.06 45.5 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.746 2.117 . . . . 1.45 113.65 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -155.73 147.83 23.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.397 -1.901 . . . . 4.51 111.355 -172.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.01 167.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.359 2.264 . . . . 1.68 109.958 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.97 129.37 38.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.81 0.814 . . . . 4.3 111.201 168.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -75.53 71.88 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.539 1.536 . . . . 1.06 109.291 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -68.37 140.59 92.81 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.635 1.574 . . . . 3.02 111.697 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.7 -32.33 68.49 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.023 2.482 . . . . 1.51 112.928 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.42 51.56 4.53 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.851 0.75 . . . . 1.19 111.311 163.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.65 -136.92 4.29 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.119 1.343 . . . . 2.62 112.974 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -73.07 144.58 47.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.838 0.855 . . . . 2.02 112.167 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -171.04 174.22 4.77 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.322 1.049 . . . . 0.84 109.762 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -101.62 131.82 47.62 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.107 0.563 . . . . 2.11 110.518 166.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -90.76 141.66 28.57 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.538 0.735 . . . . 0.88 109.969 160.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.44 141.59 51.45 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.909 1.683 . . . . 1.67 109.66 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -147.43 144.49 28.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.992 1.317 . . . . 2.07 111.232 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.84 0.56 Allowed Glycine 0 N--CA 1.466 0.66 0 N-CA-C 109.202 -1.559 . . . . 2.33 109.202 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.43 101.38 4.79 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.001 0.905 . . . . 0.94 110.265 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -79.5 -4.73 52.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.32 0.859 . . . . 1.85 113.32 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -126.39 142.51 43.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 126.715 2.006 . . . . 5.32 108.585 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.14 151.6 72.58 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.655 1.57 . . . . 1.75 108.624 157.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.3 mt -120.86 132.0 54.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.098 0.951 . . . . 2.93 112.122 -170.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 127.71 54.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.793 1.637 . . . . 3.36 106.968 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 151.5 11.75 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.985 -1.072 . . . . 1.64 113.329 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.88 39.03 94.83 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.554 -0.581 . . . . 1.81 113.747 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -116.3 -166.52 1.16 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.617 -1.253 . . . . 2.71 107.617 154.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -126.08 159.08 33.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.79 0.805 . . . . 3.58 111.913 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.24 116.58 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 125.702 1.601 . . . . 0.95 107.273 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.95 134.43 47.2 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.712 -1.218 . . . . 2.92 107.712 164.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.98 129.25 15.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.192 0.997 . . . . 1.54 111.13 -168.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.4 99.77 9.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.556 1.942 . . . . 2.04 110.353 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.8 mt -72.43 116.67 13.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.281 . . . . 1.18 109.789 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.42 131.52 35.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.457 1.103 . . . . 0.6 111.234 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -122.73 155.56 36.22 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.044 0.938 . . . . 1.82 112.681 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.69 121.11 12.57 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 2.06 112.852 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.71 -156.48 28.95 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.095 1.331 . . . . 3.1 111.415 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.73 51.58 3.77 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.103 -0.832 . . . . 1.64 114.8 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -125.05 137.79 54.21 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.518 1.659 . . . . 4.74 111.136 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.61 136.77 19.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.294 1.838 . . . . 0.98 106.992 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.9 mt -119.76 115.08 23.16 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.921 0.888 . . . . 1.62 109.506 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -79.11 133.38 36.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.239 0.615 . . . . 2.45 111.658 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.47 170.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.843 1.657 . . . . 1.34 110.443 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.95 132.5 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.848 -1.167 . . . . 2.09 107.848 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 mt -143.58 144.03 25.97 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.186 1.394 . . . . 1.69 110.011 -168.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.88 152.37 57.84 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.831 3.021 . . . . 1.03 115.12 -172.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.4 t -83.67 107.43 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.293 2.237 . . . . 1.41 109.881 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.95 136.55 36.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.541 1.936 . . . . 4.01 108.83 160.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -105.82 135.79 46.62 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.897 0.379 . . . . 1.9 110.319 163.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 130.49 3.516 . . . . 7.0 106.53 -161.678 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 113.252 0.834 . . . . 5.25 113.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.36 -173.95 34.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 126.389 1.947 . . . . 0.89 112.36 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.7 p90 -155.26 140.88 17.94 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.135 1.374 . . . . 1.65 110.509 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.08 136.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.333 1.053 . . . . 1.06 109.633 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -24.46 31.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.934 1.694 . . . . 4.1 114.962 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.34 174.24 0.26 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.015 2.126 . . . . 3.42 115.138 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 m -174.73 174.46 0.92 Allowed Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.209 3.404 . . . . 1.75 107.737 151.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.17 -21.85 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.007 1.805 . . . . 2.35 112.461 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.3 173.99 13.49 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.259 1.885 . . . . 1.77 111.92 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.79 -11.5 39.54 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 119.263 1.532 . . . . 2.03 113.124 -5.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -122.26 168.74 11.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.479 . . . . 1.96 112.914 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.56 -175.72 4.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.569 2.348 . . . . 0.62 110.339 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.56 17.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.676 1.19 . . . . 0.86 112.207 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 158.36 38.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 0.76 113.424 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -147.23 154.16 40.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.007 1.723 . . . . 2.27 110.75 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.3 160.75 6.3 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.918 1.822 . . . . 1.71 115.918 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.9 m -91.72 105.36 17.66 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.28 2.632 . . . . 1.12 109.178 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.6 142.02 28.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.724 1.61 . . . . 3.32 110.471 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -109.32 155.77 20.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.149 0.58 . . . . 4.69 111.893 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -134.06 110.04 11.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.391 -0.822 . . . . 1.05 109.057 155.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.91 -7.03 3.33 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.212 2.608 . . . . 0.92 114.471 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 169.19 42.7 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.994 1.27 . . . . 1.19 112.883 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -85.88 5.28 33.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.556 1.542 . . . . 3.94 112.914 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.48 156.26 35.49 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.966 1.707 . . . . 2.64 109.266 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.25 157.33 22.91 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.216 2.611 . . . . 0.84 110.448 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.93 134.33 54.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.07 0.948 . . . . 2.23 110.656 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -126.54 111.06 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.701 1.201 . . . . 4.41 110.347 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.06 136.78 32.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.279 1.832 . . . . 0.86 108.862 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.42 -10.29 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.21 1.004 . . . . 0.53 113.354 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.11 -164.57 35.22 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.447 1.022 . . . . 0.52 111.968 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.64 -176.69 5.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.216 1.007 . . . . 0.81 109.626 164.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mtm-85 -142.61 147.27 35.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.877 1.217 . . . . 6.04 108.934 163.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -142.9 154.52 62.2 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 125.07 1.348 . . . . 0.7 109.018 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -20.0 27.97 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.058 1.838 . . . . 0.89 112.707 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.326 3.2 m -92.84 15.87 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.709 1.003 . . . . 1.2 113.709 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.28 165.63 35.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.09 0.956 . . . . 0.83 112.728 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.82 -71.83 0.75 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.557 1.543 . . . . 3.51 108.004 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -79.2 103.77 9.37 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.991 -1.068 . . . . 3.44 109.85 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.91 143.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.9 0.88 . . . . 2.17 110.124 160.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.39 117.0 10.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.823 1.249 . . . . 2.3 109.408 168.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.77 120.47 25.19 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.825 -1.172 . . . . 0.76 110.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.1 m170 -105.19 152.03 23.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.75 112.567 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.37 172.14 10.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.721 1.609 . . . . 2.8 110.451 161.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.8 m -151.63 111.85 4.11 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.021 1.328 . . . . 0.99 108.396 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -129.08 160.02 34.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.069 1.348 . . . . 1.92 112.383 -161.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -97.48 143.9 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.653 0.781 . . . . 3.35 110.197 160.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -155.19 145.35 21.8 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.475 0.71 . . . . 5.53 110.932 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -64.42 148.51 50.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.904 1.682 . . . . 3.82 111.034 167.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.6 t -138.94 -88.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.667 1.587 . . . . 2.66 108.614 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -77.81 44.97 0.48 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.197 2.199 . . . . 3.4 110.319 170.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.69 -37.02 0.48 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 126.283 1.897 . . . . 2.17 113.65 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -78.8 150.64 32.29 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.238 2.615 . . . . 2.57 109.218 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -87.71 142.42 27.84 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.235 1.198 . . . . 3.31 114.235 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.21 150.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.314 2.246 . . . . 1.87 108.354 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.2 mmt -93.57 133.96 36.35 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.933 0.893 . . . . 2.82 110.946 175.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.01 167.6 24.84 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 123.738 0.685 . . . . 0.95 113.461 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.73 137.61 35.26 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.665 1.586 . . . . 2.18 109.344 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -150.33 144.85 17.87 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.276 1.43 . . . . 3.8 109.247 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 37.7 Cg_endo -65.65 142.38 70.47 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.965 1.777 . . . . 0.66 110.773 169.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.39 154.38 47.6 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 126.074 1.749 . . . . 0.65 110.606 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.96 -9.31 23.47 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.882 2.388 . . . . 0.9 113.954 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -175.57 170.37 2.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.263 1.392 . . . . 2.39 111.397 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 166.21 17.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.813 1.645 . . . . 0.68 109.215 157.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.49 161.53 40.91 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.188 -0.945 . . . . 2.89 113.034 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -148.3 142.67 16.62 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.726 1.21 . . . . 1.25 109.517 -166.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.8 16.61 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.475 2.117 . . . . 1.01 112.278 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.32 148.36 86.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.894 3.062 . . . . 1.05 112.211 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 64.89 -0.27 1.05 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.602 1.561 . . . . 2.31 113.843 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.53 111.2 3.67 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.901 1.715 . . . . 0.89 111.398 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.45 123.42 44.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.68 1.192 . . . . 4.19 109.061 165.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.41 143.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.106 1.362 . . . . 2.0 111.796 -165.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -88.91 144.31 26.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.202 1.001 . . . . 3.24 111.765 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.24 73.77 2.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.402 1.081 . . . . 1.33 109.457 158.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -59.53 131.77 88.31 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.886 -1.054 . . . . 4.01 111.111 173.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.43 -32.89 89.16 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.873 2.382 . . . . 1.44 112.893 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.18 51.77 4.41 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.229 0.919 . . . . 1.73 112.328 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.04 -56.6 0.08 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.82 1.2 . . . . 1.49 114.209 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -155.47 141.62 18.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.055 1.742 . . . . 2.09 111.411 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -163.08 176.32 10.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.008 -1.057 . . . . 0.78 111.233 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.46 131.07 55.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.825 0.45 . . . . 1.79 110.949 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mmt -85.36 144.54 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.88 1.272 . . . . 1.02 110.759 154.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -124.05 129.02 50.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.204 1.802 . . . . 1.77 108.682 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -133.64 136.57 44.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.094 0.958 . . . . 2.06 111.624 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.36 76.04 0.79 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.675 -1.37 . . . . 2.86 109.675 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.2 mt -78.15 135.25 37.62 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.176 -1.046 . . . . 0.9 108.176 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -80.51 -0.32 36.97 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.968 -1.082 . . . . 2.22 112.264 -169.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -174.21 160.13 2.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.601 2.36 . . . . 6.79 110.156 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.62 146.73 55.64 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.48 2.12 . . . . 3.0 110.092 163.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -112.93 168.53 9.62 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.551 1.54 . . . . 2.82 111.874 -172.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.39 137.48 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.658 1.183 . . . . 3.51 111.862 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.86 129.47 41.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.785 -1.197 . . . . 2.32 110.437 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 52.11 3.66 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 112.174 -0.37 . . . . 2.34 112.174 -165.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -129.02 165.02 21.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.955 1.702 . . . . 3.63 107.616 161.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.64 155.56 16.93 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.993 1.317 . . . . 5.53 111.003 168.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.06 124.06 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 126.113 1.765 . . . . 0.86 108.567 169.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.62 125.69 29.53 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.079 -0.712 . . . . 3.93 109.079 161.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mt -126.67 125.42 41.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.991 0.916 . . . . 1.66 111.81 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -105.06 94.7 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.78 1.232 . . . . 2.54 110.568 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.5 mt -65.67 123.36 19.51 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 1.53 110.446 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.8 mt -97.43 131.37 44.14 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.31 1.444 . . . . 0.79 110.342 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -125.67 167.09 15.61 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.683 1.23 . . . . 2.29 111.566 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.76 166.47 10.92 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.993 -1.003 . . . . 3.01 111.432 168.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.4 15.44 80.3 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.802 0.681 . . . . 4.29 114.802 173.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.62 6.16 89.33 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 118.427 1.113 . . . . 1.85 113.767 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -79.29 138.38 37.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.903 1.352 . . . . 6.46 112.376 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.15 148.94 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.19 1.796 . . . . 1.44 108.105 158.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.0 mt -124.15 125.28 44.2 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.573 1.549 . . . . 2.3 108.4 172.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -87.68 133.31 33.85 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.761 0.824 . . . . 2.26 111.651 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.29 127.45 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.835 1.254 . . . . 1.56 113.23 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.88 135.48 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.8 1.24 . . . . 1.81 111.56 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.9 mt -143.78 160.68 49.47 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 128.041 2.536 . . . . 2.11 111.079 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -84.92 157.17 11.62 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.085 3.19 . . . . 0.97 114.624 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -94.32 124.1 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.33 2.252 . . . . 1.07 110.576 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.34 156.09 18.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.983 1.313 . . . . 3.25 109.044 156.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.83 81.51 4.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.366 -0.976 . . . . 2.25 108.366 161.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 115.761 -2.066 . . . . 6.5 115.486 -158.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 121.043 0.449 . . . . 6.32 111.292 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.55 167.45 30.9 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.608 1.099 . . . . 1.05 114.476 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -152.22 143.13 23.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.781 1.232 . . . . 1.54 111.999 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.06 118.16 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 122.963 0.505 . . . . 1.0 109.676 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -85.72 96.45 9.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.293 1.037 . . . . 4.66 110.405 -169.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.71 154.53 3.73 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.666 2.386 . . . . 2.18 112.884 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.83 149.08 20.26 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 118.463 -0.78 . . . . 2.15 109.668 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 56.68 5.6 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.415 2.743 . . . . 2.16 109.281 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.79 -164.38 46.15 Favored Glycine 0 CA--C 1.541 1.677 0 O-C-N 121.482 -0.761 . . . . 2.03 112.582 -168.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.54 -11.73 20.11 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 117.681 0.74 . . . . 2.46 111.331 -28.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -146.82 168.09 22.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.751 2.021 . . . . 2.18 109.976 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 -177.34 6.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.535 1.534 . . . . 0.64 111.819 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.81 156.69 43.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 0.76 111.99 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.1 143.21 36.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.118 0.967 . . . . 0.73 112.111 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -136.66 141.4 43.16 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.389 1.876 . . . . 2.15 109.58 -172.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -165.22 147.33 7.81 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.331 1.975 . . . . 1.94 116.331 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 m -99.54 129.77 45.73 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.569 1.548 . . . . 1.66 108.786 169.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tp -130.69 162.95 28.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 4.14 110.734 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.28 141.82 51.86 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.092 1.357 . . . . 3.16 111.214 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -100.28 110.91 61.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.512 -0.921 . . . . 1.25 108.512 157.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.87 -15.37 3.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.364 2.709 . . . . 1.3 113.769 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.75 -176.27 51.37 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.045 0.838 . . . . 1.37 113.23 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -105.33 12.97 31.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.707 1.603 . . . . 4.07 111.437 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mt -113.8 156.37 43.83 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 126.957 2.103 . . . . 2.72 109.132 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.72 158.33 24.8 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.991 2.461 . . . . 0.84 109.926 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.3 130.56 42.93 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.56 1.144 . . . . 2.38 109.73 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -117.26 115.61 25.62 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.864 1.266 . . . . 4.15 110.422 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -94.63 117.14 29.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.537 2.335 . . . . 0.84 108.68 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.77 -10.88 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.729 1.011 . . . . 0.58 113.729 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.25 -163.17 31.66 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.664 -0.648 . . . . 0.4 112.344 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.97 12.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.731 0.813 . . . . 0.65 111.189 167.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -144.85 133.31 21.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.921 1.688 . . . . 7.01 108.058 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -148.9 149.74 30.96 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.421 1.489 . . . . 0.73 110.335 -166.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.1 -37.93 4.31 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.337 2.024 . . . . 1.03 112.157 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.273 2.6 m -84.79 3.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.907 1.447 . . . . 0.91 114.907 -169.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -133.31 137.08 45.82 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.356 -1.465 . . . . 0.8 112.23 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -76.11 -70.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.319 -1.363 . . . . 5.23 107.319 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -84.92 143.32 29.08 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.266 2.226 . . . . 3.22 109.37 169.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.75 131.81 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.359 1.864 . . . . 1.33 107.932 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -142.94 128.68 19.3 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.234 1.414 . . . . 2.24 109.493 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.87 121.42 24.82 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.367 1.079 . . . . 0.78 110.454 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -112.36 158.38 19.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.019 2.128 . . . . 0.63 112.035 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.86 179.39 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.912 1.685 . . . . 2.02 110.909 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 m -135.22 106.23 6.65 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.195 1.398 . . . . 1.15 107.274 163.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -107.0 152.06 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.706 1.202 . . . . 2.29 111.225 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -84.77 145.33 27.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.527 0.679 . . . . 3.96 110.27 166.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -148.14 160.17 43.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.558 1.543 . . . . 5.66 110.333 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -84.57 148.12 26.65 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.528 0.731 . . . . 6.7 109.393 164.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.95 -87.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.55 -1.648 . . . . 2.51 106.55 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -77.68 43.96 0.43 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.999 2.52 . . . . 3.8 110.809 170.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.9 -29.63 0.29 Allowed Glycine 0 N--CA 1.482 1.751 0 O-C-N 119.999 -1.688 . . . . 2.5 115.117 -171.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -69.71 132.22 45.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.828 2.051 . . . . 3.65 109.853 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -83.46 102.18 11.9 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.904 -1.147 . . . . 5.46 107.904 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.11 155.26 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.516 1.926 . . . . 2.84 110.823 -167.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.0 mtm -75.22 153.22 38.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.622 0.971 . . . . 4.41 113.622 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.64 160.7 28.28 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.446 1.974 . . . . 1.16 110.567 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -123.01 148.31 45.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.897 1.279 . . . . 1.83 110.322 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -171.68 157.85 4.49 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 117.165 -1.398 . . . . 3.99 111.223 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.4 Cg_endo -69.75 157.35 60.71 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.026 1.817 . . . . 0.59 112.605 168.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.03 158.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 126.029 1.732 . . . . 0.67 110.613 171.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.4 -11.67 24.75 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.918 2.412 . . . . 0.81 113.577 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -179.05 162.24 1.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.307 1.843 . . . . 2.24 110.192 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.99 172.85 6.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.471 1.909 . . . . 0.8 108.756 156.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.04 170.17 23.14 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.837 -1.164 . . . . 2.53 113.389 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.05 135.28 11.87 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 125.288 1.435 . . . . 0.93 109.465 -167.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.05 168.32 24.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.15 1.9 . . . . 0.92 110.688 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.58 148.59 92.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.082 2.521 . . . . 1.1 111.95 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 68.39 -3.38 1.33 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.94 2.096 . . . . 1.78 114.48 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.29 117.93 5.18 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 126.204 1.859 . . . . 1.05 112.184 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 127.96 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.54 -0.83 . . . . 6.23 110.264 159.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.05 165.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.568 1.547 . . . . 1.29 110.608 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.08 114.03 8.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.885 0.874 . . . . 3.67 112.099 -163.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.25 67.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.848 2.059 . . . . 1.07 109.379 165.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.44 143.56 98.73 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.996 1.719 . . . . 3.46 111.83 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.1 -61.17 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.172 3.248 . . . . 1.36 112.668 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 102.32 2.05 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.802 -1.719 . . . . 1.53 108.802 162.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.99 -69.83 0.3 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.822 1.677 . . . . 1.22 112.662 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -155.71 139.19 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.946 1.699 . . . . 2.02 109.495 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -167.1 172.36 10.12 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.135 -0.978 . . . . 0.86 109.598 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -103.66 141.5 35.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.415 0.552 . . . . 2.18 110.225 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.7 mmt -89.17 139.29 30.63 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.858 0.863 . . . . 1.01 110.077 159.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -122.0 130.33 53.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.53 1.932 . . . . 1.94 109.24 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -136.65 159.45 41.78 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.636 0.774 . . . . 2.28 112.241 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.32 -57.08 3.28 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 126.54 2.019 . . . . 2.8 113.672 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.1 mt 76.64 91.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 130.423 3.489 . . . . 1.14 111.847 172.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -74.54 4.37 6.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.627 1.343 . . . . 2.49 114.627 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -144.67 152.84 53.7 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 128.713 2.805 . . . . 6.34 108.063 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.21 150.64 81.76 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.242 1.961 . . . . 2.28 109.516 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.54 134.22 44.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.413 1.485 . . . . 2.93 110.141 -170.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.41 101.49 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.029 0.919 . . . . 4.28 109.37 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.64 130.73 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.211 -0.931 . . . . 2.57 111.176 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.09 50.7 2.97 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.057 -0.519 . . . . 2.08 112.923 -167.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -137.17 -167.28 2.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.077 1.351 . . . . 2.94 109.899 159.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -130.55 153.44 48.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.4 1.08 . . . . 3.38 108.742 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.8 115.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.606 1.162 . . . . 1.21 108.686 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -63.69 122.99 17.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.701 -1.591 . . . . 3.59 109.327 160.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -129.72 116.52 18.91 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.711 0.767 . . . . 1.67 110.917 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.32 96.47 9.04 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.833 1.653 . . . . 2.27 108.77 165.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.8 126.76 31.53 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.238 -0.914 . . . . 1.69 109.091 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.35 136.86 37.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.929 1.292 . . . . 0.71 111.056 -168.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -132.94 148.49 52.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.296 1.046 . . . . 2.51 113.014 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.55 163.85 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.067 -0.97 . . . . 2.96 111.971 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.08 76.44 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.791 -0.568 . . . . 4.66 113.575 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.01 63.71 3.2 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.553 1.073 . . . . 1.97 111.069 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -144.35 166.03 26.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.872 1.32 . . . . 3.73 112.755 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -170.78 147.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 128.234 2.614 . . . . 1.95 108.239 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.0 mt -134.62 118.72 17.51 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.052 1.341 . . . . 2.59 108.703 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -86.19 125.08 33.28 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.353 -0.842 . . . . 2.15 110.673 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.16 133.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.272 1.029 . . . . 1.74 108.691 166.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.92 136.96 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.849 -1.167 . . . . 1.94 107.849 168.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -142.6 136.39 14.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.321 1.448 . . . . 2.03 109.001 -170.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.09 154.05 75.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.323 3.349 . . . . 1.0 114.034 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.4 t -79.76 125.94 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 122.797 0.439 . . . . 1.1 110.309 170.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.45 141.77 28.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.485 1.914 . . . . 3.38 108.125 162.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.53 22.46 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.629 2.085 . . . . 2.79 116.629 -161.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.272 2.3 tmt_? . . . . . 0 N--CA 1.481 1.079 1 C-N-CA 132.063 4.145 . . . . 8.49 113.789 171.737 . . . . . . . . 2 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 109.409 -0.589 . . . . 5.3 109.409 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.94 175.79 22.42 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 119.08 0.855 . . . . 1.26 115.127 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 p90 -155.75 162.67 40.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.962 1.705 . . . . 2.11 111.296 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.1 t -131.16 117.73 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.758 -0.589 . . . . 1.04 109.655 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.47 95.6 8.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.003 0.921 . . . . 6.14 109.914 -171.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.93 145.88 55.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.867 1.667 . . . . 2.37 112.709 -176.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.0 t -142.61 148.01 44.89 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.482 1.513 . . . . 2.71 107.747 162.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.59 48.31 1.57 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.599 3.533 . . . . 1.74 112.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.55 -173.11 55.16 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 121.346 -0.846 . . . . 1.51 112.419 -168.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.28 -21.45 8.91 Favored 'Cis proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.139 -1.192 . . . . 1.45 110.761 -24.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -121.84 165.72 15.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.813 2.045 . . . . 1.91 111.81 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.33 -179.15 7.81 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.23 2.212 . . . . 0.71 110.356 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.08 155.36 48.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.726 1.148 . . . . 0.8 113.443 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.48 45.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.466 1.106 . . . . 0.71 113.19 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -156.11 157.94 36.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.013 1.325 . . . . 2.38 112.133 -158.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 178.93 149.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.15 1.537 . . . . 1.61 115.15 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.2 m -85.0 135.08 34.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.347 1.859 . . . . 1.49 108.838 160.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 tp -136.29 153.16 51.26 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.841 1.257 . . . . 3.91 109.693 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.56 134.17 28.46 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.601 -0.687 . . . . 4.31 111.047 166.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.73 114.38 47.63 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.453 1.501 . . . . 1.0 110.444 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.69 -15.35 10.91 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.778 2.318 . . . . 1.17 113.875 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.62 166.01 54.8 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 122.509 1.061 . . . . 1.11 113.611 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -77.72 -17.63 57.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.173 2.189 . . . . 4.77 112.281 162.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.01 156.02 60.71 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.479 1.512 . . . . 2.82 111.752 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.6 155.26 9.03 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.014 3.143 . . . . 1.43 110.73 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.67 145.74 50.03 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.592 1.557 . . . . 2.05 110.432 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -142.45 108.97 5.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.619 1.167 . . . . 5.01 111.719 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -94.37 114.73 26.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.098 2.159 . . . . 0.77 109.629 -169.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 m -106.29 -11.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.109 1.364 . . . . 1.05 113.724 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.76 -167.61 39.52 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 121.604 -0.685 . . . . 0.72 111.749 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.26 152.13 30.83 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.38 1.072 . . . . 1.47 110.598 166.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 -110.96 131.25 55.2 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.65 -1.611 . . . . 8.2 106.65 -174.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -139.35 149.56 60.97 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.593 1.157 . . . . 0.59 109.243 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.52 -21.19 19.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.988 2.459 . . . . 0.79 113.069 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.333 2.5 m -90.93 9.64 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 114.607 1.336 . . . . 0.86 114.607 -176.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.3 167.71 27.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.98 0.912 . . . . 0.9 112.792 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -107.4 -77.15 0.6 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.654 1.582 . . . . 3.55 109.068 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -75.53 105.24 6.45 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.799 -1.188 . . . . 3.52 109.74 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 p -79.56 143.16 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.13 0.972 . . . . 1.86 110.456 158.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -136.29 134.19 37.73 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.53 1.532 . . . . 2.17 108.48 161.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -86.43 124.79 33.15 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.628 1.558 . . . . 0.79 110.882 167.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -116.15 164.72 14.07 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.842 2.057 . . . . 0.64 112.43 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -114.63 -174.57 2.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.115 1.766 . . . . 1.96 111.606 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.1 m -138.25 114.5 10.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.161 -1.422 . . . . 1.24 107.161 155.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -90.8 160.01 15.99 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.315 1.046 . . . . 1.89 111.593 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.4 mtm -92.08 148.48 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.319 0.648 . . . . 2.48 110.089 154.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -158.96 120.81 3.45 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.486 1.514 . . . . 6.02 108.008 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.45 152.27 18.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.143 0.577 . . . . 4.84 110.74 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.8 t -144.25 116.77 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.145 0.978 . . . . 3.75 108.637 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 61.84 17.92 9.29 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.483 1.513 . . . . 3.71 111.785 -168.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.22 74.19 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.9 1.238 . . . . 2.89 113.972 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -77.46 137.14 38.5 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.889 1.345 . . . . 3.12 108.972 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.97 137.62 58.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.599 -0.715 . . . . 4.48 111.807 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 160.21 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.966 0.506 . . . . 2.0 110.418 164.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.1 mtm -133.81 156.31 48.25 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.528 1.531 . . . . 2.65 110.233 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.37 163.49 33.46 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 123.376 0.512 . . . . 0.97 112.914 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -103.59 166.97 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.753 1.221 . . . . 1.55 111.096 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -176.51 154.17 1.27 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 126.442 1.897 . . . . 3.71 110.34 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -70.98 153.72 63.22 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.123 1.882 . . . . 0.61 111.685 167.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.31 156.22 53.08 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 126.208 1.803 . . . . 0.7 110.602 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.08 -20.6 37.8 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.829 2.353 . . . . 0.73 112.461 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -176.39 169.5 2.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.914 2.085 . . . . 2.26 110.755 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.63 170.53 8.03 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.343 1.457 . . . . 0.81 109.598 154.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -139.21 166.81 23.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.189 0.519 . . . . 2.53 110.86 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.59 120.62 5.19 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.15 1.38 . . . . 1.16 107.734 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.87 164.74 32.87 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.677 1.584 . . . . 1.09 110.864 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.19 138.46 72.32 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.38 2.72 . . . . 1.0 111.368 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 67.0 -0.37 1.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.563 1.545 . . . . 1.86 113.415 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 117.37 4.5 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 127.382 2.42 . . . . 1.31 112.071 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -79.77 133.12 36.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.75 -1.225 . . . . 5.61 110.923 163.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.85 166.2 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.175 2.19 . . . . 2.08 110.088 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.15 110.38 2.31 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.699 0.799 . . . . 4.31 109.424 -168.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.09 75.64 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.131 1.372 . . . . 1.16 108.004 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' H ' ' HG2' ' A' ' 78' ' ' LYS . 15.8 ptpt -69.34 153.23 96.06 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 127.894 2.478 . . . . 2.77 113.555 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.39 -41.92 24.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.655 2.904 . . . . 2.87 114.092 -162.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.33 128.28 9.52 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.984 -2.046 . . . . 2.24 107.984 152.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.08 -143.42 14.85 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.072 1.32 . . . . 2.92 111.393 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -73.21 138.7 45.78 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.848 -0.795 . . . . 2.07 111.537 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -161.28 158.3 26.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.454 1.102 . . . . 0.93 109.433 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -87.59 135.2 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.973 -0.751 . . . . 2.1 108.973 160.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.55 120.34 41.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.549 1.54 . . . . 1.18 108.077 168.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.63 142.68 35.89 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.272 1.029 . . . . 3.33 110.467 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.35 135.74 24.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.745 1.618 . . . . 2.12 111.543 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.07 81.84 0.58 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.714 -0.954 . . . . 2.66 110.714 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.16 100.79 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.921 0.867 . . . . 1.04 110.459 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -86.75 10.5 15.65 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.534 1.309 . . . . 2.01 114.534 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -145.14 166.29 18.53 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 127.349 2.259 . . . . 4.93 109.128 167.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.19 -176.73 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.851 1.7 . . . . 2.35 110.278 151.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -176.5 59.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.797 2.439 . . . . 3.1 107.781 -163.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.91 151.25 30.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 5.87 113.031 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.38 120.22 8.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.56 -1.2 . . . . 1.59 108.455 156.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.23 17.46 46.57 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.107 -1.385 . . . . 1.93 114.808 -170.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.84 167.25 10.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.733 1.766 . . . . 3.28 107.779 151.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -116.22 147.49 41.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.823 0.849 . . . . 3.49 109.163 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.79 116.86 51.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.18 1.792 . . . . 0.93 108.665 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.36 129.37 39.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.174 -1.047 . . . . 3.14 108.174 156.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.39 126.56 42.66 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.595 0.758 . . . . 1.81 110.898 168.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.95 94.13 5.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.215 1.806 . . . . 2.7 109.912 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.39 118.6 8.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.275 1.43 . . . . 1.14 110.568 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.2 mt -92.41 127.7 38.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.322 1.449 . . . . 0.82 110.821 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.12 133.79 50.33 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.815 1.293 . . . . 2.38 113.76 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.06 53.59 2.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.965 1.706 . . . . 2.24 112.383 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -151.5 26.49 0.96 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.682 2.087 . . . . 5.07 113.557 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.98 50.59 45.64 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 124.132 0.873 . . . . 2.42 111.368 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -149.73 160.56 43.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.035 1.734 . . . . 3.58 112.832 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -162.81 130.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 129.149 2.98 . . . . 1.42 108.51 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.95 121.01 36.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 2.57 109.35 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.18 134.56 34.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.901 1.074 . . . . 2.7 113.901 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.62 163.67 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.375 1.47 . . . . 1.89 109.42 164.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.09 134.88 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.975 -1.491 . . . . 1.93 106.975 164.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.8 mt -135.62 148.0 63.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 126.239 1.815 . . . . 1.98 108.594 -172.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.87 163.32 33.97 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.511 2.808 . . . . 1.32 111.904 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -102.27 118.75 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.781 0.832 . . . . 1.56 110.802 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -95.36 140.63 29.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.841 2.456 . . . . 4.96 109.189 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.56 -176.66 5.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.456 -1.403 . . . . 2.72 111.53 164.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 126.566 1.946 . . . . 11.39 116.108 -170.767 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 13.3 tt0 . . . . . 0 CA--C 1.547 0.847 0 CA-C-O 120.999 0.428 . . . . 6.33 111.377 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -93.97 169.92 30.01 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 125.253 1.406 . . . . 1.26 116.354 -174.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -155.05 133.91 12.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.668 1.587 . . . . 1.82 111.264 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.97 122.94 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.784 -1.191 . . . . 1.15 107.784 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -103.8 87.33 2.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.693 0.797 . . . . 4.47 110.127 -161.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.58 144.05 38.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.909 2.083 . . . . 2.14 111.389 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -138.32 153.36 72.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.513 1.125 . . . . 2.18 109.6 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -65.71 -9.59 23.38 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.977 2.452 . . . . 1.72 113.195 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.71 177.83 18.44 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.463 1.03 . . . . 1.55 113.836 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 -7.77 32.89 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 117.68 0.74 . . . . 1.4 113.105 -4.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -128.47 160.61 31.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.335 1.054 . . . . 3.28 112.559 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.98 -174.21 4.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.775 1.63 . . . . 0.57 111.916 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.22 154.62 49.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.888 0.875 . . . . 0.9 112.978 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.15 146.27 50.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.083 0.953 . . . . 0.96 112.257 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -143.87 156.52 44.49 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.356 1.863 . . . . 2.28 110.703 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -168.46 160.21 10.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.346 1.058 . . . . 2.13 113.748 -176.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.4 m -81.9 147.8 29.1 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.048 1.339 . . . . 2.02 108.558 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -155.2 131.65 10.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.157 0.983 . . . . 2.67 111.507 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -113.32 145.16 41.53 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.654 1.981 . . . . 3.72 112.003 173.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -95.14 97.31 2.53 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 114.372 -1.285 . . . . 1.25 109.652 155.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.46 -8.22 18.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.25 1.967 . . . . 1.12 112.939 173.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.17 176.49 50.35 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 124.401 1.001 . . . . 1.11 113.606 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.37 -5.42 27.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.737 2.015 . . . . 2.7 113.0 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 160.33 44.02 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.84 2.056 . . . . 1.48 109.7 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 158.73 31.05 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.859 2.372 . . . . 0.77 112.877 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.19 146.63 28.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.72 1.208 . . . . 1.85 110.197 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -131.82 112.38 12.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.934 1.294 . . . . 3.59 109.844 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -97.91 115.6 28.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.017 2.527 . . . . 0.77 108.751 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.92 -9.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.448 1.099 . . . . 0.55 113.116 -166.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.87 -168.86 41.02 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.535 1.064 . . . . 0.44 111.841 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.824 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -146.89 -178.62 6.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.894 1.278 . . . . 0.7 110.848 172.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 7.0 ttp85 -151.34 139.97 20.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.372 -2.455 . . . . 7.77 104.372 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -147.37 155.4 46.08 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.055 -1.091 . . . . 0.63 108.055 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.39 -29.93 24.81 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.486 2.124 . . . . 0.79 113.19 171.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -85.36 -19.98 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.188 1.181 . . . . 1.12 114.188 -169.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.84 159.03 22.05 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.21 1.004 . . . . 0.75 112.909 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.441 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 11.0 tp10 -98.11 -91.96 0.26 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.183 0.993 . . . . 3.04 111.202 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -78.66 110.49 13.84 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 121.079 -1.013 . . . . 3.89 108.736 -172.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -79.61 142.31 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 124.565 1.146 . . . . 2.22 111.253 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -142.05 128.49 20.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.211 1.004 . . . . 2.82 109.75 164.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -80.41 116.46 20.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.299 1.047 . . . . 0.75 110.476 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 15.5 m170 -107.96 155.13 20.66 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.509 1.524 . . . . 0.72 111.876 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.67 -171.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.142 1.777 . . . . 2.18 110.432 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -146.45 114.09 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.888 -1.132 . . . . 1.06 108.206 163.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -103.33 174.1 6.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.282 1.433 . . . . 1.9 111.989 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -118.16 154.41 32.21 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.267 1.427 . . . . 2.97 110.823 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -155.87 164.35 38.62 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.732 1.613 . . . . 6.46 111.731 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -85.74 142.63 28.86 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.529 0.732 . . . . 4.16 110.513 162.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.34 -96.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.988 -0.745 . . . . 2.66 108.988 163.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -76.68 37.41 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.972 2.109 . . . . 3.72 111.919 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.25 0.44 4.49 Favored Glycine 0 CA--C 1.542 1.738 0 O-C-N 120.388 -1.445 . . . . 2.14 113.463 -159.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -95.47 141.32 29.15 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.241 2.616 . . . . 3.14 110.17 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -73.03 136.88 45.09 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.565 -0.743 . . . . 5.09 109.821 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -139.78 143.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.647 1.179 . . . . 1.68 109.5 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -114.56 145.66 41.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.753 1.221 . . . . 2.82 111.28 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.36 168.87 34.26 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 123.794 0.711 . . . . 1.07 113.547 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -103.17 161.1 14.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.93 1.292 . . . . 1.8 112.416 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -167.14 154.45 8.39 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.289 1.835 . . . . 3.49 110.071 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 41.0 Cg_endo -69.01 150.03 72.3 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.685 2.257 . . . . 1.05 111.458 167.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.11 158.43 41.01 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.955 1.702 . . . . 0.81 110.459 169.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.84 -16.9 41.93 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.659 2.24 . . . . 0.91 112.937 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 177.49 163.43 0.56 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.951 2.1 . . . . 1.94 109.756 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mt -105.22 170.82 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.312 1.445 . . . . 0.78 109.638 155.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.15 158.06 39.82 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.189 -0.944 . . . . 2.44 111.813 170.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.45 128.31 13.73 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.461 1.504 . . . . 0.81 108.863 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.01 162.67 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.532 2.155 . . . . 0.84 111.522 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.04 139.47 87.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.704 2.936 . . . . 0.91 112.639 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt 69.13 2.83 3.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.158 2.183 . . . . 1.83 114.301 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.42 144.13 16.97 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 126.989 2.233 . . . . 1.19 109.645 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -117.24 150.65 38.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.978 1.311 . . . . 3.87 112.714 166.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.65 168.26 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.324 1.85 . . . . 1.58 110.677 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -135.07 132.88 38.71 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.199 -1.408 . . . . 4.51 107.199 162.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.59 77.39 1.99 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.156 1.455 . . . . 1.06 111.356 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -64.25 123.78 83.55 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 117.575 -1.202 . . . . 4.36 111.452 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -47.87 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.844 3.696 . . . . 1.71 114.606 -171.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 56.86 4.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.566 1.079 . . . . 1.35 111.991 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.86 -53.86 0.05 OUTLIER Glycine 0 N--CA 1.466 0.635 0 C-N-CA 126.097 1.808 . . . . 1.53 112.781 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -152.93 140.45 19.76 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.925 2.09 . . . . 2.35 111.223 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -166.58 172.35 10.8 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.857 -1.152 . . . . 0.81 111.784 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 61.1 m-85 -105.05 126.69 52.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.012 0.925 . . . . 1.89 111.032 168.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.5 mmt -86.65 137.56 32.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.794 1.238 . . . . 0.84 111.42 167.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.7 mt -115.35 88.77 2.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.791 1.636 . . . . 1.78 109.261 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -86.92 101.6 13.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.555 1.542 . . . . 2.2 110.599 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.5 133.03 4.83 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.347 0.975 . . . . 3.07 110.779 -173.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.0 mt -112.98 112.55 24.08 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.374 1.087 . . . . 1.04 109.439 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.441 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 2.3 pttm -90.54 -9.57 46.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.198 1.184 . . . . 1.92 114.198 -172.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.7 mmt-85 -146.45 150.91 42.18 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.567 1.547 . . . . 8.35 109.389 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.1 174.72 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.393 2.729 . . . . 2.47 111.432 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -176.42 158.08 1.77 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.346 1.858 . . . . 2.67 109.355 -160.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.33 178.17 7.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.025 1.73 . . . . 3.85 112.219 174.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.4 133.99 15.53 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.925 1.29 . . . . 1.89 112.939 165.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.93 -0.3 89.5 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.301 -1.277 . . . . 2.16 115.268 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -77.83 167.41 21.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.863 1.331 . . . . 3.92 111.861 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.14 152.96 20.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.306 -1.315 . . . . 3.79 110.525 162.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.8 t -139.84 126.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 126.148 1.779 . . . . 1.51 109.049 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.31 142.35 57.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.599 -0.519 . . . . 3.6 109.599 164.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.824 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.3 tt -141.05 127.37 19.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.52 1.152 . . . . 1.65 111.987 157.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.428 ' N ' HD23 ' A' ' 101' ' ' LEU . 1.5 m-20 -98.94 114.63 27.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.614 1.965 . . . . 2.2 109.935 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.54 125.7 29.92 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.546 -0.721 . . . . 2.39 109.816 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt -98.1 128.66 44.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.089 0.956 . . . . 0.62 109.879 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.28 156.78 31.77 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.015 0.926 . . . . 2.0 112.024 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.81 143.34 57.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.953 0.501 . . . . 2.14 111.039 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -168.27 53.53 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.0 -0.84 . . . . 2.94 111.0 -164.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.45 40.59 2.21 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.806 -0.82 . . . . 1.74 114.379 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -115.84 122.0 44.07 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.047 1.423 . . . . 4.43 112.529 -173.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.45 135.49 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.424 1.49 . . . . 1.07 108.466 161.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.5 mt -129.81 128.58 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.587 1.155 . . . . 1.57 109.204 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -88.34 134.8 33.72 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.87 0.868 . . . . 2.31 112.656 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.32 167.37 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.801 0.84 . . . . 1.53 110.514 153.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.74 141.51 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.853 -1.536 . . . . 2.2 106.853 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.2 mt -137.44 151.97 72.22 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.632 1.573 . . . . 1.78 110.133 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.71 155.5 44.34 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.627 2.885 . . . . 1.15 112.036 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.79 123.34 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.083 0.953 . . . . 1.01 110.823 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.6 149.19 22.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.828 1.651 . . . . 3.44 109.233 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.0 23.09 11.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 113.927 1.084 . . . . 2.21 113.927 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.384 1.473 . . . . 7.15 112.662 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 109.362 -0.607 . . . . 5.03 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.75 157.48 27.42 Favored Glycine 0 N--CA 1.469 0.854 0 O-C-N 120.707 -1.246 . . . . 1.51 115.095 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -136.06 144.63 45.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.904 1.281 . . . . 1.72 111.966 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.8 t -102.28 136.86 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.718 -1.216 . . . . 0.88 107.718 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -104.17 106.62 17.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.156 0.982 . . . . 3.7 110.187 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.36 147.86 29.72 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.085 1.754 . . . . 2.54 112.401 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -150.95 158.86 34.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.707 1.603 . . . . 1.79 109.805 162.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.43 -15.33 31.11 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.161 2.574 . . . . 1.67 113.497 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.4 170.24 14.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.529 1.062 . . . . 1.73 113.0 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.06 -5.56 15.82 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 118.215 1.008 . . . . 1.89 113.025 -3.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -122.69 170.06 10.43 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.243 1.817 . . . . 2.22 113.997 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.52 -177.21 5.47 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.138 2.175 . . . . 0.79 111.319 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.36 154.25 51.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.159 0.89 . . . . 0.89 112.19 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.53 157.16 43.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.029 0.918 . . . . 0.72 112.806 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -149.62 161.85 41.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.46 1.504 . . . . 2.02 110.356 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -162.5 159.26 24.72 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 112.854 0.687 . . . . 1.49 112.854 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.0 m -83.5 119.65 24.95 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.403 -1.332 . . . . 1.21 107.403 150.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.83 134.52 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 2.51 107.452 166.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 6.4 mt-10 -128.39 121.77 29.85 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.957 0.903 . . . . 3.52 110.125 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -95.49 111.94 57.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.308 1.043 . . . . 1.2 109.974 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -86.44 -12.22 5.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.263 2.642 . . . . 0.91 113.711 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.36 160.57 42.15 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.108 0.861 . . . . 1.3 112.488 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -90.62 6.78 42.41 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.029 1.732 . . . . 2.94 113.616 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.75 157.97 53.16 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.01 1.724 . . . . 1.34 110.595 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.99 160.52 30.29 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.229 2.619 . . . . 0.77 111.935 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -124.5 124.41 42.22 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.718 1.207 . . . . 2.1 111.547 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -118.75 112.0 19.2 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.217 1.407 . . . . 4.01 112.791 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.3 tp -100.03 110.23 22.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.897 2.479 . . . . 0.86 109.951 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -98.12 -11.94 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.859 1.664 . . . . 0.98 112.954 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.5 -159.82 30.79 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 119.097 0.862 . . . . 0.54 113.556 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.45 -171.13 3.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.866 1.267 . . . . 1.0 111.164 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -166.43 124.46 1.42 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.674 -1.232 . . . . 5.36 107.674 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -138.35 162.08 55.5 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.989 1.316 . . . . 0.89 109.494 -167.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.2 -22.71 3.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.636 2.891 . . . . 0.82 113.989 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 2.6 m -86.93 -0.77 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 114.393 1.257 . . . . 1.17 114.393 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.7 168.19 27.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.089 2.156 . . . . 1.08 109.867 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -106.28 -79.22 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.539 1.063 . . . . 3.79 110.737 171.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -75.27 105.31 6.23 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 120.917 -1.115 . . . . 3.25 110.082 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.6 137.69 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.094 1.358 . . . . 1.27 111.262 171.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -132.17 129.49 39.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.239 1.816 . . . . 2.01 109.137 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.79 117.15 22.48 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.538 1.161 . . . . 0.75 110.953 168.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 20.2 m170 -105.01 152.63 22.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.197 1.799 . . . . 0.57 112.032 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.66 172.7 8.09 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.613 1.165 . . . . 1.94 110.228 161.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.565 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 53.0 m -149.05 102.32 3.24 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.392 1.477 . . . . 1.31 107.487 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -105.6 162.92 13.08 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.174 1.79 . . . . 2.39 112.49 -164.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -102.91 151.1 22.84 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.948 -0.569 . . . . 2.76 110.777 151.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -158.97 145.06 16.69 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.754 1.622 . . . . 5.09 109.873 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.31 146.86 23.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.258 0.551 . . . . 4.33 111.287 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.24 135.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.384 1.874 . . . . 3.24 109.309 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 60.13 20.14 9.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.386 1.075 . . . . 4.22 112.185 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.96 -3.81 68.89 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.894 1.235 . . . . 2.31 113.959 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -99.44 146.24 26.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.156 1.782 . . . . 3.37 110.407 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -77.2 131.03 38.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.834 -0.541 . . . . 4.01 110.53 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -128.6 153.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.909 1.684 . . . . 1.95 108.841 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.4 mtm -121.03 146.68 46.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.916 . . . . 2.96 110.816 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.58 -177.24 31.48 Favored Glycine 0 N--CA 1.468 0.829 0 C-N-CA 124.346 0.974 . . . . 0.98 113.081 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.11 162.0 34.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.24 1.416 . . . . 2.3 110.655 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -171.45 151.85 3.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.147 1.379 . . . . 3.61 111.45 172.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 35.6 Cg_endo -65.54 146.69 85.46 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.494 2.129 . . . . 0.74 111.803 166.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.49 155.79 51.77 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.922 1.689 . . . . 0.57 110.237 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.31 -18.62 44.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.674 2.25 . . . . 0.7 112.637 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -179.1 167.22 1.58 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 126.676 1.99 . . . . 2.25 110.903 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.69 168.28 9.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.069 1.348 . . . . 0.74 109.468 154.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -151.96 161.99 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.822 0.675 . . . . 2.77 112.822 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.29 134.78 24.43 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.952 1.701 . . . . 0.88 108.564 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.71 164.05 32.82 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.062 1.841 . . . . 0.89 111.289 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.39 147.52 93.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.094 2.529 . . . . 0.97 111.663 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt 68.12 -0.61 2.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.325 1.85 . . . . 1.31 113.508 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.69 127.58 9.04 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 127.679 2.561 . . . . 1.0 111.646 -170.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 9.2 ptp180 -98.22 134.61 41.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.974 1.31 . . . . 6.02 112.465 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.35 136.29 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.043 . . . . 1.31 111.202 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.84 115.68 31.06 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.555 1.542 . . . . 3.38 110.352 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -68.15 77.02 0.24 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.746 2.019 . . . . 1.09 109.95 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -74.05 138.11 75.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.293 1.437 . . . . 3.4 111.773 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.49 -43.33 59.18 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.08 3.187 . . . . 1.18 112.757 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.29 89.71 1.11 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.243 -1.543 . . . . 1.27 109.243 161.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.53 -76.2 0.26 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.909 1.719 . . . . 1.25 113.589 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -154.74 142.4 19.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.437 1.895 . . . . 1.98 111.163 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -162.06 167.95 23.49 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.409 -0.807 . . . . 0.93 111.692 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.37 127.95 46.55 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.665 0.786 . . . . 1.85 110.186 168.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.8 mmt -91.44 132.8 35.98 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.15 0.98 . . . . 0.98 110.068 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.7 147.47 35.51 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.612 1.165 . . . . 2.94 110.609 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mt -146.43 160.81 41.59 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.135 2.174 . . . . 2.32 110.175 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.46 57.61 11.06 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-O 118.917 -0.935 . . . . 2.54 111.152 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 mt -66.98 100.13 0.71 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.382 1.091 . . . . 0.97 112.054 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -71.12 -15.08 62.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.452 0.908 . . . . 1.72 113.452 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -128.42 147.0 62.05 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.986 2.114 . . . . 5.76 110.95 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.01 145.15 35.17 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.246 1.964 . . . . 1.9 108.938 149.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 163.88 35.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.424 1.89 . . . . 2.43 111.334 -168.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.01 168.16 19.57 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 118.94 2.941 . . . . 6.99 118.94 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.37 133.94 23.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.412 1.885 . . . . 1.72 112.406 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 2.34 88.45 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.988 -1.451 . . . . 2.28 114.727 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.69 159.84 23.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.788 1.794 . . . . 2.89 111.333 170.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -108.66 128.18 54.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.492 1.917 . . . . 3.63 109.13 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.41 103.72 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.574 1.15 . . . . 0.9 109.545 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -63.25 126.94 29.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.579 -0.897 . . . . 2.97 108.579 157.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.9 144.92 27.19 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.248 -0.907 . . . . 1.87 110.501 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -94.03 138.64 31.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.487 2.715 . . . . 3.59 110.156 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.8 mt -110.77 125.46 53.57 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.397 2.279 . . . . 1.28 109.908 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.2 mt -98.59 124.15 43.2 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.883 0.873 . . . . 0.74 111.633 -170.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.76 141.82 49.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.242 1.201 . . . . 1.99 114.242 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.65 88.68 0.71 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.879 1.272 . . . . 2.42 111.145 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.74 67.57 0.12 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.051 1.31 . . . . 4.02 113.165 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.3 17.41 72.26 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 116.59 1.396 . . . . 1.55 116.59 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.04 114.22 20.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.038 1.419 . . . . 3.66 112.005 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.37 136.59 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.835 2.454 . . . . 2.46 105.863 146.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.4 mt -144.92 119.63 9.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.198 0.999 . . . . 2.01 109.569 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -90.27 146.6 24.1 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.007 1.114 . . . . 4.15 114.007 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.6 m -135.17 152.18 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.352 1.861 . . . . 1.29 110.034 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.3 p -106.56 132.36 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.132 0.973 . . . . 1.55 109.553 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.9 mt -135.07 134.95 22.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.428 1.491 . . . . 1.82 110.239 -171.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.62 151.28 79.55 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.984 2.456 . . . . 0.95 113.5 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.99 119.75 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.886 1.275 . . . . 0.94 110.873 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -90.32 149.37 22.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.872 2.069 . . . . 3.55 108.892 156.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.25 4.66 4.06 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 116.222 1.934 . . . . 3.07 116.222 -155.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.784 1.634 . . . . 7.53 112.542 -168.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 107.559 -1.274 . . . . 5.9 107.559 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.42 137.11 9.21 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 120.961 1.71 . . . . 1.88 114.202 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -128.1 127.07 42.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.473 1.13 . . . . 2.02 111.957 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.74 95.21 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.81 -1.552 . . . . 1.52 106.81 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.42 105.82 9.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.575 1.178 . . . . 3.31 110.238 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -74.03 159.81 32.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.631 1.572 . . . . 2.46 112.55 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.416 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 75.6 m -149.71 159.25 36.45 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.29 1.836 . . . . 2.8 110.691 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.47 -2.86 12.4 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.369 2.712 . . . . 1.75 114.879 -171.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 167.61 27.95 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.33 0.967 . . . . 1.33 112.83 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.82 -2.65 18.35 Favored 'Cis proline' 0 CA--C 1.541 0.833 0 CA-C-N 118.579 1.19 . . . . 1.74 112.91 -4.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.39 169.84 13.81 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.047 1.739 . . . . 2.23 113.791 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.22 171.81 18.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.377 2.271 . . . . 0.9 111.586 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.96 120.45 31.62 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.761 0.824 . . . . 1.14 110.668 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.02 32.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.567 0.747 . . . . 0.79 111.83 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.88 162.92 31.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.395 1.478 . . . . 2.04 111.137 -174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.07 143.6 3.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 115.635 1.717 . . . . 1.63 115.635 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -69.96 87.88 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.205 -1.035 . . . . 1.27 108.205 160.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 tt -75.27 143.55 42.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.928 -0.768 . . . . 2.93 108.928 169.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -125.98 143.45 51.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.52 0.676 . . . . 3.27 112.044 170.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.67 100.9 13.54 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.99 -1.005 . . . . 0.98 109.193 161.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.96 -7.77 15.44 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.587 2.192 . . . . 1.17 112.624 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.56 179.73 51.46 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.802 1.192 . . . . 1.24 113.486 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.98 -3.18 20.4 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.272 1.829 . . . . 3.04 113.044 -171.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.02 162.67 28.35 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.367 1.867 . . . . 1.33 109.682 167.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.34 154.29 21.53 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.832 2.355 . . . . 1.04 112.672 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.0 mt -104.05 126.88 51.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.016 0.926 . . . . 2.0 110.832 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.57 109.02 20.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.03 -0.986 . . . . 3.3 110.304 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.2 tp -95.14 120.58 35.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.736 2.014 . . . . 0.81 108.598 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.01 -14.72 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.684 0.794 . . . . 0.6 112.453 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.49 -167.95 40.13 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 121.789 0.661 . . . . 0.4 113.139 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.52 176.9 8.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 0.8 109.393 159.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -157.43 145.41 19.03 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 106.425 -1.694 . . . . 6.49 106.425 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -149.13 155.27 40.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.359 1.064 . . . . 0.85 108.149 -164.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.04 -26.78 36.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.857 2.371 . . . . 1.27 112.749 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -78.16 -12.24 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 114.415 1.265 . . . . 1.25 114.415 -171.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.06 156.23 46.68 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.897 1.279 . . . . 0.84 111.818 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -102.54 -62.87 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.014 0.526 . . . . 3.57 110.753 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -79.16 146.57 33.06 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.768 -0.827 . . . . 4.09 108.768 165.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.79 133.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.748 1.619 . . . . 1.58 108.329 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -140.89 129.27 22.45 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.711 1.604 . . . . 2.14 109.351 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.22 123.01 29.66 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.995 1.271 . . . . 0.77 110.648 167.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -111.33 159.96 17.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.177 1.791 . . . . 0.53 112.256 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -116.51 179.19 4.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.188 2.195 . . . . 2.12 111.034 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -131.22 133.14 45.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.707 1.603 . . . . 1.62 107.713 166.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -125.7 150.92 47.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.349 1.059 . . . . 1.95 111.94 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.2 ptp -84.74 153.7 22.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.715 1.606 . . . . 4.37 110.433 167.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -153.79 34.54 0.44 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.061 1.504 . . . . 6.1 115.061 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -56.74 146.78 24.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.647 1.579 . . . . 5.25 113.268 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -156.4 136.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.622 2.369 . . . . 6.2 105.416 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 60.89 23.43 13.48 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.813 0.816 . . . . 5.86 111.68 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.72 0.35 24.84 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 119.916 -1.74 . . . . 4.45 114.862 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -86.42 132.88 33.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.507 1.923 . . . . 3.5 108.836 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.74 142.86 29.76 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.401 1.26 . . . . 7.16 114.401 -166.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -155.37 138.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.443 1.897 . . . . 2.09 108.618 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 ptp -141.21 138.92 33.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.46 0.704 . . . . 3.15 111.126 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.52 175.74 20.79 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 124.623 1.106 . . . . 0.98 112.451 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.5 mtt -128.45 156.79 42.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.787 1.635 . . . . 2.38 110.78 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -167.93 154.79 7.6 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 125.149 1.379 . . . . 3.69 111.441 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.3 Cg_endo -70.23 151.2 66.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.011 1.807 . . . . 0.56 112.221 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.0 156.78 54.17 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.748 2.019 . . . . 0.65 110.614 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.49 -16.0 27.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.954 2.436 . . . . 0.75 113.113 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.4 p90 179.14 170.72 0.93 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.027 2.131 . . . . 2.52 110.321 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.0 174.69 7.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.679 2.392 . . . . 0.75 108.933 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -152.8 164.42 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.028 -1.045 . . . . 2.27 112.535 164.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 t -138.86 128.83 14.67 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.524 1.53 . . . . 1.04 109.58 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.58 163.41 39.07 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.506 2.137 . . . . 1.19 111.69 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.9 138.18 84.18 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.503 2.802 . . . . 1.22 112.055 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt 68.92 2.64 3.63 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.966 2.106 . . . . 1.52 113.708 -175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.11 114.1 3.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 125.85 1.691 . . . . 1.31 111.269 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -93.18 125.81 37.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.391 1.077 . . . . 8.06 109.32 162.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.5 m -145.44 130.18 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.219 1.008 . . . . 1.56 111.296 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.85 132.93 34.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.197 0.999 . . . . 6.93 111.248 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.27 60.34 3.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.018 1.866 . . . . 1.8 111.979 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -47.94 133.91 11.56 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 128.038 2.535 . . . . 3.68 113.27 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.2 -51.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.325 2.684 . . . . 1.62 111.99 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.65 94.98 1.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.264 -1.535 . . . . 1.57 109.264 166.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -76.96 0.29 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.993 1.758 . . . . 1.34 113.008 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -158.03 130.55 7.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.6 1.56 . . . . 2.11 111.299 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -162.13 173.3 14.51 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.938 1.699 . . . . 0.75 111.977 -166.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.95 120.5 41.6 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.742 -0.599 . . . . 2.05 112.078 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 mmt -84.75 121.49 27.76 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.233 1.013 . . . . 0.96 109.854 164.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -106.02 131.14 53.66 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.223 1.409 . . . . 1.72 108.496 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -140.07 142.37 36.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.791 0.836 . . . . 2.11 111.133 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 60.45 4.37 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 109.042 -1.623 . . . . 2.42 109.042 -166.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -65.66 127.57 32.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.32 1.06 . . . . 1.02 108.998 172.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -106.3 12.64 29.71 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 1.73 112.89 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -162.33 153.21 14.69 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.811 1.644 . . . . 5.96 110.919 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.94 163.45 39.17 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.921 2.414 . . . . 2.27 109.378 159.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mp -133.93 162.77 31.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.104 0.954 . . . . 3.35 112.139 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -119.36 120.01 35.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.888 2.075 . . . . 5.74 110.478 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.06 118.29 4.52 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.85 -1.156 . . . . 2.58 109.79 168.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.94 48.09 22.25 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.719 -0.489 . . . . 2.3 112.761 -167.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.28 -168.33 1.32 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 107.53 -1.285 . . . . 2.76 107.53 140.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -128.85 155.53 45.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 4.39 111.639 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.08 118.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.685 1.594 . . . . 1.62 108.938 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.42 138.9 39.54 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.524 0.729 . . . . 3.46 110.021 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.413 ' C ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -155.3 143.02 19.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.873 1.269 . . . . 1.99 110.912 -168.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -89.82 110.36 21.29 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 128.995 2.918 . . . . 3.03 110.323 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.43 113.08 21.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.426 1.012 . . . . 1.56 109.372 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.2 mt -93.6 123.47 36.94 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.043 0.937 . . . . 0.58 110.772 -166.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -124.58 137.64 54.38 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.427 -0.796 . . . . 2.26 112.571 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.98 130.89 30.74 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.614 1.166 . . . . 1.85 113.164 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.5 -150.17 20.59 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.367 -1.093 . . . . 3.48 110.367 -163.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.29 28.02 9.56 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.402 1.001 . . . . 2.08 114.715 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mppt? -100.38 135.38 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.722 1.761 . . . . 5.25 112.084 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.88 138.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.763 1.225 . . . . 1.29 109.454 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -116.41 104.87 11.89 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.837 0.855 . . . . 1.62 109.319 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.22 114.03 17.83 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 3.46 109.36 174.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.09 150.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.093 1.357 . . . . 3.24 112.546 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.75 142.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.051 1.74 . . . . 2.13 111.904 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -142.5 146.1 37.4 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.086 1.755 . . . . 3.09 110.55 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.8 152.53 69.14 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.823 3.015 . . . . 1.86 113.007 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.6 t -93.81 127.04 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.938 1.295 . . . . 1.56 110.746 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.64 -177.7 3.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.376 1.47 . . . . 5.36 109.186 165.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.25 154.2 31.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 119.769 -1.832 . . . . 2.53 114.027 -164.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 125.918 1.687 . . . . 5.88 113.448 156.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 . . . . . 0 CA--C 1.545 0.769 0 CA-C-O 120.286 0.089 . . . . 4.74 111.019 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -161.28 170.39 37.06 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 120.556 -1.34 . . . . 1.29 114.183 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -157.87 147.79 20.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.292 1.037 . . . . 1.54 111.935 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -93.45 121.62 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.146 -0.971 . . . . 1.11 108.809 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -63.46 -29.84 71.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.749 1.62 . . . . 4.85 113.719 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.99 -179.74 0.22 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.221 2.208 . . . . 2.3 112.692 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m 176.25 165.84 0.44 Allowed Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 128.751 2.82 . . . . 1.89 108.575 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.27 5.65 3.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.248 2.632 . . . . 2.16 113.726 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.5 170.66 36.04 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.35 0.976 . . . . 2.36 112.333 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.86 -6.48 33.06 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 CA-C-N 118.612 1.206 . . . . 2.81 113.66 -5.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -135.42 171.84 13.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.962 2.105 . . . . 5.66 110.804 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.62 -168.3 1.14 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.785 2.434 . . . . 1.3 112.21 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.23 166.97 24.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.317 1.847 . . . . 1.38 111.786 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.33 159.32 42.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.647 1.179 . . . . 0.92 114.067 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -141.53 156.77 45.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.665 2.386 . . . . 2.0 110.942 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.415 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.2 pp -175.04 167.69 3.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.286 1.217 . . . . 2.13 114.286 -174.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.3 m -124.7 137.48 54.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.775 1.63 . . . . 1.54 109.033 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.4 tp -131.14 156.4 45.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.152 1.381 . . . . 4.47 110.849 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -130.58 129.49 42.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.3 -1.0 . . . . 3.97 108.3 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -94.75 105.8 20.84 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.634 1.174 . . . . 1.04 109.162 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.66 -8.98 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.729 2.286 . . . . 0.99 113.637 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.06 156.21 43.44 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 118.942 0.792 . . . . 1.28 112.693 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.3 m-20 -88.26 7.67 31.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.978 1.711 . . . . 3.21 113.209 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.02 158.84 43.13 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.999 1.72 . . . . 1.39 110.64 166.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.31 156.9 25.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.304 2.669 . . . . 0.8 110.782 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.5 mt -107.18 151.45 25.4 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.706 -0.621 . . . . 1.85 110.58 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -128.68 112.38 14.17 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.641 1.176 . . . . 4.8 109.572 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.06 127.54 42.16 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.122 1.769 . . . . 0.91 109.228 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -116.33 -14.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.444 0.905 . . . . 0.65 113.444 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.27 -165.57 35.0 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 121.626 -0.671 . . . . 0.53 112.514 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -137.5 -179.4 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.249 1.02 . . . . 0.85 110.356 167.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -159.95 145.21 15.23 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.945 -1.872 . . . . 6.42 105.945 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.75 156.06 26.18 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 119.088 0.858 . . . . 1.06 109.97 -159.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.71 -37.17 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.341 2.027 . . . . 0.9 112.465 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.52 -10.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 115.236 1.569 . . . . 1.35 115.236 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 163.29 32.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.285 1.434 . . . . 0.79 110.374 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -105.23 -77.76 0.58 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.315 1.046 . . . . 3.67 109.881 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -79.46 104.29 9.97 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.757 0.823 . . . . 3.42 110.467 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -110.18 137.61 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.126 1.37 . . . . 1.28 110.587 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -141.23 128.46 20.97 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.499 1.52 . . . . 2.28 111.41 -170.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.59 122.83 28.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.76 0.791 . . . . 0.75 111.691 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 13.2 m170 -104.91 151.42 23.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.686 1.594 . . . . 0.94 114.173 172.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.11 165.87 14.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.613 1.965 . . . . 2.13 110.937 160.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.2 m -148.76 112.96 5.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.512 1.525 . . . . 1.84 107.952 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -126.02 171.5 10.74 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.934 1.294 . . . . 2.7 112.598 -163.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.0 mtm -124.3 118.27 26.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.851 1.26 . . . . 4.86 110.053 161.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -153.04 159.73 42.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.058 1.343 . . . . 6.71 110.651 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -64.34 147.89 51.56 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.322 1.449 . . . . 4.29 112.518 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.21 -18.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.497 1.295 . . . . 3.6 114.497 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -155.93 33.13 0.35 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.938 2.095 . . . . 3.39 108.96 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.79 -25.21 0.64 Allowed Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.235 -1.541 . . . . 2.62 113.141 -160.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -80.34 139.32 36.63 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.305 2.242 . . . . 2.41 109.2 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -76.45 144.63 39.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.612 0.642 . . . . 4.28 112.667 169.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.37 164.79 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 3.19 109.798 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.7 mtm -78.46 154.2 30.79 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 4.06 111.081 168.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.2 166.47 38.8 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 121.738 -0.601 . . . . 1.59 113.668 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.6 149.8 46.93 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.88 1.272 . . . . 1.85 110.831 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -158.62 152.04 19.01 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-O 117.133 -1.413 . . . . 3.45 110.428 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 47.5 Cg_endo -69.03 148.27 69.44 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.177 1.918 . . . . 0.79 111.412 162.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.58 152.33 68.66 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 125.44 1.496 . . . . 0.65 110.582 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.13 -6.79 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.885 2.39 . . . . 1.05 113.477 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -176.69 159.91 1.89 Allowed 'General case' 0 C--N 1.348 0.508 0 C-N-CA 125.222 1.409 . . . . 2.3 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -111.19 175.7 5.32 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.88 1.672 . . . . 0.86 109.194 152.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.39 167.18 31.23 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.807 -1.183 . . . . 2.98 110.291 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -144.18 136.89 13.57 Favored Pre-proline 0 C--N 1.328 -0.367 0 C-N-CA 124.21 1.004 . . . . 0.99 108.762 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 167.38 25.4 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.571 1.514 . . . . 1.0 111.373 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.36 143.9 99.58 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.217 2.611 . . . . 0.99 111.003 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 14.9 mmmt 66.25 4.12 3.03 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.448 1.499 . . . . 1.51 112.797 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.92 3.74 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 127.403 2.43 . . . . 1.08 112.857 -170.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 118.37 31.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.535 1.534 . . . . 5.0 109.772 172.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.11 147.03 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 120.465 1.484 . . . . 1.51 114.403 -166.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 131.62 54.37 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.805 1.242 . . . . 3.48 112.826 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.94 71.64 0.54 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.464 1.505 . . . . 1.39 109.929 157.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -78.0 144.3 67.58 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.939 1.696 . . . . 3.64 112.688 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.1 -23.16 72.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.546 2.83 . . . . 1.65 114.644 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.74 38.78 3.04 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.248 1.404 . . . . 1.45 113.02 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.95 -58.74 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 CA-C-N 118.581 1.19 . . . . 1.39 114.948 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -155.12 144.2 20.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.975 1.71 . . . . 2.3 110.395 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -164.0 173.84 12.11 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.798 -1.189 . . . . 0.87 110.213 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 54.0 m-85 -108.95 135.42 50.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.093 0.557 . . . . 2.2 110.182 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 mmt -85.08 140.69 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.673 0.789 . . . . 1.32 109.955 156.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.3 mt -122.8 112.28 17.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 1.71 108.375 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -111.21 140.96 45.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.836 1.654 . . . . 2.86 108.436 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.02 72.95 0.91 Allowed Glycine 0 N--CA 1.471 0.968 0 O-C-N 121.206 -0.934 . . . . 2.57 111.097 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.79 104.24 4.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 122.523 1.154 . . . . 1.0 110.13 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -82.83 13.94 3.56 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 2.43 113.008 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -147.07 159.07 43.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.694 1.998 . . . . 4.7 110.392 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.45 163.29 39.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.584 2.189 . . . . 1.76 109.6 152.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -141.92 162.48 35.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.754 1.222 . . . . 2.51 110.781 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.12 109.19 2.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.105 1.762 . . . . 3.31 109.574 -175.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.04 126.08 24.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.93 -1.106 . . . . 2.29 110.26 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.29 7.42 40.38 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.762 -1.021 . . . . 1.9 114.562 -165.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -107.13 -170.82 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.263 1.531 . . . . 2.86 110.057 147.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -125.9 165.06 19.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.857 1.663 . . . . 3.32 110.509 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.56 116.7 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.115 1.366 . . . . 1.33 108.446 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.92 144.59 33.24 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.77 -1.105 . . . . 3.42 111.213 167.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.643 HD21 ' HB1' ' A' ' 35' ' ' ALA . 3.0 tt -155.6 132.9 10.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.988 0.899 . . . . 1.48 110.527 -167.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -86.5 101.51 13.25 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.874 3.27 . . . . 2.68 111.363 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.99 111.77 17.77 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.273 -1.517 . . . . 1.31 109.575 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.28 125.71 35.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.391 1.476 . . . . 0.57 110.1 -166.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.84 153.08 31.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.005 0.522 . . . . 2.26 112.027 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.43 128.77 37.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.062 0.545 . . . . 1.95 110.398 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 -153.97 30.35 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.475 0.559 . . . . 2.89 111.878 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.15 54.32 4.85 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.932 -0.927 . . . . 2.25 114.434 -169.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -143.78 147.12 33.71 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.293 1.546 . . . . 4.09 115.057 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.83 131.72 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 128.19 2.596 . . . . 1.07 108.171 166.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.42 101.46 7.97 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.028 1.331 . . . . 2.51 108.031 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.26 133.6 33.82 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.466 -0.771 . . . . 2.59 112.727 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.7 m -140.94 153.45 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.061 1.744 . . . . 1.28 110.986 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.88 128.49 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.836 1.254 . . . . 2.04 111.188 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.9 155.33 60.71 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.272 1.829 . . . . 3.16 110.3 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.0 152.38 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.929 2.42 . . . . 1.1 111.125 168.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.58 116.41 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.569 -1.641 . . . . 1.17 106.569 161.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -127.97 118.92 24.43 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.877 -1.527 . . . . 3.82 106.877 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.62 118.36 16.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.791 -0.818 . . . . 2.62 108.791 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 117.952 -1.023 . . . . 9.25 113.174 176.737 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--O 1.238 0.464 0 N-CA-C 107.726 -1.212 . . . . 6.08 107.726 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . 140.27 172.47 12.88 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.592 1.568 . . . . 1.6 113.521 174.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -155.52 155.28 33.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.38 1.072 . . . . 2.33 111.585 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.63 119.2 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.592 -0.892 . . . . 1.15 108.592 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.28 108.74 16.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.557 0.743 . . . . 4.03 109.687 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 136.41 48.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 2.56 110.427 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.2 t -131.22 156.03 80.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.486 1.914 . . . . 2.63 109.222 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.01 -10.38 28.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.872 2.381 . . . . 1.91 112.717 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.53 -174.36 15.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.624 1.583 . . . . 1.64 112.166 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -76.71 -0.58 23.69 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 118.306 1.053 . . . . 1.61 112.629 -8.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -149.65 178.05 9.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.848 1.659 . . . . 1.86 111.191 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.0 -166.22 1.53 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.529 1.931 . . . . 0.76 112.42 -172.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.74 154.57 34.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.716 1.206 . . . . 0.86 111.761 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.13 46.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.297 1.439 . . . . 0.67 111.281 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -136.13 148.54 48.27 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.484 1.914 . . . . 2.19 109.011 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.8 pp -171.6 155.92 4.22 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.803 0.841 . . . . 1.67 112.741 -171.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.424 HG21 ' CZ ' ' A' ' 74' ' ' ARG . 25.0 m -97.71 136.59 37.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.486 -1.234 . . . . 1.32 111.827 166.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 23' ' ' GLU . 6.7 tt -112.65 149.3 33.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.873 2.469 . . . . 2.79 109.083 173.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 22' ' ' LEU . 8.0 pt-20 -148.89 120.36 7.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.127 0.965 . . . . 2.76 112.89 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -90.14 115.36 63.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.722 1.209 . . . . 1.07 110.233 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -86.52 -8.69 7.17 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.155 2.57 . . . . 0.96 113.441 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.72 169.29 54.65 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.006 0.812 . . . . 0.98 113.722 -172.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.08 -2.24 50.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.489 1.916 . . . . 2.88 112.702 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.27 161.15 32.85 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 126.221 1.809 . . . . 1.19 110.299 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.03 161.54 23.63 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.05 2.5 . . . . 0.68 111.184 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.02 150.52 28.41 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.552 0.741 . . . . 1.86 110.48 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -125.52 114.6 19.0 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.231 1.012 . . . . 4.05 109.532 167.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -90.85 119.43 31.05 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.822 2.449 . . . . 0.93 109.095 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.17 -8.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.54 1.136 . . . . 0.63 113.931 -171.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -162.03 32.31 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.512 -0.742 . . . . 0.47 112.275 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.59 -172.0 3.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.488 1.115 . . . . 1.02 111.219 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -148.22 143.88 27.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.789 2.036 . . . . 5.89 105.506 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -149.05 153.73 38.54 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.409 1.004 . . . . 0.88 109.339 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.43 -43.46 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.514 2.809 . . . . 1.37 111.696 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.281 1.1 m -76.46 -5.23 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.416 1.636 . . . . 1.02 115.416 -170.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.1 -175.91 4.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.601 1.56 . . . . 1.17 110.751 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -132.92 -60.94 0.85 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.156 0.889 . . . . 4.68 111.721 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -65.02 129.93 41.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.395 -1.335 . . . . 3.05 107.395 158.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.89 117.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.454 -1.684 . . . . 1.82 106.454 171.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -138.76 115.65 10.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.635 -1.166 . . . . 2.83 109.013 -155.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.446 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 6.1 tt -78.04 120.66 23.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.216 1.008 . . . . 0.78 110.546 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.6 m170 -107.47 150.0 27.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.84 1.656 . . . . 0.52 112.222 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.74 168.55 19.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.843 -1.526 . . . . 2.47 110.306 159.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -143.65 86.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.882 -1.525 . . . . 1.29 106.882 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -94.14 153.41 18.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.177 1.791 . . . . 1.98 112.373 -164.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 ttp -91.74 137.68 32.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.389 1.476 . . . . 2.78 110.003 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -153.53 122.78 6.58 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.377 0.671 . . . . 5.48 111.461 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.06 155.28 17.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.845 1.258 . . . . 5.74 110.133 169.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.37 127.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.91 . . . . 3.71 110.678 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 58.72 26.4 14.58 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.317 1.056 . . . . 4.96 111.053 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.43 1.19 57.03 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 119.825 -1.797 . . . . 3.31 114.379 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -92.84 143.19 26.52 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.032 1.733 . . . . 3.53 109.488 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.27 130.22 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.754 1.622 . . . . 6.18 112.607 -164.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.05 169.5 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 122.387 1.089 . . . . 2.05 113.044 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 14.6 tpp -137.48 160.91 37.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.913 2.885 . . . . 2.94 107.938 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.07 169.31 33.12 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.562 1.074 . . . . 1.24 114.078 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.11 139.48 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.433 1.493 . . . . 1.89 109.598 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -154.6 145.38 16.2 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 125.652 1.581 . . . . 3.55 109.531 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 40.3 Cg_endo -65.39 143.25 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.967 1.778 . . . . 0.8 110.657 165.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.64 156.16 42.82 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.691 1.596 . . . . 0.58 110.663 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.75 -14.66 33.11 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.919 2.413 . . . . 0.73 113.369 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -177.16 162.17 1.95 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.574 1.55 . . . . 1.94 110.816 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mt -109.48 171.08 7.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.673 1.189 . . . . 0.68 108.682 149.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -155.57 165.09 37.63 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.03 -1.044 . . . . 2.35 111.774 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.87 136.36 11.67 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.841 0.857 . . . . 0.99 109.516 -161.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.83 169.58 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.715 1.61 . . . . 0.86 111.429 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.78 143.9 94.53 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.172 2.581 . . . . 0.75 111.26 163.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt 67.31 0.57 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.524 1.53 . . . . 1.29 114.215 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.16 113.7 3.68 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 126.01 1.767 . . . . 0.94 112.869 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.424 ' CZ ' HG21 ' A' ' 21' ' ' THR . 23.1 ttt85 -81.04 133.2 35.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.082 -1.059 . . . . 4.61 109.746 154.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.95 134.16 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.624 1.569 . . . . 1.37 110.597 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.1 118.02 25.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.127 -1.064 . . . . 4.67 108.127 -160.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.54 73.11 1.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.236 1.493 . . . . 1.43 111.87 -169.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -55.24 116.88 12.68 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.226 1.41 . . . . 4.98 110.347 168.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.21 -30.37 88.33 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.24 2.627 . . . . 1.35 114.108 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.89 41.68 1.75 Allowed Glycine 0 CA--C 1.533 1.181 0 CA-C-N 118.858 0.754 . . . . 1.94 112.791 167.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.33 -49.82 0.04 OUTLIER Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.954 2.216 . . . . 1.47 113.609 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -151.26 146.89 26.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.691 1.596 . . . . 2.19 112.049 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -156.48 167.41 30.54 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.735 1.214 . . . . 1.12 110.983 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.446 ' CZ ' HD12 ' A' ' 45' ' ' LEU . 31.7 m-85 -105.83 117.8 34.95 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.704 -0.85 . . . . 1.91 108.704 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.87 133.08 34.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.975 0.51 . . . . 1.22 110.258 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.71 133.39 53.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.854 1.662 . . . . 1.91 111.659 -172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -142.91 157.97 44.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.758 1.223 . . . . 2.02 112.028 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -43.76 2.66 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 124.759 1.171 . . . . 2.27 112.129 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt 47.37 71.83 0.3 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.975 2.51 . . . . 1.28 113.706 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -69.67 -1.7 9.71 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.032 1.123 . . . . 2.33 114.032 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 97' ' ' GLU . 10.3 mtp85 -125.45 142.36 41.53 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 126.308 1.843 . . . . 5.84 109.053 172.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.22 124.12 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 107.245 -1.867 . . . . 1.95 107.245 145.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.578 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.5 pt? -127.21 157.54 39.52 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.675 1.99 . . . . 2.96 111.164 -163.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -165.11 142.69 6.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.527 1.306 . . . . 8.1 114.527 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 124.86 19.1 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.279 -0.888 . . . . 1.88 109.669 164.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.24 -12.25 14.26 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.94 -1.478 . . . . 1.86 113.363 -161.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 91' ' ' ARG . 6.7 pt-20 -106.1 172.68 6.68 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.162 1.481 . . . . 3.87 110.828 155.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.5 155.18 46.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.529 1.532 . . . . 4.75 108.959 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.66 110.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.582 1.153 . . . . 1.33 108.975 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.35 129.41 38.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.534 -0.913 . . . . 4.39 108.534 153.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -134.63 140.03 45.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.578 1.151 . . . . 1.86 108.761 172.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.3 103.41 12.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.996 2.519 . . . . 3.35 110.587 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.38 125.18 28.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.731 1.613 . . . . 1.29 110.813 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.5 mt -93.18 129.86 39.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.654 1.182 . . . . 0.75 111.565 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -127.74 119.97 26.91 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.38 0.672 . . . . 2.15 112.295 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.51 27.9 0.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.975 2.11 . . . . 2.51 114.784 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.57 -53.38 1.57 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.741 1.638 . . . . 3.91 113.104 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.68 3.71 63.04 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 117.036 1.574 . . . . 1.8 117.036 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 150.36 44.08 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.112 1.956 . . . . 3.91 111.316 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.31 136.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.854 1.662 . . . . 1.08 109.205 166.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.7 mt -146.18 132.56 19.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.501 1.521 . . . . 1.54 109.499 -172.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.1 ptmt -102.1 158.56 16.08 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.951 1.834 . . . . 2.88 115.951 -169.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.21 147.21 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.605 1.962 . . . . 2.42 109.915 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -107.55 133.71 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.115 1.366 . . . . 2.94 111.247 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 mt -140.44 131.38 13.92 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 127.059 2.144 . . . . 2.15 109.365 -165.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.35 151.47 71.39 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.318 2.678 . . . . 1.62 112.146 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.42 125.85 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.53 0.681 . . . . 1.46 112.087 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.48 148.32 24.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.086 2.154 . . . . 4.96 109.838 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.33 129.62 54.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.919 -1.039 . . . . 2.03 109.395 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 131.365 3.866 . . . . 6.82 107.677 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 119.607 -0.235 . . . . 5.82 110.749 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.19 175.3 47.59 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 115.455 0.942 . . . . 1.29 115.455 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -156.23 123.65 5.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.034 1.334 . . . . 1.61 113.094 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.33 153.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 120.75 -1.219 . . . . 1.16 108.823 164.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -110.15 -19.19 13.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 116.438 2.014 . . . . 6.64 116.438 -168.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 60.79 173.42 0.1 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.401 1.48 . . . . 2.12 112.781 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.29 171.8 0.5 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.947 2.899 . . . . 1.79 109.657 171.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.97 -0.41 9.0 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.301 2.667 . . . . 1.71 113.78 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 174.23 33.69 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.93 1.252 . . . . 1.78 112.418 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.23 -5.37 34.2 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 118.596 1.198 . . . . 2.06 112.998 -4.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -130.4 177.23 7.5 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.989 1.716 . . . . 1.89 112.767 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -168.63 -168.8 0.94 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.789 2.436 . . . . 0.79 110.64 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.45 167.92 17.84 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.848 1.659 . . . . 1.17 112.15 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.14 149.72 31.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.525 1.53 . . . . 0.78 111.337 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -146.04 151.8 38.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.481 1.512 . . . . 2.39 110.135 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -173.84 161.02 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.938 1.295 . . . . 2.07 113.05 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.9 m -84.35 150.23 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.685 1.594 . . . . 1.34 109.037 166.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.72 176.27 9.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.365 1.066 . . . . 3.9 110.955 152.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -154.83 162.02 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.476 -0.765 . . . . 3.71 111.424 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -114.61 101.64 54.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.876 1.67 . . . . 1.31 109.577 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.06 -2.65 11.86 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.786 2.991 . . . . 1.56 113.112 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.9 -172.35 48.79 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.786 1.184 . . . . 1.49 113.726 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -119.21 2.32 11.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.818 1.647 . . . . 3.79 112.954 -169.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.1 161.35 35.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.185 1.794 . . . . 1.59 109.374 165.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.8 154.68 15.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.096 2.531 . . . . 1.12 111.123 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.37 158.04 17.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.962 0.905 . . . . 2.25 111.175 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -135.35 113.42 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.855 1.262 . . . . 3.71 110.381 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.44 115.35 27.51 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 127.943 2.497 . . . . 0.92 108.985 -173.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.7 -8.73 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.725 1.009 . . . . 0.71 113.725 -165.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.69 -162.25 32.22 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.749 -0.594 . . . . 0.45 112.81 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.93 -175.43 4.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.606 0.595 . . . . 0.83 112.606 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -156.95 144.25 18.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.924 0.889 . . . . 5.44 109.551 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -152.74 155.13 32.23 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.961 0.904 . . . . 0.92 110.471 -170.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.31 -21.17 23.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.809 2.339 . . . . 1.17 113.617 169.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.785 HG21 HD13 ' A' ' 93' ' ' LEU . 1.4 m -90.53 -15.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 114.639 1.348 . . . . 1.16 114.639 -166.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.36 40.25 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.084 0.954 . . . . 1.1 112.347 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -93.63 -86.2 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.386 1.074 . . . . 3.76 110.597 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -85.02 90.96 7.96 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.807 -1.183 . . . . 5.32 108.741 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -76.03 139.16 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.51 -0.768 . . . . 1.55 111.014 165.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -138.14 120.7 16.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.204 2.202 . . . . 3.38 111.048 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.3 118.18 22.41 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.016 0.912 . . . . 0.83 111.809 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -103.22 153.68 20.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.782 1.633 . . . . 0.73 113.661 172.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -95.18 178.21 5.61 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.42 1.888 . . . . 2.47 110.021 162.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.9 m -145.7 111.93 5.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.891 -1.151 . . . . 1.19 107.891 164.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -97.15 158.34 15.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.379 1.472 . . . . 2.43 112.498 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -101.95 148.03 25.83 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.42 1.088 . . . . 3.76 108.92 163.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -158.92 146.64 17.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.379 1.471 . . . . 6.25 110.147 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.45 145.84 24.86 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.582 0.353 . . . . 3.76 110.917 165.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -139.78 120.48 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.019 -1.475 . . . . 3.13 107.019 165.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.6 tm-20 57.52 33.57 23.44 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.28 1.032 . . . . 5.42 110.757 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.64 -9.92 4.37 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 119.995 -1.69 . . . . 2.18 114.547 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.463 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 33.7 mmtm -78.39 139.98 38.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 4.08 110.367 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -69.97 131.1 43.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.044 0.938 . . . . 3.32 110.825 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.93 146.84 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.685 1.994 . . . . 2.13 109.361 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -128.43 148.98 50.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.685 1.194 . . . . 3.63 110.893 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.71 -179.83 34.78 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.906 0.765 . . . . 1.07 112.855 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -127.95 149.27 50.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.245 1.018 . . . . 2.32 111.981 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -142.76 147.46 42.18 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.552 1.541 . . . . 3.52 108.908 172.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 151.62 78.42 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.697 1.598 . . . . 0.77 110.867 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.13 154.55 78.69 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 125.156 1.382 . . . . 1.13 110.79 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -70.2 -11.8 30.91 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.671 2.247 . . . . 1.45 113.063 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -177.47 163.45 1.97 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.618 1.567 . . . . 2.33 111.885 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -113.2 174.11 6.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.329 2.251 . . . . 0.83 109.4 155.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -154.88 167.62 29.68 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.041 -1.037 . . . . 2.55 112.277 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.73 135.42 11.07 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.818 0.847 . . . . 1.11 110.543 -165.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.76 167.08 27.04 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.295 1.997 . . . . 1.03 111.893 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -65.26 144.61 81.45 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.709 2.939 . . . . 1.42 111.655 166.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.261 0.6 OUTLIER 46.69 55.29 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 123.454 1.597 . . . . 2.76 114.757 -166.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.35 121.33 2.66 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 113.962 -1.472 . . . . 1.06 114.164 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.53 146.99 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.65 0.78 . . . . 4.96 109.978 162.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.18 137.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.544 1.138 . . . . 1.63 109.974 171.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -111.92 140.25 46.74 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.794 0.807 . . . . 3.45 110.957 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.24 63.78 2.53 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.323 1.535 . . . . 1.32 109.926 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -58.37 121.39 51.9 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.954 1.302 . . . . 4.89 110.709 170.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.88 -58.14 1.58 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.888 3.726 . . . . 1.48 114.598 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.69 2.9 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.678 1.132 . . . . 1.94 113.405 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.75 -51.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.352 1.93 . . . . 1.48 113.339 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -156.01 139.47 15.84 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.631 1.972 . . . . 2.19 109.654 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -166.93 173.66 9.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.353 1.061 . . . . 0.84 111.477 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.13 134.0 52.64 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.025 0.53 . . . . 1.81 111.246 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.3 mmt -84.73 144.02 28.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.977 1.311 . . . . 1.09 110.316 157.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.59 116.47 28.2 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.68 1.592 . . . . 1.92 107.861 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -109.63 134.86 51.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.967 0.803 . . . . 2.28 110.147 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.2 0.6 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.042 -1.223 . . . . 2.58 110.042 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.53 100.52 2.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.086 0.943 . . . . 1.06 110.068 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -76.71 -12.7 60.03 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.235 0.828 . . . . 1.77 113.235 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.42 148.63 31.99 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.905 . . . . 5.22 111.139 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -67.56 148.71 79.0 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.735 2.29 . . . . 2.09 109.229 159.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.785 HD13 HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -156.96 30.94 0.3 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.861 1.315 . . . . 4.24 113.59 -160.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.25 149.22 0.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.183 2.193 . . . . 4.34 113.904 -169.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.79 134.93 30.38 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.603 -1.311 . . . . 2.49 112.107 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.42 -11.79 66.77 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.061 -1.41 . . . . 2.41 114.354 -166.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 158.02 37.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.052 1.426 . . . . 4.28 109.009 160.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.9 147.54 29.67 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.812 2.045 . . . . 4.27 108.174 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.19 123.07 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.576 1.55 . . . . 1.08 109.995 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 121.49 21.16 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.708 0.803 . . . . 4.13 109.068 159.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.07 126.6 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.078 0.951 . . . . 1.59 110.521 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.17 95.87 8.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.53 1.932 . . . . 2.6 109.779 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.93 126.18 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.794 1.179 . . . . 2.6 110.106 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.6 mt -95.1 137.97 33.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.516 1.526 . . . . 0.85 110.589 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -134.11 148.51 51.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.213 1.006 . . . . 2.31 113.028 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.77 162.77 18.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.128 -0.942 . . . . 2.88 111.853 169.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.75 24.9 66.11 Favored Glycine 0 N--CA 1.473 1.145 0 O-C-N 121.66 -0.65 . . . . 4.7 113.696 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.94 60.65 4.77 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.303 0.954 . . . . 2.11 111.116 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -143.63 165.16 28.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.984 1.313 . . . . 3.68 112.412 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -169.98 144.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 129.39 3.076 . . . . 2.19 107.213 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.2 mt -137.4 96.93 3.35 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.393 1.477 . . . . 2.69 107.766 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.45 143.24 32.24 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.956 0.724 . . . . 2.66 112.956 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.33 140.55 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.414 1.086 . . . . 1.88 109.899 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 145.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.668 0.787 . . . . 2.03 109.61 172.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.5 153.19 12.79 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.924 1.29 . . . . 2.84 113.17 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.09 161.66 40.49 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.039 2.493 . . . . 1.24 112.555 -175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -93.46 130.61 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.978 . . . . 1.43 109.786 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.01 164.44 12.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.723 1.209 . . . . 3.45 108.931 156.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.41 115.84 26.59 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.068 -1.02 . . . . 2.46 112.772 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.521 2.328 . . . . 5.68 113.133 167.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.022 0.439 . . . . 5.03 112.171 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.15 164.34 21.47 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 124.822 1.201 . . . . 0.98 114.078 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -152.53 145.2 24.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 1.74 112.026 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.1 131.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.381 -0.6 . . . . 1.12 109.381 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 116.75 22.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.207 0.603 . . . . 4.08 109.405 -171.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.86 133.23 33.94 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.592 -1.317 . . . . 2.34 110.914 167.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -149.48 163.24 25.85 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.567 1.947 . . . . 2.45 109.007 165.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.91 31.14 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.062 3.175 . . . . 1.93 114.113 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.06 -173.16 54.51 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.248 -0.908 . . . . 1.72 113.125 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.26 -4.42 18.31 Favored 'Cis proline' 0 CA--C 1.539 0.741 0 CA-C-N 118.228 1.014 . . . . 1.83 112.8 -10.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -139.51 178.87 6.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.701 1.6 . . . . 2.61 111.484 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.07 -173.93 3.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.004 2.122 . . . . 1.11 108.647 163.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.42 161.15 17.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 1.06 112.161 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.1 136.58 48.51 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.039 -1.038 . . . . 1.12 111.106 163.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -122.61 155.56 36.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.413 1.885 . . . . 2.07 111.015 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -166.24 142.28 4.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.708 1.744 . . . . 1.57 115.708 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.9 m -72.13 132.73 44.56 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.79 -0.819 . . . . 1.18 108.79 156.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.1 tt -140.68 147.41 39.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.313 1.845 . . . . 2.52 110.1 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -131.92 147.14 52.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.289 1.042 . . . . 3.32 112.414 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -88.07 108.9 23.93 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.362 -1.29 . . . . 1.02 109.216 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.74 -11.51 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.631 2.221 . . . . 1.23 113.287 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.04 -173.39 49.84 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.867 1.222 . . . . 0.96 113.812 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -114.17 -0.85 13.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.884 1.674 . . . . 2.98 112.855 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.04 161.77 36.79 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.457 1.903 . . . . 1.43 109.464 165.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 155.61 28.22 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.554 2.169 . . . . 0.74 112.287 -169.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.43 149.82 23.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.437 1.095 . . . . 1.8 110.532 168.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -130.94 111.93 12.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.735 1.214 . . . . 3.27 110.408 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 tp -94.21 118.33 31.41 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.564 2.345 . . . . 0.75 108.746 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -110.15 -10.37 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.977 0.911 . . . . 0.58 113.003 -171.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.94 -167.14 38.31 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 124.242 0.925 . . . . 0.5 112.233 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.15 -179.03 6.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.165 0.986 . . . . 0.66 110.746 164.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 102' ' ' ASP . 22.0 mmt-85 -149.48 139.66 22.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.26 1.424 . . . . 6.3 109.271 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -150.01 152.12 33.4 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.218 -0.896 . . . . 0.55 110.572 -169.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.98 -23.94 53.51 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.827 2.351 . . . . 0.77 113.629 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.546 HG12 HH11 ' A' ' 91' ' ' ARG 0.351 1.6 m -94.25 3.07 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.049 1.5 . . . . 0.91 115.049 -171.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.86 164.1 36.28 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.418 1.636 . . . . 0.72 115.418 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.18 -89.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.907 2.083 . . . . 3.43 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -80.27 80.12 6.74 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.385 -1.447 . . . . 3.55 109.62 -173.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.59 131.7 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 128.146 2.579 . . . . 1.5 112.269 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.51 132.07 30.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.487 1.915 . . . . 2.48 110.27 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.14 121.74 26.49 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 121.278 1.854 . . . . 0.72 111.64 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.2 m170 -107.92 154.3 21.8 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.548 1.939 . . . . 0.49 112.975 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -109.99 166.33 11.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 2.39 110.699 166.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.3 m -115.21 117.83 31.6 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.563 1.945 . . . . 1.4 107.114 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -126.26 154.44 43.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.343 1.057 . . . . 2.37 112.699 -168.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.4 mtt -92.63 153.77 18.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.657 -1.156 . . . . 2.67 111.339 166.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -153.17 137.77 16.87 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.647 0.779 . . . . 6.0 112.706 159.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.14 151.03 16.18 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.853 1.661 . . . . 4.59 110.269 160.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.818 HG13 ' H ' ' A' ' 54' ' ' GLU 0.298 11.8 p -158.03 -88.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 126.249 1.82 . . . . 2.9 110.287 175.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.818 ' H ' HG13 ' A' ' 53' ' ' VAL . 20.6 tt0 -78.58 47.72 0.74 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.296 2.239 . . . . 3.72 110.296 168.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.48 -43.78 0.91 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 127.595 2.522 . . . . 2.24 113.912 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -77.83 152.9 33.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.974 2.11 . . . . 3.4 113.178 -173.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.37 107.08 18.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.91 0.484 . . . . 4.55 112.069 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -80.95 142.03 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.886 1.275 . . . . 1.61 109.017 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.11 133.95 50.01 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.912 1.685 . . . . 4.58 110.622 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 -179.2 30.23 Favored Glycine 0 N--CA 1.472 1.09 0 C-N-CA 124.226 0.917 . . . . 1.56 113.079 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.48 160.53 19.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.802 1.241 . . . . 2.45 112.138 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.16 149.96 2.29 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.505 1.522 . . . . 3.69 112.652 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 28.2 Cg_endo -71.6 141.52 38.22 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.097 2.532 . . . . 0.63 113.275 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -110.82 156.07 41.31 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.892 1.677 . . . . 0.66 109.798 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.2 -13.31 30.95 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.899 2.4 . . . . 0.72 113.292 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.7 p90 178.63 168.34 0.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.005 2.122 . . . . 1.79 110.301 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.16 169.43 9.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.189 1.795 . . . . 0.73 109.104 157.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.5 159.0 39.41 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.141 -0.974 . . . . 2.57 111.655 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.27 126.81 9.21 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.506 1.122 . . . . 0.81 110.133 -163.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.76 161.34 44.1 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.308 2.005 . . . . 0.74 111.712 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.11 139.29 86.73 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.89 3.06 . . . . 0.78 112.865 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm 67.34 -1.2 1.59 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.958 2.103 . . . . 1.38 113.647 -173.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.79 119.64 4.93 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 126.615 2.055 . . . . 0.82 111.279 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -84.22 142.79 30.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.316 1.046 . . . . 5.41 110.722 156.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 m -148.48 147.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.518 1.927 . . . . 1.22 110.218 168.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.91 123.93 46.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.315 1.055 . . . . 3.09 112.327 170.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.46 85.88 0.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.799 1.239 . . . . 1.9 107.716 158.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -100.41 160.65 26.39 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.055 2.542 . . . . 3.18 113.279 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -58.56 -55.31 2.17 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.554 2.836 . . . . 1.4 112.664 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.92 65.53 3.73 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 110.884 -0.886 . . . . 1.62 110.884 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.94 -108.37 0.28 Allowed Glycine 0 N--CA 1.468 0.816 0 C-N-CA 124.616 1.103 . . . . 1.56 113.005 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -130.84 143.19 50.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.002 1.401 . . . . 2.16 111.029 -172.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -170.21 163.37 8.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 120.995 -1.066 . . . . 1.59 109.935 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -88.23 133.31 34.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.678 -0.677 . . . . 2.46 110.29 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.1 mmt -84.13 136.36 34.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.78 0.832 . . . . 0.85 110.196 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.42 75.67 0.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.578 1.551 . . . . 1.73 109.164 -170.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.39 116.04 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.245 -1.02 . . . . 3.27 108.245 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.98 96.69 0.4 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.291 -1.123 . . . . 2.85 110.291 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.1 119.52 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.291 -1.374 . . . . 1.33 107.291 167.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.79 4.76 23.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.798 -1.189 . . . . 1.79 112.833 -164.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.546 HH11 HG12 ' A' ' 39' ' ' VAL . 9.4 ptm180 -167.66 152.69 6.76 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.739 2.016 . . . . 5.21 109.595 -172.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.19 151.94 82.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.46 -1.4 . . . . 1.77 108.46 161.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.63 162.43 41.0 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.627 1.971 . . . . 2.63 108.64 -164.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -154.19 162.6 41.08 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.896 1.813 . . . . 4.2 115.896 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.57 133.21 48.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 1.89 107.989 157.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.57 13.81 62.54 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.956 -0.914 . . . . 2.16 113.493 -162.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.0 169.24 9.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.689 1.245 . . . . 3.11 107.868 151.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -136.72 150.35 48.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.523 1.929 . . . . 3.67 107.805 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.47 103.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 124.788 1.235 . . . . 0.89 108.384 -168.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -59.82 134.04 56.66 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 125.1 1.5 . . . . 4.14 108.46 154.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.94 130.37 23.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.855 1.662 . . . . 1.45 109.579 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' CG ' ' HZ3' ' A' ' 112' ' ' LYS . 5.0 m-20 -103.5 92.23 4.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.994 1.718 . . . . 2.4 109.063 -175.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.7 mt -77.68 112.33 14.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.893 1.677 . . . . 1.31 110.226 -172.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -86.5 128.07 34.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.805 0.842 . . . . 0.69 111.475 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.29 142.87 50.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.687 0.795 . . . . 2.01 113.003 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.59 133.05 30.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.528 1.531 . . . . 1.87 114.292 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.11 -142.93 23.61 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.777 -1.329 . . . . 3.61 109.777 -162.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.46 71.12 0.25 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.979 0.8 . . . . 1.73 112.951 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -131.0 148.59 52.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.701 1.25 . . . . 5.03 111.416 168.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.82 139.73 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.639 1.575 . . . . 0.93 109.235 170.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.71 145.71 48.79 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.424 1.09 . . . . 1.38 110.378 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HZ3' ' CG ' ' A' ' 102' ' ' ASP . 17.2 mtpp -112.83 143.71 43.61 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.079 0.952 . . . . 2.6 112.323 -169.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -158.64 125.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.326 1.45 . . . . 1.42 109.689 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.0 p -92.29 121.72 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.338 1.055 . . . . 1.91 109.142 170.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.04 143.28 48.34 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.293 1.437 . . . . 2.22 111.634 -171.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.36 150.22 70.4 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.373 2.715 . . . . 1.04 112.992 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.13 127.02 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.464 0.705 . . . . 1.24 110.256 171.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.85 142.4 27.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.274 2.23 . . . . 5.08 108.411 163.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.33 134.61 12.38 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.515 0.561 . . . . 2.38 112.515 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 116.179 -1.867 . . . . 9.03 113.492 164.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 111.632 0.234 . . . . 5.15 111.632 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.85 169.54 40.21 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 120.941 -1.1 . . . . 1.28 114.781 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.42 152.18 19.89 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.14 0.793 . . . . 1.71 113.14 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.78 124.2 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.452 -0.944 . . . . 0.89 108.452 163.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -83.34 109.17 17.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.177 0.991 . . . . 5.43 108.655 167.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.48 ' HB2' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.1 -179.31 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.841 1.052 . . . . 2.63 113.841 -173.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m -168.48 167.56 6.17 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.572 1.949 . . . . 1.85 109.198 162.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.15 -26.78 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.039 2.493 . . . . 2.57 112.105 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.2 177.96 15.72 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.384 1.468 . . . . 1.61 112.668 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.02 -15.8 19.87 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 118.69 1.245 . . . . 1.75 113.247 -1.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -129.15 164.98 22.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.631 1.572 . . . . 2.11 112.77 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.97 163.4 30.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.391 2.276 . . . . 0.99 109.883 171.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.98 145.44 38.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.33 1.052 . . . . 0.89 110.876 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.67 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.317 0.858 . . . . 0.81 113.317 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -145.78 158.44 43.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.998 1.719 . . . . 1.98 110.844 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.7 152.31 13.71 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.497 1.119 . . . . 1.78 111.395 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 m -79.57 149.74 31.3 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.594 1.558 . . . . 1.67 108.065 155.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -155.7 134.44 11.9 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.916 1.287 . . . . 2.9 108.902 173.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.62 119.05 27.91 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.895 1.278 . . . . 4.32 109.693 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -77.42 117.01 62.63 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 1.44 109.939 173.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.32 -11.12 8.58 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.042 2.495 . . . . 1.56 113.825 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.72 163.93 54.74 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 119.025 0.83 . . . . 1.59 113.521 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.439 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.4 m-20 -91.87 -1.7 57.19 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.275 1.83 . . . . 3.54 112.634 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.28 159.74 40.32 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.311 1.844 . . . . 1.67 110.856 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.03 159.09 23.92 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.042 2.495 . . . . 1.14 111.41 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.72 156.48 17.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.857 0.837 . . . . 2.69 110.537 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -129.54 120.32 25.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.086 1.355 . . . . 5.29 108.308 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -101.16 118.52 37.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.839 1.655 . . . . 1.1 108.541 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.77 -11.18 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.289 1.036 . . . . 0.71 113.346 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.92 -170.78 43.7 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.601 1.096 . . . . 0.65 111.314 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 149.99 25.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 1.73 111.809 166.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -118.3 139.76 50.85 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.848 -1.158 . . . . 5.51 110.065 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -140.94 152.25 64.79 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.629 1.172 . . . . 0.87 110.083 -171.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.65 -26.67 83.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.239 1.959 . . . . 1.11 113.978 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.566 HG21 HD21 ' A' ' 93' ' ' LEU . 1.9 m -88.38 -7.9 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 114.991 1.478 . . . . 1.4 114.991 -170.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.55 168.96 21.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.9 0.88 . . . . 1.07 113.349 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.84 -73.89 0.63 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.586 0.354 . . . . 4.22 111.036 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -68.39 139.89 55.82 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.721 -1.237 . . . . 2.78 109.298 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.55 139.85 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 125.242 1.417 . . . . 2.19 108.336 162.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -129.95 117.34 19.95 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.465 1.106 . . . . 2.08 108.682 164.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -77.21 120.85 22.84 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.743 0.782 . . . . 0.91 109.253 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -106.77 151.05 25.67 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.414 1.486 . . . . 0.67 112.681 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -95.78 160.59 14.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.782 2.033 . . . . 1.98 110.151 164.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.3 m -131.44 108.74 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.464 1.905 . . . . 1.13 107.127 166.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -109.85 160.31 16.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 2.45 112.232 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -113.06 139.34 48.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.083 0.953 . . . . 2.59 110.115 157.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -151.56 150.94 30.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.107 1.363 . . . . 6.29 111.985 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.68 144.34 52.28 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.835 0.854 . . . . 4.22 110.74 154.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -154.58 -39.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 114.718 1.377 . . . . 3.87 114.718 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 3.7 tm-20 -112.28 38.21 2.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.667 1.987 . . . . 4.21 109.205 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.67 -35.03 0.59 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.204 1.383 . . . . 3.4 113.445 -164.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 16.0 mtmt -92.7 160.22 15.08 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.722 2.409 . . . . 4.1 111.037 175.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -74.27 142.28 45.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.48 0.919 . . . . 3.86 113.48 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.59 158.03 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 127.792 2.437 . . . . 2.47 108.09 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.2 mtm -111.08 152.82 26.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 3.21 112.535 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.76 177.1 41.08 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 123.716 0.674 . . . . 1.14 113.468 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -124.45 161.01 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.692 1.197 . . . . 1.85 111.646 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -158.61 151.65 18.52 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 126.806 2.042 . . . . 5.08 109.447 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.57 142.41 71.05 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 CA-C-N 121.375 1.527 . . . . 0.67 110.672 154.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -104.23 155.31 37.4 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.739 1.216 . . . . 0.62 110.76 168.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.19 -19.46 56.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.76 112.641 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -177.63 165.55 2.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.243 2.217 . . . . 1.9 110.617 175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -105.91 170.56 7.83 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.828 1.251 . . . . 0.9 110.05 153.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -143.08 169.71 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.326 0.65 . . . . 2.53 110.811 171.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -146.91 133.16 9.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 107.926 -1.139 . . . . 1.03 107.926 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.01 167.57 25.67 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.127 1.218 . . . . 1.19 111.319 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.99 140.98 87.6 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.32 2.68 . . . . 1.3 110.952 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 59.3 mmtt 66.07 4.01 2.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.146 1.379 . . . . 1.79 113.074 -173.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.88 114.05 3.96 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 127.129 2.3 . . . . 1.47 113.06 -169.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -75.86 132.16 40.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.028 -1.586 . . . . 4.77 110.076 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.93 164.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.119 2.168 . . . . 1.58 109.428 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.97 117.89 0.91 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.024 0.929 . . . . 3.44 109.574 -171.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -74.96 64.3 1.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.762 2.025 . . . . 1.65 111.615 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -63.42 133.35 95.46 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.791 -1.193 . . . . 3.2 110.789 167.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.49 -20.91 66.32 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.339 2.692 . . . . 1.78 113.76 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.21 55.98 5.05 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.081 0.848 . . . . 1.49 111.23 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.46 -64.49 0.13 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.635 1.112 . . . . 1.35 113.998 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -153.85 145.0 22.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.64 1.576 . . . . 1.99 111.254 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -166.06 163.73 18.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.296 1.038 . . . . 1.12 111.169 -174.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -107.73 127.02 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.069 0.548 . . . . 2.11 111.065 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -90.69 108.41 19.8 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.265 1.426 . . . . 1.19 110.142 164.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.39 130.76 37.98 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.144 0.978 . . . . 3.4 108.772 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.82 150.62 51.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.265 1.426 . . . . 1.88 110.781 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.35 53.31 5.19 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.979 -0.848 . . . . 2.99 110.979 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.6 mt -68.95 114.04 6.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.883 0.842 . . . . 0.97 109.555 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -98.96 -0.1 42.86 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.866 1.266 . . . . 2.02 111.961 -166.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -157.04 148.84 17.3 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.526 1.93 . . . . 6.05 108.7 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.44 156.38 54.43 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.363 2.042 . . . . 1.84 109.624 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 39' ' ' VAL . 4.2 mp -103.11 155.56 18.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.573 1.178 . . . . 3.16 112.139 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -120.53 123.58 43.25 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.099 2.16 . . . . 4.8 109.392 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 131.58 50.82 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.151 -0.968 . . . . 1.9 111.586 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.08 44.06 78.71 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.16 -0.8 . . . . 1.78 112.669 -172.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.95 -178.07 3.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.741 -1.207 . . . . 3.04 107.741 151.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -127.0 161.29 28.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.472 1.109 . . . . 3.77 109.543 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.8 t -126.22 120.78 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 124.615 1.166 . . . . 1.07 109.816 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -68.89 119.23 12.89 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 124.488 1.117 . . . . 2.76 108.619 154.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.99 120.81 40.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.735 0.779 . . . . 1.72 109.055 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.9 93.66 8.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.762 -1.563 . . . . 2.43 107.964 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.05 119.45 11.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.685 -0.857 . . . . 1.2 108.685 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.8 mt -90.92 120.59 32.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.665 -0.865 . . . . 0.64 108.665 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 88.6 m-85 -116.12 131.18 57.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.069 0.938 . . . . 2.14 112.343 -176.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.61 -18.51 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 131.014 3.726 . . . . 3.76 116.932 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.81 -22.42 0.71 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.345 1.926 . . . . 5.8 113.721 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.01 -6.56 0.06 OUTLIER Glycine 0 N--CA 1.474 1.204 0 N-CA-C 117.362 1.705 . . . . 3.81 117.362 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -79.74 101.0 8.18 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 120.384 2.092 . . . . 4.87 109.582 175.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.21 138.44 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.729 1.212 . . . . 1.61 110.041 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.53 136.55 33.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.36 1.064 . . . . 1.87 111.748 166.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.45 125.41 25.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.975 0.51 . . . . 2.12 111.967 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -101.54 154.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.946 -0.761 . . . . 1.82 108.946 142.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.8 p -118.99 139.8 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.062 -1.088 . . . . 2.11 108.062 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -162.55 155.57 16.9 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.022 1.729 . . . . 2.64 110.127 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.93 160.12 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.389 3.393 . . . . 1.01 115.04 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.3 t -87.6 122.59 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.697 1.199 . . . . 0.94 110.058 164.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -92.64 131.17 37.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.729 2.011 . . . . 3.82 107.554 161.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.21 116.17 5.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.308 0.643 . . . . 3.41 111.431 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 129.3 3.04 . . . . 7.41 107.208 176.68 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 110.122 -0.325 . . . . 5.16 110.122 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.94 154.82 18.24 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 120.885 -1.135 . . . . 1.06 112.684 166.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -158.3 145.09 17.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.476 1.111 . . . . 1.33 111.675 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -97.33 137.16 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.791 -0.818 . . . . 1.15 108.791 171.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.28 92.32 4.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.921 1.289 . . . . 3.46 109.536 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.18 159.67 9.4 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 123.548 1.642 . . . . 2.08 112.383 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -162.85 154.69 15.4 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 129.08 2.952 . . . . 2.23 106.54 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 39.06 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.058 3.172 . . . . 1.97 112.418 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.23 178.79 51.42 Favored Glycine 0 CA--C 1.541 1.668 0 O-C-N 121.206 -0.934 . . . . 2.3 112.173 -156.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.82 -12.23 23.54 Favored 'Cis proline' 0 CA--C 1.54 0.798 0 CA-C-N 118.435 1.118 . . . . 2.73 112.457 -11.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -155.7 168.54 26.84 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.411 1.884 . . . . 2.25 110.997 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.61 -177.15 4.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 0.86 111.042 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.24 152.67 47.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.224 1.01 . . . . 0.99 112.506 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.01 140.32 52.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.166 0.986 . . . . 0.97 111.858 167.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -128.19 152.0 48.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.499 1.92 . . . . 2.08 110.517 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pp -165.11 133.51 3.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.938 1.829 . . . . 1.75 115.938 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 m -76.81 139.02 40.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.143 -1.39 . . . . 1.11 108.685 156.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.25 145.07 16.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 2.76 108.257 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.43 144.94 49.18 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.518 0.599 . . . . 3.34 111.502 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -86.9 109.58 25.68 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 108.621 -0.881 . . . . 1.25 108.621 155.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.05 -14.07 5.24 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.965 1.777 . . . . 1.16 114.411 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.27 -153.98 24.16 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.63 1.012 . . . . 1.46 115.63 -159.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -93.74 -32.03 14.18 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.138 2.575 . . . . 5.82 113.932 -173.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.12 158.83 36.91 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.375 1.47 . . . . 1.66 112.052 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.85 155.33 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.798 2.332 . . . . 1.28 111.786 -170.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.91 132.52 56.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.142 1.377 . . . . 2.46 109.138 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -125.98 106.54 9.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.297 1.039 . . . . 4.89 111.937 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.7 tp -92.21 112.51 24.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.463 2.305 . . . . 0.9 109.651 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.02 -7.4 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.155 1.382 . . . . 0.76 113.277 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.94 -167.09 38.67 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 121.458 -0.776 . . . . 0.62 112.247 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.34 175.29 10.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.107 0.563 . . . . 0.8 111.9 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -156.31 91.27 1.24 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.221 -1.77 . . . . 6.65 106.221 -164.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -104.7 152.85 39.54 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.116 1.366 . . . . 0.86 110.59 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -27.55 16.28 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.394 2.729 . . . . 1.08 113.531 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.31 1.7 m -89.93 -0.11 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 114.355 1.243 . . . . 0.91 114.355 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.96 140.66 50.88 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.876 0.871 . . . . 0.81 112.24 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -72.48 -68.89 0.44 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.173 -1.047 . . . . 5.54 108.173 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -90.09 149.25 22.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.442 2.297 . . . . 3.02 109.653 168.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.23 139.66 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.545 1.538 . . . . 1.5 109.548 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -142.17 140.82 32.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.906 1.682 . . . . 2.03 110.521 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -81.79 122.5 27.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.515 1.052 . . . . 0.92 111.346 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.9 m170 -111.74 156.9 21.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.561 1.544 . . . . 0.6 112.553 174.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.95 -179.64 4.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.228 2.211 . . . . 1.82 111.112 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.5 m -126.85 114.29 17.71 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.808 -1.553 . . . . 1.42 106.808 151.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -89.5 152.15 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 2.35 111.025 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.1 ptp -101.24 144.88 29.55 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.499 -0.773 . . . . 3.54 110.133 155.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.4 158.79 34.88 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.216 1.806 . . . . 7.25 109.468 171.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.37 148.95 22.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.585 -0.895 . . . . 3.88 108.585 167.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.96 -79.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.649 0.737 . . . . 2.91 110.372 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -76.19 35.18 0.14 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.445 2.298 . . . . 4.64 111.651 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.33 -12.37 0.94 Allowed Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.289 -1.507 . . . . 2.0 113.744 -161.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -106.78 154.34 21.14 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 128.032 2.533 . . . . 4.09 109.736 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -70.14 137.49 51.11 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.696 0.399 . . . . 3.84 110.868 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.71 148.69 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.482 1.913 . . . . 2.0 108.402 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 19.8 mmt -115.5 142.04 47.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.697 1.199 . . . . 4.27 109.351 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.82 151.76 23.37 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.283 0.947 . . . . 1.24 114.19 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -93.64 159.27 15.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.147 0.979 . . . . 2.19 111.833 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -173.41 140.21 0.86 Allowed Pre-proline 0 N--CA 1.473 0.692 0 CA-C-O 116.67 -1.633 . . . . 3.58 110.246 -168.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.0 OUTLIER -70.63 148.76 60.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.363 1.88 . . . . 0.93 111.378 170.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.86 151.9 74.47 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 125.254 1.422 . . . . 0.69 110.206 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.06 -13.65 26.12 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.938 2.425 . . . . 1.0 113.777 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -175.03 164.71 3.4 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.8 1.24 . . . . 2.08 111.572 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -121.64 170.25 9.9 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 127.404 2.282 . . . . 0.76 108.915 152.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.57 172.43 18.57 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.244 -0.91 . . . . 2.23 110.804 169.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.9 t -147.55 122.57 5.18 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 125.161 1.385 . . . . 1.05 109.664 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.11 159.66 51.55 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.947 1.765 . . . . 1.3 110.656 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.3 139.11 88.45 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.872 3.048 . . . . 1.15 111.588 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.07 -8.32 1.32 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.252 2.221 . . . . 3.24 115.088 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.08 129.03 8.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 126.525 2.012 . . . . 1.13 110.283 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -87.65 148.16 24.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.556 -0.822 . . . . 4.8 112.411 163.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.99 167.02 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.653 1.581 . . . . 2.3 110.788 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -154.23 85.28 1.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.845 1.658 . . . . 3.04 107.0 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.83 68.87 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.894 1.678 . . . . 1.61 112.055 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -72.36 151.45 92.01 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.497 2.719 . . . . 3.29 113.658 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.45 -58.91 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.752 2.968 . . . . 1.63 112.614 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.85 83.3 1.16 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.389 -1.484 . . . . 1.5 109.389 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.6 -97.18 0.16 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 125.274 1.416 . . . . 1.3 111.492 -166.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -151.65 134.23 15.47 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.658 1.583 . . . . 2.03 109.455 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -163.53 175.73 10.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.724 1.147 . . . . 1.04 110.647 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -108.65 125.81 52.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.128 0.571 . . . . 2.26 110.497 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -85.57 144.46 27.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.334 1.054 . . . . 1.02 110.273 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -124.18 138.9 54.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.418 1.887 . . . . 1.92 109.543 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.69 157.22 46.12 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.153 0.981 . . . . 2.25 112.106 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.26 -54.78 3.59 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 126.343 1.925 . . . . 2.86 114.732 167.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.8 mt 76.81 95.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 130.305 3.442 . . . . 1.2 113.037 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -78.62 -0.97 31.97 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.834 1.42 . . . . 2.47 114.834 -172.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -144.3 145.66 30.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 127.136 2.174 . . . . 5.34 108.206 172.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.31 115.67 4.38 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.19 1.26 . . . . 2.47 110.174 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.72 151.69 23.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 112.869 -1.969 . . . . 2.68 109.913 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -144.82 -7.84 0.65 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 117.121 2.267 . . . . 5.16 117.121 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.67 170.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.103 2.561 . . . . 2.2 112.972 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.51 34.51 53.97 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.253 -0.748 . . . . 1.69 111.681 -164.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.32 174.01 13.82 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 127.224 2.21 . . . . 3.37 109.694 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 164.18 14.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.021 2.128 . . . . 4.0 111.696 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.2 t -133.86 108.38 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.593 1.157 . . . . 0.95 109.455 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -71.34 98.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.979 -1.119 . . . . 3.64 107.979 159.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 tt -98.74 138.61 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.697 -0.853 . . . . 1.91 108.697 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.01 138.6 31.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 3.77 112.053 168.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.38 122.74 43.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.457 2.303 . . . . 1.31 109.075 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.6 mt -92.89 119.73 32.5 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.136 0.974 . . . . 0.9 109.935 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -115.57 150.52 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.943 0.877 . . . . 2.21 113.254 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 162.83 28.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.996 -0.547 . . . . 2.19 111.332 165.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 20.4 79.55 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.263 -0.743 . . . . 4.68 114.266 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.52 61.28 2.8 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 118.61 1.205 . . . . 2.43 112.319 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 154.76 43.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.071 2.148 . . . . 4.06 110.115 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -168.66 140.83 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.392 2.277 . . . . 1.57 107.407 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.8 mt -150.21 109.61 3.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.187 0.903 . . . . 1.45 111.175 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -81.7 111.6 18.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.284 0.634 . . . . 2.85 110.769 173.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -117.0 141.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.188 1.795 . . . . 1.61 110.427 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.83 116.16 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.049 0.939 . . . . 1.79 112.227 -173.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.8 150.57 46.02 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.573 1.549 . . . . 3.24 110.018 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.11 159.91 26.75 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.074 3.183 . . . . 1.05 111.954 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 130.59 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.086 0.955 . . . . 1.36 111.342 169.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -97.96 139.65 33.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.832 2.453 . . . . 3.24 107.48 159.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.05 9.31 32.49 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.345 1.98 . . . . 2.26 116.345 -162.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.785 0 C-N-CA 126.956 2.102 . . . . 6.68 110.133 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 . . . . . 0 CA--C 1.547 0.853 0 CA-C-O 120.444 0.164 . . . . 5.34 110.692 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.81 163.1 12.86 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.714 1.149 . . . . 1.33 115.277 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -151.37 149.46 29.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.4 1.08 . . . . 1.67 113.228 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.49 121.55 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.405 0.682 . . . . 0.9 110.118 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -86.69 90.43 8.27 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.027 0.931 . . . . 5.6 110.754 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.03 149.33 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.246 1.418 . . . . 2.6 112.054 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.0 m -155.59 162.54 27.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.774 2.029 . . . . 2.17 109.724 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.03 -5.87 13.87 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.522 2.814 . . . . 2.05 113.582 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 170.29 31.99 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.517 1.056 . . . . 1.81 113.328 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.84 -2.29 21.84 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 117.951 0.875 . . . . 1.87 113.272 -4.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.73 152.85 33.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.43 1.092 . . . . 2.99 112.595 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.89 175.1 14.38 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.377 1.871 . . . . 0.72 111.318 166.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.61 156.23 36.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.846 0.858 . . . . 0.81 110.73 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.5 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.747 0.784 . . . . 0.61 111.311 162.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.52 143.28 49.82 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.947 1.699 . . . . 2.27 108.3 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.02 144.78 23.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 120.687 -1.258 . . . . 1.68 113.985 174.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -92.39 111.48 23.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.913 -1.494 . . . . 1.27 107.35 170.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.1 tt -120.16 147.18 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.873 2.469 . . . . 3.02 109.126 -174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -142.71 152.43 42.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.16 0.981 . . . . 2.75 113.418 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -100.14 102.39 17.84 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 113.976 -1.465 . . . . 1.13 109.269 171.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.88 -9.93 16.84 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.811 2.341 . . . . 1.18 113.041 174.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.84 -179.12 52.78 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 124.55 1.071 . . . . 1.12 113.464 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.73 -2.73 19.8 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.182 1.793 . . . . 3.15 112.965 -172.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.25 160.66 40.52 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.479 1.911 . . . . 1.4 109.873 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.41 156.47 32.68 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.47 2.113 . . . . 0.75 111.884 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.13 120.02 36.5 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.991 1.316 . . . . 2.47 110.05 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -106.89 103.72 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.936 1.294 . . . . 5.07 111.609 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.22 114.45 26.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.858 2.063 . . . . 0.82 109.282 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 m -92.21 -23.48 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.486 0.714 . . . . 0.89 112.554 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.77 -168.64 40.24 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 123.751 0.691 . . . . 0.54 111.529 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' CD2' ' A' ' 101' ' ' LEU . . . -150.93 175.07 12.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.506 -0.759 . . . . 1.38 111.019 169.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 2.4 mmt85 -154.96 157.69 38.09 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.101 1.319 . . . . 6.99 111.96 -167.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 t -161.18 154.88 18.49 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 124.843 1.257 . . . . 0.83 110.226 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -68.21 -17.42 45.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.995 1.797 . . . . 1.0 113.074 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 1.5 m -86.22 11.74 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.123 1.157 . . . . 1.04 114.123 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.62 162.18 40.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.747 1.219 . . . . 0.77 111.917 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.9 -75.68 0.62 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.482 -0.562 . . . . 3.31 109.482 170.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -75.31 146.0 41.34 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.763 -1.199 . . . . 4.04 107.763 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -165.12 137.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.029 1.332 . . . . 1.41 108.58 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -142.64 136.28 28.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.733 1.213 . . . . 1.99 110.547 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -79.97 120.15 23.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.568 0.699 . . . . 0.79 109.635 163.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -104.27 152.75 21.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.032 1.333 . . . . 0.57 111.327 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -106.54 163.67 12.69 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.562 1.945 . . . . 2.51 110.016 163.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.6 m -152.2 113.71 4.33 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.104 1.362 . . . . 1.67 108.403 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -131.77 151.65 51.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.689 1.196 . . . . 2.61 112.343 -160.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.32 154.33 25.35 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.151 0.98 . . . . 4.12 112.262 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -156.05 160.23 39.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.23 1.012 . . . . 5.94 111.516 172.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.12 155.21 16.92 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.975 1.31 . . . . 5.21 109.658 162.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.29 113.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 124.99 1.431 . . . . 3.37 111.175 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 60.53 17.41 7.32 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.032 0.933 . . . . 4.39 112.345 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.85 4.91 89.62 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.239 -1.538 . . . . 3.46 114.267 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.43 128.75 34.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.722 1.609 . . . . 2.97 109.795 168.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.05 134.75 51.16 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.252 -0.905 . . . . 6.14 109.699 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.56 165.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.881 0.872 . . . . 3.15 110.829 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.6 ptp -130.24 148.81 52.11 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.25 1.02 . . . . 3.68 111.649 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 164.83 15.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.005 1.288 . . . . 2.14 111.716 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.31 157.21 46.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 2.71 110.609 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -160.77 137.15 6.3 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 116.153 -1.879 . . . . 4.4 108.99 -173.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.34 146.36 85.6 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.971 1.74 . . . . 0.87 110.403 151.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.98 155.96 52.54 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.853 1.261 . . . . 0.99 110.538 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.14 -14.59 25.91 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.005 2.47 . . . . 1.37 113.095 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -176.18 165.96 2.86 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.492 1.917 . . . . 2.69 112.292 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -117.59 176.0 5.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.459 2.304 . . . . 1.1 109.022 154.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.83 168.92 23.57 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.883 -1.135 . . . . 2.68 112.217 163.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.8 t -140.72 130.83 13.37 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.222 1.009 . . . . 0.83 109.446 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.61 162.67 38.19 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.473 2.115 . . . . 0.89 111.206 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.6 143.67 99.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.162 2.575 . . . . 1.01 111.638 176.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 66.93 1.45 2.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.614 1.966 . . . . 1.56 113.752 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.4 119.69 4.97 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 126.94 2.21 . . . . 1.03 111.164 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 135.21 36.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.77 1.228 . . . . 3.91 111.147 160.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.96 152.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.024 1.729 . . . . 1.38 110.77 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.55 120.56 32.32 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.85 1.66 . . . . 4.68 109.075 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.34 69.24 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.251 1.5 . . . . 1.36 112.973 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.49 133.6 53.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.405 1.882 . . . . 3.03 113.368 169.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -56.34 -44.96 41.2 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.411 2.074 . . . . 1.9 111.201 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.69 2.4 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.948 1.261 . . . . 1.4 111.65 167.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -74.24 0.2 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.756 2.122 . . . . 1.59 112.271 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -151.87 132.74 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.35 1.46 . . . . 2.33 111.574 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -158.89 176.76 11.92 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.679 -1.263 . . . . 0.88 111.357 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -111.93 130.46 55.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 112.359 0.503 . . . . 2.17 112.359 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -94.3 130.11 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.836 1.255 . . . . 0.94 111.066 165.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.0 mt -109.83 132.74 53.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.797 1.639 . . . . 1.85 109.001 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.02 150.49 49.23 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.32 1.057 . . . . 1.65 112.969 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.92 -61.96 4.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.517 1.056 . . . . 2.68 110.979 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mt 68.42 88.56 0.11 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 129.925 3.29 . . . . 0.89 110.42 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -74.86 -3.81 34.16 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.131 -0.981 . . . . 1.97 113.281 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -145.56 144.39 22.61 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 127.809 2.444 . . . . 4.55 107.768 168.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.71 173.2 14.49 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.649 2.233 . . . . 1.97 110.186 157.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.3 172.01 10.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.516 1.926 . . . . 4.25 108.149 166.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -126.79 1.9 6.71 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.828 1.788 . . . . 3.88 115.828 174.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 76.38 158.43 0.2 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.785 2.834 . . . . 1.56 110.922 -167.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 55.8 6.83 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 121.532 -0.73 . . . . 1.75 111.626 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.92 176.9 11.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.302 2.241 . . . . 3.58 109.494 173.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.66 171.76 7.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.858 1.263 . . . . 4.25 109.804 166.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.7 t -128.8 125.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.825 1.65 . . . . 0.87 107.376 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -77.68 140.95 39.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.474 0.484 . . . . 3.17 109.81 166.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.536 ' CD2' ' HB1' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -147.71 126.6 12.73 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.856 1.058 . . . . 1.29 113.856 -168.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.82 102.21 14.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.742 2.417 . . . . 2.68 111.314 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.3 mt -78.58 111.91 15.13 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.926 -1.109 . . . . 1.64 111.166 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -90.8 122.38 33.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.884 1.274 . . . . 0.78 112.01 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.46 134.94 55.08 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.011 -1.056 . . . . 1.97 113.597 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.03 -28.03 69.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.896 1.278 . . . . 2.44 113.605 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 31.25 1.09 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.73 1.157 . . . . 4.21 114.366 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.75 44.76 88.61 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.913 1.244 . . . . 1.78 112.628 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 150.22 45.66 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.394 1.478 . . . . 4.37 111.283 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.83 137.28 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.048 -1.464 . . . . 1.49 107.048 155.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.4 mt -120.2 104.94 10.49 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 107.897 -1.149 . . . . 1.78 107.897 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -84.15 128.49 34.6 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.881 -0.512 . . . . 3.02 110.99 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.02 149.93 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.619 1.568 . . . . 2.39 110.637 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.62 150.85 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.62 1.168 . . . . 3.1 111.121 171.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -149.36 150.1 30.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.258 1.823 . . . . 2.03 109.577 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.37 156.22 54.88 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.299 3.333 . . . . 1.51 114.054 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 69.1 t -87.22 145.9 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.379 1.072 . . . . 1.87 111.882 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.25 152.52 51.3 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.378 3.471 . . . . 3.85 107.065 176.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.87 168.58 19.44 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.251 1.575 . . . . 2.31 115.251 -152.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 C-N-CA 128.006 2.523 . . . . 10.02 110.718 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 CA--C 1.545 0.761 0 CA-C-O 121.456 0.646 . . . . 5.52 111.067 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -124.42 146.77 16.36 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.323 1.439 . . . . 1.38 113.244 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -137.31 141.48 41.89 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.591 0.96 . . . . 1.3 113.591 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.8 t -95.47 107.95 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.709 0.804 . . . . 0.94 109.48 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -88.92 111.72 22.44 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.492 1.042 . . . . 3.89 111.027 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.26 168.92 18.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.399 1.48 . . . . 2.64 112.844 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -160.98 158.3 23.91 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.267 1.827 . . . . 1.88 110.212 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.69 6.65 3.96 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.027 3.151 . . . . 1.51 114.022 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.07 166.98 29.16 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.363 0.982 . . . . 1.42 112.367 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.11 -2.27 22.87 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 CA-C-N 118.359 1.079 . . . . 1.52 112.724 -5.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -136.61 169.66 17.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.29 1.436 . . . . 2.08 113.54 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.46 171.04 21.08 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.134 1.774 . . . . 0.78 112.372 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.55 101.88 6.37 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.199 0.999 . . . . 1.37 112.845 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.6 139.08 31.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.88 0.696 . . . . 0.8 112.88 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.12 156.47 28.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.389 . . . . 2.18 111.0 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.503 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -160.77 146.02 14.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.732 1.753 . . . . 1.53 115.732 166.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 m -79.66 126.9 31.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.461 -0.94 . . . . 1.15 108.461 158.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -130.22 138.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.855 1.662 . . . . 2.82 110.215 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.09 160.22 39.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.84 0.829 . . . . 2.74 113.07 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.19 94.28 47.14 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.507 1.523 . . . . 1.01 109.999 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.98 -5.01 15.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.938 1.759 . . . . 1.13 112.769 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.14 156.31 37.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.33 0.967 . . . . 1.14 113.085 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.3 m-20 -91.91 4.73 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.456 1.902 . . . . 2.98 113.668 -171.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.84 159.07 42.16 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.859 1.663 . . . . 1.3 110.506 168.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.09 154.24 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.14 2.56 . . . . 0.65 111.286 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.74 155.09 20.58 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.042 0.937 . . . . 1.86 111.104 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.402 HH21 ' CD ' ' A' ' 68' ' ' GLU . 19.5 ttm180 -133.47 112.34 11.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.042 1.337 . . . . 4.08 109.012 168.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.6 tp -93.93 110.47 22.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.759 2.024 . . . . 0.76 108.051 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -102.06 -13.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.277 0.843 . . . . 0.56 113.277 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -160.72 29.53 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.117 0.865 . . . . 0.46 112.76 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.59 174.4 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.788 1.235 . . . . 0.8 111.229 166.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -141.99 135.89 29.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.458 1.503 . . . . 5.46 109.279 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -145.09 147.65 35.36 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 119.594 1.088 . . . . 0.7 110.643 -171.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.29 -0.39 10.0 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.5 2.8 . . . . 1.07 113.92 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 93' ' ' LEU . 1.7 m -107.08 13.28 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.781 1.232 . . . . 1.0 114.093 174.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.34 157.04 43.75 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.431 -1.418 . . . . 1.03 111.667 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -105.35 -70.49 0.78 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.733 -0.84 . . . . 3.95 108.733 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -79.22 146.85 32.83 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.969 -1.123 . . . . 3.75 107.969 161.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -147.09 137.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.097 1.359 . . . . 1.3 108.713 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -128.45 133.76 48.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.701 2.0 . . . . 2.33 108.565 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -82.82 123.34 29.26 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.839 1.199 . . . . 0.84 110.28 167.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 15.3 m170 -109.1 154.96 21.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.387 1.475 . . . . 0.65 111.913 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -109.49 -179.14 3.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.594 1.958 . . . . 2.38 110.923 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.7 m -133.63 114.34 13.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.497 1.519 . . . . 1.24 108.013 164.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -100.72 151.96 21.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.369 1.068 . . . . 1.9 111.712 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -83.96 149.63 26.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.814 0.846 . . . . 4.36 111.082 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -154.66 135.9 14.01 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.779 0.832 . . . . 5.48 110.844 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.91 146.57 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.051 -0.722 . . . . 4.9 109.051 157.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -152.6 123.61 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.329 1.452 . . . . 3.23 108.586 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 50.11 38.33 16.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.205 1.002 . . . . 4.44 111.806 -169.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.32 -2.69 9.33 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.895 1.712 . . . . 2.6 115.924 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -84.67 130.36 34.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.356 1.578 . . . . 2.8 109.514 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.08 136.79 40.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.856 1.262 . . . . 5.12 112.609 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -151.75 151.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.225 2.21 . . . . 2.32 108.685 -167.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -113.72 131.65 56.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.196 0.998 . . . . 3.68 109.9 168.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.81 164.21 22.0 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 124.384 0.992 . . . . 1.29 112.857 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -106.73 160.52 15.41 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.665 1.186 . . . . 1.88 112.58 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -168.65 155.82 7.14 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 126.334 1.854 . . . . 3.87 110.583 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.8 Cg_endo -69.58 152.84 70.28 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.79 1.66 . . . . 0.6 112.286 167.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.27 158.42 48.63 Favored Pre-proline 0 N--CA 1.473 0.694 0 C-N-CA 126.312 1.845 . . . . 0.79 110.148 172.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.77 -16.76 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.594 2.196 . . . . 0.84 112.68 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -179.74 162.55 1.08 Allowed 'General case' 0 C--N 1.347 0.465 0 C-N-CA 126.236 1.815 . . . . 1.96 110.573 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -109.63 174.23 5.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.002 2.121 . . . . 1.03 109.554 157.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.5 pt-20 -154.83 166.84 32.23 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.145 -0.972 . . . . 2.38 112.125 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.28 135.9 11.18 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 124.024 0.93 . . . . 0.83 109.403 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.21 168.22 22.76 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.021 1.814 . . . . 0.79 111.435 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.66 143.18 91.99 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.365 2.71 . . . . 0.76 111.615 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.9 mmmt 68.15 1.0 2.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.968 2.107 . . . . 1.36 114.012 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.92 -171.61 27.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.353 1.93 . . . . 1.14 112.289 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -158.16 160.89 37.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.276 1.213 . . . . 3.96 114.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 m -143.9 132.14 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.365 1.466 . . . . 2.01 111.136 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -93.4 126.55 38.59 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.283 0.633 . . . . 3.69 109.336 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -71.03 66.6 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.834 1.302 . . . . 1.45 109.268 161.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -73.11 141.55 81.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.533 2.333 . . . . 3.14 111.422 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.13 -44.46 49.16 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 1.2 113.677 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.89 80.85 1.56 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.671 -1.372 . . . . 1.39 109.671 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.17 -70.33 0.2 Allowed Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.097 -0.835 . . . . 1.31 114.211 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -157.17 146.98 20.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.344 1.857 . . . . 2.15 110.154 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -172.89 152.56 2.44 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.569 -1.332 . . . . 1.25 110.444 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -88.98 123.89 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.537 0.335 . . . . 2.34 110.961 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.6 mmt -83.54 100.9 11.08 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.881 1.272 . . . . 0.97 109.798 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -78.79 138.6 38.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.723 1.209 . . . . 1.85 107.811 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -144.09 148.9 35.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.443 1.116 . . . . 1.71 112.178 -173.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.8 -53.13 4.53 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.8 1.191 . . . . 2.57 111.42 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 61.15 95.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.667 2.787 . . . . 0.85 110.92 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.9 -15.1 62.09 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.794 -1.191 . . . . 2.38 112.339 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -147.14 145.66 22.87 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 128.292 2.637 . . . . 4.75 107.848 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.72 176.63 8.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.984 2.456 . . . . 2.36 109.879 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 39' ' ' VAL . 1.5 mp -130.55 -179.0 5.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.972 0.909 . . . . 3.79 111.93 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -151.0 144.65 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.461 1.904 . . . . 5.01 110.022 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 131.57 49.3 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.624 1.169 . . . . 2.28 112.955 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.58 -16.37 52.05 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.887 -1.507 . . . . 3.93 115.125 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.69 172.11 8.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.541 1.67 . . . . 6.08 111.191 -166.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.42 111.88 23.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.263 1.825 . . . . 4.43 111.485 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.67 117.63 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.085 -1.08 . . . . 1.0 108.085 165.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -74.19 140.91 45.44 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.38 1.086 . . . . 2.94 110.911 157.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.78 125.97 12.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.938 1.695 . . . . 1.76 109.843 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.57 96.29 7.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.98 2.112 . . . . 2.84 109.439 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.0 mt -80.27 112.42 17.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.023 1.729 . . . . 1.69 110.222 -171.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.4 mt -82.85 128.61 34.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.314 1.046 . . . . 1.0 111.472 -170.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 89.0 m-85 -124.2 126.96 47.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.649 0.78 . . . . 2.36 112.055 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 41.28 29.34 0.09 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.59 2.356 . . . . 2.53 116.399 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.73 -55.39 3.8 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.321 1.439 . . . . 4.31 113.087 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.33 -3.13 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.82 1.2 . . . . 2.09 115.374 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 6.2 mtpp -130.52 161.16 32.1 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.07 1.435 . . . . 5.21 114.025 175.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.48 166.44 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.874 2.07 . . . . 1.22 108.715 155.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.6 mt -137.24 126.5 24.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.713 1.605 . . . . 1.64 109.339 159.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -83.48 131.71 34.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.133 0.424 . . . . 2.56 111.469 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.02 156.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.592 1.157 . . . . 3.12 109.535 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.396 1.878 . . . . 1.71 109.995 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -143.49 144.44 27.79 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.495 1.518 . . . . 2.63 110.773 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 149.46 28.52 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.202 2.602 . . . . 1.16 113.616 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.4 t -84.23 130.56 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.006 1.322 . . . . 1.06 112.571 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.0 144.67 29.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.106 1.762 . . . . 3.31 109.527 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.51 86.77 2.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.643 1.177 . . . . 2.15 109.784 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.167 1.387 . . . . 7.55 110.733 -166.002 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 122.288 1.042 . . . . 5.66 110.942 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.18 170.59 42.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.415 1.959 . . . . 1.22 111.353 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.0 p90 -158.13 146.49 18.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.596 1.158 . . . . 1.4 110.998 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -106.72 118.35 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.583 -1.266 . . . . 0.94 107.583 170.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -89.51 114.61 26.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.159 0.984 . . . . 3.75 109.769 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.07 166.92 21.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.05 1.405 . . . . 2.4 113.497 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t -156.32 155.26 28.71 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.602 2.361 . . . . 3.12 108.385 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.93 -13.78 39.36 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.544 2.163 . . . . 1.89 112.559 165.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.87 174.71 18.37 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.964 1.745 . . . . 1.72 112.737 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 -5.91 48.26 Favored 'Cis proline' 0 CA--C 1.54 0.809 0 CA-C-N 118.415 1.107 . . . . 1.79 113.513 -1.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -126.98 161.98 27.07 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.611 1.165 . . . . 1.97 113.23 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.01 -176.37 5.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.361 2.264 . . . . 0.71 111.635 -175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.56 146.6 25.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.211 0.819 . . . . 0.8 113.211 -168.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.37 156.08 45.2 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.749 1.018 . . . . 0.73 113.749 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.37 149.77 28.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.381 1.872 . . . . 2.14 109.881 -169.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -171.74 160.81 5.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.281 1.032 . . . . 1.78 113.66 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -94.54 119.9 33.94 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.16 0.984 . . . . 1.23 109.875 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.2 124.95 40.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.861 1.264 . . . . 3.1 108.619 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -120.18 122.63 41.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.983 1.313 . . . . 3.86 110.328 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -102.61 103.96 35.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.349 -0.611 . . . . 0.98 109.349 164.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -86.6 -11.32 5.92 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.223 2.616 . . . . 1.05 113.122 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.83 160.44 43.03 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 124.273 0.939 . . . . 1.14 112.657 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.45 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.2 m-20 -90.25 5.97 44.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 2.95 113.235 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.98 160.02 40.54 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.241 1.816 . . . . 1.84 110.602 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.82 152.16 22.07 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.915 2.41 . . . . 0.83 111.432 -171.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -116.63 123.76 48.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.674 1.19 . . . . 2.07 110.385 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ttp-105 -117.77 110.45 17.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.227 1.411 . . . . 4.49 111.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -97.73 106.15 18.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.278 2.231 . . . . 0.85 108.936 -170.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.04 -19.36 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.056 0.942 . . . . 0.83 112.683 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.93 -162.34 30.57 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.536 0.607 . . . . 0.71 112.674 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -138.0 -177.57 4.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.054 0.942 . . . . 0.82 110.444 170.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -148.26 141.7 25.32 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 105.149 -2.167 . . . . 7.43 105.149 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.68 152.3 37.44 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.649 -1.167 . . . . 0.72 109.195 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.6 -34.21 98.7 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.647 2.231 . . . . 0.98 113.029 167.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.284 2.2 m -81.94 4.04 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.484 0.92 . . . . 0.95 113.484 -165.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.08 19.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.527 1.058 . . . . 0.72 113.51 -174.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.09 -51.8 1.54 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 3.63 110.656 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -79.51 133.54 36.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.037 -1.097 . . . . 3.2 108.037 155.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -145.75 126.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 127.062 2.145 . . . . 1.29 108.364 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.91 115.87 6.03 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.69 0.796 . . . . 2.57 110.972 -157.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.39 121.42 23.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.821 1.192 . . . . 0.8 110.377 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.3 m170 -108.1 151.67 25.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.75 1.62 . . . . 0.52 113.259 174.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.91 172.02 8.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.746 1.618 . . . . 2.23 110.125 163.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -151.06 86.58 1.37 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.382 1.473 . . . . 1.07 107.674 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -96.56 -173.81 2.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.802 2.041 . . . . 2.48 111.576 -171.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.44 139.72 27.08 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.028 0.918 . . . . 3.21 111.855 170.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.22 150.43 26.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.602 1.161 . . . . 6.42 111.959 -170.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.327 16.6 pm0 -64.99 142.17 58.53 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.227 1.811 . . . . 6.1 113.44 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 t -130.21 -95.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.157 1.383 . . . . 2.76 107.37 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -73.08 45.48 0.15 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.908 2.083 . . . . 4.86 111.919 164.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.98 -40.15 1.18 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.533 1.539 . . . . 2.25 113.265 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -61.81 138.62 58.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.023 1.729 . . . . 3.79 110.862 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -77.89 112.23 14.56 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.201 0.6 . . . . 4.94 109.803 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.86 139.56 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.443 1.897 . . . . 1.66 108.632 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -83.86 139.65 32.51 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.725 1.21 . . . . 3.08 110.824 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.41 163.36 31.54 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.493 0.557 . . . . 0.95 114.493 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -112.85 165.56 12.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.276 1.43 . . . . 1.71 112.406 -176.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.252 76.0 mtt180 -169.52 141.58 1.98 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 128.738 2.815 . . . . 4.82 106.55 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.2 Cg_endo -68.95 150.73 73.39 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 CA-C-N 122.024 1.759 . . . . 0.66 110.192 156.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.97 156.87 47.73 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.143 1.377 . . . . 0.55 110.438 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.42 -23.48 50.86 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.356 2.037 . . . . 0.7 112.395 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -178.78 167.38 1.7 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 126.434 1.893 . . . . 2.23 111.585 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.091 1.356 . . . . 0.94 110.071 150.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.251 2.8 pt-20 -153.55 160.0 42.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.888 -0.507 . . . . 2.72 111.949 164.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 t -141.42 134.46 14.31 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 125.798 1.639 . . . . 1.1 108.851 -166.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.52 164.61 32.19 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.409 2.073 . . . . 0.99 111.679 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.38 145.03 99.12 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.346 2.697 . . . . 0.79 111.825 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 16.5 mmmt 68.96 -1.62 2.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.36 1.864 . . . . 1.41 113.66 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.02 125.94 7.85 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 127.649 2.547 . . . . 0.92 112.811 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -86.37 149.43 25.03 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.994 -1.103 . . . . 5.37 111.79 156.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 m -152.45 131.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.64 1.576 . . . . 1.66 109.52 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -89.84 134.43 34.2 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.287 1.035 . . . . 4.09 111.028 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 mp -76.13 66.22 2.25 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.214 1.483 . . . . 1.53 110.122 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -56.97 124.47 65.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 4.85 109.838 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.32 -33.96 88.35 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.574 2.85 . . . . 1.38 113.765 -169.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.94 45.63 2.52 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.068 0.849 . . . . 1.89 112.361 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.45 -57.87 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.567 2.032 . . . . 1.44 113.988 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -150.26 145.54 26.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.889 1.676 . . . . 2.03 110.877 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -166.14 179.83 5.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.344 1.058 . . . . 0.79 110.941 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -115.7 132.48 56.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.23 1.012 . . . . 2.24 111.132 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.7 mmt -93.11 139.77 30.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 0.86 110.772 165.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 143.18 51.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.719 1.608 . . . . 2.98 109.736 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -146.18 160.32 42.12 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 2.2 112.079 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.58 -82.39 1.69 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.084 1.326 . . . . 2.78 109.895 -169.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 76.85 125.68 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.786 3.634 . . . . 0.92 110.941 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -77.74 -22.97 49.51 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.818 -1.176 . . . . 2.02 112.881 -170.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -161.83 158.15 21.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 130.233 3.413 . . . . 6.85 109.059 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.39 149.09 56.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.758 2.305 . . . . 3.45 109.653 160.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 -176.57 2.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.037 1.735 . . . . 3.42 109.82 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.35 141.63 19.55 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.214 -1.554 . . . . 3.5 110.513 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -34.79 135.99 0.17 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.637 1.717 . . . . 1.81 115.637 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.83 22.39 69.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.124 0.81 . . . . 1.91 115.124 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -88.83 -179.46 5.98 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.754 1.222 . . . . 3.31 109.839 158.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -130.74 168.89 16.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.103 0.961 . . . . 3.59 111.321 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.9 t -136.33 117.71 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.391 1.476 . . . . 0.93 109.967 -172.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.42 42.04 0.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.016 2.127 . . . . 4.34 114.214 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.5 tt -65.39 137.09 57.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 123.4 1.571 . . . . 1.86 112.958 -164.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.09 112.61 25.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.781 2.032 . . . . 2.49 111.303 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -82.43 120.32 25.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.084 1.354 . . . . 1.19 110.752 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.8 mt -96.68 123.42 40.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.614 1.166 . . . . 0.84 111.54 -168.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.45 133.65 55.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.147 1.536 . . . . 1.87 115.147 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.17 48.28 0.85 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.821 2.048 . . . . 2.68 112.768 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.38 19.79 2.81 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.106 2.289 . . . . 4.93 112.307 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.98 38.07 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 118.275 1.037 . . . . 2.25 112.098 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 150.01 36.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.155 1.782 . . . . 3.67 111.197 -175.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.85 131.62 20.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 126.015 1.726 . . . . 1.11 108.073 161.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.14 122.69 41.56 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.331 1.452 . . . . 2.2 109.277 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -79.84 132.34 36.09 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.835 -0.541 . . . . 2.45 111.548 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -129.55 127.47 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.393 1.077 . . . . 1.49 109.567 167.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.22 138.38 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.059 0.943 . . . . 2.83 110.224 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.4 mt -143.55 142.62 21.37 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.252 1.421 . . . . 1.83 110.083 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.85 153.04 64.13 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.385 2.723 . . . . 1.11 112.667 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.5 t -83.4 113.95 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.113 1.365 . . . . 1.15 108.926 165.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -100.36 145.81 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.583 1.953 . . . . 3.8 108.015 167.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.91 55.21 0.78 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.3 1.593 . . . . 2.91 115.3 -152.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.076 2.15 . . . . 7.84 111.25 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 110.312 -0.255 . . . . 5.16 110.312 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.97 169.04 26.31 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.647 -1.283 . . . . 0.87 114.436 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -150.63 146.59 26.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.762 1.625 . . . . 1.48 111.558 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -109.44 107.66 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.682 -1.229 . . . . 1.07 107.682 171.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -82.4 121.9 27.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.276 -0.639 . . . . 3.77 109.276 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -160.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.447 1.099 . . . . 2.23 112.016 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 8.6 t 174.0 157.65 0.31 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 128.641 2.776 . . . . 2.77 106.935 168.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.97 -10.78 29.74 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.572 2.182 . . . . 1.7 113.197 167.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.53 177.69 26.06 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.005 1.288 . . . . 1.49 112.007 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.51 -1.21 32.26 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 CA-C-N 118.665 1.232 . . . . 1.49 113.621 1.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -140.58 158.27 44.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.793 1.237 . . . . 2.07 112.478 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 11' ' ' SER . . . -152.98 -178.74 7.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.155 2.582 . . . . 0.63 110.27 -177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.22 133.59 16.43 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.344 1.239 . . . . 0.99 114.344 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.55 153.02 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.847 1.259 . . . . 0.72 111.981 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.44 136.95 15.9 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.911 1.684 . . . . 2.21 109.373 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -161.53 150.8 16.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.07 1.508 . . . . 2.18 115.07 -167.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -72.11 125.79 28.15 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.282 1.033 . . . . 1.45 108.714 165.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 tt -107.13 155.33 19.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.939 1.696 . . . . 3.04 110.47 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.01 161.77 37.24 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 115.536 1.68 . . . . 3.75 115.536 165.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -130.79 96.46 23.07 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 127.306 2.242 . . . . 1.18 109.425 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.88 -8.19 13.28 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.506 2.138 . . . . 1.0 113.703 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.05 157.71 41.48 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 119.655 1.116 . . . . 1.36 112.179 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -82.87 9.8 9.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.126 1.771 . . . . 3.3 112.681 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mt -110.58 165.32 12.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 129.031 2.933 . . . . 2.46 108.507 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.34 157.58 12.79 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.958 2.439 . . . . 0.77 111.445 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.99 147.76 38.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.437 1.095 . . . . 1.9 111.231 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 ttp-105 -135.79 112.24 9.92 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.125 1.37 . . . . 3.47 110.768 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -88.07 120.68 29.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.957 2.103 . . . . 1.16 108.741 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.78 -20.85 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.03 1.332 . . . . 0.65 112.669 -177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.67 -162.2 20.31 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 122.214 0.897 . . . . 0.65 112.061 169.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.889 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -149.48 177.58 9.58 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.229 1.811 . . . . 0.65 108.64 171.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -161.82 152.64 17.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.04 1.291 . . . . 6.11 109.323 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -153.72 151.42 25.05 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 125.469 1.508 . . . . 0.61 108.932 -166.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.1 -23.03 46.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.184 1.923 . . . . 0.88 113.843 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 m -88.01 -3.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 115.36 1.615 . . . . 1.06 115.36 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.58 134.71 49.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.931 1.241 . . . . 0.86 111.176 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -56.44 18.94 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.777 1.171 . . . . 5.71 109.277 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -124.12 151.48 43.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.53 1.932 . . . . 4.23 110.974 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.86 135.2 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.904 2.082 . . . . 2.45 107.934 163.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -126.77 130.1 49.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.95 0.9 . . . . 2.38 109.666 167.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tp -85.92 117.34 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.59 1.556 . . . . 3.44 108.843 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.3 m170 -126.43 151.96 47.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.084 1.354 . . . . 0.84 113.778 -170.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.65 167.7 13.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.079 1.751 . . . . 2.52 111.806 165.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.4 m -153.61 92.66 1.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.706 2.002 . . . . 2.08 107.213 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -109.61 163.48 13.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.111 1.152 . . . . 2.48 114.111 -156.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.68 143.93 27.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.301 1.04 . . . . 4.0 109.907 150.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -149.57 151.75 34.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.665 2.386 . . . . 7.82 107.09 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.33 145.44 37.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.683 0.793 . . . . 4.91 111.72 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.88 117.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.81 -1.552 . . . . 3.95 106.81 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.3 28.58 17.96 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.3 1.04 . . . . 7.29 111.461 -172.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.33 -12.79 12.38 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 120.486 -1.384 . . . . 4.31 114.049 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -75.52 135.09 40.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.305 1.442 . . . . 5.04 109.75 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -74.06 135.24 43.01 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.205 1.002 . . . . 4.52 111.878 -170.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.03 144.84 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.775 1.63 . . . . 2.54 109.421 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.97 139.0 51.14 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.804 1.242 . . . . 3.09 111.905 172.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -179.15 38.66 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 123.854 0.74 . . . . 1.29 113.694 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.4 177.63 4.96 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.057 1.343 . . . . 2.04 111.823 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 175.64 143.1 0.22 Allowed Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 126.813 2.045 . . . . 7.45 110.039 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.3 Cg_endo -67.83 154.46 72.96 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 121.617 1.613 . . . . 0.76 110.783 161.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.93 156.43 69.0 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 125.989 1.716 . . . . 0.85 109.986 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.77 -19.92 40.52 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.028 1.819 . . . . 0.74 112.58 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 178.84 169.96 0.88 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.728 1.611 . . . . 1.85 111.031 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.03 163.58 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.11 1.364 . . . . 0.7 108.938 157.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.253 0.2 OUTLIER -153.57 158.39 41.13 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.504 -0.748 . . . . 2.01 112.28 177.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -146.34 133.65 10.2 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.298 1.439 . . . . 0.99 108.863 -162.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.11 168.36 24.95 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.0 2.467 . . . . 0.82 111.902 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.49 137.65 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.188 3.925 . . . . 1.28 114.287 165.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt 68.38 1.21 2.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.951 1.7 . . . . 1.58 114.049 169.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 115.08 4.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.86 1.695 . . . . 1.09 112.209 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.71 122.26 42.45 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.065 1.746 . . . . 4.83 109.5 161.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.1 m -155.22 146.29 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.273 1.429 . . . . 2.01 112.288 -163.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -91.27 142.79 27.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.085 0.954 . . . . 3.15 113.021 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.4 68.85 0.23 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 1.22 108.508 148.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -54.19 122.62 37.53 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.054 1.742 . . . . 4.05 110.381 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.15 -42.16 66.29 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.546 2.831 . . . . 1.52 112.891 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.02 75.3 2.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.7 -0.96 . . . . 1.2 110.7 161.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.77 -61.03 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.759 1.647 . . . . 1.3 112.462 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -151.55 150.67 30.61 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.482 1.513 . . . . 3.07 111.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -160.19 170.72 20.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.221 1.008 . . . . 1.4 111.079 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -102.51 127.4 49.58 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.249 1.019 . . . . 2.2 110.64 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mmt -83.44 124.87 31.12 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.798 0.839 . . . . 1.29 110.574 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.28 134.35 48.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.195 1.398 . . . . 1.87 108.707 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.3 mt -134.2 161.01 36.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.65 1.18 . . . . 1.7 112.008 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.91 35.06 39.11 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 126.144 1.83 . . . . 2.41 114.998 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 mt -37.14 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.245 2.218 . . . . 0.97 114.652 -156.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -77.25 14.25 0.97 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.977 1.473 . . . . 1.89 114.977 -165.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -159.49 147.03 13.04 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 131.44 3.896 . . . . 7.2 109.468 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.98 170.52 15.45 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.015 2.476 . . . . 2.19 109.317 166.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 157.64 43.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.302 1.049 . . . . 4.44 112.791 -165.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -143.18 144.11 32.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.821 1.648 . . . . 4.29 109.639 176.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.4 144.04 57.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.856 0.863 . . . . 1.8 111.901 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.91 45.22 27.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.854 -0.97 . . . . 1.73 112.934 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -109.35 177.87 4.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.534 0.734 . . . . 4.85 109.741 148.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.57 161.62 17.64 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.216 1.806 . . . . 4.6 110.201 152.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -125.58 133.16 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.691 1.597 . . . . 1.18 109.721 163.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.65 144.76 28.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.901 1.68 . . . . 3.17 110.292 172.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.889 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.8 tt -156.37 131.74 9.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.39 1.076 . . . . 1.68 112.087 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.42 115.18 27.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.537 2.335 . . . . 2.28 111.947 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.19 118.9 22.96 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.688 1.585 . . . . 1.26 109.547 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.7 mt -98.37 122.51 41.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.231 1.012 . . . . 0.71 110.36 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -113.82 154.41 27.48 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.036 0.934 . . . . 2.02 112.6 -173.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.7 95.97 0.37 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.088 1.355 . . . . 1.96 112.605 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.45 -147.78 18.61 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.056 1.312 . . . . 3.03 111.317 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.47 36.94 2.02 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.287 0.946 . . . . 1.71 115.379 -171.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -127.74 134.08 49.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.696 1.748 . . . . 4.73 113.075 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.61 147.32 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.362 1.865 . . . . 1.09 108.064 158.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -141.17 115.89 9.66 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.182 1.393 . . . . 1.58 108.164 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.11 153.06 21.81 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.705 1.002 . . . . 2.55 113.705 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.75 166.88 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.319 2.248 . . . . 1.26 109.768 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.23 133.99 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.21 1.004 . . . . 1.72 108.457 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt -145.64 152.44 49.03 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.28 1.432 . . . . 2.05 110.56 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.81 151.97 74.04 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 125.2 3.933 . . . . 0.86 115.16 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.2 t -83.41 100.72 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.681 1.592 . . . . 1.05 109.719 170.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -90.7 74.68 6.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.009 1.724 . . . . 3.07 109.018 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.16 128.6 37.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.077 -1.014 . . . . 2.11 113.544 -166.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 . . . . . 0 N--CA 1.484 1.273 1 C-N-CA 132.647 4.379 . . . . 7.33 108.493 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 106.55 -1.648 . . . . 5.7 106.55 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.21 156.06 22.61 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.681 -0.637 . . . . 0.96 113.638 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -154.73 147.32 24.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.19 0.996 . . . . 1.66 111.797 175.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.44 116.97 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.616 0.767 . . . . 0.91 110.649 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 ttp85 -81.61 103.23 11.18 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.028 1.331 . . . . 4.04 110.577 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.55 165.06 25.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 123.431 1.586 . . . . 2.3 112.465 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -161.22 154.08 17.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.58 2.352 . . . . 1.94 107.949 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.28 27.6 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.398 3.398 . . . . 1.56 113.503 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.71 169.42 42.76 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.477 -0.764 . . . . 1.42 113.049 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.14 -5.58 25.77 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 118.005 0.902 . . . . 1.53 112.604 -10.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.99 157.65 44.06 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.073 1.349 . . . . 3.0 113.34 -168.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.27 -176.21 5.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.63 1.972 . . . . 0.67 111.294 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.44 129.0 15.04 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.986 0.914 . . . . 1.01 111.814 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.27 138.41 44.59 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.787 1.235 . . . . 0.72 111.84 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -124.83 151.32 45.39 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.138 2.175 . . . . 2.5 109.102 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.03 150.11 16.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.173 1.175 . . . . 1.74 114.173 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -89.49 113.63 25.03 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.501 -0.926 . . . . 1.43 108.501 166.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.82 156.54 20.97 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.038 1.735 . . . . 2.7 110.806 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.15 157.45 43.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.911 0.708 . . . . 3.56 112.911 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -96.34 109.79 49.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 114.359 -1.291 . . . . 1.09 110.19 166.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.84 -2.82 10.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.371 2.714 . . . . 1.21 113.78 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.69 171.27 37.64 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.4 1.0 . . . . 1.04 113.133 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -95.57 0.13 52.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.525 1.53 . . . . 3.53 113.781 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -116.84 154.61 49.55 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.674 1.589 . . . . 1.35 110.056 167.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.91 159.05 27.55 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.501 2.801 . . . . 0.69 112.506 -164.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -106.59 152.23 23.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.68 1.192 . . . . 1.82 110.837 171.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -130.78 112.25 12.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.084 1.353 . . . . 3.89 109.619 171.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 tp -94.81 112.3 24.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.065 2.546 . . . . 0.73 109.601 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.79 -11.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.922 1.082 . . . . 0.59 113.922 -165.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.74 -167.95 40.67 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.506 -0.746 . . . . 0.63 112.583 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.54 -179.69 7.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.506 0.558 . . . . 0.86 112.506 167.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -145.69 142.19 28.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.327 1.051 . . . . 7.21 109.044 169.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -153.9 151.09 24.09 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.544 1.138 . . . . 0.65 110.448 -164.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.72 -17.81 37.55 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.396 2.064 . . . . 1.04 112.652 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.32 2.0 m -96.91 11.07 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.199 1.555 . . . . 1.64 115.199 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . . . -154.82 144.29 21.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.91 1.448 . . . . 0.98 114.91 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.87 -69.82 0.75 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.934 -0.765 . . . . 3.12 108.934 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.912 -1.514 . . . . 2.76 106.912 164.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.19 129.17 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.173 1.789 . . . . 1.28 107.548 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.3 131.95 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.325 1.45 . . . . 1.91 109.273 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.07 122.17 27.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.086 0.945 . . . . 0.78 110.579 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -112.52 159.29 18.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.834 2.054 . . . . 0.5 111.986 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.37 -177.34 3.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.742 2.017 . . . . 2.66 110.925 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 m -137.12 116.28 12.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.339 1.456 . . . . 1.33 107.59 163.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -96.74 162.53 13.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.863 0.865 . . . . 2.25 110.996 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -112.32 143.14 43.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 3.58 110.822 162.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -153.78 159.67 41.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.742 1.617 . . . . 5.64 111.295 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 141.35 36.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.823 -0.806 . . . . 4.14 108.823 156.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.33 -8.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 115.139 1.533 . . . . 3.14 115.139 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -158.27 46.0 0.33 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.673 1.989 . . . . 4.08 107.586 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.74 -24.06 0.4 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.766 1.651 . . . . 2.0 114.706 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -99.79 153.47 19.1 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.122 2.169 . . . . 3.12 112.49 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -61.66 136.54 58.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.956 0.902 . . . . 3.89 111.34 169.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.8 t -140.0 150.44 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.061 2.144 . . . . 1.93 108.275 168.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.3 mtm -111.57 144.48 40.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.396 1.079 . . . . 3.18 111.347 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.47 158.03 28.16 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 123.597 0.618 . . . . 1.09 113.012 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.67 165.56 11.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.413 1.085 . . . . 1.74 112.551 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -171.15 155.29 4.32 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.535 1.934 . . . . 3.87 109.848 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.6 Cg_endo -69.75 152.33 69.36 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.926 1.75 . . . . 0.6 111.482 167.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -115.17 157.97 42.27 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 126.381 1.872 . . . . 0.78 110.278 170.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -69.36 -21.43 35.36 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 0.82 111.952 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -177.93 161.25 1.54 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.267 1.827 . . . . 2.12 110.82 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -108.2 174.97 5.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.741 2.016 . . . . 0.76 109.455 157.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.55 165.07 36.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.048 -1.032 . . . . 2.31 111.222 170.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -146.07 130.14 8.61 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 123.436 0.694 . . . . 0.79 109.334 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.12 164.85 34.34 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.197 1.932 . . . . 0.8 111.108 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.39 137.01 75.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.514 2.809 . . . . 0.81 112.144 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 64.05 11.15 5.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.834 1.654 . . . . 1.58 113.622 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.08 120.06 5.13 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 127.766 2.603 . . . . 0.91 111.197 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -85.38 142.91 28.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.005 1.322 . . . . 5.71 111.87 162.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.98 148.32 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.029 1.731 . . . . 1.73 110.398 172.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -129.92 114.5 15.94 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.289 -1.004 . . . . 5.02 108.289 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.76 67.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.64 1.976 . . . . 1.35 112.388 -171.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.57 133.92 44.88 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.854 2.461 . . . . 2.68 113.634 166.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.6 -52.59 7.23 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.502 2.802 . . . . 1.56 112.132 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.33 89.12 1.01 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.401 -1.48 . . . . 1.53 109.401 166.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.95 -72.25 0.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.73 2.109 . . . . 1.25 112.753 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -155.43 132.25 10.62 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.474 1.51 . . . . 1.94 112.299 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -156.88 165.93 34.81 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.023 -1.048 . . . . 0.75 111.487 -171.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.27 113.71 26.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.307 0.575 . . . . 1.78 109.699 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.26 125.13 33.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.508 1.123 . . . . 1.43 109.195 175.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 24.0 mt -113.68 135.91 53.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.912 1.285 . . . . 1.76 110.077 -168.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -146.65 154.67 41.73 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.782 1.633 . . . . 2.06 111.02 -172.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.39 -54.46 4.32 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.734 1.159 . . . . 2.41 112.371 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt 70.02 107.51 0.06 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.875 3.27 . . . . 1.39 111.133 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.18 14.33 2.41 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.76 -1.212 . . . . 1.99 113.712 -169.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.452 HH21 ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.8 153.52 15.91 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.682 2.393 . . . . 5.57 109.633 176.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.7 140.61 23.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.772 2.314 . . . . 2.43 109.875 166.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.3 mt -115.57 152.68 32.61 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.148 1.379 . . . . 3.15 111.794 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -147.75 9.63 0.91 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.724 2.12 . . . . 3.94 116.724 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 64.0 172.87 0.18 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.934 2.094 . . . . 2.72 112.225 -169.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.58 52.48 52.82 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 121.661 -0.649 . . . . 2.4 111.99 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.452 ' CD ' HH21 ' A' ' 91' ' ' ARG . 9.8 pt-20 -152.01 163.88 38.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.003 2.121 . . . . 3.77 111.051 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -101.51 123.1 45.0 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.279 1.831 . . . . 4.43 109.499 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.68 106.09 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.001 -1.111 . . . . 1.21 108.001 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 143.22 42.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.631 -1.168 . . . . 3.14 109.171 160.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -155.33 116.39 3.93 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.946 -1.096 . . . . 1.59 111.213 -167.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.86 100.58 12.65 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.297 1.439 . . . . 2.39 110.378 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 mt -80.52 119.65 23.46 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.646 -0.659 . . . . 1.58 109.528 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.8 mt -93.6 129.93 39.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.178 0.991 . . . . 0.84 110.61 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -130.37 122.49 27.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.408 0.623 . . . . 2.0 112.504 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.0 12.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.401 2.001 . . . . 2.43 116.401 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.62 -45.73 1.6 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.967 1.27 . . . . 3.39 112.64 -165.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.87 4.67 44.19 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.194 1.378 . . . . 2.46 116.042 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.69 152.85 33.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.53 1.932 . . . . 3.86 112.686 176.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.9 140.64 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.647 1.979 . . . . 1.03 107.819 161.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -139.04 124.05 18.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.755 1.222 . . . . 1.59 108.056 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.45 150.7 20.01 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.817 1.414 . . . . 2.37 114.817 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.91 145.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.823 1.649 . . . . 1.26 110.91 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -106.84 129.81 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.614 1.166 . . . . 1.8 108.623 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.3 mt -140.68 150.52 60.47 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.743 1.617 . . . . 1.82 110.183 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.02 146.49 37.11 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.096 2.53 . . . . 0.89 112.874 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.29 139.43 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.636 -0.711 . . . . 1.07 110.567 156.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.57 151.34 39.54 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.428 3.491 . . . . 3.58 108.672 170.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.72 73.27 1.46 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.194 1.554 . . . . 2.27 115.194 -157.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.377 1.071 . . . . 7.42 112.556 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 113.543 0.942 . . . . 5.67 113.543 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.04 165.24 17.26 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.592 1.568 . . . . 1.97 114.525 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -148.97 134.4 18.52 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.146 1.778 . . . . 2.59 110.552 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.4 t -91.33 140.15 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.74 1.216 . . . . 1.06 107.879 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.46 -24.4 18.04 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.884 1.439 . . . . 3.41 114.884 -175.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.28 175.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.697 1.999 . . . . 2.23 114.559 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 m 176.34 167.24 0.43 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 130.92 3.688 . . . . 1.69 107.903 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.24 -6.55 18.58 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.993 2.462 . . . . 2.19 113.584 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 112.28 166.34 17.41 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.115 1.816 . . . . 1.86 111.696 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.62 -7.71 45.1 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.112 1.456 . . . . 1.85 113.633 -1.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -130.17 174.08 10.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.05 1.34 . . . . 2.18 112.836 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.51 -174.66 3.23 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.216 2.206 . . . . 0.6 112.037 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.19 165.49 22.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.598 1.159 . . . . 0.88 111.352 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.66 162.35 40.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.241 1.816 . . . . 0.71 111.355 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -155.6 165.0 37.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.727 1.611 . . . . 2.23 111.274 -173.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.467 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.4 pt? -160.44 161.3 32.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 116.0 1.852 . . . . 1.54 116.0 170.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -70.06 125.6 27.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 112.663 -2.062 . . . . 1.5 106.164 153.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -134.67 129.58 35.03 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.559 1.544 . . . . 2.75 107.108 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -153.9 150.76 28.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 114.583 1.327 . . . . 2.77 114.583 -173.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -103.63 103.65 37.58 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 112.987 -1.915 . . . . 0.96 109.099 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.8 -10.49 14.22 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.631 2.22 . . . . 1.32 113.018 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.15 -177.19 49.9 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.848 1.214 . . . . 1.16 113.466 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.89 -2.62 21.13 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.075 1.75 . . . . 3.43 113.018 -170.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.72 161.26 42.84 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.447 1.899 . . . . 1.35 110.062 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.75 149.05 20.5 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.674 2.249 . . . . 0.65 111.969 -169.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.14 120.89 42.07 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.624 1.17 . . . . 2.46 110.692 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -105.81 103.87 13.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.967 1.707 . . . . 3.77 110.65 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -91.84 116.56 29.0 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.805 1.642 . . . . 1.07 109.024 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -95.0 -22.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.995 0.918 . . . . 0.94 112.387 -174.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -161.52 28.21 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 121.78 -0.575 . . . . 0.63 112.581 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.43 -178.16 5.17 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.185 0.994 . . . . 0.71 110.7 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 136.82 17.37 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.895 2.078 . . . . 5.64 106.518 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -153.29 151.58 26.04 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 120.737 1.608 . . . . 0.62 111.097 -166.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.09 -18.36 27.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.82 3.013 . . . . 0.78 114.097 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.269 3.0 m -89.91 -2.07 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 114.081 1.141 . . . . 0.83 114.081 -173.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.88 39.5 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.576 0.954 . . . . 0.75 113.576 -174.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.22 -86.86 0.34 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.284 1.833 . . . . 3.42 108.41 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -78.49 86.36 4.52 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.67 -1.269 . . . . 3.18 110.614 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.77 139.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.793 1.237 . . . . 1.16 110.486 158.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -136.51 126.52 26.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.489 1.915 . . . . 2.24 109.821 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.18 121.57 26.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.209 1.368 . . . . 0.74 111.245 167.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.6 m170 -107.26 151.64 25.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.596 1.558 . . . . 0.68 112.3 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.42 173.14 8.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.721 1.209 . . . . 2.19 110.5 158.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -148.72 96.64 2.61 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.166 1.386 . . . . 1.02 107.515 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -109.04 153.96 22.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.948 1.699 . . . . 2.62 112.2 -166.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.7 mtm -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.081 0.952 . . . . 2.91 110.937 170.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -155.62 167.92 28.81 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.198 1.799 . . . . 9.1 111.235 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.73 157.73 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.264 0.625 . . . . 3.47 111.115 160.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -135.11 -89.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.215 1.006 . . . . 3.12 108.922 160.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.45 55.34 1.91 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.683 1.993 . . . . 3.84 110.338 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.92 -18.52 0.35 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 125.62 1.581 . . . . 2.04 114.906 -173.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -108.2 163.28 13.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.752 2.421 . . . . 3.06 111.38 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -66.64 135.63 54.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.673 1.189 . . . . 3.7 112.817 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.1 160.42 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 126.895 2.078 . . . . 1.99 109.221 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.1 mmt -79.96 165.09 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 3.62 112.647 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.17 143.11 11.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.735 1.635 . . . . 1.56 110.707 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.03 142.21 49.04 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.355 1.462 . . . . 2.06 109.539 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -172.86 127.46 0.52 Allowed Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 117.116 -1.421 . . . . 4.07 111.136 -152.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 38.2 Cg_endo -66.63 146.07 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.184 1.922 . . . . 0.55 111.251 170.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.28 156.71 60.13 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.799 1.64 . . . . 0.54 110.589 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.99 -24.37 28.69 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.258 1.972 . . . . 0.71 112.509 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -174.06 166.25 4.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.882 1.273 . . . . 2.13 112.273 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.52 173.04 6.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.065 2.146 . . . . 0.7 109.526 157.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.56 163.19 40.3 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.663 -0.648 . . . . 1.89 112.236 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.38 130.74 11.68 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 124.844 1.258 . . . . 0.96 109.606 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.18 161.62 43.72 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.026 2.484 . . . . 0.84 111.295 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.27 140.88 90.97 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.238 2.626 . . . . 1.02 112.105 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt 67.96 -3.32 1.23 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.967 2.107 . . . . 1.83 113.921 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.74 134.82 13.52 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 127.136 2.303 . . . . 0.86 110.052 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -109.9 146.7 34.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.514 -1.343 . . . . 6.45 112.192 163.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.08 171.69 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.968 1.707 . . . . 1.32 110.099 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -139.03 117.68 12.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.722 1.609 . . . . 3.88 108.036 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.77 70.77 0.99 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.95 1.7 . . . . 1.3 111.323 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.48 140.5 94.85 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.967 -1.083 . . . . 2.98 111.754 171.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.98 -33.4 83.5 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.83 2.353 . . . . 1.35 112.201 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.01 53.41 4.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.058 0.837 . . . . 1.44 112.31 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.14 -64.26 0.05 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.452 1.025 . . . . 1.39 114.842 177.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -154.63 137.79 15.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.657 1.583 . . . . 2.12 110.558 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -162.17 172.24 16.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.227 -0.921 . . . . 0.75 111.963 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -105.12 131.83 52.11 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.099 0.559 . . . . 1.91 110.405 167.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.3 mmt -88.91 143.93 26.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.279 1.032 . . . . 0.96 109.9 156.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.8 125.56 46.8 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.932 1.293 . . . . 2.7 108.801 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mt -124.85 133.87 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.314 1.846 . . . . 2.02 110.692 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.67 78.37 0.67 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.778 -1.329 . . . . 2.47 109.778 -174.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.39 104.08 4.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.332 1.066 . . . . 0.93 109.972 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.46 17.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.834 1.05 . . . . 2.12 113.834 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -122.6 140.3 32.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.529 1.932 . . . . 6.22 109.647 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -69.39 140.33 43.79 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 N-CA-C 108.26 -1.477 . . . . 2.02 108.26 148.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.7 mt -120.51 155.62 33.24 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.464 1.106 . . . . 3.12 111.433 -174.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -130.92 1.37 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.188 1.551 . . . . 3.71 115.188 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 59.11 178.62 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.219 2.207 . . . . 2.08 111.92 -171.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.2 56.22 25.81 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 110.445 -1.062 . . . . 1.91 110.445 -172.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -166.72 157.12 11.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 128.572 2.749 . . . . 3.09 109.961 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -112.46 148.41 34.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.533 1.133 . . . . 4.35 112.054 -167.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.1 t -125.41 117.48 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.18 1.792 . . . . 1.16 108.342 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.72 133.28 33.69 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.836 -0.801 . . . . 4.04 108.836 157.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -138.71 141.71 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.957 1.703 . . . . 1.95 108.708 -173.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.06 123.1 31.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.891 1.677 . . . . 2.35 109.961 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.74 120.33 27.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.103 0.961 . . . . 1.36 109.8 168.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.77 125.61 40.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.18 0.992 . . . . 0.57 111.731 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -125.51 114.14 18.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.996 0.903 . . . . 2.06 111.73 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.12 25.7 0.12 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 127.502 2.321 . . . . 3.3 116.317 171.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.68 -42.03 1.04 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.52 1.533 . . . . 4.26 113.906 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.04 0.09 87.93 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.224 1.392 . . . . 2.13 116.102 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.25 155.24 41.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.933 2.093 . . . . 4.44 111.748 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.72 141.0 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.429 1.892 . . . . 1.1 108.599 171.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.9 112.4 9.32 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.112 1.365 . . . . 1.63 109.24 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -83.92 137.39 33.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.016 0.747 . . . . 3.71 113.016 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 m -138.24 153.43 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.988 1.715 . . . . 1.59 110.894 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 m -95.2 149.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.265 1.426 . . . . 3.04 112.416 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -147.13 141.77 16.26 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.89 2.076 . . . . 3.0 108.382 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.09 156.75 33.97 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.979 2.452 . . . . 1.05 111.027 163.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -84.17 109.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.074 0.949 . . . . 1.09 109.828 164.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 120' ' ' ARG . 4.8 mm-40 -79.01 146.51 33.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.284 1.034 . . . . 3.7 108.288 155.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.37 94.03 4.77 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.045 -1.095 . . . . 2.16 108.045 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 118' ' ' GLU . 32.0 ttm-85 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 113.57 0.952 . . . . 8.57 113.57 -164.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 . . . . . 0 CA--C 1.546 0.822 0 CA-C-O 121.303 0.573 . . . . 4.56 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.69 -175.91 43.49 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.956 1.741 . . . . 1.32 114.762 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -159.62 156.44 27.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.126 1.371 . . . . 1.76 113.257 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -113.92 131.07 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.543 -0.723 . . . . 0.88 109.947 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -72.2 114.17 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.776 1.231 . . . . 4.68 109.249 174.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 129.09 37.17 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.723 0.809 . . . . 2.13 109.136 162.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.35 163.26 38.09 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.877 1.671 . . . . 2.33 108.1 167.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.12 17.68 0.49 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.459 3.439 . . . . 1.48 115.456 -167.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.31 174.38 49.48 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.599 -0.688 . . . . 1.3 112.772 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.23 -3.0 36.91 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.364 1.082 . . . . 1.42 113.034 -4.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -141.2 169.41 17.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.297 1.439 . . . . 2.03 112.5 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.19 -158.5 0.34 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.985 2.514 . . . . 0.85 111.177 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.49 171.08 20.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.62 1.168 . . . . 0.8 113.664 -169.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.93 151.0 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.343 1.057 . . . . 0.87 113.186 170.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -142.81 145.65 33.43 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.594 1.558 . . . . 2.07 110.468 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -169.62 160.97 9.25 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.46 0.911 . . . . 1.58 113.46 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.0 m -78.19 141.53 38.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.54 1.536 . . . . 1.29 109.076 162.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -128.21 136.72 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.458 1.103 . . . . 2.86 108.561 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -130.69 148.98 52.54 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.97 0.908 . . . . 2.72 110.657 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.453 HD21 HD13 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -119.35 70.91 12.21 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.366 0.666 . . . . 3.83 112.309 -159.307 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 -14.65 44.46 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.231 2.621 . . . . 1.05 115.438 -168.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.25 161.33 53.35 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.397 0.998 . . . . 1.17 112.92 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 3.8 m-20 -91.08 -2.24 57.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.507 1.523 . . . . 3.1 113.353 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -117.73 160.06 39.92 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.034 1.733 . . . . 1.3 110.618 172.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.43 157.38 25.56 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.77 2.314 . . . . 0.66 111.235 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.453 HD13 HD21 ' A' ' 24' ' ' ASN . 2.3 mp -124.02 127.95 48.64 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.58 1.552 . . . . 2.37 110.727 -172.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -113.37 104.98 12.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.263 1.425 . . . . 4.67 110.794 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.2 tp -89.64 115.68 27.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.664 2.385 . . . . 0.84 108.78 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.8 m -110.24 -8.65 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.403 1.081 . . . . 0.55 113.541 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.6 -159.76 32.14 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 121.636 -0.665 . . . . 0.38 113.331 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.813 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -147.71 178.74 8.23 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.59 0.756 . . . . 0.68 112.221 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -152.58 145.92 24.79 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.572 -1.27 . . . . 6.97 107.572 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -155.76 156.06 30.2 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.927 1.291 . . . . 0.63 109.279 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.35 -26.94 71.24 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.585 2.19 . . . . 0.97 113.339 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.323 1.5 m -92.45 11.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.914 1.45 . . . . 1.5 114.914 -170.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -155.9 151.01 26.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.981 1.312 . . . . 0.9 112.409 177.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -97.34 -78.19 0.48 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.318 -0.993 . . . . 3.36 108.318 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -74.6 107.42 6.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.078 -1.453 . . . . 3.36 107.078 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.21 129.24 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 1.47 108.22 173.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.39 127.81 18.9 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.026 1.331 . . . . 2.31 110.138 -162.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -79.21 121.16 24.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.825 0.821 . . . . 0.76 110.588 175.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -107.4 153.49 22.71 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.393 1.877 . . . . 0.73 112.94 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.0 164.17 13.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.852 1.661 . . . . 2.29 110.89 161.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 81.5 m -129.75 105.88 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.888 1.675 . . . . 1.03 108.334 166.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -106.2 158.1 17.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.788 1.235 . . . . 2.25 113.261 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.0 mtp -124.52 100.82 6.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.363 1.465 . . . . 4.02 110.36 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -122.63 145.87 47.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.415 1.486 . . . . 5.52 110.928 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.2 mp0 -59.96 147.33 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.529 0.731 . . . . 3.57 111.349 165.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -159.31 -47.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.944 1.09 . . . . 2.96 113.944 170.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -93.28 38.28 1.04 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.485 1.914 . . . . 5.83 110.746 171.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.54 -40.16 0.76 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.5 1.524 . . . . 2.56 113.043 -167.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -86.93 154.52 20.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.581 2.352 . . . . 3.71 111.122 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -68.44 122.99 19.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.875 0.87 . . . . 4.13 111.267 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.84 151.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.351 1.461 . . . . 2.72 109.935 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -83.55 141.95 31.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.61 1.564 . . . . 2.91 111.155 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.77 170.5 33.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.967 0.794 . . . . 1.13 112.884 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.98 145.12 41.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.76 1.224 . . . . 2.1 111.229 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -153.32 143.36 15.34 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 125.447 1.499 . . . . 3.29 109.964 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.78 145.56 75.52 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.755 1.637 . . . . 0.75 110.595 163.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -118.32 154.16 51.92 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.687 1.595 . . . . 0.76 110.084 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.09 -9.56 26.28 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.827 2.351 . . . . 1.23 114.136 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -172.37 163.03 5.56 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.098 1.317 . . . . 2.12 111.664 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -119.19 169.69 9.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.586 1.554 . . . . 0.69 108.482 148.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -158.16 164.24 36.77 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.045 -1.034 . . . . 2.3 112.118 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.02 138.5 14.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 1.12 110.593 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.07 161.6 45.37 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.676 2.25 . . . . 1.1 111.314 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.38 146.2 93.2 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.98 2.453 . . . . 0.83 111.798 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 68.7 mmtt 69.97 -12.48 0.48 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.507 2.723 . . . . 1.36 114.624 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.5 130.86 29.13 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 126.456 1.979 . . . . 0.95 111.974 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -94.49 129.02 41.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.095 -1.553 . . . . 5.57 110.045 161.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.73 178.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.681 1.592 . . . . 1.4 110.345 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -141.07 140.2 34.18 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.128 0.971 . . . . 3.3 110.169 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.59 59.77 3.1 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.702 1.239 . . . . 1.15 108.912 155.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -72.14 122.41 87.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.677 -1.154 . . . . 3.52 110.116 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.95 -27.08 83.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.372 2.715 . . . . 1.55 114.792 -168.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.13 84.31 1.6 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.746 -1.742 . . . . 1.58 108.746 157.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.443 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.01 -87.44 0.16 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.334 1.921 . . . . 1.36 111.55 -166.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -143.42 153.77 43.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.246 1.818 . . . . 1.91 110.881 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -157.79 165.43 35.35 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.509 1.123 . . . . 0.74 109.736 175.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -93.2 137.23 32.73 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.8 -1.185 . . . . 2.09 107.8 159.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.7 139.5 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.744 1.218 . . . . 1.46 109.411 168.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.5 mt -117.83 131.69 56.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.86 1.264 . . . . 1.96 110.459 -172.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.85 159.49 42.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.721 1.608 . . . . 1.79 111.928 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -56.87 4.51 Favored Glycine 0 N--CA 1.47 0.934 0 C-N-CA 124.897 1.237 . . . . 2.37 112.73 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.4 mt 70.76 98.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 129.715 3.206 . . . . 1.4 113.252 171.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -11.01 59.83 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.17 1.174 . . . . 1.78 114.17 -171.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -141.33 158.1 64.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 129.588 3.155 . . . . 7.69 108.928 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.49 163.2 39.83 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.513 2.809 . . . . 1.89 110.294 160.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.27 151.6 44.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.183 0.993 . . . . 2.52 112.275 -167.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -142.34 120.58 12.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.446 1.098 . . . . 3.81 110.445 -170.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 140.27 54.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.548 0.739 . . . . 1.76 112.783 172.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.02 -20.6 33.14 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.339 1.447 . . . . 3.08 115.158 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -173.72 4.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.249 1.024 . . . . 5.34 111.084 -169.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -95.64 152.06 18.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.715 0.769 . . . . 4.25 110.727 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.26 127.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.388 2.275 . . . . 1.37 108.156 163.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.03 150.14 24.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.731 0.812 . . . . 3.27 109.842 170.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.813 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.2 tt -158.68 140.04 13.27 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.248 1.019 . . . . 1.67 113.252 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.472 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.7 m-20 -101.99 107.08 18.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.513 2.325 . . . . 2.2 111.443 171.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.9 119.22 21.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.154 0.982 . . . . 1.11 110.397 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.4 mt -95.05 131.93 40.49 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.788 1.235 . . . . 0.59 111.768 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.23 139.47 53.7 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.226 1.195 . . . . 1.91 114.226 -177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.27 72.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.895 1.278 . . . . 2.36 114.203 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.49 33.43 1.83 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.588 1.09 . . . . 4.42 114.176 -174.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.25 49.21 67.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.721 1.153 . . . . 1.68 112.645 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 160.75 39.28 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.865 1.666 . . . . 4.15 112.053 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.22 145.55 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.523 1.929 . . . . 1.08 107.707 170.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.71 121.68 25.93 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.826 1.25 . . . . 1.68 110.717 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 3.0 tpmt? -72.07 131.19 42.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.039 0.536 . . . . 2.42 111.331 176.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.86 150.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.232 1.413 . . . . 1.58 109.832 166.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.82 152.15 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.958 1.703 . . . . 2.57 109.045 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.5 mt -148.69 144.77 18.74 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.254 1.422 . . . . 2.24 109.708 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.25 149.0 81.34 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.17 2.58 . . . . 1.19 112.214 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.28 128.08 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.829 1.252 . . . . 1.12 109.24 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -118.23 135.08 54.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.726 1.61 . . . . 3.32 107.501 166.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.9 125.07 30.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.695 0.68 . . . . 2.06 110.283 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.037 1.335 . . . . 7.49 111.795 -175.487 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 105.835 -1.913 . . . . 6.44 105.835 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.57 -151.98 28.85 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.297 0.951 . . . . 1.59 112.586 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -166.22 138.54 3.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.771 1.228 . . . . 1.64 112.487 177.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.73 145.27 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.377 1.071 . . . . 1.46 108.356 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.437 ' HE ' ' HB3' ' A' ' 17' ' ' ALA . 5.3 tmm_? -117.03 85.95 2.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.106 0.962 . . . . 4.66 109.758 -166.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.76 149.46 48.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.878 1.671 . . . . 2.78 112.222 -174.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -152.43 153.44 30.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.32 2.248 . . . . 2.08 107.743 174.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.27 -12.67 35.68 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.227 2.618 . . . . 2.22 112.865 170.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.78 -167.84 13.96 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.395 0.998 . . . . 1.67 114.162 170.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.34 -2.23 19.84 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 CA-C-N 118.195 0.998 . . . . 1.78 113.309 -3.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -134.63 163.26 30.14 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.248 1.819 . . . . 2.41 112.482 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.43 179.51 9.06 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.757 2.023 . . . . 0.74 111.288 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB3' ' HE ' ' A' ' 9' ' ' ARG . . . -134.67 166.08 23.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.668 0.787 . . . . 1.07 112.864 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.88 135.35 32.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.309 0.644 . . . . 0.78 111.806 170.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.45 147.87 42.32 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.329 1.452 . . . . 2.49 108.252 172.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.06 148.6 20.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.418 0.687 . . . . 2.0 111.593 -170.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -91.17 116.07 28.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.722 0.772 . . . . 1.78 109.452 166.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 125.44 35.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.204 -1.406 . . . . 2.79 107.204 164.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.59 146.45 47.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.128 0.966 . . . . 3.64 111.328 165.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -114.87 90.88 24.11 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-N 114.725 -1.125 . . . . 0.98 109.22 171.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.04 -9.59 20.78 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.539 2.159 . . . . 0.95 112.98 176.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 -167.18 42.34 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.84 1.209 . . . . 1.14 113.394 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -121.57 5.51 10.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.376 1.47 . . . . 2.73 112.855 -166.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.93 163.06 41.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.61 1.964 . . . . 1.44 109.915 173.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.82 148.09 15.5 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.406 2.071 . . . . 0.66 112.272 -171.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -111.44 108.36 17.89 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.344 1.458 . . . . 2.09 109.703 -177.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -102.18 102.49 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.536 1.534 . . . . 4.63 112.355 -178.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.51 124.57 37.59 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.636 1.974 . . . . 0.94 108.394 -173.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.92 -11.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.662 1.185 . . . . 0.73 112.723 -172.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -162.57 29.96 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 123.789 0.709 . . . . 0.61 112.463 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.564 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -152.87 -179.27 7.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.421 1.089 . . . . 0.82 110.697 174.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -156.1 145.17 20.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.136 -1.431 . . . . 5.17 107.136 173.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.59 149.17 23.47 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 118.95 0.795 . . . . 0.68 109.928 -176.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.08 -10.74 29.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.948 2.432 . . . . 0.85 113.305 173.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 3.0 m -92.51 7.36 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 114.324 1.231 . . . . 1.1 114.324 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.39 165.83 28.17 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.071 -1.018 . . . . 0.83 112.801 -179.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -111.29 -62.49 1.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.966 -0.753 . . . . 3.66 108.966 170.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -86.12 138.76 31.68 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.286 -0.884 . . . . 3.59 109.862 168.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.12 138.75 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.432 2.293 . . . . 1.48 109.19 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -143.11 136.54 28.37 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.952 1.701 . . . . 2.86 110.157 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.445 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 6.4 tt -84.11 119.27 24.78 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.325 0.966 . . . . 0.73 110.686 167.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.3 m170 -110.42 167.0 10.54 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.547 1.939 . . . . 0.84 112.111 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 6.0 pt-20 -136.74 -173.18 3.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.848 1.659 . . . . 3.42 112.172 175.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.8 m -136.79 124.11 21.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.273 -1.01 . . . . 1.54 108.273 167.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -114.02 176.96 4.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 2.25 111.09 179.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtm -131.93 139.25 48.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.322 1.049 . . . . 2.87 110.457 163.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtp85 -143.16 156.62 44.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.096 1.358 . . . . 5.45 111.961 173.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 mp0 -67.25 151.63 47.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.025 1.73 . . . . 4.69 110.948 159.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.29 -41.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 114.38 -1.282 . . . . 2.94 114.238 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -117.68 32.4 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.769 2.028 . . . . 3.94 110.541 167.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.4 -35.68 1.34 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.845 -1.159 . . . . 2.6 112.785 -166.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 mttp -70.58 144.5 51.2 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.274 -1.133 . . . . 2.95 109.095 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -99.48 140.72 33.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.439 0.903 . . . . 4.02 113.439 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.21 150.57 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.497 1.919 . . . . 2.31 108.819 -171.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.3 mtm -80.26 149.81 30.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.147 1.379 . . . . 3.23 111.517 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.16 160.67 30.63 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.961 -0.462 . . . . 1.28 113.184 173.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -115.64 152.58 32.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.786 1.234 . . . . 2.03 111.385 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -164.87 156.99 13.76 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.955 1.302 . . . . 6.77 111.646 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 43.4 Cg_endo -66.01 145.17 78.77 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.79 2.327 . . . . 0.95 110.73 161.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 156.39 53.83 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.838 1.655 . . . . 1.02 109.758 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.99 -11.01 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.062 2.508 . . . . 1.11 114.338 -179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -175.91 168.9 2.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.515 1.526 . . . . 2.39 110.638 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.77 168.78 13.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.091 1.757 . . . . 0.85 108.58 154.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -155.44 164.04 39.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.058 -1.026 . . . . 2.27 111.978 163.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.79 129.08 16.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 124.034 0.934 . . . . 0.83 110.03 -172.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.22 162.88 40.66 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.435 2.09 . . . . 0.75 111.082 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.6 141.48 91.43 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.111 2.541 . . . . 0.93 112.083 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt 70.23 -1.33 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.77 2.428 . . . . 1.19 113.728 -172.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.34 121.49 5.54 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 127.248 2.356 . . . . 0.82 111.644 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -99.23 135.76 40.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.43 1.492 . . . . 5.94 110.48 161.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.34 148.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.6 1.56 . . . . 1.26 110.285 174.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -131.4 120.93 23.75 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.647 -0.501 . . . . 5.48 109.647 -166.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.6 68.65 9.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.448 1.594 . . . . 1.34 112.565 -161.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -64.54 142.31 98.42 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.52 2.328 . . . . 4.1 114.519 173.24 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -30.77 47.47 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.955 3.104 . . . . 1.46 113.397 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.73 74.21 2.43 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 108.424 -1.87 . . . . 1.45 108.424 163.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.78 -152.77 21.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.954 1.74 . . . . 2.49 111.514 -167.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 6.0 m-85 -72.47 135.91 45.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.226 1.41 . . . . 2.63 111.839 -174.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -168.09 178.88 4.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.613 1.165 . . . . 1.14 109.457 -174.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.445 ' CZ ' HD12 ' A' ' 45' ' ' LEU . 57.7 m-85 -114.2 139.83 49.05 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.336 0.516 . . . . 2.52 111.823 173.244 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 mmt -101.72 131.1 48.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.902 1.681 . . . . 1.07 110.101 168.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.94 138.94 53.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.631 1.573 . . . . 3.12 110.684 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.96 157.67 45.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.902 1.681 . . . . 2.39 112.036 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.39 -47.86 3.93 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 124.854 1.216 . . . . 2.58 112.799 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt 57.92 88.76 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.923 2.489 . . . . 0.94 112.97 169.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.43 0.49 12.15 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.168 1.544 . . . . 2.23 115.168 -169.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.3 mtp-105 -149.04 151.36 34.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.347 2.259 . . . . 4.96 108.837 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -88.72 -10.27 4.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.71 3.607 . . . . 3.37 117.86 -176.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.0 mt 80.09 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 127.904 2.481 . . . . 3.59 114.357 156.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.22 -175.66 4.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 130.781 3.633 . . . . 4.73 109.43 176.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.1 149.84 32.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.247 -1.39 . . . . 2.54 107.247 139.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.96 15.44 77.39 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 118.849 0.749 . . . . 2.71 112.819 -164.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -115.57 140.68 48.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.095 -1.446 . . . . 3.63 107.095 144.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.42 134.75 53.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.16 -1.836 . . . . 4.93 109.457 -160.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.6 t -106.42 104.74 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.299 -0.409 . . . . 1.24 111.462 -150.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.14 128.4 35.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.456 -1.247 . . . . 3.39 110.097 160.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.564 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.3 tt -138.49 137.88 37.55 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.628 1.571 . . . . 2.03 108.755 -177.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -91.31 106.63 18.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.33 2.252 . . . . 2.56 111.12 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.73 106.58 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.445 1.098 . . . . 1.75 110.863 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.39 118.11 22.94 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.76 -0.459 . . . . 0.88 109.76 -174.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.28 147.78 38.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.011 0.924 . . . . 1.93 111.726 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.61 130.5 28.26 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.22 1.008 . . . . 1.79 112.329 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.64 -151.98 20.85 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.277 0.941 . . . . 3.79 110.756 -163.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.92 23.21 35.37 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.828 1.204 . . . . 2.59 114.104 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.55 125.36 35.18 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.042 -1.269 . . . . 5.39 111.428 -177.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.96 124.79 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.322 1.049 . . . . 1.81 110.928 171.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.31 122.12 41.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.542 1.537 . . . . 3.42 109.811 -174.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -85.76 124.09 31.88 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.903 -0.498 . . . . 2.69 111.566 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.71 148.22 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.16 1.384 . . . . 1.9 111.242 178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.97 131.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.881 1.272 . . . . 1.69 111.333 -177.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -128.66 151.96 77.88 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 125.289 1.436 . . . . 2.08 112.71 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.51 145.79 26.81 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.645 3.563 . . . . 1.86 112.147 177.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.18 139.56 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.537 1.135 . . . . 1.7 112.057 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -131.11 148.78 52.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.527 2.731 . . . . 3.54 108.487 173.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.73 48.28 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.062 -1.024 . . . . 2.24 110.711 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 N-CA-C 115.084 1.513 . . . . 5.98 115.084 -175.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 110.105 -0.331 . . . . 6.52 110.105 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.7 -169.97 42.77 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 114.967 0.747 . . . . 1.25 114.967 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -164.99 160.7 19.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 1.59 112.949 -175.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.53 132.72 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.766 -0.584 . . . . 1.27 110.605 177.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.3 ttp85 -96.61 97.89 9.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.85 1.26 . . . . 4.19 110.056 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 152.51 44.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.973 1.709 . . . . 2.04 111.625 -175.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 m -155.14 149.8 20.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 119.77 -1.832 . . . . 1.86 111.209 168.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.32 25.52 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.622 3.548 . . . . 1.66 114.19 -175.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.86 165.31 29.15 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.47 -0.769 . . . . 1.32 113.952 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.87 -3.77 31.52 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 CA-C-N 118.097 0.949 . . . . 1.53 113.629 -2.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -154.69 -179.53 8.09 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.591 1.556 . . . . 1.87 111.644 -175.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.67 -175.06 4.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.891 1.677 . . . . 0.62 111.924 -179.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.11 149.47 45.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.782 0.833 . . . . 0.93 112.654 -175.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.31 51.77 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.203 1.401 . . . . 0.75 112.159 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.57 157.95 43.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.108 1.363 . . . . 2.3 111.906 -177.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.6 159.66 12.24 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.73 1.212 . . . . 1.64 111.92 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.3 m -79.99 146.39 32.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.617 1.567 . . . . 1.66 108.455 154.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -143.43 136.92 28.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.483 0.713 . . . . 2.62 109.609 169.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -116.21 143.04 46.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.053 0.941 . . . . 2.93 112.71 167.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -87.98 111.98 46.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.46 1.104 . . . . 1.12 108.624 161.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -85.48 -12.12 6.75 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.156 2.571 . . . . 1.16 113.456 174.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.24 161.92 39.79 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.519 1.057 . . . . 1.28 112.482 -177.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.09 4.06 53.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.217 1.807 . . . . 3.31 113.327 -174.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.31 161.36 35.5 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.397 1.879 . . . . 1.32 110.02 168.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.85 154.4 26.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.853 2.369 . . . . 0.68 111.574 -171.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.58 127.6 52.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.33 1.452 . . . . 2.15 110.169 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -118.0 114.11 22.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.66 1.184 . . . . 3.8 111.787 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.9 tp -100.51 109.9 22.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.369 2.668 . . . . 1.06 109.806 -171.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.41 -13.76 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.413 1.085 . . . . 0.68 113.84 -165.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.39 -160.56 31.91 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.0 0.81 . . . . 0.43 112.41 -176.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.71 -174.08 4.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 117.73 0.765 . . . . 0.95 112.998 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 102' ' ' ASP . 2.1 mmp_? -149.77 138.17 20.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.813 2.445 . . . . 6.09 107.541 176.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -150.02 153.89 36.18 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 119.855 1.207 . . . . 0.88 110.686 -170.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.45 -32.33 12.51 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.252 1.968 . . . . 1.21 111.716 165.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.402 1.3 m -93.1 6.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 115.503 1.668 . . . . 1.22 115.503 -169.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.75 174.26 13.24 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.052 1.341 . . . . 1.17 109.744 167.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -118.01 -74.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.778 0.717 . . . . 4.31 109.618 175.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttm105 -66.25 133.98 51.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.735 -1.209 . . . . 4.69 107.735 163.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.26 129.62 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.823 1.249 . . . . 1.54 108.406 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -134.44 127.76 32.14 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.084 0.954 . . . . 2.39 109.452 -160.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.81 117.6 20.07 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.496 1.141 . . . . 0.81 109.909 171.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.6 m170 -107.1 154.02 21.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.671 1.588 . . . . 0.8 111.326 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.74 179.46 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.261 -1.336 . . . . 1.94 110.449 167.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.7 m -149.97 94.46 2.16 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.284 1.433 . . . . 1.16 107.725 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -90.71 165.53 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.169 1.788 . . . . 2.15 112.857 -169.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.7 mtm -98.52 152.45 19.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.349 -0.841 . . . . 2.52 109.891 158.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -151.67 132.0 13.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.216 1.806 . . . . 6.07 108.895 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.75 144.14 31.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.519 0.728 . . . . 4.39 110.899 173.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.2 122.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.154 1.382 . . . . 3.4 107.542 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.6 tm-20 58.76 29.69 19.02 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.325 1.059 . . . . 5.56 110.994 -174.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.49 -6.57 16.03 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 120.089 -1.632 . . . . 2.17 114.47 -173.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 34.7 mmtm -85.06 138.92 32.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.455 1.502 . . . . 4.09 109.115 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -85.79 142.97 28.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.278 0.49 . . . . 4.13 112.24 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.92 159.61 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 2.7 110.433 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.7 mtp -102.93 166.08 10.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.04 0.936 . . . . 4.62 111.688 169.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.48 174.74 34.94 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 123.829 0.728 . . . . 1.18 112.006 167.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.37 159.94 38.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.803 1.241 . . . . 1.89 110.025 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.81 151.18 0.98 Allowed Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.928 1.691 . . . . 3.46 110.431 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.7 Cg_endo -68.9 149.74 72.62 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.613 1.542 . . . . 1.0 111.103 166.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.28 157.84 39.95 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 0.58 109.859 172.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -66.78 -20.15 52.53 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.229 1.953 . . . . 0.74 112.522 174.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -179.56 161.28 1.02 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 126.731 2.012 . . . . 2.3 110.877 178.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mt -103.99 168.83 8.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.082 0.953 . . . . 0.81 109.705 150.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.47 164.58 36.45 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.843 -0.536 . . . . 2.42 111.419 167.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.7 t -140.51 129.49 13.06 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 125.555 1.542 . . . . 0.77 108.664 -164.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.79 161.83 44.7 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.977 1.784 . . . . 0.91 111.161 177.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.2 140.71 96.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.182 2.588 . . . . 0.93 111.74 177.09 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 67.95 -3.27 1.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.857 2.063 . . . . 1.37 113.368 -177.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.07 119.85 4.97 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 127.277 2.37 . . . . 1.17 111.891 -172.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -81.76 136.95 35.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.642 1.177 . . . . 4.85 110.459 156.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 m -150.99 145.48 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.102 1.761 . . . . 1.68 109.807 173.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -103.35 139.28 38.97 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.477 0.917 . . . . 3.57 113.477 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.38 54.95 0.95 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.128 1.442 . . . . 1.29 109.72 156.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -54.2 114.99 7.42 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.546 -1.216 . . . . 4.82 109.966 162.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.58 -28.18 85.05 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.211 2.607 . . . . 1.35 114.824 -170.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.19 36.24 0.94 Allowed Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.342 0.973 . . . . 1.87 113.367 166.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.06 -48.19 0.04 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.93 2.205 . . . . 1.37 113.65 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -154.08 145.12 22.75 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.072 1.749 . . . . 1.9 110.39 -174.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -165.66 171.81 12.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.969 1.308 . . . . 0.77 110.52 -178.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -103.35 135.08 45.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.108 0.563 . . . . 1.95 110.667 165.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.1 mmt -92.74 134.74 34.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.532 1.133 . . . . 0.86 110.467 165.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.2 mt -109.78 114.98 29.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.802 1.641 . . . . 2.23 110.186 -176.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.77 155.48 31.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.223 1.409 . . . . 3.55 111.039 -174.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.55 -39.69 3.1 Favored Glycine 0 N--CA 1.48 1.572 0 O-C-N 120.628 -1.295 . . . . 2.29 113.55 165.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 49.78 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 124.434 2.064 . . . . 1.39 115.822 162.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -79.72 4.63 15.67 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.245 -1.798 . . . . 2.85 114.187 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -155.42 158.97 32.05 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.837 2.855 . . . . 4.86 107.32 -175.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.08 -13.77 21.14 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.518 . . . . 4.37 117.552 -173.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mp 60.82 -4.77 0.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 130.069 3.348 . . . . 4.28 113.716 -169.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -42.64 149.65 0.17 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.7 2.8 . . . . 3.36 115.124 -171.007 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.7 126.34 21.58 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.955 1.302 . . . . 1.88 112.125 178.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.74 30.1 45.19 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.778 -0.457 . . . . 3.53 112.931 -165.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 -176.7 3.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.992 -1.855 . . . . 4.28 105.992 139.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.23 155.11 50.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.634 -1.247 . . . . 4.72 107.634 165.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.5 93.18 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 122.428 1.109 . . . . 1.27 110.538 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.05 123.1 16.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.856 -1.974 . . . . 3.82 108.857 153.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.1 114.28 16.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.656 0.741 . . . . 1.76 109.062 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 9.7 m-20 -89.99 89.33 7.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.291 1.836 . . . . 2.45 108.307 176.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.9 120.46 13.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.923 1.689 . . . . 1.31 109.567 -178.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.3 mt -86.1 139.04 31.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.084 1.353 . . . . 0.57 110.391 -175.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -117.04 165.02 13.85 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.845 -0.534 . . . . 2.16 112.421 177.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.96 70.84 1.53 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.504 1.122 . . . . 1.94 112.681 -176.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 137.07 -154.11 22.13 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.95 1.738 . . . . 3.12 111.638 -178.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.67 46.84 2.65 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.372 0.987 . . . . 1.92 114.894 -173.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -136.03 143.43 44.73 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.53 1.932 . . . . 4.43 110.673 173.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -152.07 143.85 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 127.506 2.323 . . . . 1.12 107.108 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -133.71 118.3 17.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.85 0.86 . . . . 1.78 111.538 -171.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -74.67 117.88 16.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.843 0.457 . . . . 2.45 111.612 173.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.46 165.28 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.767 1.227 . . . . 2.05 110.42 160.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.21 136.15 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.457 1.103 . . . . 2.63 109.195 171.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.9 mt -146.9 109.35 4.04 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.509 1.123 . . . . 2.02 110.693 -167.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.77 156.56 65.05 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.13 2.553 . . . . 1.21 113.165 -174.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -80.36 133.87 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 122.084 0.945 . . . . 1.3 112.018 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -121.5 151.65 40.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 130.44 3.496 . . . . 3.78 106.711 165.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.55 16.41 7.59 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.377 1.621 . . . . 2.78 115.377 -154.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 113.717 1.006 . . . . 7.31 113.717 -160.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 111.911 0.337 . . . . 6.08 111.911 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.99 167.52 28.3 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.699 1.619 . . . . 1.32 113.981 176.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -151.49 128.04 10.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.739 1.216 . . . . 2.04 111.593 -170.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -100.03 112.21 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.344 -0.847 . . . . 1.27 109.952 -170.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 1.8 tmt_? -84.03 89.71 7.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.333 1.453 . . . . 3.41 111.649 -161.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.3 147.53 40.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.78 2.032 . . . . 2.28 111.768 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.0 m -159.05 156.76 27.1 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 127.524 2.33 . . . . 2.75 109.273 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.01 12.61 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.852 3.035 . . . . 2.51 114.457 -172.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.44 171.82 36.46 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.026 0.83 . . . . 2.43 112.455 -167.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.65 -3.69 11.03 Favored 'Cis proline' 0 C--N 1.351 0.7 0 CA-C-N 119.143 1.472 . . . . 3.23 113.352 -4.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -146.67 175.12 10.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.73 1.612 . . . . 2.51 110.625 175.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.16 -177.37 5.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.665 2.386 . . . . 0.69 108.869 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.7 175.29 9.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.446 1.021 . . . . 1.04 113.401 -173.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.51 152.74 29.24 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.425 0.898 . . . . 0.69 113.425 169.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.18 162.42 38.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.599 1.56 . . . . 2.11 110.582 174.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -174.12 150.2 1.53 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.977 1.711 . . . . 1.95 113.646 -173.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.7 m -68.55 135.24 51.24 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.701 1.6 . . . . 1.81 109.12 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.21 133.78 37.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.359 -0.978 . . . . 2.94 108.359 173.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -149.56 138.09 20.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.082 0.944 . . . . 3.5 111.391 175.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -100.26 100.69 12.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.885 1.674 . . . . 1.22 108.961 -178.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.69 -8.89 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.109 1.873 . . . . 1.28 112.998 174.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.98 161.17 43.5 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.058 0.837 . . . . 1.09 113.092 -178.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.04 5.8 50.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.115 1.766 . . . . 3.07 113.422 -172.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.02 159.06 42.5 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.936 1.694 . . . . 1.73 109.949 165.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.39 159.21 25.97 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.274 2.65 . . . . 1.16 111.796 -170.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.8 mt -110.95 156.32 21.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.396 1.093 . . . . 1.84 111.384 170.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -144.12 106.62 4.41 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.511 1.524 . . . . 3.6 109.432 175.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.3 tp -91.66 122.37 34.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.312 2.245 . . . . 0.93 108.576 -177.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.23 -16.1 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 113.898 1.074 . . . . 0.65 113.898 -174.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -160.83 30.68 Favored Glycine 0 C--N 1.341 0.853 0 O-C-N 121.47 -0.769 . . . . 0.47 112.27 177.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.7 178.6 8.95 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 0.65 111.081 168.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -147.03 141.22 26.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.35 1.06 . . . . 6.9 110.39 177.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -149.19 157.23 39.85 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.296 1.438 . . . . 0.92 111.369 -167.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.1 -25.14 8.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.343 2.029 . . . . 1.3 113.355 165.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.29 3.6 m -87.5 12.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.484 1.29 . . . . 1.22 114.484 -173.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.12 145.99 30.72 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.521 1.128 . . . . 0.97 110.741 173.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.05 -74.71 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.707 -1.59 . . . . 5.8 106.707 170.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -80.17 142.19 34.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.305 1.842 . . . . 2.93 109.692 169.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.22 131.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.66 1.584 . . . . 1.47 108.811 177.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -146.65 133.82 20.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.445 1.498 . . . . 1.95 109.96 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.65 123.81 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.296 1.046 . . . . 0.91 111.003 171.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 14.9 m170 -117.29 152.02 35.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.847 2.059 . . . . 0.72 113.492 -178.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.49 160.18 15.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.003 1.321 . . . . 2.13 110.493 165.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.2 m -110.53 144.14 39.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.172 1.789 . . . . 1.46 107.7 163.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -152.19 162.42 41.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 114.679 1.363 . . . . 2.39 114.679 -169.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.2 ptp -121.08 144.6 48.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.233 1.413 . . . . 3.81 110.332 159.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -147.76 142.31 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.113 1.365 . . . . 8.31 110.402 171.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.18 149.07 46.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.611 1.564 . . . . 4.13 111.718 175.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 p -146.63 -11.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.458 1.281 . . . . 3.24 114.458 173.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.21 30.56 0.49 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.175 1.79 . . . . 4.1 110.875 178.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.35 -14.97 3.72 Favored Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.494 -1.379 . . . . 1.98 113.659 -167.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 167.76 9.57 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.185 2.194 . . . . 2.62 110.019 158.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.56 148.68 34.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.997 1.851 . . . . 3.67 115.997 -170.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.82 141.94 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.402 1.881 . . . . 3.16 109.086 165.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 tpp -93.25 137.59 32.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.589 1.555 . . . . 2.81 109.836 171.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 -177.77 29.01 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.801 0.715 . . . . 1.64 114.584 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.4 mtt -141.48 156.64 45.74 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.159 1.784 . . . . 3.17 110.211 176.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -164.96 156.07 12.87 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.25 1.42 . . . . 4.37 110.84 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 33.0 Cg_endo -66.93 150.45 82.98 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.933 1.755 . . . . 0.81 112.284 169.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.96 158.69 41.75 Favored Pre-proline 0 N--CA 1.471 0.625 0 C-N-CA 126.599 1.96 . . . . 0.96 109.829 174.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.04 -29.5 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.142 1.895 . . . . 1.36 112.247 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 p90 175.92 160.88 0.3 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.499 1.52 . . . . 1.9 107.14 -175.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -112.13 162.55 15.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.275 1.036 . . . . 2.62 111.033 155.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -145.27 157.66 44.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.071 -1.422 . . . . 2.52 114.174 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -145.88 133.74 10.5 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 114.553 -1.203 . . . . 1.07 108.481 -161.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.9 171.22 15.01 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.011 1.807 . . . . 1.33 111.334 176.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.86 144.06 99.51 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.075 2.517 . . . . 1.24 111.435 165.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 66.62 4.85 3.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.859 1.664 . . . . 1.58 113.173 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.46 126.23 8.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 128.232 2.825 . . . . 1.16 112.494 -170.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -98.78 141.82 31.1 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.642 1.577 . . . . 3.92 112.601 166.27 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.4 122.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.321 1.848 . . . . 1.42 108.744 168.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.443 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 18.0 mp0 -89.68 143.37 26.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.255 -0.903 . . . . 4.05 111.163 176.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.44 148.49 43.21 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.321 -0.862 . . . . 2.62 109.07 164.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' A' ' 76' ' ' GLU . 12.3 ptpt -166.86 138.72 2.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.947 1.299 . . . . 4.14 111.363 -165.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.91 -26.79 58.94 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.153 3.236 . . . . 1.45 114.294 -169.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.72 78.71 1.03 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.145 -1.582 . . . . 1.74 109.145 161.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.42 -76.5 0.21 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 124.247 0.927 . . . . 1.24 114.236 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -148.3 136.64 21.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.167 1.387 . . . . 2.26 111.623 -168.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.55 167.24 29.03 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.801 -0.562 . . . . 0.88 110.053 -172.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -96.88 133.73 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.392 -0.966 . . . . 2.34 108.392 165.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 mmt -82.92 137.57 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.182 -0.673 . . . . 0.89 109.182 157.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.94 127.81 55.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.967 2.107 . . . . 1.88 107.112 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -136.2 158.37 44.57 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.495 1.118 . . . . 1.88 111.412 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.58 -61.36 3.23 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.421 1.486 . . . . 3.14 112.551 178.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.5 mt 76.84 100.33 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 130.861 3.664 . . . . 1.23 110.837 173.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.026 -1.046 . . . . 1.93 113.139 -169.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -150.4 153.8 35.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.488 2.715 . . . . 6.67 108.282 169.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -67.43 158.79 55.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.857 2.372 . . . . 2.42 110.386 166.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.19 157.29 26.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.383 1.473 . . . . 2.53 111.565 -171.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -139.28 134.43 32.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.344 1.057 . . . . 3.69 111.142 176.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.87 38.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.202 0.601 . . . . 1.66 111.906 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.13 -15.12 8.28 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.372 1.463 . . . . 2.21 116.038 173.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -176.04 3.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.19 1.495 . . . . 4.64 111.243 -171.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -89.28 160.97 16.64 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.62 1.568 . . . . 4.75 112.362 171.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.37 127.59 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.054 1.742 . . . . 1.34 108.863 167.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.32 134.11 41.1 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.326 1.45 . . . . 2.69 110.259 164.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.67 127.37 10.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.498 1.142 . . . . 1.7 113.59 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.71 94.5 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.534 1.534 . . . . 2.6 110.446 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.27 115.94 11.01 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.379 1.472 . . . . 1.21 110.524 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.0 mt -88.09 129.92 35.16 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.685 1.194 . . . . 0.82 110.643 -172.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.66 144.9 50.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.056 0.931 . . . . 2.04 112.463 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.91 125.55 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.856 1.262 . . . . 1.96 113.473 -169.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.2 70.23 1.25 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.643 1.115 . . . . 3.34 112.549 177.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.49 15.76 81.27 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.557 1.383 . . . . 1.95 116.557 163.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -105.92 148.36 27.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.967 1.883 . . . . 4.89 110.972 171.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.11 140.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.84 1.656 . . . . 1.12 107.914 167.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -120.2 116.99 26.72 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.224 1.009 . . . . 1.43 109.385 178.009 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -75.73 128.81 35.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.83 0.452 . . . . 2.57 110.835 174.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -137.04 144.32 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.01 1.724 . . . . 1.73 109.612 175.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.55 130.98 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.927 1.291 . . . . 2.44 108.473 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 mp -140.26 153.56 69.02 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.667 1.587 . . . . 2.58 110.013 -172.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.89 155.86 43.49 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.597 2.865 . . . . 1.41 112.937 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.46 142.75 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.776 1.23 . . . . 1.41 110.491 168.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.5 151.46 39.34 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.652 1.981 . . . . 2.81 108.501 164.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.72 28.68 7.19 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.914 1.45 . . . . 1.96 114.914 -161.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.412 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.86 1.264 . . . . 7.89 111.978 -165.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 CA--C 1.551 1.016 0 N-CA-C 110.528 -0.175 . . . . 5.61 110.528 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.91 170.95 23.54 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.168 -1.582 . . . . 0.94 114.581 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 p90 -165.58 149.78 8.4 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.137 0.975 . . . . 1.38 111.291 -175.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.42 147.54 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.368 -0.975 . . . . 0.97 108.368 167.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -97.08 119.72 36.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.947 0.794 . . . . 5.2 110.043 164.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.12 134.62 38.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.864 0.84 . . . . 2.56 108.86 156.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.2 m -139.66 160.89 59.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 125.635 1.574 . . . . 2.62 109.336 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.24 -7.26 13.41 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.485 2.79 . . . . 2.31 115.038 178.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.91 -164.47 18.53 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.254 0.934 . . . . 2.35 113.549 175.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.33 -7.46 12.99 Favored 'Cis proline' 0 C--N 1.351 0.672 0 CA-C-N 118.69 1.245 . . . . 2.04 113.389 -4.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.06 136.92 34.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.345 1.458 . . . . 3.31 110.919 176.496 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.57 -177.94 3.27 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.097 1.759 . . . . 0.59 110.695 -177.17 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.63 136.66 34.56 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.243 0.929 . . . . 0.73 113.068 -169.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.49 141.42 52.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 0.86 112.294 -178.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -135.62 165.43 25.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.806 1.643 . . . . 2.43 110.658 -172.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -171.34 148.96 2.68 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 1.5 112.783 168.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.0 m -77.28 138.07 39.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.809 -1.182 . . . . 1.22 107.809 149.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -136.33 143.22 44.02 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.522 1.929 . . . . 2.46 107.967 -177.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.63 135.24 49.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.731 0.812 . . . . 3.5 111.003 -177.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -97.23 100.73 8.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.515 -0.92 . . . . 1.15 108.515 165.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.79 -10.79 15.5 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.637 2.225 . . . . 1.28 113.146 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.44 -173.08 49.49 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.729 1.157 . . . . 1.4 113.413 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.21 1.34 16.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.913 1.685 . . . . 3.0 112.802 -168.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -123.03 161.0 47.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.327 1.851 . . . . 1.58 110.392 174.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 148.63 17.29 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.509 2.14 . . . . 0.8 111.833 -171.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.07 111.68 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.053 1.341 . . . . 2.08 110.605 -176.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -98.79 101.91 13.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.871 1.268 . . . . 4.28 110.865 -179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.07 114.56 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.676 1.99 . . . . 0.74 108.629 -175.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.77 -19.51 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.29 0.848 . . . . 0.62 113.29 -171.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.37 -163.55 30.43 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.267 0.937 . . . . 0.39 111.552 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.82 179.53 7.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 0.72 110.658 164.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -149.41 135.36 18.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.859 1.664 . . . . 6.63 108.068 -177.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -140.0 156.96 70.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.421 1.488 . . . . 0.79 109.997 -171.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.48 -25.19 9.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.276 1.984 . . . . 0.94 112.103 169.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.259 14.3 m -82.91 -11.52 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.469 1.285 . . . . 1.01 114.469 -173.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.11 155.71 47.65 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.526 0.935 . . . . 0.8 113.526 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.26 -91.83 0.11 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.945 1.298 . . . . 3.39 110.212 175.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -84.28 92.2 7.93 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.886 0.874 . . . . 3.1 108.826 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -87.15 139.26 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.288 1.035 . . . . 1.42 110.798 172.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -137.52 138.79 40.03 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.356 1.862 . . . . 1.93 110.751 -174.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.43 121.04 29.35 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.913 1.233 . . . . 0.75 111.747 169.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -108.61 155.91 20.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.266 1.826 . . . . 0.59 112.339 175.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.55 -179.76 4.04 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 2.58 110.696 169.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -140.32 116.19 10.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.144 1.378 . . . . 1.11 107.442 172.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -117.47 -179.49 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.509 1.524 . . . . 1.81 110.854 -174.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 73.6 mtm -130.16 128.04 40.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.169 0.988 . . . . 3.36 110.868 164.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -97.61 168.17 10.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.744 1.218 . . . . 7.33 111.527 167.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -88.51 142.57 27.6 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.535 0.734 . . . . 5.97 109.397 153.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.04 -6.92 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.141 1.163 . . . . 3.74 114.141 175.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -175.84 31.66 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.804 2.042 . . . . 4.01 109.425 -165.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.66 -19.68 0.15 Allowed Glycine 0 N--CA 1.479 1.501 0 O-C-N 119.545 -1.972 . . . . 2.29 114.769 -158.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -74.2 132.36 42.11 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.115 1.766 . . . . 3.96 109.159 175.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -76.4 126.34 30.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.101 -1.074 . . . . 4.2 108.101 169.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -140.01 139.13 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.176 1.391 . . . . 2.51 108.79 -175.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.8 mtp -69.9 162.25 28.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.217 1.192 . . . . 5.1 114.217 -175.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.71 164.17 32.52 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.791 1.186 . . . . 0.97 111.597 167.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.13 157.88 30.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.994 1.317 . . . . 1.79 110.183 172.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -169.44 151.56 4.51 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 3.82 110.607 177.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.3 Cg_endo -69.02 153.23 72.65 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.758 1.639 . . . . 0.56 111.708 169.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.76 159.02 50.42 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 126.261 1.824 . . . . 0.72 110.53 174.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -72.46 -21.49 22.59 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.677 2.251 . . . . 0.78 112.58 172.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -175.75 169.96 2.92 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.739 1.616 . . . . 2.33 110.839 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -122.11 174.33 7.01 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.905 2.482 . . . . 0.77 108.78 160.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -152.88 165.54 35.11 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.257 -0.902 . . . . 2.66 113.217 164.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -135.04 128.29 18.54 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 125.45 1.5 . . . . 1.22 109.058 -176.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.85 162.2 43.45 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.474 2.116 . . . . 1.16 111.03 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.21 94.45 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.975 2.45 . . . . 1.23 111.649 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt 68.1 -1.05 1.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.685 1.994 . . . . 1.53 113.671 -174.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.09 117.86 4.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 126.556 2.027 . . . . 1.19 111.894 -177.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -91.75 129.61 37.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.235 1.014 . . . . 6.17 110.035 157.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.07 171.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.861 1.664 . . . . 1.51 110.226 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -139.65 146.03 39.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.7 1.238 . . . . 4.65 114.117 176.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -85.34 71.64 10.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.939 1.696 . . . . 1.27 109.391 178.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -61.4 141.56 94.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 114.133 -1.394 . . . . 3.72 112.262 177.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.48 -18.04 51.58 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.653 2.236 . . . . 1.3 113.149 165.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.59 26.09 23.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.252 1.406 . . . . 1.26 114.107 172.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.52 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.476 1.36 0 CA-C-N 119.414 1.607 . . . . 1.35 115.735 175.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -159.97 140.4 11.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.632 1.573 . . . . 1.95 109.413 -176.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -171.0 168.68 6.89 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.491 1.951 . . . . 1.3 111.173 -175.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.31 125.75 46.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.507 0.723 . . . . 1.73 111.46 -178.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mmt -91.99 142.57 27.4 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.449 1.099 . . . . 1.12 110.014 170.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 mt -119.89 85.79 2.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.618 1.567 . . . . 1.78 109.053 -171.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.68 107.71 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.242 1.017 . . . . 3.32 108.632 -176.179 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.03 130.37 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.118 0.866 . . . . 2.77 111.801 -172.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.475 HD13 HD11 ' A' ' 93' ' ' LEU . 64.3 mt -112.6 118.49 35.22 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.771 0.828 . . . . 0.88 108.999 178.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.2 9.79 19.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.069 0.766 . . . . 2.49 113.069 -166.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -172.55 159.2 3.93 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 128.016 2.527 . . . . 5.3 108.919 -171.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.24 160.61 48.96 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.374 1.383 . . . . 2.13 110.018 162.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.475 HD11 HD13 ' A' ' 89' ' ' LEU . 3.6 mp -115.48 -164.72 0.97 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.453 1.901 . . . . 3.19 108.728 -171.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.15 136.95 13.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.399 1.48 . . . . 5.09 110.976 168.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.04 126.97 29.88 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.055 -1.091 . . . . 1.43 108.055 151.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.38 78.53 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.137 -1.924 . . . . 1.89 115.614 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -93.7 177.96 5.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.514 2.157 . . . . 3.56 110.051 153.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -103.58 149.13 25.18 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.589 0.756 . . . . 4.85 109.783 167.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.433 HG23 ' CG2' ' A' ' 117' ' ' VAL . 8.4 t -105.52 123.13 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.651 1.18 . . . . 1.15 108.215 168.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.64 124.06 21.81 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 113.949 -1.478 . . . . 4.71 107.5 162.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.17 109.42 10.8 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.932 0.873 . . . . 1.82 111.074 174.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.79 86.11 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.702 2.401 . . . . 2.63 109.673 173.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.18 117.22 8.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.829 1.252 . . . . 1.13 109.623 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.4 126.2 35.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.853 1.261 . . . . 0.81 110.735 -175.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.42 117.77 25.18 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.535 -0.728 . . . . 1.95 111.58 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.96 22.04 0.18 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.196 2.199 . . . . 2.69 115.985 171.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.9 -41.72 1.07 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.786 1.66 . . . . 3.94 113.847 -171.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.06 -1.82 90.15 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.987 -1.452 . . . . 1.73 116.071 -174.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.45 159.32 42.46 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.712 2.005 . . . . 4.03 111.727 168.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.14 145.99 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 126.42 1.888 . . . . 1.03 108.179 168.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -134.76 108.42 7.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.265 1.026 . . . . 1.63 109.858 -177.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.87 96.83 6.46 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.604 0.361 . . . . 2.94 110.817 176.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.86 151.39 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.631 0.772 . . . . 1.46 110.837 176.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.23 131.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.813 1.645 . . . . 1.93 108.734 168.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.7 mt -139.93 130.63 14.19 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 1.78 109.499 176.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.93 151.6 56.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.489 2.793 . . . . 1.1 111.692 176.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 99' ' ' VAL . 53.3 t -97.84 117.14 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.924 0.89 . . . . 1.23 111.787 178.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -75.57 155.36 36.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.553 2.741 . . . . 3.98 109.072 159.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.3 131.19 45.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.833 -1.167 . . . . 1.84 112.631 171.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.0 mtt180 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 127.577 2.351 . . . . 7.21 108.153 169.699 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 118.745 -0.645 . . . . 5.46 109.697 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 170.97 24.26 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 120.877 1.671 . . . . 0.95 114.232 177.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -155.31 164.98 38.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.285 1.041 . . . . 1.88 113.681 174.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.58 119.13 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.169 -0.923 . . . . 1.26 108.549 174.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.531 ' HE ' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -80.83 113.46 19.04 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.435 0.636 . . . . 4.07 110.383 175.095 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.5 134.64 53.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.021 0.915 . . . . 2.9 108.98 162.319 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.03 164.62 20.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.691 1.996 . . . . 2.93 107.298 170.312 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.62 -10.65 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.755 2.304 . . . . 1.63 114.283 -174.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.17 -159.74 27.78 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.95 0.786 . . . . 1.49 111.743 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.37 -6.57 12.46 Favored 'Cis proline' 0 CA--C 1.538 0.704 0 CA-C-N 119.141 1.471 . . . . 1.71 113.7 3.076 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -136.9 158.83 43.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.821 1.248 . . . . 2.21 112.021 170.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.78 -162.57 1.11 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.004 2.122 . . . . 1.06 111.226 -176.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB3' ' HE ' ' A' ' 9' ' ' ARG . . . -156.23 163.07 40.01 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.537 1.31 . . . . 0.73 114.537 -170.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.27 150.37 36.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.688 1.595 . . . . 0.62 112.256 172.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.38 134.36 20.28 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.271 1.828 . . . . 2.34 108.778 -172.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.56 137.81 8.11 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 115.055 1.502 . . . . 2.05 115.055 -160.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -66.97 136.08 54.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.609 -0.723 . . . . 1.75 110.637 167.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.31 153.59 40.04 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.971 2.108 . . . . 2.68 109.926 163.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.64 149.49 48.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.772 0.796 . . . . 3.41 110.582 164.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -106.2 95.24 10.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.141 -0.936 . . . . 1.25 110.004 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.15 -5.09 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.875 2.384 . . . . 1.79 113.0 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.84 162.19 52.77 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 124.972 1.273 . . . . 1.5 113.39 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -74.56 -32.03 62.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.265 2.226 . . . . 5.82 112.788 174.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.28 164.09 17.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.358 1.863 . . . . 1.73 112.102 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.55 152.54 17.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.864 2.376 . . . . 0.71 111.497 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.28 115.98 30.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.852 1.261 . . . . 2.32 110.226 -176.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.447 ' HB2' HH11 ' A' ' 31' ' ' ARG . 0.1 OUTLIER -99.58 107.27 19.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.528 1.131 . . . . 4.24 110.538 177.065 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -95.55 119.24 33.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.093 1.357 . . . . 0.87 109.318 -174.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.21 -12.93 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.476 1.11 . . . . 0.67 113.927 -171.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.5 -162.73 30.19 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.426 1.012 . . . . 0.57 111.971 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB1' ' CD1' ' A' ' 101' ' ' LEU . . . -156.09 -167.96 2.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 0.73 111.442 165.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -159.13 161.04 36.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.252 0.933 . . . . 5.69 108.824 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.24 156.96 30.93 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 125.842 1.657 . . . . 0.74 111.088 -178.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.5 -17.97 15.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.612 2.875 . . . . 1.09 114.462 170.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -98.35 -18.17 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 115.013 1.486 . . . . 1.27 115.013 -174.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.432 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -108.55 152.8 24.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.75 1.159 . . . . 0.76 112.073 176.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.95 -90.9 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.747 0.819 . . . . 3.55 109.497 173.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -79.53 141.81 36.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.114 -1.069 . . . . 3.63 108.114 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.08 131.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.715 1.206 . . . . 1.55 110.462 173.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.04 132.21 20.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.277 1.031 . . . . 2.17 111.847 -163.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tt -79.13 124.22 28.11 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 121.474 0.654 . . . . 0.76 111.034 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -112.62 157.07 21.66 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.196 1.798 . . . . 0.81 112.147 172.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.44 -170.85 1.84 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.548 1.139 . . . . 2.71 112.319 165.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.6 m -147.42 88.09 1.69 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.32 1.848 . . . . 1.12 107.447 170.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -78.46 157.24 29.0 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 2.24 112.009 -177.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.9 mtm -107.69 130.72 54.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.401 1.08 . . . . 2.83 110.012 166.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 -146.89 149.39 33.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.308 1.043 . . . . 5.03 111.542 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 145.54 55.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.544 0.738 . . . . 3.99 109.843 155.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.74 -90.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.727 1.611 . . . . 3.1 108.693 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -77.43 41.29 0.31 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.392 2.277 . . . . 3.55 111.613 175.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.97 -10.27 1.26 Allowed Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.544 -1.348 . . . . 2.02 114.327 -166.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -102.45 155.79 18.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 128.625 2.77 . . . . 2.61 109.374 175.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -90.59 145.62 24.71 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.303 1.223 . . . . 3.42 114.303 178.003 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.9 t -141.27 148.16 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.306 1.843 . . . . 1.87 109.421 -178.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -89.87 123.45 33.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.577 1.551 . . . . 3.53 110.11 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.87 138.31 10.51 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 119.041 0.837 . . . . 1.3 113.678 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -90.04 156.62 18.27 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.828 0.851 . . . . 1.76 111.676 170.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -167.42 153.7 7.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.135 1.774 . . . . 4.38 110.088 168.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -68.46 156.95 63.85 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.342 1.361 . . . . 0.58 110.698 170.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.99 156.14 78.63 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.237 1.415 . . . . 0.66 110.751 -178.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.87 -20.07 30.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.969 2.446 . . . . 0.72 113.112 178.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.6 166.91 3.86 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.444 1.098 . . . . 1.87 112.455 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -115.92 178.0 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.471 2.308 . . . . 0.67 109.296 153.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.12 159.63 44.36 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.122 -0.986 . . . . 2.08 111.57 164.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.41 126.53 20.29 Favored Pre-proline 0 N--CA 1.468 0.425 0 C-N-CA 126.021 1.728 . . . . 1.0 108.202 -178.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.64 162.39 42.3 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.509 2.14 . . . . 0.88 110.998 178.184 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.51 131.76 32.99 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.29 2.66 . . . . 1.02 110.622 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.9 1.52 3.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.869 2.467 . . . . 2.59 114.226 -170.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.84 118.81 9.24 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 125.811 1.672 . . . . 1.0 109.055 172.024 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -117.79 114.58 23.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.833 2.053 . . . . 4.46 109.171 172.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -149.96 154.02 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.459 1.103 . . . . 1.99 112.174 -165.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -102.96 134.49 46.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.302 0.572 . . . . 3.05 111.751 176.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.13 137.0 57.36 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.241 -1.392 . . . . 2.08 107.241 141.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -150.17 143.75 16.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.489 2.316 . . . . 3.26 109.938 -161.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.05 -43.68 28.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.807 3.005 . . . . 1.54 113.151 -167.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 118.34 5.86 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.371 -1.892 . . . . 2.11 108.371 157.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -77.29 0.38 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.683 1.135 . . . . 1.23 112.937 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -154.5 131.9 11.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.41 1.105 . . . . 2.02 110.448 -175.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -163.66 172.17 14.64 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.764 -1.21 . . . . 0.83 111.714 -167.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.13 122.08 45.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.162 0.585 . . . . 1.9 109.776 173.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 mmt -80.39 134.23 36.0 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.171 -0.678 . . . . 1.24 109.171 165.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.52 118.52 36.77 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.198 1.399 . . . . 2.1 107.711 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.78 104.71 9.78 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.373 1.469 . . . . 1.96 109.192 -171.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.06 141.39 1.05 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.302 -0.719 . . . . 3.15 111.302 -159.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.9 mt -117.67 120.47 38.11 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.489 -0.93 . . . . 1.23 108.489 171.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.79 -4.38 54.41 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.946 1.091 . . . . 2.2 113.946 -170.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -150.41 159.21 35.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.134 2.173 . . . . 6.61 110.076 178.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -66.76 159.11 52.88 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.354 2.036 . . . . 2.24 109.226 153.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.54 160.4 31.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.689 1.596 . . . . 2.65 109.75 -162.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.69 129.53 10.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.412 1.101 . . . . 4.67 112.902 -158.22 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.31 121.19 13.72 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.479 -0.763 . . . . 2.05 110.213 174.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.43 7.69 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.423 -1.209 . . . . 2.29 114.804 -166.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.9 174.2 7.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.652 1.726 . . . . 3.62 108.958 144.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -89.7 148.28 23.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.045 0.938 . . . . 3.94 110.617 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.4 HG23 ' CG2' ' A' ' 117' ' ' VAL . 3.1 t -93.63 127.48 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.254 -1.017 . . . . 1.14 108.254 161.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.526 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 51.5 mt-10 -65.45 111.87 3.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.281 -0.872 . . . . 3.19 108.678 153.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.404 ' CD1' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -100.95 123.29 44.91 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.594 -1.262 . . . . 2.53 107.594 163.113 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -102.68 85.64 2.61 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.835 2.054 . . . . 2.28 109.145 177.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.28 121.47 16.31 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.444 1.898 . . . . 3.01 110.5 -175.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.5 mt -92.98 133.54 36.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.42 1.088 . . . . 0.98 111.279 -176.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.77 153.31 38.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.159 0.984 . . . . 1.85 111.454 178.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.9 132.35 53.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.346 0.658 . . . . 1.78 111.303 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.83 -142.92 16.27 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.662 -0.975 . . . . 3.8 110.662 -167.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -100.62 12.25 59.6 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.676 1.131 . . . . 2.57 115.359 -176.02 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -87.36 137.36 32.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.589 1.694 . . . . 5.79 113.306 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.38 138.52 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.749 1.62 . . . . 1.38 109.787 165.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.07 113.4 25.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.472 1.509 . . . . 2.41 109.898 177.416 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.526 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 23.0 ttmm -78.69 116.91 19.37 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.126 -0.694 . . . . 2.65 109.126 168.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.83 149.46 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.408 1.083 . . . . 1.76 109.89 173.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -95.8 138.07 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.663 1.185 . . . . 2.84 109.62 170.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.3 mt -144.91 140.61 16.43 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.678 1.591 . . . . 1.88 109.807 178.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.04 144.37 63.53 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.079 3.186 . . . . 1.3 114.005 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 99' ' ' VAL . 60.4 t -88.16 126.22 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.45 1.1 . . . . 1.59 110.831 172.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -97.31 168.79 10.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.038 2.935 . . . . 3.17 109.222 169.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.57 30.89 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.622 1.556 . . . . 2.03 110.386 161.494 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.2 ttm-85 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.862 1.665 . . . . 7.16 113.075 -171.704 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 121.353 0.597 . . . . 5.85 110.692 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.06 172.34 30.69 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.371 -0.83 . . . . 0.87 114.824 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -159.63 129.8 5.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 2.15 112.66 -173.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.01 103.09 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.79 -1.189 . . . . 1.0 107.79 175.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.5 ttp85 -85.46 114.37 22.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.576 0.703 . . . . 4.17 110.695 -174.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.24 163.21 18.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.138 1.775 . . . . 2.87 112.903 -167.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -168.89 142.31 2.36 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.17 1.788 . . . . 2.6 109.95 156.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.61 -8.38 18.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.069 3.179 . . . . 2.2 114.425 -169.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.94 161.93 10.62 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.929 0.776 . . . . 2.69 113.302 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.87 -1.44 8.12 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 118.612 1.206 . . . . 3.16 112.659 -11.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -153.51 173.09 16.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 2.77 113.322 -179.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.02 171.57 14.24 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.139 2.576 . . . . 0.79 110.373 168.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.69 104.42 4.91 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.885 0.874 . . . . 2.26 111.307 -171.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 149.99 21.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.508 0.929 . . . . 0.63 113.508 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.12 162.97 32.82 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.625 1.57 . . . . 2.38 111.167 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.93 152.62 6.59 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.46 1.104 . . . . 1.44 112.075 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 m -84.24 142.37 30.32 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.251 -1.018 . . . . 1.31 108.251 154.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.82 146.33 39.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.447 1.899 . . . . 2.76 106.951 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 7.7 pt-20 -116.97 142.51 46.86 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.484 0.714 . . . . 3.56 111.548 173.107 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -101.58 105.14 38.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.121 0.969 . . . . 1.11 109.685 166.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.14 -8.43 11.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.641 2.227 . . . . 0.96 113.672 178.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.26 166.92 48.6 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 119.707 1.139 . . . . 1.22 112.93 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.83 2.37 51.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.195 2.198 . . . . 3.27 111.877 173.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -109.67 159.53 31.26 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 128.333 2.653 . . . . 2.75 108.888 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.76 152.03 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.094 2.53 . . . . 1.11 111.287 177.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.99 106.51 17.06 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.013 0.925 . . . . 2.32 110.495 173.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.1 114.16 21.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.581 -1.645 . . . . 3.55 109.112 170.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 104' ' ' LEU . 2.3 tm? -105.14 128.77 53.53 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.535 1.934 . . . . 2.97 108.693 -177.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.79 -7.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.169 0.988 . . . . 0.63 113.259 -175.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.9 -159.18 32.19 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 119.588 -1.291 . . . . 0.52 114.303 178.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.4 173.15 14.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.674 0.79 . . . . 0.73 112.351 -179.143 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 45.4 mtm180 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.139 -1.43 . . . . 6.14 107.139 164.041 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -147.2 142.96 17.49 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 117.886 -1.054 . . . . 1.25 109.066 -175.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.29 -21.72 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.005 1.803 . . . . 1.21 111.517 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.367 1.0 OUTLIER -77.86 11.73 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 118.739 0.7 . . . . 1.5 112.453 174.894 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.43 145.71 39.2 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 114.584 1.327 . . . . 0.97 114.584 176.456 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -87.17 -83.19 0.2 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.742 -1.207 . . . . 4.12 107.742 170.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -77.99 147.59 34.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.1 0.96 . . . . 3.26 108.84 162.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.28 143.54 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.231 1.412 . . . . 1.36 109.279 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -139.87 137.44 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.424 1.49 . . . . 2.27 109.773 -174.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.453 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.0 tt -86.56 121.97 29.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.962 1.255 . . . . 0.9 110.511 164.624 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -109.92 153.66 24.19 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.038 1.335 . . . . 0.92 112.329 174.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.82 169.69 10.73 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.053 1.741 . . . . 2.21 110.618 163.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -152.11 128.27 10.47 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.898 1.279 . . . . 1.72 108.992 175.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.65 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.136 0.974 . . . . 1.98 112.674 -161.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 ptt? -105.48 148.92 26.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.239 0.616 . . . . 3.07 110.474 155.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -162.11 164.55 27.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.572 1.949 . . . . 5.2 109.98 174.04 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.0 149.68 22.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.922 0.889 . . . . 4.38 110.959 -174.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -128.36 -96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 124.329 1.018 . . . . 3.06 109.244 -178.111 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -76.72 42.02 0.28 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.909 2.084 . . . . 3.72 110.963 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.61 -9.12 3.69 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 119.827 -1.796 . . . . 2.91 114.04 -168.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.17 148.02 24.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.702 1.601 . . . . 3.42 110.285 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -65.58 134.41 53.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.472 0.709 . . . . 3.72 110.203 167.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -137.5 153.75 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.377 1.471 . . . . 2.12 109.126 176.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 ptp -108.02 142.44 38.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.371 1.068 . . . . 5.36 111.866 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.22 32.63 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 123.741 0.686 . . . . 1.35 113.342 -176.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.18 167.18 23.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 2.33 110.329 -173.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -173.69 154.35 2.36 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.763 1.625 . . . . 3.92 111.215 170.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.67 143.82 69.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.397 2.065 . . . . 0.96 112.01 166.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.27 156.86 59.91 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.005 2.122 . . . . 0.75 110.521 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.97 -21.46 18.35 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.522 2.148 . . . . 0.74 113.186 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -172.7 174.8 3.58 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.841 1.201 . . . . 2.36 111.905 -177.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.1 176.34 8.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.455 2.702 . . . . 0.87 108.513 165.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.87 168.45 27.17 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 120.728 -1.232 . . . . 2.47 112.649 166.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.37 129.9 18.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.516 1.527 . . . . 1.5 108.969 179.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.52 162.97 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.15 2.566 . . . . 1.52 112.219 -177.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.01 136.04 70.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.885 3.056 . . . . 1.32 112.005 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt 67.02 5.57 4.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.08 1.752 . . . . 1.35 113.665 -178.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.39 123.43 7.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 126.809 2.147 . . . . 1.33 110.238 -178.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -102.35 129.96 48.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.156 0.982 . . . . 4.56 110.915 159.565 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.8 m -153.01 158.8 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.171 1.388 . . . . 2.29 110.693 -174.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.63 142.47 46.85 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.15 1.38 . . . . 3.6 114.278 -177.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.58 73.22 0.53 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.863 1.665 . . . . 1.22 108.954 165.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -62.6 140.88 96.94 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.251 1.42 . . . . 3.27 112.272 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.06 -37.63 91.77 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.281 2.654 . . . . 1.19 112.822 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.22 71.08 2.99 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.943 -1.263 . . . . 1.32 109.943 164.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.77 -58.65 0.2 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.553 1.073 . . . . 1.41 115.09 176.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -157.63 149.46 22.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.4 1.88 . . . . 2.82 111.898 -172.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -161.18 165.08 29.99 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.117 -0.989 . . . . 1.33 111.166 177.247 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.453 ' CE1' HD12 ' A' ' 45' ' ' LEU . 53.9 m-85 -100.14 109.87 22.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.796 -0.816 . . . . 1.77 108.796 168.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 119.73 22.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 1.53 108.335 172.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.03 121.29 41.14 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.054 1.342 . . . . 1.68 107.877 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.36 144.6 43.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.956 1.302 . . . . 3.69 109.667 -173.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.33 -61.36 4.72 Favored Glycine 0 N--CA 1.475 1.249 0 O-C-N 121.15 -0.969 . . . . 2.74 113.477 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt 78.23 119.15 0.05 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.62 3.168 . . . . 1.27 111.996 171.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.52 -2.45 20.37 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.719 1.007 . . . . 2.33 113.719 -174.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.52 159.67 40.9 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.887 1.275 . . . . 6.3 108.597 169.022 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.24 158.68 54.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.905 2.403 . . . . 2.61 110.602 173.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.24 13.61 8.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.684 1.194 . . . . 4.39 112.423 -160.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 160.76 5.31 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.174 1.176 . . . . 3.41 114.174 -167.332 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.45 121.53 9.21 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.233 -0.917 . . . . 1.73 110.26 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.12 20.37 55.38 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.264 -0.742 . . . . 2.5 114.209 -169.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.25 161.34 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.647 1.724 . . . . 3.23 108.655 135.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.41 131.21 56.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.513 -2.032 . . . . 3.98 105.513 155.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.4 102.51 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.901 0.858 . . . . 1.16 110.555 -174.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -65.3 146.79 54.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.976 -1.011 . . . . 4.75 111.248 164.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.2 tt -152.85 128.41 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.657 0.783 . . . . 1.67 110.835 178.038 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 28.9 m-20 -84.73 106.62 16.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.192 1.797 . . . . 2.47 111.235 173.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.6 mt -78.14 120.71 23.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.02 0.827 . . . . 1.22 109.097 176.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.488 ' O ' HD22 ' A' ' 32' ' ' LEU . 37.0 mt -100.85 112.66 25.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.145 0.978 . . . . 0.77 110.486 -168.187 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.53 149.51 31.28 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.243 1.02 . . . . 2.14 112.263 -174.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.72 118.95 6.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.326 1.05 . . . . 2.35 112.106 -170.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.02 71.71 1.14 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.645 1.117 . . . . 3.62 113.011 178.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.72 -3.72 68.01 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 117.239 1.655 . . . . 1.93 117.239 162.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.87 130.86 34.76 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.225 2.012 . . . . 4.42 110.081 173.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.6 136.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.306 1.042 . . . . 1.19 109.89 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.58 115.15 13.54 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.615 1.166 . . . . 1.84 109.965 -174.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -77.05 119.37 20.67 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.662 -0.649 . . . . 2.96 111.971 172.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.93 167.79 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.344 1.457 . . . . 1.3 110.205 163.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.67 149.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.354 1.862 . . . . 2.77 109.195 163.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.8 mt -146.49 127.33 7.17 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.126 1.37 . . . . 1.91 109.235 -172.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 162.82 41.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.896 2.397 . . . . 0.97 111.507 174.242 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -87.62 134.91 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.621 1.169 . . . . 1.86 111.614 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.0 164.38 13.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.092 1.757 . . . . 3.14 107.8 157.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.02 -166.85 1.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.021 1.489 . . . . 4.34 115.021 -171.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 115.729 1.751 . . . . 10.89 115.729 -158.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 121.144 0.497 . . . . 6.05 111.427 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.45 167.1 32.93 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.388 1.47 . . . . 0.96 113.727 -176.234 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -162.16 167.16 24.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.75 1.22 . . . . 1.66 113.377 -173.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -113.12 136.42 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.76 1.224 . . . . 1.3 108.868 171.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -92.93 100.63 13.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.289 0.566 . . . . 4.24 109.493 162.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -69.4 122.55 19.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.363 -0.977 . . . . 2.58 108.363 160.932 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.6 167.63 19.7 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 125.732 1.613 . . . . 3.31 108.452 172.017 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.07 5.08 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.794 2.996 . . . . 2.92 116.637 -162.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.01 -177.17 44.46 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.207 0.912 . . . . 2.33 113.408 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.12 -2.8 13.64 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 118.347 1.073 . . . . 1.91 112.923 -4.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -121.7 165.66 15.45 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.617 1.567 . . . . 2.41 112.752 173.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.06 -171.49 3.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.383 2.673 . . . . 0.94 109.443 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.38 160.12 39.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.772 1.397 . . . . 0.99 114.772 -173.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.4 145.77 51.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.865 1.266 . . . . 0.76 112.328 170.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.0 139.72 26.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.877 1.671 . . . . 2.05 110.308 -171.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.06 150.38 9.51 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.983 1.846 . . . . 1.62 115.983 -173.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.9 m -86.67 129.87 34.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.531 2.333 . . . . 1.55 109.179 165.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.55 171.67 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.644 1.178 . . . . 4.67 110.911 171.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -147.05 138.71 24.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.227 1.011 . . . . 2.94 111.374 -173.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -96.36 108.43 41.89 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.767 1.227 . . . . 1.07 109.236 168.491 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.58 -9.18 14.8 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.441 2.094 . . . . 1.01 113.196 174.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.34 169.64 52.83 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.362 0.982 . . . . 1.03 114.062 -176.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.46 -6.19 37.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.506 1.923 . . . . 3.06 113.358 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.52 160.9 27.69 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.682 . . . . 1.24 110.157 168.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.57 161.5 19.36 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.192 2.595 . . . . 0.84 112.094 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.8 mt -104.94 147.92 27.26 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.237 1.015 . . . . 2.09 111.426 167.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -117.92 115.52 25.09 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.699 1.599 . . . . 5.53 108.823 164.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.6 tp -95.53 115.26 27.18 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.704 1.602 . . . . 0.96 108.303 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.91 -8.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.558 0.948 . . . . 0.87 113.558 -167.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.12 -174.03 46.2 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.992 0.806 . . . . 0.53 111.805 175.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.07 174.84 10.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.161 -0.923 . . . . 0.93 110.188 166.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.97 148.84 19.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.867 1.212 . . . . 5.44 110.54 169.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.35 160.56 54.09 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 0.76 109.107 -159.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.75 -31.14 40.24 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.307 2.004 . . . . 1.04 113.607 167.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 2.1 m -88.11 -5.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.501 1.667 . . . . 0.99 115.501 -163.575 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.17 159.34 42.82 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.099 1.148 . . . . 0.97 114.099 -171.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 12.3 tp10 -99.18 -78.82 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.295 1.038 . . . . 3.41 111.477 -175.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -74.37 127.62 33.47 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.97 -1.122 . . . . 2.97 107.97 169.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.95 131.77 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.306 1.842 . . . . 1.31 109.291 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -150.15 135.79 18.31 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.416 1.086 . . . . 2.38 111.236 -167.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -80.11 125.04 29.31 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.653 1.115 . . . . 0.88 110.817 169.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.6 m170 -114.96 153.9 29.74 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.171 1.788 . . . . 0.72 112.811 178.275 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -86.66 168.68 13.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.135 2.174 . . . . 2.46 111.164 164.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.4 m -150.62 131.73 14.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.882 1.273 . . . . 1.3 108.633 171.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -148.67 162.99 38.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.024 1.12 . . . . 2.25 114.024 -158.445 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 mtp -114.72 119.22 35.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.427 1.891 . . . . 4.82 108.863 162.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -148.66 156.65 42.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.538 1.135 . . . . 8.56 111.977 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.0 145.19 42.74 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.233 1.413 . . . . 4.05 111.903 165.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -148.75 -63.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.482 1.513 . . . . 4.28 109.41 176.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 56' ' ' LYS . 1.2 tt0 -78.77 30.21 0.2 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.562 2.745 . . . . 4.62 111.719 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.0 -21.21 0.29 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.167 1.365 . . . . 4.5 113.629 -162.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 54' ' ' GLU . 6.6 mtmt -113.09 168.88 9.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 128.891 2.876 . . . . 3.12 110.332 170.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -89.42 146.78 24.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.634 2.087 . . . . 3.52 116.634 -172.213 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 59' ' ' MET . 8.1 p -145.36 175.08 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 127.788 2.435 . . . . 3.5 108.894 174.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.456 ' H ' HG22 ' A' ' 58' ' ' VAL . 19.7 mtm -107.1 146.37 31.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.049 1.339 . . . . 4.18 112.466 -178.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.8 176.86 33.18 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 114.731 0.652 . . . . 1.31 114.731 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 mtt -139.22 146.17 40.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.125 2.17 . . . . 2.93 109.796 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -158.34 148.49 15.54 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 125.746 1.619 . . . . 5.49 110.237 -177.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.2 Cg_endo -69.18 154.17 70.43 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.914 1.743 . . . . 0.62 112.359 170.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.32 158.16 65.03 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.923 1.689 . . . . 0.64 110.624 176.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.93 -19.02 35.87 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.447 2.098 . . . . 0.97 113.129 175.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -178.79 172.18 1.38 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.676 1.591 . . . . 2.41 111.579 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -117.28 173.38 6.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.378 1.871 . . . . 0.79 109.634 154.144 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.49 168.76 18.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.208 0.603 . . . . 3.77 110.596 169.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -145.58 129.54 8.64 Favored Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 125.691 1.596 . . . . 0.9 107.461 177.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.78 167.63 25.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.777 1.652 . . . . 1.0 111.414 178.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.83 139.71 86.66 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.949 2.433 . . . . 0.87 110.785 168.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt 65.97 1.88 2.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.78 1.632 . . . . 1.26 113.694 -175.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.25 115.23 4.06 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.143 1.83 . . . . 0.85 111.149 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.93 135.18 33.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.206 1.002 . . . . 5.12 109.61 157.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 m -153.17 151.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.929 1.292 . . . . 1.57 110.678 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 133.23 55.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.661 1.22 . . . . 3.7 113.173 172.119 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.04 78.99 0.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.803 1.641 . . . . 1.18 107.641 161.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -70.61 138.41 85.97 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.363 1.465 . . . . 3.16 111.748 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.09 -24.27 76.21 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.153 2.569 . . . . 1.21 113.229 178.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.83 59.27 0.77 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.125 1.345 . . . . 1.23 111.668 166.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.64 -55.47 0.13 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 115.57 0.988 . . . . 1.39 115.57 173.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -155.1 140.42 17.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.241 1.416 . . . . 2.04 110.34 -176.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -164.31 178.35 7.58 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.094 -1.003 . . . . 0.82 111.034 -173.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -110.21 126.39 54.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.497 0.719 . . . . 1.83 110.455 170.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 mmt -82.7 139.68 33.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.301 1.04 . . . . 0.88 110.938 168.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.1 mt -116.91 128.93 55.71 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.091 1.756 . . . . 1.79 108.162 175.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.05 116.42 11.2 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.884 1.274 . . . . 2.02 110.943 -173.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.95 130.53 0.55 Allowed Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.616 -1.393 . . . . 2.76 109.616 -167.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.654 HD13 HD11 ' A' ' 93' ' ' LEU . 86.0 mt -127.76 108.63 10.9 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 122.21 1.005 . . . . 1.03 110.391 -171.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 4.0 pttm -88.38 0.31 56.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.924 1.29 . . . . 1.95 114.378 -173.653 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -149.85 157.22 38.28 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.781 2.433 . . . . 5.87 108.552 175.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.29 145.83 79.12 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.653 1.568 . . . . 2.28 108.584 162.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.654 HD11 HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -100.77 17.95 20.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.606 1.562 . . . . 4.13 111.161 -175.404 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.84 138.1 1.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.325 2.25 . . . . 4.07 115.048 -161.495 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 116.86 6.0 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.593 -1.317 . . . . 1.5 109.845 170.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.82 17.22 33.54 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.749 -1.029 . . . . 2.76 113.792 -163.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -81.97 175.06 10.68 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.01 1.405 . . . . 3.26 108.366 133.257 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -125.19 131.01 53.26 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.901 -1.888 . . . . 5.03 105.901 155.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -94.73 94.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.64 -0.874 . . . . 0.87 108.64 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.34 113.85 3.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.345 -0.942 . . . . 3.93 108.981 153.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -121.75 142.44 50.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.727 1.211 . . . . 1.69 109.542 170.221 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.64 126.83 34.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.585 2.354 . . . . 2.71 111.634 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.35 125.23 37.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.393 1.077 . . . . 1.22 110.712 167.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.58 123.45 43.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.729 1.212 . . . . 0.79 109.721 -174.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -119.49 126.75 52.04 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.236 -0.915 . . . . 2.19 112.948 -174.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.36 -22.64 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 130.474 3.509 . . . . 2.99 117.538 173.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.53 10.18 3.03 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.035 1.779 . . . . 4.04 115.432 -173.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -165.5 -28.44 0.02 OUTLIER Glycine 0 N--CA 1.477 1.419 0 CA-C-N 119.645 1.723 . . . . 2.39 117.225 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.02 133.98 35.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.537 1.668 . . . . 5.81 109.331 173.331 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.07 145.93 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.831 0.852 . . . . 0.98 109.812 168.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.77 128.35 18.09 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.937 1.695 . . . . 2.21 108.083 172.193 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -99.08 151.76 20.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.655 0.983 . . . . 3.06 113.655 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.56 146.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.87 1.668 . . . . 1.54 110.823 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.21 144.04 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.377 1.471 . . . . 3.13 110.771 168.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.3 mt -149.87 95.54 3.66 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 2.2 108.761 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.26 152.8 74.2 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.49 2.793 . . . . 1.27 112.809 -172.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.2 t -92.63 119.33 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.086 0.954 . . . . 1.32 111.741 -171.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.31 132.98 35.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.033 0.933 . . . . 3.79 108.638 152.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -93.34 99.81 12.26 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.65 -1.241 . . . . 2.02 107.65 159.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 117.933 -1.032 . . . . 7.81 112.55 -159.862 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.557 -0.905 . . . . 4.66 108.557 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.34 179.38 37.75 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 115.213 0.845 . . . . 1.22 115.213 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -161.02 151.37 17.83 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.829 1.252 . . . . 1.69 113.548 176.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.8 t -110.09 145.66 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.995 0.918 . . . . 1.07 108.828 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.39 122.64 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.91 1.284 . . . . 4.88 109.639 -175.319 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.21 174.25 10.95 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.764 1.765 . . . . 2.45 115.764 -171.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.7 t -171.5 158.28 4.75 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 128.118 2.567 . . . . 3.35 108.083 170.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.68 -21.16 19.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.596 2.197 . . . . 2.97 112.07 164.491 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.62 175.72 14.12 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.754 1.645 . . . . 2.16 113.155 178.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.91 -4.53 56.48 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 118.3 1.05 . . . . 2.42 112.965 -9.712 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.01 150.03 40.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.863 1.265 . . . . 3.21 112.181 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.22 -173.51 3.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.854 1.662 . . . . 0.53 112.007 174.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.6 151.12 46.99 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.798 0.839 . . . . 0.79 113.065 -173.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.61 150.06 39.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.478 1.111 . . . . 0.67 112.726 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.25 153.79 41.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.062 1.745 . . . . 2.09 109.495 -175.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -177.62 157.51 1.25 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.124 1.77 . . . . 1.83 109.957 -170.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 76' ' ' GLU 0.26 14.1 t -85.44 140.91 30.33 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.363 1.078 . . . . 3.61 111.406 166.072 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -92.67 131.9 37.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.132 -1.803 . . . . 3.4 106.132 162.668 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.55 102.15 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.542 0.737 . . . . 5.01 110.406 -173.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.57 112.02 56.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.758 1.223 . . . . 1.0 111.347 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.7 -9.01 8.03 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.232 2.621 . . . . 1.01 113.924 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.26 54.73 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 119.216 0.916 . . . . 1.07 114.139 -172.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.2 -0.24 30.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.204 1.802 . . . . 2.89 112.708 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.68 161.56 29.75 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.128 1.771 . . . . 1.46 109.877 165.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.08 159.67 20.64 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.149 2.566 . . . . 0.82 111.617 -172.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.78 145.57 33.37 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.463 1.105 . . . . 1.89 111.012 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -129.6 109.18 10.8 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.129 1.372 . . . . 3.26 109.955 173.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.33 120.14 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.007 2.523 . . . . 0.96 108.837 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.9 -8.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.665 0.987 . . . . 0.6 113.665 -171.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -164.59 35.12 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 118.931 0.787 . . . . 0.55 111.967 176.192 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -144.72 -176.09 4.92 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.049 -0.976 . . . . 0.79 111.301 172.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 17.9 mmt180 -160.1 156.17 26.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.81 1.244 . . . . 6.88 108.162 166.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -157.93 155.84 27.18 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.155 1.382 . . . . 0.89 109.152 -171.449 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.29 -39.51 9.92 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.72 1.614 . . . . 1.17 112.316 173.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -82.0 -20.65 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.204 1.366 . . . . 1.37 114.44 -169.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB3' HG23 ' A' ' 37' ' ' THR . . . -99.55 169.05 9.57 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.787 0.835 . . . . 1.41 111.221 169.322 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -91.92 -82.91 0.3 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.443 -1.688 . . . . 3.88 106.443 161.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -74.81 163.07 28.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.756 2.022 . . . . 6.22 112.234 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -168.71 107.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.65 1.58 . . . . 2.18 109.306 176.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.17 130.72 55.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.042 -1.89 . . . . 5.0 110.053 -167.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.13 126.08 31.62 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.018 0.913 . . . . 0.85 112.248 -171.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.4 m170 -113.52 158.79 20.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.996 2.118 . . . . 0.64 113.025 176.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -108.57 -178.87 3.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.525 1.93 . . . . 1.79 111.616 172.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.4 m -132.4 119.04 20.14 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.337 -1.357 . . . . 1.6 107.337 155.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -102.83 162.64 12.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.188 1.395 . . . . 2.03 111.727 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.2 mtt -103.74 150.22 24.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.357 1.063 . . . . 2.5 110.502 158.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -160.15 144.81 14.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 6.14 112.486 167.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.84 145.88 15.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.258 1.423 . . . . 4.82 110.34 156.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.24 -80.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.339 1.455 . . . . 3.02 107.985 172.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -77.02 26.73 0.14 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.835 2.054 . . . . 3.75 111.837 171.154 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.34 -33.71 0.67 Allowed Glycine 0 CA--C 1.537 1.461 0 O-C-N 120.373 -1.455 . . . . 2.61 112.839 -158.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -63.67 145.2 56.18 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.7 1.6 . . . . 2.4 109.673 166.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -88.87 135.31 33.6 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.844 0.313 . . . . 4.7 111.844 -179.295 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.88 147.81 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.036 2.135 . . . . 1.94 108.894 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.52 129.29 55.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.001 1.32 . . . . 4.56 110.127 175.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.72 162.35 28.28 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 123.973 0.797 . . . . 1.08 113.3 -174.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.4 mtt -106.77 158.84 16.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.903 1.281 . . . . 2.26 111.724 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -169.95 155.43 5.55 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.553 1.541 . . . . 4.0 110.406 173.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.9 Cg_endo -69.69 153.51 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.768 1.645 . . . . 0.78 111.297 168.391 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.51 157.73 64.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 125.576 1.55 . . . . 0.77 110.88 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.4 -17.23 39.32 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.772 2.315 . . . . 1.01 112.828 179.316 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.2 p90 178.03 169.56 0.73 Allowed 'General case' 0 C--N 1.345 0.396 0 C-N-CA 126.882 2.073 . . . . 2.17 110.266 179.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.02 165.69 13.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.085 1.354 . . . . 0.91 109.262 156.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.98 161.85 42.04 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.304 -0.873 . . . . 2.24 112.44 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 22' ' ' LEU . 21.9 t -149.96 136.78 11.04 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.016 1.326 . . . . 1.18 109.694 -163.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.58 170.16 17.01 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.044 2.496 . . . . 0.85 112.597 177.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.32 142.99 99.87 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.638 2.892 . . . . 0.86 112.039 166.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm 66.52 1.32 2.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.075 1.75 . . . . 1.58 113.948 -178.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.13 124.75 7.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 127.064 2.269 . . . . 1.02 111.579 -173.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 140.79 36.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.934 0.894 . . . . 4.78 111.255 159.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.2 m -147.31 125.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.23 1.412 . . . . 1.73 110.082 173.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.0 mp0 -83.08 131.99 35.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.03 0.932 . . . . 3.59 112.132 -177.281 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.2 159.82 33.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.114 0.959 . . . . 2.29 109.834 162.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -167.07 145.4 4.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.714 1.206 . . . . 2.8 112.436 -161.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 -25.54 30.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.728 2.952 . . . . 2.02 114.148 -176.332 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.23 95.08 1.19 Allowed Glycine 0 N--CA 1.467 0.765 0 N-CA-C 108.694 -1.762 . . . . 1.45 108.694 161.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.82 -148.39 18.4 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.889 1.233 . . . . 2.6 111.748 -168.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.15 136.99 37.28 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.213 -0.581 . . . . 2.31 111.634 -171.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.62 167.45 21.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.373 0.669 . . . . 0.73 110.257 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.46 122.81 48.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.743 0.817 . . . . 1.9 110.526 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -86.35 111.81 20.84 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.854 0.862 . . . . 0.84 109.557 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.7 mt -80.73 138.87 36.34 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.213 1.405 . . . . 2.17 109.749 176.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -133.18 154.03 51.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.901 1.334 . . . . 1.93 113.732 -176.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 -60.33 3.78 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 127.101 2.286 . . . . 2.43 112.959 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mt 60.36 93.12 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.278 3.031 . . . . 1.06 111.452 -166.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.99 -10.94 60.63 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.011 -1.055 . . . . 3.23 112.81 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 -153.78 140.22 12.73 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 129.266 3.026 . . . . 7.94 107.148 171.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.2 154.18 41.36 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.331 2.687 . . . . 2.5 110.373 175.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.03 142.99 28.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.381 1.073 . . . . 3.67 111.556 -173.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -19.11 26.17 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.627 1.343 . . . . 4.7 114.627 -177.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 83.3 136.64 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 1 C-N-CA 132.213 4.205 . . . . 2.44 109.822 -171.093 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.73 52.98 8.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.149 -0.781 . . . . 1.96 111.149 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 176.31 5.21 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.108 0.963 . . . . 3.38 108.489 155.007 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -100.09 163.08 12.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.905 -0.776 . . . . 3.96 108.905 152.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.5 120.15 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.236 1.414 . . . . 1.19 109.021 175.684 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 147.04 32.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 3.57 109.224 167.141 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.486 HD11 ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -152.39 123.76 7.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.322 1.049 . . . . 2.92 111.073 -174.64 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.81 114.06 21.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.925 2.09 . . . . 2.56 111.231 177.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.4 mt -80.71 114.07 19.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.956 -1.09 . . . . 1.33 109.006 176.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.23 125.58 35.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.245 0.618 . . . . 0.71 110.116 -173.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.39 164.19 12.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.792 0.664 . . . . 2.21 112.792 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.96 62.08 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.082 1.753 . . . . 2.23 113.753 -173.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 141.45 -149.98 21.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.545 1.545 . . . . 3.1 111.506 -178.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.77 37.83 1.06 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.692 1.139 . . . . 1.93 115.696 -172.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -127.64 133.71 49.66 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.311 1.556 . . . . 4.29 110.75 170.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.78 140.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.179 1.792 . . . . 1.02 107.24 163.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -142.83 116.09 8.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.758 1.223 . . . . 1.52 109.742 -172.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -88.66 142.39 27.72 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.875 1.435 . . . . 2.58 114.875 -177.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.2 164.02 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.753 2.021 . . . . 1.76 111.278 175.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.91 134.63 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.593 1.157 . . . . 2.46 110.67 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.6 mt -141.58 145.14 36.17 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.402 1.881 . . . . 1.85 109.602 -165.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.33 159.93 15.04 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.932 3.088 . . . . 1.32 112.623 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.81 112.78 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.502 1.121 . . . . 1.29 113.006 174.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.39 147.39 28.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.732 2.813 . . . . 3.66 109.774 160.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.23 -171.07 3.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.588 1.329 . . . . 1.87 114.588 -162.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.307 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 130.875 3.67 . . . . 9.02 113.901 174.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 122.484 1.135 . . . . 6.86 109.522 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.95 171.95 43.6 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.177 0.894 . . . . 1.13 113.868 174.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -160.11 156.68 27.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.121 1.368 . . . . 1.89 112.358 -176.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 99' ' ' VAL . 93.8 t -109.62 129.02 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.988 . . . . 1.17 110.118 175.14 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -82.73 112.79 19.9 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.894 -1.15 . . . . 3.98 107.894 166.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -60.95 -45.19 95.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.768 1.766 . . . . 3.5 115.768 -164.923 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 6.0 t 58.86 155.57 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 128.35 2.66 . . . . 2.2 113.941 -159.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.91 0.5 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.997 2.464 . . . . 1.68 113.219 160.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.98 177.38 36.41 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.15 0.881 . . . . 1.31 113.11 -177.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -80.36 -2.55 41.66 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 118.99 1.395 . . . . 1.58 113.507 -3.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -138.45 165.6 26.41 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.676 1.991 . . . . 1.86 111.648 178.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.96 -175.51 5.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.507 1.523 . . . . 0.71 113.588 -169.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.2 149.41 33.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.818 0.847 . . . . 1.23 112.678 -172.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.46 152.52 40.75 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.428 0.899 . . . . 1.25 113.428 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 150.53 32.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.04 1.336 . . . . 2.41 110.462 -170.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.38 159.32 4.6 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.707 1.603 . . . . 1.93 110.541 -175.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 m -78.24 152.73 32.41 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.399 -0.963 . . . . 1.73 108.399 155.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 134.63 38.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.793 2.037 . . . . 3.47 107.751 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.25 139.0 42.41 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.793 1.237 . . . . 5.26 113.543 -177.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -104.44 107.83 58.83 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.796 -0.638 . . . . 1.51 109.676 149.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -92.04 -7.74 3.06 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.601 2.867 . . . . 1.41 114.04 175.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.75 178.72 41.12 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.467 1.03 . . . . 1.35 113.322 -176.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -95.62 -0.79 51.41 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.587 . . . . 3.61 113.376 176.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.59 160.07 31.86 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.463 1.505 . . . . 1.54 110.516 171.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.43 153.97 24.15 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.758 2.306 . . . . 0.75 111.413 -171.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -116.26 119.31 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.746 1.218 . . . . 2.3 110.053 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -115.13 102.55 10.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.266 1.426 . . . . 4.52 111.342 -177.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 tp -92.08 119.91 32.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.975 2.51 . . . . 0.79 109.196 -172.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.04 -8.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.513 1.125 . . . . 0.63 113.459 -169.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.08 -158.93 31.76 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 124.627 1.108 . . . . 0.39 111.391 173.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.07 -177.04 5.52 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 122.467 -0.431 . . . . 0.8 111.745 169.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -146.33 129.5 16.59 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.322 1.049 . . . . 6.67 109.732 170.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.5 t -141.16 156.78 67.75 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 126.704 2.002 . . . . 0.7 109.526 -173.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.51 -32.97 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.151 1.901 . . . . 1.07 113.203 170.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.289 1.4 m -75.42 -9.53 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 120.27 1.396 . . . . 0.99 114.21 -164.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.61 147.11 52.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.165 1.786 . . . . 0.8 109.894 175.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -50.02 -59.64 3.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.039 1.29 . . . . 5.62 108.693 168.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -130.4 153.36 48.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.872 2.069 . . . . 3.84 109.951 -168.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.15 127.57 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.858 1.663 . . . . 1.94 107.091 173.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -121.38 128.02 51.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.353 1.861 . . . . 1.94 107.41 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.05 122.3 26.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.98 0.895 . . . . 0.95 109.806 170.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.7 m170 -111.45 158.49 19.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.019 1.728 . . . . 0.53 110.993 179.451 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.85 -178.59 3.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.663 1.985 . . . . 2.24 111.656 177.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 m -140.51 113.26 8.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.911 -1.144 . . . . 1.85 107.911 150.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -96.2 -171.34 2.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.446 1.498 . . . . 2.46 109.811 173.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -141.55 149.14 40.42 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.568 0.747 . . . . 3.33 110.982 163.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -134.65 141.89 46.7 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.35 1.06 . . . . 7.03 110.309 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -75.85 116.38 16.5 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.187 0.995 . . . . 5.8 109.552 162.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 t -88.01 -119.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 106.455 -1.683 . . . . 3.2 106.455 169.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.03 75.68 8.01 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.541 1.064 . . . . 4.71 108.33 163.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.44 -20.72 0.1 OUTLIER Glycine 0 N--CA 1.475 1.287 0 C-N-CA 129.522 3.439 . . . . 2.0 117.004 178.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -68.34 122.92 19.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.595 -1.532 . . . . 4.53 110.468 169.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -99.42 69.16 1.65 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.078 1.751 . . . . 5.57 109.121 -170.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -87.26 139.59 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.924 1.69 . . . . 1.77 110.67 -163.367 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -78.52 134.02 37.32 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.6 1.56 . . . . 3.74 111.576 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.49 150.79 19.95 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.354 0.978 . . . . 1.43 112.925 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -112.67 152.71 28.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.845 1.258 . . . . 1.86 111.397 -179.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 mtp-105 -164.42 153.86 11.96 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 127.081 2.152 . . . . 3.77 108.151 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.8 Cg_endo -69.0 151.83 73.32 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.971 1.382 . . . . 0.71 111.001 157.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.7 152.66 56.1 Favored Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.944 1.298 . . . . 0.63 110.253 173.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.94 -9.48 25.77 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.692 2.261 . . . . 0.78 113.355 178.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -177.91 165.5 1.99 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.643 1.577 . . . . 2.13 110.526 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -117.27 166.17 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.664 1.586 . . . . 0.76 109.053 151.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.97 162.34 39.6 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.498 -0.751 . . . . 2.0 112.621 167.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -143.18 129.87 10.56 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-N 114.669 -1.151 . . . . 1.49 110.187 -168.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.32 162.02 42.24 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.665 2.244 . . . . 1.2 111.374 176.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.82 145.48 96.37 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.038 3.159 . . . . 1.04 113.637 -178.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp 67.21 -5.68 0.69 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.213 2.205 . . . . 1.93 115.196 178.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.21 123.78 7.02 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 126.613 2.054 . . . . 1.28 111.095 176.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -86.42 147.95 25.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.052 0.541 . . . . 4.83 110.677 154.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -146.15 155.83 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.05 1.34 . . . . 1.78 110.242 175.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.43 142.53 29.93 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.673 0.749 . . . . 4.6 112.988 -178.116 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.99 65.69 1.47 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.983 1.373 . . . . 1.53 108.422 152.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.36 113.92 7.63 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.522 1.529 . . . . 3.38 109.787 169.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.99 -45.38 41.47 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.392 2.728 . . . . 1.33 114.634 -161.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.94 90.88 1.56 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.79 -1.724 . . . . 1.46 108.79 161.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.35 -64.82 0.39 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.819 1.676 . . . . 1.5 111.197 -174.001 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -150.42 145.8 26.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.761 1.625 . . . . 2.24 111.194 170.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -158.77 157.4 31.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.292 1.437 . . . . 0.94 109.779 178.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.93 131.7 34.5 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.298 -0.631 . . . . 2.08 109.298 164.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.3 125.58 51.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.559 1.544 . . . . 1.46 109.027 173.191 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.58 139.12 46.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.324 1.45 . . . . 2.29 110.545 -170.562 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -133.79 158.25 43.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.032 0.933 . . . . 1.64 112.842 -171.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.69 60.86 7.37 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.553 1.549 . . . . 2.12 113.29 169.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.52 101.08 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.872 1.32 . . . . 0.99 112.743 -164.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -83.54 -3.99 58.14 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.547 -0.751 . . . . 2.06 113.006 -166.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -131.04 153.77 81.85 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 129.474 3.109 . . . . 7.3 108.568 168.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.74 167.43 27.11 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.089 2.526 . . . . 1.77 109.31 157.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.5 164.85 29.38 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.199 1.4 . . . . 2.82 112.037 -165.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 140.22 2.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.621 1.568 . . . . 5.63 113.185 -163.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.91 134.24 37.49 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.358 -1.464 . . . . 1.74 112.868 173.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.93 56.31 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.734 -1.592 . . . . 1.94 115.063 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.76 -177.94 3.48 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.339 1.57 . . . . 3.23 108.585 156.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.89 138.93 52.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.444 1.116 . . . . 3.64 112.054 -172.086 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 8' ' ' VAL . 95.3 t -90.19 107.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.366 1.466 . . . . 1.31 108.753 -172.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.61 130.46 45.32 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 124.525 1.141 . . . . 2.87 108.856 158.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mt -154.74 132.09 11.15 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.914 1.686 . . . . 1.52 112.283 -177.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.11 114.45 27.97 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.71 1.604 . . . . 2.85 110.836 169.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.83 118.2 19.2 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.029 1.331 . . . . 1.17 109.986 175.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.78 133.65 34.59 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.861 0.864 . . . . 0.67 110.54 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -125.19 164.36 20.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.961 0.886 . . . . 2.11 112.41 176.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.01 156.01 9.97 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.686 -0.688 . . . . 2.55 111.478 164.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.78 10.97 85.8 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.247 -0.751 . . . . 3.64 114.885 -178.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.98 1.85 85.8 Favored Glycine 0 N--CA 1.473 1.163 0 CA-C-N 118.57 1.185 . . . . 2.43 113.977 -178.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.99 130.98 44.91 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.093 -1.239 . . . . 5.83 110.266 179.132 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.89 149.97 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.978 0.911 . . . . 1.01 110.239 170.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -146.44 129.26 16.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.681 1.192 . . . . 1.86 112.453 -174.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -63.48 134.47 55.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.669 1.188 . . . . 2.29 112.393 172.693 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.2 m -138.98 146.1 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.14 1.776 . . . . 1.48 109.568 163.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.2 123.06 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.981 0.912 . . . . 1.65 110.509 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -139.07 146.33 48.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.992 1.317 . . . . 1.75 110.176 -169.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.3 146.2 68.46 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.033 2.489 . . . . 1.02 113.202 -175.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.2 t -79.37 134.78 27.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 124.524 1.13 . . . . 1.31 108.385 161.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.58 141.91 51.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.224 1.81 . . . . 5.18 109.21 169.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -128.34 71.7 1.4 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 122.275 1.036 . . . . 3.36 113.788 -167.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.195 0 C-N-CA 126.544 1.938 . . . . 8.59 109.196 169.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 110.836 -0.061 . . . . 4.68 110.836 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.14 179.62 48.86 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.167 0.889 . . . . 1.14 113.256 -174.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -155.09 153.42 30.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.275 1.43 . . . . 1.36 112.902 -177.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.69 122.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.463 1.105 . . . . 1.25 110.548 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -57.36 -39.93 77.0 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.649 1.979 . . . . 5.58 114.126 -168.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.34 151.79 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.655 1.982 . . . . 2.6 113.528 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.28 165.99 2.01 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 119.748 -1.845 . . . . 1.82 109.889 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.79 23.15 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.034 3.156 . . . . 2.01 112.819 175.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.69 -176.06 54.73 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 121.312 -0.867 . . . . 1.53 111.837 -159.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.72 -11.41 18.03 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 CA-C-N 118.499 1.15 . . . . 2.04 112.233 -12.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -134.73 154.22 51.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.372 1.069 . . . . 2.8 112.294 168.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.58 -177.67 3.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.291 1.836 . . . . 0.63 108.31 156.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.64 173.35 11.77 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.169 0.988 . . . . 0.88 110.537 173.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.46 151.03 41.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.223 1.009 . . . . 0.74 112.396 167.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.09 142.39 38.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.842 2.457 . . . . 2.29 109.235 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -169.66 159.49 8.27 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.598 1.333 . . . . 1.94 114.598 -175.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -97.96 119.57 36.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.02 1.728 . . . . 1.4 108.379 173.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -110.31 142.72 41.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.018 1.327 . . . . 2.65 109.931 176.094 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.456 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.9 pt-20 -142.35 150.0 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.196 1.398 . . . . 2.95 110.941 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -118.48 108.22 41.88 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.831 0.852 . . . . 1.23 110.962 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -86.41 -5.39 8.32 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.77 2.313 . . . . 1.1 114.325 175.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 -157.31 16.09 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 120.129 1.331 . . . . 2.09 115.365 -167.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -95.12 -41.03 9.31 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.57 2.348 . . . . 6.03 112.384 178.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.03 166.13 13.12 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.136 1.774 . . . . 1.75 111.729 -173.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.07 167.13 25.53 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.505 2.137 . . . . 1.2 113.691 -166.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.56 148.11 26.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.773 1.229 . . . . 2.73 109.747 165.148 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -141.81 103.53 4.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.638 1.575 . . . . 4.06 108.141 171.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.15 104.4 16.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.867 2.467 . . . . 0.94 108.941 -166.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.62 -12.44 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.872 1.269 . . . . 0.6 112.924 -172.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.92 -163.6 33.25 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 123.733 0.682 . . . . 0.43 112.349 178.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.18 178.4 9.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.005 1.322 . . . . 0.74 110.401 173.028 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -143.18 145.54 32.9 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.993 -1.114 . . . . 7.66 107.993 174.955 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 t -151.37 151.6 29.36 Favored Pre-proline 0 N--CA 1.47 0.534 0 CA-C-O 118.374 -0.822 . . . . 0.66 110.949 172.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.43 -23.41 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.725 2.95 . . . . 1.32 114.891 160.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.28 1.3 m -95.17 5.65 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.96 1.467 . . . . 1.07 114.96 -168.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.38 163.43 32.81 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.884 1.274 . . . . 0.8 111.946 -178.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.444 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 8.8 tp10 -100.72 -89.87 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.912 -0.773 . . . . 3.47 108.912 164.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -76.55 114.89 15.77 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.032 -1.042 . . . . 3.08 109.013 -179.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.76 140.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.698 1.599 . . . . 2.18 111.161 163.467 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -144.02 122.5 12.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.274 1.43 . . . . 2.6 109.623 166.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -80.08 119.07 22.39 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.746 1.157 . . . . 0.74 110.88 169.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.5 m170 -107.36 152.83 23.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.941 1.696 . . . . 0.66 112.395 175.45 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.93 -178.06 3.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.41 1.484 . . . . 2.18 110.603 167.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -146.57 130.25 17.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.887 1.275 . . . . 1.01 107.777 174.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.78 165.4 27.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.527 1.131 . . . . 2.0 112.655 -165.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.9 mtm -98.23 144.69 27.4 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.798 1.239 . . . . 2.68 111.56 174.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -156.59 178.93 9.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.139 1.376 . . . . 10.46 112.523 -175.045 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.67 158.16 17.07 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.198 1.799 . . . . 9.0 110.3 167.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.03 121.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 125.893 1.677 . . . . 4.71 109.232 140.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 55.54 54.14 8.82 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.907 1.283 . . . . 4.75 109.78 -174.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.49 -26.23 0.17 Allowed Glycine 0 N--CA 1.476 1.322 0 C-N-CA 128.964 3.174 . . . . 3.47 116.129 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -78.18 140.38 38.96 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.793 -1.416 . . . . 4.07 111.778 -171.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.54 122.94 17.04 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 4.37 111.094 174.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.9 t -142.71 161.63 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.118 1.767 . . . . 2.45 108.154 173.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.18 158.54 15.79 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.024 -1.047 . . . . 2.93 112.6 -178.773 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.75 159.01 24.41 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 124.944 1.259 . . . . 1.15 112.038 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -125.88 155.87 40.55 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.9 1.68 . . . . 1.6 108.307 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -169.06 150.26 4.32 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.004 1.322 . . . . 4.67 110.3 177.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 40.8 Cg_endo -67.36 153.14 77.79 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.314 2.009 . . . . 0.96 111.264 169.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -125.14 155.96 70.29 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.454 1.502 . . . . 0.76 110.172 171.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.05 -14.5 41.11 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.782 2.321 . . . . 0.9 112.92 176.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -179.48 162.24 1.12 Allowed 'General case' 0 C--N 1.348 0.51 0 C-N-CA 126.092 1.757 . . . . 2.22 110.362 178.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -104.43 176.63 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.313 1.445 . . . . 0.73 109.732 153.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.29 168.95 25.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.049 -1.032 . . . . 1.96 113.76 171.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.81 136.18 10.35 Favored Pre-proline 0 N--CA 1.467 0.406 0 C-N-CA 125.395 1.478 . . . . 0.86 108.246 -176.558 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.78 171.41 11.02 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 121.812 1.675 . . . . 1.1 111.251 170.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.04 142.62 75.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.741 2.294 . . . . 1.25 110.341 163.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt 73.83 -4.96 2.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.73 2.412 . . . . 1.36 113.261 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.07 -170.99 44.29 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 126.369 1.938 . . . . 1.41 112.389 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -167.25 154.89 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.194 1.798 . . . . 6.28 112.178 -178.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.62 159.3 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.202 1.801 . . . . 1.92 110.42 177.046 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.49 116.7 23.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.773 -1.195 . . . . 4.48 107.773 177.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.5 67.86 2.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.784 1.233 . . . . 1.08 108.823 170.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -75.67 149.12 83.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.344 1.058 . . . . 3.72 111.428 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.97 -30.31 92.95 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.741 2.294 . . . . 1.42 113.336 176.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.33 48.68 2.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.565 1.079 . . . . 1.35 112.453 168.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.84 -64.92 0.05 OUTLIER Glycine 0 N--CA 1.473 1.163 0 N-CA-C 115.837 1.095 . . . . 1.36 115.837 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -156.55 146.3 20.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.353 1.861 . . . . 2.34 109.541 -173.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -165.55 170.92 13.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.739 -1.225 . . . . 0.73 110.438 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.04 136.3 42.11 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.916 -0.772 . . . . 1.82 108.916 168.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -83.1 128.79 34.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.104 0.961 . . . . 1.11 110.047 156.027 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 mt -113.87 104.3 12.04 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.421 1.489 . . . . 1.74 107.85 177.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.99 155.77 17.52 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.443 0.639 . . . . 1.73 112.349 -176.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.79 -53.39 4.84 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.248 1.404 . . . . 2.69 113.757 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 62.98 85.15 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.782 2.433 . . . . 1.07 112.806 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HE3' ' OE1' ' A' ' 41' ' ' GLU . 4.3 ptpp? -73.84 -0.48 16.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.759 1.392 . . . . 1.63 114.759 -168.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -149.44 159.37 36.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 128.766 2.827 . . . . 5.12 108.837 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.29 162.33 36.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.12 1.88 . . . . 2.01 109.583 154.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.11 43.8 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 123.065 1.412 . . . . 4.1 111.929 -158.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -74.42 143.82 44.57 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.101 1.76 . . . . 5.21 113.631 -168.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.03 118.59 2.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.754 1.222 . . . . 1.95 113.153 177.274 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.1 16.82 26.81 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 117.991 -1.45 . . . . 1.78 114.817 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.22 166.02 11.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.279 1.539 . . . . 3.89 108.797 136.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -111.83 134.26 53.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.972 1.709 . . . . 5.41 108.753 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.44 113.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.639 0.776 . . . . 1.08 110.352 -178.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -68.8 129.16 39.14 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.148 -0.933 . . . . 3.52 109.091 161.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -139.91 147.92 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.624 0.77 . . . . 1.52 111.269 -173.669 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -114.53 132.15 56.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.469 -1.241 . . . . 2.47 110.342 162.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.4 mt -98.33 121.13 39.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.737 1.215 . . . . 1.31 109.021 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.2 mt -96.76 129.88 44.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.084 0.954 . . . . 0.97 111.333 -170.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -122.34 145.76 47.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.939 0.896 . . . . 2.05 112.179 -176.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.88 131.02 45.96 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.116 0.966 . . . . 2.48 111.826 176.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.69 -159.6 23.12 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.495 1.045 . . . . 2.92 110.705 -164.374 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.51 26.46 6.41 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.264 0.935 . . . . 1.91 113.783 178.518 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -99.43 129.55 45.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.015 1.408 . . . . 5.31 111.632 -173.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.83 138.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.449 1.499 . . . . 1.29 108.866 167.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.53 121.34 39.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.267 1.027 . . . . 1.95 109.645 177.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -79.96 139.82 36.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.972 0.509 . . . . 2.28 110.937 175.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m -145.1 171.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.719 2.007 . . . . 1.29 109.893 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.87 131.14 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.376 1.071 . . . . 1.79 109.124 176.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mp -145.75 152.64 49.09 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.917 1.287 . . . . 1.9 111.063 -168.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.2 155.37 67.97 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.422 2.748 . . . . 1.32 114.279 -177.498 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.31 125.42 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.168 -0.923 . . . . 1.38 108.681 157.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.64 138.23 35.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.415 1.486 . . . . 3.78 109.068 170.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.03 134.79 55.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.941 2.2 . . . . 3.01 116.941 -128.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.078 1 C-N-CA 132.372 4.269 . . . . 7.13 111.243 160.688 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.537 ' N ' ' HG1' ' A' ' 21' ' ' THR . 36.9 mt-10 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 111.913 0.338 . . . . 4.44 111.913 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.1 151.64 21.88 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 121.304 -0.872 . . . . 1.36 114.323 169.39 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -155.01 152.7 29.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.999 1.719 . . . . 1.61 111.596 -179.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.32 122.55 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.029 -1.1 . . . . 0.85 108.029 178.793 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 89.47 8.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.825 1.25 . . . . 3.33 108.477 171.334 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.427 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -67.09 139.25 57.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.363 1.065 . . . . 2.23 109.027 168.092 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.6 m -138.39 158.31 70.88 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.49 . . . . 2.66 108.026 168.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.88 27.91 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.616 3.544 . . . . 2.28 115.113 -171.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.49 170.18 44.51 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.141 -0.974 . . . . 1.65 113.957 178.878 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.36 -7.94 35.4 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 117.811 0.806 . . . . 1.63 113.373 -7.038 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -130.69 161.98 30.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.216 1.806 . . . . 3.66 111.216 -175.528 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.91 -173.88 4.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.541 1.936 . . . . 0.67 112.038 -177.2 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.61 40.5 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.315 0.858 . . . . 0.96 113.315 -172.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.07 146.4 27.71 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 0.81 112.148 173.341 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.25 151.04 51.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.595 1.958 . . . . 2.37 109.644 -173.23 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -169.4 145.35 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.336 1.236 . . . . 1.61 114.336 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.537 ' HG1' ' N ' ' A' ' 5' ' ' GLU . 52.9 m -75.68 139.97 42.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.081 1.752 . . . . 1.43 108.977 163.19 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.0 133.51 21.96 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.139 1.376 . . . . 2.8 108.944 174.195 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.46 156.76 46.15 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 114.225 1.195 . . . . 3.14 114.225 -175.666 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -116.85 100.06 53.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.249 -1.342 . . . . 1.61 110.47 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -85.02 -3.16 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.222 2.615 . . . . 1.33 114.091 176.237 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.19 -119.78 0.81 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.797 1.189 . . . . 2.95 114.626 -168.618 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -154.15 -41.98 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.371 1.868 . . . . 5.39 112.021 -161.786 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -96.12 165.06 17.1 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.833 2.053 . . . . 1.57 111.335 171.419 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.44 157.5 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.227 2.618 . . . . 0.83 112.282 -174.277 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.37 156.71 17.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.308 1.043 . . . . 1.91 111.33 171.195 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -146.54 101.06 3.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.104 1.361 . . . . 4.08 112.811 177.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.3 tp -85.07 108.25 17.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.15 2.18 . . . . 0.93 109.115 -176.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -99.17 -16.13 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.677 1.191 . . . . 0.77 112.987 -173.458 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.32 42.72 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.773 0.701 . . . . 0.48 111.717 -177.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -138.03 -178.95 5.5 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.308 1.043 . . . . 0.81 110.434 169.196 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -154.31 128.56 9.05 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 106.363 -1.718 . . . . 6.34 106.363 175.736 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -146.34 151.31 43.58 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.578 1.151 . . . . 0.9 109.295 -168.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.32 -23.11 21.07 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.412 2.074 . . . . 1.15 113.5 175.779 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.98 -13.16 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 115.569 1.692 . . . . 1.21 115.569 -165.251 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -131.4 152.35 50.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.319 1.048 . . . . 1.49 112.711 -165.675 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -56.45 22.01 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.59 1.087 . . . . 6.63 109.185 171.771 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 43' ' ' VAL . 16.1 ttm180 -128.85 176.07 8.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.006 2.522 . . . . 3.88 109.926 179.177 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.404 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 2.3 p -155.43 137.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.287 2.235 . . . . 1.2 107.455 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -142.32 137.53 30.63 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.585 1.554 . . . . 1.9 108.851 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.37 126.97 32.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.676 1.125 . . . . 0.85 110.165 166.673 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.3 m170 -119.35 155.38 32.0 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.795 2.038 . . . . 0.63 112.017 176.478 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -92.57 166.07 12.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.761 1.624 . . . . 2.47 110.46 164.679 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.3 m -123.63 127.72 48.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 106.357 -1.719 . . . . 1.28 106.357 154.117 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -122.4 170.96 9.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.442 1.275 . . . . 2.38 114.442 -166.392 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.9 mtm -125.82 127.15 45.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.097 1.359 . . . . 3.16 109.389 161.794 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -153.52 165.81 34.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.099 1.76 . . . . 9.29 110.416 174.303 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.51 152.46 43.0 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.684 1.194 . . . . 3.45 111.285 168.606 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.32 -86.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.599 1.16 . . . . 3.22 109.241 176.256 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -78.44 51.31 1.03 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.681 1.992 . . . . 4.2 110.562 176.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -20.69 0.3 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.951 1.738 . . . . 3.0 114.683 -170.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -107.78 159.24 16.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.474 2.71 . . . . 2.94 110.276 -176.466 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -72.5 138.35 46.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.095 1.358 . . . . 3.3 112.977 179.017 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -137.7 154.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.61 1.964 . . . . 1.65 108.773 177.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 ptp -125.35 135.63 52.63 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.694 1.198 . . . . 2.84 112.99 176.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.7 -179.74 40.59 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.609 1.099 . . . . 1.86 113.171 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.31 166.42 11.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.812 1.245 . . . . 2.26 113.438 -177.47 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -171.44 155.6 4.17 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 6.14 110.576 164.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.7 Cg_exo -64.98 157.01 59.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.88 1.72 . . . . 0.95 112.146 171.583 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.81 159.12 72.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 126.013 1.725 . . . . 0.91 110.151 176.716 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.92 -24.8 23.97 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.23 1.953 . . . . 1.25 112.853 175.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -179.59 171.26 1.24 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.659 1.584 . . . . 2.22 112.63 -178.37 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mt -118.89 167.61 11.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.925 2.09 . . . . 1.12 109.573 152.266 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -154.82 156.47 36.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.563 -0.711 . . . . 2.61 111.823 178.621 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -137.49 126.94 15.22 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 1.09 108.965 -166.576 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.9 160.43 43.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.0 1.8 . . . . 1.1 111.402 175.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.15 140.0 86.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.617 2.878 . . . . 1.31 111.304 176.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 71.37 -1.56 2.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.309 2.244 . . . . 1.77 113.051 -178.218 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.04 -177.74 31.88 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 126.599 2.047 . . . . 1.75 111.414 178.811 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -161.93 156.41 22.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 5.72 113.759 -179.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.92 161.01 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.286 1.434 . . . . 1.83 109.413 174.538 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -123.6 135.91 54.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.444 -0.947 . . . . 5.01 108.444 158.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.33 55.73 1.01 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.041 1.336 . . . . 1.11 109.216 168.504 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -50.17 132.29 23.84 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.645 1.578 . . . . 4.19 111.349 179.249 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.2 -36.86 97.42 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.946 3.097 . . . . 2.35 114.983 -166.537 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.97 52.34 4.68 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-N 119.327 0.967 . . . . 1.84 111.527 169.984 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.55 -145.5 5.66 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.524 2.011 . . . . 2.84 112.024 -166.726 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -67.79 141.86 56.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.625 0.713 . . . . 2.18 110.376 178.037 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -160.3 165.79 30.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.952 0.797 . . . . 0.88 111.003 -172.445 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -95.64 123.99 39.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.22 -0.659 . . . . 2.16 109.22 163.406 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.52 126.06 45.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.612 1.165 . . . . 1.5 108.959 174.437 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.36 139.79 49.19 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.602 1.561 . . . . 2.92 110.009 -172.557 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mp -132.51 166.08 22.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.606 0.762 . . . . 2.39 112.789 -172.043 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 50.22 41.33 38.91 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 126.81 2.148 . . . . 2.13 114.753 168.445 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 93' ' ' LEU . 57.9 mt -53.17 117.51 3.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.566 1.321 . . . . 1.6 114.566 -147.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -86.54 -3.18 58.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.547 0.943 . . . . 2.61 113.547 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -111.41 150.38 42.01 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.712 1.205 . . . . 4.83 107.898 155.297 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 -10.94 23.17 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.567 2.845 . . . . 4.13 115.15 166.394 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.493 HD11 HD13 ' A' ' 89' ' ' LEU . 3.0 mp 72.39 -173.24 0.15 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.768 3.627 . . . . 2.84 111.293 173.711 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -170.03 119.02 0.6 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.197 1.399 . . . . 3.72 110.094 -167.372 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.39 124.57 21.27 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.322 -0.861 . . . . 1.68 109.495 166.779 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.21 54.79 27.67 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.699 -0.56 . . . . 2.02 111.699 -166.744 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -112.46 163.14 14.81 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 122.455 1.121 . . . . 4.13 110.092 138.643 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -110.26 105.6 14.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.074 1.749 . . . . 4.59 107.742 -172.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.86 112.62 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.134 0.973 . . . . 1.1 109.412 -173.537 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -70.96 137.83 49.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.887 -0.597 . . . . 3.19 110.342 159.322 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.8 tt -149.37 135.46 18.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.902 1.281 . . . . 1.7 109.852 179.484 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.31 110.99 22.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.679 2.792 . . . . 2.1 110.842 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.0 117.95 20.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.989 0.916 . . . . 1.26 109.228 176.344 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.63 121.42 34.04 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 0.58 110.522 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -118.1 121.84 41.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 2.12 113.053 -179.613 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.08 23.55 0.3 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.267 2.227 . . . . 2.73 116.975 168.608 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.7 10.97 80.53 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 115.947 1.139 . . . . 4.58 115.947 174.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.69 -31.18 0.03 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 119.076 1.438 . . . . 2.4 116.478 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -89.11 139.48 30.43 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.741 -1.446 . . . . 4.44 109.398 169.541 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -141.2 140.56 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.644 1.178 . . . . 1.3 108.203 165.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.12 122.98 15.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.101 1.36 . . . . 2.08 108.852 -178.269 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 ptmt -83.1 140.38 32.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.323 0.86 . . . . 2.68 113.323 -179.544 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.85 165.71 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.565 1.946 . . . . 1.29 109.782 167.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.07 139.41 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.757 1.223 . . . . 1.69 109.957 173.677 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 mt -138.32 130.07 15.84 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.612 1.965 . . . . 2.16 109.782 -167.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.37 144.74 37.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.601 2.2 . . . . 1.06 111.051 176.661 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 10' ' ' PHE . 90.4 t -79.95 118.59 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.862 0.839 . . . . 1.22 111.956 169.442 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 145.51 28.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.977 3.311 . . . . 3.42 107.46 166.574 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.2 101.74 5.92 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.974 -1.079 . . . . 1.88 112.003 -161.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.262 1.025 . . . . 6.73 112.705 -166.83 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.06 0 CA-C-O 119.581 -0.566 . . . . 9.93 113.104 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 m -169.38 -43.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.382 2.273 . . . . 8.55 109.716 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -137.63 -165.05 1.71 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.846 2.458 . . . . 8.66 109.485 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.6 p -73.43 95.97 2.3 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.161 -0.962 . . . . 6.74 110.616 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' H ' ' HB ' ' A' ' 21' ' ' THR . 8.5 mt-10 -122.75 119.93 32.12 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.56 1.944 . . . . 5.62 109.665 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.59 176.71 29.88 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.386 0.993 . . . . 0.88 113.768 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -161.12 161.94 31.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.528 1.531 . . . . 1.68 112.186 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.07 126.4 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.822 -0.807 . . . . 0.79 108.822 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.01 117.84 30.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.112 1.365 . . . . 4.22 109.013 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -74.59 -171.53 1.27 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.263 1.03 . . . . 2.81 113.637 -170.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.11 167.64 2.73 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.311 1.845 . . . . 1.74 109.95 160.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.04 -6.91 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.123 2.548 . . . . 1.58 113.088 171.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.39 169.19 21.19 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.109 1.338 . . . . 1.59 113.109 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.41 -7.68 39.15 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 118.068 0.934 . . . . 1.67 113.542 -0.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -128.55 167.53 16.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.182 1.393 . . . . 2.02 114.173 -170.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.85 -173.1 2.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.028 2.131 . . . . 0.57 112.585 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.24 154.43 43.82 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.611 0.967 . . . . 0.83 113.611 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.89 146.89 33.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.769 1.228 . . . . 0.73 112.958 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -140.82 157.42 45.42 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.404 1.482 . . . . 1.89 112.657 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -166.41 158.44 13.73 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.949 1.463 . . . . 1.62 114.949 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 5' ' ' GLU . 15.7 m -84.54 133.0 34.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.773 2.029 . . . . 1.43 107.778 159.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.73 141.32 27.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.622 1.169 . . . . 2.55 111.175 -167.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.31 153.07 23.0 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.002 0.742 . . . . 3.07 113.002 -160.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -120.93 112.43 33.54 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.106 1.362 . . . . 1.06 110.972 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.17 -9.06 10.67 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.858 2.372 . . . . 1.17 113.666 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.01 168.88 52.55 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 124.177 0.894 . . . . 1.15 113.665 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.55 -4.81 47.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.13 1.772 . . . . 2.79 112.823 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.68 160.34 38.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.046 1.738 . . . . 1.42 109.949 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.87 156.42 30.92 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.919 2.413 . . . . 0.64 111.902 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.94 150.41 21.96 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.556 0.742 . . . . 1.98 109.97 166.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -133.57 109.83 9.5 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.058 1.343 . . . . 3.32 109.169 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 tp -91.17 112.8 24.86 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.706 2.402 . . . . 0.97 108.519 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.58 -11.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.198 0.999 . . . . 0.77 112.962 -169.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.65 -160.61 28.13 Favored Glycine 0 C--N 1.343 0.954 0 C-N-CA 124.202 0.906 . . . . 0.57 112.318 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.69 -178.29 6.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.5 1.12 . . . . 0.69 110.618 164.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -155.41 135.94 13.35 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.052 -1.462 . . . . 5.33 107.052 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -152.55 152.8 29.54 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.936 0.895 . . . . 0.76 110.909 -163.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.45 -11.37 10.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.521 2.814 . . . . 0.87 113.707 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.324 0.8 OUTLIER -94.0 -4.01 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 114.1 1.148 . . . . 0.92 114.1 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.29 158.74 44.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.677 1.191 . . . . 0.76 112.04 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -98.67 -60.91 1.45 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 3.3 109.806 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -84.39 134.44 34.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.373 1.069 . . . . 2.84 109.34 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 p -147.97 136.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.649 1.979 . . . . 1.29 108.527 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -148.62 135.98 20.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.174 1.39 . . . . 1.99 110.458 -168.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -81.21 125.51 30.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.85 1.31 . . . . 0.97 110.875 168.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.5 m170 -119.05 157.54 27.6 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.576 2.35 . . . . 0.68 111.461 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -99.58 173.76 6.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.908 1.683 . . . . 2.02 110.272 164.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -127.99 130.25 48.06 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.961 -1.866 . . . . 1.19 105.961 157.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -111.85 163.91 13.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.74 1.216 . . . . 2.64 113.125 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -108.46 143.87 36.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.893 -1.048 . . . . 2.78 108.24 146.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.1 136.34 10.89 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.331 1.053 . . . . 5.25 109.832 -175.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.43 148.25 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.146 0.578 . . . . 4.0 110.631 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.46 -87.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.118 1.367 . . . . 2.87 109.305 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -75.41 34.75 0.11 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.902 2.081 . . . . 3.36 111.456 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.52 -19.79 0.65 Allowed Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.272 -1.517 . . . . 1.97 113.827 -164.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -83.03 146.53 28.69 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.892 2.077 . . . . 2.61 109.743 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -79.52 121.1 24.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.574 0.75 . . . . 3.75 111.412 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.1 t -112.64 148.73 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.653 1.981 . . . . 1.96 108.686 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.4 mtm -134.56 142.08 46.86 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.21 1.004 . . . . 3.53 111.963 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.82 -177.61 44.07 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.616 1.103 . . . . 1.83 113.078 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -107.55 159.13 16.67 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.903 1.281 . . . . 2.17 112.643 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.92 155.42 10.84 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.44 1.496 . . . . 3.72 111.158 171.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.9 Cg_endo -67.44 149.38 80.34 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.646 1.564 . . . . 0.92 112.033 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -114.26 158.65 39.15 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.923 1.689 . . . . 1.21 109.565 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.62 -19.37 36.9 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.238 1.958 . . . . 1.51 112.63 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.2 p90 177.47 171.52 0.58 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.744 2.018 . . . . 2.2 110.924 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mt -116.57 171.68 7.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.021 1.729 . . . . 1.07 108.969 153.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -155.21 164.92 38.15 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.06 -1.025 . . . . 1.97 111.743 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.36 128.66 9.13 Favored Pre-proline 0 N--CA 1.466 0.365 0 C-N-CA 125.02 1.328 . . . . 1.06 108.162 -171.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.82 164.69 32.46 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.762 1.641 . . . . 0.98 111.05 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.6 137.99 83.26 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.173 2.582 . . . . 1.12 110.971 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt 66.31 0.93 1.86 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 1.84 113.646 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.28 -179.06 45.5 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.746 2.117 . . . . 1.45 113.65 -174.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -155.73 147.83 23.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.397 -1.901 . . . . 4.51 111.355 -172.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.01 167.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 127.359 2.264 . . . . 1.68 109.958 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.97 129.37 38.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.81 0.814 . . . . 4.3 111.201 168.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -75.53 71.88 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.539 1.536 . . . . 1.06 109.291 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -68.37 140.59 92.81 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.635 1.574 . . . . 3.02 111.697 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.7 -32.33 68.49 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.023 2.482 . . . . 1.51 112.928 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.42 51.56 4.53 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.851 0.75 . . . . 1.19 111.311 163.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.65 -136.92 4.29 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.119 1.343 . . . . 2.62 112.974 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -73.07 144.58 47.0 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.838 0.855 . . . . 2.02 112.167 -173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -171.04 174.22 4.77 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.322 1.049 . . . . 0.84 109.762 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -101.62 131.82 47.62 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.107 0.563 . . . . 2.11 110.518 166.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.4 mmt -90.76 141.66 28.57 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.538 0.735 . . . . 0.88 109.969 160.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.44 141.59 51.45 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.909 1.683 . . . . 1.67 109.66 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -147.43 144.49 28.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.992 1.317 . . . . 2.07 111.232 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.84 0.56 Allowed Glycine 0 N--CA 1.466 0.66 0 N-CA-C 109.202 -1.559 . . . . 2.33 109.202 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.43 101.38 4.79 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.001 0.905 . . . . 0.94 110.265 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -79.5 -4.73 52.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.32 0.859 . . . . 1.85 113.32 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -126.39 142.51 43.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 126.715 2.006 . . . . 5.32 108.585 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.14 151.6 72.58 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.655 1.57 . . . . 1.75 108.624 157.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.3 mt -120.86 132.0 54.74 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.098 0.951 . . . . 2.93 112.122 -170.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 127.71 54.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.793 1.637 . . . . 3.36 106.968 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 151.5 11.75 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.985 -1.072 . . . . 1.64 113.329 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.88 39.03 94.83 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.554 -0.581 . . . . 1.81 113.747 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -116.3 -166.52 1.16 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.617 -1.253 . . . . 2.71 107.617 154.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -126.08 159.08 33.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.79 0.805 . . . . 3.58 111.913 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.24 116.58 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 125.702 1.601 . . . . 0.95 107.273 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.95 134.43 47.2 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.712 -1.218 . . . . 2.92 107.712 164.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.98 129.25 15.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.192 0.997 . . . . 1.54 111.13 -168.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -105.4 99.77 9.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.556 1.942 . . . . 2.04 110.353 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.8 mt -72.43 116.67 13.16 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.901 1.281 . . . . 1.18 109.789 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.9 mt -89.42 131.52 35.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.457 1.103 . . . . 0.6 111.234 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -122.73 155.56 36.22 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.044 0.938 . . . . 1.82 112.681 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.69 121.11 12.57 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 2.06 112.852 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.71 -156.48 28.95 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.095 1.331 . . . . 3.1 111.415 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.73 51.58 3.77 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.103 -0.832 . . . . 1.64 114.8 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -125.05 137.79 54.21 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.518 1.659 . . . . 4.74 111.136 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.61 136.77 19.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.294 1.838 . . . . 0.98 106.992 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.9 mt -119.76 115.08 23.16 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.921 0.888 . . . . 1.62 109.506 -176.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -79.11 133.38 36.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.239 0.615 . . . . 2.45 111.658 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.47 170.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.843 1.657 . . . . 1.34 110.443 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.95 132.5 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.848 -1.167 . . . . 2.09 107.848 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.9 mt -143.58 144.03 25.97 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.186 1.394 . . . . 1.69 110.011 -168.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.88 152.37 57.84 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.831 3.021 . . . . 1.03 115.12 -172.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.4 t -83.67 107.43 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.293 2.237 . . . . 1.41 109.881 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.95 136.55 36.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.541 1.936 . . . . 4.01 108.83 160.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -105.82 135.79 46.62 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.897 0.379 . . . . 1.9 110.319 163.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 130.49 3.516 . . . . 7.0 106.53 -161.678 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 109.893 -1.283 . . . . 12.84 109.893 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -90.13 26.46 1.87 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.203 1.801 . . . . 13.52 113.079 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 78.59 5.91 2.44 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.012 2.125 . . . . 10.01 111.022 -146.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.5 p -87.15 85.83 7.24 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.059 2.144 . . . . 7.57 109.876 163.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.487 ' H ' ' HB ' ' A' ' 21' ' ' THR . 42.0 mm-40 -113.93 142.62 45.91 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.425 1.09 . . . . 5.25 113.252 -163.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.36 -173.95 34.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 126.389 1.947 . . . . 0.89 112.36 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.7 p90 -155.26 140.88 17.94 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.135 1.374 . . . . 1.65 110.509 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.08 136.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.333 1.053 . . . . 1.06 109.633 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -24.46 31.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.934 1.694 . . . . 4.1 114.962 -169.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.34 174.24 0.26 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.015 2.126 . . . . 3.42 115.138 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 m -174.73 174.46 0.92 Allowed Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.209 3.404 . . . . 1.75 107.737 151.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.17 -21.85 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.007 1.805 . . . . 2.35 112.461 165.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.3 173.99 13.49 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.259 1.885 . . . . 1.77 111.92 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.79 -11.5 39.54 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 119.263 1.532 . . . . 2.03 113.124 -5.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -122.26 168.74 11.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.396 1.479 . . . . 1.96 112.914 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.56 -175.72 4.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.569 2.348 . . . . 0.62 110.339 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.56 17.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.676 1.19 . . . . 0.86 112.207 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 158.36 38.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 0.76 113.424 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -147.23 154.16 40.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.007 1.723 . . . . 2.27 110.75 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.3 160.75 6.3 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 115.918 1.822 . . . . 1.71 115.918 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.487 ' HB ' ' H ' ' A' ' 5' ' ' GLU . 87.9 m -91.72 105.36 17.66 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.28 2.632 . . . . 1.12 109.178 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.6 142.02 28.06 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.724 1.61 . . . . 3.32 110.471 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -109.32 155.77 20.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.149 0.58 . . . . 4.69 111.893 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -134.06 110.04 11.8 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.391 -0.822 . . . . 1.05 109.057 155.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -91.91 -7.03 3.33 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.212 2.608 . . . . 0.92 114.471 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.62 169.19 42.7 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.994 1.27 . . . . 1.19 112.883 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -85.88 5.28 33.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.556 1.542 . . . . 3.94 112.914 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.48 156.26 35.49 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.966 1.707 . . . . 2.64 109.266 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.25 157.33 22.91 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.216 2.611 . . . . 0.84 110.448 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.93 134.33 54.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.07 0.948 . . . . 2.23 110.656 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -126.54 111.06 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.701 1.201 . . . . 4.41 110.347 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -90.06 136.78 32.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.279 1.832 . . . . 0.86 108.862 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -123.42 -10.29 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.21 1.004 . . . . 0.53 113.354 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.11 -164.57 35.22 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.447 1.022 . . . . 0.52 111.968 176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.64 -176.69 5.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.216 1.007 . . . . 0.81 109.626 164.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mtm-85 -142.61 147.27 35.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.877 1.217 . . . . 6.04 108.934 163.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -142.9 154.52 62.2 Favored Pre-proline 0 N--CA 1.465 0.303 0 C-N-CA 125.07 1.348 . . . . 0.7 109.018 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.44 -20.0 27.97 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.058 1.838 . . . . 0.89 112.707 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.326 3.2 m -92.84 15.87 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.709 1.003 . . . . 1.2 113.709 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.28 165.63 35.34 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.09 0.956 . . . . 0.83 112.728 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.82 -71.83 0.75 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.557 1.543 . . . . 3.51 108.004 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -79.2 103.77 9.37 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.991 -1.068 . . . . 3.44 109.85 174.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.91 143.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.9 0.88 . . . . 2.17 110.124 160.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.39 117.0 10.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.823 1.249 . . . . 2.3 109.408 168.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.77 120.47 25.19 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.825 -1.172 . . . . 0.76 110.34 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.1 m170 -105.19 152.03 23.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.75 112.567 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.37 172.14 10.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.721 1.609 . . . . 2.8 110.451 161.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.8 m -151.63 111.85 4.11 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.021 1.328 . . . . 0.99 108.396 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -129.08 160.02 34.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.069 1.348 . . . . 1.92 112.383 -161.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -97.48 143.9 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.653 0.781 . . . . 3.35 110.197 160.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 -155.19 145.35 21.8 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.475 0.71 . . . . 5.53 110.932 168.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -64.42 148.51 50.35 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.904 1.682 . . . . 3.82 111.034 167.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.6 t -138.94 -88.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.667 1.587 . . . . 2.66 108.614 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -77.81 44.97 0.48 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.197 2.199 . . . . 3.4 110.319 170.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.69 -37.02 0.48 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 126.283 1.897 . . . . 2.17 113.65 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -78.8 150.64 32.29 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 128.238 2.615 . . . . 2.57 109.218 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -87.71 142.42 27.84 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.235 1.198 . . . . 3.31 114.235 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.21 150.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.314 2.246 . . . . 1.87 108.354 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.2 mmt -93.57 133.96 36.35 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.933 0.893 . . . . 2.82 110.946 175.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.01 167.6 24.84 Favored Glycine 0 N--CA 1.471 0.98 0 C-N-CA 123.738 0.685 . . . . 0.95 113.461 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.73 137.61 35.26 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.665 1.586 . . . . 2.18 109.344 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -150.33 144.85 17.87 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.276 1.43 . . . . 3.8 109.247 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 37.7 Cg_endo -65.65 142.38 70.47 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.965 1.777 . . . . 0.66 110.773 169.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.39 154.38 47.6 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 126.074 1.749 . . . . 0.65 110.606 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.96 -9.31 23.47 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.882 2.388 . . . . 0.9 113.954 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -175.57 170.37 2.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.263 1.392 . . . . 2.39 111.397 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.42 166.21 17.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.813 1.645 . . . . 0.68 109.215 157.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.49 161.53 40.91 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.188 -0.945 . . . . 2.89 113.034 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -148.3 142.67 16.62 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.726 1.21 . . . . 1.25 109.517 -166.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.8 16.61 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.475 2.117 . . . . 1.01 112.278 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.32 148.36 86.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.894 3.062 . . . . 1.05 112.211 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 64.89 -0.27 1.05 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.602 1.561 . . . . 2.31 113.843 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.53 111.2 3.67 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.901 1.715 . . . . 0.89 111.398 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.45 123.42 44.65 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.68 1.192 . . . . 4.19 109.061 165.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.41 143.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.106 1.362 . . . . 2.0 111.796 -165.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -88.91 144.31 26.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.202 1.001 . . . . 3.24 111.765 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.24 73.77 2.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.402 1.081 . . . . 1.33 109.457 158.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -59.53 131.77 88.31 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 117.886 -1.054 . . . . 4.01 111.111 173.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.43 -32.89 89.16 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.873 2.382 . . . . 1.44 112.893 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.18 51.77 4.41 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.229 0.919 . . . . 1.73 112.328 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.04 -56.6 0.08 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.82 1.2 . . . . 1.49 114.209 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -155.47 141.62 18.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.055 1.742 . . . . 2.09 111.411 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -163.08 176.32 10.18 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.008 -1.057 . . . . 0.78 111.233 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -108.46 131.07 55.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.825 0.45 . . . . 1.79 110.949 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.0 mmt -85.36 144.54 27.98 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.88 1.272 . . . . 1.02 110.759 154.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -124.05 129.02 50.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.204 1.802 . . . . 1.77 108.682 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -133.64 136.57 44.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.094 0.958 . . . . 2.06 111.624 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.36 76.04 0.79 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.675 -1.37 . . . . 2.86 109.675 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.2 mt -78.15 135.25 37.62 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.176 -1.046 . . . . 0.9 108.176 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -80.51 -0.32 36.97 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.968 -1.082 . . . . 2.22 112.264 -169.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -174.21 160.13 2.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.601 2.36 . . . . 6.79 110.156 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.62 146.73 55.64 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.48 2.12 . . . . 3.0 110.092 163.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.5 mt -112.93 168.53 9.62 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.551 1.54 . . . . 2.82 111.874 -172.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.39 137.48 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.658 1.183 . . . . 3.51 111.862 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.86 129.47 41.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.785 -1.197 . . . . 2.32 110.437 172.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 52.11 3.66 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 112.174 -0.37 . . . . 2.34 112.174 -165.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -129.02 165.02 21.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.955 1.702 . . . . 3.63 107.616 161.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.64 155.56 16.93 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.993 1.317 . . . . 5.53 111.003 168.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.06 124.06 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 126.113 1.765 . . . . 0.86 108.567 169.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.62 125.69 29.53 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.079 -0.712 . . . . 3.93 109.079 161.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mt -126.67 125.42 41.83 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.991 0.916 . . . . 1.66 111.81 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -105.06 94.7 5.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.78 1.232 . . . . 2.54 110.568 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.5 mt -65.67 123.36 19.51 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.174 1.39 . . . . 1.53 110.446 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.8 mt -97.43 131.37 44.14 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.31 1.444 . . . . 0.79 110.342 -176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -125.67 167.09 15.61 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.683 1.23 . . . . 2.29 111.566 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.76 166.47 10.92 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.993 -1.003 . . . . 3.01 111.432 168.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.4 15.44 80.3 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.802 0.681 . . . . 4.29 114.802 173.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.62 6.16 89.33 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 118.427 1.113 . . . . 1.85 113.767 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -79.29 138.38 37.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.903 1.352 . . . . 6.46 112.376 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.15 148.94 31.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.19 1.796 . . . . 1.44 108.105 158.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.0 mt -124.15 125.28 44.2 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.573 1.549 . . . . 2.3 108.4 172.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -87.68 133.31 33.85 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.761 0.824 . . . . 2.26 111.651 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.29 127.45 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.835 1.254 . . . . 1.56 113.23 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.88 135.48 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.8 1.24 . . . . 1.81 111.56 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.9 mt -143.78 160.68 49.47 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 128.041 2.536 . . . . 2.11 111.079 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -84.92 157.17 11.62 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.085 3.19 . . . . 0.97 114.624 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -94.32 124.1 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.33 2.252 . . . . 1.07 110.576 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.34 156.09 18.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.983 1.313 . . . . 3.25 109.044 156.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.83 81.51 4.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.366 -0.976 . . . . 2.25 108.366 161.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 115.761 -2.066 . . . . 6.5 115.486 -158.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.029 0 N-CA-C 107.154 -2.378 . . . . 12.91 107.154 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 t -84.7 -134.77 0.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 117.609 -1.636 . . . . 10.87 107.461 128.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 76.74 -3.36 2.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.939 1.295 . . . . 9.93 114.226 155.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.5 p -74.3 85.15 1.93 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.582 1.553 . . . . 6.56 110.028 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.453 ' H ' ' HB ' ' A' ' 21' ' ' THR . 37.0 tt0 -93.98 108.4 20.21 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.929 1.692 . . . . 6.32 111.292 -163.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.55 167.45 30.9 Favored Glycine 0 N--CA 1.466 0.658 0 C-N-CA 124.608 1.099 . . . . 1.05 114.476 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -152.22 143.13 23.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.781 1.232 . . . . 1.54 111.999 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.06 118.16 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 122.963 0.505 . . . . 1.0 109.676 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -85.72 96.45 9.71 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.293 1.037 . . . . 4.66 110.405 -169.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.71 154.53 3.73 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.666 2.386 . . . . 2.18 112.884 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.83 149.08 20.26 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-O 118.463 -0.78 . . . . 2.15 109.668 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.34 56.68 5.6 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.415 2.743 . . . . 2.16 109.281 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.79 -164.38 46.15 Favored Glycine 0 CA--C 1.541 1.677 0 O-C-N 121.482 -0.761 . . . . 2.03 112.582 -168.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.54 -11.73 20.11 Favored 'Cis proline' 0 CA--C 1.541 0.864 0 CA-C-N 117.681 0.74 . . . . 2.46 111.331 -28.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -146.82 168.09 22.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.751 2.021 . . . . 2.18 109.976 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 -177.34 6.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.535 1.534 . . . . 0.64 111.819 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.81 156.69 43.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.476 1.11 . . . . 0.76 111.99 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.1 143.21 36.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.118 0.967 . . . . 0.73 112.111 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -136.66 141.4 43.16 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.389 1.876 . . . . 2.15 109.58 -172.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -165.22 147.33 7.81 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.331 1.975 . . . . 1.94 116.331 -174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.453 ' HB ' ' H ' ' A' ' 5' ' ' GLU . 16.2 m -99.54 129.77 45.73 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.569 1.548 . . . . 1.66 108.786 169.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tp -130.69 162.95 28.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 4.14 110.734 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.28 141.82 51.86 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.092 1.357 . . . . 3.16 111.214 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -100.28 110.91 61.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.512 -0.921 . . . . 1.25 108.512 157.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.87 -15.37 3.9 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.364 2.709 . . . . 1.3 113.769 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.75 -176.27 51.37 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.045 0.838 . . . . 1.37 113.23 -173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -105.33 12.97 31.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.707 1.603 . . . . 4.07 111.437 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mt -113.8 156.37 43.83 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 126.957 2.103 . . . . 2.72 109.132 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.72 158.33 24.8 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.991 2.461 . . . . 0.84 109.926 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.3 130.56 42.93 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.56 1.144 . . . . 2.38 109.73 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -117.26 115.61 25.62 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.864 1.266 . . . . 4.15 110.422 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -94.63 117.14 29.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.537 2.335 . . . . 0.84 108.68 -176.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 m -111.77 -10.88 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 113.729 1.011 . . . . 0.58 113.729 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.25 -163.17 31.66 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.664 -0.648 . . . . 0.4 112.344 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.6 174.97 12.37 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.731 0.813 . . . . 0.65 111.189 167.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -144.85 133.31 21.94 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.921 1.688 . . . . 7.01 108.058 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -148.9 149.74 30.96 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.421 1.489 . . . . 0.73 110.335 -166.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.1 -37.93 4.31 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.337 2.024 . . . . 1.03 112.157 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.273 2.6 m -84.79 3.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.907 1.447 . . . . 0.91 114.907 -169.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -133.31 137.08 45.82 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.356 -1.465 . . . . 0.8 112.23 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -76.11 -70.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.319 -1.363 . . . . 5.23 107.319 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -84.92 143.32 29.08 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.266 2.226 . . . . 3.22 109.37 169.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.75 131.81 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 126.359 1.864 . . . . 1.33 107.932 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -142.94 128.68 19.3 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.234 1.414 . . . . 2.24 109.493 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.87 121.42 24.82 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.367 1.079 . . . . 0.78 110.454 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -112.36 158.38 19.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 127.019 2.128 . . . . 0.63 112.035 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -112.86 179.39 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.912 1.685 . . . . 2.02 110.909 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 m -135.22 106.23 6.65 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.195 1.398 . . . . 1.15 107.274 163.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -107.0 152.06 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.706 1.202 . . . . 2.29 111.225 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -84.77 145.33 27.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.527 0.679 . . . . 3.96 110.27 166.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -148.14 160.17 43.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.558 1.543 . . . . 5.66 110.333 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -84.57 148.12 26.65 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.528 0.731 . . . . 6.7 109.393 164.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.95 -87.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.55 -1.648 . . . . 2.51 106.55 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -77.68 43.96 0.43 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.999 2.52 . . . . 3.8 110.809 170.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.9 -29.63 0.29 Allowed Glycine 0 N--CA 1.482 1.751 0 O-C-N 119.999 -1.688 . . . . 2.5 115.117 -171.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -69.71 132.22 45.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.828 2.051 . . . . 3.65 109.853 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -83.46 102.18 11.9 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.904 -1.147 . . . . 5.46 107.904 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.11 155.26 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 126.516 1.926 . . . . 2.84 110.823 -167.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.0 mtm -75.22 153.22 38.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.622 0.971 . . . . 4.41 113.622 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.64 160.7 28.28 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.446 1.974 . . . . 1.16 110.567 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -123.01 148.31 45.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.897 1.279 . . . . 1.83 110.322 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -171.68 157.85 4.49 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 117.165 -1.398 . . . . 3.99 111.223 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.4 Cg_endo -69.75 157.35 60.71 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.026 1.817 . . . . 0.59 112.605 168.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.03 158.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 126.029 1.732 . . . . 0.67 110.613 171.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.4 -11.67 24.75 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.918 2.412 . . . . 0.81 113.577 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -179.05 162.24 1.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.307 1.843 . . . . 2.24 110.192 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.99 172.85 6.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.471 1.909 . . . . 0.8 108.756 156.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.04 170.17 23.14 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.837 -1.164 . . . . 2.53 113.389 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.05 135.28 11.87 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 125.288 1.435 . . . . 0.93 109.465 -167.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.05 168.32 24.33 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.15 1.9 . . . . 0.92 110.688 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.58 148.59 92.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.082 2.521 . . . . 1.1 111.95 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 68.39 -3.38 1.33 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.94 2.096 . . . . 1.78 114.48 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.29 117.93 5.18 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 126.204 1.859 . . . . 1.05 112.184 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 127.96 34.63 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.54 -0.83 . . . . 6.23 110.264 159.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.05 165.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.568 1.547 . . . . 1.29 110.608 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.08 114.03 8.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.885 0.874 . . . . 3.67 112.099 -163.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.25 67.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.848 2.059 . . . . 1.07 109.379 165.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.44 143.56 98.73 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.996 1.719 . . . . 3.46 111.83 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.1 -61.17 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.172 3.248 . . . . 1.36 112.668 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.22 102.32 2.05 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.802 -1.719 . . . . 1.53 108.802 162.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.99 -69.83 0.3 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.822 1.677 . . . . 1.22 112.662 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -155.71 139.19 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.946 1.699 . . . . 2.02 109.495 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -167.1 172.36 10.12 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.135 -0.978 . . . . 0.86 109.598 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -103.66 141.5 35.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.415 0.552 . . . . 2.18 110.225 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.7 mmt -89.17 139.29 30.63 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.858 0.863 . . . . 1.01 110.077 159.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -122.0 130.33 53.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.53 1.932 . . . . 1.94 109.24 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -136.65 159.45 41.78 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.636 0.774 . . . . 2.28 112.241 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.32 -57.08 3.28 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 126.54 2.019 . . . . 2.8 113.672 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.1 mt 76.64 91.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 130.423 3.489 . . . . 1.14 111.847 172.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -74.54 4.37 6.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.627 1.343 . . . . 2.49 114.627 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -144.67 152.84 53.7 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 128.713 2.805 . . . . 6.34 108.063 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -67.21 150.64 81.76 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.242 1.961 . . . . 2.28 109.516 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.54 134.22 44.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.413 1.485 . . . . 2.93 110.141 -170.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.41 101.49 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.029 0.919 . . . . 4.28 109.37 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.64 130.73 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.211 -0.931 . . . . 2.57 111.176 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.09 50.7 2.97 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 116.057 -0.519 . . . . 2.08 112.923 -167.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -137.17 -167.28 2.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.077 1.351 . . . . 2.94 109.899 159.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -130.55 153.44 48.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.4 1.08 . . . . 3.38 108.742 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.8 115.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.606 1.162 . . . . 1.21 108.686 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -63.69 122.99 17.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.701 -1.591 . . . . 3.59 109.327 160.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -129.72 116.52 18.91 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.711 0.767 . . . . 1.67 110.917 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.32 96.47 9.04 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.833 1.653 . . . . 2.27 108.77 165.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.8 126.76 31.53 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.238 -0.914 . . . . 1.69 109.091 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.35 136.86 37.91 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.929 1.292 . . . . 0.71 111.056 -168.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -132.94 148.49 52.28 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.296 1.046 . . . . 2.51 113.014 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.55 163.85 17.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.067 -0.97 . . . . 2.96 111.971 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.08 76.44 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.791 -0.568 . . . . 4.66 113.575 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.01 63.71 3.2 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.553 1.073 . . . . 1.97 111.069 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -144.35 166.03 26.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.872 1.32 . . . . 3.73 112.755 -171.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -170.78 147.19 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 128.234 2.614 . . . . 1.95 108.239 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 70.0 mt -134.62 118.72 17.51 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.052 1.341 . . . . 2.59 108.703 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -86.19 125.08 33.28 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.353 -0.842 . . . . 2.15 110.673 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.16 133.9 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.272 1.029 . . . . 1.74 108.691 166.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.92 136.96 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.849 -1.167 . . . . 1.94 107.849 168.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -142.6 136.39 14.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.321 1.448 . . . . 2.03 109.001 -170.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.09 154.05 75.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 124.323 3.349 . . . . 1.0 114.034 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.4 t -79.76 125.94 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 122.797 0.439 . . . . 1.1 110.309 170.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.45 141.77 28.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.485 1.914 . . . . 3.38 108.125 162.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.53 22.46 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.629 2.085 . . . . 2.79 116.629 -161.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.272 2.3 tmt_? . . . . . 0 N--CA 1.481 1.079 1 C-N-CA 132.063 4.145 . . . . 8.49 113.789 171.737 . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 109.159 -1.577 . . . . 11.93 109.159 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 173.67 -160.9 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 130.4 3.48 . . . . 9.08 106.576 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -95.85 -171.18 2.28 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.803 1.183 . . . . 9.5 109.934 162.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.6 p -92.77 86.55 5.56 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.784 -1.197 . . . . 6.65 110.042 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.66 103.11 8.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.758 -1.11 . . . . 5.3 109.409 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.94 175.79 22.42 Favored Glycine 0 N--CA 1.472 1.069 0 CA-C-N 119.08 0.855 . . . . 1.26 115.127 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 p90 -155.75 162.67 40.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.962 1.705 . . . . 2.11 111.296 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.1 t -131.16 117.73 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.758 -0.589 . . . . 1.04 109.655 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.47 95.6 8.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.003 0.921 . . . . 6.14 109.914 -171.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.93 145.88 55.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.867 1.667 . . . . 2.37 112.709 -176.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.0 t -142.61 148.01 44.89 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.482 1.513 . . . . 2.71 107.747 162.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.59 48.31 1.57 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.599 3.533 . . . . 1.74 112.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.55 -173.11 55.16 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 121.346 -0.846 . . . . 1.51 112.419 -168.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.28 -21.45 8.91 Favored 'Cis proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.139 -1.192 . . . . 1.45 110.761 -24.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -121.84 165.72 15.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.813 2.045 . . . . 1.91 111.81 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.33 -179.15 7.81 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.23 2.212 . . . . 0.71 110.356 176.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.08 155.36 48.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.726 1.148 . . . . 0.8 113.443 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.48 45.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.466 1.106 . . . . 0.71 113.19 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -156.11 157.94 36.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.013 1.325 . . . . 2.38 112.133 -158.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 178.93 149.12 0.23 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.15 1.537 . . . . 1.61 115.15 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.2 m -85.0 135.08 34.18 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.347 1.859 . . . . 1.49 108.838 160.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 tp -136.29 153.16 51.26 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.841 1.257 . . . . 3.91 109.693 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.56 134.17 28.46 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.601 -0.687 . . . . 4.31 111.047 166.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.73 114.38 47.63 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.453 1.501 . . . . 1.0 110.444 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.69 -15.35 10.91 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.778 2.318 . . . . 1.17 113.875 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.62 166.01 54.8 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 122.509 1.061 . . . . 1.11 113.611 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -77.72 -17.63 57.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.173 2.189 . . . . 4.77 112.281 162.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.01 156.02 60.71 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.479 1.512 . . . . 2.82 111.752 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.6 155.26 9.03 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.014 3.143 . . . . 1.43 110.73 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -125.67 145.74 50.03 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.592 1.557 . . . . 2.05 110.432 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -142.45 108.97 5.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.619 1.167 . . . . 5.01 111.719 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -94.37 114.73 26.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.098 2.159 . . . . 0.77 109.629 -169.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 m -106.29 -11.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.109 1.364 . . . . 1.05 113.724 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.76 -167.61 39.52 Favored Glycine 0 C--N 1.337 0.584 0 O-C-N 121.604 -0.685 . . . . 0.72 111.749 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.26 152.13 30.83 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.38 1.072 . . . . 1.47 110.598 166.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 -110.96 131.25 55.2 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.65 -1.611 . . . . 8.2 106.65 -174.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -139.35 149.56 60.97 Favored Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 124.593 1.157 . . . . 0.59 109.243 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.52 -21.19 19.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.988 2.459 . . . . 0.79 113.069 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.333 2.5 m -90.93 9.64 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 114.607 1.336 . . . . 0.86 114.607 -176.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.3 167.71 27.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.98 0.912 . . . . 0.9 112.792 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -107.4 -77.15 0.6 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.654 1.582 . . . . 3.55 109.068 172.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -75.53 105.24 6.45 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.799 -1.188 . . . . 3.52 109.74 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 p -79.56 143.16 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.13 0.972 . . . . 1.86 110.456 158.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -136.29 134.19 37.73 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.53 1.532 . . . . 2.17 108.48 161.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 tt -86.43 124.79 33.15 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.628 1.558 . . . . 0.79 110.882 167.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -116.15 164.72 14.07 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.842 2.057 . . . . 0.64 112.43 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -114.63 -174.57 2.51 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.115 1.766 . . . . 1.96 111.606 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.1 m -138.25 114.5 10.24 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.161 -1.422 . . . . 1.24 107.161 155.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -90.8 160.01 15.99 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.315 1.046 . . . . 1.89 111.593 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.4 mtm -92.08 148.48 22.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.319 0.648 . . . . 2.48 110.089 154.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -158.96 120.81 3.45 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.486 1.514 . . . . 6.02 108.008 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.45 152.27 18.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.143 0.577 . . . . 4.84 110.74 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.8 t -144.25 116.77 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.145 0.978 . . . . 3.75 108.637 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 61.84 17.92 9.29 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.483 1.513 . . . . 3.71 111.785 -168.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.22 74.19 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.9 1.238 . . . . 2.89 113.972 -169.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -77.46 137.14 38.5 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.889 1.345 . . . . 3.12 108.972 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -63.97 137.62 58.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.599 -0.715 . . . . 4.48 111.807 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -144.47 160.21 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.966 0.506 . . . . 2.0 110.418 164.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.1 mtm -133.81 156.31 48.25 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.528 1.531 . . . . 2.65 110.233 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.37 163.49 33.46 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 123.376 0.512 . . . . 0.97 112.914 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -103.59 166.97 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.753 1.221 . . . . 1.55 111.096 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -176.51 154.17 1.27 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 126.442 1.897 . . . . 3.71 110.34 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -70.98 153.72 63.22 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.123 1.882 . . . . 0.61 111.685 167.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.31 156.22 53.08 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 126.208 1.803 . . . . 0.7 110.602 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.08 -20.6 37.8 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.829 2.353 . . . . 0.73 112.461 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -176.39 169.5 2.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.914 2.085 . . . . 2.26 110.755 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mt -110.63 170.53 8.03 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.343 1.457 . . . . 0.81 109.598 154.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -139.21 166.81 23.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.189 0.519 . . . . 2.53 110.86 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -146.59 120.62 5.19 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.15 1.38 . . . . 1.16 107.734 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.87 164.74 32.87 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.677 1.584 . . . . 1.09 110.864 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.19 138.46 72.32 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.38 2.72 . . . . 1.0 111.368 174.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 67.0 -0.37 1.72 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.563 1.545 . . . . 1.86 113.415 -172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.59 117.37 4.5 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 127.382 2.42 . . . . 1.31 112.071 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -79.77 133.12 36.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.75 -1.225 . . . . 5.61 110.923 163.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.85 166.2 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 127.175 2.19 . . . . 2.08 110.088 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.15 110.38 2.31 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.699 0.799 . . . . 4.31 109.424 -168.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.09 75.64 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.131 1.372 . . . . 1.16 108.004 169.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' H ' ' HG2' ' A' ' 78' ' ' LYS . 15.8 ptpt -69.34 153.23 96.06 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 127.894 2.478 . . . . 2.77 113.555 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.39 -41.92 24.31 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.655 2.904 . . . . 2.87 114.092 -162.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.33 128.28 9.52 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.984 -2.046 . . . . 2.24 107.984 152.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.08 -143.42 14.85 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.072 1.32 . . . . 2.92 111.393 -168.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -73.21 138.7 45.78 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.848 -0.795 . . . . 2.07 111.537 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -161.28 158.3 26.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.454 1.102 . . . . 0.93 109.433 -172.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -87.59 135.2 33.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.973 -0.751 . . . . 2.1 108.973 160.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.55 120.34 41.06 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.549 1.54 . . . . 1.18 108.077 168.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.63 142.68 35.89 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.272 1.029 . . . . 3.33 110.467 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.35 135.74 24.12 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.745 1.618 . . . . 2.12 111.543 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.07 81.84 0.58 Allowed Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.714 -0.954 . . . . 2.66 110.714 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.16 100.79 13.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.921 0.867 . . . . 1.04 110.459 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -86.75 10.5 15.65 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.534 1.309 . . . . 2.01 114.534 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -145.14 166.29 18.53 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 127.349 2.259 . . . . 4.93 109.128 167.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.19 -176.73 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.851 1.7 . . . . 2.35 110.278 151.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -176.5 59.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 127.797 2.439 . . . . 3.1 107.781 -163.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -60.91 151.25 30.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 5.87 113.031 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.38 120.22 8.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.56 -1.2 . . . . 1.59 108.455 156.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.23 17.46 46.57 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.107 -1.385 . . . . 1.93 114.808 -170.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -98.84 167.25 10.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.733 1.766 . . . . 3.28 107.779 151.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -116.22 147.49 41.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.823 0.849 . . . . 3.49 109.163 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.79 116.86 51.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.18 1.792 . . . . 0.93 108.665 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -65.36 129.37 39.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.174 -1.047 . . . . 3.14 108.174 156.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.39 126.56 42.66 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.595 0.758 . . . . 1.81 110.898 168.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.95 94.13 5.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.215 1.806 . . . . 2.7 109.912 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 mt -63.39 118.6 8.3 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.275 1.43 . . . . 1.14 110.568 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.2 mt -92.41 127.7 38.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.322 1.449 . . . . 0.82 110.821 -173.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.12 133.79 50.33 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.815 1.293 . . . . 2.38 113.76 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.06 53.59 2.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.965 1.706 . . . . 2.24 112.383 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -151.5 26.49 0.96 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.682 2.087 . . . . 5.07 113.557 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.98 50.59 45.64 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 124.132 0.873 . . . . 2.42 111.368 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -149.73 160.56 43.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.035 1.734 . . . . 3.58 112.832 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -162.81 130.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 129.149 2.98 . . . . 1.42 108.51 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.95 121.01 36.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 2.57 109.35 -172.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.18 134.56 34.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.901 1.074 . . . . 2.7 113.901 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.62 163.67 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.375 1.47 . . . . 1.89 109.42 164.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.09 134.88 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.975 -1.491 . . . . 1.93 106.975 164.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.8 mt -135.62 148.0 63.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 126.239 1.815 . . . . 1.98 108.594 -172.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.87 163.32 33.97 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.511 2.808 . . . . 1.32 111.904 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -102.27 118.75 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.781 0.832 . . . . 1.56 110.802 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -95.36 140.63 29.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.841 2.456 . . . . 4.96 109.189 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.56 -176.66 5.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.456 -1.403 . . . . 2.72 111.53 164.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 126.566 1.946 . . . . 11.39 116.108 -170.767 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' H3 ' ' CD ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.478 1.434 0 N-CA-C 109.234 -1.547 . . . . 12.21 109.234 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 p -68.96 -171.22 0.29 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.465 1.132 . . . . 10.62 109.694 139.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -69.14 -28.4 66.41 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.634 -1.291 . . . . 13.27 113.622 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.6 p -166.03 -60.47 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.417 2.287 . . . . 7.13 111.451 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 13.3 tt0 -132.01 -167.49 1.89 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.894 1.678 . . . . 6.33 111.377 -152.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -93.97 169.92 30.01 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 125.253 1.406 . . . . 1.26 116.354 -174.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -155.05 133.91 12.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.668 1.587 . . . . 1.82 111.264 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.97 122.94 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.784 -1.191 . . . . 1.15 107.784 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -103.8 87.33 2.78 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.693 0.797 . . . . 4.47 110.127 -161.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.58 144.05 38.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.909 2.083 . . . . 2.14 111.389 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 t -138.32 153.36 72.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.513 1.125 . . . . 2.18 109.6 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -65.71 -9.59 23.38 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.977 2.452 . . . . 1.72 113.195 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.71 177.83 18.44 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.463 1.03 . . . . 1.55 113.836 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 -7.77 32.89 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 117.68 0.74 . . . . 1.4 113.105 -4.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -128.47 160.61 31.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.335 1.054 . . . . 3.28 112.559 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.98 -174.21 4.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.775 1.63 . . . . 0.57 111.916 -175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.22 154.62 49.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.888 0.875 . . . . 0.9 112.978 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.15 146.27 50.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.083 0.953 . . . . 0.96 112.257 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -143.87 156.52 44.49 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.356 1.863 . . . . 2.28 110.703 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -168.46 160.21 10.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.346 1.058 . . . . 2.13 113.748 -176.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.4 m -81.9 147.8 29.1 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.048 1.339 . . . . 2.02 108.558 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -155.2 131.65 10.43 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.157 0.983 . . . . 2.67 111.507 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -113.32 145.16 41.53 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.654 1.981 . . . . 3.72 112.003 173.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -95.14 97.31 2.53 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 114.372 -1.285 . . . . 1.25 109.652 155.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.46 -8.22 18.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.25 1.967 . . . . 1.12 112.939 173.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.17 176.49 50.35 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 124.401 1.001 . . . . 1.11 113.606 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.37 -5.42 27.3 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.737 2.015 . . . . 2.7 113.0 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 160.33 44.02 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.84 2.056 . . . . 1.48 109.7 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 158.73 31.05 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.859 2.372 . . . . 0.77 112.877 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.19 146.63 28.49 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.72 1.208 . . . . 1.85 110.197 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -131.82 112.38 12.43 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.934 1.294 . . . . 3.59 109.844 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -97.91 115.6 28.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.017 2.527 . . . . 0.77 108.751 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.92 -9.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.448 1.099 . . . . 0.55 113.116 -166.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.87 -168.86 41.02 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 124.535 1.064 . . . . 0.44 111.841 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.824 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -146.89 -178.62 6.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.894 1.278 . . . . 0.7 110.848 172.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 7.0 ttp85 -151.34 139.97 20.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.372 -2.455 . . . . 7.77 104.372 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -147.37 155.4 46.08 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.055 -1.091 . . . . 0.63 108.055 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.39 -29.93 24.81 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.486 2.124 . . . . 0.79 113.19 171.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -85.36 -19.98 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.188 1.181 . . . . 1.12 114.188 -169.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.84 159.03 22.05 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.21 1.004 . . . . 0.75 112.909 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.441 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 11.0 tp10 -98.11 -91.96 0.26 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.183 0.993 . . . . 3.04 111.202 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -78.66 110.49 13.84 Favored 'General case' 0 C--N 1.341 0.221 0 O-C-N 121.079 -1.013 . . . . 3.89 108.736 -172.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -79.61 142.31 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 124.565 1.146 . . . . 2.22 111.253 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -142.05 128.49 20.09 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.211 1.004 . . . . 2.82 109.75 164.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -80.41 116.46 20.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.299 1.047 . . . . 0.75 110.476 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 15.5 m170 -107.96 155.13 20.66 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.509 1.524 . . . . 0.72 111.876 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.67 -171.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.142 1.777 . . . . 2.18 110.432 170.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -146.45 114.09 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.888 -1.132 . . . . 1.06 108.206 163.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -103.33 174.1 6.02 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.282 1.433 . . . . 1.9 111.989 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.6 ptp -118.16 154.41 32.21 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.267 1.427 . . . . 2.97 110.823 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -155.87 164.35 38.62 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.732 1.613 . . . . 6.46 111.731 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -85.74 142.63 28.86 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.529 0.732 . . . . 4.16 110.513 162.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.34 -96.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.988 -0.745 . . . . 2.66 108.988 163.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -76.68 37.41 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.972 2.109 . . . . 3.72 111.919 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.25 0.44 4.49 Favored Glycine 0 CA--C 1.542 1.738 0 O-C-N 120.388 -1.445 . . . . 2.14 113.463 -159.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -95.47 141.32 29.15 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.241 2.616 . . . . 3.14 110.17 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -73.03 136.88 45.09 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.565 -0.743 . . . . 5.09 109.821 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -139.78 143.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.647 1.179 . . . . 1.68 109.5 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -114.56 145.66 41.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.753 1.221 . . . . 2.82 111.28 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.36 168.87 34.26 Favored Glycine 0 N--CA 1.468 0.814 0 C-N-CA 123.794 0.711 . . . . 1.07 113.547 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -103.17 161.1 14.07 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.93 1.292 . . . . 1.8 112.416 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -167.14 154.45 8.39 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 126.289 1.835 . . . . 3.49 110.071 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 41.0 Cg_endo -69.01 150.03 72.3 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.685 2.257 . . . . 1.05 111.458 167.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.11 158.43 41.01 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.955 1.702 . . . . 0.81 110.459 169.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.84 -16.9 41.93 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.659 2.24 . . . . 0.91 112.937 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 177.49 163.43 0.56 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.951 2.1 . . . . 1.94 109.756 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mt -105.22 170.82 7.66 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.312 1.445 . . . . 0.78 109.638 155.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.15 158.06 39.82 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.189 -0.944 . . . . 2.44 111.813 170.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.45 128.31 13.73 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.461 1.504 . . . . 0.81 108.863 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.01 162.67 40.36 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.532 2.155 . . . . 0.84 111.522 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.04 139.47 87.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.704 2.936 . . . . 0.91 112.639 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt 69.13 2.83 3.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.158 2.183 . . . . 1.83 114.301 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.42 144.13 16.97 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 126.989 2.233 . . . . 1.19 109.645 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -117.24 150.65 38.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.978 1.311 . . . . 3.87 112.714 166.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.65 168.26 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.324 1.85 . . . . 1.58 110.677 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.406 ' CD ' ' H3 ' ' A' ' 1' ' ' GLY . 47.3 mt-10 -135.07 132.88 38.71 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.199 -1.408 . . . . 4.51 107.199 162.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.59 77.39 1.99 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.156 1.455 . . . . 1.06 111.356 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -64.25 123.78 83.55 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 117.575 -1.202 . . . . 4.36 111.452 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -47.87 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.844 3.696 . . . . 1.71 114.606 -171.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.5 56.86 4.14 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.566 1.079 . . . . 1.35 111.991 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.86 -53.86 0.05 OUTLIER Glycine 0 N--CA 1.466 0.635 0 C-N-CA 126.097 1.808 . . . . 1.53 112.781 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -152.93 140.45 19.76 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.925 2.09 . . . . 2.35 111.223 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -166.58 172.35 10.8 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.857 -1.152 . . . . 0.81 111.784 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 61.1 m-85 -105.05 126.69 52.34 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.012 0.925 . . . . 1.89 111.032 168.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.5 mmt -86.65 137.56 32.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.794 1.238 . . . . 0.84 111.42 167.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.7 mt -115.35 88.77 2.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.791 1.636 . . . . 1.78 109.261 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 mt -86.92 101.6 13.55 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.555 1.542 . . . . 2.2 110.599 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.5 133.03 4.83 Favored Glycine 0 N--CA 1.469 0.851 0 C-N-CA 124.347 0.975 . . . . 3.07 110.779 -173.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.0 mt -112.98 112.55 24.08 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.374 1.087 . . . . 1.04 109.439 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.441 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 2.3 pttm -90.54 -9.57 46.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.198 1.184 . . . . 1.92 114.198 -172.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.7 mmt-85 -146.45 150.91 42.18 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.567 1.547 . . . . 8.35 109.389 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.1 174.72 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.393 2.729 . . . . 2.47 111.432 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -176.42 158.08 1.77 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.346 1.858 . . . . 2.67 109.355 -160.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.33 178.17 7.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.025 1.73 . . . . 3.85 112.219 174.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.4 133.99 15.53 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.925 1.29 . . . . 1.89 112.939 165.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.93 -0.3 89.5 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.301 -1.277 . . . . 2.16 115.268 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -77.83 167.41 21.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.863 1.331 . . . . 3.92 111.861 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.14 152.96 20.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.306 -1.315 . . . . 3.79 110.525 162.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.8 t -139.84 126.79 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 126.148 1.779 . . . . 1.51 109.049 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.31 142.35 57.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.599 -0.519 . . . . 3.6 109.599 164.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.824 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.3 tt -141.05 127.37 19.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.52 1.152 . . . . 1.65 111.987 157.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.428 ' N ' HD23 ' A' ' 101' ' ' LEU . 1.5 m-20 -98.94 114.63 27.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.614 1.965 . . . . 2.2 109.935 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.54 125.7 29.92 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.546 -0.721 . . . . 2.39 109.816 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt -98.1 128.66 44.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.089 0.956 . . . . 0.62 109.879 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.28 156.78 31.77 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.015 0.926 . . . . 2.0 112.024 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.81 143.34 57.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.953 0.501 . . . . 2.14 111.039 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 -168.27 53.53 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.0 -0.84 . . . . 2.94 111.0 -164.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.45 40.59 2.21 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.806 -0.82 . . . . 1.74 114.379 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -115.84 122.0 44.07 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.047 1.423 . . . . 4.43 112.529 -173.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.45 135.49 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.424 1.49 . . . . 1.07 108.466 161.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.5 mt -129.81 128.58 42.62 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.587 1.155 . . . . 1.57 109.204 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -88.34 134.8 33.72 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.87 0.868 . . . . 2.31 112.656 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.32 167.37 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.801 0.84 . . . . 1.53 110.514 153.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.74 141.51 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 106.853 -1.536 . . . . 2.2 106.853 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.2 mt -137.44 151.97 72.22 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.632 1.573 . . . . 1.78 110.133 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.71 155.5 44.34 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.627 2.885 . . . . 1.15 112.036 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.79 123.34 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.083 0.953 . . . . 1.01 110.823 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.6 149.19 22.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.828 1.651 . . . . 3.44 109.233 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.0 23.09 11.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 113.927 1.084 . . . . 2.21 113.927 -170.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.384 1.473 . . . . 7.15 112.662 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 CA-C-O 117.686 -1.619 . . . . 10.46 109.518 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m 62.87 60.56 1.24 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.524 1.162 . . . . 10.8 111.275 -164.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.301 9.1 m-85 67.08 169.37 0.25 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.939 1.696 . . . . 10.1 112.05 -154.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.61 159.42 1.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.443 -0.799 . . . . 6.61 111.251 -136.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -170.56 -167.26 0.58 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.168 2.587 . . . . 5.03 109.362 -170.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.75 157.48 27.42 Favored Glycine 0 N--CA 1.469 0.854 0 O-C-N 120.707 -1.246 . . . . 1.51 115.095 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -136.06 144.63 45.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.904 1.281 . . . . 1.72 111.966 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.8 t -102.28 136.86 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.718 -1.216 . . . . 0.88 107.718 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -104.17 106.62 17.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.156 0.982 . . . . 3.7 110.187 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.36 147.86 29.72 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.085 1.754 . . . . 2.54 112.401 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -150.95 158.86 34.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.707 1.603 . . . . 1.79 109.805 162.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.43 -15.33 31.11 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.161 2.574 . . . . 1.67 113.497 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.4 170.24 14.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.529 1.062 . . . . 1.73 113.0 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.06 -5.56 15.82 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 118.215 1.008 . . . . 1.89 113.025 -3.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -122.69 170.06 10.43 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.243 1.817 . . . . 2.22 113.997 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.52 -177.21 5.47 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.138 2.175 . . . . 0.79 111.319 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.36 154.25 51.56 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.159 0.89 . . . . 0.89 112.19 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -147.53 157.16 43.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.029 0.918 . . . . 0.72 112.806 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -149.62 161.85 41.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.46 1.504 . . . . 2.02 110.356 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -162.5 159.26 24.72 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 112.854 0.687 . . . . 1.49 112.854 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.0 m -83.5 119.65 24.95 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.403 -1.332 . . . . 1.21 107.403 150.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.83 134.52 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 2.51 107.452 166.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 6.4 mt-10 -128.39 121.77 29.85 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.957 0.903 . . . . 3.52 110.125 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -95.49 111.94 57.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.308 1.043 . . . . 1.2 109.974 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -86.44 -12.22 5.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.263 2.642 . . . . 0.91 113.711 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.36 160.57 42.15 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.108 0.861 . . . . 1.3 112.488 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -90.62 6.78 42.41 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.029 1.732 . . . . 2.94 113.616 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.75 157.97 53.16 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.01 1.724 . . . . 1.34 110.595 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.99 160.52 30.29 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.229 2.619 . . . . 0.77 111.935 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -124.5 124.41 42.22 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.718 1.207 . . . . 2.1 111.547 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -118.75 112.0 19.2 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.217 1.407 . . . . 4.01 112.791 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.3 tp -100.03 110.23 22.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.897 2.479 . . . . 0.86 109.951 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -98.12 -11.94 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.859 1.664 . . . . 0.98 112.954 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.5 -159.82 30.79 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 119.097 0.862 . . . . 0.54 113.556 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.45 -171.13 3.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.866 1.267 . . . . 1.0 111.164 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -166.43 124.46 1.42 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.674 -1.232 . . . . 5.36 107.674 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -138.35 162.08 55.5 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.989 1.316 . . . . 0.89 109.494 -167.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.2 -22.71 3.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.636 2.891 . . . . 0.82 113.989 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 2.6 m -86.93 -0.77 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 114.393 1.257 . . . . 1.17 114.393 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.7 168.19 27.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.089 2.156 . . . . 1.08 109.867 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -106.28 -79.22 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.539 1.063 . . . . 3.79 110.737 171.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -75.27 105.31 6.23 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 120.917 -1.115 . . . . 3.25 110.082 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.6 137.69 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 125.094 1.358 . . . . 1.27 111.262 171.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -132.17 129.49 39.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.239 1.816 . . . . 2.01 109.137 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.79 117.15 22.48 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.538 1.161 . . . . 0.75 110.953 168.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 20.2 m170 -105.01 152.63 22.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.197 1.799 . . . . 0.57 112.032 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.66 172.7 8.09 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.613 1.165 . . . . 1.94 110.228 161.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.565 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 53.0 m -149.05 102.32 3.24 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.392 1.477 . . . . 1.31 107.487 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -105.6 162.92 13.08 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.174 1.79 . . . . 2.39 112.49 -164.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -102.91 151.1 22.84 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.948 -0.569 . . . . 2.76 110.777 151.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -158.97 145.06 16.69 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.754 1.622 . . . . 5.09 109.873 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.31 146.86 23.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.258 0.551 . . . . 4.33 111.287 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.24 135.87 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.384 1.874 . . . . 3.24 109.309 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 60.13 20.14 9.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.386 1.075 . . . . 4.22 112.185 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.96 -3.81 68.89 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.894 1.235 . . . . 2.31 113.959 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -99.44 146.24 26.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.156 1.782 . . . . 3.37 110.407 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -77.2 131.03 38.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.834 -0.541 . . . . 4.01 110.53 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -128.6 153.85 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.909 1.684 . . . . 1.95 108.841 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.4 mtm -121.03 146.68 46.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.989 0.916 . . . . 2.96 110.816 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.58 -177.24 31.48 Favored Glycine 0 N--CA 1.468 0.829 0 C-N-CA 124.346 0.974 . . . . 0.98 113.081 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.11 162.0 34.59 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.24 1.416 . . . . 2.3 110.655 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -171.45 151.85 3.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.147 1.379 . . . . 3.61 111.45 172.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 35.6 Cg_endo -65.54 146.69 85.46 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.494 2.129 . . . . 0.74 111.803 166.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.49 155.79 51.77 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.922 1.689 . . . . 0.57 110.237 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.31 -18.62 44.46 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.674 2.25 . . . . 0.7 112.637 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -179.1 167.22 1.58 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 126.676 1.99 . . . . 2.25 110.903 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.69 168.28 9.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.069 1.348 . . . . 0.74 109.468 154.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -151.96 161.99 41.78 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.822 0.675 . . . . 2.77 112.822 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 t -133.29 134.78 24.43 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.952 1.701 . . . . 0.88 108.564 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.71 164.05 32.82 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.062 1.841 . . . . 0.89 111.289 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.39 147.52 93.73 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.094 2.529 . . . . 0.97 111.663 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt 68.12 -0.61 2.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.325 1.85 . . . . 1.31 113.508 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.69 127.58 9.04 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 127.679 2.561 . . . . 1.0 111.646 -170.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 9.2 ptp180 -98.22 134.61 41.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.974 1.31 . . . . 6.02 112.465 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.35 136.29 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.043 . . . . 1.31 111.202 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.84 115.68 31.06 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.555 1.542 . . . . 3.38 110.352 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -68.15 77.02 0.24 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.746 2.019 . . . . 1.09 109.95 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -74.05 138.11 75.91 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.293 1.437 . . . . 3.4 111.773 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.49 -43.33 59.18 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.08 3.187 . . . . 1.18 112.757 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.29 89.71 1.11 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.243 -1.543 . . . . 1.27 109.243 161.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.53 -76.2 0.26 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.909 1.719 . . . . 1.25 113.589 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -154.74 142.4 19.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.437 1.895 . . . . 1.98 111.163 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -162.06 167.95 23.49 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.409 -0.807 . . . . 0.93 111.692 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.37 127.95 46.55 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.665 0.786 . . . . 1.85 110.186 168.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.8 mmt -91.44 132.8 35.98 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.15 0.98 . . . . 0.98 110.068 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.7 147.47 35.51 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.612 1.165 . . . . 2.94 110.609 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mt -146.43 160.81 41.59 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.135 2.174 . . . . 2.32 110.175 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.46 57.61 11.06 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-O 118.917 -0.935 . . . . 2.54 111.152 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.2 mt -66.98 100.13 0.71 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.382 1.091 . . . . 0.97 112.054 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -71.12 -15.08 62.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.452 0.908 . . . . 1.72 113.452 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -128.42 147.0 62.05 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.986 2.114 . . . . 5.76 110.95 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.01 145.15 35.17 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.246 1.964 . . . . 1.9 108.938 149.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.04 163.88 35.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.424 1.89 . . . . 2.43 111.334 -168.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.01 168.16 19.57 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 118.94 2.941 . . . . 6.99 118.94 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.37 133.94 23.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.412 1.885 . . . . 1.72 112.406 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.92 2.34 88.45 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.988 -1.451 . . . . 2.28 114.727 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.69 159.84 23.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.788 1.794 . . . . 2.89 111.333 170.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -108.66 128.18 54.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.492 1.917 . . . . 3.63 109.13 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.41 103.72 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.574 1.15 . . . . 0.9 109.545 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -63.25 126.94 29.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.579 -0.897 . . . . 2.97 108.579 157.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.9 144.92 27.19 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.248 -0.907 . . . . 1.87 110.501 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -94.03 138.64 31.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.487 2.715 . . . . 3.59 110.156 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.8 mt -110.77 125.46 53.57 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.397 2.279 . . . . 1.28 109.908 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.2 mt -98.59 124.15 43.2 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.883 0.873 . . . . 0.74 111.633 -170.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -119.76 141.82 49.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.242 1.201 . . . . 1.99 114.242 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.65 88.68 0.71 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.879 1.272 . . . . 2.42 111.145 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.74 67.57 0.12 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.051 1.31 . . . . 4.02 113.165 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.3 17.41 72.26 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 116.59 1.396 . . . . 1.55 116.59 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.04 114.22 20.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.038 1.419 . . . . 3.66 112.005 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.37 136.59 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.835 2.454 . . . . 2.46 105.863 146.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.4 mt -144.92 119.63 9.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.198 0.999 . . . . 2.01 109.569 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -90.27 146.6 24.1 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.007 1.114 . . . . 4.15 114.007 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.6 m -135.17 152.18 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.352 1.861 . . . . 1.29 110.034 171.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.3 p -106.56 132.36 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.132 0.973 . . . . 1.55 109.553 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.9 mt -135.07 134.95 22.04 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.428 1.491 . . . . 1.82 110.239 -171.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.62 151.28 79.55 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.984 2.456 . . . . 0.95 113.5 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.99 119.75 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.886 1.275 . . . . 0.94 110.873 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -90.32 149.37 22.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.872 2.069 . . . . 3.55 108.892 156.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -132.25 4.66 4.06 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 116.222 1.934 . . . . 3.07 116.222 -155.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.784 1.634 . . . . 7.53 112.542 -168.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.27 0 N-CA-C 107.77 -2.132 . . . . 15.53 107.77 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 m -155.72 166.99 31.84 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.68 1.24 . . . . 12.39 110.182 -164.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -174.41 144.0 0.88 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.106 2.162 . . . . 12.01 108.64 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.9 m -94.53 -45.58 7.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.536 0.734 . . . . 7.95 111.437 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -170.84 -137.27 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.251 2.22 . . . . 5.9 107.559 -162.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -131.42 137.11 9.21 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 120.961 1.71 . . . . 1.88 114.202 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -128.1 127.07 42.39 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.473 1.13 . . . . 2.02 111.957 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.74 95.21 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.81 -1.552 . . . . 1.52 106.81 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.42 105.82 9.93 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.575 1.178 . . . . 3.31 110.238 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -74.03 159.81 32.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.631 1.572 . . . . 2.46 112.55 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.416 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 75.6 m -149.71 159.25 36.45 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 126.29 1.836 . . . . 2.8 110.691 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.47 -2.86 12.4 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.369 2.712 . . . . 1.75 114.879 -171.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 167.61 27.95 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.33 0.967 . . . . 1.33 112.83 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.82 -2.65 18.35 Favored 'Cis proline' 0 CA--C 1.541 0.833 0 CA-C-N 118.579 1.19 . . . . 1.74 112.91 -4.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -128.39 169.84 13.81 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.047 1.739 . . . . 2.23 113.791 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.22 171.81 18.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.377 2.271 . . . . 0.9 111.586 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.96 120.45 31.62 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.761 0.824 . . . . 1.14 110.668 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.02 32.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.567 0.747 . . . . 0.79 111.83 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.88 162.92 31.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.395 1.478 . . . . 2.04 111.137 -174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.07 143.6 3.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 115.635 1.717 . . . . 1.63 115.635 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -69.96 87.88 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.205 -1.035 . . . . 1.27 108.205 160.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 tt -75.27 143.55 42.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.928 -0.768 . . . . 2.93 108.928 169.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -125.98 143.45 51.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.52 0.676 . . . . 3.27 112.044 170.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.67 100.9 13.54 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.99 -1.005 . . . . 0.98 109.193 161.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -78.96 -7.77 15.44 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.587 2.192 . . . . 1.17 112.624 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.56 179.73 51.46 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.802 1.192 . . . . 1.24 113.486 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.98 -3.18 20.4 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.272 1.829 . . . . 3.04 113.044 -171.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.02 162.67 28.35 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 126.367 1.867 . . . . 1.33 109.682 167.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.34 154.29 21.53 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 122.832 2.355 . . . . 1.04 112.672 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.0 mt -104.05 126.88 51.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.016 0.926 . . . . 2.0 110.832 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.57 109.02 20.51 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.03 -0.986 . . . . 3.3 110.304 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.2 tp -95.14 120.58 35.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.736 2.014 . . . . 0.81 108.598 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.01 -14.72 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.684 0.794 . . . . 0.6 112.453 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.49 -167.95 40.13 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 121.789 0.661 . . . . 0.4 113.139 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.52 176.9 8.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.038 0.935 . . . . 0.8 109.393 159.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -157.43 145.41 19.03 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 106.425 -1.694 . . . . 6.49 106.425 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -149.13 155.27 40.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.359 1.064 . . . . 0.85 108.149 -164.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.04 -26.78 36.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.857 2.371 . . . . 1.27 112.749 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -78.16 -12.24 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 114.415 1.265 . . . . 1.25 114.415 -171.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.06 156.23 46.68 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.897 1.279 . . . . 0.84 111.818 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -102.54 -62.87 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.014 0.526 . . . . 3.57 110.753 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -79.16 146.57 33.06 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.768 -0.827 . . . . 4.09 108.768 165.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -152.79 133.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.748 1.619 . . . . 1.58 108.329 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -140.89 129.27 22.45 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.711 1.604 . . . . 2.14 109.351 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.22 123.01 29.66 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.995 1.271 . . . . 0.77 110.648 167.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -111.33 159.96 17.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.177 1.791 . . . . 0.53 112.256 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -116.51 179.19 4.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.188 2.195 . . . . 2.12 111.034 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -131.22 133.14 45.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.707 1.603 . . . . 1.62 107.713 166.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -125.7 150.92 47.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.349 1.059 . . . . 1.95 111.94 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.2 ptp -84.74 153.7 22.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.715 1.606 . . . . 4.37 110.433 167.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -153.79 34.54 0.44 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.061 1.504 . . . . 6.1 115.061 -169.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -56.74 146.78 24.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.647 1.579 . . . . 5.25 113.268 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -156.4 136.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.622 2.369 . . . . 6.2 105.416 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 60.89 23.43 13.48 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.813 0.816 . . . . 5.86 111.68 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.72 0.35 24.84 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 119.916 -1.74 . . . . 4.45 114.862 -174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -86.42 132.88 33.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.507 1.923 . . . . 3.5 108.836 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.74 142.86 29.76 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.401 1.26 . . . . 7.16 114.401 -166.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -155.37 138.18 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.443 1.897 . . . . 2.09 108.618 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 ptp -141.21 138.92 33.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.46 0.704 . . . . 3.15 111.126 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.52 175.74 20.79 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 124.623 1.106 . . . . 0.98 112.451 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.5 mtt -128.45 156.79 42.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.787 1.635 . . . . 2.38 110.78 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -167.93 154.79 7.6 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 125.149 1.379 . . . . 3.69 111.441 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.3 Cg_endo -70.23 151.2 66.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.011 1.807 . . . . 0.56 112.221 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.0 156.78 54.17 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.748 2.019 . . . . 0.65 110.614 175.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.49 -16.0 27.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.954 2.436 . . . . 0.75 113.113 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.4 p90 179.14 170.72 0.93 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.027 2.131 . . . . 2.52 110.321 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.0 174.69 7.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.679 2.392 . . . . 0.75 108.933 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -152.8 164.42 37.85 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.028 -1.045 . . . . 2.27 112.535 164.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 t -138.86 128.83 14.67 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.524 1.53 . . . . 1.04 109.58 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.58 163.41 39.07 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.506 2.137 . . . . 1.19 111.69 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.9 138.18 84.18 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.503 2.802 . . . . 1.22 112.055 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt 68.92 2.64 3.63 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.966 2.106 . . . . 1.52 113.708 -175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.11 114.1 3.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 125.85 1.691 . . . . 1.31 111.269 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -93.18 125.81 37.97 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.391 1.077 . . . . 8.06 109.32 162.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.5 m -145.44 130.18 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.219 1.008 . . . . 1.56 111.296 -176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.85 132.93 34.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.197 0.999 . . . . 6.93 111.248 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.27 60.34 3.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 124.018 1.866 . . . . 1.8 111.979 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -47.94 133.91 11.56 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 128.038 2.535 . . . . 3.68 113.27 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.2 -51.28 9.78 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.325 2.684 . . . . 1.62 111.99 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.65 94.98 1.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.264 -1.535 . . . . 1.57 109.264 166.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.06 -76.96 0.29 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.993 1.758 . . . . 1.34 113.008 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -158.03 130.55 7.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.6 1.56 . . . . 2.11 111.299 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -162.13 173.3 14.51 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.938 1.699 . . . . 0.75 111.977 -166.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.95 120.5 41.6 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.742 -0.599 . . . . 2.05 112.078 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.4 mmt -84.75 121.49 27.76 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.233 1.013 . . . . 0.96 109.854 164.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -106.02 131.14 53.66 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.223 1.409 . . . . 1.72 108.496 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -140.07 142.37 36.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.791 0.836 . . . . 2.11 111.133 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.42 60.45 4.37 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 109.042 -1.623 . . . . 2.42 109.042 -166.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -65.66 127.57 32.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.32 1.06 . . . . 1.02 108.998 172.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -106.3 12.64 29.71 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 1.73 112.89 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -162.33 153.21 14.69 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.811 1.644 . . . . 5.96 110.919 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.94 163.45 39.17 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.921 2.414 . . . . 2.27 109.378 159.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mp -133.93 162.77 31.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.104 0.954 . . . . 3.35 112.139 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -119.36 120.01 35.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.888 2.075 . . . . 5.74 110.478 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.06 118.29 4.52 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.85 -1.156 . . . . 2.58 109.79 168.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.94 48.09 22.25 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.719 -0.489 . . . . 2.3 112.761 -167.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.28 -168.33 1.32 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 107.53 -1.285 . . . . 2.76 107.53 140.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -128.85 155.53 45.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 4.39 111.639 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.08 118.5 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.685 1.594 . . . . 1.62 108.938 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.42 138.9 39.54 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.524 0.729 . . . . 3.46 110.021 163.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.413 ' C ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -155.3 143.02 19.8 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.873 1.269 . . . . 1.99 110.912 -168.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -89.82 110.36 21.29 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 128.995 2.918 . . . . 3.03 110.323 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.43 113.08 21.44 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.426 1.012 . . . . 1.56 109.372 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.2 mt -93.6 123.47 36.94 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.043 0.937 . . . . 0.58 110.772 -166.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -124.58 137.64 54.38 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.427 -0.796 . . . . 2.26 112.571 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.98 130.89 30.74 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.614 1.166 . . . . 1.85 113.164 -170.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.5 -150.17 20.59 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.367 -1.093 . . . . 3.48 110.367 -163.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.29 28.02 9.56 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.402 1.001 . . . . 2.08 114.715 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mppt? -100.38 135.38 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.722 1.761 . . . . 5.25 112.084 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.88 138.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 124.763 1.225 . . . . 1.29 109.454 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -116.41 104.87 11.89 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.837 0.855 . . . . 1.62 109.319 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.22 114.03 17.83 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 3.46 109.36 174.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.09 150.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.093 1.357 . . . . 3.24 112.546 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.4 p -87.75 142.17 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.051 1.74 . . . . 2.13 111.904 176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -142.5 146.1 37.4 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.086 1.755 . . . . 3.09 110.55 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.8 152.53 69.14 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.823 3.015 . . . . 1.86 113.007 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.6 t -93.81 127.04 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.938 1.295 . . . . 1.56 110.746 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.64 -177.7 3.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.376 1.47 . . . . 5.36 109.186 165.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.25 154.2 31.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 119.769 -1.832 . . . . 2.53 114.027 -164.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 125.918 1.687 . . . . 5.88 113.448 156.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 107.346 -2.302 . . . . 13.23 107.346 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 p 170.05 173.51 0.06 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.425 1.112 . . . . 10.29 110.164 -150.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -56.04 168.61 0.47 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.635 1.174 . . . . 8.14 111.991 167.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.3 m -153.26 162.91 40.78 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.693 1.597 . . . . 7.59 107.913 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -115.4 -147.57 0.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.648 1.179 . . . . 4.74 111.019 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -161.28 170.39 37.06 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 120.556 -1.34 . . . . 1.29 114.183 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -157.87 147.79 20.23 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.292 1.037 . . . . 1.54 111.935 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -93.45 121.62 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 121.146 -0.971 . . . . 1.11 108.809 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -63.46 -29.84 71.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.749 1.62 . . . . 4.85 113.719 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.99 -179.74 0.22 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.221 2.208 . . . . 2.3 112.692 173.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m 176.25 165.84 0.44 Allowed Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 128.751 2.82 . . . . 1.89 108.575 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.27 5.65 3.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.248 2.632 . . . . 2.16 113.726 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.5 170.66 36.04 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.35 0.976 . . . . 2.36 112.333 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.86 -6.48 33.06 Favored 'Cis proline' 0 CA--C 1.537 0.675 0 CA-C-N 118.612 1.206 . . . . 2.81 113.66 -5.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -135.42 171.84 13.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.962 2.105 . . . . 5.66 110.804 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.62 -168.3 1.14 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.785 2.434 . . . . 1.3 112.21 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.23 166.97 24.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.317 1.847 . . . . 1.38 111.786 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.33 159.32 42.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.647 1.179 . . . . 0.92 114.067 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -141.53 156.77 45.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.665 2.386 . . . . 2.0 110.942 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.415 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.2 pp -175.04 167.69 3.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.286 1.217 . . . . 2.13 114.286 -174.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.3 m -124.7 137.48 54.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.775 1.63 . . . . 1.54 109.033 174.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.4 tp -131.14 156.4 45.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.152 1.381 . . . . 4.47 110.849 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -130.58 129.49 42.83 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.3 -1.0 . . . . 3.97 108.3 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -94.75 105.8 20.84 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.634 1.174 . . . . 1.04 109.162 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.66 -8.98 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.729 2.286 . . . . 0.99 113.637 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.06 156.21 43.44 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 118.942 0.792 . . . . 1.28 112.693 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.3 m-20 -88.26 7.67 31.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.978 1.711 . . . . 3.21 113.209 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.02 158.84 43.13 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.999 1.72 . . . . 1.39 110.64 166.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.31 156.9 25.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.304 2.669 . . . . 0.8 110.782 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.5 mt -107.18 151.45 25.4 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.706 -0.621 . . . . 1.85 110.58 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -128.68 112.38 14.17 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.641 1.176 . . . . 4.8 109.572 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 tp -96.06 127.54 42.16 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.122 1.769 . . . . 0.91 109.228 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -116.33 -14.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 113.444 0.905 . . . . 0.65 113.444 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.27 -165.57 35.0 Favored Glycine 0 C--N 1.339 0.724 0 O-C-N 121.626 -0.671 . . . . 0.53 112.514 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -137.5 -179.4 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.249 1.02 . . . . 0.85 110.356 167.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -159.95 145.21 15.23 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 105.945 -1.872 . . . . 6.42 105.945 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.75 156.06 26.18 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-N 119.088 0.858 . . . . 1.06 109.97 -159.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.71 -37.17 5.52 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.341 2.027 . . . . 0.9 112.465 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.52 -10.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 115.236 1.569 . . . . 1.35 115.236 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.77 163.29 32.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.285 1.434 . . . . 0.79 110.374 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -105.23 -77.76 0.58 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.315 1.046 . . . . 3.67 109.881 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -79.46 104.29 9.97 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.757 0.823 . . . . 3.42 110.467 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -110.18 137.61 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.126 1.37 . . . . 1.28 110.587 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -141.23 128.46 20.97 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.499 1.52 . . . . 2.28 111.41 -170.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.59 122.83 28.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.76 0.791 . . . . 0.75 111.691 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 13.2 m170 -104.91 151.42 23.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.686 1.594 . . . . 0.94 114.173 172.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.11 165.87 14.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.613 1.965 . . . . 2.13 110.937 160.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.2 m -148.76 112.96 5.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.512 1.525 . . . . 1.84 107.952 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -126.02 171.5 10.74 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.934 1.294 . . . . 2.7 112.598 -163.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.0 mtm -124.3 118.27 26.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.851 1.26 . . . . 4.86 110.053 161.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -153.04 159.73 42.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.058 1.343 . . . . 6.71 110.651 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -64.34 147.89 51.56 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.322 1.449 . . . . 4.29 112.518 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.21 -18.95 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.497 1.295 . . . . 3.6 114.497 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -155.93 33.13 0.35 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.938 2.095 . . . . 3.39 108.96 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.79 -25.21 0.64 Allowed Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.235 -1.541 . . . . 2.62 113.141 -160.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -80.34 139.32 36.63 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.305 2.242 . . . . 2.41 109.2 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -76.45 144.63 39.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.612 0.642 . . . . 4.28 112.667 169.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.37 164.79 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 3.19 109.798 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.7 mtm -78.46 154.2 30.79 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 4.06 111.081 168.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.2 166.47 38.8 Favored Glycine 0 N--CA 1.468 0.783 0 O-C-N 121.738 -0.601 . . . . 1.59 113.668 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.6 149.8 46.93 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.88 1.272 . . . . 1.85 110.831 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -158.62 152.04 19.01 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-O 117.133 -1.413 . . . . 3.45 110.428 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 47.5 Cg_endo -69.03 148.27 69.44 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.177 1.918 . . . . 0.79 111.412 162.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.58 152.33 68.66 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 125.44 1.496 . . . . 0.65 110.582 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.13 -6.79 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.885 2.39 . . . . 1.05 113.477 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -176.69 159.91 1.89 Allowed 'General case' 0 C--N 1.348 0.508 0 C-N-CA 125.222 1.409 . . . . 2.3 110.44 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -111.19 175.7 5.32 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.88 1.672 . . . . 0.86 109.194 152.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.39 167.18 31.23 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.807 -1.183 . . . . 2.98 110.291 172.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -144.18 136.89 13.57 Favored Pre-proline 0 C--N 1.328 -0.367 0 C-N-CA 124.21 1.004 . . . . 0.99 108.762 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 167.38 25.4 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.571 1.514 . . . . 1.0 111.373 173.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.36 143.9 99.58 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.217 2.611 . . . . 0.99 111.003 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 14.9 mmmt 66.25 4.12 3.03 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.448 1.499 . . . . 1.51 112.797 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.92 3.74 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 127.403 2.43 . . . . 1.08 112.857 -170.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.91 118.37 31.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.535 1.534 . . . . 5.0 109.772 172.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.11 147.03 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 120.465 1.484 . . . . 1.51 114.403 -166.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 131.62 54.37 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.805 1.242 . . . . 3.48 112.826 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.94 71.64 0.54 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.464 1.505 . . . . 1.39 109.929 157.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -78.0 144.3 67.58 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.939 1.696 . . . . 3.64 112.688 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.1 -23.16 72.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.546 2.83 . . . . 1.65 114.644 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.74 38.78 3.04 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.248 1.404 . . . . 1.45 113.02 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.95 -58.74 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 CA-C-N 118.581 1.19 . . . . 1.39 114.948 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -155.12 144.2 20.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.975 1.71 . . . . 2.3 110.395 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -164.0 173.84 12.11 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.798 -1.189 . . . . 0.87 110.213 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 54.0 m-85 -108.95 135.42 50.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.093 0.557 . . . . 2.2 110.182 174.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.5 mmt -85.08 140.69 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.673 0.789 . . . . 1.32 109.955 156.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.3 mt -122.8 112.28 17.7 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 1.71 108.375 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -111.21 140.96 45.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.836 1.654 . . . . 2.86 108.436 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.02 72.95 0.91 Allowed Glycine 0 N--CA 1.471 0.968 0 O-C-N 121.206 -0.934 . . . . 2.57 111.097 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.79 104.24 4.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 122.523 1.154 . . . . 1.0 110.13 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -82.83 13.94 3.56 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 2.43 113.008 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -147.07 159.07 43.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.694 1.998 . . . . 4.7 110.392 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.45 163.29 39.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.584 2.189 . . . . 1.76 109.6 152.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -141.92 162.48 35.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.754 1.222 . . . . 2.51 110.781 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.12 109.19 2.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.105 1.762 . . . . 3.31 109.574 -175.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.04 126.08 24.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.93 -1.106 . . . . 2.29 110.26 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.29 7.42 40.38 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.762 -1.021 . . . . 1.9 114.562 -165.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -107.13 -170.82 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.263 1.531 . . . . 2.86 110.057 147.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -125.9 165.06 19.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.857 1.663 . . . . 3.32 110.509 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.56 116.7 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 125.115 1.366 . . . . 1.33 108.446 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.92 144.59 33.24 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.77 -1.105 . . . . 3.42 111.213 167.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.643 HD21 ' HB1' ' A' ' 35' ' ' ALA . 3.0 tt -155.6 132.9 10.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.988 0.899 . . . . 1.48 110.527 -167.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -86.5 101.51 13.25 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.874 3.27 . . . . 2.68 111.363 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.99 111.77 17.77 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.273 -1.517 . . . . 1.31 109.575 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.28 125.71 35.21 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.391 1.476 . . . . 0.57 110.1 -166.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.84 153.08 31.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.005 0.522 . . . . 2.26 112.027 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.43 128.77 37.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.062 0.545 . . . . 1.95 110.398 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.8 -153.97 30.35 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.475 0.559 . . . . 2.89 111.878 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.15 54.32 4.85 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.932 -0.927 . . . . 2.25 114.434 -169.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -143.78 147.12 33.71 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.293 1.546 . . . . 4.09 115.057 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.83 131.72 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 128.19 2.596 . . . . 1.07 108.171 166.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -119.42 101.46 7.97 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.028 1.331 . . . . 2.51 108.031 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.26 133.6 33.82 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.466 -0.771 . . . . 2.59 112.727 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.7 m -140.94 153.45 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.061 1.744 . . . . 1.28 110.986 -172.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.88 128.49 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.836 1.254 . . . . 2.04 111.188 -175.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.9 155.33 60.71 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.272 1.829 . . . . 3.16 110.3 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.0 152.38 82.59 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.929 2.42 . . . . 1.1 111.125 168.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.58 116.41 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.569 -1.641 . . . . 1.17 106.569 161.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -127.97 118.92 24.43 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.877 -1.527 . . . . 3.82 106.877 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.62 118.36 16.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.791 -0.818 . . . . 2.62 108.791 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 117.952 -1.023 . . . . 9.25 113.174 176.737 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.057 0 N-CA-C 107.801 -2.12 . . . . 13.84 107.801 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 t -169.58 -142.98 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.505 1.522 . . . . 10.83 107.283 -171.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -62.02 105.9 0.64 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.441 1.018 . . . . 9.37 110.464 166.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.9 m -63.34 148.33 48.68 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.987 1.315 . . . . 6.79 108.785 166.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -141.49 144.47 34.39 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.012 1.325 . . . . 6.08 107.726 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . 140.27 172.47 12.88 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.592 1.568 . . . . 1.6 113.521 174.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -155.52 155.28 33.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.38 1.072 . . . . 2.33 111.585 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.63 119.2 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.592 -0.892 . . . . 1.15 108.592 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.28 108.74 16.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.557 0.743 . . . . 4.03 109.687 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 136.41 48.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 2.56 110.427 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.2 t -131.22 156.03 80.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 126.486 1.914 . . . . 2.63 109.222 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.01 -10.38 28.7 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.872 2.381 . . . . 1.91 112.717 167.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.53 -174.36 15.19 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.624 1.583 . . . . 1.64 112.166 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -76.71 -0.58 23.69 Favored 'Cis proline' 0 CA--C 1.541 0.869 0 CA-C-N 118.306 1.053 . . . . 1.61 112.629 -8.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -149.65 178.05 9.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.848 1.659 . . . . 1.86 111.191 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.0 -166.22 1.53 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.529 1.931 . . . . 0.76 112.42 -172.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.74 154.57 34.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.716 1.206 . . . . 0.86 111.761 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.13 46.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.297 1.439 . . . . 0.67 111.281 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -136.13 148.54 48.27 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.484 1.914 . . . . 2.19 109.011 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.8 pp -171.6 155.92 4.22 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.803 0.841 . . . . 1.67 112.741 -171.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.424 HG21 ' CZ ' ' A' ' 74' ' ' ARG . 25.0 m -97.71 136.59 37.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.486 -1.234 . . . . 1.32 111.827 166.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 23' ' ' GLU . 6.7 tt -112.65 149.3 33.05 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.873 2.469 . . . . 2.79 109.083 173.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' N ' HD23 ' A' ' 22' ' ' LEU . 8.0 pt-20 -148.89 120.36 7.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.127 0.965 . . . . 2.76 112.89 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -90.14 115.36 63.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.722 1.209 . . . . 1.07 110.233 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -86.52 -8.69 7.17 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.155 2.57 . . . . 0.96 113.441 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.72 169.29 54.65 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.006 0.812 . . . . 0.98 113.722 -172.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.08 -2.24 50.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.489 1.916 . . . . 2.88 112.702 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.27 161.15 32.85 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 126.221 1.809 . . . . 1.19 110.299 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.03 161.54 23.63 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.05 2.5 . . . . 0.68 111.184 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.8 mt -110.02 150.52 28.41 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.552 0.741 . . . . 1.86 110.48 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -125.52 114.6 19.0 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.231 1.012 . . . . 4.05 109.532 167.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -90.85 119.43 31.05 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.822 2.449 . . . . 0.93 109.095 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.17 -8.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.54 1.136 . . . . 0.63 113.931 -171.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -162.03 32.31 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.512 -0.742 . . . . 0.47 112.275 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.59 -172.0 3.93 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.488 1.115 . . . . 1.02 111.219 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -148.22 143.88 27.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.789 2.036 . . . . 5.89 105.506 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -149.05 153.73 38.54 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.409 1.004 . . . . 0.88 109.339 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.43 -43.46 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.514 2.809 . . . . 1.37 111.696 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.281 1.1 m -76.46 -5.23 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.416 1.636 . . . . 1.02 115.416 -170.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.1 -175.91 4.79 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.601 1.56 . . . . 1.17 110.751 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -132.92 -60.94 0.85 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.156 0.889 . . . . 4.68 111.721 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -65.02 129.93 41.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.395 -1.335 . . . . 3.05 107.395 158.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.89 117.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.454 -1.684 . . . . 1.82 106.454 171.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -138.76 115.65 10.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.635 -1.166 . . . . 2.83 109.013 -155.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.446 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 6.1 tt -78.04 120.66 23.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 122.216 1.008 . . . . 0.78 110.546 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.6 m170 -107.47 150.0 27.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.84 1.656 . . . . 0.52 112.222 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.74 168.55 19.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.843 -1.526 . . . . 2.47 110.306 159.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.2 m -143.65 86.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.882 -1.525 . . . . 1.29 106.882 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -94.14 153.41 18.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.177 1.791 . . . . 1.98 112.373 -164.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 ttp -91.74 137.68 32.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.389 1.476 . . . . 2.78 110.003 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -153.53 122.78 6.58 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.377 0.671 . . . . 5.48 111.461 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.06 155.28 17.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.845 1.258 . . . . 5.74 110.133 169.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 p -158.37 127.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.974 0.91 . . . . 3.71 110.678 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 58.72 26.4 14.58 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.317 1.056 . . . . 4.96 111.053 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.43 1.19 57.03 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 119.825 -1.797 . . . . 3.31 114.379 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -92.84 143.19 26.52 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.032 1.733 . . . . 3.53 109.488 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.27 130.22 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.754 1.622 . . . . 6.18 112.607 -164.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.05 169.5 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 122.387 1.089 . . . . 2.05 113.044 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 14.6 tpp -137.48 160.91 37.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.913 2.885 . . . . 2.94 107.938 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.07 169.31 33.12 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 119.562 1.074 . . . . 1.24 114.078 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.11 139.48 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.433 1.493 . . . . 1.89 109.598 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -154.6 145.38 16.2 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 125.652 1.581 . . . . 3.55 109.531 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 40.3 Cg_endo -65.39 143.25 75.71 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.967 1.778 . . . . 0.8 110.657 165.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.64 156.16 42.82 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.691 1.596 . . . . 0.58 110.663 174.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.75 -14.66 33.11 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.919 2.413 . . . . 0.73 113.369 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -177.16 162.17 1.95 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.574 1.55 . . . . 1.94 110.816 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mt -109.48 171.08 7.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.673 1.189 . . . . 0.68 108.682 149.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -155.57 165.09 37.63 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.03 -1.044 . . . . 2.35 111.774 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.87 136.36 11.67 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.841 0.857 . . . . 0.99 109.516 -161.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.83 169.58 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.715 1.61 . . . . 0.86 111.429 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.78 143.9 94.53 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.172 2.581 . . . . 0.75 111.26 163.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt 67.31 0.57 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.524 1.53 . . . . 1.29 114.215 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.16 113.7 3.68 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 126.01 1.767 . . . . 0.94 112.869 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' CZ ' HG21 ' A' ' 21' ' ' THR . 23.1 ttt85 -81.04 133.2 35.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.082 -1.059 . . . . 4.61 109.746 154.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.95 134.16 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.624 1.569 . . . . 1.37 110.597 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.1 118.02 25.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.127 -1.064 . . . . 4.67 108.127 -160.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.54 73.11 1.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.236 1.493 . . . . 1.43 111.87 -169.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -55.24 116.88 12.68 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.226 1.41 . . . . 4.98 110.347 168.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.21 -30.37 88.33 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.24 2.627 . . . . 1.35 114.108 -172.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.89 41.68 1.75 Allowed Glycine 0 CA--C 1.533 1.181 0 CA-C-N 118.858 0.754 . . . . 1.94 112.791 167.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.33 -49.82 0.04 OUTLIER Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.954 2.216 . . . . 1.47 113.609 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -151.26 146.89 26.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.691 1.596 . . . . 2.19 112.049 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -156.48 167.41 30.54 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.735 1.214 . . . . 1.12 110.983 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.446 ' CZ ' HD12 ' A' ' 45' ' ' LEU . 31.7 m-85 -105.83 117.8 34.95 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.704 -0.85 . . . . 1.91 108.704 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.87 133.08 34.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.975 0.51 . . . . 1.22 110.258 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.5 mt -110.71 133.39 53.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.854 1.662 . . . . 1.91 111.659 -172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -142.91 157.97 44.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.758 1.223 . . . . 2.02 112.028 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -43.76 2.66 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 124.759 1.171 . . . . 2.27 112.129 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt 47.37 71.83 0.3 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.975 2.51 . . . . 1.28 113.706 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -69.67 -1.7 9.71 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.032 1.123 . . . . 2.33 114.032 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 97' ' ' GLU . 10.3 mtp85 -125.45 142.36 41.53 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 126.308 1.843 . . . . 5.84 109.053 172.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.22 124.12 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 107.245 -1.867 . . . . 1.95 107.245 145.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.578 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.5 pt? -127.21 157.54 39.52 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.675 1.99 . . . . 2.96 111.164 -163.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? -165.11 142.69 6.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.527 1.306 . . . . 8.1 114.527 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 124.86 19.1 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.279 -0.888 . . . . 1.88 109.669 164.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.24 -12.25 14.26 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.94 -1.478 . . . . 1.86 113.363 -161.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 91' ' ' ARG . 6.7 pt-20 -106.1 172.68 6.68 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 119.162 1.481 . . . . 3.87 110.828 155.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.5 155.18 46.16 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.529 1.532 . . . . 4.75 108.959 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.66 110.63 28.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.582 1.153 . . . . 1.33 108.975 -170.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.35 129.41 38.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.534 -0.913 . . . . 4.39 108.534 153.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -134.63 140.03 45.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.578 1.151 . . . . 1.86 108.761 172.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.3 103.41 12.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.996 2.519 . . . . 3.35 110.587 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -77.38 125.18 28.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.731 1.613 . . . . 1.29 110.813 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.5 mt -93.18 129.86 39.05 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.654 1.182 . . . . 0.75 111.565 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -127.74 119.97 26.91 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.38 0.672 . . . . 2.15 112.295 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.51 27.9 0.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.975 2.11 . . . . 2.51 114.784 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.57 -53.38 1.57 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.741 1.638 . . . . 3.91 113.104 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.68 3.71 63.04 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 117.036 1.574 . . . . 1.8 117.036 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.19 150.36 44.08 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.112 1.956 . . . . 3.91 111.316 169.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.31 136.98 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.854 1.662 . . . . 1.08 109.205 166.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.7 mt -146.18 132.56 19.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.501 1.521 . . . . 1.54 109.499 -172.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.1 ptmt -102.1 158.56 16.08 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.951 1.834 . . . . 2.88 115.951 -169.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.21 147.21 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.605 1.962 . . . . 2.42 109.915 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -107.55 133.71 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.115 1.366 . . . . 2.94 111.247 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 mt -140.44 131.38 13.92 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 127.059 2.144 . . . . 2.15 109.365 -165.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.35 151.47 71.39 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.318 2.678 . . . . 1.62 112.146 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t -81.42 125.85 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.53 0.681 . . . . 1.46 112.087 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -88.48 148.32 24.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.086 2.154 . . . . 4.96 109.838 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.33 129.62 54.07 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.919 -1.039 . . . . 2.03 109.395 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttp-105 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 131.365 3.866 . . . . 6.82 107.677 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 109.119 -1.592 . . . . 16.89 109.119 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -142.63 152.74 42.79 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.246 1.018 . . . . 13.54 109.212 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -161.88 -4.88 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.752 1.39 . . . . 12.97 114.752 -167.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.9 p -89.95 103.29 15.96 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.114 0.965 . . . . 7.49 109.916 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -85.13 128.27 34.59 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.578 0.751 . . . . 5.82 110.749 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.19 175.3 47.59 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 115.455 0.942 . . . . 1.29 115.455 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -156.23 123.65 5.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.034 1.334 . . . . 1.61 113.094 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -80.33 153.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 120.75 -1.219 . . . . 1.16 108.823 164.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -110.15 -19.19 13.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 116.438 2.014 . . . . 6.64 116.438 -168.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 60.79 173.42 0.1 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.401 1.48 . . . . 2.12 112.781 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.29 171.8 0.5 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.947 2.899 . . . . 1.79 109.657 171.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.97 -0.41 9.0 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.301 2.667 . . . . 1.71 113.78 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.68 174.23 33.69 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.93 1.252 . . . . 1.78 112.418 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.23 -5.37 34.2 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 118.596 1.198 . . . . 2.06 112.998 -4.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -130.4 177.23 7.5 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.989 1.716 . . . . 1.89 112.767 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -168.63 -168.8 0.94 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.789 2.436 . . . . 0.79 110.64 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.45 167.92 17.84 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.848 1.659 . . . . 1.17 112.15 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.14 149.72 31.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.525 1.53 . . . . 0.78 111.337 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -146.04 151.8 38.32 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.481 1.512 . . . . 2.39 110.135 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -173.84 161.02 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.938 1.295 . . . . 2.07 113.05 -177.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.9 m -84.35 150.23 25.51 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.685 1.594 . . . . 1.34 109.037 166.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.72 176.27 9.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.365 1.066 . . . . 3.9 110.955 152.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -154.83 162.02 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.476 -0.765 . . . . 3.71 111.424 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -114.61 101.64 54.42 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.876 1.67 . . . . 1.31 109.577 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.06 -2.65 11.86 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.786 2.991 . . . . 1.56 113.112 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.9 -172.35 48.79 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.786 1.184 . . . . 1.49 113.726 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -119.21 2.32 11.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.818 1.647 . . . . 3.79 112.954 -169.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.1 161.35 35.15 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.185 1.794 . . . . 1.59 109.374 165.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.8 154.68 15.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.096 2.531 . . . . 1.12 111.123 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.37 158.04 17.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.962 0.905 . . . . 2.25 111.175 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -135.35 113.42 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.855 1.262 . . . . 3.71 110.381 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.44 115.35 27.51 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 127.943 2.497 . . . . 0.92 108.985 -173.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.7 -8.73 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.725 1.009 . . . . 0.71 113.725 -165.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.69 -162.25 32.22 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.749 -0.594 . . . . 0.45 112.81 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.93 -175.43 4.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.606 0.595 . . . . 0.83 112.606 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -156.95 144.25 18.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.924 0.889 . . . . 5.44 109.551 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -152.74 155.13 32.23 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.961 0.904 . . . . 0.92 110.471 -170.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.31 -21.17 23.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.809 2.339 . . . . 1.17 113.617 169.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.785 HG21 HD13 ' A' ' 93' ' ' LEU . 1.4 m -90.53 -15.57 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 114.639 1.348 . . . . 1.16 114.639 -166.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.36 40.25 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.084 0.954 . . . . 1.1 112.347 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -93.63 -86.2 0.27 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.386 1.074 . . . . 3.76 110.597 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -85.02 90.96 7.96 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 120.807 -1.183 . . . . 5.32 108.741 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -76.03 139.16 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.51 -0.768 . . . . 1.55 111.014 165.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -138.14 120.7 16.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.204 2.202 . . . . 3.38 111.048 -167.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -81.3 118.18 22.41 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.016 0.912 . . . . 0.83 111.809 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -103.22 153.68 20.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.782 1.633 . . . . 0.73 113.661 172.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -95.18 178.21 5.61 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.42 1.888 . . . . 2.47 110.021 162.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.9 m -145.7 111.93 5.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.891 -1.151 . . . . 1.19 107.891 164.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -97.15 158.34 15.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.379 1.472 . . . . 2.43 112.498 -170.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -101.95 148.03 25.83 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.42 1.088 . . . . 3.76 108.92 163.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -158.92 146.64 17.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.379 1.471 . . . . 6.25 110.147 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.45 145.84 24.86 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 122.582 0.353 . . . . 3.76 110.917 165.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -139.78 120.48 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.019 -1.475 . . . . 3.13 107.019 165.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.6 tm-20 57.52 33.57 23.44 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.28 1.032 . . . . 5.42 110.757 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.64 -9.92 4.37 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 119.995 -1.69 . . . . 2.18 114.547 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.463 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 33.7 mmtm -78.39 139.98 38.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.078 1.351 . . . . 4.08 110.367 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -69.97 131.1 43.87 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.044 0.938 . . . . 3.32 110.825 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.93 146.84 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.685 1.994 . . . . 2.13 109.361 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -128.43 148.98 50.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.685 1.194 . . . . 3.63 110.893 170.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.71 -179.83 34.78 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.906 0.765 . . . . 1.07 112.855 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -127.95 149.27 50.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.245 1.018 . . . . 2.32 111.981 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -142.76 147.46 42.18 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 125.552 1.541 . . . . 3.52 108.908 172.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 151.62 78.42 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.697 1.598 . . . . 0.77 110.867 158.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.13 154.55 78.69 Favored Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 125.156 1.382 . . . . 1.13 110.79 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -70.2 -11.8 30.91 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.671 2.247 . . . . 1.45 113.063 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -177.47 163.45 1.97 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.618 1.567 . . . . 2.33 111.885 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -113.2 174.11 6.06 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.329 2.251 . . . . 0.83 109.4 155.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -154.88 167.62 29.68 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.041 -1.037 . . . . 2.55 112.277 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.73 135.42 11.07 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.818 0.847 . . . . 1.11 110.543 -165.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.76 167.08 27.04 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.295 1.997 . . . . 1.03 111.893 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -65.26 144.61 81.45 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.709 2.939 . . . . 1.42 111.655 166.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.261 0.6 OUTLIER 46.69 55.29 7.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 123.454 1.597 . . . . 2.76 114.757 -166.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.35 121.33 2.66 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 113.962 -1.472 . . . . 1.06 114.164 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.53 146.99 28.04 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.65 0.78 . . . . 4.96 109.978 162.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.18 137.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.544 1.138 . . . . 1.63 109.974 171.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -111.92 140.25 46.74 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.794 0.807 . . . . 3.45 110.957 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.24 63.78 2.53 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.323 1.535 . . . . 1.32 109.926 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -58.37 121.39 51.9 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.954 1.302 . . . . 4.89 110.709 170.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.88 -58.14 1.58 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.888 3.726 . . . . 1.48 114.598 -171.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.47 48.69 2.9 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.678 1.132 . . . . 1.94 113.405 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.75 -51.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.352 1.93 . . . . 1.48 113.339 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -156.01 139.47 15.84 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.631 1.972 . . . . 2.19 109.654 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -166.93 173.66 9.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.353 1.061 . . . . 0.84 111.477 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -110.13 134.0 52.64 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.025 0.53 . . . . 1.81 111.246 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.3 mmt -84.73 144.02 28.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.977 1.311 . . . . 1.09 110.316 157.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.59 116.47 28.2 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.68 1.592 . . . . 1.92 107.861 174.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -109.63 134.86 51.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.967 0.803 . . . . 2.28 110.147 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.2 0.6 Allowed Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.042 -1.223 . . . . 2.58 110.042 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 mt -72.53 100.52 2.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.086 0.943 . . . . 1.06 110.068 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -76.71 -12.7 60.03 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.235 0.828 . . . . 1.77 113.235 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.42 148.63 31.99 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.905 . . . . 5.22 111.139 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -67.56 148.71 79.0 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.735 2.29 . . . . 2.09 109.229 159.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.785 HD13 HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -156.96 30.94 0.3 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.861 1.315 . . . . 4.24 113.59 -160.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.25 149.22 0.17 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.183 2.193 . . . . 4.34 113.904 -169.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.79 134.93 30.38 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.603 -1.311 . . . . 2.49 112.107 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.42 -11.79 66.77 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.061 -1.41 . . . . 2.41 114.354 -166.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 158.02 37.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.052 1.426 . . . . 4.28 109.009 160.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.9 147.54 29.67 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.812 2.045 . . . . 4.27 108.174 169.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.19 123.07 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.576 1.55 . . . . 1.08 109.995 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 121.49 21.16 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.708 0.803 . . . . 4.13 109.068 159.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.07 126.6 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.078 0.951 . . . . 1.59 110.521 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.17 95.87 8.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.53 1.932 . . . . 2.6 109.779 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.93 126.18 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.794 1.179 . . . . 2.6 110.106 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.6 mt -95.1 137.97 33.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.516 1.526 . . . . 0.85 110.589 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -134.11 148.51 51.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 122.213 1.006 . . . . 2.31 113.028 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.77 162.77 18.02 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.128 -0.942 . . . . 2.88 111.853 169.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.75 24.9 66.11 Favored Glycine 0 N--CA 1.473 1.145 0 O-C-N 121.66 -0.65 . . . . 4.7 113.696 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.94 60.65 4.77 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 124.303 0.954 . . . . 2.11 111.116 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -143.63 165.16 28.37 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.984 1.313 . . . . 3.68 112.412 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -169.98 144.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 129.39 3.076 . . . . 2.19 107.213 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.2 mt -137.4 96.93 3.35 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.393 1.477 . . . . 2.69 107.766 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.45 143.24 32.24 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.956 0.724 . . . . 2.66 112.956 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.33 140.55 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.414 1.086 . . . . 1.88 109.899 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 145.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.668 0.787 . . . . 2.03 109.61 172.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.5 153.19 12.79 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.924 1.29 . . . . 2.84 113.17 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.09 161.66 40.49 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.039 2.493 . . . . 1.24 112.555 -175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.0 t -93.46 130.61 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.978 . . . . 1.43 109.786 162.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.01 164.44 12.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.723 1.209 . . . . 3.45 108.931 156.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.41 115.84 26.59 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.068 -1.02 . . . . 2.46 112.772 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.521 2.328 . . . . 5.68 113.133 167.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.207 0 N-CA-C 105.751 -2.94 . . . . 12.59 105.751 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -55.37 170.28 0.24 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.284 0.564 . . . . 10.37 111.722 134.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -148.45 31.93 0.81 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.34 1.856 . . . . 9.67 110.481 -174.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -155.48 -10.12 0.12 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 128.034 2.534 . . . . 6.7 113.115 -149.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -146.52 156.74 43.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.549 1.94 . . . . 5.03 112.171 -150.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.15 164.34 21.47 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 124.822 1.201 . . . . 0.98 114.078 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -152.53 145.2 24.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.187 0.995 . . . . 1.74 112.026 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.1 131.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.381 -0.6 . . . . 1.12 109.381 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.93 116.75 22.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.207 0.603 . . . . 4.08 109.405 -171.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.86 133.23 33.94 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.592 -1.317 . . . . 2.34 110.914 167.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -149.48 163.24 25.85 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.567 1.947 . . . . 2.45 109.007 165.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.91 31.14 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.062 3.175 . . . . 1.93 114.113 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.06 -173.16 54.51 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 121.248 -0.908 . . . . 1.72 113.125 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.26 -4.42 18.31 Favored 'Cis proline' 0 CA--C 1.539 0.741 0 CA-C-N 118.228 1.014 . . . . 1.83 112.8 -10.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -139.51 178.87 6.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.701 1.6 . . . . 2.61 111.484 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.07 -173.93 3.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.004 2.122 . . . . 1.11 108.647 163.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.42 161.15 17.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.771 1.228 . . . . 1.06 112.161 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.1 136.58 48.51 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.039 -1.038 . . . . 1.12 111.106 163.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -122.61 155.56 36.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.413 1.885 . . . . 2.07 111.015 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -166.24 142.28 4.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.708 1.744 . . . . 1.57 115.708 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.9 m -72.13 132.73 44.56 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.79 -0.819 . . . . 1.18 108.79 156.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.1 tt -140.68 147.41 39.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.313 1.845 . . . . 2.52 110.1 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -131.92 147.14 52.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.289 1.042 . . . . 3.32 112.414 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -88.07 108.9 23.93 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 114.362 -1.29 . . . . 1.02 109.216 159.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.74 -11.51 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.631 2.221 . . . . 1.23 113.287 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.04 -173.39 49.84 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.867 1.222 . . . . 0.96 113.812 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -114.17 -0.85 13.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.884 1.674 . . . . 2.98 112.855 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.04 161.77 36.79 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.457 1.903 . . . . 1.43 109.464 165.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.49 155.61 28.22 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.554 2.169 . . . . 0.74 112.287 -169.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.43 149.82 23.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.437 1.095 . . . . 1.8 110.532 168.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -130.94 111.93 12.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.735 1.214 . . . . 3.27 110.408 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 tp -94.21 118.33 31.41 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.564 2.345 . . . . 0.75 108.746 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -110.15 -10.37 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.977 0.911 . . . . 0.58 113.003 -171.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.94 -167.14 38.31 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 124.242 0.925 . . . . 0.5 112.233 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.15 -179.03 6.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.165 0.986 . . . . 0.66 110.746 164.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 102' ' ' ASP . 22.0 mmt-85 -149.48 139.66 22.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.26 1.424 . . . . 6.3 109.271 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -150.01 152.12 33.4 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.218 -0.896 . . . . 0.55 110.572 -169.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.98 -23.94 53.51 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.827 2.351 . . . . 0.77 113.629 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.546 HG12 HH11 ' A' ' 91' ' ' ARG 0.351 1.6 m -94.25 3.07 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 115.049 1.5 . . . . 0.91 115.049 -171.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.86 164.1 36.28 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.418 1.636 . . . . 0.72 115.418 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.18 -89.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.907 2.083 . . . . 3.43 110.755 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -80.27 80.12 6.74 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.385 -1.447 . . . . 3.55 109.62 -173.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.59 131.7 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 128.146 2.579 . . . . 1.5 112.269 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.51 132.07 30.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.487 1.915 . . . . 2.48 110.27 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -81.14 121.74 26.49 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 121.278 1.854 . . . . 0.72 111.64 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.2 m170 -107.92 154.3 21.8 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.548 1.939 . . . . 0.49 112.975 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -109.99 166.33 11.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 2.39 110.699 166.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.3 m -115.21 117.83 31.6 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.563 1.945 . . . . 1.4 107.114 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -126.26 154.44 43.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.343 1.057 . . . . 2.37 112.699 -168.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.4 mtt -92.63 153.77 18.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.657 -1.156 . . . . 2.67 111.339 166.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -153.17 137.77 16.87 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.647 0.779 . . . . 6.0 112.706 159.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.14 151.03 16.18 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.853 1.661 . . . . 4.59 110.269 160.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.818 HG13 ' H ' ' A' ' 54' ' ' GLU 0.298 11.8 p -158.03 -88.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 126.249 1.82 . . . . 2.9 110.287 175.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.818 ' H ' HG13 ' A' ' 53' ' ' VAL . 20.6 tt0 -78.58 47.72 0.74 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.296 2.239 . . . . 3.72 110.296 168.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.48 -43.78 0.91 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 127.595 2.522 . . . . 2.24 113.912 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -77.83 152.9 33.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.974 2.11 . . . . 3.4 113.178 -173.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.37 107.08 18.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.91 0.484 . . . . 4.55 112.069 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -80.95 142.03 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.886 1.275 . . . . 1.61 109.017 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.11 133.95 50.01 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.912 1.685 . . . . 4.58 110.622 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 -179.2 30.23 Favored Glycine 0 N--CA 1.472 1.09 0 C-N-CA 124.226 0.917 . . . . 1.56 113.079 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.48 160.53 19.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.802 1.241 . . . . 2.45 112.138 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.16 149.96 2.29 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.505 1.522 . . . . 3.69 112.652 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 28.2 Cg_endo -71.6 141.52 38.22 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.097 2.532 . . . . 0.63 113.275 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -110.82 156.07 41.31 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.892 1.677 . . . . 0.66 109.798 172.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -71.2 -13.31 30.95 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.899 2.4 . . . . 0.72 113.292 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.7 p90 178.63 168.34 0.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.005 2.122 . . . . 1.79 110.301 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.16 169.43 9.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.189 1.795 . . . . 0.73 109.104 157.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.5 159.0 39.41 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.141 -0.974 . . . . 2.57 111.655 175.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.27 126.81 9.21 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.506 1.122 . . . . 0.81 110.133 -163.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.76 161.34 44.1 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.308 2.005 . . . . 0.74 111.712 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.11 139.29 86.73 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.89 3.06 . . . . 0.78 112.865 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm 67.34 -1.2 1.59 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.958 2.103 . . . . 1.38 113.647 -173.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.79 119.64 4.93 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 126.615 2.055 . . . . 0.82 111.279 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -84.22 142.79 30.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.316 1.046 . . . . 5.41 110.722 156.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.8 m -148.48 147.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.518 1.927 . . . . 1.22 110.218 168.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.91 123.93 46.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.315 1.055 . . . . 3.09 112.327 170.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.46 85.88 0.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.799 1.239 . . . . 1.9 107.716 158.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -100.41 160.65 26.39 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.055 2.542 . . . . 3.18 113.279 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -58.56 -55.31 2.17 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.554 2.836 . . . . 1.4 112.664 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.92 65.53 3.73 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 110.884 -0.886 . . . . 1.62 110.884 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.94 -108.37 0.28 Allowed Glycine 0 N--CA 1.468 0.816 0 C-N-CA 124.616 1.103 . . . . 1.56 113.005 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -130.84 143.19 50.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.002 1.401 . . . . 2.16 111.029 -172.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -170.21 163.37 8.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 120.995 -1.066 . . . . 1.59 109.935 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -88.23 133.31 34.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.678 -0.677 . . . . 2.46 110.29 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.1 mmt -84.13 136.36 34.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.78 0.832 . . . . 0.85 110.196 159.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.42 75.67 0.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.578 1.551 . . . . 1.73 109.164 -170.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.39 116.04 18.52 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.245 -1.02 . . . . 3.27 108.245 -177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.98 96.69 0.4 Allowed Glycine 0 N--CA 1.465 0.568 0 N-CA-C 110.291 -1.123 . . . . 2.85 110.291 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.1 119.52 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.291 -1.374 . . . . 1.33 107.291 167.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.79 4.76 23.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.798 -1.189 . . . . 1.79 112.833 -164.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.546 HH11 HG12 ' A' ' 39' ' ' VAL . 9.4 ptm180 -167.66 152.69 6.76 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.739 2.016 . . . . 5.21 109.595 -172.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -66.19 151.94 82.35 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.46 -1.4 . . . . 1.77 108.46 161.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.63 162.43 41.0 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.627 1.971 . . . . 2.63 108.64 -164.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -154.19 162.6 41.08 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.896 1.813 . . . . 4.2 115.896 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.57 133.21 48.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 1.89 107.989 157.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.57 13.81 62.54 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.956 -0.914 . . . . 2.16 113.493 -162.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.0 169.24 9.4 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.689 1.245 . . . . 3.11 107.868 151.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -136.72 150.35 48.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.523 1.929 . . . . 3.67 107.805 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.47 103.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 124.788 1.235 . . . . 0.89 108.384 -168.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -59.82 134.04 56.66 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 125.1 1.5 . . . . 4.14 108.46 154.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.94 130.37 23.81 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.855 1.662 . . . . 1.45 109.579 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' CG ' ' HZ3' ' A' ' 112' ' ' LYS . 5.0 m-20 -103.5 92.23 4.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.994 1.718 . . . . 2.4 109.063 -175.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.7 mt -77.68 112.33 14.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.893 1.677 . . . . 1.31 110.226 -172.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -86.5 128.07 34.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.805 0.842 . . . . 0.69 111.475 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.29 142.87 50.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.687 0.795 . . . . 2.01 113.003 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.59 133.05 30.8 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.528 1.531 . . . . 1.87 114.292 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.11 -142.93 23.61 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.777 -1.329 . . . . 3.61 109.777 -162.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.46 71.12 0.25 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.979 0.8 . . . . 1.73 112.951 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -131.0 148.59 52.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.701 1.25 . . . . 5.03 111.416 168.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.82 139.73 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.639 1.575 . . . . 0.93 109.235 170.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.71 145.71 48.79 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.424 1.09 . . . . 1.38 110.378 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HZ3' ' CG ' ' A' ' 102' ' ' ASP . 17.2 mtpp -112.83 143.71 43.61 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.079 0.952 . . . . 2.6 112.323 -169.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -158.64 125.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.326 1.45 . . . . 1.42 109.689 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.0 p -92.29 121.72 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.338 1.055 . . . . 1.91 109.142 170.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.0 mt -132.04 143.28 48.34 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.293 1.437 . . . . 2.22 111.634 -171.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.36 150.22 70.4 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.373 2.715 . . . . 1.04 112.992 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.13 127.02 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.464 0.705 . . . . 1.24 110.256 171.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.85 142.4 27.42 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.274 2.23 . . . . 5.08 108.411 163.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.33 134.61 12.38 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.515 0.561 . . . . 2.38 112.515 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 116.179 -1.867 . . . . 9.03 113.492 164.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.386 0 N-CA-C 108.925 -1.67 . . . . 16.8 108.925 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 m -135.98 163.37 30.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.57 1.148 . . . . 12.95 110.266 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -116.21 155.86 27.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.762 1.225 . . . . 12.28 108.199 159.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.7 t -157.02 169.17 25.43 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.487 1.115 . . . . 5.64 109.81 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -108.78 117.19 33.55 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.977 0.911 . . . . 5.15 111.632 -162.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.85 169.54 40.21 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 120.941 -1.1 . . . . 1.28 114.781 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -160.42 152.18 19.89 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.14 0.793 . . . . 1.71 113.14 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.78 124.2 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.452 -0.944 . . . . 0.89 108.452 163.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -83.34 109.17 17.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.177 0.991 . . . . 5.43 108.655 167.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.48 ' HB2' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.1 -179.31 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.841 1.052 . . . . 2.63 113.841 -173.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 m -168.48 167.56 6.17 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.572 1.949 . . . . 1.85 109.198 162.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.15 -26.78 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.039 2.493 . . . . 2.57 112.105 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.2 177.96 15.72 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.384 1.468 . . . . 1.61 112.668 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.02 -15.8 19.87 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 118.69 1.245 . . . . 1.75 113.247 -1.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -129.15 164.98 22.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.631 1.572 . . . . 2.11 112.77 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.97 163.4 30.79 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.391 2.276 . . . . 0.99 109.883 171.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.98 145.44 38.4 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.33 1.052 . . . . 0.89 110.876 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.67 50.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.317 0.858 . . . . 0.81 113.317 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -145.78 158.44 43.86 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.998 1.719 . . . . 1.98 110.844 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -163.7 152.31 13.71 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.497 1.119 . . . . 1.78 111.395 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 m -79.57 149.74 31.3 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.594 1.558 . . . . 1.67 108.065 155.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -155.7 134.44 11.9 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.916 1.287 . . . . 2.9 108.902 173.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.62 119.05 27.91 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.895 1.278 . . . . 4.32 109.693 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -77.42 117.01 62.63 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 1.44 109.939 173.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.32 -11.12 8.58 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.042 2.495 . . . . 1.56 113.825 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.72 163.93 54.74 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 119.025 0.83 . . . . 1.59 113.521 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.439 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.4 m-20 -91.87 -1.7 57.19 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.275 1.83 . . . . 3.54 112.634 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -117.28 159.74 40.32 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.311 1.844 . . . . 1.67 110.856 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.03 159.09 23.92 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.042 2.495 . . . . 1.14 111.41 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.72 156.48 17.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.857 0.837 . . . . 2.69 110.537 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -129.54 120.32 25.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.086 1.355 . . . . 5.29 108.308 165.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.5 tp -101.16 118.52 37.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.839 1.655 . . . . 1.1 108.541 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.77 -11.18 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.289 1.036 . . . . 0.71 113.346 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.92 -170.78 43.7 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.601 1.096 . . . . 0.65 111.314 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 149.99 25.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.141 0.976 . . . . 1.73 111.809 166.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -118.3 139.76 50.85 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.848 -1.158 . . . . 5.51 110.065 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -140.94 152.25 64.79 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.629 1.172 . . . . 0.87 110.083 -171.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.65 -26.67 83.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.239 1.959 . . . . 1.11 113.978 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.566 HG21 HD21 ' A' ' 93' ' ' LEU . 1.9 m -88.38 -7.9 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 114.991 1.478 . . . . 1.4 114.991 -170.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.55 168.96 21.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.9 0.88 . . . . 1.07 113.349 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.84 -73.89 0.63 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.586 0.354 . . . . 4.22 111.036 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -68.39 139.89 55.82 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.721 -1.237 . . . . 2.78 109.298 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.55 139.85 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 125.242 1.417 . . . . 2.19 108.336 162.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -129.95 117.34 19.95 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.465 1.106 . . . . 2.08 108.682 164.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -77.21 120.85 22.84 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.743 0.782 . . . . 0.91 109.253 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -106.77 151.05 25.67 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.414 1.486 . . . . 0.67 112.681 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -95.78 160.59 14.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.782 2.033 . . . . 1.98 110.151 164.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.3 m -131.44 108.74 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.464 1.905 . . . . 1.13 107.127 166.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -109.85 160.31 16.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 2.45 112.232 -171.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -113.06 139.34 48.77 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.083 0.953 . . . . 2.59 110.115 157.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -151.56 150.94 30.9 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.107 1.363 . . . . 6.29 111.985 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.68 144.34 52.28 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.835 0.854 . . . . 4.22 110.74 154.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -154.58 -39.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 114.718 1.377 . . . . 3.87 114.718 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 3.7 tm-20 -112.28 38.21 2.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.667 1.987 . . . . 4.21 109.205 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.67 -35.03 0.59 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.204 1.383 . . . . 3.4 113.445 -164.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 16.0 mtmt -92.7 160.22 15.08 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.722 2.409 . . . . 4.1 111.037 175.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -74.27 142.28 45.27 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.48 0.919 . . . . 3.86 113.48 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.59 158.03 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 127.792 2.437 . . . . 2.47 108.09 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.2 mtm -111.08 152.82 26.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.682 1.193 . . . . 3.21 112.535 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.76 177.1 41.08 Favored Glycine 0 N--CA 1.469 0.892 0 C-N-CA 123.716 0.674 . . . . 1.14 113.468 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -124.45 161.01 26.96 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.692 1.197 . . . . 1.85 111.646 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -158.61 151.65 18.52 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 126.806 2.042 . . . . 5.08 109.447 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.57 142.41 71.05 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 CA-C-N 121.375 1.527 . . . . 0.67 110.672 154.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -104.23 155.31 37.4 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.739 1.216 . . . . 0.62 110.76 168.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.19 -19.46 56.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.777 2.318 . . . . 0.76 112.641 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -177.63 165.55 2.12 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.243 2.217 . . . . 1.9 110.617 175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -105.91 170.56 7.83 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.828 1.251 . . . . 0.9 110.05 153.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -143.08 169.71 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.326 0.65 . . . . 2.53 110.811 171.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 t -146.91 133.16 9.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 107.926 -1.139 . . . . 1.03 107.926 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.01 167.57 25.67 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.127 1.218 . . . . 1.19 111.319 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.99 140.98 87.6 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.32 2.68 . . . . 1.3 110.952 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 59.3 mmtt 66.07 4.01 2.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.146 1.379 . . . . 1.79 113.074 -173.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.88 114.05 3.96 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 127.129 2.3 . . . . 1.47 113.06 -169.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -75.86 132.16 40.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.028 -1.586 . . . . 4.77 110.076 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.93 164.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.119 2.168 . . . . 1.58 109.428 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.97 117.89 0.91 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.024 0.929 . . . . 3.44 109.574 -171.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -74.96 64.3 1.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.762 2.025 . . . . 1.65 111.615 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -63.42 133.35 95.46 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.791 -1.193 . . . . 3.2 110.789 167.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.49 -20.91 66.32 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.339 2.692 . . . . 1.78 113.76 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.21 55.98 5.05 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.081 0.848 . . . . 1.49 111.23 160.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.46 -64.49 0.13 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.635 1.112 . . . . 1.35 113.998 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -153.85 145.0 22.87 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.64 1.576 . . . . 1.99 111.254 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -166.06 163.73 18.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.296 1.038 . . . . 1.12 111.169 -174.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -107.73 127.02 53.31 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.069 0.548 . . . . 2.11 111.065 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -90.69 108.41 19.8 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.265 1.426 . . . . 1.19 110.142 164.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.39 130.76 37.98 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.144 0.978 . . . . 3.4 108.772 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.82 150.62 51.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.265 1.426 . . . . 1.88 110.781 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.35 53.31 5.19 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.979 -0.848 . . . . 2.99 110.979 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.6 mt -68.95 114.04 6.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 117.883 0.842 . . . . 0.97 109.555 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -98.96 -0.1 42.86 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.866 1.266 . . . . 2.02 111.961 -166.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -157.04 148.84 17.3 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.526 1.93 . . . . 6.05 108.7 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.44 156.38 54.43 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.363 2.042 . . . . 1.84 109.624 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 39' ' ' VAL . 4.2 mp -103.11 155.56 18.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.573 1.178 . . . . 3.16 112.139 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -120.53 123.58 43.25 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.099 2.16 . . . . 4.8 109.392 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 131.58 50.82 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.151 -0.968 . . . . 1.9 111.586 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.08 44.06 78.71 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.16 -0.8 . . . . 1.78 112.669 -172.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.95 -178.07 3.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.741 -1.207 . . . . 3.04 107.741 151.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -127.0 161.29 28.72 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.472 1.109 . . . . 3.77 109.543 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.8 t -126.22 120.78 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 124.615 1.166 . . . . 1.07 109.816 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -68.89 119.23 12.89 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 124.488 1.117 . . . . 2.76 108.619 154.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.99 120.81 40.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.735 0.779 . . . . 1.72 109.055 166.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.9 93.66 8.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.762 -1.563 . . . . 2.43 107.964 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.05 119.45 11.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.685 -0.857 . . . . 1.2 108.685 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.8 mt -90.92 120.59 32.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.665 -0.865 . . . . 0.64 108.665 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 88.6 m-85 -116.12 131.18 57.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.069 0.938 . . . . 2.14 112.343 -176.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 56.61 -18.51 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 131.014 3.726 . . . . 3.76 116.932 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.81 -22.42 0.71 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.345 1.926 . . . . 5.8 113.721 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.01 -6.56 0.06 OUTLIER Glycine 0 N--CA 1.474 1.204 0 N-CA-C 117.362 1.705 . . . . 3.81 117.362 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -79.74 101.0 8.18 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 120.384 2.092 . . . . 4.87 109.582 175.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.21 138.44 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.729 1.212 . . . . 1.61 110.041 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.53 136.55 33.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.36 1.064 . . . . 1.87 111.748 166.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.45 125.41 25.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.975 0.51 . . . . 2.12 111.967 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -101.54 154.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.946 -0.761 . . . . 1.82 108.946 142.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.8 p -118.99 139.8 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.062 -1.088 . . . . 2.11 108.062 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pp -162.55 155.57 16.9 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.022 1.729 . . . . 2.64 110.127 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.93 160.12 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 124.389 3.393 . . . . 1.01 115.04 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.3 t -87.6 122.59 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.697 1.199 . . . . 0.94 110.058 164.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -92.64 131.17 37.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.729 2.011 . . . . 3.82 107.554 161.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.21 116.17 5.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.308 0.643 . . . . 3.41 111.431 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 129.3 3.04 . . . . 7.41 107.208 176.68 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 N-CA-C 109.448 -1.461 . . . . 15.56 109.448 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 t -165.43 178.73 6.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.204 1.002 . . . . 12.45 109.458 -174.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.76 -11.28 14.41 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.291 1.219 . . . . 14.75 114.291 -167.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.5 m -137.01 3.27 2.65 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.76 1.624 . . . . 8.89 112.371 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -98.61 -176.37 3.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.934 1.294 . . . . 5.16 110.122 171.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.94 154.82 18.24 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 120.885 -1.135 . . . . 1.06 112.684 166.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -158.3 145.09 17.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.476 1.111 . . . . 1.33 111.675 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -97.33 137.16 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.791 -0.818 . . . . 1.15 108.791 171.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.28 92.32 4.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.921 1.289 . . . . 3.46 109.536 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.18 159.67 9.4 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 123.548 1.642 . . . . 2.08 112.383 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -162.85 154.69 15.4 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 129.08 2.952 . . . . 2.23 106.54 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.08 39.06 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.058 3.172 . . . . 1.97 112.418 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.23 178.79 51.42 Favored Glycine 0 CA--C 1.541 1.668 0 O-C-N 121.206 -0.934 . . . . 2.3 112.173 -156.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.82 -12.23 23.54 Favored 'Cis proline' 0 CA--C 1.54 0.798 0 CA-C-N 118.435 1.118 . . . . 2.73 112.457 -11.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -155.7 168.54 26.84 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.411 1.884 . . . . 2.25 110.997 -176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -164.61 -177.15 4.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 0.86 111.042 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.24 152.67 47.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.224 1.01 . . . . 0.99 112.506 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.01 140.32 52.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.166 0.986 . . . . 0.97 111.858 167.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -128.19 152.0 48.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.499 1.92 . . . . 2.08 110.517 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pp -165.11 133.51 3.27 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.938 1.829 . . . . 1.75 115.938 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 m -76.81 139.02 40.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.143 -1.39 . . . . 1.11 108.685 156.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.25 145.07 16.25 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 2.76 108.257 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -123.43 144.94 49.18 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.518 0.599 . . . . 3.34 111.502 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -86.9 109.58 25.68 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 108.621 -0.881 . . . . 1.25 108.621 155.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -86.05 -14.07 5.24 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.965 1.777 . . . . 1.16 114.411 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.27 -153.98 24.16 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.63 1.012 . . . . 1.46 115.63 -159.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -93.74 -32.03 14.18 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.138 2.575 . . . . 5.82 113.932 -173.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.12 158.83 36.91 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.375 1.47 . . . . 1.66 112.052 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.85 155.33 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.798 2.332 . . . . 1.28 111.786 -170.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.91 132.52 56.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.142 1.377 . . . . 2.46 109.138 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -125.98 106.54 9.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.297 1.039 . . . . 4.89 111.937 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.7 tp -92.21 112.51 24.48 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.463 2.305 . . . . 0.9 109.651 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.02 -7.4 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.155 1.382 . . . . 0.76 113.277 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.94 -167.09 38.67 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 121.458 -0.776 . . . . 0.62 112.247 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.34 175.29 10.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.107 0.563 . . . . 0.8 111.9 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -156.31 91.27 1.24 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.221 -1.77 . . . . 6.65 106.221 -164.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -104.7 152.85 39.54 Favored Pre-proline 0 N--CA 1.471 0.603 0 C-N-CA 125.116 1.366 . . . . 0.86 110.59 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.28 -27.55 16.28 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.394 2.729 . . . . 1.08 113.531 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.31 1.7 m -89.93 -0.11 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 114.355 1.243 . . . . 0.91 114.355 -172.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.96 140.66 50.88 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.876 0.871 . . . . 0.81 112.24 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -72.48 -68.89 0.44 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.173 -1.047 . . . . 5.54 108.173 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -90.09 149.25 22.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.442 2.297 . . . . 3.02 109.653 168.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.23 139.66 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.545 1.538 . . . . 1.5 109.548 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -142.17 140.82 32.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.906 1.682 . . . . 2.03 110.521 -171.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -81.79 122.5 27.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.515 1.052 . . . . 0.92 111.346 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.9 m170 -111.74 156.9 21.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.561 1.544 . . . . 0.6 112.553 174.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.95 -179.64 4.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.228 2.211 . . . . 1.82 111.112 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.5 m -126.85 114.29 17.71 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.808 -1.553 . . . . 1.42 106.808 151.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -89.5 152.15 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 2.35 111.025 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.1 ptp -101.24 144.88 29.55 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.499 -0.773 . . . . 3.54 110.133 155.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.4 158.79 34.88 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.216 1.806 . . . . 7.25 109.468 171.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.37 148.95 22.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.585 -0.895 . . . . 3.88 108.585 167.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.96 -79.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.649 0.737 . . . . 2.91 110.372 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -76.19 35.18 0.14 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.445 2.298 . . . . 4.64 111.651 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.33 -12.37 0.94 Allowed Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.289 -1.507 . . . . 2.0 113.744 -161.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -106.78 154.34 21.14 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 128.032 2.533 . . . . 4.09 109.736 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -70.14 137.49 51.11 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.696 0.399 . . . . 3.84 110.868 175.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.71 148.69 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.482 1.913 . . . . 2.0 108.402 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 19.8 mmt -115.5 142.04 47.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.697 1.199 . . . . 4.27 109.351 175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.82 151.76 23.37 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.283 0.947 . . . . 1.24 114.19 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -93.64 159.27 15.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.147 0.979 . . . . 2.19 111.833 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -173.41 140.21 0.86 Allowed Pre-proline 0 N--CA 1.473 0.692 0 CA-C-O 116.67 -1.633 . . . . 3.58 110.246 -168.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.0 OUTLIER -70.63 148.76 60.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.363 1.88 . . . . 0.93 111.378 170.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.86 151.9 74.47 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 125.254 1.422 . . . . 0.69 110.206 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.06 -13.65 26.12 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.938 2.425 . . . . 1.0 113.777 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -175.03 164.71 3.4 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.8 1.24 . . . . 2.08 111.572 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mt -121.64 170.25 9.9 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 127.404 2.282 . . . . 0.76 108.915 152.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.57 172.43 18.57 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.244 -0.91 . . . . 2.23 110.804 169.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.9 t -147.55 122.57 5.18 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 125.161 1.385 . . . . 1.05 109.664 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.11 159.66 51.55 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.947 1.765 . . . . 1.3 110.656 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.3 139.11 88.45 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.872 3.048 . . . . 1.15 111.588 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.07 -8.32 1.32 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 127.252 2.221 . . . . 3.24 115.088 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.08 129.03 8.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 126.525 2.012 . . . . 1.13 110.283 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 ptt85 -87.65 148.16 24.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.556 -0.822 . . . . 4.8 112.411 163.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.99 167.02 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.653 1.581 . . . . 2.3 110.788 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -154.23 85.28 1.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.845 1.658 . . . . 3.04 107.0 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.83 68.87 3.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.894 1.678 . . . . 1.61 112.055 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -72.36 151.45 92.01 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.497 2.719 . . . . 3.29 113.658 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.45 -58.91 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.752 2.968 . . . . 1.63 112.614 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.85 83.3 1.16 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.389 -1.484 . . . . 1.5 109.389 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.6 -97.18 0.16 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 125.274 1.416 . . . . 1.3 111.492 -166.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -151.65 134.23 15.47 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.658 1.583 . . . . 2.03 109.455 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -163.53 175.73 10.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 119.724 1.147 . . . . 1.04 110.647 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -108.65 125.81 52.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.128 0.571 . . . . 2.26 110.497 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.3 mmt -85.57 144.46 27.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.334 1.054 . . . . 1.02 110.273 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -124.18 138.9 54.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.418 1.887 . . . . 1.92 109.543 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.69 157.22 46.12 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.153 0.981 . . . . 2.25 112.106 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.26 -54.78 3.59 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 126.343 1.925 . . . . 2.86 114.732 167.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.8 mt 76.81 95.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 130.305 3.442 . . . . 1.2 113.037 170.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -78.62 -0.97 31.97 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.834 1.42 . . . . 2.47 114.834 -172.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -144.3 145.66 30.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 127.136 2.174 . . . . 5.34 108.206 172.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.31 115.67 4.38 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.19 1.26 . . . . 2.47 110.174 170.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.72 151.69 23.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 112.869 -1.969 . . . . 2.68 109.913 168.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -144.82 -7.84 0.65 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 117.121 2.267 . . . . 5.16 117.121 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.67 170.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.103 2.561 . . . . 2.2 112.972 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.51 34.51 53.97 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.253 -0.748 . . . . 1.69 111.681 -164.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.32 174.01 13.82 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 127.224 2.21 . . . . 3.37 109.694 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 164.18 14.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.021 2.128 . . . . 4.0 111.696 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.2 t -133.86 108.38 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.593 1.157 . . . . 0.95 109.455 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -71.34 98.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.979 -1.119 . . . . 3.64 107.979 159.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 tt -98.74 138.61 35.65 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.697 -0.853 . . . . 1.91 108.697 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.01 138.6 31.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 3.77 112.053 168.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.38 122.74 43.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.457 2.303 . . . . 1.31 109.075 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.6 mt -92.89 119.73 32.5 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.136 0.974 . . . . 0.9 109.935 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -115.57 150.52 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.943 0.877 . . . . 2.21 113.254 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.36 162.83 28.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.996 -0.547 . . . . 2.19 111.332 165.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 20.4 79.55 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 119.263 -0.743 . . . . 4.68 114.266 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.52 61.28 2.8 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 118.61 1.205 . . . . 2.43 112.319 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.65 154.76 43.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.071 2.148 . . . . 4.06 110.115 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -168.66 140.83 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.392 2.277 . . . . 1.57 107.407 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.8 mt -150.21 109.61 3.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.187 0.903 . . . . 1.45 111.175 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -81.7 111.6 18.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.284 0.634 . . . . 2.85 110.769 173.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -117.0 141.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.188 1.795 . . . . 1.61 110.427 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -108.83 116.16 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.049 0.939 . . . . 1.79 112.227 -173.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.8 150.57 46.02 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.573 1.549 . . . . 3.24 110.018 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.11 159.91 26.75 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.074 3.183 . . . . 1.05 111.954 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.3 t -82.99 130.59 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.086 0.955 . . . . 1.36 111.342 169.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -97.96 139.65 33.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.832 2.453 . . . . 3.24 107.48 159.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -106.05 9.31 32.49 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.345 1.98 . . . . 2.26 116.345 -162.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.785 0 C-N-CA 126.956 2.102 . . . . 6.68 110.133 -172.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.416 0 N-CA-C 108.921 -1.671 . . . . 12.83 108.921 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 p -179.18 165.25 1.46 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.811 1.244 . . . . 9.89 109.893 -166.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -76.53 54.64 0.96 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.807 1.243 . . . . 13.69 112.134 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.6 m -91.32 -28.61 17.63 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.536 1.934 . . . . 6.82 110.643 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -130.87 179.95 5.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.839 2.456 . . . . 5.34 110.692 -161.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.81 163.1 12.86 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.714 1.149 . . . . 1.33 115.277 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -151.37 149.46 29.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.4 1.08 . . . . 1.67 113.228 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.49 121.55 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.405 0.682 . . . . 0.9 110.118 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -86.69 90.43 8.27 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.027 0.931 . . . . 5.6 110.754 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.03 149.33 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.246 1.418 . . . . 2.6 112.054 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.0 m -155.59 162.54 27.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.774 2.029 . . . . 2.17 109.724 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.03 -5.87 13.87 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.522 2.814 . . . . 2.05 113.582 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.27 170.29 31.99 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.517 1.056 . . . . 1.81 113.328 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.84 -2.29 21.84 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 CA-C-N 117.951 0.875 . . . . 1.87 113.272 -4.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -116.73 152.85 33.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.43 1.092 . . . . 2.99 112.595 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.89 175.1 14.38 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.377 1.871 . . . . 0.72 111.318 166.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.61 156.23 36.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.846 0.858 . . . . 0.81 110.73 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.5 44.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.747 0.784 . . . . 0.61 111.311 162.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.52 143.28 49.82 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.947 1.699 . . . . 2.27 108.3 173.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.02 144.78 23.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 120.687 -1.258 . . . . 1.68 113.985 174.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -92.39 111.48 23.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 113.913 -1.494 . . . . 1.27 107.35 170.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.1 tt -120.16 147.18 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.873 2.469 . . . . 3.02 109.126 -174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -142.71 152.43 42.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 122.16 0.981 . . . . 2.75 113.418 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -100.14 102.39 17.84 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-N 113.976 -1.465 . . . . 1.13 109.269 171.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.88 -9.93 16.84 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.811 2.341 . . . . 1.18 113.041 174.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.84 -179.12 52.78 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 124.55 1.071 . . . . 1.12 113.464 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.73 -2.73 19.8 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.182 1.793 . . . . 3.15 112.965 -172.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -119.25 160.66 40.52 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.479 1.911 . . . . 1.4 109.873 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.41 156.47 32.68 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.47 2.113 . . . . 0.75 111.884 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.13 120.02 36.5 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.991 1.316 . . . . 2.47 110.05 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -106.89 103.72 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.936 1.294 . . . . 5.07 111.609 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.22 114.45 26.55 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.858 2.063 . . . . 0.82 109.282 -171.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 m -92.21 -23.48 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.486 0.714 . . . . 0.89 112.554 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.77 -168.64 40.24 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 123.751 0.691 . . . . 0.54 111.529 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' CD2' ' A' ' 101' ' ' LEU . . . -150.93 175.07 12.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.506 -0.759 . . . . 1.38 111.019 169.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 2.4 mmt85 -154.96 157.69 38.09 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-N 120.101 1.319 . . . . 6.99 111.96 -167.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 t -161.18 154.88 18.49 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 124.843 1.257 . . . . 0.83 110.226 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -68.21 -17.42 45.08 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.995 1.797 . . . . 1.0 113.074 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.331 1.5 m -86.22 11.74 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.123 1.157 . . . . 1.04 114.123 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.62 162.18 40.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.747 1.219 . . . . 0.77 111.917 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.9 -75.68 0.62 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.482 -0.562 . . . . 3.31 109.482 170.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -75.31 146.0 41.34 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.763 -1.199 . . . . 4.04 107.763 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -165.12 137.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.029 1.332 . . . . 1.41 108.58 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -142.64 136.28 28.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.733 1.213 . . . . 1.99 110.547 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 tt -79.97 120.15 23.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.568 0.699 . . . . 0.79 109.635 163.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -104.27 152.75 21.83 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.032 1.333 . . . . 0.57 111.327 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -106.54 163.67 12.69 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.562 1.945 . . . . 2.51 110.016 163.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.6 m -152.2 113.71 4.33 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.104 1.362 . . . . 1.67 108.403 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -131.77 151.65 51.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.689 1.196 . . . . 2.61 112.343 -160.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.32 154.33 25.35 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.151 0.98 . . . . 4.12 112.262 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -156.05 160.23 39.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.23 1.012 . . . . 5.94 111.516 172.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.12 155.21 16.92 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.975 1.31 . . . . 5.21 109.658 162.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.29 113.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 124.99 1.431 . . . . 3.37 111.175 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 60.53 17.41 7.32 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.032 0.933 . . . . 4.39 112.345 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.85 4.91 89.62 Favored Glycine 0 CA--C 1.538 1.494 0 O-C-N 120.239 -1.538 . . . . 3.46 114.267 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.43 128.75 34.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.722 1.609 . . . . 2.97 109.795 168.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.05 134.75 51.16 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.252 -0.905 . . . . 6.14 109.699 172.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.0 p -147.56 165.69 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.881 0.872 . . . . 3.15 110.829 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.6 ptp -130.24 148.81 52.11 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.25 1.02 . . . . 3.68 111.649 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.37 164.83 15.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.005 1.288 . . . . 2.14 111.716 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.31 157.21 46.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 2.71 110.609 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -160.77 137.15 6.3 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 116.153 -1.879 . . . . 4.4 108.99 -173.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.34 146.36 85.6 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.971 1.74 . . . . 0.87 110.403 151.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.98 155.96 52.54 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.853 1.261 . . . . 0.99 110.538 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.14 -14.59 25.91 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.005 2.47 . . . . 1.37 113.095 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -176.18 165.96 2.86 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.492 1.917 . . . . 2.69 112.292 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -117.59 176.0 5.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.459 2.304 . . . . 1.1 109.022 154.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.83 168.92 23.57 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.883 -1.135 . . . . 2.68 112.217 163.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.8 t -140.72 130.83 13.37 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.222 1.009 . . . . 0.83 109.446 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.61 162.67 38.19 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.473 2.115 . . . . 0.89 111.206 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.6 143.67 99.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.162 2.575 . . . . 1.01 111.638 176.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 66.93 1.45 2.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.614 1.966 . . . . 1.56 113.752 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.4 119.69 4.97 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 126.94 2.21 . . . . 1.03 111.164 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 135.21 36.24 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.77 1.228 . . . . 3.91 111.147 160.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.96 152.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.024 1.729 . . . . 1.38 110.77 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -124.55 120.56 32.32 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.85 1.66 . . . . 4.68 109.075 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.34 69.24 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.251 1.5 . . . . 1.36 112.973 -173.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.49 133.6 53.87 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.405 1.882 . . . . 3.03 113.368 169.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -56.34 -44.96 41.2 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.411 2.074 . . . . 1.9 111.201 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.5 68.69 2.4 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.948 1.261 . . . . 1.4 111.65 167.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -74.24 0.2 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.756 2.122 . . . . 1.59 112.271 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -151.87 132.74 14.16 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.35 1.46 . . . . 2.33 111.574 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -158.89 176.76 11.92 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.679 -1.263 . . . . 0.88 111.357 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -111.93 130.46 55.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 112.359 0.503 . . . . 2.17 112.359 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -94.3 130.11 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.836 1.255 . . . . 0.94 111.066 165.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.0 mt -109.83 132.74 53.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.797 1.639 . . . . 1.85 109.001 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.02 150.49 49.23 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.32 1.057 . . . . 1.65 112.969 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.92 -61.96 4.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.517 1.056 . . . . 2.68 110.979 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mt 68.42 88.56 0.11 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 129.925 3.29 . . . . 0.89 110.42 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -74.86 -3.81 34.16 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.131 -0.981 . . . . 1.97 113.281 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -145.56 144.39 22.61 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 127.809 2.444 . . . . 4.55 107.768 168.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.71 173.2 14.49 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.649 2.233 . . . . 1.97 110.186 157.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mp -126.3 172.01 10.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.516 1.926 . . . . 4.25 108.149 166.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -126.79 1.9 6.71 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.828 1.788 . . . . 3.88 115.828 174.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 76.38 158.43 0.2 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.785 2.834 . . . . 1.56 110.922 -167.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.1 55.8 6.83 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 121.532 -0.73 . . . . 1.75 111.626 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.92 176.9 11.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.302 2.241 . . . . 3.58 109.494 173.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.66 171.76 7.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.858 1.263 . . . . 4.25 109.804 166.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.7 t -128.8 125.1 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.825 1.65 . . . . 0.87 107.376 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -77.68 140.95 39.64 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.474 0.484 . . . . 3.17 109.81 166.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.536 ' CD2' ' HB1' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -147.71 126.6 12.73 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.856 1.058 . . . . 1.29 113.856 -168.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.82 102.21 14.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.742 2.417 . . . . 2.68 111.314 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.3 mt -78.58 111.91 15.13 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.926 -1.109 . . . . 1.64 111.166 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -90.8 122.38 33.48 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.884 1.274 . . . . 0.78 112.01 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.46 134.94 55.08 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.011 -1.056 . . . . 1.97 113.597 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.03 -28.03 69.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.896 1.278 . . . . 2.44 113.605 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 31.25 1.09 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.73 1.157 . . . . 4.21 114.366 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.75 44.76 88.61 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.913 1.244 . . . . 1.78 112.628 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.94 150.22 45.66 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.394 1.478 . . . . 4.37 111.283 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.83 137.28 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.048 -1.464 . . . . 1.49 107.048 155.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.4 mt -120.2 104.94 10.49 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 107.897 -1.149 . . . . 1.78 107.897 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -84.15 128.49 34.6 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.881 -0.512 . . . . 3.02 110.99 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.02 149.93 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.619 1.568 . . . . 2.39 110.637 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.62 150.85 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.62 1.168 . . . . 3.1 111.121 171.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -149.36 150.1 30.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.258 1.823 . . . . 2.03 109.577 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.37 156.22 54.88 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.299 3.333 . . . . 1.51 114.054 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 69.1 t -87.22 145.9 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.379 1.072 . . . . 1.87 111.882 169.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.25 152.52 51.3 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.378 3.471 . . . . 3.85 107.065 176.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -140.87 168.58 19.44 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.251 1.575 . . . . 2.31 115.251 -152.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 C-N-CA 128.006 2.523 . . . . 10.02 110.718 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.234 0 N-CA-C 106.265 -2.734 . . . . 13.93 106.265 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -53.83 154.32 4.02 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 119.392 -0.923 . . . . 12.24 109.946 134.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.1 144.99 41.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.021 0.928 . . . . 14.02 111.039 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.7 m -147.16 -27.5 0.38 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.493 1.917 . . . . 7.15 111.193 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -89.36 173.52 8.33 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.24 1.416 . . . . 5.52 111.067 164.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -124.42 146.77 16.36 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.323 1.439 . . . . 1.38 113.244 168.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -137.31 141.48 41.89 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.591 0.96 . . . . 1.3 113.591 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.8 t -95.47 107.95 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.709 0.804 . . . . 0.94 109.48 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -88.92 111.72 22.44 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.492 1.042 . . . . 3.89 111.027 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.26 168.92 18.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.399 1.48 . . . . 2.64 112.844 -168.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -160.98 158.3 23.91 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.267 1.827 . . . . 1.88 110.212 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.69 6.65 3.96 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.027 3.151 . . . . 1.51 114.022 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.07 166.98 29.16 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.363 0.982 . . . . 1.42 112.367 -169.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.11 -2.27 22.87 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 CA-C-N 118.359 1.079 . . . . 1.52 112.724 -5.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -136.61 169.66 17.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.29 1.436 . . . . 2.08 113.54 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.46 171.04 21.08 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.134 1.774 . . . . 0.78 112.372 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.55 101.88 6.37 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.199 0.999 . . . . 1.37 112.845 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.6 139.08 31.04 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.88 0.696 . . . . 0.8 112.88 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -118.12 156.47 28.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.174 1.389 . . . . 2.18 111.0 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.503 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -160.77 146.02 14.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.732 1.753 . . . . 1.53 115.732 166.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 m -79.66 126.9 31.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.461 -0.94 . . . . 1.15 108.461 158.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -130.22 138.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.855 1.662 . . . . 2.82 110.215 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.09 160.22 39.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.84 0.829 . . . . 2.74 113.07 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.19 94.28 47.14 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 125.507 1.523 . . . . 1.01 109.999 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.98 -5.01 15.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.938 1.759 . . . . 1.13 112.769 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.14 156.31 37.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.33 0.967 . . . . 1.14 113.085 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.3 m-20 -91.91 4.73 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.456 1.902 . . . . 2.98 113.668 -171.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.84 159.07 42.16 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.859 1.663 . . . . 1.3 110.506 168.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.09 154.24 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.14 2.56 . . . . 0.65 111.286 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.74 155.09 20.58 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.042 0.937 . . . . 1.86 111.104 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.402 HH21 ' CD ' ' A' ' 68' ' ' GLU . 19.5 ttm180 -133.47 112.34 11.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.042 1.337 . . . . 4.08 109.012 168.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.6 tp -93.93 110.47 22.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.759 2.024 . . . . 0.76 108.051 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -102.06 -13.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.277 0.843 . . . . 0.56 113.277 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -160.72 29.53 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.117 0.865 . . . . 0.46 112.76 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.59 174.4 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.788 1.235 . . . . 0.8 111.229 166.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -141.99 135.89 29.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.458 1.503 . . . . 5.46 109.279 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -145.09 147.65 35.36 Favored Pre-proline 0 N--CA 1.48 1.057 0 CA-C-N 119.594 1.088 . . . . 0.7 110.643 -171.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.29 -0.39 10.0 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.5 2.8 . . . . 1.07 113.92 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 93' ' ' LEU . 1.7 m -107.08 13.28 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.781 1.232 . . . . 1.0 114.093 174.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.34 157.04 43.75 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.431 -1.418 . . . . 1.03 111.667 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -105.35 -70.49 0.78 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.733 -0.84 . . . . 3.95 108.733 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -79.22 146.85 32.83 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.969 -1.123 . . . . 3.75 107.969 161.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -147.09 137.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.097 1.359 . . . . 1.3 108.713 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -128.45 133.76 48.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.701 2.0 . . . . 2.33 108.565 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -82.82 123.34 29.26 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.839 1.199 . . . . 0.84 110.28 167.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 15.3 m170 -109.1 154.96 21.55 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.387 1.475 . . . . 0.65 111.913 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -109.49 -179.14 3.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.594 1.958 . . . . 2.38 110.923 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.7 m -133.63 114.34 13.4 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.497 1.519 . . . . 1.24 108.013 164.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -100.72 151.96 21.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.369 1.068 . . . . 1.9 111.712 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -83.96 149.63 26.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.814 0.846 . . . . 4.36 111.082 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -154.66 135.9 14.01 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.779 0.832 . . . . 5.48 110.844 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.91 146.57 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.051 -0.722 . . . . 4.9 109.051 157.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -152.6 123.61 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.329 1.452 . . . . 3.23 108.586 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 50.11 38.33 16.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.205 1.002 . . . . 4.44 111.806 -169.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.32 -2.69 9.33 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.895 1.712 . . . . 2.6 115.924 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -84.67 130.36 34.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.356 1.578 . . . . 2.8 109.514 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.08 136.79 40.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.856 1.262 . . . . 5.12 112.609 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -151.75 151.49 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 127.225 2.21 . . . . 2.32 108.685 -167.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -113.72 131.65 56.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.196 0.998 . . . . 3.68 109.9 168.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.81 164.21 22.0 Favored Glycine 0 N--CA 1.472 1.088 0 C-N-CA 124.384 0.992 . . . . 1.29 112.857 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -106.73 160.52 15.41 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.665 1.186 . . . . 1.88 112.58 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -168.65 155.82 7.14 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 126.334 1.854 . . . . 3.87 110.583 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.8 Cg_endo -69.58 152.84 70.28 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.79 1.66 . . . . 0.6 112.286 167.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.27 158.42 48.63 Favored Pre-proline 0 N--CA 1.473 0.694 0 C-N-CA 126.312 1.845 . . . . 0.79 110.148 172.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.77 -16.76 29.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.594 2.196 . . . . 0.84 112.68 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -179.74 162.55 1.08 Allowed 'General case' 0 C--N 1.347 0.465 0 C-N-CA 126.236 1.815 . . . . 1.96 110.573 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mt -109.63 174.23 5.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.002 2.121 . . . . 1.03 109.554 157.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.5 pt-20 -154.83 166.84 32.23 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.145 -0.972 . . . . 2.38 112.125 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.28 135.9 11.18 Favored Pre-proline 0 N--CA 1.468 0.455 0 C-N-CA 124.024 0.93 . . . . 0.83 109.403 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.21 168.22 22.76 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.021 1.814 . . . . 0.79 111.435 172.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.66 143.18 91.99 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.365 2.71 . . . . 0.76 111.615 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.9 mmmt 68.15 1.0 2.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.968 2.107 . . . . 1.36 114.012 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.92 -171.61 27.6 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.353 1.93 . . . . 1.14 112.289 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -158.16 160.89 37.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.276 1.213 . . . . 3.96 114.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 m -143.9 132.14 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.365 1.466 . . . . 2.01 111.136 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -93.4 126.55 38.59 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.283 0.633 . . . . 3.69 109.336 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -71.03 66.6 0.39 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.834 1.302 . . . . 1.45 109.268 161.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -73.11 141.55 81.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.533 2.333 . . . . 3.14 111.422 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.13 -44.46 49.16 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.515 2.81 . . . . 1.2 113.677 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.89 80.85 1.56 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.671 -1.372 . . . . 1.39 109.671 166.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.17 -70.33 0.2 Allowed Glycine 0 N--CA 1.469 0.868 0 CA-C-O 119.097 -0.835 . . . . 1.31 114.211 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -157.17 146.98 20.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.344 1.857 . . . . 2.15 110.154 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -172.89 152.56 2.44 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.569 -1.332 . . . . 1.25 110.444 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -88.98 123.89 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.537 0.335 . . . . 2.34 110.961 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.6 mmt -83.54 100.9 11.08 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.881 1.272 . . . . 0.97 109.798 164.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -78.79 138.6 38.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.723 1.209 . . . . 1.85 107.811 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -144.09 148.9 35.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.443 1.116 . . . . 1.71 112.178 -173.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.8 -53.13 4.53 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.8 1.191 . . . . 2.57 111.42 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 61.15 95.75 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.667 2.787 . . . . 0.85 110.92 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.9 -15.1 62.09 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.794 -1.191 . . . . 2.38 112.339 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -147.14 145.66 22.87 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 128.292 2.637 . . . . 4.75 107.848 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.72 176.63 8.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.984 2.456 . . . . 2.36 109.879 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 39' ' ' VAL . 1.5 mp -130.55 -179.0 5.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.972 0.909 . . . . 3.79 111.93 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -151.0 144.65 25.03 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.461 1.904 . . . . 5.01 110.022 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 131.57 49.3 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.624 1.169 . . . . 2.28 112.955 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.58 -16.37 52.05 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.887 -1.507 . . . . 3.93 115.125 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.69 172.11 8.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.541 1.67 . . . . 6.08 111.191 -166.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.42 111.88 23.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.263 1.825 . . . . 4.43 111.485 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.67 117.63 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.085 -1.08 . . . . 1.0 108.085 165.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -74.19 140.91 45.44 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.38 1.086 . . . . 2.94 110.911 157.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.78 125.97 12.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.938 1.695 . . . . 1.76 109.843 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.57 96.29 7.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.98 2.112 . . . . 2.84 109.439 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.0 mt -80.27 112.42 17.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.023 1.729 . . . . 1.69 110.222 -171.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.4 mt -82.85 128.61 34.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.314 1.046 . . . . 1.0 111.472 -170.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 89.0 m-85 -124.2 126.96 47.01 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.649 0.78 . . . . 2.36 112.055 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 41.28 29.34 0.09 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.59 2.356 . . . . 2.53 116.399 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.73 -55.39 3.8 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.321 1.439 . . . . 4.31 113.087 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.33 -3.13 85.47 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.82 1.2 . . . . 2.09 115.374 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 6.2 mtpp -130.52 161.16 32.1 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.07 1.435 . . . . 5.21 114.025 175.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.48 166.44 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.874 2.07 . . . . 1.22 108.715 155.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.6 mt -137.24 126.5 24.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.713 1.605 . . . . 1.64 109.339 159.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -83.48 131.71 34.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.133 0.424 . . . . 2.56 111.469 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.02 156.28 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.592 1.157 . . . . 3.12 109.535 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.396 1.878 . . . . 1.71 109.995 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -143.49 144.44 27.79 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.495 1.518 . . . . 2.63 110.773 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 149.46 28.52 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.202 2.602 . . . . 1.16 113.616 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.4 t -84.23 130.56 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.006 1.322 . . . . 1.06 112.571 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.0 144.67 29.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.106 1.762 . . . . 3.31 109.527 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.51 86.77 2.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.643 1.177 . . . . 2.15 109.784 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.167 1.387 . . . . 7.55 110.733 -166.002 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 N-CA-C 108.05 -2.02 . . . . 12.7 108.05 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m 62.1 -15.04 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 121.296 3.813 . . . . 11.16 121.296 125.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 63.56 113.78 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.521 1.055 . . . . 10.0 109.66 -129.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -137.17 127.94 27.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.062 1.345 . . . . 6.39 108.512 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -119.02 128.53 54.46 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.715 1.259 . . . . 5.66 110.942 -161.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.18 170.59 42.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.415 1.959 . . . . 1.22 111.353 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 21.0 p90 -158.13 146.49 18.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.596 1.158 . . . . 1.4 110.998 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -106.72 118.35 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.583 -1.266 . . . . 0.94 107.583 170.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -89.51 114.61 26.16 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.159 0.984 . . . . 3.75 109.769 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.07 166.92 21.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.05 1.405 . . . . 2.4 113.497 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t -156.32 155.26 28.71 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 127.602 2.361 . . . . 3.12 108.385 171.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.93 -13.78 39.36 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.544 2.163 . . . . 1.89 112.559 165.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.87 174.71 18.37 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.964 1.745 . . . . 1.72 112.737 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 -5.91 48.26 Favored 'Cis proline' 0 CA--C 1.54 0.809 0 CA-C-N 118.415 1.107 . . . . 1.79 113.513 -1.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -126.98 161.98 27.07 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.611 1.165 . . . . 1.97 113.23 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.01 -176.37 5.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.361 2.264 . . . . 0.71 111.635 -175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.56 146.6 25.35 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.211 0.819 . . . . 0.8 113.211 -168.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.37 156.08 45.2 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.749 1.018 . . . . 0.73 113.749 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -152.37 149.77 28.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.381 1.872 . . . . 2.14 109.881 -169.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -171.74 160.81 5.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.281 1.032 . . . . 1.78 113.66 -173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -94.54 119.9 33.94 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.16 0.984 . . . . 1.23 109.875 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.2 124.95 40.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.861 1.264 . . . . 3.1 108.619 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -120.18 122.63 41.41 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.983 1.313 . . . . 3.86 110.328 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -102.61 103.96 35.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.349 -0.611 . . . . 0.98 109.349 164.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -86.6 -11.32 5.92 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.223 2.616 . . . . 1.05 113.122 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.83 160.44 43.03 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 124.273 0.939 . . . . 1.14 112.657 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.45 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.2 m-20 -90.25 5.97 44.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 2.95 113.235 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.98 160.02 40.54 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.241 1.816 . . . . 1.84 110.602 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.82 152.16 22.07 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.915 2.41 . . . . 0.83 111.432 -171.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -116.63 123.76 48.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.674 1.19 . . . . 2.07 110.385 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.7 ttp-105 -117.77 110.45 17.83 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.227 1.411 . . . . 4.49 111.658 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -97.73 106.15 18.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.278 2.231 . . . . 0.85 108.936 -170.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.04 -19.36 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.056 0.942 . . . . 0.83 112.683 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.93 -162.34 30.57 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.536 0.607 . . . . 0.71 112.674 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -138.0 -177.57 4.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.054 0.942 . . . . 0.82 110.444 170.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -148.26 141.7 25.32 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 105.149 -2.167 . . . . 7.43 105.149 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.68 152.3 37.44 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.649 -1.167 . . . . 0.72 109.195 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.6 -34.21 98.7 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.647 2.231 . . . . 0.98 113.029 167.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.284 2.2 m -81.94 4.04 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.484 0.92 . . . . 0.95 113.484 -165.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.04 170.08 19.17 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.527 1.058 . . . . 0.72 113.51 -174.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.09 -51.8 1.54 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 3.63 110.656 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -79.51 133.54 36.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.037 -1.097 . . . . 3.2 108.037 155.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -145.75 126.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 127.062 2.145 . . . . 1.29 108.364 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.91 115.87 6.03 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.69 0.796 . . . . 2.57 110.972 -157.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.39 121.42 23.01 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.821 1.192 . . . . 0.8 110.377 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.3 m170 -108.1 151.67 25.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.75 1.62 . . . . 0.52 113.259 174.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.91 172.02 8.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.746 1.618 . . . . 2.23 110.125 163.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -151.06 86.58 1.37 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.382 1.473 . . . . 1.07 107.674 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -96.56 -173.81 2.85 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.802 2.041 . . . . 2.48 111.576 -171.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.44 139.72 27.08 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.028 0.918 . . . . 3.21 111.855 170.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.22 150.43 26.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.602 1.161 . . . . 6.42 111.959 -170.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.327 16.6 pm0 -64.99 142.17 58.53 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.227 1.811 . . . . 6.1 113.44 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 t -130.21 -95.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.157 1.383 . . . . 2.76 107.37 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -73.08 45.48 0.15 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.908 2.083 . . . . 4.86 111.919 164.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.98 -40.15 1.18 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.533 1.539 . . . . 2.25 113.265 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -61.81 138.62 58.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.023 1.729 . . . . 3.79 110.862 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -77.89 112.23 14.56 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.201 0.6 . . . . 4.94 109.803 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.86 139.56 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.443 1.897 . . . . 1.66 108.632 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -83.86 139.65 32.51 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.725 1.21 . . . . 3.08 110.824 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.41 163.36 31.54 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.493 0.557 . . . . 0.95 114.493 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -112.85 165.56 12.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.276 1.43 . . . . 1.71 112.406 -176.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.252 76.0 mtt180 -169.52 141.58 1.98 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 128.738 2.815 . . . . 4.82 106.55 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.2 Cg_endo -68.95 150.73 73.39 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 CA-C-N 122.024 1.759 . . . . 0.66 110.192 156.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.97 156.87 47.73 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.143 1.377 . . . . 0.55 110.438 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.42 -23.48 50.86 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.356 2.037 . . . . 0.7 112.395 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -178.78 167.38 1.7 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 126.434 1.893 . . . . 2.23 111.585 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.091 1.356 . . . . 0.94 110.071 150.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.251 2.8 pt-20 -153.55 160.0 42.36 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.888 -0.507 . . . . 2.72 111.949 164.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 t -141.42 134.46 14.31 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 125.798 1.639 . . . . 1.1 108.851 -166.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.52 164.61 32.19 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.409 2.073 . . . . 0.99 111.679 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.38 145.03 99.12 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.346 2.697 . . . . 0.79 111.825 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 16.5 mmmt 68.96 -1.62 2.02 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.36 1.864 . . . . 1.41 113.66 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.02 125.94 7.85 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 127.649 2.547 . . . . 0.92 112.811 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -86.37 149.43 25.03 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.994 -1.103 . . . . 5.37 111.79 156.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 m -152.45 131.75 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.64 1.576 . . . . 1.66 109.52 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -89.84 134.43 34.2 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.287 1.035 . . . . 4.09 111.028 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.8 mp -76.13 66.22 2.25 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.214 1.483 . . . . 1.53 110.122 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -56.97 124.47 65.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.607 1.163 . . . . 4.85 109.838 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.32 -33.96 88.35 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.574 2.85 . . . . 1.38 113.765 -169.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.94 45.63 2.52 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 119.068 0.849 . . . . 1.89 112.361 168.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.45 -57.87 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.567 2.032 . . . . 1.44 113.988 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -150.26 145.54 26.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.889 1.676 . . . . 2.03 110.877 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -166.14 179.83 5.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.344 1.058 . . . . 0.79 110.941 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -115.7 132.48 56.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.23 1.012 . . . . 2.24 111.132 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.7 mmt -93.11 139.77 30.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.453 1.501 . . . . 0.86 110.772 165.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 143.18 51.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.719 1.608 . . . . 2.98 109.736 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -146.18 160.32 42.12 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 2.2 112.079 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.58 -82.39 1.69 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.084 1.326 . . . . 2.78 109.895 -169.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt 76.85 125.68 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.786 3.634 . . . . 0.92 110.941 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -77.74 -22.97 49.51 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.818 -1.176 . . . . 2.02 112.881 -170.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -161.83 158.15 21.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 130.233 3.413 . . . . 6.85 109.059 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.39 149.09 56.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.758 2.305 . . . . 3.45 109.653 160.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.36 -176.57 2.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.037 1.735 . . . . 3.42 109.82 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.35 141.63 19.55 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.214 -1.554 . . . . 3.5 110.513 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -34.79 135.99 0.17 Allowed 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.637 1.717 . . . . 1.81 115.637 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.83 22.39 69.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.124 0.81 . . . . 1.91 115.124 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -88.83 -179.46 5.98 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.754 1.222 . . . . 3.31 109.839 158.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -130.74 168.89 16.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.103 0.961 . . . . 3.59 111.321 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.9 t -136.33 117.71 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.391 1.476 . . . . 0.93 109.967 -172.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.42 42.04 0.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.016 2.127 . . . . 4.34 114.214 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.5 tt -65.39 137.09 57.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 123.4 1.571 . . . . 1.86 112.958 -164.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -106.09 112.61 25.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.781 2.032 . . . . 2.49 111.303 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -82.43 120.32 25.31 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.084 1.354 . . . . 1.19 110.752 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.8 mt -96.68 123.42 40.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.614 1.166 . . . . 0.84 111.54 -168.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.45 133.65 55.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.147 1.536 . . . . 1.87 115.147 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.17 48.28 0.85 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.821 2.048 . . . . 2.68 112.768 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.38 19.79 2.81 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 127.106 2.289 . . . . 4.93 112.307 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.98 38.07 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 118.275 1.037 . . . . 2.25 112.098 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 150.01 36.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.155 1.782 . . . . 3.67 111.197 -175.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.85 131.62 20.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 126.015 1.726 . . . . 1.11 108.073 161.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.14 122.69 41.56 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.331 1.452 . . . . 2.2 109.277 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -79.84 132.34 36.09 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.835 -0.541 . . . . 2.45 111.548 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 m -129.55 127.47 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.393 1.077 . . . . 1.49 109.567 167.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.22 138.38 20.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 124.059 0.943 . . . . 2.83 110.224 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.4 mt -143.55 142.62 21.37 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.252 1.421 . . . . 1.83 110.083 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.85 153.04 64.13 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.385 2.723 . . . . 1.11 112.667 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.5 t -83.4 113.95 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.113 1.365 . . . . 1.15 108.926 165.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -100.36 145.81 27.73 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.583 1.953 . . . . 3.8 108.015 167.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.91 55.21 0.78 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.3 1.593 . . . . 2.91 115.3 -152.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.076 2.15 . . . . 7.84 111.25 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.197 0 N-CA-C 106.968 -2.453 . . . . 11.56 106.968 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.8 t 64.53 -147.55 0.27 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.043 -1.466 . . . . 10.78 107.043 -121.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -58.52 157.87 8.4 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.793 1.179 . . . . 9.64 112.494 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.83 151.71 27.5 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.014 2.126 . . . . 7.99 108.279 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -129.06 -142.09 0.25 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.333 1.453 . . . . 5.16 110.312 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.97 169.04 26.31 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.647 -1.283 . . . . 0.87 114.436 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -150.63 146.59 26.61 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.762 1.625 . . . . 1.48 111.558 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -109.44 107.66 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.682 -1.229 . . . . 1.07 107.682 171.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -82.4 121.9 27.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.276 -0.639 . . . . 3.77 109.276 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -160.3 0.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.447 1.099 . . . . 2.23 112.016 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 8.6 t 174.0 157.65 0.31 Allowed Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 128.641 2.776 . . . . 2.77 106.935 168.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.97 -10.78 29.74 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.572 2.182 . . . . 1.7 113.197 167.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.53 177.69 26.06 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.005 1.288 . . . . 1.49 112.007 -174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.51 -1.21 32.26 Favored 'Cis proline' 0 CA--C 1.538 0.707 0 CA-C-N 118.665 1.232 . . . . 1.49 113.621 1.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -140.58 158.27 44.24 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.793 1.237 . . . . 2.07 112.478 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 11' ' ' SER . . . -152.98 -178.74 7.11 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.155 2.582 . . . . 0.63 110.27 -177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.22 133.59 16.43 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.344 1.239 . . . . 0.99 114.344 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.55 153.02 33.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.847 1.259 . . . . 0.72 111.981 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.44 136.95 15.9 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.911 1.684 . . . . 2.21 109.373 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -161.53 150.8 16.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.07 1.508 . . . . 2.18 115.07 -167.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -72.11 125.79 28.15 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.282 1.033 . . . . 1.45 108.714 165.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 tt -107.13 155.33 19.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.939 1.696 . . . . 3.04 110.47 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.01 161.77 37.24 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 115.536 1.68 . . . . 3.75 115.536 165.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -130.79 96.46 23.07 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 127.306 2.242 . . . . 1.18 109.425 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.88 -8.19 13.28 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.506 2.138 . . . . 1.0 113.703 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.05 157.71 41.48 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 119.655 1.116 . . . . 1.36 112.179 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -82.87 9.8 9.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.126 1.771 . . . . 3.3 112.681 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mt -110.58 165.32 12.91 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 129.031 2.933 . . . . 2.46 108.507 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.34 157.58 12.79 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.958 2.439 . . . . 0.77 111.445 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -113.99 147.76 38.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.437 1.095 . . . . 1.9 111.231 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 ttp-105 -135.79 112.24 9.92 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.125 1.37 . . . . 3.47 110.768 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -88.07 120.68 29.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.957 2.103 . . . . 1.16 108.741 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.78 -20.85 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.03 1.332 . . . . 0.65 112.669 -177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.67 -162.2 20.31 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 122.214 0.897 . . . . 0.65 112.061 169.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.889 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -149.48 177.58 9.58 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.229 1.811 . . . . 0.65 108.64 171.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -161.82 152.64 17.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 120.04 1.291 . . . . 6.11 109.323 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -153.72 151.42 25.05 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 125.469 1.508 . . . . 0.61 108.932 -166.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.1 -23.03 46.52 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.184 1.923 . . . . 0.88 113.843 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 m -88.01 -3.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 115.36 1.615 . . . . 1.06 115.36 -171.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.58 134.71 49.7 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.931 1.241 . . . . 0.86 111.176 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.6 -56.44 18.94 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 119.777 1.171 . . . . 5.71 109.277 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -124.12 151.48 43.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.53 1.932 . . . . 4.23 110.974 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.86 135.2 50.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.904 2.082 . . . . 2.45 107.934 163.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -126.77 130.1 49.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.95 0.9 . . . . 2.38 109.666 167.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tp -85.92 117.34 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.59 1.556 . . . . 3.44 108.843 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.3 m170 -126.43 151.96 47.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.084 1.354 . . . . 0.84 113.778 -170.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.65 167.7 13.14 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.079 1.751 . . . . 2.52 111.806 165.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.4 m -153.61 92.66 1.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.706 2.002 . . . . 2.08 107.213 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -109.61 163.48 13.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.111 1.152 . . . . 2.48 114.111 -156.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.68 143.93 27.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.301 1.04 . . . . 4.0 109.907 150.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -149.57 151.75 34.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.665 2.386 . . . . 7.82 107.09 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.33 145.44 37.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.683 0.793 . . . . 4.91 111.72 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.88 117.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 106.81 -1.552 . . . . 3.95 106.81 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.3 28.58 17.96 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.3 1.04 . . . . 7.29 111.461 -172.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.33 -12.79 12.38 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 120.486 -1.384 . . . . 4.31 114.049 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -75.52 135.09 40.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.305 1.442 . . . . 5.04 109.75 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -74.06 135.24 43.01 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.205 1.002 . . . . 4.52 111.878 -170.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.03 144.84 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.775 1.63 . . . . 2.54 109.421 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.97 139.0 51.14 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.804 1.242 . . . . 3.09 111.905 172.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -179.15 38.66 Favored Glycine 0 N--CA 1.468 0.816 0 C-N-CA 123.854 0.74 . . . . 1.29 113.694 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -120.4 177.63 4.96 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.057 1.343 . . . . 2.04 111.823 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 175.64 143.1 0.22 Allowed Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 126.813 2.045 . . . . 7.45 110.039 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.3 Cg_endo -67.83 154.46 72.96 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 CA-C-N 121.617 1.613 . . . . 0.76 110.783 161.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.93 156.43 69.0 Favored Pre-proline 0 N--CA 1.471 0.58 0 C-N-CA 125.989 1.716 . . . . 0.85 109.986 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.77 -19.92 40.52 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.028 1.819 . . . . 0.74 112.58 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 178.84 169.96 0.88 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.728 1.611 . . . . 1.85 111.031 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.03 163.58 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.11 1.364 . . . . 0.7 108.938 157.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.253 0.2 OUTLIER -153.57 158.39 41.13 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.504 -0.748 . . . . 2.01 112.28 177.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -146.34 133.65 10.2 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.298 1.439 . . . . 0.99 108.863 -162.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.11 168.36 24.95 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.0 2.467 . . . . 0.82 111.902 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -38.49 137.65 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.188 3.925 . . . . 1.28 114.287 165.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt 68.38 1.21 2.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.951 1.7 . . . . 1.58 114.049 169.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 115.08 4.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.86 1.695 . . . . 1.09 112.209 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.71 122.26 42.45 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.065 1.746 . . . . 4.83 109.5 161.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.1 m -155.22 146.29 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.273 1.429 . . . . 2.01 112.288 -163.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -91.27 142.79 27.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.085 0.954 . . . . 3.15 113.021 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.4 68.85 0.23 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 1.22 108.508 148.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -54.19 122.62 37.53 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.054 1.742 . . . . 4.05 110.381 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.15 -42.16 66.29 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.546 2.831 . . . . 1.52 112.891 -169.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.02 75.3 2.07 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.7 -0.96 . . . . 1.2 110.7 161.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.77 -61.03 0.23 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.759 1.647 . . . . 1.3 112.462 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -151.55 150.67 30.61 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.482 1.513 . . . . 3.07 111.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -160.19 170.72 20.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.221 1.008 . . . . 1.4 111.079 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -102.51 127.4 49.58 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.249 1.019 . . . . 2.2 110.64 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mmt -83.44 124.87 31.12 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.798 0.839 . . . . 1.29 110.574 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.28 134.35 48.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.195 1.398 . . . . 1.87 108.707 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.3 mt -134.2 161.01 36.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.65 1.18 . . . . 1.7 112.008 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 51.91 35.06 39.11 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 126.144 1.83 . . . . 2.41 114.998 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 mt -37.14 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.245 2.218 . . . . 0.97 114.652 -156.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -77.25 14.25 0.97 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.977 1.473 . . . . 1.89 114.977 -165.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -159.49 147.03 13.04 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 131.44 3.896 . . . . 7.2 109.468 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.98 170.52 15.45 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.015 2.476 . . . . 2.19 109.317 166.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 157.64 43.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 122.302 1.049 . . . . 4.44 112.791 -165.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -143.18 144.11 32.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.821 1.648 . . . . 4.29 109.639 176.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.4 144.04 57.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.856 0.863 . . . . 1.8 111.901 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.91 45.22 27.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.854 -0.97 . . . . 1.73 112.934 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -109.35 177.87 4.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.534 0.734 . . . . 4.85 109.741 148.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.57 161.62 17.64 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.216 1.806 . . . . 4.6 110.201 152.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -125.58 133.16 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.691 1.597 . . . . 1.18 109.721 163.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.65 144.76 28.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.901 1.68 . . . . 3.17 110.292 172.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.889 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.8 tt -156.37 131.74 9.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.39 1.076 . . . . 1.68 112.087 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.42 115.18 27.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.537 2.335 . . . . 2.28 111.947 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.19 118.9 22.96 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.688 1.585 . . . . 1.26 109.547 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.7 mt -98.37 122.51 41.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.231 1.012 . . . . 0.71 110.36 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -113.82 154.41 27.48 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.036 0.934 . . . . 2.02 112.6 -173.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.7 95.97 0.37 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.088 1.355 . . . . 1.96 112.605 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.45 -147.78 18.61 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.056 1.312 . . . . 3.03 111.317 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.47 36.94 2.02 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.287 0.946 . . . . 1.71 115.379 -171.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -127.74 134.08 49.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.696 1.748 . . . . 4.73 113.075 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.61 147.32 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 126.362 1.865 . . . . 1.09 108.064 158.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -141.17 115.89 9.66 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.182 1.393 . . . . 1.58 108.164 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.11 153.06 21.81 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.705 1.002 . . . . 2.55 113.705 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.75 166.88 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.319 2.248 . . . . 1.26 109.768 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.23 133.99 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.21 1.004 . . . . 1.72 108.457 175.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt -145.64 152.44 49.03 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.28 1.432 . . . . 2.05 110.56 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.81 151.97 74.04 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 125.2 3.933 . . . . 0.86 115.16 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.2 t -83.41 100.72 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.681 1.592 . . . . 1.05 109.719 170.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -90.7 74.68 6.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.009 1.724 . . . . 3.07 109.018 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.16 128.6 37.16 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.077 -1.014 . . . . 2.11 113.544 -166.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 . . . . . 0 N--CA 1.484 1.273 1 C-N-CA 132.647 4.379 . . . . 7.33 108.493 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 109.371 -1.492 . . . . 10.77 109.371 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 p -60.7 -32.98 72.2 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.469 1.635 . . . . 9.81 110.742 150.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -152.81 176.24 12.02 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 131.634 3.974 . . . . 8.65 105.982 156.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -139.48 -135.9 0.12 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 104.988 -2.227 . . . . 7.88 104.988 168.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -155.25 163.38 40.23 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 127.573 2.349 . . . . 5.7 106.55 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.21 156.06 22.61 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.681 -0.637 . . . . 0.96 113.638 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -154.73 147.32 24.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.19 0.996 . . . . 1.66 111.797 175.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.44 116.97 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.616 0.767 . . . . 0.91 110.649 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 ttp85 -81.61 103.23 11.18 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.028 1.331 . . . . 4.04 110.577 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.55 165.06 25.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 123.431 1.586 . . . . 2.3 112.465 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.8 m -161.22 154.08 17.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.58 2.352 . . . . 1.94 107.949 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.28 27.6 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.398 3.398 . . . . 1.56 113.503 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.71 169.42 42.76 Favored Glycine 0 CA--C 1.538 1.491 0 O-C-N 121.477 -0.764 . . . . 1.42 113.049 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.14 -5.58 25.77 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 118.005 0.902 . . . . 1.53 112.604 -10.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.99 157.65 44.06 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.073 1.349 . . . . 3.0 113.34 -168.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.27 -176.21 5.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.63 1.972 . . . . 0.67 111.294 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.44 129.0 15.04 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.986 0.914 . . . . 1.01 111.814 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.27 138.41 44.59 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.787 1.235 . . . . 0.72 111.84 174.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -124.83 151.32 45.39 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.138 2.175 . . . . 2.5 109.102 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -161.03 150.11 16.62 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.173 1.175 . . . . 1.74 114.173 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -89.49 113.63 25.03 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.501 -0.926 . . . . 1.43 108.501 166.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.82 156.54 20.97 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.038 1.735 . . . . 2.7 110.806 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.15 157.45 43.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.911 0.708 . . . . 3.56 112.911 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -96.34 109.79 49.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 114.359 -1.291 . . . . 1.09 110.19 166.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.84 -2.82 10.4 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.371 2.714 . . . . 1.21 113.78 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.69 171.27 37.64 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.4 1.0 . . . . 1.04 113.133 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -95.57 0.13 52.61 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.525 1.53 . . . . 3.53 113.781 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -116.84 154.61 49.55 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.674 1.589 . . . . 1.35 110.056 167.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.91 159.05 27.55 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.501 2.801 . . . . 0.69 112.506 -164.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -106.59 152.23 23.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.68 1.192 . . . . 1.82 110.837 171.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -130.78 112.25 12.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.084 1.353 . . . . 3.89 109.619 171.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 tp -94.81 112.3 24.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.065 2.546 . . . . 0.73 109.601 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.79 -11.86 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.922 1.082 . . . . 0.59 113.922 -165.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.74 -167.95 40.67 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.506 -0.746 . . . . 0.63 112.583 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.54 -179.69 7.29 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.506 0.558 . . . . 0.86 112.506 167.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -145.69 142.19 28.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.327 1.051 . . . . 7.21 109.044 169.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -153.9 151.09 24.09 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.544 1.138 . . . . 0.65 110.448 -164.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.72 -17.81 37.55 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.396 2.064 . . . . 1.04 112.652 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.32 2.0 m -96.91 11.07 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.199 1.555 . . . . 1.64 115.199 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . . . -154.82 144.29 21.33 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.91 1.448 . . . . 0.98 114.91 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -99.87 -69.82 0.75 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.934 -0.765 . . . . 3.12 108.934 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.912 -1.514 . . . . 2.76 106.912 164.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.19 129.17 75.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.173 1.789 . . . . 1.28 107.548 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.3 131.95 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.325 1.45 . . . . 1.91 109.273 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.07 122.17 27.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.086 0.945 . . . . 0.78 110.579 168.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -112.52 159.29 18.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.834 2.054 . . . . 0.5 111.986 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.37 -177.34 3.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.742 2.017 . . . . 2.66 110.925 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 m -137.12 116.28 12.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.339 1.456 . . . . 1.33 107.59 163.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -96.74 162.53 13.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.863 0.865 . . . . 2.25 110.996 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -112.32 143.14 43.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 3.58 110.822 162.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -153.78 159.67 41.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.742 1.617 . . . . 5.64 111.295 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 141.35 36.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.823 -0.806 . . . . 4.14 108.823 156.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.33 -8.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 115.139 1.533 . . . . 3.14 115.139 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -158.27 46.0 0.33 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.673 1.989 . . . . 4.08 107.586 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.74 -24.06 0.4 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.766 1.651 . . . . 2.0 114.706 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -99.79 153.47 19.1 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.122 2.169 . . . . 3.12 112.49 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -61.66 136.54 58.04 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.956 0.902 . . . . 3.89 111.34 169.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.8 t -140.0 150.44 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.061 2.144 . . . . 1.93 108.275 168.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.3 mtm -111.57 144.48 40.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.396 1.079 . . . . 3.18 111.347 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.47 158.03 28.16 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 123.597 0.618 . . . . 1.09 113.012 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.67 165.56 11.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.413 1.085 . . . . 1.74 112.551 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -171.15 155.29 4.32 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.535 1.934 . . . . 3.87 109.848 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 1.6 Cg_endo -69.75 152.33 69.36 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.926 1.75 . . . . 0.6 111.482 167.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -115.17 157.97 42.27 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 126.381 1.872 . . . . 0.78 110.278 170.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -69.36 -21.43 35.36 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 0.82 111.952 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -177.93 161.25 1.54 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.267 1.827 . . . . 2.12 110.82 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mt -108.2 174.97 5.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.741 2.016 . . . . 0.76 109.455 157.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.55 165.07 36.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.048 -1.032 . . . . 2.31 111.222 170.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 t -146.07 130.14 8.61 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 123.436 0.694 . . . . 0.79 109.334 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.12 164.85 34.34 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.197 1.932 . . . . 0.8 111.108 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.39 137.01 75.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.514 2.809 . . . . 0.81 112.144 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp 64.05 11.15 5.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.834 1.654 . . . . 1.58 113.622 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.08 120.06 5.13 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 127.766 2.603 . . . . 0.91 111.197 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -85.38 142.91 28.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.005 1.322 . . . . 5.71 111.87 162.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.98 148.32 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 126.029 1.731 . . . . 1.73 110.398 172.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -129.92 114.5 15.94 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.289 -1.004 . . . . 5.02 108.289 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.76 67.96 2.26 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.64 1.976 . . . . 1.35 112.388 -171.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.57 133.92 44.88 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 127.854 2.461 . . . . 2.68 113.634 166.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.6 -52.59 7.23 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.502 2.802 . . . . 1.56 112.132 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.33 89.12 1.01 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.401 -1.48 . . . . 1.53 109.401 166.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.95 -72.25 0.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.73 2.109 . . . . 1.25 112.753 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -155.43 132.25 10.62 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.474 1.51 . . . . 1.94 112.299 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -156.88 165.93 34.81 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.023 -1.048 . . . . 0.75 111.487 -171.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.27 113.71 26.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.307 0.575 . . . . 1.78 109.699 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.26 125.13 33.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.508 1.123 . . . . 1.43 109.195 175.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 24.0 mt -113.68 135.91 53.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.912 1.285 . . . . 1.76 110.077 -168.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -146.65 154.67 41.73 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.782 1.633 . . . . 2.06 111.02 -172.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.39 -54.46 4.32 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 124.734 1.159 . . . . 2.41 112.371 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 mt 70.02 107.51 0.06 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 129.875 3.27 . . . . 1.39 111.133 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.18 14.33 2.41 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.76 -1.212 . . . . 1.99 113.712 -169.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.452 HH21 ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.8 153.52 15.91 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.682 2.393 . . . . 5.57 109.633 176.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.7 140.61 23.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.772 2.314 . . . . 2.43 109.875 166.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.3 mt -115.57 152.68 32.61 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.148 1.379 . . . . 3.15 111.794 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -147.75 9.63 0.91 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.724 2.12 . . . . 3.94 116.724 -173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 64.0 172.87 0.18 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.934 2.094 . . . . 2.72 112.225 -169.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.58 52.48 52.82 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 121.661 -0.649 . . . . 2.4 111.99 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.452 ' CD ' HH21 ' A' ' 91' ' ' ARG . 9.8 pt-20 -152.01 163.88 38.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.003 2.121 . . . . 3.77 111.051 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -101.51 123.1 45.0 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.279 1.831 . . . . 4.43 109.499 -173.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.68 106.09 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 N-CA-C 108.001 -1.111 . . . . 1.21 108.001 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 143.22 42.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.631 -1.168 . . . . 3.14 109.171 160.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -155.33 116.39 3.93 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.946 -1.096 . . . . 1.59 111.213 -167.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.86 100.58 12.65 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.297 1.439 . . . . 2.39 110.378 171.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 mt -80.52 119.65 23.46 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.646 -0.659 . . . . 1.58 109.528 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.8 mt -93.6 129.93 39.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.178 0.991 . . . . 0.84 110.61 -171.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -130.37 122.49 27.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.408 0.623 . . . . 2.0 112.504 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.0 12.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.401 2.001 . . . . 2.43 116.401 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.62 -45.73 1.6 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.967 1.27 . . . . 3.39 112.64 -165.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.87 4.67 44.19 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.194 1.378 . . . . 2.46 116.042 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.69 152.85 33.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.53 1.932 . . . . 3.86 112.686 176.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.9 140.64 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.647 1.979 . . . . 1.03 107.819 161.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -139.04 124.05 18.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.755 1.222 . . . . 1.59 108.056 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.45 150.7 20.01 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.817 1.414 . . . . 2.37 114.817 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.91 145.18 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.823 1.649 . . . . 1.26 110.91 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -106.84 129.81 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.614 1.166 . . . . 1.8 108.623 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.3 mt -140.68 150.52 60.47 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.743 1.617 . . . . 1.82 110.183 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.02 146.49 37.11 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.096 2.53 . . . . 0.89 112.874 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.5 t -72.29 139.43 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.636 -0.711 . . . . 1.07 110.567 156.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.57 151.34 39.54 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.428 3.491 . . . . 3.58 108.672 170.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.72 73.27 1.46 Allowed 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.194 1.554 . . . . 2.27 115.194 -157.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.377 1.071 . . . . 7.42 112.556 172.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 107.006 -2.438 . . . . 12.25 107.006 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 m 64.72 136.41 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 O-C-N 124.752 0.913 . . . . 10.52 109.025 -126.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -169.53 145.34 3.16 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.292 -0.88 . . . . 11.67 111.859 -160.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -154.99 -52.19 0.09 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.134 2.174 . . . . 6.22 109.867 -173.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -134.52 -173.1 3.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.57 1.148 . . . . 5.67 113.543 -159.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.04 165.24 17.26 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.592 1.568 . . . . 1.97 114.525 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -148.97 134.4 18.52 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.146 1.778 . . . . 2.59 110.552 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.4 t -91.33 140.15 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.74 1.216 . . . . 1.06 107.879 171.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.46 -24.4 18.04 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.884 1.439 . . . . 3.41 114.884 -175.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 64.28 175.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.697 1.999 . . . . 2.23 114.559 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 m 176.34 167.24 0.43 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 130.92 3.688 . . . . 1.69 107.903 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.24 -6.55 18.58 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.993 2.462 . . . . 2.19 113.584 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 112.28 166.34 17.41 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.115 1.816 . . . . 1.86 111.696 -169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.62 -7.71 45.1 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.112 1.456 . . . . 1.85 113.633 -1.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -130.17 174.08 10.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.05 1.34 . . . . 2.18 112.836 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.51 -174.66 3.23 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.216 2.206 . . . . 0.6 112.037 177.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.19 165.49 22.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.598 1.159 . . . . 0.88 111.352 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.66 162.35 40.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.241 1.816 . . . . 0.71 111.355 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -155.6 165.0 37.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.727 1.611 . . . . 2.23 111.274 -173.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.467 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.4 pt? -160.44 161.3 32.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 116.0 1.852 . . . . 1.54 116.0 170.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -70.06 125.6 27.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 112.663 -2.062 . . . . 1.5 106.164 153.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -134.67 129.58 35.03 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.559 1.544 . . . . 2.75 107.108 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -153.9 150.76 28.71 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 114.583 1.327 . . . . 2.77 114.583 -173.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -103.63 103.65 37.58 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 112.987 -1.915 . . . . 0.96 109.099 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.8 -10.49 14.22 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.631 2.22 . . . . 1.32 113.018 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.15 -177.19 49.9 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.848 1.214 . . . . 1.16 113.466 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.89 -2.62 21.13 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.075 1.75 . . . . 3.43 113.018 -170.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -121.72 161.26 42.84 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.447 1.899 . . . . 1.35 110.062 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.75 149.05 20.5 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.674 2.249 . . . . 0.65 111.969 -169.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.14 120.89 42.07 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.624 1.17 . . . . 2.46 110.692 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -105.81 103.87 13.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.967 1.707 . . . . 3.77 110.65 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -91.84 116.56 29.0 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.805 1.642 . . . . 1.07 109.024 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -95.0 -22.99 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.995 0.918 . . . . 0.94 112.387 -174.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -161.52 28.21 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 121.78 -0.575 . . . . 0.63 112.581 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.43 -178.16 5.17 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.185 0.994 . . . . 0.71 110.7 169.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 136.82 17.37 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.895 2.078 . . . . 5.64 106.518 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -153.29 151.58 26.04 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 120.737 1.608 . . . . 0.62 111.097 -166.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.09 -18.36 27.4 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.82 3.013 . . . . 0.78 114.097 174.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.269 3.0 m -89.91 -2.07 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 114.081 1.141 . . . . 0.83 114.081 -173.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.88 39.5 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.576 0.954 . . . . 0.75 113.576 -174.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.22 -86.86 0.34 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.284 1.833 . . . . 3.42 108.41 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -78.49 86.36 4.52 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.67 -1.269 . . . . 3.18 110.614 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.77 139.24 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.793 1.237 . . . . 1.16 110.486 158.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -136.51 126.52 26.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.489 1.915 . . . . 2.24 109.821 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.18 121.57 26.78 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.209 1.368 . . . . 0.74 111.245 167.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.6 m170 -107.26 151.64 25.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.596 1.558 . . . . 0.68 112.3 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.42 173.14 8.06 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.721 1.209 . . . . 2.19 110.5 158.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.6 m -148.72 96.64 2.61 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.166 1.386 . . . . 1.02 107.515 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -109.04 153.96 22.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.948 1.699 . . . . 2.62 112.2 -166.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.7 mtm -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.081 0.952 . . . . 2.91 110.937 170.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -155.62 167.92 28.81 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.198 1.799 . . . . 9.1 111.235 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.73 157.73 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.264 0.625 . . . . 3.47 111.115 160.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -135.11 -89.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.215 1.006 . . . . 3.12 108.922 160.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.45 55.34 1.91 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.683 1.993 . . . . 3.84 110.338 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.92 -18.52 0.35 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 125.62 1.581 . . . . 2.04 114.906 -173.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -108.2 163.28 13.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.752 2.421 . . . . 3.06 111.38 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -66.64 135.63 54.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.673 1.189 . . . . 3.7 112.817 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.1 160.42 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 126.895 2.078 . . . . 1.99 109.221 168.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.1 mmt -79.96 165.09 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 3.62 112.647 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.17 143.11 11.74 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.735 1.635 . . . . 1.56 110.707 163.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -120.03 142.21 49.04 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.355 1.462 . . . . 2.06 109.539 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -172.86 127.46 0.52 Allowed Pre-proline 0 N--CA 1.47 0.538 0 CA-C-O 117.116 -1.421 . . . . 4.07 111.136 -152.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 38.2 Cg_endo -66.63 146.07 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.184 1.922 . . . . 0.55 111.251 170.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -122.28 156.71 60.13 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.799 1.64 . . . . 0.54 110.589 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.99 -24.37 28.69 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.258 1.972 . . . . 0.71 112.509 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -174.06 166.25 4.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.882 1.273 . . . . 2.13 112.273 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.52 173.04 6.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.065 2.146 . . . . 0.7 109.526 157.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.56 163.19 40.3 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 121.663 -0.648 . . . . 1.89 112.236 167.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.38 130.74 11.68 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 124.844 1.258 . . . . 0.96 109.606 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.18 161.62 43.72 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.026 2.484 . . . . 0.84 111.295 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.27 140.88 90.97 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.238 2.626 . . . . 1.02 112.105 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt 67.96 -3.32 1.23 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.967 2.107 . . . . 1.83 113.921 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.74 134.82 13.52 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 127.136 2.303 . . . . 0.86 110.052 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -109.9 146.7 34.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.514 -1.343 . . . . 6.45 112.192 163.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.08 171.69 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.968 1.707 . . . . 1.32 110.099 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -139.03 117.68 12.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.722 1.609 . . . . 3.88 108.036 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.77 70.77 0.99 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.95 1.7 . . . . 1.3 111.323 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.48 140.5 94.85 Favored Pre-proline 0 CA--C 1.55 0.948 0 O-C-N 120.967 -1.083 . . . . 2.98 111.754 171.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.98 -33.4 83.5 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.83 2.353 . . . . 1.35 112.201 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.01 53.41 4.81 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.058 0.837 . . . . 1.44 112.31 166.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.14 -64.26 0.05 OUTLIER Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.452 1.025 . . . . 1.39 114.842 177.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -154.63 137.79 15.64 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.657 1.583 . . . . 2.12 110.558 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -162.17 172.24 16.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.227 -0.921 . . . . 0.75 111.963 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -105.12 131.83 52.11 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.099 0.559 . . . . 1.91 110.405 167.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.3 mmt -88.91 143.93 26.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.279 1.032 . . . . 0.96 109.9 156.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.8 125.56 46.8 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.932 1.293 . . . . 2.7 108.801 172.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mt -124.85 133.87 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.314 1.846 . . . . 2.02 110.692 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.67 78.37 0.67 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.778 -1.329 . . . . 2.47 109.778 -174.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.39 104.08 4.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.332 1.066 . . . . 0.93 109.972 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -1.46 17.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.834 1.05 . . . . 2.12 113.834 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -122.6 140.3 32.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.529 1.932 . . . . 6.22 109.647 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -69.39 140.33 43.79 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 N-CA-C 108.26 -1.477 . . . . 2.02 108.26 148.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.7 mt -120.51 155.62 33.24 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.464 1.106 . . . . 3.12 111.433 -174.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -130.92 1.37 4.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.188 1.551 . . . . 3.71 115.188 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 59.11 178.62 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.219 2.207 . . . . 2.08 111.92 -171.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.2 56.22 25.81 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 110.445 -1.062 . . . . 1.91 110.445 -172.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -166.72 157.12 11.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 128.572 2.749 . . . . 3.09 109.961 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -112.46 148.41 34.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.533 1.133 . . . . 4.35 112.054 -167.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.1 t -125.41 117.48 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.18 1.792 . . . . 1.16 108.342 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.72 133.28 33.69 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.836 -0.801 . . . . 4.04 108.836 157.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -138.71 141.71 38.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.957 1.703 . . . . 1.95 108.708 -173.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.06 123.1 31.77 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.891 1.677 . . . . 2.35 109.961 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.74 120.33 27.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.103 0.961 . . . . 1.36 109.8 168.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.77 125.61 40.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.18 0.992 . . . . 0.57 111.731 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -125.51 114.14 18.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.996 0.903 . . . . 2.06 111.73 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.12 25.7 0.12 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 127.502 2.321 . . . . 3.3 116.317 171.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.68 -42.03 1.04 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.52 1.533 . . . . 4.26 113.906 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.04 0.09 87.93 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.224 1.392 . . . . 2.13 116.102 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.25 155.24 41.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.933 2.093 . . . . 4.44 111.748 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.72 141.0 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.429 1.892 . . . . 1.1 108.599 171.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.9 112.4 9.32 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.112 1.365 . . . . 1.63 109.24 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -83.92 137.39 33.67 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.016 0.747 . . . . 3.71 113.016 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 m -138.24 153.43 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.988 1.715 . . . . 1.59 110.894 -177.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 m -95.2 149.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.265 1.426 . . . . 3.04 112.416 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -147.13 141.77 16.26 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.89 2.076 . . . . 3.0 108.382 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.09 156.75 33.97 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.979 2.452 . . . . 1.05 111.027 163.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -84.17 109.29 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.074 0.949 . . . . 1.09 109.828 164.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 120' ' ' ARG . 4.8 mm-40 -79.01 146.51 33.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.284 1.034 . . . . 3.7 108.288 155.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.37 94.03 4.77 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.045 -1.095 . . . . 2.16 108.045 165.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 118' ' ' GLU . 32.0 ttm-85 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 113.57 0.952 . . . . 8.57 113.57 -164.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' H1 ' ' CD ' ' A' ' 23' ' ' GLU . . . . . . . . 0 CA--C 1.498 -0.987 0 N-CA-C 107.383 -2.287 . . . . 11.2 107.383 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -153.62 -141.22 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.734 0.813 . . . . 9.42 108.826 -161.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -76.44 -170.93 1.64 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.056 0.843 . . . . 11.11 108.814 149.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -80.23 98.39 7.35 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.569 -1.332 . . . . 7.75 108.198 161.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -79.32 84.64 5.22 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.522 0.729 . . . . 4.56 110.588 -172.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.69 -175.91 43.49 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.956 1.741 . . . . 1.32 114.762 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -159.62 156.44 27.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.126 1.371 . . . . 1.76 113.257 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -113.92 131.07 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.543 -0.723 . . . . 0.88 109.947 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -72.2 114.17 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.776 1.231 . . . . 4.68 109.249 174.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 129.09 37.17 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.723 0.809 . . . . 2.13 109.136 162.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.35 163.26 38.09 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.877 1.671 . . . . 2.33 108.1 167.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.12 17.68 0.49 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.459 3.439 . . . . 1.48 115.456 -167.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.31 174.38 49.48 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.599 -0.688 . . . . 1.3 112.772 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.23 -3.0 36.91 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.364 1.082 . . . . 1.42 113.034 -4.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -141.2 169.41 17.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.297 1.439 . . . . 2.03 112.5 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.19 -158.5 0.34 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.985 2.514 . . . . 0.85 111.177 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.49 171.08 20.91 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.62 1.168 . . . . 0.8 113.664 -169.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.93 151.0 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.343 1.057 . . . . 0.87 113.186 170.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -142.81 145.65 33.43 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.594 1.558 . . . . 2.07 110.468 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -169.62 160.97 9.25 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.46 0.911 . . . . 1.58 113.46 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.0 m -78.19 141.53 38.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.54 1.536 . . . . 1.29 109.076 162.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -128.21 136.72 51.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.458 1.103 . . . . 2.86 108.561 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' CD ' ' H1 ' ' A' ' 1' ' ' GLY . 20.8 pt-20 -130.69 148.98 52.54 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.97 0.908 . . . . 2.72 110.657 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.453 HD21 HD13 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -119.35 70.91 12.21 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.366 0.666 . . . . 3.83 112.309 -159.307 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 -14.65 44.46 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.231 2.621 . . . . 1.05 115.438 -168.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.25 161.33 53.35 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.397 0.998 . . . . 1.17 112.92 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 3.8 m-20 -91.08 -2.24 57.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.507 1.523 . . . . 3.1 113.353 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -117.73 160.06 39.92 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.034 1.733 . . . . 1.3 110.618 172.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.43 157.38 25.56 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.77 2.314 . . . . 0.66 111.235 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.453 HD13 HD21 ' A' ' 24' ' ' ASN . 2.3 mp -124.02 127.95 48.64 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.58 1.552 . . . . 2.37 110.727 -172.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -113.37 104.98 12.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.263 1.425 . . . . 4.67 110.794 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.2 tp -89.64 115.68 27.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.664 2.385 . . . . 0.84 108.78 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.8 m -110.24 -8.65 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.403 1.081 . . . . 0.55 113.541 -170.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.6 -159.76 32.14 Favored Glycine 0 C--N 1.337 0.596 0 O-C-N 121.636 -0.665 . . . . 0.38 113.331 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.813 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -147.71 178.74 8.23 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.59 0.756 . . . . 0.68 112.221 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -152.58 145.92 24.79 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.572 -1.27 . . . . 6.97 107.572 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -155.76 156.06 30.2 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.927 1.291 . . . . 0.63 109.279 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.35 -26.94 71.24 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.585 2.19 . . . . 0.97 113.339 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.323 1.5 m -92.45 11.57 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 114.914 1.45 . . . . 1.5 114.914 -170.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -155.9 151.01 26.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.981 1.312 . . . . 0.9 112.409 177.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -97.34 -78.19 0.48 Allowed 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.318 -0.993 . . . . 3.36 108.318 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -74.6 107.42 6.71 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.078 -1.453 . . . . 3.36 107.078 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.21 129.24 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 1.47 108.22 173.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.39 127.81 18.9 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.026 1.331 . . . . 2.31 110.138 -162.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -79.21 121.16 24.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.825 0.821 . . . . 0.76 110.588 175.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -107.4 153.49 22.71 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.393 1.877 . . . . 0.73 112.94 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.0 164.17 13.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.852 1.661 . . . . 2.29 110.89 161.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 81.5 m -129.75 105.88 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.888 1.675 . . . . 1.03 108.334 166.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -106.2 158.1 17.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.788 1.235 . . . . 2.25 113.261 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.0 mtp -124.52 100.82 6.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.363 1.465 . . . . 4.02 110.36 171.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -122.63 145.87 47.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.415 1.486 . . . . 5.52 110.928 -174.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.2 mp0 -59.96 147.33 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.529 0.731 . . . . 3.57 111.349 165.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -159.31 -47.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.944 1.09 . . . . 2.96 113.944 170.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -93.28 38.28 1.04 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.485 1.914 . . . . 5.83 110.746 171.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.54 -40.16 0.76 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.5 1.524 . . . . 2.56 113.043 -167.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -86.93 154.52 20.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.581 2.352 . . . . 3.71 111.122 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -68.44 122.99 19.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.875 0.87 . . . . 4.13 111.267 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.84 151.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.351 1.461 . . . . 2.72 109.935 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -83.55 141.95 31.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.61 1.564 . . . . 2.91 111.155 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.77 170.5 33.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.967 0.794 . . . . 1.13 112.884 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.98 145.12 41.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.76 1.224 . . . . 2.1 111.229 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -153.32 143.36 15.34 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 125.447 1.499 . . . . 3.29 109.964 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.78 145.56 75.52 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.755 1.637 . . . . 0.75 110.595 163.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -118.32 154.16 51.92 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.687 1.595 . . . . 0.76 110.084 171.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.09 -9.56 26.28 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.827 2.351 . . . . 1.23 114.136 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -172.37 163.03 5.56 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.098 1.317 . . . . 2.12 111.664 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -119.19 169.69 9.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.586 1.554 . . . . 0.69 108.482 148.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -158.16 164.24 36.77 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.045 -1.034 . . . . 2.3 112.118 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.02 138.5 14.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 1.12 110.593 -169.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.07 161.6 45.37 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.676 2.25 . . . . 1.1 111.314 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.38 146.2 93.2 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.98 2.453 . . . . 0.83 111.798 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 68.7 mmtt 69.97 -12.48 0.48 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.507 2.723 . . . . 1.36 114.624 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.5 130.86 29.13 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 126.456 1.979 . . . . 0.95 111.974 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.9 ttp85 -94.49 129.02 41.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.095 -1.553 . . . . 5.57 110.045 161.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.73 178.63 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.681 1.592 . . . . 1.4 110.345 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -141.07 140.2 34.18 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.128 0.971 . . . . 3.3 110.169 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.59 59.77 3.1 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.702 1.239 . . . . 1.15 108.912 155.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -72.14 122.41 87.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.677 -1.154 . . . . 3.52 110.116 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.95 -27.08 83.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.372 2.715 . . . . 1.55 114.792 -168.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.13 84.31 1.6 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.746 -1.742 . . . . 1.58 108.746 157.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 147.01 -87.44 0.16 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.334 1.921 . . . . 1.36 111.55 -166.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -143.42 153.77 43.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.246 1.818 . . . . 1.91 110.881 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -157.79 165.43 35.35 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.509 1.123 . . . . 0.74 109.736 175.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -93.2 137.23 32.73 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.8 -1.185 . . . . 2.09 107.8 159.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.7 139.5 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.744 1.218 . . . . 1.46 109.411 168.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.5 mt -117.83 131.69 56.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.86 1.264 . . . . 1.96 110.459 -172.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.85 159.49 42.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.721 1.608 . . . . 1.79 111.928 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -56.87 4.51 Favored Glycine 0 N--CA 1.47 0.934 0 C-N-CA 124.897 1.237 . . . . 2.37 112.73 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 12.4 mt 70.76 98.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 129.715 3.206 . . . . 1.4 113.252 171.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -11.01 59.83 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.17 1.174 . . . . 1.78 114.17 -171.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -141.33 158.1 64.65 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 129.588 3.155 . . . . 7.69 108.928 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.49 163.2 39.83 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.513 2.809 . . . . 1.89 110.294 160.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -124.27 151.6 44.0 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.183 0.993 . . . . 2.52 112.275 -167.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -142.34 120.58 12.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.446 1.098 . . . . 3.81 110.445 -170.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 140.27 54.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.548 0.739 . . . . 1.76 112.783 172.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.02 -20.6 33.14 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.339 1.447 . . . . 3.08 115.158 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.81 -173.72 4.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.249 1.024 . . . . 5.34 111.084 -169.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -95.64 152.06 18.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.715 0.769 . . . . 4.25 110.727 162.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.2 t -106.26 127.43 61.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 127.388 2.275 . . . . 1.37 108.156 163.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.03 150.14 24.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.731 0.812 . . . . 3.27 109.842 170.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.813 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.2 tt -158.68 140.04 13.27 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.248 1.019 . . . . 1.67 113.252 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.472 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.7 m-20 -101.99 107.08 18.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.513 2.325 . . . . 2.2 111.443 171.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.9 119.22 21.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.154 0.982 . . . . 1.11 110.397 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.4 mt -95.05 131.93 40.49 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.788 1.235 . . . . 0.59 111.768 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.23 139.47 53.7 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.226 1.195 . . . . 1.91 114.226 -177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.27 72.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.895 1.278 . . . . 2.36 114.203 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.49 33.43 1.83 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.588 1.09 . . . . 4.42 114.176 -174.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.25 49.21 67.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.721 1.153 . . . . 1.68 112.645 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 160.75 39.28 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.865 1.666 . . . . 4.15 112.053 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.22 145.55 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.523 1.929 . . . . 1.08 107.707 170.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.71 121.68 25.93 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.826 1.25 . . . . 1.68 110.717 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 3.0 tpmt? -72.07 131.19 42.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.039 0.536 . . . . 2.42 111.331 176.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.86 150.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.232 1.413 . . . . 1.58 109.832 166.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.82 152.15 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.958 1.703 . . . . 2.57 109.045 168.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.5 mt -148.69 144.77 18.74 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.254 1.422 . . . . 2.24 109.708 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.25 149.0 81.34 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.17 2.58 . . . . 1.19 112.214 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.28 128.08 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.829 1.252 . . . . 1.12 109.24 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -118.23 135.08 54.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.726 1.61 . . . . 3.32 107.501 166.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.9 125.07 30.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.695 0.68 . . . . 2.06 110.283 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.037 1.335 . . . . 7.49 111.795 -175.487 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' HA2' ' CE2' ' A' ' 7' ' ' TRP . . . . . . . . 0 N--CA 1.467 0.754 0 N-CA-C 110.314 -1.115 . . . . 15.61 110.314 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 m -147.61 -140.12 0.1 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.2 1.0 . . . . 12.2 112.012 -164.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.2 p90 177.95 159.58 0.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 129.888 3.275 . . . . 10.76 108.442 -172.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m 90.87 -44.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 128.841 2.856 . . . . 7.02 110.612 -176.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.62 163.77 20.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.291 2.637 . . . . 6.44 105.835 156.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.57 -151.98 28.85 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.297 0.951 . . . . 1.59 112.586 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.465 ' CE2' ' HA2' ' A' ' 1' ' ' GLY . 9.2 p90 -166.22 138.54 3.86 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.771 1.228 . . . . 1.64 112.487 177.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.73 145.27 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.377 1.071 . . . . 1.46 108.356 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.437 ' HE ' ' HB3' ' A' ' 17' ' ' ALA . 5.3 tmm_? -117.03 85.95 2.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.106 0.962 . . . . 4.66 109.758 -166.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.76 149.46 48.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.878 1.671 . . . . 2.78 112.222 -174.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -152.43 153.44 30.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 127.32 2.248 . . . . 2.08 107.743 174.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.27 -12.67 35.68 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.227 2.618 . . . . 2.22 112.865 170.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.78 -167.84 13.96 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.395 0.998 . . . . 1.67 114.162 170.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.34 -2.23 19.84 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 CA-C-N 118.195 0.998 . . . . 1.78 113.309 -3.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -134.63 163.26 30.14 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.248 1.819 . . . . 2.41 112.482 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.43 179.51 9.06 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.757 2.023 . . . . 0.74 111.288 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB3' ' HE ' ' A' ' 9' ' ' ARG . . . -134.67 166.08 23.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.668 0.787 . . . . 1.07 112.864 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -139.88 135.35 32.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.309 0.644 . . . . 0.78 111.806 170.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.45 147.87 42.32 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.329 1.452 . . . . 2.49 108.252 172.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.06 148.6 20.58 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.418 0.687 . . . . 2.0 111.593 -170.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -91.17 116.07 28.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.722 0.772 . . . . 1.78 109.452 166.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 125.44 35.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.204 -1.406 . . . . 2.79 107.204 164.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -122.59 146.45 47.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.128 0.966 . . . . 3.64 111.328 165.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -114.87 90.88 24.11 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-N 114.725 -1.125 . . . . 0.98 109.22 171.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -75.04 -9.59 20.78 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.539 2.159 . . . . 0.95 112.98 176.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 -167.18 42.34 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.84 1.209 . . . . 1.14 113.394 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -121.57 5.51 10.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.376 1.47 . . . . 2.73 112.855 -166.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.93 163.06 41.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.61 1.964 . . . . 1.44 109.915 173.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.82 148.09 15.5 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.406 2.071 . . . . 0.66 112.272 -171.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -111.44 108.36 17.89 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.344 1.458 . . . . 2.09 109.703 -177.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -102.18 102.49 12.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.536 1.534 . . . . 4.63 112.355 -178.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -93.51 124.57 37.59 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.636 1.974 . . . . 0.94 108.394 -173.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.92 -11.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.662 1.185 . . . . 0.73 112.723 -172.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.46 -162.57 29.96 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 123.789 0.709 . . . . 0.61 112.463 178.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.564 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -152.87 -179.27 7.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.421 1.089 . . . . 0.82 110.697 174.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -156.1 145.17 20.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.136 -1.431 . . . . 5.17 107.136 173.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.59 149.17 23.47 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 118.95 0.795 . . . . 0.68 109.928 -176.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.08 -10.74 29.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.948 2.432 . . . . 0.85 113.305 173.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 3.0 m -92.51 7.36 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 114.324 1.231 . . . . 1.1 114.324 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.39 165.83 28.17 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.071 -1.018 . . . . 0.83 112.801 -179.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -111.29 -62.49 1.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.966 -0.753 . . . . 3.66 108.966 170.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.8 ttt85 -86.12 138.76 31.68 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.286 -0.884 . . . . 3.59 109.862 168.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.12 138.75 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.432 2.293 . . . . 1.48 109.19 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -143.11 136.54 28.37 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.952 1.701 . . . . 2.86 110.157 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.445 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 6.4 tt -84.11 119.27 24.78 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.325 0.966 . . . . 0.73 110.686 167.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.3 m170 -110.42 167.0 10.54 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.547 1.939 . . . . 0.84 112.111 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 6.0 pt-20 -136.74 -173.18 3.36 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.848 1.659 . . . . 3.42 112.172 175.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.8 m -136.79 124.11 21.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.273 -1.01 . . . . 1.54 108.273 167.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -114.02 176.96 4.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 2.25 111.09 179.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.6 mtm -131.93 139.25 48.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.322 1.049 . . . . 2.87 110.457 163.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.0 mtp85 -143.16 156.62 44.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.096 1.358 . . . . 5.45 111.961 173.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 mp0 -67.25 151.63 47.17 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.025 1.73 . . . . 4.69 110.948 159.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.29 -41.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 114.38 -1.282 . . . . 2.94 114.238 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -117.68 32.4 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.769 2.028 . . . . 3.94 110.541 167.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.4 -35.68 1.34 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.845 -1.159 . . . . 2.6 112.785 -166.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.7 mttp -70.58 144.5 51.2 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.274 -1.133 . . . . 2.95 109.095 166.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -99.48 140.72 33.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.439 0.903 . . . . 4.02 113.439 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.21 150.57 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.497 1.919 . . . . 2.31 108.819 -171.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.3 mtm -80.26 149.81 30.25 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.147 1.379 . . . . 3.23 111.517 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.16 160.67 30.63 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.961 -0.462 . . . . 1.28 113.184 173.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -115.64 152.58 32.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.786 1.234 . . . . 2.03 111.385 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -164.87 156.99 13.76 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.955 1.302 . . . . 6.77 111.646 177.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 43.4 Cg_endo -66.01 145.17 78.77 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.79 2.327 . . . . 0.95 110.73 161.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 156.39 53.83 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.838 1.655 . . . . 1.02 109.758 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.99 -11.01 25.24 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.062 2.508 . . . . 1.11 114.338 -179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -175.91 168.9 2.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.515 1.526 . . . . 2.39 110.638 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.77 168.78 13.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.091 1.757 . . . . 0.85 108.58 154.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -155.44 164.04 39.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.058 -1.026 . . . . 2.27 111.978 163.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.79 129.08 16.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 124.034 0.934 . . . . 0.83 110.03 -172.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.22 162.88 40.66 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.435 2.09 . . . . 0.75 111.082 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.6 141.48 91.43 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.111 2.541 . . . . 0.93 112.083 177.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt 70.23 -1.33 2.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.77 2.428 . . . . 1.19 113.728 -172.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.34 121.49 5.54 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 127.248 2.356 . . . . 0.82 111.644 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -99.23 135.76 40.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.43 1.492 . . . . 5.94 110.48 161.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.34 148.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.6 1.56 . . . . 1.26 110.285 174.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -131.4 120.93 23.75 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.647 -0.501 . . . . 5.48 109.647 -166.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -83.6 68.65 9.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.448 1.594 . . . . 1.34 112.565 -161.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -64.54 142.31 98.42 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 127.52 2.328 . . . . 4.1 114.519 173.24 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 -30.77 47.47 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.955 3.104 . . . . 1.46 113.397 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.73 74.21 2.43 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 108.424 -1.87 . . . . 1.45 108.424 163.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.78 -152.77 21.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.954 1.74 . . . . 2.49 111.514 -167.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 6.0 m-85 -72.47 135.91 45.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.226 1.41 . . . . 2.63 111.839 -174.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -168.09 178.88 4.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.613 1.165 . . . . 1.14 109.457 -174.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.445 ' CZ ' HD12 ' A' ' 45' ' ' LEU . 57.7 m-85 -114.2 139.83 49.05 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.336 0.516 . . . . 2.52 111.823 173.244 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.7 mmt -101.72 131.1 48.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.902 1.681 . . . . 1.07 110.101 168.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.94 138.94 53.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.631 1.573 . . . . 3.12 110.684 -177.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -139.96 157.67 45.3 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.902 1.681 . . . . 2.39 112.036 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.39 -47.86 3.93 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 124.854 1.216 . . . . 2.58 112.799 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt 57.92 88.76 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.923 2.489 . . . . 0.94 112.97 169.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.43 0.49 12.15 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.168 1.544 . . . . 2.23 115.168 -169.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.3 mtp-105 -149.04 151.36 34.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.347 2.259 . . . . 4.96 108.837 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -88.72 -10.27 4.42 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.71 3.607 . . . . 3.37 117.86 -176.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.0 mt 80.09 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 127.904 2.481 . . . . 3.59 114.357 156.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.22 -175.66 4.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 130.781 3.633 . . . . 4.73 109.43 176.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.1 149.84 32.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.247 -1.39 . . . . 2.54 107.247 139.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.96 15.44 77.39 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 118.849 0.749 . . . . 2.71 112.819 -164.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -115.57 140.68 48.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.095 -1.446 . . . . 3.63 107.095 144.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.42 134.75 53.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.16 -1.836 . . . . 4.93 109.457 -160.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.6 t -106.42 104.74 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.299 -0.409 . . . . 1.24 111.462 -150.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.14 128.4 35.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.456 -1.247 . . . . 3.39 110.097 160.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.564 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.3 tt -138.49 137.88 37.55 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.628 1.571 . . . . 2.03 108.755 -177.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -91.31 106.63 18.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.33 2.252 . . . . 2.56 111.12 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.73 106.58 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.445 1.098 . . . . 1.75 110.863 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.39 118.11 22.94 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.76 -0.459 . . . . 0.88 109.76 -174.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.28 147.78 38.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.011 0.924 . . . . 1.93 111.726 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.61 130.5 28.26 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.22 1.008 . . . . 1.79 112.329 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.64 -151.98 20.85 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.277 0.941 . . . . 3.79 110.756 -163.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.92 23.21 35.37 Favored Glycine 0 N--CA 1.475 1.28 0 C-N-CA 124.828 1.204 . . . . 2.59 114.104 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.55 125.36 35.18 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.042 -1.269 . . . . 5.39 111.428 -177.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.96 124.79 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.322 1.049 . . . . 1.81 110.928 171.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.31 122.12 41.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.542 1.537 . . . . 3.42 109.811 -174.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -85.76 124.09 31.88 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.903 -0.498 . . . . 2.69 111.566 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.71 148.22 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.16 1.384 . . . . 1.9 111.242 178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.9 p -109.97 131.4 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.881 1.272 . . . . 1.69 111.333 -177.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mp -128.66 151.96 77.88 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 125.289 1.436 . . . . 2.08 112.71 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.51 145.79 26.81 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.645 3.563 . . . . 1.86 112.147 177.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.8 t -100.18 139.56 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.537 1.135 . . . . 1.7 112.057 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -131.11 148.78 52.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.527 2.731 . . . . 3.54 108.487 173.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.73 48.28 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.062 -1.024 . . . . 2.24 110.711 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 N-CA-C 115.084 1.513 . . . . 5.98 115.084 -175.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.03 0 N-CA-C 109.785 -1.326 . . . . 12.41 109.785 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -52.97 -31.31 39.95 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 118.455 1.127 . . . . 12.36 113.171 171.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -112.24 142.26 44.94 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.707 -1.59 . . . . 12.31 106.707 153.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.8 p -94.0 115.39 27.72 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.374 0.67 . . . . 8.0 109.209 -178.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.77 104.41 17.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.141 2.176 . . . . 6.52 110.105 -165.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.7 -169.97 42.77 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 114.967 0.747 . . . . 1.25 114.967 -178.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -164.99 160.7 19.33 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 1.59 112.949 -175.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.53 132.72 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.766 -0.584 . . . . 1.27 110.605 177.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.3 ttp85 -96.61 97.89 9.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.85 1.26 . . . . 4.19 110.056 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.79 152.51 44.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.973 1.709 . . . . 2.04 111.625 -175.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.4 m -155.14 149.8 20.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 119.77 -1.832 . . . . 1.86 111.209 168.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.32 25.52 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.622 3.548 . . . . 1.66 114.19 -175.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.86 165.31 29.15 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.47 -0.769 . . . . 1.32 113.952 -175.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.87 -3.77 31.52 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 CA-C-N 118.097 0.949 . . . . 1.53 113.629 -2.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -154.69 -179.53 8.09 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.591 1.556 . . . . 1.87 111.644 -175.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.67 -175.06 4.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.891 1.677 . . . . 0.62 111.924 -179.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.11 149.47 45.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.782 0.833 . . . . 0.93 112.654 -175.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.31 51.77 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.203 1.401 . . . . 0.75 112.159 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.57 157.95 43.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.108 1.363 . . . . 2.3 111.906 -177.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.6 159.66 12.24 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.73 1.212 . . . . 1.64 111.92 177.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.3 m -79.99 146.39 32.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.617 1.567 . . . . 1.66 108.455 154.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -143.43 136.92 28.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.483 0.713 . . . . 2.62 109.609 169.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -116.21 143.04 46.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.053 0.941 . . . . 2.93 112.71 167.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -87.98 111.98 46.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.46 1.104 . . . . 1.12 108.624 161.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -85.48 -12.12 6.75 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.156 2.571 . . . . 1.16 113.456 174.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.24 161.92 39.79 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 124.519 1.057 . . . . 1.28 112.482 -177.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.09 4.06 53.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.217 1.807 . . . . 3.31 113.327 -174.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.31 161.36 35.5 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 126.397 1.879 . . . . 1.32 110.02 168.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.85 154.4 26.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.853 2.369 . . . . 0.68 111.574 -171.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.58 127.6 52.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.33 1.452 . . . . 2.15 110.169 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 ttp-105 -118.0 114.11 22.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.66 1.184 . . . . 3.8 111.787 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.9 tp -100.51 109.9 22.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.369 2.668 . . . . 1.06 109.806 -171.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.41 -13.76 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.413 1.085 . . . . 0.68 113.84 -165.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.39 -160.56 31.91 Favored Glycine 0 N--CA 1.468 0.833 0 C-N-CA 124.0 0.81 . . . . 0.43 112.41 -176.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.71 -174.08 4.83 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 117.73 0.765 . . . . 0.95 112.998 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 102' ' ' ASP . 2.1 mmp_? -149.77 138.17 20.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.813 2.445 . . . . 6.09 107.541 176.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -150.02 153.89 36.18 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 119.855 1.207 . . . . 0.88 110.686 -170.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.45 -32.33 12.51 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.252 1.968 . . . . 1.21 111.716 165.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.402 1.3 m -93.1 6.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 115.503 1.668 . . . . 1.22 115.503 -169.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.75 174.26 13.24 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.052 1.341 . . . . 1.17 109.744 167.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -118.01 -74.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.778 0.717 . . . . 4.31 109.618 175.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttm105 -66.25 133.98 51.72 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.735 -1.209 . . . . 4.69 107.735 163.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.26 129.62 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.823 1.249 . . . . 1.54 108.406 -178.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -134.44 127.76 32.14 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.084 0.954 . . . . 2.39 109.452 -160.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.81 117.6 20.07 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.496 1.141 . . . . 0.81 109.909 171.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.6 m170 -107.1 154.02 21.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.671 1.588 . . . . 0.8 111.326 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.74 179.46 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.261 -1.336 . . . . 1.94 110.449 167.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.7 m -149.97 94.46 2.16 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.284 1.433 . . . . 1.16 107.725 174.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -90.71 165.53 13.64 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.169 1.788 . . . . 2.15 112.857 -169.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 74.7 mtm -98.52 152.45 19.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.349 -0.841 . . . . 2.52 109.891 158.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -151.67 132.0 13.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.216 1.806 . . . . 6.07 108.895 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.75 144.14 31.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.519 0.728 . . . . 4.39 110.899 173.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.2 122.83 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.154 1.382 . . . . 3.4 107.542 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.6 tm-20 58.76 29.69 19.02 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.325 1.059 . . . . 5.56 110.994 -174.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.49 -6.57 16.03 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 120.089 -1.632 . . . . 2.17 114.47 -173.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 34.7 mmtm -85.06 138.92 32.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.455 1.502 . . . . 4.09 109.115 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -85.79 142.97 28.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.278 0.49 . . . . 4.13 112.24 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.92 159.61 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.98 0.912 . . . . 2.7 110.433 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.7 mtp -102.93 166.08 10.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.04 0.936 . . . . 4.62 111.688 169.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.48 174.74 34.94 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 123.829 0.728 . . . . 1.18 112.006 167.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -133.37 159.94 38.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.803 1.241 . . . . 1.89 110.025 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.81 151.18 0.98 Allowed Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.928 1.691 . . . . 3.46 110.431 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.7 Cg_endo -68.9 149.74 72.62 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.613 1.542 . . . . 1.0 111.103 166.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.28 157.84 39.95 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 0.58 109.859 172.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -66.78 -20.15 52.53 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.229 1.953 . . . . 0.74 112.522 174.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -179.56 161.28 1.02 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 126.731 2.012 . . . . 2.3 110.877 178.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mt -103.99 168.83 8.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.082 0.953 . . . . 0.81 109.705 150.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.47 164.58 36.45 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.843 -0.536 . . . . 2.42 111.419 167.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.7 t -140.51 129.49 13.06 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 125.555 1.542 . . . . 0.77 108.664 -164.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.79 161.83 44.7 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.977 1.784 . . . . 0.91 111.161 177.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.2 140.71 96.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.182 2.588 . . . . 0.93 111.74 177.09 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 67.95 -3.27 1.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.857 2.063 . . . . 1.37 113.368 -177.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.07 119.85 4.97 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 127.277 2.37 . . . . 1.17 111.891 -172.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -81.76 136.95 35.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.642 1.177 . . . . 4.85 110.459 156.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.4 m -150.99 145.48 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.102 1.761 . . . . 1.68 109.807 173.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -103.35 139.28 38.97 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.477 0.917 . . . . 3.57 113.477 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.38 54.95 0.95 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.128 1.442 . . . . 1.29 109.72 156.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -54.2 114.99 7.42 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.546 -1.216 . . . . 4.82 109.966 162.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.58 -28.18 85.05 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.211 2.607 . . . . 1.35 114.824 -170.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.19 36.24 0.94 Allowed Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.342 0.973 . . . . 1.87 113.367 166.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.06 -48.19 0.04 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.93 2.205 . . . . 1.37 113.65 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -154.08 145.12 22.75 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.072 1.749 . . . . 1.9 110.39 -174.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -165.66 171.81 12.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.969 1.308 . . . . 0.77 110.52 -178.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -103.35 135.08 45.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.108 0.563 . . . . 1.95 110.667 165.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.1 mmt -92.74 134.74 34.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.532 1.133 . . . . 0.86 110.467 165.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.2 mt -109.78 114.98 29.0 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.802 1.641 . . . . 2.23 110.186 -176.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.77 155.48 31.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.223 1.409 . . . . 3.55 111.039 -174.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.55 -39.69 3.1 Favored Glycine 0 N--CA 1.48 1.572 0 O-C-N 120.628 -1.295 . . . . 2.29 113.55 165.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 49.78 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 124.434 2.064 . . . . 1.39 115.822 162.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -79.72 4.63 15.67 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.245 -1.798 . . . . 2.85 114.187 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -155.42 158.97 32.05 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 128.837 2.855 . . . . 4.86 107.32 -175.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.08 -13.77 21.14 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.518 . . . . 4.37 117.552 -173.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mp 60.82 -4.77 0.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 130.069 3.348 . . . . 4.28 113.716 -169.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -42.64 149.65 0.17 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.7 2.8 . . . . 3.36 115.124 -171.007 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.7 126.34 21.58 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.955 1.302 . . . . 1.88 112.125 178.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.74 30.1 45.19 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.778 -0.457 . . . . 3.53 112.931 -165.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 -176.7 3.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 105.992 -1.855 . . . . 4.28 105.992 139.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.23 155.11 50.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.634 -1.247 . . . . 4.72 107.634 165.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.5 93.18 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 122.428 1.109 . . . . 1.27 110.538 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.05 123.1 16.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 112.856 -1.974 . . . . 3.82 108.857 153.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.1 114.28 16.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.656 0.741 . . . . 1.76 109.062 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 9.7 m-20 -89.99 89.33 7.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.291 1.836 . . . . 2.45 108.307 176.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.9 120.46 13.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.923 1.689 . . . . 1.31 109.567 -178.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.3 mt -86.1 139.04 31.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.084 1.353 . . . . 0.57 110.391 -175.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -117.04 165.02 13.85 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.845 -0.534 . . . . 2.16 112.421 177.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.96 70.84 1.53 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.504 1.122 . . . . 1.94 112.681 -176.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 137.07 -154.11 22.13 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.95 1.738 . . . . 3.12 111.638 -178.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.67 46.84 2.65 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.372 0.987 . . . . 1.92 114.894 -173.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -136.03 143.43 44.73 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.53 1.932 . . . . 4.43 110.673 173.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -152.07 143.85 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 127.506 2.323 . . . . 1.12 107.108 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.4 mt -133.71 118.3 17.96 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.85 0.86 . . . . 1.78 111.538 -171.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -74.67 117.88 16.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.843 0.457 . . . . 2.45 111.612 173.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.46 165.28 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.767 1.227 . . . . 2.05 110.42 160.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.21 136.15 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.457 1.103 . . . . 2.63 109.195 171.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.9 mt -146.9 109.35 4.04 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.509 1.123 . . . . 2.02 110.693 -167.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.77 156.56 65.05 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.13 2.553 . . . . 1.21 113.165 -174.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -80.36 133.87 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 122.084 0.945 . . . . 1.3 112.018 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -121.5 151.65 40.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 130.44 3.496 . . . . 3.78 106.711 165.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.55 16.41 7.59 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.377 1.621 . . . . 2.78 115.377 -154.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 113.717 1.006 . . . . 7.31 113.717 -160.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 0 N-CA-C 109.287 -1.525 . . . . 12.27 109.287 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m -83.12 160.04 21.96 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.032 0.916 . . . . 11.17 112.253 172.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 76.61 155.94 0.17 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.365 2.266 . . . . 12.72 113.631 170.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p 177.23 -44.95 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.125 2.57 . . . . 6.55 109.116 -158.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -124.77 -165.44 1.39 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.54 1.536 . . . . 6.08 111.911 -166.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.99 167.52 28.3 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.699 1.619 . . . . 1.32 113.981 176.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -151.49 128.04 10.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.739 1.216 . . . . 2.04 111.593 -170.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -100.03 112.21 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.344 -0.847 . . . . 1.27 109.952 -170.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 1.8 tmt_? -84.03 89.71 7.31 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.333 1.453 . . . . 3.41 111.649 -161.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.3 147.53 40.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.78 2.032 . . . . 2.28 111.768 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.0 m -159.05 156.76 27.1 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 127.524 2.33 . . . . 2.75 109.273 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.01 12.61 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.852 3.035 . . . . 2.51 114.457 -172.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.44 171.82 36.46 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 119.026 0.83 . . . . 2.43 112.455 -167.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.65 -3.69 11.03 Favored 'Cis proline' 0 C--N 1.351 0.7 0 CA-C-N 119.143 1.472 . . . . 3.23 113.352 -4.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -146.67 175.12 10.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.73 1.612 . . . . 2.51 110.625 175.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.16 -177.37 5.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.665 2.386 . . . . 0.69 108.869 175.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.7 175.29 9.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.446 1.021 . . . . 1.04 113.401 -173.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.51 152.74 29.24 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.425 0.898 . . . . 0.69 113.425 169.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.18 162.42 38.07 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.599 1.56 . . . . 2.11 110.582 174.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -174.12 150.2 1.53 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.977 1.711 . . . . 1.95 113.646 -173.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.7 m -68.55 135.24 51.24 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.701 1.6 . . . . 1.81 109.12 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.21 133.78 37.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.359 -0.978 . . . . 2.94 108.359 173.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -149.56 138.09 20.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.082 0.944 . . . . 3.5 111.391 175.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -100.26 100.69 12.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.885 1.674 . . . . 1.22 108.961 -178.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.69 -8.89 17.11 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.109 1.873 . . . . 1.28 112.998 174.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.98 161.17 43.5 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.058 0.837 . . . . 1.09 113.092 -178.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.04 5.8 50.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.115 1.766 . . . . 3.07 113.422 -172.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -117.02 159.06 42.5 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.936 1.694 . . . . 1.73 109.949 165.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.39 159.21 25.97 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.274 2.65 . . . . 1.16 111.796 -170.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.8 mt -110.95 156.32 21.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.396 1.093 . . . . 1.84 111.384 170.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -144.12 106.62 4.41 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.511 1.524 . . . . 3.6 109.432 175.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.3 tp -91.66 122.37 34.17 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.312 2.245 . . . . 0.93 108.576 -177.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.23 -16.1 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 113.898 1.074 . . . . 0.65 113.898 -174.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.22 -160.83 30.68 Favored Glycine 0 C--N 1.341 0.853 0 O-C-N 121.47 -0.769 . . . . 0.47 112.27 177.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.7 178.6 8.95 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.58 0.752 . . . . 0.65 111.081 168.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -147.03 141.22 26.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.35 1.06 . . . . 6.9 110.39 177.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 t -149.19 157.23 39.85 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.296 1.438 . . . . 0.92 111.369 -167.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.1 -25.14 8.99 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.343 2.029 . . . . 1.3 113.355 165.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.29 3.6 m -87.5 12.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 114.484 1.29 . . . . 1.22 114.484 -173.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.12 145.99 30.72 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.521 1.128 . . . . 0.97 110.741 173.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -79.05 -74.71 0.27 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.707 -1.59 . . . . 5.8 106.707 170.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -80.17 142.19 34.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.305 1.842 . . . . 2.93 109.692 169.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.22 131.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.66 1.584 . . . . 1.47 108.811 177.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -146.65 133.82 20.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.445 1.498 . . . . 1.95 109.96 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.65 123.81 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.296 1.046 . . . . 0.91 111.003 171.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 14.9 m170 -117.29 152.02 35.76 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.847 2.059 . . . . 0.72 113.492 -178.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.49 160.18 15.56 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.003 1.321 . . . . 2.13 110.493 165.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.2 m -110.53 144.14 39.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.172 1.789 . . . . 1.46 107.7 163.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -152.19 162.42 41.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 114.679 1.363 . . . . 2.39 114.679 -169.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.2 ptp -121.08 144.6 48.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.233 1.413 . . . . 3.81 110.332 159.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -147.76 142.31 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.113 1.365 . . . . 8.31 110.402 171.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.18 149.07 46.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.611 1.564 . . . . 4.13 111.718 175.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.2 p -146.63 -11.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.458 1.281 . . . . 3.24 114.458 173.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.21 30.56 0.49 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.175 1.79 . . . . 4.1 110.875 178.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.35 -14.97 3.72 Favored Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.494 -1.379 . . . . 1.98 113.659 -167.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 167.76 9.57 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.185 2.194 . . . . 2.62 110.019 158.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.56 148.68 34.0 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.997 1.851 . . . . 3.67 115.997 -170.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -96.82 141.94 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.402 1.881 . . . . 3.16 109.086 165.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 36.1 tpp -93.25 137.59 32.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.589 1.555 . . . . 2.81 109.836 171.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.43 -177.77 29.01 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.801 0.715 . . . . 1.64 114.584 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.4 mtt -141.48 156.64 45.74 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.159 1.784 . . . . 3.17 110.211 176.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -164.96 156.07 12.87 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.25 1.42 . . . . 4.37 110.84 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 33.0 Cg_endo -66.93 150.45 82.98 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.933 1.755 . . . . 0.81 112.284 169.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.96 158.69 41.75 Favored Pre-proline 0 N--CA 1.471 0.625 0 C-N-CA 126.599 1.96 . . . . 0.96 109.829 174.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.04 -29.5 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.142 1.895 . . . . 1.36 112.247 177.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 p90 175.92 160.88 0.3 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.499 1.52 . . . . 1.9 107.14 -175.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -112.13 162.55 15.31 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 122.275 1.036 . . . . 2.62 111.033 155.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -145.27 157.66 44.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.071 -1.422 . . . . 2.52 114.174 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -145.88 133.74 10.5 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 114.553 -1.203 . . . . 1.07 108.481 -161.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.9 171.22 15.01 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.011 1.807 . . . . 1.33 111.334 176.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.86 144.06 99.51 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.075 2.517 . . . . 1.24 111.435 165.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 66.62 4.85 3.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.859 1.664 . . . . 1.58 113.173 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.46 126.23 8.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 128.232 2.825 . . . . 1.16 112.494 -170.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -98.78 141.82 31.1 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.642 1.577 . . . . 3.92 112.601 166.27 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.4 122.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.321 1.848 . . . . 1.42 108.744 168.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.443 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 18.0 mp0 -89.68 143.37 26.86 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.255 -0.903 . . . . 4.05 111.163 176.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.44 148.49 43.21 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.321 -0.862 . . . . 2.62 109.07 164.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' A' ' 76' ' ' GLU . 12.3 ptpt -166.86 138.72 2.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.947 1.299 . . . . 4.14 111.363 -165.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.91 -26.79 58.94 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.153 3.236 . . . . 1.45 114.294 -169.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.72 78.71 1.03 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.145 -1.582 . . . . 1.74 109.145 161.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.42 -76.5 0.21 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 124.247 0.927 . . . . 1.24 114.236 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -148.3 136.64 21.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.167 1.387 . . . . 2.26 111.623 -168.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -159.55 167.24 29.03 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.801 -0.562 . . . . 0.88 110.053 -172.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -96.88 133.73 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.392 -0.966 . . . . 2.34 108.392 165.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 mmt -82.92 137.57 34.17 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.182 -0.673 . . . . 0.89 109.182 157.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.94 127.81 55.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.967 2.107 . . . . 1.88 107.112 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -136.2 158.37 44.57 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.495 1.118 . . . . 1.88 111.412 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.58 -61.36 3.23 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.421 1.486 . . . . 3.14 112.551 178.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.5 mt 76.84 100.33 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 130.861 3.664 . . . . 1.23 110.837 173.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -75.52 -7.87 55.29 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.026 -1.046 . . . . 1.93 113.139 -169.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -150.4 153.8 35.05 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 128.488 2.715 . . . . 6.67 108.282 169.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -67.43 158.79 55.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.857 2.372 . . . . 2.42 110.386 166.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.19 157.29 26.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.383 1.473 . . . . 2.53 111.565 -171.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -139.28 134.43 32.6 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.344 1.057 . . . . 3.69 111.142 176.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 128.87 38.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.202 0.601 . . . . 1.66 111.906 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 123.13 -15.12 8.28 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.372 1.463 . . . . 2.21 116.038 173.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.85 -176.04 3.74 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.19 1.495 . . . . 4.64 111.243 -171.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -89.28 160.97 16.64 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.62 1.568 . . . . 4.75 112.362 171.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.37 127.59 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.054 1.742 . . . . 1.34 108.863 167.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.32 134.11 41.1 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.326 1.45 . . . . 2.69 110.259 164.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -150.67 127.37 10.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.498 1.142 . . . . 1.7 113.59 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.71 94.5 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.534 1.534 . . . . 2.6 110.446 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.27 115.94 11.01 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.379 1.472 . . . . 1.21 110.524 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.0 mt -88.09 129.92 35.16 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.685 1.194 . . . . 0.82 110.643 -172.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.66 144.9 50.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.056 0.931 . . . . 2.04 112.463 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.91 125.55 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.856 1.262 . . . . 1.96 113.473 -169.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.2 70.23 1.25 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.643 1.115 . . . . 3.34 112.549 177.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.49 15.76 81.27 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.557 1.383 . . . . 1.95 116.557 163.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -105.92 148.36 27.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.967 1.883 . . . . 4.89 110.972 171.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.11 140.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.84 1.656 . . . . 1.12 107.914 167.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -120.2 116.99 26.72 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.224 1.009 . . . . 1.43 109.385 178.009 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -75.73 128.81 35.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.83 0.452 . . . . 2.57 110.835 174.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -137.04 144.32 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.01 1.724 . . . . 1.73 109.612 175.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.55 130.98 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.927 1.291 . . . . 2.44 108.473 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 mp -140.26 153.56 69.02 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.667 1.587 . . . . 2.58 110.013 -172.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.89 155.86 43.49 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.597 2.865 . . . . 1.41 112.937 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.46 142.75 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.776 1.23 . . . . 1.41 110.491 168.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.5 151.46 39.34 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.652 1.981 . . . . 2.81 108.501 164.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.72 28.68 7.19 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.914 1.45 . . . . 1.96 114.914 -161.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.412 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 C-N-CA 124.86 1.264 . . . . 7.89 111.978 -165.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 109.755 -1.338 . . . . 14.89 109.755 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -165.29 171.1 13.95 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.801 1.641 . . . . 11.27 108.974 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.93 100.86 5.61 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.277 1.031 . . . . 11.77 109.598 178.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.4 p -145.49 168.23 21.08 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.931 1.292 . . . . 8.2 112.137 -163.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -114.71 -157.8 0.64 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.822 2.449 . . . . 5.61 110.528 -178.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.91 170.95 23.54 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.168 -1.582 . . . . 0.94 114.581 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.4 p90 -165.58 149.78 8.4 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.137 0.975 . . . . 1.38 111.291 -175.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.42 147.54 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.368 -0.975 . . . . 0.97 108.368 167.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -97.08 119.72 36.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.947 0.794 . . . . 5.2 110.043 164.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.12 134.62 38.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.864 0.84 . . . . 2.56 108.86 156.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.2 m -139.66 160.89 59.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 125.635 1.574 . . . . 2.62 109.336 177.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.24 -7.26 13.41 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.485 2.79 . . . . 2.31 115.038 178.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.91 -164.47 18.53 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-N 119.254 0.934 . . . . 2.35 113.549 175.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.33 -7.46 12.99 Favored 'Cis proline' 0 C--N 1.351 0.672 0 CA-C-N 118.69 1.245 . . . . 2.04 113.389 -4.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.06 136.92 34.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.345 1.458 . . . . 3.31 110.919 176.496 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.57 -177.94 3.27 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.097 1.759 . . . . 0.59 110.695 -177.17 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.63 136.66 34.56 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.243 0.929 . . . . 0.73 113.068 -169.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.49 141.42 52.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 0.86 112.294 -178.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -135.62 165.43 25.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.806 1.643 . . . . 2.43 110.658 -172.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -171.34 148.96 2.68 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 1.5 112.783 168.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.0 m -77.28 138.07 39.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.809 -1.182 . . . . 1.22 107.809 149.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -136.33 143.22 44.02 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.522 1.929 . . . . 2.46 107.967 -177.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.63 135.24 49.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.731 0.812 . . . . 3.5 111.003 -177.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -97.23 100.73 8.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.515 -0.92 . . . . 1.15 108.515 165.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.79 -10.79 15.5 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.637 2.225 . . . . 1.28 113.146 176.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.44 -173.08 49.49 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.729 1.157 . . . . 1.4 113.413 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.21 1.34 16.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.913 1.685 . . . . 3.0 112.802 -168.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -123.03 161.0 47.06 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.327 1.851 . . . . 1.58 110.392 174.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 148.63 17.29 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.509 2.14 . . . . 0.8 111.833 -171.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.07 111.68 22.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.053 1.341 . . . . 2.08 110.605 -176.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -98.79 101.91 13.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.871 1.268 . . . . 4.28 110.865 -179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 tp -88.07 114.56 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.676 1.99 . . . . 0.74 108.629 -175.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.77 -19.51 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.29 0.848 . . . . 0.62 113.29 -171.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.37 -163.55 30.43 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.267 0.937 . . . . 0.39 111.552 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.82 179.53 7.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 0.72 110.658 164.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -149.41 135.36 18.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.859 1.664 . . . . 6.63 108.068 -177.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -140.0 156.96 70.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.421 1.488 . . . . 0.79 109.997 -171.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.48 -25.19 9.87 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.276 1.984 . . . . 0.94 112.103 169.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.259 14.3 m -82.91 -11.52 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 114.469 1.285 . . . . 1.01 114.469 -173.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.11 155.71 47.65 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.526 0.935 . . . . 0.8 113.526 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.26 -91.83 0.11 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.945 1.298 . . . . 3.39 110.212 175.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -84.28 92.2 7.93 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.886 0.874 . . . . 3.1 108.826 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.6 p -87.15 139.26 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.288 1.035 . . . . 1.42 110.798 172.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -137.52 138.79 40.03 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.356 1.862 . . . . 1.93 110.751 -174.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -87.43 121.04 29.35 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.913 1.233 . . . . 0.75 111.747 169.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.8 m170 -108.61 155.91 20.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.266 1.826 . . . . 0.59 112.339 175.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.55 -179.76 4.04 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.909 1.683 . . . . 2.58 110.696 169.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -140.32 116.19 10.32 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 125.144 1.378 . . . . 1.11 107.442 172.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -117.47 -179.49 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.509 1.524 . . . . 1.81 110.854 -174.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 73.6 mtm -130.16 128.04 40.95 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.169 0.988 . . . . 3.36 110.868 164.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -97.61 168.17 10.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.744 1.218 . . . . 7.33 111.527 167.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -88.51 142.57 27.6 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.535 0.734 . . . . 5.97 109.397 153.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.04 -6.92 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.141 1.163 . . . . 3.74 114.141 175.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -175.84 31.66 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.804 2.042 . . . . 4.01 109.425 -165.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.66 -19.68 0.15 Allowed Glycine 0 N--CA 1.479 1.501 0 O-C-N 119.545 -1.972 . . . . 2.29 114.769 -158.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -74.2 132.36 42.11 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.115 1.766 . . . . 3.96 109.159 175.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -76.4 126.34 30.81 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.101 -1.074 . . . . 4.2 108.101 169.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -140.01 139.13 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.176 1.391 . . . . 2.51 108.79 -175.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.8 mtp -69.9 162.25 28.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.217 1.192 . . . . 5.1 114.217 -175.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.71 164.17 32.52 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.791 1.186 . . . . 0.97 111.597 167.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.13 157.88 30.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.994 1.317 . . . . 1.79 110.183 172.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -169.44 151.56 4.51 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 3.82 110.607 177.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.3 Cg_endo -69.02 153.23 72.65 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.758 1.639 . . . . 0.56 111.708 169.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.76 159.02 50.42 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 126.261 1.824 . . . . 0.72 110.53 174.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -72.46 -21.49 22.59 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.677 2.251 . . . . 0.78 112.58 172.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -175.75 169.96 2.92 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.739 1.616 . . . . 2.33 110.839 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -122.11 174.33 7.01 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.905 2.482 . . . . 0.77 108.78 160.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -152.88 165.54 35.11 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 121.257 -0.902 . . . . 2.66 113.217 164.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -135.04 128.29 18.54 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 125.45 1.5 . . . . 1.22 109.058 -176.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.85 162.2 43.45 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.474 2.116 . . . . 1.16 111.03 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.48 142.21 94.45 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.975 2.45 . . . . 1.23 111.649 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt 68.1 -1.05 1.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.685 1.994 . . . . 1.53 113.671 -174.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.09 117.86 4.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 126.556 2.027 . . . . 1.19 111.894 -177.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -91.75 129.61 37.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.235 1.014 . . . . 6.17 110.035 157.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.07 171.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.861 1.664 . . . . 1.51 110.226 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -139.65 146.03 39.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.7 1.238 . . . . 4.65 114.117 176.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -85.34 71.64 10.8 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.939 1.696 . . . . 1.27 109.391 178.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -61.4 141.56 94.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 114.133 -1.394 . . . . 3.72 112.262 177.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.48 -18.04 51.58 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.653 2.236 . . . . 1.3 113.149 165.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.59 26.09 23.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.252 1.406 . . . . 1.26 114.107 172.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.52 -55.44 0.01 OUTLIER Glycine 0 N--CA 1.476 1.36 0 CA-C-N 119.414 1.607 . . . . 1.35 115.735 175.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -159.97 140.4 11.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.632 1.573 . . . . 1.95 109.413 -176.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -171.0 168.68 6.89 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.491 1.951 . . . . 1.3 111.173 -175.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.31 125.75 46.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.507 0.723 . . . . 1.73 111.46 -178.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mmt -91.99 142.57 27.4 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.449 1.099 . . . . 1.12 110.014 170.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 mt -119.89 85.79 2.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.618 1.567 . . . . 1.78 109.053 -171.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.68 107.71 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.242 1.017 . . . . 3.32 108.632 -176.179 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.03 130.37 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.118 0.866 . . . . 2.77 111.801 -172.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.475 HD13 HD11 ' A' ' 93' ' ' LEU . 64.3 mt -112.6 118.49 35.22 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.771 0.828 . . . . 0.88 108.999 178.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.2 9.79 19.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.069 0.766 . . . . 2.49 113.069 -166.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -172.55 159.2 3.93 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 128.016 2.527 . . . . 5.3 108.919 -171.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.24 160.61 48.96 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.374 1.383 . . . . 2.13 110.018 162.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.475 HD11 HD13 ' A' ' 89' ' ' LEU . 3.6 mp -115.48 -164.72 0.97 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.453 1.901 . . . . 3.19 108.728 -171.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.15 136.95 13.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.399 1.48 . . . . 5.09 110.976 168.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.04 126.97 29.88 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.055 -1.091 . . . . 1.43 108.055 151.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.38 78.53 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.137 -1.924 . . . . 1.89 115.614 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -93.7 177.96 5.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.514 2.157 . . . . 3.56 110.051 153.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -103.58 149.13 25.18 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.589 0.756 . . . . 4.85 109.783 167.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.433 HG23 ' CG2' ' A' ' 117' ' ' VAL . 8.4 t -105.52 123.13 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.651 1.18 . . . . 1.15 108.215 168.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.64 124.06 21.81 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 113.949 -1.478 . . . . 4.71 107.5 162.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -130.17 109.42 10.8 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.932 0.873 . . . . 1.82 111.074 174.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.79 86.11 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.702 2.401 . . . . 2.63 109.673 173.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.18 117.22 8.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.829 1.252 . . . . 1.13 109.623 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.4 126.2 35.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.853 1.261 . . . . 0.81 110.735 -175.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.42 117.77 25.18 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.535 -0.728 . . . . 1.95 111.58 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.96 22.04 0.18 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.196 2.199 . . . . 2.69 115.985 171.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.9 -41.72 1.07 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.786 1.66 . . . . 3.94 113.847 -171.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.06 -1.82 90.15 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.987 -1.452 . . . . 1.73 116.071 -174.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.45 159.32 42.46 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.712 2.005 . . . . 4.03 111.727 168.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.14 145.99 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 126.42 1.888 . . . . 1.03 108.179 168.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -134.76 108.42 7.96 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.265 1.026 . . . . 1.63 109.858 -177.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -79.87 96.83 6.46 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.604 0.361 . . . . 2.94 110.817 176.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.86 151.39 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.631 0.772 . . . . 1.46 110.837 176.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.23 131.54 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.813 1.645 . . . . 1.93 108.734 168.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.7 mt -139.93 130.63 14.19 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.8 1.24 . . . . 1.78 109.499 176.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.93 151.6 56.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.489 2.793 . . . . 1.1 111.692 176.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 99' ' ' VAL . 53.3 t -97.84 117.14 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.924 0.89 . . . . 1.23 111.787 178.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -75.57 155.36 36.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.553 2.741 . . . . 3.98 109.072 159.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.3 131.19 45.3 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.833 -1.167 . . . . 1.84 112.631 171.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.0 mtt180 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 127.577 2.351 . . . . 7.21 108.153 169.699 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.45 0 N-CA-C 108.908 -1.677 . . . . 13.32 108.908 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -71.23 -23.27 61.97 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.469 1.655 . . . . 14.04 115.469 -173.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -171.73 162.49 6.28 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.556 1.942 . . . . 14.02 109.839 -175.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.5 p -136.16 -29.95 0.97 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.9 1.28 . . . . 7.75 114.068 -176.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -113.05 -133.62 0.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.289 2.236 . . . . 5.46 109.697 -173.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 170.97 24.26 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 120.877 1.671 . . . . 0.95 114.232 177.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -155.31 164.98 38.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 122.285 1.041 . . . . 1.88 113.681 174.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.58 119.13 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.169 -0.923 . . . . 1.26 108.549 174.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.531 ' HE ' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -80.83 113.46 19.04 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.435 0.636 . . . . 4.07 110.383 175.095 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.5 134.64 53.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.021 0.915 . . . . 2.9 108.98 162.319 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.03 164.62 20.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.691 1.996 . . . . 2.93 107.298 170.312 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.62 -10.65 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.755 2.304 . . . . 1.63 114.283 -174.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.17 -159.74 27.78 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.95 0.786 . . . . 1.49 111.743 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.37 -6.57 12.46 Favored 'Cis proline' 0 CA--C 1.538 0.704 0 CA-C-N 119.141 1.471 . . . . 1.71 113.7 3.076 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -136.9 158.83 43.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.821 1.248 . . . . 2.21 112.021 170.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.78 -162.57 1.11 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.004 2.122 . . . . 1.06 111.226 -176.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB3' ' HE ' ' A' ' 9' ' ' ARG . . . -156.23 163.07 40.01 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.537 1.31 . . . . 0.73 114.537 -170.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.27 150.37 36.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.688 1.595 . . . . 0.62 112.256 172.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.38 134.36 20.28 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.271 1.828 . . . . 2.34 108.778 -172.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.56 137.81 8.11 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 115.055 1.502 . . . . 2.05 115.055 -160.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -66.97 136.08 54.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.609 -0.723 . . . . 1.75 110.637 167.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.31 153.59 40.04 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.971 2.108 . . . . 2.68 109.926 163.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.64 149.49 48.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.772 0.796 . . . . 3.41 110.582 164.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -106.2 95.24 10.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.141 -0.936 . . . . 1.25 110.004 172.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.15 -5.09 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.875 2.384 . . . . 1.79 113.0 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.84 162.19 52.77 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 124.972 1.273 . . . . 1.5 113.39 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -74.56 -32.03 62.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.265 2.226 . . . . 5.82 112.788 174.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.28 164.09 17.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.358 1.863 . . . . 1.73 112.102 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.55 152.54 17.63 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.864 2.376 . . . . 0.71 111.497 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.28 115.98 30.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.852 1.261 . . . . 2.32 110.226 -176.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.447 ' HB2' HH11 ' A' ' 31' ' ' ARG . 0.1 OUTLIER -99.58 107.27 19.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.528 1.131 . . . . 4.24 110.538 177.065 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -95.55 119.24 33.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.093 1.357 . . . . 0.87 109.318 -174.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.21 -12.93 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.476 1.11 . . . . 0.67 113.927 -171.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.5 -162.73 30.19 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.426 1.012 . . . . 0.57 111.971 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB1' ' CD1' ' A' ' 101' ' ' LEU . . . -156.09 -167.96 2.61 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.785 0.834 . . . . 0.73 111.442 165.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -159.13 161.04 36.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.252 0.933 . . . . 5.69 108.824 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.24 156.96 30.93 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 125.842 1.657 . . . . 0.74 111.088 -178.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.5 -17.97 15.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.612 2.875 . . . . 1.09 114.462 170.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 m -98.35 -18.17 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 115.013 1.486 . . . . 1.27 115.013 -174.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.432 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -108.55 152.8 24.26 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.75 1.159 . . . . 0.76 112.073 176.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.95 -90.9 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.747 0.819 . . . . 3.55 109.497 173.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -79.53 141.81 36.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.114 -1.069 . . . . 3.63 108.114 170.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.08 131.09 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.715 1.206 . . . . 1.55 110.462 173.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -145.04 132.21 20.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.277 1.031 . . . . 2.17 111.847 -163.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tt -79.13 124.22 28.11 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 121.474 0.654 . . . . 0.76 111.034 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.5 m170 -112.62 157.07 21.66 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.196 1.798 . . . . 0.81 112.147 172.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.44 -170.85 1.84 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.548 1.139 . . . . 2.71 112.319 165.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.6 m -147.42 88.09 1.69 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.32 1.848 . . . . 1.12 107.447 170.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -78.46 157.24 29.0 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 2.24 112.009 -177.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.9 mtm -107.69 130.72 54.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.401 1.08 . . . . 2.83 110.012 166.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 -146.89 149.39 33.15 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.308 1.043 . . . . 5.03 111.542 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 145.54 55.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.544 0.738 . . . . 3.99 109.843 155.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.74 -90.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.727 1.611 . . . . 3.1 108.693 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -77.43 41.29 0.31 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.392 2.277 . . . . 3.55 111.613 175.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.97 -10.27 1.26 Allowed Glycine 0 CA--C 1.537 1.455 0 O-C-N 120.544 -1.348 . . . . 2.02 114.327 -166.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -102.45 155.79 18.03 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 128.625 2.77 . . . . 2.61 109.374 175.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -90.59 145.62 24.71 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.303 1.223 . . . . 3.42 114.303 178.003 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.9 t -141.27 148.16 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.306 1.843 . . . . 1.87 109.421 -178.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -89.87 123.45 33.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.577 1.551 . . . . 3.53 110.11 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.87 138.31 10.51 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 119.041 0.837 . . . . 1.3 113.678 178.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -90.04 156.62 18.27 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.828 0.851 . . . . 1.76 111.676 170.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -167.42 153.7 7.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 126.135 1.774 . . . . 4.38 110.088 168.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.1 Cg_endo -68.46 156.95 63.85 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.342 1.361 . . . . 0.58 110.698 170.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.99 156.14 78.63 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.237 1.415 . . . . 0.66 110.751 -178.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.87 -20.07 30.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.969 2.446 . . . . 0.72 113.112 178.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.6 166.91 3.86 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.444 1.098 . . . . 1.87 112.455 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -115.92 178.0 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.471 2.308 . . . . 0.67 109.296 153.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.12 159.63 44.36 Favored 'General case' 0 N--CA 1.462 0.137 0 O-C-N 121.122 -0.986 . . . . 2.08 111.57 164.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 t -132.41 126.53 20.29 Favored Pre-proline 0 N--CA 1.468 0.425 0 C-N-CA 126.021 1.728 . . . . 1.0 108.202 -178.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.64 162.39 42.3 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.509 2.14 . . . . 0.88 110.998 178.184 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.51 131.76 32.99 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.29 2.66 . . . . 1.02 110.622 177.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.9 1.52 3.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.869 2.467 . . . . 2.59 114.226 -170.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.84 118.81 9.24 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 125.811 1.672 . . . . 1.0 109.055 172.024 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -117.79 114.58 23.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.833 2.053 . . . . 4.46 109.171 172.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.7 m -149.96 154.02 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.459 1.103 . . . . 1.99 112.174 -165.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -102.96 134.49 46.31 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.302 0.572 . . . . 3.05 111.751 176.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.13 137.0 57.36 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.241 -1.392 . . . . 2.08 107.241 141.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -150.17 143.75 16.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.489 2.316 . . . . 3.26 109.938 -161.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.05 -43.68 28.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.807 3.005 . . . . 1.54 113.151 -167.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 118.34 5.86 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.371 -1.892 . . . . 2.11 108.371 157.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.6 -77.29 0.38 Allowed Glycine 0 N--CA 1.467 0.757 0 C-N-CA 124.683 1.135 . . . . 1.23 112.937 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -154.5 131.9 11.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.41 1.105 . . . . 2.02 110.448 -175.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -163.66 172.17 14.64 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.764 -1.21 . . . . 0.83 111.714 -167.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.13 122.08 45.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.162 0.585 . . . . 1.9 109.776 173.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 mmt -80.39 134.23 36.0 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.171 -0.678 . . . . 1.24 109.171 165.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.52 118.52 36.77 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.198 1.399 . . . . 2.1 107.711 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mt -121.78 104.71 9.78 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.373 1.469 . . . . 1.96 109.192 -171.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.06 141.39 1.05 Allowed Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.302 -0.719 . . . . 3.15 111.302 -159.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.9 mt -117.67 120.47 38.11 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.489 -0.93 . . . . 1.23 108.489 171.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.79 -4.38 54.41 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.946 1.091 . . . . 2.2 113.946 -170.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -150.41 159.21 35.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.134 2.173 . . . . 6.61 110.076 178.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -66.76 159.11 52.88 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.354 2.036 . . . . 2.24 109.226 153.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.54 160.4 31.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.689 1.596 . . . . 2.65 109.75 -162.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.69 129.53 10.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.412 1.101 . . . . 4.67 112.902 -158.22 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.31 121.19 13.72 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.479 -0.763 . . . . 2.05 110.213 174.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.43 7.69 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.423 -1.209 . . . . 2.29 114.804 -166.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.9 174.2 7.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.652 1.726 . . . . 3.62 108.958 144.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -89.7 148.28 23.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.045 0.938 . . . . 3.94 110.617 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.4 HG23 ' CG2' ' A' ' 117' ' ' VAL . 3.1 t -93.63 127.48 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.254 -1.017 . . . . 1.14 108.254 161.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.526 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 51.5 mt-10 -65.45 111.87 3.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.281 -0.872 . . . . 3.19 108.678 153.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.404 ' CD1' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -100.95 123.29 44.91 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.594 -1.262 . . . . 2.53 107.594 163.113 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -102.68 85.64 2.61 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.835 2.054 . . . . 2.28 109.145 177.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.28 121.47 16.31 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.444 1.898 . . . . 3.01 110.5 -175.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.5 mt -92.98 133.54 36.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.42 1.088 . . . . 0.98 111.279 -176.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.77 153.31 38.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.159 0.984 . . . . 1.85 111.454 178.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.9 132.35 53.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.346 0.658 . . . . 1.78 111.303 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.83 -142.92 16.27 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.662 -0.975 . . . . 3.8 110.662 -167.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -100.62 12.25 59.6 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.676 1.131 . . . . 2.57 115.359 -176.02 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -87.36 137.36 32.41 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.589 1.694 . . . . 5.79 113.306 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.38 138.52 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.749 1.62 . . . . 1.38 109.787 165.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.07 113.4 25.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.472 1.509 . . . . 2.41 109.898 177.416 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.526 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 23.0 ttmm -78.69 116.91 19.37 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.126 -0.694 . . . . 2.65 109.126 168.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.83 149.46 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.408 1.083 . . . . 1.76 109.89 173.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.5 m -95.8 138.07 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.663 1.185 . . . . 2.84 109.62 170.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.3 mt -144.91 140.61 16.43 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.678 1.591 . . . . 1.88 109.807 178.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.04 144.37 63.53 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.079 3.186 . . . . 1.3 114.005 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 99' ' ' VAL . 60.4 t -88.16 126.22 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.45 1.1 . . . . 1.59 110.831 172.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -97.31 168.79 10.2 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.038 2.935 . . . . 3.17 109.222 169.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.57 30.89 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.622 1.556 . . . . 2.03 110.386 161.494 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.2 ttm-85 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.862 1.665 . . . . 7.16 113.075 -171.704 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.235 0 N-CA-C 105.166 -3.174 . . . . 15.25 105.166 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.3 m -157.28 146.38 19.99 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 118.963 -1.095 . . . . 12.91 111.823 -123.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -153.98 121.17 5.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.301 1.44 . . . . 9.86 110.042 -173.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.5 p -141.05 97.56 3.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.474 1.11 . . . . 6.63 110.55 -178.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -104.28 122.54 45.61 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 126.159 1.784 . . . . 5.85 110.692 -173.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.06 172.34 30.69 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.371 -0.83 . . . . 0.87 114.824 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -159.63 129.8 5.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 2.15 112.66 -173.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.01 103.09 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.79 -1.189 . . . . 1.0 107.79 175.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.5 ttp85 -85.46 114.37 22.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.576 0.703 . . . . 4.17 110.695 -174.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.24 163.21 18.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.138 1.775 . . . . 2.87 112.903 -167.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -168.89 142.31 2.36 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.17 1.788 . . . . 2.6 109.95 156.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.61 -8.38 18.17 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.069 3.179 . . . . 2.2 114.425 -169.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.94 161.93 10.62 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.929 0.776 . . . . 2.69 113.302 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -70.87 -1.44 8.12 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 118.612 1.206 . . . . 3.16 112.659 -11.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -153.51 173.09 16.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.808 1.243 . . . . 2.77 113.322 -179.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.02 171.57 14.24 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.139 2.576 . . . . 0.79 110.373 168.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.69 104.42 4.91 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.885 0.874 . . . . 2.26 111.307 -171.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 149.99 21.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.508 0.929 . . . . 0.63 113.508 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.12 162.97 32.82 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.625 1.57 . . . . 2.38 111.167 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.93 152.62 6.59 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.46 1.104 . . . . 1.44 112.075 171.344 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 m -84.24 142.37 30.32 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.251 -1.018 . . . . 1.31 108.251 154.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.82 146.33 39.27 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.447 1.899 . . . . 2.76 106.951 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 7.7 pt-20 -116.97 142.51 46.86 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.484 0.714 . . . . 3.56 111.548 173.107 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -101.58 105.14 38.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.121 0.969 . . . . 1.11 109.685 166.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.14 -8.43 11.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.641 2.227 . . . . 0.96 113.672 178.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.26 166.92 48.6 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 119.707 1.139 . . . . 1.22 112.93 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.83 2.37 51.58 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.195 2.198 . . . . 3.27 111.877 173.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mt -109.67 159.53 31.26 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 128.333 2.653 . . . . 2.75 108.888 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.76 152.03 14.79 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.094 2.53 . . . . 1.11 111.287 177.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.99 106.51 17.06 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.013 0.925 . . . . 2.32 110.495 173.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.1 114.16 21.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.581 -1.645 . . . . 3.55 109.112 170.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 104' ' ' LEU . 2.3 tm? -105.14 128.77 53.53 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.535 1.934 . . . . 2.97 108.693 -177.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.79 -7.77 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.169 0.988 . . . . 0.63 113.259 -175.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.9 -159.18 32.19 Favored Glycine 0 C--N 1.349 1.272 0 C-N-CA 119.588 -1.291 . . . . 0.52 114.303 178.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.4 173.15 14.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.674 0.79 . . . . 0.73 112.351 -179.143 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 45.4 mtm180 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.139 -1.43 . . . . 6.14 107.139 164.041 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t -147.2 142.96 17.49 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-O 117.886 -1.054 . . . . 1.25 109.066 -175.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.29 -21.72 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.005 1.803 . . . . 1.21 111.517 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.367 1.0 OUTLIER -77.86 11.73 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 118.739 0.7 . . . . 1.5 112.453 174.894 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.43 145.71 39.2 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 114.584 1.327 . . . . 0.97 114.584 176.456 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -87.17 -83.19 0.2 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 107.742 -1.207 . . . . 4.12 107.742 170.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -77.99 147.59 34.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.1 0.96 . . . . 3.26 108.84 162.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.28 143.54 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.231 1.412 . . . . 1.36 109.279 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -139.87 137.44 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.424 1.49 . . . . 2.27 109.773 -174.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.453 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.0 tt -86.56 121.97 29.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.962 1.255 . . . . 0.9 110.511 164.624 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -109.92 153.66 24.19 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.038 1.335 . . . . 0.92 112.329 174.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.82 169.69 10.73 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.053 1.741 . . . . 2.21 110.618 163.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -152.11 128.27 10.47 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.898 1.279 . . . . 1.72 108.992 175.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.65 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.136 0.974 . . . . 1.98 112.674 -161.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.8 ptt? -105.48 148.92 26.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.239 0.616 . . . . 3.07 110.474 155.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -162.11 164.55 27.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.572 1.949 . . . . 5.2 109.98 174.04 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.0 149.68 22.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.922 0.889 . . . . 4.38 110.959 -174.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -128.36 -96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 124.329 1.018 . . . . 3.06 109.244 -178.111 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -76.72 42.02 0.28 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.909 2.084 . . . . 3.72 110.963 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.61 -9.12 3.69 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 119.827 -1.796 . . . . 2.91 114.04 -168.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -88.17 148.02 24.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.702 1.601 . . . . 3.42 110.285 -179.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -65.58 134.41 53.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.472 0.709 . . . . 3.72 110.203 167.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.3 t -137.5 153.75 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.377 1.471 . . . . 2.12 109.126 176.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 20.2 ptp -108.02 142.44 38.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.371 1.068 . . . . 5.36 111.866 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.22 32.63 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 123.741 0.686 . . . . 1.35 113.342 -176.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.18 167.18 23.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 2.33 110.329 -173.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -173.69 154.35 2.36 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 125.763 1.625 . . . . 3.92 111.215 170.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.67 143.82 69.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.397 2.065 . . . . 0.96 112.01 166.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.27 156.86 59.91 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.005 2.122 . . . . 0.75 110.521 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.97 -21.46 18.35 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.522 2.148 . . . . 0.74 113.186 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -172.7 174.8 3.58 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.841 1.201 . . . . 2.36 111.905 -177.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.1 176.34 8.76 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.455 2.702 . . . . 0.87 108.513 165.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.87 168.45 27.17 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 120.728 -1.232 . . . . 2.47 112.649 166.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.37 129.9 18.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.516 1.527 . . . . 1.5 108.969 179.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.52 162.97 39.91 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.15 2.566 . . . . 1.52 112.219 -177.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.01 136.04 70.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.885 3.056 . . . . 1.32 112.005 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt 67.02 5.57 4.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.08 1.752 . . . . 1.35 113.665 -178.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.39 123.43 7.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 126.809 2.147 . . . . 1.33 110.238 -178.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -102.35 129.96 48.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.156 0.982 . . . . 4.56 110.915 159.565 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.8 m -153.01 158.8 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.171 1.388 . . . . 2.29 110.693 -174.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.63 142.47 46.85 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.15 1.38 . . . . 3.6 114.278 -177.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mp -70.58 73.22 0.53 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.863 1.665 . . . . 1.22 108.954 165.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -62.6 140.88 96.94 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.251 1.42 . . . . 3.27 112.272 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.06 -37.63 91.77 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.281 2.654 . . . . 1.19 112.822 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.22 71.08 2.99 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.943 -1.263 . . . . 1.32 109.943 164.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.77 -58.65 0.2 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.553 1.073 . . . . 1.41 115.09 176.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -157.63 149.46 22.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.4 1.88 . . . . 2.82 111.898 -172.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -161.18 165.08 29.99 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.117 -0.989 . . . . 1.33 111.166 177.247 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.453 ' CE1' HD12 ' A' ' 45' ' ' LEU . 53.9 m-85 -100.14 109.87 22.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.796 -0.816 . . . . 1.77 108.796 168.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 119.73 22.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 1.53 108.335 172.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.03 121.29 41.14 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.054 1.342 . . . . 1.68 107.877 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.36 144.6 43.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.956 1.302 . . . . 3.69 109.667 -173.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.33 -61.36 4.72 Favored Glycine 0 N--CA 1.475 1.249 0 O-C-N 121.15 -0.969 . . . . 2.74 113.477 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt 78.23 119.15 0.05 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 129.62 3.168 . . . . 1.27 111.996 171.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.52 -2.45 20.37 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.719 1.007 . . . . 2.33 113.719 -174.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.52 159.67 40.9 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.887 1.275 . . . . 6.3 108.597 169.022 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.24 158.68 54.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.905 2.403 . . . . 2.61 110.602 173.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.24 13.61 8.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.684 1.194 . . . . 4.39 112.423 -160.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 160.76 5.31 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.174 1.176 . . . . 3.41 114.174 -167.332 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.45 121.53 9.21 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.233 -0.917 . . . . 1.73 110.26 169.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.12 20.37 55.38 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.264 -0.742 . . . . 2.5 114.209 -169.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.25 161.34 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.647 1.724 . . . . 3.23 108.655 135.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.41 131.21 56.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.513 -2.032 . . . . 3.98 105.513 155.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.4 102.51 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.901 0.858 . . . . 1.16 110.555 -174.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -65.3 146.79 54.48 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.976 -1.011 . . . . 4.75 111.248 164.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.2 tt -152.85 128.41 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.657 0.783 . . . . 1.67 110.835 178.038 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 28.9 m-20 -84.73 106.62 16.41 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.192 1.797 . . . . 2.47 111.235 173.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.6 mt -78.14 120.71 23.33 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.02 0.827 . . . . 1.22 109.097 176.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.488 ' O ' HD22 ' A' ' 32' ' ' LEU . 37.0 mt -100.85 112.66 25.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.145 0.978 . . . . 0.77 110.486 -168.187 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.53 149.51 31.28 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.243 1.02 . . . . 2.14 112.263 -174.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.72 118.95 6.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.326 1.05 . . . . 2.35 112.106 -170.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.02 71.71 1.14 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.645 1.117 . . . . 3.62 113.011 178.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.72 -3.72 68.01 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 117.239 1.655 . . . . 1.93 117.239 162.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.87 130.86 34.76 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.225 2.012 . . . . 4.42 110.081 173.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.6 136.25 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.306 1.042 . . . . 1.19 109.89 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.58 115.15 13.54 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.615 1.166 . . . . 1.84 109.965 -174.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -77.05 119.37 20.67 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.662 -0.649 . . . . 2.96 111.971 172.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.93 167.79 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.344 1.457 . . . . 1.3 110.205 163.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.67 149.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.354 1.862 . . . . 2.77 109.195 163.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.8 mt -146.49 127.33 7.17 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.126 1.37 . . . . 1.91 109.235 -172.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 162.82 41.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.896 2.397 . . . . 0.97 111.507 174.242 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -87.62 134.91 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.621 1.169 . . . . 1.86 111.614 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.0 164.38 13.52 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.092 1.757 . . . . 3.14 107.8 157.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.02 -166.85 1.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.021 1.489 . . . . 4.34 115.021 -171.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 115.729 1.751 . . . . 10.89 115.729 -158.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -1.025 0 N-CA-C 108.652 -1.779 . . . . 13.4 108.652 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.4 t 151.79 56.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 131.216 3.806 . . . . 11.28 104.074 -164.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 43.21 -119.51 0.57 Allowed 'General case' 0 CA--C 1.551 1.009 0 O-C-N 120.618 -1.301 . . . . 9.12 109.171 -132.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.312 30.2 p 106.6 77.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 1 C-N-CA 133.763 4.825 . . . . 6.46 109.23 173.418 . . . . . . . . 3 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -79.65 106.98 12.07 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.305 1.842 . . . . 6.05 111.427 -160.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.45 167.1 32.93 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.388 1.47 . . . . 0.96 113.727 -176.234 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -162.16 167.16 24.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.75 1.22 . . . . 1.66 113.377 -173.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -113.12 136.42 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.76 1.224 . . . . 1.3 108.868 171.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -92.93 100.63 13.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.289 0.566 . . . . 4.24 109.493 162.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 93' ' ' LEU . 0.8 OUTLIER -69.4 122.55 19.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.363 -0.977 . . . . 2.58 108.363 160.932 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.6 167.63 19.7 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 125.732 1.613 . . . . 3.31 108.452 172.017 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.07 5.08 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.794 2.996 . . . . 2.92 116.637 -162.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.01 -177.17 44.46 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.207 0.912 . . . . 2.33 113.408 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -73.12 -2.8 13.64 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 118.347 1.073 . . . . 1.91 112.923 -4.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -121.7 165.66 15.45 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.617 1.567 . . . . 2.41 112.752 173.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.06 -171.49 3.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.383 2.673 . . . . 0.94 109.443 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.38 160.12 39.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.772 1.397 . . . . 0.99 114.772 -173.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.4 145.77 51.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.865 1.266 . . . . 0.76 112.328 170.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.0 139.72 26.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.877 1.671 . . . . 2.05 110.308 -171.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.06 150.38 9.51 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.983 1.846 . . . . 1.62 115.983 -173.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.9 m -86.67 129.87 34.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.531 2.333 . . . . 1.55 109.179 165.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.55 171.67 13.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.644 1.178 . . . . 4.67 110.911 171.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -147.05 138.71 24.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.227 1.011 . . . . 2.94 111.374 -173.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -96.36 108.43 41.89 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.767 1.227 . . . . 1.07 109.236 168.491 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.58 -9.18 14.8 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.441 2.094 . . . . 1.01 113.196 174.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.34 169.64 52.83 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.362 0.982 . . . . 1.03 114.062 -176.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.46 -6.19 37.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.506 1.923 . . . . 3.06 113.358 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.52 160.9 27.69 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.682 . . . . 1.24 110.157 168.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.57 161.5 19.36 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.192 2.595 . . . . 0.84 112.094 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.8 mt -104.94 147.92 27.26 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.237 1.015 . . . . 2.09 111.426 167.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -117.92 115.52 25.09 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.699 1.599 . . . . 5.53 108.823 164.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.6 tp -95.53 115.26 27.18 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.704 1.602 . . . . 0.96 108.303 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.91 -8.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.558 0.948 . . . . 0.87 113.558 -167.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.12 -174.03 46.2 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.992 0.806 . . . . 0.53 111.805 175.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.07 174.84 10.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.161 -0.923 . . . . 0.93 110.188 166.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.97 148.84 19.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.867 1.212 . . . . 5.44 110.54 169.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.35 160.56 54.09 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.79 1.236 . . . . 0.76 109.107 -159.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.75 -31.14 40.24 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.307 2.004 . . . . 1.04 113.607 167.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.272 2.1 m -88.11 -5.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.501 1.667 . . . . 0.99 115.501 -163.575 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.17 159.34 42.82 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.099 1.148 . . . . 0.97 114.099 -171.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 12.3 tp10 -99.18 -78.82 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.295 1.038 . . . . 3.41 111.477 -175.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -74.37 127.62 33.47 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.97 -1.122 . . . . 2.97 107.97 169.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.95 131.77 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.306 1.842 . . . . 1.31 109.291 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -150.15 135.79 18.31 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.416 1.086 . . . . 2.38 111.236 -167.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tt -80.11 125.04 29.31 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.653 1.115 . . . . 0.88 110.817 169.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.6 m170 -114.96 153.9 29.74 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.171 1.788 . . . . 0.72 112.811 178.275 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -86.66 168.68 13.38 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.135 2.174 . . . . 2.46 111.164 164.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.4 m -150.62 131.73 14.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.882 1.273 . . . . 1.3 108.633 171.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -148.67 162.99 38.61 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.024 1.12 . . . . 2.25 114.024 -158.445 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 mtp -114.72 119.22 35.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.427 1.891 . . . . 4.82 108.863 162.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -148.66 156.65 42.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.538 1.135 . . . . 8.56 111.977 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.0 145.19 42.74 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.233 1.413 . . . . 4.05 111.903 165.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -148.75 -63.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.482 1.513 . . . . 4.28 109.41 176.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 56' ' ' LYS . 1.2 tt0 -78.77 30.21 0.2 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.562 2.745 . . . . 4.62 111.719 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.0 -21.21 0.29 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.167 1.365 . . . . 4.5 113.629 -162.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 54' ' ' GLU . 6.6 mtmt -113.09 168.88 9.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 128.891 2.876 . . . . 3.12 110.332 170.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -89.42 146.78 24.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.634 2.087 . . . . 3.52 116.634 -172.213 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 59' ' ' MET . 8.1 p -145.36 175.08 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 127.788 2.435 . . . . 3.5 108.894 174.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.456 ' H ' HG22 ' A' ' 58' ' ' VAL . 19.7 mtm -107.1 146.37 31.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.049 1.339 . . . . 4.18 112.466 -178.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.8 176.86 33.18 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 114.731 0.652 . . . . 1.31 114.731 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.1 mtt -139.22 146.17 40.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.125 2.17 . . . . 2.93 109.796 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -158.34 148.49 15.54 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 125.746 1.619 . . . . 5.49 110.237 -177.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.2 Cg_endo -69.18 154.17 70.43 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.914 1.743 . . . . 0.62 112.359 170.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.32 158.16 65.03 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 125.923 1.689 . . . . 0.64 110.624 176.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.93 -19.02 35.87 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.447 2.098 . . . . 0.97 113.129 175.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -178.79 172.18 1.38 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.676 1.591 . . . . 2.41 111.579 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -117.28 173.38 6.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.378 1.871 . . . . 0.79 109.634 154.144 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.49 168.76 18.86 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.208 0.603 . . . . 3.77 110.596 169.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 t -145.58 129.54 8.64 Favored Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 125.691 1.596 . . . . 0.9 107.461 177.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.78 167.63 25.23 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.777 1.652 . . . . 1.0 111.414 178.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.83 139.71 86.66 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.949 2.433 . . . . 0.87 110.785 168.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt 65.97 1.88 2.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.78 1.632 . . . . 1.26 113.694 -175.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.25 115.23 4.06 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.143 1.83 . . . . 0.85 111.149 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.93 135.18 33.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.206 1.002 . . . . 5.12 109.61 157.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 m -153.17 151.86 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.929 1.292 . . . . 1.57 110.678 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 133.23 55.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.661 1.22 . . . . 3.7 113.173 172.119 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.04 78.99 0.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.803 1.641 . . . . 1.18 107.641 161.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -70.61 138.41 85.97 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.363 1.465 . . . . 3.16 111.748 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.09 -24.27 76.21 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.153 2.569 . . . . 1.21 113.229 178.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.83 59.27 0.77 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.125 1.345 . . . . 1.23 111.668 166.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.64 -55.47 0.13 Allowed Glycine 0 N--CA 1.472 1.079 0 N-CA-C 115.57 0.988 . . . . 1.39 115.57 173.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -155.1 140.42 17.67 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.241 1.416 . . . . 2.04 110.34 -176.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -164.31 178.35 7.58 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.094 -1.003 . . . . 0.82 111.034 -173.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -110.21 126.39 54.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.497 0.719 . . . . 1.83 110.455 170.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 mmt -82.7 139.68 33.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.301 1.04 . . . . 0.88 110.938 168.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.1 mt -116.91 128.93 55.71 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.091 1.756 . . . . 1.79 108.162 175.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.05 116.42 11.2 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.884 1.274 . . . . 2.02 110.943 -173.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.95 130.53 0.55 Allowed Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.616 -1.393 . . . . 2.76 109.616 -167.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.654 HD13 HD11 ' A' ' 93' ' ' LEU . 86.0 mt -127.76 108.63 10.9 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 122.21 1.005 . . . . 1.03 110.391 -171.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 4.0 pttm -88.38 0.31 56.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.924 1.29 . . . . 1.95 114.378 -173.653 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -149.85 157.22 38.28 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 127.781 2.433 . . . . 5.87 108.552 175.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.29 145.83 79.12 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.653 1.568 . . . . 2.28 108.584 162.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.654 HD11 HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -100.77 17.95 20.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.606 1.562 . . . . 4.13 111.161 -175.404 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.84 138.1 1.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.325 2.25 . . . . 4.07 115.048 -161.495 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 116.86 6.0 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.593 -1.317 . . . . 1.5 109.845 170.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.82 17.22 33.54 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.749 -1.029 . . . . 2.76 113.792 -163.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -81.97 175.06 10.68 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.01 1.405 . . . . 3.26 108.366 133.257 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -125.19 131.01 53.26 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.901 -1.888 . . . . 5.03 105.901 155.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.7 t -94.73 94.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.64 -0.874 . . . . 0.87 108.64 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -64.34 113.85 3.89 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.345 -0.942 . . . . 3.93 108.981 153.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -121.75 142.44 50.19 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.727 1.211 . . . . 1.69 109.542 170.221 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.64 126.83 34.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.585 2.354 . . . . 2.71 111.634 178.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.35 125.23 37.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.393 1.077 . . . . 1.22 110.712 167.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.58 123.45 43.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.729 1.212 . . . . 0.79 109.721 -174.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -119.49 126.75 52.04 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.236 -0.915 . . . . 2.19 112.948 -174.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.36 -22.64 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 130.474 3.509 . . . . 2.99 117.538 173.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.53 10.18 3.03 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 126.035 1.779 . . . . 4.04 115.432 -173.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -165.5 -28.44 0.02 OUTLIER Glycine 0 N--CA 1.477 1.419 0 CA-C-N 119.645 1.723 . . . . 2.39 117.225 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.02 133.98 35.06 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.537 1.668 . . . . 5.81 109.331 173.331 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.07 145.93 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.831 0.852 . . . . 0.98 109.812 168.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.77 128.35 18.09 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.937 1.695 . . . . 2.21 108.083 172.193 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -99.08 151.76 20.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.655 0.983 . . . . 3.06 113.655 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.56 146.75 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.87 1.668 . . . . 1.54 110.823 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.21 144.04 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.377 1.471 . . . . 3.13 110.771 168.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.3 mt -149.87 95.54 3.66 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 2.2 108.761 -174.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.26 152.8 74.2 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.49 2.793 . . . . 1.27 112.809 -172.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.2 t -92.63 119.33 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.086 0.954 . . . . 1.32 111.741 -171.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.31 132.98 35.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.033 0.933 . . . . 3.79 108.638 152.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -93.34 99.81 12.26 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.65 -1.241 . . . . 2.02 107.65 159.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 117.933 -1.032 . . . . 7.81 112.55 -159.862 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 N-CA-C 110.578 -1.009 . . . . 10.44 110.578 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m 170.93 -70.91 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 129.277 3.031 . . . . 10.19 109.577 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -99.76 61.71 1.15 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.572 1.149 . . . . 13.37 108.261 175.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t 106.97 176.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 1 C-N-CA 131.798 4.039 . . . . 6.79 111.483 -168.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -145.63 133.16 20.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.752 2.421 . . . . 4.66 108.557 173.122 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.34 179.38 37.75 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 115.213 0.845 . . . . 1.22 115.213 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -161.02 151.37 17.83 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.829 1.252 . . . . 1.69 113.548 176.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.8 t -110.09 145.66 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.995 0.918 . . . . 1.07 108.828 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.39 122.64 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.91 1.284 . . . . 4.88 109.639 -175.319 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.21 174.25 10.95 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.764 1.765 . . . . 2.45 115.764 -171.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.7 t -171.5 158.28 4.75 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 128.118 2.567 . . . . 3.35 108.083 170.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.68 -21.16 19.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.596 2.197 . . . . 2.97 112.07 164.491 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.62 175.72 14.12 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.754 1.645 . . . . 2.16 113.155 178.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.91 -4.53 56.48 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 118.3 1.05 . . . . 2.42 112.965 -9.712 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.01 150.03 40.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.863 1.265 . . . . 3.21 112.181 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.22 -173.51 3.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.854 1.662 . . . . 0.53 112.007 174.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.6 151.12 46.99 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.798 0.839 . . . . 0.79 113.065 -173.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.61 150.06 39.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.478 1.111 . . . . 0.67 112.726 178.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.25 153.79 41.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.062 1.745 . . . . 2.09 109.495 -175.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -177.62 157.51 1.25 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.124 1.77 . . . . 1.83 109.957 -170.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 76' ' ' GLU 0.26 14.1 t -85.44 140.91 30.33 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 122.363 1.078 . . . . 3.61 111.406 166.072 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -92.67 131.9 37.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.132 -1.803 . . . . 3.4 106.132 162.668 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.55 102.15 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.542 0.737 . . . . 5.01 110.406 -173.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.57 112.02 56.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.758 1.223 . . . . 1.0 111.347 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.7 -9.01 8.03 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.232 2.621 . . . . 1.01 113.924 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.19 175.26 54.73 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 119.216 0.916 . . . . 1.07 114.139 -172.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.2 -0.24 30.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.204 1.802 . . . . 2.89 112.708 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.68 161.56 29.75 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 126.128 1.771 . . . . 1.46 109.877 165.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.08 159.67 20.64 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.149 2.566 . . . . 0.82 111.617 -172.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.78 145.57 33.37 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.463 1.105 . . . . 1.89 111.012 171.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -129.6 109.18 10.8 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.129 1.372 . . . . 3.26 109.955 173.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.33 120.14 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.007 2.523 . . . . 0.96 108.837 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.9 -8.31 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.665 0.987 . . . . 0.6 113.665 -171.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.29 -164.59 35.12 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 118.931 0.787 . . . . 0.55 111.967 176.192 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -144.72 -176.09 4.92 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.049 -0.976 . . . . 0.79 111.301 172.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 17.9 mmt180 -160.1 156.17 26.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.81 1.244 . . . . 6.88 108.162 166.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -157.93 155.84 27.18 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.155 1.382 . . . . 0.89 109.152 -171.449 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.29 -39.51 9.92 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.72 1.614 . . . . 1.17 112.316 173.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -82.0 -20.65 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.204 1.366 . . . . 1.37 114.44 -169.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB3' HG23 ' A' ' 37' ' ' THR . . . -99.55 169.05 9.57 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.787 0.835 . . . . 1.41 111.221 169.322 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -91.92 -82.91 0.3 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.443 -1.688 . . . . 3.88 106.443 161.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -74.81 163.07 28.08 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.756 2.022 . . . . 6.22 112.234 173.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -168.71 107.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.65 1.58 . . . . 2.18 109.306 176.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.17 130.72 55.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.042 -1.89 . . . . 5.0 110.053 -167.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.13 126.08 31.62 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.018 0.913 . . . . 0.85 112.248 -171.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.4 m170 -113.52 158.79 20.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.996 2.118 . . . . 0.64 113.025 176.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -108.57 -178.87 3.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.525 1.93 . . . . 1.79 111.616 172.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.4 m -132.4 119.04 20.14 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.337 -1.357 . . . . 1.6 107.337 155.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -102.83 162.64 12.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.188 1.395 . . . . 2.03 111.727 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.2 mtt -103.74 150.22 24.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.357 1.063 . . . . 2.5 110.502 158.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -160.15 144.81 14.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 6.14 112.486 167.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.84 145.88 15.12 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.258 1.423 . . . . 4.82 110.34 156.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.24 -80.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.339 1.455 . . . . 3.02 107.985 172.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -77.02 26.73 0.14 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.835 2.054 . . . . 3.75 111.837 171.154 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.34 -33.71 0.67 Allowed Glycine 0 CA--C 1.537 1.461 0 O-C-N 120.373 -1.455 . . . . 2.61 112.839 -158.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -63.67 145.2 56.18 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.7 1.6 . . . . 2.4 109.673 166.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -88.87 135.31 33.6 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 111.844 0.313 . . . . 4.7 111.844 -179.295 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.88 147.81 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 127.036 2.135 . . . . 1.94 108.894 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.52 129.29 55.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.001 1.32 . . . . 4.56 110.127 175.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.72 162.35 28.28 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 123.973 0.797 . . . . 1.08 113.3 -174.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 56.4 mtt -106.77 158.84 16.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.903 1.281 . . . . 2.26 111.724 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -169.95 155.43 5.55 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.553 1.541 . . . . 4.0 110.406 173.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.9 Cg_endo -69.69 153.51 69.17 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.768 1.645 . . . . 0.78 111.297 168.391 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.51 157.73 64.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 125.576 1.55 . . . . 0.77 110.88 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.4 -17.23 39.32 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.772 2.315 . . . . 1.01 112.828 179.316 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.2 p90 178.03 169.56 0.73 Allowed 'General case' 0 C--N 1.345 0.396 0 C-N-CA 126.882 2.073 . . . . 2.17 110.266 179.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.02 165.69 13.81 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.085 1.354 . . . . 0.91 109.262 156.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.98 161.85 42.04 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.304 -0.873 . . . . 2.24 112.44 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 22' ' ' LEU . 21.9 t -149.96 136.78 11.04 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.016 1.326 . . . . 1.18 109.694 -163.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.58 170.16 17.01 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.044 2.496 . . . . 0.85 112.597 177.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.32 142.99 99.87 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.638 2.892 . . . . 0.86 112.039 166.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm 66.52 1.32 2.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.075 1.75 . . . . 1.58 113.948 -178.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.13 124.75 7.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 127.064 2.269 . . . . 1.02 111.579 -173.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.97 140.79 36.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.934 0.894 . . . . 4.78 111.255 159.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.2 m -147.31 125.05 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.23 1.412 . . . . 1.73 110.082 173.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.0 mp0 -83.08 131.99 35.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.03 0.932 . . . . 3.59 112.132 -177.281 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.2 159.82 33.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.114 0.959 . . . . 2.29 109.834 162.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -167.07 145.4 4.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.714 1.206 . . . . 2.8 112.436 -161.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 -25.54 30.17 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.728 2.952 . . . . 2.02 114.148 -176.332 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.23 95.08 1.19 Allowed Glycine 0 N--CA 1.467 0.765 0 N-CA-C 108.694 -1.762 . . . . 1.45 108.694 161.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.82 -148.39 18.4 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.889 1.233 . . . . 2.6 111.748 -168.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.15 136.99 37.28 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.213 -0.581 . . . . 2.31 111.634 -171.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.7 p-80 -163.62 167.45 21.2 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.373 0.669 . . . . 0.73 110.257 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.46 122.81 48.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.743 0.817 . . . . 1.9 110.526 178.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -86.35 111.81 20.84 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.854 0.862 . . . . 0.84 109.557 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.7 mt -80.73 138.87 36.34 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.213 1.405 . . . . 2.17 109.749 176.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mt -133.18 154.03 51.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.901 1.334 . . . . 1.93 113.732 -176.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 -60.33 3.78 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 127.101 2.286 . . . . 2.43 112.959 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mt 60.36 93.12 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.278 3.031 . . . . 1.06 111.452 -166.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.99 -10.94 60.63 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.011 -1.055 . . . . 3.23 112.81 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 -153.78 140.22 12.73 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 129.266 3.026 . . . . 7.94 107.148 171.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.2 154.18 41.36 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.331 2.687 . . . . 2.5 110.373 175.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.03 142.99 28.31 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.381 1.073 . . . . 3.67 111.556 -173.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -19.11 26.17 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.627 1.343 . . . . 4.7 114.627 -177.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 83.3 136.64 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 1 C-N-CA 132.213 4.205 . . . . 2.44 109.822 -171.093 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.73 52.98 8.74 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.149 -0.781 . . . . 1.96 111.149 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.82 176.31 5.21 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.108 0.963 . . . . 3.38 108.489 155.007 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -100.09 163.08 12.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.905 -0.776 . . . . 3.96 108.905 152.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.5 120.15 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.236 1.414 . . . . 1.19 109.021 175.684 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 147.04 32.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 3.57 109.224 167.141 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.486 HD11 ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -152.39 123.76 7.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.322 1.049 . . . . 2.92 111.073 -174.64 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.81 114.06 21.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.925 2.09 . . . . 2.56 111.231 177.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.4 mt -80.71 114.07 19.34 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.956 -1.09 . . . . 1.33 109.006 176.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt -90.23 125.58 35.53 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.245 0.618 . . . . 0.71 110.116 -173.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.39 164.19 12.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.792 0.664 . . . . 2.21 112.792 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.96 62.08 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.082 1.753 . . . . 2.23 113.753 -173.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 141.45 -149.98 21.52 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.545 1.545 . . . . 3.1 111.506 -178.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.77 37.83 1.06 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.692 1.139 . . . . 1.93 115.696 -172.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -127.64 133.71 49.66 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.311 1.556 . . . . 4.29 110.75 170.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.78 140.35 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.179 1.792 . . . . 1.02 107.24 163.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -142.83 116.09 8.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.758 1.223 . . . . 1.52 109.742 -172.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -88.66 142.39 27.72 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.875 1.435 . . . . 2.58 114.875 -177.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.2 164.02 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.753 2.021 . . . . 1.76 111.278 175.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.91 134.63 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.593 1.157 . . . . 2.46 110.67 176.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.6 mt -141.58 145.14 36.17 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 126.402 1.881 . . . . 1.85 109.602 -165.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.33 159.93 15.04 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.932 3.088 . . . . 1.32 112.623 175.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.7 t -92.81 112.78 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.502 1.121 . . . . 1.29 113.006 174.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -82.39 147.39 28.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.732 2.813 . . . . 3.66 109.774 160.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.23 -171.07 3.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.588 1.329 . . . . 1.87 114.588 -162.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.307 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 130.875 3.67 . . . . 9.02 113.901 174.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.319 0 N-CA-C 108.189 -1.964 . . . . 15.66 108.189 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.8 m -149.25 153.28 37.34 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.347 1.073 . . . . 12.6 109.25 -168.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -130.96 125.16 32.66 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.351 -0.981 . . . . 10.64 108.351 -178.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -77.05 97.33 4.65 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 122.204 1.002 . . . . 7.76 110.152 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.46 74.4 5.0 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.54 1.536 . . . . 6.86 109.522 173.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.95 171.95 43.6 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.177 0.894 . . . . 1.13 113.868 174.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -160.11 156.68 27.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.121 1.368 . . . . 1.89 112.358 -176.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 99' ' ' VAL . 93.8 t -109.62 129.02 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.988 . . . . 1.17 110.118 175.14 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -82.73 112.79 19.9 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.894 -1.15 . . . . 3.98 107.894 166.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -60.95 -45.19 95.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.768 1.766 . . . . 3.5 115.768 -164.923 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 10' ' ' PHE . 6.0 t 58.86 155.57 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 128.35 2.66 . . . . 2.2 113.941 -159.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.91 0.5 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.997 2.464 . . . . 1.68 113.219 160.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.98 177.38 36.41 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.15 0.881 . . . . 1.31 113.11 -177.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -80.36 -2.55 41.66 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 118.99 1.395 . . . . 1.58 113.507 -3.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -138.45 165.6 26.41 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.676 1.991 . . . . 1.86 111.648 178.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.96 -175.51 5.33 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.507 1.523 . . . . 0.71 113.588 -169.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.2 149.41 33.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.818 0.847 . . . . 1.23 112.678 -172.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.46 152.52 40.75 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.428 0.899 . . . . 1.25 113.428 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 150.53 32.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.04 1.336 . . . . 2.41 110.462 -170.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.38 159.32 4.6 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.707 1.603 . . . . 1.93 110.541 -175.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 m -78.24 152.73 32.41 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.399 -0.963 . . . . 1.73 108.399 155.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 134.63 38.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.793 2.037 . . . . 3.47 107.751 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.25 139.0 42.41 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.793 1.237 . . . . 5.26 113.543 -177.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -104.44 107.83 58.83 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.796 -0.638 . . . . 1.51 109.676 149.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -92.04 -7.74 3.06 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.601 2.867 . . . . 1.41 114.04 175.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.75 178.72 41.12 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.467 1.03 . . . . 1.35 113.322 -176.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -95.62 -0.79 51.41 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.669 1.587 . . . . 3.61 113.376 176.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -112.59 160.07 31.86 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.463 1.505 . . . . 1.54 110.516 171.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.43 153.97 24.15 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.758 2.306 . . . . 0.75 111.413 -171.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -116.26 119.31 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.746 1.218 . . . . 2.3 110.053 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -115.13 102.55 10.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.266 1.426 . . . . 4.52 111.342 -177.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 tp -92.08 119.91 32.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.975 2.51 . . . . 0.79 109.196 -172.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -113.04 -8.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.513 1.125 . . . . 0.63 113.459 -169.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.08 -158.93 31.76 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 124.627 1.108 . . . . 0.39 111.391 173.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.07 -177.04 5.52 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 122.467 -0.431 . . . . 0.8 111.745 169.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -146.33 129.5 16.59 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.322 1.049 . . . . 6.67 109.732 170.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.5 t -141.16 156.78 67.75 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 126.704 2.002 . . . . 0.7 109.526 -173.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.51 -32.97 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.151 1.901 . . . . 1.07 113.203 170.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.289 1.4 m -75.42 -9.53 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 120.27 1.396 . . . . 0.99 114.21 -164.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.61 147.11 52.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.165 1.786 . . . . 0.8 109.894 175.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -50.02 -59.64 3.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 120.039 1.29 . . . . 5.62 108.693 168.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -130.4 153.36 48.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.872 2.069 . . . . 3.84 109.951 -168.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.15 127.57 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.858 1.663 . . . . 1.94 107.091 173.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -121.38 128.02 51.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.353 1.861 . . . . 1.94 107.41 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.05 122.3 26.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.98 0.895 . . . . 0.95 109.806 170.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.7 m170 -111.45 158.49 19.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.019 1.728 . . . . 0.53 110.993 179.451 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.85 -178.59 3.7 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.663 1.985 . . . . 2.24 111.656 177.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 m -140.51 113.26 8.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.911 -1.144 . . . . 1.85 107.911 150.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -96.2 -171.34 2.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.446 1.498 . . . . 2.46 109.811 173.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -141.55 149.14 40.42 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.568 0.747 . . . . 3.33 110.982 163.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -134.65 141.89 46.7 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.35 1.06 . . . . 7.03 110.309 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -75.85 116.38 16.5 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.187 0.995 . . . . 5.8 109.552 162.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 t -88.01 -119.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 106.455 -1.683 . . . . 3.2 106.455 169.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.03 75.68 8.01 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.541 1.064 . . . . 4.71 108.33 163.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.44 -20.72 0.1 OUTLIER Glycine 0 N--CA 1.475 1.287 0 C-N-CA 129.522 3.439 . . . . 2.0 117.004 178.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -68.34 122.92 19.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.595 -1.532 . . . . 4.53 110.468 169.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -99.42 69.16 1.65 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.078 1.751 . . . . 5.57 109.121 -170.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -87.26 139.59 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.924 1.69 . . . . 1.77 110.67 -163.367 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -78.52 134.02 37.32 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.6 1.56 . . . . 3.74 111.576 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.49 150.79 19.95 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.354 0.978 . . . . 1.43 112.925 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -112.67 152.71 28.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.845 1.258 . . . . 1.86 111.397 -179.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 mtp-105 -164.42 153.86 11.96 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 127.081 2.152 . . . . 3.77 108.151 -175.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.8 Cg_endo -69.0 151.83 73.32 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 CA-C-N 120.971 1.382 . . . . 0.71 111.001 157.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.7 152.66 56.1 Favored Pre-proline 0 N--CA 1.469 0.479 0 C-N-CA 124.944 1.298 . . . . 0.63 110.253 173.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.94 -9.48 25.77 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.692 2.261 . . . . 0.78 113.355 178.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -177.91 165.5 1.99 Allowed 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.643 1.577 . . . . 2.13 110.526 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -117.27 166.17 12.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.664 1.586 . . . . 0.76 109.053 151.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.97 162.34 39.6 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.498 -0.751 . . . . 2.0 112.621 167.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -143.18 129.87 10.56 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-N 114.669 -1.151 . . . . 1.49 110.187 -168.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.32 162.02 42.24 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.665 2.244 . . . . 1.2 111.374 176.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.82 145.48 96.37 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.038 3.159 . . . . 1.04 113.637 -178.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp 67.21 -5.68 0.69 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.213 2.205 . . . . 1.93 115.196 178.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.21 123.78 7.02 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 126.613 2.054 . . . . 1.28 111.095 176.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -86.42 147.95 25.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.052 0.541 . . . . 4.83 110.677 154.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -146.15 155.83 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.05 1.34 . . . . 1.78 110.242 175.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.43 142.53 29.93 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.673 0.749 . . . . 4.6 112.988 -178.116 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.99 65.69 1.47 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 122.983 1.373 . . . . 1.53 108.422 152.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.36 113.92 7.63 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.522 1.529 . . . . 3.38 109.787 169.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -52.99 -45.38 41.47 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.392 2.728 . . . . 1.33 114.634 -161.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.94 90.88 1.56 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.79 -1.724 . . . . 1.46 108.79 161.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.35 -64.82 0.39 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.819 1.676 . . . . 1.5 111.197 -174.001 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -150.42 145.8 26.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.761 1.625 . . . . 2.24 111.194 170.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -158.77 157.4 31.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.292 1.437 . . . . 0.94 109.779 178.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -87.93 131.7 34.5 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.298 -0.631 . . . . 2.08 109.298 164.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.3 125.58 51.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.559 1.544 . . . . 1.46 109.027 173.191 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.58 139.12 46.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.324 1.45 . . . . 2.29 110.545 -170.562 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 mt -133.79 158.25 43.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.032 0.933 . . . . 1.64 112.842 -171.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.69 60.86 7.37 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.553 1.549 . . . . 2.12 113.29 169.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.52 101.08 0.16 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.872 1.32 . . . . 0.99 112.743 -164.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -83.54 -3.99 58.14 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.547 -0.751 . . . . 2.06 113.006 -166.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -131.04 153.77 81.85 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 129.474 3.109 . . . . 7.3 108.568 168.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.74 167.43 27.11 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.089 2.526 . . . . 1.77 109.31 157.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.5 164.85 29.38 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.199 1.4 . . . . 2.82 112.037 -165.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 140.22 2.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.621 1.568 . . . . 5.63 113.185 -163.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.91 134.24 37.49 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.358 -1.464 . . . . 1.74 112.868 173.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.93 56.31 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 117.734 -1.592 . . . . 1.94 115.063 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.76 -177.94 3.48 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.339 1.57 . . . . 3.23 108.585 156.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.89 138.93 52.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.444 1.116 . . . . 3.64 112.054 -172.086 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 8' ' ' VAL . 95.3 t -90.19 107.06 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.366 1.466 . . . . 1.31 108.753 -172.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -56.61 130.46 45.32 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 124.525 1.141 . . . . 2.87 108.856 158.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mt -154.74 132.09 11.15 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.914 1.686 . . . . 1.52 112.283 -177.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.11 114.45 27.97 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.71 1.604 . . . . 2.85 110.836 169.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.83 118.2 19.2 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.029 1.331 . . . . 1.17 109.986 175.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.78 133.65 34.59 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.861 0.864 . . . . 0.67 110.54 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -125.19 164.36 20.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.961 0.886 . . . . 2.11 112.41 176.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.01 156.01 9.97 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.686 -0.688 . . . . 2.55 111.478 164.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.78 10.97 85.8 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.247 -0.751 . . . . 3.64 114.885 -178.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.98 1.85 85.8 Favored Glycine 0 N--CA 1.473 1.163 0 CA-C-N 118.57 1.185 . . . . 2.43 113.977 -178.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.99 130.98 44.91 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.093 -1.239 . . . . 5.83 110.266 179.132 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.89 149.97 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.978 0.911 . . . . 1.01 110.239 170.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -146.44 129.26 16.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.681 1.192 . . . . 1.86 112.453 -174.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -63.48 134.47 55.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.669 1.188 . . . . 2.29 112.393 172.693 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.2 m -138.98 146.1 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.14 1.776 . . . . 1.48 109.568 163.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.2 123.06 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.981 0.912 . . . . 1.65 110.509 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -139.07 146.33 48.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.992 1.317 . . . . 1.75 110.176 -169.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.3 146.2 68.46 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.033 2.489 . . . . 1.02 113.202 -175.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.2 t -79.37 134.78 27.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 124.524 1.13 . . . . 1.31 108.385 161.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.58 141.91 51.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.224 1.81 . . . . 5.18 109.21 169.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -128.34 71.7 1.4 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 122.275 1.036 . . . . 3.36 113.788 -167.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.195 0 C-N-CA 126.544 1.938 . . . . 8.59 109.196 169.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 N-CA-C 108.609 -1.796 . . . . 11.4 108.609 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 t 168.25 -164.63 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 129.761 3.225 . . . . 9.94 106.241 -166.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -66.92 -26.76 67.02 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.746 1.612 . . . . 12.05 114.092 -178.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 m 105.6 112.27 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.982 1 C-N-CA 133.493 4.717 . . . . 7.59 106.989 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -96.52 109.46 22.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.782 -1.099 . . . . 4.68 110.836 -154.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.14 179.62 48.86 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.167 0.889 . . . . 1.14 113.256 -174.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -155.09 153.42 30.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.275 1.43 . . . . 1.36 112.902 -177.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.69 122.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.463 1.105 . . . . 1.25 110.548 175.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -57.36 -39.93 77.0 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.649 1.979 . . . . 5.58 114.126 -168.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.34 151.79 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.655 1.982 . . . . 2.6 113.528 -178.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.28 165.99 2.01 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 119.748 -1.845 . . . . 1.82 109.889 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.79 23.15 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.034 3.156 . . . . 2.01 112.819 175.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.69 -176.06 54.73 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 121.312 -0.867 . . . . 1.53 111.837 -159.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.72 -11.41 18.03 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 CA-C-N 118.499 1.15 . . . . 2.04 112.233 -12.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -134.73 154.22 51.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.372 1.069 . . . . 2.8 112.294 168.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -118.58 -177.67 3.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.291 1.836 . . . . 0.63 108.31 156.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.64 173.35 11.77 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.169 0.988 . . . . 0.88 110.537 173.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.46 151.03 41.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.223 1.009 . . . . 0.74 112.396 167.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.09 142.39 38.13 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.842 2.457 . . . . 2.29 109.235 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -169.66 159.49 8.27 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.598 1.333 . . . . 1.94 114.598 -175.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -97.96 119.57 36.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.02 1.728 . . . . 1.4 108.379 173.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -110.31 142.72 41.56 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.018 1.327 . . . . 2.65 109.931 176.094 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.9 pt-20 -142.35 150.0 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.196 1.398 . . . . 2.95 110.941 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -118.48 108.22 41.88 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.831 0.852 . . . . 1.23 110.962 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -86.41 -5.39 8.32 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.77 2.313 . . . . 1.1 114.325 175.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 -157.31 16.09 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 120.129 1.331 . . . . 2.09 115.365 -167.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -95.12 -41.03 9.31 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.57 2.348 . . . . 6.03 112.384 178.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.03 166.13 13.12 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 126.136 1.774 . . . . 1.75 111.729 -173.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.07 167.13 25.53 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.505 2.137 . . . . 1.2 113.691 -166.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.56 148.11 26.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.773 1.229 . . . . 2.73 109.747 165.148 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -141.81 103.53 4.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.638 1.575 . . . . 4.06 108.141 171.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.15 104.4 16.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.867 2.467 . . . . 0.94 108.941 -166.146 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.62 -12.44 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.872 1.269 . . . . 0.6 112.924 -172.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.92 -163.6 33.25 Favored Glycine 0 C--N 1.341 0.82 0 C-N-CA 123.733 0.682 . . . . 0.43 112.349 178.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.18 178.4 9.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.005 1.322 . . . . 0.74 110.401 173.028 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -143.18 145.54 32.9 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.993 -1.114 . . . . 7.66 107.993 174.955 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 t -151.37 151.6 29.36 Favored Pre-proline 0 N--CA 1.47 0.534 0 CA-C-O 118.374 -0.822 . . . . 0.66 110.949 172.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.43 -23.41 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.725 2.95 . . . . 1.32 114.891 160.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.28 1.3 m -95.17 5.65 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.96 1.467 . . . . 1.07 114.96 -168.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.38 163.43 32.81 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.884 1.274 . . . . 0.8 111.946 -178.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.444 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 8.8 tp10 -100.72 -89.87 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.912 -0.773 . . . . 3.47 108.912 164.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -76.55 114.89 15.77 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.032 -1.042 . . . . 3.08 109.013 -179.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.76 140.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.698 1.599 . . . . 2.18 111.161 163.467 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -144.02 122.5 12.42 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.274 1.43 . . . . 2.6 109.623 166.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -80.08 119.07 22.39 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.746 1.157 . . . . 0.74 110.88 169.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.5 m170 -107.36 152.83 23.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.941 1.696 . . . . 0.66 112.395 175.45 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.93 -178.06 3.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.41 1.484 . . . . 2.18 110.603 167.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -146.57 130.25 17.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.887 1.275 . . . . 1.01 107.777 174.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -141.78 165.4 27.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.527 1.131 . . . . 2.0 112.655 -165.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.9 mtm -98.23 144.69 27.4 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.798 1.239 . . . . 2.68 111.56 174.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -156.59 178.93 9.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.139 1.376 . . . . 10.46 112.523 -175.045 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.67 158.16 17.07 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.198 1.799 . . . . 9.0 110.3 167.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.03 121.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 125.893 1.677 . . . . 4.71 109.232 140.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 55.54 54.14 8.82 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.907 1.283 . . . . 4.75 109.78 -174.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.49 -26.23 0.17 Allowed Glycine 0 N--CA 1.476 1.322 0 C-N-CA 128.964 3.174 . . . . 3.47 116.129 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -78.18 140.38 38.96 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.793 -1.416 . . . . 4.07 111.778 -171.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.54 122.94 17.04 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 4.37 111.094 174.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.9 t -142.71 161.63 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.118 1.767 . . . . 2.45 108.154 173.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.18 158.54 15.79 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.024 -1.047 . . . . 2.93 112.6 -178.773 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.75 159.01 24.41 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 124.944 1.259 . . . . 1.15 112.038 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -125.88 155.87 40.55 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.9 1.68 . . . . 1.6 108.307 170.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.1 ptt85 -169.06 150.26 4.32 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.004 1.322 . . . . 4.67 110.3 177.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 40.8 Cg_endo -67.36 153.14 77.79 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.314 2.009 . . . . 0.96 111.264 169.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -125.14 155.96 70.29 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.454 1.502 . . . . 0.76 110.172 171.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.05 -14.5 41.11 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.782 2.321 . . . . 0.9 112.92 176.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -179.48 162.24 1.12 Allowed 'General case' 0 C--N 1.348 0.51 0 C-N-CA 126.092 1.757 . . . . 2.22 110.362 178.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -104.43 176.63 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.313 1.445 . . . . 0.73 109.732 153.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -155.29 168.95 25.38 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.049 -1.032 . . . . 1.96 113.76 171.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.81 136.18 10.35 Favored Pre-proline 0 N--CA 1.467 0.406 0 C-N-CA 125.395 1.478 . . . . 0.86 108.246 -176.558 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -66.78 171.41 11.02 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 121.812 1.675 . . . . 1.1 111.251 170.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.04 142.62 75.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.741 2.294 . . . . 1.25 110.341 163.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt 73.83 -4.96 2.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.73 2.412 . . . . 1.36 113.261 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.07 -170.99 44.29 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 126.369 1.938 . . . . 1.41 112.389 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -167.25 154.89 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.194 1.798 . . . . 6.28 112.178 -178.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.4 m -135.62 159.3 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.202 1.801 . . . . 1.92 110.42 177.046 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -123.49 116.7 23.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.773 -1.195 . . . . 4.48 107.773 177.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.5 67.86 2.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.784 1.233 . . . . 1.08 108.823 170.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -75.67 149.12 83.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.344 1.058 . . . . 3.72 111.428 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.97 -30.31 92.95 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.741 2.294 . . . . 1.42 113.336 176.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.33 48.68 2.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.565 1.079 . . . . 1.35 112.453 168.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.84 -64.92 0.05 OUTLIER Glycine 0 N--CA 1.473 1.163 0 N-CA-C 115.837 1.095 . . . . 1.36 115.837 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -156.55 146.3 20.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.353 1.861 . . . . 2.34 109.541 -173.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -165.55 170.92 13.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.739 -1.225 . . . . 0.73 110.438 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.04 136.3 42.11 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.916 -0.772 . . . . 1.82 108.916 168.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -83.1 128.79 34.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.104 0.961 . . . . 1.11 110.047 156.027 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 mt -113.87 104.3 12.04 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.421 1.489 . . . . 1.74 107.85 177.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.7 mt -99.99 155.77 17.52 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.443 0.639 . . . . 1.73 112.349 -176.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.79 -53.39 4.84 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.248 1.404 . . . . 2.69 113.757 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt 62.98 85.15 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.782 2.433 . . . . 1.07 112.806 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HE3' ' OE1' ' A' ' 41' ' ' GLU . 4.3 ptpp? -73.84 -0.48 16.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.759 1.392 . . . . 1.63 114.759 -168.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -149.44 159.37 36.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 128.766 2.827 . . . . 5.12 108.837 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.29 162.33 36.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.12 1.88 . . . . 2.01 109.583 154.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.11 43.8 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 123.065 1.412 . . . . 4.1 111.929 -158.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -74.42 143.82 44.57 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.101 1.76 . . . . 5.21 113.631 -168.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.03 118.59 2.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.754 1.222 . . . . 1.95 113.153 177.274 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.1 16.82 26.81 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 117.991 -1.45 . . . . 1.78 114.817 -170.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.22 166.02 11.06 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.279 1.539 . . . . 3.89 108.797 136.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -111.83 134.26 53.51 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.972 1.709 . . . . 5.41 108.753 178.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.44 113.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.639 0.776 . . . . 1.08 110.352 -178.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -68.8 129.16 39.14 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.148 -0.933 . . . . 3.52 109.091 161.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -139.91 147.92 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.624 0.77 . . . . 1.52 111.269 -173.669 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -114.53 132.15 56.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.469 -1.241 . . . . 2.47 110.342 162.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.4 mt -98.33 121.13 39.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.737 1.215 . . . . 1.31 109.021 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.2 mt -96.76 129.88 44.11 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.084 0.954 . . . . 0.97 111.333 -170.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -122.34 145.76 47.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.939 0.896 . . . . 2.05 112.179 -176.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.88 131.02 45.96 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.116 0.966 . . . . 2.48 111.826 176.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.69 -159.6 23.12 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.495 1.045 . . . . 2.92 110.705 -164.374 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.51 26.46 6.41 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.264 0.935 . . . . 1.91 113.783 178.518 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -99.43 129.55 45.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.015 1.408 . . . . 5.31 111.632 -173.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.83 138.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.449 1.499 . . . . 1.29 108.866 167.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.53 121.34 39.17 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.267 1.027 . . . . 1.95 109.645 177.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -79.96 139.82 36.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.972 0.509 . . . . 2.28 110.937 175.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m -145.1 171.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.719 2.007 . . . . 1.29 109.893 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.87 131.14 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.376 1.071 . . . . 1.79 109.124 176.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mp -145.75 152.64 49.09 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.917 1.287 . . . . 1.9 111.063 -168.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.2 155.37 67.97 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.422 2.748 . . . . 1.32 114.279 -177.498 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.31 125.42 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.168 -0.923 . . . . 1.38 108.681 157.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.64 138.23 35.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.415 1.486 . . . . 3.78 109.068 170.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.03 134.79 55.3 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.941 2.2 . . . . 3.01 116.941 -128.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.078 1 C-N-CA 132.372 4.269 . . . . 7.13 111.243 160.688 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.175 0 N-CA-C 110.245 -1.142 . . . . 11.26 110.245 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m -129.85 -30.94 1.99 Allowed 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.049 0.759 . . . . 10.88 113.049 178.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -174.86 84.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 130.883 3.673 . . . . 12.51 104.253 179.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -170.31 -32.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.889 1.44 . . . . 7.34 114.889 -144.596 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -148.29 -172.43 4.07 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.19 0.996 . . . . 4.44 111.913 -151.103 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.1 151.64 21.88 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 121.304 -0.872 . . . . 1.36 114.323 169.39 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -155.01 152.7 29.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.999 1.719 . . . . 1.61 111.596 -179.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.32 122.55 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.029 -1.1 . . . . 0.85 108.029 178.793 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.19 89.47 8.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.825 1.25 . . . . 3.33 108.477 171.334 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.427 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -67.09 139.25 57.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.363 1.065 . . . . 2.23 109.027 168.092 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.6 m -138.39 158.31 70.88 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.49 . . . . 2.66 108.026 168.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.88 27.91 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.616 3.544 . . . . 2.28 115.113 -171.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.49 170.18 44.51 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.141 -0.974 . . . . 1.65 113.957 178.878 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.36 -7.94 35.4 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 117.811 0.806 . . . . 1.63 113.373 -7.038 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -130.69 161.98 30.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.216 1.806 . . . . 3.66 111.216 -175.528 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.91 -173.88 4.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.541 1.936 . . . . 0.67 112.038 -177.2 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.09 161.61 40.5 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.315 0.858 . . . . 0.96 113.315 -172.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.07 146.4 27.71 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.018 1.327 . . . . 0.81 112.148 173.341 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.25 151.04 51.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.595 1.958 . . . . 2.37 109.644 -173.23 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -169.4 145.35 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.336 1.236 . . . . 1.61 114.336 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.9 m -75.68 139.97 42.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.081 1.752 . . . . 1.43 108.977 163.19 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -145.0 133.51 21.96 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.139 1.376 . . . . 2.8 108.944 174.195 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.46 156.76 46.15 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 114.225 1.195 . . . . 3.14 114.225 -175.666 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -116.85 100.06 53.2 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.249 -1.342 . . . . 1.61 110.47 -179.091 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -85.02 -3.16 9.67 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.222 2.615 . . . . 1.33 114.091 176.237 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.19 -119.78 0.81 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.797 1.189 . . . . 2.95 114.626 -168.618 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -154.15 -41.98 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.371 1.868 . . . . 5.39 112.021 -161.786 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -96.12 165.06 17.1 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.833 2.053 . . . . 1.57 111.335 171.419 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.44 157.5 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.227 2.618 . . . . 0.83 112.282 -174.277 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.6 mt -104.37 156.71 17.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.308 1.043 . . . . 1.91 111.33 171.195 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -146.54 101.06 3.43 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.104 1.361 . . . . 4.08 112.811 177.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.3 tp -85.07 108.25 17.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.15 2.18 . . . . 0.93 109.115 -176.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -99.17 -16.13 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.677 1.191 . . . . 0.77 112.987 -173.458 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.32 42.72 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.773 0.701 . . . . 0.48 111.717 -177.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -138.03 -178.95 5.5 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.308 1.043 . . . . 0.81 110.434 169.196 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -154.31 128.56 9.05 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 106.363 -1.718 . . . . 6.34 106.363 175.736 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -146.34 151.31 43.58 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.578 1.151 . . . . 0.9 109.295 -168.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.32 -23.11 21.07 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.412 2.074 . . . . 1.15 113.5 175.779 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 m -76.98 -13.16 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 115.569 1.692 . . . . 1.21 115.569 -165.251 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -131.4 152.35 50.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.319 1.048 . . . . 1.49 112.711 -165.675 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -56.45 22.01 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.59 1.087 . . . . 6.63 109.185 171.771 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 43' ' ' VAL . 16.1 ttm180 -128.85 176.07 8.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.006 2.522 . . . . 3.88 109.926 179.177 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 2.3 p -155.43 137.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.287 2.235 . . . . 1.2 107.455 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -142.32 137.53 30.63 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.585 1.554 . . . . 1.9 108.851 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.37 126.97 32.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.676 1.125 . . . . 0.85 110.165 166.673 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.3 m170 -119.35 155.38 32.0 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.795 2.038 . . . . 0.63 112.017 176.478 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -92.57 166.07 12.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.761 1.624 . . . . 2.47 110.46 164.679 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.3 m -123.63 127.72 48.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 106.357 -1.719 . . . . 1.28 106.357 154.117 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -122.4 170.96 9.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.442 1.275 . . . . 2.38 114.442 -166.392 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.9 mtm -125.82 127.15 45.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.097 1.359 . . . . 3.16 109.389 161.794 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -153.52 165.81 34.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.099 1.76 . . . . 9.29 110.416 174.303 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.51 152.46 43.0 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.684 1.194 . . . . 3.45 111.285 168.606 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.32 -86.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.599 1.16 . . . . 3.22 109.241 176.256 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -78.44 51.31 1.03 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.681 1.992 . . . . 4.2 110.562 176.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.02 -20.69 0.3 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.951 1.738 . . . . 3.0 114.683 -170.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -107.78 159.24 16.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.474 2.71 . . . . 2.94 110.276 -176.466 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -72.5 138.35 46.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.095 1.358 . . . . 3.3 112.977 179.017 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -137.7 154.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.61 1.964 . . . . 1.65 108.773 177.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.4 ptp -125.35 135.63 52.63 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.694 1.198 . . . . 2.84 112.99 176.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.7 -179.74 40.59 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.609 1.099 . . . . 1.86 113.171 -179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -98.31 166.42 11.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.812 1.245 . . . . 2.26 113.438 -177.47 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -171.44 155.6 4.17 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 6.14 110.576 164.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 4.7 Cg_exo -64.98 157.01 59.33 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.88 1.72 . . . . 0.95 112.146 171.583 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.81 159.12 72.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 126.013 1.725 . . . . 0.91 110.151 176.716 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.92 -24.8 23.97 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.23 1.953 . . . . 1.25 112.853 175.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -179.59 171.26 1.24 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.659 1.584 . . . . 2.22 112.63 -178.37 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mt -118.89 167.61 11.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.925 2.09 . . . . 1.12 109.573 152.266 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -154.82 156.47 36.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.563 -0.711 . . . . 2.61 111.823 178.621 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 t -137.49 126.94 15.22 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 1.09 108.965 -166.576 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.9 160.43 43.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.0 1.8 . . . . 1.1 111.402 175.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.15 140.0 86.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.617 2.878 . . . . 1.31 111.304 176.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt 71.37 -1.56 2.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.309 2.244 . . . . 1.77 113.051 -178.218 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.04 -177.74 31.88 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 126.599 2.047 . . . . 1.75 111.414 178.811 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -161.93 156.41 22.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 5.72 113.759 -179.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.92 161.01 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.286 1.434 . . . . 1.83 109.413 174.538 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -123.6 135.91 54.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.444 -0.947 . . . . 5.01 108.444 158.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.33 55.73 1.01 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.041 1.336 . . . . 1.11 109.216 168.504 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -50.17 132.29 23.84 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.645 1.578 . . . . 4.19 111.349 179.249 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.2 -36.86 97.42 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.946 3.097 . . . . 2.35 114.983 -166.537 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.97 52.34 4.68 Favored Glycine 0 N--CA 1.472 1.09 0 CA-C-N 119.327 0.967 . . . . 1.84 111.527 169.984 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.55 -145.5 5.66 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.524 2.011 . . . . 2.84 112.024 -166.726 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -67.79 141.86 56.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.625 0.713 . . . . 2.18 110.376 178.037 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -160.3 165.79 30.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.952 0.797 . . . . 0.88 111.003 -172.445 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -95.64 123.99 39.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.22 -0.659 . . . . 2.16 109.22 163.406 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.52 126.06 45.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.612 1.165 . . . . 1.5 108.959 174.437 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.36 139.79 49.19 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.602 1.561 . . . . 2.92 110.009 -172.557 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mp -132.51 166.08 22.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.606 0.762 . . . . 2.39 112.789 -172.043 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 50.22 41.33 38.91 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 126.81 2.148 . . . . 2.13 114.753 168.445 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 93' ' ' LEU . 57.9 mt -53.17 117.51 3.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.566 1.321 . . . . 1.6 114.566 -147.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -86.54 -3.18 58.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.547 0.943 . . . . 2.61 113.547 -171.136 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -111.41 150.38 42.01 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.712 1.205 . . . . 4.83 107.898 155.297 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.07 -10.94 23.17 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.567 2.845 . . . . 4.13 115.15 166.394 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.493 HD11 HD13 ' A' ' 89' ' ' LEU . 3.0 mp 72.39 -173.24 0.15 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.768 3.627 . . . . 2.84 111.293 173.711 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -170.03 119.02 0.6 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.197 1.399 . . . . 3.72 110.094 -167.372 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.39 124.57 21.27 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 121.322 -0.861 . . . . 1.68 109.495 166.779 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.21 54.79 27.67 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.699 -0.56 . . . . 2.02 111.699 -166.744 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -112.46 163.14 14.81 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 122.455 1.121 . . . . 4.13 110.092 138.643 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -110.26 105.6 14.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.074 1.749 . . . . 4.59 107.742 -172.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.86 112.62 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.134 0.973 . . . . 1.1 109.412 -173.537 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -70.96 137.83 49.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.887 -0.597 . . . . 3.19 110.342 159.322 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 35' ' ' ALA . 1.8 tt -149.37 135.46 18.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.902 1.281 . . . . 1.7 109.852 179.484 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.31 110.99 22.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.679 2.792 . . . . 2.1 110.842 -179.299 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.0 117.95 20.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.989 0.916 . . . . 1.26 109.228 176.344 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.63 121.42 34.04 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.582 0.753 . . . . 0.58 110.522 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -118.1 121.84 41.59 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 2.12 113.053 -179.613 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.08 23.55 0.3 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.267 2.227 . . . . 2.73 116.975 168.608 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.7 10.97 80.53 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 115.947 1.139 . . . . 4.58 115.947 174.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.69 -31.18 0.03 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 119.076 1.438 . . . . 2.4 116.478 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -89.11 139.48 30.43 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.741 -1.446 . . . . 4.44 109.398 169.541 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -141.2 140.56 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.644 1.178 . . . . 1.3 108.203 165.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.12 122.98 15.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.101 1.36 . . . . 2.08 108.852 -178.269 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 ptmt -83.1 140.38 32.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.323 0.86 . . . . 2.68 113.323 -179.544 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.85 165.71 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.565 1.946 . . . . 1.29 109.782 167.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.07 139.41 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.757 1.223 . . . . 1.69 109.957 173.677 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 mt -138.32 130.07 15.84 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.612 1.965 . . . . 2.16 109.782 -167.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.37 144.74 37.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.601 2.2 . . . . 1.06 111.051 176.661 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 10' ' ' PHE . 90.4 t -79.95 118.59 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.862 0.839 . . . . 1.22 111.956 169.442 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.65 145.51 28.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 129.977 3.311 . . . . 3.42 107.46 166.574 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.2 101.74 5.92 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.974 -1.079 . . . . 1.88 112.003 -161.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.262 1.025 . . . . 6.73 112.705 -166.83 . . . . . . . . 0 0 . 1 stop_ save_